Citrus Sinensis ID: 003301

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830--
Protein Sequence
MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCKSGNSSSHRKSRKNTILLGVLLPLSTVFIIAVILAVRYAMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF
Secondary Structure (PSIPRED)
cEEEcccccEEEccccccccccccEEEccccccEEcccccccccccccEEEcccccccccccHHHHcccccccEEEEccccccccccHHHHHccccccEEEcccccccccccccccccccccEEEEEccccEEccccccccccccccEEcccccccccccHHHHcccccccEEcccccccccccHHHHccccccEEEcccccccccccccccccccccccEEEccccEEEEcccHHHHHcccccEEEccccEEEEcccccccccccccEEEccccccccccccccccccccccccccEEEcccccccccccHHHHcccccccEEEccccEEEEcccccccccccccEEEccccEEcccccccccccccccEEEcccccccccccHHHHccccccEEEccccEEEEcccccccccccccccccccccccccccHHHHcccccccEEcccccccccccHHHHccccccEEEcccccccccccHHHHccccccEEccccccccccccHHHHccccccEEcccccccccccHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEEccccEEEEEEEcccccccHHHHHHHHHHHccccccccccEEEEEEcccccEEEEcccccccHHHHcccccccccHHHHHHHHHHHHHHHHHHccccccccEEccccccccccccccEEEEcccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccccEEEccccEEEEEccHHHHHHcccccEEEcccccccccccHHHcccccccEEEEccccccccccHHHcccccccEEEcccccccccccHHHcccccccEEEEccccccccccHHHccccccEEEEEccccccccccHHHcccccccccEEEEccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEEcccccccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEEEccccccccccHHHccccccEEEEEccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccEEccccccccccccEEEcccccccEEccccccccccccEEEccccccccccHHHHcccccccEEEccccccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccccccHHHccHHHcccccEEEcccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccHHHHHHHHccccHHcEEEccccEEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHcccccccEEEEEEcccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEccccccEEccccccHHHHHHcHHHEEcccccccccHHcccccccccccc
Coil and Loop (DISEMBL)
mlslsfndlsgaipkeignLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTnnflsgtipstifnlsslstgmdfsnnsltgslpddmcrrlplikglymsnnkltgpipnniwQCKELIVISLAYNqfteriprglgnltslKTLYLGFnnltgeipyemgnlrnLEILGLQLNKLVGFVPTSIFNLSAMktlalpsnalsgslpssidlvrlpnleiislagnnfsgiipsfIFNASKLSVLelgensfsgfipntlgnlrKLEWLRLSYNFLTSSTSELSFLSswancknlklldlsnnpingvlpssignlslslsrifisncsirgtipkEIGNLinlrelglwgneligsipitfgklqnlqgldlvnnklegpipnglcqLARLSVLYMdgnklsgpippcigdltslrLLSLASNElnsvipstfwnLKDILSlnfssnflngslpedignLKVVVIIDLsrnnlsgdiptaigglmnlqdlslrdnglqgsipksigglvslesldlsnnslsgniptsMEKLLYLKDLNLSFNklegeiprggpfanfsnrsfmgnDLLCGLAQvqvpvcksgnssshrksrknTILLGVLLPLSTVFIIAVILAVRYAMISRCQeknakqsniesnmlpqatRRRFSYKELLQATNqfnasnligtggfgsvykgsflDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEympngsledylysnnfsfDILQRLSVIIDVALALEYLhfgysnpvvhcdikpsnvlldKDMVAHLSDFGIAKLLSGEESMKQTLTLATIgymapglf
Flexible Loop (DISEMBL)
mlslsfndlsgaipkeignlTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSnnsltgslpdDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCKsgnssshrksrkNTILLGVLLPLSTVFIIAVILAVRYAMISRCqeknakqsniesnmlpQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRhrnlvkiissctnndfKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF
Low Complexity Region (SEG)
MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNfltsstselsflssWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDIlslnfssnflngslPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGlvslesldlsnnslsgnIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCKSGNSSSHRKSRKNTILLGVLLPLSTVFIIAVILAVRYAMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF
Disordered region (IsUnstruct)
***********AIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLE************IPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCK************NTILLGVLLPLSTVFIIAVILAVRYAMISRC*********************RFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYM*****
Disordered Region (DISOPRED)
MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQV*********************LLGVLLPLSTVFIIAVILAVRYAM**********************TRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES*KQTLTLATIGYMAPGLF
Disordered Region (DISEMBL)
MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVC***********RKNTILLGVLLPLSTVFIIAVILAVRYAMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF
Disordered Region (DISPRO)
MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCKSG*S**HRKSRKNTILLGVLLPLSTVFIIAVILAVRYAMISRCQ***********NMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCKSGNSSSHRKSRKNTILLGVLLPLSTVFIIAVILAVRYAMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	832	2.2.26 [Sep-21-2011]
C0LGT6	1031	LRR receptor-like serine/	yes	no	0.949	0.766	0.381	1e-145
C0LGP4	1010	Probable LRR receptor-lik	no	no	0.949	0.782	0.386	1e-139
Q9FL28	1173	LRR receptor-like serine/	no	no	0.985	0.699	0.364	1e-128
Q9SD62	1025	Putative receptor-like pr	no	no	0.949	0.770	0.375	1e-119
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.983	0.654	0.330	1e-119
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.977	0.649	0.326	1e-115
Q8VZG8	1045	Probable LRR receptor-lik	no	no	0.947	0.754	0.341	1e-112
Q9LP24	1120	Probable leucine-rich rep	no	no	0.975	0.725	0.336	1e-110
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.861	0.731	0.354	1e-110
O49318	1124	Probable leucine-rich rep	no	no	0.983	0.727	0.323	1e-109

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  515 bits (1327), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 323/847 (38%), Positives = 487/847 (57%), Gaps = 57/847 (6%)

Query: 9   LSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNL 68
           L+G I   IGNL+ L+ L L  N     IPQ++G L  L+ ++++ N L G IPS++ N 
Sbjct: 85  LTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSLSNC 144

Query: 69  SSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAY 128
           S LST                          + +S+N L   +P+ +    +L ++ L+ 
Sbjct: 145 SRLST--------------------------VDLSSNHLGHGVPSELGSLSKLAILDLSK 178

Query: 129 NQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIF 188
           N  T   P  LGNLTSL+ L   +N + GEIP E+  L  +    + LN   G  P +++
Sbjct: 179 NNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALY 238

Query: 189 NLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLEL 248
           N+S++++L+L  N+ SG+L +    +   NL  + L  N F+G IP  + N S L   ++
Sbjct: 239 NISSLESLSLADNSFSGNLRADFGYLLP-NLRRLLLGTNQFTGAIPKTLANISSLERFDI 297

Query: 249 GENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSEL-SFLSSWANCKNLKLLDLSNNPIN 307
             N  SG IP + G LR L WL +  N L +++S    F+ + ANC  L+ LD+  N + 
Sbjct: 298 SSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLG 357

Query: 308 GVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQ 367
           G LP+SI NLS +L+ +F+    I GTIP +IGNL++L+EL L  N L G +P++FGKL 
Sbjct: 358 GELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLL 417

Query: 368 NLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNEL 427
           NLQ +DL +N + G IP+    + RL  L+++ N   G IP  +G    L  L + +N L
Sbjct: 418 NLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRL 477

Query: 428 NSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLM 487
           N  IP     +  +  ++ S+NFL G  PE++G L+++V +  S N LSG +P AIGG +
Sbjct: 478 NGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCL 537

Query: 488 NLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKL 547
           +++ L ++ N   G+IP  I  LVSL+++D SNN+LSG IP  +  L  L++LNLS NK 
Sbjct: 538 SMEFLFMQGNSFDGAIP-DISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKF 596

Query: 548 EGEIPRGGPFANFSNRSFMGNDLLC-GLAQVQVPVCKSGNSSSHRK--SRKNTILLGVLL 604
           EG +P  G F N +  S  GN  +C G+ ++Q+  C    S   RK  S +  ++ G+ +
Sbjct: 597 EGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICI 656

Query: 605 PLSTVFIIAVILAVRYAMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNAS 664
            ++++ +I ++ ++ + M  R ++ NA   N   +        + SY+EL  AT++F+++
Sbjct: 657 GIASLLLIIIVASLCWFM-KRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSST 715

Query: 665 NLIGTGGFGSVYKGSFLDGME---VAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKII 721
           NLIG+G FG+V+KG  L G E   VA+KV +L   GA KSF  ECE  K +RHRNLVK+I
Sbjct: 716 NLIGSGNFGNVFKG--LLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLI 773

Query: 722 SSCTN-----NDFKALVLEYMPNGSLEDYLY--------SNNFSFDILQRLSVIIDVALA 768
           + C++     NDF+ALV E+MP GSL+ +L          ++ S    ++L++ IDVA A
Sbjct: 774 TVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASA 833

Query: 769 LEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL--SGEESMKQTLTLA---- 822
           LEYLH    +PV HCDIKPSN+LLD D+ AH+SDFG+A+LL     ES     + A    
Sbjct: 834 LEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRG 893

Query: 823 TIGYMAP 829
           TIGY AP
Sbjct: 894 TIGYAAP 900

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  498 bits (1281), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 327/846 (38%), Positives = 477/846 (56%), Gaps = 56/846 (6%)

Query: 8   DLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFN 67
            L G I   IGNL+ L  L L  N   G IPQE+G L+ LE + +  N+L G IP  ++N
Sbjct: 77  QLGGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEYLDMGINYLRGPIPLGLYN 136

Query: 68  LSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLA 127
                                  C RL     L + +N+L G +P+ +     L+ ++L 
Sbjct: 137 -----------------------CSRL---LNLRLDSNRLGGSVPSELGSLTNLVQLNLY 170

Query: 128 YNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSI 187
            N    ++P  LGNLT L+ L L  NNL GEIP ++  L  +  L L  N   G  P ++
Sbjct: 171 GNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPAL 230

Query: 188 FNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLE 247
           +NLS++K L +  N  SG L   + ++ LPNL   ++ GN F+G IP+ + N S L  L 
Sbjct: 231 YNLSSLKLLGIGYNHFSGRLRPDLGIL-LPNLLSFNMGGNYFTGSIPTTLSNISTLERLG 289

Query: 248 LGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTS-ELSFLSSWANCKNLKLLDLSNNPI 306
           + EN+ +G IP T GN+  L+ L L  N L S +S +L FL+S  NC  L+ L +  N +
Sbjct: 290 MNENNLTGSIP-TFGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRL 348

Query: 307 NGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKL 366
            G LP SI NLS  L  + +    I G+IP +IGNLINL++L L  N L G +P + GKL
Sbjct: 349 GGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKL 408

Query: 367 QNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNE 426
            NL+ L L +N+L G IP  +  +  L  L +  N   G +P  +G+ + L  L +  N+
Sbjct: 409 LNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNK 468

Query: 427 LNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGL 486
           LN  IP     ++ +L L+ S N L GSLP+DIG L+ +  + L  N LSG +P  +G  
Sbjct: 469 LNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNC 528

Query: 487 MNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNK 546
           + ++ L L  N   G IP  + GLV ++ +DLSNN LSG+IP        L+ LNLSFN 
Sbjct: 529 LTMESLFLEGNLFYGDIP-DLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNN 587

Query: 547 LEGEIPRGGPFANFSNRSFMGNDLLC-GLAQVQVPVCKSGNSSSHRK--SRKNTILLGVL 603
           LEG++P  G F N +  S +GN+ LC G+   Q+  C S   S  +K  SR   +++GV 
Sbjct: 588 LEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGV- 646

Query: 604 LPLSTVFIIAVILAVRYAMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNA 663
             +    ++ + +A    +  R ++KN + +N   + L +    + SY +L  ATN F++
Sbjct: 647 -SVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTL-EVLHEKISYGDLRNATNGFSS 704

Query: 664 SNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           SN++G+G FG+VYK   L +   VA+KV ++Q  GA+KSF  ECE LK +RHRNLVK+++
Sbjct: 705 SNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLT 764

Query: 723 SCTN-----NDFKALVLEYMPNGSLEDYLYSNNF--------SFDILQRLSVIIDVALAL 769
           +C++     N+F+AL+ E+MPNGSL+ +L+            +  +L+RL++ IDVA  L
Sbjct: 765 ACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVL 824

Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL--SGEESMKQTLTLA----T 823
           +YLH     P+ HCD+KPSNVLLD D+ AH+SDFG+A+LL    EES    L+ A    T
Sbjct: 825 DYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGT 884

Query: 824 IGYMAP 829
           IGY AP
Sbjct: 885 IGYAAP 890

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  459 bits (1180), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 330/906 (36%), Positives = 479/906 (52%), Gaps = 86/906 (9%)

Query: 2    LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
            L L  N LSG +P+EI   + L  +G  YN L G+IP+ LG+L  L++     N L+G+I
Sbjct: 149  LDLRNNLLSGDVPEEICKTSSLVLIGFDYNNLTGKIPECLGDLVHLQMFVAAGNHLTGSI 208

Query: 62   PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
            P +I  L++L T +D S N LTG +P D    L L + L ++ N L G IP  I  C  L
Sbjct: 209  PVSIGTLANL-TDLDLSGNQLTGKIPRDFGNLLNL-QSLVLTENLLEGDIPAEIGNCSSL 266

Query: 122  IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVG 181
            + + L  NQ T +IP  LGNL  L+ L +  N LT  IP  +  L  L  LGL  N LVG
Sbjct: 267  VQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENHLVG 326

Query: 182  FVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNAS 241
             +   I  L +++ L L SN  +G  P SI  +R  NL ++++  NN SG +P+ +   +
Sbjct: 327  PISEEIGFLESLEVLTLHSNNFTGEFPQSITNLR--NLTVLTVGFNNISGELPADLGLLT 384

Query: 242  KLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSE------LSFLS------- 288
             L  L   +N  +G IP+++ N   L+ L LS+N +T           L+F+S       
Sbjct: 385  NLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRMNLTFISIGRNHFT 444

Query: 289  -----SWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLI 343
                    NC NL+ L +++N + G L   IG L   L  + +S  S+ G IP+EIGNL 
Sbjct: 445  GEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQ-KLRILQVSYNSLTGPIPREIGNLK 503

Query: 344  NLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKL 403
            +L  L L  N   G IP     L  LQGL + +N LEGPIP  +  +  LSVL +  NK 
Sbjct: 504  DLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKF 563

Query: 404  SGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLK-----DI----------------- 441
            SG IP     L SL  LSL  N+ N  IP++  +L      DI                 
Sbjct: 564  SGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASL 623

Query: 442  ----LSLNFSSNFLNGSLPEDIGNLKVVVIIDLS------------------------RN 473
                L LNFS+N L G++P+++G L++V  IDLS                        +N
Sbjct: 624  KNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQN 683

Query: 474  NLSGDIPTAI-GGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSME 532
            NLSG IP  +  G+  +  L+L  N   G IP+S G +  L SLDLS+N+L+G IP S+ 
Sbjct: 684  NLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLA 743

Query: 533  KLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCKSGNSSSHRK 592
             L  LK L L+ N L+G +P  G F N +    MGN  LCG  +   P C     SSH  
Sbjct: 744  NLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLKP-CTIKQKSSHFS 802

Query: 593  SRKNTILLGVLLPLSTVFIIAVILAVRYAMISRCQEKNAKQSNIESNMLPQATR-RRFSY 651
             R   IL+ +    + + ++ ++L +        + +N+ +S++    L  A + +RF  
Sbjct: 803  KRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPD--LDSALKLKRFEP 860

Query: 652  KELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVL 709
            KEL QAT+ FN++N+IG+    +VYKG   DG  +A+KV +L+   A   K F  E + L
Sbjct: 861  KELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTL 920

Query: 710  KSVRHRNLVKIIS-SCTNNDFKALVLEYMPNGSLEDYLYSNNFSF-DILQRLSVIIDVAL 767
              ++HRNLVKI+  +  +   KALVL +M NG+LED ++ +      +L+++ + + +A 
Sbjct: 921  SQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIAS 980

Query: 768  ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA----T 823
             ++YLH GY  P+VHCD+KP+N+LLD D VAH+SDFG A++L   E    T + +    T
Sbjct: 981  GIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGT 1040

Query: 824  IGYMAP 829
            IGY+AP
Sbjct: 1041 IGYLAP 1046

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  430 bits (1105), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 318/846 (37%), Positives = 461/846 (54%), Gaps = 56/846 (6%)

Query: 9   LSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNL 68
           L+G +   +GNL+ L+ L L  N   G IP E+GNL  L+ ++++NN   G IP  + N 
Sbjct: 93  LTGVVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPVVLSNC 152

Query: 69  SSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAY 128
           SSLST    SN+   G                          +P       +L+++SL  
Sbjct: 153 SSLSTLDLSSNHLEQG--------------------------VPLEFGSLSKLVLLSLGR 186

Query: 129 NQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIF 188
           N  T + P  LGNLTSL+ L   +N + GEIP ++  L+ +    + LNK  G  P  I+
Sbjct: 187 NNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIY 246

Query: 189 NLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLEL 248
           NLS++  L++  N+ SG+L      + LPNL+I+ +  N+F+G IP  + N S L  L++
Sbjct: 247 NLSSLIFLSITGNSFSGTLRPDFGSL-LPNLQILYMGINSFTGTIPETLSNISSLRQLDI 305

Query: 249 GENSFSGFIPNTLGNLRKLEWLRLSYNFLTS-STSELSFLSSWANCKNLKLLDLSNNPIN 307
             N  +G IP + G L+ L  L L+ N L + S+ +L FL +  NC  L+ L++  N + 
Sbjct: 306 PSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLG 365

Query: 308 GVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQ 367
           G LP  I NLS  L+ + +    I G+IP  IGNL++L+ L L  N L G +P + G+L 
Sbjct: 366 GQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELS 425

Query: 368 NLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNEL 427
            L+ + L +N L G IP+ L  ++ L+ LY+  N   G IP  +G  + L  L+L +N+L
Sbjct: 426 ELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKL 485

Query: 428 NSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLM 487
           N  IP     L  ++ LN S N L G L +DIG LK ++ +D+S N LSG IP  +   +
Sbjct: 486 NGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCL 545

Query: 488 NLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKL 547
           +L+ L L+ N   G IP  I GL  L  LDLS N+LSG IP  M     L++LNLS N  
Sbjct: 546 SLEFLLLQGNSFVGPIP-DIRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNF 604

Query: 548 EGEIPRGGPFANFSNRSFMGNDLLC-GLAQVQVPVCKSGNSSSHRKSRK-NTILLGVLLP 605
           +G +P  G F N S  S  GN  LC G+  +Q+  C       H   RK  TI +  ++ 
Sbjct: 605 DGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMA 664

Query: 606 LSTVFIIAVILAVRYAMISRCQEKNAKQSNIESNMLP-QATRRRFSYKELLQATNQFNAS 664
              +  + V+    Y +  R +   A  +  + +  P ++   + SY EL + T  F++S
Sbjct: 665 ALLLLCLCVVYLCWYKL--RVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSS 722

Query: 665 NLIGTGGFGSVYKGSFL--DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           NLIG+G FG+V+KG FL      VAIKV +L   GA KSF  ECE L  +RHRNLVK+++
Sbjct: 723 NLIGSGNFGAVFKG-FLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVT 781

Query: 723 SCTN-----NDFKALVLEYMPNGSLEDYLYSNNF--------SFDILQRLSVIIDVALAL 769
            C++     NDF+ALV E+MPNG+L+ +L+ +          +  +  RL++ IDVA AL
Sbjct: 782 ICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASAL 841

Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL------SGEESMKQTLTLAT 823
            YLH    NP+ HCDIKPSN+LLDKD+ AH+SDFG+A+LL      +            T
Sbjct: 842 VYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGT 901

Query: 824 IGYMAP 829
           IGY AP
Sbjct: 902 IGYAAP 907

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  428 bits (1101), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 298/901 (33%), Positives = 472/901 (52%), Gaps = 83/901 (9%)

Query: 1    MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
            +L+L+ N L+G IP ++G ++ L+ L L  N+L+G IP+ L +L  L+ + L+ N L+G 
Sbjct: 243  ILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGE 302

Query: 61   IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
            IP   +N+S L   +  +NN L+GSLP  +C     ++ L +S  +L+G IP  + +C+ 
Sbjct: 303  IPEEFWNMSQL-LDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQS 361

Query: 121  LIVISLAYNQFTERIPRGL------------------------GNLTSLKTLYLGFNNLT 156
            L  + L+ N     IP  L                         NLT+L+ L L  NNL 
Sbjct: 362  LKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLE 421

Query: 157  GEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRL 216
            G++P E+  LR LE+L L  N+  G +P  I N +++K + +  N   G +P SI   RL
Sbjct: 422  GKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIG--RL 479

Query: 217  PNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNF 276
              L ++ L  N   G +P+ + N  +L++L+L +N  SG IP++ G L+ LE L L  N 
Sbjct: 480  KELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNS 539

Query: 277  LTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIP 336
            L  +  +     S  + +NL  ++LS+N +NG +    G  S S     ++N      IP
Sbjct: 540  LQGNLPD-----SLISLRNLTRINLSHNRLNGTIHPLCG--SSSYLSFDVTNNGFEDEIP 592

Query: 337  KEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVL 396
             E+GN  NL  L L  N+L G IP T GK++ L  LD+ +N L G IP  L    +L+ +
Sbjct: 593  LELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHI 652

Query: 397  YMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLP 456
             ++ N LSGPIPP +G L+ L  L L+SN+    +P+  +N   +L L+   N LNGS+P
Sbjct: 653  DLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIP 712

Query: 457  EDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLES- 515
            ++IGNL  + +++L +N  SG +P A+G L  L +L L  N L G IP  IG L  L+S 
Sbjct: 713  QEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSA 772

Query: 516  LDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPR------------------GGP- 556
            LDLS N+ +G+IP+++  L  L+ L+LS N+L GE+P                   GG  
Sbjct: 773  LDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKL 832

Query: 557  ---FANFSNRSFMGNDLLCGLAQVQVPVCKSGNSSSHRKSRKNTILLGVLLPLST----V 609
               F+ +   SF+GN  LCG    +    +S N      +R + +++  +  L+     +
Sbjct: 833  KKQFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSAR-SVVIISAISALTAIGLMI 891

Query: 610  FIIAVILAVRYAMISRCQEKNAK--------QSNIESNMLPQATRRRFSYKELLQATNQF 661
             +IA+    R+    +    +          Q+  +      A++    ++++++AT+  
Sbjct: 892  LVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNL 951

Query: 662  NASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVKI 720
            +   +IG+GG G VYK    +G  VA+K    + +  + KSF  E + L  +RHR+LVK+
Sbjct: 952  SEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKL 1011

Query: 721  ISSCTNND--FKALVLEYMPNGSLEDYLYSNNFS-------FDILQRLSVIIDVALALEY 771
            +  C++       L+ EYM NGS+ D+L+ +           D   RL + + +A  +EY
Sbjct: 1012 MGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEY 1071

Query: 772  LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS---GEESMKQTLTLATIGYMA 828
            LH     P+VH DIK SNVLLD +M AHL DFG+AK+L+      +   T    + GY+A
Sbjct: 1072 LHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIA 1131

Query: 829  P 829
            P
Sbjct: 1132 P 1132

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  415 bits (1067), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 302/924 (32%), Positives = 475/924 (51%), Gaps = 111/924 (12%)

Query: 1    MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
            + + +FN L+G++P E+  L  L+ L LG N   GEIP +LG+L  ++ ++L  N L G 
Sbjct: 220  LFAAAFNRLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGL 279

Query: 61   IPSTIFNLSSLSTGMDFSNNSLTG------------------------SLPDDMCRRLPL 96
            IP  +  L++L T +D S+N+LTG                        SLP  +C     
Sbjct: 280  IPKRLTELANLQT-LDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTS 338

Query: 97   IKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGL----------------- 139
            +K L++S  +L+G IP  I  C+ L ++ L+ N  T +IP  L                 
Sbjct: 339  LKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLE 398

Query: 140  -------GNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSA 192
                    NLT+L+   L  NNL G++P E+G L  LEI+ L  N+  G +P  I N + 
Sbjct: 399  GTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTR 458

Query: 193  MKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENS 252
            ++ +    N LSG +PSSI   RL +L  + L  N   G IP+ + N  +++V++L +N 
Sbjct: 459  LQEIDWYGNRLSGEIPSSIG--RLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQ 516

Query: 253  FSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPS 312
             SG IP++ G L  LE   +  N L  +  +     S  N KNL  ++ S+N  NG +  
Sbjct: 517  LSGSIPSSFGFLTALELFMIYNNSLQGNLPD-----SLINLKNLTRINFSSNKFNGSISP 571

Query: 313  SIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGL 372
              G  S S     ++     G IP E+G   NL  L L  N+  G IP TFGK+  L  L
Sbjct: 572  LCG--SSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLL 629

Query: 373  DLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIP 432
            D+  N L G IP  L    +L+ + ++ N LSG IP  +G L  L  L L+SN+    +P
Sbjct: 630  DISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLP 689

Query: 433  STFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDL 492
            +  ++L +IL+L    N LNGS+P++IGNL+ +  ++L  N LSG +P+ IG L  L +L
Sbjct: 690  TEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFEL 749

Query: 493  SLRDNGLQGSIPKSIGGLVSLES-LDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEI 551
             L  N L G IP  IG L  L+S LDLS N+ +G IP+++  L  L+ L+LS N+L GE+
Sbjct: 750  RLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEV 809

Query: 552  PR----------------------GGPFANFSNRSFMGNDLLCGLAQVQVPVCKSGNSSS 589
            P                          F+ +   +F+GN  LCG     +  C    S +
Sbjct: 810  PGQIGDMKSLGYLNLSYNNLEGKLKKQFSRWQADAFVGNAGLCG---SPLSHCNRAGSKN 866

Query: 590  HRK-SRKNTILLGVLLPLSTVFIIAVIL------------AVRYAMISRCQEKNAKQSNI 636
             R  S K  +++  +  L+ + ++ +++             VR    +     ++ Q+ +
Sbjct: 867  QRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPL 926

Query: 637  ESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLE 696
             SN      +    + ++++AT+  N   +IG+GG G VYK    +G  +A+K    + +
Sbjct: 927  FSN---GGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDD 983

Query: 697  -GALKSFDVECEVLKSVRHRNLVKIISSCTN--NDFKALVLEYMPNGSLEDYLYSNNFS- 752
              + KSF+ E + L ++RHR+LVK++  C++  +    L+ EYM NGS+ D+L++N  + 
Sbjct: 984  LMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTK 1043

Query: 753  -FDIL---QRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL 808
              ++L    RL + + +A  +EYLH+    P+VH DIK SNVLLD ++ AHL DFG+AK+
Sbjct: 1044 KKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKI 1103

Query: 809  LSGE---ESMKQTLTLATIGYMAP 829
            L+G     +   T+   + GY+AP
Sbjct: 1104 LTGNYDTNTESNTMFAGSYGYIAP 1127

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  407 bits (1047), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 289/847 (34%), Positives = 444/847 (52%), Gaps = 59/847 (6%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
             LS N L G IP E+G+L+ L  L L  NKL G IP E+G L ++  +++ +N L+G I
Sbjct: 147 FDLSINQLVGEIPPELGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNLLTGPI 206

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
           PS+  NL+ L     F N SL+GS+P ++   LP ++ L +  N LTG IP++    K +
Sbjct: 207 PSSFGNLTKLVNLYLFIN-SLSGSIPSEIGN-LPNLRELCLDRNNLTGKIPSSFGNLKNV 264

Query: 122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVG 181
            ++++  NQ +  IP  +GN+T+L TL L  N LTG IP  +GN++ L +L L LN+L G
Sbjct: 265 TLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNG 324

Query: 182 FVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNAS 241
            +P  +  + +M  L +  N L+G +P S    +L  LE + L  N  SG IP  I N++
Sbjct: 325 SIPPELGEMESMIDLEISENKLTGPVPDSFG--KLTALEWLFLRDNQLSGPIPPGIANST 382

Query: 242 KLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDL 301
           +L+VL+L  N+F+GF+P+T+    KLE L L  N       +     S  +CK+L  +  
Sbjct: 383 ELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPK-----SLRDCKSLIRVRF 437

Query: 302 SNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPI 361
             N  +G +  + G +  +L+ I +SN +  G +         L    L  N + G+IP 
Sbjct: 438 KGNSFSGDISEAFG-VYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPP 496

Query: 362 TFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLS 421
               +  L  LDL +N++ G +P  +  + R+S L ++GN+LSG IP  I  LT+L  L 
Sbjct: 497 EIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLD 556

Query: 422 LASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPT 481
           L+SN  +S IP T  NL  +  +N S N L+ ++PE +  L  + ++DLS N L G+I +
Sbjct: 557 LSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISS 616

Query: 482 AIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLN 541
               L NL                        E LDLS+N+LSG IP S + +L L  ++
Sbjct: 617 QFRSLQNL------------------------ERLDLSHNNLSGQIPPSFKDMLALTHVD 652

Query: 542 LSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCKSGNSSSHRKSRKNTILLG 601
           +S N L+G IP    F N    +F GN  LCG       +     +SS +  +   +++ 
Sbjct: 653 VSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIY 712

Query: 602 VLLPLSTVFIIAVILAVRYAMISRCQEKNAKQSNIESNMLPQATRRRFS---------YK 652
           +L+P+    I A+I+    A I  C  K  KQ  IE +   ++     S         Y+
Sbjct: 713 ILVPI----IGAIIILSVCAGIFICFRKRTKQ--IEEHTDSESGGETLSIFSFDGKVRYQ 766

Query: 653 ELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL------KSFDVEC 706
           E+++AT +F+   LIGTGG G VYK    + + +A+K  +   + ++      + F  E 
Sbjct: 767 EIIKATGEFDPKYLIGTGGHGKVYKAKLPNAI-MAVKKLNETTDSSISNPSTKQEFLNEI 825

Query: 707 EVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFS--FDILQRLSVIID 764
             L  +RHRN+VK+   C++     LV EYM  GSL   L +++ +   D  +R++V+  
Sbjct: 826 RALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKG 885

Query: 765 VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATI 824
           VA AL Y+H   S  +VH DI   N+LL +D  A +SDFG AKLL  + S   +    T 
Sbjct: 886 VAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSS-NWSAVAGTY 944

Query: 825 GYMAPGL 831
           GY+AP L
Sbjct: 945 GYVAPEL 951

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  399 bits (1026), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 290/863 (33%), Positives = 450/863 (52%), Gaps = 51/863 (5%)

Query: 2    LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
            L+LS N L+G+IP  +GNL  L  L L  N L G IP ELGN+  +  ++L+ N L+G+I
Sbjct: 179  LALSQNKLTGSIPSSLGNLKNLMVLYLYENYLTGVIPPELGNMESMTDLALSQNKLTGSI 238

Query: 62   PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
            PST+ NL +L   +    N LTG +P ++   +  +  L +S NKLTG IP+++   K L
Sbjct: 239  PSTLGNLKNLMV-LYLYENYLTGVIPPEIGN-MESMTNLALSQNKLTGSIPSSLGNLKNL 296

Query: 122  IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVG 181
             ++SL  N  T  IP  LGN+ S+  L L  N LTG IP  +GNL+NL IL L  N L G
Sbjct: 297  TLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYENYLTG 356

Query: 182  FVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNAS 241
             +P  + N+ +M  L L +N L+GS+PSS     L NL  + L  N  +G+IP  + N  
Sbjct: 357  VIPPELGNMESMIDLQLNNNKLTGSIPSSFG--NLKNLTYLYLYLNYLTGVIPQELGNME 414

Query: 242  KLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDL 301
             +  L+L +N  +G +P++ GN  KLE L L  N L+ +          AN  +L  L L
Sbjct: 415  SMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIP-----PGVANSSHLTTLIL 469

Query: 302  SNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPI 361
              N   G  P ++      L  I +    + G IPK + +  +L      GN+  G I  
Sbjct: 470  DTNNFTGFFPETVCK-GRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFE 528

Query: 362  TFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLS 421
             FG   +L  +D  +NK  G I +   +  +L  L M  N ++G IP  I ++T L  L 
Sbjct: 529  AFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELD 588

Query: 422  LASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPT 481
            L++N L   +P    NL ++  L  + N L+G +P  +  L  +  +DLS NN S +IP 
Sbjct: 589  LSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQ 648

Query: 482  AIGGLMNLQDLSLRDNGLQGSIPK-----------------------SIGGLVSLESLDL 518
                 + L D++L  N   GSIP+                        +  L SL+ LDL
Sbjct: 649  TFDSFLKLHDMNLSRNKFDGSIPRLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDL 708

Query: 519  SNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQ 578
            S+N+LSG IPT+ E ++ L ++++S NKLEG +P    F   +  +   N  LC      
Sbjct: 709  SHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCS----N 764

Query: 579  VPVCKSGNSSSHRKSRKN-TILLGVLLPLSTVFIIAVILAVRYAMISRCQE-KNAKQSNI 636
            +P  +       +K +KN  +++ +L+P+  V +I  I A  +    R ++ +N + ++ 
Sbjct: 765  IPKQRLKPCRELKKPKKNGNLVVWILVPILGVLVILSICANTFTYCIRKRKLQNGRNTDP 824

Query: 637  ES--NMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ 694
            E+  NM   +   +F Y++++++TN+F+ ++LIGTGG+  VY+ +  D + +A+K  H  
Sbjct: 825  ETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQDTI-IAVKRLHDT 883

Query: 695  LEGAL------KSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYS 748
            ++  +      + F  E + L  +RHRN+VK+   C++     L+ EYM  GSL   L +
Sbjct: 884  IDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLAN 943

Query: 749  NNFS--FDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA 806
            +  +      +R++V+  VA AL Y+H     P+VH DI   N+LLD D  A +SDFG A
Sbjct: 944  DEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTA 1003

Query: 807  KLLSGEESMKQTLTLATIGYMAP 829
            KLL  + S   +    T GY+AP
Sbjct: 1004 KLLKTDSS-NWSAVAGTYGYVAP 1025

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  399 bits (1024), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 279/787 (35%), Positives = 423/787 (53%), Gaps = 70/787 (8%)

Query: 100 LYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNL-TSLKTLYLGFNNLTGE 158
           L +S   L G I  +I     L V+ L+ N F  +IP  +G+L  +LK L L  N L G 
Sbjct: 71  LDISGRDLGGEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSENLLHGN 130

Query: 159 IPYEMGNLRNLEILGLQLNKLVGFVPTSIF---NLSAMKTLALPSNALSGSLPSSIDLVR 215
           IP E+G L  L  L L  N+L G +P  +F   + S+++ + L +N+L+G +P +     
Sbjct: 131 IPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYH-CH 189

Query: 216 LPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPN-TLGNLRKLEWLRLSY 274
           L  L  + L  N  +G +PS + N++ L  ++L  N  SG +P+  +  + +L++L LSY
Sbjct: 190 LKELRFLLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSY 249

Query: 275 NFLTSS---TSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSI 331
           N   S    T+   F +S AN  +L+ L+L+ N + G + SS+ +LS++L +I +    I
Sbjct: 250 NHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRI 309

Query: 332 RGTIPKEIG------------------------NLINLRELGLWGNELIGSIPITFGKLQ 367
            G+IP EI                          L  L  + L  N L G IP+  G + 
Sbjct: 310 HGSIPPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIP 369

Query: 368 NLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNEL 427
            L  LD+  N L G IP+    L++L  L + GN LSG +P  +G   +L +L L+ N L
Sbjct: 370 RLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNL 429

Query: 428 NSVIP----STFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAI 483
              IP    S   NLK  L LN SSN L+G +P ++  + +V+ +DLS N LSG IP  +
Sbjct: 430 TGTIPVEVVSNLRNLK--LYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQL 487

Query: 484 GGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLS 543
           G  + L+ L+L  NG   ++P S+G L  L+ LD+S N L+G IP S ++   LK LN S
Sbjct: 488 GSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFS 547

Query: 544 FNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCKSGNSSSHRKSRKNTILLGVL 603
           FN L G +   G F+  +  SF+G+ LLCG  +  +  CK  +   +       +L  + 
Sbjct: 548 FNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIK-GMQACKKKH--KYPSVLLPVLLSLIA 604

Query: 604 LPLSTVFIIAVILAVRY----AMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATN 659
            P+  VF   ++   R+     + ++ + ++ ++ N      P     R SY++L+ AT 
Sbjct: 605 TPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYP-----RISYQQLIAATG 659

Query: 660 QFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALK---SFDVECEVLKSVRHRN 716
            FNAS+LIG+G FG VYKG   +  +VA+KV  L  + AL+   SF  EC++LK  RHRN
Sbjct: 660 GFNASSLIGSGRFGHVYKGVLRNNTKVAVKV--LDPKTALEFSGSFKRECQILKRTRHRN 717

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFS---FDILQRLSVIIDVALALEYLH 773
           L++II++C+   F ALVL  MPNGSLE +LY   +S    D++Q +++  DVA  + YLH
Sbjct: 718 LIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLH 777

Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT-----------LTLA 822
                 VVHCD+KPSN+LLD +M A ++DFGI++L+ G E    T           L   
Sbjct: 778 HYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCG 837

Query: 823 TIGYMAP 829
           ++GY+AP
Sbjct: 838 SVGYIAP 844

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  397 bits (1019), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 289/894 (32%), Positives = 447/894 (50%), Gaps = 76/894 (8%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L+L++N L+G IP+EIGN + L+ + L  N+  G IP E+  L++L   ++ NN LSG +
Sbjct: 114 LNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPL 173

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
           P  I +L +L   + ++NN LTG LP  +   L  +       N  +G IP  I +C  L
Sbjct: 174 PEEIGDLYNLEELVAYTNN-LTGPLPRSL-GNLNKLTTFRAGQNDFSGNIPTEIGKCLNL 231

Query: 122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVG 181
            ++ LA N  +  +P+ +G L  L+ + L  N  +G IP ++GNL +LE L L  N LVG
Sbjct: 232 KLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVG 291

Query: 182 FVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNAS 241
            +P+ I N+ ++K L L  N L+G++P   +L +L  +  I  + N  SG IP  +   S
Sbjct: 292 PIPSEIGNMKSLKKLYLYQNQLNGTIPK--ELGKLSKVMEIDFSENLLSGEIPVELSKIS 349

Query: 242 KLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDL 301
           +L +L L +N  +G IPN L  LR L  L LS N LT           + N  +++ L L
Sbjct: 350 ELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIP-----PGFQNLTSMRQLQL 404

Query: 302 SNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPI 361
            +N ++GV+P  +G L   L  +  S   + G IP  I    NL  L L  N + G+IP 
Sbjct: 405 FHNSLSGVIPQGLG-LYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPP 463

Query: 362 TFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLS 421
              + ++L  L +V N+L G  P  LC+L  LS + +D N+ SGP+PP IG    L+ L 
Sbjct: 464 GVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLH 523

Query: 422 LASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPT 481
           LA+N+ +S +P+    L ++++ N SSN L G +P +I N K++  +DLSRN+  G +P 
Sbjct: 524 LAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPP 583

Query: 482 AIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLD------------------------ 517
            +G L  L+ L L +N   G+IP +IG L  L  L                         
Sbjct: 584 ELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAM 643

Query: 518 -------------------------LSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIP 552
                                    L+NN LSG IPT+ E L  L   N S+N L G++P
Sbjct: 644 NLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLP 703

Query: 553 RGGPFANFSNRSFMGNDLLCG-------LAQVQVPVCKSGNSSSHRKSRKNTILLGVLLP 605
               F N +  SF+GN  LCG        +    P   S  + S R+ R   I+  V+  
Sbjct: 704 HTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGG 763

Query: 606 LSTVFIIAVILAVRYAMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASN 665
           +S + I  V+  +R  +       + K+   + + +    + RF+ K++L+AT  F+ S 
Sbjct: 764 ISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSY 823

Query: 666 LIGTGGFGSVYKGSFLDGMEVAIKVFH-------LQLEGALKSFDVECEVLKSVRHRNLV 718
           ++G G  G+VYK     G  +A+K                  SF  E   L  +RHRN+V
Sbjct: 824 IVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIV 883

Query: 719 KIISSCTNNDFKA--LVLEYMPNGSLEDYLY-SNNFSFDILQRLSVIIDVALALEYLHFG 775
           ++ S C +    +  L+ EYM  GSL + L+   + S D   R ++ +  A  L YLH  
Sbjct: 884 RLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKSHSMDWPTRFAIALGAAEGLAYLHHD 943

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
               ++H DIK +N+L+D++  AH+ DFG+AK++    S   +    + GY+AP
Sbjct: 944 CKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAP 997

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	832
359483677	1229	PREDICTED: LRR receptor-like serine/thre	0.985	0.667	0.531	0.0
147853795	1420	hypothetical protein VITISV_005816 [Viti	0.980	0.574	0.533	0.0
359485453	1202	PREDICTED: probable LRR receptor-like se	0.981	0.679	0.540	0.0
147852480	1229	hypothetical protein VITISV_039533 [Viti	0.983	0.665	0.525	0.0
147776333	1205	hypothetical protein VITISV_000078 [Viti	0.985	0.680	0.522	0.0
359483198	1087	PREDICTED: probable LRR receptor-like se	0.975	0.747	0.538	0.0
147769371	1241	hypothetical protein VITISV_010511 [Viti	0.983	0.659	0.522	0.0
359483675	1250	PREDICTED: LRR receptor-like serine/thre	0.985	0.656	0.524	0.0
359497186	1140	PREDICTED: LRR receptor-like serine/thre	0.984	0.718	0.518	0.0
359483683	1228	PREDICTED: LRR receptor-like serine/thre	0.985	0.667	0.522	0.0

>gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  813 bits (2100), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 442/831 (53%), Positives = 580/831 (69%), Gaps = 11/831 (1%)

Query: 1    MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
            +LSLSFN  +G IP+ IG+L+ L++L L +NKL G IP+E+GNL+ L ++ L++N +SG 
Sbjct: 296  VLSLSFNQFTGGIPQAIGSLSNLEELYLSHNKLTGGIPREIGNLSNLNILQLSSNGISGP 355

Query: 61   IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
            IP+ IFN+SSL   + F++NSL+GSLP D+C+ LP ++GL +S N L+G +P  +  C E
Sbjct: 356  IPAEIFNVSSLQV-IAFTDNSLSGSLPKDICKHLPNLQGLSLSQNHLSGQLPTTLSLCGE 414

Query: 121  LIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLV 180
            L+ +SL++N+F   IP+ +GNL+ L+ +YLG N+L G IP   GNL+ L+ L L +N L 
Sbjct: 415  LLFLSLSFNKFRGSIPKEIGNLSKLEKIYLGTNSLIGSIPTSFGNLKALKFLNLGINNLT 474

Query: 181  GFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNA 240
            G VP +IFN+S +++LA+  N LSGSLPSSI    L +LE + +AGN FSGIIP  I N 
Sbjct: 475  GTVPEAIFNISKLQSLAMVKNHLSGSLPSSIG-TWLSDLEGLFIAGNEFSGIIPMSISNM 533

Query: 241  SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSS--TSELSFLSSWANCKNLKL 298
            SKL+VL L  NSF+G +P  LGNL KL+ L L+ N LT     SE+ FL+S  NCK LK 
Sbjct: 534  SKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGNQLTDEHVASEVGFLTSLTNCKFLKN 593

Query: 299  LDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGS 358
            L + NNP  G LP+S+GNL ++L     S C  RGTIP  IGNL NL  L L  N+L GS
Sbjct: 594  LWIGNNPFKGTLPNSLGNLPIALESFIASACQFRGTIPTRIGNLTNLIWLDLGANDLTGS 653

Query: 359  IPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLR 418
            IP T G+L+ LQ L +V N+L G IPN LC L  L  L++  NKLSG IP C GDL +L+
Sbjct: 654  IPTTLGRLKKLQKLHIVGNRLRGSIPNDLCHLKNLGYLHLSSNKLSGSIPSCFGDLPALQ 713

Query: 419  LLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGD 478
             L L SN L   IP++ W+L+D+L LN SSNFL G+LP ++GN+K +  +DLS+N +SG 
Sbjct: 714  ELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGH 773

Query: 479  IPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLK 538
            IP  +G   NL  LSL  N LQG IP   G LVSLESLDLS N+LSG IP S+E L+YLK
Sbjct: 774  IPRKMGEQQNLAKLSLSQNKLQGPIPIEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLK 833

Query: 539  DLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCKSGNSSSHRKSRKNTI 598
             LN+S NKL+GEIP GGPF NF+  SFM N+ LCG    QV  C   N +   K+ K+ I
Sbjct: 834  YLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKT-KSFI 892

Query: 599  LLGVLLPLSTVFIIAVILAVRYAMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQAT 658
            L  +LLP+ ++    V L V   +  R ++     + I+S  LP  T  + S+++LL AT
Sbjct: 893  LKYILLPVGSI----VTLVVFIVLWIRRRDNMEIPTPIDS-WLP-GTHEKISHQQLLYAT 946

Query: 659  NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLV 718
            N F   NLIG G  G VYKG   +G+ VAIKVF+L+ +GAL+SFD ECEV++ +RHRNLV
Sbjct: 947  NDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLV 1006

Query: 719  KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
            +II+ C+N DFKALVLEYMPNGSLE +LYS+N+  D++QRL+++IDVA ALEYLH   S+
Sbjct: 1007 RIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSS 1066

Query: 779  PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             VVHCD+KP+NVLLD DMVAH++DFGI KLL+  ESM+QT TL TIGYMAP
Sbjct: 1067 LVVHCDLKPNNVLLDDDMVAHVADFGITKLLTKTESMQQTKTLGTIGYMAP 1117

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera]

 Score =  805 bits (2078), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 444/832 (53%), Positives = 582/832 (69%), Gaps = 16/832 (1%)

Query: 2    LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
            LSLS N  +G IP+ IG+L+ L+++ L YN L G IP+E+GNL+ L  + L +  +SG I
Sbjct: 268  LSLSLNQFTGGIPQAIGSLSNLEEVYLAYNNLAGGIPREIGNLSNLNSLQLGSCGISGPI 327

Query: 62   PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
            P  IFN+SSL   +D ++NSL GSLP D+C+ L  ++GLY+S N+L+G +P  +  C +L
Sbjct: 328  PPEIFNISSLQM-IDLTDNSLHGSLPMDICKHLHNLQGLYLSFNQLSGQLPTTLSLCGQL 386

Query: 122  IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVG 181
            + +SL  N+FT  IP   GNLT L+ L L  NN+ G IP E+GNL NL+ L L +N L G
Sbjct: 387  LSLSLWGNRFTGNIPPSFGNLTVLQDLELXENNIQGNIPNELGNLINLQNLKLSVNNLTG 446

Query: 182  FVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNAS 241
             +P +IFN+S ++TL L  N  SGSLPSSI   +LP+LE +++  N FSGIIP  I N S
Sbjct: 447  IIPEAIFNISKLQTLXLAQNHFSGSLPSSIG-TQLPDLEGLAIGXNEFSGIIPMSISNMS 505

Query: 242  KLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTS--STSELSFLSSWANCKNLKLL 299
            +L+VL++  N F+G +P  LGNLR+LE+L L +N LT   STSE+ FL+S  NCK L+ L
Sbjct: 506  ELTVLDIWANFFTGDVPKDLGNLRRLEFLNLGFNQLTDEHSTSEVGFLTSLTNCKFLRRL 565

Query: 300  DLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSI 359
             + +NP+ G+LP+S+GNLS+SL     S C  +GTIP  IGNLINL +L L  N+L G I
Sbjct: 566  WIEDNPLKGILPNSLGNLSISLESFDASACQFKGTIPTGIGNLINLIDLRLNDNDLTGLI 625

Query: 360  PITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRL 419
            PI+FG LQ LQ   +  N++ G IP+ LC L  L  L +  NKLSG IP C G+LT+LR 
Sbjct: 626  PISFGHLQKLQWFAISGNRIHGSIPSVLCHLRNLGYLDLSSNKLSGTIPGCFGNLTALRN 685

Query: 420  LSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDI 479
            +SL SN L S IPS+ W L+D+L LN SSNFLN  LP ++GN+K ++++DLS+N  SG+I
Sbjct: 686  ISLHSNGLASEIPSSLWTLRDLLVLNLSSNFLNCQLPLEVGNMKSLLVLDLSKNQFSGNI 745

Query: 480  PTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKD 539
            P+ I  L NL  L L  N LQG +P + G LVSLE LDLS N+ SG IPTS+E L YLK 
Sbjct: 746  PSTISLLQNLLQLYLSHNKLQGHMPPNFGALVSLEYLDLSGNNFSGTIPTSLEALKYLKY 805

Query: 540  LNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCKSGNSSSHRKSRKNT-- 597
            LN+SFNKL+GEIP  GPFANF+  SF+ N  LCG  + QV  C+       + +R+NT  
Sbjct: 806  LNVSFNKLQGEIPNRGPFANFTAESFISNLALCGAPRFQVMACE-------KDARRNTKS 858

Query: 598  ILLGVLLPLSTVFIIAVILAVRYAMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQA 657
            +LL  ++PLS V +  +IL V + +  R Q ++  +S ++ ++L     R  S++ELL A
Sbjct: 859  LLLKCIVPLS-VSLSTMILVVLFTLWKRRQTES--ESPVQVDLLLPRMHRLISHQELLYA 915

Query: 658  TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNL 717
            T+ F   NLIG G  G VYKG   DG+ VA+KVF+L+L GA KSF+VECEV++++RHRNL
Sbjct: 916  TSYFGEENLIGKGSLGMVYKGVLSDGLIVAVKVFNLELHGAFKSFEVECEVMRNIRHRNL 975

Query: 718  VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
             KIISSC+N DFKALVLEYMPN SLE +LYS+N+  D +QRL ++IDVA  LEYLH  YS
Sbjct: 976  AKIISSCSNLDFKALVLEYMPNESLEKWLYSHNYCLDFIQRLKIMIDVASGLEYLHHDYS 1035

Query: 778  NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            NPVVHCD+KPSNVLLD DMVAH+SDFGIAKLL G E MK+T TL TIGYMAP
Sbjct: 1036 NPVVHCDLKPSNVLLDDDMVAHISDFGIAKLLMGSEFMKRTKTLGTIGYMAP 1087

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  800 bits (2067), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 450/833 (54%), Positives = 585/833 (70%), Gaps = 16/833 (1%)

Query: 1    MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
            +L LS N  +G IP+ IG+L+ L+ L LG+N+L G IP E+GNL+ L L++  ++ LSG 
Sbjct: 266  LLDLSINQFTGFIPQAIGSLSNLETLYLGFNQLAGGIPGEIGNLSNLNLLNSASSGLSGP 325

Query: 61   IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
            IP+ IFN+SSL   + F+NNSL+GSLP D+C+ LP ++ L +S N+L+G +P  +  C E
Sbjct: 326  IPAEIFNISSLQE-IGFANNSLSGSLPMDICKHLPNLQWLLLSLNQLSGQLPTTLSLCGE 384

Query: 121  LIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLV 180
            L+ ++LAYN FT  IPR +GNL+ L+ +Y   ++ TG IP E+GNL NL+ L L +N L 
Sbjct: 385  LLTLTLAYNNFTGSIPREIGNLSKLEQIYFRRSSFTGNIPKELGNLVNLQFLSLNVNNLT 444

Query: 181  GFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNA 240
            G VP +IFN+S ++ L+L  N LSGSLPSSI    LPNLE + + GN FSGIIP  I N 
Sbjct: 445  GIVPEAIFNISKLQVLSLAGNHLSGSLPSSIG-SWLPNLEQLLIGGNEFSGIIPMSISNM 503

Query: 241  SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTS--STSELSFLSSWANCKNLKL 298
            S L  L++ +N F G +P  LGNLR+L+ L LS+N LT+  S SEL+FL+S  NC  L+ 
Sbjct: 504  SNLISLDISDNFFIGNVPKDLGNLRQLQLLGLSHNQLTNEHSASELAFLTSLTNCIFLRT 563

Query: 299  LDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGS 358
            L +S+NP+ G++P+S+GNLS+SL  I+ S+C +RGTIP  I NL NL  L L  N+L G 
Sbjct: 564  LSISDNPLKGMIPNSLGNLSISLEIIYASDCQLRGTIPTGISNLTNLIGLRLDDNDLTGL 623

Query: 359  IPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLR 418
            IP  FG+LQ LQ L +  N++ G IP+GLC L  L+ L +  NKLSG IP C G+LT LR
Sbjct: 624  IPTPFGRLQKLQMLSISQNRIHGSIPSGLCHLTNLAFLDLSSNKLSGTIPSCSGNLTGLR 683

Query: 419  LLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGD 478
             + L SN L S IPS+  NL+ +L LN SSNFLN  LP  +GN+K +V +DLS+N  SG+
Sbjct: 684  NVYLHSNGLASEIPSSLCNLRGLLVLNLSSNFLNSQLPLQVGNMKSLVALDLSKNQFSGN 743

Query: 479  IPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLK 538
            IP+ I  L NL  L L  N LQG IP + G LVSLESLDLS N+LSG IP S+E L YL+
Sbjct: 744  IPSTISLLQNLLQLYLSHNKLQGHIPPNFGDLVSLESLDLSGNNLSGTIPKSLEHLKYLE 803

Query: 539  DLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCKSGNSSSHRKSRKNT- 597
             LN+SFNKL+GEIP GGPFANF+  SF+ N  LCG  + QV  C+       + SRKNT 
Sbjct: 804  YLNVSFNKLQGEIPNGGPFANFTAESFISNLALCGAPRFQVMACE-------KDSRKNTK 856

Query: 598  -ILLGVLLPLSTVFIIAVILAVRYAMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQ 656
             +LL  ++PLS V +  +IL V +    R Q K+  ++ I+ ++      R   ++ELL 
Sbjct: 857  SLLLKCIVPLS-VSLSTIILVVLFVQWKRRQTKS--ETPIQVDLSLPRMHRMIPHQELLY 913

Query: 657  ATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRN 716
            ATN F   NLIG G  G VYKG   DG+ VA+KVF+L+L+GA KSF+VECEV++++RHRN
Sbjct: 914  ATNYFGEDNLIGKGSLGMVYKGVLSDGLIVAVKVFNLELQGAFKSFEVECEVMRNIRHRN 973

Query: 717  LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
            L KIISSC+N DFKALVLEYMPNGSLE +LYS+N+  D +QRL ++IDVA  LEYLH  Y
Sbjct: 974  LAKIISSCSNLDFKALVLEYMPNGSLEKWLYSHNYYLDFVQRLKIMIDVASGLEYLHHYY 1033

Query: 777  SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            SNPVVHCD+KPSNVLLD DMVAH+SDFGIAKLL G E MK+T TL T+GYMAP
Sbjct: 1034 SNPVVHCDLKPSNVLLDDDMVAHISDFGIAKLLMGSEFMKRTKTLGTVGYMAP 1086

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147852480|emb|CAN78527.1| hypothetical protein VITISV_039533 [Vitis vinifera]

 Score =  796 bits (2057), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 438/833 (52%), Positives = 574/833 (68%), Gaps = 15/833 (1%)

Query: 1    MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
            +LSLS N  +G IP+ IG+L+ L++L LGYNKL G IP+E+GNL+ L ++ L +N +SG 
Sbjct: 296  VLSLSINRFTGGIPQAIGSLSDLEELYLGYNKLTGGIPREIGNLSNLNILQLGSNGISGP 355

Query: 61   IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
            IP+ IFN+SSL  G+ FSNNSL+GSLP D+C+ LP ++ L ++ N L+G +P  +  C+E
Sbjct: 356  IPAEIFNISSLQ-GIGFSNNSLSGSLPMDICKHLPNLQWLDLALNHLSGQLPTTLSLCRE 414

Query: 121  LIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLV 180
            L+V+SL++N+F   IPR +GNL+ L+ + L  N+L G IP   GNL  L+ L L +N L 
Sbjct: 415  LLVLSLSFNKFRGSIPREIGNLSKLEWIDLSSNSLVGSIPTSFGNLMALKFLNLGINNLT 474

Query: 181  GFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNA 240
            G VP +IFN+S +++LA+  N LSGSLPSSI    LP+LE + + GN FSGIIP  I N 
Sbjct: 475  GTVPEAIFNISKLQSLAMAINHLSGSLPSSIG-TWLPDLEGLFIGGNEFSGIIPVSISNM 533

Query: 241  SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSS--TSELSFLSSWANCKNLKL 298
            SKL+ L++  NSF G +P  LGNL KLE L L+ N  T+    SE+SFL+S  NCK LK 
Sbjct: 534  SKLTQLDVSRNSFIGNVPKDLGNLTKLEVLNLAGNQFTNEHLASEVSFLTSLTNCKFLKN 593

Query: 299  LDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGS 358
            L + NNP  G LP+S+GNL ++L     S C  RGTIP  IGNL NL  L L  N+L GS
Sbjct: 594  LWIGNNPFKGTLPNSLGNLPIALESFIASACQFRGTIPTGIGNLTNLIWLDLGANDLTGS 653

Query: 359  IPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLR 418
            IP   G+L+ LQ L +  N+L G IPN LC L  L  L++  NKLSG IP C GDL +L+
Sbjct: 654  IPTILGRLKKLQRLHIAGNRLRGSIPNDLCHLKNLGYLHLSSNKLSGSIPSCFGDLPALQ 713

Query: 419  LLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGD 478
             L L SN L   IP++ W+L+D+L LN SSNFL G+LP ++GN+K +  +DLS+N +SG 
Sbjct: 714  ELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGY 773

Query: 479  IPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLK 538
            IP  +G   NL  LSL  N LQG IP   G LVSLESLDLS N+LSG IP S+E L+YLK
Sbjct: 774  IPRRMGEQQNLAKLSLSQNRLQGPIPVEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLK 833

Query: 539  DLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCKSGNSSSHRKSRKNTI 598
             LN+S NKL+GEIP GGPF NF+  SFM N+ LCG    QV  C   N +   K+ K+ I
Sbjct: 834  YLNVSSNKLQGEIPNGGPFVNFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKT-KSFI 892

Query: 599  LLGVLLPL--STVFIIAVILAVRYAMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQ 656
            L  +LLP+  +   ++ ++L +R       +  N +      + LP  T  + S++ LL 
Sbjct: 893  LKYILLPVGSTITLVVFIVLWIR-------RRDNMEIPTPIDSWLP-GTHEKISHQRLLY 944

Query: 657  ATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRN 716
            ATN F   NLIG G  G VYKG   +G+ VAIKVF+L+ +GAL+SFD ECEV++ +RHRN
Sbjct: 945  ATNDFGEDNLIGKGSQGMVYKGVLSNGLIVAIKVFNLEFQGALRSFDSECEVMQGIRHRN 1004

Query: 717  LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
            LV+II+ C+N DFKALVL+YMPNGSLE +LYS+N+  D++QRL+++IDVA ALEYLH   
Sbjct: 1005 LVRIITCCSNLDFKALVLKYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDC 1064

Query: 777  SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            S+ VVHCD+KPSNVLLD DMVAH++DFGI KLL+  ESM+QT TL TIGYMAP
Sbjct: 1065 SSLVVHCDLKPSNVLLDDDMVAHVADFGITKLLTKTESMQQTKTLGTIGYMAP 1117

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera]

 Score =  794 bits (2051), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 434/831 (52%), Positives = 571/831 (68%), Gaps = 11/831 (1%)

Query: 1    MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
            +LS SFN  +G IP+ IG+L  L++L L +NKL G IP+E+GNL+ L ++ L +N +SG 
Sbjct: 272  VLSSSFNQFTGGIPQAIGSLCNLEELYLAFNKLTGGIPREIGNLSNLNILQLGSNGISGP 331

Query: 61   IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
            IP+ IFN+SSL   +DF+NNSL+GSLP  +C+ LP ++GLY++ N L+G +P  +  C E
Sbjct: 332  IPAEIFNISSLQV-IDFTNNSLSGSLPMGICKHLPNLQGLYLAQNHLSGQLPTTLSLCGE 390

Query: 121  LIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLV 180
            L+ +SL++N+F   IPR +GNL+ L+ + L  N+L G IP   GNL+ L+ L L +N L 
Sbjct: 391  LLFLSLSFNKFRGSIPREIGNLSKLEHIDLRSNSLVGSIPTSFGNLKALKFLNLGINFLT 450

Query: 181  GFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNA 240
            G VP +IFN+S ++ LAL  N LSGSLPSSI    LP+LE + +  N FSG IP  I N 
Sbjct: 451  GTVPEAIFNISELQNLALVQNHLSGSLPSSIG-TWLPDLEGLYIGANEFSGTIPMSISNM 509

Query: 241  SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSS--TSELSFLSSWANCKNLKL 298
            SKL+VL L +NSF+G +P  L NL KL++L L++N LT     S + FL+S  NCK L+ 
Sbjct: 510  SKLTVLSLSDNSFTGNVPKDLCNLTKLKFLNLAHNQLTDEHLASGVGFLTSLTNCKFLRY 569

Query: 299  LDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGS 358
            L +  NP+ G LP+S+GNL ++L       C  RGTIP  IGNL NL  L L  N+L GS
Sbjct: 570  LWIGYNPLKGTLPNSLGNLPIALESFTAYACQFRGTIPTGIGNLTNLIWLDLGANDLTGS 629

Query: 359  IPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLR 418
            IP T G+LQ LQ L +  N++ G IPN LC L  L  L +  NKLSG  P C GDL +LR
Sbjct: 630  IPTTLGRLQKLQRLHIAGNRIRGSIPNDLCHLKNLGYLGLSSNKLSGSTPSCFGDLLALR 689

Query: 419  LLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGD 478
             L L SN L   IP++ W+L+D+L LN SSNFL G+LP ++GN+K +  +DLS+N +SG 
Sbjct: 690  ELFLDSNALAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGY 749

Query: 479  IPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLK 538
            IP+ +G L  L  LSL  N LQG I    G LVSLESLDLS+N+LSG IP S+E L+YLK
Sbjct: 750  IPSRMGKLQYLITLSLSQNRLQGPIXVEFGDLVSLESLDLSHNNLSGTIPKSLEALIYLK 809

Query: 539  DLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCKSGNSSSHRKSRKNTI 598
             LN+SFNKL+GEIP GGPF  F+  SFM N+ LCG    QV  C   N +   K+ K+ I
Sbjct: 810  YLNVSFNKLQGEIPNGGPFVKFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKT-KSFI 868

Query: 599  LLGVLLPLSTVFIIAVILAVRYAMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQAT 658
            L  +LLP+ +     V L V   +  R ++     + I+S +L   T  + S+++LL AT
Sbjct: 869  LKYILLPVGS----TVTLVVFIVLWIRRRDNMEIPTPIDSWLL--GTHEKISHQQLLYAT 922

Query: 659  NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLV 718
            N F   NLIG G  G VYKG   +G+ VAIKVF+L+ +GAL+SFD ECEV++ +RHRNLV
Sbjct: 923  NDFGEDNLIGKGSQGMVYKGVLSNGLNVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLV 982

Query: 719  KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
            +II+ C+N DFKALVLEYMPNGSLE +LYS+N+  D++QRL+++IDVA ALEYLH   S+
Sbjct: 983  RIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSS 1042

Query: 779  PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             VVHCD+KPSNVLLD DMVAH++DFGIAKLL+  ESM+QT TL TIGYMAP
Sbjct: 1043 LVVHCDLKPSNVLLDDDMVAHVADFGIAKLLTETESMQQTKTLGTIGYMAP 1093

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  794 bits (2050), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 447/830 (53%), Positives = 580/830 (69%), Gaps = 18/830 (2%)

Query: 7   NDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIF 66
           N  +G IP  IGN++ML+ LGLG N L+G IP+E+G L+ ++++ + +N L G IPS IF
Sbjct: 156 NSFTGTIPPSIGNMSMLETLGLGGNHLQGNIPEEIGKLSTMKILDIQSNQLVGAIPSAIF 215

Query: 67  NLSSLSTGMDFSNNSLTGSLPDDMC-RRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVIS 125
           N+SSL   +  + NSL+G LP  MC   L  ++G+ +S N+ TGPIP+N+ +C EL  + 
Sbjct: 216 NISSLQE-IALTYNSLSGDLPSSMCNHELSALRGIRLSANRFTGPIPSNLSKCGELQTLY 274

Query: 126 LAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPT 185
           L++N+FT  IPR + +LT L  L L  N+L+GE+P E+G+L  L +L ++ N L G +P 
Sbjct: 275 LSFNKFTGGIPRSIDSLTKLTMLSLAANSLSGEVPCEIGSLCTLNVLNIEDNSLTGHIPF 334

Query: 186 SIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSV 245
            IFN+S+M + +L  N LSG+LP +     LPNLE + L  N  SGIIPS I NASKL  
Sbjct: 335 QIFNISSMVSGSLTRNNLSGNLPPNFG-SYLPNLENLILEINWLSGIIPSSIGNASKLRS 393

Query: 246 LELGENSFSGFIPNTLGNLRKLEWLRLSYNFLT--SSTSELSFLSSWANCKNLKLLDLSN 303
           L+ G N  +G IP+ LG+LR LE L L  N L   S   ELSFL+S  NCK L++L LS 
Sbjct: 394 LDFGYNMLTGSIPHALGSLRFLERLNLGVNNLKGESYIQELSFLTSLTNCKRLRILYLSF 453

Query: 304 NPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITF 363
           NP+ G+LP SIGNLS SL R   + C ++G IP EIGNL NL  L L  N+L G+IP + 
Sbjct: 454 NPLIGILPISIGNLSTSLQRFEANTCKLKGNIPTEIGNLSNLYLLSLNNNDLTGTIPPSI 513

Query: 364 GKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLA 423
           G+LQ LQGL L +NKL+G IPN +CQL  L  L++  N+LSG IP C+G+LT LR L L 
Sbjct: 514 GQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQLSGSIPACLGELTFLRHLYLG 573

Query: 424 SNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAI 483
           SN+LNS IPST W+L  ILSL+ SSNFL G LP D+GNLKV+V IDLSRN LSG+IP+ I
Sbjct: 574 SNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLKVLVKIDLSRNQLSGEIPSNI 633

Query: 484 GGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLS 543
           GGL +L  LSL  N  +G I  S   L SLE +DLS+N+L G IP S+E L+YLK L++S
Sbjct: 634 GGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNALFGEIPKSLEGLVYLKYLDVS 693

Query: 544 FNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCKSGNSSSHRKSRKNTILLGVL 603
           FN L GEIP  GPFANFS  SFM N  LCG  ++++P C++G   S   S    +LL  +
Sbjct: 694 FNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCRTGTRWSTTISW---LLLKYI 750

Query: 604 LP--LSTVFIIAVILAVRYAMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATNQF 661
           LP  LST+  +A+I      + +RC+++NA     +S  L  AT RR SY+E+ QATN F
Sbjct: 751 LPAILSTLLFLALIF-----VWTRCRKRNAVLPT-QSESLLTATWRRISYQEIFQATNGF 804

Query: 662 NASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKII 721
           +A NL+G G  GSVY+G+  DG   AIKVF+LQ E A KSFD ECEV+  +RHRNL+KI+
Sbjct: 805 SAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIV 864

Query: 722 SSCTNN--DFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
           SSC+N+  DFKALVLEY+PNGSLE +LYS+N+  DILQRL+++IDVALA+EYLH G S P
Sbjct: 865 SSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCSTP 924

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           VVHCD+KPSN+LLD+D   H+ DFGIAKLL  EES+++T TLATIGYMAP
Sbjct: 925 VVHCDLKPSNILLDEDFGGHVGDFGIAKLLREEESIRETQTLATIGYMAP 974

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147769371|emb|CAN72496.1| hypothetical protein VITISV_010511 [Vitis vinifera]

 Score =  792 bits (2045), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 435/833 (52%), Positives = 569/833 (68%), Gaps = 15/833 (1%)

Query: 1    MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
            +LSLSFN  +G IP+ IG+L+ L+ L L YNKL G IP+E+GNL+ L ++ L +N +SG 
Sbjct: 308  VLSLSFNQFTGGIPQAIGSLSNLEGLYLSYNKLTGGIPREIGNLSNLNILQLGSNGISGP 367

Query: 61   IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
            IP+ IFN+SSL   +DFSNNSL+GSLP D+C+ LP ++GLY+  N L+G +P  +  C E
Sbjct: 368  IPAEIFNISSLQI-IDFSNNSLSGSLPMDICKHLPNLQGLYLLQNHLSGQLPTTLSLCGE 426

Query: 121  LIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLV 180
            L+ +SLA N+F   IPR +GNL+ L+ + L  N+L G IP   GNL  L+ L L +N L 
Sbjct: 427  LLYLSLAVNKFRGSIPREIGNLSKLEDISLRSNSLVGSIPTSFGNLMALKYLDLGMNFLT 486

Query: 181  GFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNA 240
            G VP +IFN+S ++ L L  N LSGSLP SI    LP+LE + +  N FSG IP  I N 
Sbjct: 487  GTVPEAIFNISELQILVLVQNHLSGSLPPSIG-TWLPDLEGLYIGSNKFSGTIPMSISNM 545

Query: 241  SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSS--TSELSFLSSWANCKNLKL 298
            SKL  L++ +NSF+G +P  LGNL KLE L L+ N LT+    S + FL+S  NCK L+ 
Sbjct: 546  SKLIQLQVWDNSFTGNVPKDLGNLTKLEVLNLAANQLTNEHLASGVGFLTSLTNCKFLRH 605

Query: 299  LDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGS 358
            L + +NP  G LP+S+GNL ++L     S C  RGTIP  IGNL NL EL L  N+L  S
Sbjct: 606  LWIDDNPFKGTLPNSLGNLPIALESFTASACQFRGTIPTGIGNLTNLIELDLGANDLTRS 665

Query: 359  IPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLR 418
            IP T G+LQ LQ L +  N++ G IPN LC L  L  L++  NKLSG IP C GDL +L+
Sbjct: 666  IPTTLGRLQKLQRLHIAGNRIRGSIPNDLCHLKNLGYLHLXSNKLSGSIPSCFGDLPALQ 725

Query: 419  LLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGD 478
             L L SN L   IP++ W+L+D+L LN SSNFL G+LP ++GN+K +  +DLS+N +SG 
Sbjct: 726  ELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGY 785

Query: 479  IPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLK 538
            IP  +G   NL  LSL  N LQG IP   G LVSLESLDLS N+LSG IP S+E L+YLK
Sbjct: 786  IPRRMGEQQNLAKLSLSQNRLQGPIPXEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLK 845

Query: 539  DLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCKSGNSSSHRKSRKNTI 598
             LN+S NKL+GEIP GGPF NF+  SFM N+ LCG    QV  C   N +   K+ K+ I
Sbjct: 846  YLNVSSNKLQGEIPNGGPFXNFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKT-KSFI 904

Query: 599  LLGVLLPLST--VFIIAVILAVRYAMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQ 656
            L  +LLP+ +    ++ ++L +R       +  N +      + LP  T  + S+++LL 
Sbjct: 905  LKYILLPVGSTITLVVFIVLWIR-------RRDNMEIXTPIDSWLP-GTHEKISHQQLLY 956

Query: 657  ATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRN 716
            ATN F   NLIG G  G VYKG   +G+ VAIKVF+L+ +GAL+SFD ECEV++ +RHRN
Sbjct: 957  ATNDFGEDNLIGKGSQGMVYKGVLSNGLIVAIKVFNLEFQGALRSFDSECEVMQGIRHRN 1016

Query: 717  LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
            LV+II+ C+N DFKALVL+YMPNGSLE +LYS+N+  D++QRL+++IDVA ALEYLH   
Sbjct: 1017 LVRIITCCSNLDFKALVLKYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDC 1076

Query: 777  SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            S+ VVHCD+KPSNVLLD BMVAH++DFGIAKLL+  ESM+QT TL TIGYMAP
Sbjct: 1077 SSLVVHCDLKPSNVLLDDBMVAHVTDFGIAKLLTKTESMQQTKTLGTIGYMAP 1129

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483675|ref|XP_003632999.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  788 bits (2035), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 436/831 (52%), Positives = 575/831 (69%), Gaps = 11/831 (1%)

Query: 1    MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
            +L LS N  +G IPK +G+L+ L++L LGYNKL G IP+E+G L+ L ++ L ++ ++G 
Sbjct: 295  VLKLSINQFTGGIPKALGSLSDLEELYLGYNKLTGGIPREIGILSNLNILHLASSGINGP 354

Query: 61   IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
            IP+ IFN+SSL   +DF+NNSL+G LP D+C+ LP ++GLY+S N L+G +P  ++ C E
Sbjct: 355  IPAEIFNISSLHR-IDFTNNSLSGGLPMDICKHLPNLQGLYLSQNHLSGQLPTTLFLCGE 413

Query: 121  LIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLV 180
            L+++SL+ N+FT  IPR +GNL+ LK +YL  N+L G IP   GNL+ L+ L L  N L+
Sbjct: 414  LLLLSLSINKFTRSIPRDIGNLSKLKKIYLSTNSLIGSIPTSFGNLKALKFLQLGSNNLI 473

Query: 181  GFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNA 240
            G +P  IFN+S ++TLAL  N LSG LPSSI    LP+LE + + GN FSG IP  I N 
Sbjct: 474  GTIPEDIFNISKLQTLALAQNHLSGGLPSSIS-TWLPDLEGLFIGGNEFSGTIPVSISNM 532

Query: 241  SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSS--TSELSFLSSWANCKNLKL 298
            SKL  L + +N F G +P  L NLRKLE L L+ N LT    TSE+ FL+S  NCK L+ 
Sbjct: 533  SKLIRLHISDNYFIGNVPKDLSNLRKLEVLNLAGNQLTDEHLTSEVGFLTSLTNCKFLRT 592

Query: 299  LDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGS 358
            L +  NP+ G LP+S+GNLS++L     S C  RGTIP  IGNL NL  L L  N+L GS
Sbjct: 593  LWIDYNPLKGTLPNSLGNLSVALESFTASACHFRGTIPTGIGNLTNLIWLDLGANDLTGS 652

Query: 359  IPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLR 418
            IP T G+LQ LQ L +  N+++G IPN L  L  L  L++  NKLSG IP C GDL +LR
Sbjct: 653  IPTTLGQLQKLQRLYIAGNRIQGSIPNDLFHLKNLGYLHLSSNKLSGSIPSCFGDLPALR 712

Query: 419  LLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGD 478
             LSL SN L   IP +FW+L+D+L L+ SSNFL G+LP ++GN+K +  +DLS+N +SG 
Sbjct: 713  ELSLDSNVLAFNIPMSFWSLRDLLVLSLSSNFLTGNLPPEVGNMKSITTLDLSKNLISGY 772

Query: 479  IPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLK 538
            IP  +G L NL +L L  N LQGSIP   G L+SLES+DLS N+LSG IP S+E L+YLK
Sbjct: 773  IPRRMGELQNLVNLCLSQNKLQGSIPVEFGDLLSLESMDLSQNNLSGTIPKSLEALIYLK 832

Query: 539  DLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCKSGNSSSHRKSRKNTI 598
             LN+SFNKL+GEIP GGPF NF+  SF+ N+ LCG    QV  C   N +   K+ K+ I
Sbjct: 833  HLNVSFNKLQGEIPDGGPFVNFTAESFIFNEALCGAPHFQVIACDKNNHTQSWKT-KSFI 891

Query: 599  LLGVLLPLSTVFIIAVILAVRYAMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQAT 658
            L  +LLP+ ++    V L     +  R Q+     + I+S  LP A   + S ++LL AT
Sbjct: 892  LKYILLPVGSI----VTLVAFIVLWIRRQDNTEIPAPIDS-WLPGA-HEKISQQQLLYAT 945

Query: 659  NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLV 718
            N F   NLIG G  G VYKG   +G+ VAIKVF+L+ +GAL+SFD ECEV++ + HRNL+
Sbjct: 946  NDFGEDNLIGKGSLGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGICHRNLI 1005

Query: 719  KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
            +II+ C+N DFKALVLEYMP GSL+ +LYS+N+  D+ QRL+++IDVALALEYLH   S+
Sbjct: 1006 RIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLFQRLNIMIDVALALEYLHHDCSS 1065

Query: 779  PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             VVHCD+KPSNVLLD +MVAH++DFGIA+LL+  ESM+QT TL TIGYMAP
Sbjct: 1066 LVVHCDLKPSNVLLDNNMVAHVADFGIARLLTETESMQQTKTLGTIGYMAP 1116

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359497186|ref|XP_003635448.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  785 bits (2028), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 434/837 (51%), Positives = 568/837 (67%), Gaps = 18/837 (2%)

Query: 2    LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSG-- 59
            L+LS N LSG IP  +G    L+ + L YN   G IP  + NL EL+ +SL NN  +   
Sbjct: 201  LNLSSNHLSGKIPTGLGQCIQLQVISLAYNDFTGSIPSGIDNLVELQRLSLQNNSFTAFK 260

Query: 60   -----TIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNN 114
                  + + IFN+SSL   + F++NSL+GSLP D+C+ LP ++GL +S N L+G +P  
Sbjct: 261  DISKALLFAEIFNVSSLQV-IAFTDNSLSGSLPKDICKHLPNLQGLSLSQNHLSGQLPTT 319

Query: 115  IWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGL 174
            +  C EL+ +SL++N+F   IP+ +GNL+ L+ +YLG N+L G IP   GNL+ L+ L L
Sbjct: 320  LSLCGELLFLSLSFNKFRGSIPKEIGNLSKLEEIYLGTNSLIGSIPTSFGNLKALKFLNL 379

Query: 175  QLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIP 234
             +N L G VP +IFN+S +++LA+  N LSGSLPSSI    LP+LE + +AGN FSGIIP
Sbjct: 380  GINNLTGTVPEAIFNISKLQSLAMVKNHLSGSLPSSIG-TWLPDLEGLFIAGNEFSGIIP 438

Query: 235  SFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSS--TSELSFLSSWAN 292
              I N SKL+VL L  NSF+G +P  LGNL KL+ L L+ N LT     SE+ FL+S  N
Sbjct: 439  MSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGNQLTDEHVASEVGFLTSLTN 498

Query: 293  CKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWG 352
            CK LK L + N P  G LP+S+GNL ++L     S C  RGTIP  IGNL NL  L L  
Sbjct: 499  CKFLKNLWIGNIPFKGTLPNSLGNLPIALESFIASACQFRGTIPTGIGNLTNLIRLDLGA 558

Query: 353  NELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIG 412
            N+L GSIP T G+LQ LQ L +  N++ G IPN LC L  L  L++  NKLSG IP C G
Sbjct: 559  NDLTGSIPTTLGQLQKLQWLYIAGNRIRGSIPNDLCHLKDLGYLFLSSNKLSGSIPSCFG 618

Query: 413  DLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSR 472
            DL +L+ L L SN L   IP++ W+L+D+L+LN SSNFL G+LP ++GN+K +  +DLS+
Sbjct: 619  DLLALQELFLDSNVLAFNIPTSLWSLRDLLALNLSSNFLTGNLPPEVGNMKSITTLDLSK 678

Query: 473  NNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSME 532
            N +SG IP+ +G L +L  LSL  N LQG IP   G LVSLESLDLS N+LSG IP S+E
Sbjct: 679  NLVSGYIPSKMGKLQSLITLSLSQNRLQGPIPIEFGDLVSLESLDLSQNNLSGTIPKSLE 738

Query: 533  KLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCKSGNSSSHRK 592
             L+YLK LN+S NKL+GEIP GGPF NF+  SFM N+ LCG    QV  C   N +   K
Sbjct: 739  ALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKNNRTQSWK 798

Query: 593  SRKNTILLGVLLPLSTVFIIAVILAVRYAMISRCQEKNAKQSNIESNMLPQATRRRFSYK 652
            + K+ IL  +LLP+ ++    V L V   +  R ++     + I+S  LP  T  + S++
Sbjct: 799  T-KSFILKYILLPVGSI----VTLVVFIVLWIRRRDNMEIPTPIDS-WLP-GTHEKISHQ 851

Query: 653  ELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV 712
            +LL ATN F   NLIG G  G VYKG   +G+ VAIKVF+L+ +GAL+SFD ECEV++ +
Sbjct: 852  QLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGI 911

Query: 713  RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            RHRNLV+II+ C+N DFKALVLEYMPNGSLE +LYS+N+  D++QRL+++IDVA ALEYL
Sbjct: 912  RHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYL 971

Query: 773  HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            H   S+ VVHCD+KP+NVLLD DMVAH++DFGI KLL+  ESM+QT TL TIGYMAP
Sbjct: 972  HHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGITKLLTKTESMQQTKTLGTIGYMAP 1028

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483683|ref|XP_003633001.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  784 bits (2025), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 434/831 (52%), Positives = 574/831 (69%), Gaps = 11/831 (1%)

Query: 1    MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
            +L LS N  +G IPK +G+L+ L++L LGYNKL G IP+E+GNL+ L ++ L ++ ++G 
Sbjct: 295  VLKLSINQFTGGIPKALGSLSDLEELYLGYNKLTGGIPREIGNLSNLNILHLASSGINGP 354

Query: 61   IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
            IP+ IFN+SSL   +DF+NNSL+G LP D+C+ LP ++GLY+S N L+G +P  ++ C E
Sbjct: 355  IPAEIFNISSLHR-IDFTNNSLSGGLPMDICKHLPNLQGLYLSQNHLSGQLPTTLFLCGE 413

Query: 121  LIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLV 180
            L+++SL+ N+FT  IPR +GNL+ L+ +YL  N+L G IP   GNL+ L+ L L  N L 
Sbjct: 414  LLLLSLSINKFTGSIPRDIGNLSKLEKIYLSTNSLIGSIPTSFGNLKALKFLQLGSNNLT 473

Query: 181  GFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNA 240
            G +P  IFN+S ++TLAL  N LSG LPSSI    LP+LE + + GN FSG IP  I N 
Sbjct: 474  GTIPEDIFNISKLQTLALAQNHLSGGLPSSIG-TWLPDLEGLFIGGNEFSGTIPVSISNM 532

Query: 241  SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSS--TSELSFLSSWANCKNLKL 298
            SKL  L + +N F+G +P  L NLRKLE L L+ N LT    TSE+ FL+S  NCK L+ 
Sbjct: 533  SKLIRLHISDNYFTGNVPKDLSNLRKLEVLNLAGNQLTDEHLTSEVGFLTSLTNCKFLRT 592

Query: 299  LDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGS 358
            L +  NP+ G LP+S+GNLS++L     S C  RGTIP  IGNL NL  L L  N+L GS
Sbjct: 593  LWIDYNPLKGTLPNSLGNLSVALESFTASACHFRGTIPTGIGNLTNLIWLDLGANDLTGS 652

Query: 359  IPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLR 418
            IP T G LQ LQ L +  N+++G IPN LC L  L  L++  NKLSG IP C GDL +LR
Sbjct: 653  IPTTLGHLQKLQRLYIAGNRIQGSIPNDLCHLKNLGYLHLSSNKLSGSIPSCFGDLPALR 712

Query: 419  LLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGD 478
             LSL SN L   IP +FW+L+D++ L+ SSNFL G+LP ++GN+K +  +DLS+N +SG 
Sbjct: 713  ELSLDSNVLAFNIPMSFWSLRDLMVLSLSSNFLTGNLPPEVGNMKSITTLDLSKNLISGY 772

Query: 479  IPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLK 538
            IP  +G L NL +L L  N LQGSIP   G L+SLES+DLS N+L G IP S+E L+YLK
Sbjct: 773  IPRRMGELQNLVNLCLSQNKLQGSIPVEFGDLLSLESMDLSQNNLFGTIPKSLEALIYLK 832

Query: 539  DLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCKSGNSSSHRKSRKNTI 598
             LN+SFNKL+GEIP GGPF NF+  SF+ N+ LCG    QV  C   N +   K+ K+ I
Sbjct: 833  HLNVSFNKLQGEIPNGGPFVNFTAESFIFNEALCGAPHFQVIACDKNNRTQSWKT-KSFI 891

Query: 599  LLGVLLPLSTVFIIAVILAVRYAMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQAT 658
            L  +LLP+ +    AV L     +  R ++     + I+S  LP A   + S ++LL AT
Sbjct: 892  LKYILLPVGS----AVTLVAFIVLWIRRRDNTEIPAPIDS-WLPGA-HEKISQQQLLYAT 945

Query: 659  NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLV 718
            N F   NLIG G  G VYKG   +G+ VAIKVF+L+ +GAL+SFD ECEV++ + HRNL+
Sbjct: 946  NGFGEDNLIGKGSLGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGICHRNLI 1005

Query: 719  KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
            +II+ C+N DFKALVLEYMP GSL+ +LYS+N+  D+ QRL+++IDVA ALEYLH   S+
Sbjct: 1006 RIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLFQRLNIMIDVASALEYLHHDCSS 1065

Query: 779  PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             VVHCD+KPSNVLLD +MVAH++DFGIA+LL+  ESM+QT TL TIGYMAP
Sbjct: 1066 LVVHCDLKPSNVLLDNNMVAHVADFGIARLLTETESMQQTKTLGTIGYMAP 1116

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	832
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.931	0.751	0.369	2.2e-130
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.947	0.768	0.388	5.7e-130
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.974	0.691	0.357	1.1e-124
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.948	0.781	0.360	2.7e-123
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.931	0.756	0.358	1.1e-119
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.951	0.783	0.334	1.6e-118
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.948	0.781	0.343	1.6e-116
UNIPROTKB|O24435	813	O24435 "Receptor kinase-like p	0.820	0.840	0.370	1.3e-109
TAIR|locus:2122239	1136	AT4G36180 [Arabidopsis thalian	0.756	0.553	0.328	6.5e-104
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.960	0.639	0.299	2.3e-85

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 1279 (455.3 bits), Expect = 2.2e-130, P = 2.2e-130
 Identities = 298/806 (36%), Positives = 445/806 (55%)

Query:    26 LGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGS 85
             L LG  KL G I   +GNL+ L L++L +N    TIP  +  L  L   ++ S N L G 
Sbjct:    78 LNLGGFKLTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQY-LNMSYNLLEGR 136

Query:    86 LPDDM--CRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLT 143
             +P  +  C RL  +    +S+N L   +P+ +    +L ++ L+ N  T   P  LGNLT
Sbjct:   137 IPSSLSNCSRLSTVD---LSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLT 193

Query:   144 SLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNAL 203
             SL+ L   +N + GEIP E+  L  +    + LN   G  P +++N+S++++L+L  N+ 
Sbjct:   194 SLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSF 253

Query:   204 SGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGN 263
             SG+L +    + LPNL  + L  N F+G IP  + N S L   ++  N  SG IP + G 
Sbjct:   254 SGNLRADFGYL-LPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGK 312

Query:   264 LRKLEWLRLSYNXXXXXXXXXXXXX-XWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLS 322
             LR L WL +  N                ANC  L+ LD+  N + G LP+SI NLS +L+
Sbjct:   313 LRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLT 372

Query:   323 RIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGP 382
              +F+    I GTIP +IGNL++L+EL L  N L G +P++FGKL NLQ +DL +N + G 
Sbjct:   373 SLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGE 432

Query:   383 IPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDIX 442
             IP+    + RL  L+++ N   G IP  +G    L  L + +N LN  IP     +  + 
Sbjct:   433 IPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLA 492

Query:   443 XXXXXXXXXXXXXPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGS 502
                          PE++G L+++V +  S N LSG +P AIGG ++++ L ++ N   G+
Sbjct:   493 YIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGA 552

Query:   503 IPKSIGGXXXXXXXXXXXXXXXXXIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSN 562
             IP  I                   IP  +  L  L++LNLS NK EG +P  G F N + 
Sbjct:   553 IP-DISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATA 611

Query:   563 RSFMGNDLLCG-LAQVQVPVCKSGNSSSHRK--SRKNTILLGVLLPLSTVFIIAVILAVR 619
              S  GN  +CG + ++Q+  C    S   RK  S +  ++ G+ + ++++ +I ++ ++ 
Sbjct:   612 VSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLC 671

Query:   620 YAMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGS 679
             + M  R ++ NA   N   +        + SY+EL  AT++F+++NLIG+G FG+V+KG 
Sbjct:   672 WFM-KRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKG- 729

Query:   680 FLDGME---VAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN-----NDFKA 731
              L G E   VA+KV +L   GA KSF  ECE  K +RHRNLVK+I+ C++     NDF+A
Sbjct:   730 -LLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRA 788

Query:   732 LVLEYMPNGSL------EDYLYSNNFSFDIL--QRLSVIIDVALALEYLHFGYSNPVVHC 783
             LV E+MP GSL      ED    N+ S  +   ++L++ IDVA ALEYLH    +PV HC
Sbjct:   789 LVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHC 848

Query:   784 DIKPSNVLLDKDMVAHLSDFGIAKLL 809
             DIKPSN+LLD D+ AH+SDFG+A+LL
Sbjct:   849 DIKPSNILLDDDLTAHVSDFGLAQLL 874

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1275 (453.9 bits), Expect = 5.7e-130, P = 5.7e-130
 Identities = 321/827 (38%), Positives = 457/827 (55%)

Query:    25 KLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTG 84
             KL L  + L G I   LGNL+ L  + L +N+LSG IP  +  LS L   ++ S+NS+ G
Sbjct:    83 KLLLRSSNLSGIISPSLGNLSFLRELDLGDNYLSGEIPPELSRLSRLQL-LELSDNSIQG 141

Query:    85 SLPDDM--CRRLPLIKGLYMSNNKLTGPIPNNIW-QCKELIVISLAYNQFTERIPRGLGN 141
             S+P  +  C +L     L +S+N+L G IP  I    K L  + L  N  +  IP  LGN
Sbjct:   142 SIPAAIGACTKLT---SLDLSHNQLRGMIPREIGASLKHLSNLYLYKNGLSGEIPSALGN 198

Query:   142 LTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSN 201
             LTSL+   L FN L+G IP  +G L +L  + L  N L G +P SI+NLS+++  ++  N
Sbjct:   199 LTSLQEFDLSFNRLSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVREN 258

Query:   202 ALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTL 261
              L G +P++     L  LE+I +  N F G IP+ + NAS L+V+++  N FSG I +  
Sbjct:   259 KLGGMIPTNA-FKTLHLLEVIDMGTNRFHGKIPASVANASHLTVIQIYGNLFSGIITSGF 317

Query:   262 GNLRKLEWLRLSYNXXXXXXXXX-XXXXXWANCKNLKLLDLSNNPINGVLPSSIGNLSLS 320
             G LR L  L L  N                 NC  L+ L+L  N + GVLP+S  NLS S
Sbjct:   318 GRLRNLTELYLWRNLFQTREQDDWGFISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTS 377

Query:   321 LSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLE 380
             LS + +    I G+IPK+IGNLI L+ L L  N   GS+P + G+L+NL  L    N L 
Sbjct:   378 LSFLALELNKITGSIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLS 437

Query:   381 GPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKD 440
             G IP  +  L  L++L +  NK SG IP  + +LT+L  L L++N L+  IPS  +N++ 
Sbjct:   438 GSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQT 497

Query:   441 IXXXXXXXXXXXXXX-PEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGL 499
             +               P++IG+LK +V      N LSG IP  +G    L+ L L++N L
Sbjct:   498 LSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLL 557

Query:   500 QGSIPKSIGGXXXXXXXXXXXXXXXXXIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFAN 559
              GSIP ++G                  IPTS+  +  L  LNLSFN   GE+P  G FA 
Sbjct:   558 SGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAA 617

Query:   560 FSNRSFMGNDLLCG-LAQVQVPVCKSGNSSSHRKSRKNTILLGVLLPLSTVFIIAVILAV 618
              S  S  GN  LCG +  + +P C         ++RK+  +L + + L+       IL+ 
Sbjct:   618 ASGISIQGNAKLCGGIPDLHLPRC-----CPLLENRKHFPVLPISVSLAAAL---AILSS 669

Query:   619 RYAMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKG 678
              Y +I+   ++  K +   ++M         SY +L++AT+ F  +NL+G+G FGSVYKG
Sbjct:   670 LYLLIT-WHKRTKKGAPSRTSMKGHPL---VSYSQLVKATDGFAPTNLLGSGSFGSVYKG 725

Query:   679 SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN-----NDFKALV 733
                    VA+KV  L+   ALKSF  ECE L+++RHRNLVKI++ C++     NDFKA+V
Sbjct:   726 KLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIV 785

Query:   734 LEYMPNGSLEDYLY-SNNFSFD-----ILQRLSVIIDVALALEYLHFGYSNPVVHCDIKP 787
              ++MPNGSLED+++   N   D     + +R+++++DVA AL+YLH     PVVHCDIK 
Sbjct:   786 YDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKS 845

Query:   788 SNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT-----LATIGYMAP 829
             SNVLLD DMVAH+ DFG+A++L    S+ Q  T     + TIGY AP
Sbjct:   846 SNVLLDSDMVAHVGDFGLARILVDGTSLIQQSTSSMGFIGTIGYAAP 892

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1225 (436.3 bits), Expect = 1.1e-124, P = 1.1e-124
 Identities = 301/843 (35%), Positives = 447/843 (53%)

Query:     2 LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
             L LS N L+G IP++ GNL  L+ L L  N L G+IP E+GN + L  + L +N L+G I
Sbjct:   221 LDLSGNQLTGKIPRDFGNLLNLQSLVLTENLLEGDIPAEIGNCSSLVQLELYDNQLTGKI 280

Query:    62 PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
             P+ + NL  L   +    N LT S+P  + R L  +  L +S N L GPI   I   + L
Sbjct:   281 PAELGNLVQLQA-LRIYKNKLTSSIPSSLFR-LTQLTHLGLSENHLVGPISEEIGFLESL 338

Query:   122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVG 181
              V++L  N FT   P+ + NL +L  L +GFNN++GE+P ++G L NL  L    N L G
Sbjct:   339 EVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGLLTNLRNLSAHDNLLTG 398

Query:   182 FVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNAS 241
              +P+SI N + +K L L  N ++G +P      R+ NL  IS+  N+F+G IP  IFN S
Sbjct:   399 PIPSSISNCTGLKLLDLSHNQMTGEIPRGFG--RM-NLTFISIGRNHFTGEIPDDIFNCS 455

Query:   242 KLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNXXXXXXXXXXXXXXWANCKNLKLLDL 301
              L  L + +N+ +G +   +G L+KL  L++SYN                N K+L +L L
Sbjct:   456 NLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPREI-----GNLKDLNILYL 510

Query:   302 SNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPI 361
              +N   G +P  + NL+L       SN  + G IP+E+ ++  L  L L  N+  G IP 
Sbjct:   511 HSNGFTGRIPREMSNLTLLQGLRMYSN-DLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPA 569

Query:   362 TFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIP-PCIGDLTSLRL- 419
              F KL++L  L L  NK  G IP  L  L+ L+   +  N L+G IP   +  L +++L 
Sbjct:   570 LFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLY 629

Query:   420 LSLASNELNSVIPSTFWNLKDIXXXXXXXXXXXXXXPEDIGNLKVVVIIDLSRNNLSGDI 479
             L+ ++N L   IP     L+ +              P  +   K V  +D S+NNLSG I
Sbjct:   630 LNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHI 689

Query:   480 PTAI-GGLMNLQDLSLRDNGLQGSIPKSIGGXXXXXXXXXXXXXXXXXIPTSMEKLLYLK 538
             P  +  G+  +  L+L  N   G IP+S G                  IP S+  L  LK
Sbjct:   690 PDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLK 749

Query:   539 DLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCKSGNSSSHRKSRKNTI 598
              L L+ N L+G +P  G F N +    MGN  LCG  +   P C     SSH   R   I
Sbjct:   750 HLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLKP-CTIKQKSSHFSKRTRVI 808

Query:   599 LLGVLLPLSTVFIIAVILAVRYAMISRCQEKNAKQSNIESNMLPQ---ATR-RRFSYKEL 654
             L  ++L  +   ++ ++L +   +++ C++K  K  N   + LP    A + +RF  KEL
Sbjct:   809 L--IILGSAAALLLVLLLVL---ILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKEL 863

Query:   655 LQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSV 712
              QAT+ FN++N+IG+    +VYKG   DG  +A+KV +L+   A   K F  E + L  +
Sbjct:   864 EQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQL 923

Query:   713 RHRNLVKIIS-SCTNNDFKALVLEYMPNGSLEDYLYSNNFSF-DILQRLSVIIDVALALE 770
             +HRNLVKI+  +  +   KALVL +M NG+LED ++ +      +L+++ + + +A  ++
Sbjct:   924 KHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGID 983

Query:   771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA----TIGY 826
             YLH GY  P+VHCD+KP+N+LLD D VAH+SDFG A++L   E    T + +    TIGY
Sbjct:   984 YLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGY 1043

Query:   827 MAP 829
             +AP
Sbjct:  1044 LAP 1046

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 1212 (431.7 bits), Expect = 2.7e-123, P = 2.7e-123
 Identities = 296/821 (36%), Positives = 441/821 (53%)

Query:    26 LGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGS 85
             L LG  +L G I   +GNL+ L  + L  NF  GTIP  +  LS L   +D   N L G 
Sbjct:    71 LELGRLQLGGVISPSIGNLSFLVSLDLYENFFGGTIPQEVGQLSRLEY-LDMGINYLRGP 129

Query:    86 LPDDM--CRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLT 143
             +P  +  C RL     L + +N+L G +P+ +     L+ ++L  N    ++P  LGNLT
Sbjct:   130 IPLGLYNCSRL---LNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLT 186

Query:   144 SLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNAL 203
              L+ L L  NNL GEIP ++  L  +  L L  N   G  P +++NLS++K L +  N  
Sbjct:   187 LLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHF 246

Query:   204 SGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGN 263
             SG L   + ++ LPNL   ++ GN F+G IP+ + N S L  L + EN+ +G IP T GN
Sbjct:   247 SGRLRPDLGIL-LPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGN 304

Query:   264 LRKLEWLRLSYNXXXXXXXXXXXX-XXWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLS 322
             +  L+ L L  N                 NC  L+ L +  N + G LP SI NLS  L 
Sbjct:   305 VPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLV 364

Query:   323 RIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGP 382
              + +    I G+IP +IGNLINL++L L  N L G +P + GKL NL+ L L +N+L G 
Sbjct:   365 TLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGG 424

Query:   383 IPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDIX 442
             IP  +  +  L  L +  N   G +P  +G+ + L  L +  N+LN  IP     ++ + 
Sbjct:   425 IPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLL 484

Query:   443 XXXXXXXXXXXXXPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGS 502
                          P+DIG L+ +  + L  N LSG +P  +G  + ++ L L  N   G 
Sbjct:   485 RLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGD 544

Query:   503 IPKSIGGXXXXXXXXXXXXXXXXXIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSN 562
             IP  + G                 IP        L+ LNLSFN LEG++P  G F N + 
Sbjct:   545 IP-DLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATT 603

Query:   563 RSFMGNDLLCG-LAQVQVPVCKSGNSSSHRK--SRKNTILLGVLLPLSTVFIIAVILAVR 619
              S +GN+ LCG +   Q+  C S   S  +K  SR   +++GV + + T+ ++  + +V 
Sbjct:   604 VSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGI-TLLLLLFMASVT 662

Query:   620 YAMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGS 679
                + R ++KN + +N   + L +    + SY +L  ATN F++SN++G+G FG+VYK  
Sbjct:   663 LIWL-RKRKKNKETNNPTPSTL-EVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKAL 720

Query:   680 FLDGMEV-AIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN-----NDFKALV 733
              L   +V A+KV ++Q  GA+KSF  ECE LK +RHRNLVK++++C++     N+F+AL+
Sbjct:   721 LLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALI 780

Query:   734 LEYMPNGSLEDYLYSNNF--------SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
              E+MPNGSL+ +L+            +  +L+RL++ IDVA  L+YLH     P+ HCD+
Sbjct:   781 YEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDL 840

Query:   786 KPSNVLLDKDMVAHLSDFGIAKLLS--GEESMKQTLTLATI 824
             KPSNVLLD D+ AH+SDFG+A+LL    EES    L+ A +
Sbjct:   841 KPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGV 881

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1178 (419.7 bits), Expect = 1.1e-119, P = 1.1e-119
 Identities = 287/801 (35%), Positives = 424/801 (52%)

Query:    28 LGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLP 87
             LG  KL G +   +GNL+ L  ++L +NF  G IPS + NL  L   ++ SNN   G +P
Sbjct:    88 LGGLKLTGVVSPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQY-LNMSNNLFGGVIP 146

Query:    88 DDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKT 147
               +      +  L +S+N L   +P       +L+++SL  N  T + P  LGNLTSL+ 
Sbjct:   147 V-VLSNCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQM 205

Query:   148 LYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSL 207
             L   +N + GEIP ++  L+ +    + LNK  G  P  I+NLS++  L++  N+ SG+L
Sbjct:   206 LDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTL 265

Query:   208 PSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKL 267
                   + LPNL+I+ +  N+F+G IP  + N S L  L++  N  +G IP + G L+ L
Sbjct:   266 RPDFGSL-LPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNL 324

Query:   268 EWLRLSYNXXXXXXXXXXXXX-XWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFI 326
               L L+ N                 NC  L+ L++  N + G LP  I NLS  L+ + +
Sbjct:   325 LLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSL 384

Query:   327 SNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNG 386
                 I G+IP  IGNL++L+ L L  N L G +P + G+L  L+ + L +N L G IP+ 
Sbjct:   385 GGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSS 444

Query:   387 LCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDIXXXXX 446
             L  ++ L+ LY+  N   G IP  +G  + L  L+L +N+LN  IP     L  +     
Sbjct:   445 LGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNV 504

Query:   447 XXXXXXXXXPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKS 506
                       +DIG LK ++ +D+S N LSG IP  +   ++L+ L L+ N   G IP  
Sbjct:   505 SFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIP-D 563

Query:   507 IGGXXXXXXXXXXXXXXXXXIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFM 566
             I G                 IP  M     L++LNLS N  +G +P  G F N S  S  
Sbjct:   564 IRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVF 623

Query:   567 GNDLLCG-LAQVQVPVCKSGNSSSHRKSRKN-TILLGVLLPLSTVFIIAVILAVRYAMIS 624
             GN  LCG +  +Q+  C       H   RK  TI +  ++    +  + V+    Y +  
Sbjct:   624 GNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKL-- 681

Query:   625 RCQEKNAKQSNIESNMLP-QATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDG 683
             R +   A  +  + +  P ++   + SY EL + T  F++SNLIG+G FG+V+KG FL  
Sbjct:   682 RVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKG-FLGS 740

Query:   684 ME--VAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN-----NDFKALVLEY 736
                 VAIKV +L   GA KSF  ECE L  +RHRNLVK+++ C++     NDF+ALV E+
Sbjct:   741 KNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEF 800

Query:   737 MPNGSLEDYLYSNNF--------SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPS 788
             MPNG+L+ +L+ +          +  +  RL++ IDVA AL YLH    NP+ HCDIKPS
Sbjct:   801 MPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPS 860

Query:   789 NVLLDKDMVAHLSDFGIAKLL 809
             N+LLDKD+ AH+SDFG+A+LL
Sbjct:   861 NILLDKDLTAHVSDFGLAQLL 881

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1167 (415.9 bits), Expect = 1.6e-118, P = 1.6e-118
 Identities = 274/819 (33%), Positives = 432/819 (52%)

Query:    26 LGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGS 85
             L LG  +L G +   +GN++ L  + L++N   G IP  + NL  L   +  + NSL G 
Sbjct:    71 LNLGGLQLGGIVSPSIGNVSFLISLDLSDNAFGGIIPREVGNLFRLEH-LYMAFNSLEGG 129

Query:    86 LPDDM--CRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLT 143
             +P  +  C RL L   LY  +N L   +P+ +    +L+++ L  N    ++PR LGNLT
Sbjct:   130 IPATLSNCSRL-LNLDLY--SNPLRQGVPSELGSLTKLVILDLGRNNLKGKLPRSLGNLT 186

Query:   144 SLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNAL 203
             SLK+L    NN+ GE+P E+  L  +  LGL +NK  G  P +I+NLSA++ L L  +  
Sbjct:   187 SLKSLGFTDNNIEGEVPDELARLSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGF 246

Query:   204 SGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGN 263
             SGSL      + LPN+  ++L  N+  G IP+ + N S L    + +N  +G I    G 
Sbjct:   247 SGSLKPDFGNL-LPNIRELNLGENDLVGAIPTTLSNISTLQKFGINKNMMTGGIYPNFGK 305

Query:   264 LRKLEWLRLSYN-XXXXXXXXXXXXXXWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLS 322
             +  L++L LS N                 NC +L+LL +    + G LP+SI N+S  L 
Sbjct:   306 VPSLQYLDLSENPLGSYTFGDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELI 365

Query:   323 RIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGP 382
              + +      G+IP++IGNLI L+ L L  N L G +P + GKL  L  L L +N++ G 
Sbjct:   366 SLNLIGNHFFGSIPQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGE 425

Query:   383 IPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDIX 442
             IP+ +  L +L +LY+  N   G +PP +G  + +  L +  N+LN  IP     +  + 
Sbjct:   426 IPSFIGNLTQLEILYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTLV 485

Query:   443 XXXXXXXXXXXXXPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGS 502
                          P DIG+L+ +V + L  N  SG +P  +G  + ++ L L+ N   G+
Sbjct:   486 NLSMEGNSLSGSLPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGA 545

Query:   503 IPKSIGGXXXXXXXXXXXXXXXXXIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSN 562
             IP +I G                 IP        L+ LNLS N   G++P  G F N + 
Sbjct:   546 IP-NIRGLMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTI 604

Query:   563 RSFMGNDLLCG-LAQVQVPVCKSGNSSSHRKSRKNTILLGVLLPLSTVFIIAVILAVRYA 621
                 GN  LCG +  +++  C +       K   +   + +L+ +    ++ +++A    
Sbjct:   605 VFVFGNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVL 664

Query:   622 MISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSF- 680
                R + KN + +N+  + L +    + SY +L  ATN F++SN++G+G FG+V+K    
Sbjct:   665 CWFRKRRKNQQTNNLVPSKL-EIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLP 723

Query:   681 LDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN-----NDFKALVLE 735
              +   VA+KV ++Q  GA+KSF  ECE LK  RHRNLVK++++C +     N+F+AL+ E
Sbjct:   724 TESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYE 783

Query:   736 YMPNGSLEDYLYSNNF--------SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKP 787
             Y+PNGS++ +L+            +  +L+RL+++IDVA  L+YLH     P+ HCD+KP
Sbjct:   784 YLPNGSVDMWLHPEEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKP 843

Query:   788 SNVLLDKDMVAHLSDFGIAKLLS--GEESMKQTLTLATI 824
             SNVLL+ D+ AH+SDFG+A+LL    +ES    L+ A +
Sbjct:   844 SNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGV 882

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 1148 (409.2 bits), Expect = 1.6e-116, P = 1.6e-116
 Identities = 282/822 (34%), Positives = 438/822 (53%)

Query:    25 KLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPS---TIFNLSSLSTGMDFSNNS 81
             +L LG  +L G I   +GNL+ L  + L+NN   GTIP     +F L  L+ G ++    
Sbjct:    70 RLDLGGLQLGGVISPSIGNLSFLIYLDLSNNSFGGTIPQEMGNLFRLKYLAVGFNYLEGE 129

Query:    82 LTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGN 141
             +  SL +  C RL L   L+ SNN   G +P+ +   ++L+ + L  N    + P  + N
Sbjct:   130 IPASLSN--CSRL-LYLDLF-SNNLGDG-VPSELGSLRKLLYLYLGLNDLKGKFPVFIRN 184

Query:   142 LTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSN 201
             LTSL  L LG+N+L GEIP ++  L  +  L L +N   G  P + +NLS+++ L L  N
Sbjct:   185 LTSLIVLNLGYNHLEGEIPDDIAMLSQMVSLTLTMNNFSGVFPPAFYNLSSLENLYLLGN 244

Query:   202 ALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTL 261
               SG+L      + LPN+  +SL GN  +G IP+ + N S L +  +G+N  +G I    
Sbjct:   245 GFSGNLKPDFGNL-LPNIHELSLHGNFLTGAIPTTLANISTLEMFGIGKNRMTGSISPNF 303

Query:   262 GNLRKLEWLRLSYNXXXXXXXXXXXXX-XWANCKNLKLLDLSNNPINGVLPSSIGNLSLS 320
             G L  L +L L+ N                 NC +L  L +S N + G LP+SI N+S  
Sbjct:   304 GKLENLHYLELANNSLGSYSFGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTE 363

Query:   321 LSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLE 380
             L+ + +    I G+IP +IGNLI L+ L L  N L G +P + G L  L  L L +N+  
Sbjct:   364 LTVLNLKGNLIYGSIPHDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFS 423

Query:   381 GPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKD 440
             G IP+ +  L +L  LY+  N   G +PP +GD + +  L +  N+LN  IP     +  
Sbjct:   424 GEIPSFIGNLTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPT 483

Query:   441 IXXXXXXXXXXXXXXPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQ 500
             +              P DIG L+ +V + L  NNLSG +P  +G  ++++ + L++N   
Sbjct:   484 LVHLNMESNSLSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFD 543

Query:   501 GSIPKSIGGXXXXXXXXXXXXXXXXXIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANF 560
             G+IP  I G                 I    E    L+ LNLS N  EG +P  G F N 
Sbjct:   544 GTIP-DIKGLMGVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNA 602

Query:   561 SNRSFMGNDLLCG-LAQVQVPVCKSGNSSSHRKSRKNTILLGVLLPLSTVFIIAVILAVR 619
             +  S  GN  LCG + ++++  C +   +   ++R  ++L  V + +S    IA++L + 
Sbjct:   603 TLVSVFGNKNLCGSIKELKLKPCIA--QAPPVETRHPSLLKKVAIGVSVG--IALLLLLF 658

Query:   620 YAMISRCQE-KNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKG 678
                +S  ++ KN ++ N  +    +    + SY +L  AT+ F++SN++G+G FG+V+K 
Sbjct:   659 IVSLSWFKKRKNNQKINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKA 718

Query:   679 SF-LDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN-----NDFKAL 732
                 +   VA+KV ++Q  GA+KSF  ECE LK +RHRNLVK++++C +     N+F+AL
Sbjct:   719 LLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRAL 778

Query:   733 VLEYMPNGSLEDYLYSNNF--------SFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
             + E+MPNGSL+ +L+            +  +L+RL++ IDVA  L+YLH     P+ HCD
Sbjct:   779 IYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCD 838

Query:   785 IKPSNVLLDKDMVAHLSDFGIAKLLS--GEESMKQTLTLATI 824
             +KPSN+LLD D+ AH+SDFG+A+LL    +ES    L+ A +
Sbjct:   839 LKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSAGV 880

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1083 (386.3 bits), Expect = 1.3e-109, P = 1.3e-109
 Identities = 263/709 (37%), Positives = 392/709 (55%)

Query:    52 LTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPI 111
             L ++ L+G I  ++ NLS L T +  S+N L+G +P ++ R L  ++ L ++ N L+G I
Sbjct:    85 LRSSNLAGIISPSLGNLSFLRT-LQLSDNHLSGKIPQELSR-LSRLQQLVLNFNSLSGEI 142

Query:   112 PNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEI 171
             P  +     L V+ L  N  +  IP  LG LT L  L L  N L+G IP   G LR L  
Sbjct:   143 PAALGNLTSLSVLELTNNTLSGAIPSSLGKLTGLTDLALAENTLSGSIPSSFGQLRRLSF 202

Query:   172 LGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSG 231
             L L  N L G +P  I+N+S++    + SN LSG+LP++     LP+L+ + +  N F G
Sbjct:   203 LSLAFNNLSGAIPDPIWNISSLTIFEVISNKLSGTLPTNA-FSNLPSLQEVYMYYNQFHG 261

Query:   232 IIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNXXXXXXXXX-XXXXXW 290
              IP+ I NAS +S+  +G NSFSG +P  +G +R L+ L L                   
Sbjct:   262 RIPASIGNASNISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDWKFMTAL 321

Query:   291 ANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGL 350
              NC NL+ ++L      GVLP S+ NLS SL  + I +  I G++P++IGNL+NL+ L L
Sbjct:   322 TNCSNLQEVELGGCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIGNLVNLQYLSL 381

Query:   351 WGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPC 410
               N L GS+P +F KL+NL+ L + NNKL G +P  +  L +L+ + +  N   G IP  
Sbjct:   382 ANNSLTGSLPSSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIPST 441

Query:   411 IGDLTSLRLLSLASNELNSVIPSTFWNLKDIXXXXXXXXXXXXXX-PEDIGNLKVVVIID 469
             +G+LT L  ++L  N     IP   +++  +               P++IG LK +V   
Sbjct:   442 LGNLTKLFQINLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVEFH 501

Query:   470 LSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGXXXXXXXXXXXXXXXXXIPT 529
                N LSG+ P+ IG    LQ L L++N L GSIP ++                   IP 
Sbjct:   502 ADSNKLSGENPSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPM 561

Query:   530 SMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCG-LAQVQVPVCKSGNSS 588
             S+  +  L  LNLSFN   GE+P  G FAN S     GN  +CG + ++ +P C    S 
Sbjct:   562 SLGDMPLLHSLNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTC----SL 617

Query:   589 SHRKSRKNTILLGVLLPLSTVFIIAVILAVRYAMISRCQEKNAKQSNIESNMLPQATRRR 648
               RK +K+ ILL V++ +  V  +AV  ++ Y +++ C ++  K+    ++M  Q     
Sbjct:   618 KSRKKKKHQILLLVVV-ICLVSTLAVF-SLLYMLLT-CHKRRKKEVPATTSM--QG-HPM 671

Query:   649 FSYKELLQATNQFNASNLIGTGGFGSVYKGSF--LDG---MEVAIKVFHLQLEGALKSFD 703
              +YK+L++AT+ F++S+L+G+G FGSVYKG F   DG     VA++V  L+   ALKSF 
Sbjct:   672 ITYKQLVKATDGFSSSHLLGSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFT 731

Query:   704 VECEVLKSVRHRNLVKIISSCTN-----NDFKALVLEYMPNGSLEDYLY 747
              ECE L++ RHRNLVKI++ C++     NDFKA+V ++MPNGSLED+L+
Sbjct:   732 AECETLRNTRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWLH 780

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0016567 "protein ubiquitination" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2122239 AT4G36180 [Arabidopsis thaliana (taxid:3702)]

 Score = 802 (287.4 bits), Expect = 6.5e-104, Sum P(2) = 6.5e-104
 Identities = 213/649 (32%), Positives = 316/649 (48%)

Query:     2 LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
             L +S N  SG IP  + NLT L+ L L YN+L GEIP  LGNL  L+ + L  N L GT+
Sbjct:   167 LDISSNTFSGQIPSGLANLTQLQLLNLSYNQLTGEIPASLGNLQSLQYLWLDFNLLQGTL 226

Query:    62 PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
             PS I N SSL   +  S N + G +P      LP ++ L +SNN  +G +P +++    L
Sbjct:   227 PSAISNCSSL-VHLSASENEIGGVIPAAY-GALPKLEVLSLSNNNFSGTVPFSLFCNTSL 284

Query:   122 IVISLAYNQFTERI-PRGLGNL-TSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKL 179
              ++ L +N F++ + P    N  T L+ L L  N ++G  P  + N+ +L+ L +  N  
Sbjct:   285 TIVQLGFNAFSDIVRPETTANCRTGLQVLDLQENRISGRFPLWLTNILSLKNLDVSGNLF 344

Query:   180 VGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFN 239
              G +P  I NL  ++ L L +N+L+G +P  +++ +  +L+++   GN+  G IP F+  
Sbjct:   345 SGEIPPDIGNLKRLEELKLANNSLTGEIP--VEIKQCGSLDVLDFEGNSLKGQIPEFLGY 402

Query:   240 ASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNXXXXXXXXXXXXXXWANCKNLKLL 299
                L VL LG NSFSG++P+++ NL++LE L L  N                   +L  L
Sbjct:   403 MKALKVLSLGRNSFSGYVPSSMVNLQQLERLNLGENNLNGSFPVELMALT-----SLSEL 457

Query:   300 DLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSI 359
             DLS N  +G +P SI NLS +LS + +S     G IP  +GNL  L  L L    + G +
Sbjct:   458 DLSGNRFSGAVPVSISNLS-NLSFLNLSGNGFSGEIPASVGNLFKLTALDLSKQNMSGEV 516

Query:   360 PITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRL 419
             P+    L N+Q + L  N   G +P G   L  L  + +  N  SG IP   G L  L  
Sbjct:   517 PVELSGLPNVQVIALQGNNFSGVVPEGFSSLVSLRYVNLSSNSFSGEIPQTFGFLRLLVS 576

Query:   420 LSLASNELNSVIPSTFWNLKDIXXXXXXXXXXXXXXPEDIGNLKVVVIIDLSRNNLSGDI 479
             LSL+ N ++  IP    N   +              P D+  L  + ++DL +NNLSG+I
Sbjct:   577 LSLSDNHISGSIPPEIGNCSALEVLELRSNRLMGHIPADLSRLPRLKVLDLGQNNLSGEI 636

Query:   480 PTAIGGLMNLQDLSLRDNGLQGSIPKSIGGXXXXXXXXXXXXXXXXXIPTSMEKLLY-LK 538
             P  I    +L  LSL  N L G IP S  G                 IP S+  +   L 
Sbjct:   637 PPEISQSSSLNSLSLDHNHLSGVIPGSFSGLSNLTKMDLSVNNLTGEIPASLALISSNLV 696

Query:   539 DLNLSFNKLEGEIPRG-GPFANFSNRSFMGNDLLCGLAQVQVPVCKSGNSSSHRKSRKNT 597
               N+S N L+GEIP   G   N +   F GN  LCG    +   C+S  +   +K RK  
Sbjct:   697 YFNVSSNNLKGEIPASLGSRIN-NTSEFSGNTELCGKPLNRR--CESSTAEGKKKKRK-M 752

Query:   598 ILLGVLLPLSTVFIIAVILAVRYAMISRCQEKNAKQSNI-ESNMLPQAT 645
             IL+ V+  +   F++++        + + ++K  +QS   E    P  T
Sbjct:   753 ILMIVMAAIGA-FLLSLFCCFYVYTLLKWRKKLKQQSTTGEKKRSPGRT 800

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006260 "DNA replication" evidence=RCA

GO:0006306 "DNA methylation" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0008283 "cell proliferation" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0030244 "cellulose biosynthetic process" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0051567 "histone H3-K9 methylation" evidence=RCA

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 858 (307.1 bits), Expect = 2.3e-85, P = 2.3e-85
 Identities = 251/839 (29%), Positives = 405/839 (48%)

Query:     2 LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQEL-GNLAELELVSLTNNFLSGT 60
             L LS N+L+G IP+E  N++ L  L L  N L G +P+ +  N   LE + L+   LSG 
Sbjct:   292 LDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGE 351

Query:    61 IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
             IP  +    SL   +D SNNSL GS+P+ +   + L   LY+ NN L G +  +I     
Sbjct:   352 IPVELSKCQSLKQ-LDLSNNSLAGSIPEALFELVELTD-LYLHNNTLEGTLSPSISNLTN 409

Query:   121 LIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLV 180
             L  + L +N    ++P+ +  L  L+ L+L  N  +GEIP E+GN  +L+++ +  N   
Sbjct:   410 LQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFE 469

Query:   181 GFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNA 240
             G +P SI  L  +  L L  N L G LP+S+       L I+ LA N  SG IPS     
Sbjct:   470 GEIPPSIGRLKELNLLHLRQNELVGGLPASLG--NCHQLNILDLADNQLSGSIPSSFGFL 527

Query:   241 SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNXXXXXXXXXXXXXXWANCKNLKLLD 300
               L  L L  NS  G +P++L +LR L  + LS+N              + +       D
Sbjct:   528 KGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLS------FD 581

Query:   301 LSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIP 360
             ++NN     +P  +GN S +L R+ +    + G IP  +G +  L  L +  N L G+IP
Sbjct:   582 VTNNGFEDEIPLELGN-SQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIP 640

Query:   361 ITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLL 420
             +     + L  +DL NN L GPIP  L +L++L  L +  N+    +P  + + T L +L
Sbjct:   641 LQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVL 700

Query:   421 SLASNELNSVIPSTFWNLKDIXXXXXXXXXXXXXXPEDIGNLKVVVIIDLSRNNLSGDIP 480
             SL  N LN  IP    NL  +              P+ +G L  +  + LSRN+L+G+IP
Sbjct:   701 SLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIP 760

Query:   481 TAIGGLMNLQD-LSLRDNGLQGSIPKSIGGXXXXXXXXXXXXXXXXXIPTSMEKLLYLKD 539
               IG L +LQ  L L  N   G IP +IG                  +P S+  +  L  
Sbjct:   761 VEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGY 820

Query:   540 LNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCKSGNSSSHRKSRKNTIL 599
             LN+SFN L G++ +   F+ +   SF+GN  LCG    +    +S N      +R + ++
Sbjct:   821 LNVSFNNLGGKLKK--QFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSAR-SVVI 877

Query:   600 LGVLLPLSTVFIIAVILAV----RYAMISRCQEKN----AKQSNIESNMLPQ----ATRR 647
             +  +  L+ + ++ +++A+    R+    +    +    +  S+ ++   P     A++ 
Sbjct:   878 ISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKS 937

Query:   648 RFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVE 705
                ++++++AT+  +   +IG+GG G VYK    +G  VA+K   L  +  +  KSF  E
Sbjct:   938 DIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKI-LWKDDLMSNKSFSRE 996

Query:   706 CEVLKSVRHRNLVKIISSCTNND--FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII 763
              + L  +RHR+LVK++  C++       L+ EYM NGS+ D+L+ +     +L++   ++
Sbjct:   997 VKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDK---PVLEKKKKLL 1053

Query:   764 DVALALEYLHFGYSNPV--VHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT 820
             D    L  +  G +  V  +H D  P  V  D      L D  +   L G+  + + LT
Sbjct:  1054 DWEARLR-IAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHL-GDFGLAKVLT 1110

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00110705 hypothetical protein (1061 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	832
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-92
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-64
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-44
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-42
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-39
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-39
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-36
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-33
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-33
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-31
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-30
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-29
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-27
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-27
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-26
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-26
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-24
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-23
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-23
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-23
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-21
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-20
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-20
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-19
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-19
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-18
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-18
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-18
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-17
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-17
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-17
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-16
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-16
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-16
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-16
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	8e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-15
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-15
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-15
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-15
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-15
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-14
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-14
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-14
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-14
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-14
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-14
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-14
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-13
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-13
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-13
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-13
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-12
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-12
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-12
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-12
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-12
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-12
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	9e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-11
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-11
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-11
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-10
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-10
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-10
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-10
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-10
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-10
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-10
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-10
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-09
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-09
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-09
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-09
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	7e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	8e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	9e-09
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	9e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-08
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-08
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-08
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-08
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-08
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-08
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-08
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-08
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-08
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	6e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	6e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-08
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	9e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-07
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-07
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	8e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	9e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-06
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-06
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-06
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-06
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-06
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-06
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-06
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	8e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	8e-06
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-06
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-05
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-05
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-05
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-05
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-05
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-05
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-05
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-05
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	7e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-04
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-04
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-04
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-04
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	4e-04
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-04
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	0.001
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	0.002
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	0.002
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	0.002
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	0.002
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	0.003
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.003
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	0.003

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  310 bits (795), Expect = 6e-92
 Identities = 248/814 (30%), Positives = 388/814 (47%), Gaps = 88/814 (10%)

Query: 19  NLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFS 78
           N + +  + L    + G+I   +  L  ++ ++L+NN LSG IP  IF  SS    ++ S
Sbjct: 67  NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126

Query: 79  NNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRG 138
           NN+ TGS+P      +P ++ L +SNN L+G IPN+I     L V+ L  N    +IP  
Sbjct: 127 NNNFTGSIPRGS---IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183

Query: 139 LGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLAL 198
           L NLTSL+ L L  N L G+IP E+G +++L+ + L  N L G +P  I  L+++  L L
Sbjct: 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDL 243

Query: 199 PSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIP 258
             N L+G +PSS  L  L NL+ + L  N  SG IP  IF+  KL  L+L +NS SG IP
Sbjct: 244 VYNNLTGPIPSS--LGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301

Query: 259 NTLGNLRKLEWLRLSYNFLT-------SSTSELSFLSSWAN------------CKNLKLL 299
             +  L+ LE L L  N  T       +S   L  L  W+N              NL +L
Sbjct: 302 ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVL 361

Query: 300 DLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSI 359
           DLS N + G +P  + +       I  SN S+ G IPK +G   +LR + L  N   G +
Sbjct: 362 DLSTNNLTGEIPEGLCSSGNLFKLILFSN-SLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420

Query: 360 PITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRL 419
           P  F KL  +  LD+ NN L+G I +    +  L +L +  NK  G +P   G    L  
Sbjct: 421 PSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLEN 479

Query: 420 LSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDI 479
           L L+ N+ +  +P    +L +++ L  S N L+G +P+++ + K +V +DLS N LSG I
Sbjct: 480 LDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQI 539

Query: 480 PTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKD 539
           P +   +  L  L L  N L G IPK++G + SL  +++S+N L G++P++         
Sbjct: 540 PASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST--------- 590

Query: 540 LNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCKSGNSSSH----RKSRK 595
                          G F   +  +  GN  LCG           G+++S     ++ RK
Sbjct: 591 ---------------GAFLAINASAVAGNIDLCG-----------GDTTSGLPPCKRVRK 624

Query: 596 N-------TILLGVLLPLSTV-FIIAVILAVRYAMISRCQEKNAKQSNIESNMLPQATRR 647
                   T  LG  L L+ V F    I       + R + ++      E         +
Sbjct: 625 TPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTW---ELQFFDSKVSK 681

Query: 648 RFSYKELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVEC 706
             +  ++L +  +    N+I  G  G+ YKG S  +GM+  +K  +  +     S   + 
Sbjct: 682 SITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD- 736

Query: 707 EVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVA 766
             +  ++H N+VK+I  C +     L+ EY+   +L + L   N S++  +R  + I +A
Sbjct: 737 --MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL--RNLSWE--RRRKIAIGIA 790

Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHL 800
            AL +LH   S  VV  ++ P  +++D     HL
Sbjct: 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  232 bits (592), Expect = 4e-64
 Identities = 176/512 (34%), Positives = 250/512 (48%), Gaps = 85/512 (16%)

Query: 67  NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQ-CKELIVIS 125
           N SS    +D S  +++G +   + R LP I+ + +SNN+L+GPIP++I+     L  ++
Sbjct: 66  NNSSRVVSIDLSGKNISGKISSAIFR-LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLN 124

Query: 126 LAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPT 185
           L+ N FT  IPRG  ++ +L+TL L  N L+GEIP ++G+  +L++L L  N LVG +P 
Sbjct: 125 LSNNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182

Query: 186 SIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSV 245
           S+ NL++++ L L SN L G +P   +L ++ +L+ I L                     
Sbjct: 183 SLTNLTSLEFLTLASNQLVGQIPR--ELGQMKSLKWIYL--------------------- 219

Query: 246 LELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNP 305
              G N+ SG IP  +G L  L  L L YN LT                           
Sbjct: 220 ---GYNNLSGEIPYEIGGLTSLNHLDLVYNNLT--------------------------- 249

Query: 306 INGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGK 365
             G +PSS+GNL  +L  +F+    + G IP  I +L  L  L L  N L G IP    +
Sbjct: 250 --GPIPSSLGNLK-NLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306

Query: 366 LQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASN 425
           LQNL+ L L +N   G IP  L  L RL VL +  NK SG IP  +G   +L +L L++N
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366

Query: 426 ELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIG------------------------N 461
            L   IP    +  ++  L   SN L G +P+ +G                         
Sbjct: 367 NLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTK 426

Query: 462 LKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNN 521
           L +V  +D+S NNL G I +    + +LQ LSL  N   G +P S G    LE+LDLS N
Sbjct: 427 LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRN 485

Query: 522 SLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPR 553
             SG +P  +  L  L  L LS NKL GEIP 
Sbjct: 486 QFSGAVPRKLGSLSELMQLKLSENKLSGEIPD 517

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  171 bits (436), Expect = 4e-44
 Identities = 120/302 (39%), Positives = 161/302 (53%), Gaps = 18/302 (5%)

Query: 268 EWLRLSYNFLTSSTSELSFLSSWA--------------NCKNLKLLDLSNNPINGVLPSS 313
           E L L  +F +S    L +LS+W               N   +  +DLS   I+G + S+
Sbjct: 29  EELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSA 88

Query: 314 IGNLSLSLSRIFISNCSIRGTIPKEIGNLI-NLRELGLWGNELIGSIPITFGKLQNLQGL 372
           I  L   +  I +SN  + G IP +I     +LR L L  N   GSIP   G + NL+ L
Sbjct: 89  IFRLPY-IQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP--RGSIPNLETL 145

Query: 373 DLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIP 432
           DL NN L G IPN +   + L VL + GN L G IP  + +LTSL  L+LASN+L   IP
Sbjct: 146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIP 205

Query: 433 STFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDL 492
                +K +  +    N L+G +P +IG L  +  +DL  NNL+G IP+++G L NLQ L
Sbjct: 206 RELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYL 265

Query: 493 SLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIP 552
            L  N L G IP SI  L  L SLDLS+NSLSG IP  + +L  L+ L+L  N   G+IP
Sbjct: 266 FLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325

Query: 553 RG 554
             
Sbjct: 326 VA 327

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  152 bits (386), Expect = 5e-42
 Identities = 62/166 (37%), Positives = 95/166 (57%), Gaps = 7/166 (4%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALK-SFDVECEVLKSVRHRNLVKIISSC 724
           +G GGFG+VY       G +VAIK+   +   +L      E E+LK + H N+VK+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
            + +   LV+EY   GSL+D L  N       + L +++ +   LEYLH   SN ++H D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117

Query: 785 IKPSNVLLDKD-MVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +KP N+LLD D     L+DFG++KLL+ ++S+ +T+ + T  YMAP
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAP 162

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  147 bits (372), Expect = 1e-39
 Identities = 57/166 (34%), Positives = 87/166 (52%), Gaps = 8/166 (4%)

Query: 667 IGTGGFGSVYKGSFL-DGMEVAIKVFHLQ--LEGALKSFDVECEVLKSVRHRNLVKIISS 723
           +G+G FG+VYK      G  VA+K+   +       ++   E  +L+ + H N+V++I +
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
             + D   LV+EY   G L DYL S        +   + + +   LEYLH   SN ++H 
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQILRGLEYLH---SNGIIHR 122

Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D+KP N+LLD++ V  ++DFG+AK L    S   T    T  YMAP
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAP 167

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  146 bits (371), Expect = 2e-39
 Identities = 56/167 (33%), Positives = 82/167 (49%), Gaps = 8/167 (4%)

Query: 665 NLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQ-LEGALKSFDVECEVLKSVRHRNLVKIIS 722
             +G G FG VY       G  VAIKV   + ++   +    E ++LK ++H N+V++  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVH 782
              + D   LV+EY   G L D L          +    +  +  ALEYLH   S  +VH
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKKRGR-LSEDEARFYLRQILSALEYLH---SKGIVH 120

Query: 783 CDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            D+KP N+LLD+D    L+DFG+A+ L   E +     + T  YMAP
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT--FVGTPEYMAP 165

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  146 bits (371), Expect = 4e-36
 Identities = 118/362 (32%), Positives = 178/362 (49%), Gaps = 61/362 (16%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L LS N LSG IP+ +  L  L+ L L  N   G+IP  L +L  L+++ L +N  SG I
Sbjct: 289 LDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEI 348

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
           P  +   ++L T +D S N+LTG +P+ +C                              
Sbjct: 349 PKNLGKHNNL-TVLDLSTNNLTGEIPEGLCSS---------------------------- 379

Query: 122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVG 181
                             GNL     L L  N+L GEIP  +G  R+L  + LQ N   G
Sbjct: 380 ------------------GNLFK---LILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSG 418

Query: 182 FVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNAS 241
            +P+    L  +  L + +N L G + S      +P+L+++SLA N F G +P   F + 
Sbjct: 419 ELPSEFTKLPLVYFLDISNNNLQGRINSR--KWDMPSLQMLSLARNKFFGGLPDS-FGSK 475

Query: 242 KLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSST-SELSFLSSWANCKNLKLLD 300
           +L  L+L  N FSG +P  LG+L +L  L+LS N L+     ELS      +CK L  LD
Sbjct: 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELS------SCKKLVSLD 529

Query: 301 LSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIP 360
           LS+N ++G +P+S   + + LS++ +S   + G IPK +GN+ +L ++ +  N L GS+P
Sbjct: 530 LSHNQLSGQIPASFSEMPV-LSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588

Query: 361 IT 362
            T
Sbjct: 589 ST 590

Length = 968

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  129 bits (326), Expect = 2e-33
 Identities = 60/180 (33%), Positives = 87/180 (48%), Gaps = 28/180 (15%)

Query: 665 NLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQ--LEGALKSFDVECEVLKSVRHRNLVKII 721
            L+G G FGSVY       G  +A+K   L    E  L++ + E  +L S++H N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 722 SSCTNNDFKAL--VLEYMPNGSLEDYLYSN---------NFSFDILQRLSVIIDVALALE 770
            S  + +   L   LEY+  GSL   L             ++  IL+           L 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE----------GLA 115

Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
           YLH   SN +VH DIK +N+L+D D V  L+DFG AK L   E+ + T ++  T  +MAP
Sbjct: 116 YLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  128 bits (323), Expect = 4e-33
 Identities = 51/169 (30%), Positives = 85/169 (50%), Gaps = 9/169 (5%)

Query: 667 IGTGGFGSVYKG-----SFLDGMEVAIKVFHL-QLEGALKSFDVECEVLKSVRHRNLVKI 720
           +G G FG VYKG          +EVA+K       E  ++ F  E  +++ + H N+VK+
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPV 780
           +  CT  +   +V+EYM  G L  YL  N     +   LS  + +A  +EYL    S   
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SKNF 123

Query: 781 VHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +H D+   N L+ +++V  +SDFG+++ L  ++  ++      I +MAP
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAP 172

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  122 bits (309), Expect = 4e-31
 Identities = 53/170 (31%), Positives = 86/170 (50%), Gaps = 10/170 (5%)

Query: 667 IGTGGFGSVYKG-----SFLDGMEVAIKVFHL-QLEGALKSFDVECEVLKSVRHRNLVKI 720
           +G G FG VYKG          +EVA+K       E  ++ F  E  +++ + H N+VK+
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYL-YSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
           +  CT  +   +V+EYMP G L DYL  +      +   LS  + +A  +EYL    S  
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKN 123

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            +H D+   N L+ +++V  +SDFG+++ L  ++  K       I +MAP
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAP 173

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  120 bits (304), Expect = 2e-30
 Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 16/173 (9%)

Query: 667 IGTGGFGSVYKG-----SFLDGMEVAIKVFHLQLEGA----LKSFDVECEVLKSVRHRNL 717
           +G G FG VYKG           +VA+K      EGA     + F  E  ++K + H N+
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLK---EGASEEEREEFLEEASIMKKLSHPNI 63

Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           V+++  CT  +   +V EYMP G L D+L  +     +   L + + +A  +EYL    S
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---S 120

Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT-IGYMAP 829
              VH D+   N L+ +++V  +SDFG+++ +  ++  ++       I +MAP
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAP 173

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  116 bits (294), Expect = 4e-29
 Identities = 59/179 (32%), Positives = 84/179 (46%), Gaps = 17/179 (9%)

Query: 665 NLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQ-LEGALKSFDVECEVLKSVRHRNLVK 719
             +G G FG VYKG          EVA+K       E   K F  E  V+K + H N+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYL--------YSNNFSFDILQRLSVIIDVALALEY 771
           ++  CT  +   LVLEYM  G L DYL             +  +   LS  I +A  +EY
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL-SGEESMKQTLTLATIGYMAP 829
           L    S   VH D+   N L+ +D+V  +SDFG+++ +   +   K+T     I +MAP
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  111 bits (279), Expect = 3e-27
 Identities = 66/177 (37%), Positives = 90/177 (50%), Gaps = 16/177 (9%)

Query: 660 QFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQ--LEGALKSFDVECEVLKSVRHRN 716
            +   +LIG G FG VYKG +   G  VAIK   L+   E ALKS   E ++LK+++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVA---LALEYLH 773
           +VK I S   +D   ++LEY  NGSL   +      F       V + V      L YLH
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQ-IIKK---FGPFPESLVAVYVYQVLQGLAYLH 116

Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
                 V+H DIK +N+L  KD V  L+DFG+A  L+     K   ++  T  +MAP
Sbjct: 117 ---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS--KDDASVVGTPYWMAP 168

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  110 bits (278), Expect = 4e-27
 Identities = 62/164 (37%), Positives = 87/164 (53%), Gaps = 6/164 (3%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           IG GGFG VYK      G EVAIKV  L+ +   +    E ++LK  +H N+VK   S  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
             D   +V+E+   GSL+D L S N +    Q   V  ++   LEYLH   SN ++H DI
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDI 124

Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           K +N+LL  D    L DFG++  LS  ++  +   + T  +MAP
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLS--DTKARNTMVGTPYWMAP 166

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  116 bits (292), Expect = 1e-26
 Identities = 94/287 (32%), Positives = 139/287 (48%), Gaps = 33/287 (11%)

Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
           +L L  N  SG IPK +G    L  L L  N L GEIP+ L +   L  + L +N L G 
Sbjct: 336 VLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGE 395

Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
           IP ++    SL   +   +NS +G LP +   +LPL+  L +SNN L G I +  W    
Sbjct: 396 IPKSLGACRSLRR-VRLQDNSFSGELPSEFT-KLPLVYFLDISNNNLQGRINSRKWDMPS 453

Query: 121 LIVISLA-----------------------YNQFTERIPRGLGNLTSLKTLYLGFNNLTG 157
           L ++SLA                        NQF+  +PR LG+L+ L  L L  N L+G
Sbjct: 454 LQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSG 513

Query: 158 EIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLP 217
           EIP E+ + + L  L L  N+L G +P S   +  +  L L  N LSG +P   +L  + 
Sbjct: 514 EIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPK--NLGNVE 571

Query: 218 NLEIISLAGNNFSGIIPS----FIFNASKLS--VLELGENSFSGFIP 258
           +L  ++++ N+  G +PS       NAS ++  +   G ++ SG  P
Sbjct: 572 SLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPP 618

Length = 968

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  107 bits (269), Expect = 7e-26
 Identities = 54/175 (30%), Positives = 80/175 (45%), Gaps = 18/175 (10%)

Query: 665 NLIGTGGFGSVYKG-SFLDGMEVAIKVFHL------QLEGALKSFDVECEVLKSVRHRNL 717
             IG G FG VY      DG    +K   L      + E AL     E ++LK + H N+
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNI 61

Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDIL---QRLSVIIDVALALEYLHF 774
           +K   S        +V+EY   G L   +             Q L   + + LAL+YLH 
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH- 120

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             S  ++H DIKP N+ L  + +  L DFGI+K+LS    + +T+ + T  Y++P
Sbjct: 121 --SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-VGTPYYLSP 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 1e-24
 Identities = 59/165 (35%), Positives = 84/165 (50%), Gaps = 10/165 (6%)

Query: 666 LIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
            IG G FG V  G +  G +VA+K        A ++F  E  V+ ++RH NLV+++    
Sbjct: 13  TIGKGEFGDVMLGDYR-GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDIL-QRLSVIIDVALALEYLHFGYSNPVVHCD 784
             +   +V EYM  GSL DYL S   +   L Q+L   +DV   +EYL        VH D
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRD 127

Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +   NVL+ +D+VA +SDFG+AK    E S  Q      + + AP
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAP 168

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  106 bits (267), Expect = 1e-23
 Identities = 69/207 (33%), Positives = 111/207 (53%), Gaps = 5/207 (2%)

Query: 361 ITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLT-SLRL 419
           IT      +  +DL    + G I + + +L  +  + +  N+LSGPIP  I   + SLR 
Sbjct: 63  ITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRY 122

Query: 420 LSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDI 479
           L+L++N     IP     + ++ +L+ S+N L+G +P DIG+   + ++DL  N L G I
Sbjct: 123 LNLSNNNFTGSIPRGS--IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180

Query: 480 PTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKD 539
           P ++  L +L+ L+L  N L G IP+ +G + SL+ + L  N+LSG IP  +  L  L  
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240

Query: 540 LNLSFNKLEGEIPRGGPFANFSNRSFM 566
           L+L +N L G IP      N  N  ++
Sbjct: 241 LDLVYNNLTGPIPSS--LGNLKNLQYL 265

Length = 968

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 99.6 bits (249), Expect = 6e-23
 Identities = 61/164 (37%), Positives = 84/164 (51%), Gaps = 6/164 (3%)

Query: 667 IGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           IG G  G VYK +    G EVAIK   L+ +   +    E  ++K  +H N+V    S  
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLR-KQNKELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
             D   +V+EYM  GSL D +  N    +  Q   V  +V   LEYLH   S  V+H DI
Sbjct: 86  VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDI 142

Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           K  N+LL KD    L+DFG A  L+ E+S + ++ + T  +MAP
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV-VGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 98.4 bits (246), Expect = 9e-23
 Identities = 54/171 (31%), Positives = 83/171 (48%), Gaps = 18/171 (10%)

Query: 667 IGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGAL-KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G  G VYK      G   A+K  H+  +    K    E + L+S     +VK    C
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64

Query: 725 TNNDFK----ALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNP 779
               +K    ++VLEYM  GSL D L         +L  ++    +   L+YLH      
Sbjct: 65  YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIA--RQILKGLDYLH--TKRH 120

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT-LATIGYMAP 829
           ++H DIKPSN+L++      ++DFGI+K+L  E ++ Q  T + T+ YM+P
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSP 169

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 93.8 bits (234), Expect = 5e-21
 Identities = 56/171 (32%), Positives = 82/171 (47%), Gaps = 11/171 (6%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVF---HLQLEGALKSFDVECEVL-KSVR 713
           + F    +IG G F +V          E AIK+     L  E  +K   +E EVL +   
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYL-YSNNFSFDILQRLSVIIDVALALEYL 772
           H  ++K+  +  + +    VLEY PNG L  Y+    +      +      ++ LALEYL
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTR--FYAAEILLALEYL 118

Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
           H   S  ++H D+KP N+LLDKDM   ++DFG AK+L    S +     AT
Sbjct: 119 H---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 91.8 bits (229), Expect = 1e-20
 Identities = 59/169 (34%), Positives = 83/169 (49%), Gaps = 13/169 (7%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKV---FHLQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G FG V      D G   A+KV     +     ++    E  +L  + H  +VK+  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII-DVALALEYLHFGYSNPVV 781
           +    +   LVLEY P G L  +L S    F   +R      ++ LALEYLH   S  ++
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSE-ERARFYAAEIVLALEYLH---SLGII 115

Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
           + D+KP N+LLD D    L+DFG+AK LS E S  +T T   T  Y+AP
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAP 162

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 92.2 bits (230), Expect = 2e-20
 Identities = 56/173 (32%), Positives = 87/173 (50%), Gaps = 15/173 (8%)

Query: 667 IGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDV----ECEVLKSVRHRNLVK-- 719
           IG G +G VYK      G  VA+K   +++E   + F +    E ++L+ +RH N+V+  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALK--KIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 720 -IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
            I++S        +V EYM +  L   L S    F   Q    +  +   L+YLH   SN
Sbjct: 65  EIVTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SN 119

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
            ++H DIK SN+L++ D V  L+DFG+A+  +   S   T  + T+ Y  P L
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 94.0 bits (232), Expect = 2e-20
 Identities = 66/181 (36%), Positives = 89/181 (49%), Gaps = 17/181 (9%)

Query: 661 FNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEG---ALKSFDVECEVLKSVRH-RN 716
           +     +G G FG VY     D   VA+KV   +LE     ++ F  E ++L S+ H  N
Sbjct: 2   YRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNF--SFDILQRLSVIIDVALALEYLHF 774
           +VK+     +     LV+EY+  GSLED L            + L ++  +  ALEYLH 
Sbjct: 60  IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH- 118

Query: 775 GYSNPVVHCDIKPSNVLLDKD-MVAHLSDFGIAKLLSGEESMKQTLTLA-----TIGYMA 828
             S  ++H DIKP N+LLD+D  V  L DFG+AKLL    S      L      T GYMA
Sbjct: 119 --SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 829 P 829
           P
Sbjct: 177 P 177

Length = 384

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 90.8 bits (225), Expect = 3e-20
 Identities = 53/168 (31%), Positives = 87/168 (51%), Gaps = 8/168 (4%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           IG+G FG V+ G +L+  +VAIK      EGA+  + F  E +V+  + H  LV++   C
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR---EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
           T      LV E+M +G L DYL +    F     L + +DV   + YL    S+ V+H D
Sbjct: 69  TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRD 125

Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
           +   N L+ ++ V  +SDFG+ + +  ++    T T   + + +P +F
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVF 173

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 89.6 bits (223), Expect = 8e-20
 Identities = 56/175 (32%), Positives = 87/175 (49%), Gaps = 13/175 (7%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNL 717
             F+    +G G +GSVYK    + G  VAIKV  + +E  L+    E  +LK      +
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKV--VPVEEDLQEIIKEISILKQCDSPYI 60

Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           VK   S   N    +V+EY   GS+ D +   N +    +  +++      LEYLH   S
Sbjct: 61  VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---S 117

Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG---YMAP 829
           N  +H DIK  N+LL+++  A L+DFG++  L+   + + T+    IG   +MAP
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV----IGTPFWMAP 168

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 89.7 bits (223), Expect = 9e-20
 Identities = 57/177 (32%), Positives = 88/177 (49%), Gaps = 10/177 (5%)

Query: 660 QFNASNLIGTGGFGSVYKGSFLDGMEV-AIKVFHLQL---EGALKSFDVECEVLKSVRHR 715
            F    +IG G FG V      D  ++ A+K  + Q    +G++++   E  +L+ + H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG 775
            LV +  S  + +   LV++ +  G L  Y  S    F   Q    I ++ LALEYLH  
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLR-YHLSQKVKFSEEQVKFWICEIVLALEYLH-- 117

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
            S  ++H DIKP N+LLD+    H++DF IA  ++ +     T T  T GYMAP + 
Sbjct: 118 -SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVL 171

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 89.4 bits (222), Expect = 9e-20
 Identities = 50/143 (34%), Positives = 72/143 (50%), Gaps = 4/143 (2%)

Query: 666 LIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALK-SFDVECEVLKSVRHRNLVKIISSC 724
            IG G FG VYKG      EVA+K     L   LK  F  E E+LK   H N+VK+I  C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
                  +V+E +P GSL  +L        + + L + +D A  +EYL    S   +H D
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118

Query: 785 IKPSNVLLDKDMVAHLSDFGIAK 807
           +   N L+ ++ V  +SDFG+++
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 89.8 bits (223), Expect = 1e-19
 Identities = 46/155 (29%), Positives = 78/155 (50%), Gaps = 11/155 (7%)

Query: 664 SNLIGTGGFGSVYKG--SFLD---GMEVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNL 717
              +G G FG V       L    G +VA+K   H   E     F+ E E+L+++ H N+
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 718 VKIISSCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG 775
           VK    C     ++  L++EY+P+GSL DYL  +    ++ + L     +   ++YL   
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG-- 126

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS 810
            S   +H D+   N+L++ + +  +SDFG+AK+L 
Sbjct: 127 -SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 87.9 bits (218), Expect = 3e-19
 Identities = 51/143 (35%), Positives = 75/143 (52%), Gaps = 8/143 (5%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDV--ECEVLKSVRHRNLVKIISSC 724
           +G+G FG V+ G +   ++VAIK+     EGA+   D   E +V+  + H NLV++   C
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
           T      +V EYM NG L +YL            L +  DV  A+EYL    SN  +H D
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRD 125

Query: 785 IKPSNVLLDKDMVAHLSDFGIAK 807
           +   N L+ +D V  +SDFG+A+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 62/177 (35%), Positives = 88/177 (49%), Gaps = 26/177 (14%)

Query: 666 LIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEG-----ALKSFDVECEVLKSVRHRNLVK 719
           L+G+G FGSVY+G  LD G   A+K   L  +G     A+K  + E  +L  ++H N+V+
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII----DVALALEYLHFG 775
            + +    D   + LE +P GSL   L     SF       VI      + L LEYLH  
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFP----EPVIRLYTRQILLGLEYLH-- 119

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK---LLSGEESMKQTLTLATIGYMAP 829
                VH DIK +N+L+D + V  L+DFG+AK     S  +S K      +  +MAP
Sbjct: 120 -DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK-----GSPYWMAP 170

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 84.7 bits (210), Expect = 4e-18
 Identities = 58/174 (33%), Positives = 85/174 (48%), Gaps = 14/174 (8%)

Query: 664 SNLIGTGGFGSVYKGSFLDGMEV-AIKVFHLQLE--GALKSFDVECEVLKSVRHRNLVKI 720
            N IG G FG VY    LD  E+ A+K   +Q      +K    E +VL+ ++H NLVK 
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYL-YSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
                + +   + +EY   G+LE+ L +       +++  ++ +   LA  YLH   S+ 
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLA--YLH---SHG 119

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG----EESMKQTLTLATIGYMAP 829
           +VH DIKP+N+ LD + V  L DFG A  L           Q+L   T  YMAP
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA-GTPAYMAP 172

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 84.9 bits (211), Expect = 5e-18
 Identities = 63/179 (35%), Positives = 88/179 (49%), Gaps = 20/179 (11%)

Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFD---VECEVLKS 711
           + F     +GTG FG V    +KGS   G   A+K+        LK  +    E  +L+S
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57

Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           +RH  LV +  S  ++    LV+EY+P G L  +L  +   F           V LALEY
Sbjct: 58  IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEY 116

Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAP 829
           LH   S  +V+ D+KP N+LLD D    ++DFG AK + G     +T TL  T  Y+AP
Sbjct: 117 LH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYLAP 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 84.8 bits (210), Expect = 6e-18
 Identities = 49/164 (29%), Positives = 72/164 (43%), Gaps = 29/164 (17%)

Query: 667 IGTGGFGSVYKGSFL------DGMEVAIKVFH-LQLEGALKSFDVECEVLKSVRHRNLVK 719
           +G G FG V+ G         D   VA+K         A K F+ E E+L + +H N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDIL-------------QRLSVIIDVA 766
               CT  D   +V EYM +G L  +L S+      L             Q L + + +A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 767 LALEYL---HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
             + YL   HF      VH D+   N L+  D+V  + DFG+++
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 87.6 bits (217), Expect = 8e-18
 Identities = 58/167 (34%), Positives = 84/167 (50%), Gaps = 8/167 (4%)

Query: 468 IDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNI 527
           + L    L G IP  I  L +LQ ++L  N ++G+IP S+G + SLE LDLS NS +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 528 PTSMEKLLYLKDLNLSFNKLEGEIPR--GGPFANFSNRSFMGNDLLCGLAQVQVPVCKSG 585
           P S+ +L  L+ LNL+ N L G +P   GG   + ++ +F  N  LCG+    +  C   
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP--GLRACGPH 540

Query: 586 NSSSHRKSRKNTILLGVLLPLSTVFIIAVILAVRYAMISRCQEKNAK 632
            S       K  I  GV +    + I A+    R   I R Q   A+
Sbjct: 541 LSV----GAKIGIAFGVSVAFLFLVICAMCWWKRRQNILRAQRIAAR 583

Length = 623

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 1e-17
 Identities = 53/171 (30%), Positives = 78/171 (45%), Gaps = 11/171 (6%)

Query: 666 LIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGA---LKSFDVECEVLKSVRHRNLVKII 721
           ++G G +G V K      G  VAIK F  + E      K+   E +VL+ +RH N+V + 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 722 SSCTNNDFKALVLEYMPNGSLEDY-LYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPV 780
            +        LV EY+    LE           D ++    I  +  A+ Y H   S+ +
Sbjct: 67  EAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSY--IWQLLQAIAYCH---SHNI 121

Query: 781 VHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
           +H DIKP N+L+ +  V  L DFG A+ L    +   T  +AT  Y AP L
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPEL 172

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 55/167 (32%), Positives = 78/167 (46%), Gaps = 11/167 (6%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           IG+G +G VYK      G  VAIKV  L+     +    E  +LK  RH N+V    S  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
             D   +V+EY   GSL+D           LQ   V  +    L YLH       +H DI
Sbjct: 71  RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDI 127

Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG---YMAP 829
           K +N+LL +D    L+DFG++  L+   + +++     IG   +MAP
Sbjct: 128 KGANILLTEDGDVKLADFGVSAQLTATIAKRKSF----IGTPYWMAP 170

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 52/168 (30%), Positives = 83/168 (49%), Gaps = 7/168 (4%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQ--LEGALKSFDVECEVLKSVRHRNLVKIISS 723
           IG G  G V+K    + G  VA+K   L+    G       E + L++ +H  +VK++  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
             +     LV+EYMP   L + L          Q  S +  +   + Y+H   +N ++H 
Sbjct: 68  FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHR 123

Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
           D+KP+N+L+  D V  ++DFG+A+L S EE    +  +AT  Y AP L
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL 171

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 52/169 (30%), Positives = 79/169 (46%), Gaps = 9/169 (5%)

Query: 666 LIGTGGFGSVYKGSFLD----GMEVAIKVFHLQLEGALKS-FDVECEVLKSVRHRNLVKI 720
            IG G FG VY+G ++      + VA+K        +++  F  E  +++   H ++VK+
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPV 780
           I   T N    +V+E  P G L  YL  N +S D+   +     ++ AL YL    S   
Sbjct: 73  IGVITENPV-WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRF 128

Query: 781 VHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           VH DI   NVL+       L DFG+++ L  E   K +     I +MAP
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAP 177

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 43/154 (27%), Positives = 81/154 (52%), Gaps = 10/154 (6%)

Query: 660 QFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVK 719
           +F     +G+G FG V++G + + + VAIK+         + F  E + LK +RH++L+ 
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIID----VALALEYLHFG 775
           + + C+  +   ++ E M  GSL  +L S       +  ++ +ID    VA  + YL   
Sbjct: 67  LFAVCSVGEPVYIITELMEKGSLLAFLRS---PEGQVLPVASLIDMACQVAEGMAYLE-- 121

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
                +H D+   N+L+ +D+V  ++DFG+A+L+
Sbjct: 122 -EQNSIHRDLAARNILVGEDLVCKVADFGLARLI 154

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 46/153 (30%), Positives = 82/153 (53%), Gaps = 15/153 (9%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALK--SFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++    +VA+K       G +   +F  E +++K +RH  LV++ + C
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIID----VALALEYLHFGYSNPV 780
           +  +   +V EYM  GSL D+L S         RL  ++D    +A  + YL    S   
Sbjct: 71  SEEEPIYIVTEYMSKGSLLDFLKSGEGKK---LRLPQLVDMAAQIAEGMAYLE---SRNY 124

Query: 781 VHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
           +H D+   N+L+ +++V  ++DFG+A+L+  +E
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDE 157

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 81.9 bits (202), Expect = 3e-17
 Identities = 51/164 (31%), Positives = 90/164 (54%), Gaps = 12/164 (7%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN 726
           IG G FG+V +G +  G +VA+K   ++ +   ++F  E  V+  + H+NLV+++    +
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVKN--IKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 727 NDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
           N    +V+E M  G+L ++L +       ++Q L   +DVA  +EYL    S  +VH D+
Sbjct: 71  NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126

Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
              N+L+ +D VA +SDFG+A++     SM    +   + + AP
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAP 166

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 82.6 bits (204), Expect = 4e-17
 Identities = 58/164 (35%), Positives = 84/164 (51%), Gaps = 7/164 (4%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           IG G  G+VY       G EVAIK  +LQ +   +    E  V++  +H N+V  + S  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
             D   +V+EY+  GSL D +       D  Q  +V  +   ALE+LH   SN V+H DI
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 141

Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           K  N+LL  D    L+DFG    ++ E+S K++  + T  +MAP
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 80.8 bits (199), Expect = 9e-17
 Identities = 60/167 (35%), Positives = 85/167 (50%), Gaps = 16/167 (9%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT- 725
           IG G FG V  G +  G +VA+K   ++ +   ++F  E  V+  +RH NLV+++     
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSF---DILQRLSVIIDVALALEYLHFGYSNPVVH 782
                 +V EYM  GSL DYL S   S    D L + S  +DV  A+EYL    +N  VH
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS--LDVCEAMEYLE---ANNFVH 125

Query: 783 CDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            D+   NVL+ +D VA +SDFG+ K    E S  Q      + + AP
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAP 168

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.7 bits (200), Expect = 1e-16
 Identities = 54/176 (30%), Positives = 77/176 (43%), Gaps = 14/176 (7%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRH 714
             F     IG G FG VYK         VAIKV  + LE A    +    E + L   R 
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKV--IDLEEAEDEIEDIQQEIQFLSQCRS 58

Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII-DVALALEYLH 773
             + K   S        +++EY   GS  D L         +   + I+ +V L LEYLH
Sbjct: 59  PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYI---AFILREVLLGLEYLH 115

Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
                  +H DIK +N+LL ++    L+DFG++  L+   S + T  + T  +MAP
Sbjct: 116 ---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFWMAP 167

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 51/182 (28%), Positives = 87/182 (47%), Gaps = 32/182 (17%)

Query: 666 LIGTGGFGSVYKGSFLD-GMEVAIKVFHL-----QLEGALKSFDVECEVLKSVRHRNLVK 719
           L+G G FG VY    +D G E+A+K         + +  + + + E ++LK+++H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYL-----YSNN----FSFDILQRLSVIIDVALALE 770
                 +++  ++ +EYMP GS++D L      +      ++  IL+           +E
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE----------GVE 118

Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG---YM 827
           YLH   SN +VH DIK +N+L D      L DFG +K L        T   +  G   +M
Sbjct: 119 YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ-TICSSGTGMKSVTGTPYWM 174

Query: 828 AP 829
           +P
Sbjct: 175 SP 176

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 53/176 (30%), Positives = 81/176 (46%), Gaps = 19/176 (10%)

Query: 667 IGTGGFGSVY---KGSFLDGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRHRNLVKI 720
           I  G +G V+   K S   G   AIKV     +  +  +     E ++L   +   +VK+
Sbjct: 1   ISKGAYGRVFLAKKKS--TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPV 780
             S        LV+EY+P G L   L +   S D       I ++ LALEYLH   SN +
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGI 114

Query: 781 VHCDIKPSNVLLDKDMVAHLSDFGIAKL-LSGEESMKQTLT------LATIGYMAP 829
           +H D+KP N+L+D +    L+DFG++K+ L   +             + T  Y+AP
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 54/187 (28%), Positives = 88/187 (47%), Gaps = 31/187 (16%)

Query: 660 QFNASN---LIGTGGFGSVYKGSFLDG-MEVAIKVFHLQLEGALKSFDVECEVLKSVRHR 715
           +++ +    ++G G +G VY    L   + +AIK    +    ++    E  +   ++HR
Sbjct: 6   EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65

Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYS------------NNFSFDILQRLSVII 763
           N+V+ + S + N F  + +E +P GSL   L S              ++  IL+      
Sbjct: 66  NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE------ 119

Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDK-DMVAHLSDFGIAKLLSGEESMKQTLTLA 822
                L+YLH    N +VH DIK  NVL++    V  +SDFG +K L+G     +T T  
Sbjct: 120 ----GLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT-G 171

Query: 823 TIGYMAP 829
           T+ YMAP
Sbjct: 172 TLQYMAP 178

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 79.1 bits (195), Expect = 3e-16
 Identities = 44/167 (26%), Positives = 85/167 (50%), Gaps = 6/167 (3%)

Query: 665 NLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISS 723
           + +G G +G VY+G +    + VA+K    +    ++ F  E  V+K ++H NLV+++  
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNNFS-FDILQRLSVIIDVALALEYLHFGYSNPVVH 782
           CT      ++ E+M  G+L DYL   N    + +  L +   ++ A+EYL        +H
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 127

Query: 783 CDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            D+   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 174

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 78.5 bits (194), Expect = 5e-16
 Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 11/167 (6%)

Query: 667 IGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G  G V K      G  +A+K   L++  A+ K    E ++L       +V    + 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 725 TNNDFKALVLEYMPNGSLEDYL--YSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVH 782
            NN   ++ +EYM  GSL+  L          IL +++V   V   L YLH  +   ++H
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAV--AVLKGLTYLHEKHK--IIH 124

Query: 783 CDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            D+KPSN+L++      L DFG++  L    S+ +T    T  YMAP
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLV--NSLAKTFV-GTSSYMAP 168

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 78.3 bits (194), Expect = 8e-16
 Identities = 48/153 (31%), Positives = 74/153 (48%), Gaps = 19/153 (12%)

Query: 667 IGTGGFGSVYKGSFLD---GMEVAIKVFHL--QLEG----ALKSFDVECEVLKSVRHRNL 717
           +G G +G VYK    D   G  VA+K   L  + EG    AL+    E  +LK ++H N+
Sbjct: 7   LGEGTYGVVYKA--RDKKTGEIVALKKIRLDNEEEGIPSTALR----EISLLKELKHPNI 60

Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           VK++          LV EY     L+ YL             S++  +   L Y H   S
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---S 116

Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS 810
           + ++H D+KP N+L+++D V  L+DFG+A+   
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFG 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 8/149 (5%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKS--FDVECEVLKSVRHRNLVKIISSC 724
           +GTG FG V  G +    +VAIK+     EG++    F  E +V+  + H  LV++   C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
           T      +V EYM NG L +YL  +   F   Q L +  DV   + YL    S   +H D
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRD 125

Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
           +   N L+D      +SDFG+++ +  +E
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDE 154

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 46/143 (32%), Positives = 69/143 (48%), Gaps = 4/143 (2%)

Query: 666 LIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALK-SFDVECEVLKSVRHRNLVKIISSC 724
           L+G G FG V+KG+  D   VA+K     L   LK  F  E  +LK   H N+VK+I  C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
           T      +V+E +P G    +L          Q +   +D A  + YL    S   +H D
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118

Query: 785 IKPSNVLLDKDMVAHLSDFGIAK 807
           +   N L+ ++ V  +SDFG+++
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 11/173 (6%)

Query: 667 IGTGGFGSVYKGSFL-DGMEVAIKVFHL-QLEGALKSFDV-ECEVLKSVRHRNLVKIISS 723
           IG G FG+V K     DG  +  K      +    K   V E  +L+ ++H N+V+    
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67

Query: 724 CTNNDFKAL--VLEYMPNGSLEDYL---YSNNFSFDILQRLSVIIDVALALEYLHFGY-- 776
             +   + L  V+EY   G L   +          +      ++  + LAL   H     
Sbjct: 68  IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127

Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            N V+H D+KP+N+ LD +    L DFG+AK+L  + S  +T  + T  YM+P
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY-VGTPYYMSP 179

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 55/181 (30%), Positives = 83/181 (45%), Gaps = 16/181 (8%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHL-QLEGALKSFDVECEVLKSVRHRN 716
           + +    +IG G    VY    L    +VAIK   L + + ++     E + +    H N
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL-----ALEY 771
           +VK  +S    D   LV+ Y+  GSL D +  +++    L     II   L      LEY
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDE--AIIATVLKEVLKGLEY 117

Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL--SGEESMKQTLTLA-TIGYMA 828
           LH   SN  +H DIK  N+LL +D    ++DFG++  L   G+ + K   T   T  +MA
Sbjct: 118 LH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174

Query: 829 P 829
           P
Sbjct: 175 P 175

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 51/177 (28%), Positives = 75/177 (42%), Gaps = 12/177 (6%)

Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDV--ECEVLKSVRHRNL 717
           F   N IG G FG V+K     D    A+K   L      +  +   E  VL  +    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN---FSFDILQRLSVIIDVALALEYLHF 774
           ++   S  +     +V+EY  NG L   L          D + R    I + L L +LH 
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRF--FIQILLGLAHLH- 118

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
             S  ++H DIK  N+ LD      + D G+AKLLS   +   T+ + T  Y++P L
Sbjct: 119 --SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPEL 172

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 76.3 bits (188), Expect = 4e-15
 Identities = 49/156 (31%), Positives = 84/156 (53%), Gaps = 14/156 (8%)

Query: 667 IGTGGFGSVYKGSFL-DG----MEVAIKVFHLQLEGALKSFDV---ECEVLKSVRHRNLV 718
           +G+G FG+VYKG ++ +G    + VAIKV  L+ E + K+      E  V+ SV H ++V
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKV--LREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
           +++  C ++    L+ + MP G L DY+ ++  +      L+  + +A  + YL      
Sbjct: 73  RLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EK 128

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
            +VH D+   NVL+       ++DFG+AKLL  +E 
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 76.3 bits (188), Expect = 4e-15
 Identities = 50/186 (26%), Positives = 86/186 (46%), Gaps = 26/186 (13%)

Query: 667 IGTGGFGSVYKGSF--LDGME----VAIKVFHLQLEGALKS-FDVECEVLKSVRHRNLVK 719
           +G G FG VYKG     +       VAIK      E  ++  F  E E++  ++H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNN---------------FSFDILQRLSVIID 764
           ++  CT      ++ EY+ +G L ++L  N+                S D    L + I 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 765 VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL-SGEESMKQTLTLAT 823
           +A  +EYL    S+  VH D+   N L+ + +   +SDFG+++ + S +    Q+ +L  
Sbjct: 133 IAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 824 IGYMAP 829
           + +M P
Sbjct: 190 VRWMPP 195

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 75.5 bits (186), Expect = 8e-15
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 5/164 (3%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           +G G FG VYK      G+  A K+  ++ E  L+ F VE ++L   +H N+V +  +  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
             +   +++E+   G+L+  +          Q   V   +  AL +LH   S+ V+H D+
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129

Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           K  N+LL  D    L+DFG++         + T  + T  +MAP
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF-IGTPYWMAP 172

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 74.9 bits (184), Expect = 8e-15
 Identities = 52/171 (30%), Positives = 85/171 (49%), Gaps = 10/171 (5%)

Query: 666 LIGTGGFGSVYKGSFL-DGMEVAIKVF--HLQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           ++G G FG V+      D   V IK        +    +   EC+VLK + H N+++   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
           +   +    +V+EY P G+L +Y+    N   D    L   + + LAL ++H   +  ++
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLIL 123

Query: 782 HCDIKPSNVLLDK-DMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
           H D+K  N+LLDK  MV  + DFGI+K+LS +   K    + T  Y++P L
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--KAYTVVGTPCYISPEL 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 75.2 bits (185), Expect = 1e-14
 Identities = 58/178 (32%), Positives = 87/178 (48%), Gaps = 20/178 (11%)

Query: 660 QFNASNLIGTGGFGSVYK------GSFLDGMEVAI-KVFHLQLEGALKSFDVECEVLKSV 712
                  +GTG FG V+         +     +AI +V  L+ E  + +   E  VLK V
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN---EKRVLKEV 58

Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            H  ++++  +  +  F  +++EY+P G L  YL  N+  F     L    ++  ALEYL
Sbjct: 59  SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEYL 117

Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAP 829
           H   S  +V+ D+KP N+LLDK+    L+DFG AK L       +T TL  T  Y+AP
Sbjct: 118 H---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-----DRTWTLCGTPEYLAP 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 76.8 bits (189), Expect = 2e-14
 Identities = 36/110 (32%), Positives = 65/110 (59%), Gaps = 1/110 (0%)

Query: 420 LSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDI 479
           L L +  L   IP+    L+ + S+N S N + G++P  +G++  + ++DLS N+ +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 480 PTAIGGLMNLQDLSLRDNGLQGSIPKSIGG-LVSLESLDLSNNSLSGNIP 528
           P ++G L +L+ L+L  N L G +P ++GG L+   S + ++N+    IP
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532

Length = 623

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 74.4 bits (182), Expect = 2e-14
 Identities = 57/164 (34%), Positives = 86/164 (52%), Gaps = 7/164 (4%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           IG G  G+V+    +  G EVAIK  +LQ +   +    E  V+K +++ N+V  + S  
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
             D   +V+EY+  GSL D +       D  Q  +V  +   ALE+LH   +N V+H DI
Sbjct: 87  VGDELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDI 141

Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           K  NVLL  D    L+DFG    ++ E+S + T+ + T  +MAP
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 55/181 (30%), Positives = 86/181 (47%), Gaps = 23/181 (12%)

Query: 660 QFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDV-----ECEVLKSVR 713
            +    LIG G +G+VY+G     G  VA+K+ +L         DV     E  +L  +R
Sbjct: 2   LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQREVALLSQLR 57

Query: 714 H---RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQR-LSVII-DVALA 768
                N+ K   S        +++EY   GS+   + +      I ++ +SVII +V +A
Sbjct: 58  QSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP----IAEKYISVIIREVLVA 113

Query: 769 LEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA 828
           L+Y+H      V+H DIK +N+L+       L DFG+A LL+   S + T    T  +MA
Sbjct: 114 LKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMA 169

Query: 829 P 829
           P
Sbjct: 170 P 170

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 55/173 (31%), Positives = 84/173 (48%), Gaps = 16/173 (9%)

Query: 666 LIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEG----ALKSFDV-ECEVLKSVRHRNLVK 719
           L+G G +G V K    + G  VAIK F   LE      +K   + E  +LK +RH NLV 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKF---LESEDDKMVKKIAMREIRMLKQLRHENLVN 64

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDY-LYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
           +I          LV E++ +  L+D   Y N      +++   +  +   +E+ H   S+
Sbjct: 65  LIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRK--YLFQILRGIEFCH---SH 119

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
            ++H DIKP N+L+ +  V  L DFG A+ L+    +  T  +AT  Y AP L
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-YTDYVATRWYRAPEL 171

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 73.0 bits (179), Expect = 4e-14
 Identities = 56/180 (31%), Positives = 91/180 (50%), Gaps = 21/180 (11%)

Query: 666 LIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGA---------LKSFDVECEVLKSVRHR 715
           LIG+G FGSVY G +   G  +A+K   L    A         L +   E  +LK ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNF-SFDILQRLSVIIDVALALEYLHF 774
           N+V+ + S  + D   + LEY+P GS+   L  NN+ +F+     + +  +   L YLH 
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNFVRQILKGLNYLH- 123

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK-----LLSGEESMKQTLTLATIGYMAP 829
             +  ++H DIK +N+L+D      +SDFGI+K      LS + +  +     ++ +MAP
Sbjct: 124 --NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 72.7 bits (179), Expect = 5e-14
 Identities = 49/171 (28%), Positives = 76/171 (44%), Gaps = 18/171 (10%)

Query: 667 IGTGGFGSVYK-----GSFLDGMEVAIK--VFHLQLEGALKSFDVECEVLKSVRHRNLVK 719
           +G GGFG V        +    ++   K  +     +  + S   E E+L+   H  +VK
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
           +  +  +  +  +++EY   G L   L      FD       I  V LA EYLH   +  
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRG 113

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAP 829
           +++ D+KP N+LLD +    L DFG AK L   +   +T T   T  Y+AP
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAP 161

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 5e-14
 Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 16/170 (9%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEG------ALKSFDVECEVLKSVRHRNLVK 719
           IG G +G VYK    L G  VAIK   L+ E       AL+    E ++LK + H N++K
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
           ++    +     LV E+M +  L   +             S +  +   L + H   S+ 
Sbjct: 63  LLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           ++H D+KP N+L++ + V  L+DFG+A+          T  + T  Y AP
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP-YTHYVVTRWYRAP 167

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 73.2 bits (179), Expect = 5e-14
 Identities = 56/164 (34%), Positives = 84/164 (51%), Gaps = 7/164 (4%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           IG G  G+VY       G EVAIK  +LQ +   +    E  V++  ++ N+V  + S  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
             D   +V+EY+  GSL D +       D  Q  +V  +   AL++LH   SN V+H DI
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141

Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           K  N+LL  D    L+DFG    ++ E+S + T+ + T  +MAP
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 73.0 bits (180), Expect = 5e-14
 Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 17/177 (9%)

Query: 665 NLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALK---SFDV--ECEVLKSVRHRNLV 718
             +G G +  VYK      G  VAIK   L      K   +F    E ++L+ ++H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSF---DILQRLSVIIDVALALEYLHFG 775
            ++    +     LV E+M    LE  +   +      DI   + + +     LEYLH  
Sbjct: 66  GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL---RGLEYLH-- 119

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
            SN ++H D+KP+N+L+  D V  L+DFG+A+   G  + K T  + T  Y AP L 
Sbjct: 120 -SNWILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVVTRWYRAPELL 174

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 73.3 bits (181), Expect = 6e-14
 Identities = 55/182 (30%), Positives = 89/182 (48%), Gaps = 29/182 (15%)

Query: 665 NLIGTGGFGSVYKGSFLD---GMEVAIK----VFHLQLEG--ALKSFDVECEVLKSVRHR 715
             IG+G +G V   S +D   G +VAIK    VF   ++    L+    E ++L+ +RH 
Sbjct: 6   KPIGSGAYGVVC--SAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHE 59

Query: 716 NLVK---IISSCTNNDFKAL--VLEYMPNGSLEDYLYSNNF-SFDILQRLSVIIDVALAL 769
           N++    I+   +  DF  +  V E M    L   + S    + D +Q    +  +   L
Sbjct: 60  NIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYF--LYQILRGL 116

Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYM 827
           +YLH   S  V+H D+KPSN+L++ +    + DFG+A+ +  +E  K  LT  + T  Y 
Sbjct: 117 KYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173

Query: 828 AP 829
           AP
Sbjct: 174 AP 175

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 72.6 bits (178), Expect = 7e-14
 Identities = 51/156 (32%), Positives = 75/156 (48%), Gaps = 14/156 (8%)

Query: 667 IGTGGFGSV----YKGSFLD-GMEVAIKVFHLQLEGALKS-FDVECEVLKSVRHRNLVKI 720
           +G G FG V    Y  +    G  VA+K    +      S +  E  +LK++ H N+VK 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 721 ISSCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
              C+    K   L++EY+P GSL DYL  +  +  + Q L     +   + YLH   S 
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLN--LAQLLLFAQQICEGMAYLH---SQ 126

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL-SGEE 813
             +H D+   NVLLD D +  + DFG+AK +  G E
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 72.4 bits (178), Expect = 7e-14
 Identities = 44/160 (27%), Positives = 79/160 (49%), Gaps = 10/160 (6%)

Query: 665 NLIGTGGFGSVYKGSFL----DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVK 719
            +IG G FG V +G         ++VAIK       +     F  E  ++    H N+++
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL-HFGYSN 778
           +    T +    ++ EYM NGSL+ +L  N+  F + Q + ++  +A  ++YL    Y  
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY-- 127

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT 818
             VH D+   N+L++ ++V  +SDFG+++ L   E+   T
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT 165

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 52/170 (30%), Positives = 83/170 (48%), Gaps = 12/170 (7%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDV--ECEVLKSVRHRNLVKIISSC 724
           +G+G FG V+ G +   ++VAIK  +   EGA+   D   E +V+  + H  LV++   C
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSN--NFSFDILQRLSVIIDVALALEYLHFGYSNPVVH 782
           T      +V E+M NG L +YL       S D+L  LS+  DV   +EYL     N  +H
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLE---RNSFIH 123

Query: 783 CDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
            D+   N L+    V  +SDFG+ + +  +E    +     + +  P +F
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVF 173

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 50/152 (32%), Positives = 75/152 (49%), Gaps = 12/152 (7%)

Query: 666 LIGTGGFGSVYKGSFLD------GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVK 719
            +G G FGSV    + D      G  VA+K         L+ F+ E E+LKS++H N+VK
Sbjct: 11  QLGKGNFGSVELCRY-DPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 720 IISSCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
               C +   +   LV+EY+P GSL DYL  +    D  + L     +   +EYL    S
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---S 126

Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
              VH D+   N+L++ +    + DFG+ K+L
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVL 158

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 53/189 (28%), Positives = 83/189 (43%), Gaps = 40/189 (21%)

Query: 664 SNLIGTGGFGSVYKG-SFLDGMEVAIK--VFHLQLEGALKSFDVECEVLKSVR---HRNL 717
              IG G +G+VYK      G  VA+K     L  EG   S   E  +LK +    H N+
Sbjct: 4   LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63

Query: 718 VKIISSCTNNDFK-----ALVLEYMPNGSLEDYLYSN------------NFSFDILQRLS 760
           V+++  C            LV E++ +  L  YL S             +    +L+   
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLR--- 118

Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT 820
                   +++LH   S+ +VH D+KP N+L+  D    ++DFG+A++ S E  M  T  
Sbjct: 119 -------GVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE--MALTSV 166

Query: 821 LATIGYMAP 829
           + T+ Y AP
Sbjct: 167 VVTLWYRAP 175

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 72.1 bits (176), Expect = 1e-13
 Identities = 56/164 (34%), Positives = 84/164 (51%), Gaps = 7/164 (4%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           IG G  G+VY       G EVAI+  +LQ +   +    E  V++  ++ N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
             D   +V+EY+  GSL D +       D  Q  +V  +   ALE+LH   SN V+H DI
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142

Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           K  N+LL  D    L+DFG    ++ E+S K++  + T  +MAP
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 72.2 bits (177), Expect = 2e-13
 Identities = 55/177 (31%), Positives = 87/177 (49%), Gaps = 31/177 (17%)

Query: 665 NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALK-SFDVECEVLKSVRHRNLVKIIS 722
           N IG+G  G+VYK      G   A+KV +   E  ++     E E+L+ V H N+VK   
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 723 SCTNNDFKALVLEYMPNGSLE-----DYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
              +N    ++LE+M  GSLE     D  +  + +  IL            + YLH    
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS----------GIAYLH---R 186

Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL-----TLATIGYMAP 829
             +VH DIKPSN+L++      ++DFG++++L+      QT+     ++ TI YM+P
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILA------QTMDPCNSSVGTIAYMSP 237

Length = 353

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 42/150 (28%), Positives = 79/150 (52%), Gaps = 10/150 (6%)

Query: 666 LIGTGGFGSVYKGSF-LDGM-EVAIKVFHLQ---LEGALKSFDVECEVLKSVRHRNLVKI 720
           +IG G FG V++G   + G  EVA+ +  L+    E   + F  E  ++    H N++++
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL-HFGYSNP 779
               T      ++ EYM NG+L+ YL  ++  F   Q + ++  +A  ++YL    Y   
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNY--- 128

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
            VH D+   N+L++ ++   +SDFG++++L
Sbjct: 129 -VHRDLAARNILVNSNLECKVSDFGLSRVL 157

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 47/164 (28%), Positives = 75/164 (45%), Gaps = 29/164 (17%)

Query: 667 IGTGGFGSVY--KGSFL----DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKI 720
           +G G FG V+  +   L    D M VA+K      E A + F  E E+L  ++H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDIL--------------QRLSVIIDVA 766
              CT      +V EYM +G L  +L S+     IL              Q L++   +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 767 LALEY---LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
             + Y   LHF      VH D+   N L+ + +V  + DFG+++
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 72.9 bits (179), Expect = 3e-13
 Identities = 42/116 (36%), Positives = 59/116 (50%), Gaps = 24/116 (20%)

Query: 371 GLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSV 430
           GL L N  L G IPN + +L  L  + + GN + G IPP +G +TSL +L L        
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDL-------- 473

Query: 431 IPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGL 486
                           S N  NGS+PE +G L  + I++L+ N+LSG +P A+GG 
Sbjct: 474 ----------------SYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513

Length = 623

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 44/166 (26%), Positives = 82/166 (49%), Gaps = 9/166 (5%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V++G + +   VA+K       G +  K F  E +++K +RH  L+++ + C
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLK---PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFS-FDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
           T  +   +V E M  GSL +YL         + Q + +   VA  + YL    +   +H 
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHR 127

Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D+   NVL+ ++ +  ++DFG+A+++  +    +      I + AP
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAP 173

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 50/151 (33%), Positives = 70/151 (46%), Gaps = 16/151 (10%)

Query: 667 IGTGGFGSVYKGSFL--DG--MEVAIKVFHLQLEGALKS-FDVECEVLKSVRHRNLVKII 721
           +G G FGSV KG +L   G  +EVA+K    +   A K  F  E  V+  + H  +V++I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL---HFGYSN 778
             C       LV+E  P G L  YL        +     +   VA+ + YL   HF    
Sbjct: 63  GVCKGEPL-MLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLESKHF---- 116

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
             VH D+   NVLL     A +SDFG+++ L
Sbjct: 117 --VHRDLAARNVLLVNRHQAKISDFGMSRAL 145

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 53/173 (30%), Positives = 79/173 (45%), Gaps = 18/173 (10%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEG-------ALKSFDVECEVLKSVRHRNLV 718
           IG G +G V+K    + G  VAIK F ++ E        AL+    E  +LK ++H NLV
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF-VESEDDPVIKKIALR----EIRMLKQLKHPNLV 63

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
            +I          LV EY  + ++ + L  N           +I     A+ + H    +
Sbjct: 64  NLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH---KH 119

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
             +H D+KP N+L+ K     L DFG A++L+G      T  +AT  Y AP L
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-YTDYVATRWYRAPEL 171

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 72.5 bits (178), Expect = 5e-13
 Identities = 35/87 (40%), Positives = 52/87 (59%)

Query: 326 ISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPN 385
           + N  +RG IP +I  L +L+ + L GN + G+IP + G + +L+ LDL  N   G IP 
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484

Query: 386 GLCQLARLSVLYMDGNKLSGPIPPCIG 412
            L QL  L +L ++GN LSG +P  +G
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 69.8 bits (171), Expect = 5e-13
 Identities = 50/179 (27%), Positives = 80/179 (44%), Gaps = 11/179 (6%)

Query: 658 TNQFNASNLIGTGGFGSVYKG-SFLDGMEVA---IKVFHLQLEGALKSFDVECEVLKSVR 713
              F     IG G F  VYK    LDG  VA   +++F +    A +    E ++LK + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLE---DYLYSNNFSFDILQRLSVIIDVALALE 770
           H N++K ++S   N+   +VLE    G L     +                 + +  ALE
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           ++H   S  ++H DIKP+NV +    V  L D G+ +  S + +   +L + T  YM+P
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 69.5 bits (170), Expect = 5e-13
 Identities = 46/150 (30%), Positives = 79/150 (52%), Gaps = 10/150 (6%)

Query: 666 LIGTGGFGSVYKGSF-LDG---MEVAIKVFHL-QLEGALKSFDVECEVLKSVRHRNLVKI 720
           +IG G FG V  G   L G   + VAIK       E   + F  E  ++    H N++ +
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH-FGYSNP 779
               T +    +V EYM NGSL+ +L  ++  F ++Q + ++  +A  ++YL   GY   
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY--- 127

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
            VH D+   N+L++ ++V  +SDFG++++L
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRVL 156

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 69.4 bits (170), Expect = 6e-13
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 16/176 (9%)

Query: 666 LIGTGGFGSVYKGSFLDGMEV-AIKVFHL----------QLEGALKSFDVECEVLKSVRH 714
           LIG G +G VY    +   E+ A+K   L          + +  +K+   E E LK + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
            N+V+ +   T  ++ ++ LEY+P GS+          F+          V   L YLH 
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGS-CLRTYGRFEEQLVRFFTEQVLEGLAYLH- 125

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAP 829
             S  ++H D+K  N+L+D D +  +SDFGI+K         Q +++  ++ +MAP
Sbjct: 126 --SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 54/190 (28%), Positives = 79/190 (41%), Gaps = 22/190 (11%)

Query: 654 LLQATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSV 712
           L   T  F    +IG G +G VYK      G  VAIK+  +  +   +    E  +L+  
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKY 59

Query: 713 -RHRNLVK-----IISSCTNNDFKA-LVLEYMPNGSLEDYLYSNNFSFDILQRLS----- 760
             H N+       I  +   ND +  LV+E    GS+ D +          +RL      
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKRLKEEWIA 116

Query: 761 -VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL 819
            ++ +    L YLH    N V+H DIK  N+LL K+    L DFG++  L      + T 
Sbjct: 117 YILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF 173

Query: 820 TLATIGYMAP 829
              T  +MAP
Sbjct: 174 I-GTPYWMAP 182

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 51/189 (26%), Positives = 90/189 (47%), Gaps = 22/189 (11%)

Query: 659 NQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDV----ECEVLKSVR 713
           +++     IG G FG V+K         VA+K   + +E   + F +    E ++L+ ++
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLK 69

Query: 714 HRNLVKIISSCTN-----NDFKA---LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDV 765
           H N+V +I  C       N +K    LV E+  +  L   L + N  F + +   V+  +
Sbjct: 70  HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKML 128

Query: 766 ALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS---GEESMKQTLTLA 822
              L Y+H    N ++H D+K +N+L+ KD +  L+DFG+A+  S     +  + T  + 
Sbjct: 129 LNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185

Query: 823 TIGYMAPGL 831
           T+ Y  P L
Sbjct: 186 TLWYRPPEL 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 69.5 bits (170), Expect = 1e-12
 Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 22/178 (12%)

Query: 661 FNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFD---VECEVLKSVR 713
           F     +GTG FG V    +KG+   G   AIK    +    +K       E  +L  + 
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYL 772
           H  +V ++ S  + +    +LE++  G L  +L     F  D+ +      ++ LA EYL
Sbjct: 77  HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA--ELVLAFEYL 134

Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAP 829
           H   S  +++ D+KP N+LLD      ++DFG AK +       +T TL  T  Y+AP
Sbjct: 135 H---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-----DRTFTLCGTPEYLAP 184

Length = 329

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 45/161 (27%), Positives = 79/161 (49%), Gaps = 28/161 (17%)

Query: 665 NLIGTGGFGSVYKGSFLDGMEVAIK--VFH----LQLEGALKSFDVECEVLKSVRHRNLV 718
            ++G G +G+VY G    G  +A+K         L  E   +    E ++LKS++H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL---------AL 769
           + + +C +++  ++ +E++P GS+            IL R   + +             +
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSIS----------SILNRFGPLPEPVFCKYTKQILDGV 115

Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS 810
            YLH   +N VVH DIK +NV+L  + +  L DFG A+ L+
Sbjct: 116 AYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 48/181 (26%), Positives = 78/181 (43%), Gaps = 22/181 (12%)

Query: 660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDV--ECEVLKSVRHRN 716
            F     +G G +GSVYK   L D    A+K   L      +  D   E  +L SV H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYL-----YSNNFSFDILQRLSVIIDVALALEY 771
           ++    +  + +   +V+EY P G L   +              + R  + I +   L+ 
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR--IFIQLLRGLQA 118

Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG---YMA 828
           LH      ++H D+K +N+LL  + +  + D GI+K+      +K+ +    IG   YMA
Sbjct: 119 LH---EQKILHRDLKSANILLVANDLVKIGDLGISKV------LKKNMAKTQIGTPHYMA 169

Query: 829 P 829
           P
Sbjct: 170 P 170

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 43/164 (26%), Positives = 88/164 (53%), Gaps = 5/164 (3%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN 726
           +G G FG V+ G + +  +VA+K        ++++F  E  ++K+++H  LV++ +  T 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 727 NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL-EYLHFGYSNPVVHCDI 785
            +   ++ EYM  GSL D+L S+     +L +L   ID +  + E + +      +H D+
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL---IDFSAQIAEGMAYIERKNYIHRDL 129

Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           + +NVL+ + ++  ++DFG+A+++   E   +      I + AP
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 173

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 67.8 bits (165), Expect = 2e-12
 Identities = 49/170 (28%), Positives = 85/170 (50%), Gaps = 18/170 (10%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++     VAIK       G +  ++F  E +V+K +RH  LV++ +  
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIID----VALALEYLH-FGYSNP 779
           +      +V EYM  GSL D+L           RL  ++D    +A  + Y+    Y   
Sbjct: 71  SEEPI-YIVTEYMSKGSLLDFLKG---EMGKYLRLPQLVDMAAQIASGMAYVERMNY--- 123

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            VH D++ +N+L+ +++V  ++DFG+A+L+   E   +      I + AP
Sbjct: 124 -VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 172

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 67.6 bits (165), Expect = 3e-12
 Identities = 44/155 (28%), Positives = 79/155 (50%), Gaps = 10/155 (6%)

Query: 666 LIGTGGFGSVYKGSF-LDGME---VAIKVFHL-QLEGALKSFDVECEVLKSVRHRNLVKI 720
           +IG G FG V +G   L G     VAIK       E   + F  E  ++    H N++ +
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL-HFGYSNP 779
               T +    ++ E+M NG+L+ +L  N+  F ++Q + ++  +A  ++YL    Y   
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNY--- 127

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
            VH D+   N+L++ ++V  +SDFG+++ L  + S
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 52/185 (28%), Positives = 88/185 (47%), Gaps = 27/185 (14%)

Query: 665 NLIGTGGFGSVYKGSFL-DG--MEVAIKVF-HLQLEGALKSFDVECEVL-KSVRHRNLVK 719
           ++IG G FG V +     DG  M  AIK+      E   + F  E EVL K   H N++ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYL---------------YSNNFSFDILQRLSVIID 764
           ++ +C N  +  + +EY P G+L D+L               +    +    Q L    D
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 765 VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES-MKQTLTLAT 823
           VA  ++YL        +H D+   NVL+ +++ + ++DFG+++   GEE  +K+T+    
Sbjct: 128 VATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181

Query: 824 IGYMA 828
           + +MA
Sbjct: 182 VRWMA 186

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 67.4 bits (164), Expect = 3e-12
 Identities = 54/172 (31%), Positives = 85/172 (49%), Gaps = 21/172 (12%)

Query: 666 LIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEV--LKSVRHRNLVK 719
           L+G G FG VY     D G E+A+K      E    S +V   ECE+  LK++ H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 720 IISSCTNNDFKAL--VLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGY 776
                 +   + L   +E+MP GS++D L S    + ++ ++ +  I     LE + + +
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYLH 123

Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA 828
           SN +VH DIK +N+L D      L DFG +K L       QT+ L+  G  +
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL-------QTICLSGTGMKS 168

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 42/170 (24%), Positives = 80/170 (47%), Gaps = 20/170 (11%)

Query: 666 LIGTGGFGSVYKGSFL--DGMEVAIKVFHLQLEGA----LKSFDVECEVLKSVRHRNLVK 719
           ++G G FGSV +G     DG ++ + V  ++L+      ++ F  E   +K   H N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 720 IISSC----TNNDFKA--LVLEYMPNGSLEDYLYS-----NNFSFDILQRLSVIIDVALA 768
           +I  C    +        ++L +M +G L  +L             +   L  ++D+AL 
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 769 LEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT 818
           +EYL    +   +H D+   N +L +DM   ++DFG++K +   +  +Q 
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG 172

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 52/176 (29%), Positives = 84/176 (47%), Gaps = 11/176 (6%)

Query: 661 FNASNLIGTGGFGSVYKGSF-LDGMEVAIK---VFHLQLEGALKSFDVECEVLKSVRHRN 716
           F     IG G F  VY+ +  LDG+ VA+K   +F L    A      E ++LK + H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV---IIDVALALEYLH 773
           ++K  +S   ++   +VLE    G L   +        ++   +V    + +  ALE++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
              S  V+H DIKP+NV +    V  L D G+ +  S + +   +L + T  YM+P
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 66.8 bits (163), Expect = 4e-12
 Identities = 46/166 (27%), Positives = 87/166 (52%), Gaps = 10/166 (6%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G +    +VAIK      +G++  ++F  E  ++K ++H  LV++ +  
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL-EYLHFGYSNPVVHC 783
           T      ++ EYM NGSL D+L +      I   ++ +ID+A  + E + F      +H 
Sbjct: 71  TQEPI-YIITEYMENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126

Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+ + +   ++DFG+A+L+   E   +      I + AP
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 172

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 66.2 bits (161), Expect = 7e-12
 Identities = 42/143 (29%), Positives = 69/143 (48%), Gaps = 5/143 (3%)

Query: 667 IGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGALKS-FDVECEVLKSVRHRNLVKIISSC 724
           IG G FG V+ G    D   VA+K     L   LK+ F  E  +LK   H N+V++I  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
           T      +V+E +  G    +L +      + + + ++ + A  +EYL    S   +H D
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119

Query: 785 IKPSNVLLDKDMVAHLSDFGIAK 807
           +   N L+ +  V  +SDFG+++
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 68.3 bits (167), Expect = 8e-12
 Identities = 28/80 (35%), Positives = 46/80 (57%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           ++LS N + G IP  +G++T L+ L L YN   G IP+ LG L  L +++L  N LSG +
Sbjct: 447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRV 506

Query: 62  PSTIFNLSSLSTGMDFSNNS 81
           P+ +          +F++N+
Sbjct: 507 PAALGGRLLHRASFNFTDNA 526

Length = 623

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 66.4 bits (163), Expect = 8e-12
 Identities = 49/152 (32%), Positives = 73/152 (48%), Gaps = 22/152 (14%)

Query: 667 IGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSFDVEC----EVLKSVR----HRNL 717
           +G G FGSVY     +  E VAIK    +++    S++ EC    EV KS+R    H N+
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIK----KMKKKFYSWE-ECMNLREV-KSLRKLNEHPNI 60

Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFS-FDILQRLSVIIDVALALEYLH-FG 775
           VK+      ND    V EYM  G+L   +       F      S+I  +   L ++H  G
Sbjct: 61  VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           +     H D+KP N+L+    V  ++DFG+A+
Sbjct: 120 F----FHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 9e-12
 Identities = 49/163 (30%), Positives = 75/163 (46%), Gaps = 28/163 (17%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKS-----FDVECEV 708
           + F    +IG G FG V    +L      G   A+KV  L+    +K         E ++
Sbjct: 1   DDFEVIKVIGRGAFGEV----WLVRDKDTGQVYAMKV--LRKSDMIKRNQIAHVRAERDI 54

Query: 709 LKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV---IIDV 765
           L       +VK+  S  + +   LV+EYMP G L + L       D+    +    I ++
Sbjct: 55  LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL-IR---KDVFPEETARFYIAEL 110

Query: 766 ALALEYLH-FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
            LAL+ +H  G+    +H DIKP N+L+D D    L+DFG+ K
Sbjct: 111 VLALDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCK 149

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 66.2 bits (161), Expect = 9e-12
 Identities = 54/173 (31%), Positives = 82/173 (47%), Gaps = 12/173 (6%)

Query: 661 FNASNLIGTGGFGSVYKGSFLDGME---VAIKVFHLQ-LEGALKSFDVECEVLKSVRHRN 716
           F     IG G FG V+KG  +D      VAIK+  L+  E  ++    E  VL       
Sbjct: 6   FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
           + K   S        +++EY+  GS  D L +    FD  Q  +++ ++   L+YLH   
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH--- 118

Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           S   +H DIK +NVLL +     L+DFG+A  L+  +  + T  + T  +MAP
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAP 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 67.9 bits (166), Expect = 1e-11
 Identities = 35/86 (40%), Positives = 49/86 (56%)

Query: 348 LGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPI 407
           LGL    L G IP    KL++LQ ++L  N + G IP  L  +  L VL +  N  +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 408 PPCIGDLTSLRLLSLASNELNSVIPS 433
           P  +G LTSLR+L+L  N L+  +P+
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPA 508

Length = 623

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 46/160 (28%), Positives = 81/160 (50%), Gaps = 10/160 (6%)

Query: 660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSVR 713
           +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV 
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
           + ++ +++  C  +  + L+ + MP G L DY+  +  +      L+  + +A  + YL 
Sbjct: 68  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 126

Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
                 +VH D+   NVL+       ++DFG+AKLL  +E
Sbjct: 127 ---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 48/184 (26%), Positives = 83/184 (45%), Gaps = 28/184 (15%)

Query: 666 LIGTGGFGSVYK-------GSFLDGMEVAIKVFHLQLEGALKSFD-------VECEVLK- 710
            +G+G FG VYK        + L   E  I V +       +  D        E  ++K 
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKE--INVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64

Query: 711 SVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYS-----NNFSFDILQRLSVIIDV 765
            +RH N+V+   +   ND   +V++ +    L ++  S       F+ + +   ++ + +
Sbjct: 65  QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI--WNIFVQM 122

Query: 766 ALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG 825
            LAL YLH      +VH D+ P+N++L +D    ++DFG+AK    E  +  T  + TI 
Sbjct: 123 VLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL--TSVVGTIL 178

Query: 826 YMAP 829
           Y  P
Sbjct: 179 YSCP 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 65.5 bits (159), Expect = 1e-11
 Identities = 55/168 (32%), Positives = 81/168 (48%), Gaps = 19/168 (11%)

Query: 666 LIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEV--LKSVRHRNLVK 719
           L+G G FG VY    +D G E+A K      E    S +V   ECE+  LK+++H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 720 IISSCTNNDFKALV--LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
                 +   K L   +EYMP GS++D L +     + + R      +   + YLH   S
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH---S 124

Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG 825
           N +VH DIK +N+L D      L DFG +K L       QT+ ++  G
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRL-------QTICMSGTG 165

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 67.1 bits (164), Expect = 2e-11
 Identities = 38/92 (41%), Positives = 53/92 (57%)

Query: 96  LIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNL 155
            I GL + N  L G IPN+I + + L  I+L+ N     IP  LG++TSL+ L L +N+ 
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 156 TGEIPYEMGNLRNLEILGLQLNKLVGFVPTSI 187
            G IP  +G L +L IL L  N L G VP ++
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 44/152 (28%), Positives = 81/152 (53%), Gaps = 14/152 (9%)

Query: 666 LIGTGGFGSVYKGSFL-DG----MEVAIKVFHLQLEGALKSFDVECE---VLKSVRHRNL 717
           L+G+G FG+V+KG ++ +G    + VAIK   +Q     ++F    +    + S+ H  +
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKT--IQDRSGRQTFQEITDHMLAMGSLDHAYI 71

Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           V+++  C     + LV +  P GSL D++  +  S D  + L+  + +A  + YL     
Sbjct: 72  VRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---E 127

Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
           + +VH ++   N+LL  D +  ++DFG+A LL
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLL 159

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 65.9 bits (160), Expect = 2e-11
 Identities = 48/155 (30%), Positives = 84/155 (54%), Gaps = 12/155 (7%)

Query: 666 LIGTGGFGSVYKGSFLDGME-----VAIKVFHLQLEG--ALKSFDVECEVLKSVRHRNLV 718
           ++G+G FG+VYKG ++   E     VAIK+ + +  G  A   F  E  ++ S+ H +LV
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
           +++  C +   + LV + MP+G L DY++ +  +      L+  + +A  + YL      
Sbjct: 73  RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ER 128

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
            +VH D+   NVL+       ++DFG+A+LL G+E
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 13/168 (7%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           +G G FG VYK    + G   A KV   + E  L+ + VE E+L +  H  +VK++ +  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
            +    +++E+ P G+++  +   +     L    + +     LE L + +S  ++H D+
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVICRQMLEALQYLHSMKIIHRDL 136

Query: 786 KPSNVLLDKDMVAHLSDFGIA----KLLSGEESMKQTLTLATIGYMAP 829
           K  NVLL  D    L+DFG++    K L   +S      + T  +MAP
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF-----IGTPYWMAP 179

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 51/180 (28%), Positives = 83/180 (46%), Gaps = 19/180 (10%)

Query: 661 FNASNLIGTGGFGSVYKGS-FLDGMEVAIK---VFHLQLEGALKSFDVECEVLKSVRHRN 716
           F     IG G F  VY+ +  LD   VA+K   +F +    A +    E ++LK + H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRL-------SVIIDVALAL 769
           ++K + S   ++   +VLE    G L   +      F   +RL          + +  A+
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKY----FKKQKRLIPERTVWKYFVQLCSAV 119

Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           E++H   S  V+H DIKP+NV +    V  L D G+ +  S + +   +L + T  YM+P
Sbjct: 120 EHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 54/159 (33%), Positives = 77/159 (48%), Gaps = 30/159 (18%)

Query: 666 LIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEV--LKSVRHRNLVK 719
           L+G G FG VY     D G E+A+K      +    S +V   ECE+  LK++RH  +V+
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 720 IISSCTNNDFKALVL--EYMPNGSLEDYL---------YSNNFSFDILQRLSVIIDVALA 768
                 + + K L +  EYMP GS++D L          +  ++  ILQ +S        
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS-------- 120

Query: 769 LEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
             YLH   SN +VH DIK +N+L D      L DFG +K
Sbjct: 121 --YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.4 bits (162), Expect = 3e-11
 Identities = 33/91 (36%), Positives = 52/91 (57%), Gaps = 1/91 (1%)

Query: 74  GMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTE 133
           G+   N  L G +P+D+  +L  ++ + +S N + G IP ++     L V+ L+YN F  
Sbjct: 422 GLGLDNQGLRGFIPNDI-SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG 480

Query: 134 RIPRGLGNLTSLKTLYLGFNNLTGEIPYEMG 164
            IP  LG LTSL+ L L  N+L+G +P  +G
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 56/180 (31%), Positives = 87/180 (48%), Gaps = 17/180 (9%)

Query: 661 FNASNLIGTGGFGSVY--------KGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV 712
           F    ++GTG +G V+            L  M+V  K   +Q    ++    E  VL+ V
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 713 RHRNLVKIISSCTNNDFKA-LVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALE 770
           R    +  +      + K  L+L+Y+  G +  +LY  +NFS D ++  S   ++ LALE
Sbjct: 62  RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG--EIILALE 119

Query: 771 YLH-FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +LH  G    +V+ DIK  N+LLD +    L+DFG++K    EE  +      TI YMAP
Sbjct: 120 HLHKLG----IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 13/172 (7%)

Query: 667 IGTGGFGSVY----KGSFLDGMEVAIKVFH----LQLEGALKSFDVECEVLKSVRHRNLV 718
           +GTG +G V+     G    G   A+KV      +Q     +    E +VL++VR    +
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 719 KIISSCTNNDFKA-LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
             +      D K  L+L+Y+  G L  +LY     F   +    I ++ LAL++LH    
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH-FTESEVRVYIAEIVLALDHLH---Q 123

Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             +++ DIK  N+LLD +    L+DFG++K    EE  +      TI YMAP
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 50/166 (30%), Positives = 83/166 (50%), Gaps = 11/166 (6%)

Query: 667 IGTGGFGSV---YKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISS 723
           IG G  G V      S   G +VA+K   L+ +   +    E  +++  +H N+V++ SS
Sbjct: 27  IGEGSTGIVCIATDKST--GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84

Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
               D   +V+E++  G+L D +     + +  Q  +V + V  AL +LH   +  V+H 
Sbjct: 85  YLVGDELWVVMEFLEGGALTDIVTHTRMNEE--QIATVCLAVLKALSFLH---AQGVIHR 139

Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           DIK  ++LL  D    LSDFG    +S E   +++L + T  +MAP
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL-VGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 64.4 bits (157), Expect = 4e-11
 Identities = 49/168 (29%), Positives = 74/168 (44%), Gaps = 10/168 (5%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVF---HLQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G GGFG V        G   A K      L+     +    E ++L+ V  R +V +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
           +    D   LV+  M  G L+ ++Y+     F   + +     +   LE+LH      +V
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117

Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           + D+KP NVLLD      +SD G+A  L G + +K      T GYMAP
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKG--RAGTPGYMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 40/199 (20%)

Query: 665 NLIGTGGFGSVYKGSFLD-------GMEVAIKVFHLQLEGAL----KSFDVECEVLKSVR 713
           N +G+G FG VY+G+  D        + VA+K      +GA     K F  E  ++ +  
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR---KGATDQEKKEFLKEAHLMSNFN 57

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFS------FDILQRLSVIIDVAL 767
           H N+VK++  C  N+ + +++E M  G L  YL              + + L + +DVA 
Sbjct: 58  HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117

Query: 768 ALEYL---HFGYSNPVVHCDIKPSNVLL-----DKDMVAHLSDFGIAK-LLSGEESMKQT 818
              YL   HF      +H D+   N L+     D D V  + DFG+A+ +   +   K+ 
Sbjct: 118 GCVYLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG 171

Query: 819 LTLATIGYMAP-----GLF 832
             L  + +MAP     G F
Sbjct: 172 EGLLPVRWMAPESLLDGKF 190

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 45/169 (26%), Positives = 86/169 (50%), Gaps = 16/169 (9%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++    +VAIK       G +  ++F  E +++K +RH  LV + +  
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRL----SVIIDVALALEYLHFGYSNPV 780
           +      +V E+M  GSL D+L   +  +  L +L    + I D    +E +++      
Sbjct: 71  SEEPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY------ 123

Query: 781 VHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +H D++ +N+L+  ++V  ++DFG+A+L+   E   +      I + AP
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 64.0 bits (156), Expect = 7e-11
 Identities = 62/191 (32%), Positives = 94/191 (49%), Gaps = 27/191 (14%)

Query: 659 NQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDV----ECEVLKSVR 713
           ++F+    IG G +G VYK      G  VA+K   ++L+   + F +    E ++L+ + 
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALK--KVRLDNEKEGFPITAIREIKILRQLN 64

Query: 714 HRNLVKIISSCTNN----DFKA------LVLEYMPN---GSLEDYLYSNNFSFDILQRLS 760
           HRN+V +    T+     DFK       LV EYM +   G LE  L   +FS D ++  S
Sbjct: 65  HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV--HFSEDHIK--S 120

Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT 820
            +  +   L Y H       +H DIK SN+LL+      L+DFG+A+L + EES   T  
Sbjct: 121 FMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK 177

Query: 821 LATIGYMAPGL 831
           + T+ Y  P L
Sbjct: 178 VITLWYRPPEL 188

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 63.1 bits (153), Expect = 9e-11
 Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 6/164 (3%)

Query: 667 IGTGGFGSVYKGSFLDGMEVA-IKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           IG+G +G VYK   ++  E+A IKV  L+          E  ++K  +H N+V    S  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
             D   + +E+   GSL+D +Y         Q   V  +    L YLH   S   +H DI
Sbjct: 77  RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDI 132

Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           K +N+LL  +    L+DFG++  ++   + +++  + T  +MAP
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITATIAKRKSF-IGTPYWMAP 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 64.5 bits (157), Expect = 1e-10
 Identities = 35/89 (39%), Positives = 49/89 (55%), Gaps = 1/89 (1%)

Query: 299 LDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGS 358
           L L N  + G +P+ I  L   L  I +S  SIRG IP  +G++ +L  L L  N   GS
Sbjct: 423 LGLDNQGLRGFIPNDISKLR-HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 359 IPITFGKLQNLQGLDLVNNKLEGPIPNGL 387
           IP + G+L +L+ L+L  N L G +P  L
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 21/173 (12%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNLVKIISS 723
           IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+VK++  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH-------FGY 776
               +   LV E++ +  L+ ++ ++  S          I + L   YL        F +
Sbjct: 68  IHTENKLYLVFEFL-HQDLKKFMDASPLSG---------IPLPLIKSYLFQLLQGLAFCH 117

Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           S+ V+H D+KP N+L++ +    L+DFG+A+   G      T  + T+ Y AP
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAP 169

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 45/167 (26%), Positives = 83/167 (49%), Gaps = 12/167 (7%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++    +VA+K       G +  +SF  E +++K +RH  LV++ +  
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLH-FGYSNPVVH 782
           +      +V EYM  GSL D+L      +  +   + +   VA  + Y+    Y    +H
Sbjct: 71  SEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY----IH 125

Query: 783 CDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            D++ +N+L+   +V  ++DFG+A+L+   E   +      I + AP
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 54/191 (28%), Positives = 92/191 (48%), Gaps = 27/191 (14%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DG--MEVAIK-VFHLQLEGALKSFDVECEVL-KSVR 713
           N     ++IG G FG V K     DG  M+ AIK +     +   + F  E EVL K   
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNF-----SFDILQR---------- 758
           H N++ ++ +C +  +  L +EY P+G+L D+L  +       +F I             
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 759 LSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES-MKQ 817
           L    DVA  ++YL        +H D+   N+L+ ++ VA ++DFG+++   G+E  +K+
Sbjct: 127 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 180

Query: 818 TLTLATIGYMA 828
           T+    + +MA
Sbjct: 181 TMGRLPVRWMA 191

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 10/170 (5%)

Query: 667 IGTGGFGS--VYKGSFLDGMEVAIKVFHLQLEGALKSFDV--ECEVLKSVRHRNLVKIIS 722
           +G G FG   +Y+ +  D   V  K  +L      +  D   E  +L  ++H N++   +
Sbjct: 8   LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 723 SCTNNDFKALVLEYMPNGSLEDYL-YSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
              +++   + +EY   G+L D +       F+    L  +  +  A+ Y+H      ++
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGIL 123

Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
           H DIK  N+ L K  +  L DFGI+K+L  E SM +T+ + T  YM+P L
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-VGTPYYMSPEL 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 44/135 (32%), Positives = 62/135 (45%), Gaps = 21/135 (15%)

Query: 705 ECEVLKSVRHRNLVKIISSCTNNDFK--ALVLEYMPNGSLEDYLY------SNNFSFDIL 756
           E E+ KS +   +VK   +  +       + +EY   GSL D +Y             +L
Sbjct: 49  ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVL 107

Query: 757 QRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE--ES 814
            +++    V   L YLH   S  ++H DIKPSN+LL +     L DFG+    SGE   S
Sbjct: 108 GKIAE--SVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGV----SGELVNS 158

Query: 815 MKQTLTLATIGYMAP 829
           +  T T  T  YMAP
Sbjct: 159 LAGTFT-GTSFYMAP 172

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 26/165 (15%)

Query: 666 LIGTGGFGSVYKGSFLD------GMEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRNL 717
            +G G FG V K   +          VA+K+      E  L     E E++K + +H+N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-------NFSFDILQR--------LSVI 762
           + ++  CT      +V+EY  +G+L D+L +        +                +S  
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
             VA  +E+L    S   +H D+   NVL+ +D V  ++DFG+A+
Sbjct: 139 YQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 43/155 (27%), Positives = 78/155 (50%), Gaps = 28/155 (18%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDV-ECEVLKSVRHRNLVKIISSC 724
           +G G + +VYKG +   G  VA+K  HL  E    S  + E  ++K ++H N+V++    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSN------------NFSFDILQRLSVIIDVALALEYL 772
              +   LV EYM +  L+ Y+ ++            +F++ +L+ ++            
Sbjct: 68  HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA------------ 114

Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
            F + N V+H D+KP N+L++K     L+DFG+A+
Sbjct: 115 -FCHENRVLHRDLKPQNLLINKRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 45/189 (23%), Positives = 84/189 (44%), Gaps = 23/189 (12%)

Query: 661 FNASNL-----IGTGGFGSVY----KGSFLDGME--VAIKVF-HLQLEGALKSFDVECEV 708
           F  SNL     +G G FG V+    KG   +G E  V +K     + E     F  E ++
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 709 LKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDIL--------QRLS 760
            + + H+N+V+++  C   +   ++LEY   G L+ +L +     + L        Q+++
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121

Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT 820
           +   +AL +++L    +   VH D+   N L+       +S   ++K +   E  K    
Sbjct: 122 LCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA 178

Query: 821 LATIGYMAP 829
           L  + ++AP
Sbjct: 179 LIPLRWLAP 187

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 40/156 (25%), Positives = 67/156 (42%), Gaps = 10/156 (6%)

Query: 666 LIGTGGFGSVYKGSFL----DGMEVAIKVFH-LQLEGALKSFDVECEVLKSVRHRNLVKI 720
            +G G FG V +G +       + VA+K     +L   +  F  E  ++ S+ H NL+++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLS-VIIDVALALEYLHFGYSNP 779
                 +    +V E  P GSL D L  +     ++  L    + +A  + YL    S  
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM 815
            +H D+   N+LL  D    + DFG+ + L   E  
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 62.7 bits (153), Expect = 2e-10
 Identities = 57/193 (29%), Positives = 90/193 (46%), Gaps = 51/193 (26%)

Query: 667 IGTGGFGSVYKGSFLD---GMEVAIKVFHLQLEGALKSFDV---------ECEVLKSVRH 714
           IG+G +G V   S +D   G +VAIK           +FDV         E ++L+  +H
Sbjct: 13  IGSGAYGVV--CSAIDTRSGKKVAIKKI-------PHAFDVPTLAKRTLRELKILRHFKH 63

Query: 715 RNLVKI--ISSCTNNDFKA--LVLEYMPNGSLEDYLYSNN---------FSFDILQRLSV 761
            N++ I  I      DFK   +V++ M +  L   ++S+          F + +L+    
Sbjct: 64  DNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLR---- 118

Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG---EESMKQT 818
                  L+Y+H   S  V+H D+KPSN+L+++D    + DFG+A+ LS    E     T
Sbjct: 119 ------GLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT 169

Query: 819 LTLATIGYMAPGL 831
             +AT  Y AP L
Sbjct: 170 EYVATRWYRAPEL 182

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 15/152 (9%)

Query: 667 IGTGGFGSVYKGSFLDGMEVA-IKVFHLQLEGALKS---FDVECEVLKSVRHRNLVKIIS 722
           IG G FG V  G    G   A + V  L++  +++    F  E +  +S++H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYS----NNFSFD--ILQRLSVIIDVALALEYLHFGY 776
            CT      LV+E+ P G L+ YL S       + D   LQR++   ++AL L +LH   
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLLHLH--- 117

Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL 808
            N  +H D+   N LL  D+   + D+G++  
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHN 149

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 53/173 (30%), Positives = 82/173 (47%), Gaps = 12/173 (6%)

Query: 661 FNASNLIGTGGFGSVYKGSFLDGME---VAIKVFHLQ-LEGALKSFDVECEVLKSVRHRN 716
           F     IG G FG V+KG  +D      VAIK+  L+  E  ++    E  VL       
Sbjct: 6   FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
           + K   S   +    +++EY+  GS  D L       D  Q  +++ ++   L+YLH   
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH--- 118

Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           S   +H DIK +NVLL +     L+DFG+A  L+ +  +K+   + T  +MAP
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAP 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 53/179 (29%), Positives = 85/179 (47%), Gaps = 15/179 (8%)

Query: 659 NQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVR 713
             F+  +L+G G FG V          +  M+V +K   L  +  +  F+ E ++L    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKV-MKKSVLLAQETVSFFEEERDILSISN 59

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYL--YSNNFSFDILQRLSVIIDVALALEY 771
              + ++  +  + D   LV+EY P G L   L  Y + F  D+ Q    + ++ LA+  
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQ--FYLAELVLAIHS 117

Query: 772 LH-FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +H  GY    VH DIKP NVL+D+     L+DFG A  L+  + +   L + T  Y+AP
Sbjct: 118 VHQMGY----VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAP 172

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 33/111 (29%), Positives = 62/111 (55%), Gaps = 5/111 (4%)

Query: 705 ECEVLKSVRHRNLVKIISSCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFDILQRLSVI 762
           E E+L+++ H N+VK    CT +      L++E++P+GSL++YL  N    ++ Q+L   
Sbjct: 56  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYA 115

Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
           + +   ++YL    S   VH D+   NVL++ +    + DFG+ K +  ++
Sbjct: 116 VQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 61.8 bits (150), Expect = 3e-10
 Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 15/150 (10%)

Query: 667 IGTGGFGSVYKGSFLDGMEVA-IKVFHLQLEGALK---SFDVECEVLKSVRHRNLVKIIS 722
           IG G FG V  G    GM  A + V  L+          F  E +  + + H N+++ + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSF------DILQRLSVIIDVALALEYLHFGY 776
            C  +    LVLE+ P G L++YL SN          D+LQR++   +VA  L +LH   
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMAC--EVASGLLWLH--- 117

Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIA 806
               +H D+   N  L  D+   + D+G+A
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 15/178 (8%)

Query: 660 QFNASNLIGTGGFGSVY--KGSFLDGMEVAIKVFHLQLEGALKSFDVECEV--LKSVRHR 715
           ++     IG G FG +Y  K    D     IK   L      +    + EV  L  ++H 
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59

Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN---FSFDILQRLSVIIDVALALEYL 772
           N+V   +S   N    +V+EY   G L   +       FS D  Q LS  + ++L L+++
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED--QILSWFVQISLGLKHI 117

Query: 773 HFGYSNPVVHCDIKPSNVLLDKD-MVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H      ++H DIK  N+ L K+ MVA L DFGIA+ L+    +  T  + T  Y++P
Sbjct: 118 H---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSP 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 45/164 (27%), Positives = 85/164 (51%), Gaps = 6/164 (3%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN 726
           +G G FG V+  ++    +VA+K        ++++F  E  V+K+++H  LVK+ +  T 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72

Query: 727 NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL-EYLHFGYSNPVVHCDI 785
                ++ E+M  GSL D+L S+  S    Q L  +ID +  + E + F      +H D+
Sbjct: 73  EPI-YIITEFMAKGSLLDFLKSDEGS---KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128

Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           + +N+L+   +V  ++DFG+A+++   E   +      I + AP
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 172

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.3 bits (154), Expect = 4e-10
 Identities = 32/86 (37%), Positives = 51/86 (59%), Gaps = 1/86 (1%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L L    L G IP +I  L  L+ + L  N +RG IP  LG++  LE++ L+ N  +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLP 87
           P ++  L+SL   ++ + NSL+G +P
Sbjct: 483 PESLGQLTSLRI-LNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 53/185 (28%), Positives = 89/185 (48%), Gaps = 27/185 (14%)

Query: 665 NLIGTGGFGSVYKGSFL-DG--MEVAIKVF-HLQLEGALKSFDVECEVL-KSVRHRNLVK 719
           ++IG G FG V K     DG  M+ AIK       +   + F  E EVL K   H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYL---------------YSNNFSFDILQRLSVIID 764
           ++ +C +  +  L +EY P+G+L D+L                S   +    Q L    D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 765 VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES-MKQTLTLAT 823
           VA  ++YL        +H D+   N+L+ ++ VA ++DFG+++   G+E  +K+T+    
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174

Query: 824 IGYMA 828
           + +MA
Sbjct: 175 VRWMA 179

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 62.3 bits (151), Expect = 4e-10
 Identities = 82/246 (33%), Positives = 122/246 (49%), Gaps = 14/246 (5%)

Query: 189 NLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLEL 248
           +LS + +L L S +   SL  S +L+ L  L  + L  N     I S +   + L+ L+L
Sbjct: 65  SLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDL 123

Query: 249 GENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPING 308
             N+ +   P        L+ L LS N + S  S L       N  NLK LDLS N ++ 
Sbjct: 124 DNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPL------RNLPNLKNLDLSFNDLS- 176

Query: 309 VLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQN 368
            LP  + NLS +L+ + +S   I   +P EI  L  L EL L  N +I  +  +   L+N
Sbjct: 177 DLPKLLSNLS-NLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKN 233

Query: 369 LQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELN 428
           L GL+L NNKLE  +P  +  L+ L  L +  N++S      +G LT+LR L L+ N L+
Sbjct: 234 LSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLS 290

Query: 429 SVIPST 434
           + +P  
Sbjct: 291 NALPLI 296

Length = 394

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 60.7 bits (147), Expect = 4e-10
 Identities = 42/152 (27%), Positives = 74/152 (48%), Gaps = 8/152 (5%)

Query: 667 IGTGGFGSVYKGSFL---DGMEVAIKVFHLQLEGALK-SFDVECEVLKSVRHRNLVKIIS 722
           +G+G FG V KG +      ++VAIKV   + E +++     E E++  + +  +V++I 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVH 782
            C       LV+E    G L  +L        +   + ++  V++ ++YL        VH
Sbjct: 63  VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVH 118

Query: 783 CDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
            D+   NVLL     A +SDFG++K L  ++S
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDS 150

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 5e-10
 Identities = 49/184 (26%), Positives = 81/184 (44%), Gaps = 30/184 (16%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSFD------VECEVLKS 711
             F     +G GG+G V+     D  E VA+K     L   L   +       E ++L +
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSL---LFKLNEVRHVLTERDILTT 57

Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
            +   LVK++ +  ++++  L +EY+P G     L +N            + ++  A++ 
Sbjct: 58  TKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFEAVDA 116

Query: 772 LH-FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA--TIG--- 825
           LH  GY    +H D+KP N L+D      L+DFG++         K  +T A   +G   
Sbjct: 117 LHELGY----IHRDLKPENFLIDASGHIKLTDFGLS---------KGIVTYANSVVGSPD 163

Query: 826 YMAP 829
           YMAP
Sbjct: 164 YMAP 167

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 60.9 bits (148), Expect = 5e-10
 Identities = 46/159 (28%), Positives = 71/159 (44%), Gaps = 19/159 (11%)

Query: 665 NLIGTGGFGSVYKG--SFLDG----MEVAIKVFHLQLEGALKS-FDVECEVLKSVRHRNL 717
             +G G FG VY+G     DG    ++VA+K          +S F +E  ++    H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN------FSFDILQRLSVIIDVALALEY 771
           V++I        + ++LE M  G L+ +L  N        S  +   L    DVA   +Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 772 LHFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAK 807
           L     N  +H DI   N LL       VA ++DFG+A+
Sbjct: 132 LE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 48/164 (29%), Positives = 80/164 (48%), Gaps = 6/164 (3%)

Query: 667 IGTGGFGSVYKGSFLDGMEVA-IKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           +G+G +G VYK   L   E+A +K+  L+          E  ++K  +H N+V    S  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
           + +   + +EY   GSL+D +Y        LQ   V  +    L YLH   S   +H DI
Sbjct: 77  SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDI 132

Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           K +N+LL  +    L+DFG+A  ++   + +++  + T  +MAP
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITATIAKRKSF-IGTPYWMAP 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 60.8 bits (147), Expect = 7e-10
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 36/215 (16%)

Query: 641 LPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL--------DGMEVAIKVFH 692
           LP+  R  FS  +L            +G G FG V     L        + + VA+K+  
Sbjct: 4   LPEDPRWEFSRDKL-------TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK 56

Query: 693 LQ-LEGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN- 749
               E  L     E E++K + +H+N++ ++ +CT +    +++EY   G+L +YL +  
Sbjct: 57  DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR 116

Query: 750 ----NFSFDILQ----------RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD 795
                +S+DI +           +S    VA  +EYL    S   +H D+   NVL+ ++
Sbjct: 117 PPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTEN 173

Query: 796 MVAHLSDFGIAKLLSGEESMKQTLT-LATIGYMAP 829
            V  ++DFG+A+ ++  +  K+T      + +MAP
Sbjct: 174 NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAP 208

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 61.0 bits (148), Expect = 8e-10
 Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 25/178 (14%)

Query: 666 LIGTGGFGSVYKGSFLDG--------MEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNL 717
           ++G GG+G V++   + G        M+V  K   ++ +        E  +L++V+H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 718 VKIISSCTNNDFKALVLEYMPNGSL------EDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V +I +        L+LEY+  G L      E     +   F     LS I    LALE+
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACF----YLSEIS---LALEH 115

Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           LH      +++ D+KP N+LLD      L+DFG+ K    E ++  T    TI YMAP
Sbjct: 116 LH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMAP 169

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 47/185 (25%), Positives = 79/185 (42%), Gaps = 25/185 (13%)

Query: 667 IGTGGFGSVYKGSFL------DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKI 720
           +G G FG V+           D M VA+K        A K F  E E+L +++H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSN---------------NFSFDILQRLSVIIDV 765
              C + D   +V EYM +G L  +L ++                    + Q L +   +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 766 ALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK-LLSGEESMKQTLTLATI 824
           A  + YL    S   VH D+   N L+  +++  + DFG+++ + S +       T+  I
Sbjct: 133 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 825 GYMAP 829
            +M P
Sbjct: 190 RWMPP 194

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 60.1 bits (145), Expect = 1e-09
 Identities = 44/147 (29%), Positives = 75/147 (51%), Gaps = 6/147 (4%)

Query: 683 GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSL 742
           G +VA+K   L+ +   +    E  +++   H N+V + +S    D   +V+E++  G+L
Sbjct: 47  GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106

Query: 743 EDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSD 802
            D +     + +  Q  +V + V  AL YLH   +  V+H DIK  ++LL  D    LSD
Sbjct: 107 TDIVTHTRMNEE--QIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSD 161

Query: 803 FGIAKLLSGEESMKQTLTLATIGYMAP 829
           FG    +S E   +++L + T  +MAP
Sbjct: 162 FGFCAQVSKEVPKRKSL-VGTPYWMAP 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 60.1 bits (145), Expect = 1e-09
 Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 8/171 (4%)

Query: 661 FNASNLIGTGGFGSVYKGSFLDGMEV-AIKVFHLQ-LEGALKSFDVECEVLKSVRHRNLV 718
           F     IG G FG VYKG      EV AIK+  L+  E  ++    E  VL       + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
           +   S        +++EY+  GS  D L         +   +++ ++   L+YLH   S 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA--TILREILKGLDYLH---SE 120

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             +H DIK +NVLL +     L+DFG+A  L+ +  +K+   + T  +MAP
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAP 170

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 60.1 bits (145), Expect = 1e-09
 Identities = 41/159 (25%), Positives = 72/159 (45%), Gaps = 21/159 (13%)

Query: 667 IGTGGFGSVYKGSFL------DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKI 720
           +G G FG V+           D + VA+K      + A K F  E E+L +++H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDIL------------QRLSVIIDVALA 768
              C   D   +V EYM +G L  +L ++     ++            Q L +   +A  
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 769 LEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           + YL    S   VH D+   N L+ ++++  + DFG+++
Sbjct: 133 MVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.0 bits (148), Expect = 2e-09
 Identities = 33/83 (39%), Positives = 51/83 (61%), Gaps = 2/83 (2%)

Query: 196 LALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSG 255
           L L +  L G +P+  D+ +L +L+ I+L+GN+  G IP  + + + L VL+L  NSF+G
Sbjct: 423 LGLDNQGLRGFIPN--DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG 480

Query: 256 FIPNTLGNLRKLEWLRLSYNFLT 278
            IP +LG L  L  L L+ N L+
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLS 503

Length = 623

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 19/171 (11%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           +G G FG VYK    + G+  A KV   + E  L+ + VE ++L S  H N+VK++ +  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
             +   +++E+   G+++  +          Q   V      AL YLH    N ++H D+
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129

Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-------ATIGYMAP 829
           K  N+L   D    L+DFG+        S K T T+        T  +MAP
Sbjct: 130 KAGNILFTLDGDIKLADFGV--------SAKNTRTIQRRDSFIGTPYWMAP 172

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 56/176 (31%), Positives = 82/176 (46%), Gaps = 17/176 (9%)

Query: 661 FNASNLIGTGGFGSVYKGSFLDG--MEVAIKVFHLQLEGALKSFD---VECEVLKSVRHR 715
           FN    +GTG FG V   ++ +     VAIK F        K  D    E ++L  + H 
Sbjct: 32  FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91

Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHF 774
             V +  S  +  +  LVLE++  G    +L  N  F  D+    +    + L  EYL  
Sbjct: 92  FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAA--QIVLIFEYLQ- 148

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAP 829
             S  +V+ D+KP N+LLDKD    ++DFG AK++       +T TL  T  Y+AP
Sbjct: 149 --SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-----TRTYTLCGTPEYIAP 197

Length = 340

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 61.0 bits (148), Expect = 2e-09
 Identities = 45/163 (27%), Positives = 69/163 (42%), Gaps = 23/163 (14%)

Query: 683 GMEVAIKVF---HLQLEGALKSFDVECEVLKSVRHRNLVKIISS-CTNNDFKALVLEYMP 738
           G EVAIK+      + E     F  E  +   + H N+V ++ S          V EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 739 NGSLEDYLYSNNFSFDILQRLSVIIDVAL---ALEYLHFGYSNPVVHCDIKPSNVLL--- 792
             +L + L ++         L       L    L+ L   ++  +VH D+KP N+++   
Sbjct: 63  GRTLREVLAADG-------ALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQT 115

Query: 793 DKDMVAHLSDFGIAKLLSG-EESMKQTLTLAT--IG---YMAP 829
                A + DFGI  LL G  ++   TLT  T  +G   Y AP
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAP 158

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 46/144 (31%), Positives = 75/144 (52%), Gaps = 7/144 (4%)

Query: 667 IGTGGFGSVYKGSFLDGME-VAIKVFHLQ--LEGALKSFDVECEVLKSVRHRNLVKIISS 723
           IG G +G+V+K    +  E VA+K   L    EG   S   E  +LK ++H+N+V++   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
             ++    LV EY  +  L+ Y  S N   D     S +  +   L + H   S+ V+H 
Sbjct: 68  LHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123

Query: 784 DIKPSNVLLDKDMVAHLSDFGIAK 807
           D+KP N+L++K+    L+DFG+A+
Sbjct: 124 DLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 29/188 (15%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGME-VAIKVFH--LQLEGALKSFDVECEVLKSVRHR 715
           N+F    ++G G +G V K    +  E VAIK F    + E   ++   E ++L++++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 716 NLVKIISSCTNNDFKALVLEY-----------MPNGSLEDYLYSNNFSFDILQRLSVIID 764
           N+V++  +        LV EY           MPNG   + + S  +             
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL----------- 109

Query: 765 VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATI 824
               ++ +H+ + N +VH DIKP N+L+  + V  L DFG A+ LS   +   T  +AT 
Sbjct: 110 ----IKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATR 165

Query: 825 GYMAPGLF 832
            Y +P L 
Sbjct: 166 WYRSPELL 173

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 48/188 (25%), Positives = 81/188 (43%), Gaps = 30/188 (15%)

Query: 667 IGTGGFGSVYKGS-FLDGME----VAIKVFH-LQLEGALKSFDVECEVLKSVRHRNLVKI 720
           +G   FG +YKG  +L GM+    VAIK    +        F  E  ++  + H N+V +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNN----------------FSFDILQRLSVIID 764
           +   T      ++ EY+  G L ++L   +                 S D    L + I 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 765 VALALEYL--HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK-LLSGEESMKQTLTL 821
           +A  +EYL  HF      VH D+   N+L+ + +   +SD G+++ + S +    Q  +L
Sbjct: 133 IAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 822 ATIGYMAP 829
             I +M P
Sbjct: 188 LPIRWMPP 195

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 47/155 (30%), Positives = 76/155 (49%), Gaps = 10/155 (6%)

Query: 666 LIGTGGFGSVYKGSFL-DG----MEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVK 719
           ++G+G FG+VYKG ++ DG    + VAIKV        A K    E  V+  V    + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
           ++  C  +  + LV + MP G L DY+  N         L+  + +A  + YL       
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
           +VH D+   NVL+       ++DFG+A+LL  +E+
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 51/179 (28%), Positives = 82/179 (45%), Gaps = 15/179 (8%)

Query: 661 FNASNLIGTGGFGSVYKGSFLDG--------MEVAIKVFHLQLEGALKSFDVECEVLKSV 712
           F    ++GTG +G V+    + G        M+V  K   +Q     +    E +VL+ +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 713 RHRNLVKIISSCTNNDFKA-LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           R    +  +      D K  L+L+Y+  G L  +L S    F   +      ++ LALE+
Sbjct: 62  RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL-SQRERFKEQEVQIYSGEIVLALEH 120

Query: 772 LH-FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           LH  G    +++ DIK  N+LLD +    L+DFG++K    +E  +      TI YMAP
Sbjct: 121 LHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 58.3 bits (141), Expect = 5e-09
 Identities = 60/171 (35%), Positives = 80/171 (46%), Gaps = 16/171 (9%)

Query: 667 IGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGALKSFDV-----ECEVL-KSVRHRNLVK 719
           IG G FG V       DG   A+KV  LQ +  LK  +      E  VL K+V+H  LV 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKV--LQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
           +  S    D    VL+Y+  G L  +L       +   R     ++A AL YLH   S  
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SLN 116

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAP 829
           +++ D+KP N+LLD      L+DFG+ K   G E  K T T   T  Y+AP
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.1 bits (143), Expect = 6e-09
 Identities = 32/88 (36%), Positives = 57/88 (64%), Gaps = 4/88 (4%)

Query: 150 LGFNN--LTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSL 207
           LG +N  L G IP ++  LR+L+ + L  N + G +P S+ ++++++ L L  N+ +GS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 208 PSSIDLVRLPNLEIISLAGNNFSGIIPS 235
           P S  L +L +L I++L GN+ SG +P+
Sbjct: 483 PES--LGQLTSLRILNLNGNSLSGRVPA 508

Length = 623

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 39/126 (30%), Positives = 64/126 (50%), Gaps = 6/126 (4%)

Query: 705 ECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVII 763
           E ++L+ V  + +V +  +    D   LVL  M  G L+ ++Y+  N  F+  + L    
Sbjct: 50  EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109

Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
           ++   LE LH       V+ D+KP N+LLD      +SD G+A  +   ES++    + T
Sbjct: 110 EILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG--RVGT 164

Query: 824 IGYMAP 829
           +GYMAP
Sbjct: 165 VGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 57.6 bits (139), Expect = 6e-09
 Identities = 44/176 (25%), Positives = 81/176 (46%), Gaps = 17/176 (9%)

Query: 666 LIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDV------ECEVLKSVRHRNLV 718
            +GTG F S Y+      G  +A+K        + +  +V      E  ++  + H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
           +++ +   +    L +E+M  GS+  +L S   +F     ++    +   L YLH    N
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVS-HLLSKYGAFKEAVIINYTEQLLRGLSYLH---EN 122

Query: 779 PVVHCDIKPSNVLLDKD-MVAHLSDFGIAKLL----SGEESMKQTLTLATIGYMAP 829
            ++H D+K +N+L+D       ++DFG A  L    +G    +  L L TI +MAP
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL-LGTIAFMAP 177

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 57.8 bits (140), Expect = 6e-09
 Identities = 46/156 (29%), Positives = 72/156 (46%), Gaps = 29/156 (18%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRNLVKIISS 723
           IG G +G VYKG +   G  VA+K   L+ E  G   +   E  +LK ++H N+V +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVI-----IDVALALEYLH----- 773
                   L+ E++              S D+ + L  +     +D  L   YL+     
Sbjct: 68  LMQESRLYLIFEFL--------------SMDLKKYLDSLPKGQYMDAELVKSYLYQILQG 113

Query: 774 --FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
             F +S  V+H D+KP N+L+D   V  L+DFG+A+
Sbjct: 114 ILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 58.4 bits (141), Expect = 7e-09
 Identities = 76/281 (27%), Positives = 109/281 (38%), Gaps = 38/281 (13%)

Query: 65  IFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVI 124
             NL +L        N             L  +  L + NN +T   P        L  +
Sbjct: 86  SENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKEL 145

Query: 125 SLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVP 184
            L+ N+  E +P  L NL +LK L L FN+L+ ++P  + NL NL  L L  NK+   +P
Sbjct: 146 DLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI-SDLP 202

Query: 185 TSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLS 244
             I  LSA++ L                              NN    + S + N   LS
Sbjct: 203 PEIELLSALEEL---------------------------DLSNNSIIELLSSLSNLKNLS 235

Query: 245 VLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNN 304
            LEL  N     +P ++GNL  LE L LS N ++S       +SS  +  NL+ LDLS N
Sbjct: 236 GLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS-------ISSLGSLTNLRELDLSGN 287

Query: 305 PINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINL 345
            ++  LP     L L    + +        +      L N 
Sbjct: 288 SLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNN 328

Length = 394

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 58.1 bits (140), Expect = 7e-09
 Identities = 39/142 (27%), Positives = 74/142 (52%), Gaps = 20/142 (14%)

Query: 705 ECEVLKSV-RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----NFSFDILQ- 757
           E E++K + +H+N++ ++ +CT +    +++EY   G+L +YL +      ++SFD  + 
Sbjct: 67  EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126

Query: 758 ---------RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL 808
                     +S    VA  +EYL    S   +H D+   NVL+ +D V  ++DFG+A+ 
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183

Query: 809 LSGEESMKQTLT-LATIGYMAP 829
           +   +  K+T      + +MAP
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAP 205

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 58.0 bits (141), Expect = 8e-09
 Identities = 59/198 (29%), Positives = 84/198 (42%), Gaps = 66/198 (33%)

Query: 667 IGTGGFGSVYKGSFLD---GMEVAIKVFHLQLEGALKSFDV------------ECEVLKS 711
           +G G +G V+K   +D      VA+K          K FD             E   L+ 
Sbjct: 15  LGKGAYGIVWKA--IDRRTKEVVALK----------KIFDAFRNATDAQRTFREIMFLQE 62

Query: 712 VR-HRNLVKIISSCTNNDFKA-------LVLEYMPN--------GSLEDYLYSNNFSFDI 755
           +  H N+VK++     N  KA       LV EYM            LED           
Sbjct: 63  LGDHPNIVKLL-----NVIKAENDKDIYLVFEYMETDLHAVIRANILED----------- 106

Query: 756 LQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS--GEE 813
           + +  ++  +  AL+Y+H   S  V+H D+KPSN+LL+ D    L+DFG+A+ LS   E 
Sbjct: 107 VHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163

Query: 814 SMKQTLT--LATIGYMAP 829
                LT  +AT  Y AP
Sbjct: 164 PENPVLTDYVATRWYRAP 181

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 57.1 bits (138), Expect = 8e-09
 Identities = 41/149 (27%), Positives = 74/149 (49%), Gaps = 9/149 (6%)

Query: 665 NLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVK 719
            +IG G FG VY G+ +D     +  A+K  +   +   ++ F  E  ++K   H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 720 IISSCTNNDFKALV-LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
           ++  C  ++   LV L YM +G L +++ S   +  +   +   + VA  +EYL    S 
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SK 117

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
             VH D+   N +LD+     ++DFG+A+
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 57.2 bits (139), Expect = 8e-09
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 14/175 (8%)

Query: 665 NLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSFDV----ECEVLKSVRHRNLVK 719
           N I  G +G VY+       E VA+K   L++E   + F +    E  +L  ++H N+V 
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINILLKLQHPNIVT 68

Query: 720 I--ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           +  +   +N D   +V+EY+ +  L+  + +    F   +   +++ +   + +LH    
Sbjct: 69  VKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---D 124

Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
           N ++H D+K SN+LL+   +  + DFG+A+   G      T  + T+ Y AP L 
Sbjct: 125 NWILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVVTLWYRAPELL 178

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 57.3 bits (138), Expect = 9e-09
 Identities = 52/180 (28%), Positives = 83/180 (46%), Gaps = 18/180 (10%)

Query: 661 FNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLV 718
           F    ++G G +G VYKG  +  G   AIKV  +  E   +   +E  +LK    HRN+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIA 76

Query: 719 KII------SSCTNNDFKALVLEYMPNGSLEDYLYS---NNFSFDILQRLSVIIDVALAL 769
                    S   ++D   LV+E+   GS+ D + +   N    D +  +    ++   L
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR--EILRGL 134

Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            +LH   ++ V+H DIK  NVLL ++    L DFG++  L      + T  + T  +MAP
Sbjct: 135 AHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMAP 190

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 57.3 bits (138), Expect = 9e-09
 Identities = 50/190 (26%), Positives = 89/190 (46%), Gaps = 31/190 (16%)

Query: 667 IGTGGFGSVYKGSFLDGME---------VAIKVFHLQL-EGALKSFDVECEVLKSV-RHR 715
           +G G FG V     + G++         VA+K+      E  L     E E++K + +H+
Sbjct: 26  LGEGCFGQVVMAEAI-GLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 84

Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYL---------YSNNFSFDILQRLSV----- 761
           N++ ++ +CT +    +++EY   G+L +YL         Y  N +    ++LS      
Sbjct: 85  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144

Query: 762 -IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT 820
               VA  +EYL    S   +H D+   NVL+ +D V  ++DFG+A+ +   +  K+T  
Sbjct: 145 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201

Query: 821 -LATIGYMAP 829
               + +MAP
Sbjct: 202 GRLPVKWMAP 211

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 57.3 bits (138), Expect = 9e-09
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 18/175 (10%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQL--EGALKSFDVECEVLKSVR---HRNLVKI 720
           IG G +G+VYK      G  VA+K   +Q   +G   S   E  +LK +    H N+V++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 721 ISSC----TNNDFK-ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL-ALEYLHF 774
           +  C    T+ + K  LV E++ +  L  YL          + +  ++   L  L++LH 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH- 125

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             +N +VH D+KP N+L+       L+DFG+A++ S +  M  T  + T+ Y AP
Sbjct: 126 --ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--MALTPVVVTLWYRAP 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 56.9 bits (137), Expect = 9e-09
 Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 17/175 (9%)

Query: 667 IGTGGFGSVYKGSFL----DGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKI 720
           +G G +G V   S +    DG +  IK  +L+       K+ + E ++L  ++H N+V  
Sbjct: 8   VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 721 ISSCTNND-FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV--IIDVALALEYLHFGYS 777
             S    D    +V+ +   G L   L        + +   V   + +A+AL+YLH    
Sbjct: 65  RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLH---E 120

Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
             ++H D+K  NV L +  +  + D GIA++L  +  M  TL + T  YM+P LF
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL-IGTPYYMSPELF 174

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 1e-08
 Identities = 51/168 (30%), Positives = 75/168 (44%), Gaps = 34/168 (20%)

Query: 661 FNASNLIGTGGFGSVY----KGSFLDGMEVAIKV---FHLQLEGALKSFDVECEVLKSVR 713
           F    L+G G  G V+    KG+   G   A+KV     +     +K    E E+L ++ 
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD 59

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQR-----LSVII----- 763
           H  L  + +S     +  LV++Y P G L          F +LQR     LS  +     
Sbjct: 60  HPFLPTLYASFQTETYLCLVMDYCPGGEL----------FRLLQRQPGKCLSEEVARFYA 109

Query: 764 -DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS 810
            +V LALEYLH      +V+ D+KP N+LL +     LSDF ++K   
Sbjct: 110 AEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 42/147 (28%), Positives = 77/147 (52%), Gaps = 6/147 (4%)

Query: 683 GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSL 742
           G +VA+K+  L+ +   +    E  +++  +H+N+V++  S    +   +++E++  G+L
Sbjct: 46  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105

Query: 743 EDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSD 802
            D +     + +  Q  +V   V  AL YLH   S  V+H DIK  ++LL  D    LSD
Sbjct: 106 TDIVSQTRLNEE--QIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSD 160

Query: 803 FGIAKLLSGEESMKQTLTLATIGYMAP 829
           FG    +S +   +++L + T  +MAP
Sbjct: 161 FGFCAQISKDVPKRKSL-VGTPYWMAP 186

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 52/178 (29%), Positives = 76/178 (42%), Gaps = 21/178 (11%)

Query: 667 IGTGGFGSVYKGSF-LDGMEVAIKVFHLQ-------LEGALKSFDVECEVLKSVRHRNLV 718
           +G GGFG V        G   A K  + +        EGA+    VE  +L  V  R +V
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAM----VEKRILAKVHSRFIV 56

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYS---NNFSFDILQRLSVIIDVALALEYLHFG 775
            +  +        LV+  M  G L  ++Y+    N  F   +       +   LE+LH  
Sbjct: 57  SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH-- 114

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA-KLLSGEESMKQTLTLATIGYMAPGLF 832
               +++ D+KP NVLLD D    +SD G+A +L  G+   K      T G+MAP L 
Sbjct: 115 -QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG--YAGTPGFMAPELL 169

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 37/126 (29%), Positives = 63/126 (50%), Gaps = 6/126 (4%)

Query: 705 ECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVII 763
           E ++L+ V  R +V +  +    D   LVL  M  G L+ ++Y      F+  + +    
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109

Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
           ++   LE LH      +V+ D+KP N+LLD      +SD G+A  +   +++K    + T
Sbjct: 110 EICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG--RVGT 164

Query: 824 IGYMAP 829
           +GYMAP
Sbjct: 165 VGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 56.9 bits (138), Expect = 2e-08
 Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 25/162 (15%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIK--VFHLQLEG----ALKSFDVECEVLKSVRHRNLVK 719
           +G G FG VYK      G  VA+K  + H + +G    AL+    E ++LK ++H N+V 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKILKKLKHPNVVP 71

Query: 720 II---------SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALE 770
           +I         S         +V  YM +  L   L + +      Q    ++ +   + 
Sbjct: 72  LIDMAVERPDKSKRKRGSV-YMVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQLLEGIN 129

Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE 812
           YLH    N ++H DIK +N+L+D   +  ++DFG+A+   G 
Sbjct: 130 YLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGP 168

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 57/183 (31%), Positives = 87/183 (47%), Gaps = 19/183 (10%)

Query: 660 QFNASNLIGTGGFGSVYKGSFLD--GMEVAIKVFHLQL--EGALKSFDVECEVLK---SV 712
           Q+     IG G +G V+K   L   G  VA+K   +Q   EG   S   E  VL+   + 
Sbjct: 2   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61

Query: 713 RHRNLVKIISSCT----NNDFK-ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL 767
            H N+V++   CT    + + K  LV E++ +  L  YL   +   +       I D+  
Sbjct: 62  EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL---DKVPEPGVPTETIKDMMF 117

Query: 768 AL-EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
            L   L F +S+ VVH D+KP N+L+       L+DFG+A++ S +  M  T  + T+ Y
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWY 175

Query: 827 MAP 829
            AP
Sbjct: 176 RAP 178

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 7/166 (4%)

Query: 667 IGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           IG G  G V   +    G  VA+K   L+ +   +    E  +++  +H N+V++ +S  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
             D   +V+E++  G+L D +     + +  Q  +V + V  AL  LH   +  V+H DI
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEE--QIAAVCLAVLKALSVLH---AQGVIHRDI 142

Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
           K  ++LL  D    LSDFG    +S E   +++L + T  +MAP L
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL-VGTPYWMAPEL 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 38/142 (26%), Positives = 73/142 (51%), Gaps = 20/142 (14%)

Query: 705 ECEVLKSV-RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----NFSFDILQR 758
           E E++K + +H+N++ ++  CT      +++EY   G+L ++L +      +++FDI + 
Sbjct: 67  EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126

Query: 759 ----------LSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL 808
                     +S    VA  +EYL    S   +H D+   NVL+ +D V  ++DFG+A+ 
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARG 183

Query: 809 LSGEESMKQTLT-LATIGYMAP 829
           +   +  K+T      + +MAP
Sbjct: 184 VHDIDYYKKTSNGRLPVKWMAP 205

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 45/145 (31%), Positives = 75/145 (51%), Gaps = 8/145 (5%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISS 723
           IG G +G VYK    L G  VA+K   L+   EG   +   E  +LK + H N+V+++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 724 CTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVH 782
             + +   LV E++ +  L+ Y+ S      D     S +  +   + Y H   S+ V+H
Sbjct: 67  VHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLH 122

Query: 783 CDIKPSNVLLDKDMVAHLSDFGIAK 807
            D+KP N+L+D++    L+DFG+A+
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 56.2 bits (136), Expect = 2e-08
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 10/177 (5%)

Query: 660 QFNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLE--GALKSFDVECEVLKSVRHRN 716
           +F   N IG G +G VY+       E VA+K   +  E  G   S   E  +L ++RH N
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 717 LVKIISSCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
           +V++          +  LV+EY     L   L +    F   Q   +++ +   L+YLH 
Sbjct: 68  IVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH- 125

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
              N ++H D+K SN+LL       ++DFG+A+   G  +   T  + T+ Y AP L
Sbjct: 126 --ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVVTLWYRAPEL 179

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 27/163 (16%)

Query: 657 ATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDV-ECEVLKSVRH 714
           AT+  N   L G G + +VYKG S ++G  VA+KV  ++ E  +    + E  +LK ++H
Sbjct: 4   ATSYLNLEKL-GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62

Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDY-------LYSNN---FSFDILQRLSVIID 764
            N+V +       +    V EYM +  L  Y       L+  N   F F +L+ L+    
Sbjct: 63  ANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLA---- 117

Query: 765 VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
                 Y+H      ++H D+KP N+L+       L+DFG+A+
Sbjct: 118 ------YIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 47/177 (26%), Positives = 76/177 (42%), Gaps = 32/177 (18%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRHR-NLVKII 721
           I  G FGSVY       G   AIKV     +  +  + +   E  ++        + K+ 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV---------IIDVALALEYL 772
            S  + D+  LV+EY+  G              +++ L           I +V L +E L
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCAS----------LIKTLGGLPEDWAKQYIAEVVLGVEDL 113

Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H      ++H DIKP N+L+D+     L+DFG+++   G E+ K    + T  Y+AP
Sbjct: 114 H---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLENKK---FVGTPDYLAP 162

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 56.7 bits (137), Expect = 3e-08
 Identities = 37/117 (31%), Positives = 57/117 (48%), Gaps = 11/117 (9%)

Query: 222 ISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSST 281
           + L      G IP+ I     L  + L  NS  G IP +LG++  LE L LSYN    S 
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 282 SE-LSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISN----CSIRG 333
            E L  L+S      L++L+L+ N ++G +P+++G   L  +    ++    C I G
Sbjct: 483 PESLGQLTS------LRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG 533

Length = 623

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 6/126 (4%)

Query: 705 ECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVII 763
           E ++L+ V  R +V +  +    D   LVL  M  G L+ ++Y+  N  FD  + +    
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109

Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
           ++   LE LH      +V+ D+KP N+LLD      +SD G+A  +   E+++    + T
Sbjct: 110 EITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG--RVGT 164

Query: 824 IGYMAP 829
           +GYMAP
Sbjct: 165 VGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 55.5 bits (133), Expect = 3e-08
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 20/150 (13%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVKIISSC 724
           +G G + +VYKG S ++G  VA+KV  LQ E G   +   E  +LK ++H N+V +    
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 725 TNNDFKALVLEYMPNGSLEDY-------LYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
              +   LV EY+ +  L  Y       L+  N    + Q L         L Y+H  Y 
Sbjct: 73  HTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLR-------GLSYIHQRY- 123

Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
             ++H D+KP N+L+       L+DFG+A+
Sbjct: 124 --ILHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 55.6 bits (134), Expect = 4e-08
 Identities = 51/172 (29%), Positives = 79/172 (45%), Gaps = 16/172 (9%)

Query: 666 LIGTGGFGSVYKGSFLDGMEV-AIKVFHLQLEGALKSFDVECEVLK------SVRHRNLV 718
           ++G G FG V         EV AIKV  L+ +  L+  DV+C + +      + +H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
            +       D    V+EY+  G L  +    +  FD  +      +V LAL +LH    +
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLM-FQIQRSRKFDEPRSRFYAAEVTLALMFLH---RH 115

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAP 829
            V++ D+K  N+LLD +    L+DFG+ K   G  +   T T   T  Y+AP
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 54.8 bits (132), Expect = 4e-08
 Identities = 39/128 (30%), Positives = 65/128 (50%), Gaps = 9/128 (7%)

Query: 705 ECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN---FSFDILQRLSV 761
           E  VL +++H N+V+   S   N    +V++Y   G L   + +     F  D  Q L  
Sbjct: 49  EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPED--QILDW 106

Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL 821
            + + LAL+++H      ++H DIK  N+ L KD    L DFGIA++L+    + +T  +
Sbjct: 107 FVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CI 162

Query: 822 ATIGYMAP 829
            T  Y++P
Sbjct: 163 GTPYYLSP 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 56.4 bits (136), Expect = 5e-08
 Identities = 28/77 (36%), Positives = 47/77 (61%), Gaps = 1/77 (1%)

Query: 288 SSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRE 347
           +  +  ++L+ ++LS N I G +P S+G+++ SL  + +S  S  G+IP+ +G L +LR 
Sbjct: 436 NDISKLRHLQSINLSGNSIRGNIPPSLGSIT-SLEVLDLSYNSFNGSIPESLGQLTSLRI 494

Query: 348 LGLWGNELIGSIPITFG 364
           L L GN L G +P   G
Sbjct: 495 LNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 56.0 bits (135), Expect = 5e-08
 Identities = 38/105 (36%), Positives = 60/105 (57%), Gaps = 5/105 (4%)

Query: 172 LGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSG 231
           LGL    L GF+P  I  L  ++++ L  N++ G++P S+  +   +LE++ L+ N+F+G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSI--TSLEVLDLSYNSFNG 480

Query: 232 IIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNF 276
            IP  +   + L +L L  NS SG +P  LG  R L   R S+NF
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVPAALGG-RLLH--RASFNF 522

Length = 623

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 55.2 bits (133), Expect = 5e-08
 Identities = 52/168 (30%), Positives = 77/168 (45%), Gaps = 15/168 (8%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSF-DVECEV--LKSVRHRNLVKIIS 722
           IG G FG+VY          VAIK      + + + + D+  EV  L+ +RH N ++   
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY-K 81

Query: 723 SCTNNDFKA-LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
            C   +  A LV+EY   GS  D L  +      ++  ++       L YLH   S+  +
Sbjct: 82  GCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERI 137

Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H DIK  N+LL +     L+DFG A L+S   S      + T  +MAP
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPANSF-----VGTPYWMAP 180

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 55.1 bits (133), Expect = 5e-08
 Identities = 59/185 (31%), Positives = 81/185 (43%), Gaps = 30/185 (16%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHL-----QLEGALKSFDVECEVLKSV 712
           N       IG+G  G VYK  F   G  +A+K         + +  L   DV   VLKS 
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDV---VLKSH 71

Query: 713 RHRNLVKIISSC-----TNNDFKALVLEYMPNGSLEDYL---YSNNFSFDILQRLSVIID 764
               +VK    C     T++D   + +E M   +  D L          DIL +++V I 
Sbjct: 72  DCPYIVK----CYGYFITDSDVF-ICMELM--STCLDKLLKRIQGPIPEDILGKMTVAI- 123

Query: 765 VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATI 824
              AL YL   +   V+H D+KPSN+LLD      L DFGI+  L   +S  +T +    
Sbjct: 124 -VKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLV--DSKAKTRSAGCA 178

Query: 825 GYMAP 829
            YMAP
Sbjct: 179 AYMAP 183

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 54.5 bits (131), Expect = 5e-08
 Identities = 43/171 (25%), Positives = 82/171 (47%), Gaps = 23/171 (13%)

Query: 661 FNASNLIGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGA--LKSFDVECEVLKSVR 713
           F    ++G G FGSV + + L        +VA+K+    +  +  ++ F  E   +K   
Sbjct: 1   FTLGRMLGKGEFGSV-REAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59

Query: 714 HRNLVKIISSCTNNDFKA------LVLEYMPNGSLEDYLY-----SNNFSFDILQRLSVI 762
           H N++K+I     +  K       ++L +M +G L  +L         F+  +   +  +
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA-KLLSGE 812
           ID+A  +EYL    S   +H D+   N +L+++M   ++DFG++ K+ SG+
Sbjct: 120 IDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 55.7 bits (134), Expect = 6e-08
 Identities = 55/156 (35%), Positives = 82/156 (52%), Gaps = 5/156 (3%)

Query: 396 LYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSL 455
           L ++ N+L   I   + +LT+L  L L +N +  + P       ++  L+ S N +  SL
Sbjct: 98  LDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESL 155

Query: 456 PEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLES 515
           P  + NL  +  +DLS N+LS D+P  +  L NL +L L  N +   +P  I  L +LE 
Sbjct: 156 PSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEE 213

Query: 516 LDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEI 551
           LDLSNNS+   + +S+  L  L  L LS NKLE   
Sbjct: 214 LDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLP 248

Length = 394

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 54.8 bits (132), Expect = 6e-08
 Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 14/171 (8%)

Query: 666 LIGTGGFGSVYKGSFLDGMEV-AIKVFHLQLEGALKSFDVECEVLK------SVRHRNLV 718
           ++G G FG V         E  AIK   L+ +  L+  DVEC +++      +  H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
            +  +    +    V+EY+  G L  ++ S+   FD  +      ++   L++LH     
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KK 115

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            +++ D+K  NVLLDKD    ++DFG+ K     E    T    T  Y+AP
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 55.0 bits (133), Expect = 6e-08
 Identities = 53/179 (29%), Positives = 85/179 (47%), Gaps = 25/179 (13%)

Query: 665 NLIGTGGFGSVYKGSFLD---GMEVAIKV---FHLQLEGALKSFDVECEVLKSVRHRNLV 718
           + IG G +G V   S      G++VAIK    F  Q     ++   E ++L+  +H N++
Sbjct: 11  SYIGEGAYGMVC--SATHKPTGVKVAIKKISPFEHQTF-CQRTLR-EIKILRRFKHENII 66

Query: 719 KI------ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            I       S  + ND   +V E M    L   + + + S D +Q    +  +   L+Y+
Sbjct: 67  GILDIIRPPSFESFNDV-YIVQELMET-DLYKLIKTQHLSNDHIQYF--LYQILRGLKYI 122

Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAP 829
           H   S  V+H D+KPSN+LL+ +    + DFG+A++   E      LT  +AT  Y AP
Sbjct: 123 H---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP 178

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 54.4 bits (131), Expect = 7e-08
 Identities = 32/76 (42%), Positives = 47/76 (61%), Gaps = 6/76 (7%)

Query: 754 DILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
           DIL +++V   +  ALEYLH   S  V+H D+KPSNVL++++    L DFGI+  L   +
Sbjct: 103 DILGKIAV--SIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV--D 156

Query: 814 SMKQTLTLATIGYMAP 829
           S+ +T+      YMAP
Sbjct: 157 SVAKTIDAGCKPYMAP 172

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 55.0 bits (132), Expect = 7e-08
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 28/211 (13%)

Query: 632 KQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVF 691
           K  NI+ N L +        ++L      +    +IG G FG V     L   +   KV+
Sbjct: 17  KNKNID-NFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQ----LVRHKSTRKVY 71

Query: 692 HLQLEGALKSFDV-----------ECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNG 740
            ++L   L  F++           E +++       +V++  +  ++ +  +V+EYMP G
Sbjct: 72  AMKL---LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG 128

Query: 741 SLEDYLYSNNFSFDILQRLS--VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVA 798
            L + L SN   +D+ ++ +     +V LAL+ +H   S   +H D+KP N+LLDK    
Sbjct: 129 DLVN-LMSN---YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHL 181

Query: 799 HLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            L+DFG    ++ E  ++    + T  Y++P
Sbjct: 182 KLADFGTCMKMNKEGMVRCDTAVGTPDYISP 212

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 54.6 bits (131), Expect = 8e-08
 Identities = 55/175 (31%), Positives = 83/175 (47%), Gaps = 23/175 (13%)

Query: 666 LIGTGGFGSVY----KGSFLDGMEVAIKVFHLQLEGALKSFDV-----ECEVLKSVRHRN 716
           L+G G FG V     K +   G   A+K+  L+ E  +   +V     E  VL++ RH  
Sbjct: 2   LLGKGTFGKVILVREKAT---GRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPF 56

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFG 775
           L  +  +   +D    V+EY   G L  +L     F+ +  +      ++  ALEYLH  
Sbjct: 57  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA--EIVSALEYLH-- 112

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL-LSGEESMKQTLTLATIGYMAP 829
            S  VV+ DIK  N++LDKD    ++DFG+ K  +S   +MK      T  Y+AP
Sbjct: 113 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 54.1 bits (130), Expect = 9e-08
 Identities = 40/171 (23%), Positives = 69/171 (40%), Gaps = 35/171 (20%)

Query: 667 IGTGGFGSVYKG------SFLDGMEVAIKVFHLQLEGAL---KSFDVECEVLKSVRHRNL 717
           IG G FG V++        +     VA+K+  L+ E +      F  E  ++    H N+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFDHPNI 70

Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN---------------------FSFDIL 756
           VK++  C       L+ EYM  G L ++L   +                           
Sbjct: 71  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 757 QRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           ++L +   VA  + YL        VH D+   N L+ ++MV  ++DFG+++
Sbjct: 131 EQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR 178

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 54.3 bits (131), Expect = 1e-07
 Identities = 56/187 (29%), Positives = 84/187 (44%), Gaps = 35/187 (18%)

Query: 661 FNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDVE---CE-----V 708
           F    ++G G FG V    YK +   G   AIK   L+    +   +VE   CE      
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKT---GELYAIKA--LKKGDIIARDEVESLMCEKRIFET 55

Query: 709 LKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII--DVA 766
             S RH  LV + +     D    V+EY   G L  +++++ FS    +  +V     V 
Sbjct: 56  ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS----EPRAVFYAACVV 111

Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM---KQTLTL-A 822
           L L+YLH    N +V+ D+K  N+LLD +    ++DFG+ K     E M    +T T   
Sbjct: 112 LGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-----EGMGFGDRTSTFCG 163

Query: 823 TIGYMAP 829
           T  ++AP
Sbjct: 164 TPEFLAP 170

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 43/179 (24%), Positives = 71/179 (39%), Gaps = 35/179 (19%)

Query: 657 ATNQFNASNLIGTGGFGSVY------------KGSFLDGME-----VAIKVFHLQL-EGA 698
                N    +G G FG V+            K    +        VA+KV      + A
Sbjct: 3   PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNA 62

Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYL------------ 746
            + F  E ++L  +   N+ +++  CT +    +++EYM NG L  +L            
Sbjct: 63  REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122

Query: 747 YSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGI 805
            S + SF  L  L +   +A  + YL    S   VH D+   N L+ K+    ++DFG+
Sbjct: 123 NSKSLSFSTL--LYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGM 176

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 38/126 (30%), Positives = 63/126 (50%), Gaps = 6/126 (4%)

Query: 705 ECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVII 763
           E  +L+ V  R +V +  +    D   LVL  M  G L+ ++Y+  N  FD  + +    
Sbjct: 50  EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109

Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
           ++   LE L       +V+ D+KP N+LLD      +SD G+A  +   E+++    + T
Sbjct: 110 ELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG--RVGT 164

Query: 824 IGYMAP 829
           +GYMAP
Sbjct: 165 VGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 28/211 (13%)

Query: 632 KQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVF 691
           K  NI+ N L +  +     ++L      ++   +IG G FG V     L   + + KV+
Sbjct: 17  KNKNID-NFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQ----LVRHKSSQKVY 71

Query: 692 HLQLEGALKSFDV-----------ECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNG 740
            ++L   L  F++           E +++       +V++  +  ++ +  +V+EYMP G
Sbjct: 72  AMKL---LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGG 128

Query: 741 SLEDYLYSNNFSFDILQRLS--VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVA 798
            L + L SN   +D+ ++ +     +V LAL+ +H   S  ++H D+KP N+LLDK    
Sbjct: 129 DLVN-LMSN---YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHL 181

Query: 799 HLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            L+DFG    +     ++    + T  Y++P
Sbjct: 182 KLADFGTCMKMDETGMVRCDTAVGTPDYISP 212

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 38/137 (27%), Positives = 60/137 (43%), Gaps = 11/137 (8%)

Query: 667 IGTGGFGSVYKG--------SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLV 718
           +G G F  ++KG          L   EV +KV         +SF     ++  + H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
                C   D   +V EY+  GSL+ YL  N    +I  +L V   +A AL +L      
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DK 119

Query: 779 PVVHCDIKPSNVLLDKD 795
            + H ++   NVLL ++
Sbjct: 120 GLTHGNVCAKNVLLIRE 136

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 41/162 (25%), Positives = 68/162 (41%), Gaps = 25/162 (15%)

Query: 667 IGTGGFGSVYKG---SFLDG---MEVAIKVFHLQLEGALKS----FDVECEVLKSVRHRN 716
           +G G FG VY+G     + G     VAIK  +   E A       F  E  V+K     +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYS------NNFSFDILQRLSVI---IDVAL 767
           +V+++   +      +V+E M  G L+ YL S      NN           I    ++A 
Sbjct: 71  VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130

Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
            + YL    +   VH D+   N ++ +D+   + DFG+ + +
Sbjct: 131 GMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI 169

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 53.8 bits (130), Expect = 2e-07
 Identities = 48/174 (27%), Positives = 84/174 (48%), Gaps = 19/174 (10%)

Query: 665 NLIGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKII 721
           + +G+G +G V        G +VAIK      + A+  K    E  +LK + H N++ ++
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80

Query: 722 S----SCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG 775
                + +  DF+   LV   M    L + +     S D +Q L  +  +   L+Y+H  
Sbjct: 81  DVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFL--VYQILRGLKYIH-- 135

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            S  ++H D+KPSN+ +++D    + DFG+A+    ++ M  T  +AT  Y AP
Sbjct: 136 -SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT--DDEM--TGYVATRWYRAP 184

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 18/153 (11%)

Query: 667 IGTGGFGSVYKGSFLD------GMEVAIKVF----HLQLEGALKSFDVECEVLKSV-RHR 715
           +G G FG V + +          M+VA+K+     H     AL S   E +++  +  H 
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS---ELKIMSHLGNHE 99

Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSF-DILQRLSVIIDVALALEYLHF 774
           N+V ++ +CT      ++ EY   G L ++L     SF  +   LS    VA  + +L  
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA- 158

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
             S   +H D+   NVLL    +  + DFG+A+
Sbjct: 159 --SKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 52/192 (27%), Positives = 87/192 (45%), Gaps = 42/192 (21%)

Query: 667 IGTGGFGSVYKGSFLD---GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKI--- 720
           +G G  G V+  S +D      VA+K   L    ++K    E ++++ + H N+VK+   
Sbjct: 13  LGCGSNGLVF--SAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70

Query: 721 -----------ISSCTNNDFKALVLEYMPNG---SLEDYLYSNN----FSFDILQRLSVI 762
                      + S T  +   +V EYM       LE    S      F + +L+     
Sbjct: 71  LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR----- 125

Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLLD-KDMVAHLSDFGIAKLLSGEESMKQTLT- 820
                 L+Y+H   S  V+H D+KP+NV ++ +D+V  + DFG+A+++    S K  L+ 
Sbjct: 126 -----GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177

Query: 821 -LATIGYMAPGL 831
            L T  Y +P L
Sbjct: 178 GLVTKWYRSPRL 189

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 50/176 (28%), Positives = 88/176 (50%), Gaps = 10/176 (5%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLE--GALKSFDVECEVLKSVRHR 715
           +Q+     IG G +G VYK       E +A+K   L+ E  G   +   E  +LK ++H 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHF 774
           N+V++     +     LV EY+ +  L+ ++ S+ +F+ +     + +  +   + Y H 
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH- 119

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVA-HLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             S+ V+H D+KP N+L+D+   A  L+DFG+A+   G      T  + T+ Y AP
Sbjct: 120 --SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVVTLWYRAP 172

Length = 294

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 56/172 (32%), Positives = 82/172 (47%), Gaps = 16/172 (9%)

Query: 666 LIGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGALKSFD---VECE---VLKSVRHRNLV 718
           +IG G FG V       DG   A+KV  LQ +  LK  +   +  E   +LK+++H  LV
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
            +  S    +    VL+Y+  G L  +L       +   R     +VA A+ YLH   S 
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAA-EVASAIGYLH---SL 115

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAP 829
            +++ D+KP N+LLD      L+DFG+ K   G E  + T T   T  Y+AP
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 46/173 (26%), Positives = 75/173 (43%), Gaps = 16/173 (9%)

Query: 667 IGTGGFGSVY--KGSFLDGMEVAIKVFHLQLEGALK-----SFDVECEVLKSVRHRNLVK 719
           +G G FG+VY  K       E  +KV      G L        + E ++L  + H  +VK
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEE-RLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVI---IDVALALEYLHFGY 776
             +S    D   ++ EY     L+  L     +   L    V    I + L + Y+H   
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH--- 123

Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
              ++H D+K  N+ L  +++  + DFG+++LL G   +  T T  T  YM+P
Sbjct: 124 QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT-GTPYYMSP 174

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 53.0 bits (127), Expect = 3e-07
 Identities = 51/175 (29%), Positives = 88/175 (50%), Gaps = 24/175 (13%)

Query: 666 LIGTGGFGSVYKGSFLD---GMEVAIKVFH--LQLEGALKSFDVECEVLKSVRHRNLVKI 720
            +G+G +GSV   S +D   G +VAIK      Q E   K    E  +LK ++H N++ +
Sbjct: 22  QVGSGAYGSVC--SAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGL 79

Query: 721 I----SSCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
           +    S+ + ++F+   LV+ YM    L+  +  +  S D +Q L  +  +   L+Y+H 
Sbjct: 80  LDVFTSAVSGDEFQDFYLVMPYMQT-DLQK-IMGHPLSEDKVQYL--VYQMLCGLKYIH- 134

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             S  ++H D+KP N+ +++D    + DFG+A+    E     T  + T  Y AP
Sbjct: 135 --SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAP 183

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 52.8 bits (126), Expect = 3e-07
 Identities = 55/174 (31%), Positives = 82/174 (47%), Gaps = 21/174 (12%)

Query: 666 LIGTGGFGSVY----KGSFLDGMEVAIKVFHLQLEGALKSFDV-----ECEVLKSVRHRN 716
           L+G G FG V     K S   G   A+K+  L+ E  +   +V     E  VLK+ RH  
Sbjct: 2   LLGKGTFGKVILVREKAS---GKYYAMKI--LKKEVIIAKDEVAHTLTESRVLKNTRHPF 56

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFG 775
           L  +  S    D    V+EY+  G L  +L     FS D  +      ++  AL+YLH  
Sbjct: 57  LTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA--EIVSALDYLH-- 112

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            S  +V+ D+K  N++LDKD    ++DFG+ K    + +  +T    T  Y+AP
Sbjct: 113 -SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 40/156 (25%), Positives = 77/156 (49%), Gaps = 16/156 (10%)

Query: 686 VAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLED 744
           VA+K+    + + A   F  E +++  +++ N+++++  C ++D   ++ EYM NG L  
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 745 YL----------YSNNF-SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD 793
           +L          ++NN  S  I   L + + +A  ++YL    S   VH D+   N L+ 
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVG 163

Query: 794 KDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMA 828
                 ++DFG+++ L SG+    Q   +  I +MA
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMA 199

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 52.5 bits (126), Expect = 5e-07
 Identities = 42/147 (28%), Positives = 69/147 (46%), Gaps = 16/147 (10%)

Query: 667 IGTGGFGSVYKGSFLDGMEV-AIK------VFHLQLEGALKSFDVECEVLKSVRHRNLVK 719
           IG G FG V     +D   + A+K      V        +K+   E ++L    +  +VK
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKA---ERDILAEADNEWVVK 65

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH-FGYSN 778
           +  S  + D    V++Y+P G +   L       + L R   I ++  A+E +H  G+  
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARF-YIAELTCAIESVHKMGF-- 122

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGI 805
             +H DIKP N+L+D+D    L+DFG+
Sbjct: 123 --IHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 52.3 bits (125), Expect = 5e-07
 Identities = 56/173 (32%), Positives = 80/173 (46%), Gaps = 18/173 (10%)

Query: 666 LIGTGGFGSVYKGSF-LDGMEVAIKVFHLQL---EGALKSFDVECEVL-KSVRHRNLVKI 720
           +IG G FG V      LDG   A+KV   ++       K    E  VL K+V+H  LV +
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPV 780
             S    +    VL+++  G L  +L     SF   +      ++A AL YLH   S  +
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINI 117

Query: 781 VHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATI----GYMAP 829
           V+ D+KP N+LLD      L+DFG+ K     E + Q+ T  T      Y+AP
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK-----EGIAQSDTTTTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 52.3 bits (125), Expect = 5e-07
 Identities = 52/191 (27%), Positives = 89/191 (46%), Gaps = 35/191 (18%)

Query: 651 YKELLQATNQFNASNLIGTGGFGSVYKGSFLD---GMEVAIKVFHLQLEGAL--KSFDVE 705
           Y++L Q          +G+G +G+V   S LD   G +VAIK  +   +  L  K    E
Sbjct: 17  YRDLKQ----------VGSGAYGTVC--SALDRRTGAKVAIKKLYRPFQSELFAKRAYRE 64

Query: 706 CEVLKSVRHRNLVKIISSCTN-------NDFKALVLEYMPNGSLEDYLYSNNFSFDILQR 758
             +LK ++H N++ ++   T        +DF  LV+ +M    L   +     S D +Q 
Sbjct: 65  LRLLKHMKHENVIGLLDVFTPDLSLDRFHDF-YLVMPFM-GTDLGKLMKHEKLSEDRIQF 122

Query: 759 LSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT 818
           L  +  +   L+Y+H   +  ++H D+KP N+ +++D    + DFG+A+    E     T
Sbjct: 123 L--VYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MT 173

Query: 819 LTLATIGYMAP 829
             + T  Y AP
Sbjct: 174 GYVVTRWYRAP 184

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 47/175 (26%), Positives = 79/175 (45%), Gaps = 22/175 (12%)

Query: 666 LIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLK------SVRHRNLV 718
           ++G G FG V+           AIK   L+ +  L   DVEC +++      +  H  L 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
            +  +    +    V+EY+  G L  ++ S +  FD+ +      ++   L++LH   S 
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SK 115

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM----KQTLTLATIGYMAP 829
            +V+ D+K  N+LLD D    ++DFG+ K     E+M    K      T  Y+AP
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCK-----ENMLGDAKTCTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.4 bits (126), Expect = 6e-07
 Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 32/165 (19%)

Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVR- 713
           + F +  +IG G FG V     K +   G   A+K          KS  +E E +  VR 
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDT---GHIYAMKKL-------RKSEMLEKEQVAHVRA 50

Query: 714 HRNL---------VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVII 763
            R++         VK+  S  + ++  L++EY+P G +   L   + F+ +  +    I 
Sbjct: 51  ERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETR--FYIA 108

Query: 764 DVALALEYLH-FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           +  LA++ +H  GY    +H DIKP N+LLD      LSDFG+  
Sbjct: 109 ETILAIDSIHKLGY----IHRDIKPDNLLLDAKGHIKLSDFGLCT 149

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 51.6 bits (123), Expect = 6e-07
 Identities = 40/167 (23%), Positives = 77/167 (46%), Gaps = 19/167 (11%)

Query: 667 IGTGGFGSVYKGSFLDG---MEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKII 721
           +G G FGSV +G        ++VA+K   + +     ++ F  E   +K   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 722 SSCTNNDFK------ALVLEYMPNGSLEDYLYSNNFS----FDILQRL-SVIIDVALALE 770
             C             ++L +M +G L  +L  +       +   Q L   + D+A  +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ 817
           YL    S   +H D+   N +L+++M   ++DFG++K +   +  +Q
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ 170

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 52.1 bits (125), Expect = 6e-07
 Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 30/212 (14%)

Query: 632 KQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVF 691
           K  NI+ N L +  +      +L      F+   +IG G FG V     L   + + +V+
Sbjct: 17  KNKNID-NFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQ----LVRHKSSKQVY 71

Query: 692 HLQLEGALKSFDV-----------ECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNG 740
            ++L   L  F++           E +++       +V++  +  ++ +  +V+EYMP G
Sbjct: 72  AMKL---LSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGG 128

Query: 741 SLEDYLYSNNFSFDILQRLSV--IIDVALALEYLH-FGYSNPVVHCDIKPSNVLLDKDMV 797
            L + L SN   +DI ++ +     +V LAL+ +H  G+    +H D+KP N+LLDK   
Sbjct: 129 DLVN-LMSN---YDIPEKWARFYTAEVVLALDAIHSMGF----IHRDVKPDNMLLDKSGH 180

Query: 798 AHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             L+DFG    +     ++    + T  Y++P
Sbjct: 181 LKLADFGTCMKMDANGMVRCDTAVGTPDYISP 212

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 51.1 bits (122), Expect = 7e-07
 Identities = 39/145 (26%), Positives = 65/145 (44%), Gaps = 10/145 (6%)

Query: 666 LIGTGGFGSVYKGSF-LDG---MEVAIKVFHLQLEGALK-SFDVECEVLKSVRHRNLVKI 720
           ++GTG FG + +G   L     + VAI           +  F  E   L    H N+V++
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL-HFGYSNP 779
               T  +   +V EYM NG+L+ +L  +       Q + ++  +A  ++YL   GY   
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY--- 128

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFG 804
            VH  +    VL++ D+V  +S F 
Sbjct: 129 -VHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 51.8 bits (124), Expect = 8e-07
 Identities = 46/155 (29%), Positives = 73/155 (47%), Gaps = 14/155 (9%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLE----GALKSFDVECEVLKSVR 713
             F+   +IG G FG V      D G   A+K   L+ E      L     E +VL    
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQLAHVKAERDVLAESD 59

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYL 772
              +V +  S  +  +  L++E++P G L   L   + FS D+ +    + +  LA+E +
Sbjct: 60  SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTR--FYMAECVLAIEAV 117

Query: 773 H-FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA 806
           H  G+    +H DIKP N+L+D+     LSDFG++
Sbjct: 118 HKLGF----IHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 51.2 bits (122), Expect = 9e-07
 Identities = 43/186 (23%), Positives = 78/186 (41%), Gaps = 26/186 (13%)

Query: 667 IGTGGFGSVYKGSFL------DGMEVAIKVFHLQLEGALKS-FDVECEVLKSVRHRNLVK 719
           +G   FG VYKG             VAIK    + EG L+  F  E  +   ++H N+V 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQR---------------LSVIID 764
           ++   T     +++  Y  +  L ++L   +   D+                  + ++  
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 765 VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK-QTLTLAT 823
           +A  +E+L    S+ VVH D+   NVL+   +   +SD G+ + +   +  K    +L  
Sbjct: 133 IAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189

Query: 824 IGYMAP 829
           I +M+P
Sbjct: 190 IRWMSP 195

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 44/195 (22%), Positives = 84/195 (43%), Gaps = 33/195 (16%)

Query: 665 NLIGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKS-----------FDV--ECEVL 709
             +G G +G V K    L G  VAIK V  +++   +             F    E +++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 710 KSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL 769
             ++H N++ ++      DF  LV++ M    L+  +          Q   +++ +   L
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNGL 132

Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK---------LLSGEESMKQTLT 820
             LH  Y    +H D+ P+N+ ++   +  ++DFG+A+          LS +E+M++   
Sbjct: 133 NVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189

Query: 821 LA----TIGYMAPGL 831
           +     T+ Y AP L
Sbjct: 190 MTSKVVTLWYRAPEL 204

Length = 335

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 44/146 (30%), Positives = 76/146 (52%), Gaps = 6/146 (4%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVKIISSC 724
           +G G + +VYKG S L    VA+K   L+ E GA  +   E  +LK ++H N+V +    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
                  LV EY+ +  L+ YL   +   + +   +V + +   L  L++ +   V+H D
Sbjct: 74  HTEKSLTLVFEYL-DKDLKQYL---DDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRD 129

Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLS 810
           +KP N+L+++     L+DFG+A+  S
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKS 155

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 50.9 bits (121), Expect = 1e-06
 Identities = 50/178 (28%), Positives = 81/178 (45%), Gaps = 14/178 (7%)

Query: 661 FNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLV 718
           F    L+G G +G VYKG  +  G   AIKV  +  +   +    E  +LK    HRN+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66

Query: 719 KIISSCTN------NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII-DVALALEY 771
               +         +D   LV+E+   GS+ D + +   +    + ++ I  ++   L +
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126

Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           LH    + V+H DIK  NVLL ++    L DFG++  L      + T  + T  +MAP
Sbjct: 127 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMAP 180

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 50.8 bits (122), Expect = 1e-06
 Identities = 34/122 (27%), Positives = 55/122 (45%), Gaps = 8/122 (6%)

Query: 686 VAIKVFHL--QLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLE 743
           VA+K  +L    +  LK    E    + ++H N++  ++S   +    +V   M  GS E
Sbjct: 28  VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87

Query: 744 DYLYSNNF--SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLS 801
           D L   +F      L    ++ DV  AL+Y+H   S   +H  +K S++LL  D    LS
Sbjct: 88  D-LLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLS 143

Query: 802 DF 803
             
Sbjct: 144 GL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 44/146 (30%), Positives = 77/146 (52%), Gaps = 6/146 (4%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVKIISSC 724
           +G G + +V+KG S L    VA+K   L+ E GA  +   E  +LK ++H N+V +    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
             +    LV EY+ +  L+ Y+   +   +I+   +V I +   L  L + +   V+H D
Sbjct: 74  HTDKSLTLVFEYL-DKDLKQYM---DDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRD 129

Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLS 810
           +KP N+L+++     L+DFG+A+  S
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKS 155

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 50.7 bits (122), Expect = 1e-06
 Identities = 52/191 (27%), Positives = 86/191 (45%), Gaps = 24/191 (12%)

Query: 660 QFNASNLIGTGGFGSVYKG---SFLDGMEVAIKVF---HLQLEGALKSFDVECEVLKSVR 713
           ++     IG G +G VYK    +  DG E AIK F     Q  G  +S   E  +L+ ++
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 714 HRNLVKIISSCTNNDFKA--LVLEYMPNGSLE---DYLYSNNFSFDILQRLSVIIDVALA 768
           H N+V ++     +  K+  L+ +Y  +   +    +  +   S       S++  +   
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 769 LEYLHFGYSNPVVHCDIKPSNVLL----DKDMVAHLSDFGIAKLLSGEESMKQTLTL--- 821
           + YLH   SN V+H D+KP+N+L+     +  V  + D G+A+L      +K    L   
Sbjct: 121 VHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF--NAPLKPLADLDPV 175

Query: 822 -ATIGYMAPGL 831
             TI Y AP L
Sbjct: 176 VVTIWYRAPEL 186

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 42/130 (32%), Positives = 61/130 (46%), Gaps = 15/130 (11%)

Query: 705 ECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVII 763
           E  VL++ RH  L  +  S   +D    V+EY   G L  +L     FS D  +      
Sbjct: 45  ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-- 102

Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
           ++  AL YLH   S  VV+ D+K  N++LDKD    ++DFG+ K     E +    T+ T
Sbjct: 103 EIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKT 154

Query: 824 I----GYMAP 829
                 Y+AP
Sbjct: 155 FCGTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 43/146 (29%), Positives = 77/146 (52%), Gaps = 6/146 (4%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSC 724
           +G G + +V+KG S L    VA+K   L+  EGA  +   E  +LK+++H N+V +    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
                  LV EY+ +  L+ YL   +   +++   +V I +   L  L + +   ++H D
Sbjct: 73  HTERCLTLVFEYLDS-DLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRD 128

Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLS 810
           +KP N+L+++     L+DFG+A+  S
Sbjct: 129 LKPQNLLINEKGELKLADFGLARAKS 154

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 13/165 (7%)

Query: 667 IGTGGFGSVYKGSFLDGMEV-AIKVFHLQLEGAL-KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G  G+VYK   L    + A+KV  L +   L K    E E+L       ++    + 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
              +  ++  E+M  GSL+ Y         +L R++V   V   L YL   +S  ++H D
Sbjct: 69  FVENRISICTEFMDGGSLDVY---RKIPEHVLGRIAVA--VVKGLTYL---WSLKILHRD 120

Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +KPSN+L++      L DFG++  L    S+ +T  + T  YMAP
Sbjct: 121 VKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTY-VGTNAYMAP 162

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 30/206 (14%)

Query: 624 SRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDG 683
            R    NA +   E  M+     R             +   N+IG G FG VY+   +D 
Sbjct: 39  ERSHNNNAGEDEDEEKMIDNDINR--------SPNKSYKLGNIIGNGSFGVVYEAICIDT 90

Query: 684 ME-VAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKI--------ISSCTNNDFKALVL 734
            E VAIK    ++    +  + E  ++K++ H N++ +              N F  +V+
Sbjct: 91  SEKVAIK----KVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVM 146

Query: 735 EYMPNGSLEDYL--YS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVL 791
           E++P  ++  Y+  Y+ NN +  +         +  AL Y+H   S  + H D+KP N+L
Sbjct: 147 EFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLL 202

Query: 792 LD-KDMVAHLSDFGIAK-LLSGEESM 815
           +D       L DFG AK LL+G+ S+
Sbjct: 203 IDPNTHTLKLCDFGSAKNLLAGQRSV 228

Length = 440

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 52/186 (27%), Positives = 88/186 (47%), Gaps = 43/186 (23%)

Query: 666 LIGTGGFGSVY---KGSFLD-GMEVAIKVFHLQLEGALKSFD-----VECEVLKSVRHRN 716
           ++G G FG V+   K +  D G   A+KV     +  LK  D     +E ++L  V H  
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLK---KATLKVRDRVRTKMERDILAEVNHPF 59

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLS------------VIID 764
           +VK+  +        L+L+++  G             D+  RLS             + +
Sbjct: 60  IVKLHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAE 106

Query: 765 VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-AT 823
           +ALAL++LH   S  +++ D+KP N+LLD++    L+DFG++K     +  K+  +   T
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGT 161

Query: 824 IGYMAP 829
           + YMAP
Sbjct: 162 VEYMAP 167

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 52/191 (27%), Positives = 85/191 (44%), Gaps = 44/191 (23%)

Query: 658 TNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDV---------ECE 707
           TN++     +G G FG V      L G  VAIK         +K F           E +
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAKRTYRELK 61

Query: 708 VLKSVRHRNLVKI----ISSCTNNDFKALVL-----EYMPNGSLEDYLYSNNFSFDILQR 758
           +LK +RH N++ +    IS   +  F   +L       + +  LE   +   F + IL+ 
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQ-FIQYFLYQILR- 119

Query: 759 LSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT 818
                     L+Y+H   S  VVH D+KPSN+L++++    + DFG+A++    +  + T
Sbjct: 120 ---------GLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMT 163

Query: 819 LTLATIGYMAP 829
             ++T  Y AP
Sbjct: 164 GYVSTRYYRAP 174

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 49.9 bits (119), Expect = 3e-06
 Identities = 47/201 (23%), Positives = 87/201 (43%), Gaps = 22/201 (10%)

Query: 646 RRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQL-EGA 698
           R+R ++KE L    QF   +L    G        F         + VA+K+      + A
Sbjct: 4   RKRLTFKEKL-GEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNA 62

Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQR 758
              F  E +++  ++  N++++++ C  +D   ++ EYM NG L  +L  +       + 
Sbjct: 63  RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122

Query: 759 LSVIID----------VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK- 807
             V I           +A  ++YL    S   VH D+   N L+ K+    ++DFG+++ 
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRN 179

Query: 808 LLSGEESMKQTLTLATIGYMA 828
           L SG+    Q   +  I +M+
Sbjct: 180 LYSGDYYRIQGRAVLPIRWMS 200

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 49/181 (27%), Positives = 81/181 (44%), Gaps = 34/181 (18%)

Query: 666 LIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLK-----SVRHRNLVKI 720
           +IG GGFG VY     D  ++           A+K  D +   +K     ++  R ++ +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMY----------AMKCLDKKRIKMKQGETLALNERIMLSL 50

Query: 721 ISS-------CTNNDFKA-----LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALA 768
           +S+       C    F        +L+ M  G L  Y  S +  F   +      ++ L 
Sbjct: 51  VSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH-YHLSQHGVFSEKEMRFYATEIILG 109

Query: 769 LEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA 828
           LE++H  +   VV+ D+KP+N+LLD+     +SD G+A   S +   K   ++ T GYMA
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMA 163

Query: 829 P 829
           P
Sbjct: 164 P 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 49.5 bits (118), Expect = 3e-06
 Identities = 50/180 (27%), Positives = 84/180 (46%), Gaps = 32/180 (17%)

Query: 666 LIGTGGFGSVYKGSFLD-GMEVAIKVF---HLQLEGALKSFDVECEVLKSVRHRNLVKII 721
           +IG GGFG VY     D G   A+K      ++++          E L ++  R ++ ++
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--------ETL-ALNERIMLSLV 51

Query: 722 SS-------CTNNDFK-----ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL 769
           S+       C +  F      + +L+ M  G L  Y  S +  F   +      ++ L L
Sbjct: 52  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH-YHLSQHGVFSEAEMRFYAAEIILGL 110

Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           E++H  +   VV+ D+KP+N+LLD+     +SD G+A   S +   K   ++ T GYMAP
Sbjct: 111 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 50.6 bits (121), Expect = 3e-06
 Identities = 33/90 (36%), Positives = 55/90 (61%), Gaps = 5/90 (5%)

Query: 732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVL 791
           LV+EY+  G ++  L+   + FD    +  I +VALAL+YLH    + ++H D+KP N+L
Sbjct: 81  LVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNML 136

Query: 792 LDKDMVAHLSDFGIAKL-LSGEESMKQTLT 820
           +  +    L+DFG++K+ L+ E +M   LT
Sbjct: 137 ISNEGHIKLTDFGLSKVTLNRELNMMDILT 166

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 49/175 (28%), Positives = 81/175 (46%), Gaps = 22/175 (12%)

Query: 666 LIGTGGFGSVYKGSFLDGMEV-AIKVFHLQLEGALKSFDVEC-----EVLKSV-RHRNLV 718
           ++G G FG V         E+ A+KV  L+ +  L+  DVEC      VL    +H  L 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
           ++ S     D    V+EY+  G L  ++  +   FD  +      ++ L L++LH     
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ER 115

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATI----GYMAP 829
            +++ D+K  NVLLD +    ++DFG+ K     E +   +T +T      Y+AP
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCK-----EGILGGVTTSTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 26/153 (16%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSC 724
           +G G + +VYKG S L G  VA+K   L+  EGA  +   E  +LK ++H N+V +    
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72

Query: 725 TNNDFKALVLEYMPNGSLEDYLYS-------NN---FSFDILQRLSVIIDVALALEYLHF 774
                  LV EY+ +  L+ Y+         +N   F F +L+ L+          Y H 
Sbjct: 73  HTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLA----------YCH- 120

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
                V+H D+KP N+L+ +     L+DFG+A+
Sbjct: 121 --QRRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 49.7 bits (118), Expect = 3e-06
 Identities = 47/166 (28%), Positives = 85/166 (51%), Gaps = 10/166 (6%)

Query: 667 IGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDV-ECEVLKSVRHRNLVKIISSC 724
           +G G  G V K      G+ +A K+ HL+++ A+++  + E +VL       +V    + 
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 725 TNNDFKALVLEYMPNGSLEDYLY-SNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
            ++   ++ +E+M  GSL+  L  +     +IL ++S  I V   L YL     + ++H 
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVS--IAVLRGLAYLR--EKHQIMHR 128

Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D+KPSN+L++      L DFG++  L   +SM  +  + T  YM+P
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSF-VGTRSYMSP 171

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 49.7 bits (118), Expect = 3e-06
 Identities = 50/183 (27%), Positives = 86/183 (46%), Gaps = 41/183 (22%)

Query: 667 IGTGGFGSVYKGSFLDG---MEVAIKVFHLQLEGALKSFDV--ECEVLKSVRHRNLVKII 721
           +G+G +GSV   S  D     +VA+K      +  + +     E  +LK ++H N++ ++
Sbjct: 23  VGSGAYGSV--CSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 722 SSCTNNDFKALVLEYMPNGSLED----YLYSNNFSFDI-----LQRLS------VIIDVA 766
              T            P  S+E+    YL +N    D+      Q+LS      +I  + 
Sbjct: 81  DVFT------------PATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128

Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
             L+Y+H   S  ++H D+KPSNV +++D    + DFG+A+    ++ M  T  +AT  Y
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEM--TGYVATRWY 181

Query: 827 MAP 829
            AP
Sbjct: 182 RAP 184

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 49/174 (28%), Positives = 89/174 (51%), Gaps = 10/174 (5%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDV-ECEVLKSVRHRN 716
           + F   + +G G  G V+K S    G+ +A K+ HL+++ A+++  + E +VL       
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLY-SNNFSFDILQRLSVIIDVALALEYLHFG 775
           +V    +  ++   ++ +E+M  GSL+  L  +      IL ++S  I V   L YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS--IAVIKGLTYLR-- 120

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             + ++H D+KPSN+L++      L DFG++  L   +SM  +  + T  YM+P
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSF-VGTRSYMSP 171

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 49.2 bits (117), Expect = 4e-06
 Identities = 48/197 (24%), Positives = 87/197 (44%), Gaps = 40/197 (20%)

Query: 667 IGTGGFGSVYKGSF--LDGM----EVAIKVFHLQLEGA----LKSFDVECEVLKSVRHRN 716
           +G G FG V K +   L G      VA+K+     E A    L+    E  +LK V H +
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK---ENASSSELRDLLSEFNLLKQVNHPH 64

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYL--------------YSNNFSFD-------- 754
           ++K+  +C+ +    L++EY   GSL  +L               + N S+         
Sbjct: 65  VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 755 -ILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
            +   +S    ++  ++YL       +VH D+   NVL+ +     +SDFG+++ +  E+
Sbjct: 125 TMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181

Query: 814 S-MKQTLTLATIGYMAP 829
           S +K++     + +MA 
Sbjct: 182 SYVKRSKGRIPVKWMAI 198

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 49.2 bits (117), Expect = 4e-06
 Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 10/168 (5%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVF---HLQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G GGFG V      + G   A K      L+ +   K   +E E+L+ V    +V +  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
           +  +     LV+  M  G L+ ++Y+      ++ + +     +   + +LH   S  +V
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIV 117

Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           + D+KP NVLLD      LSD G+A  L   +++ Q     T GYMAP
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQ--RAGTNGYMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 48.8 bits (117), Expect = 4e-06
 Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 24/174 (13%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDV-----ECEVLKSVR-HRNLVK 719
           IG G F  V K  S   G   AIK     ++   KS +      E + L+ +  H N+++
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIK----CMKKHFKSLEQVNNLREIQALRRLSPHPNILR 62

Query: 720 IISSCTNNDFK--ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           +I    +      ALV E M + +L + +          +  S +  +  +L+++H    
Sbjct: 63  LIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---R 118

Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAP 829
           N + H DIKP N+L+  D++  L+DFG  + +      K   T  ++T  Y AP
Sbjct: 119 NGIFHRDIKPENILIKDDIL-KLADFGSCRGIYS----KPPYTEYISTRWYRAP 167

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 48.9 bits (117), Expect = 4e-06
 Identities = 51/183 (27%), Positives = 82/183 (44%), Gaps = 21/183 (11%)

Query: 661 FNASNL-----IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEG-ALKSFDVECEVLKSVR 713
           F A +L     IG G FG+V K      G  +A+K     ++    K   ++ +V+    
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60

Query: 714 H-RNLVKIISSCTNNDFKALVLEYMPNGSLED---YLYSN---NFSFDILQRLSVIIDVA 766
               +VK   +        + +E M + SL+    Y+Y         +IL +++V     
Sbjct: 61  DCPYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAV--ATV 117

Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
            AL YL       ++H D+KPSN+LLD++    L DFGI+  L   +S+ +T       Y
Sbjct: 118 KALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCRPY 173

Query: 827 MAP 829
           MAP
Sbjct: 174 MAP 176

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 49.3 bits (117), Expect = 4e-06
 Identities = 47/188 (25%), Positives = 89/188 (47%), Gaps = 21/188 (11%)

Query: 652 KELLQATNQFNASNLIGTGGFGSVYKGSFLD---GMEVAIKVFHLQLEGAL--KSFDVEC 706
           K + +   ++   + +G+G +GSV   +  D   G+ VA+K      +  +  K    E 
Sbjct: 10  KTIWEVPERYQNLSPVGSGAYGSVC--AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 67

Query: 707 EVLKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSV 761
            +LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  
Sbjct: 68  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-- 125

Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL 821
           I  +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +
Sbjct: 126 IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYV 178

Query: 822 ATIGYMAP 829
           AT  Y AP
Sbjct: 179 ATRWYRAP 186

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 48.5 bits (115), Expect = 8e-06
 Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 14/146 (9%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV-----ECEVLKSVRHRNLVKI 720
           +G G FG V     +D     A+K   L+ +  L    V     E ++L    +  +VK+
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKT--LRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH-FGYSNP 779
             S  + D    V++Y+P G +   L       ++L R   I ++ LA+E +H  G+   
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARF-YIAELTLAIESVHKMGF--- 122

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGI 805
            +H DIKP N+L+D D    L+DFG+
Sbjct: 123 -IHRDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 48.2 bits (115), Expect = 8e-06
 Identities = 52/183 (28%), Positives = 85/183 (46%), Gaps = 29/183 (15%)

Query: 666 LIGTGGFGSVYKGSFLD---GMEVAIKVFHLQLEGALKSFDV--ECEVLKSVRHRNLVK- 719
           +IG G +G V   S +D   G +VAIK  +   E    +  +  E ++L+ +RH ++V+ 
Sbjct: 7   VIGKGSYGVV--CSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 64

Query: 720 --IISSCTNNDFKAL--VLEYMPNG-----SLEDYLYSNNFSFDILQRLSVIIDVALALE 770
             I+   +  +FK +  V E M +         D L   +  F + Q L        AL+
Sbjct: 65  KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR-------ALK 117

Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK--LLSGEESMKQTLTLATIGYMA 828
           Y+H   +  V H D+KP N+L + D    + DFG+A+        ++  T  +AT  Y A
Sbjct: 118 YIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174

Query: 829 PGL 831
           P L
Sbjct: 175 PEL 177

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 47.6 bits (113), Expect = 9e-06
 Identities = 44/159 (27%), Positives = 76/159 (47%), Gaps = 10/159 (6%)

Query: 667 IGTGGFGSVYKGSF--LDGME-VAIKVFHLQL-EGALK-SFDVECEVLKSVRHRNLVKII 721
           +G+G FG+V KG +      + VA+K+      + ALK     E  V++ + +  +V++I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
             C    +  LV+E    G L  +L  N    +      ++  V++ ++YL        V
Sbjct: 63  GICEAESW-MLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLE---ETNFV 117

Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT 820
           H D+   NVLL     A +SDFG++K L  +E+  +  T
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 47/167 (28%), Positives = 73/167 (43%), Gaps = 13/167 (7%)

Query: 667 IGTGGFGSVYKGSFLDGMEV-AIKVFHL---QLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           IG G FG+VY    +   EV AIK       Q     +    E   L+ +RH N ++   
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVH 782
                    LV+EY   GS  D L  +      LQ + +      AL+ L + +S+ ++H
Sbjct: 83  CYLREHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHNMIH 138

Query: 783 CDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            D+K  N+LL +  +  L DFG A +++          + T  +MAP
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTPYWMAP 180

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 45/170 (26%), Positives = 79/170 (46%), Gaps = 9/170 (5%)

Query: 667 IGTGGFGSVYK-GSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVR-HRNLVKIISSC 724
           IG G +G V+K  +  +G + A+K+    +    +  + E  +LK++  H N+VK     
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 725 TNNDFKA-----LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
              D K      LVLE    GS+ D +       + ++   +   +  AL  L   + N 
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK 144

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            +H D+K +N+LL  +    L DFG++  L+     + T ++ T  +MAP
Sbjct: 145 TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT-SVGTPFWMAP 193

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 48.0 bits (114), Expect = 1e-05
 Identities = 52/177 (29%), Positives = 78/177 (44%), Gaps = 26/177 (14%)

Query: 667 IGTGGFGSVYKGSFLDGMEV-AIKVFHLQLEGALKSFDVECEVLKSVRHRNLV--KIISS 723
           IG G FG VY+    D   + A+KV   +   A K      EV  ++  RN++   ++  
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK------EVAHTIGERNILVRTLLDE 54

Query: 724 C-----------TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
                       T++D   LV +YM  G L  +L      F   +    I ++ LALE+L
Sbjct: 55  SPFIVGLKFSFQTDSDL-YLVTDYMSGGELFWHLQKEG-RFSEDRAKFYIAELVLALEHL 112

Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H      +V+ D+KP N+LLD      L DFG++K    +     T    T  Y+AP
Sbjct: 113 H---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-GTTEYLAP 165

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 55/178 (30%), Positives = 82/178 (46%), Gaps = 28/178 (15%)

Query: 666 LIGTGGFGSVY----KGSFLDGMEVAIKVFHLQLEGALKSFDV-----ECEVLKSVRHRN 716
           L+G G FG V     K +   G   A+K+  L+ E  +   +V     E  VL++ RH  
Sbjct: 2   LLGKGTFGKVILVKEKAT---GRYYAMKI--LKKEVIVAKDEVAHTLTENRVLQNSRHPF 56

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFG 775
           L  +  S   +D    V+EY   G L  +L     FS D  +      ++  AL+YLH  
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA--EIVSALDYLH-- 112

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATI----GYMAP 829
               VV+ D+K  N++LDKD    ++DFG+ K     E +K   T+ T      Y+AP
Sbjct: 113 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 49/168 (29%), Positives = 81/168 (48%), Gaps = 14/168 (8%)

Query: 667 IGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G  GSV K   +  G  +A KV H+  + ++ K    E +++   R   +V    + 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 725 TNNDFKALVLEYMPNGSLED-YLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
            N +   + +E+M  GSL+  Y        +IL +  + + V   L YL+    + ++H 
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLY--NVHRIMHR 128

Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGE--ESMKQTLTLATIGYMAP 829
           DIKPSN+L++      L DFG+    SGE   S+  T  + T  YM+P
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGV----SGELINSIADTF-VGTSTYMSP 171

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 39/144 (27%), Positives = 67/144 (46%), Gaps = 10/144 (6%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQ---LEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G FG V     +D     A+K    +   L   +     E ++L    +  +V++  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH-FGYSNPVV 781
           S  + D    V++Y+P G +   L       + L R   I ++  A+E +H  G+    +
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARF-YIAELTCAVESVHKMGF----I 123

Query: 782 HCDIKPSNVLLDKDMVAHLSDFGI 805
           H DIKP N+L+D+D    L+DFG+
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 50/168 (29%), Positives = 76/168 (45%), Gaps = 15/168 (8%)

Query: 667 IGTGGFGSVYKGSFLDGME-VAIKVFHL---QLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           IG G FG+VY  +     E VA+K       Q     +    E + L+ ++H N ++   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY-K 87

Query: 723 SCTNNDFKA-LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
            C   +  A LV+EY   GS  D L  +      LQ + +      AL+ L + +S+ ++
Sbjct: 88  GCYLKEHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHNMI 143

Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H DIK  N+LL +     L+DFG A   S   S      + T  +MAP
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSPANSF-----VGTPYWMAP 186

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 55/175 (31%), Positives = 82/175 (46%), Gaps = 22/175 (12%)

Query: 666 LIGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGALKSFD---VECE---VLKSVRHRNLV 718
           +IG G FG V       +    A+KV  LQ +  LK  +   +  E   +LK+V+H  LV
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
            +  S    D    VL+Y+  G L  +L       +   R     ++A AL YLH   S 
Sbjct: 60  GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLH---SL 115

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATI----GYMAP 829
            +V+ D+KP N+LLD      L+DFG+ K     E+++   T +T      Y+AP
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK-----ENIEHNGTTSTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.5 bits (101), Expect = 2e-05
 Identities = 17/58 (29%), Positives = 24/58 (41%)

Query: 218 NLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYN 275
           NL+ + L+ N  + I          L VL+L  N+ +   P     L  L  L LS N
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 48/168 (28%), Positives = 85/168 (50%), Gaps = 14/168 (8%)

Query: 667 IGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDV-ECEVLKSVRHRNLVKIISSC 724
           +G G  G V K      G+ +A K+ HL+++ A+++  + E +VL       +V    + 
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68

Query: 725 TNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
            ++   ++ +E+M  GSL+  L        +IL ++S  I V   L YL   +   ++H 
Sbjct: 69  YSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKIS--IAVLRGLTYLREKHK--IMHR 124

Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGE--ESMKQTLTLATIGYMAP 829
           D+KPSN+L++      L DFG+    SG+  +SM  +  + T  YM+P
Sbjct: 125 DVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSF-VGTRSYMSP 167

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 21/191 (10%)

Query: 652 KELLQATNQFNASNLIGTGGFGSVYK-GSFLDGMEVAIKVFHLQLEGALKSFDVECEVLK 710
           + L   T+ +     IG G +G VYK  +  DG   A+K+    +    +  + E  +L+
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYNILQ 73

Query: 711 SV-RHRNLVKIISSCTNNDFKA-----LVLEYMPNGSLEDYLYSNNFSFDILQRLS---- 760
           S+  H N+VK        D        LVLE    GS+ + +          QRL     
Sbjct: 74  SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG---LLICGQRLDEAMI 130

Query: 761 --VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT 818
             ++    L L++LH   +N ++H D+K +N+LL  +    L DFG++  L+    +++ 
Sbjct: 131 SYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR-LRRN 186

Query: 819 LTLATIGYMAP 829
            ++ T  +MAP
Sbjct: 187 TSVGTPFWMAP 197

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 13/167 (7%)

Query: 667 IGTGGFGSVYKGSFLDGMEV-AIKVFHLQLEGALKSF-DV--ECEVLKSVRHRNLVKIIS 722
           IG G FG+VY    +   EV AIK      + + + + D+  E + L+ ++H N ++   
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVH 782
                    LV+EY   GS  D L  +      LQ + +      AL+ L + +S+ ++H
Sbjct: 93  CYLREHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHNMIH 148

Query: 783 CDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            DIK  N+LL +     L+DFG A + S   S      + T  +MAP
Sbjct: 149 RDIKAGNILLTEPGQVKLADFGSASIASPANSF-----VGTPYWMAP 190

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 46.9 bits (111), Expect = 3e-05
 Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 7/103 (6%)

Query: 705 ECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLY-SNNFSFDILQRLSVII 763
           E  +L+++ H +++++  + T N F  L+L   P    + Y Y +   +  I   L++  
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIER 189

Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA 806
            V  A++YLH    N ++H DIK  N+ ++      L DFG A
Sbjct: 190 SVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAA 229

Length = 391

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 41/171 (23%), Positives = 78/171 (45%), Gaps = 14/171 (8%)

Query: 666 LIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLK------SVRHRNLVK 719
           ++G G FG V     L G      V  L+ +  L   DVEC +++      +  +  L  
Sbjct: 2   VLGKGSFGKVLLAE-LKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
           +  +    +    V+E++  G L  +   +   FD+ +      ++   L++LH   S  
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLM-FHIQDKGRFDLYRATFYAAEIVCGLQFLH---SKG 116

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKL-LSGEESMKQTLTLATIGYMAP 829
           +++ D+K  NV+LD+D    ++DFG+ K  + G+   + +    T  Y+AP
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RASTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 45.9 bits (109), Expect = 4e-05
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 24/166 (14%)

Query: 667 IGTGGFGSVYKG-----SFLDG------MEVAIKVFHLQLEGALKSFDVECEVLKSVRHR 715
           +G G F ++YKG     S LD       + V +KV       +L +F     ++  + H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHK 61

Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG 775
           +LVK+   C   D   +V EY+  G L+ +L+    +  +  +L V   +A AL YL   
Sbjct: 62  HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE-- 118

Query: 776 YSNPVVHCDIKPSNVLLDKD-------MVAHLSDFGIAK-LLSGEE 813
               +VH ++   N+L+ +            LSD GI   +LS EE
Sbjct: 119 -DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE 163

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 46.3 bits (110), Expect = 4e-05
 Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 23/181 (12%)

Query: 661 FNASNLIGTGGFGSVYKGSFLDGMEV-AIKVFH---LQLEGALKSFDVECEVLKSVRHRN 716
           F    +IG G FG V      +  +V A+K+ +   +        F  E +VL +   R 
Sbjct: 3   FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSL-------EDYLYSNNFSFDILQRLSVIIDVALAL 769
           +  +  +  + +   LV++Y   G L       ED L  +   F        + ++ LA+
Sbjct: 63  ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF-------YLAEMVLAI 115

Query: 770 EYLH-FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA 828
           + +H  GY    VH DIKP NVLLDK+    L+DFG    L  + +++  + + T  Y++
Sbjct: 116 DSVHQLGY----VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171

Query: 829 P 829
           P
Sbjct: 172 P 172

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.4 bits (98), Expect = 5e-05
 Identities = 23/60 (38%), Positives = 33/60 (55%)

Query: 488 NLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKL 547
           NL+ L L +N L      +  GL +L+ LDLS N+L+   P +   L  L+ L+LS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.4 bits (98), Expect = 5e-05
 Identities = 22/60 (36%), Positives = 25/60 (41%)

Query: 344 NLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKL 403
           NL+ L L  N L       F  L NL+ LDL  N L    P     L  L  L + GN L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 46.7 bits (111), Expect = 5e-05
 Identities = 52/198 (26%), Positives = 80/198 (40%), Gaps = 40/198 (20%)

Query: 666 LIGTGGFGSVYKGSFLD---GMEVAIKVFHLQL-EGAL--KSFDVECEVLKSVRHRNLVK 719
           LIG GG G VY     D      VA+K     L E  L  K F  E ++   + H  +V 
Sbjct: 9   LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQR-----------LSVIIDVALA 768
           + S C++ D     + Y+   +L+  L  + +  + L +           LS+   +   
Sbjct: 67  VYSICSDGDPVYYTMPYIEGYTLKSLL-KSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125

Query: 769 LEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE------------SMK 816
           +EY+H   S  V+H D+KP N+LL       + D+G A     EE               
Sbjct: 126 IEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 817 QTLT-----LATIGYMAP 829
            ++T     + T  YMAP
Sbjct: 183 SSMTIPGKIVGTPDYMAP 200

Length = 932

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 46.1 bits (109), Expect = 5e-05
 Identities = 48/170 (28%), Positives = 72/170 (42%), Gaps = 9/170 (5%)

Query: 667 IGTGGFGSVYKGSFLDGMEV----AIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           IG G FG V +    D   +     I+  H+     +     E  VL  V    +V +  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVH 782
           S  + +   LVL ++  G L  +L      FD+ +      ++  ALE LH      V++
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIY 116

Query: 783 CDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
            D+KP N+LLD      L DFG+ KL   ++    T    T  Y+AP L 
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELL 165

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 45.9 bits (109), Expect = 5e-05
 Identities = 27/73 (36%), Positives = 40/73 (54%), Gaps = 6/73 (8%)

Query: 760 SVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS---GEESMK 816
           S I  +   L+Y+H   S  V+H D+KP N+L++ D    + DFG+A+  S   GE +  
Sbjct: 109 SFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165

Query: 817 QTLTLATIGYMAP 829
            T  +AT  Y AP
Sbjct: 166 MTEYVATRWYRAP 178

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 45.9 bits (109), Expect = 5e-05
 Identities = 24/63 (38%), Positives = 38/63 (60%), Gaps = 3/63 (4%)

Query: 769 LEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA 828
           L+YLH   S  ++H DIKP N+L++ + V  + DFG+A++   +ES   T  + T  Y A
Sbjct: 116 LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172

Query: 829 PGL 831
           P +
Sbjct: 173 PEI 175

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 45.6 bits (108), Expect = 6e-05
 Identities = 50/173 (28%), Positives = 86/173 (49%), Gaps = 21/173 (12%)

Query: 667 IGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGA-LKSFDVECEVLKSVRHRNLVKIISSC 724
           +G G +GSVYK      G+ +A+K   L+L+ +      +E ++L       +V    + 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSF-----DILQRLSVIIDVALALEYLHFGYSNP 779
                  + +EYM  GSL D LY+   +      D+L+R++    V   L++L   ++  
Sbjct: 69  FIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYA--VVKGLKFLKEEHN-- 123

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG---YMAP 829
           ++H D+KP+NVL++ +    L DFG++  L    S+ +T     IG   YMAP
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL--VASLAKT----NIGCQSYMAP 170

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 44.8 bits (107), Expect = 7e-05
 Identities = 27/95 (28%), Positives = 45/95 (47%), Gaps = 5/95 (5%)

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
           + N +K+  S T      L+++Y+ +G L D L          +   +I  +  AL  LH
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH 126

Query: 774 FGYSNPVVHCDIKPSNVLLDKDMV-AHLSDFGIAK 807
               + ++H DIK  NVL D+     +L D+G+ K
Sbjct: 127 ---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158

Length = 267

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.6 bits (96), Expect = 1e-04
 Identities = 26/57 (45%), Positives = 32/57 (56%)

Query: 467 IIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSL 523
            +DLS N L+     A  GL NL+ L L  N L    P++  GL SL SLDLS N+L
Sbjct: 4   SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 44.8 bits (106), Expect = 1e-04
 Identities = 45/187 (24%), Positives = 82/187 (43%), Gaps = 39/187 (20%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRN-LVKIIS 722
           IG G +G VYK    + G  VA+K   L++  EG   +   E  +L+ +     +V+++ 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 723 --SCTNNDFKA---LVLEYMPNGSLEDYLYSN--------------NFSFDILQRLSVII 763
                  + K    LV EY+ +  L+ ++ SN              +F + +L+      
Sbjct: 69  VEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK------ 121

Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKD-MVAHLSDFGIAKLLSGEESMKQTLTLA 822
                + + H    + V+H D+KP N+L+DK   +  ++D G+ +  S       T  + 
Sbjct: 122 ----GVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK-SYTHEIV 173

Query: 823 TIGYMAP 829
           T+ Y AP
Sbjct: 174 TLWYRAP 180

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 29/184 (15%)

Query: 661 FNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGA---LKSFDVEC-----EVLKSV 712
           F    +IG G FG V     +  ++ A KVF +++      LK  +  C     +VL + 
Sbjct: 3   FEILKVIGRGAFGEVA----VVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG 58

Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSL-------EDYLYSNNFSFDILQRLSVIIDV 765
            ++ +  +  +  + +   LV++Y   G L       ED L  +   F  L  + + ID 
Sbjct: 59  DNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF-YLAEMVIAIDS 117

Query: 766 ALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG 825
              L Y         VH DIKP N+L+D +    L+DFG    L  + +++ ++ + T  
Sbjct: 118 VHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 168

Query: 826 YMAP 829
           Y++P
Sbjct: 169 YISP 172

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 36/152 (23%), Positives = 65/152 (42%), Gaps = 11/152 (7%)

Query: 666 LIGTGGFGSVYKGSFLDGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRHRNLVKI-- 720
           LI      S+YKG F +  EV I+ F   H   +  +   + E + L+ +   N++KI  
Sbjct: 27  LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85

Query: 721 --ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
             I    +    +L+LEY   G L + L           +L + ID    L  L+   + 
Sbjct: 86  FIIDIVDDLPRLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYKYTNK 144

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS 810
           P  + ++   + L+ ++    +   G+ K+LS
Sbjct: 145 P--YKNLTSVSFLVTENYKLKIICHGLEKILS 174

Length = 283

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 44.6 bits (105), Expect = 2e-04
 Identities = 61/191 (31%), Positives = 95/191 (49%), Gaps = 10/191 (5%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L LS N +  ++P  + NL  LK L L +N L  ++P+ L NL+ L  + L+ N +S  +
Sbjct: 145 LDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DL 201

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
           P  I  LS+L   +D SNNS+   L   +   L  + GL +SNNKL   +P +I     L
Sbjct: 202 PPEIELLSALEE-LDLSNNSII-ELLSSL-SNLKNLSGLELSNNKLE-DLPESIGNLSNL 257

Query: 122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEM-GNLRNLEILGLQLNKLV 180
             + L+ NQ +      LG+LT+L+ L L  N+L+  +P      L    +L L L    
Sbjct: 258 ETLDLSNNQISS--ISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKA 315

Query: 181 GFVPTSIFNLS 191
             +  +   L+
Sbjct: 316 LELKLNSILLN 326

Length = 394

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 39/157 (24%), Positives = 71/157 (45%), Gaps = 25/157 (15%)

Query: 664 SNLIGTGGFGSVYKGSFLDGM-----EVAIKVF-----HLQLEGALKSFDVECEVLKSVR 713
           S+L+  G FG ++ G  +D       EV +K        +Q+   L+    E  +L  + 
Sbjct: 11  SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQ----ESCLLYGLS 66

Query: 714 HRNLVKIISSCTNNDFKALVLE-YMPNGSLEDYLYS-------NNFSFDILQRLSVIIDV 765
           H+N++ I+  C  +     VL  YM  G+L+ +L         N  +    Q + + I +
Sbjct: 67  HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126

Query: 766 ALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSD 802
           A  + YLH      V+H DI   N ++D+++   ++D
Sbjct: 127 ACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD 160

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 44.4 bits (105), Expect = 2e-04
 Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 7/103 (6%)

Query: 705 ECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIID 764
           E ++LK++ HR ++ +I +      K+ V   MP    + + Y +      L++   I  
Sbjct: 136 EIDILKTISHRAIINLIHAYRW---KSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQR 192

Query: 765 VAL-ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA 806
             L AL YLH      ++H D+K  N+ LD+   A L DFG A
Sbjct: 193 RLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAA 232

Length = 392

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 49/180 (27%), Positives = 78/180 (43%), Gaps = 22/180 (12%)

Query: 661 FNASNLIGTGGFGSVYKGSFLDGMEV-AIKVFHLQLEGALKSFDVEC-----EVLKSVRH 714
           FN   ++G G FG V         E+ AIK+  L+ +  ++  DVEC      VL     
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQDK 59

Query: 715 RNLVKIISSCTNN-DFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
              +  + SC    D    V+EY+  G L  Y       F   Q +    ++++ L +LH
Sbjct: 60  PPFLTQLHSCFQTVDRLYFVMEYVNGGDLM-YHIQQVGKFKEPQAVFYAAEISVGLFFLH 118

Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATI----GYMAP 829
                 +++ D+K  NV+LD +    ++DFG+ K     E M   +T  T      Y+AP
Sbjct: 119 ---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----EHMVDGVTTRTFCGTPDYIAP 170

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 34/146 (23%), Positives = 61/146 (41%), Gaps = 10/146 (6%)

Query: 667 IGTGGFGSVYKGSFLDGMEVA-IKVFHLQLEGALK---SFDVECEVLKSVRHRNLVKIIS 722
           IG G FG V          VA + V  L+   + K    F  + +  + ++H N+++ + 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSF---DILQRLSVIIDVALALEYLHFGYSNP 779
            C       LV EY   G L+ YL    +      +L    +  ++A  + ++H    + 
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHN 119

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGI 805
            +H D+   N  L  D+   + D+GI
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 48/182 (26%), Positives = 80/182 (43%), Gaps = 38/182 (20%)

Query: 667 IGTGGFGSVYKGSFLD---GMEVAIKVFH--LQLEGALKSFDVECEVLKSVRHRNLVKII 721
           IG+G  G V   +  D   G+ VA+K      Q +   K    E  +LK V H+N++ ++
Sbjct: 29  IGSGAQGIVC--AAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86

Query: 722 SSCTNNDFKALVLEYMPNGSLED----YLYSNNFSFDILQ---------RLSVII-DVAL 767
           +  T            P  SLE+    YL       ++ Q         R+S ++  +  
Sbjct: 87  NVFT------------PQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC 134

Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYM 827
            +++LH   S  ++H D+KPSN+++  D    + DFG+A+       M  T  + T  Y 
Sbjct: 135 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVVTRYYR 189

Query: 828 AP 829
           AP
Sbjct: 190 AP 191

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 37/157 (23%), Positives = 68/157 (43%), Gaps = 19/157 (12%)

Query: 667 IGTGGFGSVY----KGSFLDGMEVAIKVFHLQLEGALKS---FDVECEVLKSVRHRNLVK 719
           +G G FG VY    KG   D  E  + +  +    +++    F  E  V+K     ++V+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYS-----NNFSFDILQRLSVII----DVALALE 770
           ++   +      +++E M  G L+ YL S      N        L  +I    ++A  + 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           YL+   +N  VH D+   N ++ +D    + DFG+ +
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 43.9 bits (103), Expect = 3e-04
 Identities = 43/156 (27%), Positives = 69/156 (44%), Gaps = 18/156 (11%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-----GMEVAIKVFHLQLEGALKSFDVECEVLKSVR 713
           + F +  +IG G FG V      D      M++  K   L+ E  +     E ++L    
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKE-QVAHIRAERDILVEAD 59

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV---IIDVALALE 770
              +VK+  S  +     L++E++P G +   L       D L   +    I +  LA++
Sbjct: 60  GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAID 115

Query: 771 YLH-FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGI 805
            +H  G+    +H DIKP N+LLD      LSDFG+
Sbjct: 116 AIHQLGF----IHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 43.4 bits (102), Expect = 3e-04
 Identities = 40/165 (24%), Positives = 77/165 (46%), Gaps = 27/165 (16%)

Query: 686 VAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLED 744
           VA+K+      + A   F  E ++L  ++  N+++++  C + D   ++ EYM NG L  
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 745 YLYSNNF--------------------SFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
           +L S++                     S+  L  L V + +A  ++YL    S   VH D
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSL--LHVALQIASGMKYLS---SLNFVHRD 163

Query: 785 IKPSNVLLDKDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMA 828
           +   N L+ +++   ++DFG+++ L +G+    Q   +  I +MA
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMA 208

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 43.1 bits (101), Expect = 4e-04
 Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 18/154 (11%)

Query: 661 FNASNLIGTGGFGSVYKGSFLD-----GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHR 715
           F +  +IG G FG V      D      M++  K   L+ E  +     E ++L      
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE-QVGHIRAERDILVEADSL 61

Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV---IIDVALALEYL 772
            +VK+  S  +     L++E++P G +   L       D L        I +  LA++ +
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSI 117

Query: 773 H-FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGI 805
           H  G+    +H DIKP N+LLD      LSDFG+
Sbjct: 118 HQLGF----IHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 43.0 bits (101), Expect = 4e-04
 Identities = 48/175 (27%), Positives = 77/175 (44%), Gaps = 22/175 (12%)

Query: 666 LIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVEC-----EVLKSVR-HRNLV 718
           ++G G FG V        G   A+KV  L+ +  L+  DVEC      +L   R H  L 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
           ++       D    V+E++  G L  ++  +   FD  +      ++  AL +LH     
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DK 115

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATI----GYMAP 829
            +++ D+K  NVLLD +    L+DFG+ K     E +    T +T      Y+AP
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGIFNGKTTSTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 43.0 bits (101), Expect = 4e-04
 Identities = 37/171 (21%), Positives = 72/171 (42%), Gaps = 34/171 (19%)

Query: 660 QFNASNLIGTGGFGSVYKGS----FLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHR 715
           ++    LIG GGFG VY+           +   K+ +L+ E    +  +E  V  ++   
Sbjct: 13  EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENE----TIVMETLVYNNIYDI 68

Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRL---------------- 759
           + + +  +  N D   +   Y         +Y   + F +L++L                
Sbjct: 69  DKIALWKNIHNIDHLGIPKYYGCGSFKRCRMY---YRFILLEKLVENTKEIFKRIKCKNK 125

Query: 760 ----SVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA 806
               +++ D+   LEY+H    + + H DIKP N+++D +   ++ D+GIA
Sbjct: 126 KLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIA 173

Length = 294

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 43.3 bits (102), Expect = 4e-04
 Identities = 52/188 (27%), Positives = 82/188 (43%), Gaps = 32/188 (17%)

Query: 664 SNLIGTGGFGSV-YKGSFLDGMEVAIKVFHLQLEGALK------SFDVEC-------EVL 709
           S ++G+G  G+V       DG   A+KV  + +EG  +        +V C        ++
Sbjct: 37  SRVLGSGATGTVLCAKRVSDGEPFAVKV--VDMEGMSEADKNRAQAEVCCLLNCDFFSIV 94

Query: 710 KSVRHRNLVKIISSCTNND----FKALVLEYMPNGSLEDYLYSN---NFSFDILQRLSVI 762
           K   H +  K       N       ALVL+Y   G L   + S    N +F   +   + 
Sbjct: 95  KC--HEDFAK---KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF 149

Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL- 821
           I V LA+ ++H   S  ++H DIK +N+LL  + +  L DFG +K+ +   S     T  
Sbjct: 150 IQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206

Query: 822 ATIGYMAP 829
            T  Y+AP
Sbjct: 207 GTPYYVAP 214

Length = 496

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 42.7 bits (100), Expect = 5e-04
 Identities = 49/182 (26%), Positives = 83/182 (45%), Gaps = 22/182 (12%)

Query: 661 FNASNLIGTGGFGSVYKGSFLDGMEV-AIKVFHLQLEGALKSFDVECEVLK------SVR 713
           FN   ++G G FG V         E+ AIK+  L+ +  ++  DVEC +++      S +
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALSGK 59

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
              L ++ S     D    V+EY+  G L  Y       F     +    ++A+ L +LH
Sbjct: 60  PPFLTQLHSCFQTMDRLYFVMEYVNGGDLM-YQIQQVGRFKEPHAVFYAAEIAIGLFFLH 118

Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATI----GYMAP 829
              S  +++ D+K  NV+LD +    ++DFG+ K     E+M   +T  T      Y+AP
Sbjct: 119 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENMWDGVTTKTFCGTPDYIAP 170

Query: 830 GL 831
            +
Sbjct: 171 EI 172

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 42.6 bits (100), Expect = 7e-04
 Identities = 23/104 (22%), Positives = 49/104 (47%), Gaps = 4/104 (3%)

Query: 704 VECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           +E  +L++V H +++++  +  +     +VL +  +  L  YL   +    I Q L +  
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEK 164

Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
            +   L YLH   +  ++H D+K  N+ ++      + D G A+
Sbjct: 165 QILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Length = 357

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.5 bits (88), Expect = 0.001
 Identities = 18/58 (31%), Positives = 28/58 (48%)

Query: 392 RLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSN 449
            L  L +  N+L+         L +L++L L+ N L S+ P  F  L  + SL+ S N
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 41/154 (26%), Positives = 70/154 (45%), Gaps = 8/154 (5%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQ---LEGALKSFDVECEVLKSVRH 714
             F    LI  G +G+VY     +  +  A+K  + Q   L   ++   VE ++L    +
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             +V +  S        +V+EY+  G     L +       + R+    +  LALEYLH 
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFA-ETVLALEYLH- 118

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL 808
             +  +VH D+KP N+L+       L+DFG++K+
Sbjct: 119 --NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 41.3 bits (97), Expect = 0.002
 Identities = 17/40 (42%), Positives = 24/40 (60%)

Query: 513 LESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIP 552
           ++ L L N  L G IP  + KL +L+ +NLS N + G IP
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIP 459

Length = 623

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.1 bits (87), Expect = 0.002
 Identities = 20/60 (33%), Positives = 30/60 (50%)

Query: 416 SLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNL 475
           +L+ L L++N L  +    F  L ++  L+ S N L    PE    L  +  +DLS NNL
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 40.7 bits (95), Expect = 0.002
 Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 10/156 (6%)

Query: 660 QFNASNLIGTGGFG-SVYKGSFLDGMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNL 717
           Q+N   ++G G FG ++         + A+K   L     A++    E  +L  ++H N+
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN---FSFDILQRLSVIIDVALALEYLHF 774
           V    S   +    +V+EY   G L   +       F  D +  L   + + L ++++H 
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI--LQWFVQMCLGVQHIH- 117

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS 810
                V+H DIK  N+ L ++    L DFG A+LL+
Sbjct: 118 --EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 40.9 bits (96), Expect = 0.002
 Identities = 51/180 (28%), Positives = 83/180 (46%), Gaps = 22/180 (12%)

Query: 661 FNASNLIGTGGFGSVYKGSFLDGMEV-AIKVFHLQLEGALKSFDVECEVL-KSV-----R 713
           FN   ++G G FG V         E+ AIK+  L+ +  ++  DVEC ++ K V     +
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVIIQDDDVECTMVEKRVLALPGK 59

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
              L ++ S     D    V+EY+  G L  Y       F     +    ++A+ L +LH
Sbjct: 60  PPFLTQLHSCFQTMDRLYFVMEYVNGGDLM-YHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118

Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM---KQTLTL-ATIGYMAP 829
              S  +++ D+K  NV+LD +    ++DFG+ K     E++   K T T   T  Y+AP
Sbjct: 119 ---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK-----ENIFGGKTTRTFCGTPDYIAP 170

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 41.1 bits (96), Expect = 0.002
 Identities = 48/193 (24%), Positives = 81/193 (41%), Gaps = 43/193 (22%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV-----R 713
           + F    +IG G FG V            +K+ H +   A+K  + + E+LK       R
Sbjct: 1   DDFEIIKVIGRGAFGEV----------AVVKMKHTERIYAMKILN-KWEMLKRAETACFR 49

Query: 714 HRNLVKIISSCT----------NNDFKALVLEYMPNGSL-------EDYLYSNNFSFDIL 756
               V +   C           + ++  LV++Y   G L       ED L  +   F   
Sbjct: 50  EERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF--- 106

Query: 757 QRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK 816
                I ++ LA+  +H       VH DIKP NVLLD +    L+DFG    ++ + +++
Sbjct: 107 ----YIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159

Query: 817 QTLTLATIGYMAP 829
            ++ + T  Y++P
Sbjct: 160 SSVAVGTPDYISP 172

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 40.5 bits (95), Expect = 0.003
 Identities = 36/132 (27%), Positives = 67/132 (50%), Gaps = 17/132 (12%)

Query: 705 ECEVLKSVRHRNLVKIISSCTNN----DFKA--LVLEYMPNGSLEDYLYSNNFSFDILQR 758
           E  ++K V H+N++ +++  T      +F+   LV+E M + +L   +       D  +R
Sbjct: 65  ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVI---QMDLD-HER 119

Query: 759 LSVIIDVAL-ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ 817
           +S ++   L  +++LH   S  ++H D+KPSN+++  D    + DFG+A+       M  
Sbjct: 120 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-- 174

Query: 818 TLTLATIGYMAP 829
           T  + T  Y AP
Sbjct: 175 TPYVVTRYYRAP 186

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 40.9 bits (95), Expect = 0.003
 Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 35/205 (17%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEV----AIKVFHLQLEGALKSFDVECEVLKSVRH 714
           N++     IG G FG V+        E     AI    L+ E       +E  V++ ++H
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKH 71

Query: 715 RNLVKIISSCTN--NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL----A 768
           +N+V+ I    N  N    +++E+   G L   +      F  ++    I+D+      A
Sbjct: 72  KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE-HAIVDITRQLLHA 130

Query: 769 LEYLHFGYSNP----VVHCDIKPSNVLLDKDM-----------------VAHLSDFGIAK 807
           L Y H     P    V+H D+KP N+ L   +                 +A + DFG++K
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190

Query: 808 LLSGEESMKQTLTLATIGYMAPGLF 832
            + G ESM  +  + T  Y +P L 
Sbjct: 191 NI-GIESMAHS-CVGTPYYWSPELL 213

Length = 1021

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 40.0 bits (94), Expect = 0.003
 Identities = 48/184 (26%), Positives = 80/184 (43%), Gaps = 36/184 (19%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEG---ALKSFDVECEVLKSVRHRNLVK--- 719
           IG G +G V      +   +VAIK      +    A ++   E ++L+ + H N++    
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKD 71

Query: 720 IISSCTNNDFKA--LVLEYMPNGSLEDYLYSNN---------FSFDILQRLSVIIDVALA 768
           I+       F    +V E M +  L   + S+          F + +L+           
Sbjct: 72  IMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR----------G 120

Query: 769 LEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG-EESMKQTLTLATIGYM 827
           L+Y+H   S  V+H D+KPSN+LL+ +    + DFG+A+  S   + M  T  + T  Y 
Sbjct: 121 LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVTRWYR 175

Query: 828 APGL 831
           AP L
Sbjct: 176 APEL 179

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	832
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.98
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.97
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.97
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.97
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.97
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG0605	550	consensus NDR and related serine/threonine kinases	99.97
KOG0198	313	consensus MEKK and related serine/threonine protei	99.97
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.97
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.97
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.96
KOG0578	550	consensus p21-activated serine/threonine protein k	99.96
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.96
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.96
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.96
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.96
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.96
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.96
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.96
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.95
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.95
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.95
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.95
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.95
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.95
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.95
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.95
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.95
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.95
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.95
KOG0589	426	consensus Serine/threonine protein kinase [General	99.95
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.95
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.95
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.95
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.95
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.95
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.95
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.95
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.95
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.94
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.94
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.94
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.94
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.94
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.94
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.94
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.94
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.94
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.94
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.94
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.94
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.94
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.94
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.94
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.94
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.94
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.94
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.94
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.94
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.94
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.94
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.94
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.94
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.94
KOG0610	459	consensus Putative serine/threonine protein kinase	99.94
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.94
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.94
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.94
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.94
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.94
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.94
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.94
KOG0586	596	consensus Serine/threonine protein kinase [General	99.94
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.94
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.94
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.94
PHA03212	391	serine/threonine kinase US3; Provisional	99.93
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.93
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.93
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.93
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.93
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.93
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.93
PTZ00267	478	NIMA-related protein kinase; Provisional	99.93
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.93
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.93
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.93
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.93
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.93
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.93
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.93
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.93
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.93
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.93
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.93
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.93
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.93
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.93
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.93
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.93
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.93
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.93
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.93
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.93
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.93
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.93
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.93
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.93
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.93
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.93
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.93
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.93
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.93
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.93
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.93
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.92
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.92
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.92
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.92
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.92
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.92
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.92
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.92
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.92
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.92
KOG1152	772	consensus Signal transduction serine/threonine kin	99.92
KOG0584	632	consensus Serine/threonine protein kinase [General	99.92
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.92
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.92
PTZ00036	440	glycogen synthase kinase; Provisional	99.92
PHA02988	283	hypothetical protein; Provisional	99.92
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.92
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.92
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.92
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.92
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.92
PHA03211	461	serine/threonine kinase US3; Provisional	99.92
PTZ00283	496	serine/threonine protein kinase; Provisional	99.92
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.92
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.92
PHA03209	357	serine/threonine kinase US3; Provisional	99.92
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.92
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.92
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.92
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.92
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.92
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.92
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.92
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.92
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.92
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.92
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.92
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.92
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.92
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.92
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.91
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.91
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.91
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.91
PHA03207	392	serine/threonine kinase US3; Provisional	99.91
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.91
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.91
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.91
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.91
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.91
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.91
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.91
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.91
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.91
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.91
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.91
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.91
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.91
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.91
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.91
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.91
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.91
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.91
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.91
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.91
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.91
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.91
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.91
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.91
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.91
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.91
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.91
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.91
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.91
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.91
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.91
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.91
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.91
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.91
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.91
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.91
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.91
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.91
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.91
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.91
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.91
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.91
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.91
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.91
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.91
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.91
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.91
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.91
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.91
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.91
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.91
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.91
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.91
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.91
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.91
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.91
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.91
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.91
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.91
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.91
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.91
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.91
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.91
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.91
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.91
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.91
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.91
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.91
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.91
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.91
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.91
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.9
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.9
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.9
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.9
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.9
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.9
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.9
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.9
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.9
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.9
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.9
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.9
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.9
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.9
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.9
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.9
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.9
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.9
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.9
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.9
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.9
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.9
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.9
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.9
PHA03210	501	serine/threonine kinase US3; Provisional	99.9
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.9
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.9
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.9
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.9
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.9
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.9
PTZ00284	467	protein kinase; Provisional	99.9
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.9
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.9
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.9
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.9
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.9
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.9
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.9
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.9
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.9
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.9
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.9
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.9
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.9
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.9
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.9
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.9
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.9
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.9
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.9
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.9
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.9
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.9
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.9
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.9
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.9
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.89
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.89
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.89
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.89
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.89
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.89
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.89
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.89
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.89
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.89
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.89
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.89
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.89
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.89
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.89
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.89
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.89
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.89
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.89
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.89
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.89
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.89
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.89
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.89
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.89
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.89
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.89
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.89
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.89
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.89
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.89
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.89
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.89
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.89
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.89
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.89
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.89
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.89
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.89
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.89
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.89
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.89
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.89
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.89
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.89
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.89
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.89
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.88
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.88
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.88
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.88
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.88
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.88
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.88
PLN00009	294	cyclin-dependent kinase A; Provisional	99.88
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.88
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.88
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.88
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.88
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.88
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.88
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.88
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.88
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.88
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.88
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.88
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.88
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.87
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.87
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.87
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.87
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.87
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.87
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.87
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.87
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.87
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.87
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.87
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.87
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.87
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.87
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.87
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.87
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.87
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.87
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.86
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.86
PHA02882	294	putative serine/threonine kinase; Provisional	99.86
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.86
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.86
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.85
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.85
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.85
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.85
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.84
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.84
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.84
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.84
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.83
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.81
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.81
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.81
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.81
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.81
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.8
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.79
PRK10345	210	hypothetical protein; Provisional	99.79
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.79
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.79
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.78
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.78
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.77
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.77
PRK12274	218	serine/threonine protein kinase; Provisional	99.76
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.76
smart00090	237	RIO RIO-like kinase.	99.76
PRK14879	211	serine/threonine protein kinase; Provisional	99.72
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.72
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.71
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.68
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.67
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.66
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.64
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.63
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.6
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.57
PLN03150	623	hypothetical protein; Provisional	99.56
PLN00181	793	protein SPA1-RELATED; Provisional	99.54
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.54
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.54
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.49
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.49
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.48
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.45
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.44
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.42
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.38
PLN03150	623	hypothetical protein; Provisional	99.37
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.37
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.31
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.28
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.27
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.27
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.25
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.24
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.22
KOG3087	229	consensus Serine/threonine protein kinase [General	99.21
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.19
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.19
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.18
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.14
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.14
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.13
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.13
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.12
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.11
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.08
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.07
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.06
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	99.05
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	98.99
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.98
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.98
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	98.97
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.92
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.91
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.91
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.88
KOG1243	690	consensus Protein kinase [General function predict	98.87
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.85
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.77
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.69
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.61
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.61
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.59
PRK09902	216	hypothetical protein; Provisional	98.59
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.58
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.56
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.48
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.47
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.46
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.44
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.43

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.6e-97  Score=913.89  Aligned_cols=775  Identities=31%  Similarity=0.503  Sum_probs=661.6

Q ss_pred             ccccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCccc-CcccccccccccccccccCCChhhhhcCCCce
Q 003301           20 LTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIK   98 (832)
Q Consensus        20 l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~-~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~   98 (832)
                      ...++.|+|++|.+++.+|..|..+++|++|+|++|++.|.+|..++ .+++| ++|||++|++++.+|..   .+++|+
T Consensus        68 ~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L-~~L~Ls~n~l~~~~p~~---~l~~L~  143 (968)
T PLN00113         68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSL-RYLNLSNNNFTGSIPRG---SIPNLE  143 (968)
T ss_pred             CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCC-CEEECcCCccccccCcc---ccCCCC
Confidence            35788999999999988999999999999999999999989998776 78888 99999999999888863   578999


Q ss_pred             EEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccccc
Q 003301           99 GLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNK  178 (832)
Q Consensus        99 ~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~  178 (832)
                      +|+|++|.+++.+|..++.+++|++|+|++|.+.+.+|..|+++++|++|+|++|++.+.+|..++++++|++|+|++|+
T Consensus       144 ~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~  223 (968)
T PLN00113        144 TLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNN  223 (968)
T ss_pred             EEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCc
Confidence            99999999998899999999999999999999998899999999999999999999998899999999999999999999


Q ss_pred             cccccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCC
Q 003301          179 LVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIP  258 (832)
Q Consensus       179 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~  258 (832)
                      +.+.+|..+.++++|++|++++|.+.+.+|..+  ..+++|++|++++|++.+..|..+.++++|++|++++|.+.+..|
T Consensus       224 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l--~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p  301 (968)
T PLN00113        224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL--GNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP  301 (968)
T ss_pred             cCCcCChhHhcCCCCCEEECcCceeccccChhH--hCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCC
Confidence            998899999999999999999999998888765  688999999999999999999999999999999999999999999


Q ss_pred             ccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCccccccccc
Q 003301          259 NTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKE  338 (832)
Q Consensus       259 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~  338 (832)
                      ..+..+++|++|++++|.++.     ..+..+..+++|+.|++++|.+.+.+|..+..+. +|+.|++++|++++.+|..
T Consensus       302 ~~~~~l~~L~~L~l~~n~~~~-----~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~-~L~~L~Ls~n~l~~~~p~~  375 (968)
T PLN00113        302 ELVIQLQNLEILHLFSNNFTG-----KIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHN-NLTVLDLSTNNLTGEIPEG  375 (968)
T ss_pred             hhHcCCCCCcEEECCCCccCC-----cCChhHhcCCCCCEEECcCCCCcCcCChHHhCCC-CCcEEECCCCeeEeeCChh
Confidence            999999999999999999987     4455688999999999999999999999888876 9999999999999999999


Q ss_pred             ccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCC
Q 003301          339 IGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLR  418 (832)
Q Consensus       339 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  418 (832)
                      +..+++|+.|++++|++.+..|..+..+++|+.|++++|++++.+|..+..+++|+.|++++|.+++.+|..+..+++|+
T Consensus       376 ~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  455 (968)
T PLN00113        376 LCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQ  455 (968)
T ss_pred             HhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeeccccc
Q 003301          419 LLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNG  498 (832)
Q Consensus       419 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  498 (832)
                      .|++++|++.+..|..+ ..++|+.|++++|++++..|..+..+++|+.|+|++|++.+.+|..+.++++|++|+|++|.
T Consensus       456 ~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  534 (968)
T PLN00113        456 MLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ  534 (968)
T ss_pred             EEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCc
Confidence            99999999999888876 45899999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCCCCCCCCCcCCCcccCCCCCCCCcc-c
Q 003301          499 LQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQ-V  577 (832)
Q Consensus       499 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~-~  577 (832)
                      +++.+|..|+.+++|+.|||++|+++|.+|..+..+++|+.|++++|+++|.+|..+++.++.+.++.||+.+||.+. .
T Consensus       535 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~  614 (968)
T PLN00113        535 LSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTS  614 (968)
T ss_pred             ccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCcccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999999653 3


Q ss_pred             CCCccCCCCCCccccccccceeeeeechhhHHHHHHHhhhhheeeeehhhhhhhhccccccccC-----ccccccccchH
Q 003301          578 QVPVCKSGNSSSHRKSRKNTILLGVLLPLSTVFIIAVILAVRYAMISRCQEKNAKQSNIESNML-----PQATRRRFSYK  652 (832)
Q Consensus       578 ~~p~c~~~~~~~~~~s~~~~i~~~v~v~~~~~~~~~v~~~v~~~~~~r~~~~~~~~~~~~~~~~-----~~~~~~~~~~~  652 (832)
                      ..|+|....     ++...++++++  ++++++++++++ +.+++++++++...++.+.+....     .......++++
T Consensus       615 ~~~~c~~~~-----~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  686 (968)
T PLN00113        615 GLPPCKRVR-----KTPSWWFYITC--TLGAFLVLALVA-FGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITIN  686 (968)
T ss_pred             CCCCCcccc-----ccceeeeehhH--HHHHHHHHHHHH-HHHHHHHhhhcccccccccccccccccccccccchhhhHH
Confidence            345674321     11112222222  222222222221 222222222211111111111000     00111223344


Q ss_pred             HHHHHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeE
Q 003301          653 ELLQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       653 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  731 (832)
                      ++   ...|...+.||+|+||.||+|++. ++..||||++.....    ...+|++.+++++|||||++++++.+++..|
T Consensus       687 ~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~  759 (968)
T PLN00113        687 DI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAY  759 (968)
T ss_pred             HH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence            43   346778899999999999999874 689999998864332    1234688999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +||||+++|+|.++++    .++|..+.+++.|++.|++|+|..++++|+||||||+||+++.++.+++. ||.+.....
T Consensus       760 lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~  834 (968)
T PLN00113        760 LIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT  834 (968)
T ss_pred             EEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence            9999999999999996    37899999999999999999997667899999999999999999888876 666544321


Q ss_pred             CcccccccccccccccCCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .     ....||++|||||++
T Consensus       835 ~-----~~~~~t~~y~aPE~~  850 (968)
T PLN00113        835 D-----TKCFISSAYVAPETR  850 (968)
T ss_pred             C-----CCccccccccCcccc
Confidence            1     123689999999974

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.2e-66  Score=641.54  Aligned_cols=533  Identities=35%  Similarity=0.578  Sum_probs=502.2

Q ss_pred             ccCCCCcceeccCccccCccccCeEeccCCccccCCCcccc-ccccCcEEEccCCcCCCCCCCcccCccccccccccccc
Q 003301            2 LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELG-NLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNN   80 (832)
Q Consensus         2 ldl~~n~~~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~-~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n   80 (832)
                      |||++|.++|.+|+.+..+++|++|+|++|++++.+|..+. .+++|++|+|++|.+++.+|.  +.+++| ++|||++|
T Consensus        74 L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L-~~L~Ls~n  150 (968)
T PLN00113         74 IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNL-ETLDLSNN  150 (968)
T ss_pred             EEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCC-CEEECcCC
Confidence            79999999999999999999999999999999988998755 999999999999999998886  567888 99999999


Q ss_pred             ccccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccC
Q 003301           81 SLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIP  160 (832)
Q Consensus        81 ~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p  160 (832)
                      .+++.+|..+. .+++|++|++++|.+++.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|++++.+|
T Consensus       151 ~~~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p  229 (968)
T PLN00113        151 MLSGEIPNDIG-SFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIP  229 (968)
T ss_pred             cccccCChHHh-cCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCC
Confidence            99988998876 89999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCccccceecccccccccccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCC
Q 003301          161 YEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNA  240 (832)
Q Consensus       161 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l  240 (832)
                      ..++++++|++|++++|++.+.+|..+.++++|++|++++|.+.+.+|..+  ..+++|++|++++|.+.+..|..+..+
T Consensus       230 ~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l--~~l~~L~~L~Ls~n~l~~~~p~~~~~l  307 (968)
T PLN00113        230 YEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI--FSLQKLISLDLSDNSLSGEIPELVIQL  307 (968)
T ss_pred             hhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhH--hhccCcCEEECcCCeeccCCChhHcCC
Confidence            999999999999999999999999999999999999999999998888765  688999999999999999999999999


Q ss_pred             CCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccc
Q 003301          241 SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLS  320 (832)
Q Consensus       241 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~  320 (832)
                      ++|++|++++|.+.+..|..+..+++|+.|++++|.++.     .++..+..+++|+.|++++|++.+..|..+.... +
T Consensus       308 ~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~-----~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~-~  381 (968)
T PLN00113        308 QNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSG-----EIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSG-N  381 (968)
T ss_pred             CCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcC-----cCChHHhCCCCCcEEECCCCeeEeeCChhHhCcC-C
Confidence            999999999999999999999999999999999999986     4556688999999999999999999999998876 8


Q ss_pred             cceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecC
Q 003301          321 LSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDG  400 (832)
Q Consensus       321 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  400 (832)
                      |+.|++++|++.+.+|..+..+++|+.|++++|++++..|..|..+++|+.|++++|++++.+|..+..+++|+.|++++
T Consensus       382 L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  461 (968)
T PLN00113        382 LFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLAR  461 (968)
T ss_pred             CCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccC
Q 003301          401 NKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIP  480 (832)
Q Consensus       401 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  480 (832)
                      |++.+.+|..+ ..++|+.|++++|++++..|..|.++++|+.|++++|++.+.+|..++.+++|++|+|++|.+++.+|
T Consensus       462 n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  540 (968)
T PLN00113        462 NKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIP  540 (968)
T ss_pred             ceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCC
Confidence            99999888876 45899999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCccc
Q 003301          481 TAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLE  548 (832)
Q Consensus       481 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~  548 (832)
                      ..|.++++|+.|+|++|+++|.+|..+..+++|+.|++++|+++|.+|.. ..+..+....+.+|+.-
T Consensus       541 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~l  607 (968)
T PLN00113        541 ASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST-GAFLAINASAVAGNIDL  607 (968)
T ss_pred             hhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCc-chhcccChhhhcCCccc
Confidence            99999999999999999999999999999999999999999999999964 33444555667788743

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=7e-51  Score=405.03  Aligned_cols=473  Identities=30%  Similarity=0.417  Sum_probs=276.5

Q ss_pred             ccCCCCcceeccCccccCccccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCcccccccccccccc
Q 003301            2 LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNS   81 (832)
Q Consensus         2 ldl~~n~~~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~   81 (832)
                      |++++|+++ .+.+.+.++..|.+|++++|+++ +.|++++++..++.+++++|.++ .+|+.++.+.++ +.||+++|.
T Consensus        50 lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l-~~l~~s~n~  125 (565)
T KOG0472|consen   50 LILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISL-VKLDCSSNE  125 (565)
T ss_pred             hhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhh-hhhhccccc
Confidence            567777777 77777777777777777777777 77777777777777777777777 777777777777 777777777


Q ss_pred             cccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCc
Q 003301           82 LTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPY  161 (832)
Q Consensus        82 l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~  161 (832)
                      +. ++|++++ ++..++.|+..+|+++ ..|+++..+.+|..+++.+|+++...|+ .-+++.|++||...|.++ .+|.
T Consensus       126 ~~-el~~~i~-~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~-~i~m~~L~~ld~~~N~L~-tlP~  200 (565)
T KOG0472|consen  126 LK-ELPDSIG-RLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPEN-HIAMKRLKHLDCNSNLLE-TLPP  200 (565)
T ss_pred             ee-ecCchHH-HHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHH-HHHHHHHHhcccchhhhh-cCCh
Confidence            77 7777776 6677777777777777 6677777777777777777777743333 333777777777777776 6777


Q ss_pred             cccCccccceecccccccccccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCC
Q 003301          162 EMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNAS  241 (832)
Q Consensus       162 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~  241 (832)
                      .++.+.+|+.|+|.+|++.. .| .|.+++.|++|+++.|.+. .+|... ..                        +++
T Consensus       201 ~lg~l~~L~~LyL~~Nki~~-lP-ef~gcs~L~Elh~g~N~i~-~lpae~-~~------------------------~L~  252 (565)
T KOG0472|consen  201 ELGGLESLELLYLRRNKIRF-LP-EFPGCSLLKELHVGENQIE-MLPAEH-LK------------------------HLN  252 (565)
T ss_pred             hhcchhhhHHHHhhhccccc-CC-CCCccHHHHHHHhcccHHH-hhHHHH-hc------------------------ccc
Confidence            77777777777777777763 44 5777777777777777665 455443 23                        444


Q ss_pred             CccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccc-cc
Q 003301          242 KLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLS-LS  320 (832)
Q Consensus       242 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~-~~  320 (832)
                      ++.+|||.+|+++ ..|+.++-+++|++||+++|.|++++.      +++++ .|+.|.+.+|++...--+.+..-+ .-
T Consensus       253 ~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~------sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~v  324 (565)
T KOG0472|consen  253 SLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPY------SLGNL-HLKFLALEGNPLRTIRREIISKGTQEV  324 (565)
T ss_pred             cceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCc------ccccc-eeeehhhcCCchHHHHHHHHcccHHHH
Confidence            5555555555554 344445555555555555555554322      23444 555555555554311000000000 00


Q ss_pred             cceEE--eecCccc---------c----cccccccCcCcccEEEeecCcccccccccccCCC--CCceEEccCCccCCCC
Q 003301          321 LSRIF--ISNCSIR---------G----TIPKEIGNLINLRELGLWGNELIGSIPITFGKLQ--NLQGLDLVNNKLEGPI  383 (832)
Q Consensus       321 L~~L~--l~~n~l~---------~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~  383 (832)
                      |++|.  +..-.++         .    ........+.+.+.|++++-+++..+.+.|..-.  -....+++.|++. .+
T Consensus       325 LKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-el  403 (565)
T KOG0472|consen  325 LKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-EL  403 (565)
T ss_pred             HHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hh
Confidence            11110  0000000         0    0011123344556666666666633333332211  1456666666665 55


Q ss_pred             chhhcCCCCCcE-EEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccc
Q 003301          384 PNGLCQLARLSV-LYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNL  462 (832)
Q Consensus       384 ~~~~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  462 (832)
                      |..+..+..+.+ +.+++|.++ .+|..++.+++|..|+|++|.+.. +|..++.+..|+.||+|.|++. ..|..+..+
T Consensus       404 Pk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln~-LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~l  480 (565)
T KOG0472|consen  404 PKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLND-LPEEMGSLVRLQTLNLSFNRFR-MLPECLYEL  480 (565)
T ss_pred             hhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhhh-cchhhhhhhhhheecccccccc-cchHHHhhH
Confidence            655555544332 334444443 555566666666666666665544 4455555555666666666655 455555555


Q ss_pred             cccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCccc
Q 003301          463 KVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLS  524 (832)
Q Consensus       463 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  524 (832)
                      ..++.+-.++|++....|..+.+|.+|..|||.+|.++ .+|..++++++|++|+|++|++.
T Consensus       481 q~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  481 QTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             HHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            55555555556665444444666666666666666665 55666666666666666666665

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=7.1e-48  Score=383.60  Aligned_cols=475  Identities=29%  Similarity=0.398  Sum_probs=320.1

Q ss_pred             CcEEEccCCcCCCCCCCcccCcccccccccccccccccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEEC
Q 003301           47 LELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISL  126 (832)
Q Consensus        47 L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L  126 (832)
                      |..+.+++|.+. .+-+.+.++..+ ++|++++|++. ++|+++. .+..++.|+.++|+++ .+|+.++.+.+|..+++
T Consensus        47 l~~lils~N~l~-~l~~dl~nL~~l-~vl~~~~n~l~-~lp~aig-~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~  121 (565)
T KOG0472|consen   47 LQKLILSHNDLE-VLREDLKNLACL-TVLNVHDNKLS-QLPAAIG-ELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDC  121 (565)
T ss_pred             hhhhhhccCchh-hccHhhhcccce-eEEEeccchhh-hCCHHHH-HHHHHHHhhcccchHh-hccHHHhhhhhhhhhhc
Confidence            444444444444 333334444444 44444444444 4444443 3444444444444444 44444444444444444


Q ss_pred             cCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccccccccccCcccccCCcccEEEecCCCCCCC
Q 003301          127 AYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGS  206 (832)
Q Consensus       127 s~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  206 (832)
                      ++|.+. .+|+.++.+..|..|+..+|+|+ ..|.++.++.+|..|++.+|++....|..+. ++.|++||..+|.+. .
T Consensus       122 s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-t  197 (565)
T KOG0472|consen  122 SSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-T  197 (565)
T ss_pred             ccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-c
Confidence            444444 24444444444445555555544 3444444444455555555554433333222 445555555555444 3


Q ss_pred             CCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCcccc
Q 003301          207 LPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSF  286 (832)
Q Consensus       207 ~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  286 (832)
                      +|..+  +.+.+|+-|+|.+|+|.. .| .|.+++.|++|+++.|+|+..+.+...+++++..|||..|++.++|.+   
T Consensus       198 lP~~l--g~l~~L~~LyL~~Nki~~-lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~Pde---  270 (565)
T KOG0472|consen  198 LPPEL--GGLESLELLYLRRNKIRF-LP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEVPDE---  270 (565)
T ss_pred             CChhh--cchhhhHHHHhhhccccc-CC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccccCchH---
Confidence            44332  445555555555555553 33 568899999999999999965555566999999999999999987766   


Q ss_pred             ccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccC-----cCcccE----EEeecCccc-
Q 003301          287 LSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGN-----LINLRE----LGLWGNELI-  356 (832)
Q Consensus       287 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~-----l~~L~~----L~L~~N~l~-  356 (832)
                         +.-+.+|..||+|+|.|+ .+|.+++++  .|+.|-+.+|.+..+-.+.+..     ++.|+.    =.++.-.=. 
T Consensus       271 ---~clLrsL~rLDlSNN~is-~Lp~sLgnl--hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~  344 (565)
T KOG0472|consen  271 ---ICLLRSLERLDLSNNDIS-SLPYSLGNL--HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGT  344 (565)
T ss_pred             ---HHHhhhhhhhcccCCccc-cCCcccccc--eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccc
Confidence               467889999999999998 678888887  7999999999987432222221     122222    011111100 


Q ss_pred             ---cc-cccc---ccCCCCCceEEccCCccCCCCchhhcCCCC---CcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCc
Q 003301          357 ---GS-IPIT---FGKLQNLQGLDLVNNKLEGPIPNGLCQLAR---LSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNE  426 (832)
Q Consensus       357 ---~~-~~~~---~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~---L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  426 (832)
                         .. .+..   ...+.+.+.|++++-+++ .+|.....-.+   ....+++.|++. .+|..+..+..+...-+.+|+
T Consensus       345 e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn  422 (565)
T KOG0472|consen  345 ETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNN  422 (565)
T ss_pred             cccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcC
Confidence               01 1111   223567899999999999 56765544444   788999999998 788888887776665555555


Q ss_pred             CCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCcc
Q 003301          427 LNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKS  506 (832)
Q Consensus       427 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  506 (832)
                      ..+.+|..++.+++|..|+|++|.+. .+|..++.+..|+.||+|.|++. .+|..+..+..++.+-.++|++....|..
T Consensus       423 ~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~  500 (565)
T KOG0472|consen  423 KISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSG  500 (565)
T ss_pred             ccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHH
Confidence            55778999999999999999999998 58999999999999999999998 88999998889999999999999666666


Q ss_pred             ccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCccc
Q 003301          507 IGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLE  548 (832)
Q Consensus       507 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~  548 (832)
                      ++++.+|.+|||.+|.+. .+|+.+++|++|++|++++|+|.
T Consensus       501 l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  501 LKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             hhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            999999999999999998 78999999999999999999999

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-44  Score=372.41  Aligned_cols=366  Identities=23%  Similarity=0.267  Sum_probs=183.1

Q ss_pred             EEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccccccccccCcccccCCcccEEEecCCC
Q 003301          123 VISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNA  202 (832)
Q Consensus       123 ~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~  202 (832)
                      .||+|+|++..+.+..|.++++|+.+++.+|.++ .+|.......+|+.|+|.+|.|..+-.+.+.-++.|++||||.|.
T Consensus        82 ~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~  160 (873)
T KOG4194|consen   82 TLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNL  160 (873)
T ss_pred             eeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhch
Confidence            3444444444444444444444444444444444 344333333334444444444444444444444444444444444


Q ss_pred             CCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCC
Q 003301          203 LSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTS  282 (832)
Q Consensus       203 l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  282 (832)
                      ++ .+|..- |..-.++++|+|++|+|+.+..+.|.++.+|.+|.|+.|+|+..++..|.++++|+.|+|..|+|..+.-
T Consensus       161 is-~i~~~s-fp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~  238 (873)
T KOG4194|consen  161 IS-EIPKPS-FPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEG  238 (873)
T ss_pred             hh-cccCCC-CCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehh
Confidence            44 222221 2333456666666666666666666666677777777777776666666667777777777776654221


Q ss_pred             ccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCccccccccc
Q 003301          283 ELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPIT  362 (832)
Q Consensus       283 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  362 (832)
                           ..|.++++|+.|.|..|.|+......|..+. .+++|+|..|+++..-.+++.+++.|+.|+||+|.|..+.++.
T Consensus       239 -----ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~-kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~  312 (873)
T KOG4194|consen  239 -----LTFQGLPSLQNLKLQRNDISKLDDGAFYGLE-KMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDS  312 (873)
T ss_pred             -----hhhcCchhhhhhhhhhcCcccccCcceeeec-ccceeecccchhhhhhcccccccchhhhhccchhhhheeecch
Confidence                 1356666666666666666543333333333 3333333334333333444444555555555555555555555


Q ss_pred             ccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccc
Q 003301          363 FGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDIL  442 (832)
Q Consensus       363 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  442 (832)
                      +.-.++|++|+||+|+|+...+..|..+..|++|+|++|++...-...|..+++|+.|||++|.|+..+.++        
T Consensus       313 WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDa--------  384 (873)
T KOG4194|consen  313 WSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDA--------  384 (873)
T ss_pred             hhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecc--------
Confidence            555555555555555555444444555555555555555554333344445555555555555544332221        


Q ss_pred             eeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccC
Q 003301          443 SLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLS  519 (832)
Q Consensus       443 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  519 (832)
                                   ...|.+|++|+.|+|.+|+|..+...+|.+++.|+.|||.+|.|..+-|++|..+ .|+.|-++
T Consensus       385 -------------a~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~n  447 (873)
T KOG4194|consen  385 -------------AVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMN  447 (873)
T ss_pred             -------------hhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhc
Confidence                         1123444455555555555544444455555555555555555554455555554 45544443

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-44  Score=371.62  Aligned_cols=388  Identities=25%  Similarity=0.276  Sum_probs=269.6

Q ss_pred             cEEEccCCcCCCCCCC-c-ccCcccccccccccccccccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEE
Q 003301           48 ELVSLTNNFLSGTIPS-T-IFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVIS  125 (832)
Q Consensus        48 ~~L~l~~n~l~~~~p~-~-l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~  125 (832)
                      ..||++++.+. .+.. . -+-+++-.+.||+|+|.+. .+....|.++++|+.+++.+|.++ .+|.......+|+.|+
T Consensus        55 ~lldcs~~~le-a~~~~~l~g~lp~~t~~LdlsnNkl~-~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~  131 (873)
T KOG4194|consen   55 RLLDCSDRELE-AIDKSRLKGFLPSQTQTLDLSNNKLS-HIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLD  131 (873)
T ss_pred             eeeecCccccc-cccccccCCcCccceeeeeccccccc-cCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEe
Confidence            45677777766 3311 0 1223333356777777777 666666667777777777777777 6776555566677777


Q ss_pred             CcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccccccccccCcccccCCcccEEEecCCCCCC
Q 003301          126 LAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSG  205 (832)
Q Consensus       126 Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~  205 (832)
                      |.+|.|+.+-.+.+..++.|+.||||.|.|+.+.-..|..-.++++|+|++|+|+.+..+.|.++.+|.+|.|++|+++ 
T Consensus       132 L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit-  210 (873)
T KOG4194|consen  132 LRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT-  210 (873)
T ss_pred             eeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccc-
Confidence            7777777666667777777777777777777444456666677777777777777777777777777777777777777 


Q ss_pred             CCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccc
Q 003301          206 SLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELS  285 (832)
Q Consensus       206 ~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  285 (832)
                      .+|... |.++++|+.|+|..|+|..+..-.|.++++|+.|.|..|.|...-.++|..+.++++|+|+.|+++.+..++ 
T Consensus       211 tLp~r~-Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~-  288 (873)
T KOG4194|consen  211 TLPQRS-FKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGW-  288 (873)
T ss_pred             ccCHHH-hhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhccc-
Confidence            444332 566777777777777777665667777777777777777777777777777777777777777777765553 


Q ss_pred             cccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccC
Q 003301          286 FLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGK  365 (832)
Q Consensus       286 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  365 (832)
                          +.++++|+.|+||+|.|..+-++++.... +|++|+|++|+|+...++.|..+..|++|+|++|.+......+|..
T Consensus       289 ----lfgLt~L~~L~lS~NaI~rih~d~Wsftq-kL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~  363 (873)
T KOG4194|consen  289 ----LFGLTSLEQLDLSYNAIQRIHIDSWSFTQ-KLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVG  363 (873)
T ss_pred             ----ccccchhhhhccchhhhheeecchhhhcc-cceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHH
Confidence                56777777777777777766555554443 6777777777777777777777777777777777777666667777


Q ss_pred             CCCCceEEccCCccCCCCc---hhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccc
Q 003301          366 LQNLQGLDLVNNKLEGPIP---NGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDIL  442 (832)
Q Consensus       366 l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  442 (832)
                      +++|++|||++|.|+..+.   ..|..+++|+.|+|.+|+|..+.-.+|.++..|++|||.+|.|.++-|++|..+ +|+
T Consensus       364 lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk  442 (873)
T KOG4194|consen  364 LSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELK  442 (873)
T ss_pred             hhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhh
Confidence            7777777777777765443   346667777777777777775555567777777777777777777777777766 666


Q ss_pred             eeeec
Q 003301          443 SLNFS  447 (832)
Q Consensus       443 ~L~Ls  447 (832)
                      +|.++
T Consensus       443 ~Lv~n  447 (873)
T KOG4194|consen  443 ELVMN  447 (873)
T ss_pred             hhhhc
Confidence            66554

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-42  Score=376.34  Aligned_cols=506  Identities=28%  Similarity=0.359  Sum_probs=423.7

Q ss_pred             ccCCCCcceeccCccccCccccCeEeccCCccccCCCc-cccccccCcEEEccCCcCCCCCCCcccCccccccccccccc
Q 003301            2 LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQ-ELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNN   80 (832)
Q Consensus         2 ldl~~n~~~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~-~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n   80 (832)
                      +|.|.-+++ .||.-+..-..++.|+++.|-+. ..|- .+.+..+|+.||+++|++. ..|..+..+..| +.|+++.|
T Consensus         3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L-~~ln~s~n   78 (1081)
T KOG0618|consen    3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHL-RQLNLSRN   78 (1081)
T ss_pred             cccccccCc-ccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHH-hhcccchh
Confidence            688899998 99999999888999999999987 4443 4555556999999999999 999999999999 99999999


Q ss_pred             ccccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccC
Q 003301           81 SLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIP  160 (832)
Q Consensus        81 ~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p  160 (832)
                      .|. ++|.+.. ++.+|++|.|.+|++. ..|.++..+++|++||+|+|++. .+|..+..++.++.++.++|.-.... 
T Consensus        79 ~i~-~vp~s~~-~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~l-  153 (1081)
T KOG0618|consen   79 YIR-SVPSSCS-NMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRL-  153 (1081)
T ss_pred             hHh-hCchhhh-hhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhh-
Confidence            999 8997766 8999999999999999 89999999999999999999997 78999999999999999999322122 


Q ss_pred             ccccCccccceecccccccccccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCC
Q 003301          161 YEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNA  240 (832)
Q Consensus       161 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l  240 (832)
                         +... .+.+++..|.+.+.++..+..+..  .|+|++|.+.     ..++..+++|+.|....|++....    -.-
T Consensus       154 ---g~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-----~~dls~~~~l~~l~c~rn~ls~l~----~~g  218 (1081)
T KOG0618|consen  154 ---GQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-----VLDLSNLANLEVLHCERNQLSELE----ISG  218 (1081)
T ss_pred             ---cccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh-----hhhhhhccchhhhhhhhcccceEE----ecC
Confidence               2222 888999999999888888887777  7999999986     235677899999999999998543    235


Q ss_pred             CCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccc
Q 003301          241 SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLS  320 (832)
Q Consensus       241 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~  320 (832)
                      ++|+.|+.++|.+....+.  ..-.+|++++++.|+++.+|      ++...+.+|+.++..+|+++ .+|..+.... +
T Consensus       219 ~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~~lp------~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~-~  288 (1081)
T KOG0618|consen  219 PSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLSNLP------EWIGACANLEALNANHNRLV-ALPLRISRIT-S  288 (1081)
T ss_pred             cchheeeeccCcceeeccc--cccccceeeecchhhhhcch------HHHHhcccceEecccchhHH-hhHHHHhhhh-h
Confidence            7899999999999843222  23468999999999999865      34789999999999999996 6777777776 8


Q ss_pred             cceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCC-CceEEccCCccCCCCchhhcCCCCCcEEEec
Q 003301          321 LSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQN-LQGLDLVNNKLEGPIPNGLCQLARLSVLYMD  399 (832)
Q Consensus       321 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  399 (832)
                      |+.|.+..|.+. .+|.....++.|+.|+|..|+|...++..|..+.. |..|+.+.|++.......=..++.|+.|++.
T Consensus       289 L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~Lyla  367 (1081)
T KOG0618|consen  289 LVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLA  367 (1081)
T ss_pred             HHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHh
Confidence            999999999998 67788888999999999999998655555555554 8889999999884332222235679999999


Q ss_pred             CCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCcc
Q 003301          400 GNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDI  479 (832)
Q Consensus       400 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  479 (832)
                      +|.++...-+.+.+..+|+.|+|++|++.......+.++..|+.|+||+|+++ .+|..+..+..|++|...+|++. ..
T Consensus       368 nN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~f  445 (1081)
T KOG0618|consen  368 NNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SF  445 (1081)
T ss_pred             cCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ec
Confidence            99999887778899999999999999999888888999999999999999999 58899999999999999999998 67


Q ss_pred             CCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCC
Q 003301          480 PTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFN  545 (832)
Q Consensus       480 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N  545 (832)
                      | .+..++.|+.+|+|.|+|+...-..-..-++|++|||++|.=....-..+..+..+...+++-|
T Consensus       446 P-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~  510 (1081)
T KOG0618|consen  446 P-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN  510 (1081)
T ss_pred             h-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence            7 8999999999999999998543222223389999999999854455566777777777777766

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-41  Score=368.09  Aligned_cols=459  Identities=28%  Similarity=0.352  Sum_probs=208.2

Q ss_pred             EeccCCccccCCCccccccccCcEEEccCCcCCCCCC-CcccCcccccccccccccccccCCChhhhhcCCCceEEEccC
Q 003301           26 LGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIP-STIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSN  104 (832)
Q Consensus        26 L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~~  104 (832)
                      +|+|..++. .+|..+..-..+..|++++|.+. ..| +.+...-.| +.||+|+|++. ..|..+. .+.+|+.|.++.
T Consensus         3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L-~~l~lsnn~~~-~fp~~it-~l~~L~~ln~s~   77 (1081)
T KOG0618|consen    3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKL-KSLDLSNNQIS-SFPIQIT-LLSHLRQLNLSR   77 (1081)
T ss_pred             cccccccCc-ccchhhccHHHHHhhhccccccc-cCchHHhhheeee-EEeeccccccc-cCCchhh-hHHHHhhcccch
Confidence            445555554 45554444444555555555554 222 111222223 44455555444 4444444 444455555555


Q ss_pred             CcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccccccccccC
Q 003301          105 NKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVP  184 (832)
Q Consensus       105 N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  184 (832)
                      |.|. ..|.+..++.+|+++.|.+|++. ..|..+..+++|++|++|.|++. .+|..+..++.++.+..++|.....  
T Consensus        78 n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~--  152 (1081)
T KOG0618|consen   78 NYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR--  152 (1081)
T ss_pred             hhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh--
Confidence            5554 34444444445555555555444 34444555555555555555554 4444444444455555554411111  


Q ss_pred             cccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCc
Q 003301          185 TSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNL  264 (832)
Q Consensus       185 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l  264 (832)
                        ++... .+.++|..|.+                          .+-++..+..++.  .|+|++|.+..   -.+..+
T Consensus       153 --lg~~~-ik~~~l~~n~l--------------------------~~~~~~~i~~l~~--~ldLr~N~~~~---~dls~~  198 (1081)
T KOG0618|consen  153 --LGQTS-IKKLDLRLNVL--------------------------GGSFLIDIYNLTH--QLDLRYNEMEV---LDLSNL  198 (1081)
T ss_pred             --hcccc-chhhhhhhhhc--------------------------ccchhcchhhhhe--eeecccchhhh---hhhhhc
Confidence              11111 44444444444                          4444433333333  35555555441   123344


Q ss_pred             cccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCc
Q 003301          265 RKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLIN  344 (832)
Q Consensus       265 ~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~  344 (832)
                      .+|+.|....|++..+.         ..-++|+.|+.++|.++...+..   .+.+|++++++.|++++ +|+++..+.+
T Consensus       199 ~~l~~l~c~rn~ls~l~---------~~g~~l~~L~a~~n~l~~~~~~p---~p~nl~~~dis~n~l~~-lp~wi~~~~n  265 (1081)
T KOG0618|consen  199 ANLEVLHCERNQLSELE---------ISGPSLTALYADHNPLTTLDVHP---VPLNLQYLDISHNNLSN-LPEWIGACAN  265 (1081)
T ss_pred             cchhhhhhhhcccceEE---------ecCcchheeeeccCcceeecccc---ccccceeeecchhhhhc-chHHHHhccc
Confidence            44555555555544321         12244555555555544221111   11245555555555542 3355555555


Q ss_pred             ccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCC-----------
Q 003301          345 LRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGD-----------  413 (832)
Q Consensus       345 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----------  413 (832)
                      |+.++..+|+++ .+|..+...++|+.|+...|.+. .+|.....++.|++|+|..|+|...++..|..           
T Consensus       266 le~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s  343 (1081)
T KOG0618|consen  266 LEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVS  343 (1081)
T ss_pred             ceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhh
Confidence            555555555553 34444444445555555555554 34444444455555555555554222212222           


Q ss_pred             --------------CCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCcc
Q 003301          414 --------------LTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDI  479 (832)
Q Consensus       414 --------------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  479 (832)
                                    +..|+.|++.+|.++...-..+.+..+|+.|+|++|++.......+.++..|+.|+||+|+++ .+
T Consensus       344 ~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~L  422 (1081)
T KOG0618|consen  344 SNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TL  422 (1081)
T ss_pred             hccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hh
Confidence                          234455555555554444444444555555555555555433344455555555555555554 44


Q ss_pred             CCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCc
Q 003301          480 PTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNK  546 (832)
Q Consensus       480 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~  546 (832)
                      |..+..+..|++|...+|++. ..| .+..++.|+.+|+|.|+|+...-..-..-++|++|||++|.
T Consensus       423 p~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  423 PDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT  487 (1081)
T ss_pred             hHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence            455555555555555555554 344 44555555555555555543221111111445555555554

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3e-37  Score=310.88  Aligned_cols=170  Identities=32%  Similarity=0.549  Sum_probs=153.0

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEecc--chhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQ--LEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      ...+|+..+.||+|+||+||+|+++. +..||||.+...  ..+..+.+..|+++++.++|||||++++++..++.+|+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            45789999999999999999999874 899999999766  455667889999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC------CcEEEecccccc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD------MVAHLSDFGIAK  807 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~------~~~kl~DFg~a~  807 (832)
                      ||||.||+|.+|+++.+ .+++..++.++.|+|.|+++||   +++||||||||+|||++..      -.+||+|||+|+
T Consensus        88 MEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999999875 7999999999999999999999   9999999999999999764      468999999999


Q ss_pred             ccCCCcccccccccccccccCCCCC
Q 003301          808 LLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       808 ~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .+....  .....||+|.|||||++
T Consensus       164 ~L~~~~--~a~tlcGSplYMAPEV~  186 (429)
T KOG0595|consen  164 FLQPGS--MAETLCGSPLYMAPEVI  186 (429)
T ss_pred             hCCchh--HHHHhhCCccccCHHHH
Confidence            986443  23346899999999984

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=1.9e-39  Score=338.85  Aligned_cols=360  Identities=31%  Similarity=0.469  Sum_probs=259.0

Q ss_pred             ccCCCCccee-ccCccccCccccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCccccccccccccc
Q 003301            2 LSLSFNDLSG-AIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNN   80 (832)
Q Consensus         2 ldl~~n~~~~-~~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n   80 (832)
                      .|+|+|.++| .+|.++..|++++-|.|...++. .+|+.++.+.+|++|.+++|++. ++-..+..+++| +.+++.+|
T Consensus        12 vDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~L-Rsv~~R~N   88 (1255)
T KOG0444|consen   12 VDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRL-RSVIVRDN   88 (1255)
T ss_pred             ccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhh-HHHhhhcc
Confidence            4899999995 58999999999999999999998 99999999999999999999998 777778888888 99999999


Q ss_pred             cccc-CCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEeccccccccc
Q 003301           81 SLTG-SLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEI  159 (832)
Q Consensus        81 ~l~~-~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~  159 (832)
                      ++.. .||.++| ++..|+.||||+|+++ ..|..+...+++.+|+||+|+|..+.-.-|.+++-|-+||||+|++. .+
T Consensus        89 ~LKnsGiP~diF-~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~L  165 (1255)
T KOG0444|consen   89 NLKNSGIPTDIF-RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-ML  165 (1255)
T ss_pred             ccccCCCCchhc-ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hc
Confidence            9873 5899999 8999999999999999 78999999999999999999998544456788899999999999998 78


Q ss_pred             CccccCccccceecccccccccccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccC
Q 003301          160 PYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFN  239 (832)
Q Consensus       160 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~  239 (832)
                      |+.+..|..|++|.|++|.+....-..+-.+.+|.+|.+++.+-+-                         .-+|..+..
T Consensus       166 PPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl-------------------------~N~Ptsld~  220 (1255)
T KOG0444|consen  166 PPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTL-------------------------DNIPTSLDD  220 (1255)
T ss_pred             CHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchh-------------------------hcCCCchhh
Confidence            8888899999999999998875433444455566666666554320                         123445566


Q ss_pred             CCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCccccccc
Q 003301          240 ASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSL  319 (832)
Q Consensus       240 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~  319 (832)
                      +.+|..+|+|.|.+. ..|+++..+++|+.|+||+|+|+.+...      .....+|++|+||.|+++ .+|+.++.++ 
T Consensus       221 l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~------~~~W~~lEtLNlSrNQLt-~LP~avcKL~-  291 (1255)
T KOG0444|consen  221 LHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMT------EGEWENLETLNLSRNQLT-VLPDAVCKLT-  291 (1255)
T ss_pred             hhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeecc------HHHHhhhhhhccccchhc-cchHHHhhhH-
Confidence            777777777777777 6777777788888888888887765433      233456777777777776 4555555444 


Q ss_pred             ccceEEeecCccc-ccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEe
Q 003301          320 SLSRIFISNCSIR-GTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYM  398 (832)
Q Consensus       320 ~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  398 (832)
                      .|+.|++.+|+++ .-+|+                        .++++.+|+++..++|.+. .+|+.+|.+..|+.|.|
T Consensus       292 kL~kLy~n~NkL~FeGiPS------------------------GIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L  346 (1255)
T KOG0444|consen  292 KLTKLYANNNKLTFEGIPS------------------------GIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKL  346 (1255)
T ss_pred             HHHHHHhccCcccccCCcc------------------------chhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcc
Confidence            4444444444444 22344                        4444555555555555554 45555555555555555


Q ss_pred             cCCcCCCCCcccCCCCCCCCeEeCCCCcC
Q 003301          399 DGNKLSGPIPPCIGDLTSLRLLSLASNEL  427 (832)
Q Consensus       399 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  427 (832)
                      ++|++. .+|..+.-++.|+.||+..|.-
T Consensus       347 ~~NrLi-TLPeaIHlL~~l~vLDlreNpn  374 (1255)
T KOG0444|consen  347 DHNRLI-TLPEAIHLLPDLKVLDLRENPN  374 (1255)
T ss_pred             ccccee-echhhhhhcCCcceeeccCCcC
Confidence            555554 4455555555555555555543

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=4.5e-38  Score=328.69  Aligned_cols=370  Identities=28%  Similarity=0.425  Sum_probs=259.5

Q ss_pred             CCccEEECcCCccc-ccCCCCCcCCCcCceEEecccccccccCccccCccccceecccccccccccCcccccCCcccEEE
Q 003301          119 KELIVISLAYNQFT-ERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLA  197 (832)
Q Consensus       119 ~~L~~L~Ls~n~i~-~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  197 (832)
                      +-.+-.|+++|.++ +..|.....+++++.|-|.+.++. .+|..++.+.+|++|.+++|++.. +.+.++.++.|+.+.
T Consensus         7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~-vhGELs~Lp~LRsv~   84 (1255)
T KOG0444|consen    7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLIS-VHGELSDLPRLRSVI   84 (1255)
T ss_pred             ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHh-hhhhhccchhhHHHh
Confidence            34455666666666 456777777888888888888887 788888888888888888888874 456677778888888


Q ss_pred             ecCCCCCC-CCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeeccccc
Q 003301          198 LPSNALSG-SLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNF  276 (832)
Q Consensus       198 L~~n~l~~-~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~  276 (832)
                      +..|++.. -+|.                          .++.+..|++||||+|+++ ..|..+.+-+++-.|+||+|+
T Consensus        85 ~R~N~LKnsGiP~--------------------------diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~  137 (1255)
T KOG0444|consen   85 VRDNNLKNSGIPT--------------------------DIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNN  137 (1255)
T ss_pred             hhccccccCCCCc--------------------------hhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCc
Confidence            88877752 2233                          2233444444444444444 234444444455555555555


Q ss_pred             CCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCccc
Q 003301          277 LTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELI  356 (832)
Q Consensus       277 l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  356 (832)
                      |.++|..+     |.+++.|-.||||+|++.                          .+|..+..+..|+.|+|++|.+.
T Consensus       138 IetIPn~l-----finLtDLLfLDLS~NrLe--------------------------~LPPQ~RRL~~LqtL~Ls~NPL~  186 (1255)
T KOG0444|consen  138 IETIPNSL-----FINLTDLLFLDLSNNRLE--------------------------MLPPQIRRLSMLQTLKLSNNPLN  186 (1255)
T ss_pred             cccCCchH-----HHhhHhHhhhccccchhh--------------------------hcCHHHHHHhhhhhhhcCCChhh
Confidence            55444432     344444445555554443                          23334444445555555555554


Q ss_pred             ccccccccCCCCCceEEccCCccC-CCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCccc
Q 003301          357 GSIPITFGKLQNLQGLDLVNNKLE-GPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTF  435 (832)
Q Consensus       357 ~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~  435 (832)
                      ...-..+..+++|++|.+|+.+-+ .-+|.++..+.+|..+|+|.|.+. ..|.++..+++|+.|+||+|+|+. .....
T Consensus       187 hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite-L~~~~  264 (1255)
T KOG0444|consen  187 HFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE-LNMTE  264 (1255)
T ss_pred             HHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceee-eeccH
Confidence            433344445566677777765432 346777777888888888888887 778888888888888888888876 34445


Q ss_pred             ccCcccceeeecCCcccCCCccccccccccceecccCcccCC-ccCCccccccccceeecccccccccCCccccCCCCCC
Q 003301          436 WNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSG-DIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLE  514 (832)
Q Consensus       436 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  514 (832)
                      ..+.+|+.|+||+|+++ .+|.++..|+.|+.|.+.+|+++- -+|..++.|.+|+.+..++|.+. ..|..++.+..|+
T Consensus       265 ~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~  342 (1255)
T KOG0444|consen  265 GEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQ  342 (1255)
T ss_pred             HHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHH
Confidence            66778888999999988 688889999999999999998864 47888999999999999999998 8899999999999


Q ss_pred             eeccCCCcccccCchhhhhhccCCeeeCCCCcccccCCC
Q 003301          515 SLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPR  553 (832)
Q Consensus       515 ~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  553 (832)
                      .|.|++|+|- .+|+.+.-++.|+.|||..|+---.+|.
T Consensus       343 kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPK  380 (1255)
T KOG0444|consen  343 KLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPK  380 (1255)
T ss_pred             Hhccccccee-echhhhhhcCCcceeeccCCcCccCCCC
Confidence            9999999987 6899999999999999999986656665

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-34  Score=306.16  Aligned_cols=187  Identities=47%  Similarity=0.726  Sum_probs=164.7

Q ss_pred             cccccchHHHHHHhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEE
Q 003301          645 TRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC  724 (832)
Q Consensus       645 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  724 (832)
                      ..+.|+++++..++++|.....||+|+||.||+|...+|..||||++........++|.+|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45679999999999999999999999999999999988999999987655432145699999999999999999999999


Q ss_pred             ecCC-eeEEEEecCCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEec
Q 003301          725 TNND-FKALVLEYMPNGSLEDYLYSNNF-SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSD  802 (832)
Q Consensus       725 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D  802 (832)
                      .+.+ ..++|+|||++|+|.+++..... .++|..+++||.++|+||+|||+.+...||||||||+|||+|+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9988 59999999999999999988765 789999999999999999999988888899999999999999999999999


Q ss_pred             cccccccCCCcccccccc-cccccccCCCCC
Q 003301          803 FGIAKLLSGEESMKQTLT-LATIGYMAPGLF  832 (832)
Q Consensus       803 Fg~a~~~~~~~~~~~~~~-~gt~~y~APE~l  832 (832)
                      ||+|+....... ..... .||.+|+|||++
T Consensus       221 FGLa~~~~~~~~-~~~~~~~gt~gY~~PEy~  250 (361)
T KOG1187|consen  221 FGLAKLGPEGDT-SVSTTVMGTFGYLAPEYA  250 (361)
T ss_pred             ccCcccCCcccc-ceeeecCCCCccCChhhh
Confidence            999976543111 11112 699999999974

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-34  Score=288.12  Aligned_cols=170  Identities=30%  Similarity=0.437  Sum_probs=148.2

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch-------hhHHHHHHHHHHHhcCCCCceeeeceEEecCC
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE-------GALKSFDVECEVLKSVRHRNLVKIISSCTNND  728 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  728 (832)
                      ..+.|.+.+.+|+|+||.|-+|..+ +|+.||||++..+..       .......+|+++|++++||+||+++++|...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4578899999999999999999765 599999999976531       12234679999999999999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC---CcEEEecccc
Q 003301          729 FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD---MVAHLSDFGI  805 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~---~~~kl~DFg~  805 (832)
                      ..|+||||++||+|.+.+-..+ .+.+...+-+++|++.|+.|||   +.||+||||||+|||+..+   ..+||+|||+
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence            9999999999999999987765 6788888999999999999999   9999999999999999755   7899999999


Q ss_pred             ccccCCCcccccccccccccccCCCCC
Q 003301          806 AKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       806 a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      |+.....  ......||||.|.|||++
T Consensus       326 AK~~g~~--sfm~TlCGTpsYvAPEVl  350 (475)
T KOG0615|consen  326 AKVSGEG--SFMKTLCGTPSYVAPEVL  350 (475)
T ss_pred             hhccccc--eehhhhcCCccccChhhe
Confidence            9987533  234457899999999985

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4e-34  Score=286.31  Aligned_cols=171  Identities=30%  Similarity=0.458  Sum_probs=153.1

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      ..++|++.++||+|+||+||.++.++ ++.||+|+++++.   ....+...+|..++.+++||+||+++..|++.+..|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            35789999999999999999998875 8899999997654   3356788899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      |+||+.||.|..++++.+ .+++..+..++.+|+.||.|||   ++||||||+||+|||+|.+|.++|+|||+|+.....
T Consensus       103 Vld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            999999999999998765 7999999999999999999999   999999999999999999999999999999865443


Q ss_pred             cccccccccccccccCCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~l  832 (832)
                      +. .....|||+.|||||++
T Consensus       179 ~~-~t~tfcGT~eYmAPEil  197 (357)
T KOG0598|consen  179 GD-ATRTFCGTPEYMAPEIL  197 (357)
T ss_pred             CC-ccccccCCccccChHHH
Confidence            33 23347899999999975

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-33  Score=295.70  Aligned_cols=169  Identities=26%  Similarity=0.407  Sum_probs=154.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEe-cCCcEEEEEEEecc---chhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSF-LDGMEVAIKVFHLQ---LEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      .+|+.++.||+|||+.||++++ ..|+.||+|++.+.   .....+.+.+||++.++++|||||+++++|++.+.+|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            6799999999999999999998 56999999999764   3455678899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |+|+.++|.++++++ ..+++.++..+++||+.|+.|||   +.+|+|||||..|++++++.+|||+|||+|..+..++.
T Consensus        98 ELC~~~sL~el~Krr-k~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR-KPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EecCCccHHHHHHhc-CCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            999999999999854 48999999999999999999999   99999999999999999999999999999999876654


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                      ... ..||||.|+||||+
T Consensus       174 rk~-TlCGTPNYIAPEVl  190 (592)
T KOG0575|consen  174 RKK-TLCGTPNYIAPEVL  190 (592)
T ss_pred             ccc-eecCCCcccChhHh
Confidence            444 36899999999985

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-33  Score=278.24  Aligned_cols=168  Identities=28%  Similarity=0.405  Sum_probs=148.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC-eeEEEEe
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNND-FKALVLE  735 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  735 (832)
                      ++.+....||+|..|+||+|.++. ++.+|+|++.... +...+++.+|+++++.++||+||++||+|..++ .++|+||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            345667899999999999999974 8889999996544 345678999999999999999999999999988 5999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      ||++|+|+++++..+ ++++....+++.+|++||.|||.  +++||||||||+|||++..|+|||||||.++.+...   
T Consensus       159 YMDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  159 YMDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---  232 (364)
T ss_pred             hcCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence            999999999998764 79999999999999999999993  389999999999999999999999999999987544   


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                      .....+||..|||||-+
T Consensus       233 ~a~tfvGT~~YMsPERi  249 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERI  249 (364)
T ss_pred             hcccccccccccChhhh
Confidence            23447899999999964

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-33  Score=287.92  Aligned_cols=171  Identities=33%  Similarity=0.459  Sum_probs=154.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecC--CeeEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNN--DFKAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  732 (832)
                      .+.|+..++||+|+||.||+|++. +|+.||+|+++...  ++......+||.++++++||||+++.+...+.  +.+|+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            456778899999999999999875 58999999998765  44556778999999999999999999998876  68999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      |+|||+ -||.-++......+++.+++.++.|++.||+|+|   .+||+|||||.+|||+|.+|.+||+|||+|+.+...
T Consensus       196 VFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  196 VFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            999995 5999999888888999999999999999999999   999999999999999999999999999999998777


Q ss_pred             cccccccccccccccCCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~l  832 (832)
                      .....+..+-|.+|+|||++
T Consensus       272 ~~~~~T~rVvTLWYRpPELL  291 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELL  291 (560)
T ss_pred             CCcccccceEEeeccChHHh
Confidence            76667778899999999975

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2e-33  Score=271.25  Aligned_cols=169  Identities=30%  Similarity=0.379  Sum_probs=149.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccch--hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      +.|+...++|+|+||+||+|++++ |+.||||++....+  ...+-..+|++++++++|+|+|.++.+|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            468888999999999999999876 99999999875543  344667899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      ||+. ++.+-+++.....+...+.++++|++.|+.|+|   ++++|||||||+|||++.+|.+|+||||+|+.+..+.. 
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd-  156 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD-  156 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc-
Confidence            9965 666667766667999999999999999999999   99999999999999999999999999999999875333 


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                      ..+.++.|.+|+|||++
T Consensus       157 ~YTDYVATRWYRaPELL  173 (396)
T KOG0593|consen  157 NYTDYVATRWYRAPELL  173 (396)
T ss_pred             hhhhhhhhhhccChhhh
Confidence            45567899999999975

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-34  Score=273.38  Aligned_cols=173  Identities=28%  Similarity=0.394  Sum_probs=147.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEecc--chhhHHHHHHHHHHHhcCCCCceeeece-EEecCCe-eEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQ--LEGALKSFDVECEVLKSVRHRNLVKIIS-SCTNNDF-KAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~l  732 (832)
                      ..+|++.++||+|.||+||++... +|..||.|.+...  .+...+....|+.++++++|||||++++ .+.++.. .+|
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            456889999999999999999764 6999999988743  2455678899999999999999999999 4555555 899


Q ss_pred             EEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeEeCCCCcEEEecccccc
Q 003301          733 VLEYMPNGSLEDYLYS---NNFSFDILQRLSVIIDVALALEYLHFGYSNP--VVHCDIKPSNVLLDKDMVAHLSDFGIAK  807 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~~~~~~kl~DFg~a~  807 (832)
                      |||||++|+|.++++.   .+..+++..+++++.|++.||.++|... ..  |+||||||.||+++.+|.||++|||+++
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHh
Confidence            9999999999999864   3446999999999999999999999311 44  8999999999999999999999999999


Q ss_pred             ccCCCcccccccccccccccCCCCC
Q 003301          808 LLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       808 ~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .+....... ...+|||+||+||++
T Consensus       177 ~l~s~~tfA-~S~VGTPyYMSPE~i  200 (375)
T KOG0591|consen  177 FLSSKTTFA-HSLVGTPYYMSPERI  200 (375)
T ss_pred             HhcchhHHH-HhhcCCCcccCHHHH
Confidence            987655433 446899999999974

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.98  E-value=5.6e-32  Score=286.38  Aligned_cols=170  Identities=31%  Similarity=0.536  Sum_probs=146.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchh--hHHHHHHHHHHHhcCCCCceeeeceEEecCC-eeEEEEe
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEG--ALKSFDVECEVLKSVRHRNLVKIISSCTNND-FKALVLE  735 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  735 (832)
                      .+..+.+.+|+|+||+||+|.|.....||||++......  ..+.|.+|+.++.+++|||||+++|++.+.. ..++|||
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE  120 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE  120 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence            344556679999999999999955555999999765422  2568999999999999999999999999887 7899999


Q ss_pred             cCCCCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEecCCCCCCeEeCCCC-cEEEeccccccccCCC
Q 003301          736 YMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNP-VVHCDIKPSNVLLDKDM-VAHLSDFGIAKLLSGE  812 (832)
Q Consensus       736 ~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dlkp~NIl~~~~~-~~kl~DFg~a~~~~~~  812 (832)
                      |+++|+|.+++.. .+..+++..+.+|+.|||+|+.|||   +.+ ||||||||+|||++.++ ++||+|||+++.....
T Consensus       121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            9999999999988 3567999999999999999999999   888 99999999999999998 9999999999876543


Q ss_pred             cccccccccccccccCCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~l  832 (832)
                      . ...+...||+.|||||++
T Consensus       198 ~-~~~~~~~GT~~wMAPEv~  216 (362)
T KOG0192|consen  198 K-TSMTSVAGTYRWMAPEVL  216 (362)
T ss_pred             c-ccccCCCCCccccChhhh
Confidence            2 223335799999999986

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-32  Score=261.82  Aligned_cols=167  Identities=34%  Similarity=0.473  Sum_probs=150.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.+.||.|+||+|..++.+. |..||+|++..+.   ....+....|..+++.+.||+++++++.+.+.+..|+|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            4678999999999999999998864 8889999997664   23446677899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||++||.|..++++.+ ++++..++.++.||+.|++|||   +.+|++||+||+|||+|++|.+||+|||+|+...+. 
T Consensus       123 meyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-  197 (355)
T ss_pred             EeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence            99999999999999876 7999999999999999999999   999999999999999999999999999999987543 


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                         .-..||||.|+|||++
T Consensus       198 ---T~TlCGTPeYLAPEii  213 (355)
T KOG0616|consen  198 ---TWTLCGTPEYLAPEII  213 (355)
T ss_pred             ---EEEecCCccccChHHh
Confidence               2336899999999975

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.9e-33  Score=284.73  Aligned_cols=170  Identities=25%  Similarity=0.385  Sum_probs=151.1

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHH-HHHHHHHHHhcCC-CCceeeeceEEecCC-eeEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALK-SFDVECEVLKSVR-HRNLVKIISSCTNND-FKAL  732 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~-~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~l  732 (832)
                      ..++|.+.++||.|+||.||+|+.. ++..||||+++.+.....+ .-.||+..+++++ |||||++.+++.+.+ ..|+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            3578999999999999999999875 4889999999876544323 3358999999998 999999999999888 9999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||||| ..+|+++++.++..+++..++.|++||++||+|+|   ++|+.|||+||+|||+.....+||+|||+|+.+...
T Consensus        88 VfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   88 VFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             eHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccC
Confidence            99999 57999999998888999999999999999999999   999999999999999998999999999999987554


Q ss_pred             cccccccccccccccCCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~l  832 (832)
                      .  ..+.++.|.+|+|||++
T Consensus       164 p--PYTeYVSTRWYRAPEvL  181 (538)
T KOG0661|consen  164 P--PYTEYVSTRWYRAPEVL  181 (538)
T ss_pred             C--CcchhhhcccccchHHh
Confidence            4  34557899999999985

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.97  E-value=5.6e-32  Score=257.07  Aligned_cols=169  Identities=28%  Similarity=0.470  Sum_probs=150.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch--hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      ++|...+++|+|.||.||+|++. +|+.||||+++....  +......+||+.++.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            47888899999999999999875 599999999986542  234567899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      ||+ .+|+.+++.+...++..+++.|+.++++|++|+|   ++.|+||||||.|+|++++|.+||+|||+|+.+......
T Consensus        82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            995 6999999988888999999999999999999999   999999999999999999999999999999988765543


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                      .. ..+.|.+|+|||++
T Consensus       158 ~~-~~V~TRWYRAPELL  173 (318)
T KOG0659|consen  158 QT-HQVVTRWYRAPELL  173 (318)
T ss_pred             cc-cceeeeeccChHHh
Confidence            32 34789999999974

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.97  E-value=7.7e-32  Score=280.32  Aligned_cols=174  Identities=34%  Similarity=0.512  Sum_probs=153.3

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCe
Q 003301          655 LQATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDF  729 (832)
Q Consensus       655 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  729 (832)
                      .....+|.+++.||+|+|++|++|+.++ +++||||++.++.   +...+.+.+|.++|.++ .||.|++++..|+++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            4456889999999999999999998765 8999999986542   33446778899999999 89999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      .|+|+||+++|+|.++|++.+ .+++..++.++.+|+.|++|||   ++|||||||||+|||+|.+|++||+|||.|+.+
T Consensus       149 LYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            999999999999999998875 8999999999999999999999   999999999999999999999999999999987


Q ss_pred             CCCccc----------c--cccccccccccCCCCC
Q 003301          810 SGEESM----------K--QTLTLATIGYMAPGLF  832 (832)
Q Consensus       810 ~~~~~~----------~--~~~~~gt~~y~APE~l  832 (832)
                      .+....          .  ....+||..|++||++
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL  259 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELL  259 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHh
Confidence            543211          1  1347899999999985

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-30  Score=278.86  Aligned_cols=172  Identities=26%  Similarity=0.410  Sum_probs=151.3

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEecc----ch-hhHHHHHHHHHHHhcCC-CCceeeeceEEecCC
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQ----LE-GALKSFDVECEVLKSVR-HRNLVKIISSCTNND  728 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  728 (832)
                      ...++|.+++.||+|+||+|+.|.+. +++.||+|++..+    .. ...+.+.+|+.+++.++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34678999999999999999999875 5899999977653    11 23456778999999998 999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC-CcEEEecccccc
Q 003301          729 FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD-MVAHLSDFGIAK  807 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~kl~DFg~a~  807 (832)
                      .+|+||||+.||+|.+++.. .+++.+..+.++++|++.|++|+|   ++||+||||||+||+++.+ +++||+|||++.
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            99999999999999999998 558999999999999999999999   9999999999999999999 999999999999


Q ss_pred             ccCCCcccccccccccccccCCCCC
Q 003301          808 LLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       808 ~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ... .........+||+.|+|||++
T Consensus       170 ~~~-~~~~~l~t~cGsp~Y~aPEvl  193 (370)
T KOG0583|consen  170 ISP-GEDGLLKTFCGSPAYAAPEVL  193 (370)
T ss_pred             ccC-CCCCcccCCCCCcccCCHHHh
Confidence            874 222234457899999999986

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=9.9e-31  Score=267.63  Aligned_cols=169  Identities=31%  Similarity=0.468  Sum_probs=144.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhc--CCCCceeeeceEEecCC----eeE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKS--VRHRNLVKIISSCTNND----FKA  731 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~  731 (832)
                      ....+..++||+|.||.||+|+. +++.||||++..+.   .+.|..|.++++.  ++|+||++++++-....    .++
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc-cCceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            45667788999999999999998 67999999997553   4678888888765  58999999999876544    789


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc------CCCCCeEecCCCCCCeEeCCCCcEEEecccc
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF------GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGI  805 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~------~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~  805 (832)
                      +|+||.+.|+|.+|++..  ..+|....+++..+++||+|||.      .++.+|+|||||++||||..|+.+.|+|||+
T Consensus       285 LVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             EEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            999999999999999876  48999999999999999999995      3577899999999999999999999999999


Q ss_pred             ccccCCCcccc-cccccccccccCCCCC
Q 003301          806 AKLLSGEESMK-QTLTLATIGYMAPGLF  832 (832)
Q Consensus       806 a~~~~~~~~~~-~~~~~gt~~y~APE~l  832 (832)
                      |..+....... ....+||.+|||||++
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvL  390 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVL  390 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHH
Confidence            99876433221 2236899999999985

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.97  E-value=1.3e-30  Score=271.72  Aligned_cols=148  Identities=28%  Similarity=0.446  Sum_probs=137.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      ..++|++.++||+|+||.||.|+.++ |..||+|++++..   ....+.+..|..+|...++|+||+++..|++.+..|+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            46899999999999999999998765 9999999998654   4456788899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      ||||.+||++..++.+.+ .+++..+..++.+++.|++-+|   +.|+|||||||+|+|||..|++|++|||++.-
T Consensus       219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccch
Confidence            999999999999998766 7999999999999999999999   99999999999999999999999999999853

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-30  Score=264.05  Aligned_cols=172  Identities=32%  Similarity=0.499  Sum_probs=149.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCC--eeEEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNND--FKALVL  734 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  734 (832)
                      ..+|...+.||+|+||.||.+...+ |..+|||.+........+.+.+|+.++++++|||||+++|......  .++++|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            4568889999999999999998865 8999999987664333577899999999999999999999855444  689999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC-CCcEEEeccccccccCC--
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK-DMVAHLSDFGIAKLLSG--  811 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~kl~DFg~a~~~~~--  811 (832)
                      ||+++|+|.+++.+.+..+++..+..+.+|+++|++|||   ++|||||||||+|||++. ++.+||+|||.|+....  
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            999999999999987657999999999999999999999   999999999999999999 79999999999987763  


Q ss_pred             CcccccccccccccccCCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ..........||+.|||||++
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi  193 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVI  193 (313)
T ss_pred             ccccccccccCCccccCchhh
Confidence            112223346799999999985

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=3.9e-31  Score=263.98  Aligned_cols=169  Identities=27%  Similarity=0.442  Sum_probs=152.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-cCCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSF-LDGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      ..+|++.+.+|+|.||.|-+|.. ..|+.||||.+++..   +...-.+++||++|..++||||+.+|.+|+..+.+.||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            46788999999999999999976 569999999887553   44456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||..+|.|++|+.+++ .+++.++.++++||..|+.|+|   +++++|||+|.+|||+|.++++||+|||++-.+....
T Consensus       132 MEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  132 MEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            99999999999998776 7999999999999999999999   9999999999999999999999999999998876544


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                      .  ...+||+|-|.+||+.
T Consensus       208 f--LqTFCGSPLYASPEIv  224 (668)
T KOG0611|consen  208 F--LQTFCGSPLYASPEIV  224 (668)
T ss_pred             H--HHHhcCCcccCCcccc
Confidence            3  3457899999999974

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.2e-30  Score=260.37  Aligned_cols=169  Identities=30%  Similarity=0.517  Sum_probs=145.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcC--CCCceeeeceEEecCC----eeE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV--RHRNLVKIISSCTNND----FKA  731 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~~----~~~  731 (832)
                      .++..+.+.||+|.||+||+|.| .|+.||||++....+   +.+.+|.++++..  +|+||..+++.-..+.    +.|
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             hheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            36778899999999999999999 789999999986544   5677899998764  9999999999865433    689


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCeEecCCCCCCeEeCCCCcEEEeccccc
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF-----GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA  806 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~-----~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a  806 (832)
                      +|++|.+.|+|+||+.+.  .++.....+++..+|.||+|||.     .-+..|.|||||+.||||.+++.+.|+|+|+|
T Consensus       286 LvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA  363 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  363 (513)
T ss_pred             EeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence            999999999999999874  58999999999999999999993     23678999999999999999999999999999


Q ss_pred             cccCCCcc---cccccccccccccCCCCC
Q 003301          807 KLLSGEES---MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       807 ~~~~~~~~---~~~~~~~gt~~y~APE~l  832 (832)
                      ........   ......+||.+|||||++
T Consensus       364 v~h~~~t~~idi~~N~rVGTKRYMAPEvL  392 (513)
T KOG2052|consen  364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVL  392 (513)
T ss_pred             EEecccCCcccCCCCCccceeeccChHHh
Confidence            88765432   234457899999999986

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.97  E-value=8.1e-31  Score=272.42  Aligned_cols=168  Identities=36%  Similarity=0.491  Sum_probs=150.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      ++|.+.+.||+|+||.||||+.+. .+.||+|.+.+..  ++..+.+.+|+++++.++|||||.++++|+...++|+|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            578899999999999999998764 7889999987554  4456789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      ||.| +|..++...+ .++++.+..+++|++.|+.|||   +.+|.|||+||+||+++..|.+|+||||+|+.+..... 
T Consensus        82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~-  155 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS-  155 (808)
T ss_pred             hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCce-
Confidence            9965 9999998765 7999999999999999999999   99999999999999999999999999999998866443 


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                      ..+...|||.|||||+.
T Consensus       156 vltsikGtPlYmAPElv  172 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELV  172 (808)
T ss_pred             eeeeccCcccccCHHHH
Confidence            34456799999999973

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.97  E-value=1.4e-30  Score=255.09  Aligned_cols=171  Identities=26%  Similarity=0.357  Sum_probs=149.2

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchh--hHHHHHHHHHHHhcCCCCceeeeceEEec--CCeeE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEG--ALKSFDVECEVLKSVRHRNLVKIISSCTN--NDFKA  731 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  731 (832)
                      ..++|+...+|++|+||.||+|+++. ++.||+|+++...+.  .--...+||.++.+++|||||.+-.+...  -+.+|
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            35678889999999999999998864 888999999866532  23456789999999999999999888764  45799


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +|||||+ -+|..++...+.++...+++.++.|+++|++|||   ...|+|||+||+|+|+...|.+||+|||+|+.+..
T Consensus       154 ~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  154 IVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             eeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence            9999996 5999999988888999999999999999999999   99999999999999999999999999999999876


Q ss_pred             CcccccccccccccccCCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +.. ..+..+-|.+|+|||++
T Consensus       230 p~k-~~T~lVVTLWYRaPELL  249 (419)
T KOG0663|consen  230 PLK-PYTPLVVTLWYRAPELL  249 (419)
T ss_pred             Ccc-cCcceEEEeeecCHHHh
Confidence            633 34556799999999975

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-30  Score=273.77  Aligned_cols=174  Identities=30%  Similarity=0.512  Sum_probs=151.8

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          655 LQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       655 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ....+.++..+.||+|.||+||.|.+.....||+|.++... ...+.|.+|+.+|++++|++||+++|+|..++.+||||
T Consensus       202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence            33445566778999999999999999777799999998653 33478889999999999999999999999989999999


Q ss_pred             ecCCCCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          735 EYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       735 e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+.|+|.++++. .+..+...+.+.++.|||+|++||+   ++++|||||.++||||+++..+||+|||+|+...++.
T Consensus       281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence            99999999999997 5556899999999999999999999   9999999999999999999999999999999665555


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                      ........-+..|.|||.+
T Consensus       358 Y~~~~~~kfPIkWtAPEa~  376 (468)
T KOG0197|consen  358 YTASEGGKFPIKWTAPEAL  376 (468)
T ss_pred             eeecCCCCCCceecCHHHH
Confidence            5444444467789999975

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.3e-30  Score=270.94  Aligned_cols=169  Identities=30%  Similarity=0.436  Sum_probs=153.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ...|+.-++||+|+.|.||.|... +++.||||++........+-+..|+.+|+..+|+|||.+++.|...+..|+||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            456778899999999999999765 5889999999988777778899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      |+||+|.+.+....  +++.++..|++++++||+|||   .+||+|||||.+||+++.+|.+||+|||+|..+......+
T Consensus       352 m~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR  426 (550)
T KOG0578|consen  352 MEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR  426 (550)
T ss_pred             cCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence            99999999998764  899999999999999999999   9999999999999999999999999999999887665544


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                       ...+|||+|||||+.
T Consensus       427 -~TmVGTPYWMAPEVv  441 (550)
T KOG0578|consen  427 -STMVGTPYWMAPEVV  441 (550)
T ss_pred             -ccccCCCCccchhhh
Confidence             346799999999974

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.5e-29  Score=254.56  Aligned_cols=173  Identities=26%  Similarity=0.417  Sum_probs=151.3

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ..+.|++.+.||.|..++||+|+.. .+..||||++..+. ....+.+++|+..++.++||||++++..|..+...|+||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            3578999999999999999999876 48999999998664 334689999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          735 EYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      +||.+|++.++++..- ..+++..+..|.+++++||.|||   .+|.||||||+.|||++.+|.|||+|||.+..+...+
T Consensus       104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            9999999999998642 24899999999999999999999   9999999999999999999999999999876654433


Q ss_pred             cccc---ccccccccccCCCCC
Q 003301          814 SMKQ---TLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~---~~~~gt~~y~APE~l  832 (832)
                      ....   ...+||++|||||++
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl  202 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVL  202 (516)
T ss_pred             ceeeEeeccccCcccccChHHh
Confidence            2211   345899999999983

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=5.2e-30  Score=240.24  Aligned_cols=168  Identities=29%  Similarity=0.424  Sum_probs=148.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++++.||+|.||.||.|+.+. +..||+|++.+..   .....++.+|+++-..++||||.++|++|.++..+|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            5789999999999999999998764 7889999987543   23346888999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          734 LEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      +||..+|++...++..+ .++++..+..+++|+|.|+.|+|   .++|+||||||+|+|++..+..||+|||.+..-.  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            99999999999998543 35899999999999999999999   9999999999999999999999999999998643  


Q ss_pred             cccccccccccccccCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~  831 (832)
                       .......|||..|.|||+
T Consensus       176 -~~kR~tlcgt~dyl~pEm  193 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEM  193 (281)
T ss_pred             -CCCceeeecccccCCHhh
Confidence             223344689999999997

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-29  Score=257.40  Aligned_cols=173  Identities=32%  Similarity=0.442  Sum_probs=143.1

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--------------hhhHHHHHHHHHHHhcCCCCceee
Q 003301          655 LQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--------------EGALKSFDVECEVLKSVRHRNLVK  719 (832)
Q Consensus       655 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~niv~  719 (832)
                      ....++|++.+.||+|.||.|-+|+.. +++.||||++.+..              ....+...+||.+++++.|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            345689999999999999999999875 48999999986432              112357889999999999999999


Q ss_pred             eceEEec--CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCc
Q 003301          720 IISSCTN--NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMV  797 (832)
Q Consensus       720 l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~  797 (832)
                      ++.+..+  .+.+|+|+|||..|.+... ...+..+++.++++++++++.||+|||   .+|||||||||+|+|++++|+
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCc
Confidence            9999876  4689999999998877532 222323899999999999999999999   999999999999999999999


Q ss_pred             EEEeccccccccCCCc----ccccccccccccccCCCC
Q 003301          798 AHLSDFGIAKLLSGEE----SMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       798 ~kl~DFg~a~~~~~~~----~~~~~~~~gt~~y~APE~  831 (832)
                      |||+|||.+.......    .......+|||.|||||.
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~  286 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPEL  286 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHh
Confidence            9999999998662221    112233689999999996

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.96  E-value=2.4e-29  Score=252.33  Aligned_cols=170  Identities=28%  Similarity=0.428  Sum_probs=146.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch--hhHHHHHHHHHHHhcCCCCc-eeeeceEEecCC-----
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRN-LVKIISSCTNND-----  728 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~-----  728 (832)
                      ...|+..++||+|+||+||+|+.. +|+.||+|+++...+  .......+|+.+++.++|+| |+++++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            455777788999999999999875 589999999986644  34456789999999999999 999999998877     


Q ss_pred             -eeEEEEecCCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccc
Q 003301          729 -FKALVLEYMPNGSLEDYLYSNN---FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFG  804 (832)
Q Consensus       729 -~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg  804 (832)
                       ..|+|+||+ ..+|.+++....   ...+...++.+++|++.|++|||   +++|+||||||+||+++++|.+||+|||
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence             899999999 579999998765   35788899999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCcccccccccccccccCCCCC
Q 003301          805 IAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       805 ~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +|+...-+.. ..+..++|.+|+|||++
T Consensus       166 lAra~~ip~~-~yt~evvTlWYRaPEvL  192 (323)
T KOG0594|consen  166 LARAFSIPMR-TYTPEVVTLWYRAPEVL  192 (323)
T ss_pred             hHHHhcCCcc-cccccEEEeeccCHHHh
Confidence            9997653332 24456799999999974

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-29  Score=266.38  Aligned_cols=178  Identities=26%  Similarity=0.503  Sum_probs=153.0

Q ss_pred             cchHHHHHHhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEec
Q 003301          649 FSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTN  726 (832)
Q Consensus       649 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  726 (832)
                      ...+++....+++.+.+.||+|.||+||+|.|.  ..||||++....  ++..+.|..|+.++++-+|.||+-+.|||..
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            334566667788889999999999999999983  479999987654  4567899999999999999999999999998


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccc
Q 003301          727 NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA  806 (832)
Q Consensus       727 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a  806 (832)
                      ... .||+.+|+|.+|+.+++-.+..++..+...|++|||+|+.|||   .++|||||+|..||++.+++.|||+|||+|
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccce
Confidence            887 9999999999999999987778999999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCC-cccccccccccccccCCCCC
Q 003301          807 KLLSGE-ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       807 ~~~~~~-~~~~~~~~~gt~~y~APE~l  832 (832)
                      .....- .........|...|||||++
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvI  562 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVI  562 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHH
Confidence            653221 11122224588899999985

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.5e-29  Score=266.88  Aligned_cols=170  Identities=25%  Similarity=0.399  Sum_probs=148.3

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  731 (832)
                      ..++|.+.++||+|.||+|+.|..+. ++.||||++++..   .+..+....|.+++... +||+++.++.+|++.+++|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            45789999999999999999998864 7889999998764   45567788888888777 5999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +||||+.||++..+.+.  ..+++..+..+++.|+.||+|||   ++|||+||||.+|||+|.+|.+||+|||+++..-.
T Consensus       446 fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             EEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCC
Confidence            99999999995544433  36999999999999999999999   99999999999999999999999999999987543


Q ss_pred             CcccccccccccccccCCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .+. ...+.||||.|||||++
T Consensus       521 ~g~-~TsTfCGTpey~aPEil  540 (694)
T KOG0694|consen  521 QGD-RTSTFCGTPEFLAPEVL  540 (694)
T ss_pred             CCC-ccccccCChhhcChhhh
Confidence            433 44557999999999985

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.96  E-value=2e-30  Score=249.32  Aligned_cols=168  Identities=29%  Similarity=0.433  Sum_probs=150.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      +-|++.+++|+|+||.||+|.++. |+.||||.+...  ...+++.+|+.++++++.|+||++||.|......|||||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            446778899999999999998865 999999988755  44588999999999999999999999999989999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccc
Q 003301          738 PNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ  817 (832)
Q Consensus       738 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~  817 (832)
                      ..|+..+.++.++..+.+.++..+++..++||+|||   ...-||||||+.|||++.+|.+|++|||.|..+.+.-. ..
T Consensus       111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KR  186 (502)
T KOG0574|consen  111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KR  186 (502)
T ss_pred             CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH-hh
Confidence            999999999988889999999999999999999999   88899999999999999999999999999987754433 23


Q ss_pred             ccccccccccCCCCC
Q 003301          818 TLTLATIGYMAPGLF  832 (832)
Q Consensus       818 ~~~~gt~~y~APE~l  832 (832)
                      ...+|||.|||||++
T Consensus       187 NTVIGTPFWMAPEVI  201 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVI  201 (502)
T ss_pred             CccccCcccccHHHH
Confidence            446799999999985

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.95  E-value=3.2e-29  Score=250.55  Aligned_cols=164  Identities=33%  Similarity=0.502  Sum_probs=137.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCC-----eeEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNND-----FKAL  732 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l  732 (832)
                      -.|+..+++|.|+||.||+|...+ +++||||++-...+    .-.+|+++|+.++|||||++..+|....     ...+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            356677999999999999998765 68999998865432    3346999999999999999998886422     3348


Q ss_pred             EEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC-CcEEEeccccccc
Q 003301          733 VLEYMPNGSLEDYLYS---NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD-MVAHLSDFGIAKL  808 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~kl~DFg~a~~  808 (832)
                      |||||+ .+|.++++.   .+.+++...++-+++|+.+|++|||   +.||+||||||+|+|||.+ |.+||||||.|+.
T Consensus       100 VleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            999996 599999884   2446888889999999999999999   9999999999999999977 9999999999998


Q ss_pred             cCCCcccccccccccccccCCCCC
Q 003301          809 LSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       809 ~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ....+..  ..+..|..|+|||++
T Consensus       176 L~~~epn--iSYicSRyYRaPELi  197 (364)
T KOG0658|consen  176 LVKGEPN--ISYICSRYYRAPELI  197 (364)
T ss_pred             eccCCCc--eeEEEeccccCHHHH
Confidence            8655433  346789999999975

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-28  Score=265.98  Aligned_cols=183  Identities=27%  Similarity=0.475  Sum_probs=155.8

Q ss_pred             cccchHHHHHHhc---------CCCCCCeeeccCCceEEEEEecC----CcEEEEEEEeccc-hhhHHHHHHHHHHHhcC
Q 003301          647 RRFSYKELLQATN---------QFNASNLIGTGGFGSVYKGSFLD----GMEVAIKVFHLQL-EGALKSFDVECEVLKSV  712 (832)
Q Consensus       647 ~~~~~~~~~~~~~---------~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l  712 (832)
                      ..++|+|.-++..         ...+.++||.|.||+||+|+.+-    ...||||.++... ++.+.+|..|+.||.++
T Consensus       608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF  687 (996)
T KOG0196|consen  608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF  687 (996)
T ss_pred             CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence            3456665544433         34678999999999999998753    4569999998654 45667899999999999


Q ss_pred             CCCceeeeceEEecCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe
Q 003301          713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL  792 (832)
Q Consensus       713 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~  792 (832)
                      +||||+++.|+......++||+|||++|+|+.+++.+.+.+++.+...+.++||.|++||-   ..++|||||.++||||
T Consensus       688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILV  764 (996)
T KOG0196|consen  688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILV  764 (996)
T ss_pred             CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheee
Confidence            9999999999999999999999999999999999999989999999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeccccccccCCCcccccccccc--cccccCCCCC
Q 003301          793 DKDMVAHLSDFGIAKLLSGEESMKQTLTLA--TIGYMAPGLF  832 (832)
Q Consensus       793 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~g--t~~y~APE~l  832 (832)
                      +.+-.+|++|||+++.++++.....+..-|  +.+|.|||.|
T Consensus       765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAI  806 (996)
T KOG0196|consen  765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAI  806 (996)
T ss_pred             ccceEEEeccccceeecccCCCccccccCCccceeecChhHh
Confidence            999999999999999886554322222222  5689999975

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.4e-29  Score=261.12  Aligned_cols=164  Identities=28%  Similarity=0.394  Sum_probs=144.9

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .|.-.+.||.|+||.||-|++. +...||||++....   .....++.+|+.++.+++|||++.+-|+|..+...|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3555678999999999999875 47889999986432   3345788999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      || -|+-.|++.-.+.++.+..+..|+.+.+.||+|||   +.+.||||||+.|||+++.|.||++|||.|....+..  
T Consensus       107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn--  180 (948)
T KOG0577|consen  107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN--  180 (948)
T ss_pred             HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCchh--
Confidence            99 67888888766667899999999999999999999   9999999999999999999999999999998875443  


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                         .++|||+||||||+
T Consensus       181 ---sFvGTPywMAPEVI  194 (948)
T KOG0577|consen  181 ---SFVGTPYWMAPEVI  194 (948)
T ss_pred             ---cccCCccccchhHh
Confidence               36899999999986

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.6e-28  Score=259.28  Aligned_cols=175  Identities=33%  Similarity=0.486  Sum_probs=148.5

Q ss_pred             HHHHhcCCCCCCeeeccCCceEEEEEecC--C--cE-EEEEEEecc---chhhHHHHHHHHHHHhcCCCCceeeeceEEe
Q 003301          654 LLQATNQFNASNLIGTGGFGSVYKGSFLD--G--ME-VAIKVFHLQ---LEGALKSFDVECEVLKSVRHRNLVKIISSCT  725 (832)
Q Consensus       654 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  725 (832)
                      |+-.-++....++||+|+||.||+|+...  +  .. ||||..+..   ......++.+|++++++++|||||++||++.
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            33445666777999999999999998753  2  23 899998852   3566789999999999999999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccc
Q 003301          726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGI  805 (832)
Q Consensus       726 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~  805 (832)
                      .+..+|+|||+|.||+|.+++++.+..++..+...++.+.|.||+|||   +++++||||.++|+|++.++.+||+|||+
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCcccc
Confidence            999999999999999999999998777999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCCCCC
Q 003301          806 AKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       806 a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ++.-.... .......-+.+|+|||.+
T Consensus       309 s~~~~~~~-~~~~~~klPirWLAPEtl  334 (474)
T KOG0194|consen  309 SRAGSQYV-MKKFLKKLPIRWLAPETL  334 (474)
T ss_pred             ccCCccee-eccccccCcceecChhhh
Confidence            88643111 111122356789999975

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.95  E-value=5.4e-28  Score=264.01  Aligned_cols=172  Identities=23%  Similarity=0.371  Sum_probs=148.7

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeE
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  731 (832)
                      ...++|++.+.||+|+||.||+|++.. ++.||+|++....   ....+.+.+|+++++.++||||+++++++.+++..|
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            345789999999999999999998864 7899999986432   223456778999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +||||+++|+|.+++...  .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|.....
T Consensus       120 lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            999999999999999754  4789999999999999999999   99999999999999999999999999999987654


Q ss_pred             CcccccccccccccccCCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .........+||+.|||||++
T Consensus       195 ~~~~~~~~~~gt~~Y~aPE~~  215 (370)
T cd05621         195 TGMVRCDTAVGTPDYISPEVL  215 (370)
T ss_pred             CCceecccCCCCcccCCHHHH
Confidence            333233345799999999964

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=3e-28  Score=258.87  Aligned_cols=169  Identities=25%  Similarity=0.397  Sum_probs=150.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      ..-|+.++.||.|+.|.|..|++. +|+.+|||++....   ......+.+|+.+|+-+.||||+++|++|++..++|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            466889999999999999999886 59999999997663   23346788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      .||++||.|.+++.+++ .+++.++.++++||+.|+.|+|   ..+|+|||+||+|+++|..+++||+|||+|..-.++.
T Consensus        91 lEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             EEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence            99999999999998765 7899999999999999999999   9999999999999999999999999999998643322


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                        .....||+|.|.|||++
T Consensus       167 --lLeTSCGSPHYA~PEIV  183 (786)
T KOG0588|consen  167 --LLETSCGSPHYAAPEIV  183 (786)
T ss_pred             --cccccCCCcccCCchhh
Confidence              23346899999999984

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-28  Score=243.66  Aligned_cols=173  Identities=28%  Similarity=0.375  Sum_probs=148.6

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEe--ccchhhHHHHHHHHHHHhcCCCCceeeeceEEec-----
Q 003301          655 LQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFH--LQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN-----  726 (832)
Q Consensus       655 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----  726 (832)
                      ......|...+.||+|+||.|+.|.+. +|+.||||++.  .+.....++..+|+++++.++|+||+.+.+++..     
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~   97 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK   97 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence            344566777899999999999999876 58999999987  3344556888999999999999999999999876     


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccc
Q 003301          727 NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA  806 (832)
Q Consensus       727 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a  806 (832)
                      -..+|+|+|+| +.+|.+.++..+ .++...+..+++|+++|++|+|   +.+|+|||+||.|++++.+..+||+|||+|
T Consensus        98 f~DvYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen   98 FNDVYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             cceeEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccce
Confidence            34789999999 679999998764 5899999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCC-cccccccccccccccCCCCC
Q 003301          807 KLLSGE-ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       807 ~~~~~~-~~~~~~~~~gt~~y~APE~l  832 (832)
                      +..... .....+.++.|.+|+|||++
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPEll  199 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELL  199 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHH
Confidence            987542 12233567899999999974

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.3e-27  Score=257.76  Aligned_cols=171  Identities=26%  Similarity=0.377  Sum_probs=149.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.+.||+|+||+||+|+... ++.||+|++....   ....+.+.+|+.+++.++|++|+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            478999999999999999998764 8899999987432   233456888999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||+++|+|.+++.+....+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            999999999999875557899999999999999999999   99999999999999999999999999999977654333


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                      ......+||+.|||||++
T Consensus       158 ~~~~~~~gt~~y~aPE~~  175 (331)
T cd05597         158 VQSNVAVGTPDYISPEIL  175 (331)
T ss_pred             ccccceeccccccCHHHH
Confidence            333335699999999964

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.95  E-value=1.4e-27  Score=261.11  Aligned_cols=147  Identities=27%  Similarity=0.406  Sum_probs=133.2

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.+.||+|+||+||+|... +++.||+|++....   ......+.+|++++.+++||+|+++++++.+....|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47899999999999999999876 48899999997543   223456788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      ||+++|+|.+++.+.+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+..
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~  151 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL  151 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence            9999999999997654 6899999999999999999999   999999999999999999999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6.9e-29  Score=252.52  Aligned_cols=169  Identities=31%  Similarity=0.439  Sum_probs=151.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ..|...+.||+|+||.||+|.+. .++.||+|++.... +...+.+++|+.++.+++++||.++|+.|..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45777799999999999999875 48899999998664 44567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      |.||++.+.++... .+++..+..+++++..|+.|+|   .++.+|||||+.||++..+|.||++|||.|..+.......
T Consensus        93 ~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr  168 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR  168 (467)
T ss_pred             hcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence            99999999998765 4588888889999999999999   9999999999999999999999999999999886665544


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                       ...+|||.||||||+
T Consensus       169 -~tfvGTPfwMAPEVI  183 (467)
T KOG0201|consen  169 -KTFVGTPFWMAPEVI  183 (467)
T ss_pred             -ccccccccccchhhh
Confidence             557899999999985

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.95  E-value=2.5e-28  Score=232.21  Aligned_cols=172  Identities=28%  Similarity=0.440  Sum_probs=150.1

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--------hhhHHHHHHHHHHHhcC-CCCceeeeceEE
Q 003301          655 LQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--------EGALKSFDVECEVLKSV-RHRNLVKIISSC  724 (832)
Q Consensus       655 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  724 (832)
                      ...-..|+..+.+|+|..++|.++.++ +|+++|+|++....        ..-.+.-.+|+.+++++ .||+|+++.++|
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            345578889999999999999998765 58999999986332        12235567899999998 799999999999


Q ss_pred             ecCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccc
Q 003301          725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFG  804 (832)
Q Consensus       725 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg  804 (832)
                      +.+..+++|+|.|+.|.|.|++...- .+++....+|++|+..|++|||   .+.|||||+||+|||+|++.++||+|||
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccc
Confidence            99999999999999999999998653 7999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCcccccccccccccccCCCCC
Q 003301          805 IAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       805 ~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +|+.+..++.  ....||||+|.|||.+
T Consensus       169 Fa~~l~~Gek--LrelCGTPgYLAPEti  194 (411)
T KOG0599|consen  169 FACQLEPGEK--LRELCGTPGYLAPETI  194 (411)
T ss_pred             eeeccCCchh--HHHhcCCCcccChhhe
Confidence            9999866553  3457899999999975

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=2.9e-28  Score=255.55  Aligned_cols=171  Identities=29%  Similarity=0.466  Sum_probs=152.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCe-eEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDF-KALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv  733 (832)
                      .++|+..+++|+|+||.++.++++ +++.||+|.+....  ....+....|+.++++++|||||.+.+.|..++. .+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            367999999999999999999876 47889999987654  3344577889999999999999999999999888 9999


Q ss_pred             EecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          734 LEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      |+||+||++.+.+.+.+ ..++++.+..|+.|++.|++|||   +..|+|||||+.||+++.++.|||+|||+|+.+...
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999999998765 56999999999999999999999   999999999999999999999999999999998776


Q ss_pred             cccccccccccccccCCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~l  832 (832)
                      .... ...+|||.||.||++
T Consensus       160 ~~~a-~tvvGTp~YmcPEil  178 (426)
T KOG0589|consen  160 DSLA-STVVGTPYYMCPEIL  178 (426)
T ss_pred             hhhh-heecCCCcccCHHHh
Confidence            5433 346799999999975

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.9e-29  Score=279.78  Aligned_cols=178  Identities=27%  Similarity=0.394  Sum_probs=161.3

Q ss_pred             hHHHHHHhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEecc---chhhHHHHHHHHHHHhcCCCCceeeeceEEec
Q 003301          651 YKELLQATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQ---LEGALKSFDVECEVLKSVRHRNLVKIISSCTN  726 (832)
Q Consensus       651 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  726 (832)
                      ..++.-..++|++.++||+|+||.|..++++. ++.||+|++.+-   .......|..|..+|..-+.+.|++++.+|++
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            34555567899999999999999999999865 888999998752   23445678899999999999999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccc
Q 003301          727 NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA  806 (832)
Q Consensus       727 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a  806 (832)
                      +.+.|+|||||+||+|-.++.+.. ++++..+..++..|+.||+-+|   +.|+|||||||+|||+|..|++|++|||.+
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhH
Confidence            999999999999999999998877 7999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCcccccccccccccccCCCCC
Q 003301          807 KLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       807 ~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ..+..++.......+|||.|++||++
T Consensus       223 lkm~~dG~V~s~~aVGTPDYISPEvL  248 (1317)
T KOG0612|consen  223 LKMDADGTVRSSVAVGTPDYISPEVL  248 (1317)
T ss_pred             HhcCCCCcEEeccccCCCCccCHHHH
Confidence            99887777777778999999999985

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-27  Score=254.66  Aligned_cols=169  Identities=29%  Similarity=0.428  Sum_probs=150.6

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchh---hHHHHHHHHHHHhcCC-CCceeeeceEEecCCeeE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEG---ALKSFDVECEVLKSVR-HRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~  731 (832)
                      ....|++.+.||+|.||.||+|+.+. |+.+|+|.+.+....   ..+.+.+|+++|+++. |||||.++++|++...+|
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            35689999999999999999999876 999999999766532   3468899999999998 999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC----CcEEEecccccc
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD----MVAHLSDFGIAK  807 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~----~~~kl~DFg~a~  807 (832)
                      +|||+|.||.|.+.+...  .+++..+..++.|++.|++|+|   +.||+|||+||+|+|+...    +.+|++|||+|.
T Consensus       113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            999999999999999876  3999999999999999999999   9999999999999999533    589999999999


Q ss_pred             ccCCCcccccccccccccccCCCCC
Q 003301          808 LLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       808 ~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ....  .......+||+.|+|||++
T Consensus       188 ~~~~--~~~~~~~~Gtp~y~APEvl  210 (382)
T KOG0032|consen  188 FIKP--GERLHTIVGTPEYVAPEVL  210 (382)
T ss_pred             EccC--CceEeeecCCccccCchhh
Confidence            8866  3344557899999999985

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.95  E-value=2.3e-27  Score=255.98  Aligned_cols=171  Identities=24%  Similarity=0.352  Sum_probs=148.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.+.||+|+||+||+|++. +++.||+|++....   ......+.+|+.++..++|++|+++++++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999876 47889999987532   223456788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||+++|+|.+++.+....+++..+..++.|++.||+|+|   ++||+||||||+||+++.++.+||+|||+|+.......
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999875557899999999999999999999   99999999999999999999999999999987654433


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                      .......||+.|||||++
T Consensus       158 ~~~~~~~gt~~y~aPE~~  175 (331)
T cd05624         158 VQSSVAVGTPDYISPEIL  175 (331)
T ss_pred             eeeccccCCcccCCHHHH
Confidence            333335699999999963

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.95  E-value=1.9e-27  Score=260.06  Aligned_cols=175  Identities=24%  Similarity=0.369  Sum_probs=150.6

Q ss_pred             HHHHHhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC
Q 003301          653 ELLQATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNND  728 (832)
Q Consensus       653 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  728 (832)
                      ++....++|++.+.||+|+||.||+|.+.. ++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+++
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            344456899999999999999999998864 7899999986432   223456778999999999999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          729 FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      ..|+||||+++|+|.+++...  .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence            999999999999999998764  4788899999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCcccccccccccccccCCCCC
Q 003301          809 LSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       809 ~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ............+||+.|||||++
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~l  215 (371)
T cd05622         192 MNKEGMVRCDTAVGTPDYISPEVL  215 (371)
T ss_pred             cCcCCcccccCcccCccccCHHHH
Confidence            654433333346799999999974

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.95  E-value=3.1e-27  Score=255.30  Aligned_cols=171  Identities=29%  Similarity=0.414  Sum_probs=149.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch---hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE---GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.+.||+|+||.||+|... +++.||+|+++....   ...+.+.+|+++++.++||+|+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47899999999999999999876 588999999975432   23456788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||+++|+|.+++.+....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|........
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            999999999999876557999999999999999999999   99999999999999999999999999999987654433


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                      .......||+.|+|||++
T Consensus       158 ~~~~~~~gt~~y~aPE~~  175 (330)
T cd05601         158 VNSKLPVGTPDYIAPEVL  175 (330)
T ss_pred             eeeecccCCccccCHHHh
Confidence            333335699999999974

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.1e-27  Score=260.27  Aligned_cols=147  Identities=28%  Similarity=0.447  Sum_probs=133.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.+.||+|+||.||+|++. +++.||||++....   ......+.+|+++++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999886 48999999997542   233456788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+++.+
T Consensus        81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  151 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL  151 (364)
T ss_pred             CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence            9999999999997654 6899999999999999999999   999999999999999999999999999998754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.95  E-value=2.5e-27  Score=255.41  Aligned_cols=167  Identities=27%  Similarity=0.393  Sum_probs=147.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            367999999999999999999886 48899999987542   23346788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+++|+|.+++...+ .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+++......
T Consensus        97 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  172 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT  172 (329)
T ss_pred             EcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence            99999999999998654 6889999999999999999999   9999999999999999999999999999998764322


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                          ....||+.|+|||++
T Consensus       173 ----~~~~gt~~y~aPE~~  187 (329)
T PTZ00263        173 ----FTLCGTPEYLAPEVI  187 (329)
T ss_pred             ----ceecCChhhcCHHHH
Confidence                224699999999974

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.95  E-value=3.1e-27  Score=258.41  Aligned_cols=171  Identities=24%  Similarity=0.380  Sum_probs=147.7

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+++..|+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3568999999999999999999886 48899999986432   2233557789999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||||+++|+|.+++...  .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||.+......
T Consensus       121 v~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999998764  4788899999999999999999   999999999999999999999999999999876543


Q ss_pred             cccccccccccccccCCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~l  832 (832)
                      ........+||+.|||||++
T Consensus       196 ~~~~~~~~~gt~~y~aPE~~  215 (370)
T cd05596         196 GMVRCDTAVGTPDYISPEVL  215 (370)
T ss_pred             CcccCCCCCCCcCeECHHHh
Confidence            33233345799999999964

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=4.2e-27  Score=254.46  Aligned_cols=166  Identities=25%  Similarity=0.438  Sum_probs=146.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.+.||+|+||.||+|.+.. ++.||+|++....   ....+.+.+|+++++.++||||+++++++...+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            468999999999999999999864 8899999997543   233456788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||+++++|.+++.... .+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||+|+....   
T Consensus        81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            9999999999997654 6889999999999999999999   99999999999999999999999999999986543   


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                       ......||+.|+|||++
T Consensus       154 -~~~~~~gt~~y~aPE~~  170 (333)
T cd05600         154 -YANSVVGSPDYMAPEVL  170 (333)
T ss_pred             -ccCCcccCccccChhHh
Confidence             22335699999999974

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.94  E-value=6.8e-27  Score=251.49  Aligned_cols=163  Identities=29%  Similarity=0.354  Sum_probs=140.8

Q ss_pred             CeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCC
Q 003301          665 NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNG  740 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  740 (832)
                      +.||+|+||.||+|+.. +|+.||+|+++...   ......+.+|++++++++||||+++++++...+..|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875 58999999987543   233456778999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccccc
Q 003301          741 SLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT  820 (832)
Q Consensus       741 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~~  820 (832)
                      +|.+++...+ .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|+....... .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~  155 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTF  155 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cccce
Confidence            9999987654 6899999999999999999999   99999999999999999999999999999975432222 22335


Q ss_pred             cccccccCCCCC
Q 003301          821 LATIGYMAPGLF  832 (832)
Q Consensus       821 ~gt~~y~APE~l  832 (832)
                      +||+.|+|||++
T Consensus       156 ~gt~~y~aPE~~  167 (323)
T cd05571         156 CGTPEYLAPEVL  167 (323)
T ss_pred             ecCccccChhhh
Confidence            699999999974

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.94  E-value=3.2e-27  Score=254.95  Aligned_cols=167  Identities=30%  Similarity=0.436  Sum_probs=146.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC--CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD--GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      .++|++.+.||+|+||.||+|.+..  +..||+|++....   ....+.+.+|+++++.++||||+++++++.+++..|+
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            4679999999999999999998654  3689999986542   2334677889999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||||+++|+|.+++.... .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|+.....
T Consensus       109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            999999999999997654 6899999999999999999999   999999999999999999999999999999876432


Q ss_pred             cccccccccccccccCCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~l  832 (832)
                      .    ....||+.|||||++
T Consensus       185 ~----~~~~gt~~y~aPE~~  200 (340)
T PTZ00426        185 T----YTLCGTPEYIAPEIL  200 (340)
T ss_pred             c----ceecCChhhcCHHHH
Confidence            1    235699999999974

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=4.2e-27  Score=258.88  Aligned_cols=146  Identities=27%  Similarity=0.418  Sum_probs=132.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.+.||+|+||.||+|... +++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47899999999999999999875 58899999986542   233467888999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|+.
T Consensus        81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence            9999999999997654 6889999999999999999999   99999999999999999999999999999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.94  E-value=4.5e-27  Score=258.75  Aligned_cols=145  Identities=26%  Similarity=0.406  Sum_probs=131.5

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .|++.+.||+|+||+||+|.+. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999875 48899999997543   2344678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      |+++|+|.+++.+.. .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~  150 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTG  150 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence            999999999997654 6889999999999999999999   99999999999999999999999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.8e-27  Score=250.70  Aligned_cols=166  Identities=31%  Similarity=0.446  Sum_probs=146.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47899999999999999999886 58999999987542   223456888999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||+++|+|.+++...+ .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-  155 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-  155 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence            9999999999997654 6899999999999999999999   9999999999999999999999999999998764321 


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                         ...+||+.|+|||++
T Consensus       156 ---~~~~gt~~y~aPE~~  170 (291)
T cd05612         156 ---WTLCGTPEYLAPEVI  170 (291)
T ss_pred             ---ccccCChhhcCHHHH
Confidence               224699999999963

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.94  E-value=4.5e-27  Score=258.68  Aligned_cols=146  Identities=26%  Similarity=0.381  Sum_probs=131.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      .+|++.+.||+|+||.||+|+.. +++.||||++....   ......+.+|++++++++||||+++++.+.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36899999999999999999876 48899999986532   223466788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      ||+++|+|.+++.+.+ .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|..
T Consensus        81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            9999999999997654 6889999999999999999999   99999999999999999999999999999853

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.94  E-value=5.8e-27  Score=253.06  Aligned_cols=171  Identities=22%  Similarity=0.346  Sum_probs=147.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.++||+|+||.||++.+.. ++.||+|++....   ......+..|+.++..++|++|+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            478999999999999999998864 7889999986432   223345788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||+++|+|.+++.+....+++..+..++.|++.|++|+|   +.+|+||||||+||+++.++.+||+|||+|........
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            999999999999875557899999999999999999999   99999999999999999999999999999976543333


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                      ......+||+.|||||++
T Consensus       158 ~~~~~~~gt~~y~aPE~~  175 (332)
T cd05623         158 VQSSVAVGTPDYISPEIL  175 (332)
T ss_pred             ceecccccCccccCHHHH
Confidence            333345799999999964

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.94  E-value=4.6e-29  Score=233.78  Aligned_cols=170  Identities=25%  Similarity=0.443  Sum_probs=145.9

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      ..+.|++.+.||+|+|+.||++.+. +|+.+|+|++....  ....+.+.+|+++.+.++||||+++.+.+.+.+..|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            4578899999999999999999775 48999999875432  33568899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeC---CCCcEEEeccccccccC
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~---~~~~~kl~DFg~a~~~~  810 (832)
                      +|+|+|++|..-+-.+ .-+++..+-.+++||+.|++|+|   .++|||||+||+|+++.   ...-+|++|||+|....
T Consensus        89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            9999999997655443 35889999999999999999999   99999999999999994   34579999999999887


Q ss_pred             CCcccccccccccccccCCCCC
Q 003301          811 GEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       811 ~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +.  ......+|||+|||||++
T Consensus       165 ~g--~~~~G~~GtP~fmaPEvv  184 (355)
T KOG0033|consen  165 DG--EAWHGFAGTPGYLSPEVL  184 (355)
T ss_pred             Cc--cccccccCCCcccCHHHh
Confidence            32  234456899999999974

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.94  E-value=1.5e-27  Score=249.13  Aligned_cols=172  Identities=26%  Similarity=0.448  Sum_probs=149.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchh-hHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEG-ALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .+...+.++||+|.||+|..|....+..||||.++..... ....|.+|+++|.+++||||++++|+|..++.+++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            4566788999999999999999877899999999876543 458899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          737 MPNGSLEDYLYSNNFS-FDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      |+.|+|.+++.+.... .......+|+.||+.|++||.   +.++||||+.++|+|++.++++||+|||+++.+-..+..
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence            9999999999876433 355667789999999999999   999999999999999999999999999999965444433


Q ss_pred             -ccccccccccccCCCCC
Q 003301          816 -KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 -~~~~~~gt~~y~APE~l  832 (832)
                       .....+-+.+|||||.+
T Consensus       694 ~vqgr~vlpiRwmawEsi  711 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESI  711 (807)
T ss_pred             eeecceeeeeeehhHHHH
Confidence             33345667899999953

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.94  E-value=7e-27  Score=257.64  Aligned_cols=145  Identities=25%  Similarity=0.385  Sum_probs=131.3

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .|++.++||+|+||+||+|... +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5889999999999999999875 48899999987543   2344678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      |+++|+|.+++.+.+ .+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||+|+.
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            999999999997654 6889999999999999999999   99999999999999999999999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.94  E-value=1.8e-27  Score=262.42  Aligned_cols=173  Identities=29%  Similarity=0.510  Sum_probs=149.0

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccchh-hHHHHHHHHHHHhcCCCCceeeeceEEecCCe
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQLEG-ALKSFDVECEVLKSVRHRNLVKIISSCTNNDF  729 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  729 (832)
                      ...+.+..+.||+|+||+||+|...      +...||||.++..... ..++|++|+++++.++|||||+++|+|..++.
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            3456677899999999999999753      2466999999877655 67899999999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC
Q 003301          730 KALVLEYMPNGSLEDYLYSNN-------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM  796 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~  796 (832)
                      .|+|+|||..|||.++++...             ..++..+.+.||.|||.|++||-   ++.+|||||..+|+||.++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccce
Confidence            999999999999999997532             12778899999999999999999   99999999999999999999


Q ss_pred             cEEEeccccccccCCCcccccc-cccccccccCCCCC
Q 003301          797 VAHLSDFGIAKLLSGEESMKQT-LTLATIGYMAPGLF  832 (832)
Q Consensus       797 ~~kl~DFg~a~~~~~~~~~~~~-~~~gt~~y~APE~l  832 (832)
                      .|||+|||+++.+-..+..+.. ...-+.+|||||.|
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsI  677 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESI  677 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHh
Confidence            9999999999976544444332 34567899999964

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.94  E-value=5.7e-28  Score=251.04  Aligned_cols=156  Identities=25%  Similarity=0.457  Sum_probs=139.3

Q ss_pred             CCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCCCH
Q 003301          663 ASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSL  742 (832)
Q Consensus       663 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  742 (832)
                      ..+-+|.|+.|.||.|+. .++.||||+++...       ..+|+-+++++||||+.|.|+|.....++||||||+.|-|
T Consensus       128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            357899999999999998 78899999876332       3478889999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccccccc
Q 003301          743 EDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA  822 (832)
Q Consensus       743 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~g  822 (832)
                      +.+++..+ .+.......|..+||.|+.|||   .+.|||||||.-||||..+..|||+|||.++...+.  .....++|
T Consensus       200 ~~VLka~~-~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaG  273 (904)
T KOG4721|consen  200 YEVLKAGR-PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAG  273 (904)
T ss_pred             HHHHhccC-ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhh
Confidence            99998766 6788888899999999999999   999999999999999999999999999999887554  23344789


Q ss_pred             cccccCCCCC
Q 003301          823 TIGYMAPGLF  832 (832)
Q Consensus       823 t~~y~APE~l  832 (832)
                      |..|||||||
T Consensus       274 TVaWMAPEvI  283 (904)
T KOG4721|consen  274 TVAWMAPEVI  283 (904)
T ss_pred             hHhhhCHHHh
Confidence            9999999986

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.94  E-value=1.4e-26  Score=248.92  Aligned_cols=163  Identities=29%  Similarity=0.371  Sum_probs=140.5

Q ss_pred             CeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCC
Q 003301          665 NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNG  740 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  740 (832)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            47999999999999875 58999999987543   233456778999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccccc
Q 003301          741 SLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT  820 (832)
Q Consensus       741 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~~  820 (832)
                      +|.+++...+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++....... .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~  155 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTF  155 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccccc
Confidence            9999887654 6899999999999999999999   99999999999999999999999999999875422221 22235


Q ss_pred             cccccccCCCCC
Q 003301          821 LATIGYMAPGLF  832 (832)
Q Consensus       821 ~gt~~y~APE~l  832 (832)
                      .||+.|+|||++
T Consensus       156 ~gt~~y~aPE~~  167 (323)
T cd05595         156 CGTPEYLAPEVL  167 (323)
T ss_pred             cCCcCcCCcccc
Confidence            699999999974

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.94  E-value=9.8e-27  Score=251.61  Aligned_cols=169  Identities=30%  Similarity=0.406  Sum_probs=145.1

Q ss_pred             CCCCCCeeeccCCceEEEEEec----CCcEEEEEEEeccc----hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCee
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL----DGMEVAIKVFHLQL----EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  730 (832)
                      +|++.+.||+|+||.||+|+..    +++.||+|++....    ....+.+.+|+++++.+ +||+|+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4888999999999999999763    47899999987532    22345678899999999 599999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      |+||||+++|+|.+++.... .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            99999999999999987654 6899999999999999999999   9999999999999999999999999999998654


Q ss_pred             CCcccccccccccccccCCCCC
Q 003301          811 GEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       811 ~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ..........+||+.|||||++
T Consensus       157 ~~~~~~~~~~~gt~~y~aPE~~  178 (332)
T cd05614         157 SEEKERTYSFCGTIEYMAPEII  178 (332)
T ss_pred             ccCCCccccccCCccccCHHHh
Confidence            4333333345799999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.94  E-value=3.8e-29  Score=250.08  Aligned_cols=418  Identities=26%  Similarity=0.253  Sum_probs=264.0

Q ss_pred             EEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccc-c
Q 003301           99 GLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQL-N  177 (832)
Q Consensus        99 ~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~-N  177 (832)
                      ..+.++-.++ .+|.++-  .+-+.++|..|+|+.+.|.+|..+++|+.||||+|.|+.+-|++|.++++|..|.+.+ |
T Consensus        50 ~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N  126 (498)
T KOG4237|consen   50 IVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN  126 (498)
T ss_pred             eEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence            4566666777 6776653  4678888999999988888899999999999999999988888999998887777666 8


Q ss_pred             ccccccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccC
Q 003301          178 KLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFI  257 (832)
Q Consensus       178 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~  257 (832)
                      +|+.+..++|.+|.+|+.|.+.-|++.-...+.  |..++++..|.+-.|.+..+....|..+..++.+.+..|.+-.  
T Consensus       127 kI~~l~k~~F~gL~slqrLllNan~i~Cir~~a--l~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic--  202 (498)
T KOG4237|consen  127 KITDLPKGAFGGLSSLQRLLLNANHINCIRQDA--LRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC--  202 (498)
T ss_pred             chhhhhhhHhhhHHHHHHHhcChhhhcchhHHH--HHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc--
Confidence            898877788888888888888888887333332  4567777777777777776666677777777777777666210  


Q ss_pred             CccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCccccccc-
Q 003301          258 PNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIP-  336 (832)
Q Consensus       258 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-  336 (832)
                         .++++.+.. ++..|.           ..++.........+.++++..+-+..|.....++..-..+.+...+..| 
T Consensus       203 ---dCnL~wla~-~~a~~~-----------ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~  267 (498)
T KOG4237|consen  203 ---DCNLPWLAD-DLAMNP-----------IETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPA  267 (498)
T ss_pred             ---ccccchhhh-HHhhch-----------hhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChH
Confidence               011111110 011111           1122223333333444444333333332211112111223333333334 


Q ss_pred             ccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCC
Q 003301          337 KEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTS  416 (832)
Q Consensus       337 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  416 (832)
                      ..|..+++|+.|+|++|+|+++-+.+|.++..+++|.|..|+|...-...|.++..|+.|+|.+|+|+...|.+|..+.+
T Consensus       268 ~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~  347 (498)
T KOG4237|consen  268 KCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFS  347 (498)
T ss_pred             HHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccce
Confidence            35778888888888888888877888888888888888888887666667777888888888888888777888888888


Q ss_pred             CCeEeCCCCcCCCC-----CCcc-----------cccCcccceeeecCCcccCC---Cccccc---------cccccc-e
Q 003301          417 LRLLSLASNELNSV-----IPST-----------FWNLKDILSLNFSSNFLNGS---LPEDIG---------NLKVVV-I  467 (832)
Q Consensus       417 L~~L~L~~N~l~~~-----~~~~-----------~~~l~~L~~L~Ls~N~l~~~---~~~~~~---------~l~~L~-~  467 (832)
                      |..|.|-.|.+.--     ..++           -..-..++.+.++.+-+...   .|++.+         ..+-+. +
T Consensus       348 l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tV  427 (498)
T KOG4237|consen  348 LSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTV  427 (498)
T ss_pred             eeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhh
Confidence            88888877765310     0000           11112344444554433211   111111         111122 2


Q ss_pred             ecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCC
Q 003301          468 IDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFN  545 (832)
Q Consensus       468 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N  545 (832)
                      ..-|++.++ .+|..+-  ..-.+|++.+|.++ .+|..  .+.+| .+|+|+|+++..--..|.+|++|.+|-||+|
T Consensus       428 vRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  428 VRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             Hhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            223344443 4444332  13567888899988 67776  66777 8899999988777778888888988888876

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.94  E-value=4.7e-27  Score=242.00  Aligned_cols=163  Identities=27%  Similarity=0.483  Sum_probs=140.7

Q ss_pred             CCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCC
Q 003301          664 SNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNG  740 (832)
Q Consensus       664 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  740 (832)
                      .+++|.|.||+||-|+++ +|+.||||++.+..  ......+++|+.+++.+.||.||.+...|++.+.+++|||-+ .|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            589999999999999886 59999999986543  233478899999999999999999999999999999999999 55


Q ss_pred             CHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC---CcEEEeccccccccCCCcccc
Q 003301          741 SLEDYL-YSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD---MVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       741 ~L~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~---~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +..+++ ...++++++...+.+..||+.||.|||   .++|+|+|+||+|||+...   -++||||||+|+++.+.... 
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR-  723 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR-  723 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh-
Confidence            666654 556668999999999999999999999   9999999999999999543   58999999999998665443 


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                       ...+|||.|.|||++
T Consensus       724 -rsVVGTPAYLaPEVL  738 (888)
T KOG4236|consen  724 -RSVVGTPAYLAPEVL  738 (888)
T ss_pred             -hhhcCCccccCHHHH
Confidence             346899999999985

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.3e-28  Score=255.16  Aligned_cols=170  Identities=27%  Similarity=0.390  Sum_probs=150.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .+.|+++..||.|+||.||+|..++ +-..|.|++........+.+.-||++++.++||+||++++.|..++..||..||
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            4567777889999999999998875 444678888888788889999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      |.||..+.++-.-+..+.+.++.-+++|++.||.|||   +..|||||+|+.|||++-+|.++++|||.+....... ..
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-qk  186 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-QK  186 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHH-hh
Confidence            9999999988777768999999999999999999999   9999999999999999999999999999876543222 22


Q ss_pred             cccccccccccCCCC
Q 003301          817 QTLTLATIGYMAPGL  831 (832)
Q Consensus       817 ~~~~~gt~~y~APE~  831 (832)
                      ...++|||+|||||+
T Consensus       187 RDsFIGTPYWMAPEV  201 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEV  201 (1187)
T ss_pred             hccccCCcccccchh
Confidence            344789999999997

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.94  E-value=1.9e-26  Score=248.37  Aligned_cols=163  Identities=29%  Similarity=0.374  Sum_probs=140.7

Q ss_pred             CeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCC
Q 003301          665 NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNG  740 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  740 (832)
                      +.||+|+||.||+|... +++.||+|++....   ......+.+|+++++.++||||+++++++..++..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875 48999999987542   233467788999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccccc
Q 003301          741 SLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT  820 (832)
Q Consensus       741 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~~  820 (832)
                      +|.+++...+ .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+++....... .....
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~  155 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKTF  155 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccccc
Confidence            9999887654 6899999999999999999999   99999999999999999999999999999876432221 22235


Q ss_pred             cccccccCCCCC
Q 003301          821 LATIGYMAPGLF  832 (832)
Q Consensus       821 ~gt~~y~APE~l  832 (832)
                      +||+.|+|||++
T Consensus       156 ~gt~~y~aPE~~  167 (328)
T cd05593         156 CGTPEYLAPEVL  167 (328)
T ss_pred             cCCcCccChhhh
Confidence            699999999974

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.94  E-value=1.3e-26  Score=245.32  Aligned_cols=170  Identities=25%  Similarity=0.409  Sum_probs=145.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++++++||||+++++++.+++..|+|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            367999999999999999999876 58899999987543 2233567789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      |++ ++|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++....... 
T Consensus        84 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-  158 (288)
T cd07871          84 YLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-  158 (288)
T ss_pred             CCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence            996 5999998776656889999999999999999999   99999999999999999999999999999976533222 


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                      ......|++.|+|||++
T Consensus       159 ~~~~~~~~~~y~aPE~~  175 (288)
T cd07871         159 TYSNEVVTLWYRPPDVL  175 (288)
T ss_pred             cccCceecccccChHHh
Confidence            12234689999999964

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.94  E-value=1.1e-26  Score=253.87  Aligned_cols=147  Identities=27%  Similarity=0.413  Sum_probs=132.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ......+.+|++++.+++||+|+++++++.+++..|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999876 48899999987532   233467788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      ||+++|+|.+++.+.+ .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|+..
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence            9999999999997654 6899999999999999999999   999999999999999999999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.94  E-value=1.4e-26  Score=247.03  Aligned_cols=170  Identities=26%  Similarity=0.431  Sum_probs=145.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch-hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+|+++++.++||||+++++++.+++..|+|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            478999999999999999999886 588999999875432 223467789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      |+ .+++.+++......+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||+|+....... 
T Consensus        84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  158 (303)
T cd07869          84 YV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-  158 (303)
T ss_pred             CC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc-
Confidence            99 47888888776667899999999999999999999   99999999999999999999999999999976433221 


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                      ......||+.|+|||++
T Consensus       159 ~~~~~~~~~~y~aPE~~  175 (303)
T cd07869         159 TYSNEVVTLWYRPPDVL  175 (303)
T ss_pred             cCCCCcccCCCCChHHH
Confidence            22335689999999963

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.6e-26  Score=247.40  Aligned_cols=161  Identities=30%  Similarity=0.359  Sum_probs=139.6

Q ss_pred             eeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCCCH
Q 003301          667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSL  742 (832)
Q Consensus       667 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  742 (832)
                      ||+|+||.||+|.+.+ ++.||+|++....   ......+.+|++++++++||||+++++++.+.+..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            6999999999998864 7899999987532   23346778899999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccccccc
Q 003301          743 EDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA  822 (832)
Q Consensus       743 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~g  822 (832)
                      .+++...+ .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+|+....... .....+|
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g  155 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFCG  155 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccccC
Confidence            99997654 6899999999999999999999   99999999999999999999999999999986433222 2233569


Q ss_pred             cccccCCCCC
Q 003301          823 TIGYMAPGLF  832 (832)
Q Consensus       823 t~~y~APE~l  832 (832)
                      |+.|+|||++
T Consensus       156 t~~y~aPE~~  165 (312)
T cd05585         156 TPEYLAPELL  165 (312)
T ss_pred             CcccCCHHHH
Confidence            9999999974

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.94  E-value=2.4e-26  Score=242.85  Aligned_cols=168  Identities=29%  Similarity=0.395  Sum_probs=143.9

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .|+..+.||+|+||.||+|.+. +++.||+|++....   ......+.+|++++++++|++|+++++++.+++..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3778899999999999999875 58999999987543   2223457789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          736 YMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       736 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |+++|+|.+++... ...+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+|........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence            99999999887643 235899999999999999999999   99999999999999999999999999999987543322


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                        .....||+.|||||++
T Consensus       158 --~~~~~g~~~y~aPE~~  173 (285)
T cd05631         158 --VRGRVGTVGYMAPEVI  173 (285)
T ss_pred             --ecCCCCCCCccCHhhh
Confidence              2234699999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.94  E-value=1.2e-26  Score=251.66  Aligned_cols=172  Identities=23%  Similarity=0.440  Sum_probs=141.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEecC-C
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTNN-D  728 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~  728 (832)
                      .++|++.++||+|+||.||+|.+.      +++.||||+++... ....+.+.+|+++++.+ +||||+++++++... +
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            468999999999999999999752      25679999987543 23346788999999999 899999999988764 4


Q ss_pred             eeEEEEecCCCCCHHHHHhhCC----------------------------------------------------------
Q 003301          729 FKALVLEYMPNGSLEDYLYSNN----------------------------------------------------------  750 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  750 (832)
                      ..|+||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            6899999999999999987532                                                          


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc-ccccccccccc
Q 003301          751 ---FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM-KQTLTLATIGY  826 (832)
Q Consensus       751 ---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y  826 (832)
                         ..+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+|+........ ......+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence               13677888999999999999999   999999999999999999999999999999865432221 12223467889


Q ss_pred             cCCCCC
Q 003301          827 MAPGLF  832 (832)
Q Consensus       827 ~APE~l  832 (832)
                      ||||++
T Consensus       243 ~aPE~~  248 (338)
T cd05102         243 MAPESI  248 (338)
T ss_pred             cCcHHh
Confidence            999974

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=1.3e-26  Score=234.10  Aligned_cols=148  Identities=30%  Similarity=0.411  Sum_probs=133.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .+.|++.+.||+|.-|+||.|...+ +..+|+|++.+..   .....+.+.|.+|++.++||+++.+|+.++.+...|++
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            3567788999999999999999875 5889999997654   33446778899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          734 LEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      ||||+||+|....+++. ..+++..+..++.+|+.||+|||   ..|||.|||||+||||.++|++.++||.++..
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~  228 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLR  228 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeecccccc
Confidence            99999999999887543 45999999999999999999999   99999999999999999999999999998753

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.94  E-value=3.2e-26  Score=246.55  Aligned_cols=163  Identities=29%  Similarity=0.357  Sum_probs=139.5

Q ss_pred             CeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCC
Q 003301          665 NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNG  740 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  740 (832)
                      +.||+|+||.||+|.+. +++.||+|++....   ......+..|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875 58999999997543   223456778999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccccc
Q 003301          741 SLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL  819 (832)
Q Consensus       741 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~  819 (832)
                      +|.+++...+ .+++..+..++.|++.||+|||   + .||+||||||+||+++.++.+||+|||+|+....... ....
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~  155 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKT  155 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cccc
Confidence            9999887654 6899999999999999999999   7 7999999999999999999999999999875432222 1223


Q ss_pred             ccccccccCCCCC
Q 003301          820 TLATIGYMAPGLF  832 (832)
Q Consensus       820 ~~gt~~y~APE~l  832 (832)
                      ..||+.|||||++
T Consensus       156 ~~gt~~y~aPE~~  168 (325)
T cd05594         156 FCGTPEYLAPEVL  168 (325)
T ss_pred             ccCCcccCCHHHH
Confidence            5699999999964

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.3e-26  Score=252.87  Aligned_cols=170  Identities=29%  Similarity=0.465  Sum_probs=148.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.+.||+|+||+||+|.+. +++.||+|++....   ......+.+|+++++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47899999999999999999886 58999999987543   234467888999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc-
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE-  813 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~-  813 (832)
                      ||+++++|.+++.+. ..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            999999999999876 46899999999999999999999   9999999999999999999999999999998764432 


Q ss_pred             ---------------------------ccccccccccccccCCCCC
Q 003301          814 ---------------------------SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ---------------------------~~~~~~~~gt~~y~APE~l  832 (832)
                                                 ........||+.|+|||++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  202 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL  202 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHH
Confidence                                       1122235699999999964

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.94  E-value=5.4e-27  Score=209.49  Aligned_cols=169  Identities=27%  Similarity=0.429  Sum_probs=148.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .+|+..++||+|.||+||+|+..+ ++.||+|.++...  +.......+|+-+++.++|.|||+++++...+....+|+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            356677899999999999998765 7889999998654  3334577899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      || ..+|..+...-.+.++.+.+..++.|+++|+.|+|   ++.+.|||+||+|.+++.+|..|++|||+|+.+.-+...
T Consensus        82 ~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvrc  157 (292)
T KOG0662|consen   82 FC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             Hh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence            99 67999999888888999999999999999999999   999999999999999999999999999999987654432


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                       ....+.|.+|++|.++
T Consensus       158 -ysaevvtlwyrppdvl  173 (292)
T KOG0662|consen  158 -YSAEVVTLWYRPPDVL  173 (292)
T ss_pred             -eeceeeeeeccCccee
Confidence             2335689999999875

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=9.7e-27  Score=258.14  Aligned_cols=174  Identities=29%  Similarity=0.419  Sum_probs=144.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCC-cEEEEEEEeccchhhHHHHHHHHHHHhcCC-CCceeeeceE-Eec---C---C
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDG-MEVAIKVFHLQLEGALKSFDVECEVLKSVR-HRNLVKIISS-CTN---N---D  728 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~---~---~  728 (832)
                      ..++++.+.|.+|||+.||.|+...+ .+||+|++....+...+.+.+||++|+.++ |+|||.+++. ...   .   -
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            35677889999999999999998776 999999998888888899999999999996 9999999993 322   1   2


Q ss_pred             eeEEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccc
Q 003301          729 FKALVLEYMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK  807 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~  807 (832)
                      ++++.||||+||.|-+++..+ ...+++.++++|++|+++|+++|| .++..|||||||-+|||+..+|..||||||.|.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            577999999999999999753 234999999999999999999999 346679999999999999999999999999997


Q ss_pred             ccCCCc-cc-------ccccccccccccCCCCC
Q 003301          808 LLSGEE-SM-------KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       808 ~~~~~~-~~-------~~~~~~gt~~y~APE~l  832 (832)
                      ...... ..       .......|+.|+|||+|
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMI  227 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMI  227 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHH
Confidence            542222 11       11124579999999986

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=4.6e-26  Score=244.99  Aligned_cols=163  Identities=29%  Similarity=0.437  Sum_probs=139.4

Q ss_pred             CeeeccCCceEEEEEec----CCcEEEEEEEeccc----hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          665 NLIGTGGFGSVYKGSFL----DGMEVAIKVFHLQL----EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      +.||+|+||.||+|+..    .++.||+|+++...    ......+.+|+++++.++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            68999999999999763    47889999987532    22335677899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +++++|.+++.+.+ .+.+..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+++....... .
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  156 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-V  156 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-c
Confidence            99999999997654 5788899999999999999999   99999999999999999999999999999875432222 2


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....||+.|+|||++
T Consensus       157 ~~~~~gt~~y~aPE~~  172 (323)
T cd05584         157 THTFCGTIEYMAPEIL  172 (323)
T ss_pred             ccccCCCccccChhhc
Confidence            2235699999999974

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.94  E-value=4.6e-26  Score=245.28  Aligned_cols=168  Identities=25%  Similarity=0.321  Sum_probs=142.6

Q ss_pred             CCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCC-CceeeeceEEecCCeeEEEE
Q 003301          660 QFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRH-RNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  734 (832)
                      +|++.+.||+|+||.||+|++.+ ++.||+|++....   ....+.+..|++++..+.| ++|+++++++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            58889999999999999998764 7889999987542   2344677889999999976 56888999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++.......
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            9999999999987654 6899999999999999999999   99999999999999999999999999999875322221


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                       .....+||+.|+|||++
T Consensus       157 -~~~~~~gt~~y~aPE~~  173 (324)
T cd05587         157 -TTRTFCGTPDYIAPEII  173 (324)
T ss_pred             -ceeeecCCccccChhhh
Confidence             22235699999999974

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.94  E-value=9.1e-29  Score=247.38  Aligned_cols=293  Identities=22%  Similarity=0.256  Sum_probs=229.1

Q ss_pred             CCCcceeccCccccCccccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCccccccccccccccccc
Q 003301            5 SFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTG   84 (832)
Q Consensus         5 ~~n~~~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~   84 (832)
                      ++-.++ ++|..+=.-+  ..++|..|+|+.+.|.+|+.+++|+.||||+|+|+..-|+.+..+.++.+-+++++|+|+ 
T Consensus        54 r~~GL~-eVP~~LP~~t--veirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-  129 (498)
T KOG4237|consen   54 RGKGLT-EVPANLPPET--VEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-  129 (498)
T ss_pred             cCCCcc-cCcccCCCcc--eEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-
Confidence            344555 6666665544  678888999985566689999999999999999997777788888888666777789999 


Q ss_pred             CCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEeccccc---------
Q 003301           85 SLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNL---------  155 (832)
Q Consensus        85 ~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i---------  155 (832)
                      .+|.+.|.+|..++.|.+.-|++.-+..+.|..+++|..|.+-+|.+..+--..|..+..++.+.+..|.+         
T Consensus       130 ~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wl  209 (498)
T KOG4237|consen  130 DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWL  209 (498)
T ss_pred             hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchh
Confidence            89999998999999999999999877777889999999999999999743334888999999999998883         


Q ss_pred             ---ccccCccccCccccceecccccccccccCccccc-CCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCcccc
Q 003301          156 ---TGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFN-LSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSG  231 (832)
Q Consensus       156 ---~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~  231 (832)
                         ....|-.++..+-.....+.++++..+.+..|.. +.++..-..+.+...+..|.. .|.++++|+.|+|++|+|+.
T Consensus       210 a~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~-cf~~L~~L~~lnlsnN~i~~  288 (498)
T KOG4237|consen  210 ADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAK-CFKKLPNLRKLNLSNNKITR  288 (498)
T ss_pred             hhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHH-HHhhcccceEeccCCCccch
Confidence               2344556666666777777888887666655543 223332233344344455543 37889999999999999999


Q ss_pred             ccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCC
Q 003301          232 IIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPIN  307 (832)
Q Consensus       232 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~  307 (832)
                      +.+++|.++.++++|.|..|+|..+....|.++..|+.|+|.+|+|+.+.     +.+|..+..|.+|.|-.|++.
T Consensus       289 i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~-----~~aF~~~~~l~~l~l~~Np~~  359 (498)
T KOG4237|consen  289 IEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVA-----PGAFQTLFSLSTLNLLSNPFN  359 (498)
T ss_pred             hhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEe-----cccccccceeeeeehccCccc
Confidence            99999999999999999999999888888999999999999999998844     446888899999999988875

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=2e-26  Score=244.68  Aligned_cols=170  Identities=29%  Similarity=0.461  Sum_probs=150.8

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      ....|.+.+.||+|.|+.|..|++. ++..||||.+.+..  ....+.+.+|+++|+.++|||||+++.+...+..+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            4578999999999999999999886 49999999987654  22335588999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+.+|.+++|+.+.+ +..+..+..++.|+..|++|+|   ++.|||||||++||+++.+.++||+|||++..+....
T Consensus       134 ~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             EEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecccc
Confidence            99999999999998876 4556889999999999999999   9999999999999999999999999999999886433


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                        .....+|++.|+|||++
T Consensus       210 --~lqt~cgsppyAaPEl~  226 (596)
T KOG0586|consen  210 --MLQTFCGSPPYAAPELF  226 (596)
T ss_pred             --cccccCCCCCccChHhh
Confidence              33447899999999985

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.94  E-value=2.8e-26  Score=242.82  Aligned_cols=170  Identities=29%  Similarity=0.373  Sum_probs=144.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      ++|++.+.||+|+||.||+|++. +++.||+|++....  ....+.+.+|++++++++||||+++++++..++..|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47899999999999999999986 47889999987543  2334677889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      |++++.+..+.+ ....+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+|+........
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence            998876665543 3446899999999999999999999   999999999999999999999999999999876443332


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                      ......||+.|+|||++
T Consensus       157 ~~~~~~~~~~y~aPE~~  173 (287)
T cd07848         157 NYTEYVATRWYRSPELL  173 (287)
T ss_pred             cccccccccccCCcHHH
Confidence            33345699999999964

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.94  E-value=5.9e-27  Score=251.94  Aligned_cols=169  Identities=32%  Similarity=0.506  Sum_probs=143.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC------ee
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNND------FK  730 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~  730 (832)
                      ..|...+.||+|+||.||+++++ .|+.||||.++... ....++..+|++++++++|||||+++++-.+..      ..
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            34566789999999999999965 59999999987643 334578899999999999999999999865433      46


Q ss_pred             EEEEecCCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeC--CCC--cEEEeccc
Q 003301          731 ALVLEYMPNGSLEDYLYSNN--FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD--KDM--VAHLSDFG  804 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~--~~~--~~kl~DFg  804 (832)
                      .+|||||.||||+.++++..  ..+++.+...+..+++.|+.|||   +.|||||||||.||++-  .+|  ..||+|||
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            79999999999999998643  35999999999999999999999   99999999999999993  333  58999999


Q ss_pred             cccccCCCcccccccccccccccCCCCC
Q 003301          805 IAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       805 ~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .|+..+++.  .....+||+.|.|||++
T Consensus       170 ~Arel~d~s--~~~S~vGT~~YLhPel~  195 (732)
T KOG4250|consen  170 AARELDDNS--LFTSLVGTEEYLHPELY  195 (732)
T ss_pred             ccccCCCCC--eeeeecCchhhcChHHH
Confidence            999987665  44557899999999974

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.94  E-value=4.3e-26  Score=243.47  Aligned_cols=172  Identities=24%  Similarity=0.440  Sum_probs=143.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-----------------CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-----------------GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVK  719 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~  719 (832)
                      .++|++.++||+|+||.||+|.+.+                 +..||+|++.... ......+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3678999999999999999997532                 3469999987543 334567889999999999999999


Q ss_pred             eceEEecCCeeEEEEecCCCCCHHHHHhhCC------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 003301          720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNN------------------FSFDILQRLSVIIDVALALEYLHFGYSNPVV  781 (832)
Q Consensus       720 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iv  781 (832)
                      +++++.+.+..++||||+++++|.+++....                  ..+++..+.+++.|++.|++|||   +.||+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            9999999999999999999999999986432                  13577888999999999999999   99999


Q ss_pred             ecCCCCCCeEeCCCCcEEEeccccccccCCCccc-ccccccccccccCCCCC
Q 003301          782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       782 H~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~l  832 (832)
                      ||||||+||+++.++.+||+|||+++........ ......++..|||||++
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  212 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI  212 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHH
Confidence            9999999999999999999999999865433321 12223467889999963

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=4.6e-26  Score=250.14  Aligned_cols=164  Identities=25%  Similarity=0.320  Sum_probs=141.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ..+|++.+.||+|+||.||+|.+. +++.||+|...      .+.+.+|++++++++||||+++++++......++|||+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            367999999999999999999875 48899999643      24567899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      + +++|.+++.... .+++..+..++.|++.||+|+|   ++||+||||||+||+++.++.+||+|||+|+.........
T Consensus       165 ~-~~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~  239 (391)
T PHA03212        165 Y-KTDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK  239 (391)
T ss_pred             C-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence            9 578998887654 6899999999999999999999   9999999999999999999999999999997543322222


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      ....+||+.|+|||++
T Consensus       240 ~~~~~gt~~y~aPE~~  255 (391)
T PHA03212        240 YYGWAGTIATNAPELL  255 (391)
T ss_pred             cccccCccCCCChhhh
Confidence            2335799999999974

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.93  E-value=5.4e-26  Score=245.00  Aligned_cols=163  Identities=23%  Similarity=0.329  Sum_probs=139.7

Q ss_pred             CeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEEEecCCC
Q 003301          665 NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      ++||+|+||.||+|++. +++.||+|+++...   ....+.+.+|..++.++ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            47999999999999876 48899999997543   23345678899999888 799999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccccc
Q 003301          740 GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL  819 (832)
Q Consensus       740 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~  819 (832)
                      |+|.+++.+.+ .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~~~  155 (329)
T cd05588          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TTST  155 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-cccc
Confidence            99999887654 6999999999999999999999   99999999999999999999999999999875322221 2233


Q ss_pred             ccccccccCCCCC
Q 003301          820 TLATIGYMAPGLF  832 (832)
Q Consensus       820 ~~gt~~y~APE~l  832 (832)
                      .+||+.|+|||++
T Consensus       156 ~~gt~~y~aPE~~  168 (329)
T cd05588         156 FCGTPNYIAPEIL  168 (329)
T ss_pred             ccCCccccCHHHH
Confidence            5799999999974

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.93  E-value=5.8e-26  Score=243.33  Aligned_cols=163  Identities=27%  Similarity=0.404  Sum_probs=137.1

Q ss_pred             CeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhc-CCCCceeeeceEEecCCeeEEEEecCCC
Q 003301          665 NLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKS-VRHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      ++||+|+||.||+|++.+ ++.||+|+++...   ....+....|.+++.. .+||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999998764 7889999987543   2233455667777765 4899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccccc
Q 003301          740 GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL  819 (832)
Q Consensus       740 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~  819 (832)
                      |+|.+++.... .+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||+|+....... ....
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~-~~~~  155 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-KAST  155 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC-cccc
Confidence            99999987654 6899999999999999999999   99999999999999999999999999999976433222 2233


Q ss_pred             ccccccccCCCCC
Q 003301          820 TLATIGYMAPGLF  832 (832)
Q Consensus       820 ~~gt~~y~APE~l  832 (832)
                      .+||+.|+|||++
T Consensus       156 ~~gt~~y~aPE~~  168 (316)
T cd05592         156 FCGTPDYIAPEIL  168 (316)
T ss_pred             ccCCccccCHHHH
Confidence            5699999999964

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.93  E-value=5.6e-26  Score=244.56  Aligned_cols=166  Identities=28%  Similarity=0.427  Sum_probs=139.8

Q ss_pred             CCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHH---hcCCCCceeeeceEEecCCeeEEE
Q 003301          661 FNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVL---KSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       661 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      |++.+.||+|+||.||+|.+. +++.||||+++...   ....+.+.+|++++   +.++||||+++++++.+.+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677899999999999999875 48999999997542   22335566676655   566899999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+++++|..++...  .+++..+..++.|++.|++|||   +.||+||||||+||++++++.+||+|||+++......
T Consensus        81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            9999999999888653  5899999999999999999999   9999999999999999999999999999987543222


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                      . .....+|++.|||||++
T Consensus       156 ~-~~~~~~g~~~y~aPE~~  173 (324)
T cd05589         156 D-RTSTFCGTPEFLAPEVL  173 (324)
T ss_pred             C-cccccccCccccCHhHh
Confidence            2 22335699999999974

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.93  E-value=5.5e-26  Score=237.55  Aligned_cols=172  Identities=23%  Similarity=0.364  Sum_probs=145.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec----CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL----DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      .++|++.+.||+|+||.||+|++.    .+..||+|.++... ......+.+|+.++++++||||+++++++..++..|+
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            357899999999999999999764    35689999987653 2334678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||||+++|+|.+++......+++..+..++.|++.|++|||   +.|++||||||+||+++.++.+|++|||.+......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999876557899999999999999999999   999999999999999999999999999987654322


Q ss_pred             cccccccccccccccCCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~l  832 (832)
                      .........++..|+|||++
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~  180 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAI  180 (266)
T ss_pred             chhcccCCCCceeecCHHHH
Confidence            21111123356789999963

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=1.5e-26  Score=225.04  Aligned_cols=173  Identities=24%  Similarity=0.392  Sum_probs=146.6

Q ss_pred             chHHHHHHhcCCCCCCeeeccCCceEEEEEe-cCCcEEEEEEEeccchhhHHHHHHHHHHHhcC-CCCceeeeceEEecC
Q 003301          650 SYKELLQATNQFNASNLIGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLVKIISSCTNN  727 (832)
Q Consensus       650 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  727 (832)
                      ++.|..+.++     +.+|+|+|+.|-.+.. .+|.+||||++.++......++.+|++++.++ .|+||++++++|+++
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            3555555544     6899999999999865 46999999999888666778999999999999 599999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC---cEEEeccc
Q 003301          728 DFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM---VAHLSDFG  804 (832)
Q Consensus       728 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~---~~kl~DFg  804 (832)
                      ..+|+|||-|.||+|..++.+.+ .+++.++.++..+|+.||+|||   .+||.|||+||+|||.....   -+|||||.
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccc
Confidence            99999999999999999998765 7999999999999999999999   99999999999999996543   58999999


Q ss_pred             cccccCCCc------ccccccccccccccCCCC
Q 003301          805 IAKLLSGEE------SMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       805 ~a~~~~~~~------~~~~~~~~gt~~y~APE~  831 (832)
                      ++.-+....      .......+|+..|||||+
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEV  257 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEV  257 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcchhH
Confidence            876442211      112233579999999997

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.93  E-value=8.2e-26  Score=234.93  Aligned_cols=170  Identities=27%  Similarity=0.427  Sum_probs=146.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCC
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMP  738 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  738 (832)
                      ++|++.+.||+|+||.||+|.+.++..||+|.+.... ...+.+.+|++++++++||||+++++++..++..|+||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            5688899999999999999999888899999876432 234678889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccc
Q 003301          739 NGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT  818 (832)
Q Consensus       739 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~  818 (832)
                      +|+|.+++......+++..+..++.|++.|++|+|   +.|++||||||+||+++.++.+|++|||.++...........
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS  159 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence            99999999865556899999999999999999999   999999999999999999999999999999865433322222


Q ss_pred             cccccccccCCCCC
Q 003301          819 LTLATIGYMAPGLF  832 (832)
Q Consensus       819 ~~~gt~~y~APE~l  832 (832)
                      ...++..|+|||++
T Consensus       160 ~~~~~~~y~aPE~~  173 (256)
T cd05114         160 GAKFPVKWSPPEVF  173 (256)
T ss_pred             CCCCchhhCChhhc
Confidence            23456789999974

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.93  E-value=8e-26  Score=255.34  Aligned_cols=171  Identities=23%  Similarity=0.328  Sum_probs=146.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC--CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD--GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ..|.+.+.||+|+||.||+|....  ++.||+|.+..........+.+|+++++.++||||+++++++..++..|+||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            348999999999999999997643  577899987655555556778899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          737 MPNGSLEDYLYSN---NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       737 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      +++|+|.++++..   ...+++..+..++.|++.||+|+|   +++|+||||||+||+++.++.+||+|||+|+......
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            9999999987642   335889999999999999999999   9999999999999999999999999999998764432


Q ss_pred             cc-ccccccccccccCCCCC
Q 003301          814 SM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~-~~~~~~gt~~y~APE~l  832 (832)
                      .. .....+||+.|+|||++
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~  243 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELW  243 (478)
T ss_pred             ccccccccCCCccccCHhHh
Confidence            21 22335699999999974

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.93  E-value=8.8e-26  Score=243.26  Aligned_cols=163  Identities=25%  Similarity=0.333  Sum_probs=138.9

Q ss_pred             CeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEEEecCCC
Q 003301          665 NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      +.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.++.++ +||||+++++++.+++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999876 47899999997542   23345677888888776 899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccccc
Q 003301          740 GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL  819 (832)
Q Consensus       740 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~  819 (832)
                      |+|..++...+ .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~  155 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTST  155 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cccc
Confidence            99999887654 6899999999999999999999   99999999999999999999999999999875432221 2233


Q ss_pred             ccccccccCCCCC
Q 003301          820 TLATIGYMAPGLF  832 (832)
Q Consensus       820 ~~gt~~y~APE~l  832 (832)
                      ..||+.|+|||++
T Consensus       156 ~~gt~~y~aPE~~  168 (329)
T cd05618         156 FCGTPNYIAPEIL  168 (329)
T ss_pred             ccCCccccCHHHH
Confidence            5699999999974

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.93  E-value=9e-26  Score=242.88  Aligned_cols=168  Identities=25%  Similarity=0.337  Sum_probs=142.2

Q ss_pred             CCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEEE
Q 003301          660 QFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      +|++.+.||+|+||.||+|.+.. ++.||+|++....   ....+.+..|.+++... +|++|+++++++.+.+..|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            58889999999999999998764 7899999987543   22334566788888777 5899999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||+++|+|.+++.... .+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||+++.......
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence            9999999999987654 6899999999999999999999   99999999999999999999999999999975432221


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                       .....+||+.|+|||++
T Consensus       157 -~~~~~~gt~~y~aPE~~  173 (323)
T cd05616         157 -TTKTFCGTPDYIAPEII  173 (323)
T ss_pred             -ccccCCCChhhcCHHHh
Confidence             22335699999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.93  E-value=6.9e-26  Score=243.17  Aligned_cols=163  Identities=25%  Similarity=0.367  Sum_probs=138.8

Q ss_pred             CeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEEEecCCC
Q 003301          665 NLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      +.||+|+||.||+|++.. ++.||+|++....   ....+.+..|.+++... +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999998864 8899999987542   23345677888888776 699999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccccc
Q 003301          740 GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL  819 (832)
Q Consensus       740 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~  819 (832)
                      |+|.+++...+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~~  155 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTST  155 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cccc
Confidence            99999987654 6899999999999999999999   99999999999999999999999999999875432222 2233


Q ss_pred             ccccccccCCCCC
Q 003301          820 TLATIGYMAPGLF  832 (832)
Q Consensus       820 ~~gt~~y~APE~l  832 (832)
                      ..||+.|+|||++
T Consensus       156 ~~gt~~y~aPE~~  168 (320)
T cd05590         156 FCGTPDYIAPEIL  168 (320)
T ss_pred             cccCccccCHHHH
Confidence            5699999999964

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.93  E-value=7.3e-26  Score=243.33  Aligned_cols=163  Identities=27%  Similarity=0.370  Sum_probs=138.7

Q ss_pred             CeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEEEecCCC
Q 003301          665 NLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      ++||+|+||.||+|++.. ++.||+|++....   ....+.+..|.+++..+ +||+|+++++++.+++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            469999999999998864 7899999987542   23345677888888866 799999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccccc
Q 003301          740 GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL  819 (832)
Q Consensus       740 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~  819 (832)
                      ++|.+++...+ .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|+....... ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~  155 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTT  155 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cccc
Confidence            99999987654 6899999999999999999999   99999999999999999999999999999876433222 2233


Q ss_pred             ccccccccCCCCC
Q 003301          820 TLATIGYMAPGLF  832 (832)
Q Consensus       820 ~~gt~~y~APE~l  832 (832)
                      ..||+.|+|||++
T Consensus       156 ~~gt~~y~aPE~~  168 (321)
T cd05591         156 FCGTPDYIAPEIL  168 (321)
T ss_pred             cccCccccCHHHH
Confidence            5699999999963

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.93  E-value=1.5e-25  Score=241.96  Aligned_cols=168  Identities=26%  Similarity=0.354  Sum_probs=146.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .++|++.+.||+|+||.||+|++. ++..||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            478999999999999999999886 48889999987653 2345678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN-PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |+++++|.+++.... .+++..+..++.|++.|+.|||   +. +|+||||||+||+++.++.+||+|||++....... 
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  158 (331)
T cd06649          84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (331)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence            999999999997654 6889999999999999999999   65 69999999999999999999999999998653322 


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                        .....||+.|+|||++
T Consensus       159 --~~~~~g~~~y~aPE~~  174 (331)
T cd06649         159 --ANSFVGTRSYMSPERL  174 (331)
T ss_pred             --cccCCCCcCcCCHhHh
Confidence              2234699999999974

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.93  E-value=1.1e-25  Score=242.33  Aligned_cols=163  Identities=32%  Similarity=0.410  Sum_probs=136.5

Q ss_pred             CeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHH-HHhcCCCCceeeeceEEecCCeeEEEEecCCC
Q 003301          665 NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECE-VLKSVRHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      +.||+|+||+||+|.+. +|+.||+|++....   ......+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999875 58999999987542   222344555554 46778999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccccc
Q 003301          740 GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL  819 (832)
Q Consensus       740 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~  819 (832)
                      |+|..++.... .+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~  155 (325)
T cd05604          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTTT  155 (325)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Cccc
Confidence            99999887654 6899999999999999999999   99999999999999999999999999999875422221 2233


Q ss_pred             ccccccccCCCCC
Q 003301          820 TLATIGYMAPGLF  832 (832)
Q Consensus       820 ~~gt~~y~APE~l  832 (832)
                      .+||+.|||||++
T Consensus       156 ~~gt~~y~aPE~~  168 (325)
T cd05604         156 FCGTPEYLAPEVI  168 (325)
T ss_pred             ccCChhhCCHHHH
Confidence            5699999999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.93  E-value=1.4e-25  Score=241.49  Aligned_cols=163  Identities=32%  Similarity=0.408  Sum_probs=136.4

Q ss_pred             CeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHH-HHhcCCCCceeeeceEEecCCeeEEEEecCCC
Q 003301          665 NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECE-VLKSVRHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      +.||+|+||+||+|.+. +|+.||+|++....   ......+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999886 58999999987542   122344455554 46789999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccccc
Q 003301          740 GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL  819 (832)
Q Consensus       740 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~  819 (832)
                      |+|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TTST  155 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-cccc
Confidence            99999987654 6899999999999999999999   99999999999999999999999999999875432222 2233


Q ss_pred             ccccccccCCCCC
Q 003301          820 TLATIGYMAPGLF  832 (832)
Q Consensus       820 ~~gt~~y~APE~l  832 (832)
                      .+||+.|+|||++
T Consensus       156 ~~gt~~y~aPE~~  168 (323)
T cd05575         156 FCGTPEYLAPEVL  168 (323)
T ss_pred             ccCChhhcChhhh
Confidence            5699999999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.93  E-value=9.1e-26  Score=242.60  Aligned_cols=168  Identities=24%  Similarity=0.325  Sum_probs=142.1

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCC-CCceeeeceEEecCCeeEEEE
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVR-HRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  734 (832)
                      +|+..+.||+|+||+||+|.+. +++.||+|++....   ....+.+..|.++++.+. |++|+++++++.+.+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4778899999999999999876 48899999987542   233456778888888885 577888999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||+++|+|.+++.... .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+++.......
T Consensus        81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence            9999999999987654 6899999999999999999999   99999999999999999999999999999876433222


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                       ......||+.|+|||++
T Consensus       157 -~~~~~~gt~~y~aPE~~  173 (323)
T cd05615         157 -TTRTFCGTPDYIAPEII  173 (323)
T ss_pred             -cccCccCCccccCHHHH
Confidence             12234699999999964

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.93  E-value=1.3e-25  Score=241.56  Aligned_cols=163  Identities=30%  Similarity=0.384  Sum_probs=136.0

Q ss_pred             CeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHH-HHhcCCCCceeeeceEEecCCeeEEEEecCCC
Q 003301          665 NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECE-VLKSVRHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      ++||+|+||.||+|++. +++.||+|++....   ......+.+|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999886 48899999987542   122344555554 57889999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccccc
Q 003301          740 GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL  819 (832)
Q Consensus       740 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~  819 (832)
                      ++|.+++.... .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (321)
T cd05603          81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TTST  155 (321)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-cccc
Confidence            99999887643 6889999999999999999999   99999999999999999999999999999875422222 2233


Q ss_pred             ccccccccCCCCC
Q 003301          820 TLATIGYMAPGLF  832 (832)
Q Consensus       820 ~~gt~~y~APE~l  832 (832)
                      .+||+.|+|||++
T Consensus       156 ~~gt~~y~aPE~~  168 (321)
T cd05603         156 FCGTPEYLAPEVL  168 (321)
T ss_pred             ccCCcccCCHHHh
Confidence            5699999999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.93  E-value=1.1e-25  Score=241.59  Aligned_cols=163  Identities=29%  Similarity=0.402  Sum_probs=140.1

Q ss_pred             CeeeccCCceEEEEEec----CCcEEEEEEEeccch--hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCC
Q 003301          665 NLIGTGGFGSVYKGSFL----DGMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMP  738 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  738 (832)
                      +.||+|+||.||+++..    +|+.||+|++.....  .....+..|++++++++||||+++++++.+++..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            67999999999998753    478999999975432  233566789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccc
Q 003301          739 NGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT  818 (832)
Q Consensus       739 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~  818 (832)
                      +|+|.+++.+.. .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~  156 (318)
T cd05582          82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAY  156 (318)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-cee
Confidence            999999997654 6899999999999999999999   99999999999999999999999999999986543322 122


Q ss_pred             cccccccccCCCCC
Q 003301          819 LTLATIGYMAPGLF  832 (832)
Q Consensus       819 ~~~gt~~y~APE~l  832 (832)
                      ...||+.|+|||++
T Consensus       157 ~~~g~~~y~aPE~~  170 (318)
T cd05582         157 SFCGTVEYMAPEVV  170 (318)
T ss_pred             cccCChhhcCHHHH
Confidence            35699999999963

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.93  E-value=1.2e-25  Score=240.82  Aligned_cols=163  Identities=23%  Similarity=0.406  Sum_probs=137.6

Q ss_pred             CeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEEEecCCC
Q 003301          665 NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      +.||+|+||.||+|++. +|+.||+|+++...   ....+....|.+++... +||+|+++++++.+++..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999886 48899999997543   22345566788887654 899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccccc
Q 003301          740 GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL  819 (832)
Q Consensus       740 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~  819 (832)
                      |+|.+++.... .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (316)
T cd05620          81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RAST  155 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-ceec
Confidence            99999987653 6899999999999999999999   99999999999999999999999999999875322221 2233


Q ss_pred             ccccccccCCCCC
Q 003301          820 TLATIGYMAPGLF  832 (832)
Q Consensus       820 ~~gt~~y~APE~l  832 (832)
                      .+||+.|+|||++
T Consensus       156 ~~gt~~y~aPE~~  168 (316)
T cd05620         156 FCGTPDYIAPEIL  168 (316)
T ss_pred             cCCCcCccCHHHH
Confidence            5699999999974

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-25  Score=257.59  Aligned_cols=172  Identities=28%  Similarity=0.526  Sum_probs=147.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC--Cc----EEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD--GM----EVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  730 (832)
                      ....+..+.||+|+||.||+|...+  |.    .||||.++... ......|.+|..+|+.++|||||+++|++.+.+..
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            4566778999999999999998764  43    38999887553 45568999999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccc
Q 003301          731 ALVLEYMPNGSLEDYLYSN------NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFG  804 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg  804 (832)
                      +|++|||++|+|..++++.      ...+.......++.|||+|+.||+   ++++|||||.++|+|++....|||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccc
Confidence            9999999999999999987      445889999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCcccccccc-cccccccCCCCC
Q 003301          805 IAKLLSGEESMKQTLT-LATIGYMAPGLF  832 (832)
Q Consensus       805 ~a~~~~~~~~~~~~~~-~gt~~y~APE~l  832 (832)
                      +|+.+-..+....... .-+.+|||||.|
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl  876 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESL  876 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHH
Confidence            9996544444333322 345689999975

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.93  E-value=1.5e-25  Score=239.90  Aligned_cols=163  Identities=26%  Similarity=0.400  Sum_probs=137.7

Q ss_pred             CeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhc-CCCCceeeeceEEecCCeeEEEEecCCC
Q 003301          665 NLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKS-VRHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      +.||+|+||+||+|.+.+ ++.||||+++...   ....+....|..++.. .+||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            479999999999998864 7899999987643   2334556678888876 4899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccccc
Q 003301          740 GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL  819 (832)
Q Consensus       740 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~  819 (832)
                      |+|.+++.... .+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (316)
T cd05619          81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCT  155 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceee
Confidence            99999997653 6889999999999999999999   99999999999999999999999999999875422221 1223


Q ss_pred             ccccccccCCCCC
Q 003301          820 TLATIGYMAPGLF  832 (832)
Q Consensus       820 ~~gt~~y~APE~l  832 (832)
                      ..||+.|+|||++
T Consensus       156 ~~gt~~y~aPE~~  168 (316)
T cd05619         156 FCGTPDYIAPEIL  168 (316)
T ss_pred             ecCCccccCHHHH
Confidence            5699999999974

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.93  E-value=1.5e-25  Score=241.33  Aligned_cols=163  Identities=31%  Similarity=0.374  Sum_probs=134.9

Q ss_pred             CeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHH-HHhcCCCCceeeeceEEecCCeeEEEEecCCC
Q 003301          665 NLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECE-VLKSVRHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      +.||+|+||+||+|.+.. ++.||+|++....   ......+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            479999999999998864 7889999987542   122234444444 56788999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccccc
Q 003301          740 GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL  819 (832)
Q Consensus       740 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~  819 (832)
                      ++|.+++.... .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|+....... ....
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~~  155 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTST  155 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cccc
Confidence            99999997654 5788899999999999999999   99999999999999999999999999999975432222 2233


Q ss_pred             ccccccccCCCCC
Q 003301          820 TLATIGYMAPGLF  832 (832)
Q Consensus       820 ~~gt~~y~APE~l  832 (832)
                      .+||+.|||||++
T Consensus       156 ~~gt~~y~aPE~~  168 (325)
T cd05602         156 FCGTPEYLAPEVL  168 (325)
T ss_pred             ccCCccccCHHHH
Confidence            5699999999963

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.93  E-value=1.7e-25  Score=240.92  Aligned_cols=163  Identities=25%  Similarity=0.341  Sum_probs=139.5

Q ss_pred             CeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEEEecCCC
Q 003301          665 NLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      +.||+|+||.||+|.... ++.||+|+++...   ....+.+.+|+.++.++ +||+|+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            479999999999998764 7899999998543   23345678899999888 699999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccccc
Q 003301          740 GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL  819 (832)
Q Consensus       740 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~  819 (832)
                      |+|.+++...+ .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TTST  155 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ceec
Confidence            99999887654 6899999999999999999999   99999999999999999999999999999875322221 2233


Q ss_pred             ccccccccCCCCC
Q 003301          820 TLATIGYMAPGLF  832 (832)
Q Consensus       820 ~~gt~~y~APE~l  832 (832)
                      .+||+.|+|||++
T Consensus       156 ~~gt~~y~aPE~~  168 (327)
T cd05617         156 FCGTPNYIAPEIL  168 (327)
T ss_pred             ccCCcccCCHHHH
Confidence            5699999999974

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.93  E-value=1.2e-25  Score=246.49  Aligned_cols=172  Identities=24%  Similarity=0.432  Sum_probs=142.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDF  729 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  729 (832)
                      .++|++.+.||+|+||.||+|++.      ++..||||+++... ....+.+.+|+++++.+ +||||+++++++.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            457999999999999999999742      35689999986443 23446788999999999 89999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCC-----------------------------------------------------------
Q 003301          730 KALVLEYMPNGSLEDYLYSNN-----------------------------------------------------------  750 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  750 (832)
                      .|+||||+++|+|.++++...                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999986532                                                           


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          751 ---------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       751 ---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                                     ..+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                           13678888999999999999999   999999999999999999999999999999876433221


Q ss_pred             c-cccccccccccCCCCC
Q 003301          816 K-QTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~-~~~~~gt~~y~APE~l  832 (832)
                      . .....++..|+|||++
T Consensus       271 ~~~~~~~~~~~y~aPE~~  288 (375)
T cd05104         271 VVKGNARLPVKWMAPESI  288 (375)
T ss_pred             cccCCCCCCcceeChhHh
Confidence            1 1123356789999974

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.93  E-value=1.1e-25  Score=245.27  Aligned_cols=165  Identities=31%  Similarity=0.441  Sum_probs=140.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ++|+..++||+|+||.||+|++. +++.||||++.... ....+.+.+|+++++.++|+||+++++++...+..|+||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45677889999999999999876 58999999986543 23346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +++++|.+..     ..++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+++....... .
T Consensus       154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~  224 (353)
T PLN00034        154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-P  224 (353)
T ss_pred             CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-c
Confidence            9999986532     3567788899999999999999   99999999999999999999999999999987643321 1


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....||..|+|||++
T Consensus       225 ~~~~~gt~~y~aPE~~  240 (353)
T PLN00034        225 CNSSVGTIAYMSPERI  240 (353)
T ss_pred             ccccccCccccCcccc
Confidence            2235699999999974

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.93  E-value=2.2e-25  Score=240.54  Aligned_cols=168  Identities=26%  Similarity=0.374  Sum_probs=146.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .++|++.+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|++++++++||||+++++++.+++..|+|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            478999999999999999999886 47889999887543 3344678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN-PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |+++++|.++++..+ .+++..+..++.|++.|++|||   +. +++||||||+||+++.++.+||+|||++....... 
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-  158 (333)
T cd06650          84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (333)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence            999999999997654 5889999999999999999999   64 79999999999999999999999999997653321 


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                        .....||+.|+|||++
T Consensus       159 --~~~~~~~~~y~aPE~~  174 (333)
T cd06650         159 --ANSFVGTRSYMSPERL  174 (333)
T ss_pred             --cccCCCCccccCHHHh
Confidence              1234689999999974

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.7e-26  Score=233.52  Aligned_cols=170  Identities=25%  Similarity=0.385  Sum_probs=151.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ..-|+..+.||+|-|++|-.|++. +|..||||++.+..  ......+.+|++.|+-++|||||++|.+..+...+|+|+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            356888899999999999999875 69999999997654  234467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe-CCCCcEEEeccccccccCCCc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL-DKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~-~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |.=++|+|++|+-+....+.+..+.+++.||+.|+.|+|   +..+||||+||+||.+ .+-|-||++|||++-.+.+..
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            999999999999887778999999999999999999999   9999999999999977 567999999999998875544


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                        ..+..||+..|-|||++
T Consensus       174 --kL~TsCGSLAYSAPEIL  190 (864)
T KOG4717|consen  174 --KLTTSCGSLAYSAPEIL  190 (864)
T ss_pred             --hhhcccchhhccCchhh
Confidence              34457899999999985

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.5e-26  Score=225.19  Aligned_cols=170  Identities=28%  Similarity=0.345  Sum_probs=148.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|+..+++|+|.||+|..++.+ .++.||+|++++..   ......-..|-++++..+||++..+-..|+..++.|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            478999999999999999999875 48999999988664   33344566799999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+.||.|.-++.+.+ .++++.+..+...|+.||.|||   +++||.||+|.+|.++|.+|.+||+|||+++.--..+
T Consensus       247 MeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG  322 (516)
T ss_pred             EEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence            99999999998887655 6999999999999999999999   9999999999999999999999999999998643332


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                      . .....||||.|.|||++
T Consensus       323 ~-t~kTFCGTPEYLAPEVl  340 (516)
T KOG0690|consen  323 D-TTKTFCGTPEYLAPEVL  340 (516)
T ss_pred             c-eeccccCChhhcCchhh
Confidence            2 34457899999999986

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.93  E-value=1.7e-25  Score=242.91  Aligned_cols=168  Identities=26%  Similarity=0.380  Sum_probs=140.4

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecC-----CeeE
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNN-----DFKA  731 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~  731 (832)
                      +|++.+.||+|+||.||+|.+. +++.||||++....  ......+.+|++++++++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5888999999999999999875 58999999986432  22345688999999999999999999987543     2579


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +||||+ +++|.+++.... .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|+....
T Consensus        81 lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELM-ESDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecC-CCCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            999999 579999987654 6899999999999999999999   99999999999999999999999999999986532


Q ss_pred             Ccc--cccccccccccccCCCCC
Q 003301          812 EES--MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~--~~~~~~~gt~~y~APE~l  832 (832)
                      ...  .......||+.|+|||++
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~  178 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELC  178 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHH
Confidence            221  112335699999999963

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=6.7e-26  Score=240.48  Aligned_cols=164  Identities=31%  Similarity=0.485  Sum_probs=145.9

Q ss_pred             CeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCCCHH
Q 003301          665 NLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLE  743 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  743 (832)
                      -++|+|.||+||.|++.+ ...+|||.+..+.....+.+..||.+.++++|.|||+++|++.+++.+-|.||-++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            479999999999999876 5668999998887777788999999999999999999999999999999999999999999


Q ss_pred             HHHhhCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeC-CCCcEEEeccccccccCCCcccccccc
Q 003301          744 DYLYSNNFSF--DILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD-KDMVAHLSDFGIAKLLSGEESMKQTLT  820 (832)
Q Consensus       744 ~~l~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-~~~~~kl~DFg~a~~~~~~~~~~~~~~  820 (832)
                      ++++..-+++  .+...-.+..||++|+.|||   ...|||||||-+||||+ -.|.+||+|||.++.+.+-.....+ .
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET-F  736 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET-F  736 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCccccc-c
Confidence            9999876565  77788889999999999999   99999999999999995 5799999999999987655444333 5


Q ss_pred             cccccccCCCCC
Q 003301          821 LATIGYMAPGLF  832 (832)
Q Consensus       821 ~gt~~y~APE~l  832 (832)
                      .||..|||||++
T Consensus       737 TGTLQYMAPEvI  748 (1226)
T KOG4279|consen  737 TGTLQYMAPEVI  748 (1226)
T ss_pred             ccchhhhChHhh
Confidence            699999999985

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.93  E-value=2.5e-25  Score=231.17  Aligned_cols=170  Identities=28%  Similarity=0.437  Sum_probs=146.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCC
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMP  738 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  738 (832)
                      ++|++.+.||+|+||.||.|++.++..||+|.+.... ...+.+.+|+.++++++||||+++++++...+..|+||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            5688899999999999999998777789999887443 234678899999999999999999999999889999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccc
Q 003301          739 NGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT  818 (832)
Q Consensus       739 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~  818 (832)
                      +++|.+++......+++..++.++.|++.|++|||   +.|++||||||+||+++.++.+||+|||.++...........
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV  159 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence            99999999875557899999999999999999999   999999999999999999999999999998865443322222


Q ss_pred             cccccccccCCCCC
Q 003301          819 LTLATIGYMAPGLF  832 (832)
Q Consensus       819 ~~~gt~~y~APE~l  832 (832)
                      ...++..|+|||++
T Consensus       160 ~~~~~~~y~~pe~~  173 (256)
T cd05113         160 GSKFPVRWSPPEVL  173 (256)
T ss_pred             CCccChhhCCHHHH
Confidence            23456789999963

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.93  E-value=2.5e-25  Score=257.05  Aligned_cols=171  Identities=28%  Similarity=0.370  Sum_probs=143.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.++||+|+||.||+|.+.. ++.||+|++....   ....+++.+|++++++++||||+++++++.+++..|+||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            579999999999999999998764 8999999987532   233467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhC----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccc
Q 003301          735 EYMPNGSLEDYLYSN----------NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFG  804 (832)
Q Consensus       735 e~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg  804 (832)
                      ||++|++|.+++...          ....++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999998642          123556778899999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCcc-----------------cccccccccccccCCCCC
Q 003301          805 IAKLLSGEES-----------------MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       805 ~a~~~~~~~~-----------------~~~~~~~gt~~y~APE~l  832 (832)
                      +|+.......                 ......+||+.|||||++
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l  203 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL  203 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHh
Confidence            9986521110                 011124699999999963

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=3.5e-25  Score=233.90  Aligned_cols=168  Identities=29%  Similarity=0.397  Sum_probs=143.8

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      +|++.+.||+|+||+||+|... +++.||+|++....   ......+.+|++++++++||||+++++++.+++..|+|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999875 58899999987532   1223456789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          736 YMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       736 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |+++|+|.+++... ...+++..+..++.|++.|++|||   +.+++||||||+||++++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence            99999999888654 235899999999999999999999   99999999999999999999999999999987543222


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                        .....|++.|+|||++
T Consensus       158 --~~~~~~~~~y~aPE~~  173 (285)
T cd05605         158 --IRGRVGTVGYMAPEVV  173 (285)
T ss_pred             --cccccCCCCccCcHHh
Confidence              1234689999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.93  E-value=3e-25  Score=233.77  Aligned_cols=162  Identities=30%  Similarity=0.383  Sum_probs=137.9

Q ss_pred             eeccCCceEEEEEec-CCcEEEEEEEeccch---hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCCCH
Q 003301          667 IGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE---GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSL  742 (832)
Q Consensus       667 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  742 (832)
                      ||+|+||+||+|.+. +++.||+|++.....   ...+.+..|+++++.++||+|+++.+++..++..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999876 588999999875432   2235677899999999999999999999999999999999999999


Q ss_pred             HHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccccc
Q 003301          743 EDYLYS---NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL  819 (832)
Q Consensus       743 ~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~  819 (832)
                      .+++..   ....+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||.+......... ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence            988753   2335899999999999999999999   999999999999999999999999999999866443322 223


Q ss_pred             ccccccccCCCCC
Q 003301          820 TLATIGYMAPGLF  832 (832)
Q Consensus       820 ~~gt~~y~APE~l  832 (832)
                      ..||+.|+|||++
T Consensus       157 ~~g~~~y~aPE~~  169 (280)
T cd05608         157 YAGTPGFMAPELL  169 (280)
T ss_pred             cCCCcCccCHHHh
Confidence            4699999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.93  E-value=1.5e-25  Score=240.92  Aligned_cols=164  Identities=26%  Similarity=0.421  Sum_probs=143.1

Q ss_pred             CCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCC-C-----CceeeeceEEecCCeeEE
Q 003301          660 QFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVR-H-----RNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~l  732 (832)
                      +|++.+.||+|+||.|.+|.+.. ++.||||+++... ....+...|+.++..++ |     -|+|+++++|...++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            89999999999999999998764 9999999998664 34466778999999996 4     479999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC--CcEEEecccccccc
Q 003301          733 VLEYMPNGSLEDYLYSNNF-SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD--MVAHLSDFGIAKLL  809 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~--~~~kl~DFg~a~~~  809 (832)
                      |+|.. ..+|+++++.++. .++...++.++.||+.||.+||   +.+|||+||||+|||+...  ..+||+|||.|+..
T Consensus       266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            99999 6799999998764 3899999999999999999999   9999999999999999644  47999999999975


Q ss_pred             CCCcccccccccccccccCCCCC
Q 003301          810 SGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       810 ~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ....    ..++-+..|+|||+|
T Consensus       342 ~q~v----ytYiQSRfYRAPEVI  360 (586)
T KOG0667|consen  342 SQRV----YTYIQSRFYRAPEVI  360 (586)
T ss_pred             CCcc----eeeeeccccccchhh
Confidence            4332    246789999999986

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.93  E-value=2.3e-25  Score=244.65  Aligned_cols=168  Identities=27%  Similarity=0.368  Sum_probs=143.1

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC-----eeE
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNND-----FKA  731 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  731 (832)
                      +|++.+.||+|+||.||+|.+. +++.||+|++....  ....+++.+|+++++.++||||+++++++...+     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788999999999999999875 58999999886432  233467889999999999999999999998776     789


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +||||+. ++|.+++.... .+++..+..++.|++.||+|||   +.|++||||||+||+++.++.+||+|||+|+....
T Consensus        81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999995 68888886543 6899999999999999999999   99999999999999999999999999999987544


Q ss_pred             CcccccccccccccccCCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ..........+|+.|+|||++
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~  176 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEIL  176 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHH
Confidence            333333345689999999963

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PLN03210 Resistant to P

Probab=99.93  E-value=1.4e-24  Score=267.89  Aligned_cols=347  Identities=24%  Similarity=0.287  Sum_probs=208.7

Q ss_pred             CCccccccccCcEEEccCCcCC------CCCCCcccCcccccccccccccccccCCChhhhhcCCCceEEEccCCccccc
Q 003301           37 IPQELGNLAELELVSLTNNFLS------GTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGP  110 (832)
Q Consensus        37 ~p~~~~~l~~L~~L~l~~n~l~------~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~  110 (832)
                      .+.+|.++.+|+.|.+.++...      ..+|+++..++.-++.|++.++.++ .+|..+  ...+|+.|++++|+++ .
T Consensus       550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f--~~~~L~~L~L~~s~l~-~  625 (1153)
T PLN03210        550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF--RPENLVKLQMQGSKLE-K  625 (1153)
T ss_pred             cHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC--CccCCcEEECcCcccc-c
Confidence            4456788888888888665432      2355555555433355566655555 555554  3455556666666555 4


Q ss_pred             CCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccccccccccCcccccC
Q 003301          111 IPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNL  190 (832)
Q Consensus       111 ~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  190 (832)
                      +|..+..+++|+.|+|++|.....+|. +..+++|++|+|++|.....+|..++++++|+.|++++|...+.+|..+ ++
T Consensus       626 L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l  703 (1153)
T PLN03210        626 LWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NL  703 (1153)
T ss_pred             cccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CC
Confidence            555555555555666555443233442 4555555555555554433555555555555555555543333334333 44


Q ss_pred             CcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCcccccee
Q 003301          191 SAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWL  270 (832)
Q Consensus       191 ~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  270 (832)
                      ++|+.|++++|...+.+|.                          .   .++|++|++++|.+.. .|..+ .+++|++|
T Consensus       704 ~sL~~L~Lsgc~~L~~~p~--------------------------~---~~nL~~L~L~~n~i~~-lP~~~-~l~~L~~L  752 (1153)
T PLN03210        704 KSLYRLNLSGCSRLKSFPD--------------------------I---STNISWLDLDETAIEE-FPSNL-RLENLDEL  752 (1153)
T ss_pred             CCCCEEeCCCCCCcccccc--------------------------c---cCCcCeeecCCCcccc-ccccc-cccccccc
Confidence            5555555555543333332                          1   2344555555555442 22222 34555555


Q ss_pred             ecccccCCCCCCccc-c-ccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEE
Q 003301          271 RLSYNFLTSSTSELS-F-LSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLREL  348 (832)
Q Consensus       271 ~L~~N~l~~~~~~~~-~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  348 (832)
                      ++.++....+..... . +..+...++|+.|++++|.....+|.++..+. +|+.|++++|...+.+|..+ ++++|+.|
T Consensus       753 ~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~-~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L  830 (1153)
T PLN03210        753 ILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLH-KLEHLEIENCINLETLPTGI-NLESLESL  830 (1153)
T ss_pred             cccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCC-CCCEEECCCCCCcCeeCCCC-CccccCEE
Confidence            554433221111000 0 00122346788888888877777888877776 88888888876555667665 78899999


Q ss_pred             EeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCc
Q 003301          349 GLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNE  426 (832)
Q Consensus       349 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  426 (832)
                      ++++|.....+|..   .++|+.|+|++|.++ .+|.++..+++|+.|+|++|.--..+|..+..+++|+.+++++|.
T Consensus       831 ~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        831 DLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             ECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence            99998755555543   367999999999998 689999999999999999954444678888899999999998875

syringae 6; Provisional

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.93  E-value=3.2e-25  Score=230.48  Aligned_cols=170  Identities=30%  Similarity=0.459  Sum_probs=144.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCC
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMP  738 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  738 (832)
                      .+|++.+.||+|+||.||+|.+.++..+|+|++.... ...+.+.+|++++++++||||+++++++...+..|+||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            4588899999999999999998777889999886432 233568889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccc
Q 003301          739 NGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT  818 (832)
Q Consensus       739 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~  818 (832)
                      +++|.+++......+++..+..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||.++...........
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ  159 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence            99999999876557899999999999999999999   999999999999999999999999999999865433222212


Q ss_pred             cccccccccCCCCC
Q 003301          819 LTLATIGYMAPGLF  832 (832)
Q Consensus       819 ~~~gt~~y~APE~l  832 (832)
                      ...++..|+|||++
T Consensus       160 ~~~~~~~y~~Pe~~  173 (256)
T cd05059         160 GTKFPVKWAPPEVF  173 (256)
T ss_pred             CCCCCccccCHHHh
Confidence            22345679999963

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.93  E-value=1.9e-25  Score=244.60  Aligned_cols=173  Identities=24%  Similarity=0.459  Sum_probs=142.7

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCC
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTNND  728 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  728 (832)
                      ..++|++.+.||+|+||.||+|.+.      ++..||+|++.... ....+.+.+|+++++.+ +||||+++++++...+
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            3468999999999999999999753      23579999987543 33346788999999999 8999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhhCC----------------------------------------------------------
Q 003301          729 FKALVLEYMPNGSLEDYLYSNN----------------------------------------------------------  750 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  750 (832)
                      ..|+||||+++|+|.++++...                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999999999999986421                                                          


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc-cc
Q 003301          751 -----------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK-QT  818 (832)
Q Consensus       751 -----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~-~~  818 (832)
                                 ..+++..+.+++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+|+......... ..
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                       13678889999999999999999   9999999999999999999999999999998654332211 11


Q ss_pred             cccccccccCCCCC
Q 003301          819 LTLATIGYMAPGLF  832 (832)
Q Consensus       819 ~~~gt~~y~APE~l  832 (832)
                      ...+++.|||||++
T Consensus       273 ~~~~~~~y~aPE~~  286 (374)
T cd05106         273 NARLPVKWMAPESI  286 (374)
T ss_pred             CCCCccceeCHHHh
Confidence            22356789999963

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=3.6e-25  Score=239.03  Aligned_cols=161  Identities=29%  Similarity=0.331  Sum_probs=134.3

Q ss_pred             eeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcC---CCCceeeeceEEecCCeeEEEEecCCC
Q 003301          667 IGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSV---RHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       667 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      ||+|+||+||+|++. +++.||||++....   .........|..++...   +||+|+++++++.+.+..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999876 48999999986532   12223445566666655   699999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccccc
Q 003301          740 GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL  819 (832)
Q Consensus       740 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~  819 (832)
                      |+|.+++.+.. .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+++....... ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~  155 (330)
T cd05586          81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNT  155 (330)
T ss_pred             ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccC
Confidence            99999987654 6899999999999999999999   99999999999999999999999999999876432222 2233


Q ss_pred             ccccccccCCCCC
Q 003301          820 TLATIGYMAPGLF  832 (832)
Q Consensus       820 ~~gt~~y~APE~l  832 (832)
                      .+||+.|||||++
T Consensus       156 ~~gt~~y~aPE~~  168 (330)
T cd05586         156 FCGTTEYLAPEVL  168 (330)
T ss_pred             ccCCccccCHHHH
Confidence            5699999999964

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.92  E-value=3.9e-25  Score=236.62  Aligned_cols=169  Identities=25%  Similarity=0.405  Sum_probs=144.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ++|.+.+.||+|+||.||+|++. +++.||+|+++... ......+.+|++++++++||||+++++++..++..|+||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            67999999999999999999876 47889999987543 22334677899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      ++ +++.+++...+..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||.++....... .
T Consensus        86 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~  160 (309)
T cd07872          86 LD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-T  160 (309)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-c
Confidence            96 5899988776656899999999999999999999   99999999999999999999999999999976533322 1


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....+|+.|+|||++
T Consensus       161 ~~~~~~~~~y~aPE~~  176 (309)
T cd07872         161 YSNEVVTLWYRPPDVL  176 (309)
T ss_pred             cccccccccccCCHHH
Confidence            2234589999999963

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.92  E-value=4.3e-25  Score=242.48  Aligned_cols=173  Identities=27%  Similarity=0.469  Sum_probs=143.6

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC------CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCC-CCceeeeceEEecCC
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD------GMEVAIKVFHLQL-EGALKSFDVECEVLKSVR-HRNLVKIISSCTNND  728 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  728 (832)
                      ..++|++.+.||+|+||.||+|++..      +..||||++.... ....+.+.+|+++++++. ||||+++++++.+.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            35789999999999999999998632      3469999986543 233467889999999996 999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhhCC----------------------------------------------------------
Q 003301          729 FKALVLEYMPNGSLEDYLYSNN----------------------------------------------------------  750 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  750 (832)
                      ..|+|||||++|+|.+++....                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999999886421                                                          


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeC
Q 003301          751 -------------------------------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD  793 (832)
Q Consensus       751 -------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~  793 (832)
                                                           ..+++..+..++.|++.|++|||   +.+|+||||||+||+++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEe
Confidence                                                 13677788899999999999999   99999999999999999


Q ss_pred             CCCcEEEeccccccccCCCccc-ccccccccccccCCCCC
Q 003301          794 KDMVAHLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       794 ~~~~~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~l  832 (832)
                      .++.+||+|||+++........ ......+++.|+|||++
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~  311 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI  311 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhh
Confidence            9999999999999865432221 12224577889999964

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.92  E-value=3.2e-26  Score=222.02  Aligned_cols=173  Identities=26%  Similarity=0.379  Sum_probs=143.6

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEecC-----CcEEEEEEEeccch--hhHHHHHHHHHHHhcCCCCceeeeceEEec-C
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFLD-----GMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRNLVKIISSCTN-N  727 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~  727 (832)
                      +....|+....||+|.||.||+|...+     .+.+|+|+++.+..  +......+|+.+++.++|||++.+..++.. +
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            345689999999999999999995433     34799999876532  233567789999999999999999999877 7


Q ss_pred             CeeEEEEecCCCCCHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC----CcEE
Q 003301          728 DFKALVLEYMPNGSLEDYLYSN----NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD----MVAH  799 (832)
Q Consensus       728 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~----~~~k  799 (832)
                      ..+++++||++. +|.++++-.    ...++...++.|+.||+.|+.|||   +.=|+|||+||.||+|..+    |.||
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeE
Confidence            889999999964 999888632    235889999999999999999999   9999999999999999877    8999


Q ss_pred             EeccccccccCCCccc--ccccccccccccCCCCC
Q 003301          800 LSDFGIAKLLSGEESM--KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       800 l~DFg~a~~~~~~~~~--~~~~~~gt~~y~APE~l  832 (832)
                      |+|||+|+.+...-..  .....+.|.+|+|||++
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELL  211 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELL  211 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHh
Confidence            9999999988654322  23346789999999975

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.92  E-value=4.2e-25  Score=237.02  Aligned_cols=163  Identities=25%  Similarity=0.366  Sum_probs=139.1

Q ss_pred             CeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEEEecCCC
Q 003301          665 NLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      +.||+|+||+||+|.+.. ++.||||+++...   ......+.+|+++++.+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999998864 7899999997543   23345677888998877 799999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccccc
Q 003301          740 GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL  819 (832)
Q Consensus       740 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~  819 (832)
                      |+|.+++.+.. .+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++....... ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTST  155 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccc
Confidence            99999987654 6899999999999999999999   99999999999999999999999999999875322222 1223


Q ss_pred             ccccccccCCCCC
Q 003301          820 TLATIGYMAPGLF  832 (832)
Q Consensus       820 ~~gt~~y~APE~l  832 (832)
                      .+||+.|+|||++
T Consensus       156 ~~g~~~y~aPE~~  168 (318)
T cd05570         156 FCGTPDYIAPEIL  168 (318)
T ss_pred             eecCccccCHHHh
Confidence            4699999999974

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.92  E-value=4.3e-26  Score=231.91  Aligned_cols=170  Identities=28%  Similarity=0.403  Sum_probs=148.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .+.|..-++||+|+||.||-++.+ +|+-||.|.+.+..   .........|..++.++..++||.+-.+|++.+..++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            467888899999999999999776 48999999875432   23334567899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          734 LEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      |..|.||+|.-++...+ ..+++..+..++.+|+.||++||   +.+||.||+||+|||+|+.|+++|+|.|+|..+...
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999988887644 35999999999999999999999   999999999999999999999999999999988666


Q ss_pred             cccccccccccccccCCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~l  832 (832)
                      ....  ..+||.+|||||++
T Consensus       341 ~~~~--~rvGT~GYMAPEvl  358 (591)
T KOG0986|consen  341 KPIR--GRVGTVGYMAPEVL  358 (591)
T ss_pred             Cccc--cccCcccccCHHHH
Confidence            5443  34799999999985

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=6.4e-25  Score=228.92  Aligned_cols=171  Identities=25%  Similarity=0.432  Sum_probs=146.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      .++|++.+.||+|++|.||+|.+.+++.||+|.++... ...+.+.+|++++++++||||+++++++...+..|+||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            46789999999999999999998778899999987543 23467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          738 PNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       738 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      ++++|.+++.... ..+++..+..++.|++.|++|+|   +.|++||||||+||+++.++.+||+|||+++.........
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA  160 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence            9999999997643 45899999999999999999999   9999999999999999999999999999998765332222


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....++..|+|||++
T Consensus       161 ~~~~~~~~~y~aPE~~  176 (261)
T cd05068         161 REGAKFPIKWTAPEAA  176 (261)
T ss_pred             cCCCcCceeccCcccc
Confidence            2212234579999963

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.92  E-value=7.4e-25  Score=229.32  Aligned_cols=170  Identities=28%  Similarity=0.419  Sum_probs=147.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++..++..|+||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            467999999999999999999875 5889999998765544556788899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +++++|.+++.... .+++..+..++.|++.|++|||   +.||+|||+||+||+++.++.+||+|||.+........ .
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~  162 (267)
T cd06646          88 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K  162 (267)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence            99999999987554 6899999999999999999999   99999999999999999999999999999986643221 1


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....|++.|+|||++
T Consensus       163 ~~~~~~~~~y~~PE~~  178 (267)
T cd06646         163 RKSFIGTPYWMAPEVA  178 (267)
T ss_pred             cCccccCccccCHhHc
Confidence            2234688999999963

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.92  E-value=8.8e-25  Score=228.61  Aligned_cols=172  Identities=26%  Similarity=0.456  Sum_probs=146.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC----CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD----GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      .++|++.+.||+|+||+||+|.+..    ...||||.++... ......+.+|+.++++++||||+++++++...+..|+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3678999999999999999998753    4579999886543 3344678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||||+++++|.+++......+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+|++|||.++.....
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999999876667899999999999999999999   999999999999999999999999999999877522


Q ss_pred             ccc-ccccccccccccCCCCC
Q 003301          813 ESM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~-~~~~~~gt~~y~APE~l  832 (832)
                      ... ......++..|+|||.+
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~  180 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAI  180 (266)
T ss_pred             ccceeccCCCCCccccChhhh
Confidence            211 11223356789999964

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PLN03210 Resistant to P

Probab=99.92  E-value=3.7e-24  Score=264.22  Aligned_cols=314  Identities=26%  Similarity=0.311  Sum_probs=137.0

Q ss_pred             CcccccCC-cccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCcccc
Q 003301          184 PTSIFNLS-AMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLG  262 (832)
Q Consensus       184 ~~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~  262 (832)
                      |..|..++ +|+.|++.++.+. .+|..+   .+.+|++|+|++|++.. .+..+..+++|+.|+|++|.....+|+ +.
T Consensus       581 p~~~~~lp~~Lr~L~~~~~~l~-~lP~~f---~~~~L~~L~L~~s~l~~-L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls  654 (1153)
T PLN03210        581 PEGFDYLPPKLRLLRWDKYPLR-CMPSNF---RPENLVKLQMQGSKLEK-LWDGVHSLTGLRNIDLRGSKNLKEIPD-LS  654 (1153)
T ss_pred             CcchhhcCcccEEEEecCCCCC-CCCCcC---CccCCcEEECcCccccc-cccccccCCCCCEEECCCCCCcCcCCc-cc
Confidence            33343332 3555555555443 444433   23445555555555442 233334455555555554432223332 44


Q ss_pred             CccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCc
Q 003301          263 NLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNL  342 (832)
Q Consensus       263 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l  342 (832)
                      .+++|++|+|++|....     .+|..+..+++|+.|++++|...+.+|..+ .+. +|+.|++++|.....+|..   .
T Consensus       655 ~l~~Le~L~L~~c~~L~-----~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~-sL~~L~Lsgc~~L~~~p~~---~  724 (1153)
T PLN03210        655 MATNLETLKLSDCSSLV-----ELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLK-SLYRLNLSGCSRLKSFPDI---S  724 (1153)
T ss_pred             cCCcccEEEecCCCCcc-----ccchhhhccCCCCEEeCCCCCCcCccCCcC-CCC-CCCEEeCCCCCCccccccc---c
Confidence            44555555555443221     223334445555555555543333334332 222 4445555444433333321   2


Q ss_pred             CcccEEEeecCcccccccccccCCCCCceEEccCCccC-------CCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCC
Q 003301          343 INLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLE-------GPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLT  415 (832)
Q Consensus       343 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-------~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  415 (832)
                      ++|++|++++|.+. .+|..+ .+++|+.|+++++...       ...+..+...++|+.|++++|...+.+|..+++++
T Consensus       725 ~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~  802 (1153)
T PLN03210        725 TNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLH  802 (1153)
T ss_pred             CCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCC
Confidence            34455555555544 223222 3444555554442211       11111122234455555555554444555555555


Q ss_pred             CCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecc
Q 003301          416 SLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLR  495 (832)
Q Consensus       416 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  495 (832)
                      +|+.|++++|...+.+|..+ ++++|+.|++++|.....+|..   ..+|+.|+|++|.++ .+|.++..+++|+.|+|+
T Consensus       803 ~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~  877 (1153)
T PLN03210        803 KLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMN  877 (1153)
T ss_pred             CCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECC
Confidence            55555555543333333333 4455555555554332223321   234445555555554 344555555555555555


Q ss_pred             c-ccccccCCccccCCCCCCeeccCCC
Q 003301          496 D-NGLQGSIPKSIGGLVSLESLDLSNN  521 (832)
Q Consensus       496 ~-N~l~~~~p~~~~~l~~L~~L~Ls~N  521 (832)
                      + |++. .+|..+..+++|+.|++++|
T Consensus       878 ~C~~L~-~l~~~~~~L~~L~~L~l~~C  903 (1153)
T PLN03210        878 GCNNLQ-RVSLNISKLKHLETVDFSDC  903 (1153)
T ss_pred             CCCCcC-ccCcccccccCCCeeecCCC
Confidence            4 2233 34444455555555555544

syringae 6; Provisional

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.92  E-value=5.9e-25  Score=229.24  Aligned_cols=171  Identities=23%  Similarity=0.456  Sum_probs=147.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      .++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..|++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            46799999999999999999998788899999876543 23468889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          738 PNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       738 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      ++++|.+++... ...+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.+..........
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA  160 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence            999999998753 345888999999999999999999   9999999999999999999999999999998765433222


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....++..|+|||++
T Consensus       161 ~~~~~~~~~y~aPE~~  176 (261)
T cd05072         161 REGAKFPIKWTAPEAI  176 (261)
T ss_pred             cCCCccceecCCHHHh
Confidence            2223467789999963

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.92  E-value=6.8e-25  Score=232.62  Aligned_cols=168  Identities=32%  Similarity=0.466  Sum_probs=137.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEec--CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcC---CCCceeeeceEEe-----c
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL--DGMEVAIKVFHLQL--EGALKSFDVECEVLKSV---RHRNLVKIISSCT-----N  726 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~-----~  726 (832)
                      ++|++.+.||+|+||+||+|++.  +++.||+|+++...  ......+.+|+++++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            47899999999999999999874  36889999887543  22234566777777665   6999999999885     2


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccc
Q 003301          727 NDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGI  805 (832)
Q Consensus       727 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~  805 (832)
                      ....++||||++ ++|.+++.... ..+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||.
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999995 69999987543 34899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCCCCC
Q 003301          806 AKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       806 a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      |+......  ......||+.|+|||++
T Consensus       157 ~~~~~~~~--~~~~~~~~~~y~aPE~~  181 (290)
T cd07862         157 ARIYSFQM--ALTSVVVTLWYRAPEVL  181 (290)
T ss_pred             eEeccCCc--ccccccccccccChHHH
Confidence            98764332  22335689999999963

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.92  E-value=1.4e-25  Score=234.30  Aligned_cols=168  Identities=24%  Similarity=0.387  Sum_probs=144.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---h-----hhHHHHHHHHHHHhcCC---CCceeeeceEEe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---E-----GALKSFDVECEVLKSVR---HRNLVKIISSCT  725 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~-----~~~~~~~~e~~~l~~l~---h~niv~l~~~~~  725 (832)
                      ..+|...+.+|.|+||.|+.|.++. ..+|+||.+.++.   .     ...-.+-.||.+|+.++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            4579999999999999999998865 6789999886543   1     11123446999999997   999999999999


Q ss_pred             cCCeeEEEEecC-CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccc
Q 003301          726 NNDFKALVLEYM-PNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFG  804 (832)
Q Consensus       726 ~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg  804 (832)
                      +++.+|++||-. +|.+|.++++.+. ++++..+.-|+.||+.|+++||   +.||||||||-+||.++.+|-+|++|||
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeecc
Confidence            999999999986 5569999998654 7999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCcccccccccccccccCCCCC
Q 003301          805 IAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       805 ~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .|.......   ....+||..|.|||++
T Consensus       716 saa~~ksgp---fd~f~gtv~~aapevl  740 (772)
T KOG1152|consen  716 SAAYTKSGP---FDVFVGTVDYAAPEVL  740 (772)
T ss_pred             chhhhcCCC---cceeeeeccccchhhh
Confidence            998764443   3446899999999985

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.92  E-value=9.7e-26  Score=239.71  Aligned_cols=166  Identities=27%  Similarity=0.450  Sum_probs=139.3

Q ss_pred             CCCCeeeccCCceEEEEEec-CCcEEEEEEEec----cchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCe--eEEEE
Q 003301          662 NASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHL----QLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDF--KALVL  734 (832)
Q Consensus       662 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~  734 (832)
                      +..++||+|+|-+||+|-+. +|.+||--.++.    +.+...+++..|+++++.++||||+++|++|.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            34578999999999999874 377776433321    224456899999999999999999999999987654  77899


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC-CCcEEEeccccccccCCCc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK-DMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~kl~DFg~a~~~~~~~  813 (832)
                      |.+..|+|..|.++.+ +.+...++.|++||++||.|||. +..+|||||||-+||+|+. -|.|||+|.|+|.......
T Consensus       123 EL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             ecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            9999999999998876 78999999999999999999994 4789999999999999974 5899999999999875443


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                      .   ...+|||.|||||++
T Consensus       201 a---ksvIGTPEFMAPEmY  216 (632)
T KOG0584|consen  201 A---KSVIGTPEFMAPEMY  216 (632)
T ss_pred             c---ceeccCccccChHHH
Confidence            2   236899999999985

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.92  E-value=1.6e-25  Score=211.09  Aligned_cols=174  Identities=25%  Similarity=0.295  Sum_probs=146.9

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecC-----Ce
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNN-----DF  729 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  729 (832)
                      ...++|.+.+.+|+|||+.||.++.. +++.||+|++.....+..+...+|++..++++|||+++++++...+     ..
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            34578999999999999999999854 5889999999888777778999999999999999999999876543     35


Q ss_pred             eEEEEecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeEeCCCCcEEEeccc
Q 003301          730 KALVLEYMPNGSLEDYLYSN---NFSFDILQRLSVIIDVALALEYLHFGYSNP--VVHCDIKPSNVLLDKDMVAHLSDFG  804 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~~~~~~kl~DFg  804 (832)
                      .|++++|...|+|.+.++..   +..+++.++++|+.++++|+++||   +..  ++||||||.||++.+++.+++.|||
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEecc
Confidence            89999999999999998753   235899999999999999999999   666  9999999999999999999999999


Q ss_pred             cccccCCCccc--------ccccccccccccCCCCC
Q 003301          805 IAKLLSGEESM--------KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       805 ~a~~~~~~~~~--------~~~~~~gt~~y~APE~l  832 (832)
                      .++...-.-..        .......|..|+|||+|
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf  210 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELF  210 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchhe
Confidence            98764321110        11123578999999986

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.92  E-value=8.3e-25  Score=234.78  Aligned_cols=171  Identities=29%  Similarity=0.452  Sum_probs=142.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-Cc----EEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GM----EVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  731 (832)
                      ..+|++.+.||+|+||.||+|.+.. +.    .||+|++.... ....+++..|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            3579999999999999999998643 33    48999986443 33456788999999999999999999998765 568


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +++||+++|+|.+++......+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|+....
T Consensus        85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            999999999999999876667899999999999999999999   99999999999999999999999999999987654


Q ss_pred             Ccccc-cccccccccccCCCCC
Q 003301          812 EESMK-QTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~-~~~~~gt~~y~APE~l  832 (832)
                      ..... .....++..|+|||++
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~  183 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESI  183 (316)
T ss_pred             CCcceeccCCccceeecChHHh
Confidence            33211 1222356789999963

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.92  E-value=7.1e-25  Score=244.68  Aligned_cols=165  Identities=28%  Similarity=0.462  Sum_probs=135.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecC--------C
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNN--------D  728 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~  728 (832)
                      ..+|++.+.||+|+||.||+|.+. +++.||||++....    ....+|+.+++.++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            467999999999999999999885 48899999885432    2345799999999999999999876432        2


Q ss_pred             eeEEEEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC-cEEEeccc
Q 003301          729 FKALVLEYMPNGSLEDYLYS---NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFG  804 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~DFg  804 (832)
                      ..++||||++ +++.+++..   ....+++..+..++.|++.||+|||   ++||+||||||+||+++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence            4679999996 578777653   3346899999999999999999999   99999999999999998665 79999999


Q ss_pred             cccccCCCcccccccccccccccCCCCC
Q 003301          805 IAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       805 ~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +|+.......  .....||+.|||||++
T Consensus       217 la~~~~~~~~--~~~~~~t~~y~aPE~~  242 (440)
T PTZ00036        217 SAKNLLAGQR--SVSYICSRFYRAPELM  242 (440)
T ss_pred             cchhccCCCC--cccCCCCcCccCHHHh
Confidence            9987643322  2235689999999964

>PHA02988 hypothetical protein; Provisional

Probab=99.92  E-value=1e-24  Score=229.78  Aligned_cols=160  Identities=23%  Similarity=0.321  Sum_probs=138.1

Q ss_pred             CCeeeccCCceEEEEEecCCcEEEEEEEeccchh---hHHHHHHHHHHHhcCCCCceeeeceEEec----CCeeEEEEec
Q 003301          664 SNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEG---ALKSFDVECEVLKSVRHRNLVKIISSCTN----NDFKALVLEY  736 (832)
Q Consensus       664 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~  736 (832)
                      ...||+|++|.||+|.+ +|+.||||+++.....   ..+.+.+|++++++++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36899999999999998 7999999998754322   24678899999999999999999999876    3468999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      +++|+|.+++.+.+ .+++..+..++.|++.|++|+|   + .+++||||||+||+++.++.+||+|||+++......  
T Consensus       104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            99999999998654 6889999999999999999999   6 489999999999999999999999999998654322  


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                        ....|++.|+|||++
T Consensus       178 --~~~~~~~~y~aPE~~  192 (283)
T PHA02988        178 --FKNVNFMVYFSYKML  192 (283)
T ss_pred             --ccccCcccccCHHHh
Confidence              124589999999974

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.92  E-value=7e-25  Score=229.48  Aligned_cols=170  Identities=29%  Similarity=0.407  Sum_probs=147.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||+|+++.........+.+|+.+++.++||||+++++++...+..|+||||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            357888899999999999999875 4889999998766555556788899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +++++|.+++...+ .+++.++..++.|++.|++|+|   +.|++||||||+||+++.++.+||+|||.+........ .
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-~  162 (267)
T cd06645          88 CGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-K  162 (267)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-c
Confidence            99999999987654 6899999999999999999999   99999999999999999999999999999876543221 2


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....|++.|+|||++
T Consensus       163 ~~~~~~~~~y~aPE~~  178 (267)
T cd06645         163 RKSFIGTPYWMAPEVA  178 (267)
T ss_pred             cccccCcccccChhhh
Confidence            2234689999999963

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.92  E-value=1.9e-24  Score=229.40  Aligned_cols=171  Identities=27%  Similarity=0.409  Sum_probs=149.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .+.|++.++||.|+||.||+|+... ++.||+|.+........+.+.+|+++++.++||||+++++++..++..|+||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            3679999999999999999998865 889999998876666667888999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      ++++++..++.+....+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.+........ .
T Consensus        91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-~  166 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ-R  166 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccccc-c
Confidence            9999999988765557899999999999999999999   99999999999999999999999999999876433221 1


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....+++.|+|||++
T Consensus       167 ~~~~~~~~~y~aPE~~  182 (292)
T cd06644         167 RDSFIGTPYWMAPEVV  182 (292)
T ss_pred             cceecCCccccCceee
Confidence            2234588999999974

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.92  E-value=2.2e-25  Score=234.21  Aligned_cols=176  Identities=29%  Similarity=0.491  Sum_probs=151.6

Q ss_pred             HHHHHhcCCCCCCeeeccCCceEEEEEecC---C--cEEEEEEEecc-chhhHHHHHHHHHHHhcCCCCceeeeceEEec
Q 003301          653 ELLQATNQFNASNLIGTGGFGSVYKGSFLD---G--MEVAIKVFHLQ-LEGALKSFDVECEVLKSVRHRNLVKIISSCTN  726 (832)
Q Consensus       653 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  726 (832)
                      +........+..+.||+|.||.||+|.+.+   |  -.||||.-+.. ..+..+.|..|..+|+.++||||++++|+|.+
T Consensus       383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e  462 (974)
T KOG4257|consen  383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE  462 (974)
T ss_pred             cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence            334445566778899999999999998753   2  34889987763 34557889999999999999999999999976


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccc
Q 003301          727 NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA  806 (832)
Q Consensus       727 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a  806 (832)
                      . ..|||||.++-|.|.+|++.++..++......+++|++.|++|||   ++.+|||||..+||||....-||++|||++
T Consensus       463 ~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  463 Q-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             c-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchh
Confidence            4 579999999999999999998888999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCcccccccccccccccCCCCC
Q 003301          807 KLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       807 ~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +.++++.....+...-+..|||||-+
T Consensus       539 R~~ed~~yYkaS~~kLPIKWmaPESI  564 (974)
T KOG4257|consen  539 RYLEDDAYYKASRGKLPIKWMAPESI  564 (974)
T ss_pred             hhccccchhhccccccceeecCcccc
Confidence            99887776665544456789999964

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=7.6e-25  Score=230.97  Aligned_cols=170  Identities=27%  Similarity=0.427  Sum_probs=150.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .++|++.+.||.|+||.||+|.+. ++..||+|.+........+.+.+|++++++++||||+++++++..++..|+||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            467999999999999999999875 5889999998866655667888999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +++++|.+++...+..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.++|+|||.+........ .
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~  159 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-K  159 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-c
Confidence            9999999999876667999999999999999999999   99999999999999999999999999999876533222 2


Q ss_pred             cccccccccccCCCC
Q 003301          817 QTLTLATIGYMAPGL  831 (832)
Q Consensus       817 ~~~~~gt~~y~APE~  831 (832)
                      .....|++.|+|||+
T Consensus       160 ~~~~~~~~~y~~PE~  174 (280)
T cd06611         160 RDTFIGTPYWMAPEV  174 (280)
T ss_pred             cceeecchhhcCHHH
Confidence            223468999999996

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.92  E-value=4.1e-25  Score=230.44  Aligned_cols=171  Identities=25%  Similarity=0.476  Sum_probs=149.5

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ...+|++.++||.|+||.||+|.+.+++.||+|++..........+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            45679999999999999999999988999999998866555567889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          737 MPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       737 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      +++++|.++++... ..+++..+..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||.+.........
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            99999999997643 35899999999999999999999   999999999999999999999999999999876443222


Q ss_pred             ccccccccccccCCCC
Q 003301          816 KQTLTLATIGYMAPGL  831 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~  831 (832)
                      . ....++..|+|||+
T Consensus       161 ~-~~~~~~~~~~~PE~  175 (261)
T cd05148         161 S-SDKKIPYKWTAPEA  175 (261)
T ss_pred             c-cCCCCceEecCHHH
Confidence            2 22346778999996

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.92  E-value=7.1e-25  Score=243.36  Aligned_cols=165  Identities=24%  Similarity=0.305  Sum_probs=141.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ...|.+.+.||+|+||.||+|.+.. ++.||||....      ..+.+|++++++++|+|||++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4579999999999999999998865 78899995321      3456799999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc-
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM-  815 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~-  815 (832)
                      + .++|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+........ 
T Consensus       242 ~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        242 Y-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            9 57999998766557999999999999999999999   999999999999999999999999999999875433221 


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                      ......||+.|||||++
T Consensus       318 ~~~~~~GT~~Y~APE~~  334 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVL  334 (461)
T ss_pred             cccccCCCcCCcCHHHH
Confidence            11234699999999974

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=6.2e-25  Score=247.97  Aligned_cols=174  Identities=28%  Similarity=0.398  Sum_probs=144.9

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC----
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNND----  728 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  728 (832)
                      ...++|++.+.||+|+||+||+|++. +++.||||++....  ......+.+|+.++..++|++++++++.+...+    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            34579999999999999999999875 58999999987543  334467788999999999999999988765432    


Q ss_pred             ----eeEEEEecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEe
Q 003301          729 ----FKALVLEYMPNGSLEDYLYSN---NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLS  801 (832)
Q Consensus       729 ----~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~  801 (832)
                          ..++||||+++|+|.++++..   ...+++..+..++.|++.||+|+|   +++|+||||||+||+++.++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEE
Confidence                368999999999999998653   235889999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCcc-cccccccccccccCCCCC
Q 003301          802 DFGIAKLLSGEES-MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       802 DFg~a~~~~~~~~-~~~~~~~gt~~y~APE~l  832 (832)
                      |||+++.+..... ......+||+.|+|||++
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~  217 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIW  217 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHh
Confidence            9999987643221 122335799999999974

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.92  E-value=1.7e-25  Score=252.97  Aligned_cols=175  Identities=30%  Similarity=0.453  Sum_probs=142.4

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecC-----
Q 003301          655 LQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNN-----  727 (832)
Q Consensus       655 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  727 (832)
                      .+-..+|+..+.||+||||.||+++.+ ||+.||||++.... ......+.+|+.++++++|||||+++..|.+.     
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            345678889999999999999999876 79999999998664 33346788999999999999999985433110     


Q ss_pred             --------------------------------------------------------------------------------
Q 003301          728 --------------------------------------------------------------------------------  727 (832)
Q Consensus       728 --------------------------------------------------------------------------------  727 (832)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHh
Q 003301          728 ----------------------------------DFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH  773 (832)
Q Consensus       728 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH  773 (832)
                                                        -..||-||||+...++++++++...-....+++++++|+.||+|+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence                                              1247899999988888888876533357788999999999999999


Q ss_pred             cCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC-----------------CCcccccccccccccccCCCCC
Q 003301          774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS-----------------GEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       774 ~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~-----------------~~~~~~~~~~~gt~~y~APE~l  832 (832)
                         ++|||||||||.||++|+++.|||+|||+|....                 .......+..+||.-|+|||++
T Consensus       715 ---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll  787 (1351)
T KOG1035|consen  715 ---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL  787 (1351)
T ss_pred             ---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence               9999999999999999999999999999998721                 0112234557899999999985

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=2.2e-25  Score=234.47  Aligned_cols=147  Identities=26%  Similarity=0.395  Sum_probs=132.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      ..-|..++.||-|+||+|..++..+ ...||+|.+++.+   ........+|..|++..+.+.||++|..|++++.+|+|
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence            4568888999999999999998766 5678999887654   33445677899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      |||++||++..++-+.+ -|++..+..++.++..|+++.|   ..|+|||||||+|||||.+|.+|++|||++.-
T Consensus       708 MdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTG  778 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  778 (1034)
T ss_pred             EeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeecccccc
Confidence            99999999999987765 6899999999999999999999   99999999999999999999999999999863

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.92  E-value=1.3e-24  Score=236.89  Aligned_cols=164  Identities=20%  Similarity=0.283  Sum_probs=140.9

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      ...+|++.+.||+|+||.||+|.+.. ++.||+|+....      ....|+.++++++||||+++++++...+..|+|||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            44689999999999999999998864 678999974322      23468999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      |+ .++|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||.++......  
T Consensus       138 ~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--  211 (357)
T PHA03209        138 HY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--  211 (357)
T ss_pred             cc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence            99 56999998776667999999999999999999999   9999999999999999999999999999997543222  


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                      ......||+.|+|||++
T Consensus       212 ~~~~~~gt~~y~aPE~~  228 (357)
T PHA03209        212 AFLGLAGTVETNAPEVL  228 (357)
T ss_pred             ccccccccccccCCeec
Confidence            12234699999999974

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=2.7e-24  Score=224.49  Aligned_cols=170  Identities=28%  Similarity=0.449  Sum_probs=145.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-----hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-----EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      ++|++.+.||+|++|.||+|... ++++||+|.+....     ....+.+.+|++++++++||||+++++++.+++..|+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57999999999999999999875 48999999886432     1223568889999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||||+++++|.+++.... .+++..+..++.|++.|++|||   +.|++||||+|+||+++.++.+||+|||.++.....
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            999999999999987654 5889999999999999999999   999999999999999999999999999999765432


Q ss_pred             ccccc--ccccccccccCCCCC
Q 003301          813 ESMKQ--TLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~--~~~~gt~~y~APE~l  832 (832)
                      .....  ....|+..|+|||++
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~  179 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVI  179 (263)
T ss_pred             ccccccccCCCcCccccCccee
Confidence            22111  234588899999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.92  E-value=1.9e-24  Score=228.16  Aligned_cols=169  Identities=27%  Similarity=0.415  Sum_probs=146.5

Q ss_pred             CCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCC
Q 003301          660 QFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMP  738 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  738 (832)
                      .|++.+.||+|+||.||+|.+.. +..+|+|.+........+.+.+|+++++.++||||+++++++..++..|+||||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            36788899999999999998864 77889998876555556788899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccc
Q 003301          739 NGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT  818 (832)
Q Consensus       739 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~  818 (832)
                      ++++..++.+....+++..+..++.|++.||+|||   +.|++||||||+||+++.++.+|++|||++........ ...
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~  161 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRD  161 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccc-ccc
Confidence            99999988765557899999999999999999999   99999999999999999999999999999876533221 222


Q ss_pred             cccccccccCCCCC
Q 003301          819 LTLATIGYMAPGLF  832 (832)
Q Consensus       819 ~~~gt~~y~APE~l  832 (832)
                      ...|++.|+|||++
T Consensus       162 ~~~~~~~y~aPE~~  175 (282)
T cd06643         162 SFIGTPYWMAPEVV  175 (282)
T ss_pred             cccccccccCHhhc
Confidence            34689999999974

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.92  E-value=1.9e-24  Score=228.38  Aligned_cols=171  Identities=30%  Similarity=0.482  Sum_probs=144.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-----CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEec--CCeeE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN--NDFKA  731 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  731 (832)
                      .+|++.+.||+|+||.||+|...     +++.||+|++........+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            57889999999999999999752     478999999876665556788999999999999999999998754  34689


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +||||+++++|.+++.+.+..+++..+..++.|++.|++|||   ++|++||||||+||+++.++.+||+|||+++....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            999999999999999876556899999999999999999999   99999999999999999999999999999987644


Q ss_pred             Ccccc--cccccccccccCCCCC
Q 003301          812 EESMK--QTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~--~~~~~gt~~y~APE~l  832 (832)
                      .....  .....++..|+|||++
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~  183 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESL  183 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHh
Confidence            32211  1112245569999963

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.92  E-value=2.4e-24  Score=226.58  Aligned_cols=161  Identities=29%  Similarity=0.395  Sum_probs=136.6

Q ss_pred             eeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCCCH
Q 003301          667 IGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSL  742 (832)
Q Consensus       667 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  742 (832)
                      ||+|+||.||++... +|+.||+|++....   ....+.+..|++++++++||||+++++++..+...|+||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999875 48999999986432   12234556799999999999999999999999999999999999999


Q ss_pred             HHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccccccc
Q 003301          743 EDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL  821 (832)
Q Consensus       743 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~  821 (832)
                      .+++.... ..+++..+..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||++........  .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~  155 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRA  155 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eeccC
Confidence            98886533 34889999999999999999999   99999999999999999999999999999987643322  22346


Q ss_pred             ccccccCCCCC
Q 003301          822 ATIGYMAPGLF  832 (832)
Q Consensus       822 gt~~y~APE~l  832 (832)
                      |++.|+|||++
T Consensus       156 ~~~~y~aPE~~  166 (277)
T cd05607         156 GTNGYMAPEIL  166 (277)
T ss_pred             CCCCccCHHHH
Confidence            89999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.92  E-value=2.4e-24  Score=223.13  Aligned_cols=165  Identities=29%  Similarity=0.483  Sum_probs=140.8

Q ss_pred             CeeeccCCceEEEEEecCCcEEEEEEEeccch-hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCCCHH
Q 003301          665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLE  743 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  743 (832)
                      ++||+|+||.||+|...+++.||+|++..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            47999999999999987889999998865432 33456889999999999999999999999999999999999999999


Q ss_pred             HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccccccccc
Q 003301          744 DYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT  823 (832)
Q Consensus       744 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~gt  823 (832)
                      +++......+++..+..++.|++.|+.|+|   ++|++||||||+||+++.++.+|++|||++...............++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence            999876656899999999999999999999   99999999999999999999999999999976533322222223456


Q ss_pred             ccccCCCCC
Q 003301          824 IGYMAPGLF  832 (832)
Q Consensus       824 ~~y~APE~l  832 (832)
                      ..|+|||++
T Consensus       158 ~~y~aPE~~  166 (250)
T cd05085         158 IKWTAPEAL  166 (250)
T ss_pred             ccccCHHHh
Confidence            789999963

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.92  E-value=1.6e-24  Score=226.04  Aligned_cols=169  Identities=27%  Similarity=0.458  Sum_probs=142.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      .++|++.++||+|+||.||+|.+.++..||+|++..... ..+.+.+|++++++++||||+++++++. ++..|+||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            356999999999999999999887777899999875432 2357889999999999999999999875 45679999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          738 PNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       738 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      ++|+|.+++.+.. ..+++..+..++.|++.|++|+|   +.+++||||||+||+++.++.+||+|||.++.........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence            9999999997632 35789999999999999999999   9999999999999999999999999999998765433322


Q ss_pred             cccccccccccCCCC
Q 003301          817 QTLTLATIGYMAPGL  831 (832)
Q Consensus       817 ~~~~~gt~~y~APE~  831 (832)
                      .....++..|+|||+
T Consensus       160 ~~~~~~~~~y~~PE~  174 (262)
T cd05071         160 RQGAKFPIKWTAPEA  174 (262)
T ss_pred             ccCCcccceecCHhH
Confidence            223346778999996

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.92  E-value=2.4e-24  Score=228.31  Aligned_cols=166  Identities=33%  Similarity=0.457  Sum_probs=146.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++....   ....+.+.+|++++++++||||+++++++..++..|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46889999999999999999876 48999999987542   233467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||+++++|.+++.... .+++..+..++.|++.|++|||   +.|++||||+|+||+++.++.+||+|||++......  
T Consensus        81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            9999999999997764 6899999999999999999999   999999999999999999999999999999876443  


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                        .....|++.|+|||.+
T Consensus       155 --~~~~~~~~~y~aPE~~  170 (290)
T cd05580         155 --TYTLCGTPEYLAPEII  170 (290)
T ss_pred             --CCCCCCCccccChhhh
Confidence              2234689999999964

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.92  E-value=2.7e-24  Score=227.17  Aligned_cols=168  Identities=29%  Similarity=0.383  Sum_probs=143.0

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .|+..+.||+|+||+||+|.+. +++.||+|.+....   ......+.+|++++++++|++|+++++++..++..|+|||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            3667789999999999999875 48899999986542   2223456789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          736 YMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |+++++|.+++.... ..+++..+..++.|++.|++|||   +.||+||||||+||++++++.+||+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            999999998886533 35899999999999999999999   99999999999999999999999999999976543221


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                        .....|+..|+|||++
T Consensus       158 --~~~~~g~~~~~aPE~~  173 (285)
T cd05632         158 --IRGRVGTVGYMAPEVL  173 (285)
T ss_pred             --ccCCCCCcCccChHHh
Confidence              1234689999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.92  E-value=2.3e-24  Score=227.57  Aligned_cols=168  Identities=27%  Similarity=0.390  Sum_probs=142.9

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .|+..+.||+|+||.||+|.+. +++.||+|.+....   ......+.+|+.++++++|++++++++.+.+++..|+|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3777899999999999999876 48899999886542   2223456789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          736 YMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |+++++|.+++.... ..+++..+..++.|++.|++|+|   +.+|+||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            999999999886433 35899999999999999999999   99999999999999999999999999999876543322


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                        .....|+..|+|||++
T Consensus       158 --~~~~~g~~~y~aPE~~  173 (285)
T cd05630         158 --IKGRVGTVGYMAPEVV  173 (285)
T ss_pred             --ccCCCCCccccChHHH
Confidence              1224699999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.92  E-value=2.6e-24  Score=227.68  Aligned_cols=169  Identities=30%  Similarity=0.433  Sum_probs=148.2

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      +|++.+.||+|+||.||+|.+. +++.||+|++....  ....+.+.+|+.++++++||||+++++++..+...|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5888999999999999999875 58999999987554  33456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      + +++|.+++......+++.++..++.|++.|++|||   +.|++|+||||+||+++.++.++++|||.+..........
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence            9 99999999776667999999999999999999999   9999999999999999999999999999998765443222


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....|+..|+|||++
T Consensus       157 ~~~~~~~~~y~aPE~~  172 (286)
T cd07832         157 YSHQVATRWYRAPELL  172 (286)
T ss_pred             cccccCcccccCceee
Confidence            2335689999999974

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.92  E-value=2.1e-24  Score=225.84  Aligned_cols=172  Identities=27%  Similarity=0.470  Sum_probs=144.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC----CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD----GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      ..+|++.+.||+|+||.||+|.+..    +..||+|.++... ....+.+.+|+.++++++||||+++++++.+++..|+
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            3578899999999999999998742    3469999886543 2345678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||||+++++|.+++......+++.++..++.|++.|++|+|   +.+++||||||+||+++.++.+|++|||.+......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999999876667899999999999999999999   999999999999999999999999999999876443


Q ss_pred             cccccc--cccccccccCCCCC
Q 003301          813 ESMKQT--LTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~--~~~gt~~y~APE~l  832 (832)
                      ......  ...++..|+|||++
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~  181 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAI  181 (267)
T ss_pred             cceeeecCCCccceeecCHhHh
Confidence            222111  12235689999974

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.92  E-value=8.8e-26  Score=256.42  Aligned_cols=171  Identities=31%  Similarity=0.444  Sum_probs=147.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      +-+|+.+..||.|.||.||.|...+ |...|+|.++.+.  ....+.+.+|..++..++|||+|+++|+-.+++..||.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            3577888999999999999998754 8889999887554  334567888999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |||++|+|.+.++..+ ..++.....+..|++.|++|||   +.|||||||||+||+++.+|.+|.+|||.|..+.....
T Consensus      1314 EyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred             HHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence            9999999999998654 4667777788899999999999   99999999999999999999999999999998765431


Q ss_pred             c---ccccccccccccCCCCC
Q 003301          815 M---KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~---~~~~~~gt~~y~APE~l  832 (832)
                      .   ......||+.|||||+|
T Consensus      1390 ~~~~el~~~~GT~~YMAPEvi 1410 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVI 1410 (1509)
T ss_pred             cCCHHHHhhcCCchhcCchhh
Confidence            1   12335799999999986

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.92  E-value=1.9e-24  Score=236.19  Aligned_cols=167  Identities=25%  Similarity=0.344  Sum_probs=139.7

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC-----
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNND-----  728 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  728 (832)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++....  ......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4588999999999999999999875 48999999986432  233467788999999999999999999986543     


Q ss_pred             -eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccc
Q 003301          729 -FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK  807 (832)
Q Consensus       729 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~  807 (832)
                       ..|+||||++ +++.+.+..   .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+
T Consensus        99 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          99 QDVYLVMELMD-ANLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             ceeEEEEeCCC-cCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence             5799999995 567776643   4788899999999999999999   9999999999999999999999999999997


Q ss_pred             ccCCCcccccccccccccccCCCCC
Q 003301          808 LLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       808 ~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ......  ......||+.|+|||++
T Consensus       172 ~~~~~~--~~~~~~~t~~y~aPE~~  194 (359)
T cd07876         172 TACTNF--MMTPYVVTRYYRAPEVI  194 (359)
T ss_pred             ccccCc--cCCCCcccCCCCCchhc
Confidence            653322  12335689999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.92  E-value=2e-24  Score=225.49  Aligned_cols=170  Identities=26%  Similarity=0.502  Sum_probs=144.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      .+|++.+.||+|+||.||+|.+.+ ++.||+|++.... ...+.+.+|++++++++||||+++++++..++..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            458888999999999999998764 8889999887543 33467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          738 PNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       738 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      ++++|.+++.... ..+++..+..++.|++.|++|||   +.|++||||||+||++++++.+||+|||.+..........
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~  161 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  161 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence            9999999997543 35899999999999999999999   9999999999999999999999999999998765433222


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....++..|+|||++
T Consensus       162 ~~~~~~~~~y~aPE~~  177 (263)
T cd05052         162 HAGAKFPIKWTAPESL  177 (263)
T ss_pred             cCCCCCccccCCHHHh
Confidence            2223346789999963

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.91  E-value=1.8e-24  Score=234.98  Aligned_cols=169  Identities=25%  Similarity=0.369  Sum_probs=142.5

Q ss_pred             HHHHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch--hhHHHHHHHHHHHhcCCCCceeeeceEEecC---
Q 003301          654 LLQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRNLVKIISSCTNN---  727 (832)
Q Consensus       654 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---  727 (832)
                      ..+..++|++.+.||+|+||.||+|.+. +++.||||++.....  ...+.+.+|++++++++||||+++++++...   
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            3445688999999999999999999875 578999999865432  2345677899999999999999999987543   


Q ss_pred             ---CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccc
Q 003301          728 ---DFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFG  804 (832)
Q Consensus       728 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg  804 (832)
                         ...|+++|++ +++|.++++..  .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCc
Confidence               3568999998 88999888643  5899999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCcccccccccccccccCCCCC
Q 003301          805 IAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       805 ~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +++.....    .....||+.|+|||++
T Consensus       164 ~~~~~~~~----~~~~~~t~~y~aPE~~  187 (343)
T cd07878         164 LARQADDE----MTGYVATRWYRAPEIM  187 (343)
T ss_pred             cceecCCC----cCCccccccccCchHh
Confidence            99875432    2234689999999974

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.91  E-value=3.1e-24  Score=223.72  Aligned_cols=160  Identities=22%  Similarity=0.361  Sum_probs=136.1

Q ss_pred             CeeeccCCceEEEEEecC-------------CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeE
Q 003301          665 NLIGTGGFGSVYKGSFLD-------------GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  731 (832)
                      +.||+|+||.||+|+...             ...||+|++..........+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999997532             2358889877655555567888999999999999999999999988999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCc-------EEEeccc
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMV-------AHLSDFG  804 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~-------~kl~DFg  804 (832)
                      +||||+++++|..++......+++..+..++.|++.|++|||   +++|+||||||+||+++.++.       +|++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998766557899999999999999999999   999999999999999987664       8999999


Q ss_pred             cccccCCCcccccccccccccccCCCCC
Q 003301          805 IAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       805 ~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .+......     ....++..|+|||++
T Consensus       158 ~~~~~~~~-----~~~~~~~~y~aPE~~  180 (262)
T cd05077         158 IPITVLSR-----QECVERIPWIAPECV  180 (262)
T ss_pred             CCccccCc-----ccccccccccChhhh
Confidence            98765322     224588899999964

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.91  E-value=2.3e-24  Score=228.23  Aligned_cols=172  Identities=26%  Similarity=0.473  Sum_probs=145.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  731 (832)
                      .++|.+.+.||+|+||.||++...      ++..||+|.+........+.+.+|++++++++||||+++++++...+..|
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            367889999999999999999752      24568999887665555678899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEE
Q 003301          732 LVLEYMPNGSLEDYLYSNN------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAH  799 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k  799 (832)
                      +||||+++++|.+++....            ..+++..+..++.|++.|++|+|   ++|++||||||+||++++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence            9999999999999997432            24899999999999999999999   99999999999999999999999


Q ss_pred             EeccccccccCCCccc-ccccccccccccCCCCC
Q 003301          800 LSDFGIAKLLSGEESM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       800 l~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~l  832 (832)
                      ++|||.++........ ......+++.|+|||++
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  194 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI  194 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHh
Confidence            9999999865433221 12223467889999964

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.91  E-value=3.4e-24  Score=222.18  Aligned_cols=165  Identities=25%  Similarity=0.451  Sum_probs=139.0

Q ss_pred             CeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCCCH
Q 003301          665 NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSL  742 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  742 (832)
                      +.||+|+||.||+|++. +++.||+|.+.... ......+.+|++++++++||||+++++++...+..|+||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999875 58899999876443 33446788999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc-ccccc
Q 003301          743 EDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK-QTLTL  821 (832)
Q Consensus       743 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~-~~~~~  821 (832)
                      .+++......+++..+..++.|++.|++|||   +.|++||||||+||+++.++.+|++|||.+.......... .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            9999876656899999999999999999999   9999999999999999999999999999987653321111 11112


Q ss_pred             ccccccCCCCC
Q 003301          822 ATIGYMAPGLF  832 (832)
Q Consensus       822 gt~~y~APE~l  832 (832)
                      ++..|+|||++
T Consensus       158 ~~~~y~aPE~~  168 (252)
T cd05084         158 IPVKWTAPEAL  168 (252)
T ss_pred             CceeecCchhh
Confidence            34579999964

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.91  E-value=1.3e-24  Score=239.94  Aligned_cols=165  Identities=24%  Similarity=0.316  Sum_probs=140.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec---CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL---DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ..+|++.+.||+|+||.||+|...   .++.||+|.+...     ....+|++++++++||||+++++++......|+||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999754   3578999987643     34467999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |++ ++++.+++... ..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.......
T Consensus       166 e~~-~~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        166 PKY-KCDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             hhc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            999 47899988543 46899999999999999999999   99999999999999999999999999999986644322


Q ss_pred             c-ccccccccccccCCCCC
Q 003301          815 M-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~-~~~~~~gt~~y~APE~l  832 (832)
                      . ......||+.|+|||++
T Consensus       241 ~~~~~~~~gt~~y~aPE~~  259 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELL  259 (392)
T ss_pred             cccccccccccCccCHhHh
Confidence            2 12235699999999974

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.91  E-value=3.7e-24  Score=228.72  Aligned_cols=167  Identities=25%  Similarity=0.347  Sum_probs=144.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ++|++.+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|++++++++||||+++++++.+++..|+||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46899999999999999999876 47889999886543 23345688899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      +++++|.++++..+ .+++..+..++.|++.|++|||   + .+++||||||+||+++.++.+||+|||.+.......  
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  154 (308)
T cd06615          81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  154 (308)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence            99999999997653 6899999999999999999999   6 589999999999999999999999999987653322  


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                       .....|++.|+|||++
T Consensus       155 -~~~~~~~~~~~aPE~~  170 (308)
T cd06615         155 -ANSFVGTRSYMSPERL  170 (308)
T ss_pred             -cccCCCCcCccChhHh
Confidence             1234689999999963

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.91  E-value=2.6e-24  Score=229.36  Aligned_cols=169  Identities=27%  Similarity=0.416  Sum_probs=144.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .++|++.+.||+|+||.||+|++. +++.||+|.++... ......+.+|+++++.++||||+++++++..++..|+|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            467999999999999999999875 47899999987543 2233567789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      |++ ++|.+++......+++..+..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||.+.........
T Consensus        85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  160 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence            996 6999998876667899999999999999999999   999999999999999999999999999999765332221


Q ss_pred             ccccccccccccCCCC
Q 003301          816 KQTLTLATIGYMAPGL  831 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~  831 (832)
                       .....+++.|+|||+
T Consensus       161 -~~~~~~~~~y~~PE~  175 (301)
T cd07873         161 -YSNEVVTLWYRPPDI  175 (301)
T ss_pred             -ccccceeecccCcHH
Confidence             122457899999996

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.91  E-value=2.3e-24  Score=227.34  Aligned_cols=172  Identities=29%  Similarity=0.494  Sum_probs=145.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC------CcEEEEEEEeccchh-hHHHHHHHHHHHhcCCCCceeeeceEEecCCee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD------GMEVAIKVFHLQLEG-ALKSFDVECEVLKSVRHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  730 (832)
                      .++|.+.+.||+|+||.||+|.+.+      ++.||+|.+...... ..+.+.+|+++++.++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3568889999999999999997643      478999998765433 457889999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCc
Q 003301          731 ALVLEYMPNGSLEDYLYSNN-------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMV  797 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~  797 (832)
                      |+||||+++++|.++++..+             ..+++..+..++.|++.|++|+|   +.|++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence            99999999999999997542             23788899999999999999999   999999999999999999999


Q ss_pred             EEEeccccccccCCCccc-ccccccccccccCCCCC
Q 003301          798 AHLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       798 ~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~l  832 (832)
                      +||+|||.++........ ......+++.|+|||++
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  196 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESI  196 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhh
Confidence            999999999765332211 12233467889999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.91  E-value=1.9e-24  Score=227.51  Aligned_cols=173  Identities=23%  Similarity=0.398  Sum_probs=143.0

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCe
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDF  729 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  729 (832)
                      ..++|++.+.||+|+||.||+|.+.      .+..||+|++.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999999763      24679999886432 2334568899999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEE
Q 003301          730 KALVLEYMPNGSLEDYLYSNN---------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHL  800 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl  800 (832)
                      .++||||+++++|.+++....         ..+++..+..++.|++.|++|||   +.|++||||||+||++++++.+|+
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999987532         13567888999999999999999   999999999999999999999999


Q ss_pred             eccccccccCCCcccc-cccccccccccCCCCC
Q 003301          801 SDFGIAKLLSGEESMK-QTLTLATIGYMAPGLF  832 (832)
Q Consensus       801 ~DFg~a~~~~~~~~~~-~~~~~gt~~y~APE~l  832 (832)
                      +|||+++......... .....+++.|||||++
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  193 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL  193 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHh
Confidence            9999987654332211 1223467889999974

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.91  E-value=1.1e-24  Score=227.12  Aligned_cols=166  Identities=35%  Similarity=0.561  Sum_probs=142.7

Q ss_pred             CCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhH--HHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          661 FNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       661 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      |++.+.||+|+||+||+|+... ++.||+|++........  ....+|+.++++++||||+++++++..+...++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            6778999999999999999875 67899999987653332  23456999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccc
Q 003301          738 PNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ  817 (832)
Q Consensus       738 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~  817 (832)
                      ++++|.+++... ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.++|+|||.+..... .....
T Consensus        81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~  155 (260)
T PF00069_consen   81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENF  155 (260)
T ss_dssp             TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEB
T ss_pred             cccccccccccc-ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-ccccc
Confidence            999999999833 36899999999999999999999   99999999999999999999999999999986422 22233


Q ss_pred             ccccccccccCCCC
Q 003301          818 TLTLATIGYMAPGL  831 (832)
Q Consensus       818 ~~~~gt~~y~APE~  831 (832)
                      ....+++.|+|||+
T Consensus       156 ~~~~~~~~y~aPE~  169 (260)
T PF00069_consen  156 NPFVGTPEYMAPEV  169 (260)
T ss_dssp             SSSSSSGGGSCHHH
T ss_pred             cccccccccccccc
Confidence            34568999999996

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=4.7e-24  Score=222.58  Aligned_cols=171  Identities=32%  Similarity=0.447  Sum_probs=150.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...+..|++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            368999999999999999999875 4788999999876655667889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +++++|.+++......+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.+||+|||.+........ .
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~  157 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K  157 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence            9999999999876557899999999999999999999   99999999999999999999999999999986543221 1


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....++..|+|||++
T Consensus       158 ~~~~~~~~~y~~Pe~~  173 (262)
T cd06613         158 RKSFIGTPYWMAPEVA  173 (262)
T ss_pred             cccccCCccccCchhh
Confidence            2234688899999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.91  E-value=3.9e-24  Score=223.89  Aligned_cols=170  Identities=27%  Similarity=0.413  Sum_probs=145.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+....   ......+.+|++++++++||||+++++++.+.+..|+||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57999999999999999999875 58999999876422   333457888999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          735 EYMPNGSLEDYLYS---NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       735 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      ||+++++|.+++..   ....+++..+..++.|++.|++|||   +.+++||||||+||+++.++.++|+|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988853   2334788999999999999999999   99999999999999999999999999999887643


Q ss_pred             CcccccccccccccccCCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ... ......|++.|+|||++
T Consensus       159 ~~~-~~~~~~~~~~~~aPE~~  178 (267)
T cd08228         159 KTT-AAHSLVGTPYYMSPERI  178 (267)
T ss_pred             hhH-HHhcCCCCccccChhhh
Confidence            322 12234588999999963

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.91  E-value=3.1e-24  Score=227.95  Aligned_cols=169  Identities=33%  Similarity=0.453  Sum_probs=147.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ..+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++||||+++++++..+...|+||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            368999999999999999999865 5889999998866555557788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +++++|.+++...  .+++.++..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||.+......... 
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-  172 (296)
T cd06654          99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-  172 (296)
T ss_pred             cCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-
Confidence            9999999998754  4789999999999999999999   999999999999999999999999999998865433221 


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....|++.|+|||++
T Consensus       173 ~~~~~~~~~y~aPE~~  188 (296)
T cd06654         173 RSTMVGTPYWMAPEVV  188 (296)
T ss_pred             cCcccCCccccCHHHH
Confidence            2234689999999963

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.91  E-value=2.9e-24  Score=230.83  Aligned_cols=163  Identities=23%  Similarity=0.333  Sum_probs=132.6

Q ss_pred             CCeeeccCCceEEEEEec---CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEec--CCeeEEEEecCC
Q 003301          664 SNLIGTGGFGSVYKGSFL---DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN--NDFKALVLEYMP  738 (832)
Q Consensus       664 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  738 (832)
                      +++||+|+||+||+|...   +++.||+|.+....  ....+.+|++++++++||||+++++++..  +...|++|||+ 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-
Confidence            468999999999999865   36789999886442  22457789999999999999999998854  45689999999 


Q ss_pred             CCCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe----CCCCcEEEeccccc
Q 003301          739 NGSLEDYLYSN--------NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL----DKDMVAHLSDFGIA  806 (832)
Q Consensus       739 ~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~----~~~~~~kl~DFg~a  806 (832)
                      ++++.+++...        ...+++..+..++.|++.|++|||   +.||+||||||+||++    +.++.+||+|||+|
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            56888887532        124889999999999999999999   9999999999999999    45679999999999


Q ss_pred             cccCCCcc--cccccccccccccCCCCC
Q 003301          807 KLLSGEES--MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       807 ~~~~~~~~--~~~~~~~gt~~y~APE~l  832 (832)
                      +.......  .......||+.|+|||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~  187 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELL  187 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHH
Confidence            87643321  122335689999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.91  E-value=3.2e-24  Score=223.55  Aligned_cols=169  Identities=25%  Similarity=0.475  Sum_probs=143.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      .++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|++++++++++. .+..|++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            457899999999999999999988888899999875433 3367889999999999999999999875 45689999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          738 PNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       738 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      ++++|.+++.... ..+++..+..++.|++.|++|||   +.+++||||||+||++++++.+||+|||.+..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            9999999997643 35899999999999999999999   9999999999999999999999999999998764433222


Q ss_pred             cccccccccccCCCC
Q 003301          817 QTLTLATIGYMAPGL  831 (832)
Q Consensus       817 ~~~~~gt~~y~APE~  831 (832)
                      .....++..|+|||+
T Consensus       160 ~~~~~~~~~y~aPE~  174 (260)
T cd05070         160 RQGAKFPIKWTAPEA  174 (260)
T ss_pred             ccCCCCCccccChHH
Confidence            222345678999996

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.91  E-value=4.2e-24  Score=223.73  Aligned_cols=173  Identities=29%  Similarity=0.426  Sum_probs=146.1

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      .+.+.+.....||+|+||.||+|.+. ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++|+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            44566666789999999999999865 47889999887665555678899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC-CCcEEEeccccccccCC
Q 003301          735 EYMPNGSLEDYLYSNNFSF--DILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK-DMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~kl~DFg~a~~~~~  811 (832)
                      ||+++++|.+++......+  ++..+..++.|++.|++|||   ++||+||||||+||+++. ++.+||+|||.+.....
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            9999999999998654344  78888999999999999999   999999999999999976 67999999999876543


Q ss_pred             CcccccccccccccccCCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ... ......|++.|+|||++
T Consensus       162 ~~~-~~~~~~~~~~~~aPE~~  181 (268)
T cd06624         162 INP-CTETFTGTLQYMAPEVI  181 (268)
T ss_pred             CCC-ccccCCCCccccChhhh
Confidence            222 12223588999999963

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.91  E-value=3.4e-24  Score=226.36  Aligned_cols=171  Identities=28%  Similarity=0.533  Sum_probs=143.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC------CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD------GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  731 (832)
                      ++|++.+.||+|+||.||+|....      ...||+|.+.... ......+.+|++++++++||||+++++++...+..|
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            578899999999999999998643      2579999886543 233467889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC
Q 003301          732 LVLEYMPNGSLEDYLYSNN---------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM  796 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~  796 (832)
                      ++|||+++++|.+++....               ..+++..+..++.|++.|++|||   +.+++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            9999999999999997532               34788899999999999999999   99999999999999999999


Q ss_pred             cEEEeccccccccCCCcc-cccccccccccccCCCCC
Q 003301          797 VAHLSDFGIAKLLSGEES-MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       797 ~~kl~DFg~a~~~~~~~~-~~~~~~~gt~~y~APE~l  832 (832)
                      .+||+|||+++....... .......+++.|+|||++
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  198 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAI  198 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHh
Confidence            999999999986533322 122234578899999963

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.91  E-value=3.9e-25  Score=231.84  Aligned_cols=178  Identities=25%  Similarity=0.464  Sum_probs=154.2

Q ss_pred             hHHHHHHhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCe
Q 003301          651 YKELLQATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDF  729 (832)
Q Consensus       651 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  729 (832)
                      +++|+....+.....+||.|.||.||.|.|+. ...||||.++.. ....++|.+|+.+|+.++|||+|+++|+|..+..
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            45666666778888999999999999999976 778999998755 3456899999999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNNF-SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      +|||+|||..|+|.+|+++... .++.-..+.++.||..|++||.   .+.+||||+.++|+||.++..||++|||+++.
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhh
Confidence            9999999999999999998653 3666667889999999999999   99999999999999999999999999999999


Q ss_pred             cCCCcccccccccccccccCCCCC
Q 003301          809 LSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       809 ~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +.++.........-+..|.|||-+
T Consensus       415 MtgDTYTAHAGAKFPIKWTAPEsL  438 (1157)
T KOG4278|consen  415 MTGDTYTAHAGAKFPIKWTAPESL  438 (1157)
T ss_pred             hcCCceecccCccCcccccCcccc
Confidence            877655443333456789999964

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.91  E-value=3.6e-24  Score=224.75  Aligned_cols=159  Identities=22%  Similarity=0.335  Sum_probs=133.8

Q ss_pred             eeeccCCceEEEEEecC-------------------------CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeee
Q 003301          666 LIGTGGFGSVYKGSFLD-------------------------GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKI  720 (832)
Q Consensus       666 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l  720 (832)
                      .||+|+||.||+|....                         ...||+|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997421                         13588898875544445678889999999999999999


Q ss_pred             ceEEecCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC----
Q 003301          721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM----  796 (832)
Q Consensus       721 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~----  796 (832)
                      ++++.++...|+||||+++|+|..++......+++..+..++.|++.|++|||   +++|+||||||+||+++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999999999876667899999999999999999999   99999999999999997643    


Q ss_pred             ---cEEEeccccccccCCCcccccccccccccccCCCCC
Q 003301          797 ---VAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       797 ---~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                         .+|++|||.+......     ....++..|+|||++
T Consensus       159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~  192 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECV  192 (274)
T ss_pred             ccceeeecCCccccccccc-----cccccCCcccCchhh
Confidence               4899999998654222     123578889999964

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.91  E-value=3.7e-24  Score=227.43  Aligned_cols=169  Identities=33%  Similarity=0.453  Sum_probs=148.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ..+|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..|+||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            478999999999999999999874 5899999999766555557788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +++++|.+++.+.  .+++.++..++.|++.|+.|||   +.|++||||||+||+++.++.+||+|||.+......... 
T Consensus        98 ~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-  171 (297)
T cd06656          98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-  171 (297)
T ss_pred             cCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-
Confidence            9999999998754  4788999999999999999999   999999999999999999999999999998765433221 


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....+++.|+|||++
T Consensus       172 ~~~~~~~~~y~aPE~~  187 (297)
T cd06656         172 RSTMVGTPYWMAPEVV  187 (297)
T ss_pred             cCcccCCccccCHHHH
Confidence            2234688999999963

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.91  E-value=5e-24  Score=221.54  Aligned_cols=169  Identities=29%  Similarity=0.384  Sum_probs=146.9

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      +|++.+.||+|++|.||+|.+. +++.|++|.+....  ....+.+.+|++++++++||||+++++++.+++..|+||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4788899999999999999876 48999999986432  34457788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          737 MPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       737 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      +++++|.+++... ...+++..+..++.|++.|+.|||   +.|++||||||+||+++.++.+|++|||.++........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            9999999999764 346899999999999999999999   999999999999999999999999999999876543322


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                       .....|++.|+|||++
T Consensus       158 -~~~~~~~~~y~aPE~~  173 (256)
T cd08529         158 -ANTIVGTPYYLSPELC  173 (256)
T ss_pred             -hhccccCccccCHHHh
Confidence             2234688999999973

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.91  E-value=1.4e-24  Score=225.78  Aligned_cols=166  Identities=37%  Similarity=0.633  Sum_probs=138.2

Q ss_pred             CCCeeeccCCceEEEEEec-----CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          663 ASNLIGTGGFGSVYKGSFL-----DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       663 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      +.+.||.|+||.||+|.+.     .+..|+||.+.... ....+.+.+|++.+++++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4678999999999999887     26779999996543 33468899999999999999999999999988889999999


Q ss_pred             CCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc-
Q 003301          737 MPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES-  814 (832)
Q Consensus       737 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~-  814 (832)
                      +++|+|.+++... ...+++..+..|+.|++.|++|||   +.+++||||+++||+++.++.+||+|||++........ 
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999987 557999999999999999999999   89999999999999999999999999999987633222 


Q ss_pred             cccccccccccccCCCC
Q 003301          815 MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~  831 (832)
                      .......+...|+|||+
T Consensus       160 ~~~~~~~~~~~~~aPE~  176 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEV  176 (259)
T ss_dssp             EESTTSESGGGGS-HHH
T ss_pred             ccccccccccccccccc
Confidence            12223457788999996

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.91  E-value=4.1e-24  Score=225.80  Aligned_cols=171  Identities=26%  Similarity=0.470  Sum_probs=143.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-----CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecC--Cee
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-----DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNN--DFK  730 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  730 (832)
                      ..|++.+.||+|+||.||.|.+.     ++..||+|.++... ....+.+.+|++++++++|||++++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            45788999999999999999742     47889999987543 33346788999999999999999999998775  568


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      ++||||+++++|.+++.+....+++..+..++.|++.|++|+|   ++|++||||||+||+++.++.+||+|||.++...
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            9999999999999999766556899999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCccc--ccccccccccccCCCCC
Q 003301          811 GEESM--KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       811 ~~~~~--~~~~~~gt~~y~APE~l  832 (832)
                      .....  ......++..|+|||++
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~  184 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECL  184 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHh
Confidence            43221  11224467789999963

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.91  E-value=5.7e-24  Score=220.96  Aligned_cols=169  Identities=25%  Similarity=0.400  Sum_probs=145.7

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      +|++.+.||+|+||.||++.+. +++.||+|.++... ....+.+.+|+.+++.++||||+++++++.+++..|+||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            5788999999999999999876 48899999986432 344567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          738 PNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       738 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +++++.+++... ...+++..+..++.|++.|++|+|   ++|++|+||||+||++++++.++++|||.+......... 
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-  156 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY-  156 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc-
Confidence            999999988653 335789999999999999999999   999999999999999999999999999999866443222 


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....|++.|+|||++
T Consensus       157 ~~~~~~~~~~~aPE~~  172 (255)
T cd08219         157 ACTYVGTPYYVPPEIW  172 (255)
T ss_pred             cccccCCccccCHHHH
Confidence            2234689999999963

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=4.1e-24  Score=226.47  Aligned_cols=162  Identities=22%  Similarity=0.241  Sum_probs=128.3

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEec--CCcEEEEEEEecc-----chhhHHHHHHHHHHHhcCCCCceee-eceEEecC
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFL--DGMEVAIKVFHLQ-----LEGALKSFDVECEVLKSVRHRNLVK-IISSCTNN  727 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~  727 (832)
                      ...++|++.+.||+|+||+||+|.+.  +++.||||++...     .....+.+.+|++++++++|+++++ ++++    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            44678999999999999999999875  4777899986533     1223467899999999999999885 4432    


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCCeEeCCCCcEEEeccccc
Q 003301          728 DFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI-KPSNVLLDKDMVAHLSDFGIA  806 (832)
Q Consensus       728 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-kp~NIl~~~~~~~kl~DFg~a  806 (832)
                      +..|+||||++|++|... ...    .   ...++.|++.|++|+|   ++||+|||| ||+||+++.++.+||+|||+|
T Consensus        91 ~~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             CCcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            457999999999999732 111    1   1467899999999999   999999999 999999999999999999999


Q ss_pred             cccCCCccccc-------ccccccccccCCCCC
Q 003301          807 KLLSGEESMKQ-------TLTLATIGYMAPGLF  832 (832)
Q Consensus       807 ~~~~~~~~~~~-------~~~~gt~~y~APE~l  832 (832)
                      +.+........       +...+++.|+|||++
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~  192 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDAL  192 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccC
Confidence            97654332111       235688999999975

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.91  E-value=3.5e-24  Score=235.10  Aligned_cols=175  Identities=24%  Similarity=0.434  Sum_probs=143.7

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCC-CCceeeeceEEec
Q 003301          655 LQATNQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVR-HRNLVKIISSCTN  726 (832)
Q Consensus       655 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  726 (832)
                      ....++|.+.++||+|+||.||+|++.      .++.||+|+++... ....+.+.+|++++.++. ||||+++++++..
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            334567889999999999999999864      24679999997543 233457889999999997 9999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCC--------------------------------------------------------
Q 003301          727 NDFKALVLEYMPNGSLEDYLYSNN--------------------------------------------------------  750 (832)
Q Consensus       727 ~~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------  750 (832)
                      .+..|+||||+++|+|.+++++.+                                                        
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            999999999999999999996532                                                        


Q ss_pred             -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 003301          751 -----------------------------------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSN  789 (832)
Q Consensus       751 -----------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N  789 (832)
                                                               ..+++..+..++.|++.|++|||   +.+++||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcce
Confidence                                                     12566778889999999999999   9999999999999


Q ss_pred             eEeCCCCcEEEeccccccccCCCcc-cccccccccccccCCCCC
Q 003301          790 VLLDKDMVAHLSDFGIAKLLSGEES-MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       790 Il~~~~~~~kl~DFg~a~~~~~~~~-~~~~~~~gt~~y~APE~l  832 (832)
                      |+++.++.+|++|||+++....... .......+++.|||||++
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~  313 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI  313 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHh
Confidence            9999999999999999986533221 112224578899999964

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.91  E-value=4.3e-24  Score=225.58  Aligned_cols=171  Identities=25%  Similarity=0.438  Sum_probs=142.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-----CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-----DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      ++|++.+.||+|+||.||+|.+.     .+..||+|.+.... ......+.+|++++++++||||+++++++..++..|+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            56888999999999999999752     36789999987433 2334678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC
Q 003301          733 VLEYMPNGSLEDYLYSNN----------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM  796 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~  796 (832)
                      ||||+++++|.+++....                ..+++.++..++.|++.|++|||   ++|++||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            999999999999985321                23778889999999999999999   99999999999999999999


Q ss_pred             cEEEeccccccccCCCcc-cccccccccccccCCCCC
Q 003301          797 VAHLSDFGIAKLLSGEES-MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       797 ~~kl~DFg~a~~~~~~~~-~~~~~~~gt~~y~APE~l  832 (832)
                      .+|++|||+++....... .......++..|+|||++
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  198 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAI  198 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHh
Confidence            999999999986533221 112223467789999964

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.91  E-value=4e-24  Score=223.00  Aligned_cols=171  Identities=27%  Similarity=0.505  Sum_probs=146.9

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ..++|++.++||+|+||.||+|...+++.||||.+..... ..+.+.+|+.++++++||||+++++++..+...++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            3578999999999999999999987788999999875432 346788999999999999999999999998999999999


Q ss_pred             CCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          737 MPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       737 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      +++++|.+++.... ..+++..+..++.|++.|++|+|   +.+++||||||+||+++.++.+|++|||.++........
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence            99999999997643 35899999999999999999999   999999999999999999999999999999876543222


Q ss_pred             ccccccccccccCCCC
Q 003301          816 KQTLTLATIGYMAPGL  831 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~  831 (832)
                      ......++..|+|||.
T Consensus       160 ~~~~~~~~~~y~~PE~  175 (261)
T cd05034         160 AREGAKFPIKWTAPEA  175 (261)
T ss_pred             hhhccCCCccccCHHH
Confidence            2222335678999995

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.91  E-value=3e-24  Score=235.60  Aligned_cols=176  Identities=27%  Similarity=0.427  Sum_probs=149.8

Q ss_pred             HHHHHHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcC-CCCceeeeceEEec---
Q 003301          652 KELLQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLVKIISSCTN---  726 (832)
Q Consensus       652 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~---  726 (832)
                      +.+...++.|++.++||.|.+|.||+++.. +++.+|+|+....... .+++..|.++++.. .|||++.++|+|..   
T Consensus        12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            334445688999999999999999999876 4888999987755433 36778899998887 69999999999863   


Q ss_pred             --CCeeEEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecc
Q 003301          727 --NDFKALVLEYMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDF  803 (832)
Q Consensus       727 --~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DF  803 (832)
                        ++.+|+|||||.+|+..|+++.. +.++.|+.+..|++.++.|+.+||   ...++|||||-.|||++.++.||++||
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDF  167 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDF  167 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeee
Confidence              56899999999999999999764 345899999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCcccccccccccccccCCCCC
Q 003301          804 GIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       804 g~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      |.+...+..... ....+|||.|||||++
T Consensus       168 GvSaQldsT~gr-RnT~iGtP~WMAPEVi  195 (953)
T KOG0587|consen  168 GVSAQLDSTVGR-RNTFIGTPYWMAPEVI  195 (953)
T ss_pred             eeeeeeeccccc-ccCcCCCcccccceee
Confidence            999887554433 3346799999999985

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.91  E-value=3.9e-24  Score=222.87  Aligned_cols=171  Identities=24%  Similarity=0.464  Sum_probs=144.9

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ..++|++.++||+|+||.||+|...+++.||+|.+..... ..+.+.+|++++++++||||+++++++. .+..|++|||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            3568999999999999999999988899999999875433 3467889999999999999999999874 4568999999


Q ss_pred             CCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          737 MPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       737 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      +++++|.+++... ...+++.++..++.|++.|++|||   +.|++||||||+||++++++.++++|||.+.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            9999999998753 345899999999999999999999   999999999999999999999999999999876533322


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                      ......++..|+|||++
T Consensus       159 ~~~~~~~~~~y~~pe~~  175 (260)
T cd05067         159 AREGAKFPIKWTAPEAI  175 (260)
T ss_pred             cccCCcccccccCHHHh
Confidence            22233467789999963

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.91  E-value=2.3e-24  Score=232.81  Aligned_cols=172  Identities=25%  Similarity=0.452  Sum_probs=140.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEec-CC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTN-ND  728 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-~~  728 (832)
                      .++|++.+.||+|+||.||+|...      +++.||+|+++... ....+.+.+|++++.++ +|+||+++++++.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            457999999999999999999643      24789999987443 23345678899999999 89999999998765 45


Q ss_pred             eeEEEEecCCCCCHHHHHhhCC----------------------------------------------------------
Q 003301          729 FKALVLEYMPNGSLEDYLYSNN----------------------------------------------------------  750 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  750 (832)
                      ..+++|||+++++|.+++....                                                          
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            7889999999999999986421                                                          


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc-cccccccccccc
Q 003301          751 --FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM-KQTLTLATIGYM  827 (832)
Q Consensus       751 --~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~  827 (832)
                        ..+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||+|+.+...... ......++..||
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              14788999999999999999999   999999999999999999999999999999876433221 222234677899


Q ss_pred             CCCCC
Q 003301          828 APGLF  832 (832)
Q Consensus       828 APE~l  832 (832)
                      |||++
T Consensus       243 aPE~~  247 (337)
T cd05054         243 APESI  247 (337)
T ss_pred             CcHHh
Confidence            99963

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.91  E-value=2.4e-24  Score=235.19  Aligned_cols=168  Identities=24%  Similarity=0.323  Sum_probs=140.5

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecC-----
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNN-----  727 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  727 (832)
                      ...++|++.+.||+|+||.||+|.+. .++.||||++....  ......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            45689999999999999999999875 48899999987542  23346778899999999999999999988643     


Q ss_pred             -CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccc
Q 003301          728 -DFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA  806 (832)
Q Consensus       728 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a  806 (832)
                       ...|+||||++ +++.+.+..   .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|
T Consensus        94 ~~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          94 FQDVYLVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             cceeEEEhhhhc-ccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence             35799999995 577777653   4788999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCcccccccccccccccCCCCC
Q 003301          807 KLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       807 ~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +......  ......||+.|+|||++
T Consensus       167 ~~~~~~~--~~~~~~~t~~y~aPE~~  190 (355)
T cd07874         167 RTAGTSF--MMTPYVVTRYYRAPEVI  190 (355)
T ss_pred             ccCCCcc--ccCCccccCCccCHHHH
Confidence            8654322  22335699999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.5e-25  Score=223.13  Aligned_cols=173  Identities=25%  Similarity=0.317  Sum_probs=146.3

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCe
Q 003301          655 LQATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDF  729 (832)
Q Consensus       655 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  729 (832)
                      .....+|....+||+|+||.|..|..+. .+.||||++++..   ....+--..|-++++-- +-|++++++.+|++-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            3445689999999999999999997764 6779999987653   23334455677887766 57899999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      .|+||||+.||+|.-.+++-+ ++.+..+..+|.+||-||-|||   ++||+.||+|.+||++|.+|.+||+|||+++.-
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccc
Confidence            999999999999998888765 6888999999999999999999   999999999999999999999999999999864


Q ss_pred             CCCcccccccccccccccCCCCC
Q 003301          810 SGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       810 ~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      --+.. .....+|||.|+|||++
T Consensus       501 i~~~~-TTkTFCGTPdYiAPEIi  522 (683)
T KOG0696|consen  501 IFDGV-TTKTFCGTPDYIAPEII  522 (683)
T ss_pred             ccCCc-ceeeecCCCcccccceE
Confidence            33332 33447899999999985

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.91  E-value=8e-24  Score=222.90  Aligned_cols=163  Identities=26%  Similarity=0.378  Sum_probs=140.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            36888999999999999999874 58899999986542 33346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      ++++++..+.     .+++..+..++.|++.|++|+|   +.||+||||||+||+++.++.+||+|||++.......   
T Consensus        81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---  149 (279)
T cd06619          81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---  149 (279)
T ss_pred             CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence            9999997652     4678889999999999999999   9999999999999999999999999999998654322   


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      ....+||..|+|||++
T Consensus       150 ~~~~~~~~~y~aPE~~  165 (279)
T cd06619         150 AKTYVGTNAYMAPERI  165 (279)
T ss_pred             ccCCCCChhhcCceee
Confidence            2234689999999974

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.91  E-value=4.9e-24  Score=223.46  Aligned_cols=171  Identities=30%  Similarity=0.483  Sum_probs=143.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC----CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD----GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      .++|.+.+.||+|+||.||+|.+.+    ...||+|...... ....+.+.+|+.++++++||||+++++++.+ +..|+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3568899999999999999998753    2468999887554 3445688899999999999999999998875 45789


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||||+++++|.+++......+++..+..++.|++.|++|+|   +.+++||||||+||+++.++.+|++|||.++.....
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            99999999999999876656899999999999999999999   999999999999999999999999999999876544


Q ss_pred             cccccccccccccccCCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~l  832 (832)
                      .........++..|+|||++
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~  180 (270)
T cd05056         161 SYYKASKGKLPIKWMAPESI  180 (270)
T ss_pred             cceecCCCCccccccChhhh
Confidence            32222223356789999963

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.91  E-value=6.7e-24  Score=222.31  Aligned_cols=165  Identities=27%  Similarity=0.433  Sum_probs=136.0

Q ss_pred             CeeeccCCceEEEEEecC---CcEEEEEEEeccch-hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCC
Q 003301          665 NLIGTGGFGSVYKGSFLD---GMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNG  740 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  740 (832)
                      +.||+|+||.||+|.+.+   +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999997643   45799998865432 23357888999999999999999999999989999999999999


Q ss_pred             CHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc-
Q 003301          741 SLEDYLYSNN----FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM-  815 (832)
Q Consensus       741 ~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~-  815 (832)
                      +|.+++....    ...++..+..++.|++.|++|+|   +.+++||||||+||+++.++.+|++|||.++........ 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999997532    23567788899999999999999   999999999999999999999999999999754332221 


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                      ......|+..|+|||++
T Consensus       158 ~~~~~~~~~~y~aPE~~  174 (269)
T cd05087         158 TPDQLWVPLRWIAPELV  174 (269)
T ss_pred             cCCCcCCcccccCHhHh
Confidence            12234578889999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.91  E-value=8.7e-24  Score=219.71  Aligned_cols=169  Identities=26%  Similarity=0.372  Sum_probs=147.0

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      +|++.+.||.|+||.||.++.. +++.|++|.+....  ....+.+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5888999999999999999875 48899999886543  34456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          737 MPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       737 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      +++++|.+++.+. ...+++..+..++.|++.|++|+|   +.|++||||+|+||+++.++.+||+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999999765 345899999999999999999999   99999999999999999999999999999987644432 


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                      ......|++.|+|||++
T Consensus       157 ~~~~~~~~~~y~ape~~  173 (256)
T cd08221         157 MAETVVGTPYYMSPELC  173 (256)
T ss_pred             cccccCCCccccCHhhc
Confidence            22335689999999963

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.91  E-value=4.4e-24  Score=226.87  Aligned_cols=172  Identities=24%  Similarity=0.418  Sum_probs=142.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC---------------CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD---------------GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKII  721 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~  721 (832)
                      .++|++.+.||+|+||.||+|...+               ...||+|+++... ......+.+|++++++++|||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3689999999999999999987642               2348999987543 33446788999999999999999999


Q ss_pred             eEEecCCeeEEEEecCCCCCHHHHHhhCC-----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCe
Q 003301          722 SSCTNNDFKALVLEYMPNGSLEDYLYSNN-----------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNV  790 (832)
Q Consensus       722 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI  790 (832)
                      +++...+..++||||+++++|.+++....           ..+++..+..++.|++.|++|||   +.|++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence            99999999999999999999999986532           13678889999999999999999   99999999999999


Q ss_pred             EeCCCCcEEEeccccccccCCCccc-ccccccccccccCCCCC
Q 003301          791 LLDKDMVAHLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       791 l~~~~~~~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~l  832 (832)
                      +++.++.+|++|||++......... ......++..|+|||++
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  203 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESI  203 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhh
Confidence            9999999999999999765332221 11223457789999963

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.91  E-value=6.5e-24  Score=223.57  Aligned_cols=170  Identities=26%  Similarity=0.423  Sum_probs=139.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-Cc----EEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GM----EVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      ++|++.+.||+|+||+||+|.+.. ++    .|++|.+.... .....++..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            578889999999999999998753 44    47777765332 2334667788889999999999999998754 55789


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ++||+++|+|.+++......+++..+..++.|++.|++|+|   +++++||||||+||+++.++.+||+|||.++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            99999999999999876667899999999999999999999   999999999999999999999999999999865433


Q ss_pred             cc-cccccccccccccCCCCC
Q 003301          813 ES-MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~-~~~~~~~gt~~y~APE~l  832 (832)
                      .. .......++..|+|||++
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~  183 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESI  183 (279)
T ss_pred             CcccccCCCCCcccccCHHHh
Confidence            22 112234477789999963

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.91  E-value=4.2e-24  Score=223.83  Aligned_cols=164  Identities=26%  Similarity=0.371  Sum_probs=133.8

Q ss_pred             CeeeccCCceEEEEEecC---CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCC
Q 003301          665 NLIGTGGFGSVYKGSFLD---GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNG  740 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  740 (832)
                      +.||+|+||.||+|...+   ...+|+|.+.... ......+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            368999999999997543   3568888765433 233456788999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc-
Q 003301          741 SLEDYLYSNNF----SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM-  815 (832)
Q Consensus       741 ~L~~~l~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~-  815 (832)
                      +|.+++.....    ..++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||.+......... 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999976432    2467788899999999999999   999999999999999999999999999998754332211 


Q ss_pred             ccccccccccccCCCC
Q 003301          816 KQTLTLATIGYMAPGL  831 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~  831 (832)
                      ......+++.|+|||+
T Consensus       158 ~~~~~~~~~~y~aPE~  173 (269)
T cd05042         158 TKDCHAVPLRWLAPEL  173 (269)
T ss_pred             ccCCCCCcccccCHHH
Confidence            1122346778999996

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.91  E-value=5.3e-24  Score=225.29  Aligned_cols=168  Identities=24%  Similarity=0.406  Sum_probs=145.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ++|++.+.||+|+||.||+|.+. .++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..|+||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46889999999999999999886 58999999887543 33346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          737 MPNGSLEDYLYSN--NFSFDILQRLSVIIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       737 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      +++++|.+++...  ...+++..+..++.|++.|+.|||   + .+++||||||+||+++.++.+||+|||.+.......
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            9999999998764  235899999999999999999999   5 599999999999999999999999999997653322


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                      .   ....+++.|+|||++
T Consensus       158 ~---~~~~~~~~y~aPE~~  173 (286)
T cd06622         158 A---KTNIGCQSYMAPERI  173 (286)
T ss_pred             c---ccCCCccCccCcchh
Confidence            1   224588899999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.91  E-value=9.8e-24  Score=220.55  Aligned_cols=169  Identities=28%  Similarity=0.455  Sum_probs=144.6

Q ss_pred             CCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccc------hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          660 QFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL------EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      +|++.+.||+|+||.||+|...+++.||+|.+....      ....+.+.+|++++++++|+||+++++++.+.+..|+|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            588899999999999999988789999999886432      22335688899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+++++|.+++.+.. .+++..+..++.|++.|++|+|   +.+++|+||+|+||++++++.+||+|||.+.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            99999999999997654 5889999999999999999999   9999999999999999999999999999987643211


Q ss_pred             -----ccccccccccccccCCCCC
Q 003301          814 -----SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 -----~~~~~~~~gt~~y~APE~l  832 (832)
                           ........|+..|+|||++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~  180 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVI  180 (265)
T ss_pred             ccccccccccccCCCccccChhhh
Confidence                 1111224589999999974

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.91  E-value=6.1e-24  Score=220.88  Aligned_cols=170  Identities=29%  Similarity=0.506  Sum_probs=145.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCC
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMP  738 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  738 (832)
                      .+|++.+.||+|+||.||+|.+.+++.+|+|.+..... ....+.+|++++++++||+++++++++......|+||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            47888999999999999999887788999998864432 23578889999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccc
Q 003301          739 NGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT  818 (832)
Q Consensus       739 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~  818 (832)
                      +++|.+++......+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.++...........
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST  159 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence            99999999876656899999999999999999999   999999999999999999999999999998765433222222


Q ss_pred             cccccccccCCCCC
Q 003301          819 LTLATIGYMAPGLF  832 (832)
Q Consensus       819 ~~~gt~~y~APE~l  832 (832)
                      ...++..|+|||++
T Consensus       160 ~~~~~~~~~aPe~~  173 (256)
T cd05112         160 GTKFPVKWSSPEVF  173 (256)
T ss_pred             CCccchhhcCHhHh
Confidence            23356789999963

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.91  E-value=2.9e-24  Score=249.11  Aligned_cols=176  Identities=23%  Similarity=0.349  Sum_probs=142.9

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEec--CCe
Q 003301          655 LQATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTN--NDF  729 (832)
Q Consensus       655 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~  729 (832)
                      ....++|++.+.||+|+||+||+|++.. +..||+|++....  ......+..|+.++++++|||||+++++|..  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            3456789999999999999999998865 7789999886442  3345678899999999999999999998854  457


Q ss_pred             eEEEEecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCeEecCCCCCCeEeCCC-------
Q 003301          730 KALVLEYMPNGSLEDYLYSN---NFSFDILQRLSVIIDVALALEYLHFGY----SNPVVHCDIKPSNVLLDKD-------  795 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~----~~~ivH~Dlkp~NIl~~~~-------  795 (832)
                      +|+||||+++++|.+++...   ...+++..++.|+.||+.||+|||...    ..+||||||||+|||++.+       
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            89999999999999998752   235899999999999999999999211    1459999999999999642       


Q ss_pred             ----------CcEEEeccccccccCCCcccccccccccccccCCCCC
Q 003301          796 ----------MVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       796 ----------~~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                                +.+||+|||++........  ....+||+.|+|||++
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL  213 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELL  213 (1021)
T ss_pred             cccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHH
Confidence                      3599999999987643322  2235699999999964

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.91  E-value=4.2e-24  Score=226.06  Aligned_cols=179  Identities=25%  Similarity=0.392  Sum_probs=147.7

Q ss_pred             cchHHHHHHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcC-CCCceeeeceEEe-
Q 003301          649 FSYKELLQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLVKIISSCT-  725 (832)
Q Consensus       649 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~-  725 (832)
                      ..++.+....++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++.+ +||||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            344556667899999999999999999999875 47899999876432 2235678899999999 6999999999874 


Q ss_pred             ----cCCeeEEEEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcE
Q 003301          726 ----NNDFKALVLEYMPNGSLEDYLYS---NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVA  798 (832)
Q Consensus       726 ----~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~  798 (832)
                          .++..|+||||+++++|.+++..   ....+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence                34578999999999999998753   2335888999999999999999999   9999999999999999999999


Q ss_pred             EEeccccccccCCCcccccccccccccccCCCCC
Q 003301          799 HLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       799 kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      |++|||.++....... ......|++.|+|||++
T Consensus       164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~  196 (286)
T cd06638         164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVI  196 (286)
T ss_pred             EEccCCceeecccCCC-ccccccCCCcccChhhh
Confidence            9999999987643322 22234699999999964

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.91  E-value=4.7e-24  Score=225.82  Aligned_cols=173  Identities=23%  Similarity=0.408  Sum_probs=141.7

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC------CcEEEEEEEeccch-hhHHHHHHHHHHHhcCCCCceeeeceEEecCCe
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD------GMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVKIISSCTNNDF  729 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  729 (832)
                      ..++|++.+.||+|+||.||+|...+      +..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            46789999999999999999996532      45799998764432 233467889999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEE
Q 003301          730 KALVLEYMPNGSLEDYLYSNN---------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHL  800 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl  800 (832)
                      .|+||||+++|+|.++++...         ...++..+..++.|++.|++|||   +++|+||||||+||+++.++.+|+
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999997532         22466788899999999999999   999999999999999999999999


Q ss_pred             eccccccccCCCccc-ccccccccccccCCCCC
Q 003301          801 SDFGIAKLLSGEESM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       801 ~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~l  832 (832)
                      +|||+++........ ......++..|+|||++
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~  193 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL  193 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHh
Confidence            999999865432221 11223457789999963

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.91  E-value=6.7e-24  Score=224.39  Aligned_cols=168  Identities=30%  Similarity=0.428  Sum_probs=142.7

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      +|++.+.||+|++|.||+|... +++.||+|++....  ....+.+.+|+.++++++||||+++++++.+++..|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            5788999999999999999876 58999999986543  22346778899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          737 MPNGSLEDYLYSNN--FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       737 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ++ +++.+++....  ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            96 68988886533  45899999999999999999999   99999999999999999999999999999976543221


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                       ......+++.|+|||++
T Consensus       157 -~~~~~~~~~~y~aPE~~  173 (285)
T cd07861         157 -VYTHEVVTLWYRAPEVL  173 (285)
T ss_pred             -cccCCcccccccChHHh
Confidence             12224578999999963

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.91  E-value=5.6e-24  Score=230.78  Aligned_cols=172  Identities=23%  Similarity=0.428  Sum_probs=139.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe------cCCcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEecC-C
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSF------LDGMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTNN-D  728 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~  728 (832)
                      .++|++.+.||+|+||.||+|.+      .+++.||||+++... ....+.+.+|++++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            46899999999999999999974      246789999987543 23346788999999999 689999999987654 5


Q ss_pred             eeEEEEecCCCCCHHHHHhhCC----------------------------------------------------------
Q 003301          729 FKALVLEYMPNGSLEDYLYSNN----------------------------------------------------------  750 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  750 (832)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999986432                                                          


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc-ccccccc
Q 003301          751 --------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES-MKQTLTL  821 (832)
Q Consensus       751 --------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~-~~~~~~~  821 (832)
                              ..+++..+..++.|++.|++|+|   ++||+||||||+||+++.++.+||+|||++........ .......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                    12577788899999999999999   99999999999999999999999999999986533221 1112233


Q ss_pred             ccccccCCCCC
Q 003301          822 ATIGYMAPGLF  832 (832)
Q Consensus       822 gt~~y~APE~l  832 (832)
                      ++..|+|||++
T Consensus       243 ~~~~y~aPE~~  253 (343)
T cd05103         243 LPLKWMAPETI  253 (343)
T ss_pred             CCcceECcHHh
Confidence            56789999963

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.91  E-value=7.3e-24  Score=224.72  Aligned_cols=171  Identities=27%  Similarity=0.470  Sum_probs=144.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      .+|.+.+.||+|+||.||+|.+.      ++..|++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            46888899999999999999753      245689998876655555778999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCc
Q 003301          733 VLEYMPNGSLEDYLYSNN---------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMV  797 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~  797 (832)
                      ||||+++++|.+++....               ..+++..++.++.|++.|++|||   ++|++||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            999999999999996532               24789999999999999999999   999999999999999999999


Q ss_pred             EEEeccccccccCCCccc-ccccccccccccCCCCC
Q 003301          798 AHLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       798 ~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~l  832 (832)
                      +||+|||.+......... ......++..|+|||++
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  197 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI  197 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHh
Confidence            999999999765433211 12234578899999963

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.91  E-value=1e-23  Score=219.27  Aligned_cols=166  Identities=34%  Similarity=0.547  Sum_probs=145.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      .++|++.+.||+|+||.||+|.. .++.||+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..|+||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            46789999999999999999987 588999999876644 4578899999999999999999999999989999999999


Q ss_pred             CCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          738 PNGSLEDYLYSNNF-SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       738 ~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      ++++|.++++.... .+++..+..++.|++.|+.|||   +.|++||||||+||+++.++.+||+|||.++.......  
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            99999999976542 5899999999999999999999   99999999999999999999999999999987633221  


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                        ...++..|+|||++
T Consensus       158 --~~~~~~~~~ape~~  171 (256)
T cd05039         158 --SGKLPVKWTAPEAL  171 (256)
T ss_pred             --cCCCcccccCchhh
Confidence              22356679999963

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.91  E-value=7.8e-24  Score=220.60  Aligned_cols=168  Identities=25%  Similarity=0.448  Sum_probs=141.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCC
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMP  738 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  738 (832)
                      ++|++.+.||+|+||.||+|.+..+..||+|.+.... ...+.+.+|++++++++||+++++++++. .+..|+||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            5688999999999999999998777789999876443 23467888999999999999999999875 456899999999


Q ss_pred             CCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccc
Q 003301          739 NGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ  817 (832)
Q Consensus       739 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~  817 (832)
                      +++|.++++... ..+++..+..++.|++.|++|||   +.|++||||||+||++++++.+||+|||.+...........
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence            999999997643 34789999999999999999999   99999999999999999999999999999987643332222


Q ss_pred             ccccccccccCCCC
Q 003301          818 TLTLATIGYMAPGL  831 (832)
Q Consensus       818 ~~~~gt~~y~APE~  831 (832)
                      ....++..|+|||+
T Consensus       161 ~~~~~~~~y~~Pe~  174 (260)
T cd05069         161 QGAKFPIKWTAPEA  174 (260)
T ss_pred             CCCccchhhCCHHH
Confidence            22346778999996

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.91  E-value=9.8e-24  Score=220.53  Aligned_cols=170  Identities=28%  Similarity=0.396  Sum_probs=142.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc-----hhhHHHHHHHHHHHhcCCCCceeeeceEEecC--Cee
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL-----EGALKSFDVECEVLKSVRHRNLVKIISSCTNN--DFK  730 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  730 (832)
                      .+|++.+.||+|+||.||+|.+.+ ++.||+|.+....     ....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            578999999999999999998754 8999999886432     22346788899999999999999999998763  468


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      |++|||+++++|.+++.... .+++..+.+++.|++.|++|+|   +.+++||||||+||+++.++.+||+|||.++...
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            89999999999999987654 5788999999999999999999   9999999999999999999999999999998653


Q ss_pred             CCcc--cccccccccccccCCCCC
Q 003301          811 GEES--MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       811 ~~~~--~~~~~~~gt~~y~APE~l  832 (832)
                      ....  .......|+..|+|||++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~  181 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVI  181 (265)
T ss_pred             cccccccccccCCCCccccChhhh
Confidence            3211  112224588999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.91  E-value=6.6e-24  Score=222.35  Aligned_cols=171  Identities=27%  Similarity=0.486  Sum_probs=143.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-C---cEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-G---MEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .+|++.+.||+|+||.||+|.+.. +   ..||+|.+.... ......+..|+.++++++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            457889999999999999998753 3   369999987542 33456889999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+++++|.++++.....+++.++..++.|++.|++|||   +.|++||||||+||+++.++.+|++|||.+.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999999876667899999999999999999999   9999999999999999999999999999987654322


Q ss_pred             ccc-ccc-c--cccccccCCCCC
Q 003301          814 SMK-QTL-T--LATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~-~~~-~--~gt~~y~APE~l  832 (832)
                      ... ... .  ..+..|+|||++
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~  183 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAI  183 (269)
T ss_pred             cccccccccCCCcceeecCHhHh
Confidence            211 111 1  124579999964

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.91  E-value=7.3e-24  Score=224.83  Aligned_cols=170  Identities=26%  Similarity=0.429  Sum_probs=144.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch-hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .++|++.+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++.+++..|+|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            468999999999999999999876 588999999875432 223456789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      |++ ++|.+++......+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.++....... 
T Consensus        84 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-  158 (291)
T cd07844          84 YLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-  158 (291)
T ss_pred             cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence            996 5999998876657899999999999999999999   99999999999999999999999999999875432221 


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                      ......++..|+|||++
T Consensus       159 ~~~~~~~~~~~~aPE~~  175 (291)
T cd07844         159 TYSNEVVTLWYRPPDVL  175 (291)
T ss_pred             cccccccccccCCcHHh
Confidence            11223478899999963

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.91  E-value=6.7e-24  Score=226.50  Aligned_cols=173  Identities=27%  Similarity=0.494  Sum_probs=143.8

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec--------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEec
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL--------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTN  726 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  726 (832)
                      ..++|++.+.||+|+||.||+|++.        ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3567889999999999999999752        24579999886543 33456788999999999 89999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 003301          727 NDFKALVLEYMPNGSLEDYLYSNN---------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVL  791 (832)
Q Consensus       727 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl  791 (832)
                      .+..|+||||+++++|.+++....               ..+++..+..++.|++.|++|||   ++|++||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEE
Confidence            999999999999999999997532               24678889999999999999999   999999999999999


Q ss_pred             eCCCCcEEEeccccccccCCCcccc-cccccccccccCCCCC
Q 003301          792 LDKDMVAHLSDFGIAKLLSGEESMK-QTLTLATIGYMAPGLF  832 (832)
Q Consensus       792 ~~~~~~~kl~DFg~a~~~~~~~~~~-~~~~~gt~~y~APE~l  832 (832)
                      ++.++.+||+|||.|+......... .....+++.|+|||++
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  211 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL  211 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhh
Confidence            9999999999999998764433221 1223467789999964

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.91  E-value=7.2e-24  Score=220.75  Aligned_cols=158  Identities=26%  Similarity=0.411  Sum_probs=134.9

Q ss_pred             CeeeccCCceEEEEEecCCc-----------EEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          665 NLIGTGGFGSVYKGSFLDGM-----------EVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      +.||+|+||.||+|.+.+..           .|++|.+...... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999886532           4777876544333 5788899999999999999999999888 778999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC-------cEEEeccccc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM-------VAHLSDFGIA  806 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-------~~kl~DFg~a  806 (832)
                      |||+++|+|.+++......+++..+..++.|++.|++|||   ++||+||||||+||+++.++       .+|++|||.+
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            9999999999999876556899999999999999999999   99999999999999999887       7999999999


Q ss_pred             cccCCCcccccccccccccccCCCCC
Q 003301          807 KLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       807 ~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ......     ....++..|+|||++
T Consensus       156 ~~~~~~-----~~~~~~~~y~aPE~~  176 (259)
T cd05037         156 ITVLSR-----EERVERIPWIAPECI  176 (259)
T ss_pred             cccccc-----cccccCCCccChhhh
Confidence            875431     123577889999974

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.91  E-value=6.3e-24  Score=223.35  Aligned_cols=171  Identities=20%  Similarity=0.389  Sum_probs=145.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC------CcEEEEEEEeccchh-hHHHHHHHHHHHhcCCCCceeeeceEEecCCeeE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD------GMEVAIKVFHLQLEG-ALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  731 (832)
                      ++|++.+.||+|+||.||+|+...      .+.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+..|
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            678899999999999999998642      467999988654433 4578899999999999999999999999989999


Q ss_pred             EEEecCCCCCHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecc
Q 003301          732 LVLEYMPNGSLEDYLYSNN--------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDF  803 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DF  803 (832)
                      +||||+++++|.+++....        ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999997543        14889999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCcccccccccccccccCCCCC
Q 003301          804 GIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       804 g~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      |.+...............++..|+|||.+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~  190 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAV  190 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhh
Confidence            99875543332233334577889999963

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.91  E-value=9.2e-24  Score=224.23  Aligned_cols=168  Identities=33%  Similarity=0.469  Sum_probs=147.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      .+|++.+.||.|+||.||+|.+. +++.||+|.+........+.+.+|+++++.++|||++++++++...+..|+|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            56899999999999999999864 58999999987665555678889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccc
Q 003301          738 PNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ  817 (832)
Q Consensus       738 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~  817 (832)
                      ++++|.+++...  .+++.++..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||++......... .
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~  172 (296)
T cd06655          99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-R  172 (296)
T ss_pred             CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-C
Confidence            999999998754  4899999999999999999999   999999999999999999999999999998865443322 2


Q ss_pred             ccccccccccCCCCC
Q 003301          818 TLTLATIGYMAPGLF  832 (832)
Q Consensus       818 ~~~~gt~~y~APE~l  832 (832)
                      ....|++.|+|||++
T Consensus       173 ~~~~~~~~y~aPE~~  187 (296)
T cd06655         173 STMVGTPYWMAPEVV  187 (296)
T ss_pred             CCcCCCccccCcchh
Confidence            234688999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.91  E-value=1e-23  Score=223.61  Aligned_cols=169  Identities=28%  Similarity=0.387  Sum_probs=144.6

Q ss_pred             CCCCCCeeeccCCceEEEEEec----CCcEEEEEEEeccc----hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCee
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL----DGMEVAIKVFHLQL----EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  730 (832)
                      +|++.+.||+|+||.||+|...    +|+.||+|++....    ....+.+.+|+++++++ +|++|+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4788999999999999999863    58899999987532    22346778899999999 599999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      |+||||+++++|.+++.... .+++..+..++.|++.|++|||   +.|++||||+|+||+++.++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            99999999999999997654 6889999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCcccccccccccccccCCCCC
Q 003301          811 GEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       811 ~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ...........|+..|+|||++
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~  178 (290)
T cd05613         157 EDEVERAYSFCGTIEYMAPDIV  178 (290)
T ss_pred             cccccccccccCCcccCChhhc
Confidence            4332222335689999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.91  E-value=8.9e-24  Score=224.99  Aligned_cols=168  Identities=29%  Similarity=0.422  Sum_probs=144.4

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchh-----hHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEG-----ALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      +|++.+.||+|+||.||+|.+. +++.||||.+......     ....+..|++++++++|+||+++++++.+.+..|+|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788899999999999999875 5899999998754322     234567899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+ +++|.+++......+++..+..++.|++.||+|||   ++|++||||||+||+++.++.+||+|||.++......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 89999999765546899999999999999999999   9999999999999999999999999999998765432


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                      .. .....+++.|+|||++
T Consensus       157 ~~-~~~~~~~~~y~aPE~~  174 (298)
T cd07841         157 RK-MTHQVVTRWYRAPELL  174 (298)
T ss_pred             cc-ccccccceeeeCHHHH
Confidence            21 2223578889999963

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.91  E-value=1.3e-23  Score=219.98  Aligned_cols=170  Identities=29%  Similarity=0.425  Sum_probs=146.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.+.||+|+||.||+|... +++.||+|.++...   ....+.+.+|++++++++|++++++++++..++..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999887 68999999886422   233567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          735 EYMPNGSLEDYLYS---NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       735 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      ||+++++|.+++..   ....+++..+..++.|++.|++|||   +.|++||||+|+||+++.++.++++|||.+.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999999864   2335889999999999999999999   99999999999999999999999999999876543


Q ss_pred             CcccccccccccccccCCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .... .....+++.|+|||++
T Consensus       159 ~~~~-~~~~~~~~~y~apE~~  178 (267)
T cd08224         159 KTTA-AHSLVGTPYYMSPERI  178 (267)
T ss_pred             CCcc-cceecCCccccCHHHh
Confidence            3221 2234588999999963

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.91  E-value=7.8e-24  Score=224.25  Aligned_cols=167  Identities=30%  Similarity=0.464  Sum_probs=136.6

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch--hhHHHHHHHHHHHhcC---CCCceeeeceEEec-----CC
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE--GALKSFDVECEVLKSV---RHRNLVKIISSCTN-----ND  728 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~  728 (832)
                      +|++.+.||+|+||+||+|.+. +++.||+|.++....  .....+.+|+++++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5888999999999999999886 488999999875432  2223556677777665   79999999998764     34


Q ss_pred             eeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccc
Q 003301          729 FKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK  807 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~  807 (832)
                      ..++||||++ +++.+++.... ..+++..+..++.|++.|++|+|   +.|++||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            5799999996 58988887643 34899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCcccccccccccccccCCCCC
Q 003301          808 LLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       808 ~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .......  .....||+.|+|||++
T Consensus       157 ~~~~~~~--~~~~~~~~~y~aPE~~  179 (288)
T cd07863         157 IYSCQMA--LTPVVVTLWYRAPEVL  179 (288)
T ss_pred             cccCccc--CCCccccccccCchHh
Confidence            7643322  2234689999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.91  E-value=8.9e-24  Score=222.66  Aligned_cols=171  Identities=29%  Similarity=0.450  Sum_probs=142.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCc----EEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGM----EVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  731 (832)
                      .++|++.+.||+|+||+||+|++. +++    .||+|++.... ....+.+.+|+.+++.+.||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            467889999999999999999864 343    48999887543 33456788999999999999999999998754 578


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      ++|||+++|+|.++++.....+++..+..++.|++.|++|||   +++++||||||+||+++.++.+||+|||+++....
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            999999999999999876657899999999999999999999   99999999999999999999999999999987643


Q ss_pred             Ccccc-cccccccccccCCCCC
Q 003301          812 EESMK-QTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~-~~~~~gt~~y~APE~l  832 (832)
                      ..... .....+++.|+|||++
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~  183 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESI  183 (279)
T ss_pred             ccceeecCCCccchhhCCHHHh
Confidence            32211 1112356789999963

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.91  E-value=1.1e-23  Score=219.11  Aligned_cols=168  Identities=31%  Similarity=0.576  Sum_probs=144.8

Q ss_pred             CCCCCeeeccCCceEEEEEecC-----CcEEEEEEEeccchh-hHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          661 FNASNLIGTGGFGSVYKGSFLD-----GMEVAIKVFHLQLEG-ALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       661 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      +++.+.||+|+||.||+|.+.+     +..||+|++...... ..+.+..|+++++.++|+||+++++++.+.+..|++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4678899999999999998864     378999998755432 5578899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          735 EYMPNGSLEDYLYSNNFS-FDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      ||+++++|.+++...... +++..+..++.|++.|++|||   +.+++||||||+||+++.++.++++|||.+.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999999765534 899999999999999999999   9999999999999999999999999999998765443


Q ss_pred             ccccccccccccccCCCC
Q 003301          814 SMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~  831 (832)
                      ........+++.|+|||.
T Consensus       158 ~~~~~~~~~~~~y~~Pe~  175 (258)
T smart00219      158 YYKKKGGKLPIRWMAPES  175 (258)
T ss_pred             ccccccCCCcccccChHH
Confidence            322222337789999996

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.91  E-value=5.5e-24  Score=233.07  Aligned_cols=167  Identities=24%  Similarity=0.319  Sum_probs=140.1

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecC------
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNN------  727 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  727 (832)
                      ..++|++.+.||+|+||.||+|.+. .++.||||++....  ....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999875 48899999986532  23346778899999999999999999987643      


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccc
Q 003301          728 DFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK  807 (832)
Q Consensus       728 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~  807 (832)
                      ...|+||||++ +++.+++..   .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            35799999995 578877753   4788899999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCcccccccccccccccCCCCC
Q 003301          808 LLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       808 ~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ......  ......||+.|+|||++
T Consensus       175 ~~~~~~--~~~~~~~t~~y~aPE~~  197 (364)
T cd07875         175 TAGTSF--MMTPYVVTRYYRAPEVI  197 (364)
T ss_pred             ccCCCC--cccCCcccCCcCCHHHH
Confidence            654322  22335689999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.91  E-value=1.3e-23  Score=223.00  Aligned_cols=171  Identities=26%  Similarity=0.418  Sum_probs=143.7

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch-hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      +.++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++|+||+++++++..++..|+||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3578999999999999999999875 588999999865432 22346678999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||++ +++.+++......+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||.++.......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9995 7888777655456788889999999999999999   99999999999999999999999999999976433221


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                       ......+++.|+|||++
T Consensus       159 -~~~~~~~~~~y~aPE~~  175 (291)
T cd07870         159 -TYSSEVVTLWYRPPDVL  175 (291)
T ss_pred             -CCCCccccccccCCcee
Confidence             12234578999999974

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.91  E-value=4.3e-24  Score=225.76  Aligned_cols=168  Identities=29%  Similarity=0.420  Sum_probs=143.4

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      +|++.+.||+|+||.||+|.+. +|+.||+|+++...  ......+.+|++++++++||||+++++++.+.+..|+|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4888899999999999999886 48899999987542  22235677899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      ++ +++.+++......+++..+..++.|++.|++|||   +++++||||||+||+++.++.+||+|||.++....... .
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~  155 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-C  155 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-C
Confidence            95 6898888765557899999999999999999999   99999999999999999999999999999986543322 1


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....+++.|+|||++
T Consensus       156 ~~~~~~~~~y~aPE~~  171 (284)
T cd07839         156 YSAEVVTLWYRPPDVL  171 (284)
T ss_pred             cCCCccccCCcChHHH
Confidence            2234578999999963

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.91  E-value=5.9e-24  Score=223.16  Aligned_cols=171  Identities=28%  Similarity=0.432  Sum_probs=144.3

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcC-CCCceeeeceEEecC------C
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLVKIISSCTNN------D  728 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------~  728 (832)
                      +.+.|++.+.||+|+||.||+|...+ ++.||+|++.... .....+.+|+++++++ +||||+++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            45778899999999999999998764 8889999987543 3346788899999998 699999999998753      4


Q ss_pred             eeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccc
Q 003301          729 FKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK  807 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~  807 (832)
                      ..|+||||+++++|.+++.... ..+++..+..++.|++.|++|||   +++|+||||||+||++++++.+||+|||++.
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence            6899999999999999988643 35889999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCcccccccccccccccCCCCC
Q 003301          808 LLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       808 ~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ....... ......|++.|+|||++
T Consensus       160 ~~~~~~~-~~~~~~g~~~y~aPE~~  183 (272)
T cd06637         160 QLDRTVG-RRNTFIGTPYWMAPEVI  183 (272)
T ss_pred             ecccccc-cCCcccccccccCHhHh
Confidence            6543222 22335689999999974

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.91  E-value=7.6e-24  Score=220.66  Aligned_cols=170  Identities=23%  Similarity=0.446  Sum_probs=144.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      .++|++.+.||+|+||.||+|.+.++..||+|.+.... ...+.+.+|++++++++|+||+++++++.+ ...|++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            57899999999999999999988778889999887542 334678889999999999999999999887 7789999999


Q ss_pred             CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          738 PNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       738 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      ++++|.+++.+. ....++..+..++.|++.|++|+|   +.|++||||||+||+++.++.+||+|||.+..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  159 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA  159 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence            999999999763 335788899999999999999999   9999999999999999999999999999998664333222


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....++..|+|||++
T Consensus       160 ~~~~~~~~~y~~PE~~  175 (260)
T cd05073         160 REGAKFPIKWTAPEAI  175 (260)
T ss_pred             ccCCcccccccCHhHh
Confidence            2223466789999974

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.91  E-value=1.2e-23  Score=218.61  Aligned_cols=162  Identities=27%  Similarity=0.488  Sum_probs=134.8

Q ss_pred             eeeccCCceEEEEEec---CCcEEEEEEEeccch-hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCCC
Q 003301          666 LIGTGGFGSVYKGSFL---DGMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGS  741 (832)
Q Consensus       666 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  741 (832)
                      .||+|+||.||+|.+.   ++..||+|++..... ...+.+.+|++++++++||||+++++++.. +..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999764   355799998875532 334678899999999999999999998864 56799999999999


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccc--cc
Q 003301          742 LEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ--TL  819 (832)
Q Consensus       742 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~--~~  819 (832)
                      |.+++......+++..+.+++.|++.|++|+|   ++|++||||||+||+++.++.+|++|||.+...........  ..
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            99999866667899999999999999999999   99999999999999999999999999999986543322111  11


Q ss_pred             ccccccccCCCC
Q 003301          820 TLATIGYMAPGL  831 (832)
Q Consensus       820 ~~gt~~y~APE~  831 (832)
                      ..+++.|+|||+
T Consensus       158 ~~~~~~y~aPE~  169 (257)
T cd05115         158 GKWPLKWYAPEC  169 (257)
T ss_pred             CCCCcccCCHHH
Confidence            224578999996

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.91  E-value=7.4e-24  Score=226.48  Aligned_cols=172  Identities=27%  Similarity=0.478  Sum_probs=142.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC--------CcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEecC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD--------GMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTNN  727 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  727 (832)
                      .++|.+.+.||+|+||.||+|.+..        ...||+|.+.... ......+..|+++++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4679999999999999999997632        3469999987543 33446788899999999 799999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe
Q 003301          728 DFKALVLEYMPNGSLEDYLYSNN---------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL  792 (832)
Q Consensus       728 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~  792 (832)
                      +..|+||||+++|+|.+++...+               ..+++..+..++.|++.|++|+|   +.|++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence            99999999999999999997542               24788899999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeccccccccCCCcccc-cccccccccccCCCCC
Q 003301          793 DKDMVAHLSDFGIAKLLSGEESMK-QTLTLATIGYMAPGLF  832 (832)
Q Consensus       793 ~~~~~~kl~DFg~a~~~~~~~~~~-~~~~~gt~~y~APE~l  832 (832)
                      +.++.+||+|||.|+......... .....+++.|+|||++
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  214 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL  214 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHh
Confidence            999999999999997654322111 1112345789999963

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.91  E-value=1.1e-23  Score=224.17  Aligned_cols=172  Identities=26%  Similarity=0.389  Sum_probs=144.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-----------------CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-----------------GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVK  719 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~  719 (832)
                      .++|++.+.||+|+||.||+|+..+                 +..||+|++.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4689999999999999999987643                 2458999887553 234567889999999999999999


Q ss_pred             eceEEecCCeeEEEEecCCCCCHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 003301          720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNN----------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSN  789 (832)
Q Consensus       720 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N  789 (832)
                      +++++..++..+++|||+++++|.+++....          ..+++..+..++.|++.|++|||   +.|++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999999999999999999999987643          25889999999999999999999   9999999999999


Q ss_pred             eEeCCCCcEEEeccccccccCCCccc-ccccccccccccCCCCC
Q 003301          790 VLLDKDMVAHLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       790 Il~~~~~~~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~l  832 (832)
                      |+++.++.+|++|||.++........ ......+++.|||||++
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  204 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV  204 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHh
Confidence            99999999999999999865433221 12234467889999963

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.91  E-value=6.3e-24  Score=242.58  Aligned_cols=261  Identities=26%  Similarity=0.308  Sum_probs=118.0

Q ss_pred             eEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCcccccccccccccccccCCChhhhhcCCCceEEEccC
Q 003301           25 KLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSN  104 (832)
Q Consensus        25 ~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~~  104 (832)
                      .|+|++|.++ .+|+.+..  +|+.|++++|+++ .+|..   .++| ++|++++|+|+ .+|..    .++|+.|++++
T Consensus       205 ~LdLs~~~Lt-sLP~~l~~--~L~~L~L~~N~Lt-~LP~l---p~~L-k~LdLs~N~Lt-sLP~l----p~sL~~L~Ls~  271 (788)
T PRK15387        205 VLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPAL---PPEL-RTLEVSGNQLT-SLPVL----PPGLLELSIFS  271 (788)
T ss_pred             EEEcCCCCCC-cCCcchhc--CCCEEEccCCcCC-CCCCC---CCCC-cEEEecCCccC-cccCc----ccccceeeccC
Confidence            4444444444 44443332  4444444444444 34432   2233 44444444444 34421    23444445555


Q ss_pred             CcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccccccccccC
Q 003301          105 NKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVP  184 (832)
Q Consensus       105 N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  184 (832)
                      |.|+ .+|..+   ++|+.|++++|+++ .+|..   .++|++|+|++|+|++ +|...   .+|+.|++++|++++ +|
T Consensus       272 N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP  338 (788)
T PRK15387        272 NPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-LP  338 (788)
T ss_pred             Cchh-hhhhch---hhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCCc---ccccccccccCcccc-cc
Confidence            5444 233211   33444455555544 23321   2344555555555542 23211   234444555555543 22


Q ss_pred             cccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCc
Q 003301          185 TSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNL  264 (832)
Q Consensus       185 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l  264 (832)
                      ..   ..+|++|+|++|+++ .+|..     .++|+.|++++|+++.+ |..   .++|+.|++++|+|++ +|..   .
T Consensus       339 ~l---p~~Lq~LdLS~N~Ls-~LP~l-----p~~L~~L~Ls~N~L~~L-P~l---~~~L~~LdLs~N~Lt~-LP~l---~  401 (788)
T PRK15387        339 TL---PSGLQELSVSDNQLA-SLPTL-----PSELYKLWAYNNRLTSL-PAL---PSGLKELIVSGNRLTS-LPVL---P  401 (788)
T ss_pred             cc---ccccceEecCCCccC-CCCCC-----CcccceehhhccccccC-ccc---ccccceEEecCCcccC-CCCc---c
Confidence            11   124555555555554 23321     13455555555555532 221   2345555555555553 2221   2


Q ss_pred             cccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccc
Q 003301          265 RKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEI  339 (832)
Q Consensus       265 ~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~  339 (832)
                      ++|+.|++++|+++.+|..         ..+|+.|++++|+++ .+|..+..+. +|+.+++++|.+++..+..+
T Consensus       402 s~L~~LdLS~N~LssIP~l---------~~~L~~L~Ls~NqLt-~LP~sl~~L~-~L~~LdLs~N~Ls~~~~~~L  465 (788)
T PRK15387        402 SELKELMVSGNRLTSLPML---------PSGLLSLSVYRNQLT-RLPESLIHLS-SETTVNLEGNPLSERTLQAL  465 (788)
T ss_pred             cCCCEEEccCCcCCCCCcc---------hhhhhhhhhccCccc-ccChHHhhcc-CCCeEECCCCCCCchHHHHH
Confidence            3455566666665543321         124555666666665 4555555554 56666666666665555544

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.91  E-value=1.1e-23  Score=240.47  Aligned_cols=167  Identities=28%  Similarity=0.319  Sum_probs=90.3

Q ss_pred             CcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeC
Q 003301          343 INLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSL  422 (832)
Q Consensus       343 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  422 (832)
                      ++|+.|++++|++++. |..   ..+|+.|++++|+|++ +|..   ..+|++|+|++|+|++ +|...   .+|+.|++
T Consensus       302 ~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~lp---~~L~~L~L  369 (788)
T PRK15387        302 PGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTLP---SELYKLWA  369 (788)
T ss_pred             cccceeECCCCccccC-CCC---cccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCCC---cccceehh
Confidence            4455555555555532 221   1235555566666552 3321   1345666666666653 33322   34555566


Q ss_pred             CCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeeccccccccc
Q 003301          423 ASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGS  502 (832)
Q Consensus       423 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  502 (832)
                      ++|+|+. +|..   ..+|+.|++++|+|++ +|...   +.|+.|++++|+|++ +|..+   .+|+.|+|++|+|+ .
T Consensus       370 s~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~  436 (788)
T PRK15387        370 YNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVLP---SELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-R  436 (788)
T ss_pred             hcccccc-Cccc---ccccceEEecCCcccC-CCCcc---cCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-c
Confidence            6666654 2322   2345666666666663 33322   355666666666663 44432   34566667777766 5


Q ss_pred             CCccccCCCCCCeeccCCCcccccCchhhhhh
Q 003301          503 IPKSIGGLVSLESLDLSNNSLSGNIPTSMEKL  534 (832)
Q Consensus       503 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  534 (832)
                      +|..++.+++|+.|+|++|+|++..|..+..+
T Consensus       437 LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l  468 (788)
T PRK15387        437 LPESLIHLSSETTVNLEGNPLSERTLQALREI  468 (788)
T ss_pred             cChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence            66666666677777777777776666655443

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.91  E-value=1.7e-24  Score=198.44  Aligned_cols=174  Identities=22%  Similarity=0.333  Sum_probs=143.2

Q ss_pred             HHHHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCee
Q 003301          654 LLQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       654 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  730 (832)
                      +....+.....+.||+|+||.|-+-++. +|...|+|.++... ....++..+|+.+..+. .+|++|.+||.+...+.+
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            3344566677789999999999888876 58999999987654 33456777888876554 799999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccc
Q 003301          731 ALVLEYMPNGSLEDYLYS---NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK  807 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~  807 (832)
                      +|.||.| .-+|+.+.++   .+...++...-+|+..++.|+.|||.  +..++|||+||+|||++.+|++||||||.+.
T Consensus       121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            9999999 5688877553   45579999999999999999999995  6789999999999999999999999999998


Q ss_pred             ccCCCcccccccccccccccCCCCC
Q 003301          808 LLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       808 ~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .+.+.  ...+...|-..|||||.+
T Consensus       198 ~L~dS--iAkt~daGCkpYmaPEri  220 (282)
T KOG0984|consen  198 YLVDS--IAKTMDAGCKPYMAPERI  220 (282)
T ss_pred             eehhh--hHHHHhcCCCccCChhhc
Confidence            77443  233334588899999974

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.91  E-value=1.1e-23  Score=219.57  Aligned_cols=165  Identities=35%  Similarity=0.572  Sum_probs=143.3

Q ss_pred             CeeeccCCceEEEEEecC----CcEEEEEEEeccchh-hHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCC
Q 003301          665 NLIGTGGFGSVYKGSFLD----GMEVAIKVFHLQLEG-ALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      +.||+|+||.||+|....    +..||+|.+...... ..+.+.+|++.++.++|+|++++++++..+...++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999998864    788999998765433 357888999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          740 GSLEDYLYSN--------NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       740 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      ++|.+++...        ...+++..+..++.|++.|++|||   +++++||||||+||++++++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999876        357899999999999999999999   99999999999999999999999999999987654


Q ss_pred             Ccc-cccccccccccccCCCCC
Q 003301          812 EES-MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~-~~~~~~~gt~~y~APE~l  832 (832)
                      ... .......+++.|+|||++
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~  179 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESL  179 (262)
T ss_pred             ccccccccCCCcCccccCHHHh
Confidence            331 112234578899999963

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.91  E-value=7.3e-24  Score=225.90  Aligned_cols=169  Identities=28%  Similarity=0.502  Sum_probs=139.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-Cc--EEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GM--EVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  732 (832)
                      .++|++.+.||+|+||.||+|.+.. +.  .+|+|.+.... ....+.+.+|++++.++ +||||+++++++.+++..|+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            4678999999999999999998753 44  45777765432 33446788899999999 89999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCc
Q 003301          733 VLEYMPNGSLEDYLYSNN---------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMV  797 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~  797 (832)
                      ||||+++++|.++++..+               ..+++..+..++.|++.|++|||   ++|++||||||+||+++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence            999999999999997542               24788999999999999999999   999999999999999999999


Q ss_pred             EEEeccccccccCCCcccccccccccccccCCCC
Q 003301          798 AHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       798 ~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      +||+|||++.......  ......++..|+|||+
T Consensus       163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~  194 (303)
T cd05088         163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIES  194 (303)
T ss_pred             EEeCccccCcccchhh--hcccCCCcccccCHHH
Confidence            9999999986432111  1111234678999996

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.91  E-value=1.4e-23  Score=218.48  Aligned_cols=166  Identities=34%  Similarity=0.485  Sum_probs=145.0

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-----hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-----EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      +|+..+.||+|+||+||+|... +++.||+|.+....     ....+.+.+|+++++.++||||+++++++..++..|++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4778899999999999999886 68999999886543     23456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+++++|.+++.+.. .+++..+..++.|++.|++|||   +.|++||||+|+||+++.++.+||+|||.+.......
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            99999999999997654 5889999999999999999999   9999999999999999999999999999988654333


Q ss_pred             ccccccccccccccCCCC
Q 003301          814 SMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~  831 (832)
                        ......|+..|+|||.
T Consensus       157 --~~~~~~~~~~y~~pe~  172 (258)
T cd06632         157 --FAKSFKGSPYWMAPEV  172 (258)
T ss_pred             --cccccCCCcceeCHHH
Confidence              1223458899999995

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.90  E-value=1.3e-23  Score=245.60  Aligned_cols=169  Identities=28%  Similarity=0.401  Sum_probs=147.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.++||+|+||.||+|.+. +++.||||+++...   ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            468999999999999999999986 48999999987542   23346788899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+++++|.+++...+ .+++..++.++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||+++......
T Consensus        83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~  158 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE  158 (669)
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCc
Confidence            99999999999997654 5889999999999999999999   8999999999999999999999999999998764433


Q ss_pred             ccccccccccccccCCCC
Q 003301          814 SMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~  831 (832)
                      . ......+|+.|+|||.
T Consensus       159 ~-~~~~~~~t~~~~~pe~  175 (669)
T cd05610         159 L-NMMDILTTPSMAKPKN  175 (669)
T ss_pred             c-cccccccCccccCccc
Confidence            2 2233568999999984

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.90  E-value=4e-24  Score=222.43  Aligned_cols=160  Identities=28%  Similarity=0.413  Sum_probs=136.8

Q ss_pred             CeeeccCCceEEEEEecC--------CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          665 NLIGTGGFGSVYKGSFLD--------GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      +.||+|+||.||+|.+..        ..+||+|.+........+.+..|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999997643        234888887655555557788999999999999999999999998899999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCc--------EEEeccccccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMV--------AHLSDFGIAKL  808 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~--------~kl~DFg~a~~  808 (832)
                      +++|+|.++++..+..+++..+..++.|++.|++|||   ++||+||||||+||+++.++.        +|++|||.+..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999999876667899999999999999999999   999999999999999987764        69999999876


Q ss_pred             cCCCcccccccccccccccCCCCC
Q 003301          809 LSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       809 ~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ....     ....+++.|+|||++
T Consensus       158 ~~~~-----~~~~~~~~y~aPE~~  176 (258)
T cd05078         158 VLPK-----EILLERIPWVPPECI  176 (258)
T ss_pred             cCCc-----hhccccCCccCchhc
Confidence            5322     224588899999974

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.90  E-value=1.1e-23  Score=224.39  Aligned_cols=172  Identities=23%  Similarity=0.410  Sum_probs=144.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDF  729 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  729 (832)
                      .++|++.+.||+|+||.||+|++.      .+..||+|+++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            467999999999999999999752      24579999887543 33346788999999999 79999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNNF-SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      .|+||||+++|+|.++++.... .+++.++..++.|++.|++|+|   +.+++||||||+||+++.++.+|++|||.++.
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence            9999999999999999976432 3899999999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCccc-ccccccccccccCCCCC
Q 003301          809 LSGEESM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       809 ~~~~~~~-~~~~~~gt~~y~APE~l  832 (832)
                      ....... ......+++.|+|||++
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~  215 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESI  215 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhh
Confidence            5433221 11223467889999963

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.90  E-value=8.3e-24  Score=224.64  Aligned_cols=174  Identities=26%  Similarity=0.471  Sum_probs=144.5

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEecC------CcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEecC
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFLD------GMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTNN  727 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  727 (832)
                      ...++|++.+.||+|+||.||+|.+..      ...||+|.+.... ......+.+|+++++++ +||||+++++++..+
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            345678999999999999999998743      3679999887543 23345688999999999 799999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe
Q 003301          728 DFKALVLEYMPNGSLEDYLYSN---------------NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL  792 (832)
Q Consensus       728 ~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~  792 (832)
                      +..|++|||+++|+|.++++..               ...+++..+..++.|++.|++|||   +.+|+||||||+||++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEE
Confidence            9999999999999999998642               235889999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeccccccccCCCcccc-cccccccccccCCCCC
Q 003301          793 DKDMVAHLSDFGIAKLLSGEESMK-QTLTLATIGYMAPGLF  832 (832)
Q Consensus       793 ~~~~~~kl~DFg~a~~~~~~~~~~-~~~~~gt~~y~APE~l  832 (832)
                      +.++.+|++|||.++......... .....++..|+|||++
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  206 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL  206 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHh
Confidence            999999999999998765433211 1122356789999963

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.90  E-value=1.1e-23  Score=221.94  Aligned_cols=171  Identities=27%  Similarity=0.454  Sum_probs=144.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      .+|+..++||+|+||.||+|...      ++..||+|.+........+.+.+|+++++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            56788999999999999999642      356789998876655666789999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcE
Q 003301          733 VLEYMPNGSLEDYLYSNN--------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVA  798 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~  798 (832)
                      +|||+++++|.+++....              ..+++..+..++.|++.|++|||   +.|++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence            999999999999987543              24788999999999999999999   9999999999999999999999


Q ss_pred             EEeccccccccCCCccc-ccccccccccccCCCCC
Q 003301          799 HLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       799 kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~l  832 (832)
                      ||+|||+++........ ......+++.|+|||++
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  196 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI  196 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHh
Confidence            99999999765332211 11223457889999963

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.90  E-value=1.4e-23  Score=219.54  Aligned_cols=165  Identities=21%  Similarity=0.367  Sum_probs=133.5

Q ss_pred             CeeeccCCceEEEEEecCCc---EEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCC
Q 003301          665 NLIGTGGFGSVYKGSFLDGM---EVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNG  740 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  740 (832)
                      +.||+|+||.||+|...++.   .+++|.+.... ....+.+.+|+.+++.++||||+++++++.+....|+||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            35999999999999765433   45666655432 234568899999999999999999999999999999999999999


Q ss_pred             CHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc-cc
Q 003301          741 SLEDYLYSNN---FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES-MK  816 (832)
Q Consensus       741 ~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~-~~  816 (832)
                      +|.+++.+..   ...++..+..++.|++.|++|+|   +.+++||||||+||+++.++.+||+|||.+........ ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999997642   23566778899999999999999   99999999999999999999999999999864322111 11


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....|+..|+|||++
T Consensus       158 ~~~~~~~~~y~aPE~~  173 (268)
T cd05086         158 EDDKCVPLRWLAPELV  173 (268)
T ss_pred             ccCCcCcccccCchhc
Confidence            2234688999999973

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.90  E-value=2.1e-23  Score=222.73  Aligned_cols=170  Identities=25%  Similarity=0.392  Sum_probs=143.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.+.||+|+||.||+|.+.. ++.||+|.+....   ....+.+.+|+++++.++||||+++++++..++..|+||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            468899999999999999998864 7899999887543   233457788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||+++++|.++++..+ .+++..+..++.|++.|++|+|   +.+++||||||+||+++.++.+|++|||.++.......
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            9999999999997654 6899999999999999999999   99999999999999999999999999999864211000


Q ss_pred             --------------cccccccccccccCCCCC
Q 003301          815 --------------MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 --------------~~~~~~~gt~~y~APE~l  832 (832)
                                    .......|+..|+|||.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  188 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI  188 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhc
Confidence                          011123578899999964

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.90  E-value=1.5e-23  Score=217.94  Aligned_cols=169  Identities=32%  Similarity=0.468  Sum_probs=149.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .++|++.+.||+|+||.||+|.+.+ ++.||+|.+.....  .+.+.+|++++++++||||+++++++.++...|+++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            4689999999999999999999875 78999999875533  57899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +++++|.+++......+++..+..++.|++.|+.|||   ..+++||||+|+||+++.++.+||+|||.+........ .
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K  155 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence            9999999999876667899999999999999999999   99999999999999999999999999999987654332 2


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....|+..|+|||++
T Consensus       156 ~~~~~~~~~y~~PE~~  171 (256)
T cd06612         156 RNTVIGTPFWMAPEVI  171 (256)
T ss_pred             cccccCCccccCHHHH
Confidence            2234588999999963

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.90  E-value=1.4e-23  Score=222.09  Aligned_cols=168  Identities=30%  Similarity=0.389  Sum_probs=144.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++....  ....+.+.+|++++++++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            47899999999999999999886 48999999886443  2233567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      |++++.+..+..... .+++..+..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||.+........ 
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            999988887765443 6899999999999999999999   99999999999999999999999999999987654332 


Q ss_pred             ccccccccccccCCCC
Q 003301          816 KQTLTLATIGYMAPGL  831 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~  831 (832)
                      ......++..|+|||+
T Consensus       156 ~~~~~~~~~~~~aPE~  171 (286)
T cd07847         156 DYTDYVATRWYRAPEL  171 (286)
T ss_pred             cccCcccccccCCHHH
Confidence            1222457889999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.90  E-value=1.1e-23  Score=220.37  Aligned_cols=170  Identities=28%  Similarity=0.425  Sum_probs=145.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.+.||+|+||.||+|... +++.||||.+....   ....+.+.+|+++++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            57888999999999999999864 68999999876432   233467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          735 EYMPNGSLEDYLYS---NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       735 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      ||+++++|.+++..   ....+++..+..++.|++.|++|||   +.|++|+||||+||+++.++.++++|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998864   2335899999999999999999999   99999999999999999999999999999886644


Q ss_pred             CcccccccccccccccCCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .... .....|+..|+|||++
T Consensus       159 ~~~~-~~~~~~~~~~~ape~~  178 (267)
T cd08229         159 KTTA-AHSLVGTPYYMSPERI  178 (267)
T ss_pred             CCcc-cccccCCcCccCHHHh
Confidence            3322 1234689999999963

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.90  E-value=1.9e-23  Score=218.72  Aligned_cols=169  Identities=31%  Similarity=0.504  Sum_probs=143.3

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch---------hhHHHHHHHHHHHhcCCCCceeeeceEEecCCe
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE---------GALKSFDVECEVLKSVRHRNLVKIISSCTNNDF  729 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  729 (832)
                      +|.+...||+|+||.||+|.+. +++.||+|.+.....         ...+.+.+|++++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4788899999999999999875 478999998864321         123567889999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      .++||||+++++|.+++...+ .+++..+..++.|++.|++|+|   +.|++||||+|+||+++.++.+||+|||.++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            999999999999999997653 6889999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCccc-----ccccccccccccCCCCC
Q 003301          810 SGEESM-----KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       810 ~~~~~~-----~~~~~~gt~~y~APE~l  832 (832)
                      ......     ......|+..|+|||++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~  184 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVV  184 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHh
Confidence            432111     11123588899999963

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.90  E-value=2.7e-23  Score=216.20  Aligned_cols=169  Identities=25%  Similarity=0.429  Sum_probs=143.2

Q ss_pred             CCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEec-CCeeEEEEe
Q 003301          660 QFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTN-NDFKALVLE  735 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  735 (832)
                      +|++.+.||+|++|.||+|.+.. ++.||+|++....  ....+.+.+|++++++++|||++++++.+.. +...|++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            48899999999999999998754 7889999986543  2344678889999999999999999998764 446899999


Q ss_pred             cCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          736 YMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       736 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |+++++|.+++... ...+++.++..++.|++.|++|+|   +.|++||||||+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            99999999999764 335899999999999999999999   99999999999999999999999999999987643322


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                       ......|++.|+|||++
T Consensus       158 -~~~~~~~~~~y~aPE~~  174 (257)
T cd08223         158 -MASTLIGTPYYMSPELF  174 (257)
T ss_pred             -ccccccCCcCccChhHh
Confidence             22234689999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.90  E-value=7.2e-24  Score=224.59  Aligned_cols=167  Identities=29%  Similarity=0.395  Sum_probs=143.5

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCC
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMP  738 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  738 (832)
                      .|+....||+|+||.||+|... ++..||||.+........+.+.+|+.+++.++||||+++++.+...+..|+||||++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            3444577999999999999875 588999999876655556778899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccc
Q 003301          739 NGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT  818 (832)
Q Consensus       739 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~  818 (832)
                      +++|.+++...  .+++..+..++.|++.|++|||   +++++||||||+||++++++.+||+|||++........ ...
T Consensus       103 ~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~  176 (292)
T cd06658         103 GGALTDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRK  176 (292)
T ss_pred             CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCc
Confidence            99999988653  4889999999999999999999   99999999999999999999999999999876533322 122


Q ss_pred             cccccccccCCCCC
Q 003301          819 LTLATIGYMAPGLF  832 (832)
Q Consensus       819 ~~~gt~~y~APE~l  832 (832)
                      ...|+..|+|||++
T Consensus       177 ~~~~~~~y~aPE~~  190 (292)
T cd06658         177 SLVGTPYWMAPEVI  190 (292)
T ss_pred             eeecCccccCHHHH
Confidence            34689999999963

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.90  E-value=1.7e-23  Score=224.94  Aligned_cols=163  Identities=24%  Similarity=0.334  Sum_probs=131.9

Q ss_pred             CCeeeccCCceEEEEEecC---CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEec--CCeeEEEEecCC
Q 003301          664 SNLIGTGGFGSVYKGSFLD---GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN--NDFKALVLEYMP  738 (832)
Q Consensus       664 ~~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  738 (832)
                      +.+||+|+||+||+|+..+   +..||+|.+....  ....+.+|++++++++||||+++++++..  +...|+||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            4689999999999998753   5789999886442  22467789999999999999999998853  557899999995


Q ss_pred             CCCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe----CCCCcEEEeccccc
Q 003301          739 NGSLEDYLYSN--------NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL----DKDMVAHLSDFGIA  806 (832)
Q Consensus       739 ~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~----~~~~~~kl~DFg~a  806 (832)
                       +++.+++...        ...+++..+..++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||+|
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence             5888877521        124788999999999999999999   9999999999999999    56679999999999


Q ss_pred             cccCCCccc--ccccccccccccCCCCC
Q 003301          807 KLLSGEESM--KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       807 ~~~~~~~~~--~~~~~~gt~~y~APE~l  832 (832)
                      +........  ......||+.|+|||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~  187 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELL  187 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHh
Confidence            876433221  12234689999999974

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.90  E-value=2.3e-23  Score=219.99  Aligned_cols=168  Identities=28%  Similarity=0.467  Sum_probs=139.1

Q ss_pred             CC-CCCCeeeccCCceEEEEEe-----cCCcEEEEEEEeccch-hhHHHHHHHHHHHhcCCCCceeeeceEEecC--Cee
Q 003301          660 QF-NASNLIGTGGFGSVYKGSF-----LDGMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVKIISSCTNN--DFK  730 (832)
Q Consensus       660 ~~-~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  730 (832)
                      +| ++.+.||+|+||+||.+.+     .+++.||+|.++.... .....+.+|++++++++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            44 8899999999999988653     2477899999875432 3456788999999999999999999987653  468


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      |+||||+++++|.+++...  .+++.++..++.|++.|++|||   +++++||||||+||++++++.+||+|||+++...
T Consensus        84 ~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999999999764  4899999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCcccc--cccccccccccCCCCC
Q 003301          811 GEESMK--QTLTLATIGYMAPGLF  832 (832)
Q Consensus       811 ~~~~~~--~~~~~gt~~y~APE~l  832 (832)
                      ......  .....++..|+|||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~  182 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECL  182 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHh
Confidence            432211  1123456779999963

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.90  E-value=1.9e-23  Score=218.81  Aligned_cols=172  Identities=26%  Similarity=0.482  Sum_probs=144.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-C---cEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-G---MEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      .++|+..+.||+|+||.||+|.... +   ..||+|.+.... ....+.+..|++++++++|||++++.+++...+..|+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3578889999999999999998753 3   368999886543 3345678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||||+++++|.+++......+++..+..++.|++.|++|+|   +.|++||||||+||+++.++.+|++|||.+......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999876567899999999999999999999   999999999999999999999999999999866433


Q ss_pred             cccccc--cccccccccCCCCC
Q 003301          813 ESMKQT--LTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~--~~~gt~~y~APE~l  832 (832)
                      ......  ....+..|+|||++
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~  182 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAI  182 (268)
T ss_pred             cccceeccCCCcCceecCHHHh
Confidence            221111  12234579999963

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.90  E-value=1.7e-23  Score=219.11  Aligned_cols=169  Identities=25%  Similarity=0.444  Sum_probs=143.8

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc------hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL------EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      +|+..+.||+|+||.||+|... +++.||+|++....      ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4788899999999999999864 58999999986433      1234678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC-cEEEeccccccccCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAKLLSG  811 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~DFg~a~~~~~  811 (832)
                      ||||+++++|.+++.+.+ .+++..+..++.|++.|++|||   +.|++||||+|+||+++.++ .+||+|||.+.....
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            999999999999997654 6889999999999999999999   99999999999999998776 699999999987644


Q ss_pred             Cccc---ccccccccccccCCCCC
Q 003301          812 EESM---KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~---~~~~~~gt~~y~APE~l  832 (832)
                      ....   ......|+..|+|||++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~  180 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVL  180 (268)
T ss_pred             ccccCCccccccccccceeCHhHh
Confidence            3211   11224588999999964

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.90  E-value=7.3e-24  Score=223.83  Aligned_cols=171  Identities=23%  Similarity=0.399  Sum_probs=141.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC------CcEEEEEEEeccch-hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD------GMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  731 (832)
                      .+|++.+.||+|+||.||+|.+.+      ++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            357778899999999999998642      47899999875543 23467889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC
Q 003301          732 LVLEYMPNGSLEDYLYSN---------------NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM  796 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~  796 (832)
                      +++||+++++|.+++...               +..+++..+..++.|++.|++|+|   ++|++||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence            999999999999998532               124788889999999999999999   99999999999999999999


Q ss_pred             cEEEeccccccccCCCccc-ccccccccccccCCCCC
Q 003301          797 VAHLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       797 ~~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~l  832 (832)
                      .+||+|||+++........ ......+++.|+|||++
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  198 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAI  198 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHH
Confidence            9999999998865433221 11223467899999963

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.90  E-value=1.4e-23  Score=222.81  Aligned_cols=170  Identities=25%  Similarity=0.382  Sum_probs=144.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch--hhHHHHHHHHHHHhcCCCCceeeeceEEecC--CeeEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRNLVKIISSCTNN--DFKAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  732 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.++....  .....+.+|++++++++||||+++++++...  +..|+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            357899999999999999999986 488999999875432  2234567899999999999999999998877  88999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||||++ ++|.+++......+++..+..++.|++.||+|||   +.|++||||||+||+++.++.+||+|||.++.....
T Consensus        84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            999996 5999998776556899999999999999999999   999999999999999999999999999999876543


Q ss_pred             cccccccccccccccCCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~l  832 (832)
                      .. ......+++.|+|||++
T Consensus       160 ~~-~~~~~~~~~~~~aPE~~  178 (293)
T cd07843         160 LK-PYTQLVVTLWYRAPELL  178 (293)
T ss_pred             cc-ccccccccccccCchhh
Confidence            22 12234578899999963

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.90  E-value=2.2e-23  Score=219.66  Aligned_cols=171  Identities=30%  Similarity=0.468  Sum_probs=142.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-Cc----EEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GM----EVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  731 (832)
                      ..+|++.+.||+|+||.||+|.+.. |+    .||+|...... ......+.+|++++++++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            3578899999999999999998753 32    58999876543 3345678899999999999999999999887 7889


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +||||+++|+|.+++......+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.++....
T Consensus        85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            999999999999999876667899999999999999999999   99999999999999999999999999999987643


Q ss_pred             Ccccc-cccccccccccCCCCC
Q 003301          812 EESMK-QTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~-~~~~~gt~~y~APE~l  832 (832)
                      ..... .....++..|+|||.+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~  183 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESI  183 (279)
T ss_pred             cccceecCCCcccccccCHHHh
Confidence            32211 1112245689999963

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.90  E-value=1.8e-23  Score=217.26  Aligned_cols=165  Identities=33%  Similarity=0.497  Sum_probs=140.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEe-cCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT-NNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~  736 (832)
                      .++|++.+.||+|+||.||+|.. .+..||+|.+....  ..+.+.+|+.++++++|++++++++++. .++..|+||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            35789999999999999999987 58889999886442  3467889999999999999999999764 45678999999


Q ss_pred             CCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          737 MPNGSLEDYLYSNNF-SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      +++++|.+++..... .+++..+..++.|++.|++|+|   +.|++||||||+||+++.++.+|++|||.+.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            999999999976543 4789999999999999999999   9999999999999999999999999999988653322  


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                        ....++..|+|||++
T Consensus       157 --~~~~~~~~y~aPE~~  171 (256)
T cd05082         157 --DTGKLPVKWTAPEAL  171 (256)
T ss_pred             --CCCccceeecCHHHH
Confidence              123356789999963

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.90  E-value=1.3e-24  Score=209.93  Aligned_cols=165  Identities=27%  Similarity=0.363  Sum_probs=136.2

Q ss_pred             hcCCCCC-CeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcC-CCCceeeeceEEec----CCee
Q 003301          658 TNQFNAS-NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLVKIISSCTN----NDFK  730 (832)
Q Consensus       658 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~  730 (832)
                      +++|.+. ++||-|-.|.|..+.++ +++++|+|++...     ...++|++..-.. .|||||.++++|..    ....
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            4566553 68999999999999876 5899999987643     4456788875444 79999999998864    4567


Q ss_pred             EEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC---CCcEEEeccccc
Q 003301          731 ALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK---DMVAHLSDFGIA  806 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~DFg~a  806 (832)
                      .+|||.|+||.|.+.++.++ ..+++.++..|+.||+.|+.|||   +.+|.||||||+|+|...   +..+|++|||+|
T Consensus       135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA  211 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA  211 (400)
T ss_pred             EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccc
Confidence            89999999999999998765 34999999999999999999999   999999999999999964   458999999999


Q ss_pred             cccCCCcccccccccccccccCCCCC
Q 003301          807 KLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       807 ~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +......  .....+.||+|.|||++
T Consensus       212 K~t~~~~--~L~TPc~TPyYvaPevl  235 (400)
T KOG0604|consen  212 KETQEPG--DLMTPCFTPYYVAPEVL  235 (400)
T ss_pred             cccCCCc--cccCCcccccccCHHHh
Confidence            9765433  23346799999999985

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.90  E-value=1.7e-23  Score=220.40  Aligned_cols=172  Identities=23%  Similarity=0.392  Sum_probs=143.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC------CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD------GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  730 (832)
                      .++|++.+.||+|+||.||+|.+.+      +..||+|.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4678999999999999999998743      3689999986443 23345788899999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEe
Q 003301          731 ALVLEYMPNGSLEDYLYSNN---------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLS  801 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~  801 (832)
                      |+||||+++++|.+++....         ..+++..+..++.|++.|++|+|   +.+++||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999986532         23678899999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCccc-ccccccccccccCCCCC
Q 003301          802 DFGIAKLLSGEESM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       802 DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~l  832 (832)
                      |||+++........ ......++..|+|||++
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  193 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESL  193 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHH
Confidence            99999865433221 12234578899999963

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.90  E-value=3e-23  Score=216.77  Aligned_cols=169  Identities=33%  Similarity=0.477  Sum_probs=147.0

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch--hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      +|++.+.||+|+||.||+|... +++.||+|.++....  ...+.+..|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5888999999999999999875 588999999876544  3567889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +++++|.+++.... .+++..+..++.|++.|++|||   +.|++||||+|+||++++++.+||+|||.+..........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            99999999998654 5788999999999999999999   9999999999999999999999999999998764433221


Q ss_pred             cc---cccccccccCCCCC
Q 003301          817 QT---LTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~---~~~gt~~y~APE~l  832 (832)
                      ..   ...+++.|+|||++
T Consensus       157 ~~~~~~~~~~~~~~~PE~~  175 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVI  175 (264)
T ss_pred             cccccCCcCCcCccChhhc
Confidence            11   24578899999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=7.4e-24  Score=240.11  Aligned_cols=172  Identities=20%  Similarity=0.275  Sum_probs=135.3

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC--CcEEEEEEE--------------ec---cchhhHHHHHHHHHHHhcCCCCce
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD--GMEVAIKVF--------------HL---QLEGALKSFDVECEVLKSVRHRNL  717 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~--------------~~---~~~~~~~~~~~e~~~l~~l~h~ni  717 (832)
                      ..++|++.+.||+|+||+||+|..+.  +..+++|.+              ..   ........+.+|++++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            45789999999999999999987542  222222211              00   112234567899999999999999


Q ss_pred             eeeceEEecCCeeEEEEecCCCCCHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeC
Q 003301          718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNF----SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD  793 (832)
Q Consensus       718 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~  793 (832)
                      +++++++...+..|+|+|++ ++++.+++.....    ......+..++.|++.||+|||   ++||+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence            99999999999999999999 5688887754321    2345667889999999999999   99999999999999999


Q ss_pred             CCCcEEEeccccccccCCCcccccccccccccccCCCCC
Q 003301          794 KDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       794 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .++.+||+|||+|+.+...........+||+.|+|||++
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~  340 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEIL  340 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhh
Confidence            999999999999987754433333345799999999974

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.90  E-value=3e-24  Score=204.84  Aligned_cols=169  Identities=25%  Similarity=0.314  Sum_probs=142.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEEEe
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      ++.+...-+|.|+.|.||+++++. |..+|||.++... .+..+++...++++... .+|+||+.+|||..+..+++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            344556779999999999999875 8899999997654 44567888888887666 48999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      .| ....+.++++-+..+++.-+-++...++.||.||.+  ++||+|||+||+|||+|+.|++|+||||++..+-+... 
T Consensus       172 lM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-  247 (391)
T KOG0983|consen  172 LM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-  247 (391)
T ss_pred             HH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccc-
Confidence            99 456777777777779999888999999999999986  78999999999999999999999999999987754433 


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                       .+...|-+.|||||-+
T Consensus       248 -htrsAGC~~YMaPERi  263 (391)
T KOG0983|consen  248 -HTRSAGCAAYMAPERI  263 (391)
T ss_pred             -cccccCCccccCcccc
Confidence             3335699999999964

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.90  E-value=1.3e-23  Score=225.22  Aligned_cols=173  Identities=25%  Similarity=0.465  Sum_probs=142.0

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec--------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEec
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL--------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTN  726 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  726 (832)
                      ..++|++.+.||+|+||.||+|+..        ....||+|.+.... ......+.+|+++++++ +||||+++++++..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            3467889999999999999999752        24568999887543 23346788899999999 69999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 003301          727 NDFKALVLEYMPNGSLEDYLYSNN---------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVL  791 (832)
Q Consensus       727 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl  791 (832)
                      ++..|+||||+++|+|.+++....               ..+++..+..++.|++.|++|+|   ++|++||||||+||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nil  166 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVL  166 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEE
Confidence            999999999999999999996532               24788899999999999999999   999999999999999


Q ss_pred             eCCCCcEEEeccccccccCCCcccc-cccccccccccCCCCC
Q 003301          792 LDKDMVAHLSDFGIAKLLSGEESMK-QTLTLATIGYMAPGLF  832 (832)
Q Consensus       792 ~~~~~~~kl~DFg~a~~~~~~~~~~-~~~~~gt~~y~APE~l  832 (832)
                      ++.++.+||+|||.++......... .....++..|||||++
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  208 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEAL  208 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHH
Confidence            9999999999999998664322211 1112345679999963

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.90  E-value=3.8e-23  Score=216.17  Aligned_cols=170  Identities=27%  Similarity=0.416  Sum_probs=142.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-----hhhHHHHHHHHHHHhcCCCCceeeeceEEec--CCee
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-----EGALKSFDVECEVLKSVRHRNLVKIISSCTN--NDFK  730 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  730 (832)
                      .+|+..+.||+|+||.||+|... +++.||+|++....     ....+.+.+|+.++++++||||+++++++.+  +...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47899999999999999999875 48899999886432     2234578889999999999999999998875  3578


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      +++|||+++++|.+++.... .+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||+++...
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            89999999999999997654 5889999999999999999999   9999999999999999999999999999987653


Q ss_pred             CCc--ccccccccccccccCCCCC
Q 003301          811 GEE--SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       811 ~~~--~~~~~~~~gt~~y~APE~l  832 (832)
                      ...  ........++..|+|||++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~  181 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVI  181 (266)
T ss_pred             cccccCCccccCCccccccCHHHh
Confidence            211  1111224588999999964

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.90  E-value=2.4e-23  Score=221.39  Aligned_cols=169  Identities=28%  Similarity=0.502  Sum_probs=138.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-C--cEEEEEEEecc-chhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-G--MEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  733 (832)
                      ++|++.+.||+|+||.||+|...+ +  ..+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..|+|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578999999999999999998754 3  34788887643 233446788999999999 799999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcE
Q 003301          734 LEYMPNGSLEDYLYSNN---------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVA  798 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~  798 (832)
                      |||+++++|.+++....               ..+++..+..++.|++.|++|||   ++|++||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999996532               24788899999999999999999   9999999999999999999999


Q ss_pred             EEeccccccccCCCcccccccccccccccCCCCC
Q 003301          799 HLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       799 kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ||+|||++.......  .......+..|+|||++
T Consensus       159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~  190 (297)
T cd05089         159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESL  190 (297)
T ss_pred             EECCcCCCcccccee--ccCCCCcCccccCchhh
Confidence            999999986432111  11112235679999963

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.90  E-value=3.3e-23  Score=214.70  Aligned_cols=165  Identities=32%  Similarity=0.518  Sum_probs=140.6

Q ss_pred             CeeeccCCceEEEEEecCCcEEEEEEEeccchh-hHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCCCHH
Q 003301          665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEG-ALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLE  743 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~  743 (832)
                      ++||+|+||.||+|.+.+++.||+|.+...... ..+.+.+|++++++++||||+++++++.+....|+||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999999877999999988755433 4567889999999999999999999999999999999999999999


Q ss_pred             HHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccc-ccccc
Q 003301          744 DYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ-TLTLA  822 (832)
Q Consensus       744 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~-~~~~g  822 (832)
                      +++......+++..+..++.+++.|++|+|   +.+++||||||+||+++.++.+||+|||.+........... ....+
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            999776556889999999999999999999   99999999999999999999999999999986542221111 11234


Q ss_pred             cccccCCCCC
Q 003301          823 TIGYMAPGLF  832 (832)
Q Consensus       823 t~~y~APE~l  832 (832)
                      +..|+|||++
T Consensus       158 ~~~y~~PE~~  167 (251)
T cd05041         158 PIKWTAPEAL  167 (251)
T ss_pred             eeccCChHhh
Confidence            6679999963

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.90  E-value=1e-23  Score=223.13  Aligned_cols=169  Identities=31%  Similarity=0.441  Sum_probs=144.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccch--hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      ++|++.+.||+|+||.||+|.+.+ ++.||+|++.....  ...+.+.+|+++++.++||||+++++++..++..|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            468899999999999999999864 89999998764332  234567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      |++++++.++..... .+++..+..++.|++.|++|||   +.|++||||+|+||++++++.+|++|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07846          81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-  155 (286)
T ss_pred             cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence            999988888765543 5899999999999999999999   99999999999999999999999999999987644332 


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                      ......++..|+|||++
T Consensus       156 ~~~~~~~~~~y~aPE~~  172 (286)
T cd07846         156 VYTDYVATRWYRAPELL  172 (286)
T ss_pred             ccCcccceeeccCcHHh
Confidence            22234588999999963

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PTZ00284 protein kinase; Provisional

Probab=99.90  E-value=1.2e-23  Score=237.69  Aligned_cols=169  Identities=22%  Similarity=0.349  Sum_probs=135.4

Q ss_pred             HHHHhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCC------CceeeeceEEec
Q 003301          654 LLQATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRH------RNLVKIISSCTN  726 (832)
Q Consensus       654 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~~  726 (832)
                      +....++|++.++||+|+||+||+|.+.. ++.||||+++... ........|+++++.++|      ++++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            33456889999999999999999998754 7889999986432 223445667777766654      558889998876


Q ss_pred             C-CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeEeCCCC--------
Q 003301          727 N-DFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDKDM--------  796 (832)
Q Consensus       727 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~--------  796 (832)
                      + +..|+|||++ +++|.+++.+.+ .+++..+..++.|++.||+|||   + .|||||||||+|||++.++        
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccc
Confidence            4 5789999998 789999887654 6899999999999999999999   7 5999999999999998765        


Q ss_pred             --------cEEEeccccccccCCCcccccccccccccccCCCCC
Q 003301          797 --------VAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       797 --------~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                              .+||+|||.+.....    .....+||+.|||||++
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~  317 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVV  317 (467)
T ss_pred             cccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHh
Confidence                    499999998864322    22345799999999974

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.90  E-value=3.3e-23  Score=217.64  Aligned_cols=169  Identities=25%  Similarity=0.520  Sum_probs=138.9

Q ss_pred             CCCCCeeeccCCceEEEEEecC----CcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCe-----
Q 003301          661 FNASNLIGTGGFGSVYKGSFLD----GMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDF-----  729 (832)
Q Consensus       661 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  729 (832)
                      |++.+.||+|+||.||+|....    +..||+|+++...  ....+.+.+|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5788999999999999998743    3679999987543  2334678899999999999999999998866543     


Q ss_pred             -eEEEEecCCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecc
Q 003301          730 -KALVLEYMPNGSLEDYLYSN-----NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDF  803 (832)
Q Consensus       730 -~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DF  803 (832)
                       .+++|||+++++|.+++...     ...+++..+..++.|++.|++|+|   +.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             79999999999999988542     235889999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCcccc-cccccccccccCCCCC
Q 003301          804 GIAKLLSGEESMK-QTLTLATIGYMAPGLF  832 (832)
Q Consensus       804 g~a~~~~~~~~~~-~~~~~gt~~y~APE~l  832 (832)
                      |.|+......... .....++..|+|||++
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~  187 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESL  187 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhc
Confidence            9998764433221 1123356789999963

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.90  E-value=2.6e-23  Score=224.32  Aligned_cols=167  Identities=20%  Similarity=0.275  Sum_probs=138.1

Q ss_pred             CCCeeecc--CCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          663 ASNLIGTG--GFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       663 ~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      +.++||+|  +|++||++... +|+.||+|++....  ....+.+.+|+++++.++||||+++++++..++..|+||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56789999  67899999875 58999999987543  233456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc-
Q 003301          738 PNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM-  815 (832)
Q Consensus       738 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~-  815 (832)
                      ++|+|.+++... ...+++..+..++.|++.||+|||   +++|+||||||+||+++.++.++++||+.+......... 
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999999753 234899999999999999999999   999999999999999999999999999876543221110 


Q ss_pred             -----ccccccccccccCCCCC
Q 003301          816 -----KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 -----~~~~~~gt~~y~APE~l  832 (832)
                           ......++..|+|||++
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~  180 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVL  180 (327)
T ss_pred             cccccccccccceecccChHHh
Confidence                 01123477889999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.90  E-value=1.8e-23  Score=219.94  Aligned_cols=172  Identities=28%  Similarity=0.452  Sum_probs=141.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC------CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD------GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  730 (832)
                      .++|++.+.||+|+||.||+|.+..      +..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678999999999999999998753      5678999876443 23345688899999999999999999999998999


Q ss_pred             EEEEecCCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC---cEEEe
Q 003301          731 ALVLEYMPNGSLEDYLYSNN------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM---VAHLS  801 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~---~~kl~  801 (832)
                      |+||||+++++|.+++...+      ..+++..+.+++.|++.|++|||   +++++||||||+||+++.++   .+|++
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999997643      24889999999999999999999   99999999999999998654   69999


Q ss_pred             ccccccccCCCcccc-cccccccccccCCCCC
Q 003301          802 DFGIAKLLSGEESMK-QTLTLATIGYMAPGLF  832 (832)
Q Consensus       802 DFg~a~~~~~~~~~~-~~~~~gt~~y~APE~l  832 (832)
                      |||+++......... ......+..|+|||++
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  193 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAF  193 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHH
Confidence            999998763322211 1112345689999963

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.90  E-value=2.1e-23  Score=221.04  Aligned_cols=170  Identities=32%  Similarity=0.400  Sum_probs=144.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      ++|++.+.||+|+||.||+|.+.+ ++.||+|+++...  ....+.+.+|++++++++|+||+++++++..++..|+|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            468999999999999999998864 8899999886432  2334678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      |++++.+..+... ...+++..+..++.|++.|++|||   ..+++|||++|+||+++.++.+||+|||.+.........
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence            9987666655544 346899999999999999999999   999999999999999999999999999999876554432


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                      ......++..|+|||++
T Consensus       157 ~~~~~~~~~~~~~PE~~  173 (288)
T cd07833         157 PLTDYVATRWYRAPELL  173 (288)
T ss_pred             cccCcccccCCcCCchh
Confidence            23335688999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.90  E-value=2.4e-23  Score=220.68  Aligned_cols=169  Identities=25%  Similarity=0.424  Sum_probs=140.1

Q ss_pred             CCCCCCeeeccCCceEEEEEecC------CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          660 QFNASNLIGTGGFGSVYKGSFLD------GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      +|++.+.||+|+||.||+|....      ...||+|.+.... ....+.+.+|+.+++.++||||+++++.+..++..|+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            47888999999999999997642      3568888876443 2334678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 003301          733 VLEYMPNGSLEDYLYSNN-----------------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSN  789 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N  789 (832)
                      +|||+++++|.+++....                       ..+++..+..++.|++.|++|||   +.+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999999986421                       23778899999999999999999   9999999999999


Q ss_pred             eEeCCCCcEEEeccccccccCCCccc-ccccccccccccCCCC
Q 003301          790 VLLDKDMVAHLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGL  831 (832)
Q Consensus       790 Il~~~~~~~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~  831 (832)
                      |++++++.+||+|||+++........ ......++..|+|||+
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~  200 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIES  200 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHH
Confidence            99999999999999999865333221 1222346778999995

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=2.4e-25  Score=211.84  Aligned_cols=168  Identities=25%  Similarity=0.398  Sum_probs=144.9

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC-----eeE
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNND-----FKA  731 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  731 (832)
                      +.+..+.||-|+||.||.+++. +|+.||.|++..-.  -...+++.+|++++..++|.|+...+++.+...     .+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            4455678999999999999874 69999999886433  234578899999999999999999988876543     568


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +++|.| ..+|.+.+-... .++.+.++-+.+||++|++|||   +.+|.||||||.|.+|+.+..+||||||+|+..+.
T Consensus       134 V~TELm-QSDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  134 VLTELM-QSDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHH-HhhhhheeccCC-CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccch
Confidence            999999 568988887654 6889999999999999999999   99999999999999999999999999999998877


Q ss_pred             CcccccccccccccccCCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ++....+..+.|.+|+|||++
T Consensus       209 d~~~hMTqEVVTQYYRAPEiL  229 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELL  229 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHh
Confidence            777777778899999999975

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=2.8e-23  Score=223.14  Aligned_cols=148  Identities=30%  Similarity=0.410  Sum_probs=133.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccch---hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLE---GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.+.||+|+||.||+|...+ ++.||+|.+.....   ...+.+..|+++++.++||+|+++++.+...+..|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            468899999999999999998865 89999999875432   24467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          735 EYMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       735 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      ||+++++|.+++... ...+++..+..++.|++.|++|||   +.|++||||||+||+++.++.++|+|||++...
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  153 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQS  153 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence            999999999998754 245899999999999999999999   999999999999999999999999999998754

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.90  E-value=2e-23  Score=225.92  Aligned_cols=172  Identities=26%  Similarity=0.479  Sum_probs=141.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC--------CcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEecC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD--------GMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTNN  727 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  727 (832)
                      ..+|++.+.||+|+||.||+|.+..        +..||+|.+.... ....+.+.+|+++++++ +||||+++++++..+
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            3578999999999999999997532        2368999877543 33456788999999999 799999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe
Q 003301          728 DFKALVLEYMPNGSLEDYLYSNN---------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL  792 (832)
Q Consensus       728 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~  792 (832)
                      +..|++|||+++|+|.+++.+..               ..+++..+..++.|++.|++|||   ++|++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEE
Confidence            99999999999999999987532               23778889999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeccccccccCCCcccc-cccccccccccCCCCC
Q 003301          793 DKDMVAHLSDFGIAKLLSGEESMK-QTLTLATIGYMAPGLF  832 (832)
Q Consensus       793 ~~~~~~kl~DFg~a~~~~~~~~~~-~~~~~gt~~y~APE~l  832 (832)
                      +.++.+||+|||.++......... .....++..|||||++
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  208 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL  208 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHh
Confidence            999999999999998664332211 1112345679999974

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.90  E-value=2.5e-23  Score=216.43  Aligned_cols=164  Identities=26%  Similarity=0.427  Sum_probs=139.9

Q ss_pred             CeeeccCCceEEEEEecC--C--cEEEEEEEeccch-hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCC
Q 003301          665 NLIGTGGFGSVYKGSFLD--G--MEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      ++||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+.+|++++++++||||+++++++.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998753  2  3689999876655 556789999999999999999999999988 889999999999


Q ss_pred             CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc--c
Q 003301          740 GSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM--K  816 (832)
Q Consensus       740 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~--~  816 (832)
                      ++|.+++.... ..+++..+..++.|++.|++|+|   +.|++||||||+||+++.++.+||+|||.++........  .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999998754 46899999999999999999999   999999999999999999999999999999876443221  1


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....++..|+|||++
T Consensus       157 ~~~~~~~~~y~~pE~~  172 (257)
T cd05040         157 EEHLKVPFAWCAPESL  172 (257)
T ss_pred             ccCCCCCceecCHHHh
Confidence            1123477889999963

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.90  E-value=3.3e-23  Score=219.73  Aligned_cols=169  Identities=34%  Similarity=0.462  Sum_probs=146.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .++|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..|+|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            368999999999999999999864 5789999998755545557788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +++++|.+++.+.  .+++..+..++.|++.|+.|||   +.|++||||||+||+++.++.+||+|||.+......... 
T Consensus        98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~-  171 (293)
T cd06647          98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-  171 (293)
T ss_pred             CCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-
Confidence            9999999999764  4788899999999999999999   999999999999999999999999999998765433322 


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....|++.|+|||++
T Consensus       172 ~~~~~~~~~y~~PE~~  187 (293)
T cd06647         172 RSTMVGTPYWMAPEVV  187 (293)
T ss_pred             cccccCChhhcCchhh
Confidence            2224588999999963

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=3e-23  Score=217.98  Aligned_cols=168  Identities=32%  Similarity=0.439  Sum_probs=147.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ++|++.+.||.|+||.||+|.+. +++.||+|.+.... ......+.+|+++++.++||||+++++++.++...|+|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888999999999999999876 48899999987553 33446788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +++++|.+++...  .+++..+..++.|++.|+.|+|   +.+++||||+|+||++++++.++++|||.++....... .
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~  154 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-K  154 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-c
Confidence            9999999999765  6899999999999999999999   99999999999999999999999999999987754322 2


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....|++.|+|||++
T Consensus       155 ~~~~~~~~~y~~PE~~  170 (274)
T cd06609         155 RNTFVGTPFWMAPEVI  170 (274)
T ss_pred             cccccCCccccChhhh
Confidence            2234688999999964

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.90  E-value=1.5e-23  Score=222.75  Aligned_cols=166  Identities=28%  Similarity=0.384  Sum_probs=142.6

Q ss_pred             CCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCC
Q 003301          661 FNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       661 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      |+....||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++|||++++++++..++..|+||||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            344557999999999999875 5899999998765544556788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccccc
Q 003301          740 GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL  819 (832)
Q Consensus       740 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~  819 (832)
                      ++|.+++...  .+++..+..++.|++.|++|+|   +.+++||||||+||+++.++.+||+|||++........ ....
T Consensus       103 ~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~  176 (297)
T cd06659         103 GALTDIVSQT--RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKS  176 (297)
T ss_pred             CCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccc
Confidence            9999988653  4889999999999999999999   99999999999999999999999999999876543322 2223


Q ss_pred             ccccccccCCCCC
Q 003301          820 TLATIGYMAPGLF  832 (832)
Q Consensus       820 ~~gt~~y~APE~l  832 (832)
                      ..|+..|+|||++
T Consensus       177 ~~~~~~y~aPE~~  189 (297)
T cd06659         177 LVGTPYWMAPEVI  189 (297)
T ss_pred             eecCccccCHHHH
Confidence            5689999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.90  E-value=2.5e-23  Score=221.20  Aligned_cols=171  Identities=22%  Similarity=0.406  Sum_probs=141.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-----------------CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-----------------GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVK  719 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~  719 (832)
                      .++|++.+.||+|+||.||+|.+.+                 +..||+|++.... ....+.+.+|+++++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            3579999999999999999986431                 3468999987543 334567889999999999999999


Q ss_pred             eceEEecCCeeEEEEecCCCCCHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 003301          720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNN----------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSN  789 (832)
Q Consensus       720 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N  789 (832)
                      +++++..++..|+||||+++++|.+++....          ..+++..+..++.|++.|++|||   +.|++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence            9999999999999999999999999987532          13667889999999999999999   9999999999999


Q ss_pred             eEeCCCCcEEEeccccccccCCCcccc-cccccccccccCCCC
Q 003301          790 VLLDKDMVAHLSDFGIAKLLSGEESMK-QTLTLATIGYMAPGL  831 (832)
Q Consensus       790 Il~~~~~~~kl~DFg~a~~~~~~~~~~-~~~~~gt~~y~APE~  831 (832)
                      |+++.++.+|++|||.++.+....... .....+++.|+|||+
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~  203 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWES  203 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHH
Confidence            999999999999999998654332211 122335678999984

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.90  E-value=3.8e-23  Score=217.03  Aligned_cols=169  Identities=30%  Similarity=0.475  Sum_probs=142.9

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc----------hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL----------EGALKSFDVECEVLKSVRHRNLVKIISSCTNND  728 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  728 (832)
                      +|.+.+.||+|+||.||+|... +++.||+|.++...          ....+.+.+|++++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            5778899999999999999765 58899999886321          112346778999999999999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          729 FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      ..++||||+++++|.+++++.. .+++..+..++.|++.|+.|+|   +.+++||||+|+||+++.++.+|++|||.++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            9999999999999999998764 6899999999999999999999   99999999999999999999999999999976


Q ss_pred             cCCCccc-ccccccccccccCCCCC
Q 003301          809 LSGEESM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       809 ~~~~~~~-~~~~~~gt~~y~APE~l  832 (832)
                      ....... ......|+..|+|||++
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~  182 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVI  182 (272)
T ss_pred             ccccccccccccccCCccccCHHHh
Confidence            5332111 12234588999999963

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.90  E-value=3.8e-23  Score=217.01  Aligned_cols=169  Identities=22%  Similarity=0.477  Sum_probs=136.3

Q ss_pred             CCCCCeeeccCCceEEEEEecCC---cEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecC------Ce
Q 003301          661 FNASNLIGTGGFGSVYKGSFLDG---MEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNN------DF  729 (832)
Q Consensus       661 ~~~~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  729 (832)
                      |.+++.||+|+||.||+|++.+.   ..||+|.++...  ....+.+.+|+++++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            45778999999999999987653   268999876542  33456788999999999999999999987432      24


Q ss_pred             eEEEEecCCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccc
Q 003301          730 KALVLEYMPNGSLEDYLYSN-----NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFG  804 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg  804 (832)
                      .+++|||+++|+|.+++...     ...+++..+..++.|++.|++|||   +++|+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999987432     234789999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCcccc-cccccccccccCCCCC
Q 003301          805 IAKLLSGEESMK-QTLTLATIGYMAPGLF  832 (832)
Q Consensus       805 ~a~~~~~~~~~~-~~~~~gt~~y~APE~l  832 (832)
                      .++......... .....+++.|+|||++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~  186 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESL  186 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHc
Confidence            998764332211 1223467789999963

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.90  E-value=1.7e-23  Score=217.83  Aligned_cols=167  Identities=33%  Similarity=0.468  Sum_probs=146.3

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      +|++.++||.|+||.||+|.+. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..|+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4888999999999999999886 48999999987543   2345788899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      |+++++|.+++... ..+++..+..++.|++.|++|||   ..+++|+||+|+||++++++.++|+|||.+.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999999776 36899999999999999999999   9999999999999999999999999999988764432  


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                      ......|+..|+|||++
T Consensus       155 ~~~~~~~~~~y~~PE~~  171 (258)
T cd05578         155 LTTSTSGTPGYMAPEVL  171 (258)
T ss_pred             cccccCCChhhcCHHHH
Confidence            12234588899999963

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.90  E-value=2.8e-23  Score=220.28  Aligned_cols=179  Identities=26%  Similarity=0.387  Sum_probs=147.9

Q ss_pred             cchHHHHHHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcC-CCCceeeeceEEec
Q 003301          649 FSYKELLQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLVKIISSCTN  726 (832)
Q Consensus       649 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  726 (832)
                      ++..++..+.++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            344555566889999999999999999999875 48899999886432 2235677899999988 89999999999865


Q ss_pred             C-----CeeEEEEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcE
Q 003301          727 N-----DFKALVLEYMPNGSLEDYLYS---NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVA  798 (832)
Q Consensus       727 ~-----~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~  798 (832)
                      .     +..|+||||+++++|.++++.   ....+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence            3     358999999999999998863   2346899999999999999999999   9999999999999999999999


Q ss_pred             EEeccccccccCCCcccccccccccccccCCCCC
Q 003301          799 HLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       799 kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ||+|||.+......... .....|+..|+|||++
T Consensus       168 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~  200 (291)
T cd06639         168 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVI  200 (291)
T ss_pred             EEeecccchhccccccc-ccCccCCccccChhhh
Confidence            99999998865433221 2234688999999963

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.90  E-value=4.6e-23  Score=214.38  Aligned_cols=162  Identities=27%  Similarity=0.440  Sum_probs=134.9

Q ss_pred             eeeccCCceEEEEEec---CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCC
Q 003301          666 LIGTGGFGSVYKGSFL---DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNG  740 (832)
Q Consensus       666 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  740 (832)
                      .||+|+||.||+|.+.   ++..||+|++....  ....+.+.+|+.+++.++||||+++++++.. +..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            5899999999999753   47889999886443  2345678899999999999999999998764 5678999999999


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc--cc
Q 003301          741 SLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK--QT  818 (832)
Q Consensus       741 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~--~~  818 (832)
                      +|.+++.... .+++..+..++.|++.|++|+|   ++|++||||||+||++++++.+||+|||.++.........  ..
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            9999997654 6899999999999999999999   9999999999999999999999999999998764433211  12


Q ss_pred             cccccccccCCCCC
Q 003301          819 LTLATIGYMAPGLF  832 (832)
Q Consensus       819 ~~~gt~~y~APE~l  832 (832)
                      ...++..|+|||++
T Consensus       157 ~~~~~~~y~aPE~~  170 (257)
T cd05116         157 HGKWPVKWYAPECM  170 (257)
T ss_pred             CCCCCccccCHhHh
Confidence            22346789999963

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.90  E-value=7.3e-25  Score=232.85  Aligned_cols=170  Identities=29%  Similarity=0.439  Sum_probs=152.6

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      ..++|+..+++|.|+||.||+|+++ .++.+|+|+++........-.++|+-+++.++|||||.++|.|..++..++.||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            3578999999999999999999886 488999999998877777888999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      ||.||+|++..+-.+ .+++.++..+++...+|++|+|   +.|-+|||||-.||++++.|.+|++|||.+..+...-. 
T Consensus        93 ycgggslQdiy~~Tg-plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~-  167 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-  167 (829)
T ss_pred             ecCCCcccceeeecc-cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhhh-
Confidence            999999999776554 6899999999999999999999   99999999999999999999999999999877644332 


Q ss_pred             ccccccccccccCCCC
Q 003301          816 KQTLTLATIGYMAPGL  831 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~  831 (832)
                      +.....||++||||||
T Consensus       168 KrksfiGtpywmapEv  183 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEV  183 (829)
T ss_pred             hhhcccCCccccchhH
Confidence            2334689999999997

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=8.2e-24  Score=220.62  Aligned_cols=170  Identities=23%  Similarity=0.315  Sum_probs=145.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEecc--chhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ--LEGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ...|++.++||+||.+.||++...+.+.||+|++...  +....+.|..|++.+.++ .|.+||++++|-..++..|+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            3578999999999999999999888888999876543  344567899999999999 5999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||= ..+|.+++++.....+.-.++.++.||+.|+.++|   .+||||.||||.|+|+ -.|.+||+|||+|..+..+..
T Consensus       440 E~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             ecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEE-EeeeEEeeeechhcccCcccc
Confidence            986 67999999987655554588899999999999999   9999999999999999 457999999999998765543


Q ss_pred             c-ccccccccccccCCCCC
Q 003301          815 M-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~-~~~~~~gt~~y~APE~l  832 (832)
                      . .....+||+.|||||.+
T Consensus       515 sI~kdsQvGT~NYMsPEAl  533 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEAL  533 (677)
T ss_pred             ceeeccccCcccccCHHHH
Confidence            2 33446899999999964

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=5.3e-23  Score=214.82  Aligned_cols=170  Identities=27%  Similarity=0.408  Sum_probs=142.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-----hhhHHHHHHHHHHHhcCCCCceeeeceEEecC--Cee
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-----EGALKSFDVECEVLKSVRHRNLVKIISSCTNN--DFK  730 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  730 (832)
                      .+|++.+.||+|+||.||+|.+. +++.||+|.+....     ......+.+|++++++++||||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47899999999999999999875 48999999875321     23346788999999999999999999998764  468


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      +++|||+++++|.+++.... .+++..+..++.|++.|+.|||   +.|++||||||+||+++.++.++|+|||.++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            89999999999999987654 5789999999999999999999   9999999999999999999999999999998653


Q ss_pred             CCcc--cccccccccccccCCCCC
Q 003301          811 GEES--MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       811 ~~~~--~~~~~~~gt~~y~APE~l  832 (832)
                      ....  .......|+..|+|||++
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~  181 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVI  181 (264)
T ss_pred             cccccCccccccCCcccccCHhhh
Confidence            2111  111234589999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.90  E-value=4.7e-23  Score=217.71  Aligned_cols=168  Identities=26%  Similarity=0.399  Sum_probs=138.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch-hhHHHHHHHHHH-HhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE-GALKSFDVECEV-LKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      ++|++.+.||+|+||.||+|.+. +|+.||+|+++.... .....+..|++. ++..+||||+++++++..++..|++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            47889999999999999999886 489999999875432 223455556665 566789999999999999999999999


Q ss_pred             cCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          736 YMPNGSLEDYLYS---NNFSFDILQRLSVIIDVALALEYLHFGYSN-PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       736 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      |++ ++|.+++..   ....+++..+..++.|++.|++|||   ++ +++||||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            995 688887754   2335899999999999999999999   76 999999999999999999999999999986533


Q ss_pred             CcccccccccccccccCCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ..  ......|+..|+|||++
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~  175 (283)
T cd06617         157 SV--AKTIDAGCKPYMAPERI  175 (283)
T ss_pred             cc--ccccccCCccccChhhc
Confidence            22  12224588899999964

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=6.2e-24  Score=214.85  Aligned_cols=173  Identities=29%  Similarity=0.459  Sum_probs=144.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc-------hhhHHHHHHHHHHHhcCCCCceeeeceEEe-cCC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL-------EGALKSFDVECEVLKSVRHRNLVKIISSCT-NND  728 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~  728 (832)
                      .++|-....||+|+|+.||+|.+.. .+.||||+-....       +...+...+|.++.+.+.||.||++|+++. +.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            4678888999999999999997754 7788999764332       233456778999999999999999999986 456


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeC---CCCcEEEecccc
Q 003301          729 FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGI  805 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~---~~~~~kl~DFg~  805 (832)
                      .+|-|+|||+|.+|+-|++..+ .+++.++..|+.||+.||.||. ..+..|||-|+||.|||+.   ..|.+||+|||+
T Consensus       542 sFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLN-EikpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLN-EIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHh-ccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            7899999999999999998765 6899999999999999999999 3478899999999999994   458999999999


Q ss_pred             ccccCCCcccc------cccccccccccCCCCC
Q 003301          806 AKLLSGEESMK------QTLTLATIGYMAPGLF  832 (832)
Q Consensus       806 a~~~~~~~~~~------~~~~~gt~~y~APE~l  832 (832)
                      +++++++....      .....||.+|.+||.|
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcF  652 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECF  652 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCccee
Confidence            99987654331      2235699999999975

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.90  E-value=5e-23  Score=214.79  Aligned_cols=165  Identities=27%  Similarity=0.485  Sum_probs=134.9

Q ss_pred             CeeeccCCceEEEEEecC----CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEe-cCCeeEEEEecCC
Q 003301          665 NLIGTGGFGSVYKGSFLD----GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCT-NNDFKALVLEYMP  738 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  738 (832)
                      +.||+|+||.||+|.+.+    +..||+|.+.... ....+.+.+|+.+++.++||||+++++++. .++..++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998643    4579999875432 334567888999999999999999999775 4556899999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc---
Q 003301          739 NGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM---  815 (832)
Q Consensus       739 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~---  815 (832)
                      +++|.+++.+.....++..+..++.|++.|++|||   +.+++||||||+||++++++.+||+|||+++........   
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999999876556778888999999999999999   999999999999999999999999999999765432211   


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                      ......++..|+|||++
T Consensus       158 ~~~~~~~~~~y~aPE~~  174 (262)
T cd05058         158 NHTGAKLPVKWMALESL  174 (262)
T ss_pred             ccccCcCCccccChhHh
Confidence            11123467789999963

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.90  E-value=6.3e-23  Score=214.69  Aligned_cols=171  Identities=30%  Similarity=0.444  Sum_probs=147.2

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ++|++.+.||.|+||+||+|... ++..||+|++.... ....+.+.+|+++++.++|+||+++++.+..++..|+||||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47899999999999999999875 47889999986443 23457889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          737 MPNGSLEDYLYSNN--FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       737 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      +++++|.++++...  ..+++..+..++.|++.|++|||   +.|++||||+|+||++++++.+||+|||.+........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999997642  35899999999999999999999   99999999999999999999999999999877654332


Q ss_pred             c---ccccccccccccCCCCC
Q 003301          815 M---KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~---~~~~~~gt~~y~APE~l  832 (832)
                      .   ......|+..|+|||++
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~  178 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVM  178 (267)
T ss_pred             ccccccccccCChhhcChHHH
Confidence            2   12234689999999963

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.89  E-value=5.7e-23  Score=216.22  Aligned_cols=168  Identities=32%  Similarity=0.463  Sum_probs=145.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ..|+..+.||.|+||.||+|.+. ++..||+|.+.... ....+.+.+|++++++++||||+++++++.++...|+||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45778899999999999999875 48899999987543 34456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +++++|.+++...  .+++..+..++.|++.|++|+|   +.+++|+||+|+||+++.++.++++|||.+........ .
T Consensus        84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06640          84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-c
Confidence            9999999998754  5889999999999999999999   99999999999999999999999999999977644332 2


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....++..|+|||++
T Consensus       158 ~~~~~~~~~y~apE~~  173 (277)
T cd06640         158 RNTFVGTPFWMAPEVI  173 (277)
T ss_pred             cccccCcccccCHhHh
Confidence            2234588899999974

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.89  E-value=2.4e-23  Score=217.56  Aligned_cols=168  Identities=27%  Similarity=0.373  Sum_probs=146.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ++|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..|+++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            46888899999999999999886 48899999987653 33456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      +++++|.+++......+++..+..++.|++.|++|+|   + .|++||||||+||+++.++.+||+|||.+.........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  157 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK  157 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence            9999999999876557899999999999999999999   8 99999999999999999999999999998765332211


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                         ...++..|+|||++
T Consensus       158 ---~~~~~~~y~~PE~~  171 (265)
T cd06605         158 ---TFVGTSSYMAPERI  171 (265)
T ss_pred             ---cccCChhccCHHHH
Confidence               15688999999963

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.89  E-value=5.2e-23  Score=217.50  Aligned_cols=168  Identities=29%  Similarity=0.461  Sum_probs=142.9

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch-hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      +|++.+.||.|++|.||+|++. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+..|+||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5888999999999999999986 488999999875532 23456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          738 PNGSLEDYLYSNN--FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       738 ~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      + +++.+++....  ..+++..+..++.|++.|++|||   +.|++||||||+||++++++.+|++|||.+........ 
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            7 58988886543  45899999999999999999999   99999999999999999999999999999976543222 


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                      ......++..|+|||++
T Consensus       156 ~~~~~~~~~~y~~PE~~  172 (284)
T cd07836         156 TFSNEVVTLWYRAPDVL  172 (284)
T ss_pred             ccccccccccccChHHh
Confidence            12234578899999963

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=6.2e-24  Score=207.66  Aligned_cols=171  Identities=23%  Similarity=0.331  Sum_probs=149.8

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  731 (832)
                      ..++|+..++||+|+|++|..+++.. .+.||+|+++++.   .+..+..+.|..++.+. +||++|.++.+|+++...+
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            35789999999999999999998764 7889999987653   34456778898888776 7999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +|.||++||+|.-++++.+ .++++.+..+..+|+.|+.|||   ++|||.||+|.+||++|..|.+|++|+|+++.--.
T Consensus       328 fvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             EEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence            9999999999988877655 6999999999999999999999   99999999999999999999999999999986544


Q ss_pred             CcccccccccccccccCCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +... ....+|||.|+|||++
T Consensus       404 ~gd~-tstfcgtpnyiapeil  423 (593)
T KOG0695|consen  404 PGDT-TSTFCGTPNYIAPEIL  423 (593)
T ss_pred             CCcc-cccccCCCcccchhhh
Confidence            4433 3457899999999985

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.89  E-value=5.9e-23  Score=217.04  Aligned_cols=170  Identities=28%  Similarity=0.484  Sum_probs=144.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-----CCcEEEEEEEeccchh-hHHHHHHHHHHHhcCCCCceeeeceEEec--CCee
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEG-ALKSFDVECEVLKSVRHRNLVKIISSCTN--NDFK  730 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  730 (832)
                      +.|++.+.||+|+||.||+|.+.     .+..||||++...... ..+.+.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            56788899999999999999863     3688999998765443 45789999999999999999999999877  5578


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      ++||||+++++|.+++......+++..+..++.|++.|++|||   +.|++||||||+||+++.++.+|++|||.+....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            9999999999999999876656999999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCcccc--cccccccccccCCCC
Q 003301          811 GEESMK--QTLTLATIGYMAPGL  831 (832)
Q Consensus       811 ~~~~~~--~~~~~gt~~y~APE~  831 (832)
                      ......  .....++..|+|||+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~  183 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPEC  183 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHH
Confidence            322211  112235667999996

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=4.8e-23  Score=216.59  Aligned_cols=171  Identities=27%  Similarity=0.420  Sum_probs=145.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcC-CCCceeeeceEEecCC------
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLVKIISSCTNND------  728 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------  728 (832)
                      ..++|++.+.||+|++|.||+|... +++.|++|++..... ..+.+.+|+++++++ +|+||+++++++.+..      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4689999999999999999999885 478899998875543 346788999999999 7999999999997644      


Q ss_pred             eeEEEEecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccc
Q 003301          729 FKALVLEYMPNGSLEDYLYSN---NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGI  805 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~  805 (832)
                      ..|+||||+++++|.+++...   +..+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.+|++|||.
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence            489999999999999988653   346899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCCCCC
Q 003301          806 AKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       806 a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +........ ......|++.|+|||++
T Consensus       160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~  185 (275)
T cd06608         160 SAQLDSTLG-RRNTFIGTPYWMAPEVI  185 (275)
T ss_pred             ceecccchh-hhcCccccccccCHhHh
Confidence            876543322 22335689999999963

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.89  E-value=3.4e-23  Score=219.28  Aligned_cols=171  Identities=25%  Similarity=0.456  Sum_probs=142.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  730 (832)
                      .++|++.+.||+|+||.||+|.+.      ++..||+|++.... ....+.+.+|+.++++++||||+++++++..++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467999999999999999999863      36789999887543 23346788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCC
Q 003301          731 ALVLEYMPNGSLEDYLYSNN---------------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSN  789 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N  789 (832)
                      |+||||+++++|.+++....                     ..+++..++.++.|++.|++|+|   .++++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999997432                     23678889999999999999999   9999999999999


Q ss_pred             eEeCCCCcEEEeccccccccCCCccc-ccccccccccccCCCC
Q 003301          790 VLLDKDMVAHLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGL  831 (832)
Q Consensus       790 Il~~~~~~~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~  831 (832)
                      |+++.++.+|++|||.+......... ......++..|+|||+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  203 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPES  203 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHH
Confidence            99999999999999998765333211 1122335678999995

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.89  E-value=5.1e-23  Score=217.05  Aligned_cols=173  Identities=22%  Similarity=0.363  Sum_probs=144.1

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC-----CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEec-CCe
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD-----GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTN-NDF  729 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~  729 (832)
                      ..++|++.+.||+|+||.||+|.+.+     +..||+|++.... ....+.+.+|+.++++++||||+++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35789999999999999999998865     6889999886443 3345678899999999999999999998766 467


Q ss_pred             eEEEEecCCCCCHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEec
Q 003301          730 KALVLEYMPNGSLEDYLYSNN-------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSD  802 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D  802 (832)
                      .++++||+++++|.+++....       ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence            899999999999999987532       34889999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCcccc-cccccccccccCCCCC
Q 003301          803 FGIAKLLSGEESMK-QTLTLATIGYMAPGLF  832 (832)
Q Consensus       803 Fg~a~~~~~~~~~~-~~~~~gt~~y~APE~l  832 (832)
                      ||+++.+....... .....++..|+|||++
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~  191 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESL  191 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHH
Confidence            99998664333211 1223467789999963

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.89  E-value=5.3e-23  Score=220.16  Aligned_cols=171  Identities=30%  Similarity=0.426  Sum_probs=143.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch--hhHHHHHHHHHHHhcCCCCceeeeceEEecC--CeeE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRNLVKIISSCTNN--DFKA  731 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  731 (832)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|+++....  .....+.+|++++++++|+||+++++++...  +..|
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            3578999999999999999999886 489999999875432  2223566799999999999999999998754  5689


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +||||++ ++|.+++......+++..+..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||.+.....
T Consensus        85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            9999995 5899988775567899999999999999999999   99999999999999999999999999999987654


Q ss_pred             CcccccccccccccccCCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ... ......+++.|+|||++
T Consensus       161 ~~~-~~~~~~~~~~y~aPE~~  180 (309)
T cd07845         161 PAK-PMTPKVVTLWYRAPELL  180 (309)
T ss_pred             ccC-CCCcccccccccChhhh
Confidence            322 12223468889999964

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.89  E-value=4.7e-23  Score=213.89  Aligned_cols=163  Identities=31%  Similarity=0.543  Sum_probs=138.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCC
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMP  738 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  738 (832)
                      ++|++.+.||+|+||.||++.. .++.||+|.+....  ..+.+.+|+.++++++|||++++++++..++ .|+||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCC
Confidence            5689999999999999999975 78889999986543  2367889999999999999999999987654 799999999


Q ss_pred             CCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccc
Q 003301          739 NGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ  817 (832)
Q Consensus       739 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~  817 (832)
                      +++|.+++.... ..+++..+..++.|++.|++|+|   +.|++||||||+||+++.++.+||+|||.+.......    
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----  154 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----  154 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence            999999997643 34789999999999999999999   9999999999999999999999999999987643221    


Q ss_pred             ccccccccccCCCCC
Q 003301          818 TLTLATIGYMAPGLF  832 (832)
Q Consensus       818 ~~~~gt~~y~APE~l  832 (832)
                      .....+..|+|||++
T Consensus       155 ~~~~~~~~y~~pe~~  169 (254)
T cd05083         155 DNSKLPVKWTAPEAL  169 (254)
T ss_pred             CCCCCCceecCHHHh
Confidence            112356789999963

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.89  E-value=9.6e-23  Score=217.86  Aligned_cols=166  Identities=29%  Similarity=0.381  Sum_probs=142.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .+.|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+++..|+|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356888999999999999999875 58999999886432   23345788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||++ |++.+++......+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.+||+|||++.......
T Consensus        94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~  169 (307)
T cd06607          94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN  169 (307)
T ss_pred             HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCCC
Confidence            99995 6888877655556899999999999999999999   9999999999999999999999999999987653322


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                           ...+++.|+|||++
T Consensus       170 -----~~~~~~~y~aPE~~  183 (307)
T cd06607         170 -----SFVGTPYWMAPEVI  183 (307)
T ss_pred             -----CccCCccccCceee
Confidence                 24588899999963

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=5.8e-23  Score=216.24  Aligned_cols=167  Identities=29%  Similarity=0.487  Sum_probs=144.5

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCC---CCceeeeceEEecCCeeEEEE
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVR---HRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  734 (832)
                      .|++.+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++   |||++++++++..+...|+||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4778899999999999999874 58999999986543 334467888999999986   999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||+++++|.++++..  .+++..+..++.|++.|+.|||   +.|++||||+|+||+++.++.++++|||.+........
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            999999999998654  5889999999999999999999   99999999999999999999999999999987654432


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                      . .....|+..|+|||++
T Consensus       157 ~-~~~~~~~~~y~aPE~~  173 (277)
T cd06917         157 K-RSTFVGTPYWMAPEVI  173 (277)
T ss_pred             c-cccccCCcceeCHHHh
Confidence            2 2234689999999963

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.89  E-value=2.7e-23  Score=218.72  Aligned_cols=168  Identities=30%  Similarity=0.438  Sum_probs=143.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      +.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..|+||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            34666788999999999999875 47889999887443 34456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +++++|.+++...  .+++..+..++.|++.|+.|+|   +.+++|+||+|+||++++++.+|++|||++........ .
T Consensus        84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06642          84 LGGGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             cCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence            9999999998653  5889999999999999999999   99999999999999999999999999999987644322 2


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....|+..|+|||++
T Consensus       158 ~~~~~~~~~y~aPE~~  173 (277)
T cd06642         158 RNTFVGTPFWMAPEVI  173 (277)
T ss_pred             hhcccCcccccCHHHh
Confidence            2224588899999964

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.89  E-value=5.7e-23  Score=216.88  Aligned_cols=178  Identities=27%  Similarity=0.424  Sum_probs=147.0

Q ss_pred             chHHHHHHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcC-CCCceeeeceEEec-
Q 003301          650 SYKELLQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLVKIISSCTN-  726 (832)
Q Consensus       650 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-  726 (832)
                      +..++....+.|++.+.||.|+||.||+|.+. +++.||+|++.... .....+..|+.+++++ +||||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            34455556789999999999999999999885 48899999886543 2335678899999998 69999999999853 


Q ss_pred             -----CCeeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEE
Q 003301          727 -----NDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHL  800 (832)
Q Consensus       727 -----~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl  800 (832)
                           .+..|++|||+++|+|.+++.... ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.++|
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence                 457899999999999999987643 34788889999999999999999   999999999999999999999999


Q ss_pred             eccccccccCCCcccccccccccccccCCCCC
Q 003301          801 SDFGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       801 ~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +|||.+........ ......|++.|+|||++
T Consensus       163 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l  193 (282)
T cd06636         163 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVI  193 (282)
T ss_pred             eeCcchhhhhcccc-CCCcccccccccCHhhc
Confidence            99999876533221 12234689999999964

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.89  E-value=9e-23  Score=213.12  Aligned_cols=169  Identities=28%  Similarity=0.403  Sum_probs=148.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccch-hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ++|++.+.||+|++|.||+|...+ ++.||+|++..... ...+.+.+|++.+.+++|+|++++++++...+..|+||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            468899999999999999998875 89999999876543 4457889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      +++++|.+++... ..+++..+..++.|++.|++|+|   + .+++||||+|+||+++.++.++++|||.+.........
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            9999999999865 36899999999999999999999   8 99999999999999999999999999999876543332


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                      . ....++..|+|||++
T Consensus       157 ~-~~~~~~~~y~~pE~~  172 (264)
T cd06623         157 C-NTFVGTVTYMSPERI  172 (264)
T ss_pred             c-cceeecccccCHhhh
Confidence            2 234588999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.89  E-value=3.7e-23  Score=218.48  Aligned_cols=168  Identities=25%  Similarity=0.369  Sum_probs=144.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .++|++.+.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..|+|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            357888999999999999999876 48889999876543 3345678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |+++++|.+++...+ .+++..+..++.+++.|+.|||   + .+++||||||+||+++.++.++|+|||++....... 
T Consensus        84 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          84 FMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             cCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            999999999987654 6899999999999999999999   5 589999999999999999999999999987543221 


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                        .....|+..|+|||++
T Consensus       159 --~~~~~~~~~~~aPE~~  174 (284)
T cd06620         159 --ADTFVGTSTYMSPERI  174 (284)
T ss_pred             --cCccccCcccCCHHHH
Confidence              1234689999999963

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.89  E-value=6.6e-23  Score=217.03  Aligned_cols=167  Identities=33%  Similarity=0.464  Sum_probs=144.1

Q ss_pred             CCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecC--CeeEEEEe
Q 003301          661 FNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNN--DFKALVLE  735 (832)
Q Consensus       661 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  735 (832)
                      |++.+.||+|+||.||+|.+.+ ++.||+|++....  ....+.+.+|++++++++|||++++++++...  +..|+|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            6788999999999999998864 8899999998653  33446788899999999999999999999887  88999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      |++ ++|.+++......+++..+..++.|++.|++|||   +.|++|+||+|+||++++++.+||+|||.+.........
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            996 5999998776557999999999999999999999   999999999999999999999999999999876544322


Q ss_pred             ccccccccccccCCCC
Q 003301          816 KQTLTLATIGYMAPGL  831 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~  831 (832)
                      ......++..|+|||+
T Consensus       157 ~~~~~~~~~~y~~PE~  172 (287)
T cd07840         157 DYTNRVITLWYRPPEL  172 (287)
T ss_pred             cccccccccccCCcee
Confidence            2233457889999995

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.89  E-value=1.1e-22  Score=214.00  Aligned_cols=168  Identities=31%  Similarity=0.450  Sum_probs=144.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      +-|++.+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..|+||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            34778889999999999999875 58899999876443 33446788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +++++|.+++...  .+++..+..++.|++.|+.|||   +.|++|+||+|+||+++.++.++++|||.+........ .
T Consensus        84 ~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06641          84 LGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-h
Confidence            9999999998753  5889999999999999999999   99999999999999999999999999999876543322 1


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....|+..|+|||++
T Consensus       158 ~~~~~~~~~y~~PE~~  173 (277)
T cd06641         158 RNTFVGTPFWMAPEVI  173 (277)
T ss_pred             hccccCCccccChhhh
Confidence            2224588899999963

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.89  E-value=4.6e-23  Score=219.86  Aligned_cols=171  Identities=29%  Similarity=0.487  Sum_probs=140.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-Cc----EEEEEEEeccch-hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GM----EVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  731 (832)
                      .++|+..+.||+|+||.||+|.+.. +.    .||+|.+..... .....+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            4568888999999999999998753 43    478888764432 2334688899999999999999999998754 467


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +++||+++|+|.+++......+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||.++....
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence            999999999999999876656899999999999999999999   99999999999999999999999999999987643


Q ss_pred             Cccc-ccccccccccccCCCCC
Q 003301          812 EESM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~-~~~~~~gt~~y~APE~l  832 (832)
                      .... ......++..|+|||++
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~  183 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECI  183 (303)
T ss_pred             cccccccCCCccccccCCHHHh
Confidence            3221 11223457789999963

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.89  E-value=7.6e-23  Score=214.40  Aligned_cols=163  Identities=29%  Similarity=0.530  Sum_probs=133.6

Q ss_pred             CeeeccCCceEEEEEecC-Cc--EEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEEEecCCC
Q 003301          665 NLIGTGGFGSVYKGSFLD-GM--EVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      +.||+|+||.||+|...+ +.  .+|+|.+.... ....+.+.+|++++.++ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999998754 43  46888876432 33456788999999999 799999999999999999999999999


Q ss_pred             CCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccc
Q 003301          740 GSLEDYLYSNN---------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFG  804 (832)
Q Consensus       740 g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg  804 (832)
                      ++|.+++...+               ..+++..+..++.|++.|++|+|   +.|++||||||+||+++.++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999987532               23788999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCcccccccccccccccCCCCC
Q 003301          805 IAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       805 ~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ++......  ........+..|+|||++
T Consensus       158 l~~~~~~~--~~~~~~~~~~~y~apE~~  183 (270)
T cd05047         158 LSRGQEVY--VKKTMGRLPVRWMAIESL  183 (270)
T ss_pred             Cccccchh--hhccCCCCccccCChHHH
Confidence            98643211  111112346679999963

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.89  E-value=6.2e-23  Score=218.96  Aligned_cols=173  Identities=33%  Similarity=0.448  Sum_probs=144.3

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC----
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNND----  728 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  728 (832)
                      ...++|++.+.||+|+||.||+|.+. +++.||+|+++...  ......+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            35678999999999999999999986 48899999987543  223356778999999999999999999987654    


Q ss_pred             ------eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEec
Q 003301          729 ------FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSD  802 (832)
Q Consensus       729 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D  802 (832)
                            ..|+|+||+++ ++.+.+......+++..+..++.|++.|++|||   +.||+||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999965 788877765557899999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCcccccccccccccccCCCCC
Q 003301          803 FGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       803 Fg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ||.+...............++..|+|||++
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~  189 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELL  189 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHh
Confidence            999987644332222223467889999963

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.89  E-value=8.4e-23  Score=212.30  Aligned_cols=169  Identities=27%  Similarity=0.422  Sum_probs=145.2

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      +|++.+.||+|+||.||.+... +++.||+|.+....  ....+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5888999999999999999875 58899999987432  33446788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          737 MPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       737 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      +++++|.+++.... ..+++.++..++.|++.|++|+|   +.+++|+||+|+||+++.++.++++|||.+.........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence            99999999987643 35789999999999999999999   999999999999999999999999999999866443221


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                       .....|++.|+|||++
T Consensus       158 -~~~~~~~~~~~~pe~~  173 (256)
T cd08218         158 -ARTCIGTPYYLSPEIC  173 (256)
T ss_pred             -hhhccCCccccCHHHh
Confidence             2234588999999963

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.2e-24  Score=223.99  Aligned_cols=169  Identities=24%  Similarity=0.342  Sum_probs=147.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCc-EEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGM-EVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      ..++++...||.|+||.|-.++..... .+|+|.+++..   ....+.+..|..+|..++.|+||++|..|.++.++|+.
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            456777889999999999998875433 47888776442   34457788899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      ||-|-||.+...++.++ .++...+..++..+.+|++|||   ++|||.||+||+|.+++.+|.+|+.|||+|+.+....
T Consensus       499 mEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             HHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence            99999999999998765 7999999999999999999999   9999999999999999999999999999999886544


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                      .  .-..||||.|.|||++
T Consensus       575 K--TwTFcGTpEYVAPEII  591 (732)
T KOG0614|consen  575 K--TWTFCGTPEYVAPEII  591 (732)
T ss_pred             c--eeeecCCcccccchhh
Confidence            2  2347899999999985

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.89  E-value=8e-23  Score=215.13  Aligned_cols=160  Identities=28%  Similarity=0.362  Sum_probs=131.2

Q ss_pred             eeeccCCceEEEEEec-CCcEEEEEEEeccch---hhHHHHHHHHHHH---hcCCCCceeeeceEEecCCeeEEEEecCC
Q 003301          666 LIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE---GALKSFDVECEVL---KSVRHRNLVKIISSCTNNDFKALVLEYMP  738 (832)
Q Consensus       666 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv~e~~~  738 (832)
                      .||+|+||.||+|... +++.||+|.+.....   .....+.+|..++   ...+||+|+.+++++..++..|+||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 488999998865421   1122334444333   34479999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccc
Q 003301          739 NGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT  818 (832)
Q Consensus       739 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~  818 (832)
                      +++|.+++...+ .+++..+..++.|++.|++|+|   +.+++||||||+||++++++.+|++|||++........   .
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~---~  153 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---H  153 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---c
Confidence            999999987654 6899999999999999999999   99999999999999999999999999999876533221   2


Q ss_pred             cccccccccCCCCC
Q 003301          819 LTLATIGYMAPGLF  832 (832)
Q Consensus       819 ~~~gt~~y~APE~l  832 (832)
                      ...|++.|+|||++
T Consensus       154 ~~~~~~~y~aPE~~  167 (279)
T cd05633         154 ASVGTHGYMAPEVL  167 (279)
T ss_pred             CcCCCcCccCHHHh
Confidence            24699999999963

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.89  E-value=5.2e-23  Score=221.11  Aligned_cols=168  Identities=29%  Similarity=0.423  Sum_probs=140.2

Q ss_pred             CCCCCCeeeccCCceEEEEEecC---CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecC--CeeE
Q 003301          660 QFNASNLIGTGGFGSVYKGSFLD---GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNN--DFKA  731 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  731 (832)
                      +|++.+.||+|+||.||+|....   ++.||+|.+....   ....+.+.+|++++++++||||+++++++.+.  +..|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47888999999999999998754   7899999987633   33346778899999999999999999999988  7899


Q ss_pred             EEEecCCCCCHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC----CCcEEEecc
Q 003301          732 LVLEYMPNGSLEDYLYSN----NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK----DMVAHLSDF  803 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~----~~~~kl~DF  803 (832)
                      +||||++ +++.+++...    ...+++..+..++.|++.|++|||   +.+++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            9999996 5777766432    125889999999999999999999   999999999999999999    899999999


Q ss_pred             ccccccCCCcc--cccccccccccccCCCC
Q 003301          804 GIAKLLSGEES--MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       804 g~a~~~~~~~~--~~~~~~~gt~~y~APE~  831 (832)
                      |++........  .......+++.|+|||+
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  186 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPEL  186 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHH
Confidence            99987543322  12223468899999995

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.89  E-value=1.5e-24  Score=206.12  Aligned_cols=165  Identities=27%  Similarity=0.324  Sum_probs=136.7

Q ss_pred             CCCeeeccCCceEEEEEecC-CcEEEEEEEeccc-hhhHHHHHHHHHHHhc-CCCCceeeeceEEecCCeeEEEEecCCC
Q 003301          663 ASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL-EGALKSFDVECEVLKS-VRHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       663 ~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      -...||.|+||+|++-.++. |+.+|||+++... +.+.+++..|.++..+ -+.|+||++||++..++..|+.||.| .
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d  146 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-D  146 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-h
Confidence            34679999999999998864 9999999998665 3566788889887554 47999999999999999999999999 5


Q ss_pred             CCHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          740 GSLEDYLYS----NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       740 g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      .+++.+.+.    .+..+++.-.-+|....+.||+||..  ...|||||+||+|||++..|.+|+||||++..+.+  +.
T Consensus       147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--Si  222 (361)
T KOG1006|consen  147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--SI  222 (361)
T ss_pred             hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH--HH
Confidence            688766532    23358888888888899999999985  67899999999999999999999999999987633  33


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                      ..+...|-..|||||-+
T Consensus       223 AkT~daGCrpYmAPERi  239 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERI  239 (361)
T ss_pred             HhhhccCCccccChhcc
Confidence            44556799999999964

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.89  E-value=1.2e-22  Score=211.13  Aligned_cols=168  Identities=30%  Similarity=0.498  Sum_probs=143.7

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      +|++.+.||+|+||.||+|... +++.||+|.+....  ....+.+.+|++++++++|||++++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5888999999999999999875 58899999986542  23456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC-CcEEEeccccccccCCCcc
Q 003301          737 MPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD-MVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       737 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~kl~DFg~a~~~~~~~~  814 (832)
                      +++++|.+++.... ..+++..+..++.|++.|++|+|   ++|++||||+|+||+++++ +.+|++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            99999999997643 34899999999999999999999   9999999999999999855 4689999999987644322


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                        .....|+..|+|||++
T Consensus       158 --~~~~~~~~~y~aPE~~  173 (256)
T cd08220         158 --AYTVVGTPCYISPELC  173 (256)
T ss_pred             --ccccccCCcccCchhc
Confidence              1224688999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.89  E-value=7.7e-23  Score=226.34  Aligned_cols=173  Identities=23%  Similarity=0.298  Sum_probs=131.5

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEe-----------------cCCcEEEEEEEeccchhhHHH--------------HHHH
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSF-----------------LDGMEVAIKVFHLQLEGALKS--------------FDVE  705 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e  705 (832)
                      ..++|++.++||+|+||+||+|..                 ..++.||||++........+.              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999964                 235679999986543322222              3346


Q ss_pred             HHHHhcCCCCc-----eeeeceEEec--------CCeeEEEEecCCCCCHHHHHhhCCC---------------------
Q 003301          706 CEVLKSVRHRN-----LVKIISSCTN--------NDFKALVLEYMPNGSLEDYLYSNNF---------------------  751 (832)
Q Consensus       706 ~~~l~~l~h~n-----iv~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~---------------------  751 (832)
                      +.++.+++|.+     +++++++|..        ++..|+||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            66677776554     4677777653        3568999999999999999864211                     


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccccccccccccCC
Q 003301          752 --SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP  829 (832)
Q Consensus       752 --~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~AP  829 (832)
                        ..++..+..++.|++.|++|+|   +.+|+||||||+||+++.++.+||+|||+++..............+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence              2356778899999999999999   99999999999999999999999999999976543322222223458999999


Q ss_pred             CCC
Q 003301          830 GLF  832 (832)
Q Consensus       830 E~l  832 (832)
                      |++
T Consensus       380 E~l  382 (507)
T PLN03224        380 EEL  382 (507)
T ss_pred             hhh
Confidence            974

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=1.9e-22  Score=209.27  Aligned_cols=167  Identities=38%  Similarity=0.520  Sum_probs=147.0

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch--hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      +|++.+.||+|++|.||+|... +++.||+|.+.....  ...+.+.+|++++++++||+++++++++.+++..|++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            5788999999999999999876 478999999876543  4557889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +++++|.+++... ..+++..+..++.|++.|+.|+|   +.|++||||+|+||+++.++.+||+|||.+......... 
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            9999999999765 36899999999999999999999   999999999999999999999999999999876544332 


Q ss_pred             cccccccccccCCCC
Q 003301          817 QTLTLATIGYMAPGL  831 (832)
Q Consensus       817 ~~~~~gt~~y~APE~  831 (832)
                      .....++..|+|||.
T Consensus       156 ~~~~~~~~~y~~pe~  170 (254)
T cd06627         156 DASVVGTPYWMAPEV  170 (254)
T ss_pred             ccccccchhhcCHhh
Confidence            223458899999996

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.89  E-value=1.9e-22  Score=209.02  Aligned_cols=168  Identities=38%  Similarity=0.529  Sum_probs=148.9

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCC
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMP  738 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  738 (832)
                      +|+..+.||+|++|.||+|... +++.|++|++........+.+.+|++.+++++||+++++++++..++..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4788899999999999999886 588999999876655456788999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccc
Q 003301          739 NGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT  818 (832)
Q Consensus       739 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~  818 (832)
                      +++|.+++......+++..+..++.|++.|++|||   ..|++||||+|+||+++.++.++|+|||.+........  ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~  155 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN  155 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence            99999999876557899999999999999999999   99999999999999999999999999999987654432  22


Q ss_pred             cccccccccCCCCC
Q 003301          819 LTLATIGYMAPGLF  832 (832)
Q Consensus       819 ~~~gt~~y~APE~l  832 (832)
                      ...++..|+|||++
T Consensus       156 ~~~~~~~~~~PE~~  169 (253)
T cd05122         156 TMVGTPYWMAPEVI  169 (253)
T ss_pred             ceecCCcccCHHHH
Confidence            34688999999963

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.89  E-value=1.5e-22  Score=214.21  Aligned_cols=171  Identities=36%  Similarity=0.464  Sum_probs=149.1

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      ..+.|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|++.+++++|+|++++++++...+..|+|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4567888999999999999999886 588999999876544 45678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      |+++++|.+++......+++..+..++.|++.|++|||   +.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  172 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK  172 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence            99999999999876546899999999999999999999   999999999999999999999999999998765433221


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                       .....++..|+|||++
T Consensus       173 -~~~~~~~~~y~~PE~~  188 (286)
T cd06614         173 -RNSVVGTPYWMAPEVI  188 (286)
T ss_pred             -hccccCCcccCCHhHh
Confidence             1223578899999963

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.89  E-value=1.4e-22  Score=211.34  Aligned_cols=160  Identities=31%  Similarity=0.441  Sum_probs=139.6

Q ss_pred             eeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCCCH
Q 003301          667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSL  742 (832)
Q Consensus       667 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  742 (832)
                      ||.|+||.||+|+... ++.||+|++....   ....+.+.+|+++++.++||||+++++++.++...|+||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6899999999999864 8999999987543   23446788999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccccccc
Q 003301          743 EDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA  822 (832)
Q Consensus       743 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~g  822 (832)
                      .+++.+.. .+++..+..++.|++.|++|+|   +.+++|+||+|+||+++.++.+||+|||.+.......  ......|
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~  154 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG  154 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence            99997654 5889999999999999999999   9999999999999999999999999999998765432  1223468


Q ss_pred             cccccCCCCC
Q 003301          823 TIGYMAPGLF  832 (832)
Q Consensus       823 t~~y~APE~l  832 (832)
                      ++.|+|||++
T Consensus       155 ~~~~~~PE~~  164 (262)
T cd05572         155 TPEYVAPEII  164 (262)
T ss_pred             CcCccChhHh
Confidence            8999999964

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.89  E-value=1.1e-22  Score=218.11  Aligned_cols=172  Identities=28%  Similarity=0.451  Sum_probs=142.1

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC-----
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNND-----  728 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  728 (832)
                      ..++|++.+.||+|+||.||+|... +++.||||.+....  ......+.+|++++++++||||+++++++...+     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3468999999999999999999876 48999999886443  222345668999999999999999999886543     


Q ss_pred             ---eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccc
Q 003301          729 ---FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGI  805 (832)
Q Consensus       729 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~  805 (832)
                         ..|+||||++ +++.+++......+++..+..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||.
T Consensus        90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence               4599999995 5898888776557899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCccc---ccccccccccccCCCCC
Q 003301          806 AKLLSGEESM---KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       806 a~~~~~~~~~---~~~~~~gt~~y~APE~l  832 (832)
                      +.........   ......++..|+|||++
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  195 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELL  195 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHh
Confidence            9866433221   11224578899999963

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.89  E-value=1.8e-22  Score=212.36  Aligned_cols=160  Identities=28%  Similarity=0.363  Sum_probs=131.3

Q ss_pred             eeeccCCceEEEEEec-CCcEEEEEEEeccch---hhHHHHHHHH---HHHhcCCCCceeeeceEEecCCeeEEEEecCC
Q 003301          666 LIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE---GALKSFDVEC---EVLKSVRHRNLVKIISSCTNNDFKALVLEYMP  738 (832)
Q Consensus       666 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  738 (832)
                      .||+|+||.||+|... +++.||+|.+.....   .....+..|.   +.++...||+|+++++++.+.+..|+||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999875 488999998865421   1112233343   34445679999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccc
Q 003301          739 NGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT  818 (832)
Q Consensus       739 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~  818 (832)
                      |++|.+++.... .+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.+.......   ..
T Consensus        81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~  153 (278)
T cd05606          81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH  153 (278)
T ss_pred             CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---Cc
Confidence            999999887644 6899999999999999999999   9999999999999999999999999999987653322   12


Q ss_pred             cccccccccCCCCC
Q 003301          819 LTLATIGYMAPGLF  832 (832)
Q Consensus       819 ~~~gt~~y~APE~l  832 (832)
                      ...|+..|+|||++
T Consensus       154 ~~~~~~~y~aPE~~  167 (278)
T cd05606         154 ASVGTHGYMAPEVL  167 (278)
T ss_pred             CcCCCcCCcCcHHh
Confidence            34699999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.89  E-value=1.8e-22  Score=213.28  Aligned_cols=167  Identities=29%  Similarity=0.386  Sum_probs=143.7

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCC
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMP  738 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  738 (832)
                      .|...+.||+|++|.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++...+..|+++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3555679999999999999874 588999999876555555678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccc
Q 003301          739 NGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT  818 (832)
Q Consensus       739 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~  818 (832)
                      +++|.+++..  ..+++..+..++.|++.|++|+|   +.|++||||+|+||+++.++.++++|||.+........ ...
T Consensus       100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~  173 (285)
T cd06648         100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRK  173 (285)
T ss_pred             CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccc
Confidence            9999999977  35889999999999999999999   99999999999999999999999999998876543222 122


Q ss_pred             cccccccccCCCCC
Q 003301          819 LTLATIGYMAPGLF  832 (832)
Q Consensus       819 ~~~gt~~y~APE~l  832 (832)
                      ...|++.|+|||++
T Consensus       174 ~~~~~~~y~aPE~~  187 (285)
T cd06648         174 SLVGTPYWMAPEVI  187 (285)
T ss_pred             cccCCccccCHHHh
Confidence            34589999999963

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.89  E-value=2e-22  Score=210.52  Aligned_cols=172  Identities=27%  Similarity=0.408  Sum_probs=143.9

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEec--CCeeEEEE
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTN--NDFKALVL  734 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  734 (832)
                      +|++.+.||.|+||.||+|.+. +++.||+|.+....  ....+.+..|++++++++||||+++++++..  ....|++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            5888999999999999999875 57899999886432  3345678889999999999999999998754  45689999


Q ss_pred             ecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          735 EYMPNGSLEDYLYSN---NFSFDILQRLSVIIDVALALEYLHFGY--SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       735 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      ||+++++|.+++...   ...+++..++.++.|++.|++|+|..+  +.+++||||||+||+++.++.+|++|||.+...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998753   346899999999999999999999443  678999999999999999999999999999876


Q ss_pred             CCCcccccccccccccccCCCCC
Q 003301          810 SGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       810 ~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ...... .....|++.|+|||++
T Consensus       161 ~~~~~~-~~~~~~~~~~~~pE~~  182 (265)
T cd08217         161 GHDSSF-AKTYVGTPYYMSPEQL  182 (265)
T ss_pred             cCCccc-ccccccCCCccChhhh
Confidence            544321 2234689999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.89  E-value=1.1e-22  Score=215.46  Aligned_cols=168  Identities=30%  Similarity=0.427  Sum_probs=142.9

Q ss_pred             CCCCCCeeeccCCceEEEEEec----CCcEEEEEEEeccc----hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCee
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL----DGMEVAIKVFHLQL----EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  730 (832)
                      +|++.+.||+|+||.||+|+..    +++.||||+++...    ....+.+.+|++++.++ +||+|+++++++..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4788899999999999999753    46889999987432    22345678899999999 599999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      |+||||+++++|.+++.... .+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.++++|||+++...
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            99999999999999987643 6889999999999999999999   9999999999999999999999999999988754


Q ss_pred             CCcccccccccccccccCCCC
Q 003301          811 GEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       811 ~~~~~~~~~~~gt~~y~APE~  831 (832)
                      ...........|+..|+|||+
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~  177 (288)
T cd05583         157 AEEEERAYSFCGTIEYMAPEV  177 (288)
T ss_pred             cccccccccccCCccccCHHH
Confidence            433322233468999999996

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=4.9e-25  Score=207.63  Aligned_cols=170  Identities=29%  Similarity=0.491  Sum_probs=141.2

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEec--cchhhHHHHHHHHHHHhcCCCCceeeeceEEec--------C
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNLVKIISSCTN--------N  727 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~  727 (832)
                      ..|+...+||+|.||+||+|+..+ |+.||+|++-.  +.++.-....+|++++..++|+|++.++..|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            456677899999999999998764 78899987543  233444667889999999999999999887743        3


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccc
Q 003301          728 DFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK  807 (832)
Q Consensus       728 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~  807 (832)
                      ..+|+||++|+ -+|.-++.....+++..++.+++.++..|+.|+|   +..|+|||+||+|+|++.+|.+||+|||+|+
T Consensus        97 ~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   97 ATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence            35899999996 4899999887778999999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCccc---ccccccccccccCCCCC
Q 003301          808 LLSGEESM---KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       808 ~~~~~~~~---~~~~~~gt~~y~APE~l  832 (832)
                      .+...+..   ..+..+.|.+|.+||.+
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEll  200 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELL  200 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHh
Confidence            76443322   23345679999999964

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.89  E-value=1.3e-22  Score=215.83  Aligned_cols=169  Identities=25%  Similarity=0.388  Sum_probs=139.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch--hhHHHHHHHHHHHhcCC-CCceeeeceEEecCCe-----
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE--GALKSFDVECEVLKSVR-HRNLVKIISSCTNNDF-----  729 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~-----  729 (832)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++.....  .....+.+|+++++.+. ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46899999999999999999876 589999998765432  23356788999999995 6999999999877665     


Q ss_pred             eEEEEecCCCCCHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC-CCcEEEeccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNN----FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK-DMVAHLSDFG  804 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~kl~DFg  804 (832)
                      .|+||||+++ ++.+++....    ..+++..+..++.||+.||+|||   ++|++||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999975 8988876432    34799999999999999999999   999999999999999998 8999999999


Q ss_pred             cccccCCCcccccccccccccccCCCCC
Q 003301          805 IAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       805 ~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .++....... ......+++.|+|||++
T Consensus       157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~  183 (295)
T cd07837         157 LGRAFSIPVK-SYTHEIVTLWYRAPEVL  183 (295)
T ss_pred             cceecCCCcc-ccCCcccccCCCChHHh
Confidence            9986533221 11223578899999963

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.89  E-value=1.8e-22  Score=209.90  Aligned_cols=163  Identities=31%  Similarity=0.477  Sum_probs=135.3

Q ss_pred             CeeeccCCceEEEEEecC----CcEEEEEEEeccch-hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCC
Q 003301          665 NLIGTGGFGSVYKGSFLD----GMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      ++||+|+||.||+|.+..    +..||+|.+..... ...+.+.+|+++++++.||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            479999999999997643    26899999875543 34567889999999999999999999876 4567999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccc--
Q 003301          740 GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ--  817 (832)
Q Consensus       740 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~--  817 (832)
                      ++|.+++.... .+++..+..++.|++.|++|||   ..+++||||||+||+++.++.+||+|||.++..........  
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999998765 6899999999999999999999   99999999999999999999999999999987644332211  


Q ss_pred             ccccccccccCCCCC
Q 003301          818 TLTLATIGYMAPGLF  832 (832)
Q Consensus       818 ~~~~gt~~y~APE~l  832 (832)
                      ....++..|+|||.+
T Consensus       156 ~~~~~~~~y~aPE~~  170 (257)
T cd05060         156 TAGRWPLKWYAPECI  170 (257)
T ss_pred             cCccccccccCHHHh
Confidence            112235679999963

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.89  E-value=2.5e-23  Score=225.52  Aligned_cols=167  Identities=29%  Similarity=0.454  Sum_probs=140.8

Q ss_pred             CCCCCeeeccCCceEEEEEec-C----CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          661 FNASNLIGTGGFGSVYKGSFL-D----GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       661 ~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      .+..++||+|+||+||+|.|. +    ..+||+|++.... .+..+++..|+-+|.+++|||+++++|++..+. ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            445689999999999999874 2    3568999886443 445678999999999999999999999998766 78999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      +|++.|+|.+|++..+..+.....+.|.+|||+|+.|||   .+++|||||.++||||.+-..+||.|||+|+....++.
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999999998888999999999999999999999   99999999999999999999999999999998765543


Q ss_pred             ccccc-ccccccccCCCC
Q 003301          815 MKQTL-TLATIGYMAPGL  831 (832)
Q Consensus       815 ~~~~~-~~gt~~y~APE~  831 (832)
                      ..... ..-.+.|||=|.
T Consensus       854 ey~~~~gK~pikwmale~  871 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALES  871 (1177)
T ss_pred             cccccccccCcHHHHHHH
Confidence            32221 223556777654

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.89  E-value=8.9e-23  Score=220.99  Aligned_cols=168  Identities=26%  Similarity=0.377  Sum_probs=140.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecC-----Cee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNN-----DFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  730 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999875 58999999986432 23346678899999999999999999987654     357


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      |+|+||++ +++.+++...  .+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELME-TDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhcc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            99999995 5888888653  5899999999999999999999   9999999999999999999999999999997654


Q ss_pred             CCcccc--cccccccccccCCCC
Q 003301          811 GEESMK--QTLTLATIGYMAPGL  831 (832)
Q Consensus       811 ~~~~~~--~~~~~gt~~y~APE~  831 (832)
                      ......  .....||+.|+|||+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~  180 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEI  180 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHH
Confidence            322211  122468999999996

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.89  E-value=1.5e-22  Score=212.96  Aligned_cols=161  Identities=29%  Similarity=0.387  Sum_probs=137.1

Q ss_pred             eeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCCCH
Q 003301          667 IGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSL  742 (832)
Q Consensus       667 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  742 (832)
                      ||+|+||+||+|... +|+.||+|.+....   ......+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999765 58899999986532   22334567899999999999999999999999999999999999999


Q ss_pred             HHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccccccc
Q 003301          743 EDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL  821 (832)
Q Consensus       743 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~  821 (832)
                      .+++.... ..+++..+..++.|++.|+.|+|   +.|++||||+|+||+++.++.+||+|||.+........  .....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~  155 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRA  155 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--ccccc
Confidence            99987644 35899999999999999999999   99999999999999999999999999999876543221  22245


Q ss_pred             ccccccCCCCC
Q 003301          822 ATIGYMAPGLF  832 (832)
Q Consensus       822 gt~~y~APE~l  832 (832)
                      ++..|+|||++
T Consensus       156 ~~~~y~~PE~~  166 (277)
T cd05577         156 GTPGYMAPEVL  166 (277)
T ss_pred             CCCCcCCHHHh
Confidence            78899999963

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.89  E-value=1.1e-22  Score=214.96  Aligned_cols=168  Identities=28%  Similarity=0.450  Sum_probs=142.2

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      +|+..+.||.|++|.||+|.+. +++.||||++....  ....+.+.+|++++++++||||+++++++.+++..|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788999999999999999875 58899999886443  22335788899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          737 MPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       737 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      +. ++|.+++... ...+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.+|++|||.+........ 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            95 6899888653 345899999999999999999999   99999999999999999999999999999876543222 


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                      ......+++.|+|||++
T Consensus       156 ~~~~~~~~~~y~aPE~~  172 (284)
T cd07860         156 TYTHEVVTLWYRAPEIL  172 (284)
T ss_pred             ccccccccccccCCeEE
Confidence            12223578899999963

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.89  E-value=3e-22  Score=215.02  Aligned_cols=164  Identities=28%  Similarity=0.379  Sum_probs=141.1

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .|+..+.||+|+||.||+|++. ++..||+|++....   ......+.+|++++++++|||++++++++.+++..|+|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            4777889999999999999875 48899999986432   2334578889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      |++ |++.+++......+++.++..++.|++.|+.|||   +.+++||||+|+||+++.++.+||+|||.+......   
T Consensus       106 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         106 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             CCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence            996 5888887665557899999999999999999999   999999999999999999999999999998754322   


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                        ....|++.|+|||++
T Consensus       179 --~~~~~~~~y~aPE~~  193 (317)
T cd06635         179 --NSFVGTPYWMAPEVI  193 (317)
T ss_pred             --ccccCCccccChhhh
Confidence              224588999999973

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.89  E-value=3.6e-22  Score=208.67  Aligned_cols=167  Identities=25%  Similarity=0.328  Sum_probs=137.0

Q ss_pred             HHHHHHhcCCCCCCee--eccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcC-CCCceeeeceEEecC
Q 003301          652 KELLQATNQFNASNLI--GTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLVKIISSCTNN  727 (832)
Q Consensus       652 ~~~~~~~~~~~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  727 (832)
                      .+.....++|++.+.+  |+|+||.||++... +++.+|+|.+........     |+.....+ +||||+++++++...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence            3445556788887777  99999999999875 478899998865422111     22222222 799999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC-cEEEeccccc
Q 003301          728 DFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIA  806 (832)
Q Consensus       728 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~DFg~a  806 (832)
                      +..|+||||+++++|.+++.... .+++..+..++.|++.|++|+|   +.|++||||||+||+++.++ .++|+|||.+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence            99999999999999999998765 7899999999999999999999   99999999999999999998 9999999998


Q ss_pred             cccCCCcccccccccccccccCCCCC
Q 003301          807 KLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       807 ~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +......     ...|+..|+|||++
T Consensus       158 ~~~~~~~-----~~~~~~~y~aPE~~  178 (267)
T PHA03390        158 KIIGTPS-----CYDGTLDYFSPEKI  178 (267)
T ss_pred             eecCCCc-----cCCCCCcccChhhh
Confidence            7654322     23588999999974

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.89  E-value=2.6e-22  Score=210.30  Aligned_cols=168  Identities=27%  Similarity=0.477  Sum_probs=141.2

Q ss_pred             CCCCCCeeeccCCceEEEEEecC--CcEEEEEEEeccc----------hhhHHHHHHHHHHHhc-CCCCceeeeceEEec
Q 003301          660 QFNASNLIGTGGFGSVYKGSFLD--GMEVAIKVFHLQL----------EGALKSFDVECEVLKS-VRHRNLVKIISSCTN  726 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~  726 (832)
                      +|++.+.||+|+||.||+|.+..  ++.+|+|.+....          .....++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47889999999999999998865  6889999875321          2234556778888765 799999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeEeCCCCcEEEec
Q 003301          727 NDFKALVLEYMPNGSLEDYLYS---NNFSFDILQRLSVIIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDKDMVAHLSD  802 (832)
Q Consensus       727 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~~~kl~D  802 (832)
                      ++..+++|||+++++|.+++..   ....+++..++.++.|++.|+.|||   . .+++||||+|+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999988743   3446899999999999999999999   6 6899999999999999999999999


Q ss_pred             cccccccCCCcccccccccccccccCCCCC
Q 003301          803 FGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       803 Fg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ||.+.......  ......|+..|+|||++
T Consensus       158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~  185 (269)
T cd08528         158 FGLAKQKQPES--KLTSVVGTILYSCPEIV  185 (269)
T ss_pred             ccceeeccccc--ccccccCcccCcChhhh
Confidence            99998765443  22335689999999963

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.88  E-value=2.2e-22  Score=209.34  Aligned_cols=168  Identities=31%  Similarity=0.471  Sum_probs=147.1

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch--hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      +|++.+.||.|+||.||+|.+. +++.||+|++.....  ...+.+.+|++++++++|||++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5788899999999999999886 488999999875532  4556788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          737 MPNGSLEDYLYSNN---FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       737 ~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      +++++|.++++...   ..+++..+..++.+++.|++|||   +.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999998752   56899999999999999999999   9999999999999999999999999999998765443


Q ss_pred             ccccccccccccccCCCC
Q 003301          814 SMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~  831 (832)
                      . ......|++.|+|||.
T Consensus       158 ~-~~~~~~~~~~y~~pe~  174 (258)
T cd08215         158 D-LAKTVVGTPYYLSPEL  174 (258)
T ss_pred             c-eecceeeeecccChhH
Confidence            2 2223468999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.88  E-value=2.2e-22  Score=212.53  Aligned_cols=167  Identities=29%  Similarity=0.469  Sum_probs=141.9

Q ss_pred             CCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          661 FNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       661 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      |++.+.||.|++|.||+|.+. +|..||+|++....  ....+.+.+|+++++.++|||++++++++.+++..|++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            678899999999999999875 58999999987543  223356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          738 PNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       738 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                       +++|.+++.... ..+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.++|+|||.++........ 
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-  155 (283)
T cd07835          81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-  155 (283)
T ss_pred             -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence             469999987644 35899999999999999999999   999999999999999999999999999999765332211 


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....+++.|+|||++
T Consensus       156 ~~~~~~~~~~~aPE~~  171 (283)
T cd07835         156 YTHEVVTLWYRAPEIL  171 (283)
T ss_pred             cCccccccCCCCCcee
Confidence            1223578899999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.88  E-value=1e-22  Score=214.69  Aligned_cols=169  Identities=35%  Similarity=0.548  Sum_probs=145.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCC-CCceeeeceEEecCCeeEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVR-HRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  733 (832)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|++++++++ ||||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47899999999999999999876 58999999986532   233467888999999998 99999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+++++|.+++.+.+ .+++..+..++.|++.|++|||   +.|++|+||+|+||+++.++.++++|||.+.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            99999999999998764 6999999999999999999999   9999999999999999999999999999988664332


Q ss_pred             c-------------------cccccccccccccCCCC
Q 003301          814 S-------------------MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       814 ~-------------------~~~~~~~gt~~y~APE~  831 (832)
                      .                   .......|+..|+|||+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~  193 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPEL  193 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHH
Confidence            1                   11222457899999996

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.88  E-value=1.6e-22  Score=220.43  Aligned_cols=168  Identities=25%  Similarity=0.335  Sum_probs=140.6

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecC-----
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNN-----  727 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  727 (832)
                      ...++|++.+.||+|+||.||+|... +++.||+|.+....  ....+.+.+|++++++++||||+++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            34578999999999999999999875 58999999986432  23345677899999999999999999988643     


Q ss_pred             -CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccc
Q 003301          728 -DFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA  806 (832)
Q Consensus       728 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a  806 (832)
                       ...|+||||++ +++.+++...   +++..+..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||.+
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence             35799999995 6888887643   788999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCcccccccccccccccCCCCC
Q 003301          807 KLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       807 ~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +.......  .....+++.|+|||++
T Consensus       166 ~~~~~~~~--~~~~~~~~~y~aPE~~  189 (353)
T cd07850         166 RTAGTSFM--MTPYVVTRYYRAPEVI  189 (353)
T ss_pred             eeCCCCCC--CCCCcccccccCHHHH
Confidence            87643322  2234588999999963

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.88  E-value=1.5e-22  Score=214.40  Aligned_cols=163  Identities=29%  Similarity=0.387  Sum_probs=140.8

Q ss_pred             CCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCCCH
Q 003301          664 SNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSL  742 (832)
Q Consensus       664 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  742 (832)
                      ..+||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++|+|++++++++...+..|+||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            367999999999999875 5899999998655545556788999999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccccccc
Q 003301          743 EDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA  822 (832)
Q Consensus       743 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~g  822 (832)
                      .+++...  .+++..+..++.|++.|++|+|   +.|++||||+|+||+++.++.++|+|||.+........ ......|
T Consensus       105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~  178 (292)
T cd06657         105 TDIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVG  178 (292)
T ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccccc
Confidence            9988653  4789999999999999999999   99999999999999999999999999999876543221 1223468


Q ss_pred             cccccCCCCC
Q 003301          823 TIGYMAPGLF  832 (832)
Q Consensus       823 t~~y~APE~l  832 (832)
                      ++.|+|||++
T Consensus       179 ~~~y~~pE~~  188 (292)
T cd06657         179 TPYWMAPELI  188 (292)
T ss_pred             CccccCHHHh
Confidence            8999999963

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.88  E-value=1.6e-22  Score=211.36  Aligned_cols=161  Identities=31%  Similarity=0.454  Sum_probs=139.2

Q ss_pred             eeccCCceEEEEEecC-CcEEEEEEEeccch---hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCCCH
Q 003301          667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLE---GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSL  742 (832)
Q Consensus       667 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  742 (832)
                      ||.|+||.||+|.+.. ++.||+|++.....   ...+.+.+|++++++++||||+++++.+..++..|++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999875 89999999865432   3456788899999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc-------c
Q 003301          743 EDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES-------M  815 (832)
Q Consensus       743 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~-------~  815 (832)
                      .+++.+.+ .+++..+..++.|++.|++|||   +.+++||||+|+||++++++.+||+|||++........       .
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99998755 6899999999999999999999   99999999999999999999999999999876533211       1


Q ss_pred             ccccccccccccCCCC
Q 003301          816 KQTLTLATIGYMAPGL  831 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~  831 (832)
                      ......++..|+|||+
T Consensus       157 ~~~~~~~~~~~~~Pe~  172 (265)
T cd05579         157 EDKRIVGTPDYIAPEV  172 (265)
T ss_pred             cccCcccCccccCHHH
Confidence            2223458889999996

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.88  E-value=1.7e-22  Score=218.88  Aligned_cols=170  Identities=29%  Similarity=0.410  Sum_probs=141.6

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcC-CCCceeeeceEEecC--Cee
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSV-RHRNLVKIISSCTNN--DFK  730 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~  730 (832)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++....  ......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4578999999999999999999876 48899999885432  23345677899999999 999999999998653  368


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      |+||||++ ++|.+++...  .+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||.+....
T Consensus        85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            99999996 6999988764  5788999999999999999999   9999999999999999999999999999998664


Q ss_pred             CCccc----ccccccccccccCCCCC
Q 003301          811 GEESM----KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       811 ~~~~~----~~~~~~gt~~y~APE~l  832 (832)
                      .....    ......|++.|+|||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~  184 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEIL  184 (337)
T ss_pred             cccccccCcchhcccccccccCceee
Confidence            33221    22234689999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.88  E-value=2.5e-22  Score=213.33  Aligned_cols=169  Identities=28%  Similarity=0.433  Sum_probs=139.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      ++|++.+.||+|++|.||+|.+. +++.||+|++....  ....+.+.+|++++++++||||+++++++...+..|+|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57899999999999999999876 58899999886443  2233567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC-CCcEEEeccccccccCCCc
Q 003301          736 YMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK-DMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~kl~DFg~a~~~~~~~  813 (832)
                      |++ +++.+++.... ..+++..+..++.|++.|++|||   +++++||||+|+||+++. ++.+||+|||.+.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            995 58888876543 23678888899999999999999   999999999999999985 5679999999997653322


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                      . ......+++.|+|||++
T Consensus       158 ~-~~~~~~~~~~y~~PE~~  175 (294)
T PLN00009        158 R-TFTHEVVTLWYRAPEIL  175 (294)
T ss_pred             c-ccccCceeecccCHHHH
Confidence            1 11224578899999963

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.88  E-value=1.5e-22  Score=219.12  Aligned_cols=170  Identities=27%  Similarity=0.373  Sum_probs=141.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEec----CCee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTN----NDFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~  730 (832)
                      .++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            378999999999999999999876 48999999987543  2334667789999999999999999998753    3468


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      |+||||+. ++|.+++.... .+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.+....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            99999995 69999987654 5899999999999999999999   9999999999999999999999999999997653


Q ss_pred             CCccc---ccccccccccccCCCCC
Q 003301          811 GEESM---KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       811 ~~~~~---~~~~~~gt~~y~APE~l  832 (832)
                      .....   ......|+..|+|||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~  183 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELL  183 (334)
T ss_pred             ccCcCCCcccccccccccccChHHh
Confidence            32211   11234689999999963

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.88  E-value=2.3e-22  Score=218.12  Aligned_cols=168  Identities=24%  Similarity=0.367  Sum_probs=141.6

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC---
Q 003301          655 LQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNND---  728 (832)
Q Consensus       655 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---  728 (832)
                      ....++|++.+.||+|+||.||+|... +++.||||++....  ....+.+.+|++++++++||||+++++++..+.   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            445688999999999999999999865 58999999885432  223456788999999999999999999987653   


Q ss_pred             ---eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccc
Q 003301          729 ---FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGI  805 (832)
Q Consensus       729 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~  805 (832)
                         ..++||||+ +++|.+++...  .+++..+..++.|++.|++|+|   +.||+||||||+||+++.++.+|++|||.
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence               458999999 78999888653  5899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCCCCC
Q 003301          806 AKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       806 a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +.......    ....+++.|+|||++
T Consensus       165 ~~~~~~~~----~~~~~~~~y~aPE~~  187 (343)
T cd07880         165 ARQTDSEM----TGYVVTRWYRAPEVI  187 (343)
T ss_pred             ccccccCc----cccccCCcccCHHHH
Confidence            98654322    223578899999963

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.88  E-value=7.5e-22  Score=211.39  Aligned_cols=163  Identities=28%  Similarity=0.367  Sum_probs=140.0

Q ss_pred             CCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          661 FNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       661 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      |...+.||+|+||+||+|+.. +++.||+|++....   ....+.+.+|+++++.++|||++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666788999999999999875 48899999986432   23345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +. +++.+++......+++.++..++.|++.|++|||   +.|++||||+|+||+++.++.+||+|||.+.....     
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----  173 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----  173 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence            95 6888888766557899999999999999999999   99999999999999999999999999999865322     


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....|+..|+|||++
T Consensus       174 ~~~~~~~~~y~aPE~~  189 (313)
T cd06633         174 ANSFVGTPYWMAPEVI  189 (313)
T ss_pred             CCCccccccccChhhc
Confidence            1234688999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.88  E-value=4.2e-22  Score=210.78  Aligned_cols=168  Identities=28%  Similarity=0.334  Sum_probs=141.2

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch-hhHHHHHHHHHHHhcCCCCceeeeceEEecC--CeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVKIISSCTNN--DFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  734 (832)
                      ++|+..+.||.|++|.||+|.+. +++.||+|.+..... .....+.+|++++++++||||+++++++.+.  +..|+||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46888999999999999999885 488899998875432 3456788999999999999999999988653  4689999


Q ss_pred             ecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          735 EYMPNGSLEDYLYS---NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       735 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      ||+++++|.+++..   ....+++..+..++.|++.|++|+|   +.|++||||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999988653   2345889999999999999999999   99999999999999999999999999999876533


Q ss_pred             CcccccccccccccccCCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ...   ....++..|+|||++
T Consensus       158 ~~~---~~~~~~~~y~~pE~~  175 (287)
T cd06621         158 SLA---GTFTGTSFYMAPERI  175 (287)
T ss_pred             ccc---ccccCCccccCHHHh
Confidence            221   123578899999963

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.88  E-value=4e-22  Score=210.46  Aligned_cols=164  Identities=25%  Similarity=0.332  Sum_probs=137.6

Q ss_pred             CCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch-hhHHHHHHHHHHHhcCC-CCceeeeceEEecC--CeeEEEEe
Q 003301          661 FNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE-GALKSFDVECEVLKSVR-HRNLVKIISSCTNN--DFKALVLE  735 (832)
Q Consensus       661 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  735 (832)
                      |++.+.||+|+||.||+|... +++.||+|+++.... .......+|+.+++++. |||++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            677889999999999999875 588999998875422 22234457888888885 99999999999887  88999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      |++ +++.+++......+++..+..++.|++.|++|||   +.|++||||+|+||+++. +.+||+|||.++........
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~  155 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY  155 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence            996 6888888765557899999999999999999999   999999999999999999 99999999999876433221


Q ss_pred             ccccccccccccCCCC
Q 003301          816 KQTLTLATIGYMAPGL  831 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~  831 (832)
                        ....+++.|+|||+
T Consensus       156 --~~~~~~~~y~aPE~  169 (282)
T cd07831         156 --TEYISTRWYRAPEC  169 (282)
T ss_pred             --CCCCCCcccCChhH
Confidence              22458899999995

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.88  E-value=3.1e-22  Score=217.35  Aligned_cols=172  Identities=26%  Similarity=0.374  Sum_probs=144.1

Q ss_pred             chHHHHHHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEec
Q 003301          650 SYKELLQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTN  726 (832)
Q Consensus       650 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  726 (832)
                      ...++....++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            34566778899999999999999999999864 58899999986532  2234567789999999999999999998864


Q ss_pred             C------CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEE
Q 003301          727 N------DFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHL  800 (832)
Q Consensus       727 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl  800 (832)
                      .      ...|++++++ +++|.++++..  .+++..+..++.|++.|++|||   +.|++||||||+||+++.++.+||
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEE
Confidence            3      3468888887 78999888654  4899999999999999999999   999999999999999999999999


Q ss_pred             eccccccccCCCcccccccccccccccCCCC
Q 003301          801 SDFGIAKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       801 ~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      +|||+++.....    .....|++.|+|||+
T Consensus       162 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~  188 (345)
T cd07877         162 LDFGLARHTDDE----MTGYVATRWYRAPEI  188 (345)
T ss_pred             eccccccccccc----ccccccCCCccCHHH
Confidence            999998865322    123468899999996

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.88  E-value=2.6e-22  Score=208.68  Aligned_cols=169  Identities=28%  Similarity=0.436  Sum_probs=143.4

Q ss_pred             CCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          660 QFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      +|++.+.||+|+||.||+|.... |..||+|.+....  ....+.+.+|++++++++|+||+++++++...+..|+|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            57889999999999999998864 8899999986542  22345778999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC-cEEEeccccccccCCCcc
Q 003301          737 MPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       737 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~DFg~a~~~~~~~~  814 (832)
                      +++++|.+++.... ..+++..+..++.|++.|++|||   +.+++||||||+||++++++ .+|++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999987643 34789999999999999999999   99999999999999998885 569999999987644322


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                      . .....|++.|+|||++
T Consensus       158 ~-~~~~~~~~~~~ape~~  174 (257)
T cd08225         158 L-AYTCVGTPYYLSPEIC  174 (257)
T ss_pred             c-ccccCCCccccCHHHH
Confidence            1 2234589999999963

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.88  E-value=2.1e-22  Score=217.83  Aligned_cols=168  Identities=27%  Similarity=0.357  Sum_probs=144.2

Q ss_pred             CCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC-----eeE
Q 003301          660 QFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNND-----FKA  731 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  731 (832)
                      +|++.+.||+|+||.||+|.... ++.||+|++....  ....+.+.+|+++++.++||||+++++++...+     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            58899999999999999998864 8999999987543  334567889999999999999999999988765     789


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +||||++ ++|.+++.... .+++..+..++.|++.|++|||   +.|++||||||+||+++.++.++|+|||.+.....
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999996 58999987654 7899999999999999999999   99999999999999999999999999999987654


Q ss_pred             Ccc--cccccccccccccCCCCC
Q 003301          812 EES--MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~--~~~~~~~gt~~y~APE~l  832 (832)
                      ...  .......+++.|+|||++
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~  178 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELL  178 (330)
T ss_pred             cccccccccccccccCcCCceee
Confidence            431  112234688999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.88  E-value=1.9e-22  Score=218.37  Aligned_cols=168  Identities=26%  Similarity=0.334  Sum_probs=141.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecC-----Ce
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNN-----DF  729 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  729 (832)
                      .++|.+.+.||+|+||+||+|... +++.||||.+....  ......+.+|+++++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            467999999999999999999875 48999999986432  22345677899999999999999999987654     34


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      .|+||||+. ++|.+++...+ .+++..+..++.|++.|++|||   +++++||||||+||+++.++.+||+|||+++..
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            799999994 79999887654 6899999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCcccccccccccccccCCCC
Q 003301          810 SGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       810 ~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      ..... ......++..|+|||+
T Consensus       159 ~~~~~-~~~~~~~~~~y~aPE~  179 (337)
T cd07858         159 SEKGD-FMTEYVVTRWYRAPEL  179 (337)
T ss_pred             CCCcc-cccccccccCccChHH
Confidence            44322 1223458899999995

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.88  E-value=6.9e-22  Score=205.64  Aligned_cols=169  Identities=33%  Similarity=0.451  Sum_probs=147.8

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch--hhHHHHHHHHHHHhcCCCCceeeeceEEecC--CeeEEEE
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRNLVKIISSCTNN--DFKALVL  734 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  734 (832)
                      +|+..+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|++++++++||||+++++.+...  +..++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999886 589999999876542  4467889999999999999999999999988  8899999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||+++++|.+++.... .+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.+||+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999998765 7899999999999999999999   99999999999999999999999999999987655432


Q ss_pred             c-ccccccccccccCCCCC
Q 003301          815 M-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~-~~~~~~gt~~y~APE~l  832 (832)
                      . ......++..|+|||.+
T Consensus       157 ~~~~~~~~~~~~y~~pE~~  175 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVI  175 (260)
T ss_pred             cccccCCCCCccccCHhhh
Confidence            1 12234688999999963

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.88  E-value=2.4e-22  Score=210.57  Aligned_cols=165  Identities=28%  Similarity=0.502  Sum_probs=135.9

Q ss_pred             CeeeccCCceEEEEEecC-------CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          665 NLIGTGGFGSVYKGSFLD-------GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      +.||+|+||.||+|++.+       ++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..|+||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998643       2579999876443 23456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC-----cEEEecccc
Q 003301          737 MPNGSLEDYLYSN------NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM-----VAHLSDFGI  805 (832)
Q Consensus       737 ~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-----~~kl~DFg~  805 (832)
                      +++++|.+++...      ...+++..+..++.|++.|++|+|   +.+++||||||+||+++.++     .+|++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999742      223788999999999999999999   99999999999999999877     899999999


Q ss_pred             ccccCCCccc-ccccccccccccCCCCC
Q 003301          806 AKLLSGEESM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       806 a~~~~~~~~~-~~~~~~gt~~y~APE~l  832 (832)
                      ++........ ......++..|+|||++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~  185 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESL  185 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHH
Confidence            9765433221 11223467889999963

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.88  E-value=5.3e-22  Score=214.97  Aligned_cols=170  Identities=22%  Similarity=0.363  Sum_probs=139.9

Q ss_pred             hcCCC-CCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhh--------------HHHHHHHHHHHhcCCCCceeeec
Q 003301          658 TNQFN-ASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGA--------------LKSFDVECEVLKSVRHRNLVKII  721 (832)
Q Consensus       658 ~~~~~-~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~  721 (832)
                      .++|. +.+.||+|+||+||+|.+. +++.||||++.......              ...+.+|++++++++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            34565 4578999999999999875 58999999986442211              12467899999999999999999


Q ss_pred             eEEecCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEe
Q 003301          722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLS  801 (832)
Q Consensus       722 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~  801 (832)
                      +++..++..|+||||++ ++|.+++.... .+++..+..++.|++.|++|||   +.|++||||+|+||+++.++.+|++
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEEC
Confidence            99999999999999995 69999987543 6899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCc-------------ccccccccccccccCCCCC
Q 003301          802 DFGIAKLLSGEE-------------SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       802 DFg~a~~~~~~~-------------~~~~~~~~gt~~y~APE~l  832 (832)
                      |||.+.......             ........+++.|+|||++
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  205 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELL  205 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhc
Confidence            999997654111             1111223478899999974

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.87  E-value=6.4e-22  Score=207.81  Aligned_cols=168  Identities=24%  Similarity=0.485  Sum_probs=136.2

Q ss_pred             CCCCCeeeccCCceEEEEEec----CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC------
Q 003301          661 FNASNLIGTGGFGSVYKGSFL----DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNND------  728 (832)
Q Consensus       661 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  728 (832)
                      |++.+.||+|+||.||+|.+.    .++.||||++....  ....+++.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            677889999999999999764    36889999987543  334567889999999999999999999886532      


Q ss_pred             eeEEEEecCCCCCHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecc
Q 003301          729 FKALVLEYMPNGSLEDYLYSN-----NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDF  803 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DF  803 (832)
                      ..++++||+++|+|.+++...     ...+++..+..++.|++.|++|+|   +.||+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            247899999999999887432     124788999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCccc-ccccccccccccCCCC
Q 003301          804 GIAKLLSGEESM-KQTLTLATIGYMAPGL  831 (832)
Q Consensus       804 g~a~~~~~~~~~-~~~~~~gt~~y~APE~  831 (832)
                      |.++........ ......+++.|+|||.
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~  186 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALES  186 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhH
Confidence            999876433211 1122345678999996

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=7.6e-22  Score=205.63  Aligned_cols=159  Identities=27%  Similarity=0.380  Sum_probs=132.5

Q ss_pred             CeeeccCCceEEEEEec-CCcEEEEEEEeccch---hhHHHHHHHHHHH-hcCCCCceeeeceEEecCCeeEEEEecCCC
Q 003301          665 NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE---GALKSFDVECEVL-KSVRHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      +.||+|+||.||+|... +++.||+|++.....   .....+..|..++ ...+|+|++++++++..++..|+||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999875 488999999865431   1223344555544 455899999999999999999999999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccccc
Q 003301          740 GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL  819 (832)
Q Consensus       740 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~  819 (832)
                      ++|.+++.... .+++..+..++.|++.|+.|+|   +.+++||||+|+||++++++.+||+|||.++....     ...
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~  152 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK  152 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence            99999997654 6889999999999999999999   99999999999999999999999999999876432     122


Q ss_pred             ccccccccCCCCC
Q 003301          820 TLATIGYMAPGLF  832 (832)
Q Consensus       820 ~~gt~~y~APE~l  832 (832)
                      ..|++.|+|||++
T Consensus       153 ~~~~~~y~~pe~~  165 (260)
T cd05611         153 FVGTPDYLAPETI  165 (260)
T ss_pred             CCCCcCccChhhh
Confidence            4588899999963

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.87  E-value=3.6e-22  Score=214.07  Aligned_cols=170  Identities=28%  Similarity=0.434  Sum_probs=140.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch--hhHHHHHHHHHHHhcCCCCceeeeceEEecC-------
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRNLVKIISSCTNN-------  727 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  727 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.....  .....+.+|+++++.++||||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999999876 488999998865432  2234667899999999999999999987543       


Q ss_pred             -CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccc
Q 003301          728 -DFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA  806 (832)
Q Consensus       728 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a  806 (832)
                       ...|+||||++ +++.+.+......+++..+..++.|+++|++|||   +.|++||||||+||++++++.+||+|||++
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence             34699999995 5788877765557999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCccc----------ccccccccccccCCCC
Q 003301          807 KLLSGEESM----------KQTLTLATIGYMAPGL  831 (832)
Q Consensus       807 ~~~~~~~~~----------~~~~~~gt~~y~APE~  831 (832)
                      +........          ..+...|++.|+|||+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  197 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPEL  197 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHH
Confidence            865432211          1122357889999996

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.87  E-value=7.1e-22  Score=210.02  Aligned_cols=169  Identities=27%  Similarity=0.334  Sum_probs=140.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      .++|++.+.||+|+||.||+|.+.+ ++.||||.++... ......+.+|++++.+. .||||+++++++.++...|++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            4678999999999999999999865 8999999987543 22345566777766666 5999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      ||+ ++++.++.......+++..+..++.|++.|++|||   + .||+||||+|+||+++.++.+||+|||.+.......
T Consensus        94 e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          94 ELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             ecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            999 45888877665557899999999999999999999   6 599999999999999999999999999997664332


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                      ..  ....++..|+|||++
T Consensus       170 ~~--~~~~~~~~y~aPE~~  186 (296)
T cd06618         170 AK--TRSAGCAAYMAPERI  186 (296)
T ss_pred             cc--cCCCCCccccCHhhc
Confidence            21  223578899999974

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.87  E-value=6.2e-22  Score=209.12  Aligned_cols=166  Identities=28%  Similarity=0.394  Sum_probs=141.0

Q ss_pred             CCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccch-hhHHHHHHHHHHHhcCC-CCceeeeceEEecCCeeEEEEecC
Q 003301          661 FNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLE-GALKSFDVECEVLKSVR-HRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       661 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      |++.+.||+|++|+||+|...+ ++.||+|++..... .......+|+..+++++ |||++++++++..++..|+||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            6788999999999999999864 78899998865432 12234457899999998 999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          738 PNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       738 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                       ++++.+++.... ..+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.++|+|||.+........  
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence             889999887654 46899999999999999999999   99999999999999999999999999999987644322  


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....++..|+|||++
T Consensus       155 ~~~~~~~~~~~aPE~~  170 (283)
T cd07830         155 YTDYVSTRWYRAPEIL  170 (283)
T ss_pred             cCCCCCcccccCceee
Confidence            1234588899999963

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.87  E-value=5.3e-22  Score=206.25  Aligned_cols=167  Identities=27%  Similarity=0.420  Sum_probs=144.1

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      +|++.+.||+|+||.||+|.+. +++.||+|.+....  ......+.+|++++++++|+||+++++++.+....|+||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            5888999999999999999775 57899999987542  33446778899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          737 MPNGSLEDYLYSN---NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       737 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      +++++|.+++.+.   +..+++..++.++.|++.|++|||   +.|++||||+|+||+++.++.+|++|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            9999999998762   235889999999999999999999   9999999999999999999999999999998765441


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                         .....+++.|+|||.+
T Consensus       158 ---~~~~~~~~~~~~Pe~~  173 (256)
T cd08530         158 ---AKTQIGTPHYMAPEVW  173 (256)
T ss_pred             ---cccccCCccccCHHHH
Confidence               1224588899999963

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.87  E-value=3.4e-22  Score=230.25  Aligned_cols=250  Identities=23%  Similarity=0.378  Sum_probs=174.8

Q ss_pred             ccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCcccccccccccccccccCCChhhhhcCCCceEEE
Q 003301           22 MLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLY  101 (832)
Q Consensus        22 ~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L~  101 (832)
                      +...|++++++++ .+|..+.  ++|++|+|++|.++ .+|..+.  .+| +.|++++|+++ .+|..+.   +.|+.|+
T Consensus       179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL-~~L~Ls~N~Lt-sLP~~l~---~~L~~L~  247 (754)
T PRK15370        179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNI-KTLYANSNQLT-SIPATLP---DTIQEME  247 (754)
T ss_pred             CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCC-CEEECCCCccc-cCChhhh---ccccEEE
Confidence            4567888888887 6776654  47888888888888 6776554  366 88888888888 7787654   4688888


Q ss_pred             ccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceeccccccccc
Q 003301          102 MSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVG  181 (832)
Q Consensus       102 l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~  181 (832)
                      |++|+++ .+|..+.  .+|+.|++++|+++ .+|..+.  .+|++|+|++|+++ .+|..+.  ++|+.|++++|+++.
T Consensus       248 Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~  318 (754)
T PRK15370        248 LSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTA  318 (754)
T ss_pred             CcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCcccc
Confidence            8888888 6676654  47888888888887 4676554  47888888888888 4565443  468888888888875


Q ss_pred             ccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccc
Q 003301          182 FVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTL  261 (832)
Q Consensus       182 ~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~  261 (832)
                       +|..+.  ++|++|++++|.++ .+|..+    .++|+.|++++|+++. +|..+  .++|++|++++|.++.+ |..+
T Consensus       319 -LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l----~~sL~~L~Ls~N~L~~-LP~~l--p~~L~~LdLs~N~Lt~L-P~~l  386 (754)
T PRK15370        319 -LPETLP--PGLKTLEAGENALT-SLPASL----PPELQVLDVSKNQITV-LPETL--PPTITTLDVSRNALTNL-PENL  386 (754)
T ss_pred             -CCcccc--ccceeccccCCccc-cCChhh----cCcccEEECCCCCCCc-CChhh--cCCcCEEECCCCcCCCC-CHhH
Confidence             444332  57888888888887 466544    2678888888888774 34443  35788888888887754 4333


Q ss_pred             cCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCC
Q 003301          262 GNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPIN  307 (832)
Q Consensus       262 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~  307 (832)
                      .  .+|+.|++++|+++.+|..  ++..+..++++..|++.+|+++
T Consensus       387 ~--~sL~~LdLs~N~L~~LP~s--l~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        387 P--AALQIMQASRNNLVRLPES--LPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             H--HHHHHHhhccCCcccCchh--HHHHhhcCCCccEEEeeCCCcc
Confidence            2  3577778888887766543  2333444566677777777664

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.87  E-value=1.2e-22  Score=234.08  Aligned_cols=244  Identities=23%  Similarity=0.424  Sum_probs=201.7

Q ss_pred             CccCCCCcceeccCccccCccccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCccccccccccccc
Q 003301            1 MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNN   80 (832)
Q Consensus         1 ~ldl~~n~~~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n   80 (832)
                      +|+|+++.++ .+|..+.  +.|+.|+|++|+++ .+|..+.  ++|++|++++|+++ .+|..+.  .+| +.|+|++|
T Consensus       182 ~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L-~~L~Ls~N  251 (754)
T PRK15370        182 ELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTI-QEMELSIN  251 (754)
T ss_pred             EEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccc-cEEECcCC
Confidence            4789999999 7888774  58999999999999 7887665  58999999999999 7887654  345 99999999


Q ss_pred             ccccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccC
Q 003301           81 SLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIP  160 (832)
Q Consensus        81 ~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p  160 (832)
                      +++ .+|..+.   .+|+.|++++|+|+ .+|..+.  .+|+.|++++|+++. +|..+.  ++|+.|++++|+++ .+|
T Consensus       252 ~L~-~LP~~l~---s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt-~LP  320 (754)
T PRK15370        252 RIT-ELPERLP---SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLT-ALP  320 (754)
T ss_pred             ccC-cCChhHh---CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccc-cCC
Confidence            999 8998875   57999999999999 6787764  589999999999984 666554  57999999999999 566


Q ss_pred             ccccCccccceecccccccccccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCC
Q 003301          161 YEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNA  240 (832)
Q Consensus       161 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l  240 (832)
                      ..+.  ++|+.|++++|.+++ +|..+.  ++|+.|++++|.++ .+|..+    .++|++|+|++|+++.+++. +  .
T Consensus       321 ~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~l----p~~L~~LdLs~N~Lt~LP~~-l--~  387 (754)
T PRK15370        321 ETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETL----PPTITTLDVSRNALTNLPEN-L--P  387 (754)
T ss_pred             cccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhh----cCCcCEEECCCCcCCCCCHh-H--H
Confidence            6553  689999999999986 566553  79999999999998 577654    36899999999999965443 3  2


Q ss_pred             CCccEEEcCCCcCcccCCcc----ccCccccceeecccccCCC
Q 003301          241 SKLSVLELGENSFSGFIPNT----LGNLRKLEWLRLSYNFLTS  279 (832)
Q Consensus       241 ~~L~~L~L~~N~i~~~~~~~----~~~l~~L~~L~L~~N~l~~  279 (832)
                      ..|+.|++++|+++. +|..    +..++++..|++.+|.++.
T Consensus       388 ~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls~  429 (754)
T PRK15370        388 AALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFSE  429 (754)
T ss_pred             HHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCccH
Confidence            479999999999985 4544    3445889999999999874

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.87  E-value=6.2e-22  Score=209.69  Aligned_cols=168  Identities=26%  Similarity=0.318  Sum_probs=137.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCC-CCceeeeceEEecCCeeEEEEe
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL-EGALKSFDVECEVLKSVR-HRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      ++|+..+.||+|+||.||++.+.. ++.||+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            356667889999999999998764 8999999987543 234467888999999996 9999999999999899999999


Q ss_pred             cCCCCCHHHHHh---h-CCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          736 YMPNGSLEDYLY---S-NNFSFDILQRLSVIIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       736 ~~~~g~L~~~l~---~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      |+. +++.++..   . ....+++..+..++.|++.|++|+|   + .+++||||||+||+++.++.+||+|||+|+...
T Consensus        84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            985 46555432   2 2346899999999999999999999   5 599999999999999999999999999997654


Q ss_pred             CCcccccccccccccccCCCCC
Q 003301          811 GEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       811 ~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ....  .....|++.|+|||++
T Consensus       160 ~~~~--~~~~~~~~~y~aPE~~  179 (288)
T cd06616         160 DSIA--KTRDAGCRPYMAPERI  179 (288)
T ss_pred             cCCc--cccccCccCccCHHHh
Confidence            3322  1223588999999974

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.87  E-value=7.1e-22  Score=208.64  Aligned_cols=167  Identities=29%  Similarity=0.427  Sum_probs=143.4

Q ss_pred             CCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch--hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          661 FNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       661 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      |++.+.||+|++|.||+|... +++.||+|.+.....  .....+.+|++++++++|++|+++++++..++..|+||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            677889999999999999875 588999999875432  24467888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccc
Q 003301          738 PNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ  817 (832)
Q Consensus       738 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~  817 (832)
                      + +++.+++......+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.+........ ..
T Consensus        81 ~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-~~  155 (283)
T cd05118          81 D-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PY  155 (283)
T ss_pred             C-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-cc
Confidence            6 5898888776557899999999999999999999   99999999999999999999999999999987654431 12


Q ss_pred             ccccccccccCCCCC
Q 003301          818 TLTLATIGYMAPGLF  832 (832)
Q Consensus       818 ~~~~gt~~y~APE~l  832 (832)
                      ....++..|+|||++
T Consensus       156 ~~~~~~~~~~~PE~~  170 (283)
T cd05118         156 THYVVTRWYRAPELL  170 (283)
T ss_pred             cCccCcccccCcHHH
Confidence            224588899999963

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.87  E-value=7.5e-22  Score=210.96  Aligned_cols=164  Identities=28%  Similarity=0.405  Sum_probs=140.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEecc---chhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQ---LEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      +.|+..+.||+|+||.||+|... +++.||+|.+...   .....+++.+|+++++.++|+|++++++++......|+||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34777789999999999999876 4788999988643   2233456788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||+. |++.+++......+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.+|++|||.+......  
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            9995 6888887655556899999999999999999999   999999999999999999999999999998765432  


Q ss_pred             cccccccccccccCCCC
Q 003301          815 MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~  831 (832)
                         ....|++.|+|||+
T Consensus       169 ---~~~~~~~~y~aPE~  182 (308)
T cd06634         169 ---NXFVGTPYWMAPEV  182 (308)
T ss_pred             ---ccccCCccccCHHH
Confidence               22458889999996

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.87  E-value=9.3e-23  Score=217.38  Aligned_cols=170  Identities=25%  Similarity=0.418  Sum_probs=144.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC--Cc--EEEEEEEeccchh-hHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD--GM--EVAIKVFHLQLEG-ALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      ++....+.||+|.||.|++|.|..  |+  .||||.++..... ..+.|.+|+.+|.+++|||++++||+..+ ....+|
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            344567889999999999999863  43  4899999866544 67899999999999999999999999987 677899


Q ss_pred             EecCCCCCHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          734 LEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||.++.|+|.+.+++ .+..+.......++.|||.|+.||.   .+++||||+..+|+++-....|||+|||+.+.+...
T Consensus       189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            999999999999987 4445778888899999999999999   999999999999999999999999999999988766


Q ss_pred             cccccc--cccccccccCCCCC
Q 003301          813 ESMKQT--LTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~--~~~gt~~y~APE~l  832 (832)
                      +.....  ...-...|.|||.+
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsL  287 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESL  287 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHh
Confidence            544321  12245679999964

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.87  E-value=8.6e-22  Score=212.13  Aligned_cols=170  Identities=27%  Similarity=0.382  Sum_probs=142.6

Q ss_pred             HHHHHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEec-CC
Q 003301          653 ELLQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTN-ND  728 (832)
Q Consensus       653 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~  728 (832)
                      ++....++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++++++.. ..
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            34456789999999999999999999876 58999999875432  2234677889999999999999999999865 55


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          729 FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      ..|++|||+ +++|.++++..  .+++..+..++.|++.|++|||   +.+++||||+|+||++++++.+||+|||.+..
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence            789999999 67999888653  4788888899999999999999   99999999999999999999999999999876


Q ss_pred             cCCCcccccccccccccccCCCCC
Q 003301          809 LSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       809 ~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .....    ....+++.|+|||++
T Consensus       158 ~~~~~----~~~~~~~~y~aPE~~  177 (328)
T cd07856         158 QDPQM----TGYVSTRYYRAPEIM  177 (328)
T ss_pred             cCCCc----CCCcccccccCceee
Confidence            43221    224578899999963

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.87  E-value=8.4e-22  Score=211.48  Aligned_cols=167  Identities=21%  Similarity=0.229  Sum_probs=136.3

Q ss_pred             CCCCeeeccCCceEEEEEecCCcEEEEEEEecc--chhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCC
Q 003301          662 NASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ--LEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       662 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      .+++.+|.|+++.||++.. +++.||+|++...  .....+.+.+|++++++++||||+++++++.+.+..|++|||+++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            3455556666666666554 6999999998754  234557899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc---
Q 003301          740 GSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM---  815 (832)
Q Consensus       740 g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~---  815 (832)
                      +++.+++... ...+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+|++|||.+.........   
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            9999999763 335889999999999999999999   999999999999999999999999999998765332211   


Q ss_pred             ---ccccccccccccCCCCC
Q 003301          816 ---KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ---~~~~~~gt~~y~APE~l  832 (832)
                         ......++..|+|||++
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~  180 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVL  180 (314)
T ss_pred             cccccccccccccccCHHHh
Confidence               11223577889999964

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.87  E-value=8.6e-22  Score=212.89  Aligned_cols=167  Identities=26%  Similarity=0.317  Sum_probs=136.7

Q ss_pred             CCCCCCeeeccCCceEEEEEecC---CcEEEEEEEeccc--hhhHHHHHHHHHHHhcC-CCCceeeeceEEec----CCe
Q 003301          660 QFNASNLIGTGGFGSVYKGSFLD---GMEVAIKVFHLQL--EGALKSFDVECEVLKSV-RHRNLVKIISSCTN----NDF  729 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~  729 (832)
                      +|++.+.||+|+||.||+|....   +..||+|++....  ....+.+.+|+++++++ +||||+++++++..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            47888999999999999998753   6789999886432  22345778899999999 59999999987543    245


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      .|+++||++ ++|.+++.... .+++..+..++.|++.||+|||   +.|++||||||+||+++.++.+||+|||.|+..
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            789999994 79999986543 6899999999999999999999   999999999999999999999999999999865


Q ss_pred             CCCccc---ccccccccccccCCCC
Q 003301          810 SGEESM---KQTLTLATIGYMAPGL  831 (832)
Q Consensus       810 ~~~~~~---~~~~~~gt~~y~APE~  831 (832)
                      ......   ......||+.|+|||+
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~  180 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEI  180 (332)
T ss_pred             ccccccccccccCcccCccccCcHH
Confidence            432211   1123468999999996

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.87  E-value=1.1e-21  Score=211.83  Aligned_cols=165  Identities=22%  Similarity=0.324  Sum_probs=134.8

Q ss_pred             Ceeecc--CCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCC
Q 003301          665 NLIGTG--GFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       665 ~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      +.||+|  +||+||+|++. +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..|+||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  99999999885 58999999987543  33456788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc--
Q 003301          740 GSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK--  816 (832)
Q Consensus       740 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~--  816 (832)
                      +++.+++.+.. ..+++..+..++.|++.||+|||   +.|++||||||+||+++.++.+|++||+.+..........  
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            99999987643 34889999999999999999999   9999999999999999999999999998654332211110  


Q ss_pred             ----cccccccccccCCCCC
Q 003301          817 ----QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ----~~~~~gt~~y~APE~l  832 (832)
                          .....++..|||||++
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~  180 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELL  180 (328)
T ss_pred             cccccccccCccCccChhhh
Confidence                1112356679999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.87  E-value=8.1e-22  Score=208.10  Aligned_cols=167  Identities=30%  Similarity=0.446  Sum_probs=143.5

Q ss_pred             CCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          661 FNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       661 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      |+..+.||+|++|.||+|+..+ ++.||+|++....  ....+.+..|++++++++|++++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            5677899999999999998865 8999999987653  333467788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccc
Q 003301          738 PNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ  817 (832)
Q Consensus       738 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~  817 (832)
                      + ++|.+++.+....+++..+..++.|++.|++|||   +.|++||||+|+||+++.++.+||+|||.++....... ..
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~  155 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY  155 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence            6 6999999876456999999999999999999999   99999999999999999999999999999987644322 12


Q ss_pred             ccccccccccCCCCC
Q 003301          818 TLTLATIGYMAPGLF  832 (832)
Q Consensus       818 ~~~~gt~~y~APE~l  832 (832)
                      ....++..|+|||++
T Consensus       156 ~~~~~~~~~~aPE~~  170 (282)
T cd07829         156 THEVVTLWYRAPEIL  170 (282)
T ss_pred             CccccCcCcCChHHh
Confidence            223467889999963

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.87  E-value=9.8e-22  Score=223.72  Aligned_cols=168  Identities=23%  Similarity=0.291  Sum_probs=121.3

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC-----CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceE------Ee
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD-----GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISS------CT  725 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~  725 (832)
                      ..++|++.+.||+|+||.||+|++.+     +..||+|++......  +....|  .+....+.+++.++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            45789999999999999999998854     688999987643221  111111  1111122222222221      23


Q ss_pred             cCCeeEEEEecCCCCCHHHHHhhCCCC-------------------CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 003301          726 NNDFKALVLEYMPNGSLEDYLYSNNFS-------------------FDILQRLSVIIDVALALEYLHFGYSNPVVHCDIK  786 (832)
Q Consensus       726 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk  786 (832)
                      .+...++||||+++++|.+++......                   .....+..++.|++.||+|+|   +++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            556789999999999999998754321                   112345679999999999999   9999999999


Q ss_pred             CCCeEeCC-CCcEEEeccccccccCCCcccccccccccccccCCCC
Q 003301          787 PSNVLLDK-DMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       787 p~NIl~~~-~~~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      |+|||++. ++.+||+|||+|+.............++|+.|||||+
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~  328 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQ  328 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHH
Confidence            99999986 5799999999998764443333344679999999995

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.86  E-value=1.3e-21  Score=212.24  Aligned_cols=164  Identities=26%  Similarity=0.384  Sum_probs=137.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC------
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNND------  728 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  728 (832)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|++....  ......+.+|+++++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999875 58999999986432  223356788999999999999999999987543      


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          729 FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      ..|+|+||+. .++.++..   ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||+++.
T Consensus        94 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            4689999995 57777653   25889999999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCcccccccccccccccCCCCC
Q 003301          809 LSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       809 ~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .....    ....+++.|+|||++
T Consensus       167 ~~~~~----~~~~~~~~y~aPE~~  186 (342)
T cd07879         167 ADAEM----TGYVVTRWYRAPEVI  186 (342)
T ss_pred             CCCCC----CCceeeecccChhhh
Confidence            53221    224578899999963

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.86  E-value=7.7e-22  Score=214.02  Aligned_cols=168  Identities=26%  Similarity=0.374  Sum_probs=139.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecC---------
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNN---------  727 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------  727 (832)
                      ..+|++.+.||.|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            368999999999999999999875 4889999998766555567788999999999999999999876543         


Q ss_pred             -----CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC-CCcEEEe
Q 003301          728 -----DFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK-DMVAHLS  801 (832)
Q Consensus       728 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~kl~  801 (832)
                           ...|+||||++ ++|.+++...  .+++..+..++.|++.|++|||   +.|++||||||+||+++. ++.+|++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence                 35789999996 6998888643  5889999999999999999999   999999999999999974 5678999


Q ss_pred             ccccccccCCCccc--ccccccccccccCCCC
Q 003301          802 DFGIAKLLSGEESM--KQTLTLATIGYMAPGL  831 (832)
Q Consensus       802 DFg~a~~~~~~~~~--~~~~~~gt~~y~APE~  831 (832)
                      |||.++........  ......|+..|+|||+
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  189 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRL  189 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHH
Confidence            99999765332111  1122357889999995

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.86  E-value=1.8e-21  Score=206.46  Aligned_cols=170  Identities=21%  Similarity=0.313  Sum_probs=125.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCC----cEEEEEEEeccchhh-----------HHHHHHHHHHHhcCCCCceeeece
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQLEGA-----------LKSFDVECEVLKSVRHRNLVKIIS  722 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~l~~  722 (832)
                      .++|++.++||+|+||+||+|.+.++    ..+|+|+........           ......+...+..+.|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            36899999999999999999987643    456666543222111           011223334556678999999999


Q ss_pred             EEecCC----eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcE
Q 003301          723 SCTNND----FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVA  798 (832)
Q Consensus       723 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~  798 (832)
                      ++....    ..++++|++ ..++.+.+.... ..++..+..++.|++.|++|+|   +.+|+||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeeEecCCceEEEEEEehh-ccCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcE
Confidence            776543    447888887 457777665432 4678888999999999999999   9999999999999999999999


Q ss_pred             EEeccccccccCCCcc------cccccccccccccCCCCC
Q 003301          799 HLSDFGIAKLLSGEES------MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       799 kl~DFg~a~~~~~~~~------~~~~~~~gt~~y~APE~l  832 (832)
                      ||+|||+|+.+.....      .......||+.|+|||++
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~  205 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAH  205 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHh
Confidence            9999999987643221      111224699999999963

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.86  E-value=2.6e-21  Score=200.26  Aligned_cols=161  Identities=34%  Similarity=0.461  Sum_probs=139.6

Q ss_pred             eeccCCceEEEEEecC-CcEEEEEEEeccch---hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCCCH
Q 003301          667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLE---GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSL  742 (832)
Q Consensus       667 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  742 (832)
                      ||+|+||.||+|.+.+ ++.||+|++.....   ...+.+..|++++++++||||+++++.+..++..|+||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6899999999998864 88999999875432   2446788899999999999999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccccccc
Q 003301          743 EDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA  822 (832)
Q Consensus       743 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~g  822 (832)
                      .+++.... .+++..+..++.|++.|+.|+|   +.+++|+||+|+||+++.++.++|+|||.+........ ......+
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~  155 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFCG  155 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCCcC
Confidence            99998664 5899999999999999999999   99999999999999999999999999999987644321 2233468


Q ss_pred             cccccCCCCC
Q 003301          823 TIGYMAPGLF  832 (832)
Q Consensus       823 t~~y~APE~l  832 (832)
                      +..|+|||++
T Consensus       156 ~~~~~~Pe~~  165 (250)
T cd05123         156 TPEYLAPEVL  165 (250)
T ss_pred             CccccChHHh
Confidence            8899999963

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.86  E-value=3e-21  Score=204.32  Aligned_cols=166  Identities=30%  Similarity=0.482  Sum_probs=137.4

Q ss_pred             CCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccch--hhHHHHHHHHHHHhcC---CCCceeeeceEEecCCe-----
Q 003301          661 FNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLE--GALKSFDVECEVLKSV---RHRNLVKIISSCTNNDF-----  729 (832)
Q Consensus       661 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~-----  729 (832)
                      |++.+.||+|+||.||+|.+.. ++.||+|+++....  .....+.+|+++++++   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            6778999999999999999875 89999999874432  2234566787777655   69999999999988776     


Q ss_pred             eEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      .+++|||+. +++.+++.... ..+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+||+|||.+..
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            899999996 58999887643 35899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCcccccccccccccccCCCCC
Q 003301          809 LSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       809 ~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .......  ....++..|+|||++
T Consensus       157 ~~~~~~~--~~~~~~~~~~~PE~~  178 (287)
T cd07838         157 YSFEMAL--TSVVVTLWYRAPEVL  178 (287)
T ss_pred             ccCCccc--ccccccccccChHHh
Confidence            6443221  223578899999964

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.85  E-value=9.4e-22  Score=213.45  Aligned_cols=166  Identities=25%  Similarity=0.377  Sum_probs=141.4

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCe---
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDF---  729 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---  729 (832)
                      ...++|++.+.||+|++|.||+|.+. +++.||+|++....  ....+.+.+|+.++++++|||++++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34678999999999999999999886 47899999886432  2234567789999999999999999998876554   


Q ss_pred             ---eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccc
Q 003301          730 ---KALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA  806 (832)
Q Consensus       730 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a  806 (832)
                         .|+|+||+ +++|.+++...  .+++..+..++.|++.|++|+|   +.||+||||||+||+++.++.+||+|||.+
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence               89999999 77999998753  5899999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCcccccccccccccccCCCC
Q 003301          807 KLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       807 ~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      ......    .....++..|+|||+
T Consensus       166 ~~~~~~----~~~~~~~~~y~aPE~  186 (343)
T cd07851         166 RHTDDE----MTGYVATRWYRAPEI  186 (343)
T ss_pred             cccccc----ccCCcccccccCHHH
Confidence            875432    223458889999995

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=2.3e-21  Score=189.29  Aligned_cols=141  Identities=18%  Similarity=0.179  Sum_probs=110.5

Q ss_pred             CCeeeccCCceEEEEEecCCcEEEEEEEeccchh--h------------------------HHHHHHHHHHHhcCCCCce
Q 003301          664 SNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEG--A------------------------LKSFDVECEVLKSVRHRNL  717 (832)
Q Consensus       664 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~ni  717 (832)
                      ...||+|+||.||+|...+|+.||||+++.....  .                        ......|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999878999999998754211  0                        1122359999999988877


Q ss_pred             eeeceEEecCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEecCCCCCCeEeCCCC
Q 003301          718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL-HFGYSNPVVHCDIKPSNVLLDKDM  796 (832)
Q Consensus       718 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dlkp~NIl~~~~~  796 (832)
                      .....+...  ..++||||++|+++....... ..++...+..++.|++.+++|+ |   +.||+||||||+||+++ ++
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence            544433222  238999999887776543222 3688999999999999999999 7   88999999999999998 47


Q ss_pred             cEEEeccccccccCC
Q 003301          797 VAHLSDFGIAKLLSG  811 (832)
Q Consensus       797 ~~kl~DFg~a~~~~~  811 (832)
                      .++++|||+|.....
T Consensus       155 ~v~LiDFG~a~~~~~  169 (190)
T cd05147         155 KLYIIDVSQSVEHDH  169 (190)
T ss_pred             cEEEEEccccccCCC
Confidence            899999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.85  E-value=5.1e-21  Score=196.21  Aligned_cols=150  Identities=19%  Similarity=0.108  Sum_probs=126.7

Q ss_pred             cCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCCCHHHHHhh
Q 003301          670 GGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYS  748 (832)
Q Consensus       670 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  748 (832)
                      |.+|.||+|.+. +++.||+|++....     ...+|...+....||||+++++++.+.+..|+||||+++|+|.+++.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999886 48899999987543     233455555566799999999999999999999999999999999876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccccccccccccC
Q 003301          749 NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA  828 (832)
Q Consensus       749 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~A  828 (832)
                      .. .+++..+..++.|++.|++|+|   ++|++||||||+||+++.++.++++|||.+.......    ....++..|+|
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~a  150 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCA  150 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccC
Confidence            54 5899999999999999999999   9999999999999999999999999999887654321    12346778999


Q ss_pred             CCCC
Q 003301          829 PGLF  832 (832)
Q Consensus       829 PE~l  832 (832)
                      ||++
T Consensus       151 PE~~  154 (237)
T cd05576         151 PEVG  154 (237)
T ss_pred             Cccc
Confidence            9964

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.85  E-value=2.5e-21  Score=201.70  Aligned_cols=167  Identities=25%  Similarity=0.372  Sum_probs=136.4

Q ss_pred             CCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc-----hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          660 QFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL-----EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      +|.+.+.||+|+||.||+|.+.. +..+++|+++...     ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            58889999999999999998754 4556666554311     12234567799999999999999999999998999999


Q ss_pred             EecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          734 LEYMPNGSLEDYLYS---NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      |||+++++|.+++..   ....+++..++.++.|++.|++|||   +.|++|+||+|+||+++. +.+|++|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998864   2346899999999999999999999   999999999999999975 579999999987764


Q ss_pred             CCcccccccccccccccCCCC
Q 003301          811 GEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       811 ~~~~~~~~~~~gt~~y~APE~  831 (832)
                      ..... .....|++.|+|||.
T Consensus       157 ~~~~~-~~~~~~~~~~~~pe~  176 (260)
T cd08222         157 GSCDL-ATTFTGTPYYMSPEA  176 (260)
T ss_pred             CCccc-ccCCCCCcCccCHHH
Confidence            33222 222458889999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.85  E-value=2.3e-21  Score=194.59  Aligned_cols=166  Identities=25%  Similarity=0.358  Sum_probs=140.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCC-C-Cc----eeeeceEEecCCee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVR-H-RN----LVKIISSCTNNDFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~n----iv~l~~~~~~~~~~  730 (832)
                      ..+|++...+|+|.||.|.++.+.. +..||+|+++.- ....+...-|+++++++. + |+    +|++.++|...++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            6899999999999999999998764 788999988743 344567778999999993 2 32    88899999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC---------------
Q 003301          731 ALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK---------------  794 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---------------  794 (832)
                      +||+|.+ |.++.++++.+. .+++..++..+++|++.+++|||   +.+++|-|+||+||++.+               
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999999 779999998754 46999999999999999999999   999999999999999932               


Q ss_pred             -----CCcEEEeccccccccCCCcccccccccccccccCCCCC
Q 003301          795 -----DMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       795 -----~~~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                           ...+|++|||.|+......    ...+.|..|+|||++
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEVi  281 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVI  281 (415)
T ss_pred             eccCCCcceEEEecCCcceeccCc----ceeeeccccCCchhe
Confidence                 2358999999998754333    335789999999986

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.85  E-value=9.9e-22  Score=214.91  Aligned_cols=163  Identities=31%  Similarity=0.498  Sum_probs=132.7

Q ss_pred             CCCCeeeccCCce-EEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEEEecCCC
Q 003301          662 NASNLIGTGGFGS-VYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       662 ~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      .-.+++|.|+-|+ ||+|.+ +|++||||++-..   ..+..++|+..++.- +|||||++++.-.++...||..|.| .
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~  586 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-A  586 (903)
T ss_pred             ccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-h
Confidence            3446788999874 699998 8999999987533   335678899999988 6999999999999999999999999 5


Q ss_pred             CCHHHHHhhCCCCC---CHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC---C--CcEEEeccccccccCC
Q 003301          740 GSLEDYLYSNNFSF---DILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK---D--MVAHLSDFGIAKLLSG  811 (832)
Q Consensus       740 g~L~~~l~~~~~~~---~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~--~~~kl~DFg~a~~~~~  811 (832)
                      .+|.++++......   .......+..|++.|++|||   +.+||||||||.||||+.   +  .+++|+|||+++.+..
T Consensus       587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~  663 (903)
T KOG1027|consen  587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG  663 (903)
T ss_pred             hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence            79999998742111   11345778999999999999   999999999999999965   3  4799999999999866


Q ss_pred             Ccccc--cccccccccccCCCCC
Q 003301          812 EESMK--QTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~--~~~~~gt~~y~APE~l  832 (832)
                      +...-  .....||-+|+|||++
T Consensus       664 ~~sS~~r~s~~sGt~GW~APE~L  686 (903)
T KOG1027|consen  664 GKSSFSRLSGGSGTSGWQAPEQL  686 (903)
T ss_pred             CcchhhcccCCCCcccccCHHHH
Confidence            54332  2335699999999975

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.84  E-value=4.5e-21  Score=220.56  Aligned_cols=176  Identities=27%  Similarity=0.466  Sum_probs=146.4

Q ss_pred             HHHHhcCCCCCCeeeccCCceEEEEEecC--------CcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceE
Q 003301          654 LLQATNQFNASNLIGTGGFGSVYKGSFLD--------GMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISS  723 (832)
Q Consensus       654 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~  723 (832)
                      ++...++.++.+.+|+|+||.|++|....        ...||||..+... ....+.+..|+++++.+ +|+||+.++|+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            33444556777899999999999996431        4569999987554 34567899999999999 59999999999


Q ss_pred             EecCCeeEEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 003301          724 CTNNDFKALVLEYMPNGSLEDYLYSNN---------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPS  788 (832)
Q Consensus       724 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~  788 (832)
                      +..++..++|+||++.|+|.++++..+               ..++..+...++.|||.|++||+   +.++||||+.++
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaR  447 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAAR  447 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhh
Confidence            999999999999999999999999876               33788899999999999999999   999999999999


Q ss_pred             CeEeCCCCcEEEeccccccccCCCcccccccccc--cccccCCCCC
Q 003301          789 NVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA--TIGYMAPGLF  832 (832)
Q Consensus       789 NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~g--t~~y~APE~l  832 (832)
                      |||+.++..+||+|||+|+.....+........|  +..|||||.+
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl  493 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESL  493 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHh
Confidence            9999999999999999999765544433222223  4459999964

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.84  E-value=3.2e-20  Score=188.60  Aligned_cols=169  Identities=31%  Similarity=0.466  Sum_probs=146.4

Q ss_pred             CCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchh-hHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCC
Q 003301          661 FNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEG-ALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMP  738 (832)
Q Consensus       661 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  738 (832)
                      |.+.+.||.|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.++.++|++++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5678899999999999999875 889999998866544 56788899999999999999999999999899999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccc
Q 003301          739 NGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT  818 (832)
Q Consensus       739 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~  818 (832)
                      +++|.+++......+++..+..++.+++.++.|+|   +.+++|+|++|+||+++.++.++|+|||.+............
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK  157 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence            99999999876533789999999999999999999   899999999999999999999999999999876544311222


Q ss_pred             cccccccccCCCCC
Q 003301          819 LTLATIGYMAPGLF  832 (832)
Q Consensus       819 ~~~gt~~y~APE~l  832 (832)
                      ...++..|+|||++
T Consensus       158 ~~~~~~~~~~pe~~  171 (225)
T smart00221      158 TVKGTPFYLAPEVL  171 (225)
T ss_pred             ceeccCCcCCHhHh
Confidence            34578899999963

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.84  E-value=1.6e-21  Score=181.53  Aligned_cols=164  Identities=22%  Similarity=0.436  Sum_probs=138.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCC-CCceeeeceEEecCC--eeEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVR-HRNLVKIISSCTNND--FKAL  732 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~l  732 (832)
                      ..++|++.+++|+|.|++||.|... +.++++||+++.-.   .+.+.+|+.++..+. ||||++++++..+..  ...+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            4678999999999999999999765 57889999987543   367889999999996 999999999987643  5679


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC-CcEEEeccccccccCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD-MVAHLSDFGIAKLLSG  811 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~kl~DFg~a~~~~~  811 (832)
                      |+||+.+.+......    .++...+..++.+++.||.|+|   +.||+|||+||.|+++|.. -.++++|+|+|..+.+
T Consensus       113 iFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             HhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            999998888776653    4677788899999999999999   9999999999999999865 5799999999998865


Q ss_pred             CcccccccccccccccCCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ...  ....+.+.+|--||++
T Consensus       186 ~~e--YnVRVASRyfKGPELL  204 (338)
T KOG0668|consen  186 GKE--YNVRVASRYFKGPELL  204 (338)
T ss_pred             Cce--eeeeeehhhcCCchhe
Confidence            543  3345688889999975

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.84  E-value=2.8e-20  Score=182.69  Aligned_cols=141  Identities=20%  Similarity=0.204  Sum_probs=112.7

Q ss_pred             CCeeeccCCceEEEEEecCCcEEEEEEEeccchh--------------------------hHHHHHHHHHHHhcCCCCce
Q 003301          664 SNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEG--------------------------ALKSFDVECEVLKSVRHRNL  717 (832)
Q Consensus       664 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~ni  717 (832)
                      ...||+|++|.||+|...+|+.||||+++.....                          ......+|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5789999999999999878999999998754210                          01234578999999999987


Q ss_pred             eeeceEEecCCeeEEEEecCCCCCHHHH-HhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeEeCCC
Q 003301          718 VKIISSCTNNDFKALVLEYMPNGSLEDY-LYSNNFSFDILQRLSVIIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDKD  795 (832)
Q Consensus       718 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~  795 (832)
                      .....+....  .|+||||++|+++... +..  ..++...+..++.|++.++.++|   . .||+||||||+||+++ +
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence            5554443332  4899999988755433 432  35778899999999999999999   8 9999999999999998 8


Q ss_pred             CcEEEeccccccccCCC
Q 003301          796 MVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       796 ~~~kl~DFg~a~~~~~~  812 (832)
                      +.++|+|||+|+....+
T Consensus       154 ~~~~liDFG~a~~~~~~  170 (190)
T cd05145         154 GKPYIIDVSQAVELDHP  170 (190)
T ss_pred             CCEEEEEcccceecCCC
Confidence            99999999999877543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.83  E-value=5.1e-21  Score=187.56  Aligned_cols=165  Identities=25%  Similarity=0.356  Sum_probs=138.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-cCCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC------
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSF-LDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNND------  728 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  728 (832)
                      ..+|.-.+.+|.|+. .|..|-+ ..+++||+|++....  ....++..+|..++..+.|+||++++.++....      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            356777888999998 6666654 358999999876443  334577889999999999999999999997643      


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          729 FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      ..|+||||| ..+|.+.+..   .++-.....+.+|++.|++|+|   +.||+|||+||+||++..++.+||.|||+|+.
T Consensus        95 e~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcc
Confidence            579999999 6799998873   4677888999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCcccccccccccccccCCCCC
Q 003301          809 LSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       809 ~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      -...  ...+.++.|..|.|||++
T Consensus       168 e~~~--~~mtpyVvtRyyrapevi  189 (369)
T KOG0665|consen  168 EDTD--FMMTPYVVTRYYRAPEVI  189 (369)
T ss_pred             cCcc--cccCchhheeeccCchhe
Confidence            5333  456778899999999985

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.81  E-value=3e-19  Score=179.27  Aligned_cols=162  Identities=37%  Similarity=0.604  Sum_probs=140.1

Q ss_pred             eeccCCceEEEEEecC-CcEEEEEEEeccchh-hHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCCCHHH
Q 003301          667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEG-ALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLED  744 (832)
Q Consensus       667 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~  744 (832)
                      ||+|++|.||++...+ ++++++|++...... ..+.+.+|++.++.++|++++++++++......+++|||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999865 899999998765432 34678999999999999999999999999999999999999899999


Q ss_pred             HHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC-CCcEEEeccccccccCCCccccccccccc
Q 003301          745 YLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK-DMVAHLSDFGIAKLLSGEESMKQTLTLAT  823 (832)
Q Consensus       745 ~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~kl~DFg~a~~~~~~~~~~~~~~~gt  823 (832)
                      ++......+++..+..++.+++.+++|+|   +.|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~  156 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT  156 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence            99876446899999999999999999999   999999999999999999 89999999999987644321 12224578


Q ss_pred             ccccCCCCC
Q 003301          824 IGYMAPGLF  832 (832)
Q Consensus       824 ~~y~APE~l  832 (832)
                      ..|++||.+
T Consensus       157 ~~~~~pe~~  165 (215)
T cd00180         157 PAYMAPEVL  165 (215)
T ss_pred             CCccChhHh
Confidence            889999963

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=8e-20  Score=171.69  Aligned_cols=166  Identities=27%  Similarity=0.377  Sum_probs=137.8

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCC-CceeeeceEEecCCeeEEEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRH-RNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  734 (832)
                      ....|.+.++||.|+||.+|.|... .|.+||||+-.....  ...+..|..++..+++ ..|+.+..+..+..+-.+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            3578999999999999999999875 599999998654432  2567779999999975 67888888888888999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC---CCcEEEeccccccccCC
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK---DMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~DFg~a~~~~~  811 (832)
                      |.. |.+|++...-....++..+++-.+-|++.-++|+|   .+++|||||||+|+|..-   ...+.++|||+|+.+.+
T Consensus        91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            999 89999998877668999999999999999999999   999999999999999953   35799999999998754


Q ss_pred             Cccc------ccccccccccccC
Q 003301          812 EESM------KQTLTLATIGYMA  828 (832)
Q Consensus       812 ~~~~------~~~~~~gt~~y~A  828 (832)
                      ..+.      ....-.||.+|.+
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYAS  189 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYAS  189 (341)
T ss_pred             ccccccCccccCCccceeeeehh
Confidence            3321      1122458888875

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.81  E-value=2.8e-20  Score=177.75  Aligned_cols=165  Identities=21%  Similarity=0.347  Sum_probs=133.6

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcC-CCCceeeece-EEecCCeeEEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLVKIIS-SCTNNDFKALV  733 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~-~~~~~~~~~lv  733 (832)
                      ..+.|++.+.+|+|.||.+-.|.++. ...+|+|.+.... ...++|.+|...--.+ .|.||+.-|+ .|++.+.++++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            45789999999999999999999975 6789999887553 3347788888765555 4899998776 46778888899


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe-C-CCCcEEEeccccccccCC
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL-D-KDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~-~-~~~~~kl~DFg~a~~~~~  811 (832)
                      +||++.|+|.+-+...+  +.+....+++.|+++|++|||   ++.+||||||.+|||| + +..++|+||||..+..+.
T Consensus       101 qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             eccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            99999999999887654  788889999999999999999   9999999999999999 3 345899999999886532


Q ss_pred             CcccccccccccccccCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~  831 (832)
                      ...    ..--+..|-|||+
T Consensus       176 tV~----~~~~~~~y~~pe~  191 (378)
T KOG1345|consen  176 TVK----YLEYVNNYHAPEL  191 (378)
T ss_pred             eeh----hhhhhcccCCcHH
Confidence            211    1224566888885

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.81  E-value=3.1e-20  Score=199.05  Aligned_cols=163  Identities=26%  Similarity=0.328  Sum_probs=136.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ..+.|++...+|.|+|+.|-.+.+. +++..++|++..+.    ....+|+.++... +||||+++.+.+.+..+.|+||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            3577888888999999999999775 48889999987662    2344577666555 7999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe-CCCCcEEEeccccccccCCCc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL-DKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~-~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |++.|+-+.+.+...+ .+. ..+..|+++|+.|+.|||   .+|+||||+||+|||+ +..+.++|+|||.++..... 
T Consensus       396 e~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             hhccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            9999998888877654 233 777889999999999999   9999999999999999 58999999999999876544 


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                         ....+-|..|.|||++
T Consensus       470 ---~~tp~~t~~y~APEvl  485 (612)
T KOG0603|consen  470 ---CDTPALTLQYVAPEVL  485 (612)
T ss_pred             ---hcccchhhcccChhhh
Confidence               1224578899999984

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=1.2e-19  Score=178.35  Aligned_cols=164  Identities=24%  Similarity=0.385  Sum_probs=139.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCC-CCceeeeceEEecCCeeEEEEec
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVR-HRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      -.|.++++||+|+||+++.|+.. +++.||||.-....+  ..++..|.+.++.+. .++|+..+-+..++-+-.+|||.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            36899999999999999999754 699999997654433  357788999999884 69999999888888888999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC-----CcEEEeccccccccCC
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD-----MVAHLSDFGIAKLLSG  811 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-----~~~kl~DFg~a~~~~~  811 (832)
                      . |.+|+|+..-++.+++...+..+|.|++.-++|+|   ++..|.|||||+|+||...     ..+.|+|||+|+.+.+
T Consensus       106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            9 89999999888888999999999999999999999   9999999999999999643     4699999999998876


Q ss_pred             Cccccc------ccccccccccC
Q 003301          812 EESMKQ------TLTLATIGYMA  828 (832)
Q Consensus       812 ~~~~~~------~~~~gt~~y~A  828 (832)
                      +.+...      ....||.+||+
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMS  204 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMS  204 (449)
T ss_pred             ccccccCccccccccccceeeeE
Confidence            654322      12359999996

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.80  E-value=3.6e-19  Score=183.04  Aligned_cols=155  Identities=35%  Similarity=0.467  Sum_probs=136.1

Q ss_pred             CCceEEEEEecC-CcEEEEEEEeccchhh-HHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCCCHHHHHhh
Q 003301          671 GFGSVYKGSFLD-GMEVAIKVFHLQLEGA-LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYS  748 (832)
Q Consensus       671 ~~g~V~~~~~~~-~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  748 (832)
                      +||.||+|.+.+ ++.||+|++....... .+.+.+|++.+++++|++++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999875 8999999987655433 67899999999999999999999999999999999999999999999976


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccccccccccccC
Q 003301          749 NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA  828 (832)
Q Consensus       749 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~A  828 (832)
                      .. .+++..+..++.+++.+++|||   +.+++|+||+|+||+++.++.++++|||.+.......  ......++..|+|
T Consensus        81 ~~-~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~  154 (244)
T smart00220       81 RG-RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA  154 (244)
T ss_pred             cc-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence            54 3889999999999999999999   9999999999999999999999999999998765432  2223458889999


Q ss_pred             CCC
Q 003301          829 PGL  831 (832)
Q Consensus       829 PE~  831 (832)
                      ||.
T Consensus       155 pE~  157 (244)
T smart00220      155 PEV  157 (244)
T ss_pred             HHH
Confidence            995

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.79  E-value=1.4e-19  Score=184.57  Aligned_cols=144  Identities=32%  Similarity=0.432  Sum_probs=127.1

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEecC----CcEEEEEEEeccchhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCe
Q 003301          655 LQATNQFNASNLIGTGGFGSVYKGSFLD----GMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDF  729 (832)
Q Consensus       655 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  729 (832)
                      ....+.|...++||+|.|++||+|.+..    .+.||+|.+.....  ..++..|++++..+ .+.||+++.+++..++.
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            3456789999999999999999997643    67899998875543  36788999999999 59999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC-CCcEEEecccccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK-DMVAHLSDFGIAK  807 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~kl~DFg~a~  807 (832)
                      ..+|+||++..+..++...    ++...+..+++.+..||+++|   ..|||||||||+|++.+. .+.-.|+|||+|.
T Consensus       110 v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             eEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence            9999999999999888864    668889999999999999999   999999999999999975 4788999999997

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=6.8e-19  Score=173.04  Aligned_cols=138  Identities=16%  Similarity=0.336  Sum_probs=108.5

Q ss_pred             CCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcC-----CCCceeeeceEEecCC---eeE-E
Q 003301          662 NASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV-----RHRNLVKIISSCTNND---FKA-L  732 (832)
Q Consensus       662 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~~-l  732 (832)
                      .-.+.||+|+||.||.  +.+....+||++........+.+.+|+.+++.+     .||||++++|++.++.   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            4467899999999996  444333479988765444557889999999999     5799999999998863   434 7


Q ss_pred             EEec--CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeEecCCCCCCeEeCC----CCcEEEec-cc
Q 003301          733 VLEY--MPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL-EYLHFGYSNPVVHCDIKPSNVLLDK----DMVAHLSD-FG  804 (832)
Q Consensus       733 v~e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~Dlkp~NIl~~~----~~~~kl~D-Fg  804 (832)
                      |+||  +++++|.+++++.  .+++.  ..++.|++.++ +|||   +.+|+||||||+||+++.    ++.++|+| ||
T Consensus        83 I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            8999  5579999999764  35555  35678888777 9999   999999999999999974    34899999 55


Q ss_pred             cccc
Q 003301          805 IAKL  808 (832)
Q Consensus       805 ~a~~  808 (832)
                      .+..
T Consensus       156 ~~~~  159 (210)
T PRK10345        156 ESTF  159 (210)
T ss_pred             Ccce
Confidence            4443

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.79  E-value=2.4e-21  Score=172.40  Aligned_cols=157  Identities=31%  Similarity=0.522  Sum_probs=81.5

Q ss_pred             ccCccccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCcccccccccccccccccCCChhhhhcCCC
Q 003301           17 IGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPL   96 (832)
Q Consensus        17 ~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~   96 (832)
                      +.++.....|-||+|+++ .+|..+..+.+|+.|++++|+++ .+|.++..++.| +.|+++-|.+. .+|..+. .+|.
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~kl-r~lnvgmnrl~-~lprgfg-s~p~  103 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKL-RILNVGMNRLN-ILPRGFG-SFPA  103 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhh-hheecchhhhh-cCccccC-CCch
Confidence            334444455555555554 44444555555555555555555 455555555555 55555555554 4454443 4555


Q ss_pred             ceEEEccCCccc-ccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceeccc
Q 003301           97 IKGLYMSNNKLT-GPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQ  175 (832)
Q Consensus        97 L~~L~l~~N~l~-~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~  175 (832)
                      |+.|||+.|++. ..+|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+.+|.+- ..|..++.++.|++|.+.
T Consensus       104 levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiq  181 (264)
T KOG0617|consen  104 LEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQ  181 (264)
T ss_pred             hhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcc
Confidence            555555555544 244555555555555555555554 45555555555555555555554 455555555555555555


Q ss_pred             ccccc
Q 003301          176 LNKLV  180 (832)
Q Consensus       176 ~N~l~  180 (832)
                      +|+++
T Consensus       182 gnrl~  186 (264)
T KOG0617|consen  182 GNRLT  186 (264)
T ss_pred             cceee
Confidence            55555

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.79  E-value=3.7e-21  Score=206.96  Aligned_cols=209  Identities=25%  Similarity=0.311  Sum_probs=111.1

Q ss_pred             ccCcCcccEEEeecCcccccccccccCCCC---CceEEccCCccCC----CCchhhcCC-CCCcEEEecCCcCCCC----
Q 003301          339 IGNLINLRELGLWGNELIGSIPITFGKLQN---LQGLDLVNNKLEG----PIPNGLCQL-ARLSVLYMDGNKLSGP----  406 (832)
Q Consensus       339 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~Ls~N~l~~----~~~~~~~~l-~~L~~L~L~~N~l~~~----  406 (832)
                      +..+++|+.|++++|.+.+..+..+..+.+   |++|++++|++++    .+...+..+ ++|+.|++++|.+++.    
T Consensus        77 l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~  156 (319)
T cd00116          77 LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEA  156 (319)
T ss_pred             HHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHH
Confidence            333444444444444443333333333222   4455555444442    111223333 4455555555555421    


Q ss_pred             CcccCCCCCCCCeEeCCCCcCCCC----CCcccccCcccceeeecCCcccCC----CccccccccccceecccCcccCCc
Q 003301          407 IPPCIGDLTSLRLLSLASNELNSV----IPSTFWNLKDILSLNFSSNFLNGS----LPEDIGNLKVVVIIDLSRNNLSGD  478 (832)
Q Consensus       407 ~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~  478 (832)
                      ++..+..+++|+.|++++|.+++.    .+..+...++|+.|++++|.+++.    ++..+..+++|++|++++|.+++.
T Consensus       157 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~  236 (319)
T cd00116         157 LAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDA  236 (319)
T ss_pred             HHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchH
Confidence            222344445555555555555431    112233334555666666655432    223445566777777777777653


Q ss_pred             cCCcccc-----ccccceeecccccccc----cCCccccCCCCCCeeccCCCccccc----Cchhhhhh-ccCCeeeCCC
Q 003301          479 IPTAIGG-----LMNLQDLSLRDNGLQG----SIPKSIGGLVSLESLDLSNNSLSGN----IPTSMEKL-LYLKDLNLSF  544 (832)
Q Consensus       479 ~~~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~l~l~~  544 (832)
                      ....+..     .+.|+.|++++|.+++    .+...+..+++|+.+|+++|.++..    ....+... +.|+++++.+
T Consensus       237 ~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (319)
T cd00116         237 GAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKD  316 (319)
T ss_pred             HHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCC
Confidence            3333222     3678888888888862    2344556668889999999998855    33344444 6788888888


Q ss_pred             Ccc
Q 003301          545 NKL  547 (832)
Q Consensus       545 N~l  547 (832)
                      |+|
T Consensus       317 ~~~  319 (319)
T cd00116         317 DSF  319 (319)
T ss_pred             CCC
Confidence            875

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.78  E-value=2.2e-19  Score=185.95  Aligned_cols=169  Identities=27%  Similarity=0.346  Sum_probs=142.9

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCC------CCceeeeceEEecCC
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVR------HRNLVKIISSCTNND  728 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~~  728 (832)
                      ....+|.+....|+|-|++|.+|.+.. |..||||+++..... .+.=.+|++++++++      .-|+++++..|...+
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            346789999999999999999998764 889999999865322 345567999999995      358999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC-CcEEEecccc
Q 003301          729 FKALVLEYMPNGSLEDYLYSNNF--SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD-MVAHLSDFGI  805 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~kl~DFg~  805 (832)
                      ++|+|+|-. ..+|.+++++.+.  .+....+..++.|+..||..|-   ..||+|.||||.||||++. ..+||||||.
T Consensus       508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCcc
Confidence            999999998 6799999987543  4778899999999999999999   9999999999999999865 5789999999


Q ss_pred             ccccCCCcccccccccccccccCCCCC
Q 003301          806 AKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       806 a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      |......+.   +.+..+..|.|||++
T Consensus       584 A~~~~enei---tPYLVSRFYRaPEIi  607 (752)
T KOG0670|consen  584 ASFASENEI---TPYLVSRFYRAPEII  607 (752)
T ss_pred             ccccccccc---cHHHHHHhccCccee
Confidence            988755543   335567789999985

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.78  E-value=8.6e-21  Score=168.85  Aligned_cols=178  Identities=33%  Similarity=0.539  Sum_probs=100.5

Q ss_pred             CCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceee
Q 003301          366 LQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLN  445 (832)
Q Consensus       366 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  445 (832)
                      ++.++.|.||+|+++ .+|..++.+.+|+.|++++|+|. .+|..++.+++|+.|+++-|++. +.|..|+.++.|+.||
T Consensus        32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld  108 (264)
T KOG0617|consen   32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD  108 (264)
T ss_pred             hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence            344445555555555 44445555555555555555555 44555555555555555555543 2344444444444444


Q ss_pred             ecCCccc-CCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCccc
Q 003301          446 FSSNFLN-GSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLS  524 (832)
Q Consensus       446 Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  524 (832)
                      |+.|++. ..+|..|..+..|+.|+|+.|.+. .+|..++++++|+.|.+.+|.+- ..|..++.++.|+.|.+.+|+++
T Consensus       109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~  186 (264)
T KOG0617|consen  109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT  186 (264)
T ss_pred             ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence            4444443 245666666666666777777765 66667777777777777777766 56777777777777777777776


Q ss_pred             ccCchhhhhhcc---CCeeeCCCCcccc
Q 003301          525 GNIPTSMEKLLY---LKDLNLSFNKLEG  549 (832)
Q Consensus       525 ~~~p~~~~~l~~---L~~l~l~~N~l~~  549 (832)
                       .+|++++.+.-   =+++.+.+|+|..
T Consensus       187 -vlppel~~l~l~~~k~v~r~E~NPwv~  213 (264)
T KOG0617|consen  187 -VLPPELANLDLVGNKQVMRMEENPWVN  213 (264)
T ss_pred             -ecChhhhhhhhhhhHHHHhhhhCCCCC
Confidence             45555554321   1333444455543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.77  E-value=9.8e-19  Score=171.88  Aligned_cols=139  Identities=16%  Similarity=0.141  Sum_probs=115.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhH---H------HHHHHHHHHhcCCCCceeeeceEEecC-
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL---K------SFDVECEVLKSVRHRNLVKIISSCTNN-  727 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---~------~~~~e~~~l~~l~h~niv~l~~~~~~~-  727 (832)
                      .++|.+.+.+|.|+||.||.+.. ++..+|+|+++.......   .      .+.+|+..+.++.||+|+.+.+++... 
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            68999999999999999999766 677899999975543222   2      267899999999999999998886533 


Q ss_pred             -------CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEE
Q 003301          728 -------DFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHL  800 (832)
Q Consensus       728 -------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl  800 (832)
                             +..++||||++|.+|.++..     .++    ....+++.++..+|   ..|++|||+||+||+++++| +++
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~l  175 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LRI  175 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EEE
Confidence                   35789999999999988732     232    24569999999999   99999999999999999998 999


Q ss_pred             eccccccccC
Q 003301          801 SDFGIAKLLS  810 (832)
Q Consensus       801 ~DFg~a~~~~  810 (832)
                      +|||..+...
T Consensus       176 iDfg~~~~~~  185 (232)
T PRK10359        176 IDLSGKRCTA  185 (232)
T ss_pred             EECCCccccc
Confidence            9999987653

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.77  E-value=1.4e-20  Score=202.53  Aligned_cols=266  Identities=25%  Similarity=0.303  Sum_probs=120.1

Q ss_pred             CCCCccEEEcCCCcCccc----CCccccCccccceeecccccCCCCCCcc-ccccccccCCCCcEEeccCCCCCCCCCCc
Q 003301          239 NASKLSVLELGENSFSGF----IPNTLGNLRKLEWLRLSYNFLTSSTSEL-SFLSSWANCKNLKLLDLSNNPINGVLPSS  313 (832)
Q Consensus       239 ~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  313 (832)
                      .++.|++|+++++.++..    ++..+...++|++|+++++.+...+..+ .++..+..+++|+.|++++|.+.+..+..
T Consensus        21 ~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~  100 (319)
T cd00116          21 KLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGV  100 (319)
T ss_pred             HHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHH
Confidence            334455555555544321    2223334444555555555444211110 12234455666666666666665433333


Q ss_pred             cccccc--ccceEEeecCcccc----cccccccCc-CcccEEEeecCcccc----cccccccCCCCCceEEccCCccCCC
Q 003301          314 IGNLSL--SLSRIFISNCSIRG----TIPKEIGNL-INLRELGLWGNELIG----SIPITFGKLQNLQGLDLVNNKLEGP  382 (832)
Q Consensus       314 ~~~~~~--~L~~L~l~~n~l~~----~~~~~~~~l-~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~  382 (832)
                      +..+..  +|++|++++|++++    .+...+..+ ++|++|++++|.+++    ..+..+..+++|++|++++|.+++.
T Consensus       101 ~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~  180 (319)
T cd00116         101 LESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDA  180 (319)
T ss_pred             HHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchH
Confidence            333221  14455555544441    112233334 555555555555542    1222344445555555555555421


Q ss_pred             ----CchhhcCCCCCcEEEecCCcCCCC----CcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCC
Q 003301          383 ----IPNGLCQLARLSVLYMDGNKLSGP----IPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGS  454 (832)
Q Consensus       383 ----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  454 (832)
                          ++..+..+++|++|++++|.+++.    ++..+..+++|++|++++|.+++.....+...                
T Consensus       181 ~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~----------------  244 (319)
T cd00116         181 GIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASA----------------  244 (319)
T ss_pred             HHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHH----------------
Confidence                122233334555555555554422    12223344445555554444443211111100                


Q ss_pred             CccccccccccceecccCcccCC----ccCCccccccccceeeccccccccc----CCccccCC-CCCCeeccCCCcc
Q 003301          455 LPEDIGNLKVVVIIDLSRNNLSG----DIPTAIGGLMNLQDLSLRDNGLQGS----IPKSIGGL-VSLESLDLSNNSL  523 (832)
Q Consensus       455 ~~~~~~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~Ls~N~l  523 (832)
                         .....+.|+.|++++|.+++    .+...+..+++|+++++++|.++..    ....+... +.|+.|++.+|++
T Consensus       245 ---~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         245 ---LLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             ---HhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence               00012456666666666642    2233444456677777777777643    23333333 5677777777653

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=3.7e-18  Score=163.70  Aligned_cols=134  Identities=16%  Similarity=0.109  Sum_probs=107.5

Q ss_pred             CCCCeeeccCCceEEEEEecCCcEEEEEEEeccchh----hHHHHHHHHHHHhcCC-CCceeeeceEEecCCeeEEEEec
Q 003301          662 NASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEG----ALKSFDVECEVLKSVR-HRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       662 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .+...|++|+||+||.+.. .+.+++.+.+......    ....+.+|+++++++. |+++++++++    +..|++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4567899999999998776 7888887766544321    1235789999999995 5889999886    346999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC-CCCCeEeCCCCcEEEeccccccccCC
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI-KPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-kp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      ++|.+|.+....        ....++.|++.+++++|   +.||+|||| ||+||+++.++.++|+|||+|.....
T Consensus        80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~  144 (218)
T PRK12274         80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP  144 (218)
T ss_pred             ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence            999998754321        11357889999999999   999999999 79999999999999999999986543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.76  E-value=3.1e-18  Score=183.13  Aligned_cols=167  Identities=30%  Similarity=0.417  Sum_probs=135.1

Q ss_pred             CCCCCCeeeccCCceEEEEEecCC--cEEEEEEEeccchhhHHHHHHHHHHHhcCCC----CceeeeceEE-ecCCeeEE
Q 003301          660 QFNASNLIGTGGFGSVYKGSFLDG--MEVAIKVFHLQLEGALKSFDVECEVLKSVRH----RNLVKIISSC-TNNDFKAL  732 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~l  732 (832)
                      +|.+.+.||+|+||.||.|.....  ..+|+|............+..|+.++..+..    +++.++++.+ ..+...|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            899999999999999999998653  4788888765433322367788999888863    6899999999 57788999


Q ss_pred             EEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC-----CcEEEeccccc
Q 003301          733 VLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD-----MVAHLSDFGIA  806 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-----~~~kl~DFg~a  806 (832)
                      ||+.+ |.+|.++.+... ..++..++.+++.|++.+|+++|   +.|++||||||+|+.+...     ..+.+.|||+|
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999 899999886554 57999999999999999999999   9999999999999999754     46999999999


Q ss_pred             c--ccCCCcc----cc---cccccccccccCCC
Q 003301          807 K--LLSGEES----MK---QTLTLATIGYMAPG  830 (832)
Q Consensus       807 ~--~~~~~~~----~~---~~~~~gt~~y~APE  830 (832)
                      +  .+.....    ..   .....||..|+++.
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~  207 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASIN  207 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHH
Confidence            8  4322211    01   12345999999875

>smart00090 RIO RIO-like kinase

Probab=99.76  E-value=4.3e-18  Score=172.05  Aligned_cols=147  Identities=18%  Similarity=0.147  Sum_probs=114.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEE--ecCCcEEEEEEEeccchh------------------------hHHHHHHHHHHHhc
Q 003301          658 TNQFNASNLIGTGGFGSVYKGS--FLDGMEVAIKVFHLQLEG------------------------ALKSFDVECEVLKS  711 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~  711 (832)
                      ...|++.+.||+|+||.||+|.  ..+|+.||+|+++.....                        ....+.+|++.+++
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3458899999999999999998  457999999998743210                        11235689999999


Q ss_pred             CCCC--ceeeeceEEecCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEecCCCCC
Q 003301          712 VRHR--NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP-VVHCDIKPS  788 (832)
Q Consensus       712 l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dlkp~  788 (832)
                      +.+.  .+++++++    ...|+||||++|+++..+.... .......+..++.|++.+++++|   ..| ++||||||+
T Consensus       107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~  178 (237)
T smart00090      107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEY  178 (237)
T ss_pred             HHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChh
Confidence            9753  34444443    2348999999988887654332 24566667889999999999999   999 999999999


Q ss_pred             CeEeCCCCcEEEeccccccccCCCc
Q 003301          789 NVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       789 NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      ||+++ ++.++++|||.|.....+.
T Consensus       179 NIli~-~~~i~LiDFg~a~~~~~~~  202 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVELDHPM  202 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhccCCcc
Confidence            99999 8899999999998765443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=3.3e-17  Score=164.65  Aligned_cols=135  Identities=24%  Similarity=0.339  Sum_probs=115.0

Q ss_pred             CeeeccCCceEEEEEecCCcEEEEEEEeccch--------hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLE--------GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      +.||+|++|.||+|.+ .|..|++|+......        .....+.+|++++..+.|++++....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999988 778899998653321        1224677899999999999988877777777788999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      ++|++|.+++....    . .+..++.+++.++.++|   ..|++|||++|+||+++ ++.++++|||.+...
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            99999999986532    2 77889999999999999   99999999999999999 789999999998764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.72  E-value=3.5e-17  Score=162.20  Aligned_cols=140  Identities=21%  Similarity=0.185  Sum_probs=110.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchh----------------------hHHHHHHHHHHHhcCCCC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEG----------------------ALKSFDVECEVLKSVRHR  715 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~  715 (832)
                      ...|.+.+.||+|+||.||+|...+|+.||||+++.....                      ......+|+.++..+.|+
T Consensus        14 ~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   93 (198)
T cd05144          14 GVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE   93 (198)
T ss_pred             CchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence            3348888999999999999999878999999987643210                      112356788888888777


Q ss_pred             c--eeeeceEEecCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeC
Q 003301          716 N--LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD  793 (832)
Q Consensus       716 n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~  793 (832)
                      +  +++.++.    +..++||||++|+++.+....       .....++.+++.++.++|   ..|++||||||+||+++
T Consensus        94 ~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~  159 (198)
T cd05144          94 GFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVD  159 (198)
T ss_pred             CCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEc
Confidence            4  4444432    345899999999998765431       245678899999999999   99999999999999999


Q ss_pred             CCCcEEEeccccccccCC
Q 003301          794 KDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       794 ~~~~~kl~DFg~a~~~~~  811 (832)
                      +++.++|+|||.|.....
T Consensus       160 ~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         160 DDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCCcEEEEECCccccCCC
Confidence            999999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.71  E-value=9.2e-18  Score=168.36  Aligned_cols=178  Identities=20%  Similarity=0.289  Sum_probs=142.1

Q ss_pred             HHHHHHhcCCCCCCeeeccCCceEEEEEecC------CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEE
Q 003301          652 KELLQATNQFNASNLIGTGGFGSVYKGSFLD------GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSC  724 (832)
Q Consensus       652 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~  724 (832)
                      .++.....+++....+-+|.||+||+|.|++      .+.|.+|.++... +-....+..|.-.+..+.|||+.++.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            3445556778888999999999999997654      3556777665443 33456788899999999999999999987


Q ss_pred             ec-CCeeEEEEecCCCCCHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC
Q 003301          725 TN-NDFKALVLEYMPNGSLEDYLYSNN-------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM  796 (832)
Q Consensus       725 ~~-~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~  796 (832)
                      .+ .+..++++.++.-|+|..++...+       ...+..+...++.|++.|++|||   ++|+||.||.++|.++|+.-
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhe
Confidence            65 456789999998899999998332       23667788899999999999999   99999999999999999999


Q ss_pred             cEEEeccccccccCCCcccccc-cccccccccCCCCC
Q 003301          797 VAHLSDFGIAKLLSGEESMKQT-LTLATIGYMAPGLF  832 (832)
Q Consensus       797 ~~kl~DFg~a~~~~~~~~~~~~-~~~gt~~y~APE~l  832 (832)
                      ++||+|=.+++.+.+.+..... ..-.+..|||||.+
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal  470 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEAL  470 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHH
Confidence            9999999999987665543221 22356789999953

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=6.7e-17  Score=160.73  Aligned_cols=132  Identities=25%  Similarity=0.355  Sum_probs=108.6

Q ss_pred             eeeccCCceEEEEEecCCcEEEEEEEeccc--------hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          666 LIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--------EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       666 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      .||+|+||.||+|.+ ++..|++|+.....        .....++.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999986 67889999865321        112356778999999999887665555556666779999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          738 PNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       738 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      +|++|.+++.....        .++.+++.++.++|   +.|++|||++|+||+++ ++.++++|||.+....
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~  140 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD  140 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence            99999998754321        78999999999999   99999999999999999 8899999999987643

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.68  E-value=1.5e-16  Score=181.95  Aligned_cols=140  Identities=24%  Similarity=0.307  Sum_probs=114.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccc--------hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--------EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDF  729 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  729 (832)
                      ...|...+.||+|+||+||+|.+.+. .+++|+.....        ....+++.+|+++++.++|++++....++.....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            45557789999999999999987443 44444432111        1123568899999999999999888877777777


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      .++||||+++++|.+++.         ....++.+++.++.|+|   +.|++|||+||+||++ .++.++|+|||+|+..
T Consensus       411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            899999999999999885         34678999999999999   9999999999999999 6789999999999875


Q ss_pred             CC
Q 003301          810 SG  811 (832)
Q Consensus       810 ~~  811 (832)
                      ..
T Consensus       478 ~~  479 (535)
T PRK09605        478 DL  479 (535)
T ss_pred             Cc
Confidence            43

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.67  E-value=5.9e-16  Score=167.76  Aligned_cols=167  Identities=38%  Similarity=0.575  Sum_probs=142.6

Q ss_pred             CCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchh---hHHHHHHHHHHHhcCCCC-ceeeeceEEecCCeeEEEEec
Q 003301          661 FNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEG---ALKSFDVECEVLKSVRHR-NLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       661 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  736 (832)
                      |.+.+.+|.|+||.||++.+.  ..+++|.+......   ....+.+|+.+++.+.|+ +++++.+.+......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            677889999999999999886  88999988765432   367889999999999988 799999999888788999999


Q ss_pred             CCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC-cEEEeccccccccCCCc
Q 003301          737 MPNGSLEDYLYSNN--FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       737 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~DFg~a~~~~~~~  813 (832)
                      +.++++.+++....  ..++...+..++.|++.+++|+|   +.+++|||+||+||+++..+ .++++|||.++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997777654  25889999999999999999999   99999999999999999988 79999999998654433


Q ss_pred             cc-----ccccccccccccCCCCC
Q 003301          814 SM-----KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~-----~~~~~~gt~~y~APE~l  832 (832)
                      ..     ......||..|+|||.+
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~  180 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVL  180 (384)
T ss_pred             ccccccccccccccccccCCHHHh
Confidence            22     23446799999999963

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.66  E-value=2.9e-16  Score=162.39  Aligned_cols=133  Identities=23%  Similarity=0.332  Sum_probs=113.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCC-----C---CceeeeceEEecC--
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVR-----H---RNLVKIISSCTNN--  727 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~~--  727 (832)
                      .+|.+.++||-|-|++||.|.+.. .+.||+|+++.. +...+....||+++++++     |   .+||++++.|...  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            789999999999999999998864 678999998755 344567788999999884     3   3699999999754  


Q ss_pred             --CeeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC
Q 003301          728 --DFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD  795 (832)
Q Consensus       728 --~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~  795 (832)
                        .++++|+|+. |.+|..+|+... ..++...+++|++||+.||.|||.  +.||||-||||+|||+...
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLCST  224 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeeecc
Confidence              4899999999 889999987654 359999999999999999999996  5699999999999999544

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.64  E-value=1e-15  Score=145.12  Aligned_cols=136  Identities=18%  Similarity=0.221  Sum_probs=114.2

Q ss_pred             CCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCC--CceeeeceEEecCCeeEEEEecCCCC
Q 003301          663 ASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRH--RNLVKIISSCTNNDFKALVLEYMPNG  740 (832)
Q Consensus       663 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  740 (832)
                      +.+.||+|.++.||++... +..+++|.......  ...+.+|+.+++.++|  ..+++++++....+..|++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            4578999999999999984 47899998765433  4678889999999976  58999999888888899999999887


Q ss_pred             CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          741 SLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       741 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      .+..+        +......++.+++.+++++|.....+++|||++|+||++++.+.++++|||.++..
T Consensus        79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            77544        45666778999999999999433358999999999999999999999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.63  E-value=1.2e-15  Score=150.18  Aligned_cols=137  Identities=23%  Similarity=0.222  Sum_probs=98.5

Q ss_pred             CCeeeccCCceEEEEEecCCcEEEEEEEeccchh--hHHH----------------------HHHHHHHHhcCCCCc--e
Q 003301          664 SNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEG--ALKS----------------------FDVECEVLKSVRHRN--L  717 (832)
Q Consensus       664 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~n--i  717 (832)
                      .+.||+|+||+||+|...+++.||||+++.....  ....                      ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            5689999999999999878999999998753211  1111                      134555555554332  4


Q ss_pred             eeeceEEecCCeeEEEEecCCCCCHHH-HHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeEeCCC
Q 003301          718 VKIISSCTNNDFKALVLEYMPNGSLED-YLYSNNFSFDILQRLSVIIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDKD  795 (832)
Q Consensus       718 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~  795 (832)
                      ++.+++    ...++||||++++++.. .+....  .. ..+..++.+++.++.++|   . .+|+||||||+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence            444443    23589999998854321 111111  11 567789999999999999   8 9999999999999999 8


Q ss_pred             CcEEEeccccccccCC
Q 003301          796 MVAHLSDFGIAKLLSG  811 (832)
Q Consensus       796 ~~~kl~DFg~a~~~~~  811 (832)
                      +.++++|||.|.....
T Consensus       151 ~~~~liDfg~a~~~~~  166 (187)
T cd05119         151 GKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CcEEEEECcccccccC
Confidence            9999999999986644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.60  E-value=7.2e-15  Score=148.93  Aligned_cols=137  Identities=18%  Similarity=0.213  Sum_probs=107.4

Q ss_pred             CCeee-ccCCceEEEEEecCCcEEEEEEEeccc-------------hhhHHHHHHHHHHHhcCCCCce--eeeceEEecC
Q 003301          664 SNLIG-TGGFGSVYKGSFLDGMEVAIKVFHLQL-------------EGALKSFDVECEVLKSVRHRNL--VKIISSCTNN  727 (832)
Q Consensus       664 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~  727 (832)
                      ...|| .|+.|+||.+.. .+..+|||.+....             .....++.+|++++..++|++|  ++.+++...+
T Consensus        36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35787 899999999887 57889999885321             1223567889999999998875  6677764432


Q ss_pred             -C---eeEEEEecCCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEec
Q 003301          728 -D---FKALVLEYMPN-GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSD  802 (832)
Q Consensus       728 -~---~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D  802 (832)
                       .   ..++||||++| .+|.+++...  .++..    .+.+++.++.++|   +.||+||||||+|||++.++.++|+|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence             2   23599999997 6999988653  34443    3578999999999   99999999999999999999999999


Q ss_pred             cccccccC
Q 003301          803 FGIAKLLS  810 (832)
Q Consensus       803 Fg~a~~~~  810 (832)
                      ||.++...
T Consensus       186 fg~~~~~~  193 (239)
T PRK01723        186 FDRGELRT  193 (239)
T ss_pred             CCCcccCC
Confidence            99998754

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=3.2e-15  Score=172.49  Aligned_cols=170  Identities=26%  Similarity=0.305  Sum_probs=126.2

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCC---CCceeeeceEEecCCeeE
Q 003301          655 LQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVR---HRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       655 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~  731 (832)
                      ......|.|.+.||+|+||.||+|...+|+.||+|+-+.......   .--.+++.+++   -+-|..+..++...+.-+
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence            344578899999999999999999998899999998765543321   11122333333   344666666666667778


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC-------CCcEEEeccc
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK-------DMVAHLSDFG  804 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-------~~~~kl~DFg  804 (832)
                      +|+||.+.|+|.+++...+ .+++.-++.+..|++..+++||   ..+|||+||||+|+++..       ...++|+|||
T Consensus       771 lv~ey~~~Gtlld~~N~~~-~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLINTNK-VMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             eeeeccccccHHHhhccCC-CCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence            9999999999999998544 6999999999999999999999   999999999999999932       3469999999


Q ss_pred             cccccCCC-cccccccccccccccCCCC
Q 003301          805 IAKLLSGE-ESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       805 ~a~~~~~~-~~~~~~~~~gt~~y~APE~  831 (832)
                      .|..+.-- +.......++|-.+-.+|+
T Consensus       847 ~siDm~lfp~~~~F~~~~~td~f~C~EM  874 (974)
T KOG1166|consen  847 RSIDMKLFPDGTKFKAVWHTDLFDCIEM  874 (974)
T ss_pred             cceeeeEcCCCcEEeeeeccccchhHHH
Confidence            98654221 1122333455555555554

>PLN03150 hypothetical protein; Provisional

Probab=99.56  E-value=6.2e-15  Score=170.16  Aligned_cols=118  Identities=38%  Similarity=0.633  Sum_probs=94.8

Q ss_pred             ccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCC
Q 003301          464 VVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLS  543 (832)
Q Consensus       464 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~  543 (832)
                      .++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|+.+..+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            36778888888888888888888888888888888888888888888888888888888888888888888888888888


Q ss_pred             CCcccccCCCC--CCCCCcCCCcccCCCCCCCCcccCCCccC
Q 003301          544 FNKLEGEIPRG--GPFANFSNRSFMGNDLLCGLAQVQVPVCK  583 (832)
Q Consensus       544 ~N~l~~~~p~~--~~~~~~~~~~~~~n~~~c~~~~~~~p~c~  583 (832)
                      +|+++|.+|..  ..........+.+|+.+|+.|..  +.|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l--~~C~  538 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL--RACG  538 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCCC--CCCc
Confidence            88888888863  12223344568899999997643  4674

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.54  E-value=2.9e-15  Score=180.11  Aligned_cols=118  Identities=21%  Similarity=0.275  Sum_probs=87.6

Q ss_pred             cCCC-CceeeeceEE-------ecCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 003301          711 SVRH-RNLVKIISSC-------TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVH  782 (832)
Q Consensus       711 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  782 (832)
                      ..+| +||.++++++       ...+.++.++||+ +++|.+++......+++..++.++.||+.||+|||   ++||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence            3445 5788888877       2234567888988 67999999865556999999999999999999999   999999


Q ss_pred             cCCCCCCeEeCC-------------------CCcEEEeccccccccCCCc---------------ccccccccccccccC
Q 003301          783 CDIKPSNVLLDK-------------------DMVAHLSDFGIAKLLSGEE---------------SMKQTLTLATIGYMA  828 (832)
Q Consensus       783 ~Dlkp~NIl~~~-------------------~~~~kl~DFg~a~~~~~~~---------------~~~~~~~~gt~~y~A  828 (832)
                      |||||+|||++.                   ++.+|++|||+++......               .......+||++|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            999999999965                   3456666666665421100               000112458999999


Q ss_pred             CCCC
Q 003301          829 PGLF  832 (832)
Q Consensus       829 PE~l  832 (832)
                      ||++
T Consensus       184 PE~~  187 (793)
T PLN00181        184 PEED  187 (793)
T ss_pred             hhhh
Confidence            9974

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.54  E-value=3.1e-16  Score=164.98  Aligned_cols=197  Identities=36%  Similarity=0.538  Sum_probs=166.7

Q ss_pred             ccCCCCcceeccCccc--cCccccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCcccccccccccc
Q 003301            2 LSLSFNDLSGAIPKEI--GNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSN   79 (832)
Q Consensus         2 ldl~~n~~~~~~~~~~--~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~   79 (832)
                      |-|++..+. ++|-.-  -.++.-...||+.|++. .+|..+..+..|+.+.|+.|.+. .||+.++++..+ +.|||+.
T Consensus        55 l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~l-t~l~ls~  130 (722)
T KOG0532|consen   55 LLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEAL-TFLDLSS  130 (722)
T ss_pred             cccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHH-HHhhhcc
Confidence            455666665 333222  34666678899999998 99999999999999999999999 899999999998 9999999


Q ss_pred             cccccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEeccccccccc
Q 003301           80 NSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEI  159 (832)
Q Consensus        80 n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~  159 (832)
                      |++. .+|..+| .++ |+.|-+++|+++ .+|+.++.+..|..||.+.|++. .+|..++.+.+|+.|.+..|++. .+
T Consensus       131 NqlS-~lp~~lC-~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~l  204 (722)
T KOG0532|consen  131 NQLS-HLPDGLC-DLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DL  204 (722)
T ss_pred             chhh-cCChhhh-cCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hC
Confidence            9999 8999988 565 899999999999 88999998889999999999997 57888999999999999999998 67


Q ss_pred             CccccCccccceecccccccccccCcccccCCcccEEEecCCCCCCCCCccc
Q 003301          160 PYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSI  211 (832)
Q Consensus       160 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~  211 (832)
                      |..++.|+ |..||+|.|++. .+|-.|.+|+.|++|.|.+|.+. ..|..+
T Consensus       205 p~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqI  253 (722)
T KOG0532|consen  205 PEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQI  253 (722)
T ss_pred             CHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHH
Confidence            87887555 889999999998 47888999999999999999997 556555

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.54  E-value=5.4e-15  Score=167.90  Aligned_cols=166  Identities=22%  Similarity=0.301  Sum_probs=128.4

Q ss_pred             CCCCeeeccCCceEEEEEecC-CcEEEEEEEec---cc--h-hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          662 NASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHL---QL--E-GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       662 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~---~~--~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ....++|.|++|.|+.+.... ....+.|.++.   ..  . .....+..|..+-..+.|||++..+..+.+....+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            356789999999888776543 33344444331   11  1 11122556777778889999988888777766666669


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |||++ +|..++.... .+....+..++.|+..|++|+|   ..|+.|||+|++|++++.+|.+||+|||.+....-+..
T Consensus       401 E~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            99998 9999998753 5788889999999999999999   99999999999999999999999999999876543322


Q ss_pred             ---cccccccccccccCCCCC
Q 003301          815 ---MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ---~~~~~~~gt~~y~APE~l  832 (832)
                         ......+|+..|+|||++
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~  496 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVL  496 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccc
Confidence               344557899999999985

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.49  E-value=4.3e-16  Score=163.93  Aligned_cols=188  Identities=30%  Similarity=0.455  Sum_probs=168.1

Q ss_pred             ccCCCCcceeccCccccCccccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCcccccccccccccc
Q 003301            2 LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNS   81 (832)
Q Consensus         2 ldl~~n~~~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~   81 (832)
                      .|||.|.+. ++|..+..+-+|+.|.|.+|.+. .+|.++..+..|++|||+.|+++ .+|..++.|+ | +.|-+++|+
T Consensus        80 aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-L-kvli~sNNk  154 (722)
T KOG0532|consen   80 ADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-L-KVLIVSNNK  154 (722)
T ss_pred             hhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-c-eeEEEecCc
Confidence            699999999 99999999999999999999998 99999999999999999999999 9999999997 4 899999999


Q ss_pred             cccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCc
Q 003301           82 LTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPY  161 (832)
Q Consensus        82 l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~  161 (832)
                      ++ .+|..+. .++.|..||.+.|.+. .+|..++.+..|+.|.+..|++. .+|+.+..| .|..||+|+|+++ .+|-
T Consensus       155 l~-~lp~~ig-~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv  228 (722)
T KOG0532|consen  155 LT-SLPEEIG-LLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPV  228 (722)
T ss_pred             cc-cCCcccc-cchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecch
Confidence            99 9999998 8999999999999999 88999999999999999999998 578878855 5999999999999 8999


Q ss_pred             cccCccccceecccccccccccCcccccCC---cccEEEecCC
Q 003301          162 EMGNLRNLEILGLQLNKLVGFVPTSIFNLS---AMKTLALPSN  201 (832)
Q Consensus       162 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~---~L~~L~L~~n  201 (832)
                      .|.+|++|++|-|.+|.+.. +|..++-.-   =-|+|+..-+
T Consensus       229 ~fr~m~~Lq~l~LenNPLqS-PPAqIC~kGkVHIFKyL~~qA~  270 (722)
T KOG0532|consen  229 DFRKMRHLQVLQLENNPLQS-PPAQICEKGKVHIFKYLSTQAC  270 (722)
T ss_pred             hhhhhhhheeeeeccCCCCC-ChHHHHhccceeeeeeecchhc
Confidence            99999999999999999985 555443221   2345555544

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.49  E-value=1.1e-13  Score=152.55  Aligned_cols=142  Identities=21%  Similarity=0.294  Sum_probs=100.0

Q ss_pred             CCeeeccCCceEEEEEecCCcEEEEEEEeccchhhH----------------------------------------HHHH
Q 003301          664 SNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL----------------------------------------KSFD  703 (832)
Q Consensus       664 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~  703 (832)
                      .+.||.|++|.||+|+..+|+.||||+.+.......                                        -++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            368999999999999999999999999864321100                                        0233


Q ss_pred             HHHHHHhcC----C-CCceeeeceEEecCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHH-HHHHHhcCCC
Q 003301          704 VECEVLKSV----R-HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL-ALEYLHFGYS  777 (832)
Q Consensus       704 ~e~~~l~~l----~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~l~~LH~~~~  777 (832)
                      +|++.+.++    + ++++.-..-++...+..++||||++|+++.++........+   ...++.+++. .+..+|   .
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~---~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL---R  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH---h
Confidence            455544444    2 33322211222234457999999999999887654321222   3446666655 468889   8


Q ss_pred             CCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       778 ~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      .|++|+|+||.||+++.++.++++|||++..+..
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            9999999999999999999999999999987753

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.48  E-value=3.3e-14  Score=157.34  Aligned_cols=201  Identities=36%  Similarity=0.496  Sum_probs=151.2

Q ss_pred             eEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCcc-cccccccccccccccCCChhhhhcCCCceEEEcc
Q 003301           25 KLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLS-SLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMS  103 (832)
Q Consensus        25 ~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~-~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~  103 (832)
                      .++++.|++. ..+..+..++.++.|++.+|.++ .+|+..+.+. ++ +.|++++|++. .+|..+. .++.|+.|+++
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL-~~L~l~~N~i~-~l~~~~~-~l~~L~~L~l~  171 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNL-KELDLSDNKIE-SLPSPLR-NLPNLKNLDLS  171 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhc-ccccccccchh-hhhhhhh-ccccccccccC
Confidence            5777777775 35555677778888888888888 7777777774 77 88888888888 7765554 78888888888


Q ss_pred             CCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceeccccccccccc
Q 003301          104 NNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFV  183 (832)
Q Consensus       104 ~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~  183 (832)
                      +|+++ .+|...+.+++|+.|++++|++. .+|........|++|++++|++. ..+..+.++.++..|.+.+|++.. .
T Consensus       172 ~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~  247 (394)
T COG4886         172 FNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-L  247 (394)
T ss_pred             Cchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-c
Confidence            88888 66666667788888888888887 56665566667888888888655 566677888888888888888764 3


Q ss_pred             CcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCccc
Q 003301          184 PTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIF  238 (832)
Q Consensus       184 ~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~  238 (832)
                      +..+..++++++|++++|.++ .++.   +..+.+++.|++++|.+....+....
T Consensus       248 ~~~~~~l~~l~~L~~s~n~i~-~i~~---~~~~~~l~~L~~s~n~~~~~~~~~~~  298 (394)
T COG4886         248 PESIGNLSNLETLDLSNNQIS-SISS---LGSLTNLRELDLSGNSLSNALPLIAL  298 (394)
T ss_pred             cchhccccccceecccccccc-cccc---ccccCccCEEeccCccccccchhhhc
Confidence            667778888888888888887 3433   45778888888888888876665543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.45  E-value=6e-15  Score=158.79  Aligned_cols=158  Identities=28%  Similarity=0.324  Sum_probs=131.3

Q ss_pred             eeeccCCceEEEEEec----CCcEEEEEEEeccchh--hHHHHHHHHHHHhcCC-CCceeeeceEEecCCeeEEEEecCC
Q 003301          666 LIGTGGFGSVYKGSFL----DGMEVAIKVFHLQLEG--ALKSFDVECEVLKSVR-HRNLVKIISSCTNNDFKALVLEYMP  738 (832)
Q Consensus       666 ~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  738 (832)
                      ++|+|+||.|+.++..    .|..||+|+.++....  .......|..++...+ ||.+++++..++.+...|++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            3799999999977432    3677899987654321  1224556888888886 9999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccc
Q 003301          739 NGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT  818 (832)
Q Consensus       739 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~  818 (832)
                      +|++...+.... .+++.....+...++-|++++|   +.+++|||+|++||+++.+|.+|+.|||.++..-....    
T Consensus        81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----  152 (612)
T ss_pred             cchhhhccccCC-chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence            999998887654 5778888888999999999999   99999999999999999999999999999986533222    


Q ss_pred             cccccccccCCCCC
Q 003301          819 LTLATIGYMAPGLF  832 (832)
Q Consensus       819 ~~~gt~~y~APE~l  832 (832)
                       .|||..|||||++
T Consensus       153 -~cgt~eymApEI~  165 (612)
T KOG0603|consen  153 -ACGTYEYRAPEII  165 (612)
T ss_pred             -cccchhhhhhHhh
Confidence             2899999999974

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.44  E-value=1.4e-13  Score=152.29  Aligned_cols=177  Identities=38%  Similarity=0.497  Sum_probs=94.9

Q ss_pred             cCCCceEEEccCCcccccCCCCccCCC-CccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccce
Q 003301           93 RLPLIKGLYMSNNKLTGPIPNNIWQCK-ELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEI  171 (832)
Q Consensus        93 ~l~~L~~L~l~~N~l~~~~p~~l~~l~-~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~  171 (832)
                      .++.++.|++.+|.++ .+|....... +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|...+.+++|+.
T Consensus       114 ~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~  190 (394)
T COG4886         114 ELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNN  190 (394)
T ss_pred             cccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhh
Confidence            3455555566665555 4444444443 5666666666555 34444555556666666666665 44444445555666


Q ss_pred             ecccccccccccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCC
Q 003301          172 LGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGEN  251 (832)
Q Consensus       172 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N  251 (832)
                      |++++|++.. +|........|++|.+++|.+. ..+..  +..+.++..+.+++|++... +..+..++.+++|++++|
T Consensus       191 L~ls~N~i~~-l~~~~~~~~~L~~l~~~~N~~~-~~~~~--~~~~~~l~~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~n  265 (394)
T COG4886         191 LDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSS--LSNLKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNN  265 (394)
T ss_pred             eeccCCcccc-CchhhhhhhhhhhhhhcCCcce-ecchh--hhhcccccccccCCceeeec-cchhccccccceeccccc
Confidence            6666665553 3333334444556666655322 11211  23455555555556655532 444555666666666666


Q ss_pred             cCcccCCccccCccccceeecccccCCC
Q 003301          252 SFSGFIPNTLGNLRKLEWLRLSYNFLTS  279 (832)
Q Consensus       252 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~  279 (832)
                      .++.+..  +..+.+++.|++++|.+..
T Consensus       266 ~i~~i~~--~~~~~~l~~L~~s~n~~~~  291 (394)
T COG4886         266 QISSISS--LGSLTNLRELDLSGNSLSN  291 (394)
T ss_pred             ccccccc--ccccCccCEEeccCccccc
Confidence            6664433  5666666666666666654

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.42  E-value=1e-13  Score=140.02  Aligned_cols=114  Identities=23%  Similarity=0.339  Sum_probs=86.2

Q ss_pred             CCCceeeeceEEecC---------------------------CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHH
Q 003301          713 RHRNLVKIISSCTNN---------------------------DFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDV  765 (832)
Q Consensus       713 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i  765 (832)
                      +|||||++.++|.++                           ...|+||..+ ..+|.+++..+.  .+...+.-+..|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC--CchHHHHHHHHHH
Confidence            599999998877432                           2568999888 469999998754  5666777899999


Q ss_pred             HHHHHHHhcCCCCCeEecCCCCCCeEeC--CC--CcEEEeccccccccCCCc-----ccccccccccccccCCCCC
Q 003301          766 ALALEYLHFGYSNPVVHCDIKPSNVLLD--KD--MVAHLSDFGIAKLLSGEE-----SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       766 ~~~l~~LH~~~~~~ivH~Dlkp~NIl~~--~~--~~~kl~DFg~a~~~~~~~-----~~~~~~~~gt~~y~APE~l  832 (832)
                      ++|+.|||   ++||.|||+|++|||+.  +|  -.+.|+|||++---+..+     ....-..-|...-||||+.
T Consensus       351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~  423 (598)
T KOG4158|consen  351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA  423 (598)
T ss_pred             HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence            99999999   99999999999999993  33  368899999875322211     0011113477789999974

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.38  E-value=1.2e-12  Score=145.68  Aligned_cols=147  Identities=18%  Similarity=0.194  Sum_probs=94.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchh----------------------------------hHHH-
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEG----------------------------------ALKS-  701 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~~-  701 (832)
                      ...|+. +.||.|++|.||+|+..+ |+.||||+.+.....                                  ..+. 
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            456776 799999999999999987 999999998754211                                  0111 


Q ss_pred             -----HHHHHHHHhcCC----CCceeeeceEEe-cCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHH-HHH
Q 003301          702 -----FDVECEVLKSVR----HRNLVKIISSCT-NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL-ALE  770 (832)
Q Consensus       702 -----~~~e~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~l~  770 (832)
                           +.+|+..+.+++    +...+.+-.++. .....++||||++|+.+.++-.-.....+...   ++...+. -+.
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~---la~~~v~~~~~  274 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKL---LAERGVEVFFT  274 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHH---HHHHHHHHHHH
Confidence                 233443333332    333233223222 23456899999999999875321111222221   2222111 133


Q ss_pred             HHhcCCCCCeEecCCCCCCeEeCCCC----cEEEeccccccccCC
Q 003301          771 YLHFGYSNPVVHCDIKPSNVLLDKDM----VAHLSDFGIAKLLSG  811 (832)
Q Consensus       771 ~LH~~~~~~ivH~Dlkp~NIl~~~~~----~~kl~DFg~a~~~~~  811 (832)
                      .++   ..|++|+|+||.||+++.++    .++++|||++..+..
T Consensus       275 Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        275 QVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            345   67999999999999999888    999999999987754

>PLN03150 hypothetical protein; Provisional

Probab=99.37  E-value=6.7e-13  Score=153.36  Aligned_cols=114  Identities=37%  Similarity=0.560  Sum_probs=106.0

Q ss_pred             ccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccC
Q 003301          440 DILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLS  519 (832)
Q Consensus       440 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  519 (832)
                      .++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            47789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcccccCchhhhhh-ccCCeeeCCCCcccccCCC
Q 003301          520 NNSLSGNIPTSMEKL-LYLKDLNLSFNKLEGEIPR  553 (832)
Q Consensus       520 ~N~l~~~~p~~~~~l-~~L~~l~l~~N~l~~~~p~  553 (832)
                      +|+++|.+|..+..+ .++..+++++|+..|.+|.
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~  533 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG  533 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCC
Confidence            999999999998864 5678999999998776664

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.37  E-value=9.3e-14  Score=157.00  Aligned_cols=166  Identities=23%  Similarity=0.278  Sum_probs=128.6

Q ss_pred             CCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccch-hhHHHHHH---HHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          660 QFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLE-GALKSFDV---ECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      +|...+.+|.+.|=+|.+|++.+|. |+||++.++.+ -..+.+.+   |++ .+.++|||++++..+-..+...|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6788899999999999999997787 99999876652 22333333   444 556689999999998888888899999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc--CCCc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL--SGEE  813 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~--~~~~  813 (832)
                      |+ .-+|+|.+..+. -+...+.+.|+.|++.|+..+|   ..||+|||||.+||||+.-..+.|+||..-+..  ..+.
T Consensus       102 yv-khnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  102 YV-KHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HH-hhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            99 459999997654 3667778889999999999999   999999999999999999999999999875542  1111


Q ss_pred             cccccc----ccccccccCCCCC
Q 003301          814 SMKQTL----TLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~----~~gt~~y~APE~l  832 (832)
                      ....+.    ...-..|.|||-|
T Consensus       177 Padf~fFFDTSrRRtCYiAPERF  199 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERF  199 (1431)
T ss_pred             cccceEEEecCCceeeecChHhh
Confidence            111111    1123469999964

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.31  E-value=5.6e-12  Score=121.83  Aligned_cols=129  Identities=22%  Similarity=0.230  Sum_probs=96.6

Q ss_pred             CCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCce-eeeceEEecCCeeEEEEecCCCCCH
Q 003301          664 SNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNL-VKIISSCTNNDFKALVLEYMPNGSL  742 (832)
Q Consensus       664 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L  742 (832)
                      .+.++.|.++.||+++. .++.|++|+...... ....+.+|+++++.+.+.++ ++++.+..  +..++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            35789999999999987 578899998754432 12345788999988865443 45555433  335899999999887


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          743 EDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP-----VVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       743 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      .+.    .     .....++.+++.+++.||   ..+     ++|||++|.||+++ ++.++++|||.|...
T Consensus        79 ~~~----~-----~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~  137 (170)
T cd05151          79 LTE----D-----FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN  137 (170)
T ss_pred             ccc----c-----ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence            643    0     111345678999999999   666     59999999999998 678999999998754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.28  E-value=4e-11  Score=115.67  Aligned_cols=138  Identities=20%  Similarity=0.184  Sum_probs=100.6

Q ss_pred             CCeeeccCCceEEEEEecC-------CcEEEEEEEeccc----------------------hhhHHHH----HHHHHHHh
Q 003301          664 SNLIGTGGFGSVYKGSFLD-------GMEVAIKVFHLQL----------------------EGALKSF----DVECEVLK  710 (832)
Q Consensus       664 ~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~----~~e~~~l~  710 (832)
                      ...||.|.-+.||.|...+       +..+|||+++...                      ....+.+    .+|.+.++
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999997643       4789999875211                      0112222    37999998


Q ss_pred             cCCC--CceeeeceEEecCCeeEEEEecCCCCCHHH-HHhhCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEecCCC
Q 003301          711 SVRH--RNLVKIISSCTNNDFKALVLEYMPNGSLED-YLYSNNFSFDILQRLSVIIDVALALEYL-HFGYSNPVVHCDIK  786 (832)
Q Consensus       711 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dlk  786 (832)
                      ++..  -.+++.+++    ...++||||+.+..+.. .++.  ..++..+...+..+++.++..+ |   ..|+||||++
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs  152 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS  152 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence            8853  456667765    34589999996643321 2222  1345566777889999999999 8   8999999999


Q ss_pred             CCCeEeCCCCcEEEeccccccccCC
Q 003301          787 PSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       787 p~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +.||+++ ++.++++|||.|.....
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeCCC
Confidence            9999996 46899999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.27  E-value=3.1e-12  Score=120.79  Aligned_cols=143  Identities=29%  Similarity=0.434  Sum_probs=38.9

Q ss_pred             CccCCCCcceeccCccccCccccCeEeccCCccccCCCcccc-ccccCcEEEccCCcCCCCCCCcccCcccccccccccc
Q 003301            1 MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELG-NLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSN   79 (832)
Q Consensus         1 ~ldl~~n~~~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~-~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~   79 (832)
                      |..|+.+.|+  --+.+.+...+++|+|++|+|+ .+ +.++ .+.+|++|+|++|.++ .++ ++..++.| ++|++++
T Consensus         1 ~~~lt~~~i~--~~~~~~n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L-~~L~L~~   73 (175)
T PF14580_consen    1 MVRLTANMIE--QIAQYNNPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRL-KTLDLSN   73 (175)
T ss_dssp             ---------------------------------------S--TT-TT--EEE-TTS--S---T-T----TT---EEE--S
T ss_pred             Cccccccccc--cccccccccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhh-hhcccCC
Confidence            4456666666  3334455556788888888887 34 3455 5777888888888887 554 35556666 6666666


Q ss_pred             cccccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEeccccccccc
Q 003301           80 NSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEI  159 (832)
Q Consensus        80 n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~  159 (832)
                      |.|+ .++..+...+++|++|++++|+|... .+                      -..+..+++|++|+|.+|.++. .
T Consensus        74 N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l-~~----------------------l~~L~~l~~L~~L~L~~NPv~~-~  128 (175)
T PF14580_consen   74 NRIS-SISEGLDKNLPNLQELYLSNNKISDL-NE----------------------LEPLSSLPKLRVLSLEGNPVCE-K  128 (175)
T ss_dssp             S----S-CHHHHHH-TT--EEE-TTS---SC-CC----------------------CGGGGG-TT--EEE-TT-GGGG-S
T ss_pred             CCCC-ccccchHHhCCcCCEEECcCCcCCCh-HH----------------------hHHHHcCCCcceeeccCCcccc-h
Confidence            6666 45544433456666666666666521 10                      1234445566666666666652 2


Q ss_pred             Cc----cccCccccceeccc
Q 003301          160 PY----EMGNLRNLEILGLQ  175 (832)
Q Consensus       160 p~----~~~~l~~L~~L~L~  175 (832)
                      +.    .+..+|+|+.||-.
T Consensus       129 ~~YR~~vi~~lP~Lk~LD~~  148 (175)
T PF14580_consen  129 KNYRLFVIYKLPSLKVLDGQ  148 (175)
T ss_dssp             TTHHHHHHHH-TT-SEETTE
T ss_pred             hhHHHHHHHHcChhheeCCE
Confidence            22    35566777776653

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.27  E-value=2e-11  Score=124.21  Aligned_cols=164  Identities=24%  Similarity=0.358  Sum_probs=103.9

Q ss_pred             CCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCC----------CceeeeceEEe
Q 003301          660 QFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRH----------RNLVKIISSCT  725 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~  725 (832)
                      .+..++.||.|+++.||.+++.+ ++++|+|++....   ....+.+.+|.-....+.+          -.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            45567899999999999999975 8999999986443   2334566666655544322          12222222221


Q ss_pred             ---------cC---C-----eeEEEEecCCCCCHHHHHhh---CCCC---CCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 003301          726 ---------NN---D-----FKALVLEYMPNGSLEDYLYS---NNFS---FDILQRLSVIIDVALALEYLHFGYSNPVVH  782 (832)
Q Consensus       726 ---------~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~~---~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  782 (832)
                               ..   .     ..+++|+-+ .++|.+++..   ....   .....+..+..|+++.++++|   ..|++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence                     11   1     125788888 5799887642   2111   223445667789999999999   999999


Q ss_pred             cCCCCCCeEeCCCCcEEEeccccccccCCCcccccccccccccccCCCC
Q 003301          783 CDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       783 ~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      +||+|+|++++++|.++++||+.....+.....    ...+..|.+||+
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~  213 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPEL  213 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhh
Confidence            999999999999999999999988765332211    235577888884

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.25  E-value=1.4e-12  Score=125.20  Aligned_cols=165  Identities=20%  Similarity=0.393  Sum_probs=125.4

Q ss_pred             CCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          660 QFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      +..+..+|.+...|+.|+|+| .|..+++|++..+.  ....+.|..|.-.++-+.||||..++|.|.......++..||
T Consensus       191 ~lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            345566789999999999999 56667778765443  223367888998999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          738 PNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       738 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +.|+|+.++++.. ...+..++.+++.++|+|++|||.- +.-|.---+.+..|++|++..++|+= +-+++     +..
T Consensus       270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kf-----sfq  342 (448)
T KOG0195|consen  270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----SFQ  342 (448)
T ss_pred             cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-cccee-----eee
Confidence            9999999998653 2377889999999999999999932 23344446888999999998877641 11111     111


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .......|.|||||.+
T Consensus       343 e~gr~y~pawmspeal  358 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEAL  358 (448)
T ss_pred             ccccccCcccCCHHHH
Confidence            1223467889999964

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.24  E-value=1.5e-12  Score=126.86  Aligned_cols=129  Identities=27%  Similarity=0.332  Sum_probs=56.3

Q ss_pred             CccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccccccccccCcccccCCcccEEEec
Q 003301          120 ELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALP  199 (832)
Q Consensus       120 ~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  199 (832)
                      .|+++|||+|.|+ .+.++..-+++++.|++|+|.|. .+. .+..+++|+.||||+|.++. ..++-..+.+.++|.|+
T Consensus       285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~La  360 (490)
T KOG1259|consen  285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLKLA  360 (490)
T ss_pred             hhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhHh-hhhhHhhhcCEeeeehh
Confidence            3444444444443 23333333344444444444443 111 13444444444444444432 22233334444444444


Q ss_pred             CCCCCCCCCccccccCCCCccEEEccCCcccccc-CCcccCCCCccEEEcCCCcCccc
Q 003301          200 SNALSGSLPSSIDLVRLPNLEIISLAGNNFSGII-PSFIFNASKLSVLELGENSFSGF  256 (832)
Q Consensus       200 ~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~-~~~~~~l~~L~~L~L~~N~i~~~  256 (832)
                      .|.+.. +.   .+..+-+|.+||+++|+|.... -..+++++.|+++.|.+|.+.+.
T Consensus       361 ~N~iE~-LS---GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  361 QNKIET-LS---GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS  414 (490)
T ss_pred             hhhHhh-hh---hhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence            444431 00   1233444555555555554322 12456667777777777776643

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.22  E-value=9.8e-11  Score=108.19  Aligned_cols=133  Identities=23%  Similarity=0.314  Sum_probs=102.0

Q ss_pred             CeeeccCCceEEEEEecCCcEEEEEEEeccc--------hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--------EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ..+++|+-+.+|.+.+ -|.++++|.-..+.        .-...+..+|++++.+++--.|...+=+..+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            4578999999999977 45457777532221        11234667899999988766665555556666777899999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      ++|..|.+++...        ...++..+-.-+.-||   ..||||+|+.++||++..++ +.++|||++..-.
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            9999999888764        2456777888888999   99999999999999997664 9999999998643

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.21  E-value=1.7e-10  Score=105.81  Aligned_cols=143  Identities=22%  Similarity=0.265  Sum_probs=106.9

Q ss_pred             CCCeeeccCCceEEEEEecCCcEEEEEEEeccc--------hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          663 ASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--------EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       663 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ....+-+|+-+.|+++.+ .|+.++||.-..+.        .-..++..+|++.+.++.--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            567899999999999998 78888887533221        112456778999999886555544444555555567999


Q ss_pred             ecCCC-CCHHHHHhhCCCCCCHHHH-HHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC---cEEEecccccccc
Q 003301          735 EYMPN-GSLEDYLYSNNFSFDILQR-LSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM---VAHLSDFGIAKLL  809 (832)
Q Consensus       735 e~~~~-g~L~~~l~~~~~~~~~~~~-~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~---~~kl~DFg~a~~~  809 (832)
                      ||++| .++.+++......-..... ...+.++-+.+.-||   ..++||+|+..+||++.+++   .+.++|||++..-
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            99976 4788888764433333333 678899999999999   99999999999999997665   4589999998654

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.19  E-value=2.6e-12  Score=125.17  Aligned_cols=132  Identities=26%  Similarity=0.286  Sum_probs=93.1

Q ss_pred             CCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceee
Q 003301          414 LTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLS  493 (832)
Q Consensus       414 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  493 (832)
                      ...|+.+|||+|.|+. +..+..-++.++.|++|+|.|..  -..+..+++|+.||||+|.++ .+..+-..+-+++.|.
T Consensus       283 Wq~LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~~--v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~  358 (490)
T KOG1259|consen  283 WQELTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIRT--VQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK  358 (490)
T ss_pred             Hhhhhhccccccchhh-hhhhhhhccceeEEeccccceee--ehhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence            3556777777777765 34455556677777777777763  234777788888888888887 4555556677888888


Q ss_pred             cccccccccCCccccCCCCCCeeccCCCcccccC-chhhhhhccCCeeeCCCCcccccC
Q 003301          494 LRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNI-PTSMEKLLYLKDLNLSFNKLEGEI  551 (832)
Q Consensus       494 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~~~~  551 (832)
                      |+.|.|..  -..++.+.+|..||+++|+|.... -..+++++.|+.+.|.+|++.+.+
T Consensus       359 La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  359 LAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             hhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence            88888862  234667778888888888886421 235778888888888888888644

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.19  E-value=2.8e-13  Score=135.38  Aligned_cols=257  Identities=21%  Similarity=0.248  Sum_probs=112.4

Q ss_pred             cccCccccCeEeccCCcccc----CCCccccccccCcEEEccCCcCCCCCCCcccCcccccccccccccccccCCChhh-
Q 003301           16 EIGNLTMLKKLGLGYNKLRG----EIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDM-   90 (832)
Q Consensus        16 ~~~~l~~L~~L~ls~n~l~~----~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~-   90 (832)
                      .+-.++.+++++||+|.+..    .+...+.+.++|+..++|+- ++|..                     ..++|+.+ 
T Consensus        25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~---------------------~~Ei~e~L~   82 (382)
T KOG1909|consen   25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRL---------------------KDEIPEALK   82 (382)
T ss_pred             HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCc---------------------HHHHHHHHH
Confidence            34456666777777777642    34444556666666666653 22211                     11233221 


Q ss_pred             -----hhcCCCceEEEccCCcccccCCCC----ccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCc
Q 003301           91 -----CRRLPLIKGLYMSNNKLTGPIPNN----IWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPY  161 (832)
Q Consensus        91 -----~~~l~~L~~L~l~~N~l~~~~p~~----l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~  161 (832)
                           ....++|++||||+|-+.-..+..    +.+++.|++|.|.+|.+...--..++.  .|..|.  .|       .
T Consensus        83 ~l~~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~-------k  151 (382)
T KOG1909|consen   83 MLSKALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VN-------K  151 (382)
T ss_pred             HHHHHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HH-------h
Confidence                 114456666666666665333322    234556666666666554110011110  000000  00       0


Q ss_pred             cccCccccceeccccccccccc----CcccccCCcccEEEecCCCCCCCCC--ccccccCCCCccEEEccCCcccc----
Q 003301          162 EMGNLRNLEILGLQLNKLVGFV----PTSIFNLSAMKTLALPSNALSGSLP--SSIDLVRLPNLEIISLAGNNFSG----  231 (832)
Q Consensus       162 ~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~n~l~~~~p--~~~~~~~l~~L~~L~Ls~n~i~~----  231 (832)
                      ....-+.|+++..++|++....    ...|...+.|+.+.++.|.+....-  -...+.+++.|+.|||..|-++.    
T Consensus       152 k~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~  231 (382)
T KOG1909|consen  152 KAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSV  231 (382)
T ss_pred             ccCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHH
Confidence            0111233444444444443211    1123334444555555444431100  00112334444444444444432    


Q ss_pred             ccCCcccCCCCccEEEcCCCcCcccCCcccc-----CccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCC
Q 003301          232 IIPSFIFNASKLSVLELGENSFSGFIPNTLG-----NLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPI  306 (832)
Q Consensus       232 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l  306 (832)
                      .....++.+++|++|++++|.++.....+|.     ..++|+.|.+.+|.|+.-... .+..+....+.|+.|+|++|++
T Consensus       232 ~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~-~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  232 ALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAAL-ALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             HHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHH-HHHHHHhcchhhHHhcCCcccc
Confidence            1223344455666666666665543332221     245666666666666542211 1122334455666666666665

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.18  E-value=3.5e-12  Score=131.03  Aligned_cols=162  Identities=23%  Similarity=0.214  Sum_probs=96.6

Q ss_pred             CCCCccEEEcCCCcCcccCC-ccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCccccc
Q 003301          239 NASKLSVLELGENSFSGFIP-NTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNL  317 (832)
Q Consensus       239 ~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~  317 (832)
                      ++.+|++..|.+..+..... .....+++++.|||+.|-+.....-.   .-...+++|+.|+|+.|++.....+.....
T Consensus       119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~---~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~  195 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVL---KIAEQLPSLENLNLSSNRLSNFISSNTTLL  195 (505)
T ss_pred             hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHH---HHHHhcccchhcccccccccCCccccchhh
Confidence            45667777777766653221 34556777778888877776643222   223567888888888888764333333333


Q ss_pred             ccccceEEeecCccccc-ccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCc--hhhcCCCCCc
Q 003301          318 SLSLSRIFISNCSIRGT-IPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIP--NGLCQLARLS  394 (832)
Q Consensus       318 ~~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~~L~  394 (832)
                      ...|+.|.++.|.++.. +......+|+|+.|+|..|...........-+..|++|||++|++.. .+  .....++.|.
T Consensus       196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~  274 (505)
T KOG3207|consen  196 LSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLN  274 (505)
T ss_pred             hhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchh
Confidence            34677777777777622 22334556777777777775333444445556667777777777652 22  2344556666


Q ss_pred             EEEecCCcCC
Q 003301          395 VLYMDGNKLS  404 (832)
Q Consensus       395 ~L~L~~N~l~  404 (832)
                      .|+++.+.+.
T Consensus       275 ~Lnls~tgi~  284 (505)
T KOG3207|consen  275 QLNLSSTGIA  284 (505)
T ss_pred             hhhccccCcc
Confidence            6666666655

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.14  E-value=6.4e-12  Score=139.16  Aligned_cols=178  Identities=28%  Similarity=0.304  Sum_probs=88.4

Q ss_pred             CcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCc-hhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEe
Q 003301          343 INLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIP-NGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLS  421 (832)
Q Consensus       343 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  421 (832)
                      +.|+.|++++|.|...  ..+..+..|+.+++++|++...-+ . ...+.+++.+++++|.+...  ..+..+..+..++
T Consensus       140 ~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~  214 (414)
T KOG0531|consen  140 TLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLS  214 (414)
T ss_pred             cchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhh
Confidence            3355555555555422  233345566666666666653322 1 34555666666666666522  2333344444446


Q ss_pred             CCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccc
Q 003301          422 LASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQG  501 (832)
Q Consensus       422 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  501 (832)
                      +..|.++.+.+-.......|+.+++++|.+.. .+..+..+..+..||++.|++...  ..+.....+..+.+..|.+..
T Consensus       215 l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~  291 (414)
T KOG0531|consen  215 LLDNKISKLEGLNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLAL  291 (414)
T ss_pred             cccccceeccCcccchhHHHHHHhcccCcccc-ccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcc
Confidence            66666654322211111125666666666652 224455566666666666666532  233444555666666666542


Q ss_pred             c---CCcc-ccCCCCCCeeccCCCcccccCc
Q 003301          502 S---IPKS-IGGLVSLESLDLSNNSLSGNIP  528 (832)
Q Consensus       502 ~---~p~~-~~~l~~L~~L~Ls~N~l~~~~p  528 (832)
                      .   .... .+..+.++...+..|.+....+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
T KOG0531|consen  292 SEAISQEYITSAAPTLVTLTLELNPIRKISS  322 (414)
T ss_pred             hhhhhccccccccccccccccccCccccccc
Confidence            1   1111 3344555555566555554443

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.14  E-value=5.8e-12  Score=129.45  Aligned_cols=229  Identities=22%  Similarity=0.270  Sum_probs=151.5

Q ss_pred             eEeccCCcccc----CCCccccccccCcEEEccCCcCCCCCC--CcccCcccccccccccccccccCCC-hhhhhcCCCc
Q 003301           25 KLGLGYNKLRG----EIPQELGNLAELELVSLTNNFLSGTIP--STIFNLSSLSTGMDFSNNSLTGSLP-DDMCRRLPLI   97 (832)
Q Consensus        25 ~L~ls~n~l~~----~~p~~~~~l~~L~~L~l~~n~l~~~~p--~~l~~l~~l~~~L~ls~n~l~~~lp-~~~~~~l~~L   97 (832)
                      .+.+++.++.+    .+.+.=.++.+|+.+.|.++... .++  +....++.+ +.||||+|-+...-| ..+.+.+|+|
T Consensus        97 ~~si~nK~vE~iGfDki~akQsn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v-~~LdLS~NL~~nw~~v~~i~eqLp~L  174 (505)
T KOG3207|consen   97 VLSISNKQVEFIGFDKIAAKQSNLKKLREISLDNYRVE-DAGIEEYSKILPNV-RDLDLSRNLFHNWFPVLKIAEQLPSL  174 (505)
T ss_pred             HhhhcCceeEEecHHHHHHHhhhHHhhhheeecCcccc-ccchhhhhhhCCcc-eeecchhhhHHhHHHHHHHHHhcccc
Confidence            34455555542    12222346777888888888776 444  255667777 888888887773322 2466678889


Q ss_pred             eEEEccCCcccccCCCC-ccCCCCccEEECcCCcccccC-CCCCcCCCcCceEEecccccccccCccccCccccceeccc
Q 003301           98 KGLYMSNNKLTGPIPNN-IWQCKELIVISLAYNQFTERI-PRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQ  175 (832)
Q Consensus        98 ~~L~l~~N~l~~~~p~~-l~~l~~L~~L~Ls~n~i~~~~-p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~  175 (832)
                      +.|+|+.|++..-.... -..+++|+.|.|+.|.++... -.....+++|+.|+|+.|...........-+..|++|+|+
T Consensus       175 e~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs  254 (505)
T KOG3207|consen  175 ENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLS  254 (505)
T ss_pred             hhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhcccc
Confidence            99999999887322222 235678888999988887422 1224457888999999986443444455667888999999


Q ss_pred             ccccccccC-cccccCCcccEEEecCCCCCCC-CCcc--cc-ccCCCCccEEEccCCcccccc-CCcccCCCCccEEEcC
Q 003301          176 LNKLVGFVP-TSIFNLSAMKTLALPSNALSGS-LPSS--ID-LVRLPNLEIISLAGNNFSGII-PSFIFNASKLSVLELG  249 (832)
Q Consensus       176 ~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~-~p~~--~~-~~~l~~L~~L~Ls~n~i~~~~-~~~~~~l~~L~~L~L~  249 (832)
                      +|++..... .....++.|+.|+++.+.+... .|+.  .+ ...+++|++|+++.|+|.... -+.+..+.+|+.|...
T Consensus       255 ~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~  334 (505)
T KOG3207|consen  255 NNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRIT  334 (505)
T ss_pred             CCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcc
Confidence            888875321 3466788888899998888632 2221  00 135789999999999986332 1234456778888888


Q ss_pred             CCcCcc
Q 003301          250 ENSFSG  255 (832)
Q Consensus       250 ~N~i~~  255 (832)
                      .|.++.
T Consensus       335 ~n~ln~  340 (505)
T KOG3207|consen  335 LNYLNK  340 (505)
T ss_pred             cccccc
Confidence            888874

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.13  E-value=4.4e-12  Score=126.99  Aligned_cols=238  Identities=24%  Similarity=0.283  Sum_probs=153.4

Q ss_pred             cccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCc---ccccccc-----
Q 003301          290 WANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNE---LIGSIPI-----  361 (832)
Q Consensus       290 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~---l~~~~~~-----  361 (832)
                      ...+..++.++||+|.+...-..++                     ...+.+.++|+..++++--   +...+|.     
T Consensus        26 ~~~~~s~~~l~lsgnt~G~EAa~~i---------------------~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l   84 (382)
T KOG1909|consen   26 LEPMDSLTKLDLSGNTFGTEAARAI---------------------AKVLASKKELREVNLSDMFTGRLKDEIPEALKML   84 (382)
T ss_pred             hcccCceEEEeccCCchhHHHHHHH---------------------HHHHhhcccceeeehHhhhcCCcHHHHHHHHHHH
Confidence            4556677777777777653322222                     2233444455555554421   1112222     


Q ss_pred             --cccCCCCCceEEccCCccCCCCchh----hcCCCCCcEEEecCCcCCCCCc-------------ccCCCCCCCCeEeC
Q 003301          362 --TFGKLQNLQGLDLVNNKLEGPIPNG----LCQLARLSVLYMDGNKLSGPIP-------------PCIGDLTSLRLLSL  422 (832)
Q Consensus       362 --~~~~l~~L~~L~Ls~N~l~~~~~~~----~~~l~~L~~L~L~~N~l~~~~p-------------~~~~~l~~L~~L~L  422 (832)
                        ++.+.++|++||||+|-+....+..    +.+...|++|+|.+|.+...-.             .-...-+.|+++..
T Consensus        85 ~~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~  164 (382)
T KOG1909|consen   85 SKALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFIC  164 (382)
T ss_pred             HHHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEe
Confidence              2334556777777777665444433    3445667777777777652111             12334467888888


Q ss_pred             CCCcCCCCCC----cccccCcccceeeecCCcccCC----CccccccccccceecccCcccCCc----cCCccccccccc
Q 003301          423 ASNELNSVIP----STFWNLKDILSLNFSSNFLNGS----LPEDIGNLKVVVIIDLSRNNLSGD----IPTAIGGLMNLQ  490 (832)
Q Consensus       423 ~~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~  490 (832)
                      ++|++.....    ..|...+.|+.+.++.|.|...    +...+..++.|++|||..|.++..    +...+..+++|+
T Consensus       165 ~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~  244 (382)
T KOG1909|consen  165 GRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLR  244 (382)
T ss_pred             eccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchhe
Confidence            8888865432    3456667888888888887621    224567889999999999988743    455677788999


Q ss_pred             eeecccccccccCCccc-----cCCCCCCeeccCCCcccc----cCchhhhhhccCCeeeCCCCccc
Q 003301          491 DLSLRDNGLQGSIPKSI-----GGLVSLESLDLSNNSLSG----NIPTSMEKLLYLKDLNLSFNKLE  548 (832)
Q Consensus       491 ~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~l~l~~N~l~  548 (832)
                      .|+++++.+...-..+|     ...++|++|++.+|.++.    .+...+...+.|..|+|++|.+.
T Consensus       245 El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  245 ELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             eecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            99999999986544333     346899999999999873    33445566888999999999984

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.13  E-value=2.1e-11  Score=115.19  Aligned_cols=105  Identities=30%  Similarity=0.415  Sum_probs=24.6

Q ss_pred             CCceEEEccCCcccccCCCCcc-CCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccc-cCcccccee
Q 003301           95 PLIKGLYMSNNKLTGPIPNNIW-QCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEM-GNLRNLEIL  172 (832)
Q Consensus        95 ~~L~~L~l~~N~l~~~~p~~l~-~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~-~~l~~L~~L  172 (832)
                      .++++|+|++|+|+ .+ +.++ .+.+|+.|+||+|.|+..  +.+..+++|+.|++++|+|+ .++..+ ..+++|++|
T Consensus        19 ~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L   93 (175)
T PF14580_consen   19 VKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL   93 (175)
T ss_dssp             -------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred             cccccccccccccc-cc-cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence            34555555555555 22 2343 345555555555555532  23555555556666666555 232222 245555555


Q ss_pred             cccccccccccC-cccccCCcccEEEecCCCCC
Q 003301          173 GLQLNKLVGFVP-TSIFNLSAMKTLALPSNALS  204 (832)
Q Consensus       173 ~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~  204 (832)
                      ++++|+|..... ..+..+++|+.|+|.+|.+.
T Consensus        94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             E-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             ECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            555555543211 22334444444444444443

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.12  E-value=3.2e-10  Score=114.92  Aligned_cols=143  Identities=20%  Similarity=0.184  Sum_probs=110.7

Q ss_pred             CeeeccCCceEEEEEecCCcEEEEEEEeccch-hhHHHHHHHHHHHhcCCC--CceeeeceEEecC---CeeEEEEecCC
Q 003301          665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLE-GALKSFDVECEVLKSVRH--RNLVKIISSCTNN---DFKALVLEYMP  738 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e~~~  738 (832)
                      +.++.|.++.||++...+|+.+++|....... .....+.+|+++++.+++  ..+++++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999886678999998764332 134578889999999875  3467777776653   36689999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 003301          739 NGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG-------------------------------------------  775 (832)
Q Consensus       739 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-------------------------------------------  775 (832)
                      |.++.+.+..  ..++..+...++.++++++.++|..                                           
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9888775532  2467777788888888888888831                                           


Q ss_pred             ----------CCCCeEecCCCCCCeEeCC--CCcEEEecccccccc
Q 003301          776 ----------YSNPVVHCDIKPSNVLLDK--DMVAHLSDFGIAKLL  809 (832)
Q Consensus       776 ----------~~~~ivH~Dlkp~NIl~~~--~~~~kl~DFg~a~~~  809 (832)
                                ....++|+|++|.||+++.  ++.+.|+||+.+..-
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                      1256799999999999998  677899999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.11  E-value=1.1e-11  Score=137.44  Aligned_cols=251  Identities=27%  Similarity=0.282  Sum_probs=159.7

Q ss_pred             cccccCcEEEccCCcCCCCCCCcccCcccccccccccccccccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCc
Q 003301           42 GNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL  121 (832)
Q Consensus        42 ~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L  121 (832)
                      ..+..++.+.+..|.+. .+-..++.+.++ +.|++.+|+|. .+...+ ..+++|++|++++|+|+...  .+..++.|
T Consensus        69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l-~~l~l~~n~i~-~i~~~l-~~~~~L~~L~ls~N~I~~i~--~l~~l~~L  142 (414)
T KOG0531|consen   69 ESLTSLKELNLRQNLIA-KILNHLSKLKSL-EALDLYDNKIE-KIENLL-SSLVNLQVLDLSFNKITKLE--GLSTLTLL  142 (414)
T ss_pred             HHhHhHHhhccchhhhh-hhhcccccccce-eeeeccccchh-hcccch-hhhhcchheecccccccccc--chhhccch
Confidence            45556666666666666 344445666666 66777777766 344322 25677777777777777332  35556667


Q ss_pred             cEEECcCCcccccCCCCCcCCCcCceEEecccccccccCcc-ccCccccceecccccccccccCcccccCCcccEEEecC
Q 003301          122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYE-MGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPS  200 (832)
Q Consensus       122 ~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  200 (832)
                      +.|++++|.|+..  ..+..+++|+.+++++|++.. +... ...+.+++.+++.+|.+..+  ..+..+..+..+++..
T Consensus       143 ~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~-ie~~~~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~  217 (414)
T KOG0531|consen  143 KELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVD-IENDELSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLD  217 (414)
T ss_pred             hhheeccCcchhc--cCCccchhhhcccCCcchhhh-hhhhhhhhccchHHHhccCCchhcc--cchHHHHHHHHhhccc
Confidence            7777777777632  445667777778888887773 3332 46677778888888877643  3344555555667777


Q ss_pred             CCCCCCCCccccccCCCC--ccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccccCC
Q 003301          201 NALSGSLPSSIDLVRLPN--LEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLT  278 (832)
Q Consensus       201 n~l~~~~p~~~~~~~l~~--L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  278 (832)
                      |.++..-+.    ..+..  |+.+++++|.+.... ..+..+..+..|++.+|++...  ..+...+.+..+....|.+.
T Consensus       218 n~i~~~~~l----~~~~~~~L~~l~l~~n~i~~~~-~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~  290 (414)
T KOG0531|consen  218 NKISKLEGL----NELVMLHLRELYLSGNRISRSP-EGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLA  290 (414)
T ss_pred             ccceeccCc----ccchhHHHHHHhcccCcccccc-ccccccccccccchhhcccccc--ccccccchHHHhccCcchhc
Confidence            777632211    12233  788888888887432 4456678888888888888754  33556677788888888876


Q ss_pred             CCCCccccccccccCCCCcEEeccCCCCCCCCC
Q 003301          279 SSTSELSFLSSWANCKNLKLLDLSNNPINGVLP  311 (832)
Q Consensus       279 ~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  311 (832)
                      ....... .......+.++...+..|.+....+
T Consensus       291 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
T KOG0531|consen  291 LSEAISQ-EYITSAAPTLVTLTLELNPIRKISS  322 (414)
T ss_pred             chhhhhc-cccccccccccccccccCccccccc
Confidence            4322211 1114567788999999999876544

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.08  E-value=2e-11  Score=138.97  Aligned_cols=173  Identities=27%  Similarity=0.332  Sum_probs=138.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC--CcEEEEEEEeccc--hhhHHHHHHHHHHHhcCC-CCceeeeceEEecCCeeEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD--GMEVAIKVFHLQL--EGALKSFDVECEVLKSVR-HRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  732 (832)
                      ...|.+.+.||+|+|+.|-.+....  ...+|+|.+....  ....+....|..+-+.+. |+|++.+++.....+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            4567888889999999998886644  3445666554332  333455566888877776 9999999999999999999


Q ss_pred             EEecCCCCCHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC-cEEEeccccccccC
Q 003301          733 VLEYMPNGSLEDYL-YSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAKLLS  810 (832)
Q Consensus       733 v~e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~DFg~a~~~~  810 (832)
                      ++||.+|+++.+-+ .......+...+..++.|+..++.|+|.  ..++.|||+||+|.+++..+ ..|++|||+|..+.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            99999999999888 4433256777788899999999999995  67899999999999999999 99999999998775


Q ss_pred             C--Ccccccccccc-cccccCCCCC
Q 003301          811 G--EESMKQTLTLA-TIGYMAPGLF  832 (832)
Q Consensus       811 ~--~~~~~~~~~~g-t~~y~APE~l  832 (832)
                      .  .........+| ++.|+|||..
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~  201 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHL  201 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccc
Confidence            5  22333344678 9999999974

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.07  E-value=8.4e-11  Score=133.52  Aligned_cols=135  Identities=28%  Similarity=0.405  Sum_probs=93.5

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      ...+|+.++.|..|+||.||.++++. .+.+|+| +.++.     .+.+-  ++.....|++|                 
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhhc--cccccCCccee-----------------
Confidence            35789999999999999999999875 6678874 33221     11111  23333444444                 


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc--
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE--  813 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~--  813 (832)
                          |+-.+.++..+ .++.+        ++.+++|+|   +.||+|||+||+|.+|+.-|.+|++|||+.+..-...  
T Consensus       136 ----gDc~tllk~~g-~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 ----GDCATLLKNIG-PLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             ----chhhhhcccCC-CCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence                45555555433 33322        278999999   9999999999999999999999999999987532110  


Q ss_pred             ------------ccccccccccccccCCCCC
Q 003301          814 ------------SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ------------~~~~~~~~gt~~y~APE~l  832 (832)
                                  .......+|||.|+||||+
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi  230 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI  230 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhh
Confidence                        0111235899999999985

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.06  E-value=2.4e-10  Score=111.07  Aligned_cols=76  Identities=26%  Similarity=0.274  Sum_probs=66.1

Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccccc
Q 003301          740 GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL  819 (832)
Q Consensus       740 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~  819 (832)
                      |+|.++++..+..+++..+..++.|++.||+|||   +.+      ||+||+++.++.+|+  ||.++......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc------
Confidence            6899999876667999999999999999999999   776      999999999999999  99998754322      


Q ss_pred             ccccccccCCCCC
Q 003301          820 TLATIGYMAPGLF  832 (832)
Q Consensus       820 ~~gt~~y~APE~l  832 (832)
                      ..||+.|||||++
T Consensus        64 ~~g~~~y~aPE~~   76 (176)
T smart00750       64 SRVDPYFMAPEVI   76 (176)
T ss_pred             CCCcccccChHHh
Confidence            2589999999974

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=99.05  E-value=8.6e-11  Score=138.55  Aligned_cols=125  Identities=23%  Similarity=0.397  Sum_probs=60.6

Q ss_pred             ccccccccccccCCChhhhhcCCCceEEEccCCc--ccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEe
Q 003301           73 TGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNK--LTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYL  150 (832)
Q Consensus        73 ~~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~~N~--l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~L  150 (832)
                      +.+.+.+|.+. .++...  ..++|++|-+..|.  +....++.|..++.|++|||++|.=-+.+|+.+++|-+|++|+|
T Consensus       526 rr~s~~~~~~~-~~~~~~--~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L  602 (889)
T KOG4658|consen  526 RRMSLMNNKIE-HIAGSS--ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDL  602 (889)
T ss_pred             eEEEEeccchh-hccCCC--CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccc
Confidence            34444444444 333332  22345555555553  33122222444555555555554443455555555555555555


Q ss_pred             cccccccccCccccCccccceecccccccccccCcccccCCcccEEEecCC
Q 003301          151 GFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSN  201 (832)
Q Consensus       151 s~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n  201 (832)
                      ++..++ .+|..+++|..|.+|++..+.-...+|.....+++|++|.+...
T Consensus       603 ~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s  652 (889)
T KOG4658|consen  603 SDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRS  652 (889)
T ss_pred             cCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeecc
Confidence            555555 45555555555555555555444334444444555555555443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=98.99  E-value=4.8e-10  Score=121.62  Aligned_cols=121  Identities=33%  Similarity=0.524  Sum_probs=100.8

Q ss_pred             HhcCCCCceeeeceEEecCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe-EecCCCC
Q 003301          709 LKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPV-VHCDIKP  787 (832)
Q Consensus       709 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i-vH~Dlkp  787 (832)
                      ++.+.|.|+.+++|.+.++...++|.+||..|+|.+.+......+++.....+.++++.|++|+|   ...| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence            35678999999999999999999999999999999999987778999999999999999999999   4444 9999999


Q ss_pred             CCeEeCCCCcEEEeccccccccCCC-cccccccccccccccCCCCC
Q 003301          788 SNVLLDKDMVAHLSDFGIAKLLSGE-ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       788 ~NIl~~~~~~~kl~DFg~a~~~~~~-~~~~~~~~~gt~~y~APE~l  832 (832)
                      .|.++|....+|++|||+....... .........-..-|.|||++
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPell  123 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELL  123 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHh
Confidence            9999999999999999998776421 11111112234569999974

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.98  E-value=2.6e-09  Score=102.84  Aligned_cols=127  Identities=23%  Similarity=0.233  Sum_probs=84.5

Q ss_pred             eEEEEEecCCcEEEEEEEeccc--------------------------hhhHHHHHHHHHHHhcCCCC--ceeeeceEEe
Q 003301          674 SVYKGSFLDGMEVAIKVFHLQL--------------------------EGALKSFDVECEVLKSVRHR--NLVKIISSCT  725 (832)
Q Consensus       674 ~V~~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~  725 (832)
                      .||.|...+|..||+|+.+...                          ........+|.+.|.++...  ++++.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899998889999999985321                          01124567799999999765  467776553 


Q ss_pred             cCCeeEEEEecCC--CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeEecCCCCCCeEeCCCCcEEEec
Q 003301          726 NNDFKALVLEYMP--NGSLEDYLYSNNFSFDILQRLSVIIDVALALEY-LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSD  802 (832)
Q Consensus       726 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D  802 (832)
                         ..++||||++  |..+..+. ...  ++......++.+++..+.. +|   ..|++|+|+.+.||+++++ .+.|+|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~-~~~--~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLK-DVD--LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHH-HCG--GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred             ---CCEEEEEecCCCccchhhHH-hcc--ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence               3479999997  54454433 221  1233456677788875555 58   9999999999999999887 999999


Q ss_pred             cccccccCC
Q 003301          803 FGIAKLLSG  811 (832)
Q Consensus       803 Fg~a~~~~~  811 (832)
                      ||.|.....
T Consensus       150 f~qav~~~~  158 (188)
T PF01163_consen  150 FGQAVDSSH  158 (188)
T ss_dssp             GTTEEETTS
T ss_pred             cCcceecCC
Confidence            999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.98  E-value=7.3e-09  Score=106.09  Aligned_cols=141  Identities=16%  Similarity=0.111  Sum_probs=103.0

Q ss_pred             CCeeeccCCceEEEEEecCCcEEEEEEEeccchh-----------hHHHHHHHHHHHhcCCCCce--eeeceEEec----
Q 003301          664 SNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEG-----------ALKSFDVECEVLKSVRHRNL--VKIISSCTN----  726 (832)
Q Consensus       664 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~----  726 (832)
                      ++.+-......|+++.. +|+.|.||........           ....+.+|...+.++...+|  ++.+++...    
T Consensus        27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            35566555566778766 7889999977433211           11147789998888854443  344555532    


Q ss_pred             -CCeeEEEEecCCCC-CHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC-------CC
Q 003301          727 -NDFKALVLEYMPNG-SLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK-------DM  796 (832)
Q Consensus       727 -~~~~~lv~e~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-------~~  796 (832)
                       ....++|||++++. +|.+++... ....+...+..++.+++..+.-||   ..||+|+|++++|||++.       ++
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCc
Confidence             23578999999875 899988542 223566777889999999999999   999999999999999975       46


Q ss_pred             cEEEeccccccc
Q 003301          797 VAHLSDFGIAKL  808 (832)
Q Consensus       797 ~~kl~DFg~a~~  808 (832)
                      .+.++||+.++.
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            899999998864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=98.97  E-value=9.1e-11  Score=124.47  Aligned_cols=99  Identities=25%  Similarity=0.441  Sum_probs=82.9

Q ss_pred             CeeEEEEecCCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccc
Q 003301          728 DFKALVLEYMPNGSLEDYLYSNN--FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGI  805 (832)
Q Consensus       728 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~  805 (832)
                      .+.||.|++|+..+|.+|+.+++  ..-++.....++.|++.|++|      ++.+|||+||.||+...+..+||.|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence            35789999999999999997543  346778889999999999998      6899999999999999999999999999


Q ss_pred             ccccCCCc-----ccccccccccccccCCCCC
Q 003301          806 AKLLSGEE-----SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       806 a~~~~~~~-----~~~~~~~~gt~~y~APE~l  832 (832)
                      ........     ....+..+||..||+||.+
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi  434 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQI  434 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHH
Confidence            88765544     2233446799999999964

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.92  E-value=1e-09  Score=129.56  Aligned_cols=152  Identities=26%  Similarity=0.369  Sum_probs=113.1

Q ss_pred             cccccCcEEEccCCcCCCCCCCcccCcccccccccccccc--cccCCChhhhhcCCCceEEEccCCcccccCCCCccCCC
Q 003301           42 GNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNS--LTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCK  119 (832)
Q Consensus        42 ~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~--l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~  119 (832)
                      ......+...+-+|.+. .++.....- .+ +.|-+..|.  +. .++..+|..++.|++|||++|.=-+.+|+.++.+.
T Consensus       520 ~~~~~~rr~s~~~~~~~-~~~~~~~~~-~L-~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li  595 (889)
T KOG4658|consen  520 KSWNSVRRMSLMNNKIE-HIAGSSENP-KL-RTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELV  595 (889)
T ss_pred             cchhheeEEEEeccchh-hccCCCCCC-cc-ceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhh
Confidence            34456777777777776 555444322 45 666777775  55 78888888899999999998865568999999999


Q ss_pred             CccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccccccc--cccCcccccCCcccEEE
Q 003301          120 ELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLV--GFVPTSIFNLSAMKTLA  197 (832)
Q Consensus       120 ~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~  197 (832)
                      +|++|+|++..+. .+|..+++|++|.+||+..+.-...+|.....+++|++|.+-.-...  ...-..+.++.+|+.+.
T Consensus       596 ~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls  674 (889)
T KOG4658|consen  596 HLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLS  674 (889)
T ss_pred             hhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhe
Confidence            9999999999998 68999999999999999998876566777888999999998755421  11222334445555554


Q ss_pred             e
Q 003301          198 L  198 (832)
Q Consensus       198 L  198 (832)
                      .
T Consensus       675 ~  675 (889)
T KOG4658|consen  675 I  675 (889)
T ss_pred             e
Confidence            4

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.91  E-value=8.9e-09  Score=101.20  Aligned_cols=140  Identities=21%  Similarity=0.196  Sum_probs=104.3

Q ss_pred             CCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccc----------------------hhhHHHHHHHHHHHhcCCCC--
Q 003301          660 QFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL----------------------EGALKSFDVECEVLKSVRHR--  715 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~--  715 (832)
                      -..++..||.|.-+.||.|....|.++|||.-+...                      .-......+|.++|.++...  
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            345678999999999999999889999999643110                      01123456799999998654  


Q ss_pred             ceeeeceEEecCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC
Q 003301          716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD  795 (832)
Q Consensus       716 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~  795 (832)
                      .|++.+++    +...+||||++|-.|...-      ++......++..|+.-+...-   ..|+||+|+.+-||+++++
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~d  238 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTED  238 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecC
Confidence            67777766    4568999999886664321      234444556666666666555   6889999999999999999


Q ss_pred             CcEEEeccccccccCCC
Q 003301          796 MVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       796 ~~~kl~DFg~a~~~~~~  812 (832)
                      |.+.++||--+.....+
T Consensus       239 g~~~vIDwPQ~v~~~hp  255 (304)
T COG0478         239 GDIVVIDWPQAVPISHP  255 (304)
T ss_pred             CCEEEEeCcccccCCCC
Confidence            99999999888765443

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.91  E-value=9.9e-10  Score=119.12  Aligned_cols=170  Identities=24%  Similarity=0.248  Sum_probs=136.2

Q ss_pred             cCCCCCCeeec--cCCceEEEEEe--c-CCcEEEEEEEeccch--hhHHHHHHHHHHHhcC-CCCceeeeceEEecCCee
Q 003301          659 NQFNASNLIGT--GGFGSVYKGSF--L-DGMEVAIKVFHLQLE--GALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       659 ~~~~~~~~lg~--G~~g~V~~~~~--~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  730 (832)
                      ..|.+.+.+|.  |.+|.||.+..  . ++..+|+|.-+....  ....+-.+|+...+.+ .|++.++.+..+..++..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            45677888999  99999999976  3 588899997443322  2223445577766666 499999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeEecCCCCCCeEeCCC-CcEEEecccc
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL----ALEYLHFGYSNPVVHCDIKPSNVLLDKD-MVAHLSDFGI  805 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~kl~DFg~  805 (832)
                      |+-+|++ +.++.++.......++....+.+..+...    |+.++|   ..+++|-|+||.||+...+ ...+.+|||.
T Consensus       194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcce
Confidence            9999999 68999998876656888888888888888    999999   9999999999999999999 8999999999


Q ss_pred             ccccCCCccccc----ccccccccccCCCCC
Q 003301          806 AKLLSGEESMKQ----TLTLATIGYMAPGLF  832 (832)
Q Consensus       806 a~~~~~~~~~~~----~~~~gt~~y~APE~l  832 (832)
                      ...+........    ....|...|+|||+.
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~  300 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELL  300 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhh
Confidence            988765542211    112477789999963

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.88  E-value=1.6e-09  Score=84.13  Aligned_cols=61  Identities=36%  Similarity=0.587  Sum_probs=45.4

Q ss_pred             CCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccccC
Q 003301          217 PNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFL  277 (832)
Q Consensus       217 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l  277 (832)
                      |+|++|++++|+++.+.++.|.++++|++|++++|.++.+.+++|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4567777777777777777777777777777777777777777777777777777777764

...

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.87  E-value=1.1e-08  Score=111.85  Aligned_cols=123  Identities=19%  Similarity=0.196  Sum_probs=104.7

Q ss_pred             ecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHH
Q 003301          680 FLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRL  759 (832)
Q Consensus       680 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  759 (832)
                      ..++.+|.|.+++.......+...+.++-++.++||+|+++++.+..++..|+|+|.+  ..|..++++..    ...+.
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~----~~~v~  107 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG----KEEVC  107 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH----HHHHH
Confidence            3468899999888766544566778889999999999999999999999999999998  47888887543    55666


Q ss_pred             HHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          760 SVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       760 ~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      ..+.||+.||.|||.  ..+++|++|.-..|+|++.|..||++|..+....
T Consensus       108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~  156 (690)
T KOG1243|consen  108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKAS  156 (690)
T ss_pred             HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence            678999999999985  6789999999999999999999999999886543

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.85  E-value=3.1e-09  Score=82.51  Aligned_cols=59  Identities=34%  Similarity=0.415  Sum_probs=30.7

Q ss_pred             CceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccc
Q 003301           96 LIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNN  154 (832)
Q Consensus        96 ~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~  154 (832)
                      +|++|++++|+|+...++.|..+++|++|++++|+++...|+.|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            44555555555553333445555555555555555554444555555555555555554

...

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.77  E-value=3.2e-10  Score=98.27  Aligned_cols=136  Identities=22%  Similarity=0.276  Sum_probs=99.1

Q ss_pred             CCeEeCCCCcCCCCCCcc---cccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceee
Q 003301          417 LRLLSLASNELNSVIPST---FWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLS  493 (832)
Q Consensus       417 L~~L~L~~N~l~~~~~~~---~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  493 (832)
                      +..+||+++++-. +++.   +.....|+..+|++|.+....+..-...+.++.|+|++|.|+ .+|..+..|+.|+.|+
T Consensus        29 ~h~ldLssc~lm~-i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN  106 (177)
T KOG4579|consen   29 LHFLDLSSCQLMY-IADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN  106 (177)
T ss_pred             hhhcccccchhhH-HHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence            4556666666643 2332   234456667788888888544443344568889999999998 6788899999999999


Q ss_pred             cccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCCCCCC
Q 003301          494 LRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGP  556 (832)
Q Consensus       494 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~  556 (832)
                      ++.|.+. ..|..+..|.+|-.||..+|.+. .+|..+-.-......++.+++|.+.+|...|
T Consensus       107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klq  167 (177)
T KOG4579|consen  107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQ  167 (177)
T ss_pred             cccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccc
Confidence            9999998 78888888999999999999887 5555543334445567788999998887543

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.69  E-value=7.3e-10  Score=120.57  Aligned_cols=200  Identities=30%  Similarity=0.297  Sum_probs=137.8

Q ss_pred             cCcccEEEeecCcccccc-cccccCCCCCceEEccCCccCCCCchhhcCC-CCCcEEEecCCcCCC---CCcccCCC---
Q 003301          342 LINLRELGLWGNELIGSI-PITFGKLQNLQGLDLVNNKLEGPIPNGLCQL-ARLSVLYMDGNKLSG---PIPPCIGD---  413 (832)
Q Consensus       342 l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~---~~p~~~~~---  413 (832)
                      +++++.|.+-.-.=.+.. |-.+....+|++|.|.++.|..  ...+..+ ..|+.|.. +|.+..   .+..+.+.   
T Consensus        83 lqkt~~lkl~~~pa~~pt~pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~n  159 (1096)
T KOG1859|consen   83 LQKTKVLKLLPSPARDPTEPISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLIC-HNSLDALRHVFASCGGDISN  159 (1096)
T ss_pred             HhhheeeeecccCCCCCCCCceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhh-hccHHHHHHHHHHhcccccc
Confidence            445555555443322222 5566778899999999998873  2222222 23444432 233320   11111111   


Q ss_pred             ---CCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccc
Q 003301          414 ---LTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQ  490 (832)
Q Consensus       414 ---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  490 (832)
                         ...|...+.++|.+.- ...++.-++.|+.|||++|+++..  ..+..++.|++|||++|+++...--...++. |+
T Consensus       160 s~~Wn~L~~a~fsyN~L~~-mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~  235 (1096)
T KOG1859|consen  160 SPVWNKLATASFSYNRLVL-MDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQ  235 (1096)
T ss_pred             chhhhhHhhhhcchhhHHh-HHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-he
Confidence               1347778889999864 456677789999999999999854  3788999999999999999854334455555 99


Q ss_pred             eeecccccccccCCccccCCCCCCeeccCCCcccccCc-hhhhhhccCCeeeCCCCccccc
Q 003301          491 DLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIP-TSMEKLLYLKDLNLSFNKLEGE  550 (832)
Q Consensus       491 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~  550 (832)
                      .|++++|.++..  ..+.+|.+|+.|||++|-|++.-- .-+..|.+|..|+|.+|++.|.
T Consensus       236 ~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  236 LLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             eeeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            999999999832  356789999999999999986433 2355688899999999999875

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.61  E-value=1.6e-07  Score=93.24  Aligned_cols=107  Identities=23%  Similarity=0.291  Sum_probs=84.9

Q ss_pred             HHHHHHHHHHhcCCCCc--eeeeceEEecCC----eeEEEEecCCCC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHH
Q 003301          700 KSFDVECEVLKSVRHRN--LVKIISSCTNND----FKALVLEYMPNG-SLEDYLYSNNFSFDILQRLSVIIDVALALEYL  772 (832)
Q Consensus       700 ~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L  772 (832)
                      ....+|...+..+....  +++.+++.....    ..++|+|++++. +|.+++.... ..+......++.+++..++-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHHH
Confidence            46777888877775433  455666655422    458999999874 8999987643 256677888999999999999


Q ss_pred             hcCCCCCeEecCCCCCCeEeCCCC---cEEEeccccccccC
Q 003301          773 HFGYSNPVVHCDIKPSNVLLDKDM---VAHLSDFGIAKLLS  810 (832)
Q Consensus       773 H~~~~~~ivH~Dlkp~NIl~~~~~---~~kl~DFg~a~~~~  810 (832)
                      |   ..||+|+|+++.|||++.++   .+.++||+-++...
T Consensus       135 H---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  135 H---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             H---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            9   99999999999999998887   89999999887654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.61  E-value=1.4e-07  Score=104.74  Aligned_cols=142  Identities=21%  Similarity=0.236  Sum_probs=94.6

Q ss_pred             CeeeccCCceEEEEEecCCcEEEEEEEeccchh----------------------------------hHH------HHHH
Q 003301          665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEG----------------------------------ALK------SFDV  704 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------------------~~~------~~~~  704 (832)
                      +.|+.++-|.||+|+..+|+.||||+.+...+.                                  ..+      ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            789999999999999999999999997532110                                  001      1233


Q ss_pred             HHHHHhcCC-----CCceeeeceEEecCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHH-HHHHhcCCCC
Q 003301          705 ECEVLKSVR-----HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALA-LEYLHFGYSN  778 (832)
Q Consensus       705 e~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~-l~~LH~~~~~  778 (832)
                      |..-+.+++     .|.+.-..=|+...+...++|||++|-.+.+...-.....+...   ++..++++ +..+-   ..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~---~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLL---RD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHH---hc
Confidence            444444442     34332222233444566899999999988887432223355333   33333322 23333   56


Q ss_pred             CeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       779 ~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      |++|.|.+|.||+++.+|.+.+.|||+...+.+.
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            9999999999999999999999999998876543

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.59  E-value=7.3e-10  Score=120.56  Aligned_cols=21  Identities=24%  Similarity=0.263  Sum_probs=14.4

Q ss_pred             CccccccccCcEEEccCCcCC
Q 003301           38 PQELGNLAELELVSLTNNFLS   58 (832)
Q Consensus        38 p~~~~~l~~L~~L~l~~n~l~   58 (832)
                      |-.+..+.+|++|.|.++.+.
T Consensus       102 pi~ifpF~sLr~LElrg~~L~  122 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLS  122 (1096)
T ss_pred             CceeccccceeeEEecCcchh
Confidence            445666777777777777765

>PRK09902 hypothetical protein; Provisional

Probab=98.59  E-value=6.8e-07  Score=86.39  Aligned_cols=154  Identities=17%  Similarity=0.145  Sum_probs=110.3

Q ss_pred             hHHHHHHhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccc------hhhHHHHHHHHHHHhcCCCCc--eeeece
Q 003301          651 YKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL------EGALKSFDVECEVLKSVRHRN--LVKIIS  722 (832)
Q Consensus       651 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~n--iv~l~~  722 (832)
                      ++.+.....++...---|+||.+.|++... +|+.+-+|.-....      +.....|.+|...+.++..-+  +++...
T Consensus        10 f~~~w~~~~~wve~pN~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf   88 (216)
T PRK09902         10 FNHWWATEGDWVEEPNYRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVF   88 (216)
T ss_pred             HHHHHhCCCceecCCCcCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccce
Confidence            334444444444444457799999999876 55678888754111      224578899999998885322  555552


Q ss_pred             EEec----CCeeEEEEecCCC-CCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC
Q 003301          723 SCTN----NDFKALVLEYMPN-GSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM  796 (832)
Q Consensus       723 ~~~~----~~~~~lv~e~~~~-g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~  796 (832)
                      +...    .-..+||+|-++| .+|.+++.+.. .+.+......+..+++.+++-||   ..|+.|+|+-+.||+++.++
T Consensus        89 ~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g  165 (216)
T PRK09902         89 GEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEG  165 (216)
T ss_pred             eeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCC
Confidence            2222    1246799998754 58999886543 24677778899999999999999   99999999999999998666


Q ss_pred             c--EEEeccccccc
Q 003301          797 V--AHLSDFGIAKL  808 (832)
Q Consensus       797 ~--~kl~DFg~a~~  808 (832)
                      .  ++++||.-++.
T Consensus       166 ~~~v~lIDlEk~r~  179 (216)
T PRK09902        166 KAEAGFLDLEKSRR  179 (216)
T ss_pred             CeeEEEEEhhccch
Confidence            6  99999988764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.58  E-value=3.3e-08  Score=107.47  Aligned_cols=149  Identities=27%  Similarity=0.244  Sum_probs=119.2

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEec--CCcEEEEEEEeccchhhHHH--HHHHHHHHhcC-CCCceeeeceEEecCCee
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFL--DGMEVAIKVFHLQLEGALKS--FDVECEVLKSV-RHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  730 (832)
                      ....+|.....||.|.|+.|+.+...  ++..|++|...........+  -..|+.+...+ .|.++++++..|......
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            34568888999999999999998654  47889999775443322222  23455555555 599999999999888888


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC-CcEEEeccccccc
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD-MVAHLSDFGIAKL  808 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~kl~DFg~a~~  808 (832)
                      |+--|||++++......-. ..+++..++++..|++.++.++|   ++.++|+|+||+||++..+ +..++.|||.+..
T Consensus       342 ~ip~e~~~~~s~~l~~~~~-~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTS-QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             cCchhhhcCcchhhhhHHH-HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccc
Confidence            9999999999887766322 24778888999999999999999   9999999999999999876 8889999999864

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.56  E-value=7.5e-07  Score=87.05  Aligned_cols=155  Identities=21%  Similarity=0.215  Sum_probs=102.2

Q ss_pred             cchHHHHHHhcCCCCCCeee---ccCCceEEEEEecCCcEEEEEEEeccchhh------------------------HHH
Q 003301          649 FSYKELLQATNQFNASNLIG---TGGFGSVYKGSFLDGMEVAIKVFHLQLEGA------------------------LKS  701 (832)
Q Consensus       649 ~~~~~~~~~~~~~~~~~~lg---~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------------------------~~~  701 (832)
                      .+.+.+.....+..+.+..|   .|.-+.||+|...++..||||+++......                        ...
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            34455566666666666555   677778999988789999999986432110                        112


Q ss_pred             HHHHHHHHhcCC--CCceeeeceEEecCCeeEEEEecCCCCCH-HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 003301          702 FDVECEVLKSVR--HRNLVKIISSCTNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN  778 (832)
Q Consensus       702 ~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~  778 (832)
                      ..+|..-|+++.  +-.+++.+++..    ..+||||+..... .-.++.  .......+..+..++++.+.-|-.  ..
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~--~a  186 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYK--EA  186 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHH--hc
Confidence            334666666653  334555555532    3699999944210 001111  123333577778888888887771  48


Q ss_pred             CeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       779 ~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ++||+|++.-|||+. ++.+.|+|||-|.....+
T Consensus       187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp  219 (268)
T COG1718         187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP  219 (268)
T ss_pred             CcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence            999999999999998 889999999999876543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.48  E-value=1.2e-06  Score=84.88  Aligned_cols=137  Identities=15%  Similarity=0.164  Sum_probs=90.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHH---------HHHHHHHHhcCC---CCceeeeceEEe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKS---------FDVECEVLKSVR---HRNLVKIISSCT  725 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~---h~niv~l~~~~~  725 (832)
                      ..+|.+.+++.......|.+-.. +|+.+++|..+.......+.         ..+++....+++   -.....++.+..
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            56788888888877777776655 78999999877554322222         223333333332   222233222222


Q ss_pred             -----cCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEE
Q 003301          726 -----NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHL  800 (832)
Q Consensus       726 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl  800 (832)
                           .....+++|||++|..+.++..     +++    .++..+++++.-+|   +.|++|+|..|.|++++.+ .+++
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~i~i  175 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-GIRI  175 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-cEEE
Confidence                 2234568999999988866532     222    24456778899999   9999999999999999855 5999


Q ss_pred             eccccccc
Q 003301          801 SDFGIAKL  808 (832)
Q Consensus       801 ~DFg~a~~  808 (832)
                      +||+..+.
T Consensus       176 ID~~~k~~  183 (229)
T PF06176_consen  176 IDTQGKRM  183 (229)
T ss_pred             EECccccc
Confidence            99987754

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.47  E-value=4.4e-08  Score=96.21  Aligned_cols=84  Identities=27%  Similarity=0.263  Sum_probs=41.2

Q ss_pred             CccEEEccCCcccc--ccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCC
Q 003301          218 NLEIISLAGNNFSG--IIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKN  295 (832)
Q Consensus       218 ~L~~L~Ls~n~i~~--~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~  295 (832)
                      .++++||.+|.|+.  .+...+.+++.|++|+|+.|++...+...-..+.+|+.|-|.+..+.--..    -+.+..++.
T Consensus        72 ~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~----~s~l~~lP~  147 (418)
T KOG2982|consen   72 DVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQS----TSSLDDLPK  147 (418)
T ss_pred             hhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhh----hhhhhcchh
Confidence            44444444444442  122334456666666666666653332221345566666666555532111    112455666


Q ss_pred             CcEEeccCCC
Q 003301          296 LKLLDLSNNP  305 (832)
Q Consensus       296 L~~L~L~~N~  305 (832)
                      +++|++|.|.
T Consensus       148 vtelHmS~N~  157 (418)
T KOG2982|consen  148 VTELHMSDNS  157 (418)
T ss_pred             hhhhhhccch
Confidence            6666666663

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.46  E-value=5.3e-09  Score=90.79  Aligned_cols=69  Identities=22%  Similarity=0.375  Sum_probs=30.9

Q ss_pred             CChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccc
Q 003301           86 LPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLT  156 (832)
Q Consensus        86 lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~  156 (832)
                      +|..+...++.++.|++++|+|+ .+|.++..++.|+.|+++.|.+. ..|+.|..|.+|-+|+..+|.+.
T Consensus        68 fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~  136 (177)
T KOG4579|consen   68 FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA  136 (177)
T ss_pred             CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence            33333333333444444444444 34444444444444444444443 34444444555555555555544

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.44  E-value=2.1e-06  Score=86.25  Aligned_cols=133  Identities=12%  Similarity=0.137  Sum_probs=86.5

Q ss_pred             CeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCc--eeeeceEEecCCeeEEEEecCCCCC-
Q 003301          665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRN--LVKIISSCTNNDFKALVLEYMPNGS-  741 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~-  741 (832)
                      ..||+|..+.||+.   .+..+++|......  ......+|.++++.+..-.  +++.+++....+..++|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999984   35578889876433  2345688999998886433  5777888877778889999998863 


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHH---------------------------------------HHHHh-cCCCCCeE
Q 003301          742 LEDYLYSNNFSFDILQRLSVIIDVALA---------------------------------------LEYLH-FGYSNPVV  781 (832)
Q Consensus       742 L~~~l~~~~~~~~~~~~~~i~~~i~~~---------------------------------------l~~LH-~~~~~~iv  781 (832)
                      +...+..     +......++.++++.                                       ..++. ......++
T Consensus        82 ~~~~~~~-----~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~  156 (226)
T TIGR02172        82 FSRIISD-----NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL  156 (226)
T ss_pred             hhhhhcC-----CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence            2211110     000111111111111                                       11221 01234678


Q ss_pred             ecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          782 HCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       782 H~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      |+|+.|.||++++++ +.++||+.|..
T Consensus       157 HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       157 HGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            999999999999888 99999998864

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.43  E-value=1.5e-06  Score=92.37  Aligned_cols=138  Identities=22%  Similarity=0.267  Sum_probs=108.0

Q ss_pred             CceEEEEEe-cCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEec----CCeeEEEEecCCC-CCHHHH
Q 003301          672 FGSVYKGSF-LDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN----NDFKALVLEYMPN-GSLEDY  745 (832)
Q Consensus       672 ~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L~~~  745 (832)
                      -.+.|+|.. .+|..|++|++.............-++.++++.|+|||++.+++..    +...++|++|.++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            356788865 4799999999854332222233446788999999999999998873    4578899999876 577776


Q ss_pred             HhhC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          746 LYSN--------------NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       746 l~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      ....              +...++...+.++.|+..||.++|   +.|..-+-+.|.+|+++.+.+++|+..|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            4321              123678899999999999999999   99999999999999999999999998888766544


Q ss_pred             C
Q 003301          812 E  812 (832)
Q Consensus       812 ~  812 (832)
                      +
T Consensus       446 d  446 (655)
T KOG3741|consen  446 D  446 (655)
T ss_pred             C
Confidence            3

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	832
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		5e-44
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-43
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-25
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-25
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-22
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-22
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-20
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-19
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-19
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-19
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-17
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-16
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-15
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-14
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		8e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		6e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-13
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		9e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-12
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-12
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-12
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-12
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		7e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-12
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		8e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-11
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-11
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-11
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-11
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-11
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-11
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-11
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-11
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-11
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-11
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		7e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-11
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		7e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		8e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-11
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		8e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		8e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		8e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		9e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		9e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		9e-11
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		9e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-10
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-10
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-10
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-10
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-10
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-10
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-10
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-10
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-10
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-10
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-10
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-10
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-10
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-10
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-10
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		8e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		8e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		9e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		9e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		9e-10
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-09
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-09
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-09
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-09
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		1e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-09
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		1e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-09
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-09
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		2e-09
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		2e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-09
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-09
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-09
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-09
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-09
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-09
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		6e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		8e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		8e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		8e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		9e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		9e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-08
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-08
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-08
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-08
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-08
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-08
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-08
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		9e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		9e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-07
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-07
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-07
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-07
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-07
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-07
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-07
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-07
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		7e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-07
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		8e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		8e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-07
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		9e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		9e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-06
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-06
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-06
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-06
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-06
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-06
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-06
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-06
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-06
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-06
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-06
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-06
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-06
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		2e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-06
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		3e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-06
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		6e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-06
3v47_A	455	Crystal Structure Of The N-Tetminal Fragment Of Zeb		7e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-06
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		8e-06
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		8e-06
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-06
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		8e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		9e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		9e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-05
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-05
4b8c_D	727	Nuclease Module Of The Yeast Ccr4-Not Complex Lengt		1e-05
3a79_B	562	Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Len		1e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-05
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-05
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-05
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-05
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-05
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		3e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-05
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-05
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-05
2wfh_A	193	The Human Slit 2 Dimerization Domain D4 Length = 19		4e-05
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		5e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-05
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		7e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-05
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-05
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		8e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		8e-05
3e6j_A	229	Crystal Structure Of Variable Lymphocyte Receptor (		9e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-05
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		9e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		9e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-04
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-04
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-04
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-04
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-04
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-04
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-04
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-04
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-04
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-04
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-04
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-04
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-04
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-04
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-04
2z63_A	570	Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A		2e-04
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-04
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-04
4fmz_A	347	Crystal Structure Of An Internalin (Inlf) From List		2e-04
3soa_A	444	Full-Length Human Camkii Length = 444		2e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-04
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-04
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-04
1p8t_A	285	Crystal Structure Of Nogo-66 Receptor Length = 285		3e-04
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-04
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-04
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-04
1ozn_A	285	1.5a Crystal Structure Of The Nogo Receptor Ligand		3e-04
3rg1_A	612	Crystal Structure Of The Rp105MD-1 Complex Length =		3e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-04
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-04
3v44_A	407	Crystal Structure Of The N-Terminal Fragment Of Zeb		6e-04
3m19_A	251	Crystal Structure Of Variable Lymphocyte Receptor V		6e-04
3m18_A	251	Crystal Structure Of Variable Lymphocyte Receptor V		6e-04
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-04
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-04
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-04
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-04
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		8e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		9e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  176 bits (446), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 182/624 (29%), Positives = 277/624 (44%), Gaps = 95/624 (15%)
Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
            L +S N+ S  IP  +G+ + L+ L +  NKL G+  + +    EL+L+++++N   G 
Sbjct: 201 FLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGP 259
Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPL--IKGLYMSNNKLTGPIPNNI-WQ 117
           IP                               LPL  ++ L ++ NK TG IP+ +   
Sbjct: 260 IPP------------------------------LPLKSLQYLSLAENKFTGEIPDFLSGA 289
Query: 118 CKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYE-MGNLRNLEILGLQL 176
           C  L  + L+ N F   +P   G+ + L++L L  NN +GE+P + +  +R L++L L  
Sbjct: 290 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF 349
Query: 177 NKLVGFVPTSIFNLSA-MKTLALPSNALSGSLPSSIDLVRLP--NLEIISLAGNNFSGII 233
           N+  G +P S+ NLSA + TL L SN  SG  P   +L + P   L+ + L  N F+G I
Sbjct: 350 NEFSGELPESLTNLSASLLTLDLSSNNFSG--PILPNLCQNPKNTLQELYLQNNGFTGKI 407
Query: 234 PSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNXXXXXXXXXXXXXXWANC 293
           P  + N S+L  L L  N  SG IP++LG+L KL  L+L  N                  
Sbjct: 408 PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY-----V 462
Query: 294 KNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGN 353
           K L+ L L  N + G +PS + N + +L+ I +SN  + G IPK IG L NL  L L  N
Sbjct: 463 KTLETLILDFNDLTGEIPSGLSNCT-NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN 521
Query: 354 ELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLC-QLARLSVLYMDGNKL-----SGPI 407
              G+IP   G  ++L  LDL  N   G IP  +  Q  +++  ++ G +       G  
Sbjct: 522 SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMK 581
Query: 408 PPCIGDLTSLRLLSLASNELNSV----------------IPSTFWNLKDIXXXXXXXXXX 451
             C G    L    + S +LN +                   TF N   +          
Sbjct: 582 KECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNML 641
Query: 452 XXXXPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGXX 511
               P++IG++  + I++L  N++SG IP  +G L  L  L L  N L G IP+      
Sbjct: 642 SGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ------ 695
Query: 512 XXXXXXXXXXXXXXXIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLL 571
                             +M  L  L +++LS N L G IP  G F  F    F+ N  L
Sbjct: 696 ------------------AMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGL 737
Query: 572 CGLAQVQVPVCKSGNSSSHRKSRK 595
           CG     +P C   N+  +   ++
Sbjct: 738 CGYP---LPRCDPSNADGYAHHQR 758

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  174 bits (441), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 182/619 (29%), Positives = 275/619 (44%), Gaps = 95/619 (15%)
Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
            L +S N+ S  IP  +G+ + L+ L +  NKL G+  + +    EL+L+++++N   G 
Sbjct: 204 FLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGP 262
Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPL--IKGLYMSNNKLTGPIPNNI-WQ 117
           IP                               LPL  ++ L ++ NK TG IP+ +   
Sbjct: 263 IPP------------------------------LPLKSLQYLSLAENKFTGEIPDFLSGA 292
Query: 118 CKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYE-MGNLRNLEILGLQL 176
           C  L  + L+ N F   +P   G+ + L++L L  NN +GE+P + +  +R L++L L  
Sbjct: 293 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF 352
Query: 177 NKLVGFVPTSIFNLSA-MKTLALPSNALSGSLPSSIDLVRLP--NLEIISLAGNNFSGII 233
           N+  G +P S+ NLSA + TL L SN  SG  P   +L + P   L+ + L  N F+G I
Sbjct: 353 NEFSGELPESLTNLSASLLTLDLSSNNFSG--PILPNLCQNPKNTLQELYLQNNGFTGKI 410
Query: 234 PSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNXXXXXXXXXXXXXXWANC 293
           P  + N S+L  L L  N  SG IP++LG+L KL  L+L  N                  
Sbjct: 411 PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY-----V 465
Query: 294 KNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGN 353
           K L+ L L  N + G +PS + N + +L+ I +SN  + G IPK IG L NL  L L  N
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCT-NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN 524
Query: 354 ELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLC-QLARLSVLYMDGNKL-----SGPI 407
              G+IP   G  ++L  LDL  N   G IP  +  Q  +++  ++ G +       G  
Sbjct: 525 SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMK 584
Query: 408 PPCIGDLTSLRLLSLASNELNSV----------------IPSTFWNLKDIXXXXXXXXXX 451
             C G    L    + S +LN +                   TF N   +          
Sbjct: 585 KECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNML 644
Query: 452 XXXXPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGXX 511
               P++IG++  + I++L  N++SG IP  +G L  L  L L  N L G IP+      
Sbjct: 645 SGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ------ 698
Query: 512 XXXXXXXXXXXXXXXIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLL 571
                             +M  L  L +++LS N L G IP  G F  F    F+ N  L
Sbjct: 699 ------------------AMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGL 740
Query: 572 CGLAQVQVPVCKSGNSSSH 590
           CG     +P C   N+  +
Sbjct: 741 CGYP---LPRCDPSNADGY 756

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 66/187 (35%), Positives = 100/187 (53%), Gaps = 4/187 (2%)
Query: 647 RRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ-LEGALKSFDVE 705
           +RFS +EL  A++ F+  N++G GGFG VYKG   DG  VA+K    +  +G    F  E
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 706 CEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFS---FDILQRLSVI 762
            E++    HRNL+++   C     + LV  YM NGS+   L     S    D  +R  + 
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA 822
           +  A  L YLH      ++H D+K +N+LLD++  A + DFG+AKL+  ++         
Sbjct: 146 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRG 205
Query: 823 TIGYMAP 829
           TIG++AP
Sbjct: 206 TIGHIAP 212

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  112 bits (281), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 65/187 (34%), Positives = 98/187 (52%), Gaps = 4/187 (2%)
Query: 647 RRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ-LEGALKSFDVE 705
           +RFS +EL  A++ F   N++G GGFG VYKG   DG  VA+K    +  +G    F  E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 706 CEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFS---FDILQRLSVI 762
            E++    HRNL+++   C     + LV  YM NGS+   L     S    D  +R  + 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA 822
           +  A  L YLH      ++H D+K +N+LLD++  A + DFG+AKL+  ++         
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRG 197
Query: 823 TIGYMAP 829
            IG++AP
Sbjct: 198 XIGHIAP 204

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 70/187 (37%), Positives = 104/187 (55%), Gaps = 13/187 (6%)
Query: 653 ELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV 712
           +L +ATN F+   LIG G FG VYKG   DG +VA+K    +    ++ F+ E E L   
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNF---SFDILQRLSVIIDVALAL 769
           RH +LV +I  C   +   L+ +YM NG+L+ +LY ++    S    QRL + I  A  L
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT----LTLATIG 825
            YLH   +  ++H D+K  N+LLD++ V  ++DFGI+K   G E + QT    +   T+G
Sbjct: 153 HYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK--KGTE-LDQTHLXXVVKGTLG 206
Query: 826 YMAPGLF 832
           Y+ P  F
Sbjct: 207 YIDPEYF 213

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  103 bits (256), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 70/187 (37%), Positives = 104/187 (55%), Gaps = 13/187 (6%)
Query: 653 ELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV 712
           +L +ATN F+   LIG G FG VYKG   DG +VA+K    +    ++ F+ E E L   
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNF---SFDILQRLSVIIDVALAL 769
           RH +LV +I  C   +   L+ +YM NG+L+ +LY ++    S    QRL + I  A  L
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT----LTLATIG 825
            YLH   +  ++H D+K  N+LLD++ V  ++DFGI+K   G E + QT    +   T+G
Sbjct: 153 HYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK--KGTE-LGQTHLXXVVKGTLG 206
Query: 826 YMAPGLF 832
           Y+ P  F
Sbjct: 207 YIDPEYF 213

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 87/288 (30%), Positives = 124/288 (43%), Gaps = 34/288 (11%)
Query: 299 LDLS--NNPINGVLPSSIGNLSLSLSRIFISNCS-IRGTIPKEIGNLINLRELGLWGNEL 355
           LDLS  N P    +PSS+ NL   L+ ++I   + + G IP  I  L  L  L +    +
Sbjct: 55  LDLSGLNLPKPYPIPSSLANLPY-LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNV 113
Query: 356 IGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLT 415
            G+IP    +++ L  LD   N L G +P  +  L  L  +  DGN++SG IP   G  +
Sbjct: 114 SGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS 173
Query: 416 SL-RLLSLASNELNSVIPSTFWNLKDIXXXXXXXXXXXXXXPEDIGNLKVVVIIDLSRNN 474
            L   ++++ N L   IP TF NL                          +  +DLSRN 
Sbjct: 174 KLFTSMTISRNRLTGKIPPTFANLN-------------------------LAFVDLSRNM 208
Query: 475 LSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGXXXXXXXXXXXXXXXXXIPTSMEKL 534
           L GD     G   N Q + L  N L   + K +G                  +P  + +L
Sbjct: 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQL 267
Query: 535 LYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVC 582
            +L  LN+SFN L GEIP+GG    F   ++  N  LCG     +P C
Sbjct: 268 KFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG---SPLPAC 312

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/197 (34%), Positives = 100/197 (50%), Gaps = 23/197 (11%)
Query: 649 FSYKELLQATNQFN------ASNLIGTGGFGSVYKGSFLDGMEVAIK----VFHLQLEGA 698
           FS+ EL   TN F+        N +G GGFG VYKG +++   VA+K    +  +  E  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 73
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFS--FDIL 756
            + FD E +V+   +H NLV+++   ++ D   LV  YMPNGSL D L   + +      
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 757 QRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK 816
            R  +    A  + +LH    N  +H DIK +N+LLD+   A +SDFG+A+     E   
Sbjct: 134 MRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR---ASEKFA 187
Query: 817 QTLT----LATIGYMAP 829
           QT+     + T  YMAP
Sbjct: 188 QTVMXXRIVGTTAYMAP 204

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/197 (34%), Positives = 100/197 (50%), Gaps = 23/197 (11%)
Query: 649 FSYKELLQATNQFN------ASNLIGTGGFGSVYKGSFLDGMEVAIK----VFHLQLEGA 698
           FS+ EL   TN F+        N +G GGFG VYKG +++   VA+K    +  +  E  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 73
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFS--FDIL 756
            + FD E +V+   +H NLV+++   ++ D   LV  YMPNGSL D L   + +      
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 757 QRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK 816
            R  +    A  + +LH    N  +H DIK +N+LLD+   A +SDFG+A+     E   
Sbjct: 134 MRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR---ASEKFA 187
Query: 817 QTLT----LATIGYMAP 829
           QT+     + T  YMAP
Sbjct: 188 QTVMXSRIVGTTAYMAP 204

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/197 (34%), Positives = 99/197 (50%), Gaps = 23/197 (11%)
Query: 649 FSYKELLQATNQFN------ASNLIGTGGFGSVYKGSFLDGMEVAIK----VFHLQLEGA 698
           FS+ EL   TN F+        N +G GGFG VYKG +++   VA+K    +  +  E  
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 67
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFS--FDIL 756
            + FD E +V+   +H NLV+++   ++ D   LV  YMPNGSL D L   + +      
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 757 QRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK 816
            R  +    A  + +LH    N  +H DIK +N+LLD+   A +SDFG+A+     E   
Sbjct: 128 MRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR---ASEKFA 181
Query: 817 QTLT----LATIGYMAP 829
           Q +     + T  YMAP
Sbjct: 182 QXVMXXRIVGTTAYMAP 198

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 95/197 (48%), Gaps = 23/197 (11%)
Query: 649 FSYKELLQATNQFN------ASNLIGTGGFGSVYKGSFLDGMEVAIK----VFHLQLEGA 698
           FS+ EL   TN F+        N  G GGFG VYKG +++   VA+K    +  +  E  
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEEL 64
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFS--FDIL 756
            + FD E +V    +H NLV+++   ++ D   LV  Y PNGSL D L   + +      
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 757 QRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK 816
            R  +    A  + +LH    N  +H DIK +N+LLD+   A +SDFG+A+     E   
Sbjct: 125 XRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR---ASEKFA 178
Query: 817 QTLT----LATIGYMAP 829
           Q +     + T  Y AP
Sbjct: 179 QXVXXSRIVGTTAYXAP 195

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 89/176 (50%), Gaps = 13/176 (7%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGMEVAIKV-----FHLQLEGALKSFDVECEVLKSVRHR 715
            N    IG G FG+V++  +  G +VA+K+     FH +    +  F  E  ++K +RH 
Sbjct: 39  LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAE---RVNEFLREVAIMKRLRHP 94
Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNF--SFDILQRLSVIIDVALALEYLH 773
           N+V  + + T     ++V EY+  GSL   L+ +      D  +RLS+  DVA  + YLH
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
              + P+VH D+K  N+L+DK     + DFG+++ L     +       T  +MAP
Sbjct: 155 -NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKASXFLXSKXAAGTPEWMAP 208

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 89/176 (50%), Gaps = 13/176 (7%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGMEVAIKV-----FHLQLEGALKSFDVECEVLKSVRHR 715
            N    IG G FG+V++  +  G +VA+K+     FH +    +  F  E  ++K +RH 
Sbjct: 39  LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAE---RVNEFLREVAIMKRLRHP 94
Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNF--SFDILQRLSVIIDVALALEYLH 773
           N+V  + + T     ++V EY+  GSL   L+ +      D  +RLS+  DVA  + YLH
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
              + P+VH ++K  N+L+DK     + DFG+++ L     +       T  +MAP
Sbjct: 155 -NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAP 208

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 94/186 (50%), Gaps = 9/186 (4%)
Query: 647 RRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ--LEGALKSFDV 704
           RR S  +      Q      IG+G FG+VYKG +    +VA+K+ ++       L++F  
Sbjct: 24  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN 81
Query: 705 ECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIID 764
           E  VL+  RH N++  +   T     A+V ++    SL  +L+     F++++ + +   
Sbjct: 82  EVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 140
Query: 765 VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-T 823
            A  ++YLH   +  ++H D+K +N+ L +D+   + DFG+A + S      Q   L+ +
Sbjct: 141 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 197
Query: 824 IGYMAP 829
           I +MAP
Sbjct: 198 ILWMAP 203

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 94/186 (50%), Gaps = 9/186 (4%)
Query: 647 RRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ--LEGALKSFDV 704
           RR S  +      Q      IG+G FG+VYKG +    +VA+K+ ++       L++F  
Sbjct: 23  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN 80
Query: 705 ECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIID 764
           E  VL+  RH N++  +   T     A+V ++    SL  +L+     F++++ + +   
Sbjct: 81  EVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 139
Query: 765 VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-T 823
            A  ++YLH   +  ++H D+K +N+ L +D+   + DFG+A + S      Q   L+ +
Sbjct: 140 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 196
Query: 824 IGYMAP 829
           I +MAP
Sbjct: 197 ILWMAP 202

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 52/168 (30%), Positives = 83/168 (49%), Gaps = 8/168 (4%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDV--ECEVLKSVRHRNLVKIISSC 724
           IG+G FG V+ G +L+  +VAIK      EGA+   D   E EV+  + H  LV++   C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
                  LV E+M +G L DYL +    F     L + +DV   + YL       V+H D
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EASVIHRD 128
Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
           +   N L+ ++ V  +SDFG+ + +  ++    T T   + + +P +F
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 176

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 84/172 (48%), Gaps = 15/172 (8%)
Query: 655 LQATNQFNASNL-----IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDV 704
           ++   QF   +L     +G G FGSV    +       G  VA+K      E  L+ F+ 
Sbjct: 1   MRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 705 ECEVLKSVRHRNLVKIISSCTNNDFK--ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVI 762
           E E+LKS++H N+VK    C +   +   L++EY+P GSL DYL  +    D ++ L   
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
             +   +EYL    +   +H D+   N+L++ +    + DFG+ K+L  ++ 
Sbjct: 121 SQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 80/162 (49%), Gaps = 15/162 (9%)
Query: 660 QFNASNL-----IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDVECEVL 709
           QF   +L     +G G FGSV    +       G  VA+K      E  L+ F+ E E+L
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 710 KSVRHRNLVKIISSCTNNDFK--ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL 767
           KS++H N+VK    C +   +   L++EY+P GSL DYL  +    D ++ L     +  
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
            +EYL    +   +H D+   N+L++ +    + DFG+ K+L
Sbjct: 144 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 182

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 15/167 (8%)
Query: 660 QFNASNL-----IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDVECEVL 709
           QF   +L     +G G FGSV    +       G  VA+K      E  L+ F+ E E+L
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 710 KSVRHRNLVKIISSCTNNDFK--ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL 767
           KS++H N+VK    C +   +   L++EY+P GSL DYL  +    D ++ L     +  
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
            +EYL    +   +H D+   N+L++ +    + DFG+ K+L  ++ 
Sbjct: 144 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 187

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 15/167 (8%)
Query: 660 QFNASNL-----IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDVECEVL 709
           QF   +L     +G G FGSV    +       G  VA+K      E  L+ F+ E E+L
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 710 KSVRHRNLVKIISSCTNNDFK--ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL 767
           KS++H N+VK    C +   +   L++EY+P GSL DYL  +    D ++ L     +  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
            +EYL    +   +H D+   N+L++ +    + DFG+ K+L  ++ 
Sbjct: 126 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 101/198 (51%), Gaps = 14/198 (7%)
Query: 637 ESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHL--Q 694
           E N +    +R  SY   ++A+ +   S  IG+G FG+VYKG +    +VA+K+  +   
Sbjct: 15  EKNKIRPRGQRDSSYYWEIEAS-EVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDP 71
Query: 695 LEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD 754
                ++F  E  VL+  RH N++  +   T ++  A+V ++    SL  +L+     F 
Sbjct: 72  TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNL-AIVTQWCEGSSLYKHLHVQETKFQ 130
Query: 755 ILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL---LSG 811
           + Q + +    A  ++YLH   +  ++H D+K +N+ L + +   + DFG+A +    SG
Sbjct: 131 MFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187
Query: 812 EESMKQTLTLATIGYMAP 829
            + ++Q     ++ +MAP
Sbjct: 188 SQQVEQ--PTGSVLWMAP 203

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 80/162 (49%), Gaps = 15/162 (9%)
Query: 660 QFNASNL-----IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDVECEVL 709
           QF   +L     +G G FGSV    +       G  VA+K      E  L+ F+ E E+L
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 68
Query: 710 KSVRHRNLVKIISSCTNNDFK--ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL 767
           KS++H N+VK    C +   +   L++EY+P GSL DYL  +    D ++ L     +  
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 128
Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
            +EYL    +   +H D+   N+L++ +    + DFG+ K+L
Sbjct: 129 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 167

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 660 QFNASNL-----IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDVECEVL 709
           QF   +L     +G G FGSV    +       G  VA+K      E  L+ F+ E E+L
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 710 KSVRHRNLVKIISSCTNNDFK--ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL 767
           KS++H N+VK    C +   +   L++EY+P GSL DYL  +    D ++ L     +  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM 815
            +EYL    +   +H D+   N+L++ +    + DFG+ K+L  ++  
Sbjct: 126 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF 170

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 80/162 (49%), Gaps = 15/162 (9%)
Query: 660 QFNASNL-----IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDVECEVL 709
           QF   +L     +G G FGSV    +       G  VA+K      E  L+ F+ E E+L
Sbjct: 37  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96
Query: 710 KSVRHRNLVKIISSCTNNDFK--ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL 767
           KS++H N+VK    C +   +   L++EY+P GSL DYL  +    D ++ L     +  
Sbjct: 97  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156
Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
            +EYL    +   +H D+   N+L++ +    + DFG+ K+L
Sbjct: 157 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 15/167 (8%)
Query: 660 QFNASNL-----IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDVECEVL 709
           QF   +L     +G G FGSV    +       G  VA+K      E  L+ F+ E E+L
Sbjct: 4   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 63
Query: 710 KSVRHRNLVKIISSCTNNDFK--ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL 767
           KS++H N+VK    C +   +   L++EY+P GSL DYL  +    D ++ L     +  
Sbjct: 64  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 123
Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
            +EYL    +   +H D+   N+L++ +    + DFG+ K+L  ++ 
Sbjct: 124 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 167

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 15/167 (8%)
Query: 660 QFNASNL-----IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDVECEVL 709
           QF   +L     +G G FGSV    +       G  VA+K      E  L+ F+ E E+L
Sbjct: 10  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 69
Query: 710 KSVRHRNLVKIISSCTNNDFK--ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL 767
           KS++H N+VK    C +   +   L++EY+P GSL DYL  +    D ++ L     +  
Sbjct: 70  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 129
Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
            +EYL    +   +H D+   N+L++ +    + DFG+ K+L  ++ 
Sbjct: 130 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 173

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 90/173 (52%), Gaps = 9/173 (5%)
Query: 660 QFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ--LEGALKSFDVECEVLKSVRHRNL 717
           Q      IG+G FG+VYKG +    +VA+K+ ++       L++F  E  VL+  RH N+
Sbjct: 13  QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 70
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           +  +   T     A+V ++    SL  +L+++   F++ + + +    A  ++YLH   +
Sbjct: 71  LLFMGYSTKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---A 126
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
             ++H D+K +N+ L +D    + DFG+A + S      Q   L+ +I +MAP
Sbjct: 127 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 179

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 52/168 (30%), Positives = 83/168 (49%), Gaps = 8/168 (4%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDV--ECEVLKSVRHRNLVKIISSC 724
           IG+G FG V+ G +L+  +VAIK      EGA+   D   E EV+  + H  LV++   C
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
                  LV E+M +G L DYL +    F     L + +DV   + YL       V+H D
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 126
Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
           +   N L+ ++ V  +SDFG+ + +  ++    T T   + + +P +F
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 52/168 (30%), Positives = 83/168 (49%), Gaps = 8/168 (4%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDV--ECEVLKSVRHRNLVKIISSC 724
           IG+G FG V+ G +L+  +VAIK      EGA+   D   E EV+  + H  LV++   C
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
                  LV E+M +G L DYL +    F     L + +DV   + YL       V+H D
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 131
Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
           +   N L+ ++ V  +SDFG+ + +  ++    T T   + + +P +F
Sbjct: 132 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 179

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 80/162 (49%), Gaps = 15/162 (9%)
Query: 660 QFNASNL-----IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDVECEVL 709
           QF   +L     +G G FGSV    +       G  VA+K      E  L+ F+ E E+L
Sbjct: 13  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 72
Query: 710 KSVRHRNLVKIISSCTNNDFK--ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL 767
           KS++H N+VK    C +   +   L++EY+P GSL DYL  +    D ++ L     +  
Sbjct: 73  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 132
Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
            +EYL    +   +H D+   N+L++ +    + DFG+ K+L
Sbjct: 133 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 171

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 52/168 (30%), Positives = 83/168 (49%), Gaps = 8/168 (4%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDV--ECEVLKSVRHRNLVKIISSC 724
           IG+G FG V+ G +L+  +VAIK      EGA+   D   E EV+  + H  LV++   C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
                  LV E+M +G L DYL +    F     L + +DV   + YL       V+H D
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 128
Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
           +   N L+ ++ V  +SDFG+ + +  ++    T T   + + +P +F
Sbjct: 129 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 176

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 15/167 (8%)
Query: 660 QFNASNL-----IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDVECEVL 709
           QF   +L     +G G FGSV    +       G  VA+K      E  L+ F+ E E+L
Sbjct: 5   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 64
Query: 710 KSVRHRNLVKIISSCTNNDFK--ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL 767
           KS++H N+VK    C +   +   L++EY+P GSL DYL  +    D ++ L     +  
Sbjct: 65  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 124
Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
            +EYL    +   +H D+   N+L++ +    + DFG+ K+L  ++ 
Sbjct: 125 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 168

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 80/162 (49%), Gaps = 15/162 (9%)
Query: 660 QFNASNL-----IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDVECEVL 709
           QF   +L     +G G FGSV    +       G  VA+K      E  L+ F+ E E+L
Sbjct: 11  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 70
Query: 710 KSVRHRNLVKIISSCTNNDFK--ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL 767
           KS++H N+VK    C +   +   L++EY+P GSL DYL  +    D ++ L     +  
Sbjct: 71  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 130
Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
            +EYL    +   +H D+   N+L++ +    + DFG+ K+L
Sbjct: 131 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 169

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 80/162 (49%), Gaps = 15/162 (9%)
Query: 660 QFNASNL-----IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDVECEVL 709
           QF   +L     +G G FGSV    +       G  VA+K      E  L+ F+ E E+L
Sbjct: 12  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 71
Query: 710 KSVRHRNLVKIISSCTNNDFK--ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL 767
           KS++H N+VK    C +   +   L++EY+P GSL DYL  +    D ++ L     +  
Sbjct: 72  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 131
Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
            +EYL    +   +H D+   N+L++ +    + DFG+ K+L
Sbjct: 132 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 170

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 90/173 (52%), Gaps = 9/173 (5%)
Query: 660 QFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ--LEGALKSFDVECEVLKSVRHRNL 717
           Q      IG+G FG+VYKG +    +VA+K+ ++       L++F  E  VL+  RH N+
Sbjct: 14  QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           +  +   T     A+V ++    SL  +L+     F++++ + +    A  ++YLH   +
Sbjct: 72  LLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 127
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
             ++H D+K +N+ L +D+   + DFG+A + S      Q   L+ +I +MAP
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 180

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 90/173 (52%), Gaps = 9/173 (5%)
Query: 660 QFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ--LEGALKSFDVECEVLKSVRHRNL 717
           Q      IG+G FG+VYKG +    +VA+K+ ++       L++F  E  VL+  RH N+
Sbjct: 14  QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           +  +   T     A+V ++    SL  +L+     F++++ + +    A  ++YLH   +
Sbjct: 72  LLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 127
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
             ++H D+K +N+ L +D+   + DFG+A + S      Q   L+ +I +MAP
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 180

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 90/173 (52%), Gaps = 9/173 (5%)
Query: 660 QFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ--LEGALKSFDVECEVLKSVRHRNL 717
           Q      IG+G FG+VYKG +    +VA+K+ ++       L++F  E  VL+  RH N+
Sbjct: 11  QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 68
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           +  +   T     A+V ++    SL  +L+     F++++ + +    A  ++YLH   +
Sbjct: 69  LLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 124
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
             ++H D+K +N+ L +D+   + DFG+A + S      Q   L+ +I +MAP
Sbjct: 125 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 177

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 83/167 (49%), Gaps = 15/167 (8%)
Query: 660 QFNASNL-----IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDVECEVL 709
           QF   +L     +G G FGSV    +       G  VA+K      E  L+ F+ E E+L
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 68
Query: 710 KSVRHRNLVKIISSCTNNDFK--ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL 767
           KS++H N+VK    C +   +   L++EY+P GSL DYL ++    D ++ L     +  
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICK 128
Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
            +EYL    +   +H D+   N+L++ +    + DFG+ K+L  ++ 
Sbjct: 129 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 172

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 93/186 (50%), Gaps = 9/186 (4%)
Query: 647 RRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ--LEGALKSFDV 704
           RR S  +      Q      IG+G FG+VYKG +    +VA+K+ ++       L++F  
Sbjct: 24  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN 81
Query: 705 ECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIID 764
           E  VL+  RH N++  +   T     A+V ++    SL  +L+     F++++ + +   
Sbjct: 82  EVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 140
Query: 765 VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-T 823
            A  ++YLH   +  ++H D+K +N+ L +D+   + DFG+A   S      Q   L+ +
Sbjct: 141 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 197
Query: 824 IGYMAP 829
           I +MAP
Sbjct: 198 ILWMAP 203

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 60/167 (35%), Positives = 84/167 (50%), Gaps = 16/167 (9%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN 726
           IG G FG V  G +  G +VA+K   ++ +   ++F  E  V+  +RH NLV+++     
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 727 NDFKA-LVLEYMPNGSLEDYLYSNNFSF---DILQRLSVIIDVALALEYLHFGYSNPVVH 782
                 +V EYM  GSL DYL S   S    D L + S  +DV  A+EYL     N  VH
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS--LDVCEAMEYLE---GNNFVH 125
Query: 783 CDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            D+   NVL+ +D VA +SDFG+ K    E S  Q      + + AP
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAP 168

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 60/167 (35%), Positives = 84/167 (50%), Gaps = 16/167 (9%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN 726
           IG G FG V  G +  G +VA+K   ++ +   ++F  E  V+  +RH NLV+++     
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 727 NDFKA-LVLEYMPNGSLEDYLYSNNFSF---DILQRLSVIIDVALALEYLHFGYSNPVVH 782
                 +V EYM  GSL DYL S   S    D L + S  +DV  A+EYL     N  VH
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS--LDVCEAMEYLE---GNNFVH 131
Query: 783 CDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            D+   NVL+ +D VA +SDFG+ K    E S  Q      + + AP
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAP 174

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 52/168 (30%), Positives = 83/168 (49%), Gaps = 8/168 (4%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDV--ECEVLKSVRHRNLVKIISSC 724
           IG+G FG V+ G +L+  +VAIK      EGA+   D   E EV+  + H  LV++   C
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
                  LV E+M +G L DYL +    F     L + +DV   + YL       V+H D
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 129
Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
           +   N L+ ++ V  +SDFG+ + +  ++    T T   + + +P +F
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 177

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 93/186 (50%), Gaps = 9/186 (4%)
Query: 647 RRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ--LEGALKSFDV 704
           RR S  +      Q      IG+G FG+VYKG +    +VA+K+ ++       L++F  
Sbjct: 16  RRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN 73
Query: 705 ECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIID 764
           E  VL+  RH N++  +   T     A+V ++    SL  +L+     F++++ + +   
Sbjct: 74  EVGVLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 132
Query: 765 VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-T 823
            A  ++YLH   +  ++H D+K +N+ L +D+   + DFG+A   S      Q   L+ +
Sbjct: 133 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 189
Query: 824 IGYMAP 829
           I +MAP
Sbjct: 190 ILWMAP 195

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 83/168 (49%), Gaps = 8/168 (4%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDV--ECEVLKSVRHRNLVKIISSC 724
           IG+G FG V+ G +L+  +VAIK      EG++   D   E EV+  + H  LV++   C
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK---EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
                  LV E+M +G L DYL +    F     L + +DV   + YL       V+H D
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 148
Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
           +   N L+ ++ V  +SDFG+ + +  ++    T T   + + +P +F
Sbjct: 149 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 196

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 89/173 (51%), Gaps = 9/173 (5%)
Query: 660 QFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ--LEGALKSFDVECEVLKSVRHRNL 717
           Q      IG+G FG+VYKG +    +VA+K+ ++       L++F  E  VL+  RH N+
Sbjct: 25  QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           +  +   T     A+V ++    SL  +L+++   F++ + + +    A  ++YLH   +
Sbjct: 83  LLFMGYSTKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---A 138
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
             ++H D+K +N+ L +D    + DFG+A   S      Q   L+ +I +MAP
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 78/151 (51%), Gaps = 9/151 (5%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +GTG FG V  G +    +VAIK+     EG++    F  E +V+ ++ H  LV++   C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
           T      ++ EYM NG L +YL      F   Q L +  DV  A+EYL    S   +H D
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 145
Query: 785 IKPSNVLLDKDMVAHLSDFGIAK-LLSGEES 814
           +   N L++   V  +SDFG+++ +L  EE+
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEET 176

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 84/164 (51%), Gaps = 7/164 (4%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           IG G  G+VY       G EVAI+  +LQ +   +    E  V++  ++ N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
             D   +V+EY+  GSL D +       D  Q  +V  +   ALE+LH   SN V+H DI
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           K  N+LL  D    L+DFG    ++ E+S + T+ + T  +MAP
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAP 185

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 76/149 (51%), Gaps = 8/149 (5%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +GTG FG V  G +    +VAIK+     EG++    F  E +V+ ++ H  LV++   C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
           T      ++ EYM NG L +YL      F   Q L +  DV  A+EYL    S   +H D
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 145
Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
           +   N L++   V  +SDFG+++ +  +E
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDE 174

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/167 (35%), Positives = 84/167 (50%), Gaps = 16/167 (9%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN 726
           IG G FG V  G +  G +VA+K   ++ +   ++F  E  V+  +RH NLV+++     
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 727 NDFK-ALVLEYMPNGSLEDYLYSNNFSF---DILQRLSVIIDVALALEYLHFGYSNPVVH 782
                 +V EYM  GSL DYL S   S    D L + S  +DV  A+EYL     N  VH
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS--LDVCEAMEYLE---GNNFVH 140
Query: 783 CDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            D+   NVL+ +D VA +SDFG+ K    E S  Q      + + AP
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAP 183

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 89/173 (51%), Gaps = 9/173 (5%)
Query: 660 QFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ--LEGALKSFDVECEVLKSVRHRNL 717
           Q      IG+G FG+VYKG +    +VA+K+ ++       L++F  E  VL+  RH N+
Sbjct: 25  QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           +  +   T     A+V ++    SL  +L+++   F++ + + +    A  ++YLH   +
Sbjct: 83  LLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---A 138
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
             ++H D+K +N+ L +D    + DFG+A   S      Q   L+ +I +MAP
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 15/162 (9%)
Query: 660 QFNASNL-----IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDVECEVL 709
           QF   +L     +G G FGSV    +       G  VA+K      E  L+ F+ E E+L
Sbjct: 7   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 66
Query: 710 KSVRHRNLVKIISSCTNNDFK--ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL 767
           KS++H N+VK    C +   +   L++EY+P GSL DYL  +    D ++ L     +  
Sbjct: 67  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 126
Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
            +EYL    +   +H ++   N+L++ +    + DFG+ K+L
Sbjct: 127 GMEYLG---TKRYIHRNLATRNILVENENRVKIGDFGLTKVL 165

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 93/189 (49%), Gaps = 11/189 (5%)
Query: 636 IESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL----DGMEVAIKVF 691
           ++ +     T+    + + L ATN  +   ++G G FG V  G         + VAIK  
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 692 HL-QLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN 750
            +   E   + F  E  ++    H N++++    T +    +V EYM NGSL+ +L  ++
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141
Query: 751 FSFDILQRLSVIIDVALALEYL-HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
             F ++Q + ++  +A  ++YL   GY    VH D+   N+L++ ++V  +SDFG+A++L
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLARVL 197
Query: 810 SGEESMKQT 818
             +     T
Sbjct: 198 EDDPEAAYT 206

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 84/164 (51%), Gaps = 7/164 (4%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           IG G  G+VY       G EVAI+  +LQ +   +    E  V++  ++ N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
             D   +V+EY+  GSL D +       D  Q  +V  +   ALE+LH   SN V+H DI
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           K  N+LL  D    L+DFG    ++ E+S K++  + T  +MAP
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSXMVGTPYWMAP 185

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/167 (35%), Positives = 84/167 (50%), Gaps = 16/167 (9%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN 726
           IG G FG V  G +  G +VA+K   ++ +   ++F  E  V+  +RH NLV+++     
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 727 NDFK-ALVLEYMPNGSLEDYLYSNNFSF---DILQRLSVIIDVALALEYLHFGYSNPVVH 782
                 +V EYM  GSL DYL S   S    D L + S  +DV  A+EYL     N  VH
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS--LDVCEAMEYLE---GNNFVH 312
Query: 783 CDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            D+   NVL+ +D VA +SDFG+ K    E S  Q      + + AP
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAP 355

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 84/164 (51%), Gaps = 7/164 (4%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           IG G  G+VY       G EVAI+  +LQ +   +    E  V++  ++ N+V  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
             D   +V+EY+  GSL D +       D  Q  +V  +   ALE+LH   SN V+H DI
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 143
Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           K  N+LL  D    L+DFG    ++ E+S K++  + T  +MAP
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSXMVGTPYWMAP 186

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 49/149 (32%), Positives = 76/149 (51%), Gaps = 8/149 (5%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKS--FDVECEVLKSVRHRNLVKIISSC 724
           +GTG FG V  G +    +VAIK+     EG++    F  E +V+ ++ H  LV++   C
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
           T      ++ EYM NG L +YL      F   Q L +  DV  A+EYL    S   +H D
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 136
Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
           +   N L++   V  +SDFG+++ +  +E
Sbjct: 137 LAARNCLVNDQGVVKVSDFGLSRYVLDDE 165

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 49/149 (32%), Positives = 76/149 (51%), Gaps = 8/149 (5%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKS--FDVECEVLKSVRHRNLVKIISSC 724
           +GTG FG V  G +    +VAIK+     EG++    F  E +V+ ++ H  LV++   C
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
           T      ++ EYM NG L +YL      F   Q L +  DV  A+EYL    S   +H D
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 129
Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
           +   N L++   V  +SDFG+++ +  +E
Sbjct: 130 LAARNCLVNDQGVVKVSDFGLSRYVLDDE 158

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 49/149 (32%), Positives = 76/149 (51%), Gaps = 8/149 (5%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKS--FDVECEVLKSVRHRNLVKIISSC 724
           +GTG FG V  G +    +VAIK+     EG++    F  E +V+ ++ H  LV++   C
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
           T      ++ EYM NG L +YL      F   Q L +  DV  A+EYL    S   +H D
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 130
Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
           +   N L++   V  +SDFG+++ +  +E
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDE 159

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 49/149 (32%), Positives = 76/149 (51%), Gaps = 8/149 (5%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKS--FDVECEVLKSVRHRNLVKIISSC 724
           +GTG FG V  G +    +VAIK+     EG++    F  E +V+ ++ H  LV++   C
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
           T      ++ EYM NG L +YL      F   Q L +  DV  A+EYL    S   +H D
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 130
Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
           +   N L++   V  +SDFG+++ +  +E
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDE 159

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 49/149 (32%), Positives = 76/149 (51%), Gaps = 8/149 (5%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKS--FDVECEVLKSVRHRNLVKIISSC 724
           +GTG FG V  G +    +VAIK+     EG++    F  E +V+ ++ H  LV++   C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
           T      ++ EYM NG L +YL      F   Q L +  DV  A+EYL    S   +H D
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 125
Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
           +   N L++   V  +SDFG+++ +  +E
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDE 154

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 49/173 (28%), Positives = 90/173 (52%), Gaps = 9/173 (5%)
Query: 660 QFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ--LEGALKSFDVECEVLKSVRHRNL 717
           Q      IG+G FG+VYKG +    +VA+K+ ++       L++F  E  VL+  RH N+
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           +  +   T     A+V ++    SL  +L+     F++++ + +    A  ++YLH   +
Sbjct: 67  LLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 122
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
             ++H D+K +N+ L +D+   + DFG+A + S      Q   L+ +I +MAP
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 84/164 (51%), Gaps = 7/164 (4%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           IG G  G+VY       G EVAI+  +LQ +   +    E  V++  ++ N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
             D   +V+EY+  GSL D +       D  Q  +V  +   ALE+LH   SN V+H DI
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           K  N+LL  D    L+DFG    ++ E+S K++  + T  +MAP
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSEMVGTPYWMAP 185

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 11/198 (5%)
Query: 633 QSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL----DGMEVAI 688
           Q   E +   +  R   S+   ++A+ + +   +IG+G  G V  G         + VAI
Sbjct: 24  QFYAEPHTYEEPGRAGRSFTREIEAS-RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAI 82
Query: 689 KVFHL-QLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLY 747
           K       E   + F  E  ++    H N++++    T      +V EYM NGSL+ +L 
Sbjct: 83  KALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142
Query: 748 SNNFSFDILQRLSVIIDVALALEYL-HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA 806
           +++  F I+Q + ++  V   + YL   GY    VH D+   NVL+D ++V  +SDFG++
Sbjct: 143 THDGQFTIMQLVGMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLS 198
Query: 807 KLLSGEESMKQTLTLATI 824
           ++L  +     T T   I
Sbjct: 199 RVLEDDPDAAXTTTGGKI 216

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 15/162 (9%)
Query: 660 QFNASNL-----IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDVECEVL 709
           QF   +L     +G G FGSV    +       G  VA+K      E  L+ F+ E E+L
Sbjct: 9   QFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 68
Query: 710 KSVRHRNLVKIISSCTNNDFK--ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL 767
           KS++H N+VK    C +   +   L++E++P GSL +YL  +    D ++ L     +  
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICK 128
Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
            +EYL    +   +H D+   N+L++ +    + DFG+ K+L
Sbjct: 129 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL 167

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 95/192 (49%), Gaps = 11/192 (5%)
Query: 633 QSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL----DGMEVAI 688
           ++ ++ +     T+    + + L ATN  +   ++G G FG V  G         + VAI
Sbjct: 20  RTYVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAI 78
Query: 689 KVFHL-QLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLY 747
           K   +   E   + F  E  ++    H N++++    T +    +V EYM NGSL+ +L 
Sbjct: 79  KTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 748 SNNFSFDILQRLSVIIDVALALEYL-HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA 806
            ++  F ++Q + ++  +A  ++YL   GY    VH D+   N+L++ ++V  +SDFG++
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLS 194
Query: 807 KLLSGEESMKQT 818
           ++L  +     T
Sbjct: 195 RVLEDDPEAAYT 206

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 49/173 (28%), Positives = 90/173 (52%), Gaps = 9/173 (5%)
Query: 660 QFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ--LEGALKSFDVECEVLKSVRHRNL 717
           Q      IG+G FG+VYKG +    +VA+K+ ++       L++F  E  VL+  RH N+
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           +  +   T     A+V ++    SL  +L+     F++++ + +    A  ++YLH   +
Sbjct: 67  LLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 122
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
             ++H D+K +N+ L +D+   + DFG+A + S      Q   L+ +I +MAP
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 11/198 (5%)
Query: 633 QSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL----DGMEVAI 688
           Q   E +   +  R   S+   ++A+ + +   +IG+G  G V  G         + VAI
Sbjct: 24  QFYAEPHTYEEPGRAGRSFTREIEAS-RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAI 82
Query: 689 KVFHL-QLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLY 747
           K       E   + F  E  ++    H N++++    T      +V EYM NGSL+ +L 
Sbjct: 83  KALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142
Query: 748 SNNFSFDILQRLSVIIDVALALEYL-HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA 806
           +++  F I+Q + ++  V   + YL   GY    VH D+   NVL+D ++V  +SDFG++
Sbjct: 143 THDGQFTIMQLVGMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLS 198
Query: 807 KLLSGEESMKQTLTLATI 824
           ++L  +     T T   I
Sbjct: 199 RVLEDDPDAAYTTTGGKI 216

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 93/189 (49%), Gaps = 11/189 (5%)
Query: 636 IESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL----DGMEVAIKVF 691
           ++ +     T+    + + L ATN  +   ++G G FG V  G         + VAIK  
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 692 HL-QLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN 750
            +   E   + F  E  ++    H N++++    T +    +V EYM NGSL+ +L  ++
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141
Query: 751 FSFDILQRLSVIIDVALALEYL-HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
             F ++Q + ++  +A  ++YL   GY    VH D+   N+L++ ++V  +SDFG++++L
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 810 SGEESMKQT 818
             +     T
Sbjct: 198 EDDPEAAYT 206

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 91/181 (50%), Gaps = 11/181 (6%)
Query: 644 ATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL----DGMEVAIKVFHL-QLEGA 698
           +T+    + + L ATN  +   ++G G FG V  G         + VAIK   +   E  
Sbjct: 19  STQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 77
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQR 758
            + F  E  ++    H N++++    T +    +V EYM NGSL+ +L  ++  F ++Q 
Sbjct: 78  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 137
Query: 759 LSVIIDVALALEYL-HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ 817
           + ++  +A  ++YL   GY    VH D+   N+L++ ++V  +SDFG++++L  +     
Sbjct: 138 VGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 193
Query: 818 T 818
           T
Sbjct: 194 T 194

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/164 (33%), Positives = 84/164 (51%), Gaps = 7/164 (4%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           IG G  G+VY       G EVAI+  +LQ +   +    E  V++  ++ N+V  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
             D   +V+EY+  GSL D +       D  Q  +V  +   ALE+LH   SN V+H +I
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRNI 143
Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           K  N+LL  D    L+DFG    ++ E+S + T+ + T  +MAP
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAP 186

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 95/192 (49%), Gaps = 11/192 (5%)
Query: 633 QSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL----DGMEVAI 688
           ++ ++ +     T+    + + L ATN  +   ++G G FG V  G         + VAI
Sbjct: 18  RTYVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAI 76
Query: 689 KVFHL-QLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLY 747
           K   +   E   + F  E  ++    H N++++    T +    +V EYM NGSL+ +L 
Sbjct: 77  KTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 136
Query: 748 SNNFSFDILQRLSVIIDVALALEYL-HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA 806
            ++  F ++Q + ++  +A  ++YL   GY    VH D+   N+L++ ++V  +SDFG++
Sbjct: 137 KHDAQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLS 192
Query: 807 KLLSGEESMKQT 818
           ++L  +     T
Sbjct: 193 RVLEDDPEAAYT 204

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 95/192 (49%), Gaps = 11/192 (5%)
Query: 633 QSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL----DGMEVAI 688
           ++ ++ +     T+    + + L ATN  +   ++G G FG V  G         + VAI
Sbjct: 20  RTYVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAI 78
Query: 689 KVFHL-QLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLY 747
           K   +   E   + F  E  ++    H N++++    T +    +V EYM NGSL+ +L 
Sbjct: 79  KTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 748 SNNFSFDILQRLSVIIDVALALEYL-HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA 806
            ++  F ++Q + ++  +A  ++YL   GY    VH D+   N+L++ ++V  +SDFG++
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLS 194
Query: 807 KLLSGEESMKQT 818
           ++L  +     T
Sbjct: 195 RVLEDDPEAAYT 206

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 92/189 (48%), Gaps = 11/189 (5%)
Query: 636 IESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL----DGMEVAIKVF 691
           ++ +     T+    + + L ATN  +   ++G G FG V  G         + VAIK  
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 692 HL-QLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN 750
            +   E   + F  E  ++    H N++++    T +    +V EYM NGSL+ +L  ++
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141
Query: 751 FSFDILQRLSVIIDVALALEYL-HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
             F ++Q + ++  +A  ++YL   GY    VH D+   N+L++ ++V  +SDFG+ ++L
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVL 197
Query: 810 SGEESMKQT 818
             +     T
Sbjct: 198 EDDPEAAYT 206

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 93/189 (49%), Gaps = 11/189 (5%)
Query: 636 IESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL----DGMEVAIKVF 691
           ++ +     T+    + + L ATN  +   ++G G FG V  G         + VAIK  
Sbjct: 23  VDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 692 HL-QLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN 750
            +   E   + F  E  ++    H N++++    T +    +V EYM NGSL+ +L  ++
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141
Query: 751 FSFDILQRLSVIIDVALALEYL-HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
             F ++Q + ++  +A  ++YL   GY    VH D+   N+L++ ++V  +SDFG++++L
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 810 SGEESMKQT 818
             +     T
Sbjct: 198 EDDPEAAYT 206

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 91/181 (50%), Gaps = 11/181 (6%)
Query: 644 ATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL----DGMEVAIKVFHL-QLEGA 698
           +T+    + + L ATN  +   ++G G FG V  G         + VAIK   +   E  
Sbjct: 2   STQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 60
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQR 758
            + F  E  ++    H N++++    T +    +V EYM NGSL+ +L  ++  F ++Q 
Sbjct: 61  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 120
Query: 759 LSVIIDVALALEYL-HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ 817
           + ++  +A  ++YL   GY    VH D+   N+L++ ++V  +SDFG++++L  +     
Sbjct: 121 VGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 176
Query: 818 T 818
           T
Sbjct: 177 T 177

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 55/173 (31%), Positives = 92/173 (53%), Gaps = 18/173 (10%)
Query: 665 NLIGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGALKSFDV------ECEVLKSVRHRNL 717
           + +G G FG V  G   L G +VA+K+ + Q    ++S DV      E + LK  RH ++
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 718 VKIISS-CTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
           +K+     T  DF  +V+EY+  G L DY+  +    + ++   +   +  A++Y H   
Sbjct: 74  IKLYQVISTPTDF-FMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH--- 128
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            + VVH D+KP NVLLD  M A ++DFG++ ++S  E ++   +  +  Y AP
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRD--SCGSPNYAAP 179

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 49/173 (28%), Positives = 89/173 (51%), Gaps = 9/173 (5%)
Query: 660 QFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ--LEGALKSFDVECEVLKSVRHRNL 717
           Q      IG+G FG+VYKG +    +VA+K+ ++       L++F  E  VL+  RH N+
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           +  +   T     A+V ++    SL  +L+     F++++ + +    A  ++YLH   +
Sbjct: 67  LLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 122
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
             ++H D+K +N+ L +D+   + DFG+A   S      Q   L+ +I +MAP
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 175

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 55/173 (31%), Positives = 92/173 (53%), Gaps = 18/173 (10%)
Query: 665 NLIGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGALKSFDV------ECEVLKSVRHRNL 717
           + +G G FG V  G   L G +VA+K+ + Q    ++S DV      E + LK  RH ++
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 718 VKIISS-CTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
           +K+     T  DF  +V+EY+  G L DY+  +    + ++   +   +  A++Y H   
Sbjct: 74  IKLYQVISTPTDF-FMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH--- 128
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            + VVH D+KP NVLLD  M A ++DFG++ ++S  E ++   +  +  Y AP
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT--SCGSPNYAAP 179

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 95/190 (50%), Gaps = 19/190 (10%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKGSF-LDGMEVAIKVFHL--------QLEGALKSF 702
           KE  Q   +++  ++IG G    V +      G E A+K+  +        QLE   ++ 
Sbjct: 90  KEFYQ---KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146
Query: 703 DVECEVLKSVR-HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV 761
             E  +L+ V  H +++ +I S  ++ F  LV + M  G L DYL +   +    +  S+
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSI 205
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL 821
           +  +  A+ +LH   +N +VH D+KP N+LLD +M   LSDFG +  L   E +++    
Sbjct: 206 MRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE--LC 260
Query: 822 ATIGYMAPGL 831
            T GY+AP +
Sbjct: 261 GTPGYLAPEI 270

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/177 (31%), Positives = 92/177 (51%), Gaps = 14/177 (7%)
Query: 660 QFNASNLIGTGGFGSVY--KGSFLDGMEVAIKVFHL---QLEGALKSFDVECEVLKSVRH 714
           ++   + +G GG  +VY  + + L+ ++VAIK   +   + E  LK F+ E      + H
Sbjct: 12  RYKIVDKLGGGGMSTVYLAEDTILN-IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLH 773
           +N+V +I     +D   LV+EY+   +L +Y+ S+   S D     +  I     L+ + 
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQI-----LDGIK 125
Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT-LTLATIGYMAP 829
             +   +VH DIKP N+L+D +    + DFGIAK LS E S+ QT   L T+ Y +P
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSP 181

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 10/181 (5%)
Query: 655 LQATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVF-HLQLEGALKSFDV-ECEVLKS 711
            Q+  ++    L+G G +G V K    D G  VAIK F     +  +K   + E ++LK 
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDY-LYSNNFSFDILQRLSVIIDVALALE 770
           +RH NLV ++  C       LV E++ +  L+D  L+ N   + ++Q+    I     + 
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI-----IN 135
Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPG 830
            + F +S+ ++H DIKP N+L+ +  V  L DFG A+ L+    +     +AT  Y AP 
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD-EVATRWYRAPE 194
Query: 831 L 831
           L
Sbjct: 195 L 195

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 93/189 (49%), Gaps = 11/189 (5%)
Query: 636 IESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL----DGMEVAIKVF 691
           ++ +     T+    + + L ATN  +   ++G G FG V  G         + VAIK  
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 692 HL-QLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN 750
            +   E   + F  E  ++    H N++++    T +    +V EYM NGSL+ +L  ++
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141
Query: 751 FSFDILQRLSVIIDVALALEYL-HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
             F ++Q + ++  +A  ++YL   G+    VH D+   N+L++ ++V  +SDFG++++L
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSDMGF----VHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 810 SGEESMKQT 818
             +     T
Sbjct: 198 EDDPEAAYT 206

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 88/172 (51%), Gaps = 16/172 (9%)
Query: 665 NLIGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGALKSFDV------ECEVLKSVRHRNL 717
           + +G G FG V  G   L G +VA+K+ + Q    ++S DV      E + LK  RH ++
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQ---KIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           +K+    +      +V+EY+  G L DY+  N    D  +   +   +   ++Y H    
Sbjct: 79  IKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH---R 134
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           + VVH D+KP NVLLD  M A ++DFG++ ++S  E ++   +  +  Y AP
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR--XSCGSPNYAAP 184

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 47/168 (27%), Positives = 83/168 (49%), Gaps = 8/168 (4%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKS--FDVECEVLKSVRHRNLVKIISSC 724
           +G+G FG V  G +    +VA+K+     EG++    F  E + +  + H  LVK    C
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
           +      +V EY+ NG L +YL S+    +  Q L +  DV   + +L    S+  +H D
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRD 129
Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
           +   N L+D+D+   +SDFG+ + +  ++ +    T   + + AP +F
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVF 177

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 85/168 (50%), Gaps = 12/168 (7%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G +G VY G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 95
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
            CT      +V EYMP G+L DYL   N      +  L +   ++ A+EYL        +
Sbjct: 96  VCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFI 152
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D+   N L+ ++ V  ++DFG+++L++G+           I + AP
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 200

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 91/184 (49%), Gaps = 19/184 (10%)
Query: 650 SYKELLQATNQF---------NASNLIGTGGFGSVYKGSF-LDG---MEVAIKVFHL-QL 695
           +Y++  QA ++F             +IG G FG V  G   L G   + VAIK   +   
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 696 EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDI 755
           E   + F  E  ++    H N++ +    T +    +V EYM NGSL+ +L  N+  F +
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV 123
Query: 756 LQRLSVIIDVALALEYL-HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
           +Q + ++  ++  ++YL   GY    VH D+   N+L++ ++V  +SDFG++++L  +  
Sbjct: 124 IQLVGMLRGISAGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 179
Query: 815 MKQT 818
              T
Sbjct: 180 AAYT 183

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 642 PQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVF---HLQLEG 697
           PQ  ++R            F    ++G G F +V     L    E AIK+    H+  E 
Sbjct: 2   PQPRKKR---------PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN 52
Query: 698 ALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQ 757
            +     E +V+  + H   VK+  +  +++     L Y  NG L  Y+     SFD   
Sbjct: 53  KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETC 111
Query: 758 RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE-ESMK 816
                 ++  ALEYLH      ++H D+KP N+LL++DM   ++DFG AK+LS E +  +
Sbjct: 112 TRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 168
Query: 817 QTLTLATIGYMAPGL 831
               + T  Y++P L
Sbjct: 169 ANXFVGTAQYVSPEL 183

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 642 PQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVF---HLQLEG 697
           PQ  ++R            F    ++G G F +V     L    E AIK+    H+  E 
Sbjct: 1   PQPRKKR---------PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN 51
Query: 698 ALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQ 757
            +     E +V+  + H   VK+  +  +++     L Y  NG L  Y+     SFD   
Sbjct: 52  KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETC 110
Query: 758 RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE-ESMK 816
                 ++  ALEYLH      ++H D+KP N+LL++DM   ++DFG AK+LS E +  +
Sbjct: 111 TRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 167
Query: 817 QTLTLATIGYMAPGL 831
               + T  Y++P L
Sbjct: 168 ANXFVGTAQYVSPEL 182

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 94/192 (48%), Gaps = 11/192 (5%)
Query: 633 QSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL----DGMEVAI 688
           ++ ++ +     T+    + + L ATN  +   ++G G FG V  G         + VAI
Sbjct: 20  RTYVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAI 78
Query: 689 KVFHL-QLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLY 747
           K   +   E   + F  E  ++    H N++++    T +    +V E M NGSL+ +L 
Sbjct: 79  KTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR 138
Query: 748 SNNFSFDILQRLSVIIDVALALEYL-HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA 806
            ++  F ++Q + ++  +A  ++YL   GY    VH D+   N+L++ ++V  +SDFG++
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLS 194
Query: 807 KLLSGEESMKQT 818
           ++L  +     T
Sbjct: 195 RVLEDDPEAAYT 206

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 9/178 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRH 714
             F    ++G G F +V     L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
              VK+  +  +++     L Y  NG L  Y+     SFD         ++  ALEYLH 
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 124
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE-ESMKQTLTLATIGYMAPGL 831
                ++H D+KP N+LL++DM   ++DFG AK+LS E +  +    + T  Y++P L
Sbjct: 125 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 180

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 9/178 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRH 714
             F    ++G G F +V     L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
              VK+  +  +++     L Y  NG L  Y+     SFD         ++  ALEYLH 
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 125
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE-ESMKQTLTLATIGYMAPGL 831
                ++H D+KP N+LL++DM   ++DFG AK+LS E +  +    + T  Y++P L
Sbjct: 126 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 181

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 9/178 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRH 714
             F    ++G G F +V     L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
              VK+  +  +++     L Y  NG L  Y+     SFD         ++  ALEYLH 
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 152
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE-ESMKQTLTLATIGYMAPGL 831
                ++H D+KP N+LL++DM   ++DFG AK+LS E +  +    + T  Y++P L
Sbjct: 153 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 208

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 9/178 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRH 714
             F    ++G G F +V     L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
              VK+  +  +++     L Y  NG L  Y+     SFD         ++  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 149
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE-ESMKQTLTLATIGYMAPGL 831
                ++H D+KP N+LL++DM   ++DFG AK+LS E +  +    + T  Y++P L
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 9/178 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRH 714
             F    ++G G F +V     L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
              VK+  +  +++     L Y  NG L  Y+     SFD         ++  ALEYLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 150
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE-ESMKQTLTLATIGYMAPGL 831
                ++H D+KP N+LL++DM   ++DFG AK+LS E +  +    + T  Y++P L
Sbjct: 151 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 206

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 9/178 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRH 714
             F    ++G G F +V     L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
              VK+  +  +++     L Y  NG L  Y+     SFD         ++  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 149
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE-ESMKQTLTLATIGYMAPGL 831
                ++H D+KP N+LL++DM   ++DFG AK+LS E +  +    + T  Y++P L
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 90/181 (49%), Gaps = 11/181 (6%)
Query: 644 ATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL----DGMEVAIKVFHL-QLEGA 698
           +T+    + + L ATN  +   ++G G FG V  G         + VAIK   +   E  
Sbjct: 2   STQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 60
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQR 758
            + F  E  ++    H N++++    T +    +V E M NGSL+ +L  ++  F ++Q 
Sbjct: 61  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL 120
Query: 759 LSVIIDVALALEYL-HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ 817
           + ++  +A  ++YL   GY    VH D+   N+L++ ++V  +SDFG++++L  +     
Sbjct: 121 VGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 176
Query: 818 T 818
           T
Sbjct: 177 T 177

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 9/178 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRH 714
             F    ++G G F +V     L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
              VK+  +  +++     L Y  NG L  Y+     SFD         ++  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 149
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE-ESMKQTLTLATIGYMAPGL 831
                ++H D+KP N+LL++DM   ++DFG AK+LS E +  +    + T  Y++P L
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 9/178 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRH 714
             F    ++G G F +V     L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
              VK+  +  +++     L Y  NG L  Y+     SFD         ++  ALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 147
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE-ESMKQTLTLATIGYMAPGL 831
                ++H D+KP N+LL++DM   ++DFG AK+LS E +  +    + T  Y++P L
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 85/175 (48%), Gaps = 7/175 (4%)
Query: 656 QATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRH 714
           Q    F+    +G G +GSVYK    + G  VAIK   + +E  L+    E  +++    
Sbjct: 26  QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK--QVPVESDLQEIIKEISIMQQCDS 83
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
            ++VK   S   N    +V+EY   GS+ D +   N +    +  +++      LEYLHF
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
                 +H DIK  N+LL+ +  A L+DFG+A  L+ +   K+   + T  +MAP
Sbjct: 144 MRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLT-DXMAKRNXVIGTPFWMAP 194

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 9/178 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRH 714
             F    ++G G F +V     L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
              VK+  +  +++     L Y  NG L  Y+     SFD         ++  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 149
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE-ESMKQTLTLATIGYMAPGL 831
                ++H D+KP N+LL++DM   ++DFG AK+LS E +  +    + T  Y++P L
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 56/168 (33%), Positives = 85/168 (50%), Gaps = 8/168 (4%)
Query: 666 LIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           ++G G +G VY G  L + + +AIK    +     +    E  + K ++H+N+V+ + S 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSF-DILQRLSVIIDVAL-ALEYLHFGYSNPVVH 782
           + N F  + +E +P GSL   L S      D  Q +       L  L+YLH    N +VH
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 131
Query: 783 CDIKPSNVLLDK-DMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            DIK  NVL++    V  +SDFG +K L+G     +T T  T+ YMAP
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAP 178

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 9/178 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRH 714
             F    ++G G F +V     L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
              VK+  +  +++     L Y  NG L  Y+     SFD         ++  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 149
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE-ESMKQTLTLATIGYMAPGL 831
                ++H D+KP N+LL++DM   ++DFG AK+LS E +  +    + T  Y++P L
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 9/178 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRH 714
             F    ++G G F +V     L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
              VK+  +  +++     L Y  NG L  Y+     SFD         ++  ALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 147
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE-ESMKQTLTLATIGYMAPGL 831
                ++H D+KP N+LL++DM   ++DFG AK+LS E +  +    + T  Y++P L
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 46/168 (27%), Positives = 87/168 (51%), Gaps = 12/168 (7%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G +G VY+G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 81
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
            CT      +++E+M  G+L DYL   N    + +  L +   ++ A+EYL        +
Sbjct: 82  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 138
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D+   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 186

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 9/178 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRH 714
             F    ++G G F +V     L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
              VK+  +  +++     L Y  NG L  Y+     SFD         ++  ALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 147
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE-ESMKQTLTLATIGYMAPGL 831
                ++H D+KP N+LL++DM   ++DFG AK+LS E +  +    + T  Y++P L
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPEL 203

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 46/168 (27%), Positives = 86/168 (51%), Gaps = 12/168 (7%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G +G VY+G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 74
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
            CT      +++E+M  G+L DYL   N      +  L +   ++ A+EYL        +
Sbjct: 75  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 131
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D+   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAP 179

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 88/190 (46%), Gaps = 18/190 (9%)
Query: 656 QATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGA-LKSFDVECEVLKSVR 713
           Q    +     +GTGGFG V +    D G +VAIK    +L     + + +E +++K + 
Sbjct: 12  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 71
Query: 714 HRNLVKI------ISSCTNNDFKALVLEYMPNGSLEDYL--YSNNFSFDILQRLSVIIDV 765
           H N+V        +     ND   L +EY   G L  YL  + N          +++ D+
Sbjct: 72  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 131
Query: 766 ALALEYLHFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAKLLSGEESMKQTLTLA 822
           + AL YLH    N ++H D+KP N++L    + ++  + D G AK L   E    T  + 
Sbjct: 132 SSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVG 186
Query: 823 TIGYMAPGLF 832
           T+ Y+AP L 
Sbjct: 187 TLQYLAPELL 196

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 87/173 (50%), Gaps = 22/173 (12%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G FG VY+G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 74
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVALALEYLHFGY 776
            CT      ++ E+M  G+L DYL   N      Q +S ++       ++ A+EYL    
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLE--- 126
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
               +H D+   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAP 179

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/185 (32%), Positives = 85/185 (45%), Gaps = 26/185 (14%)
Query: 665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKS--VRHRNLVKII- 721
            LIG G +G+VYKGS LD   VA+KVF        ++F  E  + +   + H N+ + I 
Sbjct: 19  ELIGRGRYGAVYKGS-LDERPVAVKVFSF---ANRQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 722 -SSCTNNDFKA---LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF--- 774
                  D +    LV+EY PNGSL  YL  +  + D +    +   V   L YLH    
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVTRGLAYLHTELP 132
Query: 775 ---GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS-------GEESMKQTLTLATI 824
               Y   + H D+   NVL+  D    +SDFG++  L+       GEE       + TI
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTI 192
Query: 825 GYMAP 829
            YMAP
Sbjct: 193 RYMAP 197

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 86/166 (51%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++     VAIK       G +  ++F  E +V+K +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY-LHFGYSNPVVHC 783
           +      +V+EYM  GSL D+L      +    RL  ++D+A  +   + +      VH 
Sbjct: 83  SEEPI-YIVIEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+ +++V  ++DFG+A+L+   E   +      I + AP
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAP 184

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 88/190 (46%), Gaps = 18/190 (9%)
Query: 656 QATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGA-LKSFDVECEVLKSVR 713
           Q    +     +GTGGFG V +    D G +VAIK    +L     + + +E +++K + 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 714 HRNLVKI------ISSCTNNDFKALVLEYMPNGSLEDYL--YSNNFSFDILQRLSVIIDV 765
           H N+V        +     ND   L +EY   G L  YL  + N          +++ D+
Sbjct: 71  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 766 ALALEYLHFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAKLLSGEESMKQTLTLA 822
           + AL YLH    N ++H D+KP N++L    + ++  + D G AK L   E    T  + 
Sbjct: 131 SSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVG 185
Query: 823 TIGYMAPGLF 832
           T+ Y+AP L 
Sbjct: 186 TLQYLAPELL 195

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 87/168 (51%), Gaps = 12/168 (7%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G +G VY+G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 77
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
            CT      +++E+M  G+L DYL   N    + +  L +   ++ A+EYL        +
Sbjct: 78  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 134
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D+   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAP 182

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 9/178 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRH 714
             F    ++G G F +V     L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
              VK+  +  +++     L Y  NG L  Y+     SFD         ++  ALEYLH 
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 131
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE-ESMKQTLTLATIGYMAPGL 831
                ++H D+KP N+LL++DM   ++DFG AK+LS E +  +    + T  Y++P L
Sbjct: 132 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 187

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 83/178 (46%), Gaps = 9/178 (5%)
Query: 659 NQFNASNLIGTGGFGS-VYKGSFLDGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRH 714
             F    ++G G F + V         E AIK+    H+  E  +     E +V+  + H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
              VK+  +  +++     L Y  NG L  Y+     SFD         ++  ALEYLH 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 147
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE-ESMKQTLTLATIGYMAPGL 831
                ++H D+KP N+LL++DM   ++DFG AK+LS E +  +    + T  Y++P L
Sbjct: 148 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 9/178 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRH 714
             F    ++G G F +V     L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
              VK+  +  +++     L Y  NG L  Y+     SFD         ++  ALEYLH 
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 150
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT-LATIGYMAPGL 831
                ++H D+KP N+LL++DM   ++DFG AK+LS E    +  + + T  Y++P L
Sbjct: 151 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 206

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 9/178 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRH 714
             F    ++G G F +V     L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
              VK+  +  +++     L Y  NG L  Y+     SFD         ++  ALEYLH 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 146
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE-ESMKQTLTLATIGYMAPGL 831
                ++H D+KP N+LL++DM   ++DFG AK+LS E +  +    + T  Y++P L
Sbjct: 147 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 202

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 85/166 (51%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++     VAIK       G +  ++F  E +V+K +RH  LV++ +  
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 75
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY-LHFGYSNPVVHC 783
           +      +V EYM  GSL D+L      +    RL  ++D+A  +   + +      VH 
Sbjct: 76  SEEPI-YIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIASGMAYVERMNYVHR 131
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+ +++V  ++DFG+A+L+   E   +      I + AP
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 177

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 9/178 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRH 714
             F    ++G G F +V     L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
              VK+  +  +++     L Y  NG L  Y+     SFD         ++  ALEYLH 
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 149
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT-LATIGYMAPGL 831
                ++H D+KP N+LL++DM   ++DFG AK+LS E    +  + + T  Y++P L
Sbjct: 150 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 205

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 86/166 (51%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++     VAIK       G +  ++F  E +V+K +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY-LHFGYSNPVVHC 783
           +      +V+EYM  GSL D+L      +    RL  ++D+A  +   + +      VH 
Sbjct: 83  SEEPI-YIVIEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+ +++V  ++DFG+A+L+   E   +      I + AP
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 184

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 85/166 (51%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++     VAIK       G +  ++F  E +V+K +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKIRHEKLVQLYAVV 82
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY-LHFGYSNPVVHC 783
           +      +V EYM  GSL D+L      +    RL  ++D+A  +   + +      VH 
Sbjct: 83  SEEPI-YIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+ +++V  ++DFG+A+L+   E   +      I + AP
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 184

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 88/173 (50%), Gaps = 22/173 (12%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G +G VY+G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 76
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVALALEYLHFGY 776
            CT      +++E+M  G+L DYL   N      Q +S ++       ++ A+EYL    
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLE--- 128
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
               +H D+   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 88/173 (50%), Gaps = 22/173 (12%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G +G VY+G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 76
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVALALEYLHFGY 776
            CT      +++E+M  G+L DYL   N      Q +S ++       ++ A+EYL    
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLE--- 128
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
               +H D+   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 83/178 (46%), Gaps = 9/178 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRH 714
             F    ++G G F +V     L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
              VK+  +  +++     L Y  NG L  Y+     SFD         ++  ALEYLH 
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 146
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAPGL 831
                ++H D+KP N+LL++DM   ++DFG AK+LS E    +  +   T  Y++P L
Sbjct: 147 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 202

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 85/166 (51%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++     VAIK       G +  ++F  E +V+K +RH  LV++ +  
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY-LHFGYSNPVVHC 783
           +      +V EYM  GSL D+L      +    RL  ++D+A  +   + +      VH 
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIASGMAYVERMNYVHR 387
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+ +++V  ++DFG+A+L+   E   +      I + AP
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 433

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 83/178 (46%), Gaps = 9/178 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRH 714
             F    ++G G F +V     L    E AIK+    H+  E  +     E +V+  + H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
              VK+     +++     L Y  NG L  Y+     SFD         ++  ALEYLH 
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH- 154
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE-ESMKQTLTLATIGYMAPGL 831
                ++H D+KP N+LL++DM   ++DFG AK+LS E +  +    + T  Y++P L
Sbjct: 155 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 210

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 85/166 (51%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++     VAIK       G +  ++F  E +V+K +RH  LV++ +  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY-LHFGYSNPVVHC 783
           +      +V EYM  GSL D+L      +    RL  ++D+A  +   + +      VH 
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIASGMAYVERMNYVHR 304
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+ +++V  ++DFG+A+L+   E   +      I + AP
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 350

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 85/166 (51%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++     VAIK       G +  ++F  E +V+K +RH  LV++ +  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY-LHFGYSNPVVHC 783
           +      +V EYM  GSL D+L      +    RL  ++D+A  +   + +      VH 
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIASGMAYVERMNYVHR 304
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+ +++V  ++DFG+A+L+   E   +      I + AP
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 350

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 46/168 (27%), Positives = 86/168 (51%), Gaps = 12/168 (7%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G +G VY+G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 81
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
            CT      ++ E+M  G+L DYL   N    + +  L +   ++ A+EYL        +
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 138
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D+   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 186

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 46/168 (27%), Positives = 86/168 (51%), Gaps = 12/168 (7%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G +G VY+G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 76
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
            CT      ++ E+M  G+L DYL   N    + +  L +   ++ A+EYL        +
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 133
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D+   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 46/168 (27%), Positives = 86/168 (51%), Gaps = 12/168 (7%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G +G VY+G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 80
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
            CT      ++ E+M  G+L DYL   N    + +  L +   ++ A+EYL        +
Sbjct: 81  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 137
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D+   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 46/168 (27%), Positives = 86/168 (51%), Gaps = 12/168 (7%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G +G VY+G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 76
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
            CT      ++ E+M  G+L DYL   N    + +  L +   ++ A+EYL        +
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 133
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D+   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 19/190 (10%)
Query: 650 SYKELLQATNQF----NAS-----NLIGTGGFGSVYKGSF-LDG---MEVAIKVFHL-QL 695
           +Y++  +A +QF    +AS      +IG G FG V  G   L G   + VAIK   +   
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 696 EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDI 755
           E   + F  E  ++    H N+V +    T      +V+E+M NG+L+ +L  ++  F +
Sbjct: 85  EKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV 144
Query: 756 LQRLSVIIDVALALEYL-HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
           +Q + ++  +A  + YL   GY    VH D+   N+L++ ++V  +SDFG+++++  +  
Sbjct: 145 IQLVGMLRGIAAGMRYLADMGY----VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPE 200
Query: 815 MKQTLTLATI 824
              T T   I
Sbjct: 201 AVYTTTGGKI 210

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 86/168 (51%), Gaps = 12/168 (7%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G +G VY+G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 81
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
            CT      ++ E+M  G+L DYL   N    + +  L +   ++ A+EYL        +
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 138
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D+   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAP 186

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 81/164 (49%), Gaps = 11/164 (6%)
Query: 664 SNLIGTGGFGSVYKG-----SFLDGMEVAIKVFHL-QLEGALKSFDVECEVLKSVRHRNL 717
             +IG G FG VYKG     S    + VAIK       E     F  E  ++    H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL-HFGY 776
           +++    +      ++ EYM NG+L+ +L   +  F +LQ + ++  +A  ++YL +  Y
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY 168
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT 820
               VH D+   N+L++ ++V  +SDFG++++L  +     T +
Sbjct: 169 ----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 208

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 90/188 (47%), Gaps = 9/188 (4%)
Query: 636 IESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL----DGMEVAIKVF 691
           ++ +     T+    + + L ATN  +   ++G G FG V  G         + VAIK  
Sbjct: 23  VDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 692 HL-QLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN 750
            +   E   + F  E  ++    H N++++    T +    +V E M NGSL+ +L  ++
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD 141
Query: 751 FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS 810
             F ++Q + ++  +A  ++YL        VH D+   N+L++ ++V  +SDFG++++L 
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLS---DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 811 GEESMKQT 818
            +     T
Sbjct: 199 DDPEAAYT 206

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 85/166 (51%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++     VAIK       G +  ++F  E +V+K +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY-LHFGYSNPVVHC 783
           +      +V EYM  GSL D+L      +    RL  ++D+A  +   + +      VH 
Sbjct: 83  SEEPI-YIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+ +++V  ++DFG+A+L+   E   +      I + AP
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 184

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 85/166 (51%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++     VAIK       G +  ++F  E +V+K +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY-LHFGYSNPVVHC 783
           +      +V EYM  GSL D+L      +    RL  ++D+A  +   + +      VH 
Sbjct: 83  SEEPI-YIVCEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+ +++V  ++DFG+A+L+   E   +      I + AP
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 184

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 86/164 (52%), Gaps = 5/164 (3%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN 726
           +G G FG V+ G + +  +VA+K        ++++F  E  ++K+++H  LV++ +  T 
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 727 NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRL-SVIIDVALALEYLHFGYSNPVVHCDI 785
            +   ++ EYM  GSL D+L S+     +L +L      +A  + Y+        +H D+
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 136
Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           + +NVL+ + ++  ++DFG+A+++   E   +      I + AP
Sbjct: 137 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 180

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 87/173 (50%), Gaps = 22/173 (12%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G +G VY+G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 81
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVALALEYLHFGY 776
            CT      ++ E+M  G+L DYL   N      Q +S ++       ++ A+EYL    
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLE--- 133
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
               +H D+   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 186

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 82/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V  ++L  A      K    E  V+ SV
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+ + MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 109 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 167
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 168 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 206

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 87/173 (50%), Gaps = 22/173 (12%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G +G VY+G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 76
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVALALEYLHFGY 776
            CT      ++ E+M  G+L DYL   N      Q +S ++       ++ A+EYL    
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLE--- 128
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
               +H D+   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 86/168 (51%), Gaps = 12/168 (7%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G +G VY+G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 89
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
            CT      ++ E+M  G+L DYL   N    + +  L +   ++ A+EYL        +
Sbjct: 90  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 146
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D+   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 194

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 86/168 (51%), Gaps = 12/168 (7%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G +G VY+G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 81
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
            CT      ++ E+M  G+L DYL   N    + +  L +   ++ A+EYL        +
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 138
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D+   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 186

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++     VAIK       G +  ++F  E +V+K +RH  LV++ +  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 79
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSF-DILQRLSVIIDVALALEYLHFGYSNPVVHC 783
           +      +V EYM  GSL D+L      +  + Q + +   +A  + Y+        VH 
Sbjct: 80  SEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+ +++V  ++DFG+A+L+   E   +      I + AP
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAP 181

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 47/166 (28%), Positives = 85/166 (51%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++     VAIK       G +  ++F  E +V+K +RH  LV++ +  
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 72
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY-LHFGYSNPVVHC 783
           +      +V EYM  GSL D+L      +    RL  ++D+A  +   + +      VH 
Sbjct: 73  SEEPI-XIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIASGMAYVERMNYVHR 128
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+ +++V  ++DFG+A+L+   E   +      I + AP
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAP 174

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 87/173 (50%), Gaps = 22/173 (12%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G +G VY+G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 76
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVALALEYLHFGY 776
            CT      ++ E+M  G+L DYL   N      Q +S ++       ++ A+EYL    
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLE--- 128
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
               +H D+   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 86/168 (51%), Gaps = 12/168 (7%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G +G VY+G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 78
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
            CT      ++ E+M  G+L DYL   N    + +  L +   ++ A+EYL        +
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 135
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D+   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 183

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 85/164 (51%), Gaps = 6/164 (3%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN 726
           +G G FG V+  ++    +VA+K        ++++F  E  V+K+++H  LVK+ +  T 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 727 NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL-EYLHFGYSNPVVHCDI 785
                ++ E+M  GSL D+L S+  S    Q L  +ID +  + E + F      +H D+
Sbjct: 255 EPI-YIITEFMAKGSLLDFLKSDEGS---KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           + +N+L+   +V  ++DFG+A+++   E   +      I + AP
Sbjct: 311 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 354

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 86/168 (51%), Gaps = 12/168 (7%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G +G VY+G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 78
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
            CT      ++ E+M  G+L DYL   N    + +  L +   ++ A+EYL        +
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 135
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D+   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 183

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++     VAIK       G +  ++F  E +V+K +RH  LV++ +  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 79
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSF-DILQRLSVIIDVALALEYLHFGYSNPVVHC 783
           +      +V EYM  GSL D+L      +  + Q + +   +A  + Y+        VH 
Sbjct: 80  SEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+ +++V  ++DFG+A+L+   E   +      I + AP
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 181

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 93/184 (50%), Gaps = 11/184 (5%)
Query: 653 ELLQATNQFNASN---LIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEV 708
           +LL+   +++ +    ++G G +G VY G  L + + +AIK    +     +    E  +
Sbjct: 13  DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIAL 72
Query: 709 LKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSF-DILQRLSVIIDVAL 767
            K ++H+N+V+ + S + N F  + +E +P GSL   L S      D  Q +       L
Sbjct: 73  HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 768 -ALEYLHFGYSNPVVHCDIKPSNVLLDK-DMVAHLSDFGIAKLLSGEESMKQTLTLATIG 825
             L+YLH    N +VH DIK  NVL++    V  +SDFG +K L+G     +T T  T+ 
Sbjct: 133 EGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQ 188
Query: 826 YMAP 829
           YMAP
Sbjct: 189 YMAP 192

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 85/166 (51%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++     VAIK       G +  ++F  E +V+K +RH  LV++ +  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY-LHFGYSNPVVHC 783
           +      +V EYM  GSL D+L      +    RL  ++D+A  +   + +      VH 
Sbjct: 249 SEEPI-YIVGEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIASGMAYVERMNYVHR 304
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+ +++V  ++DFG+A+L+   E   +      I + AP
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 350

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 85/166 (51%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++     VAIK       G +  ++F  E +V+K +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY-LHFGYSNPVVHC 783
           +      +V+EYM  G L D+L      +    RL  ++D+A  +   + +      VH 
Sbjct: 83  SEEPI-YIVMEYMSKGCLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+ +++V  ++DFG+A+L+   E   +      I + AP
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 184

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 87/173 (50%), Gaps = 22/173 (12%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G +G VY+G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 74
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVALALEYLHFGY 776
            CT      ++ E+M  G+L DYL   N      Q +S ++       ++ A+EYL    
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLE--- 126
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
               +H D+   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 127 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAP 179

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 82/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+++ MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 137
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 138 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 176

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 86/168 (51%), Gaps = 12/168 (7%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G +G VY+G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 77
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
            CT      ++ E+M  G+L DYL   N    + +  L +   ++ A+EYL        +
Sbjct: 78  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 134
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D+   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAP 182

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 82/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+++ MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 137 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 175

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 82/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+++ MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 136 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 174

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 82/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+++ MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 134
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 135 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 173

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 95/195 (48%), Gaps = 10/195 (5%)
Query: 638 SNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEG 697
           S+M  Q  ++ +   E             +G G FG V+ G +    +VA+K      +G
Sbjct: 2   SHMQTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK---QG 58
Query: 698 AL--KSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDI 755
           ++   +F  E  ++K ++H+ LV++ +  T      ++ EYM NGSL D+L + +    I
Sbjct: 59  SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS---GI 114
Query: 756 LQRLSVIIDVALAL-EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
              ++ ++D+A  + E + F      +H D++ +N+L+   +   ++DFG+A+L+   E 
Sbjct: 115 KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 174
Query: 815 MKQTLTLATIGYMAP 829
             +      I + AP
Sbjct: 175 TAREGAKFPIKWTAP 189

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 82/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+++ MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 134 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 84/176 (47%), Gaps = 11/176 (6%)
Query: 661 FNASNLIGTGGFGSVYKGS-FLDGMEVAIK---VFHLQLEGALKSFDVECEVLKSVRHRN 716
           F     IG G F  VY+ +  LDG+ VA+K   +F L    A      E ++LK + H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV---IIDVALALEYLH 773
           ++K  +S   ++   +VLE    G L   +        ++   +V    + +  ALE++H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
              S  V+H DIKP+NV +    V  L D G+ +  S + +   +L + T  YM+P
Sbjct: 154 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSP 205

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVEC 706
           K+   A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREV 64
Query: 707 EVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVA 766
           E+   +RH N++++     +     L+LEY P G +   L   +  FD  +  + I ++A
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLS-KFDEQRTATYITELA 123
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
            AL Y H   S  V+H DIKP N+LL       ++DFG +       S ++T    T+ Y
Sbjct: 124 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDY 177
Query: 827 MAPGL 831
           + P +
Sbjct: 178 LPPEM 182

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 82/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+++ MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 134
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 135 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 173

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 86/168 (51%), Gaps = 12/168 (7%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G +G VY+G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 78
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
            CT      ++ E+M  G+L DYL   N    + +  L +   ++ A+EYL        +
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 135
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D+   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAP 183

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 86/164 (52%), Gaps = 5/164 (3%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN 726
           +G G FG V+ G + +  +VA+K        ++++F  E  ++K+++H  LV++ +  T 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 727 NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRL-SVIIDVALALEYLHFGYSNPVVHCDI 785
            +   ++ E+M  GSL D+L S+     +L +L      +A  + Y+        +H D+
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 135
Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           + +NVL+ + ++  ++DFG+A+++   E   +      I + AP
Sbjct: 136 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 179

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 84/166 (50%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++     VAIK       G +  ++F  E +V+K +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY-LHFGYSNPVVHC 783
           +      +V EYM  GSL D+L      +    RL  ++D+A  +   + +      VH 
Sbjct: 83  SEEPI-YIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D+  +N+L+ +++V  ++DFG+A+L+   E   +      I + AP
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 184

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 91/196 (46%), Gaps = 20/196 (10%)
Query: 641 LPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQL 695
           L +  +R+F+        + F+    +G G FG+VY     +  F+  ++V  K   L+ 
Sbjct: 4   LAEMPKRKFT-------IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKS-QLEK 55
Query: 696 EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDI 755
           EG       E E+   +RH N++++ +   +     L+LE+ P G L   L  +   FD 
Sbjct: 56  EGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDE 114
Query: 756 LQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM 815
            +  + + ++A AL Y H      V+H DIKP N+L+       ++DFG +       S+
Sbjct: 115 QRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSL 168
Query: 816 KQTLTLATIGYMAPGL 831
           ++     T+ Y+ P +
Sbjct: 169 RRRXMCGTLDYLPPEM 184

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 87/166 (52%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G +    +VA+K      +G++   +F  E  ++K ++H+ LV++ +  
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 85
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL-EYLHFGYSNPVVHC 783
           T      ++ EYM NGSL D+L + +    I   ++ ++D+A  + E + F      +H 
Sbjct: 86  TQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHR 141
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+   +   ++DFG+A+L+   E   +      I + AP
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAP 187

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 87/166 (52%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G +    +VA+K      +G++   +F  E  ++K ++H+ LV++ +  
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 86
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL-EYLHFGYSNPVVHC 783
           T      ++ EYM NGSL D+L + +    I   ++ ++D+A  + E + F      +H 
Sbjct: 87  TQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHR 142
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+   +   ++DFG+A+L+   E   +      I + AP
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAP 188

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 87/166 (52%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G +    +VA+K      +G++   +F  E  ++K ++H+ LV++ +  
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL-EYLHFGYSNPVVHC 783
           T      ++ EYM NGSL D+L + +    I   ++ ++D+A  + E + F      +H 
Sbjct: 84  TQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHR 139
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+   +   ++DFG+A+L+   E   +      I + AP
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAP 185

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 80/177 (45%), Gaps = 12/177 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLV 718
            +     ++G G FG V K  +    +VAIK   ++ E   K+F VE   L  V H N+V
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIK--QIESESERKAFIVELRQLSRVNHPNIV 65
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNN--FSFDILQRLSVIIDVALALEYLHFGY 776
           K+  +C N     LV+EY   GSL + L+       +     +S  +  +  + YLH   
Sbjct: 66  KLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 123
Query: 777 SNPVVHCDIKPSNVLL-DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
              ++H D+KP N+LL     V  + DFG A  +        T    +  +MAP +F
Sbjct: 124 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVF 176

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 90/180 (50%), Gaps = 26/180 (14%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV--RHRNLVKIISSC 724
           IG G FG V++G +  G EVA+K+F  + E   +S+  E E+ ++V  RH N++  I++ 
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 725 TNNDFKA----LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN-- 778
             ++       LV +Y  +GSL DYL  N ++  +   + + +  A  L +LH       
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 779 ---PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA------TIGYMAP 829
               + H D+K  N+L+ K+    ++D G+A      +S   T+ +A      T  YMAP
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 207

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 87/166 (52%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G +    +VA+K      +G++   +F  E  ++K ++H+ LV++ +  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL-EYLHFGYSNPVVHC 783
           T      ++ EYM NGSL D+L + +    I   ++ ++D+A  + E + F      +H 
Sbjct: 78  TQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+   +   ++DFG+A+L+   E   +      I + AP
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAP 179

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 86/168 (51%), Gaps = 12/168 (7%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G +G VY+G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 322
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
            CT      ++ E+M  G+L DYL   N    + +  L +   ++ A+EYL        +
Sbjct: 323 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFI 379
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H ++   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 427

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 667 IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEG-ALKSFDVECEVLKSVRHRNLVKI 720
           +G G FG V    +       G +VA+K    +  G  +     E E+L+++ H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 721 ISSCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
              CT +      L++E++P+GSL++YL  N    ++ Q+L   + +   ++YL    S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145
Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL 821
             VH D+   NVL++ +    + DFG+ K +   E+ K+  T+
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAI---ETDKEXXTV 185

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 28/181 (15%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV--RHRNLVKIISSC 724
           IG G FG V++G +  G EVA+K+F  + E   +S+  E E+ ++V  RH N++  I++ 
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA- 71
Query: 725 TNNDFKA-----LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN- 778
            N D        LV +Y  +GSL DYL  N ++  +   + + +  A  L +LH      
Sbjct: 72  DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 129
Query: 779 ----PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA------TIGYMA 828
                + H D+K  N+L+ K+    ++D G+A      +S   T+ +A      T  YMA
Sbjct: 130 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMA 186
Query: 829 P 829
           P
Sbjct: 187 P 187

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 87/173 (50%), Gaps = 22/173 (12%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G +G VY+G +    + VA+K      +++E  LK    E  V+K ++H NLV+++ 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 283
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVALALEYLHFGY 776
            CT      ++ E+M  G+L DYL   N      Q +S ++       ++ A+EYL    
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLE--- 335
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
               +H ++   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 388

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 91/180 (50%), Gaps = 26/180 (14%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV--RHRNLVKIISSC 724
           IG G FG V++G +  G EVA+K+F  + E   +S+  E E+ ++V  RH N++  I++ 
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 725 TNNDFKA----LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF----GY 776
             ++       LV +Y  +GSL DYL  N ++  +   + + +  A  L +LH       
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 777 SNPVV-HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA------TIGYMAP 829
             P + H D+K  N+L+ K+    ++D G+A      +S   T+ +A      T  YMAP
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 220

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++     VAIK       G +  ++F  E +V+K +RH  LV++ +  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 82
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY-LHFGYSNPVVHC 783
           +      +V EYM  G L D+L      +    RL  ++D+A  +   + +      VH 
Sbjct: 83  SEEPI-YIVTEYMSKGCLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVERMNYVHR 138
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+ +++V  ++DFG+A+L+   E   +      I + AP
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 184

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 45/164 (27%), Positives = 85/164 (51%), Gaps = 6/164 (3%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN 726
           +G G FG V+  ++    +VA+K        ++++F  E  V+K+++H  LVK+ +  T 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 81
Query: 727 NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL-EYLHFGYSNPVVHCDI 785
                ++ E+M  GSL D+L S+  S    Q L  +ID +  + E + F      +H D+
Sbjct: 82  EPI-YIITEFMAKGSLLDFLKSDEGS---KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           + +N+L+   +V  ++DFG+A+++   E   +      I + AP
Sbjct: 138 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 181

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 91/196 (46%), Gaps = 20/196 (10%)
Query: 641 LPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQL 695
           L +  +R+F+        + F+    +G G FG+VY     +  F+  ++V  K   L+ 
Sbjct: 3   LAEMPKRKFT-------IDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKS-QLEK 54
Query: 696 EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDI 755
           EG       E E+   +RH N++++ +   +     L+LE+ P G L   L  +   FD 
Sbjct: 55  EGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDE 113
Query: 756 LQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM 815
            +  + + ++A AL Y H      V+H DIKP N+L+       ++DFG +       S+
Sbjct: 114 QRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSL 167
Query: 816 KQTLTLATIGYMAPGL 831
           ++     T+ Y+ P +
Sbjct: 168 RRRXMCGTLDYLPPEM 183

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 90/180 (50%), Gaps = 26/180 (14%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV--RHRNLVKIISSC 724
           IG G FG V++G +  G EVA+K+F  + E   +S+  E E+ ++V  RH N++  I++ 
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 725 TNNDFKA----LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN-- 778
             ++       LV +Y  +GSL DYL  N ++  +   + + +  A  L +LH       
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 779 ---PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA------TIGYMAP 829
               + H D+K  N+L+ K+    ++D G+A      +S   T+ +A      T  YMAP
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 184

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 80/177 (45%), Gaps = 12/177 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLV 718
            +     ++G G FG V K  +    +VAIK   ++ E   K+F VE   L  V H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIK--QIESESERKAFIVELRQLSRVNHPNIV 64
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNN--FSFDILQRLSVIIDVALALEYLHFGY 776
           K+  +C N     LV+EY   GSL + L+       +     +S  +  +  + YLH   
Sbjct: 65  KLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 777 SNPVVHCDIKPSNVLL-DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
              ++H D+KP N+LL     V  + DFG A  +        T    +  +MAP +F
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVF 175

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/181 (32%), Positives = 89/181 (49%), Gaps = 19/181 (10%)
Query: 664 SNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRHRNLVK 719
           S+++G G   +V++G     G   AIKVF+      L+  DV   E EVLK + H+N+VK
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNI--SFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 720 I--ISSCTNNDFKALVLEYMPNGSLEDYLY--SNNFSFDILQRLSVIIDVALALEYLHFG 775
           +  I   T    K L++E+ P GSL   L   SN +     + L V+ DV   + +L   
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-- 129
Query: 776 YSNPVVHCDIKPSNVLL----DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
             N +VH +IKP N++     D   V  L+DFG A+ L  +E         T  Y+ P +
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VXLYGTEEYLHPDM 186
Query: 832 F 832
           +
Sbjct: 187 Y 187

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+ + MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 134 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 94/188 (50%), Gaps = 11/188 (5%)
Query: 633 QSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGME-----VA 687
           ++ +   + P  T    +   +L+ T +     ++G+G FG+VYKG ++   E     VA
Sbjct: 13  ETELVEPLTPSGTAPNQAQLRILKET-ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVA 71
Query: 688 IKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYL 746
           IK+ +      A   F  E  ++ S+ H +LV+++  C +   + LV + MP+G L +Y+
Sbjct: 72  IKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYV 130
Query: 747 YSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA 806
           + +  +      L+  + +A  + YL       +VH D+   NVL+       ++DFG+A
Sbjct: 131 HEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLA 187
Query: 807 KLLSGEES 814
           +LL G+E 
Sbjct: 188 RLLEGDEK 195

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 143/305 (46%), Gaps = 39/305 (12%)
Query: 139 LGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLAL 198
           L  +T+L+   LG  ++ G + Y    L NL  +    N+L    P  + NL+ +  + +
Sbjct: 40  LDQVTTLQADRLGIKSIDG-VEY----LNNLTQINFSNNQLTDITP--LKNLTKLVDILM 92
Query: 199 PSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIP 258
            +N ++   P    L  L NL  ++L  N  + I P  + N + L+ LEL  N+ S    
Sbjct: 93  NNNQIADITP----LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-- 144
Query: 259 NTLGNLRKLEWLRLSYNXXXXXXXXXXXXXXWANCKNLKLLDLSNNPINGVLPSSIGNLS 318
           + L  L  L+ L  S N               AN   L+ LD+S+N ++ +  S +  L+
Sbjct: 145 SALSGLTSLQQLNFSSNQVTDLKPL-------ANLTTLERLDISSNKVSDI--SVLAKLT 195
Query: 319 LSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNEL--IGSIPITFGKLQNLQGLDLVN 376
            +L  +  +N  I    P  +G L NL EL L GN+L  IG    T   L NL  LDL N
Sbjct: 196 -NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIG----TLASLTNLTDLDLAN 248
Query: 377 NKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFW 436
           N++    P  L  L +L+ L +  N++S  I P  G LT+L  L L  N+L  + P    
Sbjct: 249 NQISNLAP--LSGLTKLTELKLGANQISN-ISPLAG-LTALTNLELNENQLEDISP--IS 302
Query: 437 NLKDI 441
           NLK++
Sbjct: 303 NLKNL 307

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 90/180 (50%), Gaps = 26/180 (14%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV--RHRNLVKIISSC 724
           IG G FG V++G +  G EVA+K+F  + E   +S+  E E+ ++V  RH N++  I++ 
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 725 TNNDFKA----LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN-- 778
             ++       LV +Y  +GSL DYL  N ++  +   + + +  A  L +LH       
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 779 ---PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA------TIGYMAP 829
               + H D+K  N+L+ K+    ++D G+A      +S   T+ +A      T  YMAP
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 182

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 667 IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEG-ALKSFDVECEVLKSVRHRNLVKI 720
           +G G FG V    +       G +VA+K    +  G  +     E E+L+++ H N+VK 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 721 ISSCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
              CT +      L++E++P+GSL++YL  N    ++ Q+L   + +   ++YL    S 
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 133
Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL 821
             VH D+   NVL++ +    + DFG+ K +   E+ K+  T+
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAI---ETDKEXXTV 173

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 90/180 (50%), Gaps = 26/180 (14%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV--RHRNLVKIISSC 724
           IG G FG V++G +  G EVA+K+F  + E   +S+  E E+ ++V  RH N++  I++ 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 725 TNNDFKA----LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN-- 778
             ++       LV +Y  +GSL DYL  N ++  +   + + +  A  L +LH       
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 779 ---PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA------TIGYMAP 829
               + H D+K  N+L+ K+    ++D G+A      +S   T+ +A      T  YMAP
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 181

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 627 QEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVY-----KGSFL 681
           +E  +KQ N ES             K+   A   F     +G G FG+VY     +  F+
Sbjct: 15  EELASKQKNEES-------------KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFI 61
Query: 682 DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGS 741
             ++V  K   L+  G       E E+   +RH N++++     +     L+LEY P G+
Sbjct: 62  LALKVLFKA-QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 120
Query: 742 LEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLS 801
           +   L   +  FD  +  + I ++A AL Y H   S  V+H DIKP N+LL       ++
Sbjct: 121 VYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 176
Query: 802 DFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
           DFG +       S ++T    T+ Y+ P +
Sbjct: 177 DFGWS---VHAPSSRRTTLCGTLDYLPPEM 203

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 143/305 (46%), Gaps = 39/305 (12%)
Query: 139 LGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLAL 198
           L  +T+L+   LG  ++ G + Y    L NL  +    N+L    P  + NL+ +  + +
Sbjct: 40  LDQVTTLQADRLGIKSIDG-VEY----LNNLTQINFSNNQLTDITP--LKNLTKLVDILM 92
Query: 199 PSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIP 258
            +N ++   P    L  L NL  ++L  N  + I P  + N + L+ LEL  N+ S    
Sbjct: 93  NNNQIADITP----LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-- 144
Query: 259 NTLGNLRKLEWLRLSYNXXXXXXXXXXXXXXWANCKNLKLLDLSNNPINGVLPSSIGNLS 318
           + L  L  L+ L  S N               AN   L+ LD+S+N ++ +  S +  L+
Sbjct: 145 SALSGLTSLQQLSFSSNQVTDLKPL-------ANLTTLERLDISSNKVSDI--SVLAKLT 195
Query: 319 LSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNEL--IGSIPITFGKLQNLQGLDLVN 376
            +L  +  +N  I    P  +G L NL EL L GN+L  IG    T   L NL  LDL N
Sbjct: 196 -NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIG----TLASLTNLTDLDLAN 248
Query: 377 NKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFW 436
           N++    P  L  L +L+ L +  N++S  I P  G LT+L  L L  N+L  + P    
Sbjct: 249 NQISNLAP--LSGLTKLTELKLGANQISN-ISPLAG-LTALTNLELNENQLEDISP--IS 302
Query: 437 NLKDI 441
           NLK++
Sbjct: 303 NLKNL 307

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+ + MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 141 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+ + MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 137 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 175

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 47/166 (28%), Positives = 85/166 (51%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++     VAIK       G +  ++F  E +V+K +RH  LV++ +  
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 71
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY-LHFGYSNPVVHC 783
           +      +V EYM  GSL D+L      +    RL  ++D+A  +   + +      VH 
Sbjct: 72  SEEPI-YIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVERMNYVHR 127
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+ +++V  ++DFG+A+L+   E   +      I + AP
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 173

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 47/166 (28%), Positives = 85/166 (51%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++     VAIK       G +  ++F  E +V+K +RH  LV++ +  
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 73
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY-LHFGYSNPVVHC 783
           +      +V EYM  GSL D+L      +    RL  ++D+A  +   + +      VH 
Sbjct: 74  SEEPI-YIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVERMNYVHR 129
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+ +++V  ++DFG+A+L+   E   +      I + AP
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 175

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+ + MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 137 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 175

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+ + MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 136 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 174

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+ + MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 137 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 175

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/174 (32%), Positives = 91/174 (52%), Gaps = 20/174 (11%)
Query: 670 GGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEV--LKSVRHRNLVKIISS---C 724
           G FG V+K   L+   VA+K+F +Q +   +S+  E EV  L  ++H N+++ I +    
Sbjct: 35  GRFGCVWKAQLLNEY-VAVKIFPIQDK---QSWQNEYEVYSLPGMKHENILQFIGAEKRG 90
Query: 725 TNNDFK-ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF-------GY 776
           T+ D    L+  +   GSL D+L +N  S++ L  ++  +  A  L YLH        G+
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETM--ARGLAYLHEDIPGLKDGH 148
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIA-KLLSGEESMKQTLTLATIGYMAP 829
              + H DIK  NVLL  ++ A ++DFG+A K  +G+ +      + T  YMAP
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 93/305 (30%), Positives = 143/305 (46%), Gaps = 39/305 (12%)
Query: 139 LGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLAL 198
           L  +T+L+   LG  ++ G + Y    L NL  +    N+L    P  + NL+ +  + +
Sbjct: 40  LDQVTTLQADRLGIKSIDG-VEY----LNNLTQINFSNNQLTDITP--LKNLTKLVDILM 92
Query: 199 PSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIP 258
            +N ++   P    L  L NL  ++L  N  + I P  + N + L+ LEL  N+ S    
Sbjct: 93  NNNQIADITP----LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-- 144
Query: 259 NTLGNLRKLEWLRLSYNXXXXXXXXXXXXXXWANCKNLKLLDLSNNPINGVLPSSIGNLS 318
           + L  L  L+ L  S N               AN   L+ LD+S+N ++ +  S +  L+
Sbjct: 145 SALSGLTSLQQLSFSSNQVTDLKP-------LANLTTLERLDISSNKVSDI--SVLAKLT 195
Query: 319 LSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNEL--IGSIPITFGKLQNLQGLDLVN 376
            +L  +  +N  I    P  +G L NL EL L GN+L  IG    T   L NL  LDL N
Sbjct: 196 -NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIG----TLASLTNLTDLDLAN 248
Query: 377 NKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFW 436
           N++    P  L  L +L+ L +  N++S  I P  G LT+L  L L  N+L  + P    
Sbjct: 249 NQISNLAP--LSGLTKLTELKLGANQISN-ISPLAG-LTALTNLELNENQLEDISP--IS 302
Query: 437 NLKDI 441
           NLK++
Sbjct: 303 NLKNL 307

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+ + MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 134 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+ + MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 134 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 83/180 (46%), Gaps = 13/180 (7%)
Query: 657 ATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKS 711
           A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E E+   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A AL Y
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 123
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
            H   S  V+H DIKP N+LL       ++DFG +       S ++T    T+ Y+ P +
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEM 177

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 68/143 (47%), Gaps = 5/143 (3%)
Query: 667 IGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGALKS-FDVECEVLKSVRHRNLVKIISSC 724
           IG G FG V+ G    D   VA+K     L   LK+ F  E  +LK   H N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
           T      +V+E +  G    +L +      +   L ++ D A  +EYL    S   +H D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 785 IKPSNVLLDKDMVAHLSDFGIAK 807
           +   N L+ +  V  +SDFG+++
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSR 261

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+ + MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 85  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 143
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 144 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 182

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 44/166 (26%), Positives = 87/166 (52%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALK--SFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G +    +VA+K      +G++   +F  E  ++K ++H+ LV++ +  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL-EYLHFGYSNPVVHC 783
           T      ++ EYM NGSL D+L + +    I   ++ ++D+A  + E + F      +H 
Sbjct: 78  TQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+   +   ++DFG+A+L+   E   +      I + AP
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAP 179

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 44/166 (26%), Positives = 87/166 (52%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALK--SFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G +    +VA+K      +G++   +F  E  ++K ++H+ LV++ +  
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 78
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL-EYLHFGYSNPVVHC 783
           T      ++ EYM NGSL D+L + +    I   ++ ++D+A  + E + F      +H 
Sbjct: 79  TQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHR 134
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+   +   ++DFG+A+L+   E   +      I + AP
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAP 180

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 44/166 (26%), Positives = 87/166 (52%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALK--SFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G +    +VA+K      +G++   +F  E  ++K ++H+ LV++ +  
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 79
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL-EYLHFGYSNPVVHC 783
           T      ++ EYM NGSL D+L + +    I   ++ ++D+A  + E + F      +H 
Sbjct: 80  TQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHR 135
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+   +   ++DFG+A+L+   E   +      I + AP
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAP 181

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 649 FSYKELLQATNQF---------NASNLIGTGGFGSVYKGSF-LDGME---VAIKVFHL-Q 694
           F++++  +A  +F             +IG G FG V  G   L G     VAIK      
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 695 LEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD 754
            E   + F  E  ++    H N++ +    T +    ++ E+M NGSL+ +L  N+  F 
Sbjct: 74  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 133
Query: 755 ILQRLSVIIDVALALEYL-HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
           ++Q + ++  +A  ++YL    Y    VH D+   N+L++ ++V  +SDFG+++ L  + 
Sbjct: 134 VIQLVGMLRGIAAGMKYLADMNY----VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 189
Query: 814 S 814
           S
Sbjct: 190 S 190

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+ + MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 81  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 139
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 140 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 178

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/182 (33%), Positives = 93/182 (51%), Gaps = 21/182 (11%)
Query: 664 SNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRHRNLVK 719
           S+++G G   +V++G     G   AIKVF+      L+  DV   E EVLK + H+N+VK
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNI--SFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 720 I--ISSCTNNDFKALVLEYMPNGSLEDYLY--SNNFSFDILQRLSVIIDVALALEYLHFG 775
           +  I   T    K L++E+ P GSL   L   SN +     + L V+ DV   + +L   
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-- 129
Query: 776 YSNPVVHCDIKPSNVLL----DKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
             N +VH +IKP N++     D   V  L+DFG A+ L  +E   Q ++L  T  Y+ P 
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPD 185
Query: 831 LF 832
           ++
Sbjct: 186 MY 187

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 86/185 (46%), Gaps = 13/185 (7%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVEC 706
           K+   A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREV 60
Query: 707 EVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVA 766
           E+   +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELA 119
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
            AL Y H   S  V+H DIKP N+LL       ++DFG +       S + TL+  T+ Y
Sbjct: 120 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTTLS-GTLDY 173
Query: 827 MAPGL 831
           + P +
Sbjct: 174 LPPEM 178

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 68/143 (47%), Gaps = 5/143 (3%)
Query: 667 IGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGALKS-FDVECEVLKSVRHRNLVKIISSC 724
           IG G FG V+ G    D   VA+K     L   LK+ F  E  +LK   H N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
           T      +V+E +  G    +L +      +   L ++ D A  +EYL    S   +H D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 785 IKPSNVLLDKDMVAHLSDFGIAK 807
           +   N L+ +  V  +SDFG+++
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSR 261

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 88/178 (49%), Gaps = 8/178 (4%)
Query: 656 QATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFH---LQLEGALKSFDVECEVLKS 711
           +    F   NL+G G F  VY+  S   G+EVAIK+     +   G ++    E ++   
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           ++H +++++ +   ++++  LVLE   NG +  YL +    F   +    +  +   + Y
Sbjct: 68  LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           LH   S+ ++H D+  SN+LL ++M   ++DFG+A  L        TL   T  Y++P
Sbjct: 128 LH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISP 181

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 86/185 (46%), Gaps = 13/185 (7%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVEC 706
           K+   A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREV 60
Query: 707 EVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVA 766
           E+   +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELA 119
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
            AL Y H   S  V+H DIKP N+LL       ++DFG +  +    S + TL   T+ Y
Sbjct: 120 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDTLC-GTLDY 173
Query: 827 MAPGL 831
           + P +
Sbjct: 174 LPPEM 178

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+ + MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 72  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYL 130
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 131 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 169

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+++ MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG AKLL  EE 
Sbjct: 136 E---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 174

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+ + MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 100 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 158
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 159 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 197

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+++ MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG AKLL  EE 
Sbjct: 136 E---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 174

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+++ MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 137
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG AKLL  EE 
Sbjct: 138 E---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 176

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 13/185 (7%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVEC 706
           K+   A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E 
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREV 62
Query: 707 EVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVA 766
           E+   +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A
Sbjct: 63  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELA 121
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
            AL Y H   S  V+H DIKP N+LL       ++DFG +       S ++T    T+ Y
Sbjct: 122 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDY 175
Query: 827 MAPGL 831
           + P +
Sbjct: 176 LPPEM 180

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 13/185 (7%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVEC 706
           K+   A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREV 64
Query: 707 EVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVA 766
           E+   +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELA 123
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
            AL Y H   S  V+H DIKP N+LL       ++DFG +       S ++T    T+ Y
Sbjct: 124 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDY 177
Query: 827 MAPGL 831
           + P +
Sbjct: 178 LPPEM 182

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 627 QEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVY-----KGSFL 681
           +E  +KQ N ES             K+   A   F     +G G FG+VY     +  F+
Sbjct: 6   EELASKQKNEES-------------KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFI 52
Query: 682 DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGS 741
             ++V  K   L+  G       E E+   +RH N++++     +     L+LEY P G+
Sbjct: 53  LALKVLFKA-QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 111
Query: 742 LEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLS 801
           +   L   +  FD  +  + I ++A AL Y H   S  V+H DIKP N+LL       ++
Sbjct: 112 VYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 167
Query: 802 DFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
           DFG +       S ++T    T+ Y+ P +
Sbjct: 168 DFGWS---VHAPSSRRTTLCGTLDYLPPEM 194

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 95/194 (48%), Gaps = 26/194 (13%)
Query: 654 LLQAT--NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKS 711
           L+Q T   Q      +G G +G V++GS+  G  VA+K+F  + E   KS+  E E+  +
Sbjct: 30  LVQRTVARQITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNT 85
Query: 712 V--RHRNLVKIISSCTNNDFKA----LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDV 765
           V  RH N++  I+S   +   +    L+  Y   GSL DYL     + D +  L +++ +
Sbjct: 86  VMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSI 143
Query: 766 ALALEYLH---FGYSN--PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ--- 817
           A  L +LH   FG      + H D+K  N+L+ K+    ++D G+A + S  +S  Q   
Sbjct: 144 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS--QSTNQLDV 201
Query: 818 --TLTLATIGYMAP 829
                + T  YMAP
Sbjct: 202 GNNPRVGTKRYMAP 215

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+ + MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 69  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 128 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 83/180 (46%), Gaps = 13/180 (7%)
Query: 657 ATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKS 711
           A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E E+   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A AL Y
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 123
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
            H   S  V+H DIKP N+LL       ++DFG +       S ++T    T+ Y+ P +
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTELCGTLDYLPPEM 177

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 44/166 (26%), Positives = 87/166 (52%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALK--SFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G +    +VA+K      +G++   +F  E  ++K ++H+ LV++ +  
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 83
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL-EYLHFGYSNPVVHC 783
           T      ++ EYM NGSL D+L + +    I   ++ ++D+A  + E + F      +H 
Sbjct: 84  TQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHR 139
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+   +   ++DFG+A+L+   E   +      I + AP
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 185

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 44/166 (26%), Positives = 87/166 (52%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALK--SFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G +    +VA+K      +G++   +F  E  ++K ++H+ LV++ +  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL-EYLHFGYSNPVVHC 783
           T      ++ EYM NGSL D+L + +    I   ++ ++D+A  + E + F      +H 
Sbjct: 78  TQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+   +   ++DFG+A+L+   E   +      I + AP
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 44/166 (26%), Positives = 87/166 (52%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALK--SFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G +    +VA+K      +G++   +F  E  ++K ++H+ LV++ +  
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 72
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL-EYLHFGYSNPVVHC 783
           T      ++ EYM NGSL D+L + +    I   ++ ++D+A  + E + F      +H 
Sbjct: 73  TQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHR 128
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+   +   ++DFG+A+L+   E   +      I + AP
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 174

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 44/166 (26%), Positives = 87/166 (52%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALK--SFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G +    +VA+K      +G++   +F  E  ++K ++H+ LV++ +  
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 82
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL-EYLHFGYSNPVVHC 783
           T      ++ EYM NGSL D+L + +    I   ++ ++D+A  + E + F      +H 
Sbjct: 83  TQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHR 138
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+   +   ++DFG+A+L+   E   +      I + AP
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 184

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++     VAIK       G +  ++F  E +V+K +RH  LV++ +  
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGNMSPEAFLQEAQVMKKLRHEKLVQLYAVV 249
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY-LHFGYSNPVVHC 783
           +      +V EYM  GSL D+L      +    RL  ++D+A  +   + +      VH 
Sbjct: 250 SEEPI-YIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASGMAYVERMNYVHR 305
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+ +++V  ++DFG+ +L+   E   +      I + AP
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAP 351

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 84/183 (45%), Gaps = 13/183 (7%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVEC 706
           K+   A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREV 64
Query: 707 EVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVA 766
           E+   +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELA 123
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
            AL Y H   S  V+H DIKP N+LL       ++DFG +       S ++T    T+ Y
Sbjct: 124 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDY 177
Query: 827 MAP 829
           + P
Sbjct: 178 LPP 180

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 83/185 (44%), Gaps = 13/185 (7%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVEC 706
           K+   A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREV 64
Query: 707 EVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVA 766
           E+   +RH N++++     +     L+LEY P G +   L   +  FD  +  + I ++A
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLS-KFDEQRTATYITELA 123
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
            AL Y H   S  V+H DIKP N+LL       ++DFG +       S ++     T+ Y
Sbjct: 124 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLXGTLDY 177
Query: 827 MAPGL 831
           + P +
Sbjct: 178 LPPEM 182

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 87/186 (46%), Gaps = 20/186 (10%)
Query: 657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHL-------QLEGALKSFDVECEV 708
           A N+      IG GGFG V+KG  + D   VAIK   L       ++    + F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 709 LKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALA 768
           + ++ H N+VK+     N     +V+E++P G L   L           +L +++D+AL 
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 769 LEYLHFGYSNPVVHCDIKPSNVLL-----DKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
           +EY+    + P+VH D++  N+ L     +  + A ++DFG    LS +     +  L  
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG----LSQQSVHSVSGLLGN 189
Query: 824 IGYMAP 829
             +MAP
Sbjct: 190 FQWMAP 195

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 52/193 (26%), Positives = 92/193 (47%), Gaps = 20/193 (10%)
Query: 642 PQATRRRFSYKELLQATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLE 696
           P  ++R+++ ++       F+    +G G FG+VY     +  F+  ++V  K   L+  
Sbjct: 2   PLGSKRQWTLED-------FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKT-QLEKA 53
Query: 697 GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDIL 756
           G       E E+   +RH N++++     +     L+LEY P G++   L   +  FD  
Sbjct: 54  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-RFDEQ 112
Query: 757 QRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK 816
           +  + I ++A AL Y H   S  V+H DIKP N+LL  +    ++DFG +       S +
Sbjct: 113 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWS---VHAPSSR 166
Query: 817 QTLTLATIGYMAP 829
           +T    T+ Y+ P
Sbjct: 167 RTTLCGTLDYLPP 179

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++ +G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+++ MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 141 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 84/178 (47%), Gaps = 13/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVR 713
           + F     +G G FG+VY     K  F+  ++V  K   ++ EG       E E+   + 
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKS-QIEKEGVEHQLRREIEIQAHLH 81
Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
           H N++++ +   +     L+LEY P G L   L   + +FD  +  +++ ++A AL Y H
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKEL-QKSCTFDEQRTATIMEELADALMYCH 140
Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
                 V+H DIKP N+LL       ++DFG +       S+++     T+ Y+ P +
Sbjct: 141 ---GKKVIHRDIKPENLLLGLKGELKIADFGWS---VHAPSLRRKTMCGTLDYLPPEM 192

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 53/193 (27%), Positives = 93/193 (48%), Gaps = 20/193 (10%)
Query: 642 PQATRRRFSYKELLQATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLE 696
           P  ++R+++ ++       F+    +G G FG+VY     +  F+  ++V  K   L+  
Sbjct: 2   PLGSKRQWTLED-------FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKT-QLEKA 53
Query: 697 GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDIL 756
           G       E E+   +RH N++++     +     L+LEY P G++   L   +  FD  
Sbjct: 54  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-RFDEQ 112
Query: 757 QRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK 816
           +  + I ++A AL Y H   S  V+H DIKP N+LL  +    ++DFG +  +    S +
Sbjct: 113 RTATYITELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRR 167
Query: 817 QTLTLATIGYMAP 829
            TL   T+ Y+ P
Sbjct: 168 DTLC-GTLDYLPP 179

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 92/187 (49%), Gaps = 24/187 (12%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV--RHRN 716
           +Q      +G G +G V++GS+  G  VA+K+F  + E   KS+  E E+  +V  RH N
Sbjct: 8   HQITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHEN 63
Query: 717 LVKIISSCTNNDFKA----LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
           ++  I+S   +   +    L+  Y   GSL DYL     + D +  L +++ +A  L +L
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHL 121
Query: 773 H---FGYSN--PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ-----TLTLA 822
           H   FG      + H D+K  N+L+ K+    ++D G+A + S  +S  Q        + 
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS--QSTNQLDVGNNPRVG 179
Query: 823 TIGYMAP 829
           T  YMAP
Sbjct: 180 TKRYMAP 186

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 83/162 (51%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGME-----VAIKVFHLQL-EGALKSFDVECEVLKSV 712
            +     ++G+G FG+VYKG ++   E     VAIK+ +      A   F  E  ++ S+
Sbjct: 15  TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 74
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            H +LV+++  C +   + LV + MP+G L +Y++ +  +      L+  + +A  + YL
Sbjct: 75  DHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYL 133
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+A+LL G+E 
Sbjct: 134 E---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 172

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 86/172 (50%), Gaps = 12/172 (6%)
Query: 664 SNLIGTGGFGSVYKGSF-LDGME---VAIKVFHL-QLEGALKSFDVECEVLKSVRHRNLV 718
             +IG G FG V +G     G +   VAIK       E   + F  E  ++    H N++
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL-HFGYS 777
           ++    TN+    ++ E+M NG+L+ +L  N+  F ++Q + ++  +A  + YL    Y 
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSY- 139
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
              VH D+   N+L++ ++V  +SDFG+++ L  EE+       +++G   P
Sbjct: 140 ---VHRDLAARNILVNSNLVCKVSDFGLSRFL--EENSSDPTETSSLGGKIP 186

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 80/162 (49%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+ + MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG AKLL  EE 
Sbjct: 141 E---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 179

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 13/185 (7%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVEC 706
           K+   A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREV 60
Query: 707 EVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVA 766
           E+   +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELA 119
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
            AL Y H   S  V+H DIKP N+LL       ++DFG +       S ++T    T+ Y
Sbjct: 120 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDY 173
Query: 827 MAPGL 831
           + P +
Sbjct: 174 LPPEM 178

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 84/170 (49%), Gaps = 9/170 (5%)
Query: 665 NLIGTGGFGSVYKGSFLD--GMEVAIKVFHLQLEGAL---KSFDVECEVLKSVRHRNLVK 719
            ++G G FG VY+G + +  G ++ + V   + +  L   + F  E  ++K++ H ++VK
Sbjct: 30  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 89
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
           +I      +   +++E  P G L  YL  N  S  +L  +   + +  A+ YL    S  
Sbjct: 90  LIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SIN 145
Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            VH DI   N+L+       L DFG+++ +  E+  K ++T   I +M+P
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSP 195

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 84/178 (47%), Gaps = 14/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRH 714
           +QF     IGTG FG V     ++ G   A+K+   Q    LK  +    E  +L++V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             LVK+  S  +N    +V+EYMP G +  +L      F           + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH- 158
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPGL 831
             S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEI 209

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 13/185 (7%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVEC 706
           K+   A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREV 64
Query: 707 EVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVA 766
           E+   +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELA 123
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
            AL Y H   S  V+H DIKP N+LL       ++DFG +       S ++T    T+ Y
Sbjct: 124 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDY 177
Query: 827 MAPGL 831
           + P +
Sbjct: 178 LPPEM 182

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 46/171 (26%), Positives = 85/171 (49%), Gaps = 9/171 (5%)
Query: 664 SNLIGTGGFGSVYKGSFLD--GMEVAIKVFHLQLEGAL---KSFDVECEVLKSVRHRNLV 718
           + ++G G FG VY+G + +  G ++ + V   + +  L   + F  E  ++K++ H ++V
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
           K+I      +   +++E  P G L  YL  N  S  +L  +   + +  A+ YL    S 
Sbjct: 73  KLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 128
Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             VH DI   N+L+       L DFG+++ +  E+  K ++T   I +M+P
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSP 179

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 84/178 (47%), Gaps = 14/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRH 714
           +QF     IGTG FG V     ++ G   A+K+   Q    LK  +    E  +L++V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             LVK+  S  +N    +V+EYMP G +  +L      F           + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH- 158
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPGL 831
             S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEI 209

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 24/179 (13%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV--RHRNLVKIISSC 724
           +G G +G V++GS+  G  VA+K+F  + E   KS+  E E+  +V  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASD 71
Query: 725 TNNDFKA----LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH---FGYS 777
             +   +    L+  Y   GSL DYL     + D +  L +++ +A  L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 778 N--PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ-----TLTLATIGYMAP 829
               + H D+K  N+L+ K+    ++D G+A + S  +S  Q        + T  YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS--QSTNQLDVGNNPRVGTKRYMAP 186

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 80/162 (49%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+ + MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG AKLL  EE 
Sbjct: 136 E---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 174

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 88/175 (50%), Gaps = 21/175 (12%)
Query: 670 GGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKS--VRHRNLVKIISS---C 724
           G FG V+K   ++   VA+K+F LQ +   +S+  E E+  +  ++H NL++ I++    
Sbjct: 26  GRFGCVWKAQLMNDF-VAVKIFPLQDK---QSWQSEREIFSTPGMKHENLLQFIAAEKRG 81
Query: 725 TNNDFK-ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF--------G 775
           +N + +  L+  +   GSL DYL  N  +++ L    V   ++  L YLH         G
Sbjct: 82  SNLEVELWLITAFHDKGSLTDYLKGNIITWNEL--CHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA-KLLSGEESMKQTLTLATIGYMAP 829
           +   + H D K  NVLL  D+ A L+DFG+A +   G+        + T  YMAP
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAP 194

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 83/180 (46%), Gaps = 13/180 (7%)
Query: 657 ATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKS 711
           A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E E+   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A AL Y
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 123
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
            H   S  V+H DIKP N+LL       ++DFG +       S ++T    T+ Y+ P +
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEM 177

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 85/178 (47%), Gaps = 14/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRH 714
           +QF     +GTG FG V     ++ G   A+K+   Q    LK  +    E  +L++V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             LVK+  S  +N    +V+EY+P G +  +L      F           + L  EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH- 159
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPGL 831
             S  +++ D+KP N+L+D+     ++DFG AK + G     +T TL  T  Y+AP +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAPEI 210

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 82/163 (50%), Gaps = 11/163 (6%)
Query: 664 SNLIGTGGFGSVYKGSF-LDGME---VAIKVFHL-QLEGALKSFDVECEVLKSVRHRNLV 718
             +IG G FG V +G     G +   VAIK       E   + F  E  ++    H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL-HFGYS 777
           ++    TN+    ++ E+M NG+L+ +L  N+  F ++Q + ++  +A  + YL    Y 
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSY- 137
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT 820
              VH D+   N+L++ ++V  +SDFG+++ L  E S   T T
Sbjct: 138 ---VHRDLAARNILVNSNLVCKVSDFGLSRFLE-ENSSDPTYT 176

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 85/178 (47%), Gaps = 14/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRH 714
           +QF     +GTG FG V     ++ G   A+K+   Q    LK  +    E  +L++V  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             LVK+  S  +N    +V+EY+P G +  +L      F           + L  EYLH 
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH- 144
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPGL 831
             S  +++ D+KP N+L+D+     ++DFG AK + G     +T TL  T  Y+AP +
Sbjct: 145 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAPEI 195

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 84/170 (49%), Gaps = 9/170 (5%)
Query: 665 NLIGTGGFGSVYKGSFLD--GMEVAIKVFHLQLEGAL---KSFDVECEVLKSVRHRNLVK 719
            ++G G FG VY+G + +  G ++ + V   + +  L   + F  E  ++K++ H ++VK
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
           +I      +   +++E  P G L  YL  N  S  +L  +   + +  A+ YL    S  
Sbjct: 78  LIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SIN 133
Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            VH DI   N+L+       L DFG+++ +  E+  K ++T   I +M+P
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSP 183

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 80/162 (49%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++G+G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+ + MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG AKLL  EE 
Sbjct: 134 E---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 172

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 88/184 (47%), Gaps = 17/184 (9%)
Query: 649 FSYKELLQATNQF----NAS-----NLIGTGGFGSVYKGSF-LDGME---VAIKVFHL-Q 694
           F++++  QA  +F    +AS      +IG G FG V  G   + G     VAIK      
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 695 LEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD 754
            +   + F  E  ++    H N++ +    T      ++ EYM NGSL+ +L  N+  F 
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 129
Query: 755 ILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
           ++Q + ++  +   ++YL        VH D+   N+L++ ++V  +SDFG++++L  +  
Sbjct: 130 VIQLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE 186
Query: 815 MKQT 818
              T
Sbjct: 187 AAYT 190

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 80/164 (48%), Gaps = 16/164 (9%)
Query: 657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHL-------QLEGALKSFDVECEV 708
           A N+      IG GGFG V+KG  + D   VAIK   L       ++    + F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 709 LKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALA 768
           + ++ H N+VK+     N     +V+E++P G L   L           +L +++D+AL 
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 769 LEYLHFGYSNPVVHCDIKPSNVLL-----DKDMVAHLSDFGIAK 807
           +EY+    + P+VH D++  N+ L     +  + A ++DFG ++
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ 177

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 82/187 (43%), Gaps = 30/187 (16%)
Query: 667 IGTGGFGSVYKGSF------LDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKI 720
           +G G FG V+           D M VA+K      E A + F  E E+L  ++H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDIL--------------QRLSVIIDVA 766
              CT      +V EYM +G L  +L S+     +L              Q L+V   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 767 LALEY---LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK-LLSGEESMKQTLTLA 822
             + Y   LHF      VH D+   N L+ + +V  + DFG+++ + S +       T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 823 TIGYMAP 829
            I +M P
Sbjct: 223 PIRWMPP 229

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 92/191 (48%), Gaps = 27/191 (14%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DG--MEVAIKVF-HLQLEGALKSFDVECEVL-KSVR 713
           N     ++IG G FG V K     DG  M+ AIK       +   + F  E EVL K   
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNF-----SFDIL----------QR 758
           H N++ ++ +C +  +  L +EY P+G+L D+L  +       +F I           Q 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 759 LSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE-SMKQ 817
           L    DVA  ++YL        +H D+   N+L+ ++ VA ++DFG+++   G+E  +K+
Sbjct: 145 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 198
Query: 818 TLTLATIGYMA 828
           T+    + +MA
Sbjct: 199 TMGRLPVRWMA 209

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 82/180 (45%), Gaps = 13/180 (7%)
Query: 657 ATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKS 711
           A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E E+   
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 67
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A AL Y
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 126
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
            H   S  V+H DIKP N+LL       ++DFG +       S ++     T+ Y+ P +
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEM 180

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 627 QEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVY-----KGSFL 681
           +E  +KQ N ES             K+   A   F     +G G FG+VY     +  F+
Sbjct: 15  EELASKQKNEES-------------KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFI 61
Query: 682 DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGS 741
             ++V  K   L+  G       E E+   +RH N++++     +     L+LEY P G+
Sbjct: 62  LALKVLFKA-QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 120
Query: 742 LEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLS 801
           +   L   +  FD  +  + I ++A AL Y H   S  V+H DIKP N+LL       ++
Sbjct: 121 VYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 176
Query: 802 DFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
           DFG +  +    S +  L   T+ Y+ P +
Sbjct: 177 DFGWS--VHAPSSRRDDLC-GTLDYLPPEM 203

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 78/143 (54%), Gaps = 6/143 (4%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN 726
           +G G FG V+  ++    +VA+K        ++++F  E  V+K+++H  LVK+ +  T 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 248
Query: 727 NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL-EYLHFGYSNPVVHCDI 785
                ++ E+M  GSL D+L S+  S    Q L  +ID +  + E + F      +H D+
Sbjct: 249 EPI-YIITEFMAKGSLLDFLKSDEGS---KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 304
Query: 786 KPSNVLLDKDMVAHLSDFGIAKL 808
           + +N+L+   +V  ++DFG+A++
Sbjct: 305 RAANILVSASLVCKIADFGLARV 327

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 90/190 (47%), Gaps = 25/190 (13%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DG--MEVAIKVF-HLQLEGALKSFDVECEVL-KSVR 713
           N     ++IG G FG V K     DG  M+ AIK       +   + F  E EVL K   
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNF-----SFDIL----------QR 758
           H N++ ++ +C +  +  L +EY P+G+L D+L  +       +F I           Q 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 759 LSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT 818
           L    DVA  ++YL        +H D+   N+L+ ++ VA ++DFG+++    E  +K+T
Sbjct: 135 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 189
Query: 819 LTLATIGYMA 828
           +    + +MA
Sbjct: 190 MGRLPVRWMA 199

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 48/168 (28%), Positives = 76/168 (45%), Gaps = 9/168 (5%)
Query: 667 IGTGGFGSVYKGSFLD----GMEVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLVKII 721
           IG G FG V++G ++      M VAIK   +   +   + F  E   ++   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
              T N    +++E    G L  +L    FS D+   +     ++ AL YL    S   V
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H DI   NVL+  +    L DFG+++ +      K +     I +MAP
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAP 181

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 85/185 (45%), Gaps = 13/185 (7%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVEC 706
           K+   A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E 
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREV 61
Query: 707 EVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVA 766
           E+   +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A
Sbjct: 62  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELA 120
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
            AL Y H   S  V+H DIKP N+LL       +++FG +       S ++T    T+ Y
Sbjct: 121 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDY 174
Query: 827 MAPGL 831
           + P +
Sbjct: 175 LPPEM 179

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++ +G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+ + MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 141 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVEC 706
           K+   A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E 
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREV 61
Query: 707 EVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVA 766
           E+   +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A
Sbjct: 62  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELA 120
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
            AL Y H   S  V+H DIKP N+LL       ++DFG +       S ++     T+ Y
Sbjct: 121 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDY 174
Query: 827 MAPGL 831
           + P +
Sbjct: 175 LPPEM 179

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 43/166 (25%), Positives = 87/166 (52%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALK--SFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G +    +VA+K      +G++   +F  E  ++K ++H+ LV++ +  
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 73
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL-EYLHFGYSNPVVHC 783
           T      ++ EYM NGSL D+L + +    I   ++ ++D+A  + E + F      +H 
Sbjct: 74  TQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHR 129
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +++ +N+L+   +   ++DFG+A+L+   E   +      I + AP
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 175

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 82/187 (43%), Gaps = 30/187 (16%)
Query: 667 IGTGGFGSVYKGSF------LDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKI 720
           +G G FG V+           D M VA+K      E A + F  E E+L  ++H+++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDIL--------------QRLSVIIDVA 766
              CT      +V EYM +G L  +L S+     +L              Q L+V   VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 767 LALEY---LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK-LLSGEESMKQTLTLA 822
             + Y   LHF      VH D+   N L+ + +V  + DFG+++ + S +       T+ 
Sbjct: 140 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 823 TIGYMAP 829
            I +M P
Sbjct: 194 PIRWMPP 200

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 82/187 (43%), Gaps = 30/187 (16%)
Query: 667 IGTGGFGSVYKGSF------LDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKI 720
           +G G FG V+           D M VA+K      E A + F  E E+L  ++H+++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDIL--------------QRLSVIIDVA 766
              CT      +V EYM +G L  +L S+     +L              Q L+V   VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 767 LALEY---LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK-LLSGEESMKQTLTLA 822
             + Y   LHF      VH D+   N L+ + +V  + DFG+++ + S +       T+ 
Sbjct: 146 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 823 TIGYMAP 829
            I +M P
Sbjct: 200 PIRWMPP 206

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 76/168 (45%), Gaps = 9/168 (5%)
Query: 667 IGTGGFGSVYKGSFLD----GMEVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLVKII 721
           IG G FG V++G ++      M VAIK   +   +   + F  E   ++   H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
              T N    +++E    G L  +L    FS D+   +     ++ AL YL    S   V
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H DI   NVL+  +    L DFG+++ +      K +     I +MAP
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 76/167 (45%), Gaps = 18/167 (10%)
Query: 655 LQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVR 713
           L+  + F    ++G G FG V K  + LD    AIK      E  L +   E  +L S+ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLN 60
Query: 714 H-------------RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLS 760
           H             RN VK +++        + +EY  NG+L D ++S N +    +   
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           +   +  AL Y+H   S  ++H D+KP N+ +D+     + DFG+AK
Sbjct: 121 LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL-----KSFDVECEVLKSV 712
            +F    ++ +G FG+VYKG ++ +G +V I V   +L  A      K    E  V+ SV
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            + ++ +++  C  +  + L+ + MP G L DY+  +  +      L+  + +A  + YL
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 134 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 86/166 (51%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G  G V+ G +    +VA+K      +G++   +F  E  ++K ++H+ LV++ +  
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL-EYLHFGYSNPVVHC 783
           T      ++ EYM NGSL D+L + +    I   ++ ++D+A  + E + F      +H 
Sbjct: 78  TQEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+   +   ++DFG+A+L+   E   +      I + AP
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAP 179

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 82/165 (49%), Gaps = 9/165 (5%)
Query: 661 FNASNLI-----GTGGFGSVYKGSFLDGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRH 714
           F  S+LI     G G FG   K +  +  EV +    ++  E   ++F  E +V++ + H
Sbjct: 7   FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH 66
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
            N++K I     +     + EY+  G+L   + S +  +   QR+S   D+A  + YLH 
Sbjct: 67  PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH- 125
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL 819
             S  ++H D+   N L+ ++    ++DFG+A+L+  E++  + L
Sbjct: 126 --SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 82/166 (49%), Gaps = 10/166 (6%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G++    +VAIK       G +  +SF  E +++K ++H  LV++ +  
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLK---PGTMSPESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
           +      +V EYM  GSL D+L      +  +   + +   VA  + Y+        +H 
Sbjct: 74  SEEPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 129
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+   ++  ++DFG+A+L+   E   +      I + AP
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAP 175

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 657 ATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKS 711
           A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E E+   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A AL Y
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 123
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            H   S  V+H DIKP N+LL       ++DFG +       S ++T    T+ Y+ P
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTXLCGTLDYLPP 175

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 657 ATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKS 711
           A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E E+   
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 68
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A AL Y
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 127
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            H   S  V+H DIKP N+LL       ++DFG +       S ++T    T+ Y+ P
Sbjct: 128 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPP 179

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 657 ATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKS 711
           A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E E+   
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 63
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A AL Y
Sbjct: 64  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 122
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            H   S  V+H DIKP N+LL       ++DFG +       S ++T    T+ Y+ P
Sbjct: 123 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPP 174

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 657 ATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKS 711
           A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E E+   
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 67
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A AL Y
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 126
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            H   S  V+H DIKP N+LL       ++DFG +       S ++T    T+ Y+ P
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPP 178

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 667 IGTGGFGSVY-KGSFLDGMEVAIKVF-HLQL-EGALKSFDVECEVLKSVRHRNLVKIISS 723
           IG G F  V      L G EVA+K+    QL   +L+    E  ++K + H N+VK+   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
                   LV+EY   G + DYL ++ +  +   R +    +  A++Y H  +   +VH 
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEAR-AKFRQIVSAVQYCHQKF---IVHR 130
Query: 784 DIKPSNVLLDKDMVAHLSDFGIA 806
           D+K  N+LLD DM   ++DFG +
Sbjct: 131 DLKAENLLLDADMNIKIADFGFS 153

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 14/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRH 714
           +QF     +GTG FG V     ++ G   A+K+   Q    LK  +    E  +L++V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             LVK+  S  +N    +V+EY+P G +  +L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA-QIVLTFEYLH- 158
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPGL 831
             S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 14/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRH 714
           +QF     +GTG FG V     ++ G   A+K+   Q    LK  +    E  +L++V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             LVK+  S  +N    +V+EY+P G +  +L       +   R      + L  EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA-QIVLTFEYLH- 159
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPGL 831
             S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 84/178 (47%), Gaps = 14/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRH 714
           +QF     IGTG FG V     ++ G   A+K+   Q    LK  +    E  +L++V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             LVK+  S  +N    +V+EY+P G +  +L      F           + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH- 158
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPGL 831
             S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEI 209

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 14/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRH 714
           +QF     +GTG FG V     ++ G   A+K+   Q    LK  +    E  +L++V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             LVK+  S  +N    +V+EY+P G +  +L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA-QIVLTFEYLH- 158
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPGL 831
             S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 78/177 (44%), Gaps = 12/177 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRN 716
            Q     LIG G FG VY G +    EVAI++  ++   E  LK+F  E    +  RH N
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
           +V  + +C +    A++       +L   +       D+ +   +  ++   + YLH   
Sbjct: 91  VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH--- 147
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGI----AKLLSGEESMKQTLTLATIGYMAP 829
           +  ++H D+K  NV  D   V  ++DFG+      L +G    K  +    + ++AP
Sbjct: 148 AKGILHKDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 96/184 (52%), Gaps = 21/184 (11%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGM--EVAIKVFHLQ--LEGALKSFD------VECEV 708
           +++  S  +G+G  G V K +F      +VAIK+   +    G+ +  D       E E+
Sbjct: 16  DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 74
Query: 709 LKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALA 768
           LK + H  ++KI +     D+  +VLE M  G L D +  N    +   +L     + LA
Sbjct: 75  LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLA 132
Query: 769 LEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG 825
           ++YLH    N ++H D+KP NVLL   ++D +  ++DFG +K+L GE S+ +TL   T  
Sbjct: 133 VQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC-GTPT 187
Query: 826 YMAP 829
           Y+AP
Sbjct: 188 YLAP 191

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 84/176 (47%), Gaps = 18/176 (10%)
Query: 653 ELLQATNQF---------NASNLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQLE-GA 698
           EL+QA             + + +IG G FG VY G+ LD     +  A+K  +   + G 
Sbjct: 33  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 92
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV-LEYMPNGSLEDYLYSNNFSFDILQ 757
           +  F  E  ++K   H N++ ++  C  ++   LV L YM +G L +++ +   +  +  
Sbjct: 93  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 152
Query: 758 RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
            +   + VA  ++YL    S   VH D+   N +LD+     ++DFG+A+ +  +E
Sbjct: 153 LIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 205

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 9/168 (5%)
Query: 667 IGTGGFGSVYKGSFLD----GMEVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLVKII 721
           IG G FG V++G ++      M VAIK   +   +   + F  E   ++   H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
              T N    +++E    G L  +L    FS D+   +     ++ AL YL    S   V
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H DI   NVL+       L DFG+++ +      K +     I +MAP
Sbjct: 514 HRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 96/184 (52%), Gaps = 21/184 (11%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGM--EVAIKVFHLQ--LEGALKSFD------VECEV 708
           +++  S  +G+G  G V K +F      +VAIK+   +    G+ +  D       E E+
Sbjct: 9   DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 67
Query: 709 LKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALA 768
           LK + H  ++KI +     D+  +VLE M  G L D +  N    +   +L     + LA
Sbjct: 68  LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLA 125
Query: 769 LEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG 825
           ++YLH    N ++H D+KP NVLL   ++D +  ++DFG +K+L GE S+ +TL   T  
Sbjct: 126 VQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC-GTPT 180
Query: 826 YMAP 829
           Y+AP
Sbjct: 181 YLAP 184

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 84/176 (47%), Gaps = 18/176 (10%)
Query: 653 ELLQATNQF---------NASNLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQLE-GA 698
           EL+QA             + + +IG G FG VY G+ LD     +  A+K  +   + G 
Sbjct: 14  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 73
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV-LEYMPNGSLEDYLYSNNFSFDILQ 757
           +  F  E  ++K   H N++ ++  C  ++   LV L YM +G L +++ +   +  +  
Sbjct: 74  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 133
Query: 758 RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
            +   + VA  ++YL    S   VH D+   N +LD+     ++DFG+A+ +  +E
Sbjct: 134 LIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 186

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 84/176 (47%), Gaps = 18/176 (10%)
Query: 653 ELLQATNQF---------NASNLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQLE-GA 698
           EL+QA             + + +IG G FG VY G+ LD     +  A+K  +   + G 
Sbjct: 7   ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 66
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV-LEYMPNGSLEDYLYSNNFSFDILQ 757
           +  F  E  ++K   H N++ ++  C  ++   LV L YM +G L +++ +   +  +  
Sbjct: 67  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 126
Query: 758 RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
            +   + VA  ++YL    S   VH D+   N +LD+     ++DFG+A+ +  +E
Sbjct: 127 LIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 179

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 96/184 (52%), Gaps = 21/184 (11%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGM--EVAIKVFHLQ--LEGALKSFD------VECEV 708
           +++  S  +G+G  G V K +F      +VAIK+   +    G+ +  D       E E+
Sbjct: 10  DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 709 LKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALA 768
           LK + H  ++KI +     D+  +VLE M  G L D +  N    +   +L     + LA
Sbjct: 69  LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLA 126
Query: 769 LEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG 825
           ++YLH    N ++H D+KP NVLL   ++D +  ++DFG +K+L GE S+ +TL   T  
Sbjct: 127 VQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC-GTPT 181
Query: 826 YMAP 829
           Y+AP
Sbjct: 182 YLAP 185

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 96/184 (52%), Gaps = 21/184 (11%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGM--EVAIKVFHLQ--LEGALKSFD------VECEV 708
           +++  S  +G+G  G V K +F      +VAIK+   +    G+ +  D       E E+
Sbjct: 10  DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 709 LKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALA 768
           LK + H  ++KI +     D+  +VLE M  G L D +  N    +   +L     + LA
Sbjct: 69  LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLA 126
Query: 769 LEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG 825
           ++YLH    N ++H D+KP NVLL   ++D +  ++DFG +K+L GE S+ +TL   T  
Sbjct: 127 VQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC-GTPT 181
Query: 826 YMAP 829
           Y+AP
Sbjct: 182 YLAP 185

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 84/176 (47%), Gaps = 18/176 (10%)
Query: 653 ELLQATNQF---------NASNLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQLE-GA 698
           EL+QA             + + +IG G FG VY G+ LD     +  A+K  +   + G 
Sbjct: 34  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 93
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV-LEYMPNGSLEDYLYSNNFSFDILQ 757
           +  F  E  ++K   H N++ ++  C  ++   LV L YM +G L +++ +   +  +  
Sbjct: 94  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 153
Query: 758 RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
            +   + VA  ++YL    S   VH D+   N +LD+     ++DFG+A+ +  +E
Sbjct: 154 LIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 206

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 20/186 (10%)
Query: 657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHL-------QLEGALKSFDVECEV 708
           A N+      IG GGFG V+KG  + D   VAIK   L       ++    + F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 709 LKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALA 768
           + ++ H N+VK+     N     +V+E++P G L   L           +L +++D+AL 
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 769 LEYLHFGYSNPVVHCDIKPSNVLL-----DKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
           +EY+    + P+VH D++  N+ L     +  + A ++DF     LS +     +  L  
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFS----LSQQSVHSVSGLLGN 189
Query: 824 IGYMAP 829
             +MAP
Sbjct: 190 FQWMAP 195

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 10/157 (6%)
Query: 664 SNLIGTGGFGSVYKGSF-LDGME---VAIKVFHL-QLEGALKSFDVECEVLKSVRHRNLV 718
             +IG G FG V  G   L G     VAIK       E   + F  E  ++    H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL-HFGYS 777
            +    T +    ++ E+M NGSL+ +L  N+  F ++Q + ++  +A  ++YL    Y 
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNY- 130
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
              VH  +   N+L++ ++V  +SDFG+++ L  + S
Sbjct: 131 ---VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTS 164

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 89/194 (45%), Gaps = 32/194 (16%)
Query: 655 LQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDV-ECEVLKSV 712
           + +++QF     +G G + +VYKG +   G+ VA+K   L  E    S  + E  ++K +
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN---------------FSFDILQ 757
           +H N+V++       +   LV E+M N  L+ Y+ S                 F + +LQ
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 758 RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ 817
            L+             F + N ++H D+KP N+L++K     L DFG+A+   G      
Sbjct: 120 GLA-------------FCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTF 165
Query: 818 TLTLATIGYMAPGL 831
           +  + T+ Y AP +
Sbjct: 166 SSEVVTLWYRAPDV 179

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 96/184 (52%), Gaps = 21/184 (11%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGM--EVAIKVFHLQ--LEGALKSFD------VECEV 708
           +++  S  +G+G  G V K +F      +VAIK+   +    G+ +  D       E E+
Sbjct: 10  DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 709 LKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALA 768
           LK + H  ++KI +     D+  +VLE M  G L D +  N    +   +L     + LA
Sbjct: 69  LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLA 126
Query: 769 LEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG 825
           ++YLH    N ++H D+KP NVLL   ++D +  ++DFG +K+L GE S+ +TL   T  
Sbjct: 127 VQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC-GTPT 181
Query: 826 YMAP 829
           Y+AP
Sbjct: 182 YLAP 185

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 14/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRH 714
           +QF     +GTG FG V     ++ G   A+K+   Q    LK  +    E  +L++V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             LVK+  S  +N    +V+EY+P G +  +L      F           + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH- 158
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPGL 831
             S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 84/176 (47%), Gaps = 18/176 (10%)
Query: 653 ELLQATNQF---------NASNLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQLE-GA 698
           EL+QA             + + +IG G FG VY G+ LD     +  A+K  +   + G 
Sbjct: 15  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV-LEYMPNGSLEDYLYSNNFSFDILQ 757
           +  F  E  ++K   H N++ ++  C  ++   LV L YM +G L +++ +   +  +  
Sbjct: 75  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 134
Query: 758 RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
            +   + VA  ++YL    S   VH D+   N +LD+     ++DFG+A+ +  +E
Sbjct: 135 LIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 187

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 657 ATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKS 711
           A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E E+   
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 61
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A AL Y
Sbjct: 62  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 120
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            H   S  V+H DIKP N+LL       ++DFG +       S ++T    T+ Y+ P
Sbjct: 121 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPP 172

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 14/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRH 714
           +QF     +GTG FG V     ++ G   A+K+   Q    LK  +    E  +L++V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             LVK+  S  +N    +V+EY+P G +  +L      F           + L  EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH- 159
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPGL 831
             S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP +
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 14/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRH 714
           +QF     +GTG FG V     ++ G   A+K+   Q    LK  +    E  +L++V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             LVK+  S  +N    +V+EY+P G +  +L      F           + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH- 158
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPGL 831
             S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 84/176 (47%), Gaps = 18/176 (10%)
Query: 653 ELLQATNQF---------NASNLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQLE-GA 698
           EL+QA             + + +IG G FG VY G+ LD     +  A+K  +   + G 
Sbjct: 12  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 71
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV-LEYMPNGSLEDYLYSNNFSFDILQ 757
           +  F  E  ++K   H N++ ++  C  ++   LV L YM +G L +++ +   +  +  
Sbjct: 72  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 131
Query: 758 RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
            +   + VA  ++YL    S   VH D+   N +LD+     ++DFG+A+ +  +E
Sbjct: 132 LIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 43/160 (26%), Positives = 76/160 (47%), Gaps = 15/160 (9%)
Query: 660 QFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ----LEGALKSFDVECEVLKSVRHR 715
           +     +IG GGFG VY+ +F  G EVA+K         +   +++   E ++   ++H 
Sbjct: 8   ELTLEEIIGIGGFGKVYR-AFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG 775
           N++ +   C       LV+E+   G L   L       DIL   +V   +A  + YLH  
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAV--QIARGMNYLHDE 124
Query: 776 YSNPVVHCDIKPSNVLLDKDM--------VAHLSDFGIAK 807
              P++H D+K SN+L+ + +        +  ++DFG+A+
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 657 ATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKS 711
           A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E E+   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A AL Y
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 123
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            H   S  V+H DIKP N+LL       ++DFG +       S ++T    T+ Y+ P
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPP 175

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 9/168 (5%)
Query: 667 IGTGGFGSVYKGSFLD----GMEVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLVKII 721
           IG G FG V++G ++      + VAIK   +   +   + F  E   ++   H ++VK+I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
              T N    +++E    G L  +L    +S D+   +     ++ AL YL    S   V
Sbjct: 106 GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 161
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H DI   NVL+  +    L DFG+++ +      K +     I +MAP
Sbjct: 162 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 209

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 14/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRH 714
           +QF     +GTG FG V     ++ G   A+K+   Q    LK  +    E  +L++V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             LVK+  S  +N    +V+EY+P G +  +L      F           + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH- 158
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPGL 831
             S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 141/305 (46%), Gaps = 40/305 (13%)
Query: 139 LGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLAL 198
           L  +T+L+   LG  ++ G + Y    L NL  +    N+L    P  + NL+ +  + +
Sbjct: 40  LDQVTTLQADRLGIKSIDG-VEY----LNNLTQINFSNNQLTDITP--LKNLTKLVDILM 92
Query: 199 PSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIP 258
            +N ++   P    L  L NL  ++L  N  + I P  + N + L+ LEL  N+ S    
Sbjct: 93  NNNQIADITP----LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-- 144
Query: 259 NTLGNLRKLEWLRLSYNXXXXXXXXXXXXXXWANCKNLKLLDLSNNPINGVLPSSIGNLS 318
           + L  L  L+ L                    AN   L+ LD+S+N ++ +  S +  L+
Sbjct: 145 SALSGLTSLQQLNFG--------NQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLT 194
Query: 319 LSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNEL--IGSIPITFGKLQNLQGLDLVN 376
            +L  +  +N  I    P  +G L NL EL L GN+L  IG    T   L NL  LDL N
Sbjct: 195 -NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIG----TLASLTNLTDLDLAN 247
Query: 377 NKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFW 436
           N++    P  L  L +L+ L +  N++S  I P  G LT+L  L L  N+L  + P    
Sbjct: 248 NQISNLAP--LSGLTKLTELKLGANQISN-ISPLAG-LTALTNLELNENQLEDISP--IS 301
Query: 437 NLKDI 441
           NLK++
Sbjct: 302 NLKNL 306

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 667 IGTGGFGSVY-KGSFLDGMEVAIKVF-HLQLE-GALKSFDVECEVLKSVRHRNLVKIISS 723
           IG G F  V      L G EVAIK+    QL   +L+    E  ++K + H N+VK+   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
                   L++EY   G + DYL ++    +   R S    +  A++Y H      +VH 
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR-SKFRQIVSAVQYCH---QKRIVHR 135
Query: 784 DIKPSNVLLDKDMVAHLSDFGIA 806
           D+K  N+LLD DM   ++DFG +
Sbjct: 136 DLKAENLLLDADMNIKIADFGFS 158

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 84/176 (47%), Gaps = 18/176 (10%)
Query: 653 ELLQATNQF---------NASNLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQLE-GA 698
           EL+QA             + + +IG G FG VY G+ LD     +  A+K  +   + G 
Sbjct: 13  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 72
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV-LEYMPNGSLEDYLYSNNFSFDILQ 757
           +  F  E  ++K   H N++ ++  C  ++   LV L YM +G L +++ +   +  +  
Sbjct: 73  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 132
Query: 758 RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
            +   + VA  ++YL    S   VH D+   N +LD+     ++DFG+A+ +  +E
Sbjct: 133 LIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 185

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 84/176 (47%), Gaps = 18/176 (10%)
Query: 653 ELLQATNQF---------NASNLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQLE-GA 698
           EL+QA             + + +IG G FG VY G+ LD     +  A+K  +   + G 
Sbjct: 14  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 73
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV-LEYMPNGSLEDYLYSNNFSFDILQ 757
           +  F  E  ++K   H N++ ++  C  ++   LV L YM +G L +++ +   +  +  
Sbjct: 74  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 133
Query: 758 RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
            +   + VA  ++YL    S   VH D+   N +LD+     ++DFG+A+ +  +E
Sbjct: 134 LIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 186

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 71/149 (47%), Gaps = 7/149 (4%)
Query: 661 FNASNLIGTGGFGSVY-KGSFLDGMEVAIKVF-HLQLE-GALKSFDVECEVLKSVRHRNL 717
           +     IG G F  V      L G EVA+K+    QL   +L+    E  ++K + H N+
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           VK+           LV+EY   G + DYL ++    +   R +    +  A++Y H  Y 
Sbjct: 77  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR-AKFRQIVSAVQYCHQKY- 134
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIA 806
             +VH D+K  N+LLD DM   ++DFG +
Sbjct: 135 --IVHRDLKAENLLLDGDMNIKIADFGFS 161

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 9/168 (5%)
Query: 667 IGTGGFGSVYKGSFLD----GMEVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLVKII 721
           IG G FG V++G ++      + VAIK   +   +   + F  E   ++   H ++VK+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
              T N    +++E    G L  +L    +S D+   +     ++ AL YL    S   V
Sbjct: 83  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 138
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H DI   NVL+  +    L DFG+++ +      K +     I +MAP
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 186

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 141/305 (46%), Gaps = 40/305 (13%)
Query: 139 LGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLAL 198
           L  +T+L+   LG  ++ G + Y    L NL  +    N+L    P  + NL+ +  + +
Sbjct: 40  LDQVTTLQADRLGIKSIDG-VEY----LNNLTQINFSNNQLTDITP--LKNLTKLVDILM 92
Query: 199 PSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIP 258
            +N ++   P    L  L NL  ++L  N  + I P  + N + L+ LEL  N+ S    
Sbjct: 93  NNNQIADITP----LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-- 144
Query: 259 NTLGNLRKLEWLRLSYNXXXXXXXXXXXXXXWANCKNLKLLDLSNNPINGVLPSSIGNLS 318
           + L  L  L+ L                    AN   L+ LD+S+N ++ +  S +  L+
Sbjct: 145 SALSGLTSLQQLNFG--------NQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLT 194
Query: 319 LSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNEL--IGSIPITFGKLQNLQGLDLVN 376
            +L  +  +N  I    P  +G L NL EL L GN+L  IG    T   L NL  LDL N
Sbjct: 195 -NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIG----TLASLTNLTDLDLAN 247
Query: 377 NKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFW 436
           N++    P  L  L +L+ L +  N++S  I P  G LT+L  L L  N+L  + P    
Sbjct: 248 NQISNLAP--LSGLTKLTELKLGANQISN-ISPLAG-LTALTNLELNENQLEDISP--IS 301
Query: 437 NLKDI 441
           NLK++
Sbjct: 302 NLKNL 306

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 84/176 (47%), Gaps = 18/176 (10%)
Query: 653 ELLQATNQF---------NASNLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQLE-GA 698
           EL+QA             + + +IG G FG VY G+ LD     +  A+K  +   + G 
Sbjct: 10  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 69
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV-LEYMPNGSLEDYLYSNNFSFDILQ 757
           +  F  E  ++K   H N++ ++  C  ++   LV L YM +G L +++ +   +  +  
Sbjct: 70  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 129
Query: 758 RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
            +   + VA  ++YL    S   VH D+   N +LD+     ++DFG+A+ +  +E
Sbjct: 130 LIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVF-HLQLEGALKSFDV-ECEVLKSVRHR 715
            ++     IG G +G V+K    D G  VAIK F   + +  +K   + E  +LK ++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG 775
           NLV ++          LV EY  +  L +    + +   + + L   I     L+ ++F 
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHEL---DRYQRGVPEHLVKSI-TWQTLQAVNFC 118
Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
           + +  +H D+KP N+L+ K  V  L DFG A+LL+G         +AT  Y +P L
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD-EVATRWYRSPEL 173

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 84/176 (47%), Gaps = 18/176 (10%)
Query: 653 ELLQATNQF---------NASNLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQLE-GA 698
           EL+QA             + + +IG G FG VY G+ LD     +  A+K  +   + G 
Sbjct: 15  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV-LEYMPNGSLEDYLYSNNFSFDILQ 757
           +  F  E  ++K   H N++ ++  C  ++   LV L YM +G L +++ +   +  +  
Sbjct: 75  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 134
Query: 758 RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
            +   + VA  ++YL    S   VH D+   N +LD+     ++DFG+A+ +  +E
Sbjct: 135 LIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 187

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 14/159 (8%)
Query: 667 IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKS-FDVECEVLKSVRHRNLVKI 720
           +G G FG V    +       G  VA+K          +S +  E ++L+++ H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 721 ISSCTNNDFKAL--VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
              C +   K+L  V+EY+P GSL DYL     S  + Q L     +   + YLH   S 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---SQ 136
Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL-SGEESMK 816
             +H ++   NVLLD D +  + DFG+AK +  G E  +
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 175

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 90/190 (47%), Gaps = 25/190 (13%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DG--MEVAIKVF-HLQLEGALKSFDVECEVL-KSVR 713
           N     ++IG G FG V K     DG  M+ AIK       +   + F  E EVL K   
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNF-----SFDIL----------QR 758
           H N++ ++ +C +  +  L +EY P+G+L D+L  +       +F I           Q 
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 759 LSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT 818
           L    DVA  ++YL        +H ++   N+L+ ++ VA ++DFG+++    E  +K+T
Sbjct: 142 LHFAADVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 196
Query: 819 LTLATIGYMA 828
           +    + +MA
Sbjct: 197 MGRLPVRWMA 206

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 50/178 (28%), Positives = 81/178 (45%), Gaps = 13/178 (7%)
Query: 657 ATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKS 711
           A   F     +G G FG+VY        F+  ++V  K   L+  G       E E+   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           +RH N++++     ++    L+LEY P G++   L   +  FD  +  + I ++A AL Y
Sbjct: 65  LRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 123
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            H   S  V+H DIKP N+LL       ++DFG +       S ++     T+ Y+ P
Sbjct: 124 CH---SKKVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPP 175

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 667 IGTGGFGSVY-KGSFLDGMEVAIKVF-HLQLE-GALKSFDVECEVLKSVRHRNLVKIISS 723
           IG G F  V      L G EVAIK+    QL   +L+    E  ++K + H N+VK+   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
                   L++EY   G + DYL ++    +   R S    +  A++Y H      +VH 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR-SKFRQIVSAVQYCH---QKRIVHR 138
Query: 784 DIKPSNVLLDKDMVAHLSDFGIA 806
           D+K  N+LLD DM   ++DFG +
Sbjct: 139 DLKAENLLLDADMNIKIADFGFS 161

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 84/179 (46%), Gaps = 13/179 (7%)
Query: 658 TNQFNASNLIGTGGFGSVY-KGSFLDGMEVAIKVF---HLQLEGALKSFDVECEVLKSVR 713
           ++++    ++G G FG V      + G E A+KV     ++ +   +S   E ++LK + 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
           H N++K+     +  +  LV E    G L D + S    F  +    +I  V   + Y+H
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH 149
Query: 774 FGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
               N +VH D+KP N+LL+   KD    + DFG++      + MK    + T  Y+AP
Sbjct: 150 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAP 203

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 9/168 (5%)
Query: 667 IGTGGFGSVYKGSFLD----GMEVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLVKII 721
           IG G FG V++G ++      + VAIK   +   +   + F  E   ++   H ++VK+I
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
              T N    +++E    G L  +L    +S D+   +     ++ AL YL    S   V
Sbjct: 81  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 136
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H DI   NVL+  +    L DFG+++ +      K +     I +MAP
Sbjct: 137 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 184

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 86/181 (47%), Gaps = 8/181 (4%)
Query: 655 LQATNQFNASNLIGTGGFG-SVYKGSFLDGMEVAIKVFHLQLEGALKSFDV--ECEVLKS 711
            Q+  ++     IG G FG ++   S  DG +  IK  ++    + +  +   E  VL +
Sbjct: 20  FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN 79
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALE 770
           ++H N+V+   S   N    +V++Y   G L   + +     F   Q L   + + LAL+
Sbjct: 80  MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK 139
Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPG 830
           ++H      ++H DIK  N+ L KD    L DFGIA++L+    + +   + T  Y++P 
Sbjct: 140 HVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPE 195
Query: 831 L 831
           +
Sbjct: 196 I 196

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 9/168 (5%)
Query: 667 IGTGGFGSVYKGSFLD----GMEVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLVKII 721
           IG G FG V++G ++      M VAIK   +   +   + F  E   ++   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
              T N    +++E    G L  +L    FS D+   +     ++ AL YL    S   V
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H DI   NVL+       L DFG+++ +      K +     I +MAP
Sbjct: 134 HRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 181

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 141/305 (46%), Gaps = 40/305 (13%)
Query: 139 LGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLAL 198
           L  +T+L+   LG  ++ G + Y    L NL  +    N+L    P  + NL+ +  + +
Sbjct: 45  LDQVTTLQADRLGIKSIDG-VEY----LNNLTQINFSNNQLTDITP--LKNLTKLVDILM 97
Query: 199 PSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIP 258
            +N ++   P    L  L NL  ++L  N  + I P  + N + L+ LEL  N+ S    
Sbjct: 98  NNNQIADITP----LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-- 149
Query: 259 NTLGNLRKLEWLRLSYNXXXXXXXXXXXXXXWANCKNLKLLDLSNNPINGVLPSSIGNLS 318
           + L  L  L+ L                    AN   L+ LD+S+N ++ +  S +  L+
Sbjct: 150 SALSGLTSLQQLSFG--------NQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLT 199
Query: 319 LSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNEL--IGSIPITFGKLQNLQGLDLVN 376
            +L  +  +N  I    P  +G L NL EL L GN+L  IG    T   L NL  LDL N
Sbjct: 200 -NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIG----TLASLTNLTDLDLAN 252
Query: 377 NKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFW 436
           N++    P  L  L +L+ L +  N++S  I P  G LT+L  L L  N+L  + P    
Sbjct: 253 NQISNLAP--LSGLTKLTELKLGANQISN-ISPLAG-LTALTNLELNENQLEDISP--IS 306
Query: 437 NLKDI 441
           NLK++
Sbjct: 307 NLKNL 311

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 91/305 (29%), Positives = 141/305 (46%), Gaps = 40/305 (13%)
Query: 139 LGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLAL 198
           L  +T+L+   LG  ++ G + Y    L NL  +    N+L    P  + NL+ +  + +
Sbjct: 44  LDQVTTLQADRLGIKSIDG-VEY----LNNLTQINFSNNQLTDITP--LKNLTKLVDILM 96
Query: 199 PSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIP 258
            +N ++   P    L  L NL  ++L  N  + I P  + N + L+ LEL  N+ S    
Sbjct: 97  NNNQIADITP----LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-- 148
Query: 259 NTLGNLRKLEWLRLSYNXXXXXXXXXXXXXXWANCKNLKLLDLSNNPINGVLPSSIGNLS 318
           + L  L  L+ L                    AN   L+ LD+S+N ++ +  S +  L+
Sbjct: 149 SALSGLTSLQQLSFG--------NQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLT 198
Query: 319 LSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNEL--IGSIPITFGKLQNLQGLDLVN 376
            +L  +  +N  I    P  +G L NL EL L GN+L  IG    T   L NL  LDL N
Sbjct: 199 -NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIG----TLASLTNLTDLDLAN 251
Query: 377 NKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFW 436
           N++    P  L  L +L+ L +  N++S  I P  G LT+L  L L  N+L  + P    
Sbjct: 252 NQISNLAP--LSGLTKLTELKLGANQISN-ISPLAG-LTALTNLELNENQLEDISP--IS 305
Query: 437 NLKDI 441
           NLK++
Sbjct: 306 NLKNL 310

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 9/168 (5%)
Query: 667 IGTGGFGSVYKGSFLD----GMEVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLVKII 721
           IG G FG V++G ++      + VAIK   +   +   + F  E   ++   H ++VK+I
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
              T N    +++E    G L  +L    +S D+   +     ++ AL YL    S   V
Sbjct: 80  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 135
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H DI   NVL+  +    L DFG+++ +      K +     I +MAP
Sbjct: 136 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 183

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 47/168 (27%), Positives = 76/168 (45%), Gaps = 9/168 (5%)
Query: 667 IGTGGFGSVYKGSFLD----GMEVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLVKII 721
           IG G FG V++G ++      M VAIK   +   +   + F  E   ++   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
              T N    +++E    G L  +L    +S D+   +     ++ AL YL    S   V
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H DI   NVL+  +    L DFG+++ +      K +     I +MAP
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 181

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 667 IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKS-FDVECEVLKSVRHRNLVKI 720
           +G G FG V    +       G  VA+K         L+S +  E E+L+++ H ++VK 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 721 ISSCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
              C +   K+  LV+EY+P GSL DYL        + Q L     +   + YLH   + 
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGLAQLLLFAQQICEGMAYLH---AQ 131
Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL-SGEESMK 816
             +H  +   NVLLD D +  + DFG+AK +  G E  +
Sbjct: 132 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 170

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 667 IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKS-FDVECEVLKSVRHRNLVKI 720
           +G G FG V    +       G  VA+K         L+S +  E E+L+++ H ++VK 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 721 ISSCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
              C +   K+  LV+EY+P GSL DYL        + Q L     +   + YLH   + 
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGLAQLLLFAQQICEGMAYLH---AQ 130
Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL-SGEESMK 816
             +H  +   NVLLD D +  + DFG+AK +  G E  +
Sbjct: 131 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 169

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 70/143 (48%), Gaps = 7/143 (4%)
Query: 667 IGTGGFGSVY-KGSFLDGMEVAIKVF-HLQL-EGALKSFDVECEVLKSVRHRNLVKIISS 723
           IG G F  V      L G EVA+K+    QL   +L+    E  ++K + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
                   LV+EY   G + DYL ++    +   R +    +  A++Y H  +   +VH 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR-AKFRQIVSAVQYCHQKF---IVHR 137
Query: 784 DIKPSNVLLDKDMVAHLSDFGIA 806
           D+K  N+LLD DM   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 70/143 (48%), Gaps = 7/143 (4%)
Query: 667 IGTGGFGSVY-KGSFLDGMEVAIKVF-HLQL-EGALKSFDVECEVLKSVRHRNLVKIISS 723
           IG G F  V      L G EVA+K+    QL   +L+    E  ++K + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
                   LV+EY   G + DYL ++    +   R +    +  A++Y H  +   +VH 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR-AKFRQIVSAVQYCHQKF---IVHR 137
Query: 784 DIKPSNVLLDKDMVAHLSDFGIA 806
           D+K  N+LLD DM   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 84/178 (47%), Gaps = 14/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRH 714
           +QF     +GTG FG V     ++ G   A+K+   Q    LK  +    E  +L++V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             LVK+  S  +N    +V+EY P G +  +L      F           + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH- 158
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPGL 831
             S  +++ D+KP N+++D+     ++DFG+AK + G     +T  L  T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG-----RTWXLCGTPEYLAPEI 209

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 8/160 (5%)
Query: 664 SNLIGTGGFGSVYKGSF-LDGME---VAIKVFHL-QLEGALKSFDVECEVLKSVRHRNLV 718
             +IG G FG V  G   + G     VAIK       +   + F  E  ++    H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
            +    T      ++ EYM NGSL+ +L  N+  F ++Q + ++  +   ++YL      
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DM 129
Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT 818
             VH D+   N+L++ ++V  +SDFG++++L  +     T
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 169

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 70/143 (48%), Gaps = 7/143 (4%)
Query: 667 IGTGGFGSVY-KGSFLDGMEVAIKVF-HLQL-EGALKSFDVECEVLKSVRHRNLVKIISS 723
           IG G F  V      L G EVA+K+    QL   +L+    E  ++K + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
                   LV+EY   G + DYL ++    +   R +    +  A++Y H  +   +VH 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR-AKFRQIVSAVQYCHQKF---IVHR 137
Query: 784 DIKPSNVLLDKDMVAHLSDFGIA 806
           D+K  N+LLD DM   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 91/180 (50%), Gaps = 14/180 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEV-AIKVFHLQL---EGALKSFDVECEVLKSVRH 714
           + F     IG G FG V      D  ++ A+K  + Q       +++   E ++++ + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLH 773
             LV +  S  + +   +V++ +  G L  +L  N +F  + ++    I ++ +AL+YL 
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF--ICELVMALDYLQ 132
Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAPGLF 832
              +  ++H D+KP N+LLD+    H++DF IA +L  E    Q  T+A T  YMAP +F
Sbjct: 133 ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---TQITTMAGTKPYMAPEMF 186

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 8/160 (5%)
Query: 664 SNLIGTGGFGSVYKGSF-LDGME---VAIKVFHL-QLEGALKSFDVECEVLKSVRHRNLV 718
             +IG G FG V  G   + G     VAIK       +   + F  E  ++    H N++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
            +    T      ++ EYM NGSL+ +L  N+  F ++Q + ++  +   ++YL      
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DM 135
Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT 818
             VH D+   N+L++ ++V  +SDFG++++L  +     T
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT 175

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 83/168 (49%), Gaps = 13/168 (7%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           +G G FG VYK    + G   A KV   + E  L+ + VE E+L +  H  +VK++ +  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
           ++    +++E+ P G+++  +   +     L    + +     LE L+F +S  ++H D+
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHSKRIIHRDL 135
Query: 786 KPSNVLLDKDMVAHLSDFGIA----KLLSGEESMKQTLTLATIGYMAP 829
           K  NVL+  +    L+DFG++    K L   +S      + T  +MAP
Sbjct: 136 KAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF-----IGTPYWMAP 178

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 657 ATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKS 711
           A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E E+   
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 67
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A AL Y
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 126
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            H   S  V+H DIKP N+LL       +++FG +       S ++T    T+ Y+ P
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDYLPP 178

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 86/181 (47%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF     +GTG FG V    +K +   G   A+K+   Q    LK  +    E  +L++
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+P G +  +L       +   R      + L  EY
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAA-QIVLTFEY 149
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 150 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 201
Query: 831 L 831
           +
Sbjct: 202 I 202

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/184 (31%), Positives = 96/184 (52%), Gaps = 21/184 (11%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGM--EVAIKVFHLQ--LEGALKSFD------VECEV 708
           +++  S  +G+G  G V K +F      +VAI++   +    G+ +  D       E E+
Sbjct: 135 DEYIMSKTLGSGACGEV-KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 709 LKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALA 768
           LK + H  ++KI +     D+  +VLE M  G L D +  N    +   +L     + LA
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLA 251
Query: 769 LEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG 825
           ++YLH    N ++H D+KP NVLL   ++D +  ++DFG +K+L GE S+ +TL   T  
Sbjct: 252 VQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC-GTPT 306
Query: 826 YMAP 829
           Y+AP
Sbjct: 307 YLAP 310

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 84/179 (46%), Gaps = 13/179 (7%)
Query: 658 TNQFNASNLIGTGGFGSVY-KGSFLDGMEVAIKVF---HLQLEGALKSFDVECEVLKSVR 713
           ++++    ++G G FG V      + G E A+KV     ++ +   +S   E ++LK + 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
           H N++K+     +  +  LV E    G L D + S    F  +    +I  V   + Y+H
Sbjct: 109 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH 167
Query: 774 FGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
               N +VH D+KP N+LL+   KD    + DFG++      + MK    + T  Y+AP
Sbjct: 168 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAP 221

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/130 (35%), Positives = 73/130 (56%), Gaps = 10/130 (7%)
Query: 703 DVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVI 762
           + E E+LK + H  ++KI +     D+  +VLE M  G L D +  N    +   +L   
Sbjct: 202 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YF 259
Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTL 819
             + LA++YLH    N ++H D+KP NVLL   ++D +  ++DFG +K+L GE S+ +TL
Sbjct: 260 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTL 315
Query: 820 TLATIGYMAP 829
              T  Y+AP
Sbjct: 316 C-GTPTYLAP 324

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 84/179 (46%), Gaps = 13/179 (7%)
Query: 658 TNQFNASNLIGTGGFGSVY-KGSFLDGMEVAIKVF---HLQLEGALKSFDVECEVLKSVR 713
           ++++    ++G G FG V      + G E A+KV     ++ +   +S   E ++LK + 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
           H N++K+     +  +  LV E    G L D + S    F  +    +I  V   + Y+H
Sbjct: 108 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH 166
Query: 774 FGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
               N +VH D+KP N+LL+   KD    + DFG++      + MK    + T  Y+AP
Sbjct: 167 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAP 220

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF     +GTG FG V    +K +   G   A+K+   Q    LK  +    E  +L++
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+P G +  +L      F           + L  EY
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 156
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 831 L 831
           +
Sbjct: 209 I 209

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 667 IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKS-FDVECEVLKSVRHRNLVKI 720
           +G G FG V    +       G  VA+K          +S +  E ++L+++ H +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 721 ISSCTNNDFKAL--VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
              C +    +L  V+EY+P GSL DYL     S  + Q L     +   + YLH   + 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---AQ 153
Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL-SGEESMK 816
             +H D+   NVLLD D +  + DFG+AK +  G E  +
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYR 192

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF     +GTG FG V    +K +   G   A+K+   Q    LK  +    E  +L++
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+P G +  +L      F           + L  EY
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 156
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 831 L 831
           +
Sbjct: 209 I 209

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 50/178 (28%), Positives = 81/178 (45%), Gaps = 13/178 (7%)
Query: 657 ATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKS 711
           A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E E+   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A AL Y
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 123
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            H   S  V+H DIKP N+LL       ++DFG +       S ++     T+ Y+ P
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPP 175

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 83/178 (46%), Gaps = 14/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRH 714
           +QF     +GTG FG V     ++ G   A+K+   Q    LK  +    E  +L++V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             LVK+  S  +N    +V+EY P G +  +L      F           + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH- 158
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPGL 831
             S  +++ D+KP N+++D+     ++DFG AK + G     +T  L  T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF     +GTG FG V    +K +   G   A+K+   Q    LK  +    E  +L++
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+P G +  +L      F           + L  EY
Sbjct: 98  VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 156
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 831 L 831
           +
Sbjct: 209 I 209

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 83/168 (49%), Gaps = 13/168 (7%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           +G G FG VYK    + G   A KV   + E  L+ + VE E+L +  H  +VK++ +  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
           ++    +++E+ P G+++  +   +     L    + +     LE L+F +S  ++H D+
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHSKRIIHRDL 143
Query: 786 KPSNVLLDKDMVAHLSDFGIA----KLLSGEESMKQTLTLATIGYMAP 829
           K  NVL+  +    L+DFG++    K L   +S      + T  +MAP
Sbjct: 144 KAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF-----IGTPYWMAP 186

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 50/178 (28%), Positives = 81/178 (45%), Gaps = 13/178 (7%)
Query: 657 ATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKS 711
           A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E E+   
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 67
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A AL Y
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 126
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            H   S  V+H DIKP N+LL       ++DFG +       S ++     T+ Y+ P
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPP 178

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 84/176 (47%), Gaps = 18/176 (10%)
Query: 653 ELLQATNQF---------NASNLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQLE-GA 698
           EL+QA             + + +IG G FG VY G+ LD     +  A+K  +   + G 
Sbjct: 74  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 133
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV-LEYMPNGSLEDYLYSNNFSFDILQ 757
           +  F  E  ++K   H N++ ++  C  ++   LV L YM +G L +++ +   +  +  
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 193
Query: 758 RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
            +   + VA  +++L    S   VH D+   N +LD+     ++DFG+A+ +  +E
Sbjct: 194 LIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 50/178 (28%), Positives = 81/178 (45%), Gaps = 13/178 (7%)
Query: 657 ATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKS 711
           A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E E+   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 64
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A AL Y
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 123
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            H   S  V+H DIKP N+LL       ++DFG +       S ++     T+ Y+ P
Sbjct: 124 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPP 175

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 84/178 (47%), Gaps = 14/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRH 714
           +QF     +GTG FG V     ++ G   A+K+   Q    LK  +    E  +L++V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             LVK+  S  +N    +V+EY P G +  +L      F           + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH- 158
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPGL 831
             S  +++ D+KP N+++D+     ++DFG+AK + G     +T  L  T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG-----RTWXLCGTPEYLAPEI 209

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 14/159 (8%)
Query: 667 IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKS-FDVECEVLKSVRHRNLVKI 720
           +G G FG V    +       G  VA+K          +S +  E ++L+++ H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 721 ISSCTNNDFKAL--VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
              C +   K+L  V+EY+P GSL DYL     S  + Q L     +   + YLH   + 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---AQ 136
Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL-SGEESMK 816
             +H ++   NVLLD D +  + DFG+AK +  G E  +
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 175

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 84/178 (47%), Gaps = 14/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRH 714
           +QF     +GTG FG V     ++ G   A+K+   Q    LK  +    E  +L++V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             LVK+  S  +N    +V+EY P G +  +L       +   R      + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAA-QIVLTFEYLH- 158
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPGL 831
             S  +++ D+KP N+++D+     ++DFG AK + G     +T  L  T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 86/181 (47%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF+    +GTG FG V    +K S   G   A+K+   Q    LK  +    E  +L++
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+  G +  +L      F           + L  EY
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 156
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  LA T  Y+AP 
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLAGTPEYLAPE 208
Query: 831 L 831
           +
Sbjct: 209 I 209

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 84/179 (46%), Gaps = 13/179 (7%)
Query: 658 TNQFNASNLIGTGGFGSVY-KGSFLDGMEVAIKVF---HLQLEGALKSFDVECEVLKSVR 713
           ++++    ++G G FG V      + G E A+KV     ++ +   +S   E ++LK + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
           H N++K+     +  +  LV E    G L D + S    F  +    +I  V   + Y+H
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH 143
Query: 774 FGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
               N +VH D+KP N+LL+   KD    + DFG++      + MK    + T  Y+AP
Sbjct: 144 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAP 197

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 84/179 (46%), Gaps = 20/179 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF     +GTG FG V    +K +   G   A+K+   Q    LK  +    E  +L++
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+P G +  +L      F           + L  EY
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 177
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAP 829
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP
Sbjct: 178 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 228

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 80/175 (45%), Gaps = 7/175 (4%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRN 716
            ++     +G G +G VYK     G  VA+K   L  + EG   +   E  +LK + H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
           +V +I    +     LV E+M    L+  L  N      LQ   + I +   L  +   +
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTG---LQDSQIKIYLYQLLRGVAHCH 136
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
            + ++H D+KP N+L++ D    L+DFG+A+   G      T  + T+ Y AP +
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVVTLWYRAPDV 190

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 13/178 (7%)
Query: 657 ATNQFNASNLIGTGGFGSVY-----KGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKS 711
           A   F     +G G FG+VY     +  F+  ++V  K   L+  G       E E+   
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSH 67
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           +RH N++++     +     L+LEY P G++   L   +  FD  +  + I ++A AL Y
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSY 126
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            H   S  V+H DIKP N+LL       ++DFG +  +    S +  L   T+ Y+ P
Sbjct: 127 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLC-GTLDYLPP 178

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 20/157 (12%)
Query: 685 EVAIKVFHLQLEGALKSFDV---------ECEVLKSVR-HRNLVKIISSCTNNDFKALVL 734
           E A+K+  +   G+  + +V         E ++L+ V  H N++++  +   N F  LV 
Sbjct: 31  EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 90
Query: 735 EYMPNGSLEDYLYSNNFSFDILQR--LSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL 792
           + M  G L DYL       +   R  +  +++V  AL  L+      +VH D+KP N+LL
Sbjct: 91  DLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPENILL 144
Query: 793 DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D DM   L+DFG +  L   E +++     T  Y+AP
Sbjct: 145 DDDMNIKLTDFGFSCQLDPGEKLRE--VCGTPSYLAP 179

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 80/175 (45%), Gaps = 7/175 (4%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRN 716
            ++     +G G +G VYK     G  VA+K   L  + EG   +   E  +LK + H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
           +V +I    +     LV E+M    L+  L  N      LQ   + I +   L  +   +
Sbjct: 81  IVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTG---LQDSQIKIYLYQLLRGVAHCH 136
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
            + ++H D+KP N+L++ D    L+DFG+A+   G      T  + T+ Y AP +
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVVTLWYRAPDV 190

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF     +GTG FG V    +K +   G   A+K+   Q    LK  +    E  +L++
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+P G +  +L      F           + L  EY
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 149
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 150 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 201
Query: 831 L 831
           +
Sbjct: 202 I 202

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF     +GTG FG V    +K +   G   A+K+   Q    LK  +    E  +L++
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+P G +  +L      F           + L  EY
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 157
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 158 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 209
Query: 831 L 831
           +
Sbjct: 210 I 210

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 9/169 (5%)
Query: 667 IGTGGFGSVY-KGSFLDGMEVAIKVF-HLQL-EGALKSFDVECEVLKSVRHRNLVKIISS 723
           IG G F  V      L G EVA+++    QL   +L+    E  ++K + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
                   LV+EY   G + DYL ++    +   R +    +  A++Y H  +   +VH 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR-AKFRQIVSAVQYCHQKF---IVHR 137
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
           D+K  N+LLD DM   ++DFG +   +    + +     +  Y AP LF
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDE--FCGSPPYAAPELF 184

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF     +GTG FG V    +K +   G   A+K+   Q    LK  +    E  +L++
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+P G +  +L      F           + L  EY
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 157
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 158 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 209
Query: 831 L 831
           +
Sbjct: 210 I 210

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 84/176 (47%), Gaps = 18/176 (10%)
Query: 653 ELLQATNQF---------NASNLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQLE-GA 698
           EL+QA             + + +IG G FG VY G+ LD     +  A+K  +   + G 
Sbjct: 20  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 79
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV-LEYMPNGSLEDYLYSNNFSFDILQ 757
           +  F  E  ++K   H N++ ++  C  ++   LV L YM +G L +++ +   +  +  
Sbjct: 80  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 139
Query: 758 RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
            +   + VA  +++L    S   VH D+   N +LD+     ++DFG+A+ +  +E
Sbjct: 140 LIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 192

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 70/143 (48%), Gaps = 7/143 (4%)
Query: 667 IGTGGFGSVY-KGSFLDGMEVAIKVF-HLQL-EGALKSFDVECEVLKSVRHRNLVKIISS 723
           IG G F  V      L G EVA+++    QL   +L+    E  ++K + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
                   LV+EY   G + DYL ++    +   R +    +  A++Y H  +   +VH 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR-AKFRQIVSAVQYCHQKF---IVHR 137
Query: 784 DIKPSNVLLDKDMVAHLSDFGIA 806
           D+K  N+LLD DM   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 84/176 (47%), Gaps = 18/176 (10%)
Query: 653 ELLQATNQF---------NASNLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQLE-GA 698
           EL+QA             + + +IG G FG VY G+ LD     +  A+K  +   + G 
Sbjct: 15  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV-LEYMPNGSLEDYLYSNNFSFDILQ 757
           +  F  E  ++K   H N++ ++  C  ++   LV L YM +G L +++ +   +  +  
Sbjct: 75  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 134
Query: 758 RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
            +   + VA  +++L    S   VH D+   N +LD+     ++DFG+A+ +  +E
Sbjct: 135 LIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 187

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF     +GTG FG V    +K +   G   A+K+   Q    LK  +    E  +L++
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+P G +  +L      F           + L  EY
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 157
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 158 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 209
Query: 831 L 831
           +
Sbjct: 210 I 210

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 83/178 (46%), Gaps = 14/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRH 714
           +QF     +GTG FG V     ++ G   A+K+   Q    LK  +    E  +L++V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             LVK+  S  +N    +V+EY P G +  +L      F           + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH- 158
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPGL 831
             S  +++ D+KP N+++D+     ++DFG AK + G     +T  L  T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 18/167 (10%)
Query: 655 LQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVR 713
           L+  + F    ++G G FG V K  + LD    AIK      E  L +   E  +L S+ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLN 60
Query: 714 H-------------RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLS 760
           H             RN VK +++        + +EY  N +L D ++S N +    +   
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           +   +  AL Y+H   S  ++H D+KP N+ +D+     + DFG+AK
Sbjct: 121 LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 29/189 (15%)
Query: 667 IGTGGFGSVYKGSF--LDG------MEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRN 716
           +G G FG V       LD        +VA+K+      E  L     E E++K + +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYL---------YSNNFSFDILQRL------SV 761
           ++ ++ +CT +    +++EY   G+L +YL         YS N S +  ++L      S 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT- 820
              VA  +EYL    S   +H D+   NVL+ +D V  ++DFG+A+ +   +  K+T   
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 821 LATIGYMAP 829
              + +MAP
Sbjct: 254 RLPVKWMAP 262

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 88/185 (47%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ LS      
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLS------ 117
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G      T  + T+ Y
Sbjct: 118 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWY 169
Query: 827 MAPGL 831
            AP +
Sbjct: 170 RAPEI 174

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 84/176 (47%), Gaps = 18/176 (10%)
Query: 653 ELLQATNQF---------NASNLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQLE-GA 698
           EL+QA             + + +IG G FG VY G+ LD     +  A+K  +   + G 
Sbjct: 16  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 75
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV-LEYMPNGSLEDYLYSNNFSFDILQ 757
           +  F  E  ++K   H N++ ++  C  ++   LV L YM +G L +++ +   +  +  
Sbjct: 76  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 135
Query: 758 RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
            +   + VA  +++L    S   VH D+   N +LD+     ++DFG+A+ +  +E
Sbjct: 136 LIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 188

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 80/173 (46%), Gaps = 12/173 (6%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME---VAIKVFHLQLEGALKSF-DVECEVLKSVRHRN 716
           F     IG G FG V+KG  +D      VAIK+  L+           E  VL       
Sbjct: 25  FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSY 82
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
           + K   S        +++EY+  GS  D L +    FD  Q  +++ ++   L+YLH   
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH--- 137
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           S   +H DIK +NVLL +     L+DFG+A  L+ +  +K+   + T  +MAP
Sbjct: 138 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAP 189

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 95/188 (50%), Gaps = 33/188 (17%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSF-DVECEVLKSVRHRNLV 718
           +  + +IG G FG VY+    D  E VAIK     L+G  K+F + E ++++ + H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQG--KAFKNRELQIMRKLDHCNIV 76
Query: 719 KI----ISSCTNND--FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVA 766
           ++     SS    D  +  LVL+Y+P      Y  + ++S    Q L VI        + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYS-RAKQTLPVIYVKLYMYQLF 132
Query: 767 LALEYLH-FGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAK-LLSGEESMKQTLTLAT 823
            +L Y+H FG    + H DIKP N+LLD D  V  L DFG AK L+ GE ++     + +
Sbjct: 133 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICS 185
Query: 824 IGYMAPGL 831
             Y AP L
Sbjct: 186 RYYRAPEL 193

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 84/176 (47%), Gaps = 18/176 (10%)
Query: 653 ELLQATNQF---------NASNLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQLE-GA 698
           EL+QA             + + +IG G FG VY G+ LD     +  A+K  +   + G 
Sbjct: 15  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 74
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV-LEYMPNGSLEDYLYSNNFSFDILQ 757
           +  F  E  ++K   H N++ ++  C  ++   LV L YM +G L +++ +   +  +  
Sbjct: 75  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 134
Query: 758 RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
            +   + VA  +++L    S   VH D+   N +LD+     ++DFG+A+ +  +E
Sbjct: 135 LIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 187

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 84/179 (46%), Gaps = 20/179 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF+    +GTG FG V    +K S   G   A+K+   Q    LK  +    E  +L++
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+  G +  +L      F           + L  EY
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 177
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAP 829
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G      T TL  T  Y+AP
Sbjct: 178 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----ATWTLCGTPEYLAP 228

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 95/188 (50%), Gaps = 33/188 (17%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSF-DVECEVLKSVRHRNLV 718
           +  + +IG G FG VY+    D  E VAIK     L+G  K+F + E ++++ + H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQG--KAFKNRELQIMRKLDHCNIV 76
Query: 719 KI----ISSCTNND--FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVA 766
           ++     SS    D  +  LVL+Y+P      Y  + ++S    Q L VI        + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYS-RAKQTLPVIYVKLYMYQLF 132
Query: 767 LALEYLH-FGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAK-LLSGEESMKQTLTLAT 823
            +L Y+H FG    + H DIKP N+LLD D  V  L DFG AK L+ GE ++     + +
Sbjct: 133 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICS 185
Query: 824 IGYMAPGL 831
             Y AP L
Sbjct: 186 RYYRAPEL 193

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 84/176 (47%), Gaps = 18/176 (10%)
Query: 653 ELLQATNQF---------NASNLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQLE-GA 698
           EL+QA             + + +IG G FG VY G+ LD     +  A+K  +   + G 
Sbjct: 13  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 72
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV-LEYMPNGSLEDYLYSNNFSFDILQ 757
           +  F  E  ++K   H N++ ++  C  ++   LV L YM +G L +++ +   +  +  
Sbjct: 73  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 132
Query: 758 RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
            +   + VA  +++L    S   VH D+   N +LD+     ++DFG+A+ +  +E
Sbjct: 133 LIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 185

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 9/168 (5%)
Query: 667 IGTGGFGSVYKGSFLD----GMEVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLVKII 721
           IG G FG V++G ++      + VAIK   +   +   + F  E   ++   H ++VK+I
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
              T N    +++E    G L  +L    +S D+   +     ++ AL YL    S   V
Sbjct: 75  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 130
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H DI   NVL+  +    L DFG+++ +      K +     I +MAP
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 9/168 (5%)
Query: 667 IGTGGFGSVYKGSFLD----GMEVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLVKII 721
           IG G FG V++G ++      + VAIK   +   +   + F  E   ++   H ++VK+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
              T N    +++E    G L  +L    +S D+   +     ++ AL YL    S   V
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H DI   NVL+  +    L DFG+++ +      K +     I +MAP
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 181

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 81/182 (44%), Gaps = 22/182 (12%)
Query: 667 IGTGGFGSVYKGSFL------DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKI 720
           +G G FG V+           D + VA+K      + A K F  E E+L +++H ++VK 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDIL------------QRLSVIIDVALA 768
              C   D   +V EYM +G L  +L ++     ++            Q L +   +A  
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 769 LEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYM 827
           + YL    S   VH D+   N L+ ++++  + DFG+++ + S +       T+  I +M
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 828 AP 829
            P
Sbjct: 198 PP 199

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 95/188 (50%), Gaps = 33/188 (17%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSF-DVECEVLKSVRHRNLV 718
           +  + +IG G FG VY+    D  E VAIK     L+G  K+F + E ++++ + H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQG--KAFKNRELQIMRKLDHCNIV 76
Query: 719 KI----ISSCTNND--FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVA 766
           ++     SS    D  +  LVL+Y+P      Y  + ++S    Q L VI        + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATV---YRVARHYS-RAKQTLPVIYVKLYMYQLF 132
Query: 767 LALEYLH-FGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAK-LLSGEESMKQTLTLAT 823
            +L Y+H FG    + H DIKP N+LLD D  V  L DFG AK L+ GE ++     + +
Sbjct: 133 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICS 185
Query: 824 IGYMAPGL 831
             Y AP L
Sbjct: 186 RYYRAPEL 193

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 74/147 (50%), Gaps = 6/147 (4%)
Query: 683 GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSL 742
           G +VA+K   L+ +   +    E  +++   H N+V + SS    D   +V+E++  G+L
Sbjct: 70  GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGAL 129
Query: 743 EDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSD 802
            D +     + +  Q  +V + V  AL YLH   +  V+H DIK  ++LL  D    LSD
Sbjct: 130 TDIVTHTRMNEE--QIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSD 184
Query: 803 FGIAKLLSGEESMKQTLTLATIGYMAP 829
           FG    +S E   ++ L + T  +MAP
Sbjct: 185 FGFCAQVSKEVPKRKXL-VGTPYWMAP 210

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 29/189 (15%)
Query: 667 IGTGGFGSVYKGSF--LDG------MEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRN 716
           +G G FG V       LD        +VA+K+      E  L     E E++K + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYL---------YSNNFSFDILQRL------SV 761
           ++ ++ +CT +    +++EY   G+L +YL         YS N S +  ++L      S 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT- 820
              VA  +EYL    S   +H D+   NVL+ +D V  ++DFG+A+ +   +  K+T   
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 821 LATIGYMAP 829
              + +MAP
Sbjct: 213 RLPVKWMAP 221

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 29/189 (15%)
Query: 667 IGTGGFGSVYKGSF--LDG------MEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRN 716
           +G G FG V       LD        +VA+K+      E  L     E E++K + +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYL---------YSNNFSFDILQRL------SV 761
           ++ ++ +CT +    +++EY   G+L +YL         YS N S +  ++L      S 
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT- 820
              VA  +EYL    S   +H D+   NVL+ +D V  ++DFG+A+ +   +  K+T   
Sbjct: 148 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 821 LATIGYMAP 829
              + +MAP
Sbjct: 205 RLPVKWMAP 213

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 90/189 (47%), Gaps = 29/189 (15%)
Query: 667 IGTGGFGSVY--------KGSFLDGMEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRN 716
           +G G FG V         K    + + VA+K+      E  L     E E++K + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----NFSFDI----------LQRLSV 761
           ++ ++ +CT +    +++EY   G+L +YL +       +S+DI             +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT- 820
              +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  +  K+T   
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 821 LATIGYMAP 829
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 29/189 (15%)
Query: 667 IGTGGFGSVYKGSF--LDG------MEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRN 716
           +G G FG V       LD        +VA+K+      E  L     E E++K + +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYL---------YSNNFSFDILQRL------SV 761
           ++ ++ +CT +    +++EY   G+L +YL         YS N S +  ++L      S 
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT- 820
              VA  +EYL    S   +H D+   NVL+ +D V  ++DFG+A+ +   +  K+T   
Sbjct: 149 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 821 LATIGYMAP 829
              + +MAP
Sbjct: 206 RLPVKWMAP 214

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 29/189 (15%)
Query: 667 IGTGGFGSVYKGSF--LDG------MEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRN 716
           +G G FG V       LD        +VA+K+      E  L     E E++K + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYL---------YSNNFSFDILQRL------SV 761
           ++ ++ +CT +    +++EY   G+L +YL         YS N S +  ++L      S 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT- 820
              VA  +EYL    S   +H D+   NVL+ +D V  ++DFG+A+ +   +  K+T   
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 821 LATIGYMAP 829
              + +MAP
Sbjct: 213 RLPVKWMAP 221

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 88/185 (47%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+D++ ++           ++ F +LQ L+      
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQGLA------ 117
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G         + T+ Y
Sbjct: 118 -------FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWY 169
Query: 827 MAPGL 831
            AP +
Sbjct: 170 RAPEI 174

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 29/189 (15%)
Query: 667 IGTGGFGSVYKGSF--LDG------MEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRN 716
           +G G FG V       LD        +VA+K+      E  L     E E++K + +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYL---------YSNNFSFDILQRL------SV 761
           ++ ++ +CT +    +++EY   G+L +YL         YS N S +  ++L      S 
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT- 820
              VA  +EYL    S   +H D+   NVL+ +D V  ++DFG+A+ +   +  K+T   
Sbjct: 145 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 821 LATIGYMAP 829
              + +MAP
Sbjct: 202 RLPVKWMAP 210

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF+    +GTG FG V    +K S   G   A+K+   Q    LK  +    E  +L++
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+  G +  +L      F           + L  EY
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 156
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPA 208
Query: 831 L 831
           +
Sbjct: 209 I 209

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 80/185 (43%), Gaps = 25/185 (13%)
Query: 667 IGTGGFGSVYKGSFL------DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKI 720
           +G G FG V+           D M VA+K        A K F  E E+L +++H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDIL---------------QRLSVIIDV 765
              C + D   +V EYM +G L  +L ++     IL               Q L +   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 766 ALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK-LLSGEESMKQTLTLATI 824
           A  + YL    S   VH D+   N L+  +++  + DFG+++ + S +       T+  I
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 825 GYMAP 829
            +M P
Sbjct: 200 RWMPP 204

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 84/176 (47%), Gaps = 18/176 (10%)
Query: 653 ELLQATNQF---------NASNLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQLE-GA 698
           EL+QA             + + +IG G FG VY G+ LD     +  A+K  +   + G 
Sbjct: 16  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 75
Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV-LEYMPNGSLEDYLYSNNFSFDILQ 757
           +  F  E  ++K   H N++ ++  C  ++   LV L YM +G L +++ +   +  +  
Sbjct: 76  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 135
Query: 758 RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
            +   + VA  +++L    S   VH D+   N +LD+     ++DFG+A+ +  +E
Sbjct: 136 LIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKE 188

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 9/172 (5%)
Query: 667 IGTGGFGSVY-KGSFLDGMEVAIKVFHL-QLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           +G+G FG V+       G+E  IK  +  + +  ++  + E EVLKS+ H N++KI    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
            +     +V+E    G L + + S       L    V   +   +  L + +S  VVH D
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKD 149
Query: 785 IKPSNVLLDKDMVAH----LSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
           +KP N+L  +D   H    + DFG+A+L   +E    T    T  YMAP +F
Sbjct: 150 LKPENILF-QDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMAPEVF 198

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 87/183 (47%), Gaps = 29/183 (15%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 124
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G      T  + T+ Y
Sbjct: 125 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWY 176
Query: 827 MAP 829
            AP
Sbjct: 177 RAP 179

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 90/189 (47%), Gaps = 29/189 (15%)
Query: 667 IGTGGFGSVY--------KGSFLDGMEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRN 716
           +G G FG V         K    + + VA+K+      E  L     E E++K + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----NFSFDI----------LQRLSV 761
           ++ ++ +CT +    +++EY   G+L +YL +       +S+DI             +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT- 820
              +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  +  K+T   
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 821 LATIGYMAP 829
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 87/183 (47%), Gaps = 29/183 (15%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 124
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G      T  + T+ Y
Sbjct: 125 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWY 176
Query: 827 MAP 829
            AP
Sbjct: 177 RAP 179

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 87/185 (47%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKGS-FLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK    L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 117
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G      T  + T+ Y
Sbjct: 118 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWY 169
Query: 827 MAPGL 831
            AP +
Sbjct: 170 RAPEI 174

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 87/185 (47%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKGS-FLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK    L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 116
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G      T  + T+ Y
Sbjct: 117 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWY 168
Query: 827 MAPGL 831
            AP +
Sbjct: 169 RAPEI 173

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 87/185 (47%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKGS-FLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK    L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 117
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G      T  + T+ Y
Sbjct: 118 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWY 169
Query: 827 MAPGL 831
            AP +
Sbjct: 170 RAPEI 174

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 86/181 (47%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF+    +GTG FG V    +K S   G   A+K+   Q    LK  +    E  +L++
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 92
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+  G +  +L       +   R      + L  EY
Sbjct: 93  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA-QIVLTFEY 151
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 152 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 203
Query: 831 L 831
           +
Sbjct: 204 I 204

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 86/181 (47%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF+    +GTG FG V    +K S   G   A+K+   Q    LK  +    E  +L++
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+  G +  +L       +   R      + L  EY
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA-QIVLTFEY 156
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 831 L 831
           +
Sbjct: 209 I 209

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 90/189 (47%), Gaps = 29/189 (15%)
Query: 667 IGTGGFGSVY--------KGSFLDGMEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRN 716
           +G G FG V         K    + + VA+K+      E  L     E E++K + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----NFSFDI----------LQRLSV 761
           ++ ++ +CT +    +++EY   G+L +YL +       +S+DI             +S 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT- 820
              +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  +  K+T   
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 821 LATIGYMAP 829
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 82/175 (46%), Gaps = 7/175 (4%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRN 716
            +++    IG G +G VYK     G   A+K   L+ E  G   +   E  +LK ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
           +VK+           LV E++ +  L+  L       + +   S ++ +   + Y H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
              V+H D+KP N+L++++    ++DFG+A+   G    K T  + T+ Y AP +
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIVTLWYRAPDV 171

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 14/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRH 714
           +QF     +GTG FG V     ++ G   A+K+   Q    LK  +    E  +L++V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             L K+  S  +N    +V+EY P G +  +L       +   R      + L  EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAA-QIVLTFEYLH- 159
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPGL 831
             S  +++ D+KP N+++D+     ++DFG AK + G     +T  L  T  Y+AP +
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 86/181 (47%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF+    +GTG FG V    +K S   G   A+K+   Q    LK  +    E  +L++
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+  G +  +L       +   R      + L  EY
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA-QIVLTFEY 156
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 831 L 831
           +
Sbjct: 209 I 209

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 88/185 (47%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 118
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G      T  + T+ Y
Sbjct: 119 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWY 170
Query: 827 MAPGL 831
            AP +
Sbjct: 171 RAPEI 175

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 85/179 (47%), Gaps = 20/179 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF+    +GTG FG V    +K S   G   A+K+   Q    LK  +    E  +L++
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+  G +  +L       +   R      + L  EY
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA-QIVLTFEY 177
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAP 829
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP
Sbjct: 178 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 228

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 87/185 (47%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKGS-FLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK    L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 116
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G      T  + T+ Y
Sbjct: 117 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWY 168
Query: 827 MAPGL 831
            AP +
Sbjct: 169 RAPEI 173

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 90/189 (47%), Gaps = 29/189 (15%)
Query: 667 IGTGGFGSVY--------KGSFLDGMEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRN 716
           +G G FG V         K    + + VA+K+      E  L     E E++K + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----NFSFDI----------LQRLSV 761
           ++ ++ +CT +    +++EY   G+L +YL +       +S+DI             +S 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT- 820
              +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  +  K+T   
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 821 LATIGYMAP 829
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 88/185 (47%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 117
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G      T  + T+ Y
Sbjct: 118 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWY 169
Query: 827 MAPGL 831
            AP +
Sbjct: 170 RAPEI 174

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 87/185 (47%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKGS-FLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK    L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 121
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G      T  + T+ Y
Sbjct: 122 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWY 173
Query: 827 MAPGL 831
            AP +
Sbjct: 174 RAPEI 178

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 86/181 (47%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF+    +GTG FG V    +K S   G   A+K+   Q    LK  +    E  +L++
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+  G +  +L       +   R      + L  EY
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAA-QIVLTFEY 156
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 831 L 831
           +
Sbjct: 209 I 209

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 90/191 (47%), Gaps = 29/191 (15%)
Query: 655 LQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKS 711
           L +   F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK 
Sbjct: 1   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLS 760
           + H N+VK++      +   LV E++ +  L+D++ ++           ++ F +LQ L+
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT 820
                        F +S+ V+H D+KP N+L++ +    L+DFG+A+   G         
Sbjct: 120 -------------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHE 165
Query: 821 LATIGYMAPGL 831
           + T+ Y AP +
Sbjct: 166 VVTLWYRAPEI 176

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 89/189 (47%), Gaps = 29/189 (15%)
Query: 655 LQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKS 711
           L +   F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLS 760
           + H N+VK++      +   LV E++ +  L+D++ ++           ++ F +LQ L+
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT 820
                        F +S+ V+H D+KP N+L++ +    L+DFG+A+   G         
Sbjct: 121 -------------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHE 166
Query: 821 LATIGYMAP 829
           + T+ Y AP
Sbjct: 167 VVTLWYRAP 175

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 82/175 (46%), Gaps = 7/175 (4%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRN 716
            +++    IG G +G VYK     G   A+K   L+ E  G   +   E  +LK ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
           +VK+           LV E++ +  L+  L       + +   S ++ +   + Y H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
              V+H D+KP N+L++++    ++DFG+A+   G    K T  + T+ Y AP +
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVVTLWYRAPDV 171

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 86/181 (47%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF+    +GTG FG V    +K S   G   A+K+   Q    LK  +    E  +L++
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+  G +  +L       +   R      + L  EY
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAA-QIVLTFEY 156
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 831 L 831
           +
Sbjct: 209 I 209

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 90/189 (47%), Gaps = 29/189 (15%)
Query: 667 IGTGGFGSVY--------KGSFLDGMEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRN 716
           +G G FG V         K    + + VA+K+      E  L     E E++K + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----NFSFDI----------LQRLSV 761
           ++ ++ +CT +    +++EY   G+L +YL +       +S+DI             +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT- 820
              +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  +  K+T   
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 821 LATIGYMAP 829
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 88/189 (46%), Gaps = 29/189 (15%)
Query: 667 IGTGGFGSVYKGSF--LDG------MEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRN 716
           +G G FG V       LD        +VA+K+      E  L     E E++K + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----NFSFDILQR----------LSV 761
           ++ ++ +CT +    +++EY   G+L +YL +       FSF+              +S 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT- 820
              VA  +EYL    S   +H D+   NVL+ +D V  ++DFG+A+ +   +  K+T   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 821 LATIGYMAP 829
              + +MAP
Sbjct: 213 RLPVKWMAP 221

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 82/175 (46%), Gaps = 7/175 (4%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRN 716
            +++    IG G +G VYK     G   A+K   L+ E  G   +   E  +LK ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
           +VK+           LV E++ +  L+  L       + +   S ++ +   + Y H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
              V+H D+KP N+L++++    ++DFG+A+   G    K T  + T+ Y AP +
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVVTLWYRAPDV 171

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 71/145 (48%), Gaps = 12/145 (8%)
Query: 658 TNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV---R 713
           T +F+    IG+G FGSV+K    LDG   AIK     L G++   +   EV       +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFS----FDILQRLSVIIDVALAL 769
           H ++V+  S+   +D   +  EY   GSL D + S N+     F   +   +++ V   L
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDK 794
            Y+H   S  +VH DIKPSN+ + +
Sbjct: 129 RYIH---SMSLVHMDIKPSNIFISR 150

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF+    +GTG FG V    +K S   G   A+K+   Q    LK  +    E  +L++
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+  G +  +L      F           + L  EY
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 156
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 831 L 831
           +
Sbjct: 209 I 209

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF+    +GTG FG V    +K S   G   A+K+   Q    LK  +    E  +L++
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+  G +  +L      F           + L  EY
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 156
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLXGTPEYLAPE 208
Query: 831 L 831
           +
Sbjct: 209 I 209

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 90/189 (47%), Gaps = 29/189 (15%)
Query: 667 IGTGGFGSVY--------KGSFLDGMEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRN 716
           +G G FG V         K    + + VA+K+      E  L     E E++K + +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----NFSFDI----------LQRLSV 761
           ++ ++ +CT +    +++EY   G+L +YL +       +S+DI             +S 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT- 820
              +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  +  K+T   
Sbjct: 209 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 821 LATIGYMAP 829
              + +MAP
Sbjct: 266 RLPVKWMAP 274

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 17/224 (7%)
Query: 620 YAMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQA----------TNQFNASNLIGT 669
           Y   +R +++N           PQ   +R S+++   A           +  +    IG 
Sbjct: 25  YFQGARARQENGMPEKPPGPRSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGE 84
Query: 670 GGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNND 728
           G  G V   +    G  VA+K   L+ +   +    E  +++  +H N+V++ +S    D
Sbjct: 85  GSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 144
Query: 729 FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPS 788
              +V+E++  G+L D +     + +  Q  +V + V  AL  LH   +  V+H DIK  
Sbjct: 145 ELWVVMEFLEGGALTDIVTHTRMNEE--QIAAVCLAVLQALSVLH---AQGVIHRDIKSD 199
Query: 789 NVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
           ++LL  D    LSDFG    +S E   ++ L + T  +MAP L 
Sbjct: 200 SILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELI 242

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 84/181 (46%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF     +GTG FG V    +K +   G   A+K+   Q    LK  +    E  +L++
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY P G +  +L      F           + L  EY
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 157
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+++D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 158 LH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 209
Query: 831 L 831
           +
Sbjct: 210 I 210

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 39/199 (19%)
Query: 654 LLQATNQFNASNLIGTGGFGSVYKGSFLD--GMEVAIKVFHLQL--EGALKSFDVECEVL 709
           L +A  Q+     IG G +G V+K   L   G  VA+K   +Q   EG   S   E  VL
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 710 K---SVRHRNLVKIISSCT----NNDFK-ALVLEYMPNGSLEDYLYS-----------NN 750
           +   +  H N+V++   CT    + + K  LV E++ +  L  YL              +
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 751 FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS 810
             F +L+           L++LH   S+ VVH D+KP N+L+       L+DFG+A++ S
Sbjct: 125 MMFQLLR----------GLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
Query: 811 GEESMKQTLTLATIGYMAP 829
            +  M  T  + T+ Y AP
Sbjct: 172 FQ--MALTSVVVTLWYRAP 188

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF+    +GTG FG V    +K S   G   A+K+   Q    LK  +    E  +L++
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+  G +  +L      F           + L  EY
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 156
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 831 L 831
           +
Sbjct: 209 I 209

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF+    +GTG FG V    +K S   G   A+K+   Q    LK  +    E  +L++
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+  G +  +L      F           + L  EY
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 156
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 831 L 831
           +
Sbjct: 209 I 209

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRH 714
           +QF     +GTG FG V     ++ G   A+K+   Q    LK  +    E  +L++V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             L K+  S  +N    +V+EY P G +  +L      F           + L  EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH- 159
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPGL 831
             S  +++ D+KP N+++D+     ++DFG AK + G     +T  L  T  Y+AP +
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRH 714
           +QF     +GTG FG V     ++ G   A+K+   Q    LK  +    E  +L++V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             L K+  S  +N    +V+EY P G +  +L      F           + L  EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH- 159
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPGL 831
             S  +++ D+KP N+++D+     ++DFG AK + G     +T  L  T  Y+AP +
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF+    +GTG FG V    +K S   G   A+K+   Q    LK  +    E  +L++
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+  G +  +L      F           + L  EY
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 156
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 831 L 831
           +
Sbjct: 209 I 209

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF+    +GTG FG V    +K S   G   A+K+   Q    LK  +    E  +L++
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+  G +  +L      F           + L  EY
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 156
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 831 L 831
           +
Sbjct: 209 I 209

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 71/145 (48%), Gaps = 12/145 (8%)
Query: 658 TNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV---R 713
           T +F+    IG+G FGSV+K    LDG   AIK     L G++   +   EV       +
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFS----FDILQRLSVIIDVALAL 769
           H ++V+  S+   +D   +  EY   GSL D + S N+     F   +   +++ V   L
Sbjct: 68  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGRGL 126
Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDK 794
            Y+H   S  +VH DIKPSN+ + +
Sbjct: 127 RYIH---SMSLVHMDIKPSNIFISR 148

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF+    +GTG FG V    +K S   G   A+K+   Q    LK  +    E  +L++
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+  G +  +L      F           + L  EY
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 157
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 158 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 209
Query: 831 L 831
           +
Sbjct: 210 I 210

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 71/145 (48%), Gaps = 12/145 (8%)
Query: 658 TNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV---R 713
           T +F+    IG+G FGSV+K    LDG   AIK     L G++   +   EV       +
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 65
Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFS----FDILQRLSVIIDVALAL 769
           H ++V+  S+   +D   +  EY   GSL D + S N+     F   +   +++ V   L
Sbjct: 66  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGRGL 124
Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDK 794
            Y+H   S  +VH DIKPSN+ + +
Sbjct: 125 RYIH---SMSLVHMDIKPSNIFISR 146

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 39/199 (19%)
Query: 654 LLQATNQFNASNLIGTGGFGSVYKGSFLD--GMEVAIKVFHLQL--EGALKSFDVECEVL 709
           L +A  Q+     IG G +G V+K   L   G  VA+K   +Q   EG   S   E  VL
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 710 K---SVRHRNLVKIISSCT----NNDFK-ALVLEYMPNGSLEDYLYS-----------NN 750
           +   +  H N+V++   CT    + + K  LV E++ +  L  YL              +
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 751 FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS 810
             F +L+           L++LH   S+ VVH D+KP N+L+       L+DFG+A++ S
Sbjct: 125 MMFQLLR----------GLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
Query: 811 GEESMKQTLTLATIGYMAP 829
            +  M  T  + T+ Y AP
Sbjct: 172 FQ--MALTSVVVTLWYRAP 188

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 39/199 (19%)
Query: 654 LLQATNQFNASNLIGTGGFGSVYKGSFLD--GMEVAIKVFHLQL--EGALKSFDVECEVL 709
           L +A  Q+     IG G +G V+K   L   G  VA+K   +Q   EG   S   E  VL
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 710 K---SVRHRNLVKIISSCT----NNDFK-ALVLEYMPNGSLEDYLYS-----------NN 750
           +   +  H N+V++   CT    + + K  LV E++ +  L  YL              +
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 751 FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS 810
             F +L+           L++LH   S+ VVH D+KP N+L+       L+DFG+A++ S
Sbjct: 125 MMFQLLR----------GLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
Query: 811 GEESMKQTLTLATIGYMAP 829
            +  M  T  + T+ Y AP
Sbjct: 172 FQ--MALTSVVVTLWYRAP 188

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 89/182 (48%), Gaps = 27/182 (14%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYK-------GSFLDGMEVAIKVFHLQLEGA--LKSF 702
           +++L    QF    ++G G FGSV +       GSF+   +VA+K+    +  +  ++ F
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFV---KVAVKMLKADIIASSDIEEF 72
Query: 703 DVECEVLKSVRHRNLVKIISSCTNNDFKA------LVLEYMPNGSLEDYLYS-----NNF 751
             E   +K   H ++ K++     +  K       ++L +M +G L  +L +     N F
Sbjct: 73  LREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132
Query: 752 SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA-KLLS 810
           +  +   +  ++D+A  +EYL    S   +H D+   N +L +DM   ++DFG++ K+ S
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS 189
Query: 811 GE 812
           G+
Sbjct: 190 GD 191

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 71/145 (48%), Gaps = 12/145 (8%)
Query: 658 TNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV---R 713
           T +F+    IG+G FGSV+K    LDG   AIK     L G++   +   EV       +
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFS----FDILQRLSVIIDVALAL 769
           H ++V+  S+   +D   +  EY   GSL D + S N+     F   +   +++ V   L
Sbjct: 68  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGRGL 126
Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDK 794
            Y+H   S  +VH DIKPSN+ + +
Sbjct: 127 RYIH---SMSLVHMDIKPSNIFISR 148

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF+    +GTG FG V    +K S   G   A+K+   Q    LK  +    E  +L++
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+  G +  +L      F           + L  EY
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 156
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 831 L 831
           +
Sbjct: 209 I 209

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF+    +GTG FG V    +K S   G   A+K+   Q    LK  +    E  +L++
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 84
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+  G +  +L      F           + L  EY
Sbjct: 85  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 143
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 144 LH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 195
Query: 831 L 831
           +
Sbjct: 196 I 196

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 667 IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKI- 720
           +G G FGSV    +       G  VA+K          + F  E ++LK++    +VK  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 721 -ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
            +S         LV+EY+P+G L D+L  +    D  + L     +   +EYL    S  
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 131
Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
            VH D+   N+L++ +    ++DFG+AKLL
Sbjct: 132 CVHRDLAARNILVESEAHVKIADFGLAKLL 161

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 88/185 (47%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 64  VKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA------ 116
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G      T  + T+ Y
Sbjct: 117 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWY 168
Query: 827 MAPGL 831
            AP +
Sbjct: 169 RAPEI 173

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 89/189 (47%), Gaps = 29/189 (15%)
Query: 667 IGTGGFGSVY--------KGSFLDGMEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRN 716
           +G G FG V         K    + + VA+K+      E  L     E E++K + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----NFSFDI----------LQRLSV 761
           ++ ++ +CT +    +++EY   G+L +YL +       +S+DI             +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT- 820
              +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  +  K T   
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 821 LATIGYMAP 829
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 667 IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKI- 720
           +G G FGSV    +       G  VA+K          + F  E ++LK++    +VK  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 721 -ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
            +S         LV+EY+P+G L D+L  +    D  + L     +   +EYL    S  
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 135
Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
            VH D+   N+L++ +    ++DFG+AKLL
Sbjct: 136 CVHRDLAARNILVESEAHVKIADFGLAKLL 165

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 667 IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKI- 720
           +G G FGSV    +       G  VA+K          + F  E ++LK++    +VK  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 721 -ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
            +S         LV+EY+P+G L D+L  +    D  + L     +   +EYL    S  
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 134
Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
            VH D+   N+L++ +    ++DFG+AKLL
Sbjct: 135 CVHRDLAARNILVESEAHVKIADFGLAKLL 164

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 667 IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKI- 720
           +G G FGSV    +       G  VA+K          + F  E ++LK++    +VK  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 721 -ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
            +S         LV+EY+P+G L D+L  +    D  + L     +   +EYL    S  
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147
Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
            VH D+   N+L++ +    ++DFG+AKLL
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLL 177

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 83/178 (46%), Gaps = 14/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRH 714
           +QF     +GTG FG V     ++ G   A+K+   Q    LK  +    E  +L++V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             LVK+  S  +N    +V+EY+  G +  +L      F           + L  EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH- 158
Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPGL 831
             S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 90/189 (47%), Gaps = 29/189 (15%)
Query: 667 IGTGGFGSVY--------KGSFLDGMEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRN 716
           +G G FG V         K    + + VA+K+      E  L     E E++K + +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----NFSFDI----------LQRLSV 761
           ++ ++ +CT +    +++EY   G+L +YL +       +S+DI             +S 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT- 820
              +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  +  K+T   
Sbjct: 152 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 821 LATIGYMAP 829
              + +MAP
Sbjct: 209 RLPVKWMAP 217

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 90/189 (47%), Gaps = 29/189 (15%)
Query: 667 IGTGGFGSVY--------KGSFLDGMEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRN 716
           +G G FG V         K    + + VA+K+      E  L     E E++K + +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----NFSFDI----------LQRLSV 761
           ++ ++ +CT +    +++EY   G+L +YL +       +S+DI             +S 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT- 820
              +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  +  K+T   
Sbjct: 150 TYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 821 LATIGYMAP 829
              + +MAP
Sbjct: 207 RLPVKWMAP 215

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 90/189 (47%), Gaps = 29/189 (15%)
Query: 667 IGTGGFGSVY--------KGSFLDGMEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRN 716
           +G G FG V         K    + + VA+K+      E  L     E E++K + +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----NFSFDI----------LQRLSV 761
           ++ ++ +CT +    +++EY   G+L +YL +       +S+DI             +S 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT- 820
              +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  +  K+T   
Sbjct: 155 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 821 LATIGYMAP 829
              + +MAP
Sbjct: 212 RLPVKWMAP 220

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 89/189 (47%), Gaps = 29/189 (15%)
Query: 667 IGTGGFGSVYKGSF--LDG------MEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRN 716
           +G G FG V       LD        +VA+K+      E  L     E E++K + +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYL---------YSNNFSFDILQRL------SV 761
           ++ ++ +CT +    +++EY   G+L +YL         Y  N S +  ++L      S 
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT- 820
              VA  +EYL    S   +H D+   NVL+ +D V  ++DFG+A+ +   +  K+T   
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 821 LATIGYMAP 829
              + +MAP
Sbjct: 198 RLPVKWMAP 206

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 89/196 (45%), Gaps = 30/196 (15%)
Query: 654 LLQAT--NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKS 711
           L+Q T   Q      IG G +G V+ G +  G +VA+KVF    E    S+  E E+ ++
Sbjct: 30  LVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA---SWFRETEIYQT 85
Query: 712 V--RHRNLVKIISSCTNNDFKA--------LVLEYMPNGSLEDYLYSNNFSFDILQRLSV 761
           V  RH N++  I++    D K         L+ +Y  NGSL DYL S   + D    L +
Sbjct: 86  VLMRHENILGFIAA----DIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKL 139
Query: 762 IIDVALALEYLH---FGYSN--PVVHCDIKPSNVLLDKDMVAHLSDFGIA-KLLSG--EE 813
                  L +LH   F       + H D+K  N+L+ K+    ++D G+A K +S   E 
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199
Query: 814 SMKQTLTLATIGYMAP 829
            +     + T  YM P
Sbjct: 200 DIPPNTRVGTKRYMPP 215

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 89/188 (47%), Gaps = 21/188 (11%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKS--------FD 703
           ++L      +    +IG G FG V     L   +   KV+ ++L    +         F 
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQ----LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFW 117
Query: 704 VECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLS--V 761
            E +++       +V++  +  ++ +  +V+EYMP G L + L SN   +D+ ++ +   
Sbjct: 118 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSN---YDVPEKWARFY 173
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL 821
             +V LAL+ +H   S   +H D+KP N+LLDK     L+DFG    ++ E  ++    +
Sbjct: 174 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 822 ATIGYMAP 829
            T  Y++P
Sbjct: 231 GTPDYISP 238

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 93/188 (49%), Gaps = 33/188 (17%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSF-DVECEVLKSVRHRNLV 718
           +  + +IG G FG VY+    D  E VAIK   LQ     K F + E ++++ + H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQD----KRFKNRELQIMRKLDHCNIV 110
Query: 719 KI----ISSCTNND--FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVA 766
           ++     SS    D  +  LVL+Y+P      Y  + ++S    Q L VI        + 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYS-RAKQTLPVIYVKLYMYQLF 166
Query: 767 LALEYLH-FGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAK-LLSGEESMKQTLTLAT 823
            +L Y+H FG    + H DIKP N+LLD D  V  L DFG AK L+ GE ++     + +
Sbjct: 167 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICS 219
Query: 824 IGYMAPGL 831
             Y AP L
Sbjct: 220 RYYRAPEL 227

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 89/188 (47%), Gaps = 21/188 (11%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKS--------FD 703
           ++L      +    +IG G FG V     L   +   KV+ ++L    +         F 
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQ----LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFW 122
Query: 704 VECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLS--V 761
            E +++       +V++  +  ++ +  +V+EYMP G L + L SN   +D+ ++ +   
Sbjct: 123 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSN---YDVPEKWARFY 178
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL 821
             +V LAL+ +H   S   +H D+KP N+LLDK     L+DFG    ++ E  ++    +
Sbjct: 179 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 822 ATIGYMAP 829
            T  Y++P
Sbjct: 236 GTPDYISP 243

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 7/167 (4%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           IG G  G V   +    G  VA+K   L+ +   +    E  +++  +H N+V++ +S  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
             D   +V+E++  G+L D +     + +  Q  +V + V  AL  LH   +  V+H DI
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHTRMNEE--QIAAVCLAVLQALSVLH---AQGVIHRDI 273
Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
           K  ++LL  D    LSDFG    +S E   ++ L + T  +MAP L 
Sbjct: 274 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELI 319

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 7/167 (4%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           IG G  G V   +    G  VA+K   L+ +   +    E  +++  +H N+V++ +S  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
             D   +V+E++  G+L D +     + +  Q  +V + V  AL  LH   +  V+H DI
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTRMNEE--QIAAVCLAVLQALSVLH---AQGVIHRDI 153
Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
           K  ++LL  D    LSDFG    +S E   ++ L + T  +MAP L 
Sbjct: 154 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELI 199

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 89/188 (47%), Gaps = 21/188 (11%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKS--------FD 703
           ++L      +    +IG G FG V     L   +   KV+ ++L    +         F 
Sbjct: 67  RDLRMKAEDYEVVKVIGRGAFGEVQ----LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFW 122
Query: 704 VECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLS--V 761
            E +++       +V++  +  ++ +  +V+EYMP G L + L SN   +D+ ++ +   
Sbjct: 123 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSN---YDVPEKWARFY 178
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL 821
             +V LAL+ +H   S   +H D+KP N+LLDK     L+DFG    ++ E  ++    +
Sbjct: 179 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 822 ATIGYMAP 829
            T  Y++P
Sbjct: 236 GTPDYISP 243

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 92/187 (49%), Gaps = 31/187 (16%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVK 719
           +  + +IG G FG VY+    D  E VAIK    ++    +  + E ++++ + H N+V+
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 78
Query: 720 I----ISSCTNND--FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVAL 767
           +     SS    D  +  LVL+Y+P      Y  + ++S    Q L VI        +  
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYS-RAKQTLPVIYVKLYMYQLFR 134
Query: 768 ALEYLH-FGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAK-LLSGEESMKQTLTLATI 824
           +L Y+H FG    + H DIKP N+LLD D  V  L DFG AK L+ GE ++     + + 
Sbjct: 135 SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSR 187
Query: 825 GYMAPGL 831
            Y AP L
Sbjct: 188 YYRAPEL 194

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 92/187 (49%), Gaps = 31/187 (16%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVK 719
           +  + +IG G FG VY+    D  E VAIK    ++    +  + E ++++ + H N+V+
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 85
Query: 720 I----ISSCTNND--FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVAL 767
           +     SS    D  +  LVL+Y+P      Y  + ++S    Q L VI        +  
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYS-RAKQTLPVIYVKLYMYQLFR 141
Query: 768 ALEYLH-FGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAK-LLSGEESMKQTLTLATI 824
           +L Y+H FG    + H DIKP N+LLD D  V  L DFG AK L+ GE ++     + + 
Sbjct: 142 SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSR 194
Query: 825 GYMAPGL 831
            Y AP L
Sbjct: 195 YYRAPEL 201

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF+    +GTG FG V    +K S   G   A+K+   Q    LK  +    E  +L++
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+  G +  +L      F           + L  EY
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 156
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+++D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 157 LH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 831 L 831
           +
Sbjct: 209 I 209

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 7/167 (4%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           IG G  G V   +    G  VA+K   L+ +   +    E  +++  +H N+V++ +S  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
             D   +V+E++  G+L D +     + +  Q  +V + V  AL  LH   +  V+H DI
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTRMNEE--QIAAVCLAVLQALSVLH---AQGVIHRDI 151
Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
           K  ++LL  D    LSDFG    +S E   ++ L + T  +MAP L 
Sbjct: 152 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELI 197

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 89/189 (47%), Gaps = 29/189 (15%)
Query: 667 IGTGGFGSVYKGSF--LDG------MEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRN 716
           +G G FG V       LD        +VA+K+      E  L     E E++K + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYL---------YSNNFSFDILQRL------SV 761
           ++ ++ +CT +    +++EY   G+L +YL         Y  N S +  ++L      S 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT- 820
              VA  +EYL    S   +H D+   NVL+ +D V  ++DFG+A+ +   +  K+T   
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 821 LATIGYMAP 829
              + +MAP
Sbjct: 213 RLPVKWMAP 221

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 23/201 (11%)
Query: 642 PQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEV-AIKVFHLQLEGALK 700
           P+  + R S +  L+  + F    ++G G FG V+   F    +  AIK   L+ +  L 
Sbjct: 2   PELNKERPSLQIKLKIED-FELHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLM 58
Query: 701 SFDVECEVLK------SVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD 754
             DVEC +++      +  H  L  +  +    +    V+EY+  G L  ++ S +  FD
Sbjct: 59  DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFD 117
Query: 755 ILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
           + +      ++ L L++LH   S  +V+ D+K  N+LLDKD    ++DFG+ K     E+
Sbjct: 118 LSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK-----EN 169
Query: 815 M----KQTLTLATIGYMAPGL 831
           M    K      T  Y+AP +
Sbjct: 170 MLGDAKTNEFCGTPDYIAPEI 190

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 83/181 (45%), Gaps = 20/181 (11%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF     +GTG FG V    +K +   G   A+K+   Q    LK  +    E  + ++
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRIQQA 98
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +VLEY P G +  +L      F           + L  EY
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 157
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAPG 830
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G     +T  L  T  Y+AP 
Sbjct: 158 LH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPE 209
Query: 831 L 831
           +
Sbjct: 210 I 210

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 92/187 (49%), Gaps = 31/187 (16%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVK 719
           +  + +IG G FG VY+    D  E VAIK    ++    +  + E ++++ + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 77
Query: 720 I----ISSCTNND--FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVAL 767
           +     SS    D  +  LVL+Y+P      Y  + ++S    Q L VI        +  
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYS-RAKQTLPVIYVKLYMYQLFR 133
Query: 768 ALEYLH-FGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAK-LLSGEESMKQTLTLATI 824
           +L Y+H FG    + H DIKP N+LLD D  V  L DFG AK L+ GE ++     + + 
Sbjct: 134 SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSR 186
Query: 825 GYMAPGL 831
            Y AP L
Sbjct: 187 YYRAPEL 193

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 90/178 (50%), Gaps = 13/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEV----AIKVFH---LQLEGALKSFDVECEVLKS 711
           +QF    ++G G FG V+    + G +     A+KV     L++   +++  +E ++L  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVE 82
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V H  +VK+  +        L+L+++  G L   L S    F        + ++ALAL++
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDH 141
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           LH   S  +++ D+KP N+LLD++    L+DFG++K  S +   K      T+ YMAP
Sbjct: 142 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAP 195

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 92/187 (49%), Gaps = 31/187 (16%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVK 719
           +  + +IG G FG VY+    D  E VAIK    ++    +  + E ++++ + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 77
Query: 720 I----ISSCTNND--FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVAL 767
           +     SS    D  +  LVL+Y+P      Y  + ++S    Q L VI        +  
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPETV---YRVARHYS-RAKQTLPVIYVKLYMYQLFR 133
Query: 768 ALEYLH-FGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAK-LLSGEESMKQTLTLATI 824
           +L Y+H FG    + H DIKP N+LLD D  V  L DFG AK L+ GE ++     + + 
Sbjct: 134 SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSR 186
Query: 825 GYMAPGL 831
            Y AP L
Sbjct: 187 YYRAPEL 193

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 7/167 (4%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           IG G  G V   +    G  VA+K   L+ +   +    E  +++  +H N+V++ +S  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
             D   +V+E++  G+L D +     + +  Q  +V + V  AL  LH   +  V+H DI
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEE--QIAAVCLAVLQALSVLH---AQGVIHRDI 142
Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
           K  ++LL  D    LSDFG    +S E   ++ L + T  +MAP L 
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELI 188

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 92/187 (49%), Gaps = 31/187 (16%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVK 719
           +  + +IG G FG VY+    D  E VAIK    ++    +  + E ++++ + H N+V+
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 96
Query: 720 I----ISSCTNND--FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVAL 767
           +     SS    D  +  LVL+Y+P      Y  + ++S    Q L VI        +  
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYS-RAKQTLPVIYVKLYMYQLFR 152
Query: 768 ALEYLH-FGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAK-LLSGEESMKQTLTLATI 824
           +L Y+H FG    + H DIKP N+LLD D  V  L DFG AK L+ GE ++     + + 
Sbjct: 153 SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSR 205
Query: 825 GYMAPGL 831
            Y AP L
Sbjct: 206 YYRAPEL 212

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 89/189 (47%), Gaps = 29/189 (15%)
Query: 667 IGTGGFGSVY--------KGSFLDGMEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRN 716
           +G G FG V         K    + + VA+K+      E  L     E E++K + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----NFSFDI----------LQRLSV 761
           ++ ++ +CT +    +++EY   G+L +YL +        S+DI             +S 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT- 820
              +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  +  K+T   
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 821 LATIGYMAP 829
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 88/180 (48%), Gaps = 11/180 (6%)
Query: 658 TNQFNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHL-----QLEGALKSFDVECEVLKS 711
             ++   + +G G F +VYK    +  + VAIK   L       +G  ++   E ++L+ 
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           + H N++ ++ +  +    +LV ++M    LE  +  N+         + ++     LEY
Sbjct: 69  LSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
           LH  +   ++H D+KP+N+LLD++ V  L+DFG+AK   G  +      + T  Y AP L
Sbjct: 128 LHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYXHQVVTRWYRAPEL 183

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 93/188 (49%), Gaps = 33/188 (17%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSF-DVECEVLKSVRHRNLV 718
           +  + +IG G FG VY+    D  E VAIK   LQ     K F + E ++++ + H N+V
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQD----KRFKNRELQIMRKLDHCNIV 112
Query: 719 KI----ISSCTNND--FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVA 766
           ++     SS    D  +  LVL+Y+P      Y  + ++S    Q L VI        + 
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYS-RAKQTLPVIYVKLYMYQLF 168
Query: 767 LALEYLH-FGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAK-LLSGEESMKQTLTLAT 823
            +L Y+H FG    + H DIKP N+LLD D  V  L DFG AK L+ GE ++     + +
Sbjct: 169 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICS 221
Query: 824 IGYMAPGL 831
             Y AP L
Sbjct: 222 RYYRAPEL 229

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 92/187 (49%), Gaps = 31/187 (16%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVK 719
           +  + +IG G FG VY+    D  E VAIK    ++    +  + E ++++ + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 77
Query: 720 I----ISSCTNND--FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVAL 767
           +     SS    D  +  LVL+Y+P      Y  + ++S    Q L VI        +  
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYS-RAKQTLPVIYVKLYMYQLFR 133
Query: 768 ALEYLH-FGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAK-LLSGEESMKQTLTLATI 824
           +L Y+H FG    + H DIKP N+LLD D  V  L DFG AK L+ GE ++     + + 
Sbjct: 134 SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSR 186
Query: 825 GYMAPGL 831
            Y AP L
Sbjct: 187 YYRAPEL 193

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 92/187 (49%), Gaps = 31/187 (16%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVK 719
           +  + +IG G FG VY+    D  E VAIK    ++    +  + E ++++ + H N+V+
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 89
Query: 720 I----ISSCTNND--FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVAL 767
           +     SS    D  +  LVL+Y+P      Y  + ++S    Q L VI        +  
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYS-RAKQTLPVIYVKLYMYQLFR 145
Query: 768 ALEYLH-FGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAK-LLSGEESMKQTLTLATI 824
           +L Y+H FG    + H DIKP N+LLD D  V  L DFG AK L+ GE ++     + + 
Sbjct: 146 SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSR 198
Query: 825 GYMAPGL 831
            Y AP L
Sbjct: 199 YYRAPEL 205

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 84/180 (46%), Gaps = 13/180 (7%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDG--------MEVAIKVFHLQLEGALKSFDVECEVLKSV 712
           F    ++GTG +G V+    + G        M+V  K   +Q     +    E +VL+ +
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 713 RHRNLVKIISSCTNNDFK-ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           R    +  +      + K  L+L+Y+  G L  +L S    F   +    + ++ LALE+
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL-SQRERFTEHEVQIYVGEIVLALEH 174
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
           LH      +++ DIK  N+LLD +    L+DFG++K    +E+ +      TI YMAP +
Sbjct: 175 LH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 92/187 (49%), Gaps = 31/187 (16%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVK 719
           +  + +IG G FG VY+    D  E VAIK    ++    +  + E ++++ + H N+V+
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 89
Query: 720 I----ISSCTNND--FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVAL 767
           +     SS    D  +  LVL+Y+P      Y  + ++S    Q L VI        +  
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYS-RAKQTLPVIYVKLYMYQLFR 145
Query: 768 ALEYLH-FGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAK-LLSGEESMKQTLTLATI 824
           +L Y+H FG    + H DIKP N+LLD D  V  L DFG AK L+ GE ++     + + 
Sbjct: 146 SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSR 198
Query: 825 GYMAPGL 831
            Y AP L
Sbjct: 199 YYRAPEL 205

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 93/188 (49%), Gaps = 33/188 (17%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSF-DVECEVLKSVRHRNLV 718
           +  + +IG G FG VY+    D  E VAIK   LQ     K F + E ++++ + H N+V
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQD----KRFKNRELQIMRKLDHCNIV 114
Query: 719 KI----ISSCTNND--FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVA 766
           ++     SS    D  +  LVL+Y+P      Y  + ++S    Q L VI        + 
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYS-RAKQTLPVIYVKLYMYQLF 170
Query: 767 LALEYLH-FGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAK-LLSGEESMKQTLTLAT 823
            +L Y+H FG    + H DIKP N+LLD D  V  L DFG AK L+ GE ++     + +
Sbjct: 171 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICS 223
Query: 824 IGYMAPGL 831
             Y AP L
Sbjct: 224 RYYRAPEL 231

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 92/187 (49%), Gaps = 31/187 (16%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVK 719
           +  + +IG G FG VY+    D  E VAIK    ++    +  + E ++++ + H N+V+
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 90
Query: 720 I----ISSCTNND--FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVAL 767
           +     SS    D  +  LVL+Y+P      Y  + ++S    Q L VI        +  
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYS-RAKQTLPVIYVKLYMYQLFR 146
Query: 768 ALEYLH-FGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAK-LLSGEESMKQTLTLATI 824
           +L Y+H FG    + H DIKP N+LLD D  V  L DFG AK L+ GE ++     + + 
Sbjct: 147 SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSR 199
Query: 825 GYMAPGL 831
            Y AP L
Sbjct: 200 YYRAPEL 206

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 90/178 (50%), Gaps = 13/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEV----AIKVFH---LQLEGALKSFDVECEVLKS 711
           +QF    ++G G FG V+    + G +     A+KV     L++   +++  +E ++L  
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVE 83
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V H  +VK+  +        L+L+++  G L   L S    F        + ++ALAL++
Sbjct: 84  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDH 142
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           LH   S  +++ D+KP N+LLD++    L+DFG++K  S +   K      T+ YMAP
Sbjct: 143 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAP 196

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 93/188 (49%), Gaps = 33/188 (17%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSF-DVECEVLKSVRHRNLV 718
           +  + +IG G FG VY+    D  E VAIK   LQ     K F + E ++++ + H N+V
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQD----KRFKNRELQIMRKLDHCNIV 155
Query: 719 KI----ISSCTNND--FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVA 766
           ++     SS    D  +  LVL+Y+P      Y  + ++S    Q L VI        + 
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYS-RAKQTLPVIYVKLYMYQLF 211
Query: 767 LALEYLH-FGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAK-LLSGEESMKQTLTLAT 823
            +L Y+H FG    + H DIKP N+LLD D  V  L DFG AK L+ GE ++     + +
Sbjct: 212 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICS 264
Query: 824 IGYMAPGL 831
             Y AP L
Sbjct: 265 RYYRAPEL 272

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 92/187 (49%), Gaps = 31/187 (16%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVK 719
           +  + +IG G FG VY+    D  E VAIK    ++    +  + E ++++ + H N+V+
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 81
Query: 720 I----ISSCTNND--FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVAL 767
           +     SS    D  +  LVL+Y+P      Y  + ++S    Q L VI        +  
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYS-RAKQTLPVIYVKLYMYQLFR 137
Query: 768 ALEYLH-FGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAK-LLSGEESMKQTLTLATI 824
           +L Y+H FG    + H DIKP N+LLD D  V  L DFG AK L+ GE ++     + + 
Sbjct: 138 SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSR 190
Query: 825 GYMAPGL 831
            Y AP L
Sbjct: 191 YYRAPEL 197

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 14/160 (8%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKS 711
           +QF+    +GTG FG V    +K S   G   A+K+   Q    LK  +    E  +L++
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V    LVK+  S  +N    +V+EY+  G +  +L      F           + L  EY
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEY 156
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG 811
           LH   S  +++ D+KP N+L+D+     ++DFG AK + G
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 93/188 (49%), Gaps = 33/188 (17%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSF-DVECEVLKSVRHRNLV 718
           +  + +IG G FG VY+    D  E VAIK   LQ     K F + E ++++ + H N+V
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQD----KRFKNRELQIMRKLDHCNIV 81
Query: 719 KI----ISSCTNND--FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVA 766
           ++     SS    D  +  LVL+Y+P      Y  + ++S    Q L VI        + 
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYS-RAKQTLPVIYVKLYMYQLF 137
Query: 767 LALEYLH-FGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAK-LLSGEESMKQTLTLAT 823
            +L Y+H FG    + H DIKP N+LLD D  V  L DFG AK L+ GE ++     + +
Sbjct: 138 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICS 190
Query: 824 IGYMAPGL 831
             Y AP L
Sbjct: 191 RYYRAPEL 198

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 20/177 (11%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV--RHRNLVKIISSC 724
           +G G +G V++G    G  VA+K+F  + E   +S+  E E+  +V  RH N++  I+S 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDE---QSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 725 TNNDFKA----LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH---FGYS 777
             +   +    L+  Y  +GSL D+L        +  RL+V    A  L +LH   FG  
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAV--SAACGLAHLHVEIFGTQ 129
Query: 778 N--PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS-GEESMK--QTLTLATIGYMAP 829
               + H D K  NVL+  ++   ++D G+A + S G + +       + T  YMAP
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAP 186

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 88/179 (49%), Gaps = 11/179 (6%)
Query: 657 ATNQF---NASNLIGTGGFGSVYK-GSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV 712
           A N F   + + ++G G FG V+K      G+++A K+   +     +    E  V+  +
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            H NL+++  +  + +   LV+EY+  G L D +   +++   L  +  +  +   + ++
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 773 HFGYSNPVVHCDIKPSNVL-LDKDMVA-HLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H  Y   ++H D+KP N+L +++D     + DFG+A+     E +K  +   T  ++AP
Sbjct: 204 HQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK--VNFGTPEFLAP 257

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 7/167 (4%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           IG G  G V   +    G  VA+K   L+ +   +    E  +++  +H N+V++ +S  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
             D   +V+E++  G+L D +     + +  Q  +V + V  AL  LH   +  V+H DI
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTRMNEE--QIAAVCLAVLQALSVLH---AQGVIHRDI 146
Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
           K  ++LL  D    LSDFG    +S E   ++ L + T  +MAP L 
Sbjct: 147 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELI 192

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 93/188 (49%), Gaps = 33/188 (17%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSF-DVECEVLKSVRHRNLV 718
           +  + +IG G FG VY+    D  E VAIK   LQ     K F + E ++++ + H N+V
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQD----KRFKNRELQIMRKLDHCNIV 104
Query: 719 KI----ISSCTNND--FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVA 766
           ++     SS    D  +  LVL+Y+P      Y  + ++S    Q L VI        + 
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYS-RAKQTLPVIYVKLYMYQLF 160
Query: 767 LALEYLH-FGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAK-LLSGEESMKQTLTLAT 823
            +L Y+H FG    + H DIKP N+LLD D  V  L DFG AK L+ GE ++     + +
Sbjct: 161 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICS 213
Query: 824 IGYMAPGL 831
             Y AP L
Sbjct: 214 RYYRAPEL 221

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/188 (34%), Positives = 93/188 (49%), Gaps = 33/188 (17%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSF-DVECEVLKSVRHRNLV 718
           +  + +IG G FG VY+    D  E VAIK   LQ     K F + E ++++ + H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQD----KRFKNRELQIMRKLDHCNIV 110
Query: 719 KI----ISSCTNND--FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVA 766
           ++     SS    D  +  LVL+Y+P      Y  + ++S    Q L VI        + 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYS-RAKQTLPVIYVKLYMYQLF 166
Query: 767 LALEYLH-FGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAK-LLSGEESMKQTLTLAT 823
            +L Y+H FG    + H DIKP N+LLD D  V  L DFG AK L+ GE ++     + +
Sbjct: 167 RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICS 219
Query: 824 IGYMAPGL 831
             Y AP L
Sbjct: 220 RYYRAPEL 227

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 90/178 (50%), Gaps = 13/178 (7%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEV----AIKVFH---LQLEGALKSFDVECEVLKS 711
           +QF    ++G G FG V+    + G +     A+KV     L++   +++  +E ++L  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVE 82
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           V H  +VK+  +        L+L+++  G L   L S    F        + ++ALAL++
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDH 141
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           LH   S  +++ D+KP N+LLD++    L+DFG++K  S +   K      T+ YMAP
Sbjct: 142 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAP 195

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 88/189 (46%), Gaps = 29/189 (15%)
Query: 655 LQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKS 711
           L +   F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK 
Sbjct: 3   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLS 760
           + H N+VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT 820
                        F +S+ V+H D+KP N+L++ +    L+DFG+A+   G         
Sbjct: 122 -------------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHE 167
Query: 821 LATIGYMAP 829
           + T+ Y AP
Sbjct: 168 VVTLWYRAP 176

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 92/187 (49%), Gaps = 31/187 (16%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVK 719
           +  + +IG G FG VY+    D  E VAIK    ++    +  + E ++++ + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIVR 77
Query: 720 I----ISSCTNND--FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII------DVAL 767
           +     SS    D  +  LVL+Y+P      Y  + ++S    Q L VI        +  
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYS-RAKQTLPVIYVKLYMYQLFR 133
Query: 768 ALEYLH-FGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAK-LLSGEESMKQTLTLATI 824
           +L Y+H FG    + H DIKP N+LLD D  V  L DFG AK L+ GE ++     + + 
Sbjct: 134 SLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSR 186
Query: 825 GYMAPGL 831
            Y AP L
Sbjct: 187 YYRAPEL 193

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 10/164 (6%)
Query: 650 SYKELLQATNQFNASNL------IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSF 702
           S K+    T   N  +       +G G FG VYK    +  +  A KV   + E  L+ +
Sbjct: 22  SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 703 DVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVI 762
            VE ++L S  H N+VK++ +    +   +++E+   G+++  +          Q   V 
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 141
Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA 806
                AL YLH    N ++H D+K  N+L   D    L+DFG++
Sbjct: 142 KQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 82/179 (45%), Gaps = 13/179 (7%)
Query: 658 TNQFNASNLIGTGGFGSVY-KGSFLDGMEVAIKVF---HLQLEGALKSFDVECEVLKSVR 713
           ++++    ++G G FG V      + G E A+KV     ++ +   +S   E ++LK + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
           H N+ K+     +  +  LV E    G L D + S    F  +    +I  V   + Y H
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYXH 143
Query: 774 FGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
               N +VH D+KP N+LL+   KD    + DFG++     E S K    + T  Y+AP
Sbjct: 144 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKXKDKIGTAYYIAP 197

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 84/189 (44%), Gaps = 11/189 (5%)
Query: 650 SYKELLQATNQFNASNL------IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSF 702
           S K+    T   N  +       +G G FG VYK    +  +  A KV   + E  L+ +
Sbjct: 22  SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 703 DVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVI 762
            VE ++L S  H N+VK++ +    +   +++E+   G+++  +          Q   V 
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 141
Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA 822
                AL YLH    N ++H D+K  N+L   D    L+DFG++   +     + +  + 
Sbjct: 142 KQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSF-IG 197
Query: 823 TIGYMAPGL 831
           T  +MAP +
Sbjct: 198 TPYWMAPEV 206

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 29/191 (15%)
Query: 655 LQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKS 711
           L +   F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLS 760
           + H N+VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT 820
                        F +S+ V+H D+KP N+L++ +    L+DFG+A+   G         
Sbjct: 121 -------------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHE 166
Query: 821 LATIGYMAPGL 831
           + T+ Y AP +
Sbjct: 167 VVTLWYRAPEI 177

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 80/169 (47%), Gaps = 19/169 (11%)
Query: 665 NLIGTGGFGSVYKGSFL--DGMEVAIKVFHLQLEGA----LKSFDVECEVLKSVRHRNLV 718
            ++G G FGSV +G+    DG  + + V  ++L+ +    ++ F  E   +K   H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 719 KIISSCTNNDFKAL-----VLEYMPNGSLEDYLYSNNFS-----FDILQRLSVIIDVALA 768
           +++  C     + +     +L +M  G L  YL  +          +   L  ++D+AL 
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 769 LEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ 817
           +EYL    +   +H D+   N +L  DM   ++DFG++K +   +  +Q
Sbjct: 160 MEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ 205

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 20/159 (12%)
Query: 685 EVAIKVFHLQLEGALKSFDV---------ECEVLKSVR-HRNLVKIISSCTNNDFKALVL 734
           E A+K+  +   G+  + +V         E ++L+ V  H N++++  +   N F  LV 
Sbjct: 44  EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 103
Query: 735 EYMPNGSLEDYLYSNNFSFDILQR--LSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL 792
           + M  G L DYL       +   R  +  +++V  AL  L+      +VH D+KP N+LL
Sbjct: 104 DLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPENILL 157
Query: 793 DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
           D DM   L+DFG +  L   E +++     T  Y+AP +
Sbjct: 158 DDDMNIKLTDFGFSCQLDPGEKLRE--VCGTPSYLAPEI 194

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 84/189 (44%), Gaps = 11/189 (5%)
Query: 650 SYKELLQATNQFNASNL------IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSF 702
           S K+    T   N  +       +G G FG VYK    +  +  A KV   + E  L+ +
Sbjct: 22  SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 703 DVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVI 762
            VE ++L S  H N+VK++ +    +   +++E+   G+++  +          Q   V 
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 141
Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA 822
                AL YLH    N ++H D+K  N+L   D    L+DFG++   +     ++   + 
Sbjct: 142 KQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRXIQRRDXFIG 197
Query: 823 TIGYMAPGL 831
           T  +MAP +
Sbjct: 198 TPYWMAPEV 206

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 86/183 (46%), Gaps = 29/183 (15%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 120
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G         + T+ Y
Sbjct: 121 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWY 172
Query: 827 MAP 829
            AP
Sbjct: 173 RAP 175

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 119
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G         + T+ Y
Sbjct: 120 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWY 171
Query: 827 MAPGL 831
            AP +
Sbjct: 172 RAPEI 176

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 119
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G         + T+ Y
Sbjct: 120 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWY 171
Query: 827 MAPGL 831
            AP +
Sbjct: 172 RAPEI 176

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 116
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G         + T+ Y
Sbjct: 117 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWY 168
Query: 827 MAPGL 831
            AP +
Sbjct: 169 RAPEI 173

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 117
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G         + T+ Y
Sbjct: 118 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWY 169
Query: 827 MAPGL 831
            AP +
Sbjct: 170 RAPEI 174

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 8/139 (5%)
Query: 693 LQLEGALKSFDVECEVLKSVRHRNLVKIIS--SCTNNDFKALVLEYMPNGSLEDYLYSNN 750
           +Q  G ++    E  +LK + H N+VK++      N D   +V E +  G + +      
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 751 FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS 810
            S D  Q      D+   +EYLH+     ++H DIKPSN+L+ +D    ++DFG++    
Sbjct: 134 LSED--QARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 811 GEESMKQTLTLATIGYMAP 829
           G +++    T+ T  +MAP
Sbjct: 189 GSDALLSN-TVGTPAFMAP 206

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 86/185 (46%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKGS-FLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK    L G  VA+    L  + EG   +   E  +LK + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 117
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G      T  + T+ Y
Sbjct: 118 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWY 169
Query: 827 MAPGL 831
            AP +
Sbjct: 170 RAPEI 174

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 86/185 (46%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKGS-FLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK    L G  VA+    L  + EG   +   E  +LK + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 116
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G      T  + T+ Y
Sbjct: 117 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWY 168
Query: 827 MAPGL 831
            AP +
Sbjct: 169 RAPEI 173

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 118
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G         + T+ Y
Sbjct: 119 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWY 170
Query: 827 MAPGL 831
            AP +
Sbjct: 171 RAPEI 175

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 23/201 (11%)
Query: 642 PQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEV-AIKVFHLQLEGALK 700
           P+  + R S +  L+  + F    ++G G FG V+   F    +  AIK   L+ +  L 
Sbjct: 1   PELNKERPSLQIKLKIED-FILHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLM 57
Query: 701 SFDVECEVLK------SVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD 754
             DVEC +++      +  H  L  +  +    +    V+EY+  G L  ++ S +  FD
Sbjct: 58  DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFD 116
Query: 755 ILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
           + +      ++ L L++LH   S  +V+ D+K  N+LLDKD    ++DFG+ K     E+
Sbjct: 117 LSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK-----EN 168
Query: 815 M----KQTLTLATIGYMAPGL 831
           M    K      T  Y+AP +
Sbjct: 169 MLGDAKTNXFCGTPDYIAPEI 189

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 119
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G         + T+ Y
Sbjct: 120 -------FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWY 171
Query: 827 MAPGL 831
            AP +
Sbjct: 172 RAPEI 176

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 94/180 (52%), Gaps = 17/180 (9%)
Query: 661 FNASNLIGTGGFGS-VYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLK-SVRHRNLV 718
           F   +++G G  G+ VY+G F D  +VA+K     L       D E ++L+ S  H N++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVI 81
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
           +   +  +  F+ + +E +   +L++Y+   +F+   L+ ++++      L +LH   S 
Sbjct: 82  RYFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SL 137
Query: 779 PVVHCDIKPSNVLL-----DKDMVAHLSDFGIAKLLS-GEESM-KQTLTLATIGYMAPGL 831
            +VH D+KP N+L+        + A +SDFG+ K L+ G  S  +++    T G++AP +
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 117
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G         + T+ Y
Sbjct: 118 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWY 169
Query: 827 MAPGL 831
            AP +
Sbjct: 170 RAPEI 174

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 117
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G         + T+ Y
Sbjct: 118 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWY 169
Query: 827 MAPGL 831
            AP +
Sbjct: 170 RAPEI 174

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 118
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G         + T+ Y
Sbjct: 119 -------FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWY 170
Query: 827 MAPGL 831
            AP +
Sbjct: 171 RAPEI 175

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 86/183 (46%), Gaps = 29/183 (15%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA------ 120
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G         + T+ Y
Sbjct: 121 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWY 172
Query: 827 MAP 829
            AP
Sbjct: 173 RAP 175

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 116
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G         + T+ Y
Sbjct: 117 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWY 168
Query: 827 MAPGL 831
            AP +
Sbjct: 169 RAPEI 173

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 117
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G         + T+ Y
Sbjct: 118 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWY 169
Query: 827 MAPGL 831
            AP +
Sbjct: 170 RAPEI 174

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 93/188 (49%), Gaps = 24/188 (12%)
Query: 656 QATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHR 715
           Q    +    +IG G FG V++   ++  EVAIK    ++    +  + E ++++ V+H 
Sbjct: 37  QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIK----KVLQDKRFKNRELQIMRIVKHP 92
Query: 716 NLVKIISSCTNNDFKA------LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALA- 768
           N+V + +   +N  K       LVLEY+P     + +Y  +  +  L++   ++ + L  
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYRASRHYAKLKQTMPMLLIKLYM 147
Query: 769 ---LEYLHFGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAK-LLSGEESMKQTLTLAT 823
              L  L + +S  + H DIKP N+LLD    V  L DFG AK L++GE ++     + +
Sbjct: 148 YQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS---XICS 204
Query: 824 IGYMAPGL 831
             Y AP L
Sbjct: 205 RYYRAPEL 212

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 73/167 (43%), Gaps = 18/167 (10%)
Query: 655 LQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVR 713
           L+  + F    ++G G FG V K  + LD    AIK      E  L +   E  +L S+ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLN 60
Query: 714 H-------------RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLS 760
           H             RN VK  ++        +  EY  N +L D ++S N +    +   
Sbjct: 61  HQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           +   +  AL Y+H   S  ++H ++KP N+ +D+     + DFG+AK
Sbjct: 121 LFRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 118
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G         + T+ Y
Sbjct: 119 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWY 170
Query: 827 MAPGL 831
            AP +
Sbjct: 171 RAPEI 175

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 79/173 (45%), Gaps = 12/173 (6%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME---VAIKVFHLQLEGALKSF-DVECEVLKSVRHRN 716
           F     IG G FG V+KG  +D      VAIK+  L+           E  VL       
Sbjct: 9   FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
           + K   S   +    +++EY+  GS  D L       D  Q  +++ ++   L+YLH   
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH--- 121
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           S   +H DIK +NVLL +     L+DFG+A  L+ +  +K+   + T  +MAP
Sbjct: 122 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNXFVGTPFWMAP 173

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 79/173 (45%), Gaps = 12/173 (6%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME---VAIKVFHLQLEGALKSF-DVECEVLKSVRHRN 716
           F     IG G FG V+KG  +D      VAIK+  L+           E  VL       
Sbjct: 29  FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
           + K   S   +    +++EY+  GS  D L       D  Q  +++ ++   L+YLH   
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH--- 141
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           S   +H DIK +NVLL +     L+DFG+A  L+ +  +K+   + T  +MAP
Sbjct: 142 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAP 193

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 79/173 (45%), Gaps = 12/173 (6%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME---VAIKVFHLQLEGALKSF-DVECEVLKSVRHRN 716
           F     IG G FG V+KG  +D      VAIK+  L+           E  VL       
Sbjct: 24  FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
           + K   S   +    +++EY+  GS  D L       D  Q  +++ ++   L+YLH   
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH--- 136
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           S   +H DIK +NVLL +     L+DFG+A  L+ +  +K+   + T  +MAP
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNXFVGTPFWMAP 188

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 89/189 (47%), Gaps = 29/189 (15%)
Query: 667 IGTGGFGSVY--------KGSFLDGMEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRN 716
           +G G FG V         K    + + VA+K+      E  L     E E++K + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----NFSFDI----------LQRLSV 761
           ++ ++ +CT +    +++ Y   G+L +YL +       +S+DI             +S 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT- 820
              +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  +  K+T   
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 821 LATIGYMAP 829
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 79/173 (45%), Gaps = 12/173 (6%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME---VAIKVFHLQLEGALKSF-DVECEVLKSVRHRN 716
           F     IG G FG V+KG  +D      VAIK+  L+           E  VL       
Sbjct: 9   FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
           + K   S   +    +++EY+  GS  D L       D  Q  +++ ++   L+YLH   
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH--- 121
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           S   +H DIK +NVLL +     L+DFG+A  L+ +  +K+   + T  +MAP
Sbjct: 122 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAP 173

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 67/143 (46%), Gaps = 7/143 (4%)
Query: 667 IGTGGFGSVY-KGSFLDGMEVAIKVF-HLQL-EGALKSFDVECEVLKSVRHRNLVKIISS 723
           IG G F  V      L G EVA+K+    QL   +L+    E  + K + H N+VK+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
                   LV EY   G + DYL ++    +   R +    +  A++Y H  +   +VH 
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEAR-AKFRQIVSAVQYCHQKF---IVHR 137
Query: 784 DIKPSNVLLDKDMVAHLSDFGIA 806
           D+K  N+LLD D    ++DFG +
Sbjct: 138 DLKAENLLLDADXNIKIADFGFS 160

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 86/183 (46%), Gaps = 29/183 (15%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 68  VKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 120
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G         + T+ Y
Sbjct: 121 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWY 172
Query: 827 MAP 829
            AP
Sbjct: 173 RAP 175

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 9/168 (5%)
Query: 666 LIGTGGFGSVYKGSFLDGMEV-AIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKII 721
            +G GGF   ++ S  D  EV A K+    L       +   +E  + +S+ H+++V   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
               +NDF  +VLE     SL + L+    +    +    +  + L  +YLH    N V+
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 143
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D+K  N+ L++D+   + DFG+A  +  +   K+TL   T  Y+AP
Sbjct: 144 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC-GTPNYIAP 190

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 29/191 (15%)
Query: 655 LQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKS 711
           L +   F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLS 760
           + H N+VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT 820
                        F +S+ V+H D+KP N+L++ +    L+DFG+A+   G         
Sbjct: 121 -------------FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHE 166
Query: 821 LATIGYMAPGL 831
           + T+ Y AP +
Sbjct: 167 VVTLWYRAPEI 177

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 9/168 (5%)
Query: 666 LIGTGGFGSVYKGSFLDGMEV-AIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKII 721
            +G GGF   ++ S  D  EV A K+    L       +   +E  + +S+ H+++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
               +NDF  +VLE     SL + L+    +    +    +  + L  +YLH    N V+
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 139
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D+K  N+ L++D+   + DFG+A  +  +   K+TL   T  Y+AP
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC-GTPNYIAP 186

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 80/168 (47%), Gaps = 9/168 (5%)
Query: 666 LIGTGGFGSVYKGSFLDGMEV-AIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKII 721
            +G GGF   ++ S  D  EV A K+    L       +   +E  + +S+ H+++V   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
               +NDF  +VLE     SL + L+    +    +    +  + L  +YLH    N V+
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 139
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D+K  N+ L++D+   + DFG+A  +  +   K+TL   T  Y+AP
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC-GTPNYIAP 186

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 685 EVAIKVFHLQLEGALKSFDV---------ECEVLKSVR-HRNLVKIISSCTNNDFKALVL 734
           E A+K+  +   G+  + +V         E ++L+ V  H N++++  +   N F  LV 
Sbjct: 44  EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 103
Query: 735 EYMPNGSLEDYLYSNNFSFDILQR--LSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL 792
           + M  G L DYL       +   R  +  +++V  AL  L+      +VH D+KP N+LL
Sbjct: 104 DLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPENILL 157
Query: 793 DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
           D DM   L+DFG +  L   E ++      T  Y+AP +
Sbjct: 158 DDDMNIKLTDFGFSCQLDPGEKLRS--VCGTPSYLAPEI 194

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 29/185 (15%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK  + L G  VA+K   L  + EG   +   E  +LK + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----------NFSFDILQRLSVIIDVA 766
           VK++      +   LV E++ +  L+ ++ ++           ++ F +LQ L+      
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 118
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
                  F +S+ V+H D+KP N+L++ +    L+DFG+A+   G         + T+ Y
Sbjct: 119 -------FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWY 170
Query: 827 MAPGL 831
            AP +
Sbjct: 171 RAPEI 175

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 89/189 (47%), Gaps = 29/189 (15%)
Query: 667 IGTGGFGSVY--------KGSFLDGMEVAIKVFHLQ-LEGALKSFDVECEVLKSV-RHRN 716
           +G G FG V         K    + + VA+K+      E  L     E E++K + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-----NFSFDI----------LQRLSV 761
           ++ ++ +CT +    +++ Y   G+L +YL +       +S+DI             +S 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT- 820
              +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ ++  +  K+T   
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 821 LATIGYMAP 829
              + +MAP
Sbjct: 220 RLPVKWMAP 228

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 78/156 (50%), Gaps = 10/156 (6%)
Query: 659 NQFNASNLIGTGGFGSVY-KGSFLDGMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRH 714
             F     +GTG FG V+   S  +G   A+KV   ++   LK  +    E  +L  V H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLY-SNNFSFDILQRLSVIIDVALALEYLH 773
             ++++  +  +     ++++Y+  G L   L  S  F   + +  +   +V LALEYLH
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA--EVCLALEYLH 123
Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
              S  +++ D+KP N+LLDK+    ++DFG AK +
Sbjct: 124 ---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 156

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 15/186 (8%)
Query: 651 YKELLQATNQFNASNLIGTGGFGSVYKGSFLDGME-VAIK-VFHLQLEGALKSFDVECEV 708
           +K+     + ++  +++GTG F  V         + VAIK +    LEG   S + E  V
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 69
Query: 709 LKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALA 768
           L  ++H N+V +     +     L+++ +  G L D +    F +       +I  V  A
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDA 128
Query: 769 LEYLHFGYSNPVVHCDIKPSNVL---LDKDMVAHLSDFGIAKLLSGEESMKQTLTLA--T 823
           ++YLH      +VH D+KP N+L   LD+D    +SDFG++K+    E     L+ A  T
Sbjct: 129 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGT 181
Query: 824 IGYMAP 829
            GY+AP
Sbjct: 182 PGYVAP 187

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 15/178 (8%)
Query: 659 NQFNASNLIGTGGFGSVY----KGSFLDGMEVAIKVFHLQL---EGALKSFDVECEVLKS 711
           N F+   L+G G FG V     K +   G   A+K+   ++   +  +     E  VL++
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
            RH  L  +  +   +D    V+EY   G L  +L S    F   +      ++  ALEY
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEY 120
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           LH   S  VV+ DIK  N++LDKD    ++DFG+ K    + +  +T    T  Y+AP
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAP 174

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 15/178 (8%)
Query: 659 NQFNASNLIGTGGFGSVY----KGSFLDGMEVAIKVFHLQL---EGALKSFDVECEVLKS 711
           N F+   L+G G FG V     K +   G   A+K+   ++   +  +     E  VL++
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
            RH  L  +  +   +D    V+EY   G L  +L S    F   +      ++  ALEY
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEY 120
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           LH   S  VV+ DIK  N++LDKD    ++DFG+ K    + +  +T    T  Y+AP
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAP 174

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 19/171 (11%)
Query: 667 IGTGGFGSVYKGS-FLDGMEVAIKVFHLQLEGALKSFDVECEV------LKSVRHRNLVK 719
           +G G FG V   + +    +VA+K    QL   LK  D+   V      LK +RH +++K
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQL---LKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSN 778
           +    T      +V+EY   G L DY+      + D  +R      +  A+EY H    +
Sbjct: 74  LYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRF--FQQIICAIEYCH---RH 127
Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            +VH D+KP N+LLD ++   ++DFG++ +++    +K   +  +  Y AP
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT--SCGSPNYAAP 176

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 15/178 (8%)
Query: 659 NQFNASNLIGTGGFGSVY----KGSFLDGMEVAIKVFHLQL---EGALKSFDVECEVLKS 711
           N F+   L+G G FG V     K +   G   A+K+   ++   +  +     E  VL++
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 64
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
            RH  L  +  +   +D    V+EY   G L  +L S    F   +      ++  ALEY
Sbjct: 65  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEY 123
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           LH   S  VV+ DIK  N++LDKD    ++DFG+ K    + +  +T    T  Y+AP
Sbjct: 124 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAP 177

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 83/182 (45%), Gaps = 14/182 (7%)
Query: 658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALK---SFDVECEVLKSVR 713
           ++++    ++G GG   V+    L D  +VA+KV    L         F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 714 HRNLVKII----SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL 769
           H  +V +     +         +V+EY+   +L D +++        + + VI D   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIAD---AC 126
Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL--SGEESMKQTLTLATIGYM 827
           + L+F + N ++H D+KP+N+L+       + DFGIA+ +  SG    +    + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYL 186
Query: 828 AP 829
           +P
Sbjct: 187 SP 188

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 15/186 (8%)
Query: 651 YKELLQATNQFNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQ-LEGALKSFDVECEV 708
           +K+     + ++  +++GTG F  V         + VAIK    + LEG   S + E  V
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 709 LKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALA 768
           L  ++H N+V +     +     L+++ +  G L D +    F +       +I  V  A
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDA 128
Query: 769 LEYLHFGYSNPVVHCDIKPSNVL---LDKDMVAHLSDFGIAKLLSGEESMKQTLTLA--T 823
           ++YLH      +VH D+KP N+L   LD+D    +SDFG++K+    E     L+ A  T
Sbjct: 129 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGT 181
Query: 824 IGYMAP 829
            GY+AP
Sbjct: 182 PGYVAP 187

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 86/176 (48%), Gaps = 8/176 (4%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQL--EGALKSFDVECEVLKSVRHR 715
            ++     IG G +G+V+K    +  E VA+K   L    EG   S   E  +LK ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG 775
           N+V++     ++    LV E+  +  L+ Y  S N   D     S +  +   L+ L F 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQL---LKGLGFC 117
Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
           +S  V+H D+KP N+L++++    L+DFG+A+   G      +  + T+ Y  P +
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLADFGLARAF-GIPVRCYSAEVVTLWYRPPDV 172

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 87/186 (46%), Gaps = 21/186 (11%)
Query: 654 LLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKS--------FDVE 705
           L      ++   +IG G FG V     L   + + KV+ ++L    +         F  E
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQ----LVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEE 125
Query: 706 CEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLS--VII 763
            +++       +V++  +  ++ +  +V+EYMP G L + L SN   +D+ ++ +     
Sbjct: 126 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSN---YDVPEKWAKFYTA 181
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
           +V LAL+ +H   S  ++H D+KP N+LLDK     L+DFG    +     +     + T
Sbjct: 182 EVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGT 238
Query: 824 IGYMAP 829
             Y++P
Sbjct: 239 PDYISP 244

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 15/186 (8%)
Query: 651 YKELLQATNQFNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQ-LEGALKSFDVECEV 708
           +K+     + ++  +++GTG F  V         + VAIK    + LEG   S + E  V
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 709 LKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALA 768
           L  ++H N+V +     +     L+++ +  G L D +    F +       +I  V  A
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDA 128
Query: 769 LEYLHFGYSNPVVHCDIKPSNVL---LDKDMVAHLSDFGIAKLLSGEESMKQTLTLA--T 823
           ++YLH      +VH D+KP N+L   LD+D    +SDFG++K+    E     L+ A  T
Sbjct: 129 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGT 181
Query: 824 IGYMAP 829
            GY+AP
Sbjct: 182 PGYVAP 187

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 15/186 (8%)
Query: 651 YKELLQATNQFNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQ-LEGALKSFDVECEV 708
           +K+     + ++  +++GTG F  V         + VAIK    + LEG   S + E  V
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 709 LKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALA 768
           L  ++H N+V +     +     L+++ +  G L D +    F +       +I  V  A
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDA 128
Query: 769 LEYLHFGYSNPVVHCDIKPSNVL---LDKDMVAHLSDFGIAKLLSGEESMKQTLTLA--T 823
           ++YLH      +VH D+KP N+L   LD+D    +SDFG++K+    E     L+ A  T
Sbjct: 129 VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGT 181
Query: 824 IGYMAP 829
            GY+AP
Sbjct: 182 PGYVAP 187

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 659 NQFNASNLIGTGGFGSVY----KGSFLDGMEVAIKVFHLQL---EGALKSFDVECEVLKS 711
           N F+   L+G G FG V     K +   G   A+K+   ++   +  +     E  VL++
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
            RH  L  +  +   +D    V+EY   G L  +L S    F   +      ++  ALEY
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEY 120
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL-LSGEESMKQTLTLATIGYMAP 829
           LH   S  VV+ DIK  N++LDKD    ++DFG+ K  +S   +MK      T  Y+AP
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX--FCGTPEYLAP 174

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 659 NQFNASNLIGTGGFGSVY----KGSFLDGMEVAIKVFHLQL---EGALKSFDVECEVLKS 711
           N F+   L+G G FG V     K +   G   A+K+   ++   +  +     E  VL++
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
            RH  L  +  +   +D    V+EY   G L  +L S    F   +      ++  ALEY
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEY 120
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL-LSGEESMKQTLTLATIGYMAP 829
           LH   S  VV+ DIK  N++LDKD    ++DFG+ K  +S   +MK      T  Y+AP
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX--FCGTPEYLAP 174

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 81/184 (44%), Gaps = 22/184 (11%)
Query: 667 IGTGGFGSVYKGSFLDGM-------EVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLV 718
           +G G FG VY+G  + GM       +VA+K    +  E     F +E  ++  + H+N+V
Sbjct: 39  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIV 97
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLY------SNNFSFDILQRLSVIIDVALALEYL 772
           + I     +  + ++LE M  G L+ +L       S   S  +L  L V  D+A   +YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 773 HFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMA 828
                N  +H DI   N LL       VA + DFG+A+ +       K    +  + +M 
Sbjct: 158 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 214
Query: 829 PGLF 832
           P  F
Sbjct: 215 PEAF 218

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 81/184 (44%), Gaps = 22/184 (11%)
Query: 667 IGTGGFGSVYKGSFLDGM-------EVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLV 718
           +G G FG VY+G  + GM       +VA+K    +  E     F +E  ++  + H+N+V
Sbjct: 53  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIV 111
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLY------SNNFSFDILQRLSVIIDVALALEYL 772
           + I     +  + ++LE M  G L+ +L       S   S  +L  L V  D+A   +YL
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 773 HFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMA 828
                N  +H DI   N LL       VA + DFG+A+ +       K    +  + +M 
Sbjct: 172 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 829 PGLF 832
           P  F
Sbjct: 229 PEAF 232

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 80/184 (43%), Gaps = 22/184 (11%)
Query: 667 IGTGGFGSVYKGSFLDGM-------EVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLV 718
           +G G FG VY+G  + GM       +VA+K    +  E     F +E  ++    H+N+V
Sbjct: 53  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIV 111
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLY------SNNFSFDILQRLSVIIDVALALEYL 772
           + I     +  + ++LE M  G L+ +L       S   S  +L  L V  D+A   +YL
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 773 HFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMA 828
                N  +H DI   N LL       VA + DFG+A+ +       K    +  + +M 
Sbjct: 172 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 829 PGLF 832
           P  F
Sbjct: 229 PEAF 232

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 659 NQFNASNLIGTGGFGSVY----KGSFLDGMEVAIKVFHLQL---EGALKSFDVECEVLKS 711
           N F+   L+G G FG V     K +   G   A+K+   ++   +  +     E  VL++
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 66
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
            RH  L  +  +   +D    V+EY   G L  +L S    F   +      ++  ALEY
Sbjct: 67  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEY 125
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL-LSGEESMKQTLTLATIGYMAP 829
           LH   S  VV+ DIK  N++LDKD    ++DFG+ K  +S   +MK      T  Y+AP
Sbjct: 126 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--XFCGTPEYLAP 179

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQL---EGALKSFDVECEVLKS 711
           N F+   L+G G FG V     K +   G   A+K+   ++   +  +     E  VL++
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
            RH  L  +  +   +D    V+EY   G L  +L S    F   +      ++  ALEY
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEY 120
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL-LSGEESMKQTLTLATIGYMAP 829
           LH   S  VV+ DIK  N++LDKD    ++DFG+ K  +S   +MK      T  Y+AP
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX--FCGTPEYLAP 174

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 83/182 (45%), Gaps = 14/182 (7%)
Query: 658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALK---SFDVECEVLKSVR 713
           ++++    ++G GG   V+    L D  +VA+KV    L         F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 714 HRNLVKII----SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL 769
           H  +V +     +         +V+EY+   +L D +++        + + VI D   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIAD---AC 126
Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL--SGEESMKQTLTLATIGYM 827
           + L+F + N ++H D+KP+N+++       + DFGIA+ +  SG    +    + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 828 AP 829
           +P
Sbjct: 187 SP 188

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 80/184 (43%), Gaps = 22/184 (11%)
Query: 667 IGTGGFGSVYKGSFLDGM-------EVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLV 718
           +G G FG VY+G  + GM       +VA+K    +  E     F +E  ++    H+N+V
Sbjct: 30  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 88
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLY------SNNFSFDILQRLSVIIDVALALEYL 772
           + I     +  + ++LE M  G L+ +L       S   S  +L  L V  D+A   +YL
Sbjct: 89  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 148
Query: 773 HFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMA 828
                N  +H DI   N LL       VA + DFG+A+ +       K    +  + +M 
Sbjct: 149 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 205
Query: 829 PGLF 832
           P  F
Sbjct: 206 PEAF 209

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 80/184 (43%), Gaps = 22/184 (11%)
Query: 667 IGTGGFGSVYKGSFLDGM-------EVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLV 718
           +G G FG VY+G  + GM       +VA+K    +  E     F +E  ++    H+N+V
Sbjct: 39  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 97
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLY------SNNFSFDILQRLSVIIDVALALEYL 772
           + I     +  + ++LE M  G L+ +L       S   S  +L  L V  D+A   +YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 773 HFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMA 828
                N  +H DI   N LL       VA + DFG+A+ +       K    +  + +M 
Sbjct: 158 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 214
Query: 829 PGLF 832
           P  F
Sbjct: 215 PEAF 218

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 80/184 (43%), Gaps = 22/184 (11%)
Query: 667 IGTGGFGSVYKGSFLDGM-------EVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLV 718
           +G G FG VY+G  + GM       +VA+K    +  E     F +E  ++    H+N+V
Sbjct: 38  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLY------SNNFSFDILQRLSVIIDVALALEYL 772
           + I     +  + ++LE M  G L+ +L       S   S  +L  L V  D+A   +YL
Sbjct: 97  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 773 HFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMA 828
                N  +H DI   N LL       VA + DFG+A+ +       K    +  + +M 
Sbjct: 157 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 829 PGLF 832
           P  F
Sbjct: 214 PEAF 217

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 83/182 (45%), Gaps = 14/182 (7%)
Query: 658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALK---SFDVECEVLKSVR 713
           ++++    ++G GG   V+    L D  +VA+KV    L         F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 714 HRNLVKII----SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL 769
           H  +V +     +         +V+EY+   +L D +++        + + VI D   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIAD---AC 126
Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL--SGEESMKQTLTLATIGYM 827
           + L+F + N ++H D+KP+N+++       + DFGIA+ +  SG    +    + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 828 AP 829
           +P
Sbjct: 187 SP 188

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 83/160 (51%), Gaps = 25/160 (15%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV----ECEVLKSVRHRNLVKII 721
           IG G FG V+K      G +VA+K   + +E   + F +    E ++L+ ++H N+V +I
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 722 SSCTN-----NDFKA---LVLEYMPN---GSLEDYLYSNNFSFDILQRLSVIIDVALALE 770
             C       N  KA   LV ++  +   G L + L    F+   ++R+     + + L 
Sbjct: 84  EICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRV-----MQMLLN 136
Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS 810
            L++ + N ++H D+K +NVL+ +D V  L+DFG+A+  S
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 176

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 78/171 (45%), Gaps = 8/171 (4%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGMEV-AIKVFHLQLEGALKSF-DVECEVLKSVRHRNLV 718
           F   + IG G FG VYKG      EV AIK+  L+           E  VL       + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
           +   S   +    +++EY+  GS  D L         +   +++ ++   L+YLH   S 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIA--TILREILKGLDYLH---SE 135
Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             +H DIK +NVLL +     L+DFG+A  L+ +  +K+   + T  +MAP
Sbjct: 136 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNXFVGTPFWMAP 185

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 82/158 (51%), Gaps = 14/158 (8%)
Query: 665 NLIGTGGFGSVYKGSFLDGME-----VAIKVFHLQLEGALKSFDVECE---VLKSVRHRN 716
            ++G+G FG+V+KG ++   E     V IKV  ++ +   +SF    +    + S+ H +
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKV--IEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
           +V+++  C  +  + LV +Y+P GSL D++  +  +      L+  + +A  + YL    
Sbjct: 77  IVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE--- 132
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
            + +VH ++   NVLL       ++DFG+A LL  ++ 
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 80/184 (43%), Gaps = 22/184 (11%)
Query: 667 IGTGGFGSVYKGSFLDGM-------EVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLV 718
           +G G FG VY+G  + GM       +VA+K    +  E     F +E  ++    H+N+V
Sbjct: 55  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 113
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLY------SNNFSFDILQRLSVIIDVALALEYL 772
           + I     +  + ++LE M  G L+ +L       S   S  +L  L V  D+A   +YL
Sbjct: 114 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 173
Query: 773 HFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMA 828
                N  +H DI   N LL       VA + DFG+A+ +       K    +  + +M 
Sbjct: 174 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 230
Query: 829 PGLF 832
           P  F
Sbjct: 231 PEAF 234

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 80/184 (43%), Gaps = 22/184 (11%)
Query: 667 IGTGGFGSVYKGSFLDGM-------EVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLV 718
           +G G FG VY+G  + GM       +VA+K    +  E     F +E  ++    H+N+V
Sbjct: 45  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 103
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLY------SNNFSFDILQRLSVIIDVALALEYL 772
           + I     +  + ++LE M  G L+ +L       S   S  +L  L V  D+A   +YL
Sbjct: 104 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 163
Query: 773 HFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMA 828
                N  +H DI   N LL       VA + DFG+A+ +       K    +  + +M 
Sbjct: 164 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 220
Query: 829 PGLF 832
           P  F
Sbjct: 221 PEAF 224

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 79/168 (47%), Gaps = 9/168 (5%)
Query: 666 LIGTGGFGSVYKGSFLDGMEV-AIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKII 721
            +G GGF   ++ S  D  EV A K+    L       +   +E  + +S+ H+++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
               +NDF  +VLE     SL + L+    +    +    +  + L  +YLH    N V+
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 163
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D+K  N+ L++D+   + DFG+A  +  +   K+ L   T  Y+AP
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAP 210

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 78/176 (44%), Gaps = 17/176 (9%)
Query: 667 IGTGGFGSVYK------GSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKI 720
           IGTG +G   K      G  L   E+    +    E   +    E  +L+ ++H N+V+ 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELD---YGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 721 ISSCTN--NDFKALVLEYMPNGSLEDYLYSNNFSFDILQR---LSVIIDVALALEYLHFG 775
                +  N    +V+EY   G L   +         L     L V+  + LAL+  H  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 776 YS--NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
               + V+H D+KP+NV LD      L DFG+A++L+ + S  +T  + T  YM+P
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF-VGTPYYMSP 185

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 79/168 (47%), Gaps = 9/168 (5%)
Query: 666 LIGTGGFGSVYKGSFLDGMEV-AIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKII 721
            +G GGF   ++ S  D  EV A K+    L       +   +E  + +S+ H+++V   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
               +NDF  +VLE     SL + L+    +    +    +  + L  +YLH    N V+
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 161
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D+K  N+ L++D+   + DFG+A  +  +   K+ L   T  Y+AP
Sbjct: 162 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAP 208

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 80/184 (43%), Gaps = 22/184 (11%)
Query: 667 IGTGGFGSVYKGSFLDGM-------EVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLV 718
           +G G FG VY+G  + GM       +VA+K    +  E     F +E  ++    H+N+V
Sbjct: 65  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 123
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLY------SNNFSFDILQRLSVIIDVALALEYL 772
           + I     +  + ++LE M  G L+ +L       S   S  +L  L V  D+A   +YL
Sbjct: 124 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 183
Query: 773 HFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMA 828
                N  +H DI   N LL       VA + DFG+A+ +       K    +  + +M 
Sbjct: 184 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 240
Query: 829 PGLF 832
           P  F
Sbjct: 241 PEAF 244

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 10/162 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DG----MEVAIKVFHLQLE-GALKSFDVECEVLKSV 712
            +     ++G+G FG+VYKG ++ DG    + VAIKV        A K    E  V+  V
Sbjct: 17  TELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV 76
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
               + +++  C  +  + LV + MP G L D++  N         L+  + +A  + YL
Sbjct: 77  GSPYVSRLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYL 135
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +VH D+   NVL+       ++DFG+A+LL  +E+
Sbjct: 136 E---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 174

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 82/158 (51%), Gaps = 14/158 (8%)
Query: 665 NLIGTGGFGSVYKGSFLDGME-----VAIKVFHLQLEGALKSFDVECE---VLKSVRHRN 716
            ++G+G FG+V+KG ++   E     V IKV  ++ +   +SF    +    + S+ H +
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKV--IEDKSGRQSFQAVTDHMLAIGSLDHAH 94
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
           +V+++  C  +  + LV +Y+P GSL D++  +  +      L+  + +A  + YL    
Sbjct: 95  IVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE--- 150
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
            + +VH ++   NVLL       ++DFG+A LL  ++ 
Sbjct: 151 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 188

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 80/184 (43%), Gaps = 22/184 (11%)
Query: 667 IGTGGFGSVYKGSFLDGM-------EVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLV 718
           +G G FG VY+G  + GM       +VA+K    +  E     F +E  ++    H+N+V
Sbjct: 39  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 97
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLY------SNNFSFDILQRLSVIIDVALALEYL 772
           + I     +  + ++LE M  G L+ +L       S   S  +L  L V  D+A   +YL
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 773 HFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMA 828
                N  +H DI   N LL       VA + DFG+A+ +       K    +  + +M 
Sbjct: 158 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMP 214
Query: 829 PGLF 832
           P  F
Sbjct: 215 PEAF 218

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 89/184 (48%), Gaps = 16/184 (8%)
Query: 657 ATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQ--LEGALKSFDVECEVLK--- 710
           AT+++     IG G +G+VYK      G  VA+K   +    EG   S   E  +L+   
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 711 SVRHRNLVKIISSC----TNNDFK-ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDV 765
           +  H N+V+++  C    T+ + K  LV E++ +  L  YL  +      L   ++   +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL--DKAPPPGLPAETIKDLM 118
Query: 766 ALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG 825
              L  L F ++N +VH D+KP N+L+       L+DFG+A++ S +  M     + T+ 
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALAPVVVTLW 176
Query: 826 YMAP 829
           Y AP
Sbjct: 177 YRAP 180

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 80/184 (43%), Gaps = 22/184 (11%)
Query: 667 IGTGGFGSVYKGSFLDGM-------EVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLV 718
           +G G FG VY+G  + GM       +VA+K    +  E     F +E  ++    H+N+V
Sbjct: 79  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLY------SNNFSFDILQRLSVIIDVALALEYL 772
           + I     +  + ++LE M  G L+ +L       S   S  +L  L V  D+A   +YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 773 HFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMA 828
                N  +H DI   N LL       VA + DFG+A+ +       K    +  + +M 
Sbjct: 198 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 254
Query: 829 PGLF 832
           P  F
Sbjct: 255 PEAF 258

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 80/184 (43%), Gaps = 22/184 (11%)
Query: 667 IGTGGFGSVYKGSFLDGM-------EVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLV 718
           +G G FG VY+G  + GM       +VA+K    +  E     F +E  ++    H+N+V
Sbjct: 56  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 114
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLY------SNNFSFDILQRLSVIIDVALALEYL 772
           + I     +  + ++LE M  G L+ +L       S   S  +L  L V  D+A   +YL
Sbjct: 115 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 174
Query: 773 HFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMA 828
                N  +H DI   N LL       VA + DFG+A+ +       K    +  + +M 
Sbjct: 175 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 231
Query: 829 PGLF 832
           P  F
Sbjct: 232 PEAF 235

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 86/183 (46%), Gaps = 22/183 (12%)
Query: 658 TNQFNASNLIGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGA--LKSFDVECEVLKSVRH 714
           ++ ++    +G G F  V +      G+E A K+ + +   A   +  + E  + + ++H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSL-EDYL----YSNNFSFDILQRLSVIIDVALAL 769
            N+V++  S     F  LV + +  G L ED +    YS   +   +Q++         L
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI---------L 138
Query: 770 EYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
           E + + +SN +VH ++KP N+LL    K     L+DFG+A  ++  E+        T GY
Sbjct: 139 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPGY 196
Query: 827 MAP 829
           ++P
Sbjct: 197 LSP 199

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 85/176 (48%), Gaps = 17/176 (9%)
Query: 661 FNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQ------LEGALKSFDVECEVLKSVR 713
           +     +G G FG V        G +VA+K+ + +      ++G ++    E   L+ +R
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER---EISYLRLLR 71
Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
           H +++K+     + D   +V+EY  N  L DY+   +   +   R      +  A+EY H
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCH 129
Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
               + +VH D+KP N+LLD+ +   ++DFG++ +++    +K   +  +  Y AP
Sbjct: 130 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT--SCGSPNYAAP 180

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 80/184 (43%), Gaps = 22/184 (11%)
Query: 667 IGTGGFGSVYKGSFLDGM-------EVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLV 718
           +G G FG VY+G  + GM       +VA+K    +  E     F +E  ++    H+N+V
Sbjct: 38  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLY------SNNFSFDILQRLSVIIDVALALEYL 772
           + I     +  + +++E M  G L+ +L       S   S  +L  L V  D+A   +YL
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 773 HFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMA 828
                N  +H DI   N LL       VA + DFG+A+ +       K    +  + +M 
Sbjct: 157 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 829 PGLF 832
           P  F
Sbjct: 214 PEAF 217

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 83/186 (44%), Gaps = 31/186 (16%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDG--------MEVAIKVFHLQLEGALKSFDVECEVLKSV 712
           F    ++G GG+G V++   + G        M+V  K   ++          E  +L+ V
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIID-------- 764
           +H  +V +I +        L+LEY+  G L          F  L+R  + ++        
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGEL----------FMQLEREGIFMEDTACFYLA 128
Query: 765 -VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +++AL +LH      +++ D+KP N++L+      L+DFG+ K    + ++  T    T
Sbjct: 129 EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GT 184
Query: 824 IGYMAP 829
           I YMAP
Sbjct: 185 IEYMAP 190

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 80/184 (43%), Gaps = 22/184 (11%)
Query: 667 IGTGGFGSVYKGSFLDGM-------EVAIKVF-HLQLEGALKSFDVECEVLKSVRHRNLV 718
           +G G FG VY+G  + GM       +VA+K    +  E     F +E  ++    H+N+V
Sbjct: 53  LGHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 111
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLY------SNNFSFDILQRLSVIIDVALALEYL 772
           + I     +  + +++E M  G L+ +L       S   S  +L  L V  D+A   +YL
Sbjct: 112 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 773 HFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMA 828
                N  +H DI   N LL       VA + DFG+A+ +       K    +  + +M 
Sbjct: 172 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 829 PGLF 832
           P  F
Sbjct: 229 PEAF 232

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 87/178 (48%), Gaps = 21/178 (11%)
Query: 661 FNASNLIGTGGFGSV---YKGSFLDGMEVAIKVFHLQ------LEGALKSFDVECEVLKS 711
           +     +G G FG V   Y  +   G +VA+K+ + +      ++G ++    E   L+ 
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIER---EISYLRL 70
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           +RH +++K+     + D   +V+EY  N  L DY+   +   +   R      +  A+EY
Sbjct: 71  LRHPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQIISAVEY 128
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            H    + +VH D+KP N+LLD+ +   ++DFG++ +++    +K   +  +  Y AP
Sbjct: 129 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT--SCGSPNYAAP 181

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 90/184 (48%), Gaps = 16/184 (8%)
Query: 657 ATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQ--LEGALKSFDVECEVLK--- 710
           AT+++     IG G +G+VYK      G  VA+K   +    EG   S   E  +L+   
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 711 SVRHRNLVKIISSC----TNNDFK-ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDV 765
           +  H N+V+++  C    T+ + K  LV E++ +  L  YL  +      L   ++   +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL--DKAPPPGLPAETIKDLM 118
Query: 766 ALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG 825
              L  L F ++N +VH D+KP N+L+       L+DFG+A++ S + ++   +   T+ 
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVV--TLW 176
Query: 826 YMAP 829
           Y AP
Sbjct: 177 YRAP 180

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 79/168 (47%), Gaps = 9/168 (5%)
Query: 666 LIGTGGFGSVYKGSFLDGMEV-AIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKII 721
            +G GGF   ++ S  D  EV A K+    L       +   +E  + +S+ H+++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
               +NDF  +VLE     SL + L+    +    +    +  + L  +YLH    N V+
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 137
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D+K  N+ L++D+   + DFG+A  +  +   K+ L   T  Y+AP
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAP 184

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 83/187 (44%), Gaps = 19/187 (10%)
Query: 651 YKELLQATNQFNASNLIGTGGFG----SVYKGSFLDGMEVAIKVFHLQLEGALKSFDVEC 706
           ++  +Q T+ +     IG G +      ++K +    ME A+K+         +  ++  
Sbjct: 14  HRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKAT---NMEFAVKIIDKSKRDPTEEIEI-- 68
Query: 707 EVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVA 766
            +L+  +H N++ +     +  +  +V E M  G L D +    F F   +  +V+  + 
Sbjct: 69  -LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF-FSEREASAVLFTIT 126
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKD----MVAHLSDFGIAKLLSGEESMKQTLTLA 822
             +EYLH   +  VVH D+KPSN+L   +        + DFG AK L  E  +  T    
Sbjct: 127 KTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCY 182
Query: 823 TIGYMAP 829
           T  ++AP
Sbjct: 183 TANFVAP 189

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 8/176 (4%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQL--EGALKSFDVECEVLKSVRHR 715
            ++     IG G +G+V+K    +  E VA+K   L    EG   S   E  +LK ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG 775
           N+V++     ++    LV E+  +  L+ Y  S N   D     S +  +   L+ L F 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQL---LKGLGFC 117
Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
           +S  V+H D+KP N+L++++    L++FG+A+   G      +  + T+ Y  P +
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDV 172

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 81/181 (44%), Gaps = 18/181 (9%)
Query: 658 TNQFNASNLIGTGGFGSVYK-GSFLDGMEVAIKVFHLQLEGALKSFDV-----ECEVLKS 711
             ++N   ++G G FG V K    +   E A+KV +   + + K+ D      E E+LK 
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN---KASAKNKDTSTILREVELLKK 77
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           + H N++K+     ++    +V E    G L D +      F       +I  V   + Y
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITY 136
Query: 772 LHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA 828
           +H    + +VH D+KP N+LL   +KD    + DFG++        MK    + T  Y+A
Sbjct: 137 MH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIA 191
Query: 829 P 829
           P
Sbjct: 192 P 192

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKGSFL---DGMEVAIKVFHLQLEGA-LKSFDVECE 707
           K  L+  N   A   +G G FGSV +G +      ++VAIKV     E A  +    E +
Sbjct: 3   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 62
Query: 708 VLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL 767
           ++  + +  +V++I  C       LV+E    G L  +L        +     ++  V++
Sbjct: 63  IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 121
Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
            ++YL        VH D+   NVLL     A +SDFG++K L  ++S
Sbjct: 122 GMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 89/184 (48%), Gaps = 16/184 (8%)
Query: 657 ATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQ--LEGALKSFDVECEVLK--- 710
           AT+++     IG G +G+VYK      G  VA+K   +    EG   S   E  +L+   
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 711 SVRHRNLVKIISSC----TNNDFK-ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDV 765
           +  H N+V+++  C    T+ + K  LV E++ +  L  YL  +      L   ++   +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL--DKAPPPGLPAETIKDLM 118
Query: 766 ALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG 825
              L  L F ++N +VH D+KP N+L+       L+DFG+A++ S +  M     + T+ 
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALFPVVVTLW 176
Query: 826 YMAP 829
           Y AP
Sbjct: 177 YRAP 180

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 44/170 (25%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQ------LEGALKSFDVECEVLKSVRHRNLVK 719
           +G G FG V        G +VA+K+ + +      ++G ++    E   L+ +RH +++K
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER---EISYLRLLRHPHIIK 68
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
           +     + D   +V+EY  N  L DY+   +   +   R      +  A+EY H    + 
Sbjct: 69  LYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCH---RHK 123
Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +VH D+KP N+LLD+ +   ++DFG++ +++    +K   +  +  Y AP
Sbjct: 124 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT--SCGSPNYAAP 171

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 82/160 (51%), Gaps = 25/160 (15%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV----ECEVLKSVRHRNLVKII 721
           IG G FG V+K      G +VA+K   + +E   + F +    E ++L+ ++H N+V +I
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 722 SSCTN-----NDFKA---LVLEYMPN---GSLEDYLYSNNFSFDILQRLSVIIDVALALE 770
             C       N  K    LV ++  +   G L + L    F+   ++R+     + + L 
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRV-----MQMLLN 136
Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS 810
            L++ + N ++H D+K +NVL+ +D V  L+DFG+A+  S
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 176

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 81/181 (44%), Gaps = 18/181 (9%)
Query: 658 TNQFNASNLIGTGGFGSVYK-GSFLDGMEVAIKVFHLQLEGALKSFDV-----ECEVLKS 711
             ++N   ++G G FG V K    +   E A+KV +   + + K+ D      E E+LK 
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN---KASAKNKDTSTILREVELLKK 77
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           + H N++K+     ++    +V E    G L D +      F       +I  V   + Y
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITY 136
Query: 772 LHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA 828
           +H    + +VH D+KP N+LL   +KD    + DFG++        MK    + T  Y+A
Sbjct: 137 MH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIA 191
Query: 829 P 829
           P
Sbjct: 192 P 192

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 44/170 (25%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQ------LEGALKSFDVECEVLKSVRHRNLVK 719
           +G G FG V        G +VA+K+ + +      ++G ++    E   L+ +RH +++K
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIER---EISYLRLLRHPHIIK 72
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
           +     + D   +V+EY  N  L DY+   +   +   R      +  A+EY H    + 
Sbjct: 73  LYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCH---RHK 127
Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +VH D+KP N+LLD+ +   ++DFG++ +++    +K   +  +  Y AP
Sbjct: 128 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT--SCGSPNYAAP 175

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 81/181 (44%), Gaps = 18/181 (9%)
Query: 658 TNQFNASNLIGTGGFGSVYK-GSFLDGMEVAIKVFHLQLEGALKSFDV-----ECEVLKS 711
             ++N   ++G G FG V K    +   E A+KV +   + + K+ D      E E+LK 
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN---KASAKNKDTSTILREVELLKK 77
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           + H N++K+     ++    +V E    G L D +      F       +I  V   + Y
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITY 136
Query: 772 LHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA 828
           +H    + +VH D+KP N+LL   +KD    + DFG++        MK    + T  Y+A
Sbjct: 137 MH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIA 191
Query: 829 P 829
           P
Sbjct: 192 P 192

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 17/176 (9%)
Query: 667 IGTGGFGSVYK------GSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKI 720
           IGTG +G   K      G  L   E+    +    E   +    E  +L+ ++H N+V+ 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELD---YGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 721 ISSCTN--NDFKALVLEYMPNGSLEDYLYSNNFSFDILQR---LSVIIDVALALEYLHFG 775
                +  N    +V+EY   G L   +         L     L V+  + LAL+  H  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 776 YS--NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
               + V+H D+KP+NV LD      L DFG+A++L+ +E   +   + T  YM+P
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEF-VGTPYYMSP 185

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 87/185 (47%), Gaps = 13/185 (7%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKV---FHLQLEGALKSFDVECE 707
           KE+    + F    +IG G F  V        G   A+K+   + +   G +  F  E +
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERD 113
Query: 708 VLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLS--VIIDV 765
           VL +   R + ++  +  + ++  LV+EY   G L   L  + F   I   ++   + ++
Sbjct: 114 VLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIPAEMARFYLAEI 171
Query: 766 ALALEYLH-FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATI 824
            +A++ +H  GY    VH DIKP N+LLD+     L+DFG    L  + +++  + + T 
Sbjct: 172 VMAIDSVHRLGY----VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTP 227
Query: 825 GYMAP 829
            Y++P
Sbjct: 228 DYLSP 232

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 27/187 (14%)
Query: 661 FNASNLIGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVK 719
           F    LIG+GGFG V+K    +DG    IK      E A +    E + L  + H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68
Query: 720 IISSCTNNDFKA----------------LVLEYMPNGSLEDYLYSNN-FSFDILQRLSVI 762
                   D+                  + +E+   G+LE ++        D +  L + 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA 822
             +   ++Y+H   S  +++ D+KPSN+ L       + DFG+   L  +   K+  +  
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND--GKRXRSKG 183
Query: 823 TIGYMAP 829
           T+ YM+P
Sbjct: 184 TLRYMSP 190

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 76/174 (43%), Gaps = 8/174 (4%)
Query: 659 NQFNASNLIGTGGFGSVYK-GSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNL 717
           + ++    +GTG FG V++      G   A K      E   ++   E + +  +RH  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           V +  +  +++   ++ E+M  G L + +   +      + +  +  V   L ++H    
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 273
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLS--DFGIAKLLSGEESMKQTLTLATIGYMAP 829
           N  VH D+KP N++        L   DFG+   L  ++S+K  +T  T  + AP
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK--VTTGTAEFAAP 325

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 34/188 (18%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLK-----SVR 713
           N F+   +IG GGFG VY     D  ++           A+K  D +   +K     ++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMY----------AMKCLDKKRIKMKQGETLALN 238
Query: 714 HRNLVKIISS-------CTNNDFK-----ALVLEYMPNGSLEDYLYSNNFSFDILQRLSV 761
            R ++ ++S+       C +  F      + +L+ M  G L  Y  S +  F        
Sbjct: 239 ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH-YHLSQHGVFSEADMRFY 297
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL 821
             ++ L LE++H  +   VV+ D+KP+N+LLD+     +SD G+A   S +   K   ++
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASV 351
Query: 822 ATIGYMAP 829
            T GYMAP
Sbjct: 352 GTHGYMAP 359

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 34/188 (18%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLK-----SVR 713
           N F+   +IG GGFG VY     D  ++           A+K  D +   +K     ++ 
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMY----------AMKCLDKKRIKMKQGETLALN 237
Query: 714 HRNLVKIISS-------CTNNDFK-----ALVLEYMPNGSLEDYLYSNNFSFDILQRLSV 761
            R ++ ++S+       C +  F      + +L+ M  G L  Y  S +  F        
Sbjct: 238 ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH-YHLSQHGVFSEADMRFY 296
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL 821
             ++ L LE++H  +   VV+ D+KP+N+LLD+     +SD G+A   S +   K   ++
Sbjct: 297 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASV 350
Query: 822 ATIGYMAP 829
            T GYMAP
Sbjct: 351 GTHGYMAP 358

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 86/179 (48%), Gaps = 15/179 (8%)
Query: 659 NQFNASNLIGTGGFGSVY--------KGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLK 710
           + F    ++G G FG V+            L  M+V +K   L++   +++  +E ++L 
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKV-LKKATLKVRDRVRT-KMERDILA 85
Query: 711 SVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALE 770
            V H  +VK+  +        L+L+++  G L   L S    F        + ++AL L+
Sbjct: 86  DVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALGLD 144
Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +LH   S  +++ D+KP N+LLD++    L+DFG++K     E    +    T+ YMAP
Sbjct: 145 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC-GTVEYMAP 199

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 12/177 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSF-----LDGMEVAIKVFHLQLEGALKSFDVECEVLKSVR 713
           N F    ++G GGFG V          +   +   K    + +G   + + E ++L+ V 
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKQILEKVN 242
Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYL 772
            R +V +  +    D   LVL  M  G L+ ++Y      F   + +    ++   LE L
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H      +V+ D+KP N+LLD      +SD G+A  +   +++K    + T+GYMAP
Sbjct: 303 H---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG--RVGTVGYMAP 354

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 82/200 (41%), Gaps = 40/200 (20%)
Query: 661 FNASNLIGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVK 719
           F    LIG+GGFG V+K    +DG    I+      E A +    E + L  + H N+V 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIVH 69
Query: 720 I--------------ISSCTNNDFKA---------------LVLEYMPNGSLEDYLYSNN 750
                            S  ++D+                 + +E+   G+LE ++    
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 751 -FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
               D +  L +   +   ++Y+H   S  ++H D+KPSN+ L       + DFG+   L
Sbjct: 130 GEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSL 186
Query: 810 SGEESMKQTLTLATIGYMAP 829
             +   K+T +  T+ YM+P
Sbjct: 187 KND--GKRTRSKGTLRYMSP 204

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 66/143 (46%), Gaps = 13/143 (9%)
Query: 661 FNASNLIGTGGFGSVYKG--------SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV 712
           FN S  +G G F  ++KG          L   EV +KV         +SF     ++  +
Sbjct: 12  FNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL 69
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            H++LV     C   D   LV E++  GSL+ YL  N    +IL +L V   +A A   +
Sbjct: 70  SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA---M 126
Query: 773 HFGYSNPVVHCDIKPSNVLLDKD 795
           HF   N ++H ++   N+LL ++
Sbjct: 127 HFLEENTLIHGNVCAKNILLIRE 149

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 46/183 (25%), Positives = 86/183 (46%), Gaps = 22/183 (12%)
Query: 658 TNQFNASNLIGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGA--LKSFDVECEVLKSVRH 714
           ++ ++    +G G F  V +      G+E A K+ + +   A   +  + E  + + ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSL-EDYL----YSNNFSFDILQRLSVIIDVALAL 769
            N+V++  S     F  LV + +  G L ED +    YS   +   +Q++         L
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI---------L 115
Query: 770 EYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
           E + + +SN +VH ++KP N+LL    K     L+DFG+A  ++  E+        T GY
Sbjct: 116 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPGY 173
Query: 827 MAP 829
           ++P
Sbjct: 174 LSP 176

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 12/177 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSF-----LDGMEVAIKVFHLQLEGALKSFDVECEVLKSVR 713
           N F    ++G GGFG V          +   +   K    + +G   + + E ++L+ V 
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKQILEKVN 242
Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYL 772
            R +V +  +    D   LVL  M  G L+ ++Y      F   + +    ++   LE L
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H      +V+ D+KP N+LLD      +SD G+A  +   +++K    + T+GYMAP
Sbjct: 303 H---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG--RVGTVGYMAP 354

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 82/160 (51%), Gaps = 25/160 (15%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV----ECEVLKSVRHRNLVKII 721
           IG G FG V+K      G +VA+K   + +E   + F +    E ++L+ ++H N+V +I
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 722 SSCTN-----NDFKA---LVLEYMPN---GSLEDYLYSNNFSFDILQRLSVIIDVALALE 770
             C       N  K    LV ++  +   G L + L    F+   ++R+     + + L 
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRV-----MQMLLN 136
Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS 810
            L++ + N ++H D+K +NVL+ +D V  L+DFG+A+  S
Sbjct: 137 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 176

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 65/128 (50%), Gaps = 9/128 (7%)
Query: 705 ECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIID 764
           E  VLK + H N++K+     +     LV+E    G L D +  +   F+ +    +I  
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII-HRMKFNEVDAAVIIKQ 144
Query: 765 VALALEYLHFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAKLLSGEESMKQTLTL 821
           V   + YLH    + +VH D+KP N+LL+   KD +  + DFG++ +   ++ MK+   L
Sbjct: 145 VLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE--RL 199
Query: 822 ATIGYMAP 829
            T  Y+AP
Sbjct: 200 GTAYYIAP 207

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 34/188 (18%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLK-----SVR 713
           N F+   +IG GGFG VY     D  ++           A+K  D +   +K     ++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMY----------AMKCLDKKRIKMKQGETLALN 238
Query: 714 HRNLVKIISS-------CTNNDFK-----ALVLEYMPNGSLEDYLYSNNFSFDILQRLSV 761
            R ++ ++S+       C +  F      + +L+ M  G L  Y  S +  F        
Sbjct: 239 ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH-YHLSQHGVFSEADMRFY 297
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL 821
             ++ L LE++H  +   VV+ D+KP+N+LLD+     +SD G+A   S +   K   ++
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASV 351
Query: 822 ATIGYMAP 829
            T GYMAP
Sbjct: 352 GTHGYMAP 359

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 34/188 (18%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLK-----SVR 713
           N F+   +IG GGFG VY     D  ++           A+K  D +   +K     ++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMY----------AMKCLDKKRIKMKQGETLALN 238
Query: 714 HRNLVKIISS-------CTNNDFK-----ALVLEYMPNGSLEDYLYSNNFSFDILQRLSV 761
            R ++ ++S+       C +  F      + +L+ M  G L  Y  S +  F        
Sbjct: 239 ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH-YHLSQHGVFSEADMRFY 297
Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL 821
             ++ L LE++H  +   VV+ D+KP+N+LLD+     +SD G+A   S +   K   ++
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASV 351
Query: 822 ATIGYMAP 829
            T GYMAP
Sbjct: 352 GTHGYMAP 359

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 87/182 (47%), Gaps = 16/182 (8%)
Query: 659 NQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHR 715
           +++     +G G +G VYK    +    VAIK   L+ E  G   +   E  +LK ++HR
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHF 774
           N++++ S   +N    L+ EY  N  L+ Y+  N + S  +++       +   +  ++F
Sbjct: 94  NIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSF-----LYQLINGVNF 147
Query: 775 GYSNPVVHCDIKPSNVLL-----DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            +S   +H D+KP N+LL      +  V  + DFG+A+   G    + T  + T+ Y  P
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEIITLWYRPP 206
Query: 830 GL 831
            +
Sbjct: 207 EI 208

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 82/160 (51%), Gaps = 25/160 (15%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV----ECEVLKSVRHRNLVKII 721
           IG G FG V+K      G +VA+K   + +E   + F +    E ++L+ ++H N+V +I
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 82
Query: 722 SSCTN-----NDFKA---LVLEYMPN---GSLEDYLYSNNFSFDILQRLSVIIDVALALE 770
             C       N  K    LV ++  +   G L + L    F+   ++R+     + + L 
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRV-----MQMLLN 135
Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS 810
            L++ + N ++H D+K +NVL+ +D V  L+DFG+A+  S
Sbjct: 136 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 638 SNMLPQATRRRFSYKELLQAT-----NQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVF 691
           S+ML  +  R   Y++ L  T      ++   + +G+G +GSV        G+ VA+K  
Sbjct: 19  SHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 78
Query: 692 HLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLED 744
               +  +  K    E  +LK ++H N++ ++   T      +F  + L  ++    L +
Sbjct: 79  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 138
Query: 745 YLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFG 804
            +     + D +Q L  I  +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG
Sbjct: 139 IVKCQKLTDDHVQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 193
Query: 805 IAKLLSGEESMKQTLTLATIGYMAPGL 831
           +A+    E     T  +AT  Y AP +
Sbjct: 194 LARHTDDE----MTGYVATRWYRAPEI 216

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 76/174 (43%), Gaps = 8/174 (4%)
Query: 659 NQFNASNLIGTGGFGSVYK-GSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNL 717
           + ++    +GTG FG V++      G   A K      E   ++   E + +  +RH  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           V +  +  +++   ++ E+M  G L + +   +      + +  +  V   L ++H    
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 167
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLS--DFGIAKLLSGEESMKQTLTLATIGYMAP 829
           N  VH D+KP N++        L   DFG+   L  ++S+K  +T  T  + AP
Sbjct: 168 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK--VTTGTAEFAAP 219

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 75/152 (49%), Gaps = 9/152 (5%)
Query: 662 NASNLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRN 716
           ++  +IG G FG VY G ++D     ++ AIK      E   +++F  E  +++ + H N
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 717 LVKIISSCTNND-FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG 775
           ++ +I      +    ++L YM +G L  ++ S   +  +   +S  + VA  +EYL   
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL--- 140
Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
                VH D+   N +LD+     ++DFG+A+
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 17/176 (9%)
Query: 667 IGTGGFGSVYK------GSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKI 720
           IGTG +G   K      G  L   E+    +    E   +    E  +L+ ++H N+V+ 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELD---YGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 721 ISSCTN--NDFKALVLEYMPNGSLEDYLYSNNFSFDILQR---LSVIIDVALALEYLHFG 775
                +  N    +V+EY   G L   +         L     L V+  + LAL+  H  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 776 YS--NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
               + V+H D+KP+NV LD      L DFG+A++L+ + S  +   + T  YM+P
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF-VGTPYYMSP 185

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 66/143 (46%), Gaps = 13/143 (9%)
Query: 661 FNASNLIGTGGFGSVYKG--------SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV 712
           FN S  +G G F  ++KG          L   EV +KV         +SF     ++  +
Sbjct: 12  FNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL 69
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            H++LV     C   D   LV E++  GSL+ YL  N    +IL +L V   +A A   +
Sbjct: 70  SHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWA---M 126
Query: 773 HFGYSNPVVHCDIKPSNVLLDKD 795
           HF   N ++H ++   N+LL ++
Sbjct: 127 HFLEENTLIHGNVCAKNILLIRE 149

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 83/182 (45%), Gaps = 14/182 (7%)
Query: 658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALK---SFDVECEVLKSVR 713
           ++++    ++G GG   V+    L    +VA+KV    L         F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 714 HRNLVKIISS----CTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL 769
           H  +V + ++            +V+EY+   +L D +++        + + VI D   A 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIAD---AC 126
Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL--SGEESMKQTLTLATIGYM 827
           + L+F + N ++H D+KP+N+++       + DFGIA+ +  SG    +    + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 828 AP 829
           +P
Sbjct: 187 SP 188

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 89/187 (47%), Gaps = 19/187 (10%)
Query: 657 ATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIK---VFHLQLEGALKSFDVECEV---- 708
           AT+++     IG G +G+VYK      G  VA+K   V +    G         EV    
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 709 -LKSVRHRNLVKIISSC----TNNDFK-ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVI 762
            L++  H N+V+++  C    T+ + K  LV E++ +  L  YL  +      L   ++ 
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL--DKAPPPGLPAETIK 123
Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA 822
             +   L  L F ++N +VH D+KP N+L+       L+DFG+A++ S +  M  T  + 
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALTPVVV 181
Query: 823 TIGYMAP 829
           T+ Y AP
Sbjct: 182 TLWYRAP 188

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 89/174 (51%), Gaps = 10/174 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDV-ECEVLKSVRHRN 716
           + F   + +G G  G V+K S    G+ +A K+ HL+++ A+++  + E +VL       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLY-SNNFSFDILQRLSVIIDVALALEYLHFG 775
           +V    +  ++   ++ +E+M  GSL+  L  +      IL ++S  I V   L YL   
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS--IAVIKGLTYLREK 185
Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +   ++H D+KPSN+L++      L DFG++  L   +SM  +  + T  YM+P
Sbjct: 186 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSF-VGTRSYMSP 234

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 86/183 (46%), Gaps = 22/183 (12%)
Query: 658 TNQFNASNLIGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGA--LKSFDVECEVLKSVRH 714
           ++ ++    +G G F  V +      G+E A K+ + +   A   +  + E  + + ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSL-EDYL----YSNNFSFDILQRLSVIIDVALAL 769
            N+V++  S     F  LV + +  G L ED +    YS   +   +Q++         L
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI---------L 115
Query: 770 EYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
           E + + +SN +VH ++KP N+LL    K     L+DFG+A  ++  E+        T GY
Sbjct: 116 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPGY 173
Query: 827 MAP 829
           ++P
Sbjct: 174 LSP 176

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 638 SNMLPQATRRRFSYKELLQAT-----NQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVF 691
           S+ML  +  R   Y++ L  T      ++   + +G+G +GSV        G+ VA+K  
Sbjct: 2   SHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 61
Query: 692 HLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLED 744
               +  +  K    E  +LK ++H N++ ++   T      +F  + L  ++    L +
Sbjct: 62  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 121
Query: 745 YLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFG 804
            +     + D +Q L  I  +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG
Sbjct: 122 IVKCQKLTDDHVQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 176
Query: 805 IAKLLSGEESMKQTLTLATIGYMAPGL 831
           +A+    E     T  +AT  Y AP +
Sbjct: 177 LARHTDDE----MTGYVATRWYRAPEI 199

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 83/178 (46%), Gaps = 19/178 (10%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ------LEGALKSFDVECEVLKSVRH 714
           F     +GTG F  V     L   +   K+F ++      L+G   S + E  VL+ ++H
Sbjct: 24  FEFKETLGTGAFSEV----VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKH 79
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
            N+V +     + +   LV++ +  G L D +    F +      ++I  V  A+ YLH 
Sbjct: 80  ENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGF-YTEKDASTLIRQVLDAVYYLH- 137
Query: 775 GYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
                +VH D+KP N+L    D++    +SDFG++K+    + M  +    T GY+AP
Sbjct: 138 --RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVM--STACGTPGYVAP 191

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 86/183 (46%), Gaps = 22/183 (12%)
Query: 658 TNQFNASNLIGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGA--LKSFDVECEVLKSVRH 714
           ++ ++    +G G F  V +      G+E A K+ + +   A   +  + E  + + ++H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSL-EDYL----YSNNFSFDILQRLSVIIDVALAL 769
            N+V++  S     F  LV + +  G L ED +    YS   +   +Q++         L
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI---------L 114
Query: 770 EYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
           E + + +SN +VH ++KP N+LL    K     L+DFG+A  ++  E+        T GY
Sbjct: 115 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPGY 172
Query: 827 MAP 829
           ++P
Sbjct: 173 LSP 175

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 29/183 (15%)
Query: 665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ------------LEGALKSFDVECEVLKSV 712
            ++G GGFG V+       M+   K++  +             +GA+    VE ++L  V
Sbjct: 191 RVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAM----VEKKILAKV 242
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLY---SNNFSFDILQRLSVIIDVALAL 769
             R +V +  +        LV+  M  G +  ++Y    +N  F   + +     +   L
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA-KLLSGEESMKQTLTLATIGYMA 828
           E+LH      +++ D+KP NVLLD D    +SD G+A +L +G+   K      T G+MA
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMA 357
Query: 829 PGL 831
           P L
Sbjct: 358 PEL 360

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 29/183 (15%)
Query: 665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ------------LEGALKSFDVECEVLKSV 712
            ++G GGFG V+       M+   K++  +             +GA+    VE ++L  V
Sbjct: 191 RVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAM----VEKKILAKV 242
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLY---SNNFSFDILQRLSVIIDVALAL 769
             R +V +  +        LV+  M  G +  ++Y    +N  F   + +     +   L
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA-KLLSGEESMKQTLTLATIGYMA 828
           E+LH      +++ D+KP NVLLD D    +SD G+A +L +G+   K      T G+MA
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMA 357
Query: 829 PGL 831
           P L
Sbjct: 358 PEL 360

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 29/183 (15%)
Query: 665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ------------LEGALKSFDVECEVLKSV 712
            ++G GGFG V+       M+   K++  +             +GA+    VE ++L  V
Sbjct: 191 RVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAM----VEKKILAKV 242
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLY---SNNFSFDILQRLSVIIDVALAL 769
             R +V +  +        LV+  M  G +  ++Y    +N  F   + +     +   L
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA-KLLSGEESMKQTLTLATIGYMA 828
           E+LH      +++ D+KP NVLLD D    +SD G+A +L +G+   K      T G+MA
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMA 357
Query: 829 PGL 831
           P L
Sbjct: 358 PEL 360

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 638 SNMLPQATRRRFSYKELLQAT-----NQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVF 691
           S+ML  +  R   Y++ L  T      ++   + +G+G +GSV        G+ VA+K  
Sbjct: 1   SHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 60
Query: 692 HLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLED 744
               +  +  K    E  +LK ++H N++ ++   T      +F  + L  ++    L +
Sbjct: 61  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 120
Query: 745 YLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFG 804
            +     + D +Q L  I  +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG
Sbjct: 121 IVKCQKLTDDHVQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 175
Query: 805 IAKLLSGEESMKQTLTLATIGYMAPGL 831
           +A+    E     T  +AT  Y AP +
Sbjct: 176 LARHTDDE----MTGYVATRWYRAPEI 198

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 86/183 (46%), Gaps = 21/183 (11%)
Query: 658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRH 714
           T+++     +G G F  V +   +  G E A K+ + +   A   +  + E  + + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSL-EDYL----YSNNFSFDILQRLSVIIDVALAL 769
            N+V++  S +   F  LV + +  G L ED +    YS   +   +Q++         L
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQI---------L 113
Query: 770 EYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
           E ++  + N +VH D+KP N+LL    K     L+DFG+A  + G++         T GY
Sbjct: 114 ESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA-GTPGY 172
Query: 827 MAP 829
           ++P
Sbjct: 173 LSP 175

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 89/174 (51%), Gaps = 10/174 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDV-ECEVLKSVRHRN 716
           + F   + +G G  G V+K S    G+ +A K+ HL+++ A+++  + E +VL       
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLY-SNNFSFDILQRLSVIIDVALALEYLHFG 775
           +V    +  ++   ++ +E+M  GSL+  L  +      IL ++S  I V   L YL   
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS--IAVIKGLTYLR-- 140
Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             + ++H D+KPSN+L++      L DFG++  L   +SM  +  + T  YM+P
Sbjct: 141 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSF-VGTRSYMSP 191

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 89/174 (51%), Gaps = 10/174 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDV-ECEVLKSVRHRN 716
           + F   + +G G  G V+K S    G+ +A K+ HL+++ A+++  + E +VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLY-SNNFSFDILQRLSVIIDVALALEYLHFG 775
           +V    +  ++   ++ +E+M  GSL+  L  +      IL ++S  I V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS--IAVIKGLTYLREK 123
Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +   ++H D+KPSN+L++      L DFG++  L   +SM  +  + T  YM+P
Sbjct: 124 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSF-VGTRSYMSP 172

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 29/183 (15%)
Query: 665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQ------------LEGALKSFDVECEVLKSV 712
            ++G GGFG V+       M+   K++  +             +GA+    VE ++L  V
Sbjct: 191 RVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAM----VEKKILAKV 242
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLY---SNNFSFDILQRLSVIIDVALAL 769
             R +V +  +        LV+  M  G +  ++Y    +N  F   + +     +   L
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA-KLLSGEESMKQTLTLATIGYMA 828
           E+LH      +++ D+KP NVLLD D    +SD G+A +L +G+   K      T G+MA
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMA 357
Query: 829 PGL 831
           P L
Sbjct: 358 PEL 360

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 638 SNMLPQATRRRFSYKELLQAT-----NQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVF 691
           S+ML  +  R   Y++ L  T      ++   + +G+G +GSV        G+ VA+K  
Sbjct: 2   SHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 61
Query: 692 HLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLED 744
               +  +  K    E  +LK ++H N++ ++   T      +F  + L  ++    L +
Sbjct: 62  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 121
Query: 745 YLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFG 804
            +     + D +Q L  I  +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG
Sbjct: 122 IVKCQKLTDDHVQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFG 176
Query: 805 IAKLLSGEESMKQTLTLATIGYMAPGL 831
           +A+    E     T  +AT  Y AP +
Sbjct: 177 LARHTDDE----MTGYVATRWYRAPEI 199

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 81/178 (45%), Gaps = 14/178 (7%)
Query: 661 FNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLV 718
           F    L+G G +G VYKG  +  G   AIKV  +  +   +    E  +LK    HRN+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 84
Query: 719 KIISSCTN------NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII-DVALALEY 771
               +         +D   LV+E+   GS+ D + +   +    + ++ I  ++   L +
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           LH    + V+H DIK  NVLL ++    L DFG++  L      + T  + T  +MAP
Sbjct: 145 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMAP 198

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 82/186 (44%), Gaps = 31/186 (16%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDG--------MEVAIKVFHLQLEGALKSFDVECEVLKSV 712
           F    ++G GG+G V++   + G        M+V  K   ++          E  +L+ V
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIID-------- 764
           +H  +V +I +        L+LEY+  G L          F  L+R  + ++        
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGEL----------FMQLEREGIFMEDTACFYLA 128
Query: 765 -VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +++AL +LH      +++ D+KP N++L+      L+DFG+ K    + ++       T
Sbjct: 129 EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFC-GT 184
Query: 824 IGYMAP 829
           I YMAP
Sbjct: 185 IEYMAP 190

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 82/182 (45%), Gaps = 14/182 (7%)
Query: 658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALK---SFDVECEVLKSVR 713
           ++++    ++G GG   V+    L    +VA+KV    L         F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 714 HRNLVKII----SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL 769
           H  +V +     +         +V+EY+   +L D +++        + + VI D   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIAD---AC 126
Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL--SGEESMKQTLTLATIGYM 827
           + L+F + N ++H D+KP+N+++       + DFGIA+ +  SG    +    + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 828 AP 829
           +P
Sbjct: 187 SP 188

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 89/174 (51%), Gaps = 10/174 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDV-ECEVLKSVRHRN 716
           + F   + +G G  G V+K S    G+ +A K+ HL+++ A+++  + E +VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLY-SNNFSFDILQRLSVIIDVALALEYLHFG 775
           +V    +  ++   ++ +E+M  GSL+  L  +      IL ++S  I V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS--IAVIKGLTYLR-- 121
Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             + ++H D+KPSN+L++      L DFG++  L   +SM  +  + T  YM+P
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSF-VGTRSYMSP 172

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 89/174 (51%), Gaps = 10/174 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDV-ECEVLKSVRHRN 716
           + F   + +G G  G V+K S    G+ +A K+ HL+++ A+++  + E +VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLY-SNNFSFDILQRLSVIIDVALALEYLHFG 775
           +V    +  ++   ++ +E+M  GSL+  L  +      IL ++S  I V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS--IAVIKGLTYLR-- 121
Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             + ++H D+KPSN+L++      L DFG++  L   +SM  +  + T  YM+P
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSF-VGTRSYMSP 172

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 89/174 (51%), Gaps = 10/174 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDV-ECEVLKSVRHRN 716
           + F   + +G G  G V+K S    G+ +A K+ HL+++ A+++  + E +VL       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLY-SNNFSFDILQRLSVIIDVALALEYLHFG 775
           +V    +  ++   ++ +E+M  GSL+  L  +      IL ++S  I V   L YL   
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS--IAVIKGLTYLR-- 148
Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             + ++H D+KPSN+L++      L DFG++  L   +SM  +  + T  YM+P
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSF-VGTRSYMSP 199

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 86/183 (46%), Gaps = 21/183 (11%)
Query: 658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRH 714
           T+++     +G G F  V +   +  G E A K+ + +   A   +  + E  + + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSL-EDYL----YSNNFSFDILQRLSVIIDVALAL 769
            N+V++  S +   F  LV + +  G L ED +    YS   +   +Q++         L
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQI---------L 113
Query: 770 EYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
           E ++  + N +VH D+KP N+LL    K     L+DFG+A  + G++         T GY
Sbjct: 114 ESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA-GTPGY 172
Query: 827 MAP 829
           ++P
Sbjct: 173 LSP 175

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 75/147 (51%), Gaps = 6/147 (4%)
Query: 683 GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSL 742
           G +VA+K+  L+ +   +    E  +++  +H N+V++  S    +   +++E++  G+L
Sbjct: 70  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL 129
Query: 743 EDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSD 802
            D +  +    +  Q  +V   V  AL YLH   +  V+H DIK  ++LL  D    LSD
Sbjct: 130 TDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSD 184
Query: 803 FGIAKLLSGEESMKQTLTLATIGYMAP 829
           FG    +S +   ++ L + T  +MAP
Sbjct: 185 FGFCAQISKDVPKRKXL-VGTPYWMAP 210

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 81/180 (45%), Gaps = 15/180 (8%)
Query: 658 TNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRH 714
           T+++     IG G F  V +      G E A K+ + +   A   +  + E  + + ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSL-EDYLYSNNFS-FDILQRLSVIIDVALALEYL 772
            N+V++  S +   F  LV + +  G L ED +    +S  D    +  I++  L    +
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 122
Query: 773 HFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
                  VVH D+KP N+LL    K     L+DFG+A  + G++         T GY++P
Sbjct: 123 ------GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA-GTPGYLSP 175

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 89/174 (51%), Gaps = 10/174 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDV-ECEVLKSVRHRN 716
           + F   + +G G  G V+K S    G+ +A K+ HL+++ A+++  + E +VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLY-SNNFSFDILQRLSVIIDVALALEYLHFG 775
           +V    +  ++   ++ +E+M  GSL+  L  +      IL ++S  I V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS--IAVIKGLTYLR-- 121
Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             + ++H D+KPSN+L++      L DFG++  L   +SM  +  + T  YM+P
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSF-VGTRSYMSP 172

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 81/180 (45%), Gaps = 18/180 (10%)
Query: 659 NQFNASNLIGTGGFGSVY-KGSFLDGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRH 714
           N+F    L+G G FG V        G   A+K+   ++   +  +     E  VL++ RH
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLH 773
             L  +  S   +D    V+EY   G L  +L     FS D  +      ++  AL+YLH
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA--EIVSALDYLH 268
Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATI----GYMAP 829
                 VV+ D+K  N++LDKD    ++DFG+ K     E +K   T+ T      Y+AP
Sbjct: 269 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKTFCGTPEYLAP 321

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 89/174 (51%), Gaps = 10/174 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDV-ECEVLKSVRHRN 716
           + F   + +G G  G V+K S    G+ +A K+ HL+++ A+++  + E +VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLY-SNNFSFDILQRLSVIIDVALALEYLHFG 775
           +V    +  ++   ++ +E+M  GSL+  L  +      IL ++S  I V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS--IAVIKGLTYLR-- 121
Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             + ++H D+KPSN+L++      L DFG++  L   +SM  +  + T  YM+P
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSF-VGTRSYMSP 172

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 81/180 (45%), Gaps = 18/180 (10%)
Query: 659 NQFNASNLIGTGGFGSVY-KGSFLDGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRH 714
           N+F    L+G G FG V        G   A+K+   ++   +  +     E  VL++ RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLH 773
             L  +  S   +D    V+EY   G L  +L     FS D  +      ++  AL+YLH
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA--EIVSALDYLH 265
Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATI----GYMAP 829
                 VV+ D+K  N++LDKD    ++DFG+ K     E +K   T+ T      Y+AP
Sbjct: 266 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKTFCGTPEYLAP 318

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 76/146 (52%), Gaps = 6/146 (4%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVKIISSC 724
           +G G + +VYKG S L    VA+K   L+ E GA  +   E  +LK ++H N+V +    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
                  LV EY+ +  L+ YL   +   +I+   +V + +   L  L + +   V+H D
Sbjct: 70  HTEKSLTLVFEYL-DKDLKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRD 125
Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLS 810
           +KP N+L+++     L+DFG+A+  S
Sbjct: 126 LKPQNLLINERGELKLADFGLARAKS 151

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 85/182 (46%), Gaps = 14/182 (7%)
Query: 655 LQATN---QFNASNLIGTGGFGSVY-KGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLK 710
           +Q TN    F    ++G+G F  V+     L G   A+K           S + E  VLK
Sbjct: 2   MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLK 61
Query: 711 SVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALE 770
            ++H N+V +     +     LV++ +  G L D +       +    L VI  V  A++
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL-VIQQVLSAVK 120
Query: 771 YLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYM 827
           YLH    N +VH D+KP N+L    +++    ++DFG++K+   E++   +    T GY+
Sbjct: 121 YLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTPGYV 174
Query: 828 AP 829
           AP
Sbjct: 175 AP 176

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 89/174 (51%), Gaps = 10/174 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDV-ECEVLKSVRHRN 716
           + F   + +G G  G V K      G+ +A K+ HL+++ A+++  + E +VL       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLY-SNNFSFDILQRLSVIIDVALALEYLHFG 775
           +V    +  ++   ++ +E+M  GSL+  L  +     +IL ++S+ +   LA  YL   
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLA--YLREK 133
Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +   ++H D+KPSN+L++      L DFG++  L   +SM  +  + T  YMAP
Sbjct: 134 HQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSF-VGTRSYMAP 182

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 81/169 (47%), Gaps = 10/169 (5%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDV--ECEVLKSVRHRNLVKIISSC 724
           +G+G FG V++        V +  F +     L  + V  E  ++  + H  L+ +  + 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKF-INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
            +     L+LE++  G L D + + ++     + ++ +      L+++H    + +VH D
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 174
Query: 785 IKPSNVLLDKDMVAHLS--DFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
           IKP N++ +    + +   DFG+A  L+ +E +K  +T AT  + AP +
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVK--VTTATAEFAAPEI 221

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 82/182 (45%), Gaps = 14/182 (7%)
Query: 658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALK---SFDVECEVLKSVR 713
           ++++    ++G GG   V+    L    +VA+KV    L         F  E +   ++ 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 714 HRNLVKII----SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL 769
           H  +V +     +         +V+EY+   +L D +++        + + VI D   A 
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIAD---AC 143
Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL--SGEESMKQTLTLATIGYM 827
           + L+F + N ++H D+KP+N+++       + DFGIA+ +  SG    +    + T  Y+
Sbjct: 144 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 203
Query: 828 AP 829
           +P
Sbjct: 204 SP 205

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 38/136 (27%), Positives = 71/136 (52%), Gaps = 11/136 (8%)
Query: 673 GSVYKGSFLDGMEVAIKVFHLQLEGALKS--FDVECEVLKSVRHRNLVKIISSCTN--ND 728
           G ++KG +  G ++ +KV  ++     KS  F+ EC  L+   H N++ ++ +C +    
Sbjct: 24  GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 729 FKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVV--HCDI 785
              L+  +MP GSL + L+   NF  D  Q +   +D+A  + +LH     P++  H  +
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--TLEPLIPRHA-L 139
Query: 786 KPSNVLLDKDMVAHLS 801
              +V++D+DM A +S
Sbjct: 140 NSRSVMIDEDMTARIS 155

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 63/128 (49%), Gaps = 9/128 (7%)
Query: 705 ECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIID 764
           E  +LKS+ H N++K+     +  +  LV E+   G L + +  N   FD     +++  
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII-NRHKFDECDAANIMKQ 154
Query: 765 VALALEYLHFGYSNPVVHCDIKPSNVLLDKD---MVAHLSDFGIAKLLSGEESMKQTLTL 821
           +   + YLH    + +VH DIKP N+LL+     +   + DFG++   S +  ++    L
Sbjct: 155 ILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD--RL 209
Query: 822 ATIGYMAP 829
            T  Y+AP
Sbjct: 210 GTAYYIAP 217

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 76/167 (45%), Gaps = 8/167 (4%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKGSFL---DGMEVAIKVFHLQLEGA-LKSFDVECE 707
           K  L+  N   A   +G G FGSV +G +      ++VAIKV     E A  +    E +
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 388
Query: 708 VLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL 767
           ++  + +  +V++I  C       LV+E    G L  +L        +     ++  V++
Sbjct: 389 IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 447
Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
            ++YL        VH ++   NVLL     A +SDFG++K L  ++S
Sbjct: 448 GMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 88/174 (50%), Gaps = 10/174 (5%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDV-ECEVLKSVRHRN 716
           + F   + +G G  G V+K S    G+ +A K+ HL+++ A+++  + E +VL       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLY-SNNFSFDILQRLSVIIDVALALEYLHFG 775
           +V    +  ++   ++ +E+M  GSL+  L  +      IL ++S  I V   L YL   
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS--IAVIKGLTYLR-- 124
Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             + ++H D+KPSN+L++      L DFG++  L  E + +    + T  YM+P
Sbjct: 125 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANE---FVGTRSYMSP 175

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 655 LQATNQFNASNLIGTGGFGSVYKGS-FLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVR 713
           L+  N++     IG+G FG +Y G+    G EVAIK+  ++ +       +E ++ K ++
Sbjct: 5   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQ 62
Query: 714 HRNLVKIISSC-TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
               +  I  C    D+  +V+E +   SLED     +  F +   L +   +   +EY+
Sbjct: 63  GGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 773 HFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAK 807
           H   S   +H D+KP N L+    K  + ++ DFG+AK
Sbjct: 122 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 89/188 (47%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+++A+K      +  +  K    E  +
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRL 103
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 104 LKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 161
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 162 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 214
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 215 RWYRAPEI 222

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 78/177 (44%), Gaps = 12/177 (6%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVEC------EVLKSV 712
           + F+   +IG G FG V         EV   V  LQ +  LK  + +        +LK+V
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARH-KAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV 96
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
           +H  LV +  S    D    VL+Y+  G L  +L       +   R     ++A AL YL
Sbjct: 97  KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYL 155
Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H   S  +V+ D+KP N+LLD      L+DFG+ K      S   T    T  Y+AP
Sbjct: 156 H---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAP 208

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 655 LQATNQFNASNLIGTGGFGSVYKGS-FLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVR 713
           L+  N++     IG+G FG +Y G+    G EVAIK+  ++ +       +E ++ K ++
Sbjct: 3   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQ 60
Query: 714 HRNLVKIISSC-TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
               +  I  C    D+  +V+E +   SLED     +  F +   L +   +   +EY+
Sbjct: 61  GGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 773 HFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAK 807
           H   S   +H D+KP N L+    K  + ++ DFG+AK
Sbjct: 120 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + IG+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 20  KTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 137
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 138 QILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----MTGYVAT 190
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 191 RWYRAPEI 198

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 31/192 (16%)
Query: 659 NQFNASNLIGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGALKSFDV---------ECEV 708
           +++     IG G +G V      L G +VAIK           +FDV         E ++
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI-------PNAFDVVTNAKRTLRELKI 107
Query: 709 LKSVRHRNLVKIIS----SCTNNDFKAL--VLEYMPNGSLEDYLYSNNFSFDILQRLSVI 762
           LK  +H N++ I      +    +FK++  VL+ M    L   ++S+     +      +
Sbjct: 108 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQ-PLTLEHVRYFL 165
Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ---TL 819
             +   L+Y+H   S  V+H D+KPSN+L++++    + DFG+A+ L    +  Q   T 
Sbjct: 166 YQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTE 222
Query: 820 TLATIGYMAPGL 831
            +AT  Y AP L
Sbjct: 223 YVATRWYRAPEL 234

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 81/178 (45%), Gaps = 9/178 (5%)
Query: 656 QATNQFNASNLIGTGGFGSVYKGSFLDGMEV-AIKVFHLQL---EGALKSFDVECEVLKS 711
           +   ++     +G GGF   Y+ + +D  EV A KV    +       +    E  + KS
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           + + ++V       ++DF  +VLE     SL + L+    +    +    +      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           LH   +N V+H D+K  N+ L+ DM   + DFG+A  +  +   K+TL   T  Y+AP
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLC-GTPNYIAP 211

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 76/180 (42%), Gaps = 27/180 (15%)
Query: 661 FNASNLIGTGGFGSVYKGS-FLDGMEVAIKVFHL-QLEGALKSFDVECEVLKSVRHRNLV 718
           F     +G GGFG V++    +D    AIK   L   E A +    E + L  + H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSN-------------NFSFDILQR-----LS 760
           +  ++    +      E +   S + YLY               N    I +R     L 
Sbjct: 67  RYFNAWLEKN----TTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT 820
           + + +A A+E+LH   S  ++H D+KPSN+    D V  + DFG+   +  +E  +  LT
Sbjct: 123 IFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 89/188 (47%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 139
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+  + E     T  +AT
Sbjct: 140 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVAT 192
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 193 RWYRAPEI 200

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 642 PQATRRRFSYKELLQAT-----NQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQL 695
           P +  R   Y++ L  T      ++   + +G+G +GSV        G+ VA+K      
Sbjct: 2   PMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 61
Query: 696 EGAL--KSFDVECEVLKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYS 748
           +  +  K    E  +LK ++H N++ ++   T      +F  + L  ++    L + +  
Sbjct: 62  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC 121
Query: 749 NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL 808
              + D +Q L  I  +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+ 
Sbjct: 122 QKLTDDHVQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH 176
Query: 809 LSGEESMKQTLTLATIGYMAPGL 831
              E     T  +AT  Y AP +
Sbjct: 177 TDDE----MTGYVATRWYRAPEI 195

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 132
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 133 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGXVAT 185
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 186 RWYRAPEI 193

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 152
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 153 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 205
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 206 RWYRAPEI 213

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 151
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 152 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 204
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 205 RWYRAPEI 212

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 89/188 (47%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 139
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+  + E     T  +AT
Sbjct: 140 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVAT 192
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 193 RWYRAPEI 200

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 89/188 (47%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 139
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+  + E     T  +AT
Sbjct: 140 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVAT 192
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 193 RWYRAPEI 200

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 143
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 144 QILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----MTGYVAT 196
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 197 RWYRAPEI 204

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL--IY 132
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 133 QILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----MTGYVAT 185
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 186 RWYRAPEI 193

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 13  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 72
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 73  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 130
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 131 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 183
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 184 RWYRAPEI 191

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 80/181 (44%), Gaps = 21/181 (11%)
Query: 658 TNQFNASNLIGTGGFGS----VYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVL-KSV 712
           ++ +     IG G +      V+K +    ME A+KV    ++ + +    E E+L +  
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKAT---NMEYAVKV----IDKSKRDPSEEIEILLRYG 78
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
           +H N++ +     +     LV E M  G L D +    F F   +   V+  +   +EYL
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF-FSEREASFVLHTIGKTVEYL 137
Query: 773 HFGYSNPVVHCDIKPSNVLLDKD----MVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA 828
           H   S  VVH D+KPSN+L   +        + DFG AK L  E  +  T    T  ++A
Sbjct: 138 H---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMT-PCYTANFVA 193
Query: 829 P 829
           P
Sbjct: 194 P 194

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 137
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 138 QILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----MTGYVAT 190
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 191 RWYRAPEI 198

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 144
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 145 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 197
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 198 RWYRAPEI 205

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 31/192 (16%)
Query: 659 NQFNASNLIGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGALKSFDV---------ECEV 708
           +++     IG G +G V      L G +VAIK           +FDV         E ++
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI-------PNAFDVVTNAKRTLRELKI 106
Query: 709 LKSVRHRNLVKIIS----SCTNNDFKAL--VLEYMPNGSLEDYLYSNNFSFDILQRLSVI 762
           LK  +H N++ I      +    +FK++  VL+ M    L   ++S+     +      +
Sbjct: 107 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQ-PLTLEHVRYFL 164
Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ---TL 819
             +   L+Y+H   S  V+H D+KPSN+L++++    + DFG+A+ L    +  Q   T 
Sbjct: 165 YQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTE 221
Query: 820 TLATIGYMAPGL 831
            +AT  Y AP L
Sbjct: 222 YVATRWYRAPEL 233

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 144
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 145 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 197
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 198 RWYRAPEI 205

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 128
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 129 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 181
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 182 RWYRAPEI 189

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 132
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 133 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 185
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 186 RWYRAPEI 193

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 132
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 133 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 185
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 186 RWYRAPEI 193

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 129
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 130 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 182
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 183 RWYRAPEI 190

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 132
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 133 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 185
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 186 RWYRAPEI 193

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 132
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 133 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 185
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 186 RWYRAPEI 193

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 132
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 133 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 185
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 186 RWYRAPEI 193

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 143
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 144 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 196
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 197 RWYRAPEI 204

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 129
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 130 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 182
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 183 RWYRAPEI 190

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 132
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 133 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 185
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 186 RWYRAPEI 193

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 134
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 135 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 187
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 188 RWYRAPEI 195

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL--IY 132
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 133 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 185
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 186 RWYRAPEI 193

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 137
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 138 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 190
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 191 RWYRAPEI 198

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 14  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 73
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 74  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 131
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 132 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 184
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 185 RWYRAPEI 192

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 132
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 133 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 185
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 186 RWYRAPEI 193

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 12/147 (8%)
Query: 693 LQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSL---EDYLY-- 747
           + ++     F  E +++  +++   +      TN D   ++ EYM N S+   ++Y +  
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140
Query: 748 -SNNFSFDILQRLSVIIDVAL-ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGI 805
             N   F  +Q +  II   L +  Y+H      + H D+KPSN+L+DK+    LSDFG 
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGE 198
Query: 806 AKLLSGEESMKQTLTLATIGYMAPGLF 832
           ++ +  +   K   +  T  +M P  F
Sbjct: 199 SEYMVDK---KIKGSRGTYEFMPPEFF 222

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 139
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 140 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 192
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 193 RWYRAPEI 200

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 24/183 (13%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQL---EGALKSFDVECEVLKS 711
           N+F    L+G G FG V     K +   G   A+K+   ++   +  +     E  VL++
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 64
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALE 770
            RH  L  +  S   +D    V+EY   G L  +L     FS D  +      ++  AL+
Sbjct: 65  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA--EIVSALD 122
Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL----ATIGY 826
           YLH      VV+ D+K  N++LDKD    ++DFG+ K     E +K   T+     T  Y
Sbjct: 123 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKXFCGTPEY 175
Query: 827 MAP 829
           +AP
Sbjct: 176 LAP 178

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 134
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 135 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 187
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 188 RWYRAPEI 195

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 134
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 135 QILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE----MTGYVAT 187
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 188 RWYRAPEI 195

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 11/158 (6%)
Query: 655 LQATNQFNASNLIGTGGFGSVYKGS-FLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVR 713
           L+  N++     IG+G FG +Y G+    G EVAIK+  ++ +       +E +  K ++
Sbjct: 5   LRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHP--QLHIESKFYKMMQ 62
Query: 714 HRNLVKIISSC-TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
               +  I  C    D+  +V+E +   SLED     +  F +   L +   +   +EY+
Sbjct: 63  GGVGIPSIKWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 773 HFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAK 807
           H   S   +H D+KP N L+    K  + ++ DFG+AK
Sbjct: 122 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRL 86
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 144
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 145 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 197
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 198 RWYRAPEI 205

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + + S   + D +Q L  I 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFL--IY 132
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+ +    E     T  +AT
Sbjct: 133 QILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE----MTGYVAT 185
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 186 RWYRAPEI 193

>pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 88/353 (24%), Positives = 138/353 (39%), Gaps = 51/353 (14%)
Query: 166 LRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLA 225
           L +L IL L  N+ +     +   L+ ++ L L    L G++ S      L +LE++ L 
Sbjct: 78  LSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLR 137
Query: 226 GNNFSGIIP-SFIFNASKLSVLELGENSFSGFIPNTLGNL--RKLEWLRLSYNXXXXXXX 282
            NN   I P SF  N  +  VL+L  N         L N   +    LRLS         
Sbjct: 138 DNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLS---SITLQD 194
Query: 283 XXXXXXXWANCKN------LKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIP 336
                  W  C N      +  LDLS N               S+++ F    +I GT  
Sbjct: 195 MNEYWLGWEKCGNPFKNTSITTLDLSGN-----------GFKESMAKRFFD--AIAGT-- 239
Query: 337 KEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGL--CQLARLS 394
                   ++ L L  +  +GS   +FG   N +  D  N   +G   +G+  C L++  
Sbjct: 240 -------KIQSLILSNSYNMGS---SFGH-TNFKDPD--NFTFKGLEASGVKTCDLSK-- 284
Query: 395 VLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDIXXXXXXXXXXXXX 454
                 +K+   +       T L  L+LA NE+N +  + FW L  +             
Sbjct: 285 ------SKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSI 338
Query: 455 XPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI 507
                 NL  + ++DLS N++      +  GL NL++L+L  N L+ S+P  I
Sbjct: 339 DSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGI 390

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 132
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 133 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 185
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 186 RWYRAPEI 193

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 24/183 (13%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQL---EGALKSFDVECEVLKS 711
           N+F    L+G G FG V     K +   G   A+K+   ++   +  +     E  VL++
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 65
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALE 770
            RH  L  +  S   +D    V+EY   G L  +L     FS D  +      ++  AL+
Sbjct: 66  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA--EIVSALD 123
Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL----ATIGY 826
           YLH      VV+ D+K  N++LDKD    ++DFG+ K     E +K   T+     T  Y
Sbjct: 124 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKXFCGTPEY 176
Query: 827 MAP 829
           +AP
Sbjct: 177 LAP 179

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 24/183 (13%)
Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQL---EGALKSFDVECEVLKS 711
           N+F    L+G G FG V     K +   G   A+K+   ++   +  +     E  VL++
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 66
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALE 770
            RH  L  +  S   +D    V+EY   G L  +L     FS D  +      ++  AL+
Sbjct: 67  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA--EIVSALD 124
Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL----ATIGY 826
           YLH      VV+ D+K  N++LDKD    ++DFG+ K     E +K   T+     T  Y
Sbjct: 125 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-----EGIKDGATMKXFCGTPEY 177
Query: 827 MAP 829
           +AP
Sbjct: 178 LAP 180

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 80/186 (43%), Gaps = 26/186 (13%)
Query: 667 IGTGGFGSVYKGSFL------DGMEVAIKVFHLQLEGALKS-FDVECEVLKSVRHRNLVK 719
           +G   FG VYKG             VAIK    + EG L+  F  E  +   ++H N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDI---------------LQRLSVIID 764
           ++   T +   +++  Y  +G L ++L   +   D+                  + ++  
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 765 VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL-TLAT 823
           +A  +EYL    S+ VVH D+   NVL+   +   +SD G+ + +   +  K    +L  
Sbjct: 154 IAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 824 IGYMAP 829
           I +MAP
Sbjct: 211 IRWMAP 216

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 45/152 (29%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 667 IGTGGFGSVYKGSFL----DGMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVK 719
           +G G FG V +G +       + VA+K      L    A+  F  E   + S+ HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYL--YSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           +         K +V E  P GSL D L  +  +F    L R +V   VA  + YL    S
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 133
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
              +H D+   N+LL    +  + DFG+ + L
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 165

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 45/152 (29%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 667 IGTGGFGSVYKGSFL----DGMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVK 719
           +G G FG V +G +       + VA+K      L    A+  F  E   + S+ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYL--YSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           +         K +V E  P GSL D L  +  +F    L R +V   VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 129
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
              +H D+   N+LL    +  + DFG+ + L
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 45/152 (29%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 667 IGTGGFGSVYKGSFL----DGMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVK 719
           +G G FG V +G +       + VA+K      L    A+  F  E   + S+ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYL--YSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           +         K +V E  P GSL D L  +  +F    L R +V   VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 129
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
              +H D+   N+LL    +  + DFG+ + L
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 45/152 (29%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 667 IGTGGFGSVYKGSFL----DGMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVK 719
           +G G FG V +G +       + VA+K      L    A+  F  E   + S+ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYL--YSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           +         K +V E  P GSL D L  +  +F    L R +V   VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 129
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
              +H D+   N+LL    +  + DFG+ + L
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 80/181 (44%), Gaps = 21/181 (11%)
Query: 658 TNQFNASNLIGTGGFGS----VYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVL-KSV 712
           ++ +     IG G +      V+K +    ME A+KV    ++ + +    E E+L +  
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKAT---NMEYAVKV----IDKSKRDPSEEIEILLRYG 78
Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
           +H N++ +     +     LV E M  G L D +    F F   +   V+  +   +EYL
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF-FSEREASFVLHTIGKTVEYL 137
Query: 773 HFGYSNPVVHCDIKPSNVLLDKD----MVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA 828
           H   S  VVH D+KPSN+L   +        + DFG AK L  E  +  T    T  ++A
Sbjct: 138 H---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMT-PCYTANFVA 193
Query: 829 P 829
           P
Sbjct: 194 P 194

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 13/180 (7%)
Query: 660 QFNASNLIGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRNL 717
           ++     IG G +G V      +    VAIK +   + +   +    E ++L   RH N+
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENV 103
Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLY----SNNFSFDILQRLSVIIDVALALEYLH 773
           + I      +  +A+   Y+    +E  LY    S   S D +     +  +   L+Y+H
Sbjct: 104 IGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHI--CYFLYQILRGLKYIH 161
Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAPGL 831
              S  V+H D+KPSN+L++      + DFG+A++   E      LT  +AT  Y AP +
Sbjct: 162 ---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEI 218

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 80/186 (43%), Gaps = 26/186 (13%)
Query: 667 IGTGGFGSVYKGSFL------DGMEVAIKVFHLQLEGALKS-FDVECEVLKSVRHRNLVK 719
           +G   FG VYKG             VAIK    + EG L+  F  E  +   ++H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDI---------------LQRLSVIID 764
           ++   T +   +++  Y  +G L ++L   +   D+                  + ++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 765 VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL-TLAT 823
           +A  +EYL    S+ VVH D+   NVL+   +   +SD G+ + +   +  K    +L  
Sbjct: 137 IAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 824 IGYMAP 829
           I +MAP
Sbjct: 194 IRWMAP 199

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 87/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G  VA+K      +  +  K    E  +
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 152
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 153 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 205
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 206 RWYRAPEI 213

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 53/107 (49%), Gaps = 5/107 (4%)
Query: 705 ECEVLKSVRHRNLVKIISSCTNNDFKAL--VLEYMPNGSLEDYLYSNNFSFDILQRLSVI 762
           E ++L+ +RH+N+++++    N + + +  V+EY   G  E         F + Q     
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
             +   LEYLH   S  +VH DIKP N+LL       +S  G+A+ L
Sbjct: 116 CQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 77/162 (47%), Gaps = 13/162 (8%)
Query: 651 YKELLQATNQFNASNLIGTGGFGSVY--KGSFLDGMEVAIKVFHLQLEGALKSFDVECEV 708
           Y+ + Q +N F   + IG G F SVY        G E  I + HL           E + 
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQC 72
Query: 709 LKSVRHRNLVKIISSC-TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL 767
           L     ++ V  +  C   ND   + + Y+ + S  D L  N+ SF  ++    ++++  
Sbjct: 73  LTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL--NSLSFQEVR--EYMLNLFK 128
Query: 768 ALEYLH-FGYSNPVVHCDIKPSNVLLDKDMVAH-LSDFGIAK 807
           AL+ +H FG    +VH D+KPSN L ++ +  + L DFG+A+
Sbjct: 129 ALKRIHQFG----IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 87/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G  VA+K      +  +  K    E  +
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 151
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 152 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 204
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 205 RWYRAPEI 212

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 10/159 (6%)
Query: 667 IGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEG---ALK-SFDVECEVLKSVRHRNLVKII 721
           +G+G FG+V KG + +  +   + V  L+ E    ALK     E  V++ + +  +V++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
             C    +  LV+E    G L  YL  N    D    + ++  V++ ++YL     +  V
Sbjct: 79  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLE---ESNFV 133
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT 820
           H D+   NVLL     A +SDFG++K L  +E+  +  T
Sbjct: 134 HRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQT 172

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 138
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 139 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 191
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 192 RWYRAPEI 199

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/185 (23%), Positives = 83/185 (44%), Gaps = 18/185 (9%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFD---VECEVLKSVRHR 715
           + +    +IG+G   +V + ++    +  + +  + LE    S D    E + +    H 
Sbjct: 10  DDYELQEVIGSGA-TAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHP 68
Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYS-------NNFSFDILQRLSVIIDVALA 768
           N+V   +S    D   LV++ +  GS+ D +          +   D     +++ +V   
Sbjct: 69  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 128
Query: 769 LEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL-SGEESMKQTLTLATIG-- 825
           LEYLH    N  +H D+K  N+LL +D    ++DFG++  L +G +  +  +    +G  
Sbjct: 129 LEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 826 -YMAP 829
            +MAP
Sbjct: 186 CWMAP 190

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 10/159 (6%)
Query: 667 IGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEG---ALK-SFDVECEVLKSVRHRNLVKII 721
           +G+G FG+V KG + +  +   + V  L+ E    ALK     E  V++ + +  +V++I
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
             C    +  LV+E    G L  YL  N    D    + ++  V++ ++YL     +  V
Sbjct: 73  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLE---ESNFV 127
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT 820
           H D+   NVLL     A +SDFG++K L  +E+  +  T
Sbjct: 128 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 166

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 10/159 (6%)
Query: 667 IGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEG---ALK-SFDVECEVLKSVRHRNLVKII 721
           +G+G FG+V KG + +  +   + V  L+ E    ALK     E  V++ + +  +V++I
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
             C    +  LV+E    G L  YL  N    D    + ++  V++ ++YL     +  V
Sbjct: 75  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLE---ESNFV 129
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT 820
           H D+   NVLL     A +SDFG++K L  +E+  +  T
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 10/159 (6%)
Query: 667 IGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEG---ALK-SFDVECEVLKSVRHRNLVKII 721
           +G+G FG+V KG + +  +   + V  L+ E    ALK     E  V++ + +  +V++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
             C    +  LV+E    G L  YL  N    D    + ++  V++ ++YL     +  V
Sbjct: 79  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLE---ESNFV 133
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT 820
           H D+   NVLL     A +SDFG++K L  +E+  +  T
Sbjct: 134 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 172

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 78/177 (44%), Gaps = 18/177 (10%)
Query: 661 FNASNLIGTGGFG----SVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRN 716
           +   N IG G +G    +V KG+ +      I  + ++    +  F  E E++KS+ H N
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPN 84
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLSVIIDVALALEYLHFG 775
           ++++  +  +N    LV+E    G L E  ++   F      R  ++ DV  A+ Y H  
Sbjct: 85  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYCH-- 140
Query: 776 YSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
               V H D+KP N L      D    L DFG+A      + M+    + T  Y++P
Sbjct: 141 -KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR--TKVGTPYYVSP 194

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 75/174 (43%), Gaps = 17/174 (9%)
Query: 667 IGTGGFGSVYKGSFL----DGMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVK 719
           +G G FG V +G +       + VA+K      L    A+  F  E   + S+ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYL--YSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           +         K +V E  P GSL D L  +  +F    L R +V   VA  + YL    S
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 139
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL--SGEESMKQTLTLATIGYMAP 829
              +H D+   N+LL    +  + DFG+ + L  + +  + Q        + AP
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 193

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 26/210 (12%)
Query: 638 SNMLPQATRRRFSYKELLQAT-----NQFNASNLIGTGGFGSVYKGSFLDG---MEVAIK 689
           S+ML  +  R   Y++ L  T      +      +G+G +GSV   S  D     +VA+K
Sbjct: 2   SHMLEMSGPRAGFYRQELNKTVWEVPQRLQGLRPVGSGAYGSV--CSAYDARLRQKVAVK 59
Query: 690 VFHLQLEGALKSFDV--ECEVLKSVRHRNLVKIISSCTN----NDFKALVLEYMPNGS-L 742
                 +  + +     E  +LK ++H N++ ++   T      DF  + L     G+ L
Sbjct: 60  KLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADL 119
Query: 743 EDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSD 802
            + + S   S + +Q L  +  +   L+Y+H   S  ++H D+KPSNV +++D    + D
Sbjct: 120 NNIVKSQALSDEHVQFL--VYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILD 174
Query: 803 FGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
           FG+A+    +E M  T  +AT  Y AP + 
Sbjct: 175 FGLAR--QADEEM--TGYVATRWYRAPEIM 200

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 87/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G  VA+K      +  +  K    E  +
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 128
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 129 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 181
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 182 RWYRAPEI 189

>pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 93  RLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGF 152
           +   +  LY++ N LT  +P  I     L V+ L++N+ T  +P  LG+   LK  Y  F
Sbjct: 245 KYDFLTRLYLNGNSLTE-LPAEIKNLSNLRVLDLSHNRLTS-LPAELGSCFQLKYFYF-F 301
Query: 153 NNLTGEIPYEMGNLRNLEILGLQLNKL 179
           +N+   +P+E GNL NL+ LG++ N L
Sbjct: 302 DNMVTTLPWEFGNLCNLQFLGVEGNPL 328

>pdb|3A79|B Chain B, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Length = 562

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 114/428 (26%), Positives = 178/428 (41%), Gaps = 84/428 (19%)
Query: 2   LSLSFNDLSG-AIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELEL----VSLTNNF 56
           L LSFND     + KE GNLT L  LGL   K R     +L  +A L L    + L +  
Sbjct: 126 LDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDLVSYH 182
Query: 57  LSG------TIPST-----IFNLSSL-STGMDFSNNSLTG------SLPDDMCRRL---- 94
           + G       IP+T     +F+ +SL S  ++ S N+L         L D+ C+RL    
Sbjct: 183 IKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFL 242
Query: 95  -PLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFN 153
             L +G  + N  L        W+C      S+   QF    PR +         YL   
Sbjct: 243 SELTRGPTLLNVTLQHI--ETTWKC------SVKLFQFF--WPRPVE--------YLNIY 284
Query: 154 NLT-------GEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGS 206
           NLT        E  Y    L++L I  ++ N++  F   +++++ A   + +    LS S
Sbjct: 285 NLTITERIDREEFTYSETALKSLMIEHVK-NQVFLFSKEALYSVFAEMNIKM----LSIS 339
Query: 207 LPSSIDLVRLPN---LEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTL-- 261
               I +V  P+      ++   N F+  +        +L  L L  N    F    L  
Sbjct: 340 DTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMT 399
Query: 262 GNLRKLEWLRLSYNXXXXXXXXXXXXXXWANCKNLKLLDLSNNPING----VLPSSIGNL 317
            N+  LE L +S N              WA  +++ +L+LS+N + G     LP  +  L
Sbjct: 400 KNMSSLETLDVSLNSLNSHAYDRTCA--WA--ESILVLNLSSNMLTGSVFRCLPPKVKVL 455
Query: 318 SLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPI-TFGKLQNLQGLDLVN 376
            L  +RI         +IPK++ +L  L+EL +  N+L  S+P   F +L +LQ + L +
Sbjct: 456 DLHNNRIM--------SIPKDVTHLQALQELNVASNQL-KSVPDGVFDRLTSLQYIWLHD 506
Query: 377 NKLEGPIP 384
           N  +   P
Sbjct: 507 NPWDCTCP 514

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 80/178 (44%), Gaps = 9/178 (5%)
Query: 656 QATNQFNASNLIGTGGFGSVYKGSFLDGMEV-AIKVFHLQL---EGALKSFDVECEVLKS 711
           +   ++     +G GGF   Y+ + +D  EV A KV    +       +    E  + KS
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           + + ++V       ++DF  +VLE     SL + L+    +    +    +      ++Y
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 141
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           LH   +N V+H D+K  N+ L+ DM   + DFG+A  +  +   K+ L   T  Y+AP
Sbjct: 142 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLC-GTPNYIAP 195

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 12/170 (7%)
Query: 667 IGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEG---ALK-SFDVECEVLKSVRHRNLVKII 721
           +G+G FG+V KG + +  +   + V  L+ E    ALK     E  V++ + +  +V++I
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
             C    +  LV+E    G L  YL  N    D    + ++  V++ ++YL     +  V
Sbjct: 437 GICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLE---ESNFV 491
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM--KQTLTLATIGYMAP 829
           H D+   NVLL     A +SDFG++K L  +E+    QT     + + AP
Sbjct: 492 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 541

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 88/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 132
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + D+G+A+    E     T  +AT
Sbjct: 133 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE----MTGYVAT 185
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 186 RWYRAPEI 193

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 87/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G  VA+K      +  +  K    E  +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 132
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 133 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 185
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 186 RWYRAPEI 193

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 80/185 (43%), Gaps = 15/185 (8%)
Query: 651 YKELLQATNQFNASNLIGTGGFGSVYKGSFLDGM--EVAIKVFHLQLEGALKSFDVECEV 708
           ++  +Q T+ +     IG G + SV K         E A+K+         +  ++   +
Sbjct: 14  HRNSIQFTDGYEVKEDIGVGSY-SVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEI---L 69
Query: 709 LKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALA 768
           L+  +H N++ +     +  +  +V E    G L D +    F F   +  +V+  +   
Sbjct: 70  LRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKF-FSEREASAVLFTITKT 128
Query: 769 LEYLHFGYSNPVVHCDIKPSNVLLDKD----MVAHLSDFGIAKLLSGEESMKQTLTLATI 824
           +EYLH   +  VVH D+KPSN+L   +        + DFG AK L  E  +  T    T 
Sbjct: 129 VEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXT-PCYTA 184
Query: 825 GYMAP 829
            ++AP
Sbjct: 185 NFVAP 189

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 12/170 (7%)
Query: 667 IGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEG---ALK-SFDVECEVLKSVRHRNLVKII 721
           +G+G FG+V KG + +  +   + V  L+ E    ALK     E  V++ + +  +V++I
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
             C    +  LV+E    G L  YL  N    D    + ++  V++ ++YL     +  V
Sbjct: 438 GICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLE---ESNFV 492
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM--KQTLTLATIGYMAP 829
           H D+   NVLL     A +SDFG++K L  +E+    QT     + + AP
Sbjct: 493 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 542

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/185 (23%), Positives = 83/185 (44%), Gaps = 18/185 (9%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFD---VECEVLKSVRHR 715
           + +    +IG+G   +V + ++    +  + +  + LE    S D    E + +    H 
Sbjct: 15  DDYELQEVIGSGA-TAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHP 73
Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYS-------NNFSFDILQRLSVIIDVALA 768
           N+V   +S    D   LV++ +  GS+ D +          +   D     +++ +V   
Sbjct: 74  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 769 LEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL-SGEESMKQTLTLATIG-- 825
           LEYLH    N  +H D+K  N+LL +D    ++DFG++  L +G +  +  +    +G  
Sbjct: 134 LEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 826 -YMAP 829
            +MAP
Sbjct: 191 CWMAP 195

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 75/174 (43%), Gaps = 17/174 (9%)
Query: 667 IGTGGFGSVYKGSFL----DGMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVK 719
           +G G FG V +G +       + VA+K      L    A+  F  E   + S+ HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYL--YSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           +         K +V E  P GSL D L  +  +F    L R +V   VA  + YL    S
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 133
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL--SGEESMKQTLTLATIGYMAP 829
              +H D+   N+LL    +  + DFG+ + L  + +  + Q        + AP
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 667 IGTGGFGSVYKGSFL----DGMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVK 719
           +G G FG V +G +       + VA+K      L    A+  F  E   + S+ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYL--YSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           +         K +V E  P GSL D L  +  +F    L R +V   VA  + YL    S
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 139
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
              +H D+   N+LL    +  + DFG+ + L
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 80/178 (44%), Gaps = 9/178 (5%)
Query: 656 QATNQFNASNLIGTGGFGSVYKGSFLDGMEV-AIKVFHLQL---EGALKSFDVECEVLKS 711
           +   ++     +G GGF   Y+ + +D  EV A KV    +       +    E  + KS
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           + + ++V       ++DF  +VLE     SL + L+    +    +    +      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           LH   +N V+H D+K  N+ L+ DM   + DFG+A  +  +   K+ L   T  Y+AP
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLC-GTPNYIAP 211

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 33/189 (17%)
Query: 658 TNQFNASNLIGTGGFGSVY-KGSFLDGMEVAIKVFHLQL------EGALKSFDVECEVLK 710
           ++++     +G+G +G V      L G E AIK+            GAL     E  VLK
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLD---EVAVLK 76
Query: 711 SVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALE 770
            + H N++K+     +     LV+E    G L D +        IL++    +D A+ ++
Sbjct: 77  QLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEI--------ILRQKFSEVDAAVIMK 128
Query: 771 -------YLHFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAKLLSGEESMKQTLT 820
                  YLH    + +VH D+KP N+LL+   +D +  + DFG++        MK+   
Sbjct: 129 QVLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKE--R 183
Query: 821 LATIGYMAP 829
           L T  Y+AP
Sbjct: 184 LGTAYYIAP 192

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 65/132 (49%), Gaps = 6/132 (4%)
Query: 664 SNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVR-HRNLVKII 721
           S L+G G +  V    S  +G E A+K+   Q   +      E E L   + ++N++++I
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
               ++    LV E +  GS+  ++      F+  +   V+ DVA AL++LH   +  + 
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQK-HFNEREASRVVRDVAAALDFLH---TKGIA 133
Query: 782 HCDIKPSNVLLD 793
           H D+KP N+L +
Sbjct: 134 HRDLKPENILCE 145

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G +G V      L+ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 725 TNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLS------VIIDVALALEYLHFGYS 777
            N+  +A  +E M +  + +D + ++ +     Q LS       +  +   L+Y+H   S
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIH---S 146
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAPGL 831
             V+H D+KPSN+LL+      + DFG+A++   +      LT  +AT  Y AP +
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G +G V      L+ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 725 TNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLS------VIIDVALALEYLHFGYS 777
            N+  +A  +E M +  + +D + ++ +     Q LS       +  +   L+Y+H   S
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 146
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAPGL 831
             V+H D+KPSN+LL+      + DFG+A++   +      LT  +AT  Y AP +
Sbjct: 147 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAI-KVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G +G V      L+ + VAI K+   + +   +    E ++L   RH N++ I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 725 TNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLS------VIIDVALALEYLHFGYS 777
            N+  +A  +E M +  + +D + ++ +     Q LS       +  +   L+Y+H   S
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 146
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAPGL 831
             V+H D+KPSN+LL+      + DFG+A++   +      LT  +AT  Y AP +
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 12/170 (7%)
Query: 667 IGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEG---ALK-SFDVECEVLKSVRHRNLVKII 721
           +G+G FG+V KG + +  +   + V  L+ E    ALK     E  V++ + +  +V++I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
             C    +  LV+E    G L  YL  N    D    + ++  V++ ++YL     +  V
Sbjct: 85  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ESNFV 139
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM--KQTLTLATIGYMAP 829
           H D+   NVLL     A +SDFG++K L  +E+    QT     + + AP
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 189

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G +G V      L+ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGI---- 90
Query: 725 TNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLS------VIIDVALALEYLHFGYS 777
            N+  +A  +E M +  + +D + ++ +     Q LS       +  +   L+Y+H   S
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 146
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAPGL 831
             V+H D+KPSN+LL+      + DFG+A++   +      LT  +AT  Y AP +
Sbjct: 147 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G +G V      L+ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 84
Query: 725 TNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLS------VIIDVALALEYLHFGYS 777
            N+  +A  +E M +  + +D + ++ +     Q LS       +  +   L+Y+H   S
Sbjct: 85  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 140
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAPGL 831
             V+H D+KPSN+LL+      + DFG+A++   +      LT  +AT  Y AP +
Sbjct: 141 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G +G V      L+ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 91
Query: 725 TNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLS------VIIDVALALEYLHFGYS 777
            N+  +A  +E M +  + +D + ++ +     Q LS       +  +   L+Y+H   S
Sbjct: 92  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 147
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAPGL 831
             V+H D+KPSN+LL+      + DFG+A++   +      LT  +AT  Y AP +
Sbjct: 148 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 203

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G +G V      L+ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 92
Query: 725 TNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLS------VIIDVALALEYLHFGYS 777
            N+  +A  +E M +  + +D + ++ +     Q LS       +  +   L+Y+H   S
Sbjct: 93  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 148
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAPGL 831
             V+H D+KPSN+LL+      + DFG+A++   +      LT  +AT  Y AP +
Sbjct: 149 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 204

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G +G V      L+ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 83
Query: 725 TNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLS------VIIDVALALEYLHFGYS 777
            N+  +A  +E M +  + +D + ++ +     Q LS       +  +   L+Y+H   S
Sbjct: 84  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 139
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAPGL 831
             V+H D+KPSN+LL+      + DFG+A++   +      LT  +AT  Y AP +
Sbjct: 140 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 195

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G +G V      L+ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 725 TNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLS------VIIDVALALEYLHFGYS 777
            N+  +A  +E M +  + +D + ++ +     Q LS       +  +   L+Y+H   S
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 146
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAPGL 831
             V+H D+KPSN+LL+      + DFG+A++   +      LT  +AT  Y AP +
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 80/178 (44%), Gaps = 9/178 (5%)
Query: 656 QATNQFNASNLIGTGGFGSVYKGSFLDGMEV-AIKVFHLQL---EGALKSFDVECEVLKS 711
           +   ++     +G GGF   Y+ + +D  EV A KV    +       +    E  + KS
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           + + ++V       ++DF  +VLE     SL + L+    +    +    +      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           LH   +N V+H D+K  N+ L+ DM   + DFG+A  +  +   K+ L   T  Y+AP
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLC-GTPNYIAP 211

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 12/170 (7%)
Query: 667 IGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEG---ALK-SFDVECEVLKSVRHRNLVKII 721
           +G+G FG+V KG + +  +   + V  L+ E    ALK     E  V++ + +  +V++I
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
             C    +  LV+E    G L  YL  N    D    + ++  V++ ++YL     +  V
Sbjct: 93  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQVSMGMKYLE---ESNFV 147
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM--KQTLTLATIGYMAP 829
           H D+   NVLL     A +SDFG++K L  +E+    QT     + + AP
Sbjct: 148 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 197

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G +G V      L+ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 84
Query: 725 TNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLS------VIIDVALALEYLHFGYS 777
            N+  +A  +E M +  + +D + ++ +     Q LS       +  +   L+Y+H   S
Sbjct: 85  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 140
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAPGL 831
             V+H D+KPSN+LL+      + DFG+A++   +      LT  +AT  Y AP +
Sbjct: 141 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 87/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G  VA+K      +  +  K    E  +
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFL--IY 128
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 129 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 181
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 182 RWYRAPEI 189

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 633 QSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVF 691
           QSN  S   P   R+  + K + +   ++   + +G+G +GSV        G+ VA+K  
Sbjct: 21  QSNA-SQERPTFYRQELN-KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 78
Query: 692 HLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLED 744
               +  +  K    E  +LK ++H N++ ++   T      +F  + L  ++    L +
Sbjct: 79  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN 138
Query: 745 YLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFG 804
            +     + D +Q L  I  +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG
Sbjct: 139 IVKCQKLTDDHVQFL--IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 193
Query: 805 IAKLLSGEESMKQTLTLATIGYMAPGL 831
           +A+    E        +AT  Y AP +
Sbjct: 194 LARHTDDE----MXGYVATRWYRAPEI 216

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 87/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G  VA+K      +  +  K    E  +
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 138
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 139 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 191
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 192 RWYRAPEI 199

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 65/148 (43%), Gaps = 8/148 (5%)
Query: 667 IGTGGFGSVYKGSFLDGMEV-AIKVFHL---QLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           IG G FG+VY    +   EV AIK       Q     +    E   L+ +RH N ++   
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVH 782
                    LV+EY   GS  D L  +      ++  +V       L YLH   S+ ++H
Sbjct: 122 CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIH 177
Query: 783 CDIKPSNVLLDKDMVAHLSDFGIAKLLS 810
            D+K  N+LL +  +  L DFG A +++
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSASIMA 205

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 80/174 (45%), Gaps = 19/174 (10%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVF--HLQLEGALKSFDVEC-- 706
           +E  +A  ++    L+G GGFG+V+ G  L D ++VAIKV   +  L  +  S  V C  
Sbjct: 26  REAFEA--EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 707 ------EVLKSVRHRNLVKIISSCTNNDFKALVLEY-MPNGSLEDYLYSNNFSFDILQRL 759
                 +V     H  +++++      +   LVLE  +P   L DY+       +   R 
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR- 142
Query: 760 SVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD-KDMVAHLSDFGIAKLLSGE 812
                V  A+++ H   S  VVH DIK  N+L+D +   A L DFG   LL  E
Sbjct: 143 CFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE 193

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 86/188 (45%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++     +G+G +GSV        G  VA+K      +  +  K    E  +
Sbjct: 25  KTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 84
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 85  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 142
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E     T  +AT
Sbjct: 143 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVAT 195
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 196 RWYRAPEI 203

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 12/170 (7%)
Query: 667 IGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEG---ALK-SFDVECEVLKSVRHRNLVKII 721
           +G+G FG+V KG + +  +   + V  L+ E    ALK     E  V++ + +  +V++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
             C    +  LV+E    G L  YL  N    D    + ++  V++ ++YL     +  V
Sbjct: 95  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLE---ESNFV 149
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM--KQTLTLATIGYMAP 829
           H D+   NVLL     A +SDFG++K L  +E+    QT     + + AP
Sbjct: 150 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 199

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 12/170 (7%)
Query: 667 IGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEG---ALK-SFDVECEVLKSVRHRNLVKII 721
           +G+G FG+V KG + +  +   + V  L+ E    ALK     E  V++ + +  +V++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
             C    +  LV+E    G L  YL  N    D    + ++  V++ ++YL     +  V
Sbjct: 95  GICEAESW-MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLE---ESNFV 149
Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM--KQTLTLATIGYMAP 829
           H D+   NVLL     A +SDFG++K L  +E+    QT     + + AP
Sbjct: 150 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 199

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 85/176 (48%), Gaps = 19/176 (10%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G +G V      ++ + VAIK +   + +   +    E ++L + RH N++ I    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI---- 88
Query: 725 TNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLS------VIIDVALALEYLHFGYS 777
            N+  +A  +E M +  + +D + ++ +     Q LS       +  +   L+Y+H   S
Sbjct: 89  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 144
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAPGL 831
             V+H D+KPSN+LL+      + DFG+A++   +      LT  +AT  Y AP +
Sbjct: 145 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 77/171 (45%), Gaps = 15/171 (8%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISS 723
           +G G F  V +    L G E A K+ + +   A   +  + E  + + ++H N+V++  S
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 724 CTNNDFKALVLEYMPNGSL-EDYLYSNNFS-FDILQRLSVIIDVALALEYLHFGYSNPVV 781
            +      L+ + +  G L ED +    +S  D    +  I++  L    +       VV
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM------GVV 143
Query: 782 HCDIKPSNVLLD---KDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D+KP N+LL    K     L+DFG+A  + GE+         T GY++P
Sbjct: 144 HRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSP 193

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 85/176 (48%), Gaps = 19/176 (10%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G +G V      ++ + VAIK +   + +   +    E ++L + RH N++ I    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI---- 88
Query: 725 TNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLS------VIIDVALALEYLHFGYS 777
            N+  +A  +E M +  + +D + ++ +     Q LS       +  +   L+Y+H   S
Sbjct: 89  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 144
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAPGL 831
             V+H D+KPSN+LL+      + DFG+A++   +      LT  +AT  Y AP +
Sbjct: 145 ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 63/138 (45%), Gaps = 14/138 (10%)
Query: 700 KSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN--FSFDILQ 757
           +  + E  +L+ +RH N++ +     N     L+LE +  G L D+L         +  Q
Sbjct: 74  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ 133
Query: 758 RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNV-LLDKDM---VAHLSDFGIAKLLSGEE 813
            L  I+D    + YLH   S  + H D+KP N+ LLDK++      L DFGIA  +    
Sbjct: 134 FLKQILD---GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 187
Query: 814 SMKQTLTLATIGYMAPGL 831
             K      T  ++AP +
Sbjct: 188 EFKN--IFGTPEFVAPEI 203

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 65/194 (33%), Positives = 94/194 (48%), Gaps = 12/194 (6%)
Query: 12  AIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFN-LSS 70
           AIP  I   T  KKL L  NKL     +    L +L L+ L +N L  T+P+ IF  L +
Sbjct: 30  AIPSNIPADT--KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86
Query: 71  LSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQ 130
           L T +  ++N L  +LP  +  +L  +  L +  N+L    P       +L  +SL YN+
Sbjct: 87  LET-LWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNE 144
Query: 131 FTERIPRGL-GNLTSLKTLYLGFNNLTGEIPY-EMGNLRNLEILGLQLNKLVGFVPTSIF 188
             + +P+G+   LTSLK L L +NN    +P      L  L+ L L  N+L   VP   F
Sbjct: 145 L-QSLPKGVFDKLTSLKELRL-YNNQLKRVPEGAFDKLTELKTLKLDNNQL-KRVPEGAF 201
Query: 189 N-LSAMKTLALPSN 201
           + L  +K L L  N
Sbjct: 202 DSLEKLKMLQLQEN 215

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 63/138 (45%), Gaps = 14/138 (10%)
Query: 700 KSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN--FSFDILQ 757
           +  + E  +L+ +RH N++ +     N     L+LE +  G L D+L         +  Q
Sbjct: 53  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ 112
Query: 758 RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNV-LLDKDM---VAHLSDFGIAKLLSGEE 813
            L  I+D    + YLH   S  + H D+KP N+ LLDK++      L DFGIA  +    
Sbjct: 113 FLKQILD---GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166
Query: 814 SMKQTLTLATIGYMAPGL 831
             K      T  ++AP +
Sbjct: 167 EFKN--IFGTPEFVAPEI 182

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 86/188 (45%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G  VA+K      +  +  K    E  +
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 152
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E        +AT
Sbjct: 153 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MXGXVAT 205
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 206 RWYRAPEI 213

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 85/189 (44%), Gaps = 33/189 (17%)
Query: 658 TNQFNASNLIGTGGFGSVY-KGSFLDGMEVAIKVFHLQL------EGALKSFDVECEVLK 710
           ++++     +G+G +G V      L G E AIK+            GAL     E  VLK
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLD---EVAVLK 59
Query: 711 SVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALE 770
            + H N++K+     +     LV+E    G L D +        IL++    +D A+ ++
Sbjct: 60  QLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEI--------ILRQKFSEVDAAVIMK 111
Query: 771 -------YLHFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAKLLSGEESMKQTLT 820
                  YLH    + +VH D+KP N+LL+   +D +  + DFG++        MK+   
Sbjct: 112 QVLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKE--R 166
Query: 821 LATIGYMAP 829
           L T  Y+AP
Sbjct: 167 LGTAYYIAP 175

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 15/177 (8%)
Query: 664 SNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVR-HRNLVKII 721
            +++G G    V    + +   E A+K+   Q          E E+L   + HRN++++I
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
                 D   LV E M  GS+  +++     F+ L+   V+ DVA AL++LH   +  + 
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRH-FNELEASVVVQDVASALDFLH---NKGIA 133
Query: 782 HCDIKPSNVLLDK-DMVA--HLSDFGIAK--LLSGEESMKQTLTLAT----IGYMAP 829
           H D+KP N+L +  + V+   + DFG+     L+G+ S   T  L T      YMAP
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G +G V      ++ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 106
Query: 725 TNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLS------VIIDVALALEYLHFGYS 777
            N+  +A  +E M +  + +D + ++ +     Q LS       +  +   L+Y+H   S
Sbjct: 107 -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 162
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAPGL 831
             V+H D+KPSN+LL+      + DFG+A++   +      LT  +AT  Y AP +
Sbjct: 163 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G +G V      ++ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 88
Query: 725 TNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLS------VIIDVALALEYLHFGYS 777
            N+  +A  +E M +  + +D + ++ +     Q LS       +  +   L+Y+H   S
Sbjct: 89  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 144
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAPGL 831
             V+H D+KPSN+LL+      + DFG+A++   +      LT  +AT  Y AP +
Sbjct: 145 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 46/220 (20%)
Query: 638 SNMLPQATRRRFSYKELLQAT-----NQFNASNLIGTGGFGSVYKGSFLDG---MEVAIK 689
           S+ML  +  R   Y++ L  T      +      +G+G +GSV   S  D     +VA+K
Sbjct: 2   SHMLEMSGPRAGFYRQELNKTVWEVPQRLQGLRPVGSGAYGSV--CSAYDARLRQKVAVK 59
Query: 690 VFHLQLEGALKSFDV--ECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLED--- 744
                 +  + +     E  +LK ++H N++ ++   T            P  S+ED   
Sbjct: 60  KLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFT------------PATSIEDFSE 107
Query: 745 -YLYSNNFSFDI-----LQRLS------VIIDVALALEYLHFGYSNPVVHCDIKPSNVLL 792
            YL +     D+      Q LS      ++  +   L+Y+H   S  ++H D+KPSNV +
Sbjct: 108 VYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH---SAGIIHRDLKPSNVAV 164
Query: 793 DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
           ++D    + DFG+A+    +E M  T  +AT  Y AP + 
Sbjct: 165 NEDSELRILDFGLAR--QADEEM--TGYVATRWYRAPEIM 200

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G +G V      ++ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 725 TNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLS------VIIDVALALEYLHFGYS 777
            N+  +A  +E M +  + +D + ++ +     Q LS       +  +   L+Y+H   S
Sbjct: 87  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 142
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAPGL 831
             V+H D+KPSN+LL+      + DFG+A++   +      LT  +AT  Y AP +
Sbjct: 143 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G +G V      ++ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 725 TNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLS------VIIDVALALEYLHFGYS 777
            N+  +A  +E M +  + +D + ++ +     Q LS       +  +   L+Y+H   S
Sbjct: 87  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 142
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAPGL 831
             V+H D+KPSN+LL+      + DFG+A++   +      LT  +AT  Y AP +
Sbjct: 143 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 85/187 (45%), Gaps = 28/187 (14%)
Query: 661 FNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQL---EGALKSFDV--ECEVLKSVRH 714
           +    +IG G F  V +  +   G + A+K+  +        L + D+  E  +   ++H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV--IIDVALA---- 768
            ++V+++ + +++    +V E+M    L          F+I++R     +   A+A    
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASHYM 136
Query: 769 ---LEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLA 822
              LE L + + N ++H D+KP NVLL   +      L DFG+A  L GE  +     + 
Sbjct: 137 RQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL-GESGLVAGGRVG 195
Query: 823 TIGYMAP 829
           T  +MAP
Sbjct: 196 TPHFMAP 202

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G +G V      ++ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 725 TNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLS------VIIDVALALEYLHFGYS 777
            N+  +A  +E M +  + +D + ++ +     Q LS       +  +   L+Y+H   S
Sbjct: 87  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 142
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAPGL 831
             V+H D+KPSN+LL+      + DFG+A++   +      LT  +AT  Y AP +
Sbjct: 143 ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G +G V      ++ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 725 TNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLS------VIIDVALALEYLHFGYS 777
            N+  +A  +E M +  + +D + ++ +     Q LS       +  +   L+Y+H   S
Sbjct: 87  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 142
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAPGL 831
             V+H D+KPSN+LL+      + DFG+A++   +      LT  +AT  Y AP +
Sbjct: 143 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 63/138 (45%), Gaps = 14/138 (10%)
Query: 700 KSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN--FSFDILQ 757
           +  + E  +L+ +RH N++ +     N     L+LE +  G L D+L         +  Q
Sbjct: 60  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ 119
Query: 758 RLSVIIDVALALEYLHFGYSNPVVHCDIKPSNV-LLDKDM---VAHLSDFGIAKLLSGEE 813
            L  I+D    + YLH   S  + H D+KP N+ LLDK++      L DFGIA  +    
Sbjct: 120 FLKQILD---GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 173
Query: 814 SMKQTLTLATIGYMAPGL 831
             K      T  ++AP +
Sbjct: 174 EFKN--IFGTPEFVAPEI 189

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 91/192 (47%), Gaps = 26/192 (13%)
Query: 658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVA----IKVFHLQLEGALKSFDVECEVLKSVR 713
           ++ F   +L+G G +G V   +     E+     I+ F   L  AL++   E ++LK  +
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL-FALRTLR-EIKILKHFK 67
Query: 714 HRNLVKIISSCTNNDFK----ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL 769
           H N++ I +    + F+      +++ +    L   + +   S D +Q    I     A+
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF--IYQTLRAV 125
Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL----------SGEESMKQTL 819
           + LH    + V+H D+KPSN+L++ +    + DFG+A+++          +G++S   T 
Sbjct: 126 KVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS-GMTE 181
Query: 820 TLATIGYMAPGL 831
            +AT  Y AP +
Sbjct: 182 XVATRWYRAPEV 193

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G +G V      ++ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 94
Query: 725 TNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLS------VIIDVALALEYLHFGYS 777
            N+  +A  +E M +  + +D + ++ +     Q LS       +  +   L+Y+H   S
Sbjct: 95  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 150
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAPGL 831
             V+H D+KPSN+LL+      + DFG+A++   +      LT  +AT  Y AP +
Sbjct: 151 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 206

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G +G V      ++ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 725 TNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLS------VIIDVALALEYLHFGYS 777
            N+  +A  +E M +  + +D + ++ +     Q LS       +  +   L+Y+H   S
Sbjct: 87  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 142
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAPGL 831
             V+H D+KPSN+LL+      + DFG+A++   +      LT  +AT  Y AP +
Sbjct: 143 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198

>pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4 Length = 193

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 7/136 (5%)
Query: 117 QCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQL 176
           +C  L  +    N+  + +P+G+     +  LYL  N  T  +P E+ N ++L ++ L  
Sbjct: 7   ECTCLDTVVRCSNKGLKVLPKGIPR--DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSN 63
Query: 177 NKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSF 236
           N++      S  N++ + TL L  N L    P + D   L +L ++SL GN+ S ++P  
Sbjct: 64  NRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFD--GLKSLRLLSLHGNDIS-VVPEG 120
Query: 237 IFNA-SKLSVLELGEN 251
            FN  S LS L +G N
Sbjct: 121 AFNDLSALSHLAIGAN 136

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 73/173 (42%), Gaps = 13/173 (7%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGMEV-AIKVFHL---QLEGALKSFDVECEVLKSVRHRN 716
           F+    IG G FG+VY    +   EV AIK       Q     +    E   L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
            ++            LV+EY   GS  D L  +      ++  +V       L YLH   
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 132
Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           S+ ++H D+K  N+LL +  +  L DFG A +++          + T  +MAP
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTPYWMAP 180

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 83/180 (46%), Gaps = 15/180 (8%)
Query: 658 TNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRH 714
           T+ +     +G G F  V +        E A K+ + +   A   +  + E  + + ++H
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSL-EDYLYSNNFS-FDILQRLSVIIDVALALEYL 772
            N+V++  S +   F  LV + +  G L ED +    +S  D    +  I++   ++ ++
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILE---SVNHI 146
Query: 773 HFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H    + +VH D+KP N+LL    K     L+DFG+A  + GE+         T GY++P
Sbjct: 147 H---QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFA-GTPGYLSP 202

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 17/182 (9%)
Query: 661 FNASNLIGTGGFGSVYK-GSFLDGMEVAIKVFHLQLEGALK------SFDVECEVLKSVR 713
           ++    +G+G F  V K      G+E A K    +   A +        + E  +L+ V 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
           H N++ +     N     L+LE +  G L D+L     S    +  S I  +   + YLH
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH 132
Query: 774 FGYSNPVVHCDIKPSNV-LLDKDM-VAHLS--DFGIAKLLSGEESMKQTLTLATIGYMAP 829
              +  + H D+KP N+ LLDK++ + H+   DFG+A  +  E+ ++      T  ++AP
Sbjct: 133 ---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAP 187
Query: 830 GL 831
            +
Sbjct: 188 EI 189

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 100/194 (51%), Gaps = 34/194 (17%)
Query: 663 ASNLIGTGGFGSV-YKGSFLDGMEVAIKVFHLQL-EGALKSFDVECEVL-KSVRHRNLVK 719
           +  ++G G  G+V ++GSF  G  VA+K   +   + AL    +E ++L +S  H N+++
Sbjct: 19  SEKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIAL----MEIKLLTESDDHPNVIR 73
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD--ILQR----LSVIIDVALALEYLH 773
              S T + F  + LE + N +L+D + S N S +   LQ+    +S++  +A  + +LH
Sbjct: 74  YYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 774 FGYSNPVVHCDIKPSNVLL--------DKDMVAH-----LSDFGIAKLL-SGEESMKQTL 819
              S  ++H D+KP N+L+        D+   A      +SDFG+ K L SG+ S +  L
Sbjct: 133 ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 820 T--LATIGYMAPGL 831
                T G+ AP L
Sbjct: 190 NNPSGTSGWRAPEL 203

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 17/182 (9%)
Query: 661 FNASNLIGTGGFGSVYK-GSFLDGMEVAIKVFHLQLEGALK------SFDVECEVLKSVR 713
           ++    +G+G F  V K      G+E A K    +   A +        + E  +L+ V 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
           H N++ +     N     L+LE +  G L D+L     S    +  S I  +   + YLH
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH 132
Query: 774 FGYSNPVVHCDIKPSNV-LLDKDM-VAHLS--DFGIAKLLSGEESMKQTLTLATIGYMAP 829
              +  + H D+KP N+ LLDK++ + H+   DFG+A  +  E+ ++      T  ++AP
Sbjct: 133 ---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAP 187
Query: 830 GL 831
            +
Sbjct: 188 EI 189

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 29/221 (13%)
Query: 621 AMISRCQEKNAKQSNIESNMLPQATRR-RFSYKELLQ-ATNQFNASNLIGTGGFGSVYK- 677
           A  SR +E + K  + E  +L +  +   + Y+E +  AT+Q      +G G FG V++ 
Sbjct: 57  ARGSRSREPSPKTEDNEGVLLTEKLKPVDYEYREEVHWATHQLR----LGRGSFGEVHRM 112
Query: 678 GSFLDGMEVAIKVFHLQLEGALKSFDVE----CEVLKSVRHRNLVKIISSCTNNDFKALV 733
                G + A+K   L++      F  E    C  L S R   +V +  +     +  + 
Sbjct: 113 EDKQTGFQCAVKKVRLEV------FRAEELMACAGLTSPR---IVPLYGAVREGPWVNIF 163
Query: 734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD 793
           +E +  GSL   +         L     +  +  ALE L + +S  ++H D+K  NVLL 
Sbjct: 164 MELLEGGSLGQLVKEQG----CLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLS 219
Query: 794 KD-MVAHLSDFGIAKLLSGEESMKQTLT----LATIGYMAP 829
            D   A L DFG A  L  +   K  LT      T  +MAP
Sbjct: 220 SDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAP 260

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/190 (21%), Positives = 81/190 (42%), Gaps = 20/190 (10%)
Query: 657 ATNQFNASNLIGTGGFGSVY----KGSFLDGMEVAIKVFHLQLEGALKS---FDVECEVL 709
           A  +   S  +G G FG VY    KG   D  E  + +  +    +++    F  E  V+
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 710 KSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD---------ILQRLS 760
           K     ++V+++   +      +++E M  G L+ YL S     +         + + + 
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 127
Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK-LLSGEESMKQTL 819
           +  ++A  + YL+   +N  VH D+   N ++ +D    + DFG+ + +   +   K   
Sbjct: 128 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 184
Query: 820 TLATIGYMAP 829
            L  + +M+P
Sbjct: 185 GLLPVRWMSP 194

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 17/182 (9%)
Query: 661 FNASNLIGTGGFGSVYK-GSFLDGMEVAIKVFHLQLEGALK------SFDVECEVLKSVR 713
           ++    +G+G F  V K      G+E A K    +   A +        + E  +L+ V 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
           H N++ +     N     L+LE +  G L D+L     S    +  S I  +   + YLH
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH 132
Query: 774 FGYSNPVVHCDIKPSNV-LLDKDM-VAHLS--DFGIAKLLSGEESMKQTLTLATIGYMAP 829
              +  + H D+KP N+ LLDK++ + H+   DFG+A  +  E+ ++      T  ++AP
Sbjct: 133 ---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAP 187
Query: 830 GL 831
            +
Sbjct: 188 EI 189

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 17/182 (9%)
Query: 661 FNASNLIGTGGFGSVYK-GSFLDGMEVAIKVFHLQLEGALK------SFDVECEVLKSVR 713
           ++    +G+G F  V K      G+E A K    +   A +        + E  +L+ V 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
           H N++ +     N     L+LE +  G L D+L     S    +  S I  +   + YLH
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH 132
Query: 774 FGYSNPVVHCDIKPSNV-LLDKDM-VAHLS--DFGIAKLLSGEESMKQTLTLATIGYMAP 829
              +  + H D+KP N+ LLDK++ + H+   DFG+A  +  E+ ++      T  ++AP
Sbjct: 133 ---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAP 187
Query: 830 GL 831
            +
Sbjct: 188 EI 189

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 85/186 (45%), Gaps = 41/186 (22%)
Query: 667 IGTGGFGSVYKGSFLDG---MEVAIKVFHLQLEGALKSFDV--ECEVLKSVRHRNLVKII 721
           +G+G +GSV   S  D     +VA+K      +  + +     E  +LK ++H N++ ++
Sbjct: 28  VGSGAYGSV--CSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 722 SSCTNNDFKALVLEYMPNGSLED----YLYSNNFSFDI-----LQRLS------VIIDVA 766
              T            P  S+ED    YL +     D+      Q LS      ++  + 
Sbjct: 86  DVFT------------PATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 133
Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
             L+Y+H   S  ++H D+KPSNV +++D    + DFG+A+    +E M  T  +AT  Y
Sbjct: 134 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADEEM--TGYVATRWY 186
Query: 827 MAPGLF 832
            AP + 
Sbjct: 187 RAPEIM 192

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 91/192 (47%), Gaps = 26/192 (13%)
Query: 658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVA----IKVFHLQLEGALKSFDVECEVLKSVR 713
           ++ F   +L+G G +G V   +     E+     I+ F   L  AL++   E ++LK  +
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL-FALRTLR-EIKILKHFK 67
Query: 714 HRNLVKIISSCTNNDFK----ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL 769
           H N++ I +    + F+      +++ +    L   + +   S D +Q    I     A+
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF--IYQTLRAV 125
Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL----------SGEESMKQTL 819
           + LH    + V+H D+KPSN+L++ +    + DFG+A+++          +G++S   T 
Sbjct: 126 KVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS-GMTE 181
Query: 820 TLATIGYMAPGL 831
            +AT  Y AP +
Sbjct: 182 YVATRWYRAPEV 193

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 87/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G  VA+K      +  +  K    E  +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 132
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E +      +AT
Sbjct: 133 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG----FVAT 185
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 186 RWYRAPEI 193

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 87/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G  VA+K      +  +  K    E  +
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 128
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E +      +AT
Sbjct: 129 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG----FVAT 181
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 182 RWYRAPEI 189

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 17/182 (9%)
Query: 661 FNASNLIGTGGFGSVYK-GSFLDGMEVAIKVFHLQLEGALK------SFDVECEVLKSVR 713
           ++    +G+G F  V K      G+E A K    +   A +        + E  +L+ V 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
           H N++ +     N     L+LE +  G L D+L     S    +  S I  +   + YLH
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH 132
Query: 774 FGYSNPVVHCDIKPSNV-LLDKDM-VAHLS--DFGIAKLLSGEESMKQTLTLATIGYMAP 829
              +  + H D+KP N+ LLDK++ + H+   DFG+A  +  E+ ++      T  ++AP
Sbjct: 133 ---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAP 187
Query: 830 GL 831
            +
Sbjct: 188 EI 189

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 87/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G  VA+K      +  +  K    E  +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 132
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DFG+A+    E +      +AT
Sbjct: 133 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG----FVAT 185
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 186 RWYRAPEI 193

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 87/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 132
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    +  FG+A+    E     T  +AT
Sbjct: 133 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE----MTGYVAT 185
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 186 RWYRAPEI 193

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 75/173 (43%), Gaps = 12/173 (6%)
Query: 661 FNASNLIGTGGFGSVYKGSFLDGME-VAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVK 719
           F   + +G G    VY+       +  A+KV    ++   K    E  VL  + H N++K
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIK 112
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
           +          +LVLE +  G L D +    + +        +  +  A+ YLH    N 
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGY-YSERDAADAVKQILEAVAYLH---ENG 168
Query: 780 VVHCDIKPSNVLLDK---DMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +VH D+KP N+L      D    ++DFG++K++  +  MK      T GY AP
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--VCGTPGYCAP 219

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 87/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 132
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + D G+A+    E     T  +AT
Sbjct: 133 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE----MTGYVAT 185
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 186 RWYRAPEI 193

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 29/221 (13%)
Query: 621 AMISRCQEKNAKQSNIESNMLPQATRR-RFSYKELLQ-ATNQFNASNLIGTGGFGSVYK- 677
           A  SR +E + K  + E  +L +  +   + Y+E +  AT+Q      +G G FG V++ 
Sbjct: 38  ARGSRSREPSPKTEDNEGVLLTEKLKPVDYEYREEVHWATHQLR----LGRGSFGEVHRM 93
Query: 678 GSFLDGMEVAIKVFHLQLEGALKSFDVE----CEVLKSVRHRNLVKIISSCTNNDFKALV 733
                G + A+K   L++      F  E    C  L S R   +V +  +     +  + 
Sbjct: 94  EDKQTGFQCAVKKVRLEV------FRAEELMACAGLTSPR---IVPLYGAVREGPWVNIF 144
Query: 734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD 793
           +E +  GSL   +         L     +  +  ALE L + +S  ++H D+K  NVLL 
Sbjct: 145 MELLEGGSLGQLVKEQG----CLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLS 200
Query: 794 KD-MVAHLSDFGIAKLLSGEESMKQTLT----LATIGYMAP 829
            D   A L DFG A  L  +   K  LT      T  +MAP
Sbjct: 201 SDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAP 241

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 87/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 132
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + D G+A+    E     T  +AT
Sbjct: 133 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE----MTGYVAT 185
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 186 RWYRAPEI 193

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 83/193 (43%), Gaps = 31/193 (16%)
Query: 636 IESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL-----DG-MEVAIK 689
           I+   LP   +  F    L     QF  +  +G G FG V + +       D  ++VA+K
Sbjct: 30  IDPTQLPYNEKWEFPRNNL-----QFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVK 82
Query: 690 VF----HLQLEGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVLEYMPNGSLED 744
           +     H   + AL S   E +++  + +H N+V ++ +CT+     ++ EY   G L +
Sbjct: 83  MLKSTAHADEKEALMS---ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 745 YLYSNNFSFDILQRLSVIIDVALALEYLHFG----------YSNPVVHCDIKPSNVLLDK 794
           +L   +   +     ++    A   + LHF            S   +H D+   NVLL  
Sbjct: 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199
Query: 795 DMVAHLSDFGIAK 807
             VA + DFG+A+
Sbjct: 200 GHVAKIGDFGLAR 212

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 39/171 (22%), Positives = 72/171 (42%), Gaps = 33/171 (19%)
Query: 667 IGTGGFGSVYKGS------FLDGMEVAIKVFHLQLEGALKS-FDVECEVLKSVRHRNLVK 719
           IG G FG V++        +     VA+K+   +    +++ F  E  ++    + N+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYS-----------NNFS------------FDIL 756
           ++  C       L+ EYM  G L ++L S           ++ S                
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 757 QRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           ++L +   VA  + YL        VH D+   N L+ ++MV  ++DFG+++
Sbjct: 175 EQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR 222

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 19/176 (10%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G +G V      L+ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 725 TNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLS------VIIDVALALEYLHFGYS 777
            N+  +A  +E M +  + +D + ++ +     Q LS       +  +   L+Y+H   S
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 146
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL--TLATIGYMAPGL 831
             V+H D+KPSN+LL+      + DFG+A++   +      L   +AT  Y AP +
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 202

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 19/176 (10%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G +G V      L+ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 91
Query: 725 TNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLS------VIIDVALALEYLHFGYS 777
            N+  +A  +E M +  + +D + ++ +     Q LS       +  +   L+Y+H   S
Sbjct: 92  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 147
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL--TLATIGYMAPGL 831
             V+H D+KPSN+LL+      + DFG+A++   +      L   +AT  Y AP +
Sbjct: 148 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 203

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/190 (21%), Positives = 81/190 (42%), Gaps = 20/190 (10%)
Query: 657 ATNQFNASNLIGTGGFGSVY----KGSFLDGMEVAIKVFHLQLEGALKS---FDVECEVL 709
           A  +   S  +G G FG VY    KG   D  E  + +  +    +++    F  E  V+
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 710 KSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD---------ILQRLS 760
           K     ++V+++   +      +++E M  G L+ YL S     +         + + + 
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK-LLSGEESMKQTL 819
           +  ++A  + YL+   +N  VH D+   N ++ +D    + DFG+ + +   +   K   
Sbjct: 137 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 193
Query: 820 TLATIGYMAP 829
            L  + +M+P
Sbjct: 194 GLLPVRWMSP 203

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 77/164 (46%), Gaps = 9/164 (5%)
Query: 656 QATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSV 712
           Q  +++   +LIGTG +G V +    L+   VAIK      E  +  K    E  +L  +
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 713 RHRNLVKIISSCTNND---FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL 769
            H ++VK++      D   F  L +      S    L+        L   +++ ++ + +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGV 169
Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
           +Y+H   S  ++H D+KP+N L+++D    + DFG+A+ +   E
Sbjct: 170 KYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210

>pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 41/120 (34%), Positives = 63/120 (52%), Gaps = 5/120 (4%)
Query: 324 IFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPI-TFGKLQNLQGLDLVNNKLEGP 382
           +++ +  I    P    +LINL+EL L  N+L G++P+  F  L  L  LDL  N+L   
Sbjct: 45  LYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLT-V 102
Query: 383 IPNGLC-QLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDI 441
           +P+ +  +L  L  L+M  NKL+  +P  I  LT L  L+L  N+L S+    F  L  +
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSL 161

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/76 (40%), Positives = 45/76 (59%), Gaps = 6/76 (7%)
Query: 754 DILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
           DIL +++V I    ALE+LH   S  V+H D+KPSNVL++      + DFGI+  L   +
Sbjct: 153 DILGKIAVSI--VKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV--D 206
Query: 814 SMKQTLTLATIGYMAP 829
           S+ +T+      YMAP
Sbjct: 207 SVAKTIDAGCKPYMAP 222

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 36/167 (21%), Positives = 72/167 (43%), Gaps = 19/167 (11%)
Query: 657 ATNQFNASNLIGTGGFGSVY----KGSFLDGMEVAIKVFHLQLEGALKS---FDVECEVL 709
           A  +   S  +G G FG VY    KG   D  E  + +  +    +++    F  E  V+
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 710 KSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD---------ILQRLS 760
           K     ++V+++   +      +++E M  G L+ YL S     +         + + + 
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           +  ++A  + YL+   +N  VH D+   N ++ +D    + DFG+ +
Sbjct: 130 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 173

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 19/176 (10%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G +G V      ++ + VAIK +   + +   +    E ++L   RH N++ I    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 106
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLS------VIIDVALALEYLHFGYS 777
            N+  +A  +E M +  L  +L   + +     Q LS       +  +   L+Y+H   S
Sbjct: 107 -NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 162
Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAPGL 831
             V+H D+KPSN+LL+      + DFG+A++   +      LT  +AT  Y AP +
Sbjct: 163 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 85/186 (45%), Gaps = 23/186 (12%)
Query: 642 PQATRRRFSYKELLQATNQFNAS----NLIGTGGFGSVYKGSFLDG---MEVAIKVFHLQ 694
           P   R  F  +E+ +   +  A       +G+G +G+V   S +DG    +VAIK  +  
Sbjct: 4   PPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAV--CSAVDGRTGAKVAIKKLYRP 61
Query: 695 LEGAL--KSFDVECEVLKSVRHRNLVKIISSCTNN----DFK--ALVLEYMPNGSLEDYL 746
            +  L  K    E  +LK +RH N++ ++   T +    DF    LV+ +M    L   +
Sbjct: 62  FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM 120
Query: 747 YSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA 806
                  D +Q L  +  +   L Y+H   +  ++H D+KP N+ +++D    + DFG+A
Sbjct: 121 KHEKLGEDRIQFL--VYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 175
Query: 807 KLLSGE 812
           +    E
Sbjct: 176 RQADSE 181

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 87/188 (46%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G+ VA+K      +  +  K    E  +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 132
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + D G+A+    E     T  +AT
Sbjct: 133 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE----MTGYVAT 185
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 186 RWYRAPEI 193

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 17/182 (9%)
Query: 661 FNASNLIGTGGFGSVYK-GSFLDGMEVAIKVFHLQLEGALK------SFDVECEVLKSVR 713
           ++    +G+G F  V K      G+E A K    +   A +        + E  +L+ V 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
           H N++ +     N     L+LE +  G L D+L     S    +  S I  +   + YLH
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH 132
Query: 774 FGYSNPVVHCDIKPSNV-LLDKDM-VAHLS--DFGIAKLLSGEESMKQTLTLATIGYMAP 829
              +  + H D+KP N+ LLDK++ + H+   DFG+A  +  E+ ++      T  ++AP
Sbjct: 133 ---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAP 187
Query: 830 GL 831
            +
Sbjct: 188 EI 189

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/180 (22%), Positives = 78/180 (43%), Gaps = 20/180 (11%)
Query: 667 IGTGGFGSVYKGSFLD----GMEVAIKVFHLQLEGALKS---FDVECEVLKSVRHRNLVK 719
           +G G FG VY+G+  D      E  + V  +    +L+    F  E  V+K     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD---------ILQRLSVIIDVALALE 770
           ++   +      +V+E M +G L+ YL S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMAP 829
           YL+   +   VH D+   N ++  D    + DFG+ + +   +   K    L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/167 (21%), Positives = 72/167 (43%), Gaps = 19/167 (11%)
Query: 657 ATNQFNASNLIGTGGFGSVY----KGSFLDGMEVAIKVFHLQLEGALKS---FDVECEVL 709
           A  +   S  +G G FG VY    KG   D  E  + +  +    +++    F  E  V+
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 710 KSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD---------ILQRLS 760
           K     ++V+++   +      +++E M  G L+ YL S     +         + + + 
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           +  ++A  + YL+   +N  VH D+   N ++ +D    + DFG+ +
Sbjct: 136 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/180 (22%), Positives = 78/180 (43%), Gaps = 20/180 (11%)
Query: 667 IGTGGFGSVYKGSFLD----GMEVAIKVFHLQLEGALKS---FDVECEVLKSVRHRNLVK 719
           +G G FG VY+G+  D      E  + V  +    +L+    F  E  V+K     ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD---------ILQRLSVIIDVALALE 770
           ++   +      +V+E M +G L+ YL S     +         + + + +  ++A  + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMAP 829
           YL+   +   VH D+   N ++  D    + DFG+ + +   +   K    L  + +MAP
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 92/215 (42%), Gaps = 39/215 (18%)
Query: 650 SYKELLQATNQFNASNLI-----GTGGFGSVYKGS--FLDGME----VAIKVFHLQLE-G 697
           ++K L     +F   NL+     G G FG V K +   L G      VA+K+        
Sbjct: 9   AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS 68
Query: 698 ALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYL----------- 746
            L+    E  VLK V H +++K+  +C+ +    L++EY   GSL  +L           
Sbjct: 69  ELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 747 ------------YSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK 794
                       + +  +  +   +S    ++  ++YL       +VH D+   N+L+ +
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAE 185
Query: 795 DMVAHLSDFGIAKLLSGEES-MKQTLTLATIGYMA 828
                +SDFG+++ +  E+S +K++     + +MA
Sbjct: 186 GRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMA 220

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/180 (22%), Positives = 78/180 (43%), Gaps = 20/180 (11%)
Query: 667 IGTGGFGSVYKGSFLD----GMEVAIKVFHLQLEGALKS---FDVECEVLKSVRHRNLVK 719
           +G G FG VY+G+  D      E  + V  +    +L+    F  E  V+K     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD---------ILQRLSVIIDVALALE 770
           ++   +      +V+E M +G L+ YL S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMAP 829
           YL+   +   VH D+   N ++  D    + DFG+ + +   +   K    L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/231 (22%), Positives = 98/231 (42%), Gaps = 21/231 (9%)
Query: 612 IAVILAVRYAMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGG 671
           +  +L V   + + C     ++    +  L  A       KE+      F    +IG G 
Sbjct: 27  VETLLDVLVCLYTECSHSALRRDKYVAEFLEWAKPFTQLVKEMQLHREDFEIIKVIGRGA 86
Query: 672 FGSVYKGSFLDGMEV-AIKV---FHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNN 727
           FG V      +   + A+K+   + +        F  E +VL +   + +  +  +  + 
Sbjct: 87  FGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDE 146
Query: 728 DFKALVLEYMPNGSL-------EDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPV 780
           +   LV++Y   G L       ED L  +   F I + + + ID   ++  LH+      
Sbjct: 147 NHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGE-MVLAID---SIHQLHY------ 196
Query: 781 VHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
           VH DIKP NVLLD +    L+DFG    ++ + +++ ++ + T  Y++P +
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEI 247

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 92/215 (42%), Gaps = 39/215 (18%)
Query: 650 SYKELLQATNQFNASNLI-----GTGGFGSVYKGS--FLDGME----VAIKVFHLQLE-G 697
           ++K L     +F   NL+     G G FG V K +   L G      VA+K+        
Sbjct: 9   AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS 68
Query: 698 ALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYL----------- 746
            L+    E  VLK V H +++K+  +C+ +    L++EY   GSL  +L           
Sbjct: 69  ELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 747 ------------YSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK 794
                       + +  +  +   +S    ++  ++YL       +VH D+   N+L+ +
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMSLVHRDLAARNILVAE 185
Query: 795 DMVAHLSDFGIAKLLSGEES-MKQTLTLATIGYMA 828
                +SDFG+++ +  E+S +K++     + +MA
Sbjct: 186 GRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMA 220

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/175 (21%), Positives = 74/175 (42%), Gaps = 19/175 (10%)
Query: 649 FSYKELLQATNQFNASNLIGTGGFGSVY----KGSFLDGMEVAIKVFHLQLEGALKS--- 701
           F   E   A  +   S  +G G FG VY    KG   D  E  + +  +    +++    
Sbjct: 6   FVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 65
Query: 702 FDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD------- 754
           F  E  V+K     ++V+++   +      +++E M  G L+ YL S     +       
Sbjct: 66  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 125
Query: 755 --ILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
             + + + +  ++A  + YL+   +N  VH D+   N ++ +D    + DFG+ +
Sbjct: 126 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 177

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/231 (22%), Positives = 96/231 (41%), Gaps = 21/231 (9%)
Query: 612 IAVILAVRYAMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGG 671
           +  +L V   + + C     ++    +  L  A       KE+      F    +IG G 
Sbjct: 43  VETLLDVLVCLYTECSHSALRRDKYVAEFLEWAKPFTQLVKEMQLHREDFEIIKVIGRGA 102
Query: 672 FGSVYKGSFLDGMEV-AIKV---FHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNN 727
           FG V      +   + A+K+   + +        F  E +VL +   + +  +  +  + 
Sbjct: 103 FGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDE 162
Query: 728 DFKALVLEYMPNGSL-------EDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPV 780
           +   LV++Y   G L       ED L  +   F        I ++ LA++ +H       
Sbjct: 163 NHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARF-------YIGEMVLAIDSIH---QLHY 212
Query: 781 VHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL 831
           VH DIKP NVLLD +    L+DFG    ++ + +++ ++ + T  Y++P +
Sbjct: 213 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEI 263

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 14/169 (8%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHL-----QLEGALKSFDVECEVLKSVRHRNLVKI 720
           +G+G  G V+K  F   G  +A+K         + +  L   DV   VLKS     +V+ 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV---VLKSHDCPYIVQC 89
Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPV 780
             +   N    + +E M  G+  + L        I +R+   + VA+     +    + V
Sbjct: 90  FGTFITNTDVFIAMELM--GTCAEKL-KKRMQGPIPERILGKMTVAIVKALYYLKEKHGV 146
Query: 781 VHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +H D+KPSN+LLD+     L DFGI+  L  +++  ++   A   YMAP
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCA--AYMAP 193

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 34/194 (17%)
Query: 663 ASNLIGTGGFGSV-YKGSFLDGMEVAIKVFHLQL-EGALKSFDVECEVL-KSVRHRNLVK 719
           +  ++G G  G+V ++GSF  G  VA+K   +   + AL    +E ++L +S  H N+++
Sbjct: 37  SEKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIAL----MEIKLLTESDDHPNVIR 91
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD--ILQR----LSVIIDVALALEYLH 773
              S T + F  + LE + N +L+D + S N S +   LQ+    +S++  +A  + +LH
Sbjct: 92  YYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 774 FGYSNPVVHCDIKPSNVLL--------DKDMVAH-----LSDFGIAKLL-SGEESMKQTL 819
              S  ++H D+KP N+L+        D+   A      +SDFG+ K L SG+   +  L
Sbjct: 151 ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 820 T--LATIGYMAPGL 831
                T G+ AP L
Sbjct: 208 NNPSGTSGWRAPEL 221

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 92/215 (42%), Gaps = 39/215 (18%)
Query: 650 SYKELLQATNQFNASNLI-----GTGGFGSVYKGS--FLDGME----VAIKVFHLQLE-G 697
           ++K L     +F   NL+     G G FG V K +   L G      VA+K+        
Sbjct: 9   AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS 68
Query: 698 ALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYL----------- 746
            L+    E  VLK V H +++K+  +C+ +    L++EY   GSL  +L           
Sbjct: 69  ELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 747 ------------YSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK 794
                       + +  +  +   +S    ++  ++YL       +VH D+   N+L+ +
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAE 185
Query: 795 DMVAHLSDFGIAKLLSGEES-MKQTLTLATIGYMA 828
                +SDFG+++ +  E+S +K++     + +MA
Sbjct: 186 GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMA 220

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/167 (21%), Positives = 72/167 (43%), Gaps = 19/167 (11%)
Query: 657 ATNQFNASNLIGTGGFGSVY----KGSFLDGMEVAIKVFHLQLEGALKS---FDVECEVL 709
           A  +   S  +G G FG VY    KG   D  E  + +  +    +++    F  E  V+
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 710 KSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD---------ILQRLS 760
           K     ++V+++   +      +++E M  G L+ YL S     +         + + + 
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           +  ++A  + YL+   +N  VH D+   N ++ +D    + DFG+ +
Sbjct: 136 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 34/194 (17%)
Query: 663 ASNLIGTGGFGSV-YKGSFLDGMEVAIKVFHLQL-EGALKSFDVECEVL-KSVRHRNLVK 719
           +  ++G G  G+V ++GSF  G  VA+K   +   + AL    +E ++L +S  H N+++
Sbjct: 37  SEKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIAL----MEIKLLTESDDHPNVIR 91
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD--ILQR----LSVIIDVALALEYLH 773
              S T + F  + LE + N +L+D + S N S +   LQ+    +S++  +A  + +LH
Sbjct: 92  YYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 774 FGYSNPVVHCDIKPSNVLL--------DKDMVAH-----LSDFGIAKLL-SGEESMKQTL 819
              S  ++H D+KP N+L+        D+   A      +SDFG+ K L SG+   +  L
Sbjct: 151 ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 820 T--LATIGYMAPGL 831
                T G+ AP L
Sbjct: 208 NNPSGTSGWRAPEL 221

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 82/177 (46%), Gaps = 15/177 (8%)
Query: 664 SNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVR-HRNLVKII 721
            +++G G    V    + +   E A+K+   Q          E E+L   + HRN++++I
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
                 D   LV E M  GS+  +++     F+ L+   V+ DVA AL++LH   +  + 
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRH-FNELEASVVVQDVASALDFLH---NKGIA 133
Query: 782 HCDIKPSNVLLDK-DMVAHLS----DFGIAKLLSGEESMKQTLTLAT----IGYMAP 829
           H D+KP N+L +  + V+ +     D G    L+G+ S   T  L T      YMAP
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/167 (21%), Positives = 72/167 (43%), Gaps = 19/167 (11%)
Query: 657 ATNQFNASNLIGTGGFGSVY----KGSFLDGMEVAIKVFHLQLEGALKS---FDVECEVL 709
           A  +   S  +G G FG VY    KG   D  E  + +  +    +++    F  E  V+
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 710 KSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD---------ILQRLS 760
           K     ++V+++   +      +++E M  G L+ YL S     +         + + + 
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 142
Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           +  ++A  + YL+   +N  VH D+   N ++ +D    + DFG+ +
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/167 (21%), Positives = 72/167 (43%), Gaps = 19/167 (11%)
Query: 657 ATNQFNASNLIGTGGFGSVY----KGSFLDGMEVAIKVFHLQLEGALKS---FDVECEVL 709
           A  +   S  +G G FG VY    KG   D  E  + +  +    +++    F  E  V+
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 710 KSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD---------ILQRLS 760
           K     ++V+++   +      +++E M  G L+ YL S     +         + + + 
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           +  ++A  + YL+   +N  VH D+   N ++ +D    + DFG+ +
Sbjct: 137 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/167 (21%), Positives = 72/167 (43%), Gaps = 19/167 (11%)
Query: 657 ATNQFNASNLIGTGGFGSVY----KGSFLDGMEVAIKVFHLQLEGALKS---FDVECEVL 709
           A  +   S  +G G FG VY    KG   D  E  + +  +    +++    F  E  V+
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 710 KSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD---------ILQRLS 760
           K     ++V+++   +      +++E M  G L+ YL S     +         + + + 
Sbjct: 105 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 164
Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           +  ++A  + YL+   +N  VH D+   N ++ +D    + DFG+ +
Sbjct: 165 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 208

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 31/201 (15%)
Query: 646 RRRFSYKELLQAT-----NQFNASNLIGTGGFGSVYKGSFLD---GMEVAIKVFH--LQL 695
           R++  YK+ +  T       + +   +G+G +GSV   S +D   G +VAIK      Q 
Sbjct: 24  RKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSV--CSAIDKRSGEKVAIKKLSRPFQS 81
Query: 696 EGALKSFDVECEVLKSVRHRNLVKII------SSCTN-NDFKALVLEYMPNGSLEDYLYS 748
           E   K    E  +LK ++H N++ ++      SS  N  DF  LV+ +M     +  +  
Sbjct: 82  EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF-YLVMPFMQTDLQK--IMG 138
Query: 749 NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL 808
             FS + +Q L  +  +   L+Y+H   S  VVH D+KP N+ +++D    + DFG+A+ 
Sbjct: 139 MEFSEEKIQYL--VYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH 193
Query: 809 LSGEESMKQTLTLATIGYMAP 829
              E     T  + T  Y AP
Sbjct: 194 ADAE----MTGYVVTRWYRAP 210

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 86/188 (45%), Gaps = 17/188 (9%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEV 708
           K + +   ++   + +G+G +GSV        G  VA+K      +  +  K    E  +
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 709 LKSVRHRNLVKIISSCTN----NDFKALVL-EYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           LK ++H N++ ++   T      +F  + L  ++    L + +     + D +Q L  I 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IY 132
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +   L+Y+H   S  ++H D+KPSN+ +++D    + DF +A+    E     T  +AT
Sbjct: 133 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE----MTGYVAT 185
Query: 824 IGYMAPGL 831
             Y AP +
Sbjct: 186 RWYRAPEI 193

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 47/177 (26%), Positives = 78/177 (44%), Gaps = 18/177 (10%)
Query: 661 FNASNLIGTGGFG----SVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRN 716
           +   N IG G +G    +V KG+ +      I  + ++    +  F  E E++KS+ H N
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPN 67
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSL-EDYLYSNNFSFDILQRLSVIIDVALALEYLHFG 775
           ++++  +  +N    LV+E    G L E  ++   F      R  ++ DV  A+ Y H  
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYCH-- 123
Query: 776 YSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
               V H D+KP N L      D    L DFG+A      + M+    + T  Y++P
Sbjct: 124 -KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSP 177

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/180 (22%), Positives = 78/180 (43%), Gaps = 20/180 (11%)
Query: 667 IGTGGFGSVYKGSFLD----GMEVAIKVFHLQLEGALKS---FDVECEVLKSVRHRNLVK 719
           +G G FG VY+G+  D      E  + V  +    +L+    F  E  V+K     ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD---------ILQRLSVIIDVALALE 770
           ++   +      +V+E M +G L+ YL S     +         + + + +  ++A  + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMAP 829
           YL+   +   VH D+   N ++  D    + DFG+ + +   +   K    L  + +MAP
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 73/167 (43%), Gaps = 19/167 (11%)
Query: 657 ATNQFNASNLIGTGGFGSVY----KGSFLDGMEVAIKVFHLQLEGALKS---FDVECEVL 709
           A  +   S  +G G FG VY    KG   D  E  + +  +    +++    F  E  V+
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 710 KSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYS------NNFSF---DILQRLS 760
           K     ++V+++   +      +++E M  G L+ YL S      NN       + + + 
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           +  ++A  + YL+   +N  VH D+   N ++ +D    + DFG+ +
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/62 (35%), Positives = 35/62 (56%), Gaps = 3/62 (4%)
Query: 759 LSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT 818
           L + I +A A+E+LH   S  ++H D+KPSN+    D V  + DFG+   +  +E  +  
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 819 LT 820
           LT
Sbjct: 224 LT 225

>pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 112/279 (40%), Gaps = 46/279 (16%)
Query: 158 EIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLP 217
           +  Y  G  ++LE++  +     G  PT    L ++K L   SN   G+  S +DL   P
Sbjct: 299 DFSYNFG-WQHLELVNCKF----GQFPT--LKLKSLKRLTFTSNK-GGNAFSEVDL---P 347
Query: 218 NLEIISLAGN--NFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYN 275
           +LE + L+ N  +F G      F  + L  L+L  N       N LG L +LE L   ++
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLG-LEQLEHLDFQHS 406
Query: 276 XXXXXXXXXXXXXXWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTI 335
                         + + +NL  LD                         IS+   R   
Sbjct: 407 NLKQMSEFSV----FLSLRNLIYLD-------------------------ISHTHTRVAF 437
Query: 336 PKEIGNLINLRELGLWGNELIGS-IPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLS 394
                 L +L  L + GN    + +P  F +L+NL  LDL   +LE   P     L+ L 
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497
Query: 395 VLYMDGNKLSGPIPPCIGD-LTSLRLLSLASNELNSVIP 432
           VL M  N+L   +P  I D LTSL+ + L +N  +   P
Sbjct: 498 VLNMASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCP 535

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 81/182 (44%), Gaps = 22/182 (12%)
Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVEC-----EVLKSV 712
           + F    ++G G FG V      + G   A+KV  L+ +  L+  DVEC      +L   
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLA 80
Query: 713 R-HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
           R H  L ++       D    V+E++  G L  ++  +   FD  +      ++  AL +
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMF 139
Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATI----GYM 827
           LH      +++ D+K  NVLLD +    L+DFG+ K     E +   +T AT      Y+
Sbjct: 140 LH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGICNGVTTATFCGTPDYI 191
Query: 828 AP 829
           AP
Sbjct: 192 AP 193

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 34/194 (17%)
Query: 663 ASNLIGTGGFGSV-YKGSFLDGMEVAIKVFHLQL-EGALKSFDVECEVL-KSVRHRNLVK 719
           +  ++G G  G+V ++GSF  G  VA+K   +   + AL    +E ++L +S  H N+++
Sbjct: 19  SEKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIAL----MEIKLLTESDDHPNVIR 73
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD--ILQR----LSVIIDVALALEYLH 773
              S T + F  + LE + N +L+D + S N S +   LQ+    +S++  +A  + +LH
Sbjct: 74  YYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 774 FGYSNPVVHCDIKPSNVLL--------DKDMVAH-----LSDFGIAKLL-SGEESMKQTL 819
              S  ++H D+KP N+L+        D+   A      +SDFG+ K L SG+   +  L
Sbjct: 133 ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 189
Query: 820 T--LATIGYMAPGL 831
                T G+ AP L
Sbjct: 190 NNPSGTSGWRAPEL 203

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 73/167 (43%), Gaps = 19/167 (11%)
Query: 657 ATNQFNASNLIGTGGFGSVY----KGSFLDGMEVAIKVFHLQLEGALKS---FDVECEVL 709
           A  +   S  +G G FG VY    KG   D  E  + +  +    +++    F  E  V+
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 710 KSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYS------NNFSF---DILQRLS 760
           K     ++V+++   +      +++E M  G L+ YL S      NN       + + + 
Sbjct: 73  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 132
Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           +  ++A  + YL+   +N  VH D+   N ++ +D    + DFG+ +
Sbjct: 133 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 176

>pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 103/245 (42%), Gaps = 41/245 (16%)
Query: 138 GLGNLTSLKTLYLGFNNLTGEIPYE---------------------MGNLRNLEILGLQL 176
            L NLT+L+ LYL  +N++   P                       + N   L  L +  
Sbjct: 105 ALQNLTNLRELYLNEDNISDISPLANLTKXYSLNLGANHNLSDLSPLSNXTGLNYLTVTE 164
Query: 177 NKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSF 236
           +K+    P  I NL+ + +L+L  N +    P    L  L +L   +   N  + I P  
Sbjct: 165 SKVKDVTP--IANLTDLYSLSLNYNQIEDISP----LASLTSLHYFTAYVNQITDITP-- 216
Query: 237 IFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNXXXXXXXXXXXXXXWANCKNL 296
           + N ++L+ L++G N  +   P  L NL +L WL +  N                +   L
Sbjct: 217 VANXTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINAV-------KDLTKL 267
Query: 297 KLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELI 356
           K L++ +N I+ +  S + NLS  L+ +F++N  +     + IG L NL  L L  N + 
Sbjct: 268 KXLNVGSNQISDI--SVLNNLS-QLNSLFLNNNQLGNEDXEVIGGLTNLTTLFLSQNHIT 324
Query: 357 GSIPI 361
              P+
Sbjct: 325 DIRPL 329

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 79/180 (43%), Gaps = 15/180 (8%)
Query: 658 TNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRH 714
           T ++     +G G F  V +    L G E A  + + +   A   +  + E  + + ++H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSL-EDYLYSNNFS-FDILQRLSVIIDVALALEYL 772
            N+V++  S +      L+ + +  G L ED +    +S  D    +  I++  L    +
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 773 HFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
                  VVH ++KP N+LL    K     L+DFG+A  + GE+         T GY++P
Sbjct: 130 ------GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSP 182

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 83/195 (42%), Gaps = 29/195 (14%)
Query: 652 KELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--------EGALKSFD 703
           K++      F    +IG G FG V     +  ++ A KVF +++              F 
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVA----VVKLKNADKVFAMKILNKWEMLKRAETACFR 122
Query: 704 VECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSL-------EDYLYSNNFSFDIL 756
            E +VL +   + +  +  +  +++   LV++Y   G L       ED L      F  L
Sbjct: 123 EERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARF-YL 181
Query: 757 QRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK 816
             + + ID    L Y         VH DIKP N+L+D +    L+DFG    L  + +++
Sbjct: 182 AEMVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232
Query: 817 QTLTLATIGYMAPGL 831
            ++ + T  Y++P +
Sbjct: 233 SSVAVGTPDYISPEI 247

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 88/192 (45%), Gaps = 40/192 (20%)
Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKI----- 720
           +G GG G V+     D    VAIK   L    ++K    E ++++ + H N+VK+     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 721 ---------ISSCTNNDFKALVLEYMPNGSLEDYL--------YSNNFSFDILQRLSVII 763
                    + S T  +   +V EYM    L + L        ++  F + +L+      
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQLLR------ 131
Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLD-KDMVAHLSDFGIAKLLSGEESMKQTLT-- 820
                L+Y+H   S  V+H D+KP+N+ ++ +D+V  + DFG+A+++    S K  L+  
Sbjct: 132 ----GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 821 LATIGYMAPGLF 832
           L T  Y +P L 
Sbjct: 185 LVTKWYRSPRLL 196

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 87/191 (45%), Gaps = 24/191 (12%)
Query: 658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVA----IKVFHLQLEGALKSFDVECEVLKSVR 713
           ++ F   +L+G G +G V   +     E+     I+ F   L  AL++   E ++LK  +
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL-FALRTLR-EIKILKHFK 67
Query: 714 HRNLVKIISSCTNNDFK----ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL 769
           H N++ I +    + F+      +++ +    L   + +   S D +Q    I     A+
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF--IYQTLRAV 125
Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--------- 820
           + LH    + V+H D+KPSN+L++ +    + DFG+A+++    +     T         
Sbjct: 126 KVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 821 LATIGYMAPGL 831
           +AT  Y AP +
Sbjct: 183 VATRWYRAPEV 193

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/180 (22%), Positives = 78/180 (43%), Gaps = 20/180 (11%)
Query: 667 IGTGGFGSVYKGSFLD----GMEVAIKVFHLQLEGALKS---FDVECEVLKSVRHRNLVK 719
           +G G FG VY+G+  D      E  + V  +    +L+    F  E  V+K     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD---------ILQRLSVIIDVALALE 770
           ++   +      +V+E M +G L+ YL S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMAP 829
           YL+   +   VH D+   N ++  D    + DFG+ + +   +   K    L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 82/191 (42%), Gaps = 30/191 (15%)
Query: 656 QATNQFNASNLIGTGGFGSVYKGSFLDG-MEVAIKVFHLQ--LEGA------LKSFDVEC 706
           + + +++  + +G+G FG V+     +   EV +K    +  LE        L    +E 
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 707 EVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSF-DILQRLS----- 760
            +L  V H N++K++    N  F  LV+E   +G        + F+F D   RL      
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGL-------DLFAFIDRHPRLDEPLAS 133
Query: 761 -VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL 819
            +   +  A+ YL       ++H DIK  N+++ +D    L DFG A  L   E  K   
Sbjct: 134 YIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFY 187
Query: 820 TLA-TIGYMAP 829
           T   TI Y AP
Sbjct: 188 TFCGTIEYCAP 198

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/167 (21%), Positives = 71/167 (42%), Gaps = 19/167 (11%)
Query: 657 ATNQFNASNLIGTGGFGSVY----KGSFLDGMEVAIKVFHLQLEGALKS---FDVECEVL 709
           A  +   S  +G G FG VY    KG   D  E  + +  +    +++    F  E  V+
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 710 KSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD---------ILQRLS 760
           K     ++V+++   +      +++E M  G L+ YL S     +         + + + 
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           +  ++A  + YL+   +N  VH D+   N  + +D    + DFG+ +
Sbjct: 130 MAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTR 173

>pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 96/234 (41%), Gaps = 11/234 (4%)
Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYN-KLRGEIPQELGNLAELELVSLTNNFLSG 59
           +L L  N L+         L +L++L L  N +LR   P     L  L  + L    L  
Sbjct: 59  ILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE 118
Query: 60  TIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQ-C 118
             P     L++L   +   +N+L  +LPDD  R L  +  L++  N+++  +P   ++  
Sbjct: 119 LGPGLFRGLAALQY-LYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGL 175
Query: 119 KELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNK 178
             L  + L  N+     P    +L  L TLYL  NNL+      +  LR L+ L L  N 
Sbjct: 176 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP 235
Query: 179 LVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGI 232
            V          + ++     S+ +  SLP      RL   ++  LA N+  G 
Sbjct: 236 WVCDCRARPL-WAWLQKFRGSSSEVPCSLPQ-----RLAGRDLKRLAANDLQGC 283

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 65/137 (47%), Gaps = 17/137 (12%)
Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLE------GALKSFDVECEVLKSVRHRNLVKI 720
           IG G F +VYKG  LD  E  ++V   +L+         + F  E E LK ++H N+V+ 
Sbjct: 34  IGRGSFKTVYKG--LD-TETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRF 90
Query: 721 I----SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRL-SVIIDVALALEYLHFG 775
                S+        LV E   +G+L+ YL    F    ++ L S    +   L++LH  
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLKTYL--KRFKVXKIKVLRSWCRQILKGLQFLH-T 147
Query: 776 YSNPVVHCDIKPSNVLL 792
            + P++H D+K  N+ +
Sbjct: 148 RTPPIIHRDLKCDNIFI 164

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 31/201 (15%)
Query: 646 RRRFSYKELLQAT-----NQFNASNLIGTGGFGSVYKGSFLD---GMEVAIKVFH--LQL 695
           R++  YK+ +  T       + +   +G+G +GSV   S +D   G +VAIK      Q 
Sbjct: 6   RKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSV--CSAIDKRSGEKVAIKKLSRPFQS 63
Query: 696 EGALKSFDVECEVLKSVRHRNLVKII------SSCTN-NDFKALVLEYMPNGSLEDYLYS 748
           E   K    E  +LK ++H N++ ++      SS  N  DF  LV+ +M     +  +  
Sbjct: 64  EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF-YLVMPFMQTDLQK--IMG 120
Query: 749 NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL 808
             FS + +Q L  +  +   L+Y+H   S  VVH D+KP N+ +++D    + DFG+A+ 
Sbjct: 121 LKFSEEKIQYL--VYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH 175
Query: 809 LSGEESMKQTLTLATIGYMAP 829
              E     T  + T  Y AP
Sbjct: 176 ADAE----MTGYVVTRWYRAP 192

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 39/198 (19%)
Query: 636 IESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGS-FLDGME-----VAIK 689
           I+   LP   +  F    L     QF  +  +G G FG V + + F  G E     VA+K
Sbjct: 30  IDPTQLPYNEKWEFPRNNL-----QFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVK 82
Query: 690 VF----HLQLEGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVLEYMPNGSLED 744
           +     H   + AL S   E +++  + +H N+V ++ +CT+     ++ EY   G L +
Sbjct: 83  MLKSTAHADEKEALMS---ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 745 YL---------YSNNFSFDILQRLS------VIIDVALALEYLHFGYSNPVVHCDIKPSN 789
           +L         YS N S +  ++LS          VA  + +L    S   +H D+   N
Sbjct: 140 FLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARN 196
Query: 790 VLLDKDMVAHLSDFGIAK 807
           VLL    VA + DFG+A+
Sbjct: 197 VLLTNGHVAKIGDFGLAR 214

>pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 96/234 (41%), Gaps = 11/234 (4%)
Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYN-KLRGEIPQELGNLAELELVSLTNNFLSG 59
           +L L  N L+         L +L++L L  N +LR   P     L  L  + L    L  
Sbjct: 60  ILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE 119
Query: 60  TIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQ-C 118
             P     L++L   +   +N+L  +LPDD  R L  +  L++  N+++  +P   ++  
Sbjct: 120 LGPGLFRGLAALQY-LYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGL 176
Query: 119 KELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNK 178
             L  + L  N+     P    +L  L TLYL  NNL+      +  LR L+ L L  N 
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP 236
Query: 179 LVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGI 232
            V          + ++     S+ +  SLP      RL   ++  LA N+  G 
Sbjct: 237 WVCDCRARPL-WAWLQKFRGSSSEVPCSLPQ-----RLAGRDLKRLAANDLQGC 284

>pdb|3RG1|A Chain A, Crystal Structure Of The Rp105MD-1 Complex Length = 612

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 76/316 (24%), Positives = 127/316 (40%), Gaps = 56/316 (17%)
Query: 152 FNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNAL-------S 204
           F++L+         ++ L++    LN L    P+ I  ++++K L L +N+        +
Sbjct: 265 FSDLSSSTFRCFTRVQELDLTAAHLNGL----PSGIEGMNSLKKLVLNANSFDQLCQINA 320
Query: 205 GSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSF--SGFIPNTLG 262
            S PS  DL    N+  + L       +          L  L+L  +    S      L 
Sbjct: 321 ASFPSLRDLYIKGNMRKLDLGTRCLEKL--------ENLQKLDLSHSDIEASDCCNLQLK 372
Query: 263 NLRKLEWLRLSYNXXXXXXXXXXXXXXWANCKNLKLLDLSNNPINGVLPSS-IGNLSLSL 321
           NLR L++L LSYN              +  C  L+LLD++   ++   P S   NL L L
Sbjct: 373 NLRHLQYLNLSYN-----EPLGLEDQAFKECPQLELLDVAFTHLHVKAPHSPFQNLHL-L 426
Query: 322 SRIFISNCSIRGTIPKEIGNLINLRELGLWGN-------------ELIGSIPI------- 361
             + +S+C +  +    +  L +LR L L GN             +++GS+ I       
Sbjct: 427 RVLNLSHCLLDTSNQHLLAGLQDLRHLNLQGNSFQDGSISKTNLLQMVGSLEILILSSCN 486
Query: 362 -------TFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDL 414
                   F  L+N+  LDL +N L G   + L  L  L  L M  N +    P  +  L
Sbjct: 487 LLSIDQQAFHGLRNVNHLDLSHNSLTGDSMDALSHLKGL-YLNMASNNIRIIPPHLLPAL 545
Query: 415 TSLRLLSLASNELNSV 430
           +   +++L+ N L+  
Sbjct: 546 SQQSIINLSHNPLDCT 561

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/180 (22%), Positives = 77/180 (42%), Gaps = 20/180 (11%)
Query: 667 IGTGGFGSVYKGSFLD----GMEVAIKVFHLQLEGALKS---FDVECEVLKSVRHRNLVK 719
           +G G FG VY+G+  D      E  + V  +    +L+    F  E  V+K     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD---------ILQRLSVIIDVALALE 770
           ++   +      +V+E M +G L+ YL S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMAP 829
           YL+   +   VH D+   N ++  D    + DFG+ + +       K    L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/193 (24%), Positives = 82/193 (42%), Gaps = 31/193 (16%)
Query: 636 IESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL-----DG-MEVAIK 689
           I+   LP   +  F    L     QF  +  +G G FG V + +       D  ++VA+K
Sbjct: 30  IDPTQLPYNEKWEFPRNNL-----QFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVK 82
Query: 690 VF----HLQLEGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVLEYMPNGSLED 744
           +     H   + AL S   E +++  + +H N+V ++ +CT+     ++ EY   G L +
Sbjct: 83  MLKSTAHADEKEALMS---ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 745 YLYSNNFSFDILQRLSVIIDVALALEYLHFG----------YSNPVVHCDIKPSNVLLDK 794
           +L   +   +     ++        + LHF            S   +H D+   NVLL  
Sbjct: 140 FLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199
Query: 795 DMVAHLSDFGIAK 807
             VA + DFG+A+
Sbjct: 200 GHVAKIGDFGLAR 212

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 21/52 (40%), Positives = 30/52 (57%)
Query: 781 VHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
            H D+KP N+L+  D  A+L DFGIA   + E+  +   T+ T+ Y AP  F
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERF 207

>pdb|3V44|A Chain A, Crystal Structure Of The N-Terminal Fragment Of Zebrafish Tlr5 Length = 407

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 109/291 (37%), Gaps = 28/291 (9%)
Query: 166 LRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLA 225
           L +L IL L  N+ +     +   L+ ++ L L    L G++ S      L +LE++ L 
Sbjct: 78  LSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLR 137
Query: 226 GNNFSGIIP-SFIFNASKLSVLELGENSFSGFIPNTLGNL--RKLEWLRLSYNXXXXXXX 282
            NN   I P SF  N  +  VL+L  N         L N   +    LRLS         
Sbjct: 138 DNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLS---SITLQD 194
Query: 283 XXXXXXXWANCKN------LKLLDLSNNPINGVLPSSIGNL-------SLSLSRIFISNC 329
                  W  C N      +  LDLS N     +     +        SL LS  +    
Sbjct: 195 MNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGS 254
Query: 330 SIRGTIPKEIGNLI-------NLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGP 382
           S   T  K+  N          ++   L  +++   +   F    +L+ L L  N++   
Sbjct: 255 SFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKI 314
Query: 383 IPNGLCQLARLSVLYMDGNKLSGPIPPCIGD-LTSLRLLSLASNELNSVIP 432
             N    L  L  L +D N+L   +P  I D LTSL+ + L +N  +   P
Sbjct: 315 DDNAFWGLTHLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCP 364

>pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 75/171 (43%), Gaps = 14/171 (8%)
Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
           IP+    L   STG+         +L D   R L  +  L +  N+L            E
Sbjct: 33  IPADTEKLDLQSTGL--------ATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTE 84
Query: 121 LIVISLAYNQFTERIPRGL-GNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKL 179
           L  + LA NQ    +P G+  +LT L  LYLG N L          L  L+ L L  N+L
Sbjct: 85  LGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL 143
Query: 180 VGFVPTSIFN-LSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNF 229
              +P   F+ L+ ++TL+L +N L      + D  RL  L+ I+L GN F
Sbjct: 144 QS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFD--RLGKLQTITLFGNQF 191

>pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 75/171 (43%), Gaps = 14/171 (8%)
Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
           IP+    L   STG+         +L D   R L  +  L +  N+L            E
Sbjct: 33  IPADTEKLDLQSTGL--------ATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTE 84
Query: 121 LIVISLAYNQFTERIPRGL-GNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKL 179
           L  + LA NQ    +P G+  +LT L  LYLG N L          L  L+ L L  N+L
Sbjct: 85  LGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL 143
Query: 180 VGFVPTSIFN-LSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNF 229
              +P   F+ L+ ++TL+L +N L      + D  RL  L+ I+L GN F
Sbjct: 144 QS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFD--RLGKLQTITLFGNQF 191

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 36/136 (26%), Positives = 66/136 (48%), Gaps = 11/136 (8%)
Query: 673 GSVYKGSFLDGMEVAIKVFHLQLEGALKS--FDVECEVLKSVRHRNLVKIISSCTN--ND 728
           G ++KG +  G ++ +KV  ++     KS  F+ EC  L+   H N++ ++ +C +    
Sbjct: 24  GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 729 FKALVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALALEYLHFGYSNPVV--HCDI 785
              L+  + P GSL + L+   NF  D  Q +   +D A    +LH     P++  H  +
Sbjct: 83  HPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH--TLEPLIPRHA-L 139
Query: 786 KPSNVLLDKDMVAHLS 801
              +V +D+D  A +S
Sbjct: 140 NSRSVXIDEDXTARIS 155

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 78/181 (43%), Gaps = 13/181 (7%)
Query: 658 TNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHR 715
              ++    +G G +G V    + +    VA+K+  ++      ++   E  + K + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLH- 773
           N+VK        + + L LEY   G L D +  +        QR      +   + YLH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHG 122
Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL--SGEESMKQTLTLATIGYMAPGL 831
            G    + H DIKP N+LLD+     +SDFG+A +   +  E +   +   T+ Y+AP L
Sbjct: 123 IG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 177
Query: 832 F 832
Sbjct: 178 L 178

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 78/181 (43%), Gaps = 13/181 (7%)
Query: 658 TNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHR 715
              ++    +G G +G V    + +    VA+K+  ++      ++   E  + K + H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLH- 773
           N+VK        + + L LEY   G L D +  +        QR      +   + YLH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLHG 122
Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL--SGEESMKQTLTLATIGYMAPGL 831
            G    + H DIKP N+LLD+     +SDFG+A +   +  E +   +   T+ Y+AP L
Sbjct: 123 IG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX-GTLPYVAPEL 177
Query: 832 F 832
Sbjct: 178 L 178

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 11/171 (6%)
Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVKIISSC 724
           +G G +G V    + +    VA+K+  ++      ++   E  + K + H N+VK     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 725 TNNDFKALVLEYMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
              + + L LEY   G L D +  +        QR      +   + YLH      + H 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITHR 129
Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLL--SGEESMKQTLTLATIGYMAPGLF 832
           DIKP N+LLD+     +SDFG+A +   +  E +   +   T+ Y+AP L 
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX-GTLPYVAPELL 179

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 85/196 (43%), Gaps = 34/196 (17%)
Query: 665 NLIGTGGFGSVYKGSFLD------GMEVAIKVFHLQLEGALK-SFDVECEVLKSV-RHRN 716
            ++G+G FG V   +          ++VA+K+   + + + + +   E +++  +  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYS--NNFSFDILQR---------------- 758
           +V ++ +CT +    L+ EY   G L +YL S    FS D ++                 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 759 ----LSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK-LLSGEE 813
               L     VA  +E+L F      VH D+   NVL+    V  + DFG+A+ ++S   
Sbjct: 171 FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 814 SMKQTLTLATIGYMAP 829
            + +      + +MAP
Sbjct: 228 YVVRGNARLPVKWMAP 243

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 39/180 (21%), Positives = 78/180 (43%), Gaps = 20/180 (11%)
Query: 667 IGTGGFGSVYKGSFLD----GMEVAIKVFHLQLEGALKS---FDVECEVLKSVRHRNLVK 719
           +G G FG VY+G+  D      E  + V  +    +L+    F  E  V+K     ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD---------ILQRLSVIIDVALALE 770
           ++   +      +V+E M +G L+ YL S     +         + + + +  ++A  + 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMAP 829
           YL+   +   VH ++   N ++  D    + DFG+ + +   +   K    L  + +MAP
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 25/80 (31%), Positives = 44/80 (55%), Gaps = 7/80 (8%)
Query: 732 LVLEYMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNV 790
           +++E M  G L   +    + +F   +   ++ D+  A+++LH   S+ + H D+KP N+
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENL 159
Query: 791 LL---DKDMVAHLSDFGIAK 807
           L    +KD V  L+DFG AK
Sbjct: 160 LYTSKEKDAVLKLTDFGFAK 179

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 39/180 (21%), Positives = 78/180 (43%), Gaps = 20/180 (11%)
Query: 667 IGTGGFGSVYKGSFLD----GMEVAIKVFHLQLEGALKS---FDVECEVLKSVRHRNLVK 719
           +G G FG VY+G+  D      E  + V  +    +L+    F  E  V+K     ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD---------ILQRLSVIIDVALALE 770
           ++   +      +V+E M +G L+ YL S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK-LLSGEESMKQTLTLATIGYMAP 829
           YL+   +   VH ++   N ++  D    + DFG+ + +   +   K    L  + +MAP
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	832
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-178
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-142
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-127
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-88
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-76
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-100
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-98
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-93
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-70
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-57
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-95
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-86
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-78
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-71
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-66
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-52
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-32
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-90
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-83
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-74
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-37
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-36
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-25
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-85
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-75
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-72
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-35
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-24
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-83
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-63
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-59
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-57
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-54
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-83
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-65
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-47
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-46
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-77
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-48
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-32
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-22
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-62
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-59
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-57
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-55
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-43
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-41
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-26
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-24
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	8e-11
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-57
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-57
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-55
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-26
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-24
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-15
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-53
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-52
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-52
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-49
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-50
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-45
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-41
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-19
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-50
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-43
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-29
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-24
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-24
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-49
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-48
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-42
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-42
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-37
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-26
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-47
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-41
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-40
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-33
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-29
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-28
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-15
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-46
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-45
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-44
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-43
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-37
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-36
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-35
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-33
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-26
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-22
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-11
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-43
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-43
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-43
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-42
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-42
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-38
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-34
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-16
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-42
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-42
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-42
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-41
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-41
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-41
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-39
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-39
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-37
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-33
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-15
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-39
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-34
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-19
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-37
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-37
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-36
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	8e-32
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	8e-29
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-28
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-23
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-12
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-36
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-35
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-33
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-33
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-30
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-36
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-35
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-25
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-12
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-12
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	8e-36
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-33
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-25
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-23
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	9e-21
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	8e-20
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-35
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-33
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-32
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-31
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-15
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-10
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-35
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-33
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-33
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-31
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-29
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-29
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	9e-29
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-27
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-25
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-06
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-06
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-31
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-31
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-30
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-30
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-30
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	8e-30
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-29
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-29
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-29
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-29
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-29
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-29
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-28
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-28
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-28
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-28
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-28
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-24
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-24
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-08
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-28
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-28
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-28
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-27
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-27
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-27
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-24
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-23
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-20
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-28
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-28
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-28
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-27
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-25
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-24
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-23
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-28
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-27
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-27
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-27
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-26
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-24
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-20
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-19
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-27
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-27
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-27
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-27
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-27
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-26
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-26
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-26
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-25
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-25
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-24
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-23
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-26
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-26
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-26
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-24
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-23
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-23
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-21
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-16
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-26
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-26
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-26
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-26
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-26
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-26
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	8e-26
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-26
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-25
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-25
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-25
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-25
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-25
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-24
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-24
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-23
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-25
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-25
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	8e-25
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	9e-25
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-24
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-24
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-24
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-24
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-24
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-24
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-24
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-24
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-21
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-20
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-24
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-24
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	8e-24
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-23
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-23
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-23
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-22
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-22
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-22
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-22
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-22
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-22
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-22
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	8e-22
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-21
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-21
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-21
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-21
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-21
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-21
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	8e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-16
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-11
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-11
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-21
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-21
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-21
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-21
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	9e-21
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-20
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-18
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-14
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-17
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-17
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-15
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-15
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-17
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-13
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-05
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-20
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-20
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-20
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-20
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-20
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-20
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-20
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	8e-20
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-20
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-19
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-19
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-19
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-19
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-19
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-19
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-19
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-19
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-19
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-19
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	6e-18
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	6e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	6e-14
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-09
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-19
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-19
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-19
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-19
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-19
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-19
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-18
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-18
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-18
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-18
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-18
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-18
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-18
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-18
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-18
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	8e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	9e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-16
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	8e-18
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-18
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-18
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	9e-18
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-17
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-17
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-17
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-17
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	9e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-16
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	6e-08
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-17
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-16
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-16
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-13
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-08
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-04
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-17
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-17
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-05
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-17
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-16
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-16
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-16
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-16
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-16
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	8e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	9e-16
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-11
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-09
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	7e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	9e-11
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-15
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	7e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	9e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-12
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-14
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-07
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-14
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-14
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-14
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-14
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-14
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-08
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-04
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-13
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	9e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	8e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	8e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-13
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-12
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-12
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	6e-12
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-04
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	8e-12
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-12
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	8e-12
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-10
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-05
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	8e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-11
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-11
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-05
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-11
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-11
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-05
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	8e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	8e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	8e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	9e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-04
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	9e-11
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-07
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-10
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-10
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-10
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-10
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-09
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	4e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	7e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	8e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-06
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-05
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-09
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	8e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	4e-06
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	7e-06
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	5e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	5e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	9e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	8e-05
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-07
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-04
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	5e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	8e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	9e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	9e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-06
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-06
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-06
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	2e-06
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	5e-06
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	2e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	5e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	4e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	4e-05
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	1e-04
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	6e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  531 bits (1370), Expect = e-178
 Identities = 190/599 (31%), Positives = 284/599 (47%), Gaps = 25/599 (4%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L++S N +SG +   +     L+ L +  N     IP  LG+ + L+ + ++ N LSG  
Sbjct: 183 LAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDF 239

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIW-QCKE 120
              I   + L   ++ S+N   G +P    + L   + L ++ NK TG IP+ +   C  
Sbjct: 240 SRAISTCTELKL-LNISSNQFVGPIPPLPLKSL---QYLSLAENKFTGEIPDFLSGACDT 295

Query: 121 LIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEM-GNLRNLEILGLQLNKL 179
           L  + L+ N F   +P   G+ + L++L L  NN +GE+P +    +R L++L L  N+ 
Sbjct: 296 LTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEF 355

Query: 180 VGFVPTSIFNLSA-MKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIF 238
            G +P S+ NLSA + TL L SN  SG +  ++       L+ + L  N F+G IP  + 
Sbjct: 356 SGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLS 415

Query: 239 NASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKL 298
           N S+L  L L  N  SG IP++LG+L KL  L+L  N L                K L+ 
Sbjct: 416 NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGE-----IPQELMYVKTLET 470

Query: 299 LDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGS 358
           L L  N + G +PS + N + +L+ I +SN  + G IPK IG L NL  L L  N   G+
Sbjct: 471 LILDFNDLTGEIPSGLSNCT-NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGN 529

Query: 359 IPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLR 418
           IP   G  ++L  LDL  N   G IP  + + +      +  N ++G     I +    +
Sbjct: 530 IPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKK 585

Query: 419 LLSLASN--ELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLS 476
               A N  E   +       L      N +S    G       N   ++ +D+S N LS
Sbjct: 586 ECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLS 645

Query: 477 GDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLY 536
           G IP  IG +  L  L+L  N + GSIP  +G L  L  LDLS+N L G IP +M  L  
Sbjct: 646 GYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTM 705

Query: 537 LKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCKSGNSSSHRKSRK 595
           L +++LS N L G IP  G F  F    F+ N  LCG     +P C   N+  +   ++
Sbjct: 706 LTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGY---PLPRCDPSNADGYAHHQR 761

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  437 bits (1127), Expect = e-142
 Identities = 164/575 (28%), Positives = 253/575 (44%), Gaps = 45/575 (7%)

Query: 3   SLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIP 62
           S   N    A+   + +LT L+ L L  + + G +       A L  + L+ N LSG + 
Sbjct: 59  SKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVT 117

Query: 63  S--TIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQ--- 117
           +  ++ + S L   ++ S+N+L          +L  ++ L +S N ++G           
Sbjct: 118 TLTSLGSCSGLKF-LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDG 176

Query: 118 CKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLN 177
           C EL  ++++ N+ +  +   +    +L+ L +  NN +  IP  +G+   L+ L +  N
Sbjct: 177 CGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGN 233

Query: 178 KLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFI 237
           KL G    +I   + +K L + SN   G +P       L +L+ +SLA N F+G IP F+
Sbjct: 234 KLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP----LKSLQYLSLAENKFTGEIPDFL 289

Query: 238 F-NASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNL 296
                 L+ L+L  N F G +P   G+   LE L LS N  +          +    + L
Sbjct: 290 SGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM----DTLLKMRGL 345

Query: 297 KLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELI 356
           K+LDLS N  +G LP S+ NLS SL  + +S+ +  G I   +                 
Sbjct: 346 KVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQN-------------- 391

Query: 357 GSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTS 416
                       LQ L L NN   G IP  L   + L  L++  N LSG IP  +G L+ 
Sbjct: 392 --------PKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSK 443

Query: 417 LRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLS 476
           LR L L  N L   IP     +K + +L    N L G +P  + N   +  I LS N L+
Sbjct: 444 LRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLT 503

Query: 477 GDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLY 536
           G+IP  IG L NL  L L +N   G+IP  +G   SL  LDL+ N  +G IP +M K   
Sbjct: 504 GEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS- 562

Query: 537 LKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLL 571
                ++ N + G+                  +LL
Sbjct: 563 ---GKIAANFIAGKRYVYIKNDGMKKECHGAGNLL 594

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  398 bits (1024), Expect = e-127
 Identities = 153/523 (29%), Positives = 245/523 (46%), Gaps = 25/523 (4%)

Query: 42  GNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLY 101
             +  ++L S   N     + S++ +L+ L + +  SN+ + GS+     +    +  L 
Sbjct: 50  DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLES-LFLSNSHINGSVSG--FKCSASLTSLD 106

Query: 102 MSNNKLTGPIP--NNIWQCKELIVISLAYNQFTERIPR-GLGNLTSLKTLYLGFNNLTGE 158
           +S N L+GP+    ++  C  L  ++++ N         G   L SL+ L L  N+++G 
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166

Query: 159 IPYEM---GNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVR 215
                        L+ L +  NK+ G V   +     ++ L + SN  S  +P    L  
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF---LGD 221

Query: 216 LPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYN 275
              L+ + ++GN  SG     I   ++L +L +  N F G IP     L+ L++L L+ N
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAEN 279

Query: 276 FLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTI 335
             T    +         C  L  LDLS N   G +P   G+ S  L  + +S+ +  G +
Sbjct: 280 KFTGEIPD----FLSGACDTLTGLDLSGNHFYGAVPPFFGSCS-LLESLALSSNNFSGEL 334

Query: 336 PKE-IGNLINLRELGLWGNELIGSIPITFGKL-QNLQGLDLVNNKLEGPIPNGLCQ--LA 391
           P + +  +  L+ L L  NE  G +P +   L  +L  LDL +N   GPI   LCQ    
Sbjct: 335 PMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKN 394

Query: 392 RLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFL 451
            L  LY+  N  +G IPP + + + L  L L+ N L+  IPS+  +L  +  L    N L
Sbjct: 395 TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNML 454

Query: 452 NGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLV 511
            G +P+++  +K +  + L  N+L+G+IP+ +    NL  +SL +N L G IPK IG L 
Sbjct: 455 EGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLE 514

Query: 512 SLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRG 554
           +L  L LSNNS SGNIP  +     L  L+L+ N   G IP  
Sbjct: 515 NLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  295 bits (758), Expect = 2e-88
 Identities = 110/407 (27%), Positives = 190/407 (46%), Gaps = 21/407 (5%)

Query: 164 GNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIIS 223
             + ++++    LN     V +S+ +L+ +++L L ++ ++GS+          +L  + 
Sbjct: 50  DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG---FKCSASLTSLD 106

Query: 224 LAGNNFSGIIPSF--IFNASKLSVLELGENSFSGFIPNTLG-NLRKLEWLRLSYNFLTSS 280
           L+ N+ SG + +   + + S L  L +  N+       + G  L  LE L LS N ++ +
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166

Query: 281 TSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIG 340
                 LS    C  LK L +S N I+G +   +     +L  + +S+ +    IP  +G
Sbjct: 167 NVVGWVLSD--GCGELKHLAISGNKISGDVD--VSRCV-NLEFLDVSSNNFSTGIP-FLG 220

Query: 341 NLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDG 400
           +   L+ L + GN+L G           L+ L++ +N+  GPIP    +   L  L +  
Sbjct: 221 DCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLK--SLQYLSLAE 278

Query: 401 NKLSGPIPPCI-GDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPED- 458
           NK +G IP  + G   +L  L L+ N     +P  F +   + SL  SSN  +G LP D 
Sbjct: 279 NKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDT 338

Query: 459 IGNLKVVVIIDLSRNNLSGDIPTAIGGL-MNLQDLSLRDNGLQGSIPKSIGG--LVSLES 515
           +  ++ + ++DLS N  SG++P ++  L  +L  L L  N   G I  ++      +L+ 
Sbjct: 339 LLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE 398

Query: 516 LDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSN 562
           L L NN  +G IP ++     L  L+LSFN L G IP      + S 
Sbjct: 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSS--LGSLSK 443

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  263 bits (675), Expect = 1e-76
 Identities = 113/412 (27%), Positives = 166/412 (40%), Gaps = 63/412 (15%)

Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
            L L  N  +G IP  + N + L  L L +N L G IP  LG+L++L  + L  N L G 
Sbjct: 398 ELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGE 457

Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
           IP  +  + +L T                          L +  N LTG IP+ +  C  
Sbjct: 458 IPQELMYVKTLET--------------------------LILDFNDLTGEIPSGLSNCTN 491

Query: 121 LIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLV 180
           L  ISL+ N+ T  IP+ +G L +L  L L  N+ +G IP E+G+ R+L  L L  N   
Sbjct: 492 LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFN 551

Query: 181 GFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNA 240
           G +P ++F  S      + +N ++G     I    +      +     F GI    +   
Sbjct: 552 GTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL 607

Query: 241 SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLD 300
           S  +   +    + G    T  N   + +L +SYN L+             +   L +L+
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSG-----YIPKEIGSMPYLFILN 662

Query: 301 LSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIP 360
           L +N           ++S              G+IP E+G+L  L  L L  N+L G IP
Sbjct: 663 LGHN-----------DIS--------------GSIPDEVGDLRGLNILDLSSNKLDGRIP 697

Query: 361 ITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKL--SGPIPPC 410
                L  L  +DL NN L GPIP    Q           N      P+P C
Sbjct: 698 QAMSALTMLTEIDLSNNNLSGPIPEMG-QFETFPPAKFLNNPGLCGYPLPRC 748

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  323 bits (831), Expect = e-100
 Identities = 117/584 (20%), Positives = 203/584 (34%), Gaps = 44/584 (7%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L+L  N+LS    K     T L +L L  N ++            L  + L++N LS T 
Sbjct: 78  LNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTK 137

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCR-RLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
             T   L +L   +  SNN +     +++       +K L +S+N++    P        
Sbjct: 138 LGTQVQLENLQE-LLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGR 196

Query: 121 LIVISLAYNQFTERIPRGLG---NLTSLKTLYLGFNNLTGEIPYEMGNLR--NLEILGLQ 175
           L  + L   Q    +   L      TS++ L L  + L+         L+  NL +L L 
Sbjct: 197 LFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLS 256

Query: 176 LNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPS 235
            N L      S   L  ++   L  N +      S+    L N+  ++L  +        
Sbjct: 257 YNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLH--GLFNVRYLNLKRS-------- 306

Query: 236 FIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKN 295
                   +   +   S       +   L+ LE L +  N +    S     + +    N
Sbjct: 307 -------FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS-----NMFTGLIN 354

Query: 296 LKLLDLSNNPINGVLPSS---IGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWG 352
           LK L LSN+  +    ++   +      L  + ++   I          L +L  L L  
Sbjct: 355 LKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGL 414

Query: 353 NELIGSIPI-TFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSG--PIPP 409
           NE+   +    +  L+N+  + L  NK      N    +  L  L +    L      P 
Sbjct: 415 NEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPS 474

Query: 410 CIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLN--------GSLPEDIGN 461
               L +L +L L++N + ++       L+ +  L+   N L         G     +  
Sbjct: 475 PFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKG 534

Query: 462 LKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNN 521
           L  + I++L  N            L  L+ + L  N L           VSL+SL+L  N
Sbjct: 535 LSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594

Query: 522 SLSGNIPTSMEKLLY-LKDLNLSFNKLEGEIPRGGPFANFSNRS 564
            ++             L +L++ FN  +        F N+ N +
Sbjct: 595 LITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINET 638

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  320 bits (822), Expect = 2e-98
 Identities = 125/590 (21%), Positives = 224/590 (37%), Gaps = 42/590 (7%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
              S   L+  +P ++   T +  L L +N+LR          ++L  + +  N +S   
Sbjct: 9   ADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLE 65

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
           P     L  L   ++  +N L+  L D        +  L++ +N +     N   + K L
Sbjct: 66  PELCQKLPMLKV-LNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL 123

Query: 122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRN--LEILGLQLNKL 179
           I + L++N  +         L +L+ L L  N +      E+    N  L+ L L  N++
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183

Query: 180 VGFVPTSIFNLSAMKTLALPSNALSGSLPSSI-DLVRLPNLEIISLAGNNFSGIIPSFIF 238
             F P     +  +  L L +  L  SL   +   +   ++  +SL+ +  S    +   
Sbjct: 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243

Query: 239 N--ASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNL 296
               + L++L+L  N+ +    ++   L +LE+  L YN +    S      S     N+
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFS-----HSLHGLFNV 298

Query: 297 KLLDLSNN---------PINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRE 347
           + L+L  +          +  +   S   L   L  + + +  I G        LINL+ 
Sbjct: 299 RYLNLKRSFTKQSISLASLPKIDDFSFQWLK-CLEHLNMEDNDIPGIKSNMFTGLINLKY 357

Query: 348 LGLWGN--ELIGSIPITFGKLQN--LQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKL 403
           L L  +   L      TF  L +  L  L+L  NK+     +    L  L VL +  N++
Sbjct: 358 LSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEI 417

Query: 404 SGPIPP-CIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNG--SLPEDIG 460
              +       L ++  + L+ N+   +  ++F  +  +  L      L    S P    
Sbjct: 418 GQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 477

Query: 461 NLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQ--------GSIPKSIGGLVS 512
            L+ + I+DLS NN++      + GL  L+ L L+ N L         G     + GL  
Sbjct: 478 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSH 537

Query: 513 LESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSN 562
           L  L+L +N          + L  LK ++L  N L         F N  +
Sbjct: 538 LHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA--SVFNNQVS 585

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  306 bits (785), Expect = 4e-93
 Identities = 118/540 (21%), Positives = 206/540 (38%), Gaps = 33/540 (6%)

Query: 46  ELELVSLTNNFLSGTIPSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSN 104
             E+   ++  L+  +P  +  N++ L    + ++N L      +   R   +  L +  
Sbjct: 5   SHEVADCSHLKLT-QVPDDLPTNITVL----NLTHNQLRRLPAANF-TRYSQLTSLDVGF 58

Query: 105 NKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMG 164
           N ++   P    +   L V++L +N+ ++   +     T+L  L+L  N++         
Sbjct: 59  NTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV 118

Query: 165 NLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISL 224
             +NL  L L  N L      +   L  ++ L L +N +       +D+    +L+ + L
Sbjct: 119 KQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLEL 178

Query: 225 AGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLG---NLRKLEWLRLSYNFLTSST 281
           + N      P       +L  L L        +   L        +  L LS + L+++ 
Sbjct: 179 SSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTT- 237

Query: 282 SELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGN 341
           S  +FL       NL +LDLS N +N V   S   L   L   F+   +I+      +  
Sbjct: 238 SNTTFLGL--KWTNLTMLDLSYNNLNVVGNDSFAWLP-QLEYFFLEYNNIQHLFSHSLHG 294

Query: 342 LINLRELGLWGNELIGSI---------PITFGKLQNLQGLDLVNNKLEGPIPNGLCQLAR 392
           L N+R L L  +    SI           +F  L+ L+ L++ +N + G   N    L  
Sbjct: 295 LFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLIN 354

Query: 393 LSVLYMDGNKLSGPIPPCIG----DLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSS 448
           L  L +  +  S              + L +L+L  N+++ +    F  L  +  L+   
Sbjct: 355 LKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGL 414

Query: 449 NFLNGSLPED-IGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQG--SIPK 505
           N +   L       L+ +  I LS N        +   + +LQ L LR   L+   S P 
Sbjct: 415 NEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPS 474

Query: 506 SIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLE---GEIPRGGPFANFSN 562
               L +L  LDLSNN+++      +E L  L+ L+L  N L         GGP      
Sbjct: 475 PFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKG 534

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  244 bits (626), Expect = 2e-70
 Identities = 93/439 (21%), Positives = 171/439 (38%), Gaps = 30/439 (6%)

Query: 143 TSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNA 202
            S +        LT ++P ++    N+ +L L  N+L      +    S + +L +  N 
Sbjct: 4   VSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 203 LSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLG 262
           +S   P      +LP L++++L  N  S +        + L+ L L  NS      N   
Sbjct: 61  ISKLEPELCQ--KLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV 118

Query: 263 NLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSL-SL 321
             + L  L LS+N L+S+      L +    +NL+ L LSNN I  +    +   +  SL
Sbjct: 119 KQKNLITLDLSHNGLSSTK-----LGTQVQLENLQELLLSNNKIQALKSEELDIFANSSL 173

Query: 322 SRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFG---KLQNLQGLDLVNNK 378
            ++ +S+  I+   P     +  L  L L   +L  S+           +++ L L N++
Sbjct: 174 KKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQ 233

Query: 379 LEGPIPN--GLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFW 436
           L           +   L++L +  N L+         L  L    L  N +  +   +  
Sbjct: 234 LSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLH 293

Query: 437 NLKDILSLNFSSNFLNGSL---------PEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLM 487
            L ++  LN   +F   S+               LK +  +++  N++ G       GL+
Sbjct: 294 GLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI 353

Query: 488 NLQDLSLRDNGLQGSIPKSIG----GLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLS 543
           NL+ LSL ++        +          L  L+L+ N +S     +   L +L+ L+L 
Sbjct: 354 NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLG 413

Query: 544 FNKLEGEIPRGGPFANFSN 562
            N++  E+  G  +    N
Sbjct: 414 LNEIGQELT-GQEWRGLEN 431

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  207 bits (529), Expect = 3e-57
 Identities = 82/397 (20%), Positives = 145/397 (36%), Gaps = 33/397 (8%)

Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
           ML LS+N+L+         L  L+   L YN ++      L  L  +  ++L  +F    
Sbjct: 252 MLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQ- 310

Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
                            S  SL   + D   + L  ++ L M +N + G   N       
Sbjct: 311 ---------------SISLASLPK-IDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLIN 354

Query: 121 LIVISLAYNQF-----TERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQ 175
           L  +SL+ +       T      L + + L  L L  N ++         L +LE+L L 
Sbjct: 355 LKYLSLSNSFTSLRTLTNETFVSLAH-SPLHILNLTKNKISKIESDAFSWLGHLEVLDLG 413

Query: 176 LNKLVGFVPTSIF-NLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGI-- 232
           LN++   +    +  L  +  + L  N       +S     +P+L+ + L       +  
Sbjct: 414 LNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFA--LVPSLQRLMLRRVALKNVDS 471

Query: 233 IPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSW-- 290
            PS       L++L+L  N+ +    + L  L KLE L L +N L       +       
Sbjct: 472 SPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYF 531

Query: 291 -ANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELG 349
                +L +L+L +N  + +      +L   L  I +   ++         N ++L+ L 
Sbjct: 532 LKGLSHLHILNLESNGFDEIPVEVFKDLF-ELKIIDLGLNNLNTLPASVFNNQVSLKSLN 590

Query: 350 LWGNELIGSIPITFGK-LQNLQGLDLVNNKLEGPIPN 385
           L  N +       FG   +NL  LD+  N  +    +
Sbjct: 591 LQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  311 bits (799), Expect = 1e-95
 Identities = 92/583 (15%), Positives = 188/583 (32%), Gaps = 80/583 (13%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRG----EIPQELGNLAELELVSLTNNFL 57
           LSL     SG +P  IG LT L+ L LG +  +       P+ +      E         
Sbjct: 86  LSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHY 145

Query: 58  SGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQ 117
             T                                    +    ++++     I  +   
Sbjct: 146 QKTFVDYDPREDFSD------------------------LIKDCINSDPQQKSIKKSSRI 181

Query: 118 CKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLN 177
             +   I    N  T  + + +  LT L+  Y+G +    E   E     N E       
Sbjct: 182 TLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE-----YA 235

Query: 178 KLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGI----- 232
           +          NL  +  + + +      LP+ +    LP +++I++A N          
Sbjct: 236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL--KALPEMQLINVACNRGISGEQLKD 293

Query: 233 ---IPSFIFNASKLSVLELGENSF-SGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLS 288
                +      K+ ++ +G N+  +  +  +L  ++KL  L   YN L           
Sbjct: 294 DWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFG--- 350

Query: 289 SWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPK--EIGNLINLR 346
              +   L  L+L+ N I  +  +  G     +  +  ++  ++  IP   +  ++  + 
Sbjct: 351 ---SEIKLASLNLAYNQITEIPANFCGFTE-QVENLSFAHNKLK-YIPNIFDAKSVSVMS 405

Query: 347 ELGLWGNEL-------IGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMD 399
            +    NE+          +  T  K  N+  ++L NN++           + LS + + 
Sbjct: 406 AIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLM 465

Query: 400 GNKLSG-------PIPPCIGDLTSLRLLSLASNELNSVIPS-TFWNLKDILSLNFSSNFL 451
           GN L+               +   L  + L  N+L  +        L  ++ ++ S N  
Sbjct: 466 GNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSF 525

Query: 452 NGSLPEDIGNLK------VVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPK 505
           +   P    N        +    D   N    + P  I    +L  L +  N ++  + +
Sbjct: 526 SK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNE 583

Query: 506 SIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLE 548
            I    ++  LD+ +N       + +   +      L ++K +
Sbjct: 584 KI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  287 bits (737), Expect = 1e-86
 Identities = 86/551 (15%), Positives = 172/551 (31%), Gaps = 60/551 (10%)

Query: 40  ELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTG----SLPDDMCRRLP 95
            L +   +  +SL     SG +P  I  L+ L   +   ++          P  +   + 
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEV-LALGSHGEKVNERLFGPKGISANMS 134

Query: 96  LIKGLYMSNNKLTGPIPNNI--WQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFN 153
             +              +        +LI   +  +   + I +          +    N
Sbjct: 135 DEQ-KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSN 193

Query: 154 NLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDL 213
           N+T  +   +  L  L    +  +  V       +                 +     D 
Sbjct: 194 NITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN-----ENSEYAQQYKTEDLKWD- 246

Query: 214 VRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSF--------SGFIPNTLGNLR 265
             L +L  + +        +P+F+    ++ ++ +  N                      
Sbjct: 247 -NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGE 305

Query: 266 KLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIF 325
           K++ + + YN L +   E S        K L +L+   N + G LP + G+    L+ + 
Sbjct: 306 KIQIIYIGYNNLKTFPVETSL----QKMKKLGMLECLYNQLEGKLP-AFGSEI-KLASLN 359

Query: 326 ISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITF--GKLQNLQGLDLVNNKLEG-- 381
           ++   I        G    +  L    N+L   IP  F    +  +  +D   N++    
Sbjct: 360 LAYNQITEIPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGSVD 418

Query: 382 -----PIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSV------ 430
                P+     +   +S + +  N++S          + L  ++L  N L  +      
Sbjct: 419 GKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLK 478

Query: 431 -IPSTFWNLKDILSLNFSSNFLNGSLPEDI--GNLKVVVIIDLSRNNLSGDIPTAIGGLM 487
                F N   + S++   N L   L +D     L  +V IDLS N+ S   PT      
Sbjct: 479 DENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSS 536

Query: 488 NLQDLSLRD------NGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLN 541
            L+   +R+      N      P+ I    SL  L + +N +   +   +     +  L+
Sbjct: 537 TLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLD 593

Query: 542 LSFNKLEGEIP 552
           +  N       
Sbjct: 594 IKDNPNISIDL 604

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  264 bits (676), Expect = 6e-78
 Identities = 73/453 (16%), Positives = 149/453 (32%), Gaps = 44/453 (9%)

Query: 139 LGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVG----FVPTSIFNLSAMK 194
           L +   +  L L     +G +P  +G L  LE+L L  +        F P  I    + +
Sbjct: 77  LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136

Query: 195 TLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFS 254
                      +           +L    +  +     I        K + +    N+ +
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196

Query: 255 GFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSI 314
             +   +  L KL    +  +   +             C+  +  +              
Sbjct: 197 F-VSKAVMRLTKLRQFYMGNSPFVAE----------NICEAWENENSEYAQQYKTEDLKW 245

Query: 315 GNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELI--------GSIPITFGKL 366
            NL   L+ + + NC     +P  +  L  ++ + +  N  I                  
Sbjct: 246 DNLK-DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVG 304

Query: 367 QNLQGLDLVNNKL-EGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASN 425
           + +Q + +  N L   P+   L ++ +L +L    N+L G   P  G    L  L+LA N
Sbjct: 305 EKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYN 363

Query: 426 ELNSVIPSTFWNLKDILSLNFSSNFLNGSLPE--DIGNLKVVVIIDLSRNNLSG------ 477
           ++  +  +     + + +L+F+ N L   +P   D  ++ V+  ID S N +        
Sbjct: 364 QITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNF 422

Query: 478 -DIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSG-------NIPT 529
             +       +N+  ++L +N +     +       L S++L  N L+        +   
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENE 482

Query: 530 SMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSN 562
           + +    L  ++L FNKL   +           
Sbjct: 483 NFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPY 514

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  246 bits (630), Expect = 2e-71
 Identities = 72/456 (15%), Positives = 137/456 (30%), Gaps = 47/456 (10%)

Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
              +  +        E             Y +       +  NL +L  V + N      
Sbjct: 210 QFYMGNSPFVAENICEAWEN-----ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264

Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
           +P+ +  L  +   ++ + N                         K       +    ++
Sbjct: 265 LPTFLKALPEMQL-INVACNRGIS-----------------GEQLKDDWQALADAPVGEK 306

Query: 121 LIVISLAYNQFTE-RIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKL 179
           + +I + YN      +   L  +  L  L   +N L G++P   G+   L  L L  N++
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQI 365

Query: 180 VGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGI------- 232
                        ++ L+   N L   +P+  D   +  +  I  + N    +       
Sbjct: 366 TEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424

Query: 233 IPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTS--STSELSFLSSW 290
           +    F    +S + L  N  S F          L  + L  N LT     S      ++
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484

Query: 291 ANCKNLKLLDLSNNPINGVLPSSIGNLSL-SLSRIFISNCSIRGTIPKEIGNLINLRELG 349
            N   L  +DL  N +   L       +L  L  I +S  S     P +  N   L+  G
Sbjct: 485 KNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFG 542

Query: 350 LW------GNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKL 403
           +       GN  +   P       +L  L + +N +   +   +     +SVL +  N  
Sbjct: 543 IRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPN 599

Query: 404 SGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLK 439
                  +       +  L  ++   +      ++K
Sbjct: 600 ISIDLSYVCPYIEAGMYMLFYDKTQDIRGCDALDIK 635

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  231 bits (592), Expect = 4e-66
 Identities = 59/419 (14%), Positives = 133/419 (31%), Gaps = 34/419 (8%)

Query: 152 FNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSI 211
            +    +    + +   +  L L+     G VP +I  L+ ++ LAL S+    +     
Sbjct: 66  LDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFG 125

Query: 212 --DLVRLPNLEIISLAGNNFSGIIPSFIFNA--SKLSVLELGENSFSGFIPNTLGNLRKL 267
              +    + E       ++      +      S L    +  +     I  +     K 
Sbjct: 126 PKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185

Query: 268 EWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFIS 327
             +    N +T  +  +           L+   + N+P                      
Sbjct: 186 TQIGQLSNNITFVSKAVM------RLTKLRQFYMGNSPFVAENICEAWENEN------SE 233

Query: 328 NCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKL-------- 379
                 T   +  NL +L ++ ++    +  +P     L  +Q +++  N+         
Sbjct: 234 YAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKD 293

Query: 380 EGPIPNGLCQLARLSVLYMDGNKL-SGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNL 438
           +           ++ ++Y+  N L + P+   +  +  L +L    N+L   +P+ F + 
Sbjct: 294 DWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSE 352

Query: 439 KDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSG-DIPTAIGGLMNLQDLSLRDN 497
             + SLN + N +        G  + V  +  + N L           +  +  +    N
Sbjct: 353 IKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYN 412

Query: 498 GLQG-------SIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEG 549
            +          +  +    +++ S++LSNN +S            L  +NL  N L  
Sbjct: 413 EIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  193 bits (492), Expect = 2e-52
 Identities = 54/346 (15%), Positives = 121/346 (34%), Gaps = 19/346 (5%)

Query: 227 NNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSF 286
           + +       + +  +++ L L     SG +P+ +G L +LE L L  +    +   L  
Sbjct: 67  DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER-LFG 125

Query: 287 LSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLS-LSRIFISNCSIRGTIPKEIGNLINL 345
               +   + +                      S L +  I++   + +I K     +  
Sbjct: 126 PKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185

Query: 346 RELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSG 405
            ++G   N +   +     +L  L+   + N+           +            +   
Sbjct: 186 TQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYK 239

Query: 406 PIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFL--------NGSLPE 457
                  +L  L  + + +    + +P+    L ++  +N + N          +     
Sbjct: 240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA 299

Query: 458 DIGNLKVVVIIDLSRNNL-SGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESL 516
           D    + + II +  NNL +  + T++  +  L  L    N L+G +P + G  + L SL
Sbjct: 300 DAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASL 358

Query: 517 DLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSN 562
           +L+ N ++            +++L+ + NKL+  IP      + S 
Sbjct: 359 NLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSV 403

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  132 bits (335), Expect = 2e-32
 Identities = 31/276 (11%), Positives = 73/276 (26%), Gaps = 17/276 (6%)

Query: 299 LDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGS 358
           L+  N    G       N + +                  + +   +  L L G    G 
Sbjct: 42  LNGKNWSQQGFGTQPGANWNFNKE-----LDMWGAQPGVSLNSNGRVTGLSLEGFGASGR 96

Query: 359 IPITFGKLQNLQGLDLVNNKLEGP----IPNGLCQLARLSVLYMDGNKLSGPIPPCIGDL 414
           +P   G+L  L+ L L ++  +       P G+                           
Sbjct: 97  VPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPRE 156

Query: 415 TSLRL--LSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSR 472
               L    + S+     I  +         +   SN +   + + +  L  +    +  
Sbjct: 157 DFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGN 215

Query: 473 NNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSME 532
           +    +         N +           +       L  L  +++ N      +PT ++
Sbjct: 216 SPFVAENICEAWENENSEYAQQ-----YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK 270

Query: 533 KLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGN 568
            L  ++ +N++ N+          +   ++      
Sbjct: 271 ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  295 bits (758), Expect = 4e-90
 Identities = 110/570 (19%), Positives = 188/570 (32%), Gaps = 61/570 (10%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L LSFN L         +   L+ L L   +++        +L+ L  + LT N +    
Sbjct: 33  LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA 92

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
                 LSSL                            L      L       I   K L
Sbjct: 93  LGAFSGLSSLQK--------------------------LVAVETNLASLENFPIGHLKTL 126

Query: 122 IVISLAYNQFTE-RIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQL---- 176
             +++A+N     ++P    NLT+L+ L L  N +      ++  L  + +L L L    
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186

Query: 177 NKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSG----- 231
           N +    P +   +  +  L L +N  S ++  +  +  L  LE+  L    F       
Sbjct: 187 NPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTC-IQGLAGLEVHRLVLGEFRNEGNLE 244

Query: 232 -IIPSFIFNASKLSVLELGENSFSGF---IPNTLGNLRKLEWLRLSYNFLTSSTSELSFL 287
               S +     L++ E        +   I +    L  +    L           +  +
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSV-------TIERV 297

Query: 288 SSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRE 347
             ++     + L+L N          + +L        ++  S +G       +L +L  
Sbjct: 298 KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKR------LTFTSNKGGNAFSEVDLPSLEF 351

Query: 348 LGLWGNEL--IGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSG 405
           L L  N L   G    +     +L+ LDL  N +   + +    L +L  L    + L  
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQ 410

Query: 406 PIPP-CIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDI-GNLK 463
                    L +L  L ++           F  L  +  L  + N    +   DI   L+
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470

Query: 464 VVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSL 523
            +  +DLS+  L    PTA   L +LQ L++  N            L SL+ LD S N +
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 530

Query: 524 SGNIPTSMEKLLY-LKDLNLSFNKLEGEIP 552
             +    ++     L  LNL+ N       
Sbjct: 531 MTSKKQELQHFPSSLAFLNLTQNDFACTCE 560

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  278 bits (712), Expect = 2e-83
 Identities = 106/590 (17%), Positives = 202/590 (34%), Gaps = 60/590 (10%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L LS  ++         +L+ L  L L  N ++         L+ L+ +      L+   
Sbjct: 57  LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
              I +L +L   ++ ++N +      +    L  ++ L +S+NK+      ++    ++
Sbjct: 117 NFPIGHLKTLKE-LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175

Query: 122 ----IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYE-MGNLRNLEILGLQL 176
               + + L+ N     I  G      L  L L  N  +  +    +  L  LE+  L L
Sbjct: 176 PLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234

Query: 177 NKLVGFV------PTSIFNLSAMKTLALPSNALSGSLPSSIDL-VRLPNLEIISLAGNNF 229
            +            +++  L  +         L   L   IDL   L N+   SL     
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294

Query: 230 SGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSS 289
             +             LEL    F  F    L +L++L +                   S
Sbjct: 295 ERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNK----------GGNAFS 342

Query: 290 WANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELG 349
             +  +L+ LDLS N +                       S +G   +      +L+ L 
Sbjct: 343 EVDLPSLEFLDLSRNGL-----------------------SFKGCCSQSDFGTTSLKYLD 379

Query: 350 LWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNG-LCQLARLSVLYMDGNKLSGPIP 408
           L  N +I  +   F  L+ L+ LD  ++ L+          L  L  L +          
Sbjct: 380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438

Query: 409 PCIGDLTSLRLLSLASNELN-SVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVI 467
                L+SL +L +A N    + +P  F  L+++  L+ S   L    P    +L  + +
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498

Query: 468 IDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLV-SLESLDLSNNSLSGN 526
           +++S NN           L +LQ L    N +  S  + +     SL  L+L+ N  +  
Sbjct: 499 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 558

Query: 527 IPTS--MEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGL 574
                 ++ +   + L +   ++E   P     ++      +  ++ C +
Sbjct: 559 CEHQSFLQWIKDQRQLLVEVERMECATP-----SDKQGMPVLSLNITCQM 603

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  252 bits (646), Expect = 4e-74
 Identities = 105/522 (20%), Positives = 181/522 (34%), Gaps = 50/522 (9%)

Query: 76  DFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERI 135
                +    +PD++       K L +S N L      + +   EL V+ L+  +     
Sbjct: 13  QCMELNFY-KIPDNLPFST---KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE 68

Query: 136 PRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKT 195
                +L+ L TL L  N +          L +L+ L      L       I +L  +K 
Sbjct: 69  DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128

Query: 196 LALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSV----LELGEN 251
           L +  N +  S         L NLE + L+ N    I  + +    ++ +    L+L  N
Sbjct: 129 LNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187

Query: 252 SFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNN------P 305
             +   P     +R L  L L  NF + +  +            L++  L          
Sbjct: 188 PMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQ----GLAGLEVHRLVLGEFRNEGN 242

Query: 306 INGVLPSSIGNL-SLSLSRIFISNCSI-RGTIPKEIGNLINLRELGLWGNELIGSIPITF 363
           +     S++  L +L++    ++        I      L N+    L    +      ++
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY 302

Query: 364 GKLQNLQGLDLVNNKLE-------------------GPIPNGLCQLARLSVLYMDGNKLS 404
                 Q L+LVN K                     G        L  L  L +  N LS
Sbjct: 303 --NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS 360

Query: 405 --GPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDI-GN 461
             G         TSL+ L L+ N + + + S F  L+ +  L+F  + L       +  +
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419

Query: 462 LKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI-GGLVSLESLDLSN 520
           L+ ++ +D+S  +          GL +L+ L +  N  Q +    I   L +L  LDLS 
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479

Query: 521 NSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSN 562
             L    PT+   L  L+ LN+S N          P+   ++
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT--FPYKCLNS 519

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  148 bits (375), Expect = 2e-37
 Identities = 60/269 (22%), Positives = 99/269 (36%), Gaps = 18/269 (6%)

Query: 292 NCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLW 351
              N+    +  N           NL  S   + +S   +R        +   L+ L L 
Sbjct: 6   VVPNITYQCMELN-----FYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60

Query: 352 GNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCI 411
             E+       +  L +L  L L  N ++         L+ L  L      L+      I
Sbjct: 61  RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120

Query: 412 GDLTSLRLLSLASNELNSV-IPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLK----VVV 466
           G L +L+ L++A N + S  +P  F NL ++  L+ SSN +      D+  L     + +
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180

Query: 467 IIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPK-SIGGLVSLESLDLSNNSLSG 525
            +DLS N ++   P A   +  L  L+LR+N    ++ K  I GL  LE   L       
Sbjct: 181 SLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239

Query: 526 N------IPTSMEKLLYLKDLNLSFNKLE 548
                    +++E L  L         L+
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLD 268

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  143 bits (363), Expect = 5e-36
 Identities = 51/270 (18%), Positives = 92/270 (34%), Gaps = 8/270 (2%)

Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKL--RGEIPQELGNLAELELVSLTNNFLS 58
           +  L+F    G       +L  L+ L L  N L  +G   Q       L+ + L+ N + 
Sbjct: 327 LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386

Query: 59  GTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQC 118
            T+ S    L  L   +DF +++L       +   L  +  L +S+              
Sbjct: 387 -TMSSNFLGLEQLEH-LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 444

Query: 119 KELIVISLAYNQFTERIPRG-LGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLN 177
             L V+ +A N F E         L +L  L L    L    P    +L +L++L +  N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 504

Query: 178 KLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPS-- 235
                       L++++ L    N +  S    +      +L  ++L  N+F+       
Sbjct: 505 NFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF-PSSLAFLNLTQNDFACTCEHQS 563

Query: 236 FIFNASKLSVLELGENSFSGFIPNTLGNLR 265
           F+        L +         P+    + 
Sbjct: 564 FLQWIKDQRQLLVEVERMECATPSDKQGMP 593

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  111 bits (280), Expect = 1e-25
 Identities = 38/185 (20%), Positives = 74/185 (40%), Gaps = 7/185 (3%)

Query: 387 LCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNF 446
           +  +  ++   M+ N     IP  +    S + L L+ N L  +   +F++  ++  L+ 
Sbjct: 4   VEVVPNITYQCMELNFYK--IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59

Query: 447 SSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKS 506
           S   +         +L  +  + L+ N +      A  GL +LQ L   +  L       
Sbjct: 60  SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119

Query: 507 IGGLVSLESLDLSNNSL-SGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSF 565
           IG L +L+ L++++N + S  +P     L  L+ L+LS NK++                 
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC--TDLRVLHQMPL 177

Query: 566 MGNDL 570
           +   L
Sbjct: 178 LNLSL 182

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  283 bits (727), Expect = 2e-85
 Identities = 111/559 (19%), Positives = 202/559 (36%), Gaps = 23/559 (4%)

Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
             +     L+  IP  +      + L   +N L          L  L  + LT   +   
Sbjct: 16  TYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72

Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
              T  +   L T +  + N L   + +        +K L+     ++      +   K 
Sbjct: 73  HEDTFQSQHRLDT-LVLTANPLI-FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130

Query: 121 LIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKL- 179
           L  + L  N  +            LK L    N +      +M +L+    L L LN   
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190

Query: 180 VGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFN 239
           +  +    F+ +  ++L          +   +    + +L + +    +   I P+    
Sbjct: 191 IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250

Query: 240 ASKLSV--LELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLK 297
             ++SV  + L ++ F     NT      L+ L L+   L+   S L           LK
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLV------GLSTLK 304

Query: 298 LLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKE-IGNLINLRELGLWGNEL- 355
            L LS N    +   S  N   SL+ + I   + R  +    + NL NLREL L  +++ 
Sbjct: 305 KLVLSANKFENLCQISASNFP-SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363

Query: 356 -IGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPP-CIGD 413
                 +    L +LQ L+L  N+          +  +L +L +   +L          +
Sbjct: 364 TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQN 423

Query: 414 LTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFL---NGSLPEDIGNLKVVVIIDL 470
           L  L++L+L+ + L+      F  L  +  LN   N     N      +  L  + I+ L
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483

Query: 471 SRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTS 530
           S  +LS     A   L  +  + L  N L  S  +++  L  +  L+L++N +S  +P+ 
Sbjct: 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSL 542

Query: 531 MEKLLYLKDLNLSFNKLEG 549
           +  L   + +NL  N L+ 
Sbjct: 543 LPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  254 bits (651), Expect = 8e-75
 Identities = 98/514 (19%), Positives = 179/514 (34%), Gaps = 24/514 (4%)

Query: 50  VSLTNNFLSGTIPSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLT 108
            +  N  L+  IP T+  +   L    +FS N L         R L  +  L ++  ++ 
Sbjct: 17  YNCENLGLN-EIPGTLPNSTECL----EFSFNVLPTIQNTTFSR-LINLTFLDLTRCQIY 70

Query: 109 GPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRN 168
               +       L  + L  N         L    +LK L+     ++      + N + 
Sbjct: 71  WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130

Query: 169 LEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLA-GN 227
           LE L L  N +        F    +K L   +NA+        D+  L     +SL    
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE--DMSSLQQATNLSLNLNG 188

Query: 228 NFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGN--LRKLEWLRLSYNFLTSSTSELS 285
           N    I    F+++    L  G       I   L N  ++ L             +    
Sbjct: 189 NDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPA-- 246

Query: 286 FLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINL 345
            +       +++ ++L  +    +  ++    S  L  + ++   +   +P  +  L  L
Sbjct: 247 -VFEGLCEMSVESINLQKHYFFNISSNTFHCFS-GLQELDLTATHLS-ELPSGLVGLSTL 303

Query: 346 RELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNG-LCQLARLSVLYMDGNKL- 403
           ++L L  N+      I+     +L  L +  N     +  G L  L  L  L +  + + 
Sbjct: 304 KKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363

Query: 404 -SGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDI-GN 461
            S      + +L+ L+ L+L+ NE  S+    F     +  L+ +   L     +    N
Sbjct: 364 TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQN 423

Query: 462 LKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIG---GLVSLESLDL 518
           L ++ +++LS + L         GL  LQ L+L+ N       +       L  LE L L
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483

Query: 519 SNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIP 552
           S   LS     +   L  +  ++LS N+L     
Sbjct: 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  246 bits (631), Expect = 6e-72
 Identities = 119/535 (22%), Positives = 195/535 (36%), Gaps = 28/535 (5%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L L+ N L       +     LK L      +       L N   LE + L +N +S   
Sbjct: 86  LVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIK 145

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMC--RRLPLIKGLYMSNNKLTGPIPNNIWQCK 119
               F    L   +DF NN++     +DM   ++   +  L ++ N + G I    +   
Sbjct: 146 LPKGFPTEKLKV-LDFQNNAIHYLSKEDMSSLQQATNLS-LNLNGNDIAG-IEPGAFDSA 202

Query: 120 ELIVISLAYNQFTERIPRGLGN--LTSLKTLYLGFNNLTGEIPYEMGNLR--NLEILGLQ 175
               ++    Q    I +GL N  + SL        +     P     L   ++E + LQ
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQ 262

Query: 176 LNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPS 235
            +        +    S ++ L L +  LS  LPS   LV L  L+ + L+ N F  +   
Sbjct: 263 KHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSG--LVGLSTLKKLVLSANKFENLCQI 319

Query: 236 FIFNASKLSVLELGENSFSGFI-PNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCK 294
              N   L+ L +  N+    +    L NL  L  L LS++ + +S      L    N  
Sbjct: 320 SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR---NLS 376

Query: 295 NLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEI-GNLINLRELGLWGN 353
           +L+ L+LS N    +   +       L  + ++   ++    +    NL  L+ L L  +
Sbjct: 377 HLQSLNLSYNEPLSLKTEAFKECP-QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435

Query: 354 ELIGSIPITFGKLQNLQGLDLVNNKLEGPI---PNGLCQLARLSVLYMDGNKLSGPIPPC 410
            L  S    F  L  LQ L+L  N          N L  L RL +L +    LS      
Sbjct: 436 LLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHA 495

Query: 411 IGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDL 470
              L  +  + L+ N L S       +LK  + LN +SN ++  LP  +  L     I+L
Sbjct: 496 FTSLKMMNHVDLSHNRLTSSSIEALSHLK-GIYLNLASNHISIILPSLLPILSQQRTINL 554

Query: 471 SRNNLSGDIPTAIGGLMNLQD-LSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLS 524
            +N L           +   +        L+ +          L  + LS+ +LS
Sbjct: 555 RQNPLDCTC-----SNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  142 bits (361), Expect = 1e-35
 Identities = 54/272 (19%), Positives = 95/272 (34%), Gaps = 13/272 (4%)

Query: 297 KLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELI 356
           K  +  N  +N +     G L  S   +  S   +          LINL  L L   ++ 
Sbjct: 15  KTYNCENLGLNEI----PGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY 70

Query: 357 GSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTS 416
                TF     L  L L  N L       L     L  L+     +S      + +  +
Sbjct: 71  WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130

Query: 417 LRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLK--VVVIIDLSRNN 474
           L  L L SN ++S+     +  + +  L+F +N ++    ED+ +L+    + ++L+ N+
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190

Query: 475 LSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGG--LVSLESLDLSNNSLSGNIPTSME 532
           ++G I          Q L+         I K +    + SL      +       P   E
Sbjct: 191 IAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE 249

Query: 533 KL--LYLKDLNLSFNKLEGEIPRGGPFANFSN 562
            L  + ++ +NL  +           F  FS 
Sbjct: 250 GLCEMSVESINLQKHYFFNISS--NTFHCFSG 279

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  107 bits (270), Expect = 2e-24
 Identities = 41/202 (20%), Positives = 66/202 (32%), Gaps = 5/202 (2%)

Query: 372 LDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVI 431
            +  N  L   IP  L        L    N L          L +L  L L   ++  + 
Sbjct: 17  YNCENLGLNE-IPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73

Query: 432 PSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQD 491
             TF +   + +L  ++N L       +   K +  +   +  +S      +     L+ 
Sbjct: 74  EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133

Query: 492 LSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKL--LYLKDLNLSFNKLEG 549
           L L  N +             L+ LD  NN++       M  L       LNL+ N + G
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193

Query: 550 EIPRGGPFANFSNRSFMGNDLL 571
             P     A F + +F G   L
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNL 215

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  268 bits (688), Expect = 2e-83
 Identities = 89/289 (30%), Positives = 128/289 (44%), Gaps = 29/289 (10%)

Query: 288 SSWANCKNLKLLDLSNNPINGV--LPSSIGNLSLSLSRIFISN-CSIRGTIPKEIGNLIN 344
            +      +  LDLS   +     +PSS+ NL   L+ ++I    ++ G IP  I  L  
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQ 102

Query: 345 LRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLS 404
           L  L +    + G+IP    +++ L  LD   N L G +P  +  L  L  +  DGN++S
Sbjct: 103 LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162

Query: 405 GPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKV 464
           G IP   G  + L                         S+  S N L G +P    NL +
Sbjct: 163 GAIPDSYGSFSKL-----------------------FTSMTISRNRLTGKIPPTFANLNL 199

Query: 465 VVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLS 524
              +DLSRN L GD     G   N Q + L  N L   +   +G   +L  LDL NN + 
Sbjct: 200 AF-VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIY 257

Query: 525 GNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCG 573
           G +P  + +L +L  LN+SFN L GEIP+GG    F   ++  N  LCG
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  213 bits (546), Expect = 4e-63
 Identities = 70/278 (25%), Positives = 115/278 (41%), Gaps = 11/278 (3%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGE--IPQELGNLAELELVSLTN-NFLS 58
                    G +         +  L L    L     IP  L NL  L  + +   N L 
Sbjct: 31  TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90

Query: 59  GTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQC 118
           G IP  I  L+ L   +  ++ +++G++PD +  ++  +  L  S N L+G +P +I   
Sbjct: 91  GPIPPAIAKLTQLHY-LYITHTNVSGAIPDFLS-QIKTLVTLDFSYNALSGTLPPSISSL 148

Query: 119 KELIVISLAYNQFTERIPRGLGNLTSLKT-LYLGFNNLTGEIPYEMGNLRNLEILGLQLN 177
             L+ I+   N+ +  IP   G+ + L T + +  N LTG+IP    NL NL  + L  N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRN 207

Query: 178 KLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFI 237
            L G       +    + + L  N+L+  L     +    NL  + L  N   G +P  +
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK---VGLSKNLNGLDLRNNRIYGTLPQGL 264

Query: 238 FNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYN 275
                L  L +  N+  G IP   GNL++ +    + N
Sbjct: 265 TQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANN 301

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  204 bits (521), Expect = 1e-59
 Identities = 87/406 (21%), Positives = 136/406 (33%), Gaps = 113/406 (27%)

Query: 12  AIPKEIGNLTML----KKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT--IPSTI 65
            I K++GN T L               G +         +  + L+   L     IPS++
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 66  FNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSN-NKLTGPIPNNIWQCKELIVI 124
            NL  L+                           LY+   N L GPIP  I +  +L  +
Sbjct: 73  ANLPYLNF--------------------------LYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 125 SLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVP 184
            + +   +  IP  L  + +L TL   +N L+G +P  + +L NL  +    N++ G +P
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 185 TSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLS 244
            S  + S +                            ++++ N  +G IP    N + L+
Sbjct: 167 DSYGSFSKL-------------------------FTSMTISRNRLTGKIPPTFANLN-LA 200

Query: 245 VLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNN 304
            ++L  N   G      G+ +  + + L+ N L         L      KNL  LDL NN
Sbjct: 201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD------LGKVGLSKNLNGLDLRNN 254

Query: 305 PINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFG 364
                       +               GT+P+ +  L  L  L +  N L G IP   G
Sbjct: 255 -----------RIY--------------GTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGG 288

Query: 365 KLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPC 410
            LQ        NNK        LC                 P+P C
Sbjct: 289 NLQRFDVSAYANNK-------CLC---------------GSPLPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  198 bits (506), Expect = 1e-57
 Identities = 63/228 (27%), Positives = 108/228 (47%), Gaps = 7/228 (3%)

Query: 2   LSLS-FNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
           L +   N+L G IP  I  LT L  L + +  + G IP  L  +  L  +  + N LSGT
Sbjct: 81  LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGT 140

Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
           +P +I +L +L  G+ F  N ++G++PD       L   + +S N+LTG IP        
Sbjct: 141 LPPSISSLPNL-VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN- 198

Query: 121 LIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLV 180
           L  + L+ N          G+  + + ++L  N+L  ++  ++G  +NL  L L+ N++ 
Sbjct: 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIY 257

Query: 181 GFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNN 228
           G +P  +  L  + +L +  N L G +P       L   ++ + A N 
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG---NLQRFDVSAYANNK 302

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  188 bits (481), Expect = 5e-54
 Identities = 64/211 (30%), Positives = 93/211 (44%), Gaps = 6/211 (2%)

Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
            L ++  ++SGAIP  +  +  L  L   YN L G +P  + +L  L  ++   N +SG 
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164

Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
           IP +  + S L T M  S N LTG +P      L L   + +S N L G         K 
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFA-NLNLAF-VDLSRNMLEGDASVLFGSDKN 222

Query: 121 LIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLV 180
              I LA N     + + +G   +L  L L  N + G +P  +  L+ L  L +  N L 
Sbjct: 223 TQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281

Query: 181 GFVPTSIFNLSAMKTLALPSN-ALSGS-LPS 209
           G +P    NL      A  +N  L GS LP+
Sbjct: 282 GEIPQG-GNLQRFDVSAYANNKCLCGSPLPA 311

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  284 bits (728), Expect = 2e-83
 Identities = 88/583 (15%), Positives = 190/583 (32%), Gaps = 58/583 (9%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
            +   +        ++ N   +  L L     +G +P  +G L EL+++S   +  +   
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETV-S 362

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLT-----GPIPNNIW 116
                +        +   + +              +    +  + +       PI  +  
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422

Query: 117 QCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQL 176
              +   I    N+ T  I + +  LT L+ +Y   +  T +         + E      
Sbjct: 423 ISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDY 476

Query: 177 NKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGI---- 232
            K       S  NL  +  + L +      LP  +    LP L+ +++A N         
Sbjct: 477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFL--YDLPELQSLNIACNRGISAAQLK 534

Query: 233 -----IPSFIFNASKLSVLELGENSFSGFIPN-TLGNLRKLEWLRLSYNFLTSSTSELSF 286
                +        K+ +  +G N+   F  + +L  + KL  L   +N +         
Sbjct: 535 ADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH------- 587

Query: 287 LSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPK--EIGNLIN 344
           L ++     L  L L  N I   +P      +  +  +  S+  ++  IP      ++  
Sbjct: 588 LEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYV 645

Query: 345 LRELGLWGNELIG-----SIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMD 399
           +  +    N++       S  +   K  N   + L  N+++          + +S + + 
Sbjct: 646 MGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILS 705

Query: 400 GNKLS-------GPIPPCIGDLTSLRLLSLASNELNSVIPS-TFWNLKDILSLNFSSNFL 451
            N ++        P      +   L  + L  N+L S+        L  + +++ S N  
Sbjct: 706 NNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCF 765

Query: 452 NGSLPEDIGNLKVVVIIDLSR------NNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPK 505
           + S P    N   +    +        N +    PT I    +L  L +  N ++  + +
Sbjct: 766 S-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDE 823

Query: 506 SIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLE 548
            +     L  LD+++N       TS+   +      L ++K +
Sbjct: 824 KL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  235 bits (600), Expect = 1e-65
 Identities = 73/464 (15%), Positives = 149/464 (32%), Gaps = 44/464 (9%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           +    N ++  I K I  LT L+ +    +    +         + E  +          
Sbjct: 430 IGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYENE 483

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGP---------IP 112
             +  NL  L+  ++  N      LPD +   LP ++ L ++ N+             + 
Sbjct: 484 ELSWSNLKDLTD-VELYNCPNMTQLPDFLYD-LPELQSLNIACNRGISAAQLKADWTRLA 541

Query: 113 NNIWQCKELIVISLAYNQFTE-RIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEI 171
           ++     ++ +  + YN   E      L  +  L  L    N +   +    G    L  
Sbjct: 542 DDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTD 599

Query: 172 LGLQLNKLVGFVPTSIF-NLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFS 230
           L L  N++   +P         ++ L    N L   +P+  +   +  +  +  + N   
Sbjct: 600 LKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIG 657

Query: 231 GIIPSF-----IFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTS--STSE 283
               +       +     S + L  N    F          +  + LS N +TS    S 
Sbjct: 658 SEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSL 717

Query: 284 LSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSL-SLSRIFISNCSIRGTIPKEIGNL 342
                ++ N   L  +DL  N +   L       +L  LS + +S      + P +  N 
Sbjct: 718 KPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNS 775

Query: 343 INLRELGL------WGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVL 396
             L+  G+       GN ++   P       +L  L + +N +   +   L    +L +L
Sbjct: 776 SQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYIL 832

Query: 397 YMDGNKL-SGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLK 439
            +  N   S  +      +    +  L  ++   +       ++
Sbjct: 833 DIADNPNISIDVTSVCPYIE-AGMYVLLYDKTQDIRGCDALGIE 875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  179 bits (455), Expect = 7e-47
 Identities = 64/500 (12%), Positives = 143/500 (28%), Gaps = 81/500 (16%)

Query: 67  NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISL 126
           N  +    +          + D       + + L   N +      NN          + 
Sbjct: 249 NKLTKDANVPIQLKETAEYIKDYKAL-KAIWEALDGKNWRYYSGTINNTIHSLNW-NFNK 306

Query: 127 AYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTS 186
             + + ++    L N   +  L L      G +P  +G L  L++L    +         
Sbjct: 307 ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETV----- 361

Query: 187 IFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVL 246
                                        L                   F+    +L++ 
Sbjct: 362 --------------------SGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLS 401

Query: 247 ELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSW-ANCKNLKLLDLSNNP 305
           +L +++ +      +  ++K   + L    + + T+ ++F+S        L+++  +N+P
Sbjct: 402 DLLQDAINRN--PEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSP 459

Query: 306 INGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGK 365
                  ++     +                    NL +L ++ L+    +  +P     
Sbjct: 460 FTY-DNIAVDWEDANSD-----YAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD 513

Query: 366 LQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASN 425
           L  LQ L++  N+             R              +         +++  +  N
Sbjct: 514 LPELQSLNIACNRGIS-AAQLKADWTR--------------LADDEDTGPKIQIFYMGYN 558

Query: 426 ELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGG 485
            L     S                         +  +  + ++D   N +      A G 
Sbjct: 559 NLEEFPAS-----------------------ASLQKMVKLGLLDCVHNKVR--HLEAFGT 593

Query: 486 LMNLQDLSLRDNGLQGSIPKSIG-GLVSLESLDLSNNSLSGNIP--TSMEKLLYLKDLNL 542
            + L DL L  N ++  IP+        +E L  S+N L   IP   + + +  +  ++ 
Sbjct: 594 NVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDF 651

Query: 543 SFNKLEGEIPRGGPFANFSN 562
           S+NK+  E        +   
Sbjct: 652 SYNKIGSEGRNISCSMDDYK 671

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  178 bits (452), Expect = 2e-46
 Identities = 74/494 (14%), Positives = 151/494 (30%), Gaps = 39/494 (7%)

Query: 92  RRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLG 151
           R    +KG+ ++  + +    N      + + I +A       +P G   + +  T    
Sbjct: 168 RVTTELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVVAYTTYS-- 225

Query: 152 FNNLTGEIPYEMGNLRNLEI------------LGLQLNKLVGFVPTSIFNLSAMKTLALP 199
             +       E  ++R                + +QL +   ++       +  + L   
Sbjct: 226 -QSGIKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGK 284

Query: 200 SNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPN 259
           +        ++       N    +   + +       + N  +++ L L      G +P+
Sbjct: 285 NWRYYSGTINNTIHSLNWNF---NKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPD 341

Query: 260 TLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSL 319
            +G L +L+ L    +  T S           +    +   +  +     L         
Sbjct: 342 AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLS 401

Query: 320 SLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKL 379
            L +  I+       I K+    +   ++G   N  I  I     +L  LQ +   N+  
Sbjct: 402 DLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTN-RITFISKAIQRLTKLQIIYFANSPF 460

Query: 380 EGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLK 439
                    + A          K          +L  L  + L +    + +P   ++L 
Sbjct: 461 TYDNIAVDWEDANSD-----YAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLP 515

Query: 440 DILSLNFSSNFLNG---------SLPEDIGNLKVVVIIDLSRNNLSG-DIPTAIGGLMNL 489
           ++ SLN + N              L +D      + I  +  NNL       ++  ++ L
Sbjct: 516 ELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKL 575

Query: 490 QDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLL-YLKDLNLSFNKLE 548
             L    N +     ++ G  V L  L L  N +   IP         ++ L  S NKL+
Sbjct: 576 GLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK 632

Query: 549 GEIPRGGPFANFSN 562
             IP      +   
Sbjct: 633 -YIPNIFNAKSVYV 645

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  261 bits (669), Expect = 3e-77
 Identities = 109/564 (19%), Positives = 186/564 (32%), Gaps = 40/564 (7%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
                  LS  +P +I +    K + L +N L+        N +EL+ + L+   +    
Sbjct: 16  YQCMDQKLS-KVPDDIPSS--TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE 72

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
                 L  LS  +  + N +  S        L  ++ L     KL       I Q   L
Sbjct: 73  DKAWHGLHHLSN-LILTGNPIQ-SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL 130

Query: 122 IVISLAYNQFTE-RIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNL----EILGLQL 176
             +++A+N     ++P    NLT+L  + L +N +      ++  LR        L + L
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190

Query: 177 NKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSF 236
           N +  F+    F    +  L L  N  S ++  +  L  L  L +  L    F       
Sbjct: 191 NPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTC-LQNLAGLHVHRLILGEFKDERNLE 248

Query: 237 IFNASKLSVLE--------LGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLS 288
           IF  S +  L         L   +           L  +  + L+          + +L 
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV-------SIKYLE 301

Query: 289 SWANCKNLKLLDLSNNPINGVLPSSIGNL-SLSLSRIFISNCSIRGTIPKEIGNLINLRE 347
                   + L +    +       +  L SL+L+         +G+I  +   L +L  
Sbjct: 302 DVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLT-------MNKGSISFKKVALPSLSY 354

Query: 348 LGLWGNELIGSIPITF--GKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSG 405
           L L  N L  S   ++      +L+ LDL  N     +      L  L  L    + L  
Sbjct: 355 LDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKR 413

Query: 406 PIPP-CIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDI-GNLK 463
                    L  L  L ++           F  L  + +L  + N    +   ++  N  
Sbjct: 414 VTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTT 473

Query: 464 VVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSL 523
            +  +DLS+  L          L  LQ L++  N L          L SL +LD S N +
Sbjct: 474 NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI 533

Query: 524 SGNIPTSMEKLLYLKDLNLSFNKL 547
             +          L   NL+ N +
Sbjct: 534 ETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  179 bits (457), Expect = 4e-48
 Identities = 76/449 (16%), Positives = 152/449 (33%), Gaps = 46/449 (10%)

Query: 2   LSLSFNDLSGA-IPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELV----SLTNNF 56
           L+++ N +    +P    NLT L  + L YN ++     +L  L E   V     ++ N 
Sbjct: 133 LNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP 192

Query: 57  LSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLP------LIKGLYMSNNKLTGP 110
           +   I    F    L   +    N  + ++     + L       LI G +     L   
Sbjct: 193 ID-FIQDQAFQGIKLHE-LTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIF 250

Query: 111 IPNNIWQCKELIV--ISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPY--EMGNL 166
            P+ +    ++ +    L Y             L ++  + L   ++   +    +    
Sbjct: 251 EPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKW 309

Query: 167 RNLEILGLQLNKLVGF----------------VPTSIFNLSAMKTLALPSNALSGSLPSS 210
           ++L I+  QL +                    +      L ++  L L  NALS S   S
Sbjct: 310 QSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCS 369

Query: 211 IDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIP-NTLGNLRKLEW 269
              +   +L  + L+ N    I+ +      +L  L+   ++       +   +L KL +
Sbjct: 370 YSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY 428

Query: 270 LRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNC 329
           L +SY               +    +L  L ++ N       S++   + +L+ + +S C
Sbjct: 429 LDISYTNTKIDFDG-----IFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC 483

Query: 330 SIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQ 389
            +          L  L+ L +  N L+      + +L +L  LD   N++E         
Sbjct: 484 QLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHF 543

Query: 390 LARLSVLYMDGNKLSGPIPPCIGDLTSLR 418
              L+   +  N ++     CI +     
Sbjct: 544 PKSLAFFNLTNNSVA-----CICEHQKFL 567

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  132 bits (334), Expect = 3e-32
 Identities = 58/283 (20%), Positives = 103/283 (36%), Gaps = 18/283 (6%)

Query: 292 NCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLW 351
              N+      +  ++ V      ++  S   I +S   ++        N   L+ L L 
Sbjct: 10  VVPNITY-QCMDQKLSKVPD----DIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLS 64

Query: 352 GNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCI 411
             E+       +  L +L  L L  N ++   P     L  L  L     KL+      I
Sbjct: 65  RCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPI 124

Query: 412 GDLTSLRLLSLASNELNSV-IPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLK----VVV 466
           G L +L+ L++A N ++S  +P+ F NL +++ ++ S N++      D+  L+    V +
Sbjct: 125 GQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNL 184

Query: 467 IIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPK-SIGGLVSLESLDLSNNSLSG 525
            +D+S N +   I       + L +L+LR N    +I K  +  L  L    L       
Sbjct: 185 SLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD 243

Query: 526 NI------PTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSN 562
                   P+ ME L  +                   F   +N
Sbjct: 244 ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLAN 286

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 99.7 bits (249), Expect = 8e-22
 Identities = 41/158 (25%), Positives = 67/158 (42%), Gaps = 5/158 (3%)

Query: 405 GPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKV 464
           G + PCI  + ++        +L+ V      + K   +++ S N L         N   
Sbjct: 2   GSLNPCIEVVPNITY-QCMDQKLSKVPDDIPSSTK---NIDLSFNPLKILKSYSFSNFSE 57

Query: 465 VVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLS 524
           +  +DLSR  +      A  GL +L +L L  N +Q   P S  GL SLE+L      L+
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117

Query: 525 GNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSN 562
                 + +L+ LK LN++ N +         F+N +N
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSNLTN 154

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  212 bits (543), Expect = 1e-62
 Identities = 69/204 (33%), Positives = 109/204 (53%), Gaps = 7/204 (3%)

Query: 630 NAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIK 689
           N+    + S+ L      R    +L +ATN F+   LIG G FG VYKG   DG +VA+K
Sbjct: 10  NSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALK 69

Query: 690 VFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN 749
               +    ++ F+ E E L   RH +LV +I  C   +   L+ +YM NG+L+ +LY +
Sbjct: 70  RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS 129

Query: 750 NFSFDIL---QRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA 806
           +     +   QRL + I  A  L YLH   +  ++H D+K  N+LLD++ V  ++DFGI+
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGIS 186

Query: 807 KL-LSGEESMKQTLTLATIGYMAP 829
           K     +++   T+   T+GY+ P
Sbjct: 187 KKGTELDQTHLSTVVKGTLGYIDP 210

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  204 bits (522), Expect = 1e-59
 Identities = 68/191 (35%), Positives = 103/191 (53%), Gaps = 12/191 (6%)

Query: 647 RRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLE-----GALKS 701
           +RFS +EL  A++ F+  N++G GGFG VYKG   DG  VA+K    +L+     G    
Sbjct: 18  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK----RLKEERTQGGELQ 73

Query: 702 FDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDIL---QR 758
           F  E E++    HRNL+++   C     + LV  YM NGS+   L     S   L   +R
Sbjct: 74  FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133

Query: 759 LSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT 818
             + +  A  L YLH      ++H D+K +N+LLD++  A + DFG+AKL+  +++   T
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 193

Query: 819 LTLATIGYMAP 829
               TIG++AP
Sbjct: 194 AVRGTIGHIAP 204

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  210 bits (536), Expect = 2e-57
 Identities = 123/586 (20%), Positives = 219/586 (37%), Gaps = 52/586 (8%)

Query: 4   LSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPS 63
             F +L+  +P+    L   ++L L +N +R         L +L+L+ L + +   TI  
Sbjct: 11  YRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66

Query: 64  TIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPI--PNNIWQCKE 120
             F NL +L   +D  ++ +   L  D  + L  +  L +    L+  +         K 
Sbjct: 67  EAFRNLPNLRI-LDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKA 124

Query: 121 LIVISLAYNQFTE-RIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLR--NLEILGLQLN 177
           L  + L+ NQ     +    G L SLK++    N +     +E+  L+   L    L  N
Sbjct: 125 LTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAAN 184

Query: 178 KLVGFVPTSIFN-LSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSF 236
            L   V       ++  + + L    +SG+  +           I     N  S      
Sbjct: 185 SLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVD---------ITGNFSNAISKSQAFS 235

Query: 237 IFNASKLSVLELGENSFSGFIPNTLGNLRK--LEWLRLSYNFLTSSTSELSFLSSWANCK 294
           +  A  +     G ++      NT   L +  +  L LS+ F+ S  S       +   K
Sbjct: 236 LILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNS-----RVFETLK 290

Query: 295 NLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNE 354
           +LK+L+L+ N IN +   +   L  +L  + +S   +          L  +  + L  N 
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLD-NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349

Query: 355 LIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDL 414
           +      TF  L+ LQ LDL +N L       +  +  +  +++ GNKL       +  +
Sbjct: 350 IAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV-----TLPKI 399

Query: 415 T-SLRLLSLASNELNSV-IPSTFWNLKDILSLNFSSNFLNGSLPEDI-GNLKVVVIIDLS 471
             +  L+ L+ N L ++ I      +  +  L  + N  +    +        +  + L 
Sbjct: 400 NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLG 459

Query: 472 RNNLSGDIPTAI-----GGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGN 526
            N L     T +      GL +LQ L L  N L    P     L +L  L L++N L+  
Sbjct: 460 ENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVL 519

Query: 527 IPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLC 572
               +     L+ L++S N+L    P    F + S      N  +C
Sbjct: 520 SHNDLPAN--LEILDISRNQL--LAPNPDVFVSLSVLDITHNKFIC 561

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  205 bits (522), Expect = 2e-55
 Identities = 97/528 (18%), Positives = 185/528 (35%), Gaps = 46/528 (8%)

Query: 48  ELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKL 107
            +       L+  +P  +     L      S N +  ++       L  ++ L + +   
Sbjct: 7   RIAFYRFCNLT-QVPQVLNTTERL----LLSFNYIR-TVTASSFPFLEQLQLLELGSQYT 60

Query: 108 TGPIPNNIWQ-CKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEI--PYEMG 164
              I    ++    L ++ L  ++     P     L  L  L L F  L+  +       
Sbjct: 61  PLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR 120

Query: 165 NLRNLEILGLQLNKLVGFVPTSIF-NLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIIS 223
           NL+ L  L L  N++        F  L+++K++   SN +       ++ ++   L   S
Sbjct: 121 NLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFS 180

Query: 224 LAGNNFSGIIPSFIFNASK------LSVLELGENSFSGFIPNTLGN------------LR 265
           LA N+    +               L +L++  N ++  I     N              
Sbjct: 181 LAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAH 240

Query: 266 KLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIF 325
            +      ++ +       +F     +  +++ LDLS+  +  +       L   L  + 
Sbjct: 241 HIMGAGFGFHNIKDPDQN-TFAGLARS--SVRHLDLSHGFVFSLNSRVFETLK-DLKVLN 296

Query: 326 ISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPN 385
           ++   I     +    L NL+ L L  N L       F  L  +  +DL  N +      
Sbjct: 297 LAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQ 356

Query: 386 GLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLN 445
               L +L  L +  N L+      I  + S+  + L+ N+L ++           LS N
Sbjct: 357 TFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSEN 411

Query: 446 FSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAI-GGLMNLQDLSLRDNGLQGSIP 504
              N         + +L+   I+ L++N  S            +L+ L L +N LQ +  
Sbjct: 412 RLENLDILYFLLRVPHLQ---ILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWE 468

Query: 505 KSI-----GGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKL 547
             +      GL  L+ L L++N L+   P     L  L+ L+L+ N+L
Sbjct: 469 TELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  168 bits (427), Expect = 2e-43
 Identities = 96/415 (23%), Positives = 157/415 (37%), Gaps = 37/415 (8%)

Query: 144 SLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNAL 203
             +  +  F NLT ++P     L   E L L  N +     +S   L  ++ L L S   
Sbjct: 5   DGRIAFYRFCNLT-QVP---QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYT 60

Query: 204 SGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFI--PNTL 261
             ++        LPNL I+ L  +    + P        L  L L     S  +      
Sbjct: 61  PLTIDKEA-FRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYF 119

Query: 262 GNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLS-LS 320
            NL+ L  L LS N + S     SF        +LK +D S+N I  V    +  L   +
Sbjct: 120 RNLKALTRLDLSKNQIRSLYLHPSF----GKLNSLKSIDFSSNQIFLVCEHELEPLQGKT 175

Query: 321 LSRIFISNCSIRGTIPKEIGNLIN------LRELGLWGNELIGSIPITFGKLQNLQGLDL 374
           LS   ++  S+   +  + G  +N      L  L + GN     I   F           
Sbjct: 176 LSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNF----------- 224

Query: 375 VNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDL--TSLRLLSLASNELNSVIP 432
            +N +       L     +       + +  P       L  +S+R L L+   + S+  
Sbjct: 225 -SNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNS 283

Query: 433 STFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDL 492
             F  LKD+  LN + N +N    E    L  + +++LS N L     +   GL  +  +
Sbjct: 284 RVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYI 343

Query: 493 SLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKL 547
            L+ N +     ++   L  L++LDL +N+L     T++  +  + D+ LS NKL
Sbjct: 344 DLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKL 393

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  161 bits (410), Expect = 3e-41
 Identities = 100/517 (19%), Positives = 183/517 (35%), Gaps = 68/517 (13%)

Query: 2   LSLSFNDLSGAI--PKEIGNLTMLKKLGLGYNKLRG-EIPQELGNLAELELVSLTNNFLS 58
           L L F  LS A+       NL  L +L L  N++R   +    G L  L+ +  ++N + 
Sbjct: 102 LRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF 161

Query: 59  GTIPSTIFNLSSLS-TGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQ 117
                 +  L   + +    + NSL   +  D  + +   + + +    ++G   N    
Sbjct: 162 LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG---NGW-- 216

Query: 118 CKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLR--NLEILGLQ 175
              + +     N  ++     L     +     GF+N+          L   ++  L L 
Sbjct: 217 --TVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLS 274

Query: 176 LNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPS 235
              +                 +L S               L +L++++LA N  + I   
Sbjct: 275 HGFVF----------------SLNSRVFET----------LKDLKVLNLAYNKINKIADE 308

Query: 236 FIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKN 295
             +    L VL L  N       +    L K+ ++ L  N +           ++   + 
Sbjct: 309 AFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQD-----QTFKFLEK 363

Query: 296 LKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNEL 355
           L+ LDL +N +     ++I  +  S+  IF+S   +  T+PK       +         L
Sbjct: 364 LQTLDLRDNAL-----TTIHFIP-SIPDIFLSGNKLV-TLPKINLTANLIHLSENRLENL 416

Query: 356 IGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQ-LARLSVLYMDGNKLSGPIPPCI--- 411
              I     ++ +LQ L L  N+      +        L  L++  N L       +   
Sbjct: 417 --DILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWD 474

Query: 412 --GDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDI--GNLKVVVI 467
               L+ L++L L  N LNS+ P  F +L  +  L+ +SN L   L  +    NL+++  
Sbjct: 475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEIL-- 531

Query: 468 IDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIP 504
            D+SRN L    P      ++L  L +  N       
Sbjct: 532 -DISRNQLLAPNPDV---FVSLSVLDITHNKFICECE 564

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  113 bits (285), Expect = 5e-26
 Identities = 72/339 (21%), Positives = 118/339 (34%), Gaps = 51/339 (15%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L LS   +     +    L  LK L L YNK+     +    L  L++++L+ N L    
Sbjct: 271 LDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELY 330

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
            S  + L  ++  +D   N +   + D   + L  ++ L + +N LT             
Sbjct: 331 SSNFYGLPKVAY-IDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT------------- 375

Query: 122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVG 181
                            +  + S+  ++L  N L   +P          ++ L  N+L  
Sbjct: 376 ----------------TIHFIPSIPDIFLSGNKLV-TLPK---INLTANLIHLSENRLEN 415

Query: 182 FVPTSIF-NLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNF-----SGIIPS 235
                    +  ++ L L  N  S S          P+LE + L  N       + +   
Sbjct: 416 LDILYFLLRVPHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWD 474

Query: 236 FIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKN 295
                S L VL L  N  +   P    +L  L  L L+ N LT        LS      N
Sbjct: 475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTV-------LSHNDLPAN 527

Query: 296 LKLLDLSNNPINGVLPSSIGNLSLSLSRI--FISNCSIR 332
           L++LD+S N +    P    +LS+       FI  C + 
Sbjct: 528 LEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELS 566

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  107 bits (269), Expect = 4e-24
 Identities = 73/343 (21%), Positives = 130/343 (37%), Gaps = 28/343 (8%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L+L++N ++    +    L  L+ L L YN L          L ++  + L  N ++   
Sbjct: 295 LNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQ 354

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
             T   L  L T +D  +N+LT          +P I  +++S NKL   +P        +
Sbjct: 355 DQTFKFLEKLQT-LDLRDNALT------TIHFIPSIPDIFLSGNKLVT-LPKINLTANLI 406

Query: 122 IVISLAYNQFTE-RIPRGLGNLTSLKTLYLGFNNLTGEIPYEM--GNLRNLEILGLQLNK 178
               L+ N+     I   L  +  L+ L L  N  +     +       +LE L L  N 
Sbjct: 407 ---HLSENRLENLDILYFLLRVPHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENM 462

Query: 179 LVGFVPTSI-----FNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGII 233
           L     T +       LS ++ L L  N L+ SLP  +    L  L  +SL  N  + + 
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGV-FSHLTALRGLSLNSNRLTVLS 520

Query: 234 PSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANC 293
            + +   + L +L++  N      P+   +L  L+   +++N         +F+ +W N 
Sbjct: 521 HNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLD---ITHNKFICECELSTFI-NWLNH 574

Query: 294 KNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIP 336
            N+ +     +       S  G    SLS        +  ++ 
Sbjct: 575 TNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLK 617

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 64.8 bits (158), Expect = 8e-11
 Identities = 27/124 (21%), Positives = 49/124 (39%), Gaps = 5/124 (4%)

Query: 440 DILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGL 499
           D     +    L   +P+ +   +    + LS N +     ++   L  LQ L L     
Sbjct: 5   DGRIAFYRFCNLT-QVPQVLNTTE---RLLLSFNYIRTVTASSFPFLEQLQLLELGSQYT 60

Query: 500 QGSI-PKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFA 558
             +I  ++   L +L  LDL ++ +    P + + L +L +L L F  L   + + G F 
Sbjct: 61  PLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR 120

Query: 559 NFSN 562
           N   
Sbjct: 121 NLKA 124

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  205 bits (523), Expect = 3e-57
 Identities = 111/570 (19%), Positives = 199/570 (34%), Gaps = 45/570 (7%)

Query: 4   LSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPS 63
               +    IP  +      K L L +N LR        +  EL+++ L+   +      
Sbjct: 14  CMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70

Query: 64  TIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIV 123
              +LS LST +  + N +  SL       L  ++ L      L       I   K L  
Sbjct: 71  AYQSLSHLST-LILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128

Query: 124 ISLAYNQFTE-RIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQL----NK 178
           +++A+N     ++P    NLT+L+ L L  N +      ++  L  + +L L L    N 
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188

Query: 179 LVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIF 238
           +  F+    F    +  L L +N  S ++  +  +  L  LE+  L    F         
Sbjct: 189 M-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTC-IQGLAGLEVHRLVLGEF--------- 237

Query: 239 NASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKL 298
                      E +   F  + L  L  L        +L     ++  L +     N+  
Sbjct: 238 ---------RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN--CLTNVSS 286

Query: 299 LDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGS 358
             L +  I  V   S       L  +                 L +L+ L    N+   +
Sbjct: 287 FSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSNKGGNA 340

Query: 359 IPITFGKLQNLQGLDLVNNKLE--GPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTS 416
              +   L +L+ LDL  N L   G           L  L +  N +   +      L  
Sbjct: 341 F--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQ 397

Query: 417 LRLLSLASNELNSVIP-STFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNL 475
           L  L    + L  +   S F +L++++ L+ S      +       L  + ++ ++ N+ 
Sbjct: 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 457

Query: 476 SGDIPTAI-GGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKL 534
             +    I   L NL  L L    L+   P +   L SL+ L++++N L        ++L
Sbjct: 458 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRL 517

Query: 535 LYLKDLNLSFNKLEGEIPRGGPFANFSNRS 564
             L+ + L  N  +   PR    + + N++
Sbjct: 518 TSLQKIWLHTNPWDCSCPRIDYLSRWLNKN 547

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  204 bits (520), Expect = 6e-57
 Identities = 111/508 (21%), Positives = 189/508 (37%), Gaps = 23/508 (4%)

Query: 50  VSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTG 109
                      IP    NL   +  +D S N L   L        P ++ L +S  ++  
Sbjct: 12  YQCMELNFY-KIPD---NLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQT 66

Query: 110 PIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNL 169
                      L  + L  N            L+SL+ L     NL     + +G+L+ L
Sbjct: 67  IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126

Query: 170 EILGLQLNKLVGF-VPTSIFNLSAMKTLALPSNALSGSLPSSID-LVRLPNLEIISLAGN 227
           + L +  N +  F +P    NL+ ++ L L SN +     + +  L ++P L +      
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186

Query: 228 NFSGIIPSFIFNASKLSVLELGENSFSGFIP-NTLGNLRKLEWLRLSYNFLTSSTSELSF 286
           N    I    F   +L  L L  N  S  +    +  L  LE  RL      +  +   F
Sbjct: 187 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246

Query: 287 -LSSWANCKNLKLLDLSNNPINGVLPSSIGNLS--LSLSRIFISNCSIRGTIPKEIGNLI 343
             S+     NL + +     ++  L   I   +   ++S   + + +I   +     N  
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF- 304

Query: 344 NLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKL 403
             + L L   +          KL++L+ L   +NK           L  L  L +  N L
Sbjct: 305 GWQHLELVNCKFGQ---FPTLKLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGL 359

Query: 404 S--GPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDI-G 460
           S  G         TSL+ L L+ N + + + S F  L+ +  L+F  + L       +  
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418

Query: 461 NLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI-GGLVSLESLDLS 519
           +L+ ++ +D+S  +          GL +L+ L +  N  Q +    I   L +L  LDLS
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478

Query: 520 NNSLSGNIPTSMEKLLYLKDLNLSFNKL 547
              L    PT+   L  L+ LN++ N+L
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMASNQL 506

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  199 bits (508), Expect = 3e-55
 Identities = 105/546 (19%), Positives = 182/546 (33%), Gaps = 62/546 (11%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L LSFN L         +   L+ L L   +++        +L+ L  + LT N +    
Sbjct: 33  LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ--- 89

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
                                  SL       L  ++ L      L       I   K L
Sbjct: 90  -----------------------SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126

Query: 122 IVISLAYNQFTE-RIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQL---- 176
             +++A+N     ++P    NLT+L+ L L  N +      ++  L  + +L L L    
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186

Query: 177 NKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAG------NNFS 230
           N +  F+    F    +  L L +N  S ++  +  +  L  LE+  L         N  
Sbjct: 187 NPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTC-IQGLAGLEVHRLVLGEFRNEGNLE 244

Query: 231 GIIPSFIFNASKLSVLELGENSFSGF---IPNTLGNLRKLEWLRLSYNFLTSSTSELSFL 287
               S +     L++ E        +   I +    L  +    L    +         +
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-------V 297

Query: 288 SSWANCKNLKLLDLSNNPINGVLPSSIGNL-SLSLSRIFISNCSIRGTIPKEIGNLINLR 346
             ++     + L+L N          + +L  L+ +     N            +L +L 
Sbjct: 298 KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF-------SEVDLPSLE 350

Query: 347 ELGLWGNEL--IGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLS 404
            L L  N L   G    +     +L+ LDL  N +   + +    L +L  L    + L 
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK 409

Query: 405 GPIPPCI-GDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDI-GNL 462
                 +   L +L  L ++           F  L  +  L  + N    +   DI   L
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 469

Query: 463 KVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNS 522
           + +  +DLS+  L    PTA   L +LQ L++  N L+         L SL+ + L  N 
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNP 529

Query: 523 LSGNIP 528
              + P
Sbjct: 530 WDCSCP 535

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  112 bits (283), Expect = 4e-26
 Identities = 57/303 (18%), Positives = 102/303 (33%), Gaps = 15/303 (4%)

Query: 2   LSLSFNDLSG-AIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
             L++ D     I      LT +    L    +   +     N    + + L N      
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFGQF 319

Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLT--GPIPNNIWQC 118
               + +L  L     F++N    +  +     L   + L +S N L+  G    + +  
Sbjct: 320 PTLKLKSLKRL----TFTSNKGGNAFSEVDLPSL---EFLDLSRNGLSFKGCCSQSDFGT 372

Query: 119 KELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEM-GNLRNLEILGLQLN 177
             L  + L++N     +      L  L+ L    +NL     + +  +LRNL  L +   
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431

Query: 178 KLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFI 237
                       LS+++ L +  N+   +    I    L NL  + L+      + P+  
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI-FTELRNLTFLDLSQCQLEQLSPTAF 490

Query: 238 FNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLK 297
            + S L VL +  N            L  L+ + L  N    S   + +LS W N  + K
Sbjct: 491 NSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQK 550

Query: 298 LLD 300
              
Sbjct: 551 EQG 553

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  107 bits (269), Expect = 2e-24
 Identities = 56/230 (24%), Positives = 85/230 (36%), Gaps = 11/230 (4%)

Query: 328 NCSIRG--TIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPN 385
            C       IP  +    + + L L  N L      +F     LQ LDL   +++     
Sbjct: 13  QCMELNFYKIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70

Query: 386 GLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLN 445
               L+ LS L + GN +          L+SL+ L      L S+      +LK +  LN
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130

Query: 446 FSSNFLN-GSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQ----DLSLRDNGLQ 500
            + N +    LPE   NL  +  +DLS N +     T +  L  +      L L  N + 
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

Query: 501 GSIPKSIGGLVSLESLDLSNNSLSGNIP-TSMEKLLYLKDLNLSFNKLEG 549
             I       + L  L L NN  S N+  T ++ L  L+   L   +   
Sbjct: 191 -FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 79.8 bits (197), Expect = 1e-15
 Identities = 33/154 (21%), Positives = 62/154 (40%), Gaps = 5/154 (3%)

Query: 409 PCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVII 468
           PC+  + ++            +  +  ++ K   +L+ S N L         +   + ++
Sbjct: 2   PCVEVVPNITY-QCMELNFYKIPDNLPFSTK---NLDLSFNPLRHLGSYSFFSFPELQVL 57

Query: 469 DLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIP 528
           DLSR  +      A   L +L  L L  N +Q     +  GL SL+ L     +L+    
Sbjct: 58  DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN 117

Query: 529 TSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSN 562
             +  L  LK+LN++ N ++        F+N +N
Sbjct: 118 FPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTN 150

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  185 bits (473), Expect = 5e-53
 Identities = 65/198 (32%), Positives = 97/198 (48%), Gaps = 21/198 (10%)

Query: 647 RRFSYKELLQATNQFN------ASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALK 700
             FS+ EL   TN F+        N +G GGFG VYKG +++   VA+K   L     + 
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKK--LAAMVDIT 69

Query: 701 S------FDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLY--SNNFS 752
           +      FD E +V+   +H NLV+++   ++ D   LV  YMPNGSL D L        
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129

Query: 753 FDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL-SG 811
                R  +    A  + +LH    N  +H DIK +N+LLD+   A +SDFG+A+     
Sbjct: 130 LSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186

Query: 812 EESMKQTLTLATIGYMAP 829
            +++  +  + T  YMAP
Sbjct: 187 AQTVMTSRIVGTTAYMAP 204

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  188 bits (480), Expect = 3e-52
 Identities = 96/479 (20%), Positives = 181/479 (37%), Gaps = 46/479 (9%)

Query: 70  SLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYN 129
            L +     +  +     D     L       +    +T  +        ++  +     
Sbjct: 2   PLGSATITQDTPINQIFTDT---ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRL 56

Query: 130 QFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFN 189
                   G+  L +L  +    N LT   P  + NL  L  + +  N++    P  + N
Sbjct: 57  GIKS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LAN 110

Query: 190 LSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELG 249
           L+ +  L L +N ++        L  L NL  + L+ N  S I    +   + L  L  G
Sbjct: 111 LTNLTGLTLFNNQIT----DIDPLKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFG 164

Query: 250 ENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGV 309
            N  +   P  L NL  LE L +S N ++        +S  A   NL+ L  +NN I+ +
Sbjct: 165 -NQVTDLKP--LANLTTLERLDISSNKVSD-------ISVLAKLTNLESLIATNNQISDI 214

Query: 310 LPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNL 369
             + +G L+ +L  + ++   +       + +L NL +L L  N++    P+    L  L
Sbjct: 215 --TPLGILT-NLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAPL--SGLTKL 267

Query: 370 QGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNS 429
             L L  N++    P  L  L  L+ L ++ N+L    P  I +L +L  L+L  N ++ 
Sbjct: 268 TELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD 323

Query: 430 VIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNL 489
           + P    +L  +  L F +N ++      + NL  +  +    N +S   P  +  L  +
Sbjct: 324 ISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRI 377

Query: 490 QDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLE 548
             L L D     +       +    ++     +L    P ++       + ++++N   
Sbjct: 378 TQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  187 bits (478), Expect = 5e-52
 Identities = 108/502 (21%), Positives = 197/502 (39%), Gaps = 47/502 (9%)

Query: 53  TNNFLSGTIPSTIFNLSSLS--TGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGP 110
           +      T  + IF  ++L+          ++T ++       L  +  L      +   
Sbjct: 5   SATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLGIK-- 59

Query: 111 IPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLE 170
             + +     L  I+ + NQ T+  P  L NLT L  + +  N +    P  + NL NL 
Sbjct: 60  SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLT 115

Query: 171 ILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFS 230
            L L  N++    P  + NL+ +  L L SN +S        L  L +L+ +S  GN  +
Sbjct: 116 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTIS----DISALSGLTSLQQLSF-GNQVT 168

Query: 231 GIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSW 290
            + P  + N + L  L++  N  S    + L  L  LE L  + N ++        ++  
Sbjct: 169 DLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD-------ITPL 217

Query: 291 ANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGL 350
               NL  L L+ N +  +   ++ +L+ +L+ + ++N  I    P  +  L  L EL L
Sbjct: 218 GILTNLDELSLNGNQLKDI--GTLASLT-NLTDLDLANNQISNLAP--LSGLTKLTELKL 272

Query: 351 WGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPC 410
             N++    P+    L  L  L+L  N+LE   P  +  L  L+ L +  N +S   P  
Sbjct: 273 GANQISNISPL--AGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-- 326

Query: 411 IGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDL 470
           +  LT L+ L   +N+++    S+  NL +I  L+   N ++   P  + NL  +  + L
Sbjct: 327 VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 382

Query: 471 SRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTS 530
           +    + + P      +++ +      G     P +I    S    D++ N  S      
Sbjct: 383 NDQAWT-NAPVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLPSYT-NEV 439

Query: 531 MEKLLYLKDLNLSFNKLEGEIP 552
                    +        G + 
Sbjct: 440 SYTFSQPVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  179 bits (457), Expect = 4e-49
 Identities = 104/479 (21%), Positives = 188/479 (39%), Gaps = 68/479 (14%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L      +       +  L  L ++    N+L    P  L NL +L  + + NN ++   
Sbjct: 51  LQADRLGIK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT 106

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
           P  + NL++L+                           L + NN++T   P  +     L
Sbjct: 107 P--LANLTNLTG--------------------------LTLFNNQITDIDP--LKNLTNL 136

Query: 122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVG 181
             + L+ N  ++     L  LTSL+ L  G N +T   P  + NL  LE L +  NK+  
Sbjct: 137 NRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD 191

Query: 182 FVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNAS 241
              + +  L+ +++L   +N +S   P    L  L NL+ +SL GN    I    + + +
Sbjct: 192 --ISVLAKLTNLESLIATNNQISDITP----LGILTNLDELSLNGNQLKDI--GTLASLT 243

Query: 242 KLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDL 301
            L+ L+L  N  S   P  L  L KL  L+L  N +++       +S  A    L  L+L
Sbjct: 244 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-------ISPLAGLTALTNLEL 294

Query: 302 SNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPI 361
           + N +  +  S I NL  +L+ + +   +I    P  + +L  L+ L  + N++  S   
Sbjct: 295 NENQLEDI--SPISNLK-NLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV--SDVS 347

Query: 362 TFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLS 421
           +   L N+  L   +N++    P  L  L R++ L ++    +        +++    + 
Sbjct: 348 SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVK 405

Query: 422 LASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIP 480
             +  L  + P+T  +       + + N  +    E        V I       SG + 
Sbjct: 406 NVTGAL--IAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  180 bits (458), Expect = 2e-50
 Identities = 78/383 (20%), Positives = 155/383 (40%), Gaps = 38/383 (9%)

Query: 166 LRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLA 225
              L  L   +N++         +L+      L   +++  +        L ++  + +A
Sbjct: 2   AATLATLPAPINQI-----FPDADLAEGIRAVLQKASVTDVVT----QEELESITKLVVA 52

Query: 226 GNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELS 285
           G   + I    I   + L  L L  N  +   P  L NL KL  L +  N +T       
Sbjct: 53  GEKVASI--QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD------ 102

Query: 286 FLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINL 345
            +S+  N  NL+ L L+ + I+ +  S + NL+  +  + +       +    + N+  L
Sbjct: 103 -ISALQNLTNLRELYLNEDNISDI--SPLANLT-KMYSLNLGANHNL-SDLSPLSNMTGL 157

Query: 346 RELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSG 405
             L +  +++    P     L +L  L L  N++E   P  L  L  L       N+++ 
Sbjct: 158 NYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD 213

Query: 406 PIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVV 465
             P  + ++T L  L + +N++  + P    NL  +  L   +N ++      + +L  +
Sbjct: 214 ITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKL 267

Query: 466 VIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSG 525
            ++++  N +S    + +  L  L  L L +N L     + IGGL +L +L LS N ++ 
Sbjct: 268 KMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325

Query: 526 NIPTSMEKLLYLKDLNLSFNKLE 548
             P  +  L  +   + +   ++
Sbjct: 326 IRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  165 bits (420), Expect = 3e-45
 Identities = 83/379 (21%), Positives = 159/379 (41%), Gaps = 37/379 (9%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L+     ++   P    +L    +  L    +   +      L  +  + +    +    
Sbjct: 5   LATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV--AS 58

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
              I  L++L   ++ + N +T   P      L  +  LY+  NK+T    + +     L
Sbjct: 59  IQGIEYLTNL-EYLNLNGNQITDISP---LSNLVKLTNLYIGTNKIT--DISALQNLTNL 112

Query: 122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVG 181
             + L  +  ++  P  L NLT + +L LG N+   ++   + N+  L  L +  +K+  
Sbjct: 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKD 169

Query: 182 FVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNAS 241
             P  I NL+ + +L+L  N +    P    L  L +L   +   N  + I P  + N +
Sbjct: 170 VTP--IANLTDLYSLSLNYNQIEDISP----LASLTSLHYFTAYVNQITDITP--VANMT 221

Query: 242 KLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDL 301
           +L+ L++G N  +   P  L NL +L WL +  N ++        +++  +   LK+L++
Sbjct: 222 RLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-------INAVKDLTKLKMLNV 272

Query: 302 SNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPI 361
            +N I+ +  S + NLS  L+ +F++N  +     + IG L NL  L L  N +    P 
Sbjct: 273 GSNQISDI--SVLNNLS-QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP- 328

Query: 362 TFGKLQNLQGLDLVNNKLE 380
               L  +   D  N  ++
Sbjct: 329 -LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  153 bits (388), Expect = 6e-41
 Identities = 69/344 (20%), Positives = 131/344 (38%), Gaps = 33/344 (9%)

Query: 219 LEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLT 278
              ++      + I P    + ++     L + S +  +      L  +  L ++   + 
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 279 SSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKE 338
           S       +       NL+ L+L+ N I  +  S + NL   L+ ++I    I  T    
Sbjct: 58  S-------IQGIEYLTNLEYLNLNGNQITDI--SPLSNLV-KLTNLYIGTNKI--TDISA 105

Query: 339 IGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYM 398
           + NL NLREL L  + +    P     L  +  L+L  N       + L  +  L+ L +
Sbjct: 106 LQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTV 162

Query: 399 DGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPED 458
             +K+    P  I +LT L  LSL  N++  + P    +L  +       N +       
Sbjct: 163 TESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDI--TP 216

Query: 459 IGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDL 518
           + N+  +  + +  N ++   P  +  L  L  L +  N +      ++  L  L+ L++
Sbjct: 217 VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNV 272

Query: 519 SNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSN 562
            +N +S    + +  L  L  L L+ N+L  E          +N
Sbjct: 273 GSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDME--VIGGLTN 312

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 88.4 bits (220), Expect = 5e-19
 Identities = 39/179 (21%), Positives = 79/179 (44%), Gaps = 14/179 (7%)

Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
            LSL++N +    P  + +LT L       N++    P  + N+  L  + + NN ++  
Sbjct: 181 SLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL 236

Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
            P  + NLS L+  ++   N ++     +  + L  +K L + +N+++      +    +
Sbjct: 237 SP--LANLSQLTW-LEIGTNQISDI---NAVKDLTKLKMLNVGSNQISDISV--LNNLSQ 288

Query: 121 LIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKL 179
           L  + L  NQ        +G LT+L TL+L  N++T   P  + +L  ++        +
Sbjct: 289 LNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  184 bits (470), Expect = 3e-50
 Identities = 105/494 (21%), Positives = 196/494 (39%), Gaps = 39/494 (7%)

Query: 76  DFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERI 135
           D  + S T S+P  +      +K L +S NK+T     ++  C  L V+ L  ++     
Sbjct: 11  DGRSRSFT-SIPSGL---TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66

Query: 136 PRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIF-NLSAMK 194
                +L SL+ L L  N+L+       G L +L+ L L  N       TS+F NL+ ++
Sbjct: 67  GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ 126

Query: 195 TLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFS 254
           TL + +      +    D   L +L  + +   +        + +   +  L L  +  +
Sbjct: 127 TLRIGNVETFSEIRRI-DFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185

Query: 255 GFIPNTLGNLRKLEWLRLSYNFLTS---STSELSFLSSWANCKNLKLLDLSNNPINGVLP 311
             +      L  + +L L    L     S   +  +SS       +   L++   N +L 
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELL- 244

Query: 312 SSIGNLSLSLSRIFISNCSIRG---------TIPKEIGNL--INLRELGLWGNELIGSIP 360
             +    L LS +   +C++ G          +  E+G +  + +R L +    L   + 
Sbjct: 245 -KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLS 303

Query: 361 ITFGKLQNLQGLDLVNNKLEGPIPNGLCQ-LARLSVLYMDGNKLSGPIPP---CIGDLTS 416
             +  L+ ++ + + N+K+   +P    Q L  L  L +  N +         C G   S
Sbjct: 304 TVYSLLEKVKRITVENSKVFL-VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPS 362

Query: 417 LRLLSLASNELNSV--IPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNN 474
           L+ L L+ N L S+         LK++ SL+ S N  +  +P+     + +  ++LS   
Sbjct: 363 LQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTG 421

Query: 475 LSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKL 534
           +   + T I     L+ L + +N L  S       L  L+ L +S N L   +P +    
Sbjct: 422 IR-VVKTCI--PQTLEVLDVSNNNLD-SFSL---FLPRLQELYISRNKLK-TLPDAS-LF 472

Query: 535 LYLKDLNLSFNKLE 548
             L  + +S N+L+
Sbjct: 473 PVLLVMKISRNQLK 486

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  164 bits (416), Expect = 4e-43
 Identities = 82/499 (16%), Positives = 165/499 (33%), Gaps = 49/499 (9%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L L  + ++        +L  L+ L L  N L        G L+ L+ ++L  N      
Sbjct: 55  LILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLG 114

Query: 62  PSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
            +++F NL++L T +   N      +       L  +  L +    L      ++   ++
Sbjct: 115 VTSLFPNLTNLQT-LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD 173

Query: 121 LIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLV 180
           +  ++L  ++    +      L+S++ L L   NL       +        +     +  
Sbjct: 174 IHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS 233

Query: 181 GFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNA 240
                S   L  +    L  + +                 +     +    +        
Sbjct: 234 VLTDESFNELLKLLRYILELSEVE--------FDDCTLNGLGDFNPSESDVVSELGKVET 285

Query: 241 SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLD 300
             +  L + +      +      L K++ + +  + +          S   + K+L+ LD
Sbjct: 286 VTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPC-----SFSQHLKSLEFLD 340

Query: 301 LSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNEL--IGS 358
           LS N +      +                          G   +L+ L L  N L  +  
Sbjct: 341 LSENLMVEEYLKN----------------------SACKGAWPSLQTLVLSQNHLRSMQK 378

Query: 359 IPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLR 418
                  L+NL  LD+  N    P+P+      ++  L +    +   +  CI    +L 
Sbjct: 379 TGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLE 434

Query: 419 LLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGD 478
           +L +++N L+S        L  +  L  S N L  +LP+      V++++ +SRN L   
Sbjct: 435 VLDVSNNNLDSF----SLFLPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSV 488

Query: 479 IPTAIGGLMNLQDLSLRDN 497
                  L +LQ + L  N
Sbjct: 489 PDGIFDRLTSLQKIWLHTN 507

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  122 bits (308), Expect = 3e-29
 Identities = 58/381 (15%), Positives = 140/381 (36%), Gaps = 27/381 (7%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L +    L     + + ++  +  L L  ++    +      L+ +  + L +  L+   
Sbjct: 153 LEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQ 212

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
            S +      S     +       L D+    L  +    +  +++          C   
Sbjct: 213 FSPLPVDEVSSPMKKLAFRGSV--LTDESFNELLKLLRYILELSEVE------FDDCTLN 264

Query: 122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVG 181
            +     ++       G     +++ L++    L  ++      L  ++ + ++ +K+  
Sbjct: 265 GLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL 324

Query: 182 FVPTSIFNLSAMKTLALPSNALS-GSLPSSIDLVRLPNLEIISLAGNNFSGI--IPSFIF 238
              +   +L +++ L L  N +    L +S      P+L+ + L+ N+   +      + 
Sbjct: 325 VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILL 384

Query: 239 NASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKL 298
               L+ L++  N+F   +P++     K+ +L LS   +    + +         + L++
Sbjct: 385 TLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIP--------QTLEV 435

Query: 299 LDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGS 358
           LD+SNN +      S       L  ++IS   ++ T+P +      L  + +  N+L   
Sbjct: 436 LDVSNNNL-----DSFSLFLPRLQELYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSV 488

Query: 359 IPITFGKLQNLQGLDLVNNKL 379
               F +L +LQ + L  N  
Sbjct: 489 PDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  107 bits (269), Expect = 2e-24
 Identities = 49/259 (18%), Positives = 96/259 (37%), Gaps = 6/259 (2%)

Query: 292 NCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLW 351
           +C    + D  +     + PS    L+ ++  + +S   I      ++    NL+ L L 
Sbjct: 3   SCDASGVCDGRSRSFTSI-PS---GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILK 58

Query: 352 GNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSG-PIPPC 410
            + +       F  L +L+ LDL +N L     +    L+ L  L + GN      +   
Sbjct: 59  SSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118

Query: 411 IGDLTSLRLLSLASNELNSVIP-STFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIID 469
             +LT+L+ L + + E  S I    F  L  +  L   +  L     + + +++ +  + 
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178

Query: 470 LSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPT 529
           L  +  +  +      L +++ L LRD  L       +        +       S     
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238

Query: 530 SMEKLLYLKDLNLSFNKLE 548
           S  +LL L    L  +++E
Sbjct: 239 SFNELLKLLRYILELSEVE 257

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  107 bits (268), Expect = 3e-24
 Identities = 56/313 (17%), Positives = 112/313 (35%), Gaps = 28/313 (8%)

Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRG------EIPQELGNLAELEL--VSL 52
           +   SFN+L   + + I  L+ ++      N L        ++  ELG +  + +  + +
Sbjct: 235 LTDESFNELL-KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHI 293

Query: 53  TNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIP 112
              +L   + +    L  +   +   N+ +   +P    + L  ++ L +S N +     
Sbjct: 294 PQFYLFYDLSTVYSLLEKV-KRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYL 351

Query: 113 NN---IWQCKELIVISLAYNQFT--ERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLR 167
            N         L  + L+ N     ++    L  L +L +L +  N     +P       
Sbjct: 352 KNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPE 410

Query: 168 NLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGN 227
            +  L L    +   V T I     ++ L + +N L  S         LP L+ + ++ N
Sbjct: 411 KMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLD-SFSL-----FLPRLQELYISRN 461

Query: 228 NFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFL 287
               +  + +F    L V+++  N            L  L+ + L  N    S   + +L
Sbjct: 462 KLKTLPDASLFP--VLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 519

Query: 288 SSWANCKNLKLLD 300
           S W N  + K   
Sbjct: 520 SRWLNKNSQKEQG 532

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  177 bits (450), Expect = 1e-49
 Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 20/202 (9%)

Query: 642 PQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKS 701
             ++      + L   +       +   G FG V+K        VA+K+F +Q +   +S
Sbjct: 7   HHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDK---QS 62

Query: 702 FDVECEV--LKSVRHRNLVKIISSCTNNDFKA----LVLEYMPNGSLEDYLYSNNFSFDI 755
           +  E EV  L  ++H N+++ I +            L+  +   GSL D+L +N  S++ 
Sbjct: 63  WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWN- 121

Query: 756 LQRLSVIIDVALALEYLH------FGYSNP-VVHCDIKPSNVLLDKDMVAHLSDFGIAKL 808
            +   +   +A  L YLH           P + H DIK  NVLL  ++ A ++DFG+A  
Sbjct: 122 -ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180

Query: 809 LSGEESMKQTLTLA-TIGYMAP 829
               +S   T     T  YMAP
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAP 202

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  177 bits (452), Expect = 1e-48
 Identities = 104/546 (19%), Positives = 184/546 (33%), Gaps = 109/546 (19%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
                ++L+  +P E  N+    +    +++     P   G   E+ +  L +       
Sbjct: 16  PLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDR--- 71

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
                    L    + +N  L+ SLP+      P ++ L  S N LT  +P      K L
Sbjct: 72  -----QAHEL----ELNNLGLS-SLPEL----PPHLESLVASCNSLT-ELPELPQSLKSL 116

Query: 122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVG 181
           +V +      ++  P        L+ L +  N L  ++P E+ N   L+I+ +  N L  
Sbjct: 117 LVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK- 166

Query: 182 FVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNAS 241
            +P    +L   + +A  +N L   LP   +L  LP L  I    N+   +         
Sbjct: 167 KLPDLPPSL---EFIAAGNNQLE-ELP---ELQNLPFLTAIYADNNSLKKLPDL------ 213

Query: 242 KLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDL 301
                                    LE +    N L         L    N   L  +  
Sbjct: 214 ----------------------PLSLESIVAGNNILEE-------LPELQNLPFLTTIYA 244

Query: 302 SNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPI 361
            NN +   LP    +    L  + + +  +   +P+   +L  L       + L    P 
Sbjct: 245 DNNLLK-TLPDLPPS----LEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP- 297

Query: 362 TFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLS 421
                 NL  L+  +N++   + +       L  L +  NKL   +P        L  L 
Sbjct: 298 ------NLYYLNASSNEIRS-LCD---LPPSLEELNVSNNKLIE-LPALPP---RLERLI 343

Query: 422 LASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPT 481
            + N L   +P    NLK    L+   N L    P+   +++     DL  N+   ++P 
Sbjct: 344 ASFNHLAE-VPELPQNLK---QLHVEYNPLR-EFPDIPESVE-----DLRMNSHLAEVPE 393

Query: 482 AIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLN 541
                 NL+ L +  N L+   P       S+E L +++  +      + E    L+D  
Sbjct: 394 LPQ---NLKQLHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDV 446

Query: 542 LSFNKL 547
              +  
Sbjct: 447 FEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  160 bits (407), Expect = 1e-42
 Identities = 95/439 (21%), Positives = 154/439 (35%), Gaps = 72/439 (16%)

Query: 111 IPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLE 170
           I         L       +  TE +P    N+ S    Y  ++      P   G  R + 
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLTE-MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 171 ILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFS 230
           +  L+                    L L +  LS SLP        P+LE +  + N+ +
Sbjct: 62  VSRLRDCLDRQA-----------HELELNNLGLS-SLPELP-----PHLESLVASCNSLT 104

Query: 231 GIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSW 290
             +P    +   L V      + S   P        LE+L +S N L         L   
Sbjct: 105 -ELPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLEK-------LPEL 149

Query: 291 ANCKNLKLLDLSNNPINGVLPSSIGNL-SLSLSRIFISNCSIRGTIPKEIGNLINLRELG 349
            N   LK++D+ NN +   LP    +L  ++     +           E+ NL  L  + 
Sbjct: 150 QNSSFLKIIDVDNNSLK-KLPDLPPSLEFIAAGNNQL-------EELPELQNLPFLTAIY 201

Query: 350 LWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPP 409
              N L   +P       +L+ +   NN LE      L  L  L+ +Y D N L   +P 
Sbjct: 202 ADNNSLK-KLP---DLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKT-LPD 254

Query: 410 CIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIID 469
               L +L +      +L    P    +L     L+ S N  +  L E   NL     ++
Sbjct: 255 LPPSLEALNVRDNYLTDL----PELPQSLT---FLDVSENIFS-GLSELPPNLYY---LN 303

Query: 470 LSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPT 529
            S N +   +        +L++L++ +N L   +P        LE L  S N L+  +P 
Sbjct: 304 ASSNEIR-SLC---DLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPE 354

Query: 530 SMEKLLYLKDLNLSFNKLE 548
             +    LK L++ +N L 
Sbjct: 355 LPQN---LKQLHVEYNPLR 370

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  159 bits (404), Expect = 4e-42
 Identities = 98/468 (20%), Positives = 170/468 (36%), Gaps = 81/468 (17%)

Query: 94  LPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNL----------- 142
              ++     ++ LT  +P      K       A++++    P G G             
Sbjct: 10  NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68

Query: 143 --TSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPS 200
                  L L    L+  +P    +L +L      L +L    P    +L ++       
Sbjct: 69  LDRQAHELELNNLGLS-SLPELPPHLESLVASCNSLTEL----PELPQSLKSLLVDNNNL 123

Query: 201 NALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNT 260
            ALS  LP        P LE + ++ N    +    + N+S L ++++  NS    +P+ 
Sbjct: 124 KALS-DLP--------PLLEYLGVSNNQLEKLPE--LQNSSFLKIIDVDNNSLK-KLPDL 171

Query: 261 LGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLS 320
             +L  +       N L         L    N   L  +   NN +   LP    +L   
Sbjct: 172 PPSLEFI---AAGNNQLEE-------LPELQNLPFLTAIYADNNSLK-KLPDLPLSLE-- 218

Query: 321 LSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLE 380
              I   N  +      E+ NL  L  +    N L  ++P       +L+ L++ +N L 
Sbjct: 219 --SIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLP---DLPPSLEALNVRDNYLT 270

Query: 381 GPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKD 440
             +P     L  L V     + LS   P       +L  L+ +SNE+ S +     +L+ 
Sbjct: 271 D-LPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIRS-LCDLPPSLE- 320

Query: 441 ILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQ 500
              LN S+N L   LP     L+    +  S N+L+ ++P       NL+ L +  N L+
Sbjct: 321 --ELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVPELPQ---NLKQLHVEYNPLR 370

Query: 501 GSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLE 548
              P       S+E L ++++     +P   + L   K L++  N L 
Sbjct: 371 -EFPDIPE---SVEDLRMNSHLAE--VPELPQNL---KQLHVETNPLR 409

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  144 bits (365), Expect = 4e-37
 Identities = 94/472 (19%), Positives = 174/472 (36%), Gaps = 78/472 (16%)

Query: 2   LSLSFNDLSGAIPKEIGNL-------------TMLKKLGLGYNKLRGEIPQELGNLAELE 48
              ++++     P   G                   +L L    L   +P+   +L  L 
Sbjct: 39  YYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESL- 96

Query: 49  LVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLT 108
               + N L+  +P    +L SL    + +  +L+  LP       PL++ L +SNN+L 
Sbjct: 97  --VASCNSLT-ELPELPQSLKSLLV-DNNNLKALS-DLP-------PLLEYLGVSNNQLE 144

Query: 109 GPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRN 168
             +P  +     L +I +  N   + +P    +L  +     G N L  E+P E+ NL  
Sbjct: 145 K-LPE-LQNSSFLKIIDVDNNSLKK-LPDLPPSLEFI---AAGNNQLE-ELP-ELQNLPF 196

Query: 169 LEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNN 228
           L  +    N L    P    +L   +++   +N L   LP   +L  LP L  I    N 
Sbjct: 197 LTAIYADNNSLKKL-PDLPLSL---ESIVAGNNILE-ELP---ELQNLPFLTTIYADNNL 248

Query: 229 FSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLS 288
               +P        L  L + +N  +  +P    +L  L+     ++ L+     L +L+
Sbjct: 249 LK-TLPDLP---PSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPPNLYYLN 303

Query: 289 SWAN--------CKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIG 340
           + +N          +L+ L++SNN +   LP+    L     R+  S   +   +P+   
Sbjct: 304 ASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE----RLIASFNHLA-EVPELPQ 357

Query: 341 NLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDG 400
           NL   ++L +  N L    P     +++L+    +N+ L   +P     L     L+++ 
Sbjct: 358 NL---KQLHVEYNPLR-EFPDIPESVEDLR----MNSHLA-EVPELPQNL---KQLHVET 405

Query: 401 NKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLN 452
           N L    P     +  LR+    S  +             +    F  +  +
Sbjct: 406 NPLRE-FPDIPESVEDLRM---NSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  111 bits (280), Expect = 3e-26
 Identities = 54/309 (17%), Positives = 102/309 (33%), Gaps = 45/309 (14%)

Query: 256 FIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIG 315
           FI     +   L+      + LT    E        N K+      + +      P   G
Sbjct: 2   FINPRNVSNTFLQEPLRHSSNLTEMPVEAE------NVKSKTEYYNAWSEWERNAPPGNG 55

Query: 316 NLS------------LSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITF 363
                               + ++N  +  ++P+      +L  L    N L   +P   
Sbjct: 56  EQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELP 110

Query: 364 GKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLA 423
             L++L   +     L    P        L  L +  N+L   +P  + + + L+++ + 
Sbjct: 111 QSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLEK-LPE-LQNSSFLKIIDVD 161

Query: 424 SNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAI 483
           +N L   +P    +L+    +   +N L   LPE + NL  +  I    N+L   +P   
Sbjct: 162 NNSLKK-LPDLPPSLE---FIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLP--- 211

Query: 484 GGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLS 543
              ++L+ +   +N L       +  L  L ++   NN L   +P     L  L   +  
Sbjct: 212 DLPLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNY 268

Query: 544 FNKLEGEIP 552
              L     
Sbjct: 269 LTDLPELPQ 277

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  168 bits (429), Expect = 8e-47
 Identities = 49/328 (14%), Positives = 102/328 (31%), Gaps = 26/328 (7%)

Query: 216 LPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYN 275
               E +   G+         +    +    +               N    +    +  
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGR 66

Query: 276 FLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTI 335
            L ++   L   +          L+L + P+    P     LS  L  + I    +   +
Sbjct: 67  ALKATADLLEDATQ----PGRVALELRSVPLP-QFPDQAFRLS-HLQHMTIDAAGLM-EL 119

Query: 336 PKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLV-NNKLE--------GPIPNG 386
           P  +     L  L L  N L  ++P +   L  L+ L +    +L               
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178

Query: 387 LCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNF 446
              L  L  L ++   +   +P  I +L +L+ L + ++ L++ +     +L  +  L+ 
Sbjct: 179 HQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDL 236

Query: 447 SSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKS 506
                  + P   G    +  + L   +    +P  I  L  L+ L LR       +P  
Sbjct: 237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSL 296

Query: 507 IGGLVSLESLDLSNNSLSG---NIPTSM 531
           I  L +   + +  +  +    + P + 
Sbjct: 297 IAQLPANCIILVPPHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  153 bits (390), Expect = 2e-41
 Identities = 54/318 (16%), Positives = 108/318 (33%), Gaps = 31/318 (9%)

Query: 236 FIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKN 295
              ++S    L    ++      + L   ++      +                 AN  N
Sbjct: 7   HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW---------HSAWRQANSNN 57

Query: 296 LKLLDLSNNPINGVLPSSIGNLSL-SLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNE 354
            ++   +   +       + + +      + + +  +    P +   L +L+ + +    
Sbjct: 58  PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115

Query: 355 LIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDL 414
           L+  +P T  +   L+ L L  N L   +P  +  L RL  L +        +P  +   
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLAST 173

Query: 415 TSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNN 474
            +                     L ++ SL      +  SLP  I NL+ +  + +  + 
Sbjct: 174 DA---------------SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSP 217

Query: 475 LSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKL 534
           LS  +  AI  L  L++L LR      + P   GG   L+ L L + S    +P  + +L
Sbjct: 218 LSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRL 276

Query: 535 LYLKDLNLSFNKLEGEIP 552
             L+ L+L        +P
Sbjct: 277 TQLEKLDLRGCVNLSRLP 294

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  149 bits (379), Expect = 5e-40
 Identities = 56/381 (14%), Positives = 118/381 (30%), Gaps = 59/381 (15%)

Query: 11  GAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSS 70
           G+      + +  + L    +         L                +        N ++
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57

Query: 71  LSTGMDFSNNSLTGSLPDDMCR-RLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYN 129
                  +  +L  +  D +     P    L + +  L    P+  ++   L  +++   
Sbjct: 58  PQI-ETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAA 114

Query: 130 QFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFN 189
              E +P  +     L+TL L  N L   +P  + +L  L  L ++    +  +P  +  
Sbjct: 115 GLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPL-- 170

Query: 190 LSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELG 249
                           S  +S +   L NL+ + L                         
Sbjct: 171 ---------------ASTDASGEHQGLVNLQSLRLEWTGIR------------------- 196

Query: 250 ENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGV 309
                  +P ++ NL+ L+ L++  + L+      +   +  +   L+ LDL        
Sbjct: 197 ------SLPASIANLQNLKSLKIRNSPLS------ALGPAIHHLPKLEELDLRGCTALRN 244

Query: 310 LPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNL 369
            P   G  +  L R+ + +CS   T+P +I  L  L +L L G   +  +P    +L   
Sbjct: 245 YPPIFGGRA-PLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303

Query: 370 QGLDLVNNKLEGPIPNGLCQL 390
             + +  +       +     
Sbjct: 304 CIILVPPHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  128 bits (325), Expect = 8e-33
 Identities = 47/234 (20%), Positives = 88/234 (37%), Gaps = 16/234 (6%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L L    L    P +   L+ L+ + +    L  E+P  +   A LE ++L  N L   +
Sbjct: 86  LELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-AL 142

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLI--------KGLYMSNNKLTGPIPN 113
           P++I +L+ L   +          LP+ +               + L +    +   +P 
Sbjct: 143 PASIASLNRLRE-LSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPA 200

Query: 114 NIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILG 173
           +I   + L  + +  +  +  +   + +L  L+ L L         P   G    L+ L 
Sbjct: 201 SIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLI 259

Query: 174 LQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGN 227
           L+    +  +P  I  L+ ++ L L        LPS I   +LP   II +  +
Sbjct: 260 LKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLI--AQLPANCIILVPPH 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  119 bits (301), Expect = 1e-29
 Identities = 46/217 (21%), Positives = 78/217 (35%), Gaps = 17/217 (7%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELE---------LVSL 52
           +++    L   +P  +     L+ L L  N LR  +P  + +L  L          L  L
Sbjct: 109 MTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTEL 166

Query: 53  TNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIP 112
                S         L +L   +      +  SLP  +   L  +K L + N+ L+  + 
Sbjct: 167 PEPLASTDASGEHQGLVNL-QSLRLEWTGIR-SLPASIAN-LQNLKSLKIRNSPLSA-LG 222

Query: 113 NNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYL-GFNNLTGEIPYEMGNLRNLEI 171
             I    +L  + L         P   G    LK L L   +NL   +P ++  L  LE 
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEK 281

Query: 172 LGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLP 208
           L L+    +  +P+ I  L A   + +P +  +    
Sbjct: 282 LDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  114 bits (287), Expect = 8e-28
 Identities = 46/247 (18%), Positives = 84/247 (34%), Gaps = 36/247 (14%)

Query: 333 GTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPN------- 385
           G+      +      L   G+  +        + Q     D           N       
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61

Query: 386 --------------GLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVI 431
                                   L +    L    P     L+ L+ +++ +  L   +
Sbjct: 62  TRTGRALKATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLME-L 119

Query: 432 PSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIG------- 484
           P T      + +L  + N L  +LP  I +L  +  + +       ++P  +        
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178

Query: 485 --GLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNL 542
             GL+NLQ L L   G++ S+P SI  L +L+SL + N+ LS  +  ++  L  L++L+L
Sbjct: 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDL 236

Query: 543 S-FNKLE 548
                L 
Sbjct: 237 RGCTALR 243

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 27/144 (18%), Positives = 54/144 (37%), Gaps = 4/144 (2%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L L +  +  ++P  I NL  LK L +  + L   +   + +L +LE + L         
Sbjct: 188 LRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNY 245

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
           P      + L   +    ++L  +LP D+ R L  ++ L +        +P+ I Q    
Sbjct: 246 PPIFGGRAPLKRLILKDCSNLL-TLPLDIHR-LTQLEKLDLRGCVNLSRLPSLIAQLPAN 303

Query: 122 IVISLAYNQFTERIPRGLGNLTSL 145
            +I +  +   +          + 
Sbjct: 304 CIILVPPHLQAQLDQHRPVARPAE 327

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  166 bits (422), Expect = 5e-46
 Identities = 52/167 (31%), Positives = 88/167 (52%), Gaps = 7/167 (4%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQ--LEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G FG+V++  +  G +VA+K+   Q      +  F  E  ++K +RH N+V  + + 
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNN--FSFDILQRLSVIIDVALALEYLHFGYSNPVVH 782
           T     ++V EY+  GSL   L+ +      D  +RLS+  DVA  + YLH   + P+VH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162

Query: 783 CDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            ++K  N+L+DK     + DFG+++L +      ++    T  +MAP
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAP 208

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  165 bits (418), Expect = 3e-45
 Identities = 58/201 (28%), Positives = 83/201 (41%), Gaps = 26/201 (12%)

Query: 649 FSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEV 708
            +  E     +      LIG G +G+VYKGS LD   VA+KVF        ++F  E  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGS-LDERPVAVKVFSFANR---QNFINEKNI 58

Query: 709 --LKSVRHRNLVKIISSCTNNDFKA-----LVLEYMPNGSLEDYLYSNNFSFDILQRLSV 761
             +  + H N+ + I               LV+EY PNGSL  YL  +   +       +
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWV--SSCRL 116

Query: 762 IIDVALALEYLH------FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM 815
              V   L YLH        Y   + H D+   NVL+  D    +SDFG++  L+G   +
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 816 KQTLTLA-------TIGYMAP 829
           +             TI YMAP
Sbjct: 177 RPGEEDNAAISEVGTIRYMAP 197

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  161 bits (409), Expect = 2e-44
 Identities = 49/179 (27%), Positives = 82/179 (45%), Gaps = 20/179 (11%)

Query: 665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEV--LKSVRHRNLVKIIS 722
             +G G +G V++GS+  G  VA+K+F  + E   KS+  E E+     +RH N++  I+
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIA 69

Query: 723 SCTNNDFKA----LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH----- 773
           S   +   +    L+  Y   GSL DYL            L +++ +A  L +LH     
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTV--SCLRIVLSIASGLAHLHIEIFG 127

Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG---YMAP 829
                 + H D+K  N+L+ K+    ++D G+A + S   +         +G   YMAP
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  163 bits (415), Expect = 2e-43
 Identities = 70/467 (14%), Positives = 149/467 (31%), Gaps = 32/467 (6%)

Query: 89  DMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTL 148
           ++ +     K   ++++ L   + +       +  + L+ N  ++     L   T L+ L
Sbjct: 4   EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63

Query: 149 YLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLP 208
            L  N L  E   ++ +L  L  L L  N +       +    +++TL   +N +     
Sbjct: 64  NLSSNVLY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI----- 111

Query: 209 SSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGF-IPNTLGNLRKL 267
           S +   R    + I LA N  + +        S++  L+L  N            +   L
Sbjct: 112 SRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171

Query: 268 EWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFIS 327
           E L L YNF+         +        LK LDLS+N +   +     + +  ++ I + 
Sbjct: 172 EHLNLQYNFIYD-------VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAA-GVTWISLR 222

Query: 328 NCSIRGTIPKEIGNLINLRELGLWGNEL-IGSIPITFGKLQNLQGLDLVNNKLEGPIPNG 386
           N  +   I K +    NL    L GN    G++   F K Q +Q +      ++      
Sbjct: 223 NNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA--KQTVKKLTGQN 279

Query: 387 LCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNEL----NSVIPSTFWNLKDIL 442
             +    ++ +           P    L +L+    A           +     N     
Sbjct: 280 EEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQR 339

Query: 443 SLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGS 502
            ++         + +     +  + ++  +  L   +         L     +  G    
Sbjct: 340 EIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI-E 398

Query: 503 IPKSIGGLVSLESLDLSNNSLS-GNIPTSMEKLLYLKDLNLSFNKLE 548
           +  +      L+ L           +     +   ++D ++  +K  
Sbjct: 399 LQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  145 bits (368), Expect = 2e-37
 Identities = 61/492 (12%), Positives = 141/492 (28%), Gaps = 52/492 (10%)

Query: 12  AIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSL 71
           AI +   N    K   +  + L+  +     +   ++ + L+ N LS    + +   + L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 72  STGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQF 131
                                     + L +S+N L   +   +     L  + L  N  
Sbjct: 61  --------------------------ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV 92

Query: 132 TERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLS 191
            E     L    S++TL+   NN++  +       +  + + L  NK+           S
Sbjct: 93  QE-----LLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRS 144

Query: 192 AMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGEN 251
            ++ L L  N +  ++  +        LE ++L  N     +   +   +KL  L+L  N
Sbjct: 145 RVQYLDLKLNEID-TVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSN 201

Query: 252 SFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLP 311
             + F+     +   + W+ L  N L      L F        NL+  DL  N  +    
Sbjct: 202 KLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQ------NLEHFDLRGNGFHCGTL 254

Query: 312 SSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQG 371
               + +  +  +     +++    +                           +L  L+ 
Sbjct: 255 RDFFSKNQRVQTVAKQ--TVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKR 312

Query: 372 LDLVNNKLEG----PIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNEL 427
            +      +G     +       AR   +     +    I        +   L      L
Sbjct: 313 KEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKAL 372

Query: 428 NSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLM 487
           +  + +      ++      +               + ++  + +      +        
Sbjct: 373 DEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNN 432

Query: 488 NLQDLSLRDNGL 499
            ++D  +  +  
Sbjct: 433 AIRDWDMYQHKE 444

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  143 bits (361), Expect = 2e-36
 Identities = 54/348 (15%), Positives = 112/348 (32%), Gaps = 22/348 (6%)

Query: 216 LPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYN 275
               +I  +  ++    + S   +A  +  L+L  N  S      L    KLE L LS N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 276 FLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTI 335
            L              +   L+ LDL+NN +       +     S+  +  +N +I   +
Sbjct: 69  VLYE-------TLDLESLSTLRTLDLNNNYV-----QELLVGP-SIETLHAANNNIS-RV 114

Query: 336 PKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEG-PIPNGLCQLARLS 394
               G     + + L  N++     +  G    +Q LDL  N+++             L 
Sbjct: 115 SCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172

Query: 395 VLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGS 454
            L +  N +   +   +     L+ L L+SN+L   +   F +   +  ++  +N L   
Sbjct: 173 HLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-L 228

Query: 455 LPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLE 514
           + + +   + +   DL  N              N +  ++    ++    ++        
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK-NQRVQTVAKQTVKKLTGQNEEECTVPT 287

Query: 515 SLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSN 562
                            ++L+ LK    +    +G           + 
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQ 335

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  139 bits (353), Expect = 2e-35
 Identities = 85/493 (17%), Positives = 155/493 (31%), Gaps = 28/493 (5%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
             ++ + L  A+     +   +K+L L  N L      +L    +LEL++L++N L    
Sbjct: 15  EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-- 72

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
              + +LS+L T +D +NN +   L        P I+ L+ +NN ++  +  +  Q    
Sbjct: 73  TLDLESLSTLRT-LDLNNNYVQ-ELL-----VGPSIETLHAANNNISR-VSCSRGQ--GK 122

Query: 122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTG-EIPYEMGNLRNLEILGLQLNKLV 180
             I LA N+ T       G  + ++ L L  N +          +   LE L LQ N + 
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182

Query: 181 GFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNA 240
             V   +   + +KTL L SN L+  +           +  ISL  N    +I   +  +
Sbjct: 183 D-VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQ--SAAGVTWISLRNNKLV-LIEKALRFS 236

Query: 241 SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLD 300
             L   +L  N F           +      ++   +   T +         C    L  
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNE-----EECTVPTLGH 290

Query: 301 LSNNPINGV---LPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIG 357
                   +       +  L      +     S    +  E  N    RE+     +   
Sbjct: 291 YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRT 350

Query: 358 SIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSL 417
            I     + Q    L+     L+  + NG    A L                        
Sbjct: 351 VIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQ 410

Query: 418 RLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSG 477
            L ++        +         I   +   +       E+    K+    DL+  + + 
Sbjct: 411 LLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANA 470

Query: 478 DIPTAIGGLMNLQ 490
            +   +    NL 
Sbjct: 471 TLQELVVREQNLA 483

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  134 bits (339), Expect = 1e-33
 Identities = 44/263 (16%), Positives = 92/263 (34%), Gaps = 16/263 (6%)

Query: 292 NCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLW 351
           N    K+  ++++ +   L S   +   ++  + +S   +      ++     L  L L 
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAW-NVKELDLSGNPLSQISAADLAPFTKLELLNLS 66

Query: 352 GNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCI 411
            N L     +    L  L+ LDL NN ++      L     +  L+   N +S  +    
Sbjct: 67  SNVL--YETLDLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISR-VSC-- 116

Query: 412 GDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNG-SLPEDIGNLKVVVIIDL 470
                 + + LA+N++  +          +  L+   N ++  +  E   +   +  ++L
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176

Query: 471 SRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTS 530
             N +  D+   +     L+ L L  N L   +         +  + L NN L   I  +
Sbjct: 177 QYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKA 232

Query: 531 MEKLLYLKDLNLSFNKLEGEIPR 553
           +     L+  +L  N       R
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLR 255

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  111 bits (280), Expect = 5e-26
 Identities = 43/232 (18%), Positives = 83/232 (35%), Gaps = 24/232 (10%)

Query: 335 IPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLS 394
           I +   N    +   +  + L  ++        N++ LDL  N L       L    +L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 395 VLYMDGNKLSGPIP-----------------PCIGDLTSLRLLSLASNELNSVIPSTFWN 437
           +L +  N L   +                    +    S+  L  A+N ++ V  S    
Sbjct: 62  LLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQG 121

Query: 438 LKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSG-DIPTAIGGLMNLQDLSLRD 496
            K   ++  ++N +      D G    V  +DL  N +   +          L+ L+L+ 
Sbjct: 122 KK---NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178

Query: 497 NGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLE 548
           N +   +   +     L++LDLS+N L+  +    +    +  ++L  NKL 
Sbjct: 179 NFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 99.5 bits (248), Expect = 5e-22
 Identities = 34/192 (17%), Positives = 76/192 (39%), Gaps = 11/192 (5%)

Query: 358 SIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSL 417
           +I          +   + ++ L+  + +       +  L + GN LS      +   T L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 418 RLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSG 477
            LL+L+SN L   +     +L  + +L+ ++N++     +++     +  +  + NN+S 
Sbjct: 61  ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112

Query: 478 DIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSG-NIPTSMEKLLY 536
            +  +       +++ L +N +        G    ++ LDL  N +   N          
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 537 LKDLNLSFNKLE 548
           L+ LNL +N + 
Sbjct: 171 LEHLNLQYNFIY 182

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 65.3 bits (159), Expect = 4e-11
 Identities = 24/101 (23%), Positives = 45/101 (44%), Gaps = 3/101 (2%)

Query: 454 SLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSL 513
           ++ E   N     I  ++ ++L   + +      N+++L L  N L       +     L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 514 ESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRG 554
           E L+LS+N L       +E L  L+ L+L+ N ++ E+  G
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVG 98

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  157 bits (400), Expect = 4e-43
 Identities = 51/166 (30%), Positives = 75/166 (45%), Gaps = 12/166 (7%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN 726
           +G G FG V K  +    +VAIK    + E   K+F VE   L  V H N+VK+  +C N
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGACLN 72

Query: 727 NDFKALVLEYMPNGSLEDYLYSNN--FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
                LV+EY   GSL + L+       +     +S  +  +  + YLH      ++H D
Sbjct: 73  P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130

Query: 785 IKPSNVLLDKDM-VAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +KP N+LL     V  + DFG A     +     T    +  +MAP
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAP 172

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  156 bits (396), Expect = 7e-43
 Identities = 37/168 (22%), Positives = 76/168 (45%), Gaps = 13/168 (7%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSC 724
           +     G ++KG +  G ++ +KV  ++       + F+ EC  L+   H N++ ++ +C
Sbjct: 18  LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76

Query: 725 TNNDFK--ALVLEYMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
            +       L+  +MP GSL + L+   NF  D  Q +   +D+A  + +LH      + 
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135

Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
              +   +V++D+DM A +S   +        S +    +    ++AP
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAP 177

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  156 bits (396), Expect = 7e-43
 Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 18/175 (10%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQ----LEGALKSFDVECEVLKSVRHRNLVKIIS 722
           IG GGFG VY+  +  G EVA+K         +   +++   E ++   ++H N++ +  
Sbjct: 15  IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVH 782
            C       LV+E+   G L   L       D    ++  + +A  + YLH     P++H
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKRIPPD--ILVNWAVQIARGMNYLHDEAIVPIIH 131

Query: 783 CDIKPSNVLLDKDMVAH--------LSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            D+K SN+L+ + +           ++DFG+A+       M      A   +MAP
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYA---WMAP 183

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  159 bits (403), Expect = 1e-42
 Identities = 62/377 (16%), Positives = 134/377 (35%), Gaps = 29/377 (7%)

Query: 198 LPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFI 257
           +  +  +  +    + + L N +I++   +    +  + + +  ++ +L L +       
Sbjct: 26  VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 85

Query: 258 PNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNL 317
                    ++ L + +N +      +     + N   L +L L  N ++ +      N 
Sbjct: 86  TYAFAYAHTIQKLYMGFNAIRYLPPHV-----FQNVPLLTVLVLERNDLSSLPRGIFHNT 140

Query: 318 SLSLSRIFISNCSIRGTIPKEI-GNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVN 376
              L+ + +SN ++   I  +      +L+ L L  N L     +    + +L   ++  
Sbjct: 141 P-KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSY 195

Query: 377 NKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFW 436
           N L       L     +  L    N ++  +         L +L L  N L     +   
Sbjct: 196 NLLS-----TLAIPIAVEELDASHNSINV-VRG--PVNVELTILKLQHNNLTDT--AWLL 245

Query: 437 NLKDILSLNFSSNFLNGSLPEDI-GNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLR 495
           N   ++ ++ S N L   +       ++ +  + +S N L   +      +  L+ L L 
Sbjct: 246 NYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLS 303

Query: 496 DNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGG 555
            N L   + ++      LE+L L +NS+   +  S      LK+L LS N  +       
Sbjct: 304 HNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWD-CNSLRA 358

Query: 556 PFANFSNRSFMGNDLLC 572
            F N +  +    D  C
Sbjct: 359 LFRNVARPAVDDADQHC 375

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  147 bits (373), Expect = 1e-38
 Identities = 69/393 (17%), Positives = 136/393 (34%), Gaps = 54/393 (13%)

Query: 37  IPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPL 96
           I   L        V +               L++    + F N+++   LP  +      
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKI-VTFKNSTMR-KLPAALLDSFRQ 70

Query: 97  IKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLT 156
           ++ L +++ ++             +  + + +N      P    N+  L  L L  N+L+
Sbjct: 71  VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130

Query: 157 GEIPYEM-GNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVR 215
             +P  +  N   L  L +  N L      +    ++++ L L SN L     + +DL  
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL-----THVDLSL 184

Query: 216 LPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYN 275
           +P+L   +++ N       S +     +  L+   NS +         L     L+L +N
Sbjct: 185 IPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELT---ILKLQHN 236

Query: 276 FLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTI 335
            LT         +   N   L  +DLS N +  ++      +                  
Sbjct: 237 NLTD-------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ----------------- 272

Query: 336 PKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSV 395
                    L  L +  N  + ++ +    +  L+ LDL +N L   +     Q  RL  
Sbjct: 273 --------RLERLYISNNR-LVALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLEN 322

Query: 396 LYMDGNKLSGPIPPCIGDLTSLRLLSLASNELN 428
           LY+D N +   +        +L+ L+L+ N+ +
Sbjct: 323 LYLDHNSIV-TLKL--STHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  134 bits (340), Expect = 3e-34
 Identities = 68/381 (17%), Positives = 138/381 (36%), Gaps = 56/381 (14%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           + +           E   L   K +    + +R      L +  ++EL++L +  +   I
Sbjct: 26  VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EI 84

Query: 62  PSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNI-WQCK 119
            +  F    ++   +    N++   LP  + + +PL+  L +  N L+  +P  I     
Sbjct: 85  DTYAFAYAHTIQK-LYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTP 141

Query: 120 ELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKL 179
           +L  +S++ N             TSL+ L L  N LT  +   +  + +L    +  N L
Sbjct: 142 KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL 198

Query: 180 VGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFN 239
                +++    A++ L    N+++  +   +       L I+ L  NN +    +++ N
Sbjct: 199 -----STLAIPIAVEELDASHNSIN-VVRGPV----NVELTILKLQHNNLTDT--AWLLN 246

Query: 240 ASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLL 299
              L  ++L  N     + +    +++LE L +S N L +       +        LK+L
Sbjct: 247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIP------TLKVL 300

Query: 300 DLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSI 359
           DLS+N +                            + +       L  L L  N  I ++
Sbjct: 301 DLSHNHLL--------------------------HVERNQPQFDRLENLYLDHNS-IVTL 333

Query: 360 PITFGKLQNLQGLDLVNNKLE 380
                    L+ L L +N  +
Sbjct: 334 K--LSTHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 79.3 bits (196), Expect = 8e-16
 Identities = 28/174 (16%), Positives = 63/174 (36%), Gaps = 3/174 (1%)

Query: 383 IPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDIL 442
           I + L        +++D              L + ++++  ++ +  +  +   + + + 
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 443 SLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGS 502
            LN +   +             +  + +  N +    P     +  L  L L  N L  S
Sbjct: 73  LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-S 131

Query: 503 IPKSI-GGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGG 555
           +P+ I      L +L +SNN+L      + +    L++L LS N+L   +    
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL 184

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  155 bits (395), Expect = 1e-42
 Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 20/176 (11%)

Query: 667 IGTGGFGSVYKGSFL-DGMEVAIKVFHLQ-------LEGALKSFDVECEVLKSVRHRNLV 718
           IG GGFG V+KG  + D   VAIK   L        +    + F  E  ++ ++ H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
           K+     N     +V+E++P G L   L           +L +++D+AL +EY+    + 
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143

Query: 779 PVVHCDIKPSNVLLDK-----DMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           P+VH D++  N+ L        + A ++DFG    LS +     +  L    +MAP
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFG----LSQQSVHSVSGLLGNFQWMAP 195

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  156 bits (397), Expect = 1e-42
 Identities = 42/171 (24%), Positives = 78/171 (45%), Gaps = 12/171 (7%)

Query: 665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIIS 722
            LIG G FG VY G +    EVAI++  ++   E  LK+F  E    +  RH N+V  + 
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVH 782
           +C +    A++       +L   +       D+ +   +  ++   + YLH   +  ++H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153

Query: 783 CDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA----TIGYMAP 829
            D+K  NV  D   V  ++DFG+  +    ++ ++   L      + ++AP
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  155 bits (394), Expect = 2e-42
 Identities = 47/166 (28%), Positives = 87/166 (52%), Gaps = 9/166 (5%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG+G FG+VYKG +    +VA+K+ ++       L++F  E  VL+  RH N++  +   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
           T     A+V ++    SL  +L+++   F++ + + +    A  ++YLH   +  ++H D
Sbjct: 90  TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145

Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLS-GEESMKQTLTLATIGYMAP 829
           +K +N+ L +D    + DFG+A   S    S +      +I +MAP
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  154 bits (390), Expect = 2e-41
 Identities = 47/179 (26%), Positives = 74/179 (41%), Gaps = 20/179 (11%)

Query: 665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEV--LKSVRHRNLVKIIS 722
             IG G +G V+ G +  G +VA+KVF    E    S+  E E+     +RH N++  I+
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIA 98

Query: 723 SCTNNDFK----ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH----- 773
           +            L+ +Y  NGSL DYL S          L +       L +LH     
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAK--SMLKLAYSSVSGLCHLHTEIFS 156

Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG---YMAP 829
                 + H D+K  N+L+ K+    ++D G+A     + +         +G   YM P
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  153 bits (389), Expect = 3e-41
 Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 20/179 (11%)

Query: 665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEV--LKSVRHRNLVKIIS 722
             IG G FG V++G +  G EVA+K+F  + E   +S+  E E+     +RH N++  I+
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIA 103

Query: 723 SCTNNDFKA----LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH----- 773
           +   ++       LV +Y  +GSL DYL     + +    + + +  A  L +LH     
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE--GMIKLALSTASGLAHLHMEIVG 161

Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG---YMAP 829
                 + H D+K  N+L+ K+    ++D G+A                 +G   YMAP
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  147 bits (374), Expect = 1e-39
 Identities = 43/177 (24%), Positives = 81/177 (45%), Gaps = 17/177 (9%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           +G G FG   K +  + G  + +K      E   ++F  E +V++ + H N++K I    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
            +     + EY+  G+L   + S +  +   QR+S   D+A  + YLH   S  ++H D+
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134

Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-------------TIGYMAP 829
              N L+ ++    ++DFG+A+L+  E++  + L                   +MAP
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  152 bits (386), Expect = 4e-39
 Identities = 62/376 (16%), Positives = 134/376 (35%), Gaps = 27/376 (7%)

Query: 198 LPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFI 257
           +  +  +  +    + + L N +I++   +    +  + + +  ++ +L L +       
Sbjct: 32  VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 91

Query: 258 PNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNL 317
                    ++ L + +N +      +     + N   L +L L  N ++ +      N 
Sbjct: 92  TYAFAYAHTIQKLYMGFNAIRYLPPHV-----FQNVPLLTVLVLERNDLSSLPRGIFHNT 146

Query: 318 SLSLSRIFISNCSIRGTIPKEI-GNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVN 376
              L+ + +SN ++   I  +      +L+ L L  N L     +    + +L   ++  
Sbjct: 147 P-KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSY 201

Query: 377 NKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFW 436
           N L       L     +  L    N ++  +         L +L L  N L     +   
Sbjct: 202 NLLS-----TLAIPIAVEELDASHNSINV-VRG--PVNVELTILKLQHNNLTDT--AWLL 251

Query: 437 NLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRD 496
           N   ++ ++ S N L   +      ++ +  + +S N L   +      +  L+ L L  
Sbjct: 252 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSH 310

Query: 497 NGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGP 556
           N L   + ++      LE+L L +NS+   +  S      LK+L LS N  +        
Sbjct: 311 NHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWD-CNSLRAL 365

Query: 557 FANFSNRSFMGNDLLC 572
           F N +  +    D  C
Sbjct: 366 FRNVARPAVDDADQHC 381

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  148 bits (374), Expect = 2e-37
 Identities = 83/509 (16%), Positives = 163/509 (32%), Gaps = 39/509 (7%)

Query: 36  EIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLP 95
            I   L        V +               L++    + F N+++   LP  +     
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKI-VTFKNSTMR-KLPAALLDSFR 75

Query: 96  LIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNL 155
            ++ L +++ ++             +  + + +N      P    N+  L  L L  N+L
Sbjct: 76  QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 135

Query: 156 TGEIPYEM-GNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLV 214
           +  +P  +  N   L  L +  N L      +    ++++ L L SN L     + +DL 
Sbjct: 136 S-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL-----THVDLS 189

Query: 215 RLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSY 274
            +P+L   +++ N       S +     +  L+   NS +         L     L+L +
Sbjct: 190 LIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELT---ILKLQH 241

Query: 275 NFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGT 334
           N LT         +   N   L  +DLS N +  ++      +   L R++ISN  +   
Sbjct: 242 NNLTD-------TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ-RLERLYISNNRLV-A 292

Query: 335 IPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLS 394
           +      +  L+ L L  N L+  +     +   L+ L L +N +   +         L 
Sbjct: 293 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLK 348

Query: 395 VLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGS 454
            L +  N        C       R ++  + +         + L+  L    S       
Sbjct: 349 NLTLSHNDWD-----CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDR 403

Query: 455 LPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLE 514
           L + I    VV  +  ++   S          ++          LQG+          + 
Sbjct: 404 LLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQ----LEAEVN 459

Query: 515 SLDLSNNSLSGNIPTSMEKLLYLKDLNLS 543
            L      L+       + L  L     +
Sbjct: 460 ELRAEVQQLTNEQIQQEQLLQGLHAEIDT 488

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  135 bits (340), Expect = 3e-33
 Identities = 94/576 (16%), Positives = 207/576 (35%), Gaps = 59/576 (10%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQE-LGNLAELELVSLTNNFLSGT 60
           + +           E   L   K +    + +R ++P   L +  ++EL++L +  +   
Sbjct: 32  VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-E 89

Query: 61  IPSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNI-WQC 118
           I +  F    ++   +    N++   LP  + + +PL+  L +  N L+  +P  I    
Sbjct: 90  IDTYAFAYAHTIQK-LYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNT 146

Query: 119 KELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNK 178
            +L  +S++ N             TSL+ L L  N LT  +   +  + +L    +  N 
Sbjct: 147 PKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNL 203

Query: 179 LVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIF 238
           L     +++    A++ L    N+++  +   +       L I+ L  NN +      + 
Sbjct: 204 L-----STLAIPIAVEELDASHNSIN-VVRGPV----NVELTILKLQHNNLTD-TAWLL- 251

Query: 239 NASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKL 298
           N   L  ++L  N     + +    +++LE L +S N L +       +        LK+
Sbjct: 252 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIP------TLKV 305

Query: 299 LDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIG- 357
           LDLS+N +   +  +       L  +++ + SI  T+   +     L+ L L  N+    
Sbjct: 306 LDLSHNHLL-HVERNQPQFD-RLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN 360

Query: 358 SIPITFGKLQNLQGLDL-VNNKLEGPIPNGLC------QLARLSVLYMDGNKLSGPIPPC 410
           S+   F  +      D   + K++  + +GLC            + Y+    +   +   
Sbjct: 361 SLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRA 420

Query: 411 IGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLP----------EDIG 460
            G  ++   ++   +  + +       L+    L    N L   +           + + 
Sbjct: 421 QGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQ 480

Query: 461 NLKVVVIIDLSRNNLSGDIPTAIGGLMN------LQDLSLRDNGLQGSIPKSIGGLVSLE 514
            L   +  +L R  L  D        +N       +  + +    Q    ++       E
Sbjct: 481 GLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETE 540

Query: 515 SLDLSNNSLSGNI-PTSMEKLLYLKDLNLSFNKLEG 549
            L+  N +L   +     ++    ++ +L   K++ 
Sbjct: 541 DLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQ 576

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 78.8 bits (194), Expect = 2e-15
 Identities = 28/174 (16%), Positives = 64/174 (36%), Gaps = 5/174 (2%)

Query: 383 IPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDIL 442
           I + L        +++D              L + ++++  ++ +  +  +   + + + 
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78

Query: 443 SLNFSSNFLNGSLPEDI-GNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQG 501
            LN +   +   +          +  + +  N +    P     +  L  L L  N L  
Sbjct: 79  LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 136

Query: 502 SIPKSI-GGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRG 554
           S+P+ I      L +L +SNN+L      + +    L++L LS N+L   +   
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLS 189

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  150 bits (381), Expect = 8e-39
 Identities = 90/495 (18%), Positives = 177/495 (35%), Gaps = 39/495 (7%)

Query: 76  DFSNNSLTGSLPDDMCRRLPL-IKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTER 134
           D S N L   +P D    L      L +S N ++    ++I    +L ++ +++N+    
Sbjct: 6   DRSKNGLI-HVPKD----LSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60

Query: 135 IPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIF-NLSAM 193
                     L+ L L  N L  +I        NL+ L L  N          F N+S +
Sbjct: 61  DISVFKFNQELEYLDLSHNKLV-KISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQL 117

Query: 194 KTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSF-IFNASKLSVLELGENS 252
           K L L +  L  S    I  + +  + ++                FN   L ++      
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKE 177

Query: 253 FSGFIPNTLGNLRKLEWLRLSYN-FLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLP 311
           F   +  ++  +  LE   +         +  LS L+       L  L L+N        
Sbjct: 178 FHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSF 237

Query: 312 SSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQG 371
             I  L    +  +                  ++  + L G         +   L+ L  
Sbjct: 238 IRILQLVWHTTVWY-----------------FSISNVKLQGQLDFRDFDYSGTSLKALSI 280

Query: 372 LDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVI 431
             +V++    P        + +++     +        C   ++    L  ++N L   +
Sbjct: 281 HQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTV 340

Query: 432 PSTFWNLKDILSLNFSSNFLNGSLPEDIG---NLKVVVIIDLSRNNLSGDIPTAI-GGLM 487
                +L ++ +L    N L   L +       +K +  +D+S+N++S D          
Sbjct: 341 FENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK 399

Query: 488 NLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKL 547
           +L  L++  N L  +I + +     ++ LDL +N +  +IP  + KL  L++LN++ N+L
Sbjct: 400 SLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL 456

Query: 548 EGEIPRGGPFANFSN 562
           +  +P  G F   ++
Sbjct: 457 K-SVPD-GIFDRLTS 469

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  138 bits (348), Expect = 2e-34
 Identities = 104/538 (19%), Positives = 182/538 (33%), Gaps = 78/538 (14%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           +  S N L   +PK++   T    L +  N +      ++ +L++L ++ +++N +    
Sbjct: 5   VDRSKNGLI-HVPKDLSQKT--TILNISQNYISELWTSDILSLSKLRILIISHNRIQ--- 58

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
                                   L   + +    ++ L +S+NKL   I          
Sbjct: 59  -----------------------YLDISVFKFNQELEYLDLSHNKLVK-IS--------- 85

Query: 122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTG-EIPYEMGNLRNLEILGLQLNKLV 180
                                 +LK L L FN      I  E GN+  L+ LGL    L 
Sbjct: 86  -----------------CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128

Query: 181 GFVPTSIFNLSAMK-TLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFN 239
                 I +L+  K  L L         P  +      +L I+      F  I+   +  
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKT 188

Query: 240 ASKLSVLELGENSFSGFIPNTLGNLRKLE----WLRLSYNFLTSSTSELSFLSSWANCKN 295
            + L +  +            L  L KL+       L+ N + ++ +    +        
Sbjct: 189 VANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT 248

Query: 296 LKLLDLSNNPINGVLPSSIGNLS-LSLSRIFISNCSIRGTIPKEIG---NLINLRELGLW 351
           +    +SN  + G L     + S  SL  + I           +        N+      
Sbjct: 249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFT 308

Query: 352 GNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCI 411
            +       +   K+     LD  NN L   +      L  L  L +  N+L   +    
Sbjct: 309 VSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIA 367

Query: 412 G---DLTSLRLLSLASNELNSVIPS-TFWNLKDILSLNFSSNFLNGSLPEDI-GNLKVVV 466
                + SL+ L ++ N ++           K +LSLN SSN L  ++   +   +KV  
Sbjct: 368 EMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKV-- 425

Query: 467 IIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI-GGLVSLESLDLSNNSL 523
            +DL  N +   IP  +  L  LQ+L++  N L+ S+P  I   L SL+ + L  N  
Sbjct: 426 -LDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 90.3 bits (224), Expect = 5e-19
 Identities = 48/291 (16%), Positives = 97/291 (33%), Gaps = 18/291 (6%)

Query: 13  IPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLA---ELELVSLTNNFLSGTIPSTIFNLS 69
           I  ++     L  L L   +        +  L     +   S++N  L G +    F+ S
Sbjct: 212 ILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYS 271

Query: 70  SLS----TGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVIS 125
             S    +     ++         +      +     + +           +    + + 
Sbjct: 272 GTSLKALSIHQVVSDVFG-FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLD 330

Query: 126 LAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMG---NLRNLEILGLQLNKLVGF 182
            + N  T+ +    G+LT L+TL L  N L  E+         +++L+ L +  N +   
Sbjct: 331 FSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYD 389

Query: 183 VPTSIF-NLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNAS 241
                     ++ +L + SN L+ ++   +     P ++++ L  N    I P  +    
Sbjct: 390 EKKGDCSWTKSLLSLNMSSNILTDTIFRCL----PPRIKVLDLHSNKIKSI-PKQVVKLE 444

Query: 242 KLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWAN 292
            L  L +  N            L  L+ + L  N    S   + +LS W N
Sbjct: 445 ALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLN 495

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  142 bits (361), Expect = 1e-37
 Identities = 59/328 (17%), Positives = 103/328 (31%), Gaps = 46/328 (14%)

Query: 216 LPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYN 275
               +I  +  ++    + S   +A  +  L+L  N  S      L    KLE L LS N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 276 FLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTI 335
            L              +   L+ LDL+NN +                             
Sbjct: 69  VLYE-------TLDLESLSTLRTLDLNNNYV----------------------------- 92

Query: 336 PKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSV 395
            +E+    ++  L    N  I  +     + Q  + + L NNK+           +R+  
Sbjct: 93  -QELLVGPSIETLHAANNN-ISRVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQY 148

Query: 396 LYMDGNKLSG-PIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGS 454
           L +  N++             +L  L+L  N +  V          + +L+ SSN L   
Sbjct: 149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVV--FAKLKTLDLSSNKLA-F 205

Query: 455 LPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQ-GSIPKSIGGLVSL 513
           +  +  +   V  I L  N L   I  A+    NL+   LR NG   G++         +
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264

Query: 514 ESLDLSNNSLSGNIPTSMEKLLYLKDLN 541
           +++                 +  L    
Sbjct: 265 QTVAKQTVKKLTGQNEEECTVPTLGHYG 292

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  141 bits (357), Expect = 3e-37
 Identities = 61/302 (20%), Positives = 108/302 (35%), Gaps = 24/302 (7%)

Query: 94  LPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFN 153
               K   ++++ L   + +       +  + L+ N  ++     L   T L+ L L  N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 154 NLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDL 213
            L  E   ++ +L  L  L L  N +       +    +++TL   +N +     S +  
Sbjct: 69  VLY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI-----SRVSC 116

Query: 214 VRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGF-IPNTLGNLRKLEWLRL 272
            R    + I LA N  + +        S++  L+L  N            +   LE L L
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176

Query: 273 SYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIR 332
            YNF+         +        LK LDLS+N +   +     + +  ++ I + N  + 
Sbjct: 177 QYNFIYD-------VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAA-GVTWISLRNNKLV 227

Query: 333 GTIPKEIGNLINLRELGLWGNEL-IGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLA 391
             I K +    NL    L GN    G++   F K Q +Q +     K         C + 
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286

Query: 392 RL 393
            L
Sbjct: 287 TL 288

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  137 bits (348), Expect = 6e-36
 Identities = 58/359 (16%), Positives = 119/359 (33%), Gaps = 53/359 (14%)

Query: 119 KELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNK 178
               +  +  +   + +     +  ++K L L  N L+     ++     LE+L L  N 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 179 LVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIF 238
           L       + +LS ++TL L +N +        +L+  P++E +  A NN S  +     
Sbjct: 70  LYE--TLDLESLSTLRTLDLNNNYVQ-------ELLVGPSIETLHAANNNIS-RVSCSRG 119

Query: 239 NASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKL 298
                  + L  N  +       G   ++++L L  N + +    ++F    A+   L+ 
Sbjct: 120 --QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT----VNFAELAASSDTLEH 173

Query: 299 LDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGS 358
           L+L  N I                            +  ++     L+ L L  N+L   
Sbjct: 174 LNLQYNFIY--------------------------DVKGQV-VFAKLKTLDLSSNKLA-F 205

Query: 359 IPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLS-GPIPPCIGDLTSL 417
           +   F     +  + L NNKL   I   L     L    + GN    G +         +
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264

Query: 418 RLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLS 476
           + ++  + +  +        +  +        +    LP    +     +I L  ++  
Sbjct: 265 QTVAKQTVKKLTGQNEEECTVPTLGHYG---AYCCEDLPAPFADR----LIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  125 bits (316), Expect = 8e-32
 Identities = 57/354 (16%), Positives = 113/354 (31%), Gaps = 49/354 (13%)

Query: 12  AIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSL 71
           AI +   N    K   +  + L+  +     +   ++ + L+ N LS    + +   + L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 72  STGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQF 131
                                       L +S+N L   +   +     L  + L  N  
Sbjct: 61  EL--------------------------LNLSSNVLYETLD--LESLSTLRTLDLNNNYV 92

Query: 132 TERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLS 191
            E     L    S++TL+   NN++  +       +  + + L  NK+           S
Sbjct: 93  QE-----LLVGPSIETLHAANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRS 144

Query: 192 AMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGEN 251
            ++ L L  N +  ++  +        LE ++L  N     +   +   +KL  L+L  N
Sbjct: 145 RVQYLDLKLNEID-TVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSN 201

Query: 252 SFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLP 311
             + F+     +   + W+ L  N L      L F        NL+  DL  N  +    
Sbjct: 202 KLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQ------NLEHFDLRGNGFHCGTL 254

Query: 312 SSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGK 365
               + +  +  +          +  +      +  LG +G      +P  F  
Sbjct: 255 RDFFSKNQRVQTVAKQTVK---KLTGQNEEECTVPTLGHYGAYCCEDLPAPFAD 305

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  117 bits (294), Expect = 8e-29
 Identities = 62/309 (20%), Positives = 113/309 (36%), Gaps = 49/309 (15%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
             ++ + L  A+     +   +K+L L  N L      +L    +LEL++L++N L    
Sbjct: 15  EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-- 72

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
              + +LS+L T +D +NN +   L        P I+ L+ +NN ++  +  +  Q    
Sbjct: 73  TLDLESLSTLRT-LDLNNNYVQ-ELL-----VGPSIETLHAANNNISR-VSCSRGQ--GK 122

Query: 122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTG-EIPYEMGNLRNLEILGLQLNKLV 180
             I LA N+ T       G  + ++ L L  N +          +   LE L LQ N + 
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182

Query: 181 GFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNA 240
             V   +                               L+ + L+ N  + + P F  +A
Sbjct: 183 D-VKGQVV---------------------------FAKLKTLDLSSNKLAFMGPEF-QSA 213

Query: 241 SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLD 300
           + ++ + L  N     I   L   + LE   L  N     T    F       KN ++  
Sbjct: 214 AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS------KNQRVQT 266

Query: 301 LSNNPINGV 309
           ++   +  +
Sbjct: 267 VAKQTVKKL 275

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  113 bits (285), Expect = 9e-28
 Identities = 43/232 (18%), Positives = 83/232 (35%), Gaps = 24/232 (10%)

Query: 335 IPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLS 394
           I +   N    +   +  + L  ++        N++ LDL  N L       L    +L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 395 VLYMDGNKLSGPIP-----------------PCIGDLTSLRLLSLASNELNSVIPSTFWN 437
           +L +  N L   +                    +    S+  L  A+N ++ V  S    
Sbjct: 62  LLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQG 121

Query: 438 LKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSG-DIPTAIGGLMNLQDLSLRD 496
            K   ++  ++N +      D G    V  +DL  N +   +          L+ L+L+ 
Sbjct: 122 KK---NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178

Query: 497 NGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLE 548
           N +   +   +     L++LDLS+N L+  +    +    +  ++L  NKL 
Sbjct: 179 NFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  101 bits (254), Expect = 1e-23
 Identities = 34/192 (17%), Positives = 76/192 (39%), Gaps = 11/192 (5%)

Query: 358 SIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSL 417
           +I          +   + ++ L+  + +       +  L + GN LS      +   T L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 418 RLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSG 477
            LL+L+SN L   +     +L  + +L+ ++N++     +++     +  +  + NN+S 
Sbjct: 61  ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112

Query: 478 DIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSG-NIPTSMEKLLY 536
            +  +       +++ L +N +        G    ++ LDL  N +   N          
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 537 LKDLNLSFNKLE 548
           L+ LNL +N + 
Sbjct: 171 LEHLNLQYNFIY 182

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 24/101 (23%), Positives = 45/101 (44%), Gaps = 3/101 (2%)

Query: 454 SLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSL 513
           ++ E   N     I  ++ ++L   + +      N+++L L  N L       +     L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 514 ESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRG 554
           E L+LS+N L       +E L  L+ L+L+ N ++ E+  G
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVG 98

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  144 bits (365), Expect = 3e-36
 Identities = 73/348 (20%), Positives = 133/348 (38%), Gaps = 50/348 (14%)

Query: 205 GSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNL 264
            ++   +         ++++  +  +  +P  +     ++ L + +N+ +  +P     L
Sbjct: 28  AAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPEL 83

Query: 265 RKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRI 324
           R LE   +S N LTS                L +       +   LPS +  L +  +++
Sbjct: 84  RTLE---VSGNQLTSLPVLPP------GLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQL 133

Query: 325 FISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIP 384
                    ++P     L   +EL +  N+L  S+P    +L  L      NN+L   +P
Sbjct: 134 --------TSLPVLPPGL---QELSVSDNQL-ASLPALPSELCKL---WAYNNQLTS-LP 177

Query: 385 NGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSL 444
                L  LSV     N+L+  +P    +L  L   +   N L S +P+    LK    L
Sbjct: 178 MLPSGLQELSV---SDNQLAS-LPTLPSELYKLWAYN---NRLTS-LPALPSGLK---EL 226

Query: 445 NFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIP 504
             S N L  SLP     LK    + +S N L+  +P        L  LS+  N L   +P
Sbjct: 227 IVSGNRLT-SLPVLPSELKE---LMVSGNRLT-SLPMLPS---GLLSLSVYRNQLT-RLP 277

Query: 505 KSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIP 552
           +S+  L S  +++L  N LS     ++ ++      +    + +    
Sbjct: 278 ESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGA 325

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  141 bits (357), Expect = 3e-35
 Identities = 76/354 (21%), Positives = 129/354 (36%), Gaps = 57/354 (16%)

Query: 100 LYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEI 159
           L +  + LT  +P+ +     +  + +  N  T  +P     L +L    +  N LT  +
Sbjct: 45  LNVGESGLTT-LPDCL--PAHITTLVIPDNNLTS-LPALPPELRTL---EVSGNQLT-SL 96

Query: 160 PYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNL 219
           P     L  L I    L  L    P     L     L +  N L+ SLP        P L
Sbjct: 97  PVLPPGLLELSIFSNPLTHL----PALPSGL---CKLWIFGNQLT-SLPVLP-----PGL 143

Query: 220 EIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTS 279
           + +S++ N  + +        S+L  L    N  +  +P     L++L    +S N L S
Sbjct: 144 QELSVSDNQLASLPALP----SELCKLWAYNNQLT-SLPMLPSGLQEL---SVSDNQLAS 195

Query: 280 STSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNL-SLSLSRIFISNCSIRGTIPKE 338
             +  S          L  L   NN +   LP+    L  L +S   ++      ++P  
Sbjct: 196 LPTLPS---------ELYKLWAYNNRLT-SLPALPSGLKELIVSGNRLT------SLPVL 239

Query: 339 IGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYM 398
              L   +EL + GN L  S+P+       L  L +  N+L   +P  L  L+  + + +
Sbjct: 240 PSEL---KELMVSGNRLT-SLPML---PSGLLSLSVYRNQLTR-LPESLIHLSSETTVNL 291

Query: 399 DGNKLSGPIPPCIGDLTSLRLLS---LASNELNSVIPSTFWNLKDILSLNFSSN 449
           +GN LS      + ++TS    S   +  +   +  P     L    +      
Sbjct: 292 EGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPA 345

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  135 bits (341), Expect = 3e-33
 Identities = 72/376 (19%), Positives = 131/376 (34%), Gaps = 56/376 (14%)

Query: 190 LSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELG 249
            +    L +  + L+ +LP  +      ++  + +  NN + +         +L  LE+ 
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCL----PAHITTLVIPDNNLTSLPALP----PELRTLEVS 89

Query: 250 ENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGV 309
            N  +  +P     L +L         L +                L  L +  N +   
Sbjct: 90  GNQLT-SLPVLPPGLLELSIFSNPLTHLPAL------------PSGLCKLWIFGNQLT-S 135

Query: 310 LPSSIGNL-SLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQN 368
           LP     L  LS+S   ++      ++P     L  L     + N+L  S+P+       
Sbjct: 136 LPVLPPGLQELSVSDNQLA------SLPALPSELCKLW---AYNNQLT-SLPMLPS---G 182

Query: 369 LQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELN 428
           LQ L + +N+L   +P    +L +L       N+L+  +P        L+ L ++ N L 
Sbjct: 183 LQELSVSDNQLAS-LPTLPSELYKLWAYN---NRLT-SLPALPS---GLKELIVSGNRLT 234

Query: 429 SVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMN 488
           S +P     LK    L  S N L  SLP     L     + + RN L+  +P ++  L +
Sbjct: 235 S-LPVLPSELK---ELMVSGNRLT-SLPMLPSGLLS---LSVYRNQLT-RLPESLIHLSS 285

Query: 489 LQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIP--TSMEKLLYLKDLNLSFNK 546
              ++L  N L     +++  + S                      + L+L   +     
Sbjct: 286 ETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPA 345

Query: 547 LEGEIPRGGPFANFSN 562
            EGE      +  F  
Sbjct: 346 REGEPAPADRWHMFGQ 361

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  134 bits (339), Expect = 5e-33
 Identities = 81/385 (21%), Positives = 140/385 (36%), Gaps = 59/385 (15%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L++  + L+  +P  +     +  L +  N L   +P     L  LE   ++ N L+ ++
Sbjct: 45  LNVGESGLT-TLPDCLPAH--ITTLVIPDNNLT-SLPALPPELRTLE---VSGNQLT-SL 96

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
           P     L  LS         L  +LP  +C+       L++  N+LT  +P      +EL
Sbjct: 97  PVLPPGLLELSI-FSNPLTHLP-ALPSGLCK-------LWIFGNQLTS-LPVLPPGLQEL 146

Query: 122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVG 181
              S++ NQ    +P     L     L+   N LT  +P     L+ L +   QL  L  
Sbjct: 147 ---SVSDNQLAS-LPALPSELCK---LWAYNNQLT-SLPMLPSGLQELSVSDNQLASL-- 196

Query: 182 FVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNAS 241
             PT    L     L   +N L+ SLP+         L+ + ++GN  +  +P      S
Sbjct: 197 --PTLPSEL---YKLWAYNNRLT-SLPALP-----SGLKELIVSGNRLTS-LPVLP---S 241

Query: 242 KLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDL 301
           +L  L +  N  +  +P     L     L +  N LT     L       +  +   ++L
Sbjct: 242 ELKELMVSGNRLTS-LPMLPSGLL---SLSVYRNQLTRLPESLI------HLSSETTVNL 291

Query: 302 SNNPINGVLPSSIGNLSLS--LSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSI 359
             NP++     ++  ++ +   S   I       + P+E   L       L         
Sbjct: 292 EGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPA 351

Query: 360 PIT----FGKLQNLQGLDLVNNKLE 380
           P      FG+  N     L  ++L 
Sbjct: 352 PADRWHMFGQEDNADAFSLFLDRLS 376

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  126 bits (319), Expect = 2e-30
 Identities = 86/421 (20%), Positives = 140/421 (33%), Gaps = 79/421 (18%)

Query: 142 LTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSN 201
                 L +G + LT  +P  +    ++  L +  N L   +P     L   +TL +  N
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPEL---RTLEVSGN 91

Query: 202 ALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTL 261
            L+ SLP       L  L I S    +   +          L  L +  N  +  +P   
Sbjct: 92  QLT-SLPVLPP--GLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQLT-SLPVLP 140

Query: 262 GNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSL 321
                L+ L +S N L S  +  S          L  L   NN +               
Sbjct: 141 PG---LQELSVSDNQLASLPALPS---------ELCKLWAYNNQLT-------------- 174

Query: 322 SRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEG 381
                       ++P        L+EL +  N+L  S+P    +L     L   NN+L  
Sbjct: 175 ------------SLPMLPS---GLQELSVSDNQLA-SLPTLPSELYK---LWAYNNRLT- 214

Query: 382 PIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDI 441
            +P        L  L + GN+L+  +P    +L     L ++ N L S +P     L   
Sbjct: 215 SLPALPSG---LKELIVSGNRLTS-LPVLPSELKE---LMVSGNRLTS-LPMLPSGLL-- 264

Query: 442 LSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLS---LRDNG 498
            SL+   N L   LPE + +L     ++L  N LS     A+  + +    S   +R + 
Sbjct: 265 -SLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDM 322

Query: 499 LQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFA 558
              S P+    L    +  L         P     +   +D   +F+     +     F 
Sbjct: 323 AGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSETENFI 382

Query: 559 N 559
            
Sbjct: 383 K 383

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  143 bits (361), Expect = 6e-36
 Identities = 97/500 (19%), Positives = 180/500 (36%), Gaps = 51/500 (10%)

Query: 76  DFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERI 135
           D+SN +LT  +P D+    P  K L +S N ++     +I    EL V+ L++N+    +
Sbjct: 37  DYSNRNLT-HVPKDLP---PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS-L 91

Query: 136 PRGL-GNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIF-NLSAM 193
              +      L+ L +  N L   I      + +L  L L  N          F NL+ +
Sbjct: 92  DFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKL 148

Query: 194 KTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSF---IFNASKLSVLELGE 250
             L L +          +DL+ + +L +  +  +  S  I             +VL L  
Sbjct: 149 TFLGLSAAKFR-----QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVF 203

Query: 251 NSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVL 310
           +  S F      ++  L  L+LS   L     +          +   LL+++   I    
Sbjct: 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263

Query: 311 PSSIGNLSL----SLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKL 366
             S+          +  + I N +I   I +E                           L
Sbjct: 264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSET-------------------AL 304

Query: 367 QNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNE 426
           ++L    + N              A +++  +  +        C    +S   L+   N 
Sbjct: 305 KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNV 364

Query: 427 LNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIG---NLKVVVIIDLSRNNL-SGDIPTA 482
               +      LK + +L    N L  +  +      N+  +  +D+S N+L S      
Sbjct: 365 FTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRT 423

Query: 483 IGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNL 542
                ++  L+L  N L GS+ + +     ++ LDL NN +  +IP  +  L  L++LN+
Sbjct: 424 CAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNV 480

Query: 543 SFNKLEGEIPRGGPFANFSN 562
           + N+L+  +P  G F   ++
Sbjct: 481 ASNQLK-SVPD-GVFDRLTS 498

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  141 bits (358), Expect = 1e-35
 Identities = 92/477 (19%), Positives = 177/477 (37%), Gaps = 35/477 (7%)

Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNI-WQCK 119
           +P     L         S NS++  L       L  ++ L +S+N++   +  ++    +
Sbjct: 50  LPPRTKAL-------SLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQ 100

Query: 120 ELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPY--EMGNLRNLEILGLQLN 177
           +L  + +++N+    I      + SL+ L L FN+    +P   E GNL  L  LGL   
Sbjct: 101 DLEYLDVSHNRLQN-ISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAA 156

Query: 178 KLVGFVPTSIFNLSAMK-TLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSF 236
           K        + +L      L L S  + G    S+ +     L ++    + FS  +   
Sbjct: 157 KFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMS 216

Query: 237 IFNASKLSV--LELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCK 294
           +     L +  ++L + +    +       R    L ++   + ++      L  +   +
Sbjct: 217 VNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPR 276

Query: 295 NLKLLDLSNNPINGVLP-SSIGNLSLSLSRIFISNCSIRGTIPKEIG---NLINLRELGL 350
            ++ L++ N  I   +          +L  + I +   +  +  +         +    L
Sbjct: 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKML 336

Query: 351 WGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPC 410
             ++      +      +   L+   N     +  G   L RL  L +  N L       
Sbjct: 337 SISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN-FFKV 395

Query: 411 IGDLTSLRLLSLASNELNSVIPSTFWNL----KDILSLNFSSNFLNGSLPEDI-GNLKVV 465
                ++  L      LNS+    +       + IL LN SSN L GS+   +   +KV 
Sbjct: 396 ALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKV- 454

Query: 466 VIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI-GGLVSLESLDLSNN 521
             +DL  N +   IP  +  L  LQ+L++  N L+ S+P  +   L SL+ + L +N
Sbjct: 455 --LDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  110 bits (276), Expect = 3e-25
 Identities = 75/467 (16%), Positives = 154/467 (32%), Gaps = 35/467 (7%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQEL-GNLAELELVSLTNNFLSGT 60
           LSLS N +S     +I  L+ L+ L L +N++R  +   +     +LE + +++N L   
Sbjct: 57  LSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-N 114

Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMC-RRLPLIKGLYMSNNKLTGPIPNNIWQCK 119
           I      ++SL   +D S N     LP       L  +  L +S  K        +    
Sbjct: 115 ISCC--PMASL-RHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLH 170

Query: 120 ELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLT--------GEIPYEMGNLRNLEI 171
              ++    +   +        + +   L+L F+  +                 L N+++
Sbjct: 171 LSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKL 230

Query: 172 LGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSG 231
                 +L+ F+       + +                         +E +++     + 
Sbjct: 231 NDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITE 290

Query: 232 IIPSFIFNASKLS-----VLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSF 286
            I    F  S+ +     +  +    F            ++    LS +           
Sbjct: 291 RIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPP 350

Query: 287 LSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLR 346
                +  +   L+ + N     +      L   L  + +    ++    K      N+ 
Sbjct: 351 -----SPSSFTFLNFTQNVFTDSVFQGCSTLK-RLQTLILQRNGLK-NFFKVALMTKNMS 403

Query: 347 ELGLWGNEL----IGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNK 402
            L      L      +   T    +++  L+L +N L G +   L    ++ VL +  N+
Sbjct: 404 SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNR 461

Query: 403 LSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSN 449
           +   IP  +  L +L+ L++ASN+L SV    F  L  +  +    N
Sbjct: 462 IMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 69.1 bits (169), Expect = 3e-12
 Identities = 41/242 (16%), Positives = 83/242 (34%), Gaps = 13/242 (5%)

Query: 19  NLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSG----TIPSTIFNLSSLSTG 74
               ++ L +    +   I +E    +E  L SL    +           ++++ +    
Sbjct: 274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNI 333

Query: 75  MDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFT-- 132
              S +     +             L  + N  T  +       K L  + L  N     
Sbjct: 334 KMLSISDTP-FIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNF 392

Query: 133 ERIPRGLGNLTSLKTLYLGFNNLT-GEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLS 191
            ++     N++SL+TL +  N+L             ++ +L L  N L G V   +    
Sbjct: 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PP 450

Query: 192 AMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGEN 251
            +K L L +N +  S+P  +    L  L+ +++A N    +        + L  + L +N
Sbjct: 451 KVKVLDLHNNRIM-SIPKDVT--HLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507

Query: 252 SF 253
            +
Sbjct: 508 PW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 69.1 bits (169), Expect = 3e-12
 Identities = 56/322 (17%), Positives = 109/322 (33%), Gaps = 28/322 (8%)

Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAE-----LELVSLTNN 55
           +L L F+  S    +   ++  L  L L   KL  E  Q L            L+++T  
Sbjct: 198 VLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQ 257

Query: 56  FLSGTIPSTIFNLSSLS----TGMDFSNNSLTGSLPDDMC----RRLPLIKGLYMSNNKL 107
            +  T   ++             ++  N ++T  +  +        L  +   ++ N   
Sbjct: 258 HIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF 317

Query: 108 TGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLR 167
                       E+ +  L+ +           + +S   L    N  T  +      L+
Sbjct: 318 LFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLK 377

Query: 168 NLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSG--SLPSSIDLVRLPNLEIISLA 225
            L+ L LQ N L             M +L     +L+   S           ++ +++L+
Sbjct: 378 RLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLS 436

Query: 226 GNNFSGIIPSFIFN--ASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSE 283
            N     +   +F     K+ VL+L  N     IP  + +L+ L+ L ++ N L S    
Sbjct: 437 SNM----LTGSVFRCLPPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPD- 490

Query: 284 LSFLSSWANCKNLKLLDLSNNP 305
                 +    +L+ + L +NP
Sbjct: 491 ----GVFDRLTSLQYIWLHDNP 508

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  140 bits (355), Expect = 8e-36
 Identities = 100/435 (22%), Positives = 161/435 (37%), Gaps = 59/435 (13%)

Query: 103 SNNKLTG--PIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIP 160
            N  L     +P ++        + L+ N   E        L  L+ L +        I 
Sbjct: 18  INRGLHQVPELPAHV------NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIR 71

Query: 161 YEM-GNLRNLEILGLQLNKLVGFVPTSIF-NLSAMKTLALPSNALSGSLPSSIDLVRLPN 218
                 L +L IL L  N+ +  + T  F  L+ ++ L L    L G++ S      L +
Sbjct: 72  NNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTS 130

Query: 219 LEIISLAGNNFSGIIPSFIF-NASKLSVLELGENSFSGFIPNTLGNLRK--LEWLRLSYN 275
           LE++ L  NN   I P+  F N  +  VL+L  N         L N +      LRLS  
Sbjct: 131 LEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSI 190

Query: 276 FLTS-STSELSFLSSWA--NCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIR 332
            L   +   L +          ++  LDLS N     +     +  ++ ++I        
Sbjct: 191 TLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDA-IAGTKIQSLIL--- 246

Query: 333 GTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQ--NLQGLDLVNNKLEGPIPNGLCQL 390
                   +                    TF  L+   ++  DL  +K+   +   +   
Sbjct: 247 --------SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFA-LLKSVFS- 296

Query: 391 ARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNF 450
                                   T L  L+LA NE+N +  + FW L  +L LN S NF
Sbjct: 297 ----------------------HFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNF 334

Query: 451 LNGSLPEDI-GNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI-G 508
           L GS+   +  NL  + ++DLS N++      +  GL NL++L+L  N L+ S+P  I  
Sbjct: 335 L-GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFD 392

Query: 509 GLVSLESLDLSNNSL 523
            L SL+ + L  N  
Sbjct: 393 RLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  133 bits (336), Expect = 2e-33
 Identities = 77/439 (17%), Positives = 147/439 (33%), Gaps = 77/439 (17%)

Query: 23  LKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIF-NLSSLSTGMDFSNNS 81
           +  + L  N +          L +L+ + +        I +  F  LSSL   +    N 
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL-IILKLDYNQ 90

Query: 82  LTGSLPDDMCRRLPLIKGLYMSNNKLTG-PIPNNIWQC-KELIVISLAYNQFTERIPRGL 139
               L       L  ++ L ++   L G  +  N ++    L ++ L  N   +  P   
Sbjct: 91  FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149

Query: 140 -GNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLAL 198
             N+     L L FN +         ++   ++L  Q          ++  LS++    +
Sbjct: 150 FLNMRRFHVLDLTFNKVK--------SICEEDLLNFQGKHF------TLLRLSSITLQDM 195

Query: 199 PSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLS-----VLELGENSF 253
               L      +    +  ++  + L+GN F   +    F+A   +     +L    N  
Sbjct: 196 NEYWLGWEKCGNPF--KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253

Query: 254 SGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSS 313
           S F      +     +  L  + + +                    DLS + I       
Sbjct: 254 SSFGHTNFKDPDNFTFKGLEASGVKT-------------------CDLSKSKIF------ 288

Query: 314 IGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPI-TFGKLQNLQGL 372
                           ++  ++     +  +L +L L  NE I  I    F  L +L  L
Sbjct: 289 ----------------ALLKSVFS---HFTDLEQLTLAQNE-INKIDDNAFWGLTHLLKL 328

Query: 373 DLVNNKLEGPIPNGLCQ-LARLSVLYMDGNKLSGPIPPCIGD-LTSLRLLSLASNELNSV 430
           +L  N L   I + + + L +L VL +  N +   +       L +L+ L+L +N+L SV
Sbjct: 329 NLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQLKSV 386

Query: 431 IPSTFWNLKDILSLNFSSN 449
               F  L  +  +   +N
Sbjct: 387 PDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  109 bits (274), Expect = 2e-25
 Identities = 77/357 (21%), Positives = 125/357 (35%), Gaps = 41/357 (11%)

Query: 2   LSLSFNDLSGAIPKEI-GNLTMLKKLGLGYNKLRGEIPQE-LGNLAELELVSLTNNFL-S 58
           L +        I       L+ L  L L YN+   ++       LA LE+++LT   L  
Sbjct: 59  LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDG 117

Query: 59  GTIPSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIW- 116
             +    F  L+SL   +   +N++    P      +     L ++ NK+   I      
Sbjct: 118 AVLSGNFFKPLTSL-EMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS-ICEEDLL 175

Query: 117 --QCKELIVISLAYNQFTERIPRGLG--------NLTSLKTLYLGFNNLTG--------- 157
             Q K   ++ L+     +     LG          TS+ TL L  N             
Sbjct: 176 NFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDA 235

Query: 158 ----EIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNL--SAMKTLALPSNALSGSLPSSI 211
               +I   + +                    +   L  S +KT  L  + +  +L  S+
Sbjct: 236 IAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSV 294

Query: 212 DLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLR 271
                 +LE ++LA N  + I  +  +  + L  L L +N           NL KLE L 
Sbjct: 295 -FSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLD 353

Query: 272 LSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISN 328
           LSYN + +   + SF        NLK L L  N +  V       L+ SL +I++  
Sbjct: 354 LSYNHIRALGDQ-SF----LGLPNLKELALDTNQLKSVPDGIFDRLT-SLQKIWLHT 404

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  103 bits (258), Expect = 2e-23
 Identities = 58/327 (17%), Positives = 119/327 (36%), Gaps = 32/327 (9%)

Query: 243 LSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLS 302
           ++ ++L  NS +     +   L+ L++L++            +F        +L +L L 
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTF----RGLSSLIILKLD 87

Query: 303 NNPINGVLPSSIGNLSLSLSRIFISNCSIRGT-IPKEI-GNLINLRELGLWGNELIGSIP 360
            N    +   +   L+ +L  + ++ C++ G  +       L +L  L L  N +    P
Sbjct: 88  YNQFLQLETGAFNGLA-NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQP 146

Query: 361 IT-FGKLQNLQGLDLVNNKLEGPIPNG-----------LCQLARLSVLYMDGNKLSGPIP 408
            + F  ++    LDL  NK++  I              L +L+ +++  M+   L     
Sbjct: 147 ASFFLNMRRFHVLDLTFNKVKS-ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKC 205

Query: 409 PCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVII 468
                 TS+  L L+ N     +   F++      +       + ++    G+       
Sbjct: 206 GNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPD 265

Query: 469 DLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI-GGLVSLESLDLSNNSLSGNI 527
           + +   L             ++   L  + +  ++ KS+      LE L L+ N ++   
Sbjct: 266 NFTFKGLEAS---------GVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKID 315

Query: 528 PTSMEKLLYLKDLNLSFNKLEGEIPRG 554
             +   L +L  LNLS N L G I   
Sbjct: 316 DNAFWGLTHLLKLNLSQNFL-GSIDSR 341

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 95.2 bits (237), Expect = 9e-21
 Identities = 62/354 (17%), Positives = 114/354 (32%), Gaps = 62/354 (17%)

Query: 2   LSLSFNDLSGAIPKEI-GNLTMLKKLGLGYNKLRGEIPQE--LGNLAELELVSLTNNFLS 58
           L L +N     +       L  L+ L L    L G +        L  LE++ L +N + 
Sbjct: 84  LKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK 142

Query: 59  GTIPSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLY----------MSNNKL 107
              P++ F N+      +D + N +  S+ ++                      M+   L
Sbjct: 143 KIQPASFFLNMRRFHV-LDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWL 200

Query: 108 TGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNL------------------------- 142
                 N ++   +  + L+ N F E + +   +                          
Sbjct: 201 GWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTN 260

Query: 143 --------------TSLKTLYLGFNNLTGEIPYEM-GNLRNLEILGLQLNKLVGFVPTSI 187
                         + +KT  L  + +   +   +  +  +LE L L  N++   +  + 
Sbjct: 261 FKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNA 318

Query: 188 F-NLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVL 246
           F  L+ +  L L  N L  S+ S +    L  LE++ L+ N+   +          L  L
Sbjct: 319 FWGLTHLLKLNLSQNFLG-SIDSRM-FENLDKLEVLDLSYNHIRALGDQSFLGLPNLKEL 376

Query: 247 ELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLD 300
            L  N            L  L+ + L  N    S   + +LS W N  + K   
Sbjct: 377 ALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQG 430

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 92.5 bits (230), Expect = 8e-20
 Identities = 57/282 (20%), Positives = 108/282 (38%), Gaps = 35/282 (12%)

Query: 312 SSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPI-TFGKLQNLQ 370
             +  L   ++ + +S  SI          L +L+ L +        I   TF  L +L 
Sbjct: 23  HQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLI 82

Query: 371 GLDLVNNKLEGPIPNGLCQ-LARLSVLYMDGNKL-SGPIPP-CIGDLTSLRLLSLASNEL 427
            L L  N+    +  G    LA L VL +    L    +       LTSL +L L  N +
Sbjct: 83  ILKLDYNQFLQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141

Query: 428 NSVIPST-FWNLKDILSLNFSSNFLNGSLPEDI-----------GNLKVVVIIDLSRNNL 475
             + P++ F N++    L+ + N +  S+ E+              L  + + D++   L
Sbjct: 142 KKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWL 200

Query: 476 SGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVS---LESLDLSNN-----SLSGNI 527
             +         ++  L L  NG + S+ K     ++   ++SL LSN+     S     
Sbjct: 201 GWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTN 260

Query: 528 PTSMEKLLY-------LKDLNLSFNKLEGEIPRGGPFANFSN 562
               +   +       +K  +LS +K+   + +   F++F++
Sbjct: 261 FKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSV-FSHFTD 300

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  139 bits (351), Expect = 4e-35
 Identities = 64/310 (20%), Positives = 125/310 (40%), Gaps = 13/310 (4%)

Query: 267 LEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFI 326
              L L  N + +          +A+  +L+ L+L+ N ++ V P +  NL  +L  + +
Sbjct: 34  TRLLDLGKNRIKTLNQ-----DEFASFPHLEELELNENIVSAVEPGAFNNLF-NLRTLGL 87

Query: 327 SNCSIRGTIPKEI-GNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPN 385
            +  ++  IP  +   L NL +L +  N+++  +   F  L NL+ L++ +N L      
Sbjct: 88  RSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHR 146

Query: 386 GLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLN 445
               L  L  L ++   L+      +  L  L +L L    +N++   +F  L  +  L 
Sbjct: 147 AFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLE 206

Query: 446 FSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPK 505
            S      ++  +      +  + ++  NL+     A+  L+ L+ L+L  N +      
Sbjct: 207 ISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGS 266

Query: 506 SIGGLVSLESLDLSNNSLSGNIPTSM-EKLLYLKDLNLSFNKLEGEIPRG--GPFANFSN 562
            +  L+ L+ + L    L+  +       L YL+ LN+S N+L   +         N   
Sbjct: 267 MLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLET 324

Query: 563 RSFMGNDLLC 572
                N L C
Sbjct: 325 LILDSNPLAC 334

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  132 bits (335), Expect = 4e-33
 Identities = 73/360 (20%), Positives = 137/360 (38%), Gaps = 47/360 (13%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           +         A+P+ I   T  + L LG N+++     E  +   LE + L  N +S  +
Sbjct: 16  VLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AV 71

Query: 62  PSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
               F NL +L T +   +N L   +P  +   L  +  L +S NK+             
Sbjct: 72  EPGAFNNLFNLRT-LGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV------------ 117

Query: 121 LIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEM-GNLRNLEILGLQLNKL 179
                L    F         +L +LK+L +G N+L   I +     L +LE L L+   L
Sbjct: 118 ----ILLDYMFQ--------DLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNL 164

Query: 180 VGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFN 239
                 ++ +L  +  L L    ++ ++       RL  L+++ ++   +   +      
Sbjct: 165 TSIPTEALSHLHGLIVLRLRHLNIN-AIRDYS-FKRLYRLKVLEISHWPYLDTMTPNCLY 222

Query: 240 ASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWA--NCKNLK 297
              L+ L +   + +      + +L  L +L LSYN        +S +          L+
Sbjct: 223 GLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYN-------PISTIEGSMLHELLRLQ 275

Query: 298 LLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEI-GNLINLRELGLWGNELI 356
            + L    +  V P +   L+  L  + +S   +  T+ + +  ++ NL  L L  N L 
Sbjct: 276 EIQLVGGQLAVVEPYAFRGLN-YLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  127 bits (322), Expect = 8e-33
 Identities = 53/168 (31%), Positives = 83/168 (49%), Gaps = 8/168 (4%)

Query: 666 LIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           ++G G +G VY G  L   + +AIK    +     +    E  + K ++H+N+V+ + S 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVII--DVALALEYLHFGYSNPVVH 782
           + N F  + +E +P GSL   L S        ++        +   L+YLH    N +VH
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145

Query: 783 CDIKPSNVLLD-KDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            DIK  NVL++    V  +SDFG +K L+G     +T T  T+ YMAP
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAP 192

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  125 bits (316), Expect = 1e-31
 Identities = 64/318 (20%), Positives = 126/318 (39%), Gaps = 34/318 (10%)

Query: 218 NLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFL 277
           +L ++  +      + P  +      ++L+L  N  +        NL+ L  L L  N +
Sbjct: 32  HLRVVQCSDLGLEKV-PKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 278 TSSTSELSFLSSWANCKNLKLLDLSNNPINGV---LPSSIGNLSLSLSRIFISNCSIRGT 334
           +  +   +F    A    L+ L LS N +  +   +P ++  L +  + I          
Sbjct: 89  SKISPG-AF----APLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEIT--------K 135

Query: 335 IPKEI-GNLINLRELGLWGNELIGSI--PITFGKLQNLQGLDLVNNKLEGPIPNGLCQLA 391
           + K +   L  +  + L  N L  S      F  ++ L  + + +  +   IP GL    
Sbjct: 136 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PP 192

Query: 392 RLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFL 451
            L+ L++DGNK++      +  L +L  L L+ N +++V   +  N   +  L+ ++N L
Sbjct: 193 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252

Query: 452 NGSLPEDIGNLKVVVIIDLSRNNLSG------DIPTAIGGLMNLQDLSLRDNGLQ-GSIP 504
              +P  + + K + ++ L  NN+S         P       +   +SL  N +Q   I 
Sbjct: 253 V-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 311

Query: 505 KSI-GGLVSLESLDLSNN 521
            S    +    ++ L N 
Sbjct: 312 PSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  118 bits (298), Expect = 3e-29
 Identities = 66/337 (19%), Positives = 127/337 (37%), Gaps = 42/337 (12%)

Query: 46  ELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNN 105
            L +V  ++  L   +P    +L   +  +D  NN +T  + D   + L  +  L + NN
Sbjct: 32  HLRVVQCSDLGLE-KVPK---DLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINN 86

Query: 106 KLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGN 165
           K++   P       +L  + L+ NQ  E +P  +    +L+ L +  N +T         
Sbjct: 87  KISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNG 143

Query: 166 LRNLEILGLQLNKL-VGFVPTSIF-NLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIIS 223
           L  + ++ L  N L    +    F  +  +  + +    ++ ++P  +     P+L  + 
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL----PPSLTELH 198

Query: 224 LAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSE 283
           L GN  + +  + +   + L+ L L  NS S     +L N   L  L L+ N L      
Sbjct: 199 LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGG 258

Query: 284 LSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLI 343
           L+      + K ++++ L NN I+ +  +                       P       
Sbjct: 259 LA------DHKYIQVVYLHNNNISAIGSNDFCP-------------------PGYNTKKA 293

Query: 344 NLRELGLWGNEL-IGSI-PITFGKLQNLQGLDLVNNK 378
           +   + L+ N +    I P TF  +     + L N K
Sbjct: 294 SYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  117 bits (296), Expect = 5e-29
 Identities = 56/270 (20%), Positives = 104/270 (38%), Gaps = 17/270 (6%)

Query: 294 KNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGN 353
            +  LLDL NN I  +      NL  +L  + + N  I    P     L+ L  L L  N
Sbjct: 52  PDTALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110

Query: 354 ELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKL-SGPIPPCI- 411
           +L   +P      + LQ L +  N++     +    L ++ V+ +  N L S  I     
Sbjct: 111 QL-KELP--EKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167

Query: 412 GDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLS 471
             +  L  + +A   + ++      +L     L+   N +       +  L  +  + LS
Sbjct: 168 QGMKKLSYIRIADTNITTIPQGLPPSLT---ELHLDGNKITKVDAASLKGLNNLAKLGLS 224

Query: 472 RNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSG------ 525
            N++S     ++    +L++L L +N L   +P  +     ++ + L NN++S       
Sbjct: 225 FNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF 283

Query: 526 NIPTSMEKLLYLKDLNLSFNKLE-GEIPRG 554
             P    K      ++L  N ++  EI   
Sbjct: 284 CPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  117 bits (294), Expect = 9e-29
 Identities = 72/307 (23%), Positives = 112/307 (36%), Gaps = 38/307 (12%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L L  N ++     +  NL  L  L L  NK+    P     L +LE + L+ N L   +
Sbjct: 57  LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-EL 115

Query: 62  PSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLT-GPIPNNIWQ-C 118
           P  +   L  L        N +T  +   +   L  +  + +  N L    I N  +Q  
Sbjct: 116 PEKMPKTLQEL----RVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 170

Query: 119 KELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEM-GNLRNLEILGLQLN 177
           K+L  I +A    T  IP+GL    SL  L+L  N +T ++       L NL  LGL  N
Sbjct: 171 KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFN 226

Query: 178 KLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFI 237
            +      S+ N   ++ L L +N L   +P    L     ++++ L  NN S       
Sbjct: 227 SISAVDNGSLANTPHLRELHLNNNKLV-KVPG--GLADHKYIQVVYLHNNNIS------- 276

Query: 238 FNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLK 297
                     +G N F    P           + L  N +     E+   S++       
Sbjct: 277 ---------AIGSNDFCP--PGYNTKKASYSGVSLFSNPVQ--YWEIQP-STFRCVYVRA 322

Query: 298 LLDLSNN 304
            + L N 
Sbjct: 323 AVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  112 bits (281), Expect = 4e-27
 Identities = 67/368 (18%), Positives = 119/368 (32%), Gaps = 87/368 (23%)

Query: 134 RIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAM 193
           ++P+ L        L L  N +T     +  NL+NL  L L  NK+              
Sbjct: 45  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS------------- 89

Query: 194 KTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSF 253
               +   A +           L  LE + L+ N     +P  +     L  L + EN  
Sbjct: 90  ---KISPGAFAP----------LVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEI 133

Query: 254 SGFIPNTLGNLRKLEWLRLSYNFLTSST-SELSFLSSWANCKNLKLLDLSNNPINGVLPS 312
           +    +    L ++  + L  N L SS     +F       K L  + +++  I      
Sbjct: 134 TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF----QGMKKLSYIRIADTNIT----- 184

Query: 313 SIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIP-ITFGKLQNLQG 371
                                TIP+  G   +L EL L GN+ I  +   +   L NL  
Sbjct: 185 ---------------------TIPQ--GLPPSLTELHLDGNK-ITKVDAASLKGLNNLAK 220

Query: 372 LDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVI 431
           L L  N +       L     L  L+++ NKL   +P  + D   ++++ L +N ++++ 
Sbjct: 221 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIG 279

Query: 432 PSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDI--PTAIGGLMNL 489
            + F                         +      + L  N +      P+    +   
Sbjct: 280 SNDFCPPGYNTKKA---------------SYSG---VSLFSNPVQYWEIQPSTFRCVYVR 321

Query: 490 QDLSLRDN 497
             + L + 
Sbjct: 322 AAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  106 bits (266), Expect = 4e-25
 Identities = 60/310 (19%), Positives = 115/310 (37%), Gaps = 45/310 (14%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           +  S   L   +PK++   T    L L  NK+      +  NL  L  + L NN +S  I
Sbjct: 36  VQCSDLGLE-KVPKDLPPDT--ALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KI 91

Query: 62  PSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
               F  L  L                            LY+S N+L   +P  +   K 
Sbjct: 92  SPGAFAPLVKLER--------------------------LYLSKNQLKE-LPEKMP--KT 122

Query: 121 LIVISLAYNQFTERIPRG-LGNLTSLKTLYLGFNNLT-GEIPYEM-GNLRNLEILGLQLN 177
           L  + +  N+ T ++ +     L  +  + LG N L    I       ++ L  + +   
Sbjct: 123 LQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181

Query: 178 KLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFI 237
            +   +P  +    ++  L L  N ++  + ++  L  L NL  + L+ N+ S +    +
Sbjct: 182 NITT-IPQGLP--PSLTELHLDGNKIT-KVDAA-SLKGLNNLAKLGLSFNSISAVDNGSL 236

Query: 238 FNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTS-STSELSFLSSWANCKNL 296
            N   L  L L  N     +P  L + + ++ + L  N +++  +++           + 
Sbjct: 237 ANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASY 295

Query: 297 KLLDLSNNPI 306
             + L +NP+
Sbjct: 296 SGVSLFSNPV 305

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 48.5 bits (116), Expect = 5e-06
 Identities = 26/101 (25%), Positives = 45/101 (44%), Gaps = 6/101 (5%)

Query: 454 SLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSL 513
            +P+D+       ++DL  N ++         L NL  L L +N +    P +   LV L
Sbjct: 45  KVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102

Query: 514 ESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRG 554
           E L LS N L   +P  M     L++L +  N++  ++ + 
Sbjct: 103 ERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKS 139

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 48.1 bits (115), Expect = 7e-06
 Identities = 24/90 (26%), Positives = 41/90 (45%), Gaps = 4/90 (4%)

Query: 467 IIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGN 526
           ++  S   L   +P  +    +   L L++N +          L +L +L L NN +S  
Sbjct: 35  VVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 91

Query: 527 IPTSMEKLLYLKDLNLSFNKLEGEIPRGGP 556
            P +   L+ L+ L LS N+L+ E+P   P
Sbjct: 92  SPGAFAPLVKLERLYLSKNQLK-ELPEKMP 120

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  125 bits (315), Expect = 2e-31
 Identities = 47/175 (26%), Positives = 77/175 (44%), Gaps = 8/175 (4%)

Query: 659 NQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHR 715
            ++     IG G FG      S  DG +  IK  ++        +    E  VL +++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYL-YSNNFSFDILQRLSVIIDVALALEYLHF 774
           N+V+   S   N    +V++Y   G L   +       F   Q L   + + LAL+++H 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH- 142

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
                ++H DIK  N+ L KD    L DFGIA++L+    + +     T  Y++P
Sbjct: 143 --DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSP 194

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  123 bits (311), Expect = 4e-31
 Identities = 51/178 (28%), Positives = 78/178 (43%), Gaps = 11/178 (6%)

Query: 659 NQFNASNLIGTGGFGSVYKG-SFLDGMEVAIK---VFHLQLEGALKSFDVECEVLKSVRH 714
             F     IG G F  VY+    LDG+ VA+K   +F L    A      E ++LK + H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYL---YSNNFSFDILQRLSVIIDVALALEY 771
            N++K  +S   ++   +VLE    G L   +                   + +  ALE+
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +H   S  V+H DIKP+NV +    V  L D G+ +  S + +   +L   T  YM+P
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 205

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  123 bits (311), Expect = 3e-30
 Identities = 42/178 (23%), Positives = 84/178 (47%), Gaps = 15/178 (8%)

Query: 660 QFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLK-SVRHRNLV 718
            F   +++G G  G++      D  +VA+K    +        D E ++L+ S  H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVI 81

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
           +   +  +  F+ + +E     +L++Y+   +F+   L+ ++++      L +LH   S 
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SL 137

Query: 779 PVVHCDIKPSNVLL-----DKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYMAP 829
            +VH D+KP N+L+        + A +SDFG+ K L+         +    T G++AP
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  120 bits (304), Expect = 3e-30
 Identities = 42/170 (24%), Positives = 75/170 (44%), Gaps = 11/170 (6%)

Query: 665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNL--VKI 720
             IG+GG   V++         AIK  +L+      L S+  E   L  ++  +   +++
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPV 780
                 + +  +V+E   N  L  +L     S D  +R S   ++  A+  +H    + +
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGI 148

Query: 781 VHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
           VH D+KP+N L+   M+  L DFGIA  +  + +     +   T+ YM P
Sbjct: 149 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  119 bits (300), Expect = 6e-30
 Identities = 45/189 (23%), Positives = 77/189 (40%), Gaps = 27/189 (14%)

Query: 659 NQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNL 717
             F    LIG+GGFG V+K    +DG    IK      E A +    E + L  + H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNI 66

Query: 718 VKIISSCTNNDFKA----------------LVLEYMPNGSLEDYL-YSNNFSFDILQRLS 760
           V         D+                  + +E+   G+LE ++        D +  L 
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT 820
           +   +   ++Y+H   S  +++ D+KPSN+ L       + DFG+   L  +    +  +
Sbjct: 127 LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR--S 181

Query: 821 LATIGYMAP 829
             T+ YM+P
Sbjct: 182 KGTLRYMSP 190

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  119 bits (301), Expect = 8e-30
 Identities = 39/183 (21%), Positives = 68/183 (37%), Gaps = 19/183 (10%)

Query: 666 LIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
            +G GGF  V       DG   A+K      +   +    E ++ +   H N++++++ C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 725 TNNDFKA----LVLEYMPNGSLEDYLY---SNNFSFDILQRLSVIIDVALALEYLHFGYS 777
                      L+L +   G+L + +             Q L +++ +   LE +H   +
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152

Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA--------TIGYMAP 829
               H D+KP+N+LL  +    L D G            +             TI Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

Query: 830 GLF 832
            LF
Sbjct: 213 ELF 215

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  120 bits (303), Expect = 2e-29
 Identities = 44/209 (21%), Positives = 84/209 (40%), Gaps = 13/209 (6%)

Query: 628 EKNAKQSNIESNMLPQATRRRFSYKELLQATN--QFNASNLIGTGGFGSVYKGSFLDGME 685
            K  +Q     ++      +  S      +     ++    IG+GG   V++        
Sbjct: 23  AKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQI 82

Query: 686 VAIKVFHLQL--EGALKSFDVECEVLKSVRHRNL--VKIISSCTNNDFKALVLEYMPNGS 741
            AIK  +L+      L S+  E   L  ++  +   +++      + +  +V+E   N  
Sbjct: 83  YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNID 141

Query: 742 LEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLS 801
           L  +L     S D  +R S   ++  A+  +H    + +VH D+KP+N L+   M+  L 
Sbjct: 142 LNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLI 196

Query: 802 DFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
           DFGIA  +  + +     +    + YM P
Sbjct: 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPP 225

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  119 bits (300), Expect = 2e-29
 Identities = 44/171 (25%), Positives = 68/171 (39%), Gaps = 15/171 (8%)

Query: 665 NLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISS 723
             +G G FG V++      G + A+K   ++LE        E      +    +V +  +
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVK--KVRLEVFRVE---ELVACAGLSSPRIVPLYGA 118

Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
                +  + +E +  GSL   +          + L  +      LEYLH   +  ++H 
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHG 174

Query: 784 DIKPSNVLLDKD-MVAHLSDFGIAKLLSGEESMKQTLTLAT-IG---YMAP 829
           D+K  NVLL  D   A L DFG A  L  +   K  LT     G   +MAP
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  117 bits (296), Expect = 2e-29
 Identities = 49/181 (27%), Positives = 77/181 (42%), Gaps = 11/181 (6%)

Query: 659 NQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHR 715
             +     IGTG +G   K     DG  +  K        E   +    E  +L+ ++H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 716 NLVKIISSCTNNDFKAL--VLEYMPNGSLEDYL---YSNNFSFDILQRLSVIIDVALALE 770
           N+V+      +     L  V+EY   G L   +          D    L V+  + LAL+
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 771 YLH--FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA 828
             H      + V+H D+KP+NV LD      L DFG+A++L+ + S  +T  + T  YM+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF-VGTPYYMS 184

Query: 829 P 829
           P
Sbjct: 185 P 185

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  118 bits (298), Expect = 2e-29
 Identities = 48/211 (22%), Positives = 75/211 (35%), Gaps = 18/211 (8%)

Query: 624 SRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKG-SFLD 682
            R      + S    +     +R    +++       F   + +G G +G V+K  S  D
Sbjct: 28  PRRVSFRGEASETLQSPGYDPSRPESFFQQ------SFQRLSRLGHGSYGEVFKVRSKED 81

Query: 683 GMEVAIKVFHLQLEGA--LKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVLEYMPN 739
           G   A+K       G         E    + V +H   V++  +        L  E    
Sbjct: 82  GRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G 140

Query: 740 GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAH 799
            SL+ +  +   S    Q    + D  LAL +LH   S  +VH D+KP+N+ L       
Sbjct: 141 PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCK 197

Query: 800 LSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
           L DFG+   L    +            YMAP
Sbjct: 198 LGDFGLLVELG---TAGAGEVQEGDPRYMAP 225

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  118 bits (298), Expect = 3e-29
 Identities = 42/170 (24%), Positives = 75/170 (44%), Gaps = 11/170 (6%)

Query: 665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNL--VKI 720
             IG+GG   V++         AIK  +L+      L S+  E   L  ++  +   +++
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPV 780
                 + +  +V+E   N  L  +L     S D  +R S   ++  A+  +H    + +
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGI 129

Query: 781 VHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
           VH D+KP+N L+   M+  L DFGIA  +  + +     +   T+ YM P
Sbjct: 130 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  116 bits (293), Expect = 6e-29
 Identities = 46/199 (23%), Positives = 81/199 (40%), Gaps = 31/199 (15%)

Query: 658 TNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRN 716
            + F    ++G G FG V K  + LD    AIK      E  L +   E  +L S+ H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQY 63

Query: 717 LVKIISSCTNNDFKA-------------LVLEYMPNGSLEDYLYSNNFSFDILQRLSVII 763
           +V+  ++                     + +EY  NG+L D ++S N +    +   +  
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT 823
            +  AL Y+H   S  ++H D+KP N+ +D+     + DFG+AK +     + +  +   
Sbjct: 124 QILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 824 IG-------------YMAP 829
            G             Y+A 
Sbjct: 181 PGSSDNLTSAIGTAMYVAT 199

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  115 bits (290), Expect = 9e-29
 Identities = 51/165 (30%), Positives = 82/165 (49%), Gaps = 8/165 (4%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           IG+G FG V+ G +L+  +VAIK      EGA+  + F  E EV+  + H  LV++   C
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
                  LV E+M +G L DYL +    F     L + +DV   + YL       V+H D
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 129

Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +   N L+ ++ V  +SDFG+ + +  ++    T T   + + +P
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 174

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  121 bits (306), Expect = 1e-28
 Identities = 40/173 (23%), Positives = 72/173 (41%), Gaps = 22/173 (12%)

Query: 666 LIGTGGFGSVYKG--SFLDGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIIS 722
            I  GG G +Y      ++G  V +K         A      E + L  V H ++V+I +
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 723 SCTNNDFKA-----LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
              + D        +V+EY+   SL+           + + ++ ++++  AL YLH   S
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---S 200

Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT-LTLATIGYMAP 829
             +V+ D+KP N++L ++ +  L D G          +        T G+ AP
Sbjct: 201 IGLVYNDLKPENIMLTEEQLK-LIDLGAVS------RINSFGYLYGTPGFQAP 246

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  116 bits (292), Expect = 1e-28
 Identities = 66/327 (20%), Positives = 114/327 (34%), Gaps = 54/327 (16%)

Query: 206 SLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLR 265
           ++P  I     P+  ++ L  N+ S +          L  L L  N  S         LR
Sbjct: 47  AVPKEIS----PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLR 102

Query: 266 KLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIF 325
           KL+ L +S N L      L          +L  L + +N I  V       L        
Sbjct: 103 KLQKLYISKNHLVEIPPNLP--------SSLVELRIHDNRIRKVPKGVFSGLR------- 147

Query: 326 ISNCSIRGTIPKEIGNLINLRELGLWGNELIGSI--PITFGKLQNLQGLDLVNNKLEGPI 383
                             N+  + + GN L  S   P  F  L  L  L +   KL G I
Sbjct: 148 ------------------NMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-I 187

Query: 384 PNGLCQLARLSVLYMDGNKLSGPIPP-CIGDLTSLRLLSLASNELNSVIPSTFWNLKDIL 442
           P  L     L+ L++D NK+   I    +   + L  L L  N++  +   +   L  + 
Sbjct: 188 PKDL--PETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLR 244

Query: 443 SLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLM------NLQDLSLRD 496
            L+  +N L+  +P  + +LK++ ++ L  NN++         +           +SL +
Sbjct: 245 ELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFN 303

Query: 497 NGLQ-GSIPKSI-GGLVSLESLDLSNN 521
           N +    +  +    +    ++   N 
Sbjct: 304 NPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  116 bits (292), Expect = 2e-28
 Identities = 67/336 (19%), Positives = 117/336 (34%), Gaps = 41/336 (12%)

Query: 46  ELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNN 105
            L +V  ++  L   +P     +S  +T +D  NN ++  L  D  + L  +  L + NN
Sbjct: 34  HLRVVQCSDLGLK-AVPK---EISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNN 88

Query: 106 KLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGN 165
           K++          ++L  + ++ N   E IP  L   +SL  L +  N +          
Sbjct: 89  KISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNL--PSSLVELRIHDNRIRKVPKGVFSG 145

Query: 166 LRNLEILGLQLNKL-VGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISL 224
           LRN+  + +  N L         F+   +  L +    L+  +P  +       L  + L
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL----PETLNELHL 200

Query: 225 AGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSEL 284
             N    I    +   SKL  L LG N        +L  L  L  L L  N L+   + L
Sbjct: 201 DHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGL 260

Query: 285 SFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLIN 344
                  + K L+++ L  N I  V  +    +   +                       
Sbjct: 261 P------DLKLLQVVYLHTNNITKVGVNDFCPVGFGV-------------------KRAY 295

Query: 345 LRELGLWGNEL-IGSI-PITFGKLQNLQGLDLVNNK 378
              + L+ N +    + P TF  + +   +   N K
Sbjct: 296 YNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  114 bits (287), Expect = 8e-28
 Identities = 62/307 (20%), Positives = 108/307 (35%), Gaps = 39/307 (12%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L L  ND+S     +   L  L  L L  NK+     +    L +L+ + ++ N L   I
Sbjct: 59  LDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EI 117

Query: 62  PSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLT-GPIPNNIWQCK 119
           P  +  +L  L       +N +   +P  +   L  +  + M  N L         +   
Sbjct: 118 PPNLPSSLVEL----RIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL 172

Query: 120 ELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEM-GNLRNLEILGLQLNK 178
           +L  + ++  + T  IP+ L    +L  L+L  N +   I  E       L  LGL  N+
Sbjct: 173 KLNYLRISEAKLTG-IPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQ 228

Query: 179 LVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIF 238
           +      S+  L  ++ L L +N LS  +P+   L  L  L+++ L  NN +        
Sbjct: 229 IRMIENGSLSFLPTLRELHLDNNKLS-RVPA--GLPDLKLLQVVYLHTNNIT-------- 277

Query: 239 NASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSST-SELSFLSSWANCKNLK 297
                   ++G N F                + L  N +        +F        +  
Sbjct: 278 --------KVGVNDFCPVGFGV--KRAYYNGISLFNNPVPYWEVQPATF----RCVTDRL 323

Query: 298 LLDLSNN 304
            +   N 
Sbjct: 324 AIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  114 bits (287), Expect = 8e-28
 Identities = 60/341 (17%), Positives = 113/341 (33%), Gaps = 55/341 (16%)

Query: 218 NLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFL 277
           +L ++  +      + P  I      ++L+L  N  S    +    L+ L  L L  N +
Sbjct: 34  HLRVVQCSDLGLKAV-PKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 278 TSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPK 337
           +    E +F    +  + L+ L +S N +                            IP 
Sbjct: 91  SK-IHEKAF----SPLRKLQKLYISKNHLV--------------------------EIPP 119

Query: 338 EIGNLINLRELGLWGNELIGSIPI-TFGKLQNLQGLDLVNNKL-EGPIPNGLCQLARLSV 395
            +    +L EL +  N  I  +P   F  L+N+  +++  N L       G     +L+ 
Sbjct: 120 NL--PSSLVELRIHDNR-IRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNY 176

Query: 396 LYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSL 455
           L +   KL+G IP       +L  L L  N++ ++          +  L    N +   +
Sbjct: 177 LRISEAKLTG-IPK--DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MI 232

Query: 456 PEDI-GNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI------- 507
                  L  +  + L  N LS  +P  +  L  LQ + L  N +   +  +        
Sbjct: 233 ENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFG 290

Query: 508 GGLVSLESLDLSNNSLS-GNIPTSM-EKLLYLKDLNLSFNK 546
                   + L NN +    +  +    +     +     K
Sbjct: 291 VKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  105 bits (263), Expect = 1e-24
 Identities = 69/319 (21%), Positives = 111/319 (34%), Gaps = 40/319 (12%)

Query: 183 VPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASK 242
           VP  I        L L +N +S  L    D   L +L  + L  N  S I         K
Sbjct: 48  VPKEIS--PDTTLLDLQNNDIS-ELRKD-DFKGLQHLYALVLVNNKISKIHEKAFSPLRK 103

Query: 243 LSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLS 302
           L  L + +N      PN       L  LR+  N +            ++  +N+  +++ 
Sbjct: 104 LQKLYISKNHLVEIPPNLP---SSLVELRIHDNRIRKVPK-----GVFSGLRNMNCIEMG 155

Query: 303 NNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIP-I 361
            NP+            L L+ + IS   +   IPK       L EL L  N+ I +I   
Sbjct: 156 GNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNK-IQAIELE 211

Query: 362 TFGKLQNLQGLDLVNNKLEGPIPNGLCQ-LARLSVLYMDGNKLSGPIPPCIGDLTSLRLL 420
              +   L  L L +N++   I NG    L  L  L++D NKLS  +P  + DL  L+++
Sbjct: 212 DLLRYSKLYRLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVV 269

Query: 421 SLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDI- 479
            L +N +  V  + F  +   +                         I L  N +     
Sbjct: 270 YLHTNNITKVGVNDFCPVGFGVKRA---------------YYNG---ISLFNNPVPYWEV 311

Query: 480 -PTAIGGLMNLQDLSLRDN 497
            P     + +   +   + 
Sbjct: 312 QPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  103 bits (260), Expect = 2e-24
 Identities = 62/266 (23%), Positives = 105/266 (39%), Gaps = 23/266 (8%)

Query: 295 NLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNE 354
           +L+++  S+  +  V P     +S   + + + N  I      +   L +L  L L  N+
Sbjct: 34  HLRVVQCSDLGLKAV-PK---EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNK 89

Query: 355 LIGSIPI-TFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPP-CIG 412
            I  I    F  L+ LQ L +  N L   IP  L   + L  L +  N++   +P     
Sbjct: 90  -ISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNL--PSSLVELRIHDNRIRK-VPKGVFS 144

Query: 413 DLTSLRLLSLASNELNSVI--PSTFWNLKDILSLNFSSNFLNGSLPEDI-GNLKVVVIID 469
            L ++  + +  N L +    P  F  LK +  L  S   L   +P+D+   L     + 
Sbjct: 145 GLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLT-GIPKDLPETLN---ELH 199

Query: 470 LSRNNLSGDIPT-AIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIP 528
           L  N +   I    +     L  L L  N ++     S+  L +L  L L NN LS  +P
Sbjct: 200 LDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVP 257

Query: 529 TSMEKLLYLKDLNLSFNKLEGEIPRG 554
             +  L  L+ + L  N +  ++   
Sbjct: 258 AGLPDLKLLQVVYLHTNNIT-KVGVN 282

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 32/147 (21%), Positives = 54/147 (36%), Gaps = 12/147 (8%)

Query: 416 SLRLLSLASNELNSV---IPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSR 472
            LR++  +   L +V   I        D   L+  +N ++    +D   L+ +  + L  
Sbjct: 34  HLRVVQCSDLGLKAVPKEISP------DTTLLDLQNNDISELRKDDFKGLQHLYALVLVN 87

Query: 473 NNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSME 532
           N +S     A   L  LQ L +  N L   IP ++    SL  L + +N +         
Sbjct: 88  NKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFS 144

Query: 533 KLLYLKDLNLSFNKLEGEIPRGGPFAN 559
            L  +  + +  N LE      G F  
Sbjct: 145 GLRNMNCIEMGGNPLENSGFEPGAFDG 171

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  116 bits (291), Expect = 2e-28
 Identities = 56/182 (30%), Positives = 88/182 (48%), Gaps = 17/182 (9%)

Query: 659 NQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFH-LQLEGALKSFDVECEVLKSVRHRN 716
           + +  S+++G G   +V++G     G   AIKVF+ +     +     E EVLK + H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 717 LVKI--ISSCTNNDFKALVLEYMPNGSLEDYLYS--NNFSFDILQRLSVIIDVALALEYL 772
           +VK+  I   T    K L++E+ P GSL   L    N +     + L V+ DV   + +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 773 HFGYSNPVVHCDIKPSNVLL----DKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYM 827
                N +VH +IKP N++     D   V  L+DFG A+ L  +E      +L  T  Y+
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV---SLYGTEEYL 182

Query: 828 AP 829
            P
Sbjct: 183 HP 184

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  114 bits (287), Expect = 2e-28
 Identities = 46/165 (27%), Positives = 81/165 (49%), Gaps = 8/165 (4%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G+G FG V  G +    +VA+K+     EG++    F  E + +  + H  LVK    C
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
           +      +V EY+ NG L +YL S+    +  Q L +  DV   + +L    S+  +H D
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRD 129

Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +   N L+D+D+   +SDFG+ + +  ++ +    T   + + AP
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAP 174

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  117 bits (295), Expect = 5e-28
 Identities = 74/450 (16%), Positives = 148/450 (32%), Gaps = 51/450 (11%)

Query: 47  LELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNK 106
                     +  T   +   L++L T +D  N+S+T  +      +L  +  L  ++N 
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATL-TSLDCHNSSIT-DMTG--IEKLTGLTKLICTSNN 75

Query: 107 LTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNL 166
           +T     ++ Q   L  ++   N+ T  +   +  LT L  L    N LT     ++   
Sbjct: 76  ITTL---DLSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLT---KLDVSQN 126

Query: 167 RNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAG 226
             L  L    N L       + + + +  L    N       + +D+     L  +  + 
Sbjct: 127 PLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKI----TKLDVTPQTQLTTLDCSF 179

Query: 227 NNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSF 286
           N  + +  S       L+ L    N+ +      L    +L +L  S N LT        
Sbjct: 180 NKITELDVS---QNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE------- 226

Query: 287 LSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLR 346
                    L   D S NP+  +  S++      L+ +      +   I   + +   L 
Sbjct: 227 -IDVTPLTQLTYFDCSVNPLTELDVSTLSK----LTTLHCIQTDLL-EID--LTHNTQLI 278

Query: 347 ELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGP 406
                G   I  + +T      L  LD     +   +   L Q  +L  LY++  +L+  
Sbjct: 279 YFQAEGCRKIKELDVT--HNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE- 332

Query: 407 IPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVV 466
           +   +   T L+ LS  +  +     S+   +  + +   +         E + N  + +
Sbjct: 333 LD--VSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTITMPKETLTNNSLTI 388

Query: 467 IIDLSRNNLSGDIPTAIGGLMNLQDLSLRD 496
            +     +  G+      G   + D +   
Sbjct: 389 AVSPDLLDQFGNPMNIEPGDGGVYDQATNT 418

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  115 bits (290), Expect = 2e-27
 Identities = 64/411 (15%), Positives = 135/411 (32%), Gaps = 49/411 (11%)

Query: 139 LGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLAL 198
              L +L +L    +++T ++   +  L  L  L    N +       +   + +  LA 
Sbjct: 38  EEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNITTL---DLSQNTNLTYLAC 92

Query: 199 PSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIP 258
            SN L+     ++D+  L  L  ++   N  + +  S       L+ L    N+ +    
Sbjct: 93  DSNKLT-----NLDVTPLTKLTYLNCDTNKLTKLDVS---QNPLLTYLNCARNTLTEI-- 142

Query: 259 NTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLS 318
             + +  +L  L    N   +                L  LD S N I  +    +    
Sbjct: 143 -DVSHNTQLTELDCHLNKKITKLDV-------TPQTQLTTLDCSFNKITEL---DVSQNK 191

Query: 319 LSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNK 378
             L+R+     +I   +   +   I L  L    N+L     I    L  L   D   N 
Sbjct: 192 -LLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNP 244

Query: 379 LEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNL 438
           L   +   +  L++L+ L+     L       I    + +L+   +     +      + 
Sbjct: 245 LT-ELD--VSTLSKLTTLHCIQTDLL-----EIDLTHNTQLIYFQAEGCRKIKELDVTHN 296

Query: 439 KDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNG 498
             +  L+  +  +   L  D+     +V + L+   L+ ++   +     L+ LS  +  
Sbjct: 297 TQLYLLDCQAAGIT-EL--DLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAH 350

Query: 499 LQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEG 549
           +Q     S+G + +L +   +          ++        ++       G
Sbjct: 351 IQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFG 399

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  114 bits (286), Expect = 6e-27
 Identities = 70/443 (15%), Positives = 143/443 (32%), Gaps = 49/443 (11%)

Query: 98  KGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTG 157
                +  ++      +  Q   L  +    +  T+ +  G+  LT L  L    NN+T 
Sbjct: 21  ASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT 78

Query: 158 EIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLP 217
               ++    NL  L    NKL       +  L+ +  L   +N L+      +D+ + P
Sbjct: 79  ---LDLSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT-----KLDVSQNP 127

Query: 218 NLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFL 277
            L  ++ A N  + I  S   + ++L+ L+   N     +   +    +L  L  S+N +
Sbjct: 128 LLTYLNCARNTLTEIDVS---HNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI 182

Query: 278 TSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPK 337
           T     L      +  K L  L+   N I  +    +      L+ +  S+  +   I  
Sbjct: 183 TE----LDV----SQNKLLNRLNCDTNNITKL---DLNQNI-QLTFLDCSSNKLT-EID- 228

Query: 338 EIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLY 397
            +  L  L       N L     +    L  L  L  +   L       L    +L    
Sbjct: 229 -VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQ 281

Query: 398 MDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPE 457
            +G +    +   +   T L LL   +  +  +          ++ L  ++  L   L  
Sbjct: 282 AEGCRKIKELD--VTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELT-EL-- 333

Query: 458 DIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLD 517
           D+ +   +  +     ++  D   ++G +  L +    +        +++       ++ 
Sbjct: 334 DVSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVS 391

Query: 518 LSNNSLSGNIPTSMEKLLYLKDL 540
                  GN          + D 
Sbjct: 392 PDLLDQFGNPMNIEPGDGGVYDQ 414

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  114 bits (286), Expect = 7e-27
 Identities = 74/464 (15%), Positives = 155/464 (33%), Gaps = 58/464 (12%)

Query: 23  LKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSL 82
                    +++         LA L  +   N+ ++    + I  L+ L T +  ++N++
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGL-TKLICTSNNI 76

Query: 83  TGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNL 142
           T +L       L     L   +NKLT     ++    +L  ++   N+ T+ +   +   
Sbjct: 77  T-TLDLSQNTNL---TYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTK-LD--VSQN 126

Query: 143 TSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNA 202
             L  L    N LT     ++ +   L  L   LNK +  +   +   + + TL    N 
Sbjct: 127 PLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNK 181

Query: 203 LSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLG 262
           +     + +D+ +   L  ++   NN + +  +      +L+ L+   N  +      + 
Sbjct: 182 I-----TELDVSQNKLLNRLNCDTNNITKLDLN---QNIQLTFLDCSSNKLTEI---DVT 230

Query: 263 NLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLS 322
            L +L +   S N LT                 L  L      +  +      +L+ +  
Sbjct: 231 PLTQLTYFDCSVNPLTELDVS--------TLSKLTTLHCIQTDLLEI------DLTHNTQ 276

Query: 323 RIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGP 382
            I+      R     ++ +   L  L      +     +   +   L  L L N +L   
Sbjct: 277 LIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGI---TELDLSQNPKLVYLYLNNTELTE- 332

Query: 383 IPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDIL 442
           +   +    +L  L      +       +G + +L     A  +  ++   T  N    L
Sbjct: 333 LD--VSHNTKLKSLSCVNAHIQD--FSSVGKIPALNNNFEAEGQTITMPKETLTNNS--L 386

Query: 443 SLNFSSNFLNGS-----LPEDIGNLKVVVIIDLSRNNLSGDIPT 481
           ++  S + L+       +    G +       ++  NLS D P 
Sbjct: 387 TIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPA 430

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  105 bits (265), Expect = 3e-24
 Identities = 76/437 (17%), Positives = 140/437 (32%), Gaps = 58/437 (13%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L    + ++      I  LT L KL    N +   +   L     L  ++  +N L+   
Sbjct: 47  LDCHNSSITDM--TGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLTNLD 101

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
            + +  L+ L    +   N LT  L       L     L  + N LT     ++    +L
Sbjct: 102 VTPLTKLTYL----NCDTNKLT-KLDVSQNPLL---TYLNCARNTLT---EIDVSHNTQL 150

Query: 122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVG 181
             +    N+   ++   +   T L TL   FN +T     ++   + L  L    N +  
Sbjct: 151 TELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITK 205

Query: 182 FVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNAS 241
                +     +  L   SN L     + ID+  L  L     + N  + +  S     S
Sbjct: 206 L---DLNQNIQLTFLDCSSNKL-----TEIDVTPLTQLTYFDCSVNPLTELDVS---TLS 254

Query: 242 KLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDL 301
           KL+ L   +          L +  +L + +           EL       +   L LLD 
Sbjct: 255 KLTTLHCIQTDLLEI---DLTHNTQLIYFQAEGC---RKIKELDV----THNTQLYLLDC 304

Query: 302 SNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPI 361
               I  +    +      L  ++++N  +   +   + +   L+ L       I     
Sbjct: 305 QAAGITEL---DLSQNP-KLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAH-IQDFS- 355

Query: 362 TFGKLQNLQGLDLVNNKLEGPIP-----NGLCQLARLSVLYMDGNKLSGPIPPCIGDLTS 416
           + GK+  L        +           N L       +L   GN ++  I P  G +  
Sbjct: 356 SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN--IEPGDGGVYD 413

Query: 417 LRLLSLASNELNSVIPS 433
               ++    L++  P+
Sbjct: 414 QATNTITWENLSTDNPA 430

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  101 bits (253), Expect = 9e-23
 Identities = 56/344 (16%), Positives = 101/344 (29%), Gaps = 39/344 (11%)

Query: 205 GSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNL 264
           G   S  D     N      A               + L+ L+   +S +      +  L
Sbjct: 6   GQTQSFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTG--IEKL 63

Query: 265 RKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRI 324
             L  L  + N +T+    L      +   NL  L   +N +  +    +  L+  L+ +
Sbjct: 64  TGLTKLICTSNNITT----LDL----SQNTNLTYLACDSNKLTNL---DVTPLT-KLTYL 111

Query: 325 FISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIP 384
                 +      ++     L  L    N L     I       L  LD   NK    + 
Sbjct: 112 NCDTNKLT---KLDVSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD 165

Query: 385 NGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSL 444
             +    +L+ L    NK++  +   +     L  L+  +N +  +          +  L
Sbjct: 166 --VTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFL 217

Query: 445 NFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIP 504
           + SSN L      D+  L  +   D S N L+ ++   +  L  L  L      L   I 
Sbjct: 218 DCSSNKLTEI---DVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID 270

Query: 505 KSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLE 548
             +     L             +  +      L  L+     + 
Sbjct: 271 --LTHNTQLIYFQAEGCRKIKELDVT--HNTQLYLLDCQAAGIT 310

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 93.2 bits (232), Expect = 4e-20
 Identities = 60/328 (18%), Positives = 120/328 (36%), Gaps = 35/328 (10%)

Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
            L+ + N L+     ++ + T L +L    NK   ++   +    +L  +  + N ++  
Sbjct: 131 YLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITEL 185

Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
             S    L+ L    +   N++T  L  +   +L     L  S+NKLT     ++    +
Sbjct: 186 DVSQNKLLNRL----NCDTNNIT-KLDLNQNIQL---TFLDCSSNKLTE---IDVTPLTQ 234

Query: 121 LIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLV 180
           L     + N  TE +   +  L+ L TL+    +L          L   +  G +  K +
Sbjct: 235 LTYFDCSVNPLTE-LD--VSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKEL 291

Query: 181 GFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNA 240
                 + + + +  L   +  ++      +DL + P L  + L     + +  S   + 
Sbjct: 292 -----DVTHNTQLYLLDCQAAGIT-----ELDLSQNPKLVYLYLNNTELTELDVS---HN 338

Query: 241 SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLD 300
           +KL  L         F  +++G +  L     +     +   E    +S     +  LLD
Sbjct: 339 TKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLD 396

Query: 301 LSNNPINGVLPSSIGNLSLSLSRIFISN 328
              NP+N + P   G    + + I   N
Sbjct: 397 QFGNPMN-IEPGDGGVYDQATNTITWEN 423

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  115 bits (291), Expect = 5e-28
 Identities = 45/166 (27%), Positives = 72/166 (43%), Gaps = 6/166 (3%)

Query: 667 IGTGGFGSVYKGSF-LDGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G FG V+ G    D   VA+K     L       F  E  +LK   H N+V++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
           T      +V+E +  G    +L +      +   L ++ D A  +EYL    S   +H D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238

Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLSGEE-SMKQTLTLATIGYMAP 829
           +   N L+ +  V  +SDFG+++  +    +    L    + + AP
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  113 bits (286), Expect = 6e-28
 Identities = 52/171 (30%), Positives = 85/171 (49%), Gaps = 14/171 (8%)

Query: 666 LIGTGGFGSVYKGSFLD---GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVK 719
            +G GG  +VY     D    ++VAIK   +     E  LK F+ E      + H+N+V 
Sbjct: 18  KLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
           +I     +D   LV+EY+   +L +Y+  ++    +   ++    +   +++ H      
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT-LTLATIGYMAP 829
           +VH DIKP N+L+D +    + DFGIAK LS E S+ QT   L T+ Y +P
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSP 181

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  113 bits (286), Expect = 6e-28
 Identities = 57/264 (21%), Positives = 103/264 (39%), Gaps = 20/264 (7%)

Query: 50  VSLTNNFLSGTIPSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLT 108
           +   +  L+ ++P+ I  + + L    +  +N L  SLP  +  +L  +  L +S+N L+
Sbjct: 12  IRCNSKGLT-SVPTGIPSSATRL----ELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLS 65

Query: 109 -GPIPNNIWQ-CKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEM-GN 165
                +        L  + L++N     +      L  L+ L    +NL     + +  +
Sbjct: 66  FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 124

Query: 166 LRNLEILGLQLNKLVGFVPTSIF-NLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISL 224
           LRNL  L +            IF  LS+++ L +  N+   +    I    L NL  + L
Sbjct: 125 LRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDI-FTELRNLTFLDL 182

Query: 225 AGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTS-STSE 283
           +      + P+   + S L VL +  N+F          L  L+ L  S N + +    E
Sbjct: 183 SQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 242

Query: 284 LSFLSSWANCKNLKLLDLSNNPIN 307
           L    S     +L  L+L+ N   
Sbjct: 243 LQHFPS-----SLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  111 bits (279), Expect = 6e-27
 Identities = 52/237 (21%), Positives = 88/237 (37%), Gaps = 6/237 (2%)

Query: 316 NLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNEL--IGSIPITFGKLQNLQGLD 373
            +  S +R+ + +  ++         L  L +L L  N L   G    +     +L+ LD
Sbjct: 25  GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD 84

Query: 374 LVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCI-GDLTSLRLLSLASNELNSVIP 432
           L  N +   + +    L +L  L    + L       +   L +L  L ++         
Sbjct: 85  LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 143

Query: 433 STFWNLKDILSLNFSSNFLNGSLPEDI-GNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQD 491
             F  L  +  L  + N    +   DI   L+ +  +DLS+  L    PTA   L +LQ 
Sbjct: 144 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 203

Query: 492 LSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLY-LKDLNLSFNKL 547
           L++  N            L SL+ LD S N +  +    ++     L  LNL+ N  
Sbjct: 204 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  106 bits (266), Expect = 3e-25
 Identities = 57/260 (21%), Positives = 95/260 (36%), Gaps = 15/260 (5%)

Query: 124 ISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKL--VG 181
           I       T  +P G+   +S   L L  N L          L  L  L L  N L   G
Sbjct: 12  IRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68

Query: 182 FVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIF-NA 240
               S F  +++K L L  N +  ++ S  + + L  LE +    +N   +    +F + 
Sbjct: 69  CCSQSDFGTTSLKYLDLSFNGVI-TMSS--NFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125

Query: 241 SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLD 300
             L  L++               L  LE L+++ N    +     F       +NL  LD
Sbjct: 126 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF----TELRNLTFLD 181

Query: 301 LSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIP 360
           LS   +  + P++  +LS SL  + +S+ +           L +L+ L    N ++ S  
Sbjct: 182 LSQCQLEQLSPTAFNSLS-SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 240

Query: 361 ITFGKLQ-NLQGLDLVNNKL 379
                   +L  L+L  N  
Sbjct: 241 QELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  103 bits (259), Expect = 2e-24
 Identities = 49/235 (20%), Positives = 88/235 (37%), Gaps = 14/235 (5%)

Query: 328 NCSIRG--TIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLE-GPIP 384
            C+ +G  ++P  I    +   L L  N+L       F KL  L  L L +N L      
Sbjct: 13  RCNSKGLTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCC 70

Query: 385 NGLCQ-LARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIP-STFWNLKDIL 442
           +        L  L +  N +   +      L  L  L    + L  +   S F +L++++
Sbjct: 71  SQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 129

Query: 443 SLNFSSNFLNGSLPEDI-GNLKVVVIIDLSRNNLSGDI-PTAIGGLMNLQDLSLRDNGLQ 500
            L+ S           I   L  + ++ ++ N+   +  P     L NL  L L    L+
Sbjct: 130 YLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188

Query: 501 GSIPKSI-GGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRG 554
             +  +    L SL+ L++S+N+         + L  L+ L+ S N +     + 
Sbjct: 189 -QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQ 241

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  100 bits (251), Expect = 2e-23
 Identities = 51/234 (21%), Positives = 87/234 (37%), Gaps = 10/234 (4%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKL--RGEIPQELGNLAELELVSLTNNFLSG 59
           L L  N L          LT L KL L  N L  +G   Q       L+ + L+ N +  
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI- 91

Query: 60  TIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQ-C 118
           T+ S    L  L   +DF +++L       +   L  +  L +S+        N I+   
Sbjct: 92  TMSSNFLGLEQL-EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGL 149

Query: 119 KELIVISLAYNQFTERIPRG-LGNLTSLKTLYLGFNNLTGEIPYEM-GNLRNLEILGLQL 176
             L V+ +A N F E         L +L  L L    L  ++      +L +L++L +  
Sbjct: 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSH 208

Query: 177 NKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFS 230
           N            L++++ L    N +  +           +L  ++L  N+F+
Sbjct: 209 NNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  113 bits (284), Expect = 8e-28
 Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 17/174 (9%)

Query: 666 LIGTGGFGSVYKGSFLD---GMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNLVKI 720
            IG G F +VYKG  LD    +EVA          +   + F  E E+LK ++H N+V+ 
Sbjct: 33  EIGRGSFKTVYKG--LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 721 ISSCTNNDFKA----LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
             S  +         LV E M +G+L+ YL        I    S    +   L++LH   
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH-TR 148

Query: 777 SNPVVHCDIKPSNVLLD-KDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           + P++H D+K  N+ +        + D G+A L     S  + + + T  +MAP
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAV-IGTPEFMAP 199

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  112 bits (283), Expect = 1e-27
 Identities = 44/198 (22%), Positives = 80/198 (40%), Gaps = 30/198 (15%)

Query: 659 NQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHL-QLEGALKSFDVECEVLKSVRHRN 716
             F     +G GGFG V++  + +D    AIK   L   E A +    E + L  + H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 717 LVKIISSCTNNDFKA------------LVLEYMPNGSLEDYLYSNNFS--FDILQRLSVI 762
           +V+  ++    +               + ++     +L+D++         +    L + 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA 822
           + +A A+E+LH   S  ++H D+KPSN+    D V  + DFG+   +  +E  +  LT  
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 823 TIG-----------YMAP 829
                         YM+P
Sbjct: 182 PAYARHTGQVGTKLYMSP 199

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  114 bits (288), Expect = 1e-27
 Identities = 56/182 (30%), Positives = 88/182 (48%), Gaps = 17/182 (9%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFH-LQLEGALKSFDVECEVLKSVRHRN 716
           + +  S+++G G   +V++G     G   AIKVF+ +     +     E EVLK + H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 717 LVKI--ISSCTNNDFKALVLEYMPNGSLEDYLYS--NNFSFDILQRLSVIIDVALALEYL 772
           +VK+  I   T    K L++E+ P GSL   L    N +     + L V+ DV   + +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 773 HFGYSNPVVHCDIKPSNVLL----DKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYM 827
                N +VH +IKP N++     D   V  L+DFG A+ L  +E      +L  T  Y+
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV---SLYGTEEYL 182

Query: 828 AP 829
            P
Sbjct: 183 HP 184

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  116 bits (293), Expect = 2e-27
 Identities = 58/286 (20%), Positives = 116/286 (40%), Gaps = 34/286 (11%)

Query: 272 LSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSI 331
             YN ++ + ++    S+W   +   L   + N    +L   + N     S + ++  ++
Sbjct: 17  SFYNTISGTYADY--FSAWDKWEKQALPGENRNEAVSLLKECLIN---QFSELQLNRLNL 71

Query: 332 RGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLA 391
             ++P  +     +  L +  N LI S+P       +L+ LD  +N+L   +P     L 
Sbjct: 72  S-SLPDNLPP--QITVLEITQNALI-SLPELPA---SLEYLDACDNRLST-LPELPASLK 123

Query: 392 RLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFL 451
            L    +D N+L+  +P        L  ++  +N+L   +P    +L+    L+  +N L
Sbjct: 124 HL---DVDNNQLTM-LPELPA---LLEYINADNNQLTM-LPELPTSLE---VLSVRNNQL 172

Query: 452 NGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQD----LSLRDNGLQGSIPKSI 507
              LPE   +L+    +D+S N L   +P       + ++       R+N +   IP++I
Sbjct: 173 T-FLPELPESLEA---LDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENI 226

Query: 508 GGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPR 553
             L    ++ L +N LS  I  S+ +     D +           +
Sbjct: 227 LSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  113 bits (283), Expect = 3e-26
 Identities = 64/303 (21%), Positives = 111/303 (36%), Gaps = 38/303 (12%)

Query: 246 LELGENSFSGFIPNTLGNL----RKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDL 301
             L +NSF   I  T  +      K E   L       + S L              L L
Sbjct: 11  FSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE----CLINQFSELQL 66

Query: 302 SNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPI 361
           +   ++  LP ++      ++ + I+  ++  ++P+   +L     L    N L  ++P 
Sbjct: 67  NRLNLS-SLPDNLPP---QITVLEITQNALI-SLPELPASL---EYLDACDNRLS-TLPE 117

Query: 362 TFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLS 421
                 +L+ LD+ NN+L   +P     L     +  D N+L+  +P      TSL +LS
Sbjct: 118 LPA---SLKHLDVDNNQLTM-LPELPALL---EYINADNNQLTM-LPE---LPTSLEVLS 166

Query: 422 LASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNL----KVVVIIDLSRNNLSG 477
           + +N+L   +P    +L+    L+ S+N L  SLP          +  +      N ++ 
Sbjct: 167 VRNNQLTF-LPELPESLEA---LDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT- 220

Query: 478 DIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYL 537
            IP  I  L     + L DN L   I +S+    +           S +          L
Sbjct: 221 HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPL 280

Query: 538 KDL 540
            D 
Sbjct: 281 ADA 283

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  108 bits (270), Expect = 1e-24
 Identities = 63/517 (12%), Positives = 141/517 (27%), Gaps = 118/517 (22%)

Query: 60  TIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSN---NKLTGPIPNNIW 116
           +I   I N  SLS   +   N+++     D        +   +     N+    +   + 
Sbjct: 2   SIMLPINNNFSLSQ--NSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECLI 58

Query: 117 QCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQL 176
              +   + L     +  +P  L     +  L +  N L   +P    +L  L+    +L
Sbjct: 59  --NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLPELPASLEYLDACDNRL 112

Query: 177 NKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSF 236
           +                            +LP                            
Sbjct: 113 S----------------------------TLPELP------------------------- 119

Query: 237 IFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNL 296
               + L  L++  N  +  +P     L     +    N LT      +         +L
Sbjct: 120 ----ASLKHLDVDNNQLT-MLPELPALLEY---INADNNQLTMLPELPT---------SL 162

Query: 297 KLLDLSNNPINGVLPSSIGNL-SLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNEL 355
           ++L + NN +   LP    +L +L +S   +       ++P       +  E  ++    
Sbjct: 163 EVLSVRNNQLT-FLPELPESLEALDVSTNLLE------SLPAVPVRNHHSEETEIF---- 211

Query: 356 IGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLT 415
                                N++   IP  +  L     + ++ N LS  I   +   T
Sbjct: 212 ----------------FRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254

Query: 416 SLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNL 475
           +           +          + +      ++ +    PE+  +    +         
Sbjct: 255 AQPDYHGPRIYFSMSDGQQNTLHRPL------ADAVTAWFPENKQSDVSQIWHAFEHEEH 308

Query: 476 SGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLL 535
           +      +  L +         G +  +   +  L +   L   + +++ +   S E  +
Sbjct: 309 ANTFSAFLDRLSDTVSARNTS-GFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRV 367

Query: 536 YLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLC 572
            L   NL    L  +   G    +      +G ++  
Sbjct: 368 ALTWNNLRKTLLVHQASEGLFDNDTGALLSLGREMFR 404

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 95.4 bits (237), Expect = 1e-20
 Identities = 46/224 (20%), Positives = 81/224 (36%), Gaps = 28/224 (12%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L ++ N L  ++P+   +L     L    N+L   +P+   +L  L    + NN L+  +
Sbjct: 85  LEITQNALI-SLPELPASLE---YLDACDNRLS-TLPELPASLKHL---DVDNNQLT-ML 135

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
           P     L  +    +  NN LT  LP+        ++ L + NN+LT  +P      + L
Sbjct: 136 PELPALLEYI----NADNNQLT-MLPELPTS----LEVLSVRNNQLTF-LPELPESLEAL 185

Query: 122 IVISLAYNQFTERIPRGLGNLTSLKT----LYLGFNNLTGEIPYEMGNLRNLEILGLQLN 177
               ++ N     +P         +          N +T  IP  + +L     + L+ N
Sbjct: 186 ---DVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDN 240

Query: 178 KLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEI 221
            L   +  S+   +A      P    S S      L R     +
Sbjct: 241 PLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAV 284

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 92.3 bits (229), Expect = 1e-19
 Identities = 59/307 (19%), Positives = 101/307 (32%), Gaps = 39/307 (12%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L    N LS  +P+   +L   K L +  N+L   +P+    L  +   +  NN L+  +
Sbjct: 105 LDACDNRLS-TLPELPASL---KHLDVDNNQLT-MLPELPALLEYI---NADNNQLT-ML 155

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
           P    +L  L       NN LT  LP+        ++ L +S N L   +P    +    
Sbjct: 156 PELPTSLEVL----SVRNNQLT-FLPE----LPESLEALDVSTNLLES-LPAVPVRNHHS 205

Query: 122 ----IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILG---L 174
               I      N+ T  IP  + +L    T+ L  N L+  I   +             +
Sbjct: 206 EETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRI 264

Query: 175 QLNKLVGFVPTSIFNLSAMKTLALPSNALS---------GSLPSSIDLVRLPNLEIISLA 225
             +   G   T    L+   T   P N  S              +       +    +++
Sbjct: 265 YFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVS 324

Query: 226 GNNFSGI---IPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTS 282
             N SG    + +++   S  + L     + +     +  +   L W  L    L    S
Sbjct: 325 ARNTSGFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQAS 384

Query: 283 ELSFLSS 289
           E  F + 
Sbjct: 385 EGLFDND 391

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  111 bits (280), Expect = 3e-27
 Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 8/165 (4%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +GTG FG V  G +    +VAIK+     EG++    F  E +V+ ++ H  LV++   C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
           T      ++ EYM NG L +YL      F   Q L +  DV  A+EYL    S   +H D
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 145

Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +   N L++   V  +SDFG+++ +  +E      +   + +  P
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 190

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  114 bits (287), Expect = 3e-27
 Identities = 48/194 (24%), Positives = 86/194 (44%), Gaps = 30/194 (15%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVL-KSVRHRNL 717
           N   +  ++G G  G+V       G  VA+K   +          +E ++L +S  H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNV 71

Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLS------VIIDVALALEY 771
           ++   S T + F  + LE   N +L+D + S N S + L+         ++  +A  + +
Sbjct: 72  IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 772 LHFGYSNPVVHCDIKPSNVLLD-------------KDMVAHLSDFGIAKLLSGEESMKQT 818
           LH   S  ++H D+KP N+L+              +++   +SDFG+ K L   +S  +T
Sbjct: 131 LH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 819 LTLA---TIGYMAP 829
                  T G+ AP
Sbjct: 188 NLNNPSGTSGWRAP 201

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  111 bits (279), Expect = 4e-27
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 10/154 (6%)

Query: 667 IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKII 721
           +G G FGSV    +       G  VA+K      E  L+ F+ E E+LKS++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 722 SSCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
             C +   +   L++EY+P GSL DYL  +    D ++ L     +   +EYL    +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
            +H D+   N+L++ +    + DFG+ K+L  ++
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  112 bits (281), Expect = 4e-27
 Identities = 47/155 (30%), Positives = 78/155 (50%), Gaps = 10/155 (6%)

Query: 667 IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKII 721
           +G G FGSV    +       G  VA+K      E  L+ F+ E E+LKS++H N+VK  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 722 SSCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
             C +   +   L++EY+P GSL DYL  +    D ++ L     +   +EYL    +  
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
            +H D+   N+L++ +    + DFG+ K+L  ++ 
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  114 bits (287), Expect = 4e-27
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 10/168 (5%)

Query: 665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKS--FDVECEVLKSVRHRNLVKIIS 722
             +G G FG V+ G++     VAIK       G +    F  E +V+K +RH  LV++ +
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRL-SVIIDVALALEYLHFGYSNPVV 781
             +      +V EYM  GSL D+L      +  L +L  +   +A  + Y+        V
Sbjct: 247 VVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302

Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D++ +N+L+ +++V  ++DFG+A+L+   E   +      I + AP
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 350

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  111 bits (279), Expect = 6e-27
 Identities = 42/171 (24%), Positives = 71/171 (41%), Gaps = 14/171 (8%)

Query: 666 LIGTGGFGSVYKGSFLD---GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVK 719
           L+G GG G VY+    D      VA+K+    L            E      ++  ++V 
Sbjct: 41  LVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
           I      +    + +  +    L   L          + ++++  +  AL+  H   +  
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT-LTLATIGYMAP 829
             H D+KP N+L+  D  A+L DFGIA   + +E + Q   T+ T+ YMAP
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAP 204

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  111 bits (280), Expect = 6e-27
 Identities = 44/155 (28%), Positives = 74/155 (47%), Gaps = 14/155 (9%)

Query: 667 IGTGGFGSVYKGSFLDG----MEVAIKVFHLQLEGA----LKSFDVECEVLKSVRHRNLV 718
           IG+G  G V  G         + VAIK       G      + F  E  ++    H N++
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
           ++    T      +V EYM NGSL+ +L +++  F I+Q + ++  V   + YL      
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DL 170

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
             VH D+   NVL+D ++V  +SDFG++++L  + 
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  111 bits (280), Expect = 1e-26
 Identities = 53/272 (19%), Positives = 112/272 (41%), Gaps = 31/272 (11%)

Query: 580 PVCKSGNSSSHRKSRKNTILLGVLLPLSTVFI--IAVILAVRYAMISRCQEKNAKQSNIE 637
           P+   G+   H   R+ ++  G+L+P  +  +  I  I  +  ++  +   +N       
Sbjct: 3   PIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGAN 62

Query: 638 SNMLPQATRRRFSYKELLQATNQFNASNL-----IGTGGFGSVYKGSFLDG----MEVAI 688
           +  +  +       + +       ++  +     IG G FG VY G+ LD     +  A+
Sbjct: 63  TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 122

Query: 689 KVFHLQLEGA----LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL-VLEYMPNGSLE 743
           K  +          +  F  E  ++K   H N++ ++  C  ++   L VL YM +G L 
Sbjct: 123 KSLN---RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179

Query: 744 DYLYSNNFSFDILQRLSVIIDVALALEYL---HFGYSNPVVHCDIKPSNVLLDKDMVAHL 800
           +++ +   +  +   +   + VA  +++L    F      VH D+   N +LD+     +
Sbjct: 180 NFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF------VHRDLAARNCMLDEKFTVKV 233

Query: 801 SDFGIAKLLSGEESM---KQTLTLATIGYMAP 829
           +DFG+A+ +  +E      +T     + +MA 
Sbjct: 234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 265

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  109 bits (274), Expect = 2e-26
 Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 14/155 (9%)

Query: 667 IGTGGFGSVYKGSFLDG---MEVAIKVFHL-QLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G FGSV +G +      ++VAIKV      +   +    E +++  + +  +V++I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL---HFGYSNP 779
            C       LV+E    G L  +L        +     ++  V++ ++YL   +F     
Sbjct: 78  VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 131

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
            VH D+   NVLL     A +SDFG++K L  ++S
Sbjct: 132 -VHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  113 bits (285), Expect = 2e-26
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 10/168 (5%)

Query: 665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKS--FDVECEVLKSVRHRNLVKIIS 722
             +G G FG V+ G++     VAIK       G +    F  E +V+K +RH  LV++ +
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYA 329

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRL-SVIIDVALALEYLHFGYSNPVV 781
             +      +V EYM  GSL D+L      +  L +L  +   +A  + Y+        V
Sbjct: 330 VVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 385

Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D++ +N+L+ +++V  ++DFG+A+L+   E   +      I + AP
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 433

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  112 bits (282), Expect = 2e-26
 Identities = 43/168 (25%), Positives = 84/168 (50%), Gaps = 10/168 (5%)

Query: 665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGA--LKSFDVECEVLKSVRHRNLVKIIS 722
             +G G FG V+  ++    +VA+K       G+  +++F  E  V+K+++H  LVK+ +
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK---PGSMSVEAFLAEANVMKTLQHDKLVKLHA 250

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRL-SVIIDVALALEYLHFGYSNPVV 781
             T      ++ E+M  GSL D+L S+  S   L +L      +A  + ++        +
Sbjct: 251 VVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYI 306

Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H D++ +N+L+   +V  ++DFG+A+++   E   +      I + AP
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 354

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  112 bits (282), Expect = 2e-26
 Identities = 64/265 (24%), Positives = 104/265 (39%), Gaps = 19/265 (7%)

Query: 46  ELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNN 105
           +   V  T   LS  +P     + S +  ++   N++   +  D  R L  ++ L +  N
Sbjct: 55  QFSKVVCTRRGLS-EVPQ---GIPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRN 109

Query: 106 KLTGPIPNNIWQCKELIVISLAYNQFTERIPRG-LGNLTSLKTLYLGFNNLTGEIPYEM- 163
            +             L  + L  N  T  IP G    L+ L+ L+L  N +   IP    
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPIE-SIPSYAF 167

Query: 164 GNLRNLEILGLQLNKLVGFVPTSIF-NLSAMKTLALPSNALSGSLPSSIDLVRLPNLEII 222
             + +L  L L   K + ++    F  L  +K L L    +   +P   +L  L  LE +
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP---NLTPLVGLEEL 223

Query: 223 SLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTS 282
            ++GN+F  I P      S L  L +  +  S    N    L  L  L L++N L+S   
Sbjct: 224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPH 283

Query: 283 ELSFLSSWANCKNLKLLDLSNNPIN 307
           +L     +   + L  L L +NP N
Sbjct: 284 DL-----FTPLRYLVELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  109 bits (275), Expect = 2e-25
 Identities = 59/255 (23%), Positives = 109/255 (42%), Gaps = 13/255 (5%)

Query: 295 NLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNE 354
               +  +   ++ V P     +  +   + +   +I+        +L +L  L L  N 
Sbjct: 55  QFSKVVCTRRGLSEV-PQ---GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110

Query: 355 LIGSIPI-TFGKLQNLQGLDLVNNKLEGPIPNG-LCQLARLSVLYMDGNKLSGPIPPCI- 411
            I  I +  F  L +L  L+L +N L   IP+G    L++L  L++  N +   IP    
Sbjct: 111 -IRQIEVGAFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPIES-IPSYAF 167

Query: 412 GDLTSLRLLSLAS-NELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDL 470
             + SL  L L    +L  +    F  L ++  LN     +   +P ++  L  +  +++
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEM 225

Query: 471 SRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTS 530
           S N+     P +  GL +L+ L + ++ +      +  GL SL  L+L++N+LS      
Sbjct: 226 SGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDL 285

Query: 531 MEKLLYLKDLNLSFN 545
              L YL +L+L  N
Sbjct: 286 FTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  109 bits (274), Expect = 2e-25
 Identities = 69/310 (22%), Positives = 105/310 (33%), Gaps = 64/310 (20%)

Query: 217 PNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNF 276
                +       S + P  I   S    L L EN+      +T  +L  LE L+L  N 
Sbjct: 54  NQFSKVVCTRRGLSEV-PQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110

Query: 277 LTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIP 336
           +       +F        +L  L+L +N +     + I + +                  
Sbjct: 111 IRQIEVG-AF----NGLASLNTLELFDNWL-----TVIPSGAFE---------------- 144

Query: 337 KEIGNLINLRELGLWGNELIGSIPI-TFGKLQNLQGLDLVN-NKLEGPIPNGLCQLARLS 394
                L  LREL L  N  I SIP   F ++ +L  LDL    KLE         L  L 
Sbjct: 145 ----YLSKLRELWLRNNP-IESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLK 199

Query: 395 VLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGS 454
            L +    +     P +  L  L  L ++ N    + P +F  L                
Sbjct: 200 YLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLS--------------- 242

Query: 455 LPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI-GGLVSL 513
                 +LK    + +  + +S     A  GL +L +L+L  N L  S+P  +   L  L
Sbjct: 243 ------SLK---KLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYL 292

Query: 514 ESLDLSNNSL 523
             L L +N  
Sbjct: 293 VELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  106 bits (266), Expect = 2e-24
 Identities = 64/251 (25%), Positives = 102/251 (40%), Gaps = 12/251 (4%)

Query: 328 NCSIRG--TIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPN 385
            C+ RG   +P+ I    N R L L  N +      TF  L +L+ L L  N +      
Sbjct: 60  VCTRRGLSEVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVG 117

Query: 386 GLCQLARLSVLYMDGNKLSGPIPP-CIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSL 444
               LA L+ L +  N L+  IP      L+ LR L L +N + S+    F  +  ++ L
Sbjct: 118 AFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRL 176

Query: 445 NFSSNFLNGSLPEDI-GNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSI 503
           +         + E     L  +  ++L   N+  D+P  +  L+ L++L +  N      
Sbjct: 177 DLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIR 234

Query: 504 PKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRG--GPFANFS 561
           P S  GL SL+ L + N+ +S     + + L  L +LNL+ N L   +P     P     
Sbjct: 235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLV 293

Query: 562 NRSFMGNDLLC 572
                 N   C
Sbjct: 294 ELHLHHNPWNC 304

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  102 bits (256), Expect = 4e-23
 Identities = 61/255 (23%), Positives = 108/255 (42%), Gaps = 14/255 (5%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           +  +   LS  +P+ I   +  + L L  N ++        +L  LE++ L  N +   I
Sbjct: 59  VVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QI 114

Query: 62  PSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQ-CK 119
               F  L+SL+T ++  +N LT  +P      L  ++ L++ NN +   IP+  +    
Sbjct: 115 EVGAFNGLASLNT-LELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVP 171

Query: 120 ELIVISLA-YNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNK 178
            L+ + L    +           L +LK L LG  N+  ++P  +  L  LE L +  N 
Sbjct: 172 SLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNH 229

Query: 179 LVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIF 238
                P S   LS++K L + ++ +S  +  +     L +L  ++LA NN S +      
Sbjct: 230 FPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNA-FDGLASLVELNLAHNNLSSLPHDLFT 287

Query: 239 NASKLSVLELGENSF 253
               L  L L  N +
Sbjct: 288 PLRYLVELHLHHNPW 302

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  108 bits (273), Expect = 2e-26
 Identities = 42/155 (27%), Positives = 66/155 (42%), Gaps = 11/155 (7%)

Query: 667 IGTGGFGSVYKGSFL----DGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRHRNLVK 719
           +G G FG V +G +       + VA+K      L    A+  F  E   + S+ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
           +         K +V E  P GSL D L  +   F +       + VA  + YL    S  
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 141

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
            +H D+   N+LL    +  + DFG+ + L   + 
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  112 bits (282), Expect = 3e-26
 Identities = 44/169 (26%), Positives = 84/169 (49%), Gaps = 10/169 (5%)

Query: 665 NLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGA--LKSFDVECEVLKSVRHRNLVKII 721
           + +G G +G VY+G +    + VA+K      E    ++ F  E  V+K ++H NLV+++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLL 282

Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPV 780
             CT      ++ E+M  G+L DYL   N      +  L +   ++ A+EYL        
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 339

Query: 781 VHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +H ++   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 388

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  109 bits (275), Expect = 4e-26
 Identities = 57/300 (19%), Positives = 112/300 (37%), Gaps = 19/300 (6%)

Query: 12  AIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIF-NLSS 70
           +IP  +     +K L L  N++      +L     L+ + LT+N ++ TI    F +L S
Sbjct: 45  SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGS 101

Query: 71  LSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQ-CKELIVISLAYN 129
           L   +D S N L+ +L     + L  +  L +  N        +++    +L ++ +   
Sbjct: 102 LEH-LDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNM 159

Query: 130 QFTERIPRG-LGNLTSLKTLYLGFNNLTGEIPYEM-GNLRNLEILGLQLNKLVGFVPTSI 187
               +I R     LT L+ L +  ++L      +   +++N+  L L + + +  +    
Sbjct: 160 DTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIF 217

Query: 188 F-NLSAMKTLALPSNALSGSLPSSID------LVRLPNLEIISLAGNNFSGIIPSFIFNA 240
               S+++ L L    L     S +       L++      + +   +   ++       
Sbjct: 218 VDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLL-NQI 276

Query: 241 SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLD 300
           S L  LE   N            L  L+ + L  N    S   + +LS W N  + K   
Sbjct: 277 SGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQG 336

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  104 bits (260), Expect = 4e-24
 Identities = 58/283 (20%), Positives = 115/283 (40%), Gaps = 17/283 (6%)

Query: 78  SNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPR 137
           S+ SL  S+P  +      +K L +SNN++T    +++ +C  L  + L  N     I  
Sbjct: 39  SSGSLN-SIPSGL---TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEE 93

Query: 138 GL-GNLTSLKTLYLGFNNLTGEIPYEM-GNLRNLEILGLQLNKLVGFVPTSIF-NLSAMK 194
               +L SL+ L L +N L+  +       L +L  L L  N       TS+F +L+ ++
Sbjct: 94  DSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQ 152

Query: 195 TLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFS 254
            L + +      +    D   L  LE + +  ++     P  + +   +S L L      
Sbjct: 153 ILRVGNMDTFTKIQRK-DFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211

Query: 255 GFIPNTLGNLRKLEWLRLSYNFLTSST-SELSFLSSWA--NCKNLKLLDLSNNPINGVLP 311
             +   +     +E L L    L +   SELS   + +       + + +++  +   + 
Sbjct: 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVM 270

Query: 312 SSIGNLSLSLSRIFISNCSIRGTIPKEI-GNLINLRELGLWGN 353
             +  +S  L  +  S   ++ ++P  I   L +L+++ L  N
Sbjct: 271 KLLNQIS-GLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  102 bits (256), Expect = 1e-23
 Identities = 56/267 (20%), Positives = 107/267 (40%), Gaps = 20/267 (7%)

Query: 295 NLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEI-GNLINLRELGLWGN 353
            +K LDLSNN I  +  S +     +L  + +++  I  TI ++   +L +L  L L  N
Sbjct: 53  AVKSLDLSNNRITYISNSDLQRCV-NLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110

Query: 354 ELIGSIPI-TFGKLQNLQGLDLVNNKLEGPIPNGL-CQLARLSVLYMDGNKLSGPIPP-C 410
            L  ++    F  L +L  L+L+ N  +      L   L +L +L +        I    
Sbjct: 111 YL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169

Query: 411 IGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDI-GNLKVVVIID 469
              LT L  L + +++L S  P +  +++++  L          L E        V  ++
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLE 228

Query: 470 LSRNNLSGDIPTAI--------GGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNN 521
           L   +L     + +              +++ + D  L   + K +  +  L  L+ S N
Sbjct: 229 LRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRN 287

Query: 522 SLSGNIPTSM-EKLLYLKDLNLSFNKL 547
            L  ++P  + ++L  L+ + L  N  
Sbjct: 288 QLK-SVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  102 bits (255), Expect = 2e-23
 Identities = 59/322 (18%), Positives = 108/322 (33%), Gaps = 48/322 (14%)

Query: 214 VRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLS 273
           +      I   +  + + I PS +     +  L+L  N  +    + L     L+ L L+
Sbjct: 28  LSCDRNGICKGSSGSLNSI-PSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLT 84

Query: 274 YNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRG 333
            N + +   E SF    ++  +L+ LDLS N ++ +  S    LS               
Sbjct: 85  SNGINT-IEEDSF----SSLGSLEHLDLSYNYLSNLSSSWFKPLS--------------- 124

Query: 334 TIPKEIGNLINLRELGLWGNELIGSIP--ITFGKLQNLQGLDLVNNKLEGPIPNG-LCQL 390
                     +L  L L GN    ++     F  L  LQ L + N      I       L
Sbjct: 125 ----------SLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL 173

Query: 391 ARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNF 450
             L  L +D + L    P  +  + ++  L L   +   ++         +  L      
Sbjct: 174 TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTD 233

Query: 451 LNGSLPEDI--------GNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGS 502
           L+     ++                + ++  +L   +   +  +  L +L    N L+ S
Sbjct: 234 LDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-S 291

Query: 503 IPKSI-GGLVSLESLDLSNNSL 523
           +P  I   L SL+ + L  N  
Sbjct: 292 VPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 94.4 bits (235), Expect = 6e-21
 Identities = 60/307 (19%), Positives = 126/307 (41%), Gaps = 23/307 (7%)

Query: 269 WLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISN 328
           W+      + S + E S   +  +C    +   S+  +N + PS    L+ ++  + +SN
Sbjct: 6   WMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSI-PS---GLTEAVKSLDLSN 61

Query: 329 CSIRGTIPKEIGNLINLRELGLWGNELIGSIPI-TFGKLQNLQGLDLVNNKLEGPIPNGL 387
             I      ++   +NL+ L L  N  I +I   +F  L +L+ LDL  N L   + +  
Sbjct: 62  NRITYISNSDLQRCVNLQALVLTSNG-INTIEEDSFSSLGSLEHLDLSYNYLSN-LSSSW 119

Query: 388 CQ-LARLSVLYMDGNKLSGPIPPCI--GDLTSLRLLSLASNELNSVIPS-TFWNLKDILS 443
            + L+ L+ L + GN     +        LT L++L + + +  + I    F  L  +  
Sbjct: 120 FKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEE 178

Query: 444 LNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSI 503
           L   ++ L    P+ + +++ V  + L        +   +    +++ L LRD  L    
Sbjct: 179 LEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFH 238

Query: 504 PKSI--------GGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGG 555
              +            +  ++ +++ SL   +   + ++  L +L  S N+L+  +P G 
Sbjct: 239 FSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGI 296

Query: 556 PFANFSN 562
            F   ++
Sbjct: 297 -FDRLTS 302

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 80.2 bits (198), Expect = 3e-16
 Identities = 47/221 (21%), Positives = 86/221 (38%), Gaps = 11/221 (4%)

Query: 368 NLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCI-GDLTSLRLLSLASNE 426
            ++ LDL NN++     + L +   L  L +  N ++  I       L SL  L L+ N 
Sbjct: 53  AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYNY 111

Query: 427 LNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDI--GNLKVVVIIDLSRNNLSGDIPT-AI 483
           L+++  S F  L  +  LN   N    +L E     +L  + I+ +   +    I     
Sbjct: 112 LSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170

Query: 484 GGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLS 543
            GL  L++L +  + LQ   PKS+  + ++  L L        +   ++    ++ L L 
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELR 230

Query: 544 FNKLEG----EIPRGGPFANFSNRSFMGNDLLCGLAQVQVP 580
              L+     E+   G   +   +    N  +   +  QV 
Sbjct: 231 DTDLDTFHFSELST-GETNSLIKKFTFRNVKITDESLFQVM 270

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  108 bits (272), Expect = 4e-26
 Identities = 45/167 (26%), Positives = 80/167 (47%), Gaps = 11/167 (6%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           +G G FG VYK    + G   A KV   + E  L+ + VE E+L +  H  +VK++ +  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86

Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
           ++    +++E+ P G+++  +   +      Q   V   +  AL +LH   S  ++H D+
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDL 143

Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG---YMAP 829
           K  NVL+  +    L+DFG++         + +     IG   +MAP
Sbjct: 144 KAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF----IGTPYWMAP 186

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  109 bits (274), Expect = 4e-26
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 10/154 (6%)

Query: 667 IGTGGFGSVYKGSFLDGME-----VAIKVFHL-QLEGALKSFDVECEVLKSVRHRNLVKI 720
           +G+G FG+VYKG ++   E     VAIK         A K    E  V+ SV + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPV 780
           +  C  +  + L+ + MP G L DY+  +  +      L+  + +A  + YL       +
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRL 138

Query: 781 VHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
           VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  107 bits (270), Expect = 5e-26
 Identities = 46/171 (26%), Positives = 74/171 (43%), Gaps = 15/171 (8%)

Query: 667 IGTGGFGSVYKGSFLDG----MEVAIKVFHLQLEGA----LKSFDVECEVLKSVRHRNLV 718
           IG G FG V++G ++      + VAIK              + F  E   ++   H ++V
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
           K+I   T N    +++E    G L  +L    +S D+   +     ++ AL YL    S 
Sbjct: 80  KLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SK 135

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             VH DI   NVL+  +    L DFG+++ +      K +     I +MAP
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 186

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  107 bits (270), Expect = 6e-26
 Identities = 45/167 (26%), Positives = 83/167 (49%), Gaps = 10/167 (5%)

Query: 667 IGTGGFGSVYKGSFLDG-MEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISS 723
           +G G +G VY+G +    + VA+K      E  +  + F  E  V+K ++H NLV+++  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVH 782
           CT      ++ E+M  G+L DYL   N      +  L +   ++ A+EYL        +H
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134

Query: 783 CDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            D+   N L+ ++ +  ++DFG+++L++G+           I + AP
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 181

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  107 bits (269), Expect = 6e-26
 Identities = 42/166 (25%), Positives = 84/166 (50%), Gaps = 10/166 (6%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGAL--KSFDVECEVLKSVRHRNLVKIISSC 724
           +G G FG V+ G +    +VA+K      +G++   +F  E  ++K ++H+ LV++ +  
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
           T      ++ EYM NGSL D+L + +     I + L +   +A  + ++        +H 
Sbjct: 78  TQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133

Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D++ +N+L+   +   ++DFG+A+L+   E   +      I + AP
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  112 bits (281), Expect = 7e-26
 Identities = 40/155 (25%), Positives = 72/155 (46%), Gaps = 14/155 (9%)

Query: 667 IGTGGFGSVYKGSFLDG---MEVAIKVFHL-QLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G FGSV +G +      ++VAIKV      +   +    E +++  + +  +V++I 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL---HFGYSNP 779
            C       LV+E    G L  +L        +     ++  V++ ++YL   +F     
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 457

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
            VH ++   NVLL     A +SDFG++K L  ++S
Sbjct: 458 -VHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  107 bits (270), Expect = 8e-26
 Identities = 43/158 (27%), Positives = 78/158 (49%), Gaps = 15/158 (9%)

Query: 667 IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQ---LEGALKSFDVECEVLKSVRHRNLV 718
           +G G FG V    +       G +VA+K   L+       +     E E+L+++ H N+V
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 719 KIISSCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
           K    CT +      L++E++P+GSL++YL  N    ++ Q+L   + +   ++YL    
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG--- 143

Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
           S   VH D+   NVL++ +    + DFG+ K +  ++ 
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  112 bits (281), Expect = 9e-26
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 18/176 (10%)

Query: 667 IGTGGFGSVYKGS-FLDGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKII--- 721
           +GTGGFG V +      G +VAIK    +L     + + +E +++K + H N+V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 722 ---SSCTNNDFKALVLEYMPNGSLEDYL--YSNNFSFDILQRLSVIIDVALALEYLHFGY 776
                   ND   L +EY   G L  YL  + N          +++ D++ AL YLH   
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 138

Query: 777 SNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            N ++H D+KP N++L    + ++  + D G AK L  +  +     + T+ Y+AP
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELCTEF-VGTLQYLAP 192

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  106 bits (268), Expect = 1e-25
 Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 21/174 (12%)

Query: 667 IGTGGFGSVYKGSFLDG----MEVAIKVFHLQLEGALKS----FDVECEVLKSVRHRNLV 718
           +G G FG VY+G + +     + VA+K      +         F  E  ++K++ H ++V
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL---HFG 775
           K+I          +++E  P G L  YL  N  S  +L  +   + +  A+ YL   +  
Sbjct: 77  KLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC- 134

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
                VH DI   N+L+       L DFG+++ +  E+  K ++T   I +M+P
Sbjct: 135 -----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSP 183

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  107 bits (270), Expect = 1e-25
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 10/155 (6%)

Query: 667 IGTGGFGSVYKGSFL-----DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKII 721
           +G G FGSV    +       G  VA+K          + F  E ++LK++    +VK  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 722 SSCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
                   ++  LV+EY+P+G L D+L  +    D  + L     +   +EYL    S  
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
            VH D+   N+L++ +    ++DFG+AKLL  ++ 
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  107 bits (269), Expect = 1e-25
 Identities = 52/173 (30%), Positives = 84/173 (48%), Gaps = 13/173 (7%)

Query: 661 FNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVK 719
           F+    +G G +GSVYK    + G  VAIK   + +E  L+    E  +++     ++VK
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ--VPVESDLQEIIKEISIMQQCDSPHVVK 88

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
              S   N    +V+EY   GS+ D +   N +    +  +++      LEYLH      
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMR 145

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG---YMAP 829
            +H DIK  N+LL+ +  A L+DFG+A  L+   + + T+    IG   +MAP
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV----IGTPFWMAP 194

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  107 bits (269), Expect = 2e-25
 Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 15/157 (9%)

Query: 667 IGTGGFGSVYKGSFLDG-----MEVAIKVFHLQLEGA----LKSFDVECEVLKSVRHRNL 717
           IG G FG VYKG          + VAIK       G        F  E  ++    H N+
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           +++    +      ++ EYM NG+L+ +L   +  F +LQ + ++  +A  ++YL    +
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---N 165

Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
              VH D+   N+L++ ++V  +SDFG++++L  +  
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  106 bits (266), Expect = 2e-25
 Identities = 55/176 (31%), Positives = 86/176 (48%), Gaps = 13/176 (7%)

Query: 658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRN 716
             ++     IG G  G+VY    +  G EVAI+  +LQ +   +    E  V++  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
           +V  + S    D   +V+EY+  GSL D +          Q  +V  +   ALE+LH   
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLH--- 133

Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG---YMAP 829
           SN V+H DIK  N+LL  D    L+DFG    ++ E+S + T+    +G   +MAP
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM----VGTPYWMAP 185

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  107 bits (268), Expect = 2e-25
 Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 13/167 (7%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           IG G  G V        G +VA+K+  L+ +   +    E  +++  +H N+V++  S  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112

Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
             +   +++E++  G+L D +     + +  Q  +V   V  AL YLH   +  V+H DI
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVRLNEE--QIATVCEAVLQALAYLH---AQGVIHRDI 167

Query: 786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG---YMAP 829
           K  ++LL  D    LSDFG    +S +   +++L    +G   +MAP
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL----VGTPYWMAP 210

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  106 bits (266), Expect = 2e-25
 Identities = 43/180 (23%), Positives = 79/180 (43%), Gaps = 24/180 (13%)

Query: 665 NLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQLEGA----LKSFDVECEVLKSVRHRN 716
            +IG G FG VY G+ LD     +  A+K  +          +  F  E  ++K   H N
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 717 LVKIISSCTNNDFKAL-VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL--- 772
           ++ ++  C  ++   L VL YM +G L +++ +   +  +   +   + VA  ++YL   
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 147

Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT---IGYMAP 829
            F      VH D+   N +LD+     ++DFG+A+ +  +E             + +MA 
Sbjct: 148 KF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  105 bits (263), Expect = 5e-25
 Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 16/156 (10%)

Query: 667 IGTGGFGSVYKGSFLDG---MEVAIKVFH--LQLEGALKSFDVECEVLKSVRHRNLVKII 721
           +G+G FG+V KG +        VA+K+                E  V++ + +  +V++I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL---HFGYSN 778
             C    +  LV+E    G L  YL  N         + ++  V++ ++YL   +F    
Sbjct: 85  GICEAESWM-LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNF---- 138

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
             VH D+   NVLL     A +SDFG++K L  +E+
Sbjct: 139 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  107 bits (268), Expect = 5e-25
 Identities = 41/152 (26%), Positives = 76/152 (50%), Gaps = 8/152 (5%)

Query: 667 IGTGGFGSVYKGSFL----DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKII 721
           +G G FG V  G         + VAIK   +   E   + F  E  ++    H N++++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
              T +    +V EYM NGSL+ +L  ++  F ++Q + ++  +A  ++YL        V
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYV 169

Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
           H D+   N+L++ ++V  +SDFG+ ++L  + 
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  107 bits (270), Expect = 5e-25
 Identities = 60/265 (22%), Positives = 106/265 (40%), Gaps = 19/265 (7%)

Query: 46  ELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNN 105
           +   V      L   +P     +S+ +  ++   N +   +  +  + L  ++ L +S N
Sbjct: 44  QFSKVICVRKNLR-EVPD---GISTNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRN 98

Query: 106 KLTGPIPNNIWQCKELIVISLAYNQFTERIPRG-LGNLTSLKTLYLGFNNLTGEIPYEM- 163
            +             L  + L  N+ T  IP G    L+ LK L+L  N +   IP    
Sbjct: 99  HIRTIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNPIE-SIPSYAF 156

Query: 164 GNLRNLEILGLQLNKLVGFVPTSIF-NLSAMKTLALPSNALSGSLPSSIDLVRLPNLEII 222
             + +L  L L   K + ++    F  LS ++ L L    L   +P   +L  L  L+ +
Sbjct: 157 NRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP---NLTPLIKLDEL 212

Query: 223 SLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTS 282
            L+GN+ S I P        L  L + ++       N   NL+ L  + L++N LT    
Sbjct: 213 DLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPH 272

Query: 283 ELSFLSSWANCKNLKLLDLSNNPIN 307
           +L     +    +L+ + L +NP N
Sbjct: 273 DL-----FTPLHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  107 bits (269), Expect = 9e-25
 Identities = 59/251 (23%), Positives = 101/251 (40%), Gaps = 12/251 (4%)

Query: 328 NCSIRG--TIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPN 385
            C  +    +P  I    N R L L  N++      +F  L++L+ L L  N +      
Sbjct: 49  ICVRKNLREVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIG 106

Query: 386 GLCQLARLSVLYMDGNKLSGPIPP-CIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSL 444
               LA L+ L +  N+L+  IP      L+ L+ L L +N + S+    F  +  +  L
Sbjct: 107 AFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRL 165

Query: 445 NFSSNFLNGSLPEDI-GNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSI 503
           +         + E     L  +  ++L+  NL  +IP  +  L+ L +L L  N L    
Sbjct: 166 DLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIR 223

Query: 504 PKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRG--GPFANFS 561
           P S  GL+ L+ L +  + +      + + L  L ++NL+ N L   +P     P  +  
Sbjct: 224 PGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLE 282

Query: 562 NRSFMGNDLLC 572
                 N   C
Sbjct: 283 RIHLHHNPWNC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  106 bits (266), Expect = 2e-24
 Identities = 66/286 (23%), Positives = 107/286 (37%), Gaps = 38/286 (13%)

Query: 217 PNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNF 276
                +     N   + P  I   +   +L L EN       N+  +LR LE L+LS N 
Sbjct: 43  NQFSKVICVRKNLREV-PDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 277 LTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIP 336
           + +         ++    NL  L+L +N +  +   +   LS                  
Sbjct: 100 IRTIEIG-----AFNGLANLNTLELFDNRLTTIPNGAFVYLS------------------ 136

Query: 337 KEIGNLINLRELGLWGNELIGSIPI-TFGKLQNLQGLDLV-NNKLEGPIPNGLCQLARLS 394
                   L+EL L  N  I SIP   F ++ +L+ LDL    +L          L+ L 
Sbjct: 137 -------KLKELWLRNNP-IESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLR 188

Query: 395 VLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGS 454
            L +    L   IP  +  L  L  L L+ N L+++ P +F  L  +  L    + +   
Sbjct: 189 YLNLAMCNLRE-IPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVI 246

Query: 455 LPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQ 500
                 NL+ +V I+L+ NNL+         L +L+ + L  N   
Sbjct: 247 ERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  105 bits (263), Expect = 5e-24
 Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 9/234 (3%)

Query: 316 NLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPI-TFGKLQNLQGLDL 374
            +S +   + +    I+        +L +L  L L  N  I +I I  F  L NL  L+L
Sbjct: 61  GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN-HIRTIEIGAFNGLANLNTLEL 119

Query: 375 VNNKLEGPIPNG-LCQLARLSVLYMDGNKLSGPIPPCI-GDLTSLRLLSLAS-NELNSVI 431
            +N+L   IPNG    L++L  L++  N +   IP      + SLR L L     L+ + 
Sbjct: 120 FDNRLTT-IPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELKRLSYIS 177

Query: 432 PSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQD 491
              F  L ++  LN +   L   +P ++  L  +  +DLS N+LS   P +  GLM+LQ 
Sbjct: 178 EGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQK 235

Query: 492 LSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFN 545
           L +  + +Q     +   L SL  ++L++N+L+         L +L+ ++L  N
Sbjct: 236 LWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  101 bits (254), Expect = 6e-23
 Identities = 62/256 (24%), Positives = 110/256 (42%), Gaps = 16/256 (6%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           +     +L   +P  I   T  + L L  N+++        +L  LE++ L+ N +  TI
Sbjct: 48  VICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TI 103

Query: 62  PSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQ-CK 119
               F  L++L+T ++  +N LT ++P+     L  +K L++ NN +   IP+  +    
Sbjct: 104 EIGAFNGLANLNT-LELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIP 160

Query: 120 ELIVISLA-YNQFTERIPRG-LGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLN 177
            L  + L    + +  I  G    L++L+ L L   NL  EIP  +  L  L+ L L  N
Sbjct: 161 SLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGN 217

Query: 178 KLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFI 237
            L    P S   L  ++ L +  + +   +  +     L +L  I+LA NN + +     
Sbjct: 218 HLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNA-FDNLQSLVEINLAHNNLTLLPHDLF 275

Query: 238 FNASKLSVLELGENSF 253
                L  + L  N +
Sbjct: 276 TPLHHLERIHLHHNPW 291

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  105 bits (264), Expect = 6e-25
 Identities = 40/154 (25%), Positives = 78/154 (50%), Gaps = 10/154 (6%)

Query: 667 IGTGGFGSVYKGSFLDGME-----VAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKI 720
           +G+G FG+V+KG ++   E     V IKV   +    + ++       + S+ H ++V++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPV 780
           +  C  +  + LV +Y+P GSL D++  +  +      L+  + +A  + YL     + +
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGM 136

Query: 781 VHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
           VH ++   NVLL       ++DFG+A LL  ++ 
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  104 bits (262), Expect = 7e-25
 Identities = 44/182 (24%), Positives = 76/182 (41%), Gaps = 30/182 (16%)

Query: 667 IGTGGFGSVYKGSF--------LDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLV 718
           +G G F  ++KG          L   EV +KV         +SF     ++  + H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL---HFG 775
                C   D   LV E++  GSL+ YL  N    +IL +L V   +A A+ +L      
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134

Query: 776 YSNPVVHCDIKPSNVLLDKD--------MVAHLSDFGIAKLLSGEESMKQTLTLATIGYM 827
                +H ++   N+LL ++            LSD GI+  +  ++ ++       I ++
Sbjct: 135 -----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ-----ERIPWV 184

Query: 828 AP 829
            P
Sbjct: 185 PP 186

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  105 bits (263), Expect = 8e-25
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 10/154 (6%)

Query: 667 IGTGGFGSVYKGSFLDGME-----VAIKVFHL-QLEGALKSFDVECEVLKSVRHRNLVKI 720
           +G+G FG+VYKG ++   E     VAIK         A K    E  V+ SV + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPV 780
           +  C  +  + L+ + MP G L DY+  +  +      L+  + +A  + YL       +
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRL 138

Query: 781 VHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
           VH D+   NVL+       ++DFG+AKLL  EE 
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  109 bits (273), Expect = 9e-25
 Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 9/168 (5%)

Query: 667 IGTGGFGSVYKGSFLDG----MEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKII 721
           IG G FG V++G ++      M VAIK       +   + F  E   ++   H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
              T N    +++E    G L  +L    FS D+   +     ++ AL YL    S   V
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513

Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H DI   NVL+  +    L DFG+++ +      K +     I +MAP
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  105 bits (263), Expect = 1e-24
 Identities = 44/176 (25%), Positives = 76/176 (43%), Gaps = 25/176 (14%)

Query: 666 LIGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKII 721
            +G GGF   ++ S  D     A K+     L      +   +E  + +S+ H+++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLS------VIIDVALALEYLHFG 775
               +NDF  +VLE     SL +            + L+       +  + L  +YLH  
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRR-------KALTEPEARYYLRQIVLGCQYLH-- 158

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL--TLATIGYMAP 829
             N V+H D+K  N+ L++D+   + DFG+A  +  +   K+ L  T     Y+AP
Sbjct: 159 -RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN---YIAP 210

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  103 bits (260), Expect = 1e-24
 Identities = 42/176 (23%), Positives = 74/176 (42%), Gaps = 25/176 (14%)

Query: 666 LIGTGGFGSVYKG-SFLDGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRHRNLVKII 721
            +G GGF   ++          A K+     L      +   +E  + +S+ H+++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLS------VIIDVALALEYLHFG 775
               +NDF  +VLE     SL +            + L+       +  + L  +YLH  
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRR-------KALTEPEARYYLRQIVLGCQYLH-- 132

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL--TLATIGYMAP 829
             N V+H D+K  N+ L++D+   + DFG+A  +  +   K+ L  T     Y+AP
Sbjct: 133 -RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN---YIAP 184

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  106 bits (267), Expect = 1e-24
 Identities = 52/143 (36%), Positives = 72/143 (50%), Gaps = 8/143 (5%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN 726
           IG G FG V  G    G +VA+K   ++ +   ++F  E  V+  +RH NLV+++     
Sbjct: 201 IGKGEFGDVMLG-DYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257

Query: 727 NDFKA-LVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
                 +V EYM  GSL DYL S           L   +DV  A+EYL     N  VH D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 314

Query: 785 IKPSNVLLDKDMVAHLSDFGIAK 807
           +   NVL+ +D VA +SDFG+ K
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK 337

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  103 bits (259), Expect = 1e-24
 Identities = 49/177 (27%), Positives = 86/177 (48%), Gaps = 26/177 (14%)

Query: 666 LIGTGGFGSVYKG-SFLDGMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKII 721
           L+G G F  VY+  S   G+EVAIK+     +   G ++    E ++   ++H +++++ 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD-------ILQRLSVIIDVALALEYLHF 774
           +   ++++  LVLE   NG +  YL +    F        + Q    II     + YLH 
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ----IIT---GMLYLH- 129

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL--TLATIGYMAP 829
             S+ ++H D+  SN+LL ++M   ++DFG+A  L        TL  T     Y++P
Sbjct: 130 --SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN---YISP 181

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  103 bits (259), Expect = 1e-24
 Identities = 47/198 (23%), Positives = 80/198 (40%), Gaps = 34/198 (17%)

Query: 658 TNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGA--LKSFDVECEVLKSV-R 713
           T +F+    IG+G FGSV+K    LDG   AIK     L G+   ++   E      + +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDIL---QRLSVIIDVALALE 770
           H ++V+  S+   +D   +  EY   GSL D +  N          +   +++ V   L 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKD-------------------MVAHLSDFGIAKLLSG 811
           Y+H   S  +VH DIKPSN+ + +                    ++  + D G    +S 
Sbjct: 130 YIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 812 EESMKQTLTLATIGYMAP 829
            +  +         ++A 
Sbjct: 187 PQVEE-----GDSRFLAN 199

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  103 bits (260), Expect = 2e-24
 Identities = 42/176 (23%), Positives = 76/176 (43%), Gaps = 18/176 (10%)

Query: 666 LIGTGGFGSVYKGSFLD---GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVK 719
           ++G GG   V+     D     +VA+KV    L         F  E +   ++ H  +V 
Sbjct: 19  ILGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 720 IISSCTNNDFKA----LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG 775
           +  +            +V+EY+   +L D +          + + VI D   AL + H  
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSH-- 133

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS-GEESMKQT-LTLATIGYMAP 829
             N ++H D+KP+N+++       + DFGIA+ ++    S+ QT   + T  Y++P
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  103 bits (259), Expect = 3e-24
 Identities = 46/175 (26%), Positives = 78/175 (44%), Gaps = 19/175 (10%)

Query: 667 IGTGGFGSVYKGSFLD-----GMEVAIKVFHLQ---LEGALKSFDVECEVLKSVRHRNLV 718
           +G G FG V    +       G  VA+K   L+          +  E ++L+++ H +++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKA--LKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 719 KIISSCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
           K    C +    +  LV+EY+P GSL DYL  ++     L  L     +   + YLH   
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL--LLFAQQICEGMAYLH--- 151

Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES--MKQTLTLATIGYMAP 829
           +   +H D+   NVLLD D +  + DFG+AK +         +    + + + AP
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  101 bits (255), Expect = 4e-24
 Identities = 52/232 (22%), Positives = 88/232 (37%), Gaps = 14/232 (6%)

Query: 78  SNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPR 137
               L  ++P  +       + +++  N+++     +   C+ L ++ L  N        
Sbjct: 19  PQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA 74

Query: 138 GLGNLTSLKTLYLGFNNLTGEIPYEM-GNLRNLEILGLQLNKLVGFVPTSIF-NLSAMKT 195
               L  L+ L L  N     +       L  L  L L    L   +   +F  L+A++ 
Sbjct: 75  AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQY 133

Query: 196 LALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSG 255
           L L  NAL  +LP       L NL  + L GN  S +          L  L L +N  + 
Sbjct: 134 LYLQDNALQ-ALPDDT-FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191

Query: 256 FIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPIN 307
             P+   +L +L  L L  N L++  +E       A  + L+ L L++NP  
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEA-----LAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 55/247 (22%), Positives = 87/247 (35%), Gaps = 39/247 (15%)

Query: 134 RIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAM 193
            +P G+    + + ++L  N ++          RNL IL L  N L       I      
Sbjct: 25  AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-----ARI------ 71

Query: 194 KTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIF-NASKLSVLELGENS 252
                 + A +G          L  LE + L+ N     +    F    +L  L L    
Sbjct: 72  -----DAAAFTG----------LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116

Query: 253 FSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPS 312
                P     L  L++L L  N L +   +      + +  NL  L L  N I+ V   
Sbjct: 117 LQELGPGLFRGLAALQYLYLQDNALQALPDDT-----FRDLGNLTHLFLHGNRISSVPER 171

Query: 313 SIGNLSLSLSRIFISNCSIRGTIPKEI-GNLINLRELGLWGNELIGSIPI-TFGKLQNLQ 370
           +   L  SL R+ +    +   +      +L  L  L L+ N L  ++P      L+ LQ
Sbjct: 172 AFRGLH-SLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQ 228

Query: 371 GLDLVNN 377
            L L +N
Sbjct: 229 YLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 13/222 (5%)

Query: 12  AIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIF-NLSS 70
           A+P  I      +++ L  N++             L ++ L +N L+  I +  F  L+ 
Sbjct: 25  AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLAL 81

Query: 71  LSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQ-CKELIVISLAYN 129
           L   +D S+N+   S+       L  +  L++    L   +   +++    L  + L  N
Sbjct: 82  LEQ-LDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDN 139

Query: 130 QFTERIPRG-LGNLTSLKTLYLGFNNLTGEIPYEM-GNLRNLEILGLQLNKLVGFVPTSI 187
                +P     +L +L  L+L  N ++  +P      L +L+ L L  N++    P + 
Sbjct: 140 ALQA-LPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197

Query: 188 FNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNF 229
            +L  + TL L +N LS +LP+   L  L  L+ + L  N +
Sbjct: 198 RDLGRLMTLYLFANNLS-ALPTEA-LAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 90.4 bits (225), Expect = 4e-20
 Identities = 55/230 (23%), Positives = 78/230 (33%), Gaps = 30/230 (13%)

Query: 328 NCSIRG--TIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPN 385
           +C  +G   +P  I      + + L GN +      +F   +NL  L L +N L      
Sbjct: 17  SCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA 74

Query: 386 GLCQLARLSVLYMDGNKLSGPIPPCI-GDLTSLRLLSLASNELNSVIPSTFWNLKDILSL 444
               LA L  L +  N     + P     L  L  L L    L  + P  F  L  +  L
Sbjct: 75  AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134

Query: 445 NFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIP 504
               N L  +LP+D                           L NL  L L  N +     
Sbjct: 135 YLQDNALQ-ALPDD-----------------------TFRDLGNLTHLFLHGNRISSVPE 170

Query: 505 KSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRG 554
           ++  GL SL+ L L  N ++   P +   L  L  L L  N L   +P  
Sbjct: 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTE 219

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  102 bits (256), Expect = 5e-24
 Identities = 42/180 (23%), Positives = 79/180 (43%), Gaps = 24/180 (13%)

Query: 665 NLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQLEGA----LKSFDVECEVLKSVRHRN 716
            +IG G FG VY G ++D     ++ AIK             +++F  E  +++ + H N
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLREGLLMRGLNHPN 83

Query: 717 LVKIISSCTNND-FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL--- 772
           ++ +I      +    ++L YM +G L  ++ S   +  +   +S  + VA  +EYL   
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ 143

Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE---SMKQTLTLATIGYMAP 829
            F      VH D+   N +LD+     ++DFG+A+ +   E     +       + + A 
Sbjct: 144 KF------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  101 bits (254), Expect = 8e-24
 Identities = 48/180 (26%), Positives = 78/180 (43%), Gaps = 29/180 (16%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---------ECEVLKSV-RHR 715
           +G G    V +        E A+K+  +   G+  + +V         E ++L+ V  H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLS------VIIDVALAL 769
           N++++  +   N F  LV + M  G L DYL            LS      ++  +   +
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKIMRALLEVI 137

Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             LH      +VH D+KP N+LLD DM   L+DFG +  L   E +++     T  Y+AP
Sbjct: 138 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE--VCGTPSYLAP 192

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  101 bits (253), Expect = 8e-24
 Identities = 53/146 (36%), Positives = 70/146 (47%), Gaps = 10/146 (6%)

Query: 665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGA-LKSFDVECEVLKSVRHRNLVKIISS 723
             IG G FG V  G    G +VA+K        A  ++F  E  V+  +RH NLV+++  
Sbjct: 27  QTIGKGEFGDVMLGD-YRGNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQLLGV 82

Query: 724 CTNNDFKA-LVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVV 781
                    +V EYM  GSL DYL S           L   +DV  A+EYL     N  V
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFV 139

Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAK 807
           H D+   NVL+ +D VA +SDFG+ K
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK 165

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  100 bits (252), Expect = 1e-23
 Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 14/168 (8%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHL-QLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           IG G FG V+KG        VAIK+  L + E  ++    E  VL       + K   S 
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
             +    +++EY+  GS  D L         +   +++ ++   L+YLH   S   +H D
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA--TILREILKGLDYLH---SEKKIHRD 144

Query: 785 IKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG---YMAP 829
           IK +NVLL +     L+DFG+A  L+  +  + T     +G   +MAP
Sbjct: 145 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF----VGTPFWMAP 188

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  100 bits (252), Expect = 2e-23
 Identities = 44/185 (23%), Positives = 87/185 (47%), Gaps = 30/185 (16%)

Query: 667 IGTGGFGSVYKGSFLDG----MEVAIKVFHLQLEGA----LKSFDVECEVLKSVRHRNLV 718
           +G G FGSV +G+        ++VA+K   ++L+ +    ++ F  E   +K   H N++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 719 KIISSCTNNDFKA-----LVLEYMPNGSLEDYL-----YSNNFSFDILQRLSVIIDVALA 768
           +++  C     +      ++L +M  G L  YL      +      +   L  ++D+AL 
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 769 LEYL---HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL-SGEESMKQTLTLATI 824
           +EYL   +F      +H D+   N +L  DM   ++DFG++K + SG+   +  +    +
Sbjct: 160 MEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213

Query: 825 GYMAP 829
            ++A 
Sbjct: 214 KWIAI 218

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 50/178 (28%), Positives = 75/178 (42%), Gaps = 17/178 (9%)

Query: 659 NQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFH---LQLEGALKSFDVECEVLKSVRH 714
             F     +G G FG+VY          +A+KV     L+  G       E E+   +RH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLH 773
            N++++     +     L+LEY P G++   L   + F          I ++A AL Y H
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCH 126

Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTL--TLATIGYMAP 829
              S  V+H DIKP N+LL       ++DFG +       S +  L  TL    Y+ P
Sbjct: 127 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTDLCGTLD---YLPP 176

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  100 bits (250), Expect = 6e-23
 Identities = 40/186 (21%), Positives = 69/186 (37%), Gaps = 23/186 (12%)

Query: 666 LIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVR-HRNLVKIISS 723
           ++  GGF  VY+      G E A+K      E   ++   E   +K +  H N+V+  S+
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 724 CT-------NNDFKALVLEYMPNGSLEDYL--YSNNFSFDILQRLSVIIDVALALEYLHF 774
            +           + L+L  +  G L ++L    +         L +      A++++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-----------T 823
               P++H D+K  N+LL       L DFG A  +S       +               T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 824 IGYMAP 829
             Y  P
Sbjct: 214 PMYRTP 219

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 99.8 bits (249), Expect = 1e-22
 Identities = 57/229 (24%), Positives = 101/229 (44%), Gaps = 39/229 (17%)

Query: 624 SRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATN---QFNASNLIGTGGFGSVYKGSF 680
           +  ++ N  Q     N+  Q+        +   A     +++  ++IG G    V +   
Sbjct: 56  AEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVH 115

Query: 681 LD-GMEVAIKVF--------HLQLEGALKSFDVECEVLKSVR-HRNLVKIISSCTNNDFK 730
              G E A+K+           QLE   ++   E  +L+ V  H +++ +I S  ++ F 
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175

Query: 731 ALVLEYMPNGSLEDYLYSNNFSFD-ILQRLS--------VIIDVALALEYLHFGYSNPVV 781
            LV + M  G L          FD + ++++        ++  +  A+ +LH   +N +V
Sbjct: 176 FLVFDLMRKGEL----------FDYLTEKVALSEKETRSIMRSLLEAVSFLH---ANNIV 222

Query: 782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
           H D+KP N+LLD +M   LSDFG +  L   E ++    L  T GY+AP
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---ELCGTPGYLAP 268

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 99.7 bits (248), Expect = 1e-22
 Identities = 34/194 (17%), Positives = 60/194 (30%), Gaps = 25/194 (12%)

Query: 658 TNQFNASNLIGTGGFGSVYKGSFLD------GMEVAIKVFHLQLEGALKSFDVECEVLKS 711
           +      +L+G G F  VY+ +  D        +  +KV                E LK 
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYL----YSNNFSFDILQRLSVIIDVAL 767
                 +K  S+    +   LV E    G+L + +     +          +S  + +  
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAH-----------LSDFGIAKLLSGEESMK 816
            +E +H      ++H DIKP N +L    +             L D G +  +       
Sbjct: 184 MIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 817 QTLTLA-TIGYMAP 829
                  T G+   
Sbjct: 241 IFTAKCETSGFQCV 254

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 98.6 bits (246), Expect = 2e-22
 Identities = 40/181 (22%), Positives = 83/181 (45%), Gaps = 21/181 (11%)

Query: 667 IGTGGFGSVYKGSFLDG----MEVAIKVFH--LQLEGALKSFDVECEVLKSVRHRNLVKI 720
           +G G FGSV +          ++VA+K+    +     ++ F  E   +K   H ++ K+
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 721 ISSCTNNDFKA------LVLEYMPNGSLEDYL-----YSNNFSFDILQRLSVIIDVALAL 769
           +     +  K       ++L +M +G L  +L       N F+  +   +  ++D+A  +
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150

Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL-SGEESMKQTLTLATIGYMA 828
           EYL    S   +H D+   N +L +DM   ++DFG+++ + SG+   +   +   + ++A
Sbjct: 151 EYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207

Query: 829 P 829
            
Sbjct: 208 L 208

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 98.6 bits (246), Expect = 2e-22
 Identities = 46/170 (27%), Positives = 72/170 (42%), Gaps = 19/170 (11%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGA---LKSFDVECEVLKSVRHRNLVKIIS 722
           IG G FG+VY    +     VAIK      + +    +    E   L+ +RH N ++   
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVH 782
                    LV+EY   GS  D L  +      ++  +V       L YLH   S+ ++H
Sbjct: 122 CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIH 177

Query: 783 CDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIG---YMAP 829
            D+K  N+LL +  +  L DFG A +++   S         +G   +MAP
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSASIMAPANSF--------VGTPYWMAP 219

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 47/188 (25%), Positives = 81/188 (43%), Gaps = 37/188 (19%)

Query: 661 FNASNLIGTGGFGSVY----KGSFLDGMEVAIKVFHLQLEGALKSFDVEC-----EVLKS 711
           F    ++G G F +V       +     E AIK+  L+    +K   V       +V+  
Sbjct: 32  FKFGKILGEGSFSTVVLARELAT---SREYAIKI--LEKRHIIKENKVPYVTRERDVMSR 86

Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIID------- 764
           + H   VK+  +  +++     L Y  NG L             ++++    +       
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL----------LKYIRKIGSFDETCTRFYT 136

Query: 765 --VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL- 821
             +  ALEYLH      ++H D+KP N+LL++DM   ++DFG AK+LS E    +  +  
Sbjct: 137 AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 193

Query: 822 ATIGYMAP 829
            T  Y++P
Sbjct: 194 GTAQYVSP 201

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 97.6 bits (244), Expect = 2e-22
 Identities = 50/178 (28%), Positives = 79/178 (44%), Gaps = 31/178 (17%)

Query: 666 LIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           ++G+G F  V+       G   A+K           S + E  VLK ++H N+V +    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFD-ILQRLS--------VIIDVALALEYLHFG 775
            +     LV++ +  G L          FD IL+R          VI  V  A++YLH  
Sbjct: 76  ESTTHYYLVMQLVSGGEL----------FDRILERGVYTEKDASLVIQQVLSAVKYLH-- 123

Query: 776 YSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
             N +VH D+KP N+L    +++    ++DFG++K+      M    T   T GY+AP
Sbjct: 124 -ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-NGIMS---TACGTPGYVAP 176

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 98.5 bits (245), Expect = 3e-22
 Identities = 29/239 (12%), Positives = 73/239 (30%), Gaps = 45/239 (18%)

Query: 627 QEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKG-SFLDGME 685
             ++A  S + +++       R    EL +         ++G     +  +      G  
Sbjct: 42  YMQSAADSLVSTSLWNTGQPFRVE-SELGERPRTLVRGTVLGQEDPYAYLEATDQETGES 100

Query: 686 VAIKVFHLQLEGALKS----------------------------FDVECEVLKSVRHRNL 717
             + V +        +                            F    +++K  + + +
Sbjct: 101 FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKM 160

Query: 718 VKIISSCTNNDFKALVLEYM-PNGSLEDYL------YSNNFSFDILQRLSVIIDVALALE 770
           +++     +    +    Y     +L+ +        S + S     RL + + V   L 
Sbjct: 161 IRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLA 220

Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            LH      +VH  ++P +++LD+     L+ F             + ++  + G+  P
Sbjct: 221 SLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVSRGFEPP 271

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 97.4 bits (243), Expect = 3e-22
 Identities = 53/204 (25%), Positives = 82/204 (40%), Gaps = 20/204 (9%)

Query: 638 SNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLE 696
           ++  P  +        L      F    L+G G +G VYKG  +  G   AIKV  +   
Sbjct: 3   ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-G 61

Query: 697 GALKSFDVECEVLKSV-RHRNLVK-----IISSCTNNDFKA-LVLEYMPNGSLED-YLYS 748
              +    E  +LK    HRN+       I  +    D +  LV+E+   GS+ D    +
Sbjct: 62  DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT 121

Query: 749 NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL 808
              +        +  ++   L +LH    + V+H DIK  NVLL ++    L DFG++  
Sbjct: 122 KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178

Query: 809 LSGEESMKQTLTLATIG---YMAP 829
           L      + T     IG   +MAP
Sbjct: 179 LDRTVGRRNTF----IGTPYWMAP 198

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 98.4 bits (245), Expect = 4e-22
 Identities = 31/172 (18%), Positives = 64/172 (37%), Gaps = 13/172 (7%)

Query: 668 GTGGFGSVYKGSFLD-GMEVAIKVFHL--QLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
           G     +V    +   G  V ++  +L       +     E  V K   H N+V   ++ 
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 725 TNNDFKALVLEYMPNGSLEDYL-YSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
             ++   +V  +M  GS +D +        + L    ++  V  AL+Y+H       VH 
Sbjct: 96  IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHR 152

Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT---IG---YMAP 829
            +K S++L+  D   +LS       +      ++ +       +    +++P
Sbjct: 153 SVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 99.0 bits (246), Expect = 4e-22
 Identities = 29/239 (12%), Positives = 68/239 (28%), Gaps = 40/239 (16%)

Query: 627 QEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKG-SFLDGME 685
             ++A  S + +++       R    EL +         ++G     +  +      G  
Sbjct: 47  YMQSAADSLVSTSLWNTGQPFRVE-SELGERPRTLVRGTVLGQEDPYAYLEATDQETGES 105

Query: 686 VAIKVFHLQLEGALKS----------------------------FDVECEVLKSVRHRNL 717
             + V +        +                            F    +++K  + + +
Sbjct: 106 FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKM 165

Query: 718 VKIISSCTNNDFKALVLEYM-PNGSLEDYL------YSNNFSFDILQRLSVIIDVALALE 770
           +++     +    +    Y     +L+ +        S + S     RL + + V   L 
Sbjct: 166 IRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLA 225

Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            LH      +VH  ++P +++LD+     L+ F                  A     A 
Sbjct: 226 SLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAE 281

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 98.2 bits (245), Expect = 8e-22
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 42/217 (19%)

Query: 641 LPQATRRRFSYKELLQATNQFNASNL---------IGTGGFGSVYKG-SFLDGMEVAIKV 690
           L  +  + F + +L           L         +G+G  G V          +VAI++
Sbjct: 108 LSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRI 167

Query: 691 FH---LQLEGALKSFDV-----ECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSL 742
                  +  A ++        E E+LK + H  ++KI +     D+  +VLE M  G L
Sbjct: 168 ISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGEL 226

Query: 743 EDYLYSNNFSFDILQRLS------VIIDVALALEYLHFGYSNPVVHCDIKPSNVLL---D 793
            D +  N       +RL           + LA++YLH    N ++H D+KP NVLL   +
Sbjct: 227 FDKVVGN-------KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQE 276

Query: 794 KDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
           +D +  ++DFG +K+L     M+   TL  T  Y+AP
Sbjct: 277 EDCLIKITDFGHSKILGETSLMR---TLCGTPTYLAP 310

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 95.9 bits (239), Expect = 1e-21
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 20/178 (11%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV---ECEVLKSVRHRNLVKIIS 722
           IG+G    V          +VAIK   + LE    S D    E + +    H N+V   +
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKR--INLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRL-------SVIIDVALALEYLHFG 775
           S    D   LV++ +  GS+ D +       +    +       +++ +V   LEYLH  
Sbjct: 81  SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH-- 138

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLAT-IG---YMAP 829
             N  +H D+K  N+LL +D    ++DFG++  L+    + +     T +G   +MAP
Sbjct: 139 -KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 97.0 bits (241), Expect = 1e-21
 Identities = 30/241 (12%), Positives = 60/241 (24%), Gaps = 43/241 (17%)

Query: 624 SRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLD- 682
              +E  A    + + + PQ          L Q   +      +  G    V+    ++ 
Sbjct: 28  EALKEPAAMVEAVTATVWPQNAETTVD-SLLSQGERKLKLVEPLRVGDRSVVFLVRDVER 86

Query: 683 GMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKIISSC--------------- 724
             + A+KVF          L+           +   +  +                    
Sbjct: 87  LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146

Query: 725 -------TNNDFKA----LVLEYM-----PNGSLEDYLYSNNFSFDILQRLSVIIDVALA 768
                    +D+      L++           S  D++Y       IL    +   +   
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206

Query: 769 LEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA 828
              L    S  +VH    P N+ +  D    L D         +   +   +   + Y  
Sbjct: 207 AANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW----KVGTRGPASSVPVTYAP 259

Query: 829 P 829
            
Sbjct: 260 R 260

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 46/182 (25%), Positives = 77/182 (42%), Gaps = 25/182 (13%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVF---HLQLEGALKSFDVECEVLKSVRH 714
           + F+    +G G FG+VY          +A+KV     L+ EG       E E+   +RH
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLS------VIIDVALA 768
            N++++ +   +     L+LE+ P G L   L  +        R         + ++A A
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-------GRFDEQRSATFMEELADA 126

Query: 769 LEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYM 827
           L Y H      V+H DIKP N+L+       ++DFG +          +  T+  T+ Y+
Sbjct: 127 LHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL----RRRTMCGTLDYL 179

Query: 828 AP 829
            P
Sbjct: 180 PP 181

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 96.0 bits (239), Expect = 2e-21
 Identities = 37/197 (18%), Positives = 72/197 (36%), Gaps = 34/197 (17%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFH-----------------LQLEGALKS 701
           N +     +  G F  +      D    A+K +                  + ++     
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 702 FDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLS 760
           F  E +++  +++   +      TN D   ++ EYM N S+  +         +    + 
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 761 ------VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                 +I  V  +  Y+H      + H D+KPSN+L+DK+    LSDFG ++ +   + 
Sbjct: 150 IQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM--VDK 205

Query: 815 MKQTL--TLATIGYMAP 829
             +    T     +M P
Sbjct: 206 KIKGSRGTYE---FMPP 219

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 98.6 bits (245), Expect = 2e-21
 Identities = 54/252 (21%), Positives = 101/252 (40%), Gaps = 19/252 (7%)

Query: 296 LKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNEL 355
           +      + PI  + P      +    +  +   S+   +      L ++ ++    ++ 
Sbjct: 1   MGETITVSTPIKQIFP--DDAFA-ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD- 54

Query: 356 IGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLT 415
           I S+      L N+  L L  NKL   I   L  L  L  L++D NK+   +   + DL 
Sbjct: 55  IKSVQ-GIQYLPNVTKLFLNGNKLTD-IKP-LTNLKNLGWLFLDENKIKD-LSS-LKDLK 109

Query: 416 SLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNL 475
            L+ LSL  N ++ +      +L  + SL   +N +  +    +  L  +  + L  N +
Sbjct: 110 KLKSLSLEHNGISDING--LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQI 165

Query: 476 SGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLL 535
           S DI   + GL  LQ+L L  N +  S  +++ GL +L+ L+L +             L+
Sbjct: 166 S-DIV-PLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLV 221

Query: 536 YLKDLNLSFNKL 547
               +  +   L
Sbjct: 222 VPNTVKNTDGSL 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 96.7 bits (240), Expect = 6e-21
 Identities = 59/332 (17%), Positives = 109/332 (32%), Gaps = 55/332 (16%)

Query: 119 KELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNK 178
            E I +S       +  P             L   ++T  +      L +++ +    + 
Sbjct: 2   GETITVS---TPIKQIFP--DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSD 54

Query: 179 LVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIF 238
           +      S+  +                         LPN+  + L GN  + I P  + 
Sbjct: 55  I-----KSVQGIQY-----------------------LPNVTKLFLNGNKLTDIKP--LT 84

Query: 239 NASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKL 298
           N   L  L L EN         L +L+KL+ L L +N ++     ++ L    +   L+ 
Sbjct: 85  NLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGISD----INGLV---HLPQLES 135

Query: 299 LDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGS 358
           L L NN I  +  + +  L+  L  + + +  I   I   +  L  L+ L L  N  I  
Sbjct: 136 LYLGNNKITDI--TVLSRLT-KLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNH-ISD 189

Query: 359 IPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLR 418
           +      L+NL  L+L + +      N    L   + +      L    P  I D     
Sbjct: 190 LR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYE 246

Query: 419 LLSLASNELNSVIPSTFWNLKDILSLNFSSNF 450
             ++  +        +F   + +      + F
Sbjct: 247 KPNVKWHLPEFTNEVSFIFYQPVTIGKAKARF 278

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 96.3 bits (239), Expect = 1e-20
 Identities = 58/288 (20%), Positives = 93/288 (32%), Gaps = 56/288 (19%)

Query: 100 LYMSNNKLT--GPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTG 157
               +  +    P         E I  +L     T+ +      L S+  +    +++  
Sbjct: 4   TITVSTPIKQIFPDDA----FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK- 56

Query: 158 EIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSID-LVRL 216
            +   +  L N+  L L  NKL    P  + NL  +  L L  N +       +  L  L
Sbjct: 57  SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-----DLSSLKDL 108

Query: 217 PNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNF 276
             L+ +SL  N  S I  + + +  +L  L LG N  +      L  L KL+ L L  N 
Sbjct: 109 KKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQ 164

Query: 277 LTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIP 336
           ++        +   A    L+ L LS N I     S +  L+                  
Sbjct: 165 ISD-------IVPLAGLTKLQNLYLSKNHI-----SDLRALA------------------ 194

Query: 337 KEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIP 384
                L NL  L L+  E +         L     +   +  L  P  
Sbjct: 195 ----GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI 238

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 95.6 bits (237), Expect = 2e-20
 Identities = 54/309 (17%), Positives = 110/309 (35%), Gaps = 53/309 (17%)

Query: 241 SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLD 300
           ++     L + S +  +      L  ++ +  + + + S    +  +       N+  L 
Sbjct: 21  AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS----VQGIQ---YLPNVTKLF 71

Query: 301 LSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIP 360
           L+ N +     + I  L+                      NL NL  L L  N+ I  + 
Sbjct: 72  LNGNKL-----TDIKPLT----------------------NLKNLGWLFLDENK-IKDLS 103

Query: 361 ITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLL 420
            +   L+ L+ L L +N +     NGL  L +L  LY+  NK++      +  LT L  L
Sbjct: 104 -SLKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTL 158

Query: 421 SLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIP 480
           SL  N+++ +       L  + +L  S N +  S    +  LK + +++L          
Sbjct: 159 SLEDNQISDI--VPLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPI 214

Query: 481 TAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDL 540
                L+    +   D  L      S       +  D    ++  ++P    ++ ++   
Sbjct: 215 NHQSNLVVPNTVKNTDGSLVTPEIIS-------DDGDYEKPNVKWHLPEFTNEVSFIFYQ 267

Query: 541 NLSFNKLEG 549
            ++  K + 
Sbjct: 268 PVTIGKAKA 276

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 93.2 bits (231), Expect = 8e-20
 Identities = 57/258 (22%), Positives = 105/258 (40%), Gaps = 19/258 (7%)

Query: 291 ANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGL 350
                    +L    +      +   L+ S+ +I  +N  I     + I  L N+ +L L
Sbjct: 18  DAFAETIKDNLKKKSVTDA--VTQNELN-SIDQIIANNSDI--KSVQGIQYLPNVTKLFL 72

Query: 351 WGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPC 410
            GN+ +  I      L+NL  L L  NK++  + + L  L +L  L ++ N +S  I   
Sbjct: 73  NGNK-LTDIK-PLTNLKNLGWLFLDENKIKD-LSS-LKDLKKLKSLSLEHNGISD-ING- 126

Query: 411 IGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDL 470
           +  L  L  L L +N++  +  +    L  + +L+   N +  S    +  L  +  + L
Sbjct: 127 LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYL 182

Query: 471 SRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTS 530
           S+N++S D+  A+ GL NL  L L               LV   ++  ++ SL    P  
Sbjct: 183 SKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEI 238

Query: 531 MEKLLYLKDLNLSFNKLE 548
           +      +  N+ ++  E
Sbjct: 239 ISDDGDYEKPNVKWHLPE 256

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 81.3 bits (200), Expect = 4e-16
 Identities = 61/323 (18%), Positives = 112/323 (34%), Gaps = 47/323 (14%)

Query: 19  NLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFS 78
                 K  L    +   + Q    L  ++ +   N+ +      ++  +          
Sbjct: 19  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI-----KSVQGIQY-------- 63

Query: 79  NNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRG 138
                          LP +  L+++ NKLT  I   +   K L  + L  N+  + +   
Sbjct: 64  ---------------LPNVTKLFLNGNKLTD-IK-PLTNLKNLGWLFLDENKIKD-LS-S 104

Query: 139 LGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLAL 198
           L +L  LK+L L  N ++ +I   + +L  LE L L  NK+     T +  L+ + TL+L
Sbjct: 105 LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSL 160

Query: 199 PSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIP 258
             N +S  +     L  L  L+ + L+ N+ S +    +     L VLEL          
Sbjct: 161 EDNQIS-DIVP---LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPI 214

Query: 259 NTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPIN--GVLPSSIGN 316
           N   NL     ++ +   L +    +S    +        L    N ++     P +IG 
Sbjct: 215 NHQSNLVVPNTVKNTDGSLVTPEI-ISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGK 273

Query: 317 LSLSLSRIFISNCSIRGTIPKEI 339
                            T+  ++
Sbjct: 274 AKARFHGRVTQPLKEVYTVSYDV 296

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 65.5 bits (159), Expect = 4e-11
 Identities = 56/267 (20%), Positives = 104/267 (38%), Gaps = 25/267 (9%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           +  + +D+     + I  L  + KL L  NKL  +I + L NL  L  + L  N +    
Sbjct: 48  IIANNSDIKSV--QGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKI---- 99

Query: 62  PSTIFNLSSLS--TGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCK 119
              + +L  L     +   +N ++  +       LP ++ LY+ NNK+T      + +  
Sbjct: 100 -KDLSSLKDLKKLKSLSLEHNGIS-DING--LVHLPQLESLYLGNNKIT--DITVLSRLT 153

Query: 120 ELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKL 179
           +L  +SL  NQ ++ I   L  LT L+ LYL  N+++ ++   +  L+NL++L L   + 
Sbjct: 154 KLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQEC 209

Query: 180 VGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFN 239
           +        NL    T+     +L      S D        +      +         F 
Sbjct: 210 LNKPINHQSNLVVPNTVKNTDGSLVTPEIIS-DDGDYEKPNVK----WHLPEFTNEVSFI 264

Query: 240 ASKLSVLELGENSFSGFIPNTLGNLRK 266
             +   +   +  F G +   L  +  
Sbjct: 265 FYQPVTIGKAKARFHGRVTQPLKEVYT 291

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 64.7 bits (157), Expect = 7e-11
 Identities = 45/193 (23%), Positives = 76/193 (39%), Gaps = 22/193 (11%)

Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
            L L+ N L+   P  + NL  L  L L  NK++ ++   L +L +L+ +SL +N +S  
Sbjct: 69  KLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-- 122

Query: 61  IPSTIFNLSSLS--TGMDFSNNSLTGSLPDDMC--RRLPLIKGLYMSNNKLTGPIPNNIW 116
               I  L  L     +   NN +T     D+    RL  +  L + +N+++  I   + 
Sbjct: 123 ---DINGLVHLPQLESLYLGNNKIT-----DITVLSRLTKLDTLSLEDNQISD-IVP-LA 172

Query: 117 QCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQL 176
              +L  + L+ N  ++   R L  L +L  L L       +      NL     +    
Sbjct: 173 GLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTD 230

Query: 177 NKLVGFVPTSIFN 189
             LV     S   
Sbjct: 231 GSLVTPEIISDDG 243

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 55/191 (28%), Positives = 89/191 (46%), Gaps = 33/191 (17%)

Query: 658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFH---LQLEGALKSFDV-----ECEV 708
            +++  S  +G+G  G V          +VAIK+       +  A ++        E E+
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 709 LKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLS------VI 762
           LK + H  ++KI +     D+  +VLE M  G L D +  N       +RL         
Sbjct: 69  LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGN-------KRLKEATCKLYF 120

Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTL 819
             + LA++YLH    N ++H D+KP NVLL   ++D +  ++DFG +K+L     M+   
Sbjct: 121 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--- 174

Query: 820 TLA-TIGYMAP 829
           TL  T  Y+AP
Sbjct: 175 TLCGTPTYLAP 185

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 93.0 bits (232), Expect = 5e-21
 Identities = 46/181 (25%), Positives = 78/181 (43%), Gaps = 36/181 (19%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV-----ECEVLKSVRHRNLVKI 720
           +G G F  V +      G+E A K+ + +    L + D      E  + + ++H N+V++
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTK---KLSARDFQKLEREARICRKLQHPNIVRL 70

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD-ILQRLS--------VIIDVALALEY 771
             S     F  LV + +  G L          F+ I+ R           I  +  ++ Y
Sbjct: 71  HDSIQEESFHYLVFDLVTGGEL----------FEDIVAREFYSEADASHCIQQILESIAY 120

Query: 772 LHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA 828
            H   SN +VH ++KP N+LL    K     L+DFG+A  ++  E+        T GY++
Sbjct: 121 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPGYLS 175

Query: 829 P 829
           P
Sbjct: 176 P 176

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 94.5 bits (235), Expect = 5e-21
 Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 10/166 (6%)

Query: 667 IGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSC 724
           +G G  G V+K S    G+ +A K+ HL++          E +VL       +V    + 
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100

Query: 725 TNNDFKALVLEYMPNGSLED-YLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
            ++   ++ +E+M  GSL+     +      IL ++S+   V   L YL   +   ++H 
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLREKHK--IMHR 156

Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D+KPSN+L++      L DFG++  L   +SM  +    T  YM+P
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSP 199

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 92.7 bits (231), Expect = 8e-21
 Identities = 50/203 (24%), Positives = 84/203 (41%), Gaps = 32/203 (15%)

Query: 642 PQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFH-LQLEGA- 698
             + R    ++       ++N   ++G G FG V K        E A+KV +    +   
Sbjct: 7   HSSGRENLYFQGTF--AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64

Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD-ILQ 757
             +   E E+LK + H N++K+     ++    +V E    G L          FD I++
Sbjct: 65  TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----------FDEIIK 114

Query: 758 R--------LSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIA 806
           R          +I  V   + Y+H    + +VH D+KP N+LL   +KD    + DFG++
Sbjct: 115 RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171

Query: 807 KLLSGEESMKQTLTLATIGYMAP 829
                   MK    + T  Y+AP
Sbjct: 172 TCFQQNTKMKD--RIGTAYYIAP 192

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 92.8 bits (231), Expect = 9e-21
 Identities = 50/312 (16%), Positives = 124/312 (39%), Gaps = 31/312 (9%)

Query: 239 NASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKL 298
             +    +  G+++ +  +     +L  +  L      +T+       +       NL  
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-------IEGVQYLNNLIG 67

Query: 299 LDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGS 358
           L+L +N I  +  + + NL+  ++ + +S   +       I  L +++ L L   ++   
Sbjct: 68  LELKDNQITDL--APLKNLT-KITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDV 122

Query: 359 IPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLR 418
            P     L NLQ L L  N++    P  L  L  L  L +   ++S  + P + +L+ L 
Sbjct: 123 TP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLT 176

Query: 419 LLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGD 478
            L    N+++ +  S   +L +++ ++  +N ++   P  + N   + I+ L+   ++  
Sbjct: 177 TLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ 232

Query: 479 IPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLK 538
                  L+      ++        P +I      ++   ++ +L+ N+ + +  + Y  
Sbjct: 233 PVFYNNNLVVP--NVVKGPSGAPIAPATI-----SDNGTYASPNLTWNLTSFINNVSYTF 285

Query: 539 DLNLSFNKLEGE 550
           + +++F      
Sbjct: 286 NQSVTFKNTTVP 297

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 42/269 (15%), Positives = 104/269 (38%), Gaps = 19/269 (7%)

Query: 279 SSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKE 338
           +  + ++ +       N   +    + +      +  +L   ++ +      +  T  + 
Sbjct: 4   TQPTAINVIFPDPALANAIKIAAGKSNVTDT--VTQADLD-GITTLSAFGTGV--TTIEG 58

Query: 339 IGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYM 398
           +  L NL  L L  N+ I  +      L  +  L+L  N L+    + +  L  +  L +
Sbjct: 59  VQYLNNLIGLELKDNQ-ITDLA-PLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDL 114

Query: 399 DGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPED 458
              +++   P  +  L++L++L L  N++ ++ P     L ++  L+  +  ++      
Sbjct: 115 TSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDL--TP 168

Query: 459 IGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDL 518
           + NL  +  +    N +S DI   +  L NL ++ L++N +    P  +    +L  + L
Sbjct: 169 LANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

Query: 519 SNNSLSGNIPTSMEKLLYLKDLNLSFNKL 547
           +N +++         L+    +       
Sbjct: 225 TNQTITNQPVFYNNNLVVPNVVKGPSGAP 253

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 69/311 (22%), Positives = 120/311 (38%), Gaps = 33/311 (10%)

Query: 63  STIFNLSSLS--TGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
           + IF   +L+    +    +++T ++       L  I  L      +T      +     
Sbjct: 10  NVIFPDPALANAIKIAAGKSNVTDTVT---QADLDGITTLSAFGTGVTTI--EGVQYLNN 64

Query: 121 LIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLV 180
           LI + L  NQ T+  P  L NLT +  L L  N L   +   +  L++++ L L   ++ 
Sbjct: 65  LIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQIT 120

Query: 181 GFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNA 240
              P +   LS ++ L L  N ++    +   L  L NL+ +S+     S +  + + N 
Sbjct: 121 DVTPLA--GLSNLQVLYLDLNQIT----NISPLAGLTNLQYLSIGNAQVSDL--TPLANL 172

Query: 241 SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLD 300
           SKL+ L+  +N  S   P  L +L  L  + L  N ++        +S  AN  NL ++ 
Sbjct: 173 SKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD-------VSPLANTSNLFIVT 223

Query: 301 LSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGN--ELIGS 358
           L+N  I         NL +      +   S     P  I +        L  N    I +
Sbjct: 224 LTNQTITNQPVFYNNNLVVPNV---VKGPSGAPIAPATISDNGTYASPNLTWNLTSFINN 280

Query: 359 IPITFGKLQNL 369
           +  TF +    
Sbjct: 281 VSYTFNQSVTF 291

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 87.8 bits (218), Expect = 4e-19
 Identities = 53/270 (19%), Positives = 97/270 (35%), Gaps = 26/270 (9%)

Query: 138 GLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLA 197
               L +   +  G +N+T  +     +L  +  L      +       +  L+ +  L 
Sbjct: 14  PDPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLE 69

Query: 198 LPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFI 257
           L  N ++   P    L  L  +  + L+GN    +    I     +  L+L     +   
Sbjct: 70  LKDNQITDLAP----LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVT 123

Query: 258 PNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNL 317
           P  L  L  L+ L L  N +T+       +S  A   NL+ L + N  ++ +  + + NL
Sbjct: 124 P--LAGLSNLQVLYLDLNQITN-------ISPLAGLTNLQYLSIGNAQVSDL--TPLANL 172

Query: 318 SLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNN 377
           S  L+ +   +  I    P  + +L NL E+ L  N++    P+      NL  + L N 
Sbjct: 173 S-KLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPL--ANTSNLFIVTLTNQ 227

Query: 378 KLEGPIPNGLCQLARLSVLYMDGNKLSGPI 407
            +          L   +V+         P 
Sbjct: 228 TITNQPVFYNNNLVVPNVVKGPSGAPIAPA 257

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 54/265 (20%), Positives = 97/265 (36%), Gaps = 26/265 (9%)

Query: 119 KELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNK 178
              I I+   +  T+ +     +L  + TL      +T  I   +  L NL  L L+ N+
Sbjct: 19  ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQ 74

Query: 179 LVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIF 238
           +    P  + NL+ +  L L  N L     +   +  L +++ + L     + + P  + 
Sbjct: 75  ITDLAP--LKNLTKITELELSGNPLK----NVSAIAGLQSIKTLDLTSTQITDVTP--LA 126

Query: 239 NASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKL 298
             S L VL L  N  +   P  L  L  L++L +    ++        L+  AN   L  
Sbjct: 127 GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-------LTPLANLSKLTT 177

Query: 299 LDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGS 358
           L   +N I+ +  S + +L  +L  + + N  I    P  + N  NL  + L    +   
Sbjct: 178 LKADDNKISDI--SPLASLP-NLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ 232

Query: 359 IPITFGKLQNLQGLDLVNNKLEGPI 383
                  L     +   +     P 
Sbjct: 233 PVFYNNNLVVPNVVKGPSGAPIAPA 257

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 73.6 bits (181), Expect = 3e-14
 Identities = 59/285 (20%), Positives = 116/285 (40%), Gaps = 25/285 (8%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           ++   ++++  +     +L  +  L      +     + +  L  L  + L +N ++   
Sbjct: 24  IAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDNQITDLA 79

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
           P  + NL+ ++  ++ S N L           L  IK L +++ ++T      +     L
Sbjct: 80  P--LKNLTKITE-LELSGNPLKNVSAIA---GLQSIKTLDLTSTQITD--VTPLAGLSNL 131

Query: 122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVG 181
            V+ L  NQ T  I   L  LT+L+ L +G   ++   P  + NL  L  L    NK+  
Sbjct: 132 QVLYLDLNQITN-IS-PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD 187

Query: 182 FVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNAS 241
             P  + +L  +  + L +N +S   P    L    NL I++L     +     +  N  
Sbjct: 188 ISP--LASLPNLIEVHLKNNQISDVSP----LANTSNLFIVTLTNQTITNQPVFYNNNLV 241

Query: 242 KLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSF 286
             +V++    S +   P T+ +        L++N LTS  + +S+
Sbjct: 242 VPNVVKG--PSGAPIAPATISDNGTYASPNLTWN-LTSFINNVSY 283

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 65/232 (28%), Positives = 101/232 (43%), Gaps = 31/232 (13%)

Query: 295 NLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEI-GNLINLRELGLWGN 353
           + K LDLS NP+  +   S  +    L  + +S C I+ TI      +L +L  L L GN
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFP-ELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86

Query: 354 ELIGSIPI-TFGKLQNLQGLDLVNNKLEGPIPNGL-CQLARLSVLYMDGNKL-SGPIPPC 410
            +  S+ +  F  L +LQ L  V   L   + N     L  L  L +  N + S  +P  
Sbjct: 87  PIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 411 IGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDL 470
             +LT+L  L L+SN++ S+  +    L  +  LN S                    +DL
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS--------------------LDL 184

Query: 471 SRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI-GGLVSLESLDLSNN 521
           S N ++  I       + L++L+L  N L+ S+P  I   L SL+ + L  N
Sbjct: 185 SLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 89.6 bits (223), Expect = 8e-20
 Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 22/226 (9%)

Query: 233 IPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWA- 291
           IP  +  ++K   L+L  N        +  +  +L+ L LS   + +       +   A 
Sbjct: 22  IPDNLPFSTK--NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-------IEDGAY 72

Query: 292 -NCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGL 350
            +  +L  L L+ NPI  +   +   LS SL ++     ++       IG+L  L+EL +
Sbjct: 73  QSLSHLSTLILTGNPIQSLALGAFSGLS-SLQKLVAVETNLASLENFPIGHLKTLKELNV 131

Query: 351 WGNELIGSIPI--TFGKLQNLQGLDLVNNKLEGPIPNG----LCQLARLSV-LYMDGNKL 403
             N LI S  +   F  L NL+ LDL +NK++  I       L Q+  L++ L +  N +
Sbjct: 132 AHN-LIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLNPM 189

Query: 404 SGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSN 449
           +  I P       L+ L+L +N+L SV    F  L  +  +   +N
Sbjct: 190 NF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 59/237 (24%), Positives = 90/237 (37%), Gaps = 41/237 (17%)

Query: 328 NCSIRG--TIPKEIGNLINLRELGLWGNELIGSIPIT-FGKLQNLQGLDLVNNKLEGPIP 384
            C       IP  +    + + L L  N  +  +    F     LQ LDL   +++  I 
Sbjct: 13  QCMELNFYKIPDNL--PFSTKNLDLSFN-PLRHLGSYSFFSFPELQVLDLSRCEIQT-IE 68

Query: 385 NGLC-QLARLSVLYMDGNKLSGPIPPCI-GDLTSLRLLSLASNELNSVIPSTFWNLKDIL 442
           +G    L+ LS L + GN +   +       L+SL+ L      L S+      +LK + 
Sbjct: 69  DGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127

Query: 443 SLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGS 502
            LN + N +  S                         P     L NL+ L L  N +Q S
Sbjct: 128 ELNVAHNLIQ-SFKL----------------------PEYFSNLTNLEHLDLSSNKIQ-S 163

Query: 503 IPKSI-GGLVSLE----SLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRG 554
           I  +    L  +     SLDLS N ++  I     K + LK+L L  N+L+  +P G
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDG 218

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 81.9 bits (203), Expect = 3e-17
 Identities = 65/251 (25%), Positives = 92/251 (36%), Gaps = 46/251 (18%)

Query: 183 VPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASK 242
           +P ++    + K L L  N L   L S       P L+++ L+      I      + S 
Sbjct: 22  IPDNLP--FSTKNLDLSFNPLR-HLGSY-SFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77

Query: 243 LSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWA--NCKNLKLLD 300
           LS L L  N            L  L+ L      L S       L ++   + K LK L+
Sbjct: 78  LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS-------LENFPIGHLKTLKELN 130

Query: 301 LSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIP 360
           +++N I           S  L   F               NL NL  L L  N+ I SI 
Sbjct: 131 VAHNLIQ----------SFKLPEYFS--------------NLTNLEHLDLSSNK-IQSIY 165

Query: 361 I-TFGKLQNLQG----LDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGD-L 414
                 L  +      LDL  N +   I  G  +  RL  L +D N+L   +P  I D L
Sbjct: 166 CTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLKS-VPDGIFDRL 223

Query: 415 TSLRLLSLASN 425
           TSL+ + L +N
Sbjct: 224 TSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 57/232 (24%), Positives = 89/232 (38%), Gaps = 36/232 (15%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L LSFN L         +   L+ L L   +++        +L+ L  + LT N +  ++
Sbjct: 33  LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SL 91

Query: 62  PSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
               F  LSSL   +     +L  SL +     L  +K L +++N +             
Sbjct: 92  ALGAFSGLSSL-QKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEY----- 144

Query: 121 LIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEM-GNLRNLEILGLQL--- 176
                     F+        NLT+L+ L L  N +   I       L  + +L L L   
Sbjct: 145 ----------FS--------NLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLS 185

Query: 177 -NKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGN 227
            N +  F+    F    +K LAL +N L  S+P  I   RL +L+ I L  N
Sbjct: 186 LNPM-NFIQPGAFKEIRLKELALDTNQLK-SVPDGI-FDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 75.4 bits (186), Expect = 5e-15
 Identities = 50/230 (21%), Positives = 85/230 (36%), Gaps = 15/230 (6%)

Query: 103 SNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYE 162
                   IP+N+        + L++N           +   L+ L L    +   I   
Sbjct: 15  MELNFYK-IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDG 70

Query: 163 M-GNLRNLEILGLQLNKLVGFVPTSIF-NLSAMKTLALPSNALSGSLPSSIDLVRLPNLE 220
              +L +L  L L  N +   +    F  LS+++ L      L+ SL +   +  L  L+
Sbjct: 71  AYQSLSHLSTLILTGNPI-QSLALGAFSGLSSLQKLVAVETNLA-SLENFP-IGHLKTLK 127

Query: 221 IISLAGNNFSGIIPSFIF-NASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTS 279
            +++A N          F N + L  L+L  N         L  L ++  L LS   L  
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS---LDL 184

Query: 280 STSELSFLSSWA-NCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISN 328
           S + ++F+   A     LK L L  N +  V       L+ SL +I++  
Sbjct: 185 SLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLT-SLQKIWLHT 233

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 93.2 bits (232), Expect = 1e-20
 Identities = 45/172 (26%), Positives = 77/172 (44%), Gaps = 16/172 (9%)

Query: 667 IGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEV-LKSVRHRNLVKIISS 723
           IG G +GSV K      G  +A+K     + E   K   ++ +V ++S     +V+   +
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 724 CTNNDFKALVLEYMPNGSLEDYL------YSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
                   + +E M + S + +         +    +IL ++++      AL +L     
Sbjct: 90  LFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITL--ATVKALNHLKENLK 146

Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             ++H DIKPSN+LLD+     L DFGI+  L   +S+ +T       YMAP
Sbjct: 147 --IIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDAGCRPYMAP 194

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 92.3 bits (229), Expect = 2e-20
 Identities = 49/279 (17%), Positives = 95/279 (34%), Gaps = 17/279 (6%)

Query: 139 LGNLTSLKTLYLGFNNLTGEIPY----EMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMK 194
            G   SL+ L    +       +    +  +L+ L +   ++   + F    +  +S ++
Sbjct: 39  YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98

Query: 195 TLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPS----FIFNASKLSVLELGE 250
            L L +  ++G+ P  +     P+L I++L   +++           +    L VL + +
Sbjct: 99  ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158

Query: 251 NSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTS--ELSFLSSWANCKNLKLLDLSNNPING 308
                F    +     L  L LS N                +   + L L +      +G
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSG 218

Query: 309 VLPSSIGNLSLSLSRIFISNCSIRGTIPKEI-GNLINLRELGLWGNELIGSIPITFGKLQ 367
           V  +        L  + +S+ S+R             L  L L    L     +  G   
Sbjct: 219 VCSALAAARV-QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ---VPKGLPA 274

Query: 368 NLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGP 406
            L  LDL  N+L+   P+   +L ++  L + GN     
Sbjct: 275 KLSVLDLSYNRLDR-NPSPD-ELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 91.5 bits (227), Expect = 3e-20
 Identities = 57/277 (20%), Positives = 96/277 (34%), Gaps = 22/277 (7%)

Query: 290 WANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLIN---LR 346
           +   ++L+ L    +    +   +    SLSL R+ +    I   I      ++    L+
Sbjct: 39  YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98

Query: 347 ELGLWGNELIGSIPITFGKLQ--NLQGLDLVNNKLEGPIPN----GLCQLARLSVLYMDG 400
           EL L   E+ G+ P    +    +L  L+L N                    L VL +  
Sbjct: 99  ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158

Query: 401 NKLSGPIPPCIGDLTSLRLLSLASNEL-------NSVIPSTFWNLKDILSLNFSSNFLNG 453
                     +    +L  L L+ N         +++ P  F  L+ +   N      +G
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSG 218

Query: 454 SLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLM-NLQDLSLRDNGLQGSIPKSIGGLVS 512
                      +  +DLS N+L              L  L+L   GL+  +PK +     
Sbjct: 219 VCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAK 275

Query: 513 LESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEG 549
           L  LDLS N L    P S ++L  + +L+L  N    
Sbjct: 276 LSVLDLSYNRLDR-NP-SPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 84.6 bits (209), Expect = 6e-18
 Identities = 48/252 (19%), Positives = 77/252 (30%), Gaps = 16/252 (6%)

Query: 237 IFNASKLSVLELGENSFSGFIPNT---LGNLRKLEWLRLSYNFLTSSTSELSFLSSWANC 293
           I  +  L  L +        I      +  +  L+ L L    +T +       ++  + 
Sbjct: 64  IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDL 123

Query: 294 KNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGN 353
             L L ++S    +  L      L   L  + I+         +++     L  L L  N
Sbjct: 124 NILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDN 183

Query: 354 ELIGSIPIT----FGKLQNLQGLDLVNNKLE---GPIPNGLCQLARLSVLYMDGNKLSGP 406
             +G   +       K   LQ L L N  +E   G          +L  L +  N L   
Sbjct: 184 PELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDA 243

Query: 407 IPPCIGD-LTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVV 465
                 D  + L  L+L+   L  V       L     L+ S N L+   P     L  V
Sbjct: 244 AGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLS---VLDLSYNRLD-RNP-SPDELPQV 298

Query: 466 VIIDLSRNNLSG 477
             + L  N    
Sbjct: 299 GNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 83.0 bits (205), Expect = 2e-17
 Identities = 51/244 (20%), Positives = 87/244 (35%), Gaps = 18/244 (7%)

Query: 328 NCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGL 387
           NC     +    G       L     E          K  +L+ L +   ++   I  G 
Sbjct: 29  NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA 88

Query: 388 CQL---ARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTF------WNL 438
            ++   + L  L ++  +++G  PP + + T   L  L    ++      +      W  
Sbjct: 89  LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLK 148

Query: 439 KDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIP----TAIGGLMNLQDLSL 494
             +  L+ +         E +     +  +DLS N   G+              LQ L+L
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208

Query: 495 RDNGLQ---GSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLY-LKDLNLSFNKLEGE 550
           R+ G++   G         V L+ LDLS+NSL              L  LNLSF  L+ +
Sbjct: 209 RNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-Q 267

Query: 551 IPRG 554
           +P+G
Sbjct: 268 VPKG 271

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 48/279 (17%), Positives = 83/279 (29%), Gaps = 25/279 (8%)

Query: 42  GNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPL--IKG 99
           G  +   L+   +        + I    SL   +      +   +     R L +  ++ 
Sbjct: 41  GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKR-LTVRAARIPSRILFGALRVLGISGLQE 99

Query: 100 LYMSNNKLTGPIPNNIWQCKELIVISLAYNQFT-ERIPRGLGNL-----TSLKTLYLGFN 153
           L + N ++TG  P  + +     +  L     +       L  L       LK L +   
Sbjct: 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQA 159

Query: 154 NLTGEIPYEMGNLRNLEILGLQLNKLVGFVP----TSIFNLSAMKTLALPSNAL-SGSLP 208
           +       ++     L  L L  N  +G               ++ LAL +  + + S  
Sbjct: 160 HSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGV 219

Query: 209 SSIDLVRLPNLEIISLAGNNFSGIIPSFIF-NASKLSVLELGENSFSGFIPNTLGNLRKL 267
            S        L+ + L+ N+      +      S+L+ L L                 KL
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGL---PAKL 276

Query: 268 EWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPI 306
             L LSYN L           S      +  L L  NP 
Sbjct: 277 SVLDLSYNRLDR-------NPSPDELPQVGNLSLKGNPF 308

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 70.3 bits (172), Expect = 3e-13
 Identities = 44/263 (16%), Positives = 78/263 (29%), Gaps = 32/263 (12%)

Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQ---ELGNLAELELVSLTNNFL 57
           +L     +       +I     LK+L +   ++   I      +  ++ L+ ++L N  +
Sbjct: 48  LLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEV 107

Query: 58  SGTIPSTIFNLSSLS-TGMDFSNNSLTG---SLPDDMCRRLPLIKGLYMSNNKLTGPIPN 113
           +GT P  +   +      ++  N S       L +      P +K L ++          
Sbjct: 108 TGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCE 167

Query: 114 NIWQCKELIVISLAYNQFTERI-------PRGLGNLTSLKTLYLGFNNLTGEIPYEMGNL 166
            +     L  + L+ N             P     L  L     G    +G         
Sbjct: 168 QVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAAR 227

Query: 167 RNLEILGLQLNKLVGFVPTSIF-NLSAMKTLALPSNALS---GSLPSSI----------- 211
             L+ L L  N L            S + +L L    L      LP+ +           
Sbjct: 228 VQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVLDLSYNRLD 287

Query: 212 ---DLVRLPNLEIISLAGNNFSG 231
                  LP +  +SL GN F  
Sbjct: 288 RNPSPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 44.5 bits (105), Expect = 7e-05
 Identities = 24/112 (21%), Positives = 37/112 (33%), Gaps = 10/112 (8%)

Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQEL-GNLAELELVSLTNNFLSG 59
           + +      SG           L+ L L +N LR           ++L  ++L+   L  
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK- 266

Query: 60  TIPSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGP 110
            +P  +   LS L    D S N L    P      LP +  L +  N     
Sbjct: 267 QVPKGLPAKLSVL----DLSYNRLD-RNPS--PDELPQVGNLSLKGNPFLDS 311

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 40/183 (21%), Positives = 75/183 (40%), Gaps = 26/183 (14%)

Query: 667 IGTGGFGSVYKGSFLDG------MEVAIKVFHLQLEGA----LKSFDVECEVLKSVRHRN 716
           +G G FG VY+G             VAIK  +   E A       F  E  V+K     +
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHH 89

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYL---------YSNNFSFDILQRLSVIIDVAL 767
           +V+++   +      +++E M  G L+ YL                 + + + +  ++A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL-SGEESMKQTLTLATIGY 826
            + YL+   +N  VH D+   N ++ +D    + DFG+ + +   +   K    L  + +
Sbjct: 150 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206

Query: 827 MAP 829
           M+P
Sbjct: 207 MSP 209

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 93.2 bits (232), Expect = 2e-20
 Identities = 39/211 (18%), Positives = 86/211 (40%), Gaps = 18/211 (8%)

Query: 629 KNAKQSNIESNMLPQATRRRFSYKELLQATNQFNA----SNLIGTGGFGSVY----KGSF 680
           K       + +   +   +++  + +                +G+G FG V+    K + 
Sbjct: 17  KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKAT- 75

Query: 681 LDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNG 740
             G     K  +        +   E  ++  + H  L+ +  +  +     L+LE++  G
Sbjct: 76  --GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 133

Query: 741 SLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHL 800
            L D + + ++     + ++ +      L+++H    + +VH DIKP N++ +    + +
Sbjct: 134 ELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSV 190

Query: 801 --SDFGIAKLLSGEESMKQTLTLATIGYMAP 829
              DFG+A  L+ +E +K   T AT  + AP
Sbjct: 191 KIIDFGLATKLNPDEIVKV--TTATAEFAAP 219

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 93.9 bits (234), Expect = 2e-20
 Identities = 43/181 (23%), Positives = 73/181 (40%), Gaps = 35/181 (19%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV-----ECEVLKSVRHRNLVKI 720
           +G G F  V +   +  G E A  +        L + D      E  + + ++H N+V++
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMII---NTKKLSARDHQKLEREARICRLLKHPNIVRL 75

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD-ILQRLS--------VIIDVALALEY 771
             S +      L+ + +  G L          F+ I+ R           I  +  A+ +
Sbjct: 76  HDSISEEGHHYLIFDLVTGGEL----------FEDIVAREYYSEADASHCIQQILEAVLH 125

Query: 772 LHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA 828
            H      VVH ++KP N+LL    K     L+DFG+A  + GE+         T GY++
Sbjct: 126 CH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF-AGTPGYLS 181

Query: 829 P 829
           P
Sbjct: 182 P 182

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 92.9 bits (231), Expect = 5e-20
 Identities = 46/230 (20%), Positives = 88/230 (38%), Gaps = 41/230 (17%)

Query: 621 AMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVY---- 676
            +   C     ++       L  A       K++      F    +IG G FG V     
Sbjct: 36  CLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKL 95

Query: 677 KGSFLDGMEVAIKVFHLQLEGALKSFDVEC-----EVLKSVRHRNLVKIISSCTNNDFKA 731
           K +       A+K+  L     LK  +  C     +VL +   + +  +  +  +++   
Sbjct: 96  KNA---DKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150

Query: 732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIID----------VALALEYLHFGYSNPVV 781
           LV++Y   G L            +L +    +           + +A++ +H       V
Sbjct: 151 LVMDYYVGGDL----------LTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYV 197

Query: 782 HCDIKPSNVLLDKDMVAH--LSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H DIKP N+L+D +   H  L+DFG    L  + +++ ++ + T  Y++P
Sbjct: 198 HRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 90.4 bits (225), Expect = 5e-20
 Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 21/199 (10%)

Query: 642 PQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSF-LDGMEVAIKVFH-LQLEGAL 699
             + R    ++  +   + F     +G+G FG V+       G+E  IK  +  + +  +
Sbjct: 7   HSSGRENLYFQGTI--DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM 64

Query: 700 KSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRL 759
           +  + E EVLKS+ H N++KI     +     +V+E    G L + + S        + L
Sbjct: 65  EQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQAR---GKAL 121

Query: 760 S------VIIDVALALEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLS 810
           S      ++  +  AL Y H   S  VVH D+KP N+L           + DFG+A+L  
Sbjct: 122 SEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178

Query: 811 GEESMKQTLTLATIGYMAP 829
            +E         T  YMAP
Sbjct: 179 SDEHSTN--AAGTALYMAP 195

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 90.5 bits (225), Expect = 6e-20
 Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 10/167 (5%)

Query: 667 IGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVL-KSVRHRNLVKIISS 723
           +G+G  G V+K  F   G  +A+K       +   K   ++ +V+ KS     +V+   +
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVH 782
              N    + +E M   + +            IL +++V   +  AL YL   +   V+H
Sbjct: 93  FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTV--AIVKALYYLKEKHG--VIH 148

Query: 783 CDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            D+KPSN+LLD+     L DFGI+  L   +   +  +     YMAP
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSAGCAAYMAP 193

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 91.2 bits (227), Expect = 7e-20
 Identities = 46/181 (25%), Positives = 78/181 (43%), Gaps = 36/181 (19%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV-----ECEVLKSVRHRNLVKI 720
           +G G F  V +      G+E A K+ + +    L + D      E  + + ++H N+V++
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTK---KLSARDFQKLEREARICRKLQHPNIVRL 93

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD-ILQRLS--------VIIDVALALEY 771
             S     F  LV + +  G L          F+ I+ R           I  +  ++ Y
Sbjct: 94  HDSIQEESFHYLVFDLVTGGEL----------FEDIVAREFYSEADASHCIQQILESIAY 143

Query: 772 LHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA 828
            H   SN +VH ++KP N+LL    K     L+DFG+A  ++  E+        T GY++
Sbjct: 144 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPGYLS 198

Query: 829 P 829
           P
Sbjct: 199 P 199

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 91.6 bits (228), Expect = 7e-20
 Identities = 47/187 (25%), Positives = 83/187 (44%), Gaps = 34/187 (18%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEV-AIKVFHLQLEGALKSFDVEC-----EVLKSV 712
           + F     IG G FG V      D  ++ A+K   +  +  ++  +V       ++++ +
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKY--MNKQKCVERNEVRNVFKELQIMQGL 72

Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV---------II 763
            H  LV +  S  + +   +V++ +  G L             LQ+            I 
Sbjct: 73  EHPFLVNLWYSFQDEEDMFMVVDLLLGGDL----------RYHLQQNVHFKEETVKLFIC 122

Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA- 822
           ++ +AL+YL    +  ++H D+KP N+LLD+    H++DF IA +L  E       T+A 
Sbjct: 123 ELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAG 176

Query: 823 TIGYMAP 829
           T  YMAP
Sbjct: 177 TKPYMAP 183

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 90.9 bits (226), Expect = 8e-20
 Identities = 52/229 (22%), Positives = 86/229 (37%), Gaps = 46/229 (20%)

Query: 624 SRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNA----SNLIGTGGFGSVYKGS 679
                     S++ ++  P        Y       +  +      + +G G    VY+  
Sbjct: 14  GTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCK 73

Query: 680 FLD-GMEVAIKVFHLQLEGALKSFDV-----ECEVLKSVRHRNLVKIISSCTNNDFKALV 733
                   A+KV         K+ D      E  VL  + H N++K+          +LV
Sbjct: 74  QKGTQKPYALKVL-------KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126

Query: 734 LEYMPNGSLEDYLYSNNFSFD-ILQRLS--------VIIDVALALEYLHFGYSNPVVHCD 784
           LE +  G L          FD I+++           +  +  A+ YLH    N +VH D
Sbjct: 127 LELVTGGEL----------FDRIVEKGYYSERDAADAVKQILEAVAYLH---ENGIVHRD 173

Query: 785 IKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
           +KP N+L      D    ++DFG++K++  +  MK   T+  T GY AP
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK---TVCGTPGYCAP 219

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 92.4 bits (230), Expect = 9e-20
 Identities = 47/190 (24%), Positives = 79/190 (41%), Gaps = 14/190 (7%)

Query: 646 RRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDV 704
           R    ++       ++N   ++G G FG V K        E A+KV +        +  +
Sbjct: 11  RENLYFQGTF--AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI 68

Query: 705 --ECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVI 762
             E E+LK + H N++K+     ++    +V E    G L D +      F       +I
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARII 127

Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLL-DKDMVAHL--SDFGIAKLLSGEESMKQTL 819
             V   + Y+H    + +VH D+KP N+LL  K+    +   DFG++        MK   
Sbjct: 128 KQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD-- 182

Query: 820 TLATIGYMAP 829
            + T  Y+AP
Sbjct: 183 RIGTAYYIAP 192

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 92.5 bits (230), Expect = 1e-19
 Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 12/209 (5%)

Query: 627 QEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL-DGME 685
              ++ + N+      QAT   F   +    +  +     +G+G +G V         +E
Sbjct: 5   HHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE 64

Query: 686 VAIKVFHLQLEGALKSFDV--ECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLE 743
            AIK+          +  +  E  VLK + H N++K+     +     LV+E    G L 
Sbjct: 65  RAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELF 124

Query: 744 DYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL-DKDMVAHL-- 800
           D +      F+ +    +I  V   + YLH    + +VH D+KP N+LL  K+  A +  
Sbjct: 125 DEIIHRM-KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKI 180

Query: 801 SDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            DFG++ +   ++ MK+   L T  Y+AP
Sbjct: 181 VDFGLSAVFENQKKMKE--RLGTAYYIAP 207

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 92.1 bits (229), Expect = 1e-19
 Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 13/170 (7%)

Query: 667 IGTGGFGSVYKGSF-LDGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
           +G G FG V      + G E A+KV     ++ +   +S   E ++LK + H N++K+  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVH 782
              +  +  LV E    G L D + S    F  +    +I  V   + Y+H    N +VH
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH---KNKIVH 149

Query: 783 CDIKPSNVLL-DKDMVAHL--SDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            D+KP N+LL  K   A++   DFG++      + MK    + T  Y+AP
Sbjct: 150 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAP 197

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 43/176 (24%), Positives = 70/176 (39%), Gaps = 28/176 (15%)

Query: 667 IGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           IG G +G V         +  A K         +  F  E E++KS+ H N++++  +  
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFD-ILQR--------LSVIIDVALALEYLHFGY 776
           +N    LV+E    G L          F+ ++ +          ++ DV  A+ Y H   
Sbjct: 77  DNTDIYLVMELCTGGEL----------FERVVHKRVFRESDAARIMKDVLSAVAYCH--- 123

Query: 777 SNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
              V H D+KP N L      D    L DFG+A      + M+    + T  Y++P
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSP 177

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 45/185 (24%), Positives = 81/185 (43%), Gaps = 20/185 (10%)

Query: 658 TNQFNASNL-----IGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGA-LKSFDVECEV-L 709
           + +  A +L     +G G +G V K   +  G  +A+K     +     K   ++ ++ +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60

Query: 710 KSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLED-----YLYSNNFSFDILQRLSVIID 764
           ++V     V    +        + +E M + SL+               DIL +++V   
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV--S 117

Query: 765 VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATI 824
           +  ALE+LH   S  V+H D+KPSNVL++      + DFGI+  L   + + + +     
Sbjct: 118 IVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCK 173

Query: 825 GYMAP 829
            YMAP
Sbjct: 174 PYMAP 178

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 90.5 bits (225), Expect = 1e-19
 Identities = 38/176 (21%), Positives = 81/176 (46%), Gaps = 16/176 (9%)

Query: 661 FNASNLIGTGGFGSVY----KGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRN 716
            + + ++G G FG V+      +   G+++A K+   +     +    E  V+  + H N
Sbjct: 91  VSKTEILGGGRFGQVHKCEETAT---GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHAN 147

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
           L+++  +  + +   LV+EY+  G L D +   +++   L  +  +  +   + ++H   
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH--- 204

Query: 777 SNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
              ++H D+KP N+L    D   +  + DFG+A+     E +K      T  ++AP
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIK-IIDFGLARRYKPREKLKVNFG--TPEFLAP 257

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 90.1 bits (224), Expect = 1e-19
 Identities = 38/185 (20%), Positives = 71/185 (38%), Gaps = 36/185 (19%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV-----ECEVLKSVRHRNLVKI 720
           IG G F  V +    + G + A+K+  +    +           E  +   ++H ++V++
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD-ILQRLS------------VIIDVAL 767
           + + +++    +V E+M    L             I++R               +  +  
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL----------CFEIVKRADAGFVYSEAVASHYMRQILE 141

Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATI 824
           AL Y H    N ++H D+KP  VLL   +      L  FG+A  L     +     + T 
Sbjct: 142 ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-VGTP 197

Query: 825 GYMAP 829
            +MAP
Sbjct: 198 HFMAP 202

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 42/177 (23%), Positives = 71/177 (40%), Gaps = 31/177 (17%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVR-HRNLVKIISSC 724
           +G G F    K          A+K+   ++E   +    E   LK    H N+VK+    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFD-ILQRLS--------VIIDVALALEYLHFG 775
            +     LV+E +  G L          F+ I ++          ++  +  A+ ++H  
Sbjct: 76  HDQLHTFLVMELLNGGEL----------FERIKKKKHFSETEASYIMRKLVSAVSHMH-- 123

Query: 776 YSNPVVHCDIKPSNVLL-DKDMVAHL--SDFGIAKLLSGEESMKQTLTLATIGYMAP 829
               VVH D+KP N+L  D++    +   DFG A+L   +    +T    T+ Y AP
Sbjct: 124 -DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAP 178

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 46/209 (22%), Positives = 80/209 (38%), Gaps = 53/209 (25%)

Query: 659 NQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVF--------------------HLQLEG 697
           NQ+   + IG G +G V    +  D    A+KV                          G
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72

Query: 698 ALKSFDV------ECEVLKSVRHRNLVK---IISSCTNNDFKALVLEYMPNGSLEDYLYS 748
            ++          E  +LK + H N+VK   ++     +    +V E +  G +      
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPV------ 125

Query: 749 NNFSFDILQRLSVIIDVA--------LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHL 800
                ++     +  D A          +EYLH      ++H DIKPSN+L+ +D    +
Sbjct: 126 ----MEVPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKI 178

Query: 801 SDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +DFG++    G +++    T+ T  +MAP
Sbjct: 179 ADFGVSNEFKGSDALLSN-TVGTPAFMAP 206

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 89.3 bits (222), Expect = 3e-19
 Identities = 47/189 (24%), Positives = 75/189 (39%), Gaps = 37/189 (19%)

Query: 658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEV---LKSVR 713
           T+ +     IG G +    +       ME A+K+            D   E+   L+  +
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTEEIEILLRYGQ 74

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD-ILQRLS--------VIID 764
           H N++ +     +  +  +V E M  G L           D IL++          V+  
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGEL----------LDKILRQKFFSEREASAVLFT 124

Query: 765 VALALEYLHFGYSNPVVHCDIKPSNVLL-DKDMVAH---LSDFGIAKLLSGEESMKQTLT 820
           +   +EYLH   +  VVH D+KPSN+L  D+        + DFG AK L  E  +  T  
Sbjct: 125 ITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP- 180

Query: 821 LATIGYMAP 829
             T  ++AP
Sbjct: 181 CYTANFVAP 189

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 88.9 bits (221), Expect = 3e-19
 Identities = 48/186 (25%), Positives = 77/186 (41%), Gaps = 32/186 (17%)

Query: 667 IGTGGFGSVYKGSFLDG------MEVAIKVFHLQLEGA----LKSFDVECEVLKSVRHRN 716
           +G G FG VY+G           ++VA+K      E         F +E  ++    H+N
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 94

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYL------YSNNFSFDILQRLSVIIDVALALE 770
           +V+ I     +  + +++E M  G L+ +L       S   S  +L  L V  D+A   +
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 771 YL---HFGYSNPVVHCDIKPSNVLLDK---DMVAHLSDFGIAKLL-SGEESMKQTLTLAT 823
           YL   HF      +H DI   N LL       VA + DFG+A+ +       K    +  
Sbjct: 155 YLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 208

Query: 824 IGYMAP 829
           + +M P
Sbjct: 209 VKWMPP 214

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 87.9 bits (218), Expect = 4e-19
 Identities = 51/201 (25%), Positives = 78/201 (38%), Gaps = 18/201 (8%)

Query: 328 NCSIRG--TIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEG-PIP 384
           NC  R    +P ++    +   L L  N L      T      L  L+L   +L    + 
Sbjct: 16  NCDKRNLTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD 73

Query: 385 NGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSL 444
             L  L  L    +  N+L   +P     L +L +L ++ N L S+       L ++  L
Sbjct: 74  GTLPVLGTL---DLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129

Query: 445 NFSSNFLNGSLPEDI----GNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQ 500
               N L  +LP  +      L+    + L+ NNL+      + GL NL  L L++N L 
Sbjct: 130 YLKGNELK-TLPPGLLTPTPKLE---KLSLANNNLTELPAGLLNGLENLDTLLLQENSLY 185

Query: 501 GSIPKSIGGLVSLESLDLSNN 521
            +IPK   G   L    L  N
Sbjct: 186 -TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 84.0 bits (208), Expect = 6e-18
 Identities = 56/211 (26%), Positives = 83/211 (39%), Gaps = 19/211 (9%)

Query: 341 NLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDG 400
            + +  E+      L  ++P      ++   L L  N L       L    RL+ L +D 
Sbjct: 8   KVASHLEVNCDKRNL-TALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 401 NKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDI- 459
            +L+       G L  L  L L+ N+L S +P     L  +  L+ S N L  SLP    
Sbjct: 65  AELT--KLQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGAL 120

Query: 460 ---GNLKVVVIIDLSRNNLSGDIPTAI-GGLMNLQDLSLRDNGLQGSIPKSI-GGLVSLE 514
              G L+    + L  N L   +P  +      L+ LSL +N L   +P  +  GL +L+
Sbjct: 121 RGLGELQ---ELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLD 175

Query: 515 SLDLSNNSLSGNIPTSMEKLLYLKDLNLSFN 545
           +L L  NSL   IP        L    L  N
Sbjct: 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 58/202 (28%), Positives = 81/202 (40%), Gaps = 34/202 (16%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L LS N L       +   T L +L L   +L  ++    G L  L  + L++N L  ++
Sbjct: 36  LHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SL 92

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
           P     L +L T +D S N LT SLP    R L  ++ LY+  N+L              
Sbjct: 93  PLLGQTLPAL-TVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK------------- 137

Query: 122 IVISLAYNQFTERIPRGL-GNLTSLKTLYLGFNNLTGEIPYEM-GNLRNLEILGLQLNKL 179
                        +P GL      L+ L L  NNLT E+P  +   L NL+ L LQ N L
Sbjct: 138 ------------TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSL 184

Query: 180 VGFVPTSIFNLSAMKTLALPSN 201
              +P   F    +    L  N
Sbjct: 185 YT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 78.2 bits (193), Expect = 6e-16
 Identities = 54/207 (26%), Positives = 78/207 (37%), Gaps = 16/207 (7%)

Query: 100 LYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEI 159
           +      LT  +P ++   K+  ++ L+ N         L   T L  L L    LT ++
Sbjct: 15  VNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KL 70

Query: 160 PYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNL 219
               G L  L  L L  N+L   +P     L A+  L +  N L+ SLP    L  L  L
Sbjct: 71  Q-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGA-LRGLGEL 126

Query: 220 EIISLAGNNFSGIIPSFIFNA-SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLT 278
           + + L GN     +P  +     KL  L L  N+ +      L  L  L+ L L  N L 
Sbjct: 127 QELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY 185

Query: 279 SSTSELSFLSSWANCKNLKLLDLSNNP 305
           +   +  F S       L    L  NP
Sbjct: 186 T-IPKGFFGS-----HLLPFAFLHGNP 206

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 72.1 bits (177), Expect = 6e-14
 Identities = 46/161 (28%), Positives = 67/161 (41%), Gaps = 11/161 (6%)

Query: 396 LYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSL 455
           +  D   L+  +PP +       +L L+ N L +   +T      +  LN     L   L
Sbjct: 15  VNCDKRNLTA-LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KL 70

Query: 456 PEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI-GGLVSLE 514
             D G L V+  +DLS N L   +P     L  L  L +  N L  S+P     GL  L+
Sbjct: 71  QVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQ 127

Query: 515 SLDLSNNSLSGNIPTSM-EKLLYLKDLNLSFNKLEGEIPRG 554
            L L  N L   +P  +      L+ L+L+ N L  E+P G
Sbjct: 128 ELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAG 166

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 69.0 bits (169), Expect = 7e-13
 Identities = 49/214 (22%), Positives = 79/214 (36%), Gaps = 17/214 (7%)

Query: 141 NLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPS 200
            + S   +     NLT  +P      ++  IL L  N L  F   ++   + +  L L  
Sbjct: 8   KVASHLEVNCDKRNLT-ALP--PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 201 NALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNT 260
             L+  L        LP L  + L+ N    + P        L+VL++  N  +      
Sbjct: 65  AELT-KLQVD---GTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLTSLPLGA 119

Query: 261 LGNLRKLEWLRLSYNFLTS-STSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSL 319
           L  L +L+ L L  N L +     L+          L+ L L+NN +  +    +  L  
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTP------KLEKLSLANNNLTELPAGLLNGLE- 172

Query: 320 SLSRIFISNCSIRGTIPKEIGNLINLRELGLWGN 353
           +L  + +   S+  TIPK       L    L GN
Sbjct: 173 NLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 37/145 (25%), Positives = 61/145 (42%), Gaps = 15/145 (10%)

Query: 414 LTSLRLLSLASNELNSV---IPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDL 470
           + S   ++     L ++   +P       D   L+ S N L       +     +  ++L
Sbjct: 9   VASHLEVNCDKRNLTALPPDLPK------DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 471 SRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTS 530
            R  L+  +    G L  L  L L  N LQ S+P     L +L  LD+S N L+ ++P  
Sbjct: 63  DRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLG 118

Query: 531 M-EKLLYLKDLNLSFNKLEGEIPRG 554
               L  L++L L  N+L+  +P G
Sbjct: 119 ALRGLGELQELYLKGNELK-TLPPG 142

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 51/188 (27%), Positives = 86/188 (45%), Gaps = 31/188 (16%)

Query: 665 NLIGTGGFGSVYKGSFLDG---MEVAIKVFHLQLEGA----LKSFDVECEVLKSV-RHRN 716
           ++IG G FG V K         M+ AIK      E A     + F  E EVL  +  H N
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCKLGHHPN 87

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYL---------------YSNNFSFDILQRLSV 761
           ++ ++ +C +  +  L +EY P+G+L D+L                S   +    Q L  
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147

Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL 821
             DVA  ++YL        +H D+   N+L+ ++ VA ++DFG+++    E  +K+T+  
Sbjct: 148 AADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGR 202

Query: 822 ATIGYMAP 829
             + +MA 
Sbjct: 203 LPVRWMAI 210

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 88.7 bits (220), Expect = 4e-19
 Identities = 41/222 (18%), Positives = 71/222 (31%), Gaps = 53/222 (23%)

Query: 658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV-----ECEVLKS 711
             +++    IG G +G V            AIK+ +      +   DV     E  ++K 
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRL------------ 759
           + H N+ ++     +  +  LV+E    G L D L            +            
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 760 ---------------------------SVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL 792
                                      +++  +  AL YLH   +  + H DIKP N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLF 201

Query: 793 DKDMVAHL--SDFGIAKLL-SGEESMKQTLTLA--TIGYMAP 829
             +    +   DFG++K            +T    T  ++AP
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 87.3 bits (217), Expect = 6e-19
 Identities = 40/155 (25%), Positives = 68/155 (43%), Gaps = 18/155 (11%)

Query: 666 LIGTGGFGSVYKG-SFLDGMEVAIKVFH----LQLEGALKSFDVECEVLKSVRHRNLVK- 719
           L+G G +G V +          A+K+       ++     +   E ++L+ +RH+N+++ 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 720 --IISSCTNNDFKALVLEYMPNGSLE--DYLYSNNFSFDILQRL-SVIIDVALALEYLHF 774
             ++ +        +V+EY   G  E  D +    F           +ID    LEYLH 
Sbjct: 72  VDVLYNEEKQKM-YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID---GLEYLH- 126

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL 809
             S  +VH DIKP N+LL       +S  G+A+ L
Sbjct: 127 --SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 90.1 bits (224), Expect = 6e-19
 Identities = 46/182 (25%), Positives = 83/182 (45%), Gaps = 23/182 (12%)

Query: 665 NLIGTGGFGSVYKGSFL-DGMEVAIKV-------------FHLQLEGALKSFDVECEVLK 710
             +G+G +G V          E AIKV              +  +E   +    E  +LK
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 711 SVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALE 770
           S+ H N++K+     +  +  LV E+   G L + + + +  FD     +++  +   + 
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGIC 160

Query: 771 YLHFGYSNPVVHCDIKPSNVLL-DKDMVAHL--SDFGIAKLLSGEESMKQTLTLATIGYM 827
           YLH    + +VH DIKP N+LL +K+ + ++   DFG++   S +  ++    L T  Y+
Sbjct: 161 YLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD--RLGTAYYI 215

Query: 828 AP 829
           AP
Sbjct: 216 AP 217

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 86.8 bits (216), Expect = 6e-19
 Identities = 46/183 (25%), Positives = 74/183 (40%), Gaps = 35/183 (19%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHL-QLEGALKSFDV-----ECEVLKSVRHRNLVK 719
           +G+G F  V K      G E A K     +L  + +         E  +L+ +RH N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD-ILQRLS--------VIIDVALALE 770
           +     N     L+LE +  G L          FD + ++ S         +  +   + 
Sbjct: 73  LHDIFENKTDVVLILELVSGGEL----------FDFLAEKESLTEDEATQFLKQILDGVH 122

Query: 771 YLHFGYSNPVVHCDIKPSNVLL-DKDMVAH---LSDFGIAKLLSGEESMKQTLTLATIGY 826
           YLH   S  + H D+KP N++L DK++      L DFGIA  +      K      T  +
Sbjct: 123 YLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEF 177

Query: 827 MAP 829
           +AP
Sbjct: 178 VAP 180

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 90.3 bits (224), Expect = 7e-19
 Identities = 40/166 (24%), Positives = 73/166 (43%), Gaps = 8/166 (4%)

Query: 667 IGTGGFGSVYKGSF-LDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT 725
           +GTG FG V++ +    G   A K      E   ++   E + +  +RH  LV +  +  
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224

Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI 785
           +++   ++ E+M  G L + +   +      + +  +  V   L ++H    N  VH D+
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDL 281

Query: 786 KPSNVLLDKDMVAHL--SDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           KP N++        L   DFG+   L  ++S+K T    T  + AP
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG--TAEFAAP 325

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 87.7 bits (218), Expect = 7e-19
 Identities = 43/160 (26%), Positives = 69/160 (43%), Gaps = 23/160 (14%)

Query: 667 IGTGGFGSVYKGSFLDG------MEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKI 720
           +G G FG V+     +       M VA+K      E A + F  E E+L  ++H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSN--------------NFSFDILQRLSVIIDVA 766
              CT      +V EYM +G L  +L S+                   + Q L+V   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA 806
             + YL        VH D+   N L+ + +V  + DFG++
Sbjct: 169 AGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 88.6 bits (220), Expect = 7e-19
 Identities = 49/186 (26%), Positives = 77/186 (41%), Gaps = 32/186 (17%)

Query: 667 IGTGGFGSVYKGSFLDG------MEVAIKVFHLQLEGA----LKSFDVECEVLKSVRHRN 716
           +G G FG VY+G           ++VA+K      E         F +E  ++    H+N
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 135

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYL------YSNNFSFDILQRLSVIIDVALALE 770
           +V+ I     +  + ++LE M  G L+ +L       S   S  +L  L V  D+A   +
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 771 YL---HFGYSNPVVHCDIKPSNVLLDK---DMVAHLSDFGIAKLL-SGEESMKQTLTLAT 823
           YL   HF      +H DI   N LL       VA + DFG+A+ +       K    +  
Sbjct: 196 YLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLP 249

Query: 824 IGYMAP 829
           + +M P
Sbjct: 250 VKWMPP 255

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 87.3 bits (217), Expect = 7e-19
 Identities = 47/185 (25%), Positives = 79/185 (42%), Gaps = 25/185 (13%)

Query: 667 IGTGGFGSVYKG------SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKI 720
           +G G FG V+           D M VA+K        A K F  E E+L +++H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSN---------------NFSFDILQRLSVIIDV 765
              C + D   +V EYM +G L  +L ++                    + Q L +   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 766 ALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL-SGEESMKQTLTLATI 824
           A  + YL    S   VH D+   N L+  +++  + DFG+++ + S +       T+  I
Sbjct: 143 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199

Query: 825 GYMAP 829
            +M P
Sbjct: 200 RWMPP 204

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 88.2 bits (219), Expect = 1e-18
 Identities = 51/230 (22%), Positives = 90/230 (39%), Gaps = 41/230 (17%)

Query: 621 AMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVY---- 676
            +          Q    ++ L  A       KE+    + F    +IG G F  V     
Sbjct: 23  GVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKM 82

Query: 677 KGSFLDGMEVAIKVFHLQLEGALKSFDVEC-----EVLKSVRHRNLVKIISSCTNNDFKA 731
           K +   G   A+K+  +     LK  +V C     +VL +   R + ++  +  + ++  
Sbjct: 83  KQT---GQVYAMKI--MNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137

Query: 732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIID----------VALALEYLHFGYSNPVV 781
           LV+EY   G L            +L +    I           + +A++ +H       V
Sbjct: 138 LVMEYYVGGDL----------LTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYV 184

Query: 782 HCDIKPSNVLLDKDMVAH--LSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           H DIKP N+LLD+    H  L+DFG    L  + +++  + + T  Y++P
Sbjct: 185 HRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 41/192 (21%), Positives = 75/192 (39%), Gaps = 38/192 (19%)

Query: 667 IGTGGFGSVYKGSFLDG------MEVAIKVFHLQLEGA----LKSFDVECEVLKSVRHRN 716
           +G   FG VYKG             VAIK      + A     + F  E  +   ++H N
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAMLRARLQHPN 73

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN---------------NFSFDILQRLSV 761
           +V ++   T +   +++  Y  +G L ++L                    + +    + +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 762 IIDVALALEYL---HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL-SGEESMKQ 817
           +  +A  +EYL   H       VH D+   NVL+   +   +SD G+ + + + +     
Sbjct: 134 VAQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLL 187

Query: 818 TLTLATIGYMAP 829
             +L  I +MAP
Sbjct: 188 GNSLLPIRWMAP 199

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 45/184 (24%), Positives = 70/184 (38%), Gaps = 33/184 (17%)

Query: 666 LIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVR-HRNLVKIISS 723
           ++G G    V     L    E A+K+   Q          E E+L   + HRN++++I  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNNFSFD-ILQRLS--------VIIDVALALEYLHF 774
               D   LV E M  GS+             I +R          V+ DVA AL++LH 
Sbjct: 80  FEEEDRFYLVFEKMRGGSI----------LSHIHKRRHFNELEASVVVQDVASALDFLH- 128

Query: 775 GYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLA------TIG 825
             +  + H D+KP N+L    ++     + DF +   +          T        +  
Sbjct: 129 --NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186

Query: 826 YMAP 829
           YMAP
Sbjct: 187 YMAP 190

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 23/147 (15%), Positives = 47/147 (31%), Gaps = 14/147 (9%)

Query: 666 LIGTGGFGSVYKGSFLD---GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVK 719
             G       ++   LD     +VA+     Q    +  L+        L  +    + +
Sbjct: 38  FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
           ++          +V E++  GSL++   +   S   +  +  +  +A A +  H      
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAH---RAG 149

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIA 806
           V      PS V +  D    L+     
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATM 176

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 87.4 bits (217), Expect = 2e-18
 Identities = 50/234 (21%), Positives = 93/234 (39%), Gaps = 39/234 (16%)

Query: 615 ILAVRYAMISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGS 674
           +L    A++        +++    N L +        ++L      +    +IG G FG 
Sbjct: 25  LLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGE 84

Query: 675 VY----KGSFLDGMEVAIKVFHLQLEGALKSFDVEC-----EVLKSVRHRNLVKIISSCT 725
           V     K +       A+K+  L     +K  D        +++       +V++  +  
Sbjct: 85  VQLVRHKST---RKVYAMKL--LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139

Query: 726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVA--------LALEYLHFGYS 777
           ++ +  +V+EYMP G L           +++    V    A        LAL+ +H   S
Sbjct: 140 DDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAEVVLALDAIH---S 186

Query: 778 NPVVHCDIKPSNVLLDKDMVAH--LSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
              +H D+KP N+LLDK    H  L+DFG    ++ E  ++    + T  Y++P
Sbjct: 187 MGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 86.1 bits (214), Expect = 2e-18
 Identities = 36/177 (20%), Positives = 77/177 (43%), Gaps = 13/177 (7%)

Query: 658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV--ECEVLKSVRH 714
             ++  +  +G G FG V++            K   ++         V  E  +L   RH
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARH 60

Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
           RN++ +  S  + +   ++ E++    + + + ++ F  +  + +S +  V  AL++LH 
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH- 119

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHL--SDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             S+ + H DI+P N++      + +   +FG A+ L   ++ +   T     Y AP
Sbjct: 120 --SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT--APEYYAP 172

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 85.8 bits (213), Expect = 3e-18
 Identities = 42/197 (21%), Positives = 78/197 (39%), Gaps = 40/197 (20%)

Query: 667 IGTGGFGSVYKGSFLDG------MEVAIKVFHLQLEGA----LKSFDVECEVLKSVRHRN 716
           +G G FG V K +            VA+K+     E A    L+    E  VLK V H +
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNVLKQVNHPH 87

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQR------------------ 758
           ++K+  +C+ +    L++EY   GSL  +L  +                           
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 759 -----LSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA-KLLSGE 812
                +S    ++  ++YL       +VH D+   N+L+ +     +SDFG++  +   +
Sbjct: 148 TMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 813 ESMKQTLTLATIGYMAP 829
             +K++     + +MA 
Sbjct: 205 SYVKRSQGRIPVKWMAI 221

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 85.4 bits (212), Expect = 4e-18
 Identities = 46/183 (25%), Positives = 73/183 (39%), Gaps = 35/183 (19%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHL-QLEGALKSFDV-----ECEVLKSVRHRNLVK 719
           +G+G F  V K      G+E A K     Q   + +         E  +L+ V H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD-ILQRLS--------VIIDVALALE 770
           +     N     L+LE +  G L          FD + Q+ S         I  +   + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGEL----------FDFLAQKESLSEEEATSFIKQILDGVN 129

Query: 771 YLHFGYSNPVVHCDIKPSNVLL-DKDMVAH---LSDFGIAKLLSGEESMKQTLTLATIGY 826
           YLH   +  + H D+KP N++L DK++      L DFG+A  +      K      T  +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEF 184

Query: 827 MAP 829
           +AP
Sbjct: 185 VAP 187

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 85.3 bits (212), Expect = 4e-18
 Identities = 52/189 (27%), Positives = 83/189 (43%), Gaps = 40/189 (21%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEV-AIKVFHLQLEGALKSFDVEC-----EVLKSV 712
             F     +GTG FG V+           A+KV  L+ E  ++   VE       +L  V
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIV 63

Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV---------II 763
            H  ++++  +  +     ++++Y+  G L          F +L++              
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGEL----------FSLLRKSQRFPNPVAKFYAA 113

Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAH--LSDFGIAKLLSGEESMKQTLTL 821
           +V LALEYLH   S  +++ D+KP N+LLDK+   H  ++DFG AK          T TL
Sbjct: 114 EVCLALEYLH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAK-----YVPDVTYTL 163

Query: 822 -ATIGYMAP 829
             T  Y+AP
Sbjct: 164 CGTPDYIAP 172

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 85.9 bits (213), Expect = 4e-18
 Identities = 44/183 (24%), Positives = 69/183 (37%), Gaps = 35/183 (19%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH-LQLEGALKSFDV-----ECEVLKSVRHRNLVK 719
           +G+G F  V K      G+E A K     Q   + +         E  +L+ V H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD-ILQRLS--------VIIDVALALE 770
           +     N     L+LE +  G L          FD + Q+ S         I  +   + 
Sbjct: 80  LHDVYENRTDVVLILELVSGGEL----------FDFLAQKESLSEEEATSFIKQILDGVN 129

Query: 771 YLHFGYSNPVVHCDIKPSNVLL----DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGY 826
           YLH   +  + H D+KP N++L           L DFG+A  +      K      T  +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEF 184

Query: 827 MAP 829
           +AP
Sbjct: 185 VAP 187

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 85.0 bits (211), Expect = 5e-18
 Identities = 43/192 (22%), Positives = 76/192 (39%), Gaps = 35/192 (18%)

Query: 667 IGTGGFGSVYKGSFLD------GMEVAIKVFHLQLEGA----LKSFDVECEVLKSV-RHR 715
           +G G FG V + +          M VA+K+       A     ++   E +VL  +  H 
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87

Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQR----------------- 758
           N+V ++ +CT      ++ EY   G L ++L     SF   +                  
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 759 LSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL-SGEESMKQ 817
           LS    VA  + +L    S   +H D+   N+LL    +  + DFG+A+ + +    + +
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

Query: 818 TLTLATIGYMAP 829
                 + +MAP
Sbjct: 205 GNARLPVKWMAP 216

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 87.5 bits (217), Expect = 5e-18
 Identities = 49/184 (26%), Positives = 79/184 (42%), Gaps = 23/184 (12%)

Query: 659 NQFNASNLIGTGGFGSVY----KGSFLDGMEVAIKVFHLQLEGALKSFDVEC-----EVL 709
           + F    ++G GGFG V+    K +   G   A K   L  +   K    +      ++L
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKK--LNKKRLKKRKGYQGAMVEKKIL 239

Query: 710 KSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLY---SNNFSFDILQRLSVIIDVA 766
             V  R +V +  +        LV+  M  G +  ++Y    +N  F   + +     + 
Sbjct: 240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299

Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIG 825
             LE+LH      +++ D+KP NVLLD D    +SD G+A  L   +   +T   A T G
Sbjct: 300 SGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPG 354

Query: 826 YMAP 829
           +MAP
Sbjct: 355 FMAP 358

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 85.9 bits (213), Expect = 5e-18
 Identities = 51/192 (26%), Positives = 88/192 (45%), Gaps = 35/192 (18%)

Query: 667 IGTGGFGSVYKGSFLD--------GMEVAIKVFHLQLEGA----LKSFDVECEVLKSV-R 713
           +G G FG V     +           +VA+K+       A    L     E E++K + +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGK 133

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYL---------YSNNFSFDILQRLSVI-- 762
           H+N++ ++ +CT +    +++EY   G+L +YL         YS N S +  ++LS    
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 763 ----IDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES-MKQ 817
                 VA  +EYL    S   +H D+   NVL+ +D V  ++DFG+A+ +   +   K 
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250

Query: 818 TLTLATIGYMAP 829
           T     + +MAP
Sbjct: 251 TNGRLPVKWMAP 262

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 84.9 bits (210), Expect = 7e-18
 Identities = 44/247 (17%), Positives = 72/247 (29%), Gaps = 23/247 (9%)

Query: 76  DFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERI 135
               + +T  +P D+ R       L     KL            +L  I ++ N   E I
Sbjct: 15  LCQESKVT-EIPSDLPRNA---IELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70

Query: 136 PRG-LGNLTSLKTLYLGFNNLTGEIPYEM-GNLRNLEILGLQLNKLVGFVPTSIFNLSAM 193
                 NL  L  + +   N    I  E   NL NL+ L +    +         +    
Sbjct: 71  EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 130

Query: 194 KTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLEL-GENS 252
             L +  N    ++  +  +       I+ L  N     I +  FN ++L  L L   N+
Sbjct: 131 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNN 189

Query: 253 FSGFIPNTLGNLRKLEWLRLSYNFLTS---------------STSELSFLSSWANCKNLK 297
                 +          L +S   + S               ST  L  L +      L 
Sbjct: 190 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTLEKLVALM 249

Query: 298 LLDLSNN 304
              L+  
Sbjct: 250 EASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 83.3 bits (206), Expect = 2e-17
 Identities = 52/261 (19%), Positives = 93/261 (35%), Gaps = 40/261 (15%)

Query: 267 LEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFI 326
              LR     L           +++   +L+ +++S N +  V+ + +            
Sbjct: 32  AIELRFVLTKLRVIQK-----GAFSGFGDLEKIEISQNDVLEVIEADV------------ 74

Query: 327 SNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPI-TFGKLQNLQGLDLVNNKLEGPIPN 385
                         NL  L E+ +     +  I    F  L NLQ L + N  ++  +P+
Sbjct: 75  ------------FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH-LPD 121

Query: 386 GL-CQLARLSVLYMDGNKLSGPIPP-CIGDLTS-LRLLSLASNELNSVIPSTFWNLKDIL 442
                  +  +L +  N     I       L+    +L L  N +  +  S F   +   
Sbjct: 122 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDE 181

Query: 443 SLNFSSNFLNGSLPEDI-GNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQG 501
                +N L   LP D+       VI+D+SR  +   +P+   GL NL+ L  R      
Sbjct: 182 LNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPS--YGLENLKKLRARSTYNLK 237

Query: 502 SIPKSIGGLVSLESLDLSNNS 522
            +P ++  LV+L    L+  S
Sbjct: 238 KLP-TLEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 81.8 bits (202), Expect = 8e-17
 Identities = 40/242 (16%), Positives = 81/242 (33%), Gaps = 16/242 (6%)

Query: 328 NCSIRG--TIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPN 385
            C       IP ++    N  EL     +L       F    +L+ +++  N +   I  
Sbjct: 15  LCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 72

Query: 386 G-LCQLARLSVLYM-DGNKLSGPIPPCI-GDLTSLRLLSLASNELNSVIPSTFWNLKDIL 442
                L +L  + +   N L   I P    +L +L+ L +++  +  +      +    +
Sbjct: 73  DVFSNLPKLHEIRIEKANNLLY-INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKV 131

Query: 443 SLNFSSNFLNGSLPEDI--GNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQ 500
            L+   N    ++  +   G     VI+ L++N +     +A  G    +     +N L+
Sbjct: 132 LLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE 191

Query: 501 GSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANF 560
                   G      LD+S   +       +E L  L+  +    K   ++P        
Sbjct: 192 ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP---TLEKL 245

Query: 561 SN 562
             
Sbjct: 246 VA 247

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 81.8 bits (202), Expect = 9e-17
 Identities = 63/332 (18%), Positives = 106/332 (31%), Gaps = 43/332 (12%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
                + ++  IP ++       +L     KLR           +LE + ++ N +   I
Sbjct: 14  FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70

Query: 62  PSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
            + +F NL  L        N+L   +  +  + LP ++ L +SN  +      +     +
Sbjct: 71  EADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 129

Query: 121 LIVISLAYNQFTERIPRG-LGNLTS-LKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNK 178
            +++ +  N     I R     L+     L+L  N +  EI     N   L+ L L  N 
Sbjct: 130 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNN 188

Query: 179 LVGFVPTSIF-NLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFI 237
            +  +P  +F   S    L +    +  SLPS   L  L  L   S    N   +     
Sbjct: 189 NLEELPNDVFHGASGPVILDISRTRIH-SLPSYG-LENLKKLRARST--YNLKKLPT--- 241

Query: 238 FNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNF----LTSSTSELSFLSSWANC 293
                                  L  L  L    L+Y        +   ++S L    N 
Sbjct: 242 -----------------------LEKLVALMEASLTYPSHCCAFANWRRQISELHPICNK 278

Query: 294 KNLKLLDLSNNPINGVLPSSIGNLSLSLSRIF 325
             L+          G   S   +   S SR F
Sbjct: 279 SILRQEVDYMTQARGQRSSLAEDNESSYSRGF 310

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 79.9 bits (197), Expect = 4e-16
 Identities = 40/257 (15%), Positives = 81/257 (31%), Gaps = 16/257 (6%)

Query: 295 NLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNE 354
           + ++     + +  + PS   +L  +   +      +R           +L ++ +  N+
Sbjct: 10  SNRVFLCQESKVTEI-PS---DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 65

Query: 355 LIGSIPI-TFGKLQNLQGLDLVN-NKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIG 412
           ++  I    F  L  L  + +   N L    P     L  L  L +    +         
Sbjct: 66  VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKI 125

Query: 413 DLTSLRLLSLASNELNSVIPS-TFWNLKDIL-SLNFSSNFLNGSLPEDI-GNLKVVVIID 469
                 LL +  N     I   +F  L      L  + N +   +        ++  +  
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNL 184

Query: 470 LSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI-GGLVSLESLDLSNNSLSGNIP 528
              NNL         G      L +    +  S+P      L  L +    N      +P
Sbjct: 185 SDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLP 240

Query: 529 TSMEKLLYLKDLNLSFN 545
            ++EKL+ L + +L++ 
Sbjct: 241 -TLEKLVALMEASLTYP 256

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 83.4 bits (207), Expect = 8e-18
 Identities = 37/154 (24%), Positives = 64/154 (41%), Gaps = 24/154 (15%)

Query: 666 LIGTGGFGSVYKG-SFLDGMEVAIKVFHL-QLEGALKSFDVECEVLKSVRHRNLVKIISS 723
            +G G +G V    + +    VA+K+  + +     ++   E  + K + H N+VK    
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV---------IIDVALALEYLHF 774
               + + L LEY   G L D +  +         +           ++     + YLH 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPD-------IGMPEPDAQRFFHQLMA---GVVYLH- 122

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL 808
                + H DIKP N+LLD+     +SDFG+A +
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATV 154

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 84.6 bits (210), Expect = 8e-18
 Identities = 40/190 (21%), Positives = 78/190 (41%), Gaps = 31/190 (16%)

Query: 665 NLIGTGGFGSVYKGSFLD------GMEVAIKVFHLQLEGA----LKSFDVECEVLKSV-R 713
             +G G FG V + +          ++VA+K+       A     ++   E +++  + +
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKIMSHLGQ 108

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD-------------ILQRLS 760
           H N+V ++ +CT+     ++ EY   G L ++L   +   +                 L 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 761 VIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA-KLLSGEESMKQTL 819
               VA  + +L    S   +H D+   NVLL    VA + DFG+A  +++    + +  
Sbjct: 169 FSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225

Query: 820 TLATIGYMAP 829
               + +MAP
Sbjct: 226 ARLPVKWMAP 235

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 84.6 bits (210), Expect = 9e-18
 Identities = 44/192 (22%), Positives = 83/192 (43%), Gaps = 35/192 (18%)

Query: 667 IGTGGFGSVYKGSFLD--------GMEVAIKVFHLQLEGA----LKSFDVECEVLKSV-R 713
           +G G FG V     +          + VA+K+     + A    L     E E++K + +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 99

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYL---------------YSNNFSFDILQR 758
           H+N++ ++ +CT +    +++EY   G+L +YL                           
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 759 LSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL-SGEESMKQ 817
           +S    +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ + + +   K 
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216

Query: 818 TLTLATIGYMAP 829
           T     + +MAP
Sbjct: 217 TNGRLPVKWMAP 228

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 84.2 bits (209), Expect = 9e-18
 Identities = 41/183 (22%), Positives = 75/183 (40%), Gaps = 35/183 (19%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFH-LQLEGALKSFDV-----ECEVLKSVRHRNLVK 719
           +G+G F  V K      G++ A K     + + + +         E  +LK ++H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD-ILQRLS--------VIIDVALALE 770
           +     N     L+LE +  G L          FD + ++ S         +  +   + 
Sbjct: 79  LHEVYENKTDVILILELVAGGEL----------FDFLAEKESLTEEEATEFLKQILNGVY 128

Query: 771 YLHFGYSNPVVHCDIKPSNVLL-DKDMVAH---LSDFGIAKLLSGEESMKQTLTLATIGY 826
           YLH   S  + H D+KP N++L D+++      + DFG+A  +      K      T  +
Sbjct: 129 YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEF 183

Query: 827 MAP 829
           +AP
Sbjct: 184 VAP 186

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 84.7 bits (210), Expect = 9e-18
 Identities = 45/200 (22%), Positives = 72/200 (36%), Gaps = 46/200 (23%)

Query: 667 IGTGGFGSVYKGSFLDG------MEVAIKVFHLQLEGA----LKSFDVECEVLKSVRHRN 716
           IG G FG V++              VA+K+     E A       F  E  ++    + N
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDNPN 111

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQR------------------ 758
           +VK++  C       L+ EYM  G L ++L S +                          
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 759 -----LSVIIDVALALEYL---HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA-KLL 809
                L +   VA  + YL    F      VH D+   N L+ ++MV  ++DFG++  + 
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIY 225

Query: 810 SGEESMKQTLTLATIGYMAP 829
           S +           I +M P
Sbjct: 226 SADYYKADGNDAIPIRWMPP 245

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 84.7 bits (210), Expect = 1e-17
 Identities = 44/192 (22%), Positives = 84/192 (43%), Gaps = 35/192 (18%)

Query: 667 IGTGGFGSVYKGSFLD--------GMEVAIKVFHLQLEGA----LKSFDVECEVLKSV-R 713
           +G G FG V     +          + VA+K+     + A    L     E E++K + +
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 145

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN---------------NFSFDILQR 758
           H+N++ ++ +CT +    +++EY   G+L +YL +                         
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 759 LSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL-SGEESMKQ 817
           +S    +A  +EYL    S   +H D+   NVL+ ++ V  ++DFG+A+ + + +   K 
Sbjct: 206 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262

Query: 818 TLTLATIGYMAP 829
           T     + +MAP
Sbjct: 263 TNGRLPVKWMAP 274

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 85.2 bits (211), Expect = 1e-17
 Identities = 39/185 (21%), Positives = 69/185 (37%), Gaps = 44/185 (23%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEV---LKSVRHRNLVKII- 721
           +G G  G V +        + A+K+                EV    ++ +  ++V+I+ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 122

Query: 722 ---SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD-ILQRLS----------VIIDVAL 767
              +         +V+E +  G L          F  I  R            ++  +  
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGE 172

Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATI 824
           A++YLH   S  + H D+KP N+L      + +  L+DFG AK  +   S+       T 
Sbjct: 173 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTP 227

Query: 825 GYMAP 829
            Y+AP
Sbjct: 228 YYVAP 232

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 86.5 bits (214), Expect = 1e-17
 Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 20/181 (11%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEV-AIKVFHLQLEGALKSFDVEC--------EVL 709
           N F+   +IG GGFG VY     D  ++ A+K   L  +                   ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLV 246

Query: 710 KSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL 769
            +     +V +  +    D  + +L+ M  G L  +L   +  F          ++ L L
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGL 305

Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMA 828
           E++H   +  VV+ D+KP+N+LLD+     +SD G+A     + S K+      T GYMA
Sbjct: 306 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHASVGTHGYMA 358

Query: 829 P 829
           P
Sbjct: 359 P 359

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 44/191 (23%), Positives = 79/191 (41%), Gaps = 34/191 (17%)

Query: 667 IGTGGFGSVYKGSFLD------GMEVAIKVFHLQLEGA----LKSFDVECEVLKSV-RHR 715
           +G G FG V +              VA+K+     EGA     ++   E ++L  +  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91

Query: 716 NLVKIISSCTNNDFKALV-LEYMPNGSLEDYLYSNNFSFDILQR---------------L 759
           N+V ++ +CT      +V +E+   G+L  YL S    F   +                +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 760 SVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL-SGEESMKQT 818
                VA  +E+L    S   +H D+   N+LL +  V  + DFG+A+ +    + +++ 
Sbjct: 152 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208

Query: 819 LTLATIGYMAP 829
                + +MAP
Sbjct: 209 DARLPLKWMAP 219

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 83.9 bits (208), Expect = 2e-17
 Identities = 43/186 (23%), Positives = 76/186 (40%), Gaps = 45/186 (24%)

Query: 666 LIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEV---LKSVRHRNLVKII 721
           ++G G  G V +      G + A+K+ +        S     EV    ++    ++V I+
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCIL 88

Query: 722 SSCTNNDFKA----LVLEYMPNGSLEDYLYSNNFSFD-ILQRLS----------VIIDVA 766
               N         +++E M  G L          F  I +R            ++ D+ 
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAAEIMRDIG 138

Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLL-DKDMVAHL--SDFGIAKLLSGEESMKQTLTLAT 823
            A+++LH   S+ + H D+KP N+L   K+  A L  +DFG AK    + +++      T
Sbjct: 139 TAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET-TQNALQT--PCYT 192

Query: 824 IGYMAP 829
             Y+AP
Sbjct: 193 PYYVAP 198

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 18/203 (8%)

Query: 328 NCSIRG--TIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPN 385
           +CS +    IP  I    + ++L L  N+L       F +L  L+ L L +NKL+  +P 
Sbjct: 22  DCSSKKLTAIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPA 78

Query: 386 GLC-QLARLSVLYMDGNKLSGPIPPCIGD-LTSLRLLSLASNELNSVIPSTFWNLKDILS 443
           G+  +L  L  L++  NKL   +P  + D L +L  L L  N+L S+ P  F +L  +  
Sbjct: 79  GIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTY 137

Query: 444 LNFSSNFLNGSLPEDI----GNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGL 499
           L+   N L  SLP+ +     +LK    + L  N L      A   L  L+ L L +N L
Sbjct: 138 LSLGYNELQ-SLPKGVFDKLTSLK---ELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQL 193

Query: 500 QGSIPKSI-GGLVSLESLDLSNN 521
           +  +P+     L  L+ L L  N
Sbjct: 194 K-RVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 80.4 bits (199), Expect = 9e-17
 Identities = 50/195 (25%), Positives = 91/195 (46%), Gaps = 10/195 (5%)

Query: 100 LYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGL-GNLTSLKTLYLGFNNLTGE 158
           L + +NKL+        +  +L ++ L  N+    +P G+   L +L+TL++  N L   
Sbjct: 42  LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKLQ-A 99

Query: 159 IPYEM-GNLRNLEILGLQLNKLVGFVPTSIF-NLSAMKTLALPSNALSGSLPSSIDLVRL 216
           +P  +   L NL  L L  N+L   +P  +F +L+ +  L+L  N L  SLP  +   +L
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV-FDKL 156

Query: 217 PNLEIISLAGNNFSGIIPSFIF-NASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYN 275
            +L+ + L  N    + P   F   ++L  L+L  N           +L KL+ L+L  N
Sbjct: 157 TSLKELRLYNNQLKRV-PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

Query: 276 FLTSSTSELSFLSSW 290
               + + + +++ W
Sbjct: 216 PWDCTCNGIIYMAKW 230

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 60/222 (27%), Positives = 89/222 (40%), Gaps = 42/222 (18%)

Query: 233 IPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWA- 291
           IPS I   +    L+L  N  S         L KL  L L+ N L +       L +   
Sbjct: 31  IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-------LPAGIF 81

Query: 292 -NCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGL 350
              KNL+ L +++N +   LP  +                           L+NL EL L
Sbjct: 82  KELKNLETLWVTDNKLQ-ALPIGV------------------------FDQLVNLAELRL 116

Query: 351 WGNELIGSIPI-TFGKLQNLQGLDLVNNKLEGPIPNGLC-QLARLSVLYMDGNKLSGPIP 408
             N+ + S+P   F  L  L  L L  N+L+  +P G+  +L  L  L +  N+L   +P
Sbjct: 117 DRNQ-LKSLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLKR-VP 173

Query: 409 PCIGD-LTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSN 449
               D LT L+ L L +N+L  V    F +L+ +  L    N
Sbjct: 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 57/180 (31%), Positives = 80/180 (44%), Gaps = 10/180 (5%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQEL-GNLAELELVSLTNNFLSGT 60
           L L  N LS    K    LT L+ L L  NKL+  +P  +   L  LE + +T+N L   
Sbjct: 42  LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-A 99

Query: 61  IPSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQC- 118
           +P  +F  L +L   +    N L  SLP  +   L  +  L +  N+L   +P  ++   
Sbjct: 100 LPIGVFDQLVNL-AELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKL 156

Query: 119 KELIVISLAYNQFTERIPRGL-GNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLN 177
             L  + L  NQ   R+P G    LT LKTL L  N L         +L  L++L LQ N
Sbjct: 157 TSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 59/190 (31%), Positives = 84/190 (44%), Gaps = 31/190 (16%)

Query: 368 NLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCI-GDLTSLRLLSLASNE 426
           + + LDL +NKL         +L +L +LY++ NKL   +P  I  +L +L  L +  N+
Sbjct: 38  DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNK 96

Query: 427 LNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGL 486
           L ++    F  L ++  L    N L  SLP                       P     L
Sbjct: 97  LQALPIGVFDQLVNLAELRLDRNQLK-SLP-----------------------PRVFDSL 132

Query: 487 MNLQDLSLRDNGLQGSIPKSI-GGLVSLESLDLSNNSLSGNIPTSM-EKLLYLKDLNLSF 544
             L  LSL  N LQ S+PK +   L SL+ L L NN L   +P    +KL  LK L L  
Sbjct: 133 TKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDN 190

Query: 545 NKLEGEIPRG 554
           N+L+  +P G
Sbjct: 191 NQLK-RVPEG 199

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 54/183 (29%), Positives = 78/183 (42%), Gaps = 13/183 (7%)

Query: 126 LAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEM-GNLRNLEILGLQLNKLVGFVP 184
           L  N+ +    +    LT L+ LYL  N L   +P  +   L+NLE L +  NKL   +P
Sbjct: 44  LQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LP 101

Query: 185 TSIF-NLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNA-SK 242
             +F  L  +  L L  N L  SLP  +    L  L  +SL  N     +P  +F+  + 
Sbjct: 102 IGVFDQLVNLAELRLDRNQLK-SLPPRV-FDSLTKLTYLSLGYNELQ-SLPKGVFDKLTS 158

Query: 243 LSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLS 302
           L  L L  N            L +L+ L+L  N L     E +F     + + LK+L L 
Sbjct: 159 LKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR-VPEGAF----DSLEKLKMLQLQ 213

Query: 303 NNP 305
            NP
Sbjct: 214 ENP 216

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 53.8 bits (130), Expect = 6e-08
 Identities = 38/142 (26%), Positives = 61/142 (42%), Gaps = 29/142 (20%)

Query: 415 TSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNN 474
              + L L SN+L+S+    F  L  +  L  + N L  +LP                  
Sbjct: 37  ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLP------------------ 77

Query: 475 LSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI-GGLVSLESLDLSNNSLSGNIPTSM-E 532
                      L NL+ L + DN LQ ++P  +   LV+L  L L  N L  ++P  + +
Sbjct: 78  -----AGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFD 130

Query: 533 KLLYLKDLNLSFNKLEGEIPRG 554
            L  L  L+L +N+L+  +P+G
Sbjct: 131 SLTKLTYLSLGYNELQ-SLPKG 151

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 83.9 bits (208), Expect = 2e-17
 Identities = 50/187 (26%), Positives = 83/187 (44%), Gaps = 36/187 (19%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEV-AIKVFHLQLEGALKSFDVEC-----EVLKSV 712
           +QF+    +GTG FG V      +     A+K+  L  +  +K   +E       +L++V
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAV 98

Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIID-------- 764
               LVK+  S  +N    +V+EY+  G +          F  L+R+    +        
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----------FSHLRRIGRFSEPHARFYAA 148

Query: 765 -VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-A 822
            + L  EYLH   S  +++ D+KP N+L+D+     ++DFG AK         +T TL  
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCG 200

Query: 823 TIGYMAP 829
           T   +AP
Sbjct: 201 TPEALAP 207

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 37/154 (24%), Positives = 64/154 (41%), Gaps = 24/154 (15%)

Query: 666 LIGTGGFGSVYKG-SFLDGMEVAIKVFHL-QLEGALKSFDVECEVLKSVRHRNLVKIISS 723
            +G G +G V    + +    VA+K+  + +     ++   E  + K + H N+VK    
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV---------IIDVALALEYLHF 774
               + + L LEY   G L D +  +         +           ++     + YLH 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPD-------IGMPEPDAQRFFHQLMA---GVVYLH- 122

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL 808
                + H DIKP N+LLD+     +SDFG+A +
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATV 154

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 85.2 bits (211), Expect = 2e-17
 Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 16/179 (8%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEV-AIKVFHLQLEGALKSFDVEC-----EVLKSV 712
           N F    ++G GGFG V         ++ A K   L+ +   K           ++L+ V
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGEAMALNEKQILEKV 241

Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLY-SNNFSFDILQRLSVIIDVALALEY 771
             R +V +  +    D   LVL  M  G L+ ++Y      F   + +    ++   LE 
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301

Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
           LH      +V+ D+KP N+LLD      +SD G+A  +   ++         T+GYMAP
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAP 354

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 41/181 (22%), Positives = 70/181 (38%), Gaps = 33/181 (18%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDV--ECEVLKSVRHR-NLVKIIS 722
           +G G F  V +      G E A K    +  G     ++  E  VL+  +    ++ +  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD-ILQRLS----------VIIDVALALEY 771
              N     L+LEY   G +          F   L  L+          +I  +   + Y
Sbjct: 97  VYENTSEIILILEYAAGGEI----------FSLCLPELAEMVSENDVIRLIKQILEGVYY 146

Query: 772 LHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA 828
           LH    N +VH D+KP N+LL          + DFG+++ +     +++   + T  Y+A
Sbjct: 147 LH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEYLA 201

Query: 829 P 829
           P
Sbjct: 202 P 202

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 82.0 bits (203), Expect = 3e-17
 Identities = 59/288 (20%), Positives = 94/288 (32%), Gaps = 50/288 (17%)

Query: 95  PLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNN 154
           PL          +     ++     E I  +L     T+ +      L S+  +    ++
Sbjct: 2   PLGSETITVPTPIKQIFSDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD 57

Query: 155 LTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLV 214
           +   +   +  L N+  L L  NKL    P  + NL  +  L L  N +         L 
Sbjct: 58  IK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK----DLSSLK 109

Query: 215 RLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSY 274
            L  L+ +SL  N  S I  + + +  +L  L LG N  +      L  L KL+ L L  
Sbjct: 110 DLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLED 165

Query: 275 NFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGT 334
           N ++        +   A    L+ L LS N I     S +  L+                
Sbjct: 166 NQISD-------IVPLAGLTKLQNLYLSKNHI-----SDLRALA---------------- 197

Query: 335 IPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGP 382
                  L NL  L L+  E +         L     +   +  L  P
Sbjct: 198 ------GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 239

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 57/258 (22%), Positives = 104/258 (40%), Gaps = 19/258 (7%)

Query: 291 ANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGL 350
                    +L    +      +   L+ S+ +I  +N  I     + I  L N+ +L L
Sbjct: 21  DAFAETIKDNLKKKSVTDA--VTQNELN-SIDQIIANNSDI--KSVQGIQYLPNVTKLFL 75

Query: 351 WGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPC 410
            GN+ +  I      L+NL  L L  NK++    + L  L +L  L ++ N +S  I   
Sbjct: 76  NGNK-LTDIKP-LANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHNGISD-ING- 129

Query: 411 IGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDL 470
           +  L  L  L L +N++  +  +    L  + +L+   N +  S    +  L  +  + L
Sbjct: 130 LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYL 185

Query: 471 SRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTS 530
           S+N++S D+  A+ GL NL  L L               LV   ++  ++ SL    P  
Sbjct: 186 SKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEI 241

Query: 531 MEKLLYLKDLNLSFNKLE 548
           +      +  N+ ++  E
Sbjct: 242 ISDDGDYEKPNVKWHLPE 259

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 78.6 bits (194), Expect = 4e-16
 Identities = 53/305 (17%), Positives = 106/305 (34%), Gaps = 46/305 (15%)

Query: 241 SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLD 300
           ++     L + S +  +      L  ++ +  + + + S       +       N+  L 
Sbjct: 24  AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-------VQGIQYLPNVTKLF 74

Query: 301 LSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIP 360
           L+ N +     + I  L+                      NL NL  L L  N+ +  + 
Sbjct: 75  LNGNKL-----TDIKPLA----------------------NLKNLGWLFLDENK-VKDLS 106

Query: 361 ITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLL 420
            +   L+ L+ L L +N +     NGL  L +L  LY+  NK++      +  LT L  L
Sbjct: 107 -SLKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTL 161

Query: 421 SLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIP 480
           SL  N+++ ++P     L  + +L  S N +  S    +  LK + +++L          
Sbjct: 162 SLEDNQISDIVP--LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPI 217

Query: 481 TAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDL 540
                L+    +   D  L      S  G     ++       +  +     + + +   
Sbjct: 218 NHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKA 277

Query: 541 NLSFN 545
              F+
Sbjct: 278 KARFH 282

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 61/254 (24%), Positives = 103/254 (40%), Gaps = 25/254 (9%)

Query: 93  RLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGF 152
                    +    +T  +  N  +   +  I    +     +  G+  L ++  L+L  
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNG 77

Query: 153 NNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSID 212
           N LT +I   + NL+NL  L L  NK+       + +L  +K+L+L  N +S      I+
Sbjct: 78  NKLT-DIK-PLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-----DIN 128

Query: 213 -LVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLR 271
            LV LP LE + L  N  + I  + +   +KL  L L +N  S  +P  L  L KL+ L 
Sbjct: 129 GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 184

Query: 272 LSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSI 331
           LS N ++        L + A  KNL +L+L +        +   NL +  +        +
Sbjct: 185 LSKNHISD-------LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237

Query: 332 RGTIPKEIGNLINL 345
              I  + G+    
Sbjct: 238 TPEIISDDGDYEKP 251

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 57/271 (21%), Positives = 111/271 (40%), Gaps = 29/271 (10%)

Query: 19  NLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLS--TGMD 76
                 K  L    +   + Q    L  ++ +   N+ +      ++  +  L   T + 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI-----KSVQGIQYLPNVTKLF 74

Query: 77  FSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIP 136
            + N LT   P    + L     L++  NK+     +++   K+L  +SL +N  ++ I 
Sbjct: 75  LNGNKLTDIKPLANLKNL---GWLFLDENKVK--DLSSLKDLKKLKSLSLEHNGISD-IN 128

Query: 137 RGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTL 196
            GL +L  L++LYLG N +T      +  L  L+ L L+ N++   VP  +  L+ ++ L
Sbjct: 129 -GLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL 183

Query: 197 ALPSNALSGSLPSSID-LVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSG 255
            L  N +     S +  L  L NL+++ L          +   N    + ++  + S   
Sbjct: 184 YLSKNHI-----SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT 238

Query: 256 FIPNTLGNLRKLEWLRLSYNFLTSSTSELSF 286
             P  + +    E   + ++ L   T+E+SF
Sbjct: 239 --PEIISDDGDYEKPNVKWH-LPEFTNEVSF 266

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 54.3 bits (131), Expect = 5e-08
 Identities = 49/235 (20%), Positives = 86/235 (36%), Gaps = 23/235 (9%)

Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
            L L+ N L+   P  + NL  L  L L  NK++ ++   L +L +L+ +SL +N +S  
Sbjct: 72  KLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-- 125

Query: 61  IPSTIFNLSSLS--TGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQC 118
               I  L  L     +   NN +T         RL  +  L + +N+++  +P  +   
Sbjct: 126 ---DINGLVHLPQLESLYLGNNKITDITVLS---RLTKLDTLSLEDNQISDIVP--LAGL 177

Query: 119 KELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNK 178
            +L  + L+ N  ++   R L  L +L  L L       +      NL     +      
Sbjct: 178 TKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS 235

Query: 179 LVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGII 233
           LV     +   +S       P+        ++           I  A   F G +
Sbjct: 236 LV-----TPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRV 285

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 42.0 bits (99), Expect = 5e-04
 Identities = 16/92 (17%), Positives = 40/92 (43%), Gaps = 6/92 (6%)

Query: 457 EDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESL 516
                    +  +L + +++  +      L ++  +   ++ ++ S+ + I  L ++  L
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 73

Query: 517 DLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLE 548
            L+ N L+ +I   +  L  L  L L  NK++
Sbjct: 74  FLNGNKLT-DI-KPLANLKNLGWLFLDENKVK 103

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 81.9 bits (203), Expect = 3e-17
 Identities = 47/164 (28%), Positives = 79/164 (48%), Gaps = 26/164 (15%)

Query: 666 LIGTGGFGSVYKGS-FLDGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRHRNLVKII 721
            +G G FG V  G   L G +VA+K+     ++    +     E + LK  RH +++K+ 
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV---------IIDVALALEYL 772
              +      +V+EY+  G L DY+  +        R+           I+    A++Y 
Sbjct: 78  QVISTPTDFFMVMEYVSGGELFDYICKH-------GRVEEMEARRLFQQILS---AVDYC 127

Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK 816
           H    + VVH D+KP NVLLD  M A ++DFG++ ++S  E ++
Sbjct: 128 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 168

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 82.6 bits (204), Expect = 4e-17
 Identities = 31/142 (21%), Positives = 60/142 (42%), Gaps = 16/142 (11%)

Query: 701 SFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNF--SFDILQR 758
           +  V+   +     +N V  +   +   +  + ++     +L+D++         +    
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166

Query: 759 LSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT 818
           L + I +A A+E+LH   S  ++H D+KPSN+    D V  + DFG+   +  +E  +  
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223

Query: 819 LTLA-----------TIGYMAP 829
           LT             T  YM+P
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSP 245

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 45.3 bits (107), Expect = 6e-05
 Identities = 17/73 (23%), Positives = 30/73 (41%), Gaps = 2/73 (2%)

Query: 659 NQFNASNLIGTGGFGSVYKG-SFLDGMEVAIK-VFHLQLEGALKSFDVECEVLKSVRHRN 716
             F     +G GGFG V++  + +D    AIK +     E A +    E + L  + H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 717 LVKIISSCTNNDF 729
           +V+  ++      
Sbjct: 66  IVRYFNAWLETPP 78

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 82.7 bits (205), Expect = 4e-17
 Identities = 43/197 (21%), Positives = 76/197 (38%), Gaps = 40/197 (20%)

Query: 667 IGTGGFGSVYKGSFLDG------MEVAIKVFHLQLEGA----LKSFDVECEVLKSV-RHR 715
           +G+G FG V   +          ++VA+K+     E A     ++   E +++  +  H 
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKMMTQLGSHE 109

Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYL----------------------YSNNFSF 753
           N+V ++ +CT +    L+ EY   G L +YL                        +    
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 754 DILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA-KLLSGE 812
                L     VA  +E+L        VH D+   NVL+    V  + DFG+A  ++S  
Sbjct: 170 TFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226

Query: 813 ESMKQTLTLATIGYMAP 829
             + +      + +MAP
Sbjct: 227 NYVVRGNARLPVKWMAP 243

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 82.1 bits (203), Expect = 6e-17
 Identities = 43/179 (24%), Positives = 72/179 (40%), Gaps = 28/179 (15%)

Query: 667 IGTGGFGSVYKGS-FLDGMEVAIKVF---HLQLEGALKSFDV-----ECEVLKSVRHRNL 717
           +G+G FG V+         EV +K      +  +  ++   +     E  +L  V H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 718 VKIISSCTNNDFKALVLEYMPNGS-LEDYLYSNNFSFDILQRLS------VIIDVALALE 770
           +K++    N  F  LV+E   +G  L  ++  +        RL       +   +  A+ 
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH-------PRLDEPLASYIFRQLVSAVG 144

Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           YL       ++H DIK  N+++ +D    L DFG A  L   +         TI Y AP
Sbjct: 145 YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY--TFCGTIEYCAP 198

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 80.7 bits (200), Expect = 1e-16
 Identities = 41/147 (27%), Positives = 67/147 (45%), Gaps = 14/147 (9%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEG------ALKSFDVECEVLKSVRHRNLVKI 720
           +G G +G VYK     G  VA+K   L  E       A++    E  +LK + H N+V +
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISLLKELHHPNIVSL 84

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPV 780
           I    +     LV E+M    L+  L  N       Q    +  +   + + H    + +
Sbjct: 85  IDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRI 140

Query: 781 VHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           +H D+KP N+L++ D    L+DFG+A+
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLAR 167

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 82.1 bits (203), Expect = 2e-16
 Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 26/164 (15%)

Query: 666 LIGTGGFGSVYKGS-FLDGMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKII 721
            +G G FG V  G   L G +VA+K+ +   ++    +     E + LK  RH +++K+ 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV---------IIDVALALEYL 772
              +      +V+EY+  G L DY+  N        RL           I+     ++Y 
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYICKN-------GRLDEKESRRLFQQILS---GVDYC 132

Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK 816
           H    + VVH D+KP NVLLD  M A ++DFG++ ++S  E ++
Sbjct: 133 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 173

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 81.6 bits (202), Expect = 2e-16
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 18/170 (10%)

Query: 656 QATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHR 715
           Q    +    +IG G FG V++   ++  EVAIK          +    E ++++ V+H 
Sbjct: 37  QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHP 92

Query: 716 NLVK----IISSCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFDILQRLSV---IIDVA 766
           N+V       S+    D     LVLEY+P  ++             +  L +   +  + 
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLL 151

Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAKLLSGEESM 815
            +L Y+H   S  + H DIKP N+LLD    V  L DFG AK+L   E  
Sbjct: 152 RSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 44/165 (26%), Positives = 68/165 (41%), Gaps = 31/165 (18%)

Query: 667 IGTGGFGSVYKGS-FLDGMEVAIKVFHLQLEGALKSFDV-----ECEVLKSVRHRNLVKI 720
           IG G F  V      L G EVAIK+        L    +     E  ++K + H N+VK+
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKT---QLNPTSLQKLFREVRIMKILNHPNIVKL 79

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV---------IIDVALALEY 771
                      L++EY   G + DYL ++        R+           I+    A++Y
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVAH-------GRMKEKEARSKFRQIVS---AVQY 129

Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK 816
            H      +VH D+K  N+LLD DM   ++DFG +   +    + 
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD 171

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 79.5 bits (197), Expect = 3e-16
 Identities = 44/151 (29%), Positives = 67/151 (44%), Gaps = 15/151 (9%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEG------ALKSFDVECEVLKSVRHRNLVK 719
           IG G +G V+K  +   G  VAIK F    +       AL+    E  +LK ++H NLV 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQLKHPNLVN 66

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
           ++          LV EY  + ++   L             S+      A+ + H    + 
Sbjct: 67  LLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHN 122

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS 810
            +H D+KP N+L+ K  V  L DFG A+LL+
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLT 153

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 77.9 bits (193), Expect = 7e-16
 Identities = 41/148 (27%), Positives = 73/148 (49%), Gaps = 15/148 (10%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEG------ALKSFDVECEVLKSVRHRNLVK 719
           IG G +G+V+K  +      VA+K   L  +       AL+    E  +LK ++H+N+V+
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVR 65

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
           +     ++    LV E+     L+ Y  S N   D     S +  +   L + H   S  
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           V+H D+KP N+L++++    L++FG+A+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLAR 149

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 78.8 bits (195), Expect = 8e-16
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 15/153 (9%)

Query: 665 NLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEG------ALKSFDVECEVLKSVRHRNL 717
            L+G G +G V K    D G  VAIK F    +       A++    E ++LK +RH NL
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKLLKQLRHENL 86

Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           V ++  C       LV E++ + ++ D L       D       +  +   + + H   S
Sbjct: 87  VNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---S 142

Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS 810
           + ++H DIKP N+L+ +  V  L DFG A+ L+
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 78.8 bits (195), Expect = 8e-16
 Identities = 42/147 (28%), Positives = 73/147 (49%), Gaps = 10/147 (6%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALK-SFDV----ECEVLKSVRHRNLVKI 720
           +G G F +VYK         VAIK   L      K   +     E ++L+ + H N++ +
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPV 780
           + +  +    +LV ++M    LE  +  N+         + ++     LEYLH    + +
Sbjct: 78  LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWI 133

Query: 781 VHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           +H D+KP+N+LLD++ V  L+DFG+AK
Sbjct: 134 LHRDLKPNNLLLDENGVLKLADFGLAK 160

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 77.6 bits (192), Expect = 9e-16
 Identities = 38/147 (25%), Positives = 68/147 (46%), Gaps = 14/147 (9%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEG------ALKSFDVECEVLKSVRHRNLVKI 720
           IG G +G VYK     G   A+K   L+ E        ++    E  +LK ++H N+VK+
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKELKHSNIVKL 65

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPV 780
                      LV E++    L+  L       + +   S ++ +   + Y H      V
Sbjct: 66  YDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121

Query: 781 VHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           +H D+KP N+L++++    ++DFG+A+
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLAR 148

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 78.6 bits (194), Expect = 1e-15
 Identities = 44/178 (24%), Positives = 70/178 (39%), Gaps = 32/178 (17%)

Query: 666 LIGTGGFGSVYKG-SFLDGMEVAIKVF--HLQLEGALKSFDVECEVLKSVRHRNLVKIIS 722
            IG+G FG        L    VA+K       ++  ++    E    +S+RH N+V+   
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR---EIINHRSLRHPNIVRFKE 83

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV---------IIDVALALEYLH 773
                   A+++EY   G L + + +         R S          ++     + Y H
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNA-------GRFSEDEARFFFQQLLS---GVSYCH 133

Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHL--SDFGIAKLLSGEESMKQTLTLATIGYMAP 829
              S  + H D+K  N LLD      L   DFG +K  S   S  ++ T+ T  Y+AP
Sbjct: 134 ---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKS-TVGTPAYIAP 186

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 31/191 (16%), Positives = 73/191 (38%), Gaps = 18/191 (9%)

Query: 141 NLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPS 200
              +     LG ++       +M +L  + +  + +  L     T I     +K L + +
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDL-----TGIEYAHNIKDLTINN 75

Query: 201 NALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNT 260
              +   P    +  L NLE + + G + +      +   + L++L++  ++    I   
Sbjct: 76  IHATNYNP----ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131

Query: 261 LGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLS 320
           +  L K+  + LSYN   +    L           LK L++  + ++      I +    
Sbjct: 132 INTLPKVNSIDLSYNGAITDIMPLK------TLPELKSLNIQFDGVHDY--RGIEDFP-K 182

Query: 321 LSRIFISNCSI 331
           L++++  + +I
Sbjct: 183 LNQLYAFSQTI 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 73.5 bits (181), Expect = 5e-15
 Identities = 30/188 (15%), Positives = 68/188 (36%), Gaps = 13/188 (6%)

Query: 291 ANCKNLKLLDLSNNPINGVLPSSIGNL-SLSLSRIFISNCSIRGTIPKEIGNLINLRELG 349
           +  K      L  +    +  + + +L  ++L+ I +++ +        I    N+++L 
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLT-------GIEYAHNIKDLT 72

Query: 350 LWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPP 409
           +         PI    L NL+ L ++   +       L  L  L++L +  +     I  
Sbjct: 73  INNIHATNYNPI--SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130

Query: 410 CIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIID 469
            I  L  +  + L+ N   + I      L ++ SLN   + ++      I +   +  + 
Sbjct: 131 KINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLY 187

Query: 470 LSRNNLSG 477
                + G
Sbjct: 188 AFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 73.1 bits (180), Expect = 6e-15
 Identities = 29/170 (17%), Positives = 62/170 (36%), Gaps = 14/170 (8%)

Query: 140 GNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALP 199
             + SL  + L   N+T      +    N++ L +       + P  I  LS ++ L + 
Sbjct: 41  AQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIM 96

Query: 200 SNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPN 259
              ++       +L  L +L ++ ++ +     I + I    K++ ++L  N     I  
Sbjct: 97  GKDVTSDKIP--NLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154

Query: 260 TLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGV 309
            L  L +L+ L + ++ +              +   L  L   +  I G 
Sbjct: 155 -LKTLPELKSLNIQFDGVHD-------YRGIEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 72.3 bits (178), Expect = 1e-14
 Identities = 33/191 (17%), Positives = 65/191 (34%), Gaps = 31/191 (16%)

Query: 360 PITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRL 419
            IT  ++ +L  + L N  +      G+     +  L ++    +   P  I  L++L  
Sbjct: 37  NITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLER 92

Query: 420 LSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDI 479
           L +   ++ S        L                      +L    ++D+S +     I
Sbjct: 93  LRIMGKDVTSDKIPNLSGLT---------------------SLT---LLDISHSAHDDSI 128

Query: 480 PTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKD 539
            T I  L  +  + L  NG    I   +  L  L+SL++  + +  +    +E    L  
Sbjct: 129 LTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVH-DY-RGIEDFPKLNQ 185

Query: 540 LNLSFNKLEGE 550
           L      + G+
Sbjct: 186 LYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 69.2 bits (170), Expect = 1e-13
 Identities = 26/162 (16%), Positives = 62/162 (38%), Gaps = 9/162 (5%)

Query: 94  LPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFN 153
           +  +  + ++N  +T      I     +  +++     T   P  +  L++L+ L +   
Sbjct: 43  MNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGK 98

Query: 154 NLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDL 213
           ++T +    +  L +L +L +  +     + T I  L  + ++ L  N     +     L
Sbjct: 99  DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP---L 155

Query: 214 VRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSG 255
             LP L+ +++  +         I +  KL+ L     +  G
Sbjct: 156 KTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 65.0 bits (159), Expect = 4e-12
 Identities = 28/187 (14%), Positives = 67/187 (35%), Gaps = 12/187 (6%)

Query: 19  NLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFS 78
                    LG +        ++ +L  + L ++    L+G     I    ++   +  +
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKD-LTIN 74

Query: 79  NNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRG 138
           N   T   P      L  ++ L +    +T     N+     L ++ ++++   + I   
Sbjct: 75  NIHATNYNP---ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131

Query: 139 LGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLAL 198
           +  L  + ++ L +N    +I   +  L  L+ L +Q + +  +    I +   +  L  
Sbjct: 132 INTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYA 188

Query: 199 PSNALSG 205
            S  + G
Sbjct: 189 FSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 63.4 bits (155), Expect = 1e-11
 Identities = 23/133 (17%), Positives = 55/133 (41%), Gaps = 4/133 (3%)

Query: 415 TSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNN 474
           ++ +         +S    T   +  +  +  ++  +   L   I     +  + ++  +
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIH 77

Query: 475 LSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKL 534
            + +    I GL NL+ L +    +      ++ GL SL  LD+S+++   +I T +  L
Sbjct: 78  AT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135

Query: 535 LYLKDLNLSFNKL 547
             +  ++LS+N  
Sbjct: 136 PKVNSIDLSYNGA 148

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 59.2 bits (144), Expect = 4e-10
 Identities = 29/178 (16%), Positives = 58/178 (32%), Gaps = 33/178 (18%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           ++L+  +++      I     +K L +         P  +  L+ LE + +    ++   
Sbjct: 49  ITLANINVTDL--TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDK 104

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
              +  L+SL+                           L +S++     I   I    ++
Sbjct: 105 IPNLSGLTSLTL--------------------------LDISHSAHDDSILTKINTLPKV 138

Query: 122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKL 179
             I L+YN     I   L  L  LK+L + F+ +      E  +   L  L      +
Sbjct: 139 NSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTI 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 55.4 bits (134), Expect = 7e-09
 Identities = 24/157 (15%), Positives = 57/157 (36%), Gaps = 31/157 (19%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L+++    +   P  I  L+ L++L +    +  +    L  L  L L+ ++++    +I
Sbjct: 71  LTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI 128

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
            + I  L  +++                          + +S N     I   +    EL
Sbjct: 129 LTKINTLPKVNS--------------------------IDLSYNGAITDI-MPLKTLPEL 161

Query: 122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGE 158
             +++ ++   +   RG+ +   L  LY     + G+
Sbjct: 162 KSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGGK 196

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 77.4 bits (191), Expect = 2e-15
 Identities = 44/164 (26%), Positives = 65/164 (39%), Gaps = 27/164 (16%)

Query: 666 LIGTGGFGSVYKGS-FLDGMEVAIK------VFHLQLEGALKSFDVECEVLKSVRHR--N 716
           L+G+GGFGSVY G    D + VAIK      +             +E  +LK V      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 717 LVKIISSCTNNDFKALVLEY-MPNGSLEDYLYSNNFSFDILQRLS------VIIDVALAL 769
           +++++      D   L+LE   P   L D++            L           V  A+
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITER-------GALQEELARSFFWQVLEAV 162

Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKD-MVAHLSDFGIAKLLSGE 812
            + H   +  V+H DIK  N+L+D +     L DFG   LL   
Sbjct: 163 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 203

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 42/256 (16%), Positives = 78/256 (30%), Gaps = 35/256 (13%)

Query: 293 CKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWG 352
           C   +   ++   I       I +L  S   + +    +R        NL N+  + +  
Sbjct: 10  CHQEEDFRVTCKDI-----QRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSI 64

Query: 353 NELIGSIPI-TFGKLQNLQGLDLVNNKLEGPIPNGLCQ-LARLSVLYMDGNKLSG-PIPP 409
           +  +  +   +F  L  +  +++ N +    I     + L  L  L +    L   P   
Sbjct: 65  DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLT 124

Query: 410 CIGDLTSLRLLSLASNELNSVIPS-TFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVII 468
            +       +L +  N   + IP   F  L +                         + +
Sbjct: 125 KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNET-----------------------LTL 161

Query: 469 DLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI-GGLVS-LESLDLSNNSLSGN 526
            L  N  +  +         L  + L  N     I K   GG+ S    LD+S  S++  
Sbjct: 162 KLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL 220

Query: 527 IPTSMEKLLYLKDLNL 542
               +E L  L   N 
Sbjct: 221 PSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 74.3 bits (183), Expect = 5e-15
 Identities = 33/194 (17%), Positives = 70/194 (36%), Gaps = 15/194 (7%)

Query: 120 ELIVISLAYNQFTERIPRG-LGNLTSLKTLYLGFNNLTGEIPYEM-GNLRNLEILGLQLN 177
               + L        IP     NL ++  +Y+  +    ++      NL  +  + ++  
Sbjct: 32  STQTLKLIETHLRT-IPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90

Query: 178 KLVGFVPTSIF-NLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSF 236
           + + ++       L  +K L + +  L    P    +       I+ +  N +   IP  
Sbjct: 91  RNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149

Query: 237 IFN--ASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSF--LSSWAN 292
            F    ++   L+L  N F+  +     N  KL+ + L+ N   +   + +F  + S   
Sbjct: 150 AFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYS--- 205

Query: 293 CKNLKLLDLSNNPI 306
                LLD+S   +
Sbjct: 206 --GPSLLDVSQTSV 217

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 73.9 bits (182), Expect = 7e-15
 Identities = 39/210 (18%), Positives = 77/210 (36%), Gaps = 14/210 (6%)

Query: 243 LSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLS 302
              L+L E        +   NL  +  + +S +         SF     N   +  +++ 
Sbjct: 33  TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSF----YNLSKVTHIEIR 88

Query: 303 NNP-INGVLPSSIGNLSLSLSRIFISNCSIRGTIPKE--IGNLINLRELGLWGNELIGSI 359
           N   +  + P ++  L   L  + I N  ++   P    + +      L +  N  + SI
Sbjct: 89  NTRNLTYIDPDALKELP-LLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSI 146

Query: 360 PI-TFGKLQN-LQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCI--GDLT 415
           P+  F  L N    L L NN     +        +L  +Y++ NK    I      G  +
Sbjct: 147 PVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYS 205

Query: 416 SLRLLSLASNELNSVIPSTFWNLKDILSLN 445
              LL ++   + ++      +LK++++ N
Sbjct: 206 GPSLLDVSQTSVTALPSKGLEHLKELIARN 235

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 44/208 (21%), Positives = 77/208 (37%), Gaps = 10/208 (4%)

Query: 23  LKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIF-NLSSLSTGMDFSNNS 81
            + L L    LR        NL  +  + ++ +     + S  F NLS ++  ++  N  
Sbjct: 33  TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTH-IEIRNTR 91

Query: 82  LTGSLPDDMCRRLPLIKGLYMSNNKLTG-PIPNNIWQCKELIVISLAYNQFTERIPRG-L 139
               +  D  + LPL+K L + N  L   P    ++      ++ +  N +   IP    
Sbjct: 92  NLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151

Query: 140 GNLTS-LKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFN--LSAMKTL 196
             L +   TL L  N  T  +     N   L+ + L  NK +  +    F    S    L
Sbjct: 152 QGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210

Query: 197 ALPSNALSGSLPSSIDLVRLPNLEIISL 224
            +   +++ +LPS   L  L  L   + 
Sbjct: 211 DVSQTSVT-ALPSKG-LEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 35/196 (17%), Positives = 71/196 (36%), Gaps = 11/196 (5%)

Query: 368 NLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCI-GDLTSLRLLSLASN- 425
           + Q L L+   L     +    L  +S +Y+  +     +      +L+ +  + + +  
Sbjct: 32  STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91

Query: 426 ELNSVIPSTFWNLKDILSLNFSSNFLNGSLPED--IGNLKVVVIIDLSRNNLSGDIPT-A 482
            L  + P     L  +  L   +  L    P+   + +  +  I++++ N     IP  A
Sbjct: 92  NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150

Query: 483 IGGLMN-LQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSM-EKLL-YLKD 539
             GL N    L L +NG   S+         L+++ L+ N     I       +      
Sbjct: 151 FQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSL 209

Query: 540 LNLSFNKLEGEIPRGG 555
           L++S   +   +P  G
Sbjct: 210 LDVSQTSVT-ALPSKG 224

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 61.9 bits (151), Expect = 9e-11
 Identities = 33/177 (18%), Positives = 60/177 (33%), Gaps = 12/177 (6%)

Query: 384 PNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILS 443
            +  C+  +     +    +   IP       S + L L    L ++    F NL +I  
Sbjct: 4   SSPPCECHQEEDFRVTCKDIQR-IP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISR 59

Query: 444 LNFSSNFLNGSLPEDI-GNLKVVVIIDLSRNNLSGDIPT-AIGGLMNLQDLSLRDNGLQG 501
           +  S +     L      NL  V  I++        I   A+  L  L+ L + + GL+ 
Sbjct: 60  IYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK- 118

Query: 502 SIP--KSIGGLVSLESLDLSNNSLSGNIPTSMEKLL--YLKDLNLSFNKLEGEIPRG 554
             P    +        L++++N    +IP +  + L      L L  N     +   
Sbjct: 119 MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGY 174

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 76.5 bits (189), Expect = 3e-15
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 14/155 (9%)

Query: 659 NQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQL-EG----ALKSFDVECEVLKSV 712
             +   + +G G + +VYKG S L    VA+K   L+  EG    A++    E  +LK +
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDL 57

Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
           +H N+V +           LV EY+    L+ YL       ++      +  +   L Y 
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116

Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           H      V+H D+KP N+L+++     L+DFG+A+
Sbjct: 117 H---RQKVLHRDLKPQNLLINERGELKLADFGLAR 148

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 34/163 (20%), Positives = 61/163 (37%), Gaps = 42/163 (25%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEV---LKSVRHRNLVKII- 721
           +G G  G V +        + A+K+                EV    ++ +  ++V+I+ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78

Query: 722 ---SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD-ILQRL----------SVIIDVAL 767
              +         +V+E +  G L          F  I  R            ++  +  
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGE 128

Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAK 807
           A++YLH   S  + H D+KP N+L      + +  L+DFG AK
Sbjct: 129 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 77.4 bits (191), Expect = 5e-15
 Identities = 53/173 (30%), Positives = 76/173 (43%), Gaps = 27/173 (15%)

Query: 658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRN 716
              +  + +IG G FG VY+    D G  VAIK          +    E ++++ + H N
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 108

Query: 717 LVK----IISSCTNNDFKAL--VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL--- 767
           +V+      SS    D   L  VL+Y+P  ++       + +    Q L  +I V L   
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK---QTLP-VIYVKLYMY 163

Query: 768 ----ALEYLHFGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAKLLSGEESM 815
               +L Y+H   S  + H DIKP N+LLD D  V  L DFG AK L   E  
Sbjct: 164 QLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 77.5 bits (191), Expect = 5e-15
 Identities = 54/189 (28%), Positives = 81/189 (42%), Gaps = 36/189 (19%)

Query: 659 NQFNASNLIGTGGFGSVY----KGSFLDGMEVAIKVFHLQLEGALKSFDVEC-----EVL 709
           N+F    L+G G FG V     K +   G   A+K+  L+ E  +   +V        VL
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKAT---GRYYAMKI--LKKEVIVAKDEVAHTLTENRVL 202

Query: 710 KSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV-------- 761
           ++ RH  L  +  S   +D    V+EY   G L          F  L R  V        
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL----------FFHLSRERVFSEDRARF 252

Query: 762 -IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT 820
              ++  AL+YLH      VV+ D+K  N++LDKD    ++DFG+ K    + +  +T  
Sbjct: 253 YGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF- 309

Query: 821 LATIGYMAP 829
             T  Y+AP
Sbjct: 310 CGTPEYLAP 318

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 75.4 bits (186), Expect = 8e-15
 Identities = 43/164 (26%), Positives = 76/164 (46%), Gaps = 27/164 (16%)

Query: 666 LIGTGGFGSVYKGS-FLDGMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKII 721
            +G G FG V   + +    +VA+K      L+        + E   LK +RH +++K+ 
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 722 SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV---------IIDVALALEYL 772
              T      +V+EY   G L DY+          +R++          II    A+EY 
Sbjct: 76  DVITTPTDIVMVIEYA-GGELFDYIVEK-------KRMTEDEGRRFFQQIIC---AIEYC 124

Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK 816
           H    + +VH D+KP N+LLD ++   ++DFG++ +++    +K
Sbjct: 125 H---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK 165

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 75.7 bits (186), Expect = 9e-15
 Identities = 37/162 (22%), Positives = 66/162 (40%), Gaps = 14/162 (8%)

Query: 267 LEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFI 326
              L LS+N L+   +E +         NL  L LS+N +N +   +   +  +L  + +
Sbjct: 41  TALLDLSHNNLSRLRAEWTP----TRLTNLHSLLLSHNHLNFISSEAFVPVP-NLRYLDL 95

Query: 327 SNCSIRGTIPKEI-GNLINLRELGLWGNELIGSIPI-TFGKLQNLQGLDLVNNKLEGPIP 384
           S+  +  T+ + +  +L  L  L L+ N  I  +    F  +  LQ L L  N++    P
Sbjct: 96  SSNHLH-TLDEFLFSDLQALEVLLLYNNH-IVVVDRNAFEDMAQLQKLYLSQNQISR-FP 152

Query: 385 NG----LCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSL 422
                   +L +L +L +  NKL       +  L +     L
Sbjct: 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 74.9 bits (184), Expect = 2e-14
 Identities = 46/184 (25%), Positives = 77/184 (41%), Gaps = 17/184 (9%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQE--LGNLAELELVSLTNNFLSG 59
           LS S   L   +P+ + + T    L L +N L   +  E     L  L  + L++N L+ 
Sbjct: 23  LSCSKQQLP-NVPQSLPSYT--ALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN- 77

Query: 60  TIPSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQ- 117
            I S  F  + +L   +D S+N L  +L + +   L  ++ L + NN +   +  N ++ 
Sbjct: 78  FISSEAFVPVPNLRY-LDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFED 134

Query: 118 CKELIVISLAYNQFTERIPRG----LGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILG 173
             +L  + L+ NQ + R P         L  L  L L  N L      ++  L      G
Sbjct: 135 MAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG 193

Query: 174 LQLN 177
           L L+
Sbjct: 194 LYLH 197

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 37/187 (19%), Positives = 72/187 (38%), Gaps = 15/187 (8%)

Query: 50  VSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTG 109
           +S +   L   +P    +L S +  +D S+N+L+    +    RL  +  L +S+N L  
Sbjct: 23  LSCSKQQLP-NVPQ---SLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNF 78

Query: 110 PIPNNIW-QCKELIVISLAYNQFTERIPRG-LGNLTSLKTLYLGFNNLTGEIPYEM-GNL 166
            I +  +     L  + L+ N     +      +L +L+ L L  N++   +      ++
Sbjct: 79  -ISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDM 135

Query: 167 RNLEILGLQLNKLVGFVPTSIF----NLSAMKTLALPSNALSGSLPSSIDLVRLPNLEII 222
             L+ L L  N++    P  +      L  +  L L SN L     + +  +       +
Sbjct: 136 AQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194

Query: 223 SLAGNNF 229
            L  N  
Sbjct: 195 YLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 69.9 bits (171), Expect = 7e-13
 Identities = 41/172 (23%), Positives = 67/172 (38%), Gaps = 12/172 (6%)

Query: 183 VPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIF-NAS 241
           VP S+   S    L L  N LS  L +     RL NL  + L+ N+ +  I S  F    
Sbjct: 33  VPQSLP--SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88

Query: 242 KLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDL 301
            L  L+L  N           +L+ LE L L  N +           ++ +   L+ L L
Sbjct: 89  NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRN-----AFEDMAQLQKLYL 143

Query: 302 SNNPINGVLPSSIGNLSL--SLSRIFISNCSIRGTIPKEIGNLINLRELGLW 351
           S N I+      I + +    L  + +S+  ++     ++  L    + GL+
Sbjct: 144 SQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 67.6 bits (165), Expect = 4e-12
 Identities = 45/170 (26%), Positives = 74/170 (43%), Gaps = 12/170 (7%)

Query: 383 IPNGLCQLARLSVLYMDGNKLSGPIPPCI--GDLTSLRLLSLASNELNSVIPSTFWNLKD 440
           +P  L   +  ++L +  N LS  +        LT+L  L L+ N LN +    F  + +
Sbjct: 33  VPQSL--PSYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPN 89

Query: 441 ILSLNFSSNFLNGSLPEDI-GNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGL 499
           +  L+ SSN L+ +L E +  +L+ + ++ L  N++      A   +  LQ L L  N +
Sbjct: 90  LRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQI 148

Query: 500 QGSIP----KSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFN 545
               P    K    L  L  LDLS+N L     T ++KL       L  +
Sbjct: 149 S-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 75.0 bits (185), Expect = 1e-14
 Identities = 52/185 (28%), Positives = 73/185 (39%), Gaps = 36/185 (19%)

Query: 666 LIGTGGFGSVYKGS-FLDGMEVAIK------VFHLQLEGALKSFDVECEVLKSVR----H 714
           L+G GGFG+V+ G    D ++VAIK      V          +  +E  +L  V     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 715 RNLVKIISSCTNNDFKALVLEY-MPNGSLEDYLYSNNFSFDILQRLS------VIIDVAL 767
             +++++      +   LVLE  +P   L DY+            L           V  
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-------GPLGEGPSRCFFGQVVA 150

Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAKLLSGEESMKQTLTLA--TI 824
           A+++ H   S  VVH DIK  N+L+D     A L DFG   LL  E       T    T 
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-----YTDFDGTR 202

Query: 825 GYMAP 829
            Y  P
Sbjct: 203 VYSPP 207

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 74.5 bits (184), Expect = 1e-14
 Identities = 42/151 (27%), Positives = 75/151 (49%), Gaps = 16/151 (10%)

Query: 665 NLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEG------ALKSFDVECEVLKSVRHRNL 717
             IG G +G VYK  + L G  VA+K   L  E       A++    E  +LK + H N+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR----EISLLKELNHPNI 64

Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFS-FDILQRLSVIIDVALALEYLHFGY 776
           VK++      +   LV E++    L+ ++ ++  +   +    S +  +   L + H   
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 120

Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           S+ V+H D+KP N+L++ +    L+DFG+A+
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 76.7 bits (188), Expect = 1e-14
 Identities = 47/217 (21%), Positives = 77/217 (35%), Gaps = 12/217 (5%)

Query: 14  PKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLST 73
            ++      L +  L   K    +  EL +  EL+ +   N +   TI   +  L  L  
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400

Query: 74  GMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTE 133
               +    +     D  R       L    +K          +  ++ V+ LA+   T 
Sbjct: 401 E-KETLQYFSTLKAVDPMR----AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV 455

Query: 134 RIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAM 193
                L  L  +  L L  N L   +P  +  LR LE+L    N L       + NL  +
Sbjct: 456 --LCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRL 510

Query: 194 KTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFS 230
           + L L +N L     +   LV  P L +++L GN+  
Sbjct: 511 QELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 72.9 bits (178), Expect = 2e-13
 Identities = 56/338 (16%), Positives = 106/338 (31%), Gaps = 21/338 (6%)

Query: 207 LPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFI----PNTLG 262
           L    +   +     +S      S      +   S++  L L  +     +    P+   
Sbjct: 235 LLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRN 294

Query: 263 NLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLS 322
               +    L    L     + +F   W    + K   L  +                  
Sbjct: 295 RPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFR 353

Query: 323 RIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGP 382
                +      +  E+ +   L+EL       + +I +    L  L             
Sbjct: 354 --CELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYF--- 408

Query: 383 IPNGLCQL--ARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKD 440
             + L  +   R + L    +K          +   +R+L LA  +L  +       L  
Sbjct: 409 --STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLE--QLLL 464

Query: 441 ILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQ 500
           +  L+ S N L  +LP  +  L+ + ++  S N L  ++   +  L  LQ+L L +N LQ
Sbjct: 465 VTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ 521

Query: 501 G-SIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYL 537
             +  + +     L  L+L  NSL        E+L  +
Sbjct: 522 QSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 68.6 bits (167), Expect = 4e-12
 Identities = 42/279 (15%), Positives = 93/279 (33%), Gaps = 14/279 (5%)

Query: 270 LRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNC 329
           L + ++   +  S +  L    +   L +   + +  N      + +L          N 
Sbjct: 257 LSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDL-----PAASLND 311

Query: 330 SIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQ 389
            +     + I    + ++  +   +            + L   +L   K    + + L  
Sbjct: 312 QLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELES 370

Query: 390 LARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSN 449
              L  L  +       +   I  + +L  L      L         +      L+   +
Sbjct: 371 CKELQELEPENK---WCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRS 427

Query: 450 FLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGG 509
                          V ++ L+  +L+  +   +  L+ +  L L  N L+ ++P ++  
Sbjct: 428 KFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAA 484

Query: 510 LVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLE 548
           L  LE L  S+N+L  N+   +  L  L++L L  N+L+
Sbjct: 485 LRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ 521

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 65.9 bits (160), Expect = 3e-11
 Identities = 43/244 (17%), Positives = 81/244 (33%), Gaps = 40/244 (16%)

Query: 112 PNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEI 171
             +    ++L    L+  + +  +   L +   L+ L          I   M  L  L  
Sbjct: 342 CRDSATDEQLFRCELSVEK-STVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400

Query: 172 LGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSG 231
               L        +++  +  M+   L        L +S+  +   ++ ++ LA  + + 
Sbjct: 401 EKETLQYF-----STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV 455

Query: 232 IIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWA 291
           +    +     ++ L+L  N     +P  L  LR LE L+ S N L +       +   A
Sbjct: 456 L--CHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN-------VDGVA 505

Query: 292 NCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLW 351
           N   L+ L L NN +               + I            + + +   L  L L 
Sbjct: 506 NLPRLQELLLCNNRLQ------------QSAAI------------QPLVSCPRLVLLNLQ 541

Query: 352 GNEL 355
           GN L
Sbjct: 542 GNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 54.4 bits (130), Expect = 1e-07
 Identities = 33/181 (18%), Positives = 66/181 (36%), Gaps = 16/181 (8%)

Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGY-----NKLRGEIPQELGNLAELELVSLTNN 55
           M +L          +    L  +  +   Y     +K   E        A++ ++ L + 
Sbjct: 392 MRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHK 451

Query: 56  FLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNI 115
            L  T+   +  L  ++  +D S+N L  +LP  +   L  ++ L  S+N L   +   +
Sbjct: 452 DL--TVLCHLEQLLLVTH-LDLSHNRLR-ALPPALAA-LRCLEVLQASDNALEN-VDG-V 504

Query: 116 WQCKELIVISLAYNQFTE-RIPRGLGNLTSLKTLYLGFNNLTGEIPYE---MGNLRNLEI 171
                L  + L  N+  +    + L +   L  L L  N+L  E   +      L ++  
Sbjct: 505 ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSS 564

Query: 172 L 172
           +
Sbjct: 565 I 565

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 74.5 bits (184), Expect = 2e-14
 Identities = 52/190 (27%), Positives = 88/190 (46%), Gaps = 37/190 (19%)

Query: 659 NQFNASNLIGTGGFGSVY---KGSFLDGMEV-AIKVFHLQLEGALKSFDVEC----EVLK 710
           +QF    ++G G FG V+   K S  D  ++ A+KV  L+         V      ++L 
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKV--LKKATLKVRDRVRTKMERDILV 81

Query: 711 SVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV--------- 761
            V H  +VK+  +        L+L+++  G L          F  L +  +         
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL----------FTRLSKEVMFTEEDVKFY 131

Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAH--LSDFGIAKLLSGEESMKQTL 819
           + ++ALAL++LH   S  +++ D+KP N+LLD++   H  L+DFG++K     E    + 
Sbjct: 132 LAELALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKAYSF 186

Query: 820 TLATIGYMAP 829
              T+ YMAP
Sbjct: 187 -CGTVEYMAP 195

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 75.0 bits (185), Expect = 2e-14
 Identities = 48/181 (26%), Positives = 76/181 (41%), Gaps = 33/181 (18%)

Query: 656 QATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIK-VFH--------LQLEGALKSFDVE 705
           +  ++F    + G G FG+V  G     GM VAIK V          LQ+   ++     
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI---MQ----- 71

Query: 706 CEVLKSVRHRNLVK---IISSCTNNDFK----ALVLEYMPNGSLEDYLYSNNFSFDILQR 758
              L  + H N+V+      +    D +     +V+EY+P+ +L     +          
Sbjct: 72  --DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPP 128

Query: 759 LSV---IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK-DMVAHLSDFGIAKLLSGEES 814
           + +   +  +  ++  LH    N V H DIKP NVL+++ D    L DFG AK LS  E 
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187

Query: 815 M 815
            
Sbjct: 188 N 188

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 19/153 (12%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDV----ECEVLKSVRHRNLVKII 721
           IG G FG V+K      G +VA+K   + +E   + F +    E ++L+ ++H N+V +I
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 82

Query: 722 SSCTNNDFKA--------LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
             C               LV ++  +  L   L +    F + +   V+  +   L Y+H
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141

Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA 806
               N ++H D+K +NVL+ +D V  L+DFG+A
Sbjct: 142 ---RNKILHRDMKAANVLITRDGVLKLADFGLA 171

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 56/192 (29%), Positives = 79/192 (41%), Gaps = 43/192 (22%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEV-AIKVFHLQLEGALKSFDVEC-----EVLKSV 712
           N F+   L+G G FG V            A+K+  L+ E  +   +V        VL++ 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNT 62

Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV---------II 763
           RH  L  +  +   +D    V+EY   G L          F  L R  V           
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL----------FFHLSRERVFTEERARFYGA 112

Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAH--LSDFGIAKLLSGEESMKQ---T 818
           ++  ALEYLH   S  VV+ DIK  N++LDKD   H  ++DFG+ K     E +      
Sbjct: 113 EIVSALEYLH---SRDVVYRDIKLENLMLDKD--GHIKITDFGLCK-----EGISDGATM 162

Query: 819 LTL-ATIGYMAP 829
            T   T  Y+AP
Sbjct: 163 KTFCGTPEYLAP 174

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 73.7 bits (182), Expect = 3e-14
 Identities = 47/194 (24%), Positives = 86/194 (44%), Gaps = 43/194 (22%)

Query: 659 NQFNASNLIGTGGFGSVY---KGSFLDGMEV-AIKVF---HLQLEGALKSFDVEC----- 706
             F    ++G GG+G V+   K +  +  ++ A+KV     +       + D        
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMI----VRNAKDTAHTKAER 72

Query: 707 EVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV----- 761
            +L+ V+H  +V +I +        L+LEY+  G L          F  L+R  +     
Sbjct: 73  NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL----------FMQLEREGIFMEDT 122

Query: 762 ----IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAH--LSDFGIAKLLSGEESM 815
               + ++++AL +LH      +++ D+KP N++L+     H  L+DFG+ K    + ++
Sbjct: 123 ACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV 177

Query: 816 KQTLTLATIGYMAP 829
             T    TI YMAP
Sbjct: 178 THTF-CGTIEYMAP 190

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 40/157 (25%), Positives = 68/157 (43%), Gaps = 15/157 (9%)

Query: 659 NQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRH-RN 716
             F     IG G FG +  G +      VAIK+  ++         +E    K +     
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDG 66

Query: 717 LVKIISSCTNNDFKALVLEYMPNG-SLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG 775
           + ++        + A+VLE +  G SLED     + +F +   L + I +   +EY+H  
Sbjct: 67  IPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH-- 122

Query: 776 YSNPVVHCDIKPSNVLLDKDM-----VAHLSDFGIAK 807
            S  +++ D+KP N L+ +       V H+ DF +AK
Sbjct: 123 -SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 73.8 bits (182), Expect = 3e-14
 Identities = 44/163 (26%), Positives = 78/163 (47%), Gaps = 19/163 (11%)

Query: 655 LQATNQFNASNLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLE-G----ALKSFDVECEV 708
           + +++QF     +G G + +VYKG +   G+ VA+K   L  E G    A++    E  +
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISL 56

Query: 709 LKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFS-----FDILQRLSVII 763
           +K ++H N+V++       +   LV E+M N  L+ Y+ S          ++        
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQW 115

Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA 806
            +   L + H    N ++H D+KP N+L++K     L DFG+A
Sbjct: 116 QLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLA 155

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 73.1 bits (180), Expect = 6e-14
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 47/197 (23%)

Query: 659 NQFNASNLIGTGGFGSVY---KGSFLDGMEV-AIKVFH----LQLEGALKSFDVEC---- 706
             F    ++GTG +G V+   K S  D  ++ A+KV      +Q     K+   E     
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-----KAKTTEHTRTE 108

Query: 707 -EVLKSVRHRN-LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV--- 761
            +VL+ +R    LV +  +        L+L+Y+  G L          F  L +      
Sbjct: 109 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL----------FTHLSQRERFTE 158

Query: 762 ------IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAH--LSDFGIAKLLSGEE 813
                 + ++ LALE+LH      +++ DIK  N+LLD +   H  L+DFG++K    +E
Sbjct: 159 HEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADE 213

Query: 814 SMKQTLTLA-TIGYMAP 829
           + ++      TI YMAP
Sbjct: 214 T-ERAYDFCGTIEYMAP 229

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 73.1 bits (180), Expect = 6e-14
 Identities = 41/195 (21%), Positives = 67/195 (34%), Gaps = 22/195 (11%)

Query: 651 YKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIK--VFHLQLEGALKSFDV---- 704
             EL    + +     I +G +G+V  G   +G+ VAIK     +     +         
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73

Query: 705 -----ECEVLKSVRHRNLVK---IISSCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFD 754
                E  +L    H N++    I             LV E M    L   ++       
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVIS 132

Query: 755 ILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                  +  + L L  LH      VVH D+ P N+LL  +    + DF +A+  + + +
Sbjct: 133 PQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189

Query: 815 MKQTLTLATIGYMAP 829
              T  +    Y AP
Sbjct: 190 K--THYVTHRWYRAP 202

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 43/197 (21%), Positives = 81/197 (41%), Gaps = 24/197 (12%)

Query: 623 ISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKG-SFL 681
           ++     +      ++           S      + +++     +G G +G VYK    +
Sbjct: 1   MAHHHHHHMGTLEAQT---QGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTV 57

Query: 682 DGMEVAIKVFHLQLEG------ALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE 735
               VAIK   L+ E       A++    E  +LK ++HRN++++ S   +N    L+ E
Sbjct: 58  TNETVAIKRIRLEHEEEGVPGTAIR----EVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113

Query: 736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD 795
           Y  N  L+ Y+   N    +    S +  +   + + H   S   +H D+KP N+LL   
Sbjct: 114 YAEN-DLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVS 168

Query: 796 MVAH-----LSDFGIAK 807
             +      + DFG+A+
Sbjct: 169 DASETPVLKIGDFGLAR 185

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 40/209 (19%), Positives = 79/209 (37%), Gaps = 15/209 (7%)

Query: 339 IGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYM 398
              L N  +  L    +  +  ++  +L  +Q  +  N+ ++     G+     L  L++
Sbjct: 15  DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKELHL 70

Query: 399 DGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPED 458
             N++S  + P + DLT L  LS+  N L ++       L     L   +N L     + 
Sbjct: 71  SHNQISD-LSP-LKDLTKLEELSVNRNRLKNLNGIPSACLS---RLFLDNNEL--RDTDS 123

Query: 459 IGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDL 518
           + +LK + I+ +  N L   I   +G L  L+ L L  N +  +    +  L  +  +DL
Sbjct: 124 LIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEI--TNTGGLTRLKKVNWIDL 179

Query: 519 SNNSLSGNIPTSMEKLLYLKDLNLSFNKL 547
           +             +L     +     + 
Sbjct: 180 TGQKCVNEPVKYQPELYITNTVKDPDGRW 208

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 36/229 (15%), Positives = 78/229 (34%), Gaps = 22/229 (9%)

Query: 117 QCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQL 176
                +  +L     T+ +      L+ ++      +N+   +   M    NL+ L L  
Sbjct: 17  GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSH 72

Query: 177 NKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSF 236
           N++     + + +L+ ++ L++  N L      +++ +    L  + L  N         
Sbjct: 73  NQISDL--SPLKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNELRDT--DS 123

Query: 237 IFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNL 296
           + +   L +L +  N     +   LG L KLE L L  N +T+              K +
Sbjct: 124 LIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITN-------TGGLTRLKKV 174

Query: 297 KLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINL 345
             +DL+              L ++ +        I        G+ ++ 
Sbjct: 175 NWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDG 223

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 46/250 (18%), Positives = 82/250 (32%), Gaps = 18/250 (7%)

Query: 277 LTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIP 336
                + ++ +       N    +L    +  +   S   LS  +      N +I     
Sbjct: 2   SIQRPTPINQVFPDPGLANAVKQNLGKQSVTDL--VSQKELS-GVQNFNGDNSNI--QSL 56

Query: 337 KEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVL 396
             +    NL+EL L  N+ I  +      L  L+ L +  N+L+            LS L
Sbjct: 57  AGMQFFTNLKELHLSHNQ-ISDLS-PLKDLTKLEELSVNRNRLKNLNGIPSAC---LSRL 111

Query: 397 YMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLP 456
           ++D N+L       +  L +L +LS+ +N+L S+       L  +  L+   N +  +  
Sbjct: 112 FLDNNELRDTDS--LIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEI--TNT 165

Query: 457 EDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESL 516
             +  LK V  IDL+      +       L     +   D       P  I    S    
Sbjct: 166 GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW--ISPYYISNGGSYVDG 223

Query: 517 DLSNNSLSGN 526
            +        
Sbjct: 224 CVLWELPVYT 233

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 59.7 bits (145), Expect = 6e-10
 Identities = 41/264 (15%), Positives = 84/264 (31%), Gaps = 32/264 (12%)

Query: 63  STIFNLSSLS--TGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
           + +F    L+     +    S+T  +       +   +     N+ +       +     
Sbjct: 10  NQVFPDPGLANAVKQNLGKQSVTDLVSQKELSGV---QNFNGDNSNIQ--SLAGMQFFTN 64

Query: 121 LIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLV 180
           L  + L++NQ ++     L +LT L+ L +  N L          L  L +   +L    
Sbjct: 65  LKELHLSHNQISD--LSPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNELRDT- 121

Query: 181 GFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNA 240
                S+ +L  ++ L++ +N L     S + L  L  LE++ L GN  +      +   
Sbjct: 122 ----DSLIHLKNLEILSIRNNKLK----SIVMLGFLSKLEVLDLHGNEITNT--GGLTRL 171

Query: 241 SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLD 300
            K++ ++L               L     ++       S           +N  +     
Sbjct: 172 KKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS-------PYYISNGGSYVDGC 224

Query: 301 LSNNPINGVLPSSIGNLSLSLSRI 324
           +        LP     +S   S  
Sbjct: 225 VLWE-----LPVYTDEVSYKFSEY 243

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 38/256 (14%), Positives = 84/256 (32%), Gaps = 26/256 (10%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
            +L    ++  +      L+ ++      + ++  +   +     L+ + L++N +    
Sbjct: 24  QNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQI---- 75

Query: 62  PSTIFNLSSLS--TGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCK 119
            S +  L  L+    +  + N L              +  L++ NN+L     +++   K
Sbjct: 76  -SDLSPLKDLTKLEELSVNRNRLKNLNGIPSAC----LSRLFLDNNELRD--TDSLIHLK 128

Query: 120 ELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKL 179
            L ++S+  N+        LG L+ L+ L L  N +T         L+ +  + L   K 
Sbjct: 129 NLEILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEITNTGGLT--RLKKVNWIDLTGQKC 184

Query: 180 VGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFN 239
           V         L    T+  P          S +     +  ++               + 
Sbjct: 185 VNEPVKYQPELYITNTVKDPDGRWISPYYIS-NGGSYVDGCVL----WELPVYTDEVSYK 239

Query: 240 ASKLSVLELGENSFSG 255
            S+   +   E  F G
Sbjct: 240 FSEYINVGETEAIFDG 255

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 40/238 (16%), Positives = 82/238 (34%), Gaps = 27/238 (11%)

Query: 17  IGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLS--TG 74
              L    K  LG   +   + Q+   L+ ++  +  N+ +      ++  +   +    
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNI-----QSLAGMQFFTNLKE 67

Query: 75  MDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTER 134
           +  S+N ++   P     +L   + L ++ N+L             L  + L  N+  + 
Sbjct: 68  LHLSHNQISDLSPLKDLTKL---EELSVNRNRLKNLNGIP---SACLSRLFLDNNELRD- 120

Query: 135 IPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMK 194
               L +L +L+ L +  N L   I   +G L  LE+L L  N++       +  L  + 
Sbjct: 121 -TDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVN 175

Query: 195 TLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGII-PSFIFNASKLSVLELGEN 251
            + L           +  +   P L I +   +     I P +I N        +   
Sbjct: 176 WIDLTGQKC-----VNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWE 228

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 46/234 (19%), Positives = 77/234 (32%), Gaps = 46/234 (19%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L LS N +S   P  + +LT L++L +  N+L+        NL  +    L+  FL    
Sbjct: 68  LHLSHNQISDLSP--LKDLTKLEELSVNRNRLK--------NLNGIPSACLSRLFLDNN- 116

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
              + +  SL                      L  ++ L + NNKL       +    +L
Sbjct: 117 --ELRDTDSLIH--------------------LKNLEILSIRNNKLKS--IVMLGFLSKL 152

Query: 122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVG 181
            V+ L  N+ T     GL  L  +  + L       E       L     +     + + 
Sbjct: 153 EVLDLHGNEITN--TGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWI- 209

Query: 182 FVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGN--NFSGII 233
               S + +S   +       +   LP   D V     E I++      F G +
Sbjct: 210 ----SPYYISNGGSYV--DGCVLWELPVYTDEVSYKFSEYINVGETEAIFDGTV 257

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 30/112 (26%), Positives = 54/112 (48%), Gaps = 6/112 (5%)

Query: 341 NLINLRELGLWGNELIGSIPI-TFGKLQNLQGLDLVNNKLEGPIPNGLCQ-LARLSVLYM 398
            L  LR++    N+ I  I    F     +  + L +N+LE  + + + + L  L  L +
Sbjct: 55  KLPQLRKINFSNNK-ITDIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLML 112

Query: 399 DGNKLSGPIPPCIGD-LTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSN 449
             N+++  +       L+S+RLLSL  N++ +V P  F  L  + +LN  +N
Sbjct: 113 RSNRITC-VGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 64.7 bits (158), Expect = 9e-12
 Identities = 37/147 (25%), Positives = 61/147 (41%), Gaps = 15/147 (10%)

Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIW-QCK 119
           IP     L         +NN  T      + ++LP ++ +  SNNK+T  I    +    
Sbjct: 30  IPQYTAEL-------RLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGAS 81

Query: 120 ELIVISLAYNQFTERIPRGL-GNLTSLKTLYLGFNNLTGEIPYEM-GNLRNLEILGLQLN 177
            +  I L  N+    +   +   L SLKTL L  N +T  +  +    L ++ +L L  N
Sbjct: 82  GVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDN 139

Query: 178 KLVGFVPTSIF-NLSAMKTLALPSNAL 203
           ++   V    F  L ++ TL L +N  
Sbjct: 140 QIT-TVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 61.6 bits (150), Expect = 8e-11
 Identities = 34/138 (24%), Positives = 58/138 (42%), Gaps = 12/138 (8%)

Query: 328 NCSIRG--TIPKEIGNLINLRELGLWGNELIGSIPIT--FGKLQNLQGLDLVNNKLEGPI 383
           +CS +    IP+ I       EL L  NE    +  T  F KL  L+ ++  NNK+   I
Sbjct: 17  DCSNQKLNKIPEHIP--QYTAELRLNNNE-FTVLEATGIFKKLPQLRKINFSNNKITD-I 72

Query: 384 PNG-LCQLARLSVLYMDGNKLSGPIPPCIGD-LTSLRLLSLASNELNSVIPSTFWNLKDI 441
             G     + ++ + +  N+L   +   +   L SL+ L L SN +  V   +F  L  +
Sbjct: 73  EEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSV 131

Query: 442 LSLNFSSNFLNGSLPEDI 459
             L+   N +  ++    
Sbjct: 132 RLLSLYDNQIT-TVAPGA 148

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 34/160 (21%), Positives = 59/160 (36%), Gaps = 40/160 (25%)

Query: 2   LSLSFNDLSGAIPKEI-GNLTMLKKLGLGYNKLRGEIP----QELGNLAELELVSLTNNF 56
           L L+ N+ +      I   L  L+K+    NK+  +I     +    + E+    LT+N 
Sbjct: 37  LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEI---LLTSNR 92

Query: 57  LSGTIPSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNI 115
           L   +   +F  L SL   +   +N +T  + +D    L  ++ L + +N++T       
Sbjct: 93  LE-NVQHKMFKGLESL-KTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT------- 142

Query: 116 WQCKELIVISLAYNQFTERIPRG-LGNLTSLKTLYLGFNN 154
                              +  G    L SL TL L   N
Sbjct: 143 ------------------TVAPGAFDTLHSLSTLNL-LAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 53.5 bits (129), Expect = 5e-08
 Identities = 37/157 (23%), Positives = 59/157 (37%), Gaps = 17/157 (10%)

Query: 183 VPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFN-AS 241
           +P  I        L L +N  +  L ++    +LP L  I+ + N  + I     F  AS
Sbjct: 26  IPEHIP--QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDI-EEGAFEGAS 81

Query: 242 KLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDL 301
            ++ + L  N            L  L+ L L  N +T      SF        +++LL L
Sbjct: 82  GVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSF----IGLSSVRLLSL 136

Query: 302 SNNPINGVLPSSIGNLSLSLSRIFISN------CSIR 332
            +N I  V P +   L  SLS + +        C + 
Sbjct: 137 YDNQITTVAPGAFDTLH-SLSTLNLLANPFNCNCYLA 172

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 52.7 bits (127), Expect = 8e-08
 Identities = 38/144 (26%), Positives = 60/144 (41%), Gaps = 11/144 (7%)

Query: 407 IPPCIGDLTSLRLLSLASNELNSVIPS-TFWNLKDILSLNFSSNFLNGSLPEDI-GNLKV 464
           IP  I        L L +NE   +  +  F  L  +  +NFS+N +   + E        
Sbjct: 26  IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG 82

Query: 465 VVIIDLSRNNLSGDIPTAI-GGLMNLQDLSLRDNGLQGSIPKSI-GGLVSLESLDLSNNS 522
           V  I L+ N L  ++   +  GL +L+ L LR N +   +      GL S+  L L +N 
Sbjct: 83  VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140

Query: 523 LSGNIPTSM-EKLLYLKDLNLSFN 545
           ++  +     + L  L  LNL  N
Sbjct: 141 IT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 19/89 (21%), Positives = 37/89 (41%), Gaps = 4/89 (4%)

Query: 468 IDLSRNNLSGDIPTAI-GGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGN 526
           + L+ N  +    T I   L  L+ ++  +N +      +  G   +  + L++N L  N
Sbjct: 37  LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-N 95

Query: 527 IPTSM-EKLLYLKDLNLSFNKLEGEIPRG 554
           +   M + L  LK L L  N++   +   
Sbjct: 96  VQHKMFKGLESLKTLMLRSNRIT-CVGND 123

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 34/149 (22%), Positives = 61/149 (40%), Gaps = 15/149 (10%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRH-RNLVKIISSC 724
           IG G FG +++G + L+  +VAIK    + +        E    K +     +  +    
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 725 TNNDFKALVLEYMPNG-SLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
                  LV++ +  G SLED L      F +         +   ++ +H      +V+ 
Sbjct: 76  QEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYR 130

Query: 784 DIKPSNVLLDKDM-----VAHLSDFGIAK 807
           DIKP N L+ +       + ++ DFG+ K
Sbjct: 131 DIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 71.1 bits (175), Expect = 4e-13
 Identities = 60/193 (31%), Positives = 84/193 (43%), Gaps = 44/193 (22%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEV-AIKVFHLQLEGALKSFDVEC-----EVL-KS 711
           + F+   +IG G FG V            A+KV  LQ +  LK  + +       VL K+
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKN 95

Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV---------I 762
           V+H  LV +  S    D    VL+Y+  G L          F  LQR             
Sbjct: 96  VKHPFLVGLHFSFQTADKLYFVLDYINGGEL----------FYHLQRERCFLEPRARFYA 145

Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAH--LSDFGIAKLLSGEESMKQ--- 817
            ++A AL YLH   S  +V+ D+KP N+LLD     H  L+DFG+ K     E+++    
Sbjct: 146 AEIASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCK-----ENIEHNST 195

Query: 818 TLTL-ATIGYMAP 829
           T T   T  Y+AP
Sbjct: 196 TSTFCGTPEYLAP 208

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 42/147 (28%), Positives = 73/147 (49%), Gaps = 13/147 (8%)

Query: 667 IGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRH-RNLVKIISSC 724
           IG+G FG +Y G+ +  G EVAIK+  ++ +       +E ++ K ++    +  I    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 725 TNNDFKALVLEYMPNG-SLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
              D+  +V+E +  G SLED     +  F +   L +   +   +EY+H   S   +H 
Sbjct: 75  AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHR 129

Query: 784 DIKPSNVLL---DKDMVAHLSDFGIAK 807
           D+KP N L+    K  + ++ DFG+AK
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 70.8 bits (174), Expect = 4e-13
 Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 23/201 (11%)

Query: 642 PQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLD---GMEVAIK---VFHLQL 695
             A        ++     ++   + IG G +G V   S  D    + VAIK    F  Q 
Sbjct: 10  AAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVC--SAYDNLNKVRVAIKKISPFEHQT 67

Query: 696 EGALKSFDVECEVLKSVRHRNLVK---IISSCTNNDFKA--LVLEYMPNGSLEDYLYSNN 750
               ++   E ++L   RH N++    II + T    K   +V + M    L   L + +
Sbjct: 68  Y-CQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH 124

Query: 751 FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS 810
            S D +     +  +   L+Y+H   S  V+H D+KPSN+LL+      + DFG+A++  
Sbjct: 125 LSNDHIC--YFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179

Query: 811 GEESMKQTLT--LATIGYMAP 829
            +      LT  +AT  Y AP
Sbjct: 180 PDHDHTGFLTEYVATRWYRAP 200

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 71.0 bits (174), Expect = 5e-13
 Identities = 41/186 (22%), Positives = 73/186 (39%), Gaps = 33/186 (17%)

Query: 667 IGTGGFGSVYKG---SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVK---I 720
           +G G +G VYK       D  + A+K       G   S   E  +L+ ++H N++    +
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISMSACREIALLRELKHPNVISLQKV 86

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYL--------YSNNFSFDILQRLSVIIDVALALEYL 772
             S  +     L+ +Y  +  L   +                     S++  +   + YL
Sbjct: 87  FLSHADRKV-WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAH----LSDFGIAKLLSGEESMKQTLTLA-----T 823
           H   +N V+H D+KP+N+L+  +        ++D G A+L +   S  + L        T
Sbjct: 145 H---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN---SPLKPLADLDPVVVT 198

Query: 824 IGYMAP 829
             Y AP
Sbjct: 199 FWYRAP 204

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 70.3 bits (173), Expect = 5e-13
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 33/204 (16%)

Query: 642 PQATRRRFSYKELLQATNQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEG 697
           P+  + R S +  L+  + F    ++G G FG V    +K +       AIK   L+ + 
Sbjct: 1   PELNKERPSLQIKLKIED-FILHKMLGKGSFGKVFLAEFKKT---NQFFAIKA--LKKDV 54

Query: 698 ALKSFDVEC-----EVL-KSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNF 751
            L   DVEC      VL  +  H  L  +  +    +    V+EY+  G L  ++  +  
Sbjct: 55  VLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCH 113

Query: 752 SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAH--LSDFGIAKLL 809
            FD+ +      ++ L L++LH   S  +V+ D+K  N+LLDKD   H  ++DFG+ K  
Sbjct: 114 KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCK-- 166

Query: 810 SGEESMKQTLTLA----TIGYMAP 829
              E+M           T  Y+AP
Sbjct: 167 ---ENMLGDAKTNTFCGTPDYIAP 187

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 37/151 (24%), Positives = 73/151 (48%), Gaps = 10/151 (6%)

Query: 328 NCSIRG--TIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPN 385
           +C  +G   IP  +     + E+ L  N +    P  F   + L+ +DL NN++   +  
Sbjct: 17  DCRGKGLTEIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAP 73

Query: 386 GLC-QLARLSVLYMDGNKLSGPIPPCIGD-LTSLRLLSLASNELNSVIPSTFWNLKDILS 443
                L  L+ L + GNK++  +P  + + L SL+LL L +N++N +    F +L ++  
Sbjct: 74  DAFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNL 132

Query: 444 LNFSSNFLNGSLPEDI-GNLKVVVIIDLSRN 473
           L+   N L  ++ +     L+ +  + L++N
Sbjct: 133 LSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 61.6 bits (150), Expect = 8e-11
 Identities = 35/145 (24%), Positives = 64/145 (44%), Gaps = 16/145 (11%)

Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNI-WQCK 119
           +P TI  +           N++   +P         ++ + +SNN+++  +  +     +
Sbjct: 30  LPETITEI-------RLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLR 80

Query: 120 ELIVISLAYNQFTERIPRGL-GNLTSLKTLYLGFNNLTGEIPYEM-GNLRNLEILGLQLN 177
            L  + L  N+ TE +P+ L   L SL+ L L  N +   +  +   +L NL +L L  N
Sbjct: 81  SLNSLVLYGNKITE-LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDN 138

Query: 178 KLVGFVPTSIF-NLSAMKTLALPSN 201
           KL   +    F  L A++T+ L  N
Sbjct: 139 KL-QTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 29/137 (21%), Positives = 59/137 (43%), Gaps = 12/137 (8%)

Query: 415 TSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDI----GNLKVVVIIDL 470
            ++  + L  N +  + P  F   K +  ++ S+N ++  L  D      +L     + L
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLN---SLVL 87

Query: 471 SRNNLSGDIPTAI-GGLMNLQDLSLRDNGLQGSIPKSI-GGLVSLESLDLSNNSLSGNIP 528
             N ++ ++P ++  GL +LQ L L  N +   +       L +L  L L +N L     
Sbjct: 88  YGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAK 145

Query: 529 TSMEKLLYLKDLNLSFN 545
            +   L  ++ ++L+ N
Sbjct: 146 GTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 32/158 (20%), Positives = 59/158 (37%), Gaps = 38/158 (24%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIP----QELGNLAELELVSLTNNFL 57
           + L  N +    P        L+++ L  N++  E+     Q L +L  L    L  N +
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSL---VLYGNKI 92

Query: 58  SGTIPSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIW 116
           +  +P ++F  L SL   +  + N +   L  D  + L  +  L + +NKL         
Sbjct: 93  T-ELPKSLFEGLFSL-QLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-------- 141

Query: 117 QCKELIVISLAYNQFTERIPRG-LGNLTSLKTLYLGFN 153
                             I +G    L +++T++L  N
Sbjct: 142 -----------------TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 27/139 (19%), Positives = 55/139 (39%), Gaps = 9/139 (6%)

Query: 168 NLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGN 227
            +  + L+ N +    P +      ++ + L +N +S  L        L +L  + L GN
Sbjct: 33  TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDA-FQGLRSLNSLVLYGN 90

Query: 228 NFSGIIPSFIF-NASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSF 286
             +  +P  +F     L +L L  N  +    +   +L  L  L L  N L +       
Sbjct: 91  KITE-LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKG--- 146

Query: 287 LSSWANCKNLKLLDLSNNP 305
             +++  + ++ + L+ NP
Sbjct: 147 --TFSPLRAIQTMHLAQNP 163

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 25/92 (27%), Positives = 41/92 (44%), Gaps = 5/92 (5%)

Query: 465 VVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI-GGLVSLESLDLSNNSL 523
           +  I L +N +    P A      L+ + L +N +   +      GL SL SL L  N +
Sbjct: 34  ITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI 92

Query: 524 SGNIPTSM-EKLLYLKDLNLSFNKLEGEIPRG 554
           +  +P S+ E L  L+ L L+ NK+   +   
Sbjct: 93  T-ELPKSLFEGLFSLQLLLLNANKIN-CLRVD 122

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 40/162 (24%), Positives = 56/162 (34%), Gaps = 32/162 (19%)

Query: 217 PNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNF 276
             +  I L  N    I P       KL  ++L  N  S   P+    LR L  L L  N 
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91

Query: 277 LTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIP 336
           +T     L F        +L+LL L+ N IN                           + 
Sbjct: 92  ITELPKSL-F----EGLFSLQLLLLNANKIN--------------------------CLR 120

Query: 337 KEI-GNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNN 377
            +   +L NL  L L+ N+L      TF  L+ +Q + L  N
Sbjct: 121 VDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 40.8 bits (96), Expect = 7e-04
 Identities = 20/77 (25%), Positives = 35/77 (45%), Gaps = 7/77 (9%)

Query: 478 DIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYL 537
           ++P        + ++ L  N ++   P +      L  +DLSNN +S   P + + L  L
Sbjct: 29  NLPE------TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82

Query: 538 KDLNLSFNKLEGEIPRG 554
             L L  NK+  E+P+ 
Sbjct: 83  NSLVLYGNKIT-ELPKS 98

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 32/177 (18%), Positives = 64/177 (36%), Gaps = 37/177 (20%)

Query: 659 NQFNASNLIGTGGFGSVYKG---------SFLDGMEVAIKV--FHLQLEGALKSFDVECE 707
            Q+   +       G +Y+          S     + ++K+     +L      F    +
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101

Query: 708 V--------LKSVRHRNLVKIISS-CTNNDFKALVLEYMPNG-SLEDYLYSNN---FSFD 754
                    L S     +   +      + ++ LVL  +  G SL+  L  +     S  
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSER 159

Query: 755 ILQRLSV-IIDVALALEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAK 807
            + +++  ++D   ALE+LH    N  VH ++   N+ +   D+  V  L+ +G A 
Sbjct: 160 SVLQVACRLLD---ALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 68.4 bits (168), Expect = 1e-12
 Identities = 41/158 (25%), Positives = 67/158 (42%), Gaps = 19/158 (12%)

Query: 665 NLIGTGGFGSVYKG-SFLDGMEVAIKVFHLQLE-GALKSFDVEC--EV-----LKSVRHR 715
             IG G +G+VYK      G  VA+K   +    G      +    EV     L++  H 
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74

Query: 716 NLVKIISSCTNNDFKA-----LVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIIDVALAL 769
           N+V+++  C  +         LV E++    L  YL               ++      L
Sbjct: 75  NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGL 133

Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           ++LH   +N +VH D+KP N+L+       L+DFG+A+
Sbjct: 134 DFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR 168

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 70.4 bits (172), Expect = 1e-12
 Identities = 48/194 (24%), Positives = 81/194 (41%), Gaps = 46/194 (23%)

Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDVEC-----EVL 709
             FN   ++G G FG V     KG+       A+K+  L+ +  ++  DVEC      VL
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKI--LKKDVVIQDDDVECTMVEKRVL 395

Query: 710 KSV-RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV------- 761
               +   L ++ S     D    V+EY+  G L             +Q++         
Sbjct: 396 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL----------MYHIQQVGRFKEPHAV 445

Query: 762 --IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM---K 816
               ++A+ L +L    S  +++ D+K  NV+LD +    ++DFG+ K     E++    
Sbjct: 446 FYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----ENIWDGV 497

Query: 817 QTLTLA-TIGYMAP 829
            T T   T  Y+AP
Sbjct: 498 TTKTFCGTPDYIAP 511

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 68.8 bits (169), Expect = 2e-12
 Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 47/218 (21%)

Query: 632 KQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEV-AIKV 690
           K+S+ E N +   +  R          + F    ++G G FG V      +  ++ A+KV
Sbjct: 3   KESSKEGNGIGVNSSNRLG-------IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV 55

Query: 691 FHLQLEGALKSFDVEC-----EVL-KSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLED 744
             L+ +  L+  DVEC      +L  +  H  L ++       D    V+E++  G L  
Sbjct: 56  --LKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL-- 111

Query: 745 YLYSNNFSFDILQRLSV---------IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD 795
                      +Q+              ++  AL +LH      +++ D+K  NVLLD +
Sbjct: 112 --------MFHIQKSRRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHE 160

Query: 796 MVAHLSDFGIAKLLSGEESMKQ---TLTL-ATIGYMAP 829
               L+DFG+ K     E +     T T   T  Y+AP
Sbjct: 161 GHCKLADFGMCK-----EGICNGVTTATFCGTPDYIAP 193

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 67.5 bits (165), Expect = 5e-12
 Identities = 39/167 (23%), Positives = 65/167 (38%), Gaps = 31/167 (18%)

Query: 666 LIGTGGFGSVYKGSFLDG------MEVAIKVFH-----LQLEGAL-KSFDVECEVLKSVR 713
            IG GGFG +Y                 +KV       L  E    +      ++ K +R
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 714 HRNLVKI---------ISSCTNNDFKALVLEYMPNG-SLEDYLYSNNFSFDILQRLSVII 763
            R L  +         +       ++ ++++    G  L+    +N   F     L + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159

Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAK 807
            +   LEY+H    +  VH DIK SN+LL   + D V +L D+G+A 
Sbjct: 160 RILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 64.2 bits (157), Expect = 6e-12
 Identities = 40/126 (31%), Positives = 62/126 (49%), Gaps = 9/126 (7%)

Query: 328 NCSIRG--TIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPN 385
            CS +G   +PK I    ++ EL L GN+    +P      ++L  +DL NN++   + N
Sbjct: 16  RCSNKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIST-LSN 71

Query: 386 GLC-QLARLSVLYMDGNKLSGPIPPCIGD-LTSLRLLSLASNELNSVIPSTFWNLKDILS 443
                + +L  L +  N+L   IPP   D L SLRLLSL  N+++ V    F +L  +  
Sbjct: 72  QSFSNMTQLLTLILSYNRLRC-IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSH 130

Query: 444 LNFSSN 449
           L   +N
Sbjct: 131 LAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 54.6 bits (132), Expect = 1e-08
 Identities = 34/105 (32%), Positives = 53/105 (50%), Gaps = 7/105 (6%)

Query: 100 LYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGL-GNLTSLKTLYLGFNNLTGE 158
           LY+  N+ T  +P  +   K L +I L+ N+ +  +      N+T L TL L +N L   
Sbjct: 36  LYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILSYNRLR-C 92

Query: 159 IPYEM-GNLRNLEILGLQLNKLVGFVPTSIF-NLSAMKTLALPSN 201
           IP      L++L +L L  N +   VP   F +LSA+  LA+ +N
Sbjct: 93  IPPRTFDGLKSLRLLSLHGNDI-SVVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 31/128 (24%), Positives = 56/128 (43%), Gaps = 27/128 (21%)

Query: 395 VLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGS 454
            LY+DGN+ +  +P  + +   L L+ L++N ++++   +F N+  +L+L  S N L   
Sbjct: 35  ELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-C 92

Query: 455 LPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI-GGLVSL 513
           +P                       P    GL +L+ LSL  N +   +P+     L +L
Sbjct: 93  IP-----------------------PRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSAL 128

Query: 514 ESLDLSNN 521
             L +  N
Sbjct: 129 SHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 29/154 (18%), Positives = 50/154 (32%), Gaps = 55/154 (35%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L L  N  +  +PKE+ N   L  + L  N++                          T+
Sbjct: 36  LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-------------------------TL 69

Query: 62  PSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
            +  F N++ L T +  S N L   +P      L  ++ L +  N +             
Sbjct: 70  SNQSFSNMTQLLT-LILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDI------------- 114

Query: 121 LIVISLAYNQFTERIPRGL-GNLTSLKTLYLGFN 153
                         +P G   +L++L  L +G N
Sbjct: 115 ------------SVVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 23/76 (30%), Positives = 33/76 (43%), Gaps = 8/76 (10%)

Query: 479 IPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLK 538
           IP       ++ +L L  N     +PK +     L  +DLSNN +S     S   +  L 
Sbjct: 29  IPR------DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81

Query: 539 DLNLSFNKLEGEIPRG 554
            L LS+N+L   IP  
Sbjct: 82  TLILSYNRLR-CIPPR 96

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 66.5 bits (163), Expect = 7e-12
 Identities = 41/163 (25%), Positives = 66/163 (40%), Gaps = 31/163 (19%)

Query: 665 NLIGTGGFGSVYKG--SFLDGMEVAIKVFHLQLEG------------ALKSFDVECEVLK 710
             IG G +G V+K       G  VA+K   +Q                L+        L+
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH-------LE 69

Query: 711 SVRHRNLVKIISSCTNNDFKA-----LVLEYMPNGSLEDYLYS-NNFSFDILQRLSVIID 764
           +  H N+V++   CT +         LV E++    L  YL               ++  
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ 128

Query: 765 VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           +   L++LH   S+ VVH D+KP N+L+       L+DFG+A+
Sbjct: 129 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 67.3 bits (164), Expect = 8e-12
 Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 13/147 (8%)

Query: 667 IGTGGFGSVYKG-SFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLV-KIISSC 724
           IG+G FG +Y G +     EVAIK+ +++ +        E ++ + ++    +  +    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 725 TNNDFKALVLEYMPNG-SLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
              D+  LV++ +  G SLED     +    +   L +   +   +E++H   S   +H 
Sbjct: 73  VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHR 127

Query: 784 DIKPSNVLLDKDMVAH---LSDFGIAK 807
           DIKP N L+     A+   + DFG+AK
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 66.6 bits (163), Expect = 8e-12
 Identities = 46/179 (25%), Positives = 79/179 (44%), Gaps = 32/179 (17%)

Query: 667 IGTGGFGSVYKGSFLD---GMEVAIK----VFHLQLEGALKSFDVECEVLKSVRHRNLVK 719
           IG+G  G V   +  D      VAIK     F  Q   A +++  E  ++K V H+N++ 
Sbjct: 33  IGSGAQGIVC--AAYDAILERNVAIKKLSRPFQNQTH-AKRAYR-ELVLMKCVNHKNIIG 88

Query: 720 I----ISSCTNNDFKA--LVLEYMP---NGSLEDYLYSNNFSFDILQRLSVIIDVALALE 770
           +        +  +F+   +V+E M       ++  L     S+ + Q L         ++
Sbjct: 89  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-------GIK 141

Query: 771 YLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +LH   S  ++H D+KPSN+++  D    + DFG+A+       M  T  + T  Y AP
Sbjct: 142 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAP 195

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 67.3 bits (165), Expect = 8e-12
 Identities = 87/476 (18%), Positives = 162/476 (34%), Gaps = 86/476 (18%)

Query: 119 KELIVISLAYNQFT-ERIPRGLGNLTSLKTLYLGFNNLTGE----IPYEMGNLRNLEILG 173
            ++  + +   + +  R    L  L   + + L    LT      I   +     L  L 
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 174 LQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFS--- 230
           L+ N+L             +  +      L               ++ +SL     +   
Sbjct: 63  LRSNEL---------GDVGVHCVL---QGLQ---------TPSCKIQKLSLQNCCLTGAG 101

Query: 231 -GIIPSFIFNASKLSVLELGENSFSG-----FIPNTLGNLRKLEWLRLSYNFLTSSTSEL 284
            G++ S +     L  L L +N              L    +LE L+L Y  L++++ E 
Sbjct: 102 CGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE- 160

Query: 285 SFLSSWANCKNLKLLDLSNNPIN--GV--LPSSIGNLSLSLSRIFISNCSIRGTIPKEIG 340
              S      + K L +SNN IN  GV  L   + +    L  + + +C +     +++ 
Sbjct: 161 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLC 220

Query: 341 NLI----NLRELGLWGNEL--IGSIPITFGKLQ---NLQGLDLVNNKLEGP----IPNGL 387
            ++    +LREL L  N+L  +G   +  G L     L+ L +    +       +   L
Sbjct: 221 GIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVL 280

Query: 388 CQLARLSVLYMDGNKLSGPIPPCIGDL-----TSLRLLSLASNELNSV----IPSTFWNL 438
                L  L + GN+L       + +        L  L + S    +       S     
Sbjct: 281 RAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQN 340

Query: 439 KDILSLNFSSNFLNGSLPEDIG----------NLKVVVIIDLSRNNLS----GDIPTAIG 484
           + +L L  S+N L     ED G             V+ ++ L+  ++S      +   + 
Sbjct: 341 RFLLELQISNNRL-----EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLL 395

Query: 485 GLMNLQDLSLRDNGLQGSIPKSIGGLV-----SLESLDLSNNSLSGNIPTSMEKLL 535
              +L++L L +N L  +    +   V      LE L L +   S  +   ++ L 
Sbjct: 396 ANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 451

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 63.4 bits (155), Expect = 1e-10
 Identities = 65/389 (16%), Positives = 138/389 (35%), Gaps = 60/389 (15%)

Query: 216 LPNLEIISLAGNNFS----GIIPSFIFNASKLSVLELGENSFSG----FIPNTLGNL-RK 266
           L   +++ L     +      I S +     L+ L L  N         +   L     K
Sbjct: 27  LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 86

Query: 267 LEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPING----VLPSSIGNLSLSLS 322
           ++ L L    LT +       S+      L+ L LS+N +      +L   + +    L 
Sbjct: 87  IQKLSLQNCCLTGAGCG-VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLE 145

Query: 323 RIFISNCSIRGTIPKEIGNLI----NLRELGLWGNELI--GSIPITFGKLQN---LQGLD 373
           ++ +  CS+     + + +++    + +EL +  N++   G   +  G   +   L+ L 
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205

Query: 374 LVNNKLE----GPIPNGLCQLARLSVLYMDGNKL--SGPIPPCIGDL---TSLRLLSLAS 424
           L +  +       +   +   A L  L +  NKL   G    C G L   + LR L +  
Sbjct: 206 LESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWE 265

Query: 425 NELNSV----IPSTFWNLKDILSLNFSSNFLNGS--------LPEDIGNLKVVVIIDLSR 472
             + +     +       + +  L+ + N L           L E    L+    + +  
Sbjct: 266 CGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLES---LWVKS 322

Query: 473 NNLSGD----IPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLV-----SLESLDLSNNSL 523
            + +        + +     L +L + +N L+ +  + +   +      L  L L++  +
Sbjct: 323 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382

Query: 524 S----GNIPTSMEKLLYLKDLNLSFNKLE 548
           S     ++  ++     L++L+LS N L 
Sbjct: 383 SDSSCSSLAATLLANHSLRELDLSNNCLG 411

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 46.1 bits (110), Expect = 3e-05
 Identities = 69/353 (19%), Positives = 111/353 (31%), Gaps = 77/353 (21%)

Query: 2   LSLSFNDLSGAIPKEIG-----NLTMLKKLGLGYNKLRGEIPQELG-------NLAELEL 49
           L LS N L  A  + +          L+KL L Y  L     + L        +  EL  
Sbjct: 118 LHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKEL-- 175

Query: 50  VSLTNN--------FLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRL------- 94
            +++NN         L   +  +   L +L       +  +T     D CR L       
Sbjct: 176 -TVSNNDINEAGVRVLCQGLKDSPCQLEAL----KLESCGVT----SDNCRDLCGIVASK 226

Query: 95  PLIKGLYMSNNKLTGP-----IPNNIWQCKELIVISLAYNQFTER----IPRGLGNLTSL 145
             ++ L + +NKL         P  +     L  + +     T +    + R L    SL
Sbjct: 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESL 286

Query: 146 KTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSG 205
           K L L  N L  E              G +L        T +     +++L + S + + 
Sbjct: 287 KELSLAGNELGDE--------------GARL-----LCETLLEPGCQLESLWVKSCSFTA 327

Query: 206 SLPSSID--LVRLPNLEIISLAGNNFS-----GIIPSFIFNASKLSVLELGENSFS---- 254
           +  S     L +   L  + ++ N         +        S L VL L +   S    
Sbjct: 328 ACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSC 387

Query: 255 GFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPIN 307
             +  TL     L  L LS N L  +       S       L+ L L +   +
Sbjct: 388 SSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 66.1 bits (162), Expect = 8e-12
 Identities = 46/185 (24%), Positives = 83/185 (44%), Gaps = 32/185 (17%)

Query: 667 IGTGGFGSVYKGSFLD---GMEVAIK--VFHLQLEGALKSFDVECEVLKSVRHRNLVKII 721
           +G GG G V+  S +D      VAIK  V          +   E ++++ + H N+VK+ 
Sbjct: 19  LGCGGNGLVF--SAVDNDCDKRVAIKKIVLTDPQS-VKHALR-EIKIIRRLDHDNIVKVF 74

Query: 722 ------------SSCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVAL 767
                          +  +  +  +V EYM    L + L       +  +    +  +  
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLF--MYQLLR 131

Query: 768 ALEYLHFGYSNPVVHCDIKPSNVLLD-KDMVAHLSDFGIAKLLSGEESMKQTLT--LATI 824
            L+Y+H   S  V+H D+KP+N+ ++ +D+V  + DFG+A+++    S K  L+  L T 
Sbjct: 132 GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188

Query: 825 GYMAP 829
            Y +P
Sbjct: 189 WYRSP 193

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 66.6 bits (163), Expect = 1e-11
 Identities = 52/223 (23%), Positives = 82/223 (36%), Gaps = 41/223 (18%)

Query: 627 QEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVY----KGSFLD 682
             + A  S IE       TR        L   + F+   +IG G +  V     K +   
Sbjct: 21  YFQGAMGSGIEEEKEAMNTRESGKASSSLGLQD-FDLLRVIGRGSYAKVLLVRLKKT--- 76

Query: 683 GMEVAIKVFHLQLEGALKSFDVEC-----EVL-KSVRHRNLVKIISSCTNNDFKALVLEY 736
               A++V  ++ E      D++       V  ++  H  LV + S          V+EY
Sbjct: 77  DRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 134

Query: 737 MPNGSLEDYLYSNNFSFDILQRLSV---------IIDVALALEYLHFGYSNPVVHCDIKP 787
           +  G L             +QR              +++LAL YLH      +++ D+K 
Sbjct: 135 VNGGDL----------MFHMQRQRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKL 181

Query: 788 SNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL-ATIGYMAP 829
            NVLLD +    L+D+G+ K          T T   T  Y+AP
Sbjct: 182 DNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAP 222

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 41/128 (32%), Positives = 67/128 (52%), Gaps = 11/128 (8%)

Query: 328 NCSIRG--TIPKEIGNLINLRELGLWGNELIGSIPIT--FGKLQNLQGLDLVNNKLEGPI 383
           +C+ RG   IP++I   ++  EL L  NE +G I     FG+L +L  L+L  N+L G I
Sbjct: 14  DCTGRGLKEIPRDI--PLHTTELLLNDNE-LGRISSDGLFGRLPHLVKLELKRNQLTG-I 69

Query: 384 PNGLC-QLARLSVLYMDGNKLSGPIPPCIGD-LTSLRLLSLASNELNSVIPSTFWNLKDI 441
                   + +  L +  NK+   I   +   L  L+ L+L  N+++ V+P +F +L  +
Sbjct: 70  EPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSL 128

Query: 442 LSLNFSSN 449
            SLN +SN
Sbjct: 129 TSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 35/143 (24%), Positives = 56/143 (39%), Gaps = 35/143 (24%)

Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
           IP     L         ++N L     D +  RLP +  L +  N+LTG I  N ++   
Sbjct: 27  IPLHTTEL-------LLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFE--- 75

Query: 121 LIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEM-GNLRNLEILGLQLNKL 179
                                 + ++ L LG N +  EI  +M   L  L+ L L  N++
Sbjct: 76  --------------------GASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQI 114

Query: 180 VGFVPTSIF-NLSAMKTLALPSN 201
              V    F +L+++ +L L SN
Sbjct: 115 SC-VMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 25/91 (27%), Positives = 37/91 (40%), Gaps = 6/91 (6%)

Query: 467 IIDLSRNNLSGDIPTAI-GGLMNLQDLSLRDNGLQGSIPKSI-GGLVSLESLDLSNNSLS 524
            + L+ N L       + G L +L  L L+ N L   I  +   G   ++ L L  N + 
Sbjct: 33  ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91

Query: 525 GNIPTSM-EKLLYLKDLNLSFNKLEGEIPRG 554
             I   M   L  LK LNL  N++   +  G
Sbjct: 92  -EISNKMFLGLHQLKTLNLYDNQISC-VMPG 120

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 43.8 bits (104), Expect = 5e-05
 Identities = 28/129 (21%), Positives = 44/129 (34%), Gaps = 27/129 (20%)

Query: 395 VLYMDGNKLSGPIPPCIGD-LTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNG 453
            L ++ N+L       +   L  L  L L  N+L  + P+ F     I  L    N +  
Sbjct: 33  ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91

Query: 454 SLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI-GGLVS 512
            +                             GL  L+ L+L DN +   +       L S
Sbjct: 92  EISNK-----------------------MFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNS 127

Query: 513 LESLDLSNN 521
           L SL+L++N
Sbjct: 128 LTSLNLASN 136

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 66.8 bits (163), Expect = 1e-11
 Identities = 53/223 (23%), Positives = 93/223 (41%), Gaps = 36/223 (16%)

Query: 627 QEKNAKQSNIESNMLPQATRRRFSYKELLQAT----NQFNASNLIGTGGFGSVYKGSFLD 682
           ++ +        NM       +F   E+  +T     ++     IG+G  G V   +  D
Sbjct: 26  KQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVC--AAYD 83

Query: 683 ---GMEVAIK----VFHLQLEGALKSFDVECEVLKSVRHRNLVKII----SSCTNNDFKA 731
                 VAIK     F  Q   A +++  E  ++K V H+N++ ++       T  +F+ 
Sbjct: 84  AVLDRNVAIKKLSRPFQNQTH-AKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141

Query: 732 --LVLEYMP---NGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIK 786
             LV+E M       ++  L     S+ + Q L         +++LH   S  ++H D+K
Sbjct: 142 VYLVMELMDANLCQVIQMELDHERMSYLLYQML-------CGIKHLH---SAGIIHRDLK 191

Query: 787 PSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           PSN+++  D    + DFG+A+       M  T  + T  Y AP
Sbjct: 192 PSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAP 232

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 65.7 bits (161), Expect = 1e-11
 Identities = 49/196 (25%), Positives = 82/196 (41%), Gaps = 50/196 (25%)

Query: 659 NQFNASNLIGTGGFGSV----YKGSFLDGMEVAIKVFHLQLEGALKSFDVEC-----EVL 709
             FN   ++G G FG V     KG+       A+K+  L+ +  ++  DVEC      VL
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKI--LKKDVVIQDDDVECTMVEKRVL 74

Query: 710 -KSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV------- 761
               +   L ++ S     D    V+EY+  G L             +Q++         
Sbjct: 75  ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL----------MYHIQQVGRFKEPHAV 124

Query: 762 --IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAH--LSDFGIAKLLSGEESM-- 815
               ++A+ L +L    S  +++ D+K  NV+LD +   H  ++DFG+ K     E++  
Sbjct: 125 FYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCK-----ENIWD 174

Query: 816 -KQTLTL-ATIGYMAP 829
              T T   T  Y+AP
Sbjct: 175 GVTTKTFCGTPDYIAP 190

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 66.4 bits (162), Expect = 2e-11
 Identities = 45/223 (20%), Positives = 88/223 (39%), Gaps = 54/223 (24%)

Query: 623 ISRCQEKNAKQSNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGS-FL 681
           +S  Q++  ++    S+    +  R  S  ++    +++   +LIGTG +G V +    L
Sbjct: 20  VSGSQQEGQQRKQHHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGSYGHVCEAYDKL 76

Query: 682 DGMEVAIKVFHLQLEGALKSFDV------------ECEVLKSVRHRNLVK---IISSCTN 726
           +   VAIK          K   V            E  +L  + H ++VK   I+     
Sbjct: 77  EKRVVAIK----------KILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126

Query: 727 NDFKA--LVLEYMPNGSLEDYLYSNN---------FSFDILQRLSVIIDVALALEYLHFG 775
             F    +VLE   +   +    +             +++L            ++Y+H  
Sbjct: 127 EKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLV----------GVKYVH-- 173

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT 818
            S  ++H D+KP+N L+++D    + DFG+A+ +   E+    
Sbjct: 174 -SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 65.3 bits (160), Expect = 2e-11
 Identities = 46/189 (24%), Positives = 73/189 (38%), Gaps = 40/189 (21%)

Query: 661 FNASNLIGTGGFGSVY----KGSFLDGMEVAIKVFHLQLEGALKSFDVEC-----EVL-K 710
           F+   +IG G +  V     K +       A+KV  ++ E      D++       V  +
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKT---DRIYAMKV--VKKELVNDDEDIDWVQTEKHVFEQ 65

Query: 711 SVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSV--------- 761
           +  H  LV + S          V+EY+  G L             +QR            
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL----------MFHMQRQRKLPEEHARFY 115

Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL 821
             +++LAL YLH      +++ D+K  NVLLD +    L+D+G+ K          T T 
Sbjct: 116 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTF 170

Query: 822 -ATIGYMAP 829
             T  Y+AP
Sbjct: 171 CGTPNYIAP 179

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 66.8 bits (162), Expect = 2e-11
 Identities = 115/756 (15%), Positives = 208/756 (27%), Gaps = 271/756 (35%)

Query: 156 TGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSID-LV 214
           TGE  Y+  ++  L +          F    + N        +P + LS      ID ++
Sbjct: 11  TGEHQYQYKDI--LSV----------FEDAFVDNFDCKDVQDMPKSILSKE---EIDHII 55

Query: 215 RLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSY 274
              +    +L            +F     ++L   E     F+          E LR++Y
Sbjct: 56  MSKDAVSGTL-----------RLFW----TLLSKQEEMVQKFVE---------EVLRINY 91

Query: 275 NFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLS-LSRIFISNCSIRG 333
            FL S              +                PS +  + +    R++  N     
Sbjct: 92  KFLMSPIKT--------EQRQ---------------PSMMTRMYIEQRDRLYNDNQVFAK 128

Query: 334 ---TIPKEIGNLIN-LREL------GLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPI 383
              +  +    L   L EL       + G  ++G      GK   +     ++ K++  +
Sbjct: 129 YNVSRLQPYLKLRQALLELRPAKNVLIDG--VLG-----SGK-TWVALDVCLSYKVQCKM 180

Query: 384 PN-------GLCQ-----LARLSVLY--MDGNKLSGP-----IPPCIGDLTS--LRLLSL 422
                      C      L  L  L   +D N  S       I   I  + +   RLL  
Sbjct: 181 DFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKS 240

Query: 423 ASNE-----LNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSG 477
              E     L +V      N K   + N S               K+++    +R     
Sbjct: 241 KPYENCLLVLLNV-----QNAKAWNAFNLSC--------------KILLT---TRFK--- 275

Query: 478 DIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYL 537
            +   +        +SL  +            L   E                    L L
Sbjct: 276 QVTDFLSAA-TTTHISLDHH---------SMTLTPDEVKS-----------------LLL 308

Query: 538 KDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGL--AQVQVPVCKSGNSSSHRKSRK 595
           K L+     L  E+    P                 +    ++  +    N       + 
Sbjct: 309 KYLDCRPQDLPREVLTTNP-------------RRLSIIAESIRDGLATWDNWKHVNCDKL 355

Query: 596 NTIL---LGVLLP--LSTVFIIAVILAVRYAMISRCQEKNAKQSNIESNMLPQATRRRF- 649
            TI+   L VL P     +F    +              +A         +P        
Sbjct: 356 TTIIESSLNVLEPAEYRKMFDRLSVF-----------PPSAH--------IPTILLSLIW 396

Query: 650 ---SYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVEC 706
                 +++   N+ +  +L+                 E  I +  + LE       V+ 
Sbjct: 397 FDVIKSDVMVVVNKLHKYSLV------------EKQPKESTISIPSIYLE-----LKVKL 439

Query: 707 EVLKSVRHRNLV---KIISSCTNNDFKALVLE-Y--------MPNGSLED--------YL 746
           E   ++ HR++V    I  +  ++D     L+ Y        + N    +        +L
Sbjct: 440 ENEYAL-HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFL 498

Query: 747 YSNNFSFDILQRL----------SVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM 796
              +F F + Q++            I++    L++    Y   +  CD  P    L    
Sbjct: 499 ---DFRF-LEQKIRHDSTAWNASGSILNTLQQLKF----YKPYI--CDNDPKYERLVNA- 547

Query: 797 VAHLSDFGIAKLLSGEESMKQT--LTLATIGYMAPG 830
              + DF    L   EE++  +    L  I  MA  
Sbjct: 548 ---ILDF----LPKIEENLICSKYTDLLRIALMAED 576

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.4 bits (109), Expect = 4e-05
 Identities = 53/333 (15%), Positives = 95/333 (28%), Gaps = 108/333 (32%)

Query: 55  NFLSGTIPSTIFNLSSLSTGMD-------FSN--NSLTGSLPDDMCRRLPL---IKGLYM 102
           +FLS    + I  L   S  +             +     LP ++    P    I    +
Sbjct: 279 DFLSAATTTHIS-LDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESI 337

Query: 103 SNNKLTGPIPN----NIWQCKELIVISLA----------YNQFT-----ERIPRGLGNLT 143
            +   T    N    N  +   +I  SL           +++ +       IP       
Sbjct: 338 RDGLAT--WDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIP------- 388

Query: 144 SLKTLYLGFNNLTGEIPYEMGN-LRN------------LEILGLQLNKLVGFVPTSIFNL 190
               L L + ++       + N L              + I  + L   V      + N 
Sbjct: 389 -TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKV-----KLENE 442

Query: 191 SAM-KTL--------ALPSNALSGSLPSSID----------LVRLPNLEIISLAGNNFSG 231
            A+ +++           S+ L    P  +D          L  + + E ++L    F  
Sbjct: 443 YALHRSIVDHYNIPKTFDSDDLI---PPYLDQYFYSHIGHHLKNIEHPERMTL----FRM 495

Query: 232 IIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSY-NFLTSSTSE------- 283
           +   F F   K+       N+ SG I NTL  L+        Y  ++  +  +       
Sbjct: 496 VFLDFRFLEQKIRHDSTAWNA-SGSILNTLQQLKF-------YKPYICDNDPKYERLVNA 547

Query: 284 -LSFLSSWA----NCKNLKLLDLS-NNPINGVL 310
            L FL          K   LL ++       + 
Sbjct: 548 ILDFLPKIEENLICSKYTDLLRIALMAEDEAIF 580

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 46/215 (21%), Positives = 85/215 (39%), Gaps = 53/215 (24%)

Query: 658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRN 716
           + +++    +GTG FG V +   ++ G   A+K          +    E +++K + H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVN 61

Query: 717 LVKIIS---SCTNNDFKA-----------------------------------LVLEYMP 738
           ++K++    +  + + K                                    +++EY+P
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 739 NGSLEDYLYSNNFSFDILQRLSV---IIDVALALEYLHFGYSNPVVHCDIKPSNVLLD-K 794
           + +L   L S   S   +    +   I  +  A+ ++H   S  + H DIKP N+L++ K
Sbjct: 122 D-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSK 177

Query: 795 DMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D    L DFG AK L   E       + +  Y AP
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPS--VAYICSRFYRAP 210

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 48/156 (30%), Positives = 72/156 (46%), Gaps = 9/156 (5%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L L    L+         LT L  L L YN+L+        +L EL  + L NN L+ ++
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SL 98

Query: 62  PSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIW-QCK 119
           P  +F +L+ L   +    N L  SLP  +  RL  +K L ++ N+L   IP   + +  
Sbjct: 99  PLGVFDHLTQL-DKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLT 155

Query: 120 ELIVISLAYNQFTERIPRG-LGNLTSLKTLYLGFNN 154
            L  +SL+ NQ    +P G    L  L+T+ L F N
Sbjct: 156 NLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITL-FGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 52/159 (32%), Positives = 72/159 (45%), Gaps = 14/159 (8%)

Query: 370 QGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGD-LTSLRLLSLASNELN 428
           + LDL +  L          L +L+ L +D N+L   +   + D LT L  L LA+N+L 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96

Query: 429 SVIPSTFWNLKDILSLNFSSNFLNGSLPEDI----GNLKVVVIIDLSRNNLSGDIPT-AI 483
           S+    F +L  +  L    N L  SLP  +      LK    + L+ N L   IP  A 
Sbjct: 97  SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLK---ELRLNTNQLQ-SIPAGAF 151

Query: 484 GGLMNLQDLSLRDNGLQGSIPKSI-GGLVSLESLDLSNN 521
             L NLQ LSL  N LQ S+P      L  L+++ L  N
Sbjct: 152 DKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 51/186 (27%), Positives = 74/186 (39%), Gaps = 8/186 (4%)

Query: 126 LAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPT 185
           L               LT L  L L +N L         +L  L  LGL  N+L   +P 
Sbjct: 42  LQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPL 100

Query: 186 SIF-NLSAMKTLALPSNALSGSLPSSI-DLVRLPNLEIISLAGNNFSGIIPSFIFNA-SK 242
            +F +L+ +  L L  N L  SLPS + D  RL  L+ + L  N     IP+  F+  + 
Sbjct: 101 GVFDHLTQLDKLYLGGNQLK-SLPSGVFD--RLTKLKELRLNTNQLQS-IPAGAFDKLTN 156

Query: 243 LSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLS 302
           L  L L  N            L KL+ + L  N    S  E+ +LS W    + K+ D +
Sbjct: 157 LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRCEILYLSQWIRENSNKVKDGT 216

Query: 303 NNPING 308
              ++ 
Sbjct: 217 GQNLHE 222

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 59.3 bits (144), Expect = 8e-10
 Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 29/161 (18%)

Query: 396 LYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSL 455
           L +    L+         LT L  L+L  N+L ++    F +L ++ +L  ++N L  SL
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SL 98

Query: 456 PEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI-GGLVSLE 514
           P  + +                        L  L  L L  N L+ S+P  +   L  L+
Sbjct: 99  PLGVFD-----------------------HLTQLDKLYLGGNQLK-SLPSGVFDRLTKLK 134

Query: 515 SLDLSNNSLSGNIPTSM-EKLLYLKDLNLSFNKLEGEIPRG 554
            L L+ N L  +IP    +KL  L+ L+LS N+L+  +P G
Sbjct: 135 ELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQS-VPHG 173

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 44/166 (26%), Positives = 64/166 (38%), Gaps = 13/166 (7%)

Query: 143 TSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFN-LSAMKTLALPSN 201
              + L L    L          L  L  L L  N+L   +   +F+ L+ + TL L +N
Sbjct: 35  ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANN 93

Query: 202 ALSGSLPSSI-DLVRLPNLEIISLAGNNFSGIIPSFIF-NASKLSVLELGENSFSGFIPN 259
            L+ SLP  + D   L  L+ + L GN     +PS +F   +KL  L L  N        
Sbjct: 94  QLA-SLPLGVFD--HLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQSIPAG 149

Query: 260 TLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNP 305
               L  L+ L LS N L S         ++     L+ + L  N 
Sbjct: 150 AFDKLTNLQTLSLSTNQLQSVPH-----GAFDRLGKLQTITLFGNQ 190

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 53.2 bits (128), Expect = 8e-08
 Identities = 49/186 (26%), Positives = 71/186 (38%), Gaps = 38/186 (20%)

Query: 220 EIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTS 279
           E + L     + +  +     +KL+ L L  N           +L +L  L L+ N L S
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97

Query: 280 STSELSFLSSWA--NCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPK 337
                  L      +   L  L L  N +   LP          S +F            
Sbjct: 98  -------LPLGVFDHLTQLDKLYLGGNQLKS-LP----------SGVFDR---------- 129

Query: 338 EIGNLINLRELGLWGNELIGSIPI-TFGKLQNLQGLDLVNNKLEGPIPNG-LCQLARLSV 395
               L  L+EL L  N+L  SIP   F KL NLQ L L  N+L+  +P+G   +L +L  
Sbjct: 130 ----LTKLKELRLNTNQL-QSIPAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQT 183

Query: 396 LYMDGN 401
           + + GN
Sbjct: 184 ITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 39/150 (26%), Positives = 60/150 (40%), Gaps = 31/150 (20%)

Query: 407 IPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVV 466
           +P  I        L L S  L ++  +TF  L  +  LN   N L  +L   + +     
Sbjct: 29  VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFD----- 80

Query: 467 IIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI-GGLVSLESLDLSNNSLSG 525
                              L  L  L L +N L  S+P  +   L  L+ L L  N L  
Sbjct: 81  ------------------DLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS 121

Query: 526 NIPTSM-EKLLYLKDLNLSFNKLEGEIPRG 554
            +P+ + ++L  LK+L L+ N+L+  IP G
Sbjct: 122 -LPSGVFDRLTKLKELRLNTNQLQ-SIPAG 149

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 41/167 (24%), Positives = 73/167 (43%), Gaps = 34/167 (20%)

Query: 666 LIGTGGFGSVYKGSFL-DGMEVAIKVF------HLQLEGALKSFDV---ECEVLKSVRHR 715
            IG+GGFG +Y         + A  V       +  L   LK +     +  + K +  +
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 716 NLVKI---------ISSCTNNDFKALVLEYMPNG-SLEDYLYSNN-FSFDILQRLSV-II 763
            L  +         ++      ++ +V+E +  G  L+     N  F    + +L + ++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKSTVLQLGIRML 161

Query: 764 DVALALEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAK 807
           DV   LEY+H    N  VH DIK +N+LL   + D V +L+D+G++ 
Sbjct: 162 DV---LEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 64.7 bits (158), Expect = 4e-11
 Identities = 47/174 (27%), Positives = 84/174 (48%), Gaps = 23/174 (13%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIK----VFHLQLEGALKSFDVECEVLKSVRHRNLVKI- 720
           +G+G +GSV        G+ VA+K     F   +  A +++  E  +LK ++H N++ + 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH-AKRTYR-ELRLLKHMKHENVIGLL 94

Query: 721 ---ISSCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG 775
                + +  +F    LV   M    L + +     + D +Q L  I  +   L+Y+H  
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH-- 149

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            S  ++H D+KPSN+ +++D    + DFG+A+  + E     T  +AT  Y AP
Sbjct: 150 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYRAP 198

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 63.6 bits (154), Expect = 8e-11
 Identities = 24/104 (23%), Positives = 39/104 (37%), Gaps = 4/104 (3%)

Query: 328 NCSIRG--TIPKEIGNLINLRELGLWGNELIGSIP-ITFGKLQNLQGLDLVNNKLEGPIP 384
            C+  G       +    NL EL +   + +  +       L  L+ L +V + L    P
Sbjct: 14  RCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73

Query: 385 NGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELN 428
           +      RLS L +  N L   +        SL+ L L+ N L+
Sbjct: 74  DAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.7 bits (131), Expect = 6e-08
 Identities = 19/109 (17%), Positives = 37/109 (33%), Gaps = 9/109 (8%)

Query: 200 SNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIF-NASKLSVLELGENSFSGFIP 258
           +   +      +      NL  + +        +         +L  L + ++      P
Sbjct: 16  TRDGALDSLHHLP--GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73

Query: 259 NTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPIN 307
           +      +L  L LS+N L S + +     S      L+ L LS NP++
Sbjct: 74  DAFHFTPRLSRLNLSFNALESLSWKTVQGLS------LQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.0 bits (129), Expect = 9e-08
 Identities = 19/96 (19%), Positives = 40/96 (41%), Gaps = 4/96 (4%)

Query: 454 SLPEDIGNLKVVVIIDLSRNNLSGDIPT-AIGGLMNLQDLSLRDNGLQGSIPKSI-GGLV 511
                +   + +  + +        +    + GL  L++L++  +GL+  +         
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80

Query: 512 SLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKL 547
            L  L+LS N+L  ++     + L L++L LS N L
Sbjct: 81  RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 53.2 bits (127), Expect = 2e-07
 Identities = 26/108 (24%), Positives = 40/108 (37%), Gaps = 6/108 (5%)

Query: 468 IDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPK-SIGGLVSLESLDLSNNSLSGN 526
           +  +R+    D    + G  NL +L + +      +    + GL  L +L +  + L   
Sbjct: 13  LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71

Query: 527 IPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFS--NRSFMGNDLLC 572
            P +      L  LNLSFN LE  +         S       GN L C
Sbjct: 72  APDAFHFTPRLSRLNLSFNALE-SLSW-KTVQGLSLQELVLSGNPLHC 117

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 23/98 (23%), Positives = 34/98 (34%), Gaps = 6/98 (6%)

Query: 134 RIPRGLGNLTSLKTLYLGFNNLTGEIPYEM-GNLRNLEILGLQLNKLVGFVPTSIF-NLS 191
                L    +L  LY+        +       L  L  L +  + L  FV    F    
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80

Query: 192 AMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNF 229
            +  L L  NAL  SL      V+  +L+ + L+GN  
Sbjct: 81  RLSRLNLSFNALE-SLSW--KTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 19/78 (24%), Positives = 30/78 (38%), Gaps = 2/78 (2%)

Query: 383 IPNGLCQLARLSVLYMDGNKLSGPIPP-CIGDLTSLRLLSLASNELNSVIPSTFWNLKDI 441
             + L     L+ LY++  +    +    +  L  LR L++  + L  V P  F     +
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82

Query: 442 LSLNFSSNFLNGSLPEDI 459
             LN S N L  SL    
Sbjct: 83  SRLNLSFNALE-SLSWKT 99

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 18/99 (18%), Positives = 35/99 (35%), Gaps = 6/99 (6%)

Query: 257 IPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGN 316
             + L     L  L +                       L+ L +  + +  V P +   
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDL----RGLGELRNLTIVKSGLRFVAPDAFHF 78

Query: 317 LSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNEL 355
               LSR+ +S  ++  ++  +    ++L+EL L GN L
Sbjct: 79  TP-RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 22/104 (21%), Positives = 39/104 (37%), Gaps = 6/104 (5%)

Query: 7   NDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQE-LGNLAELELVSLTNNFLSGTIPSTI 65
            D +      +     L +L +   +    +    L  L EL  +++  + L   +    
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75

Query: 66  F-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLT 108
           F     LS  ++ S N+L  SL     + L L + L +S N L 
Sbjct: 76  FHFTPRLSR-LNLSFNALE-SLSWKTVQGLSL-QELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 46.3 bits (109), Expect = 2e-05
 Identities = 24/121 (19%), Positives = 34/121 (28%), Gaps = 27/121 (22%)

Query: 284 LSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLI 343
           L  L      +NL  L + N      L                            +  L 
Sbjct: 21  LDSLHHLPGAENLTELYIENQQHLQHLELRD------------------------LRGLG 56

Query: 344 NLRELGLWGNELIGSIPI-TFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNK 402
            LR L +  +  +  +    F     L  L+L  N LE  +     Q   L  L + GN 
Sbjct: 57  ELRNLTIVKSG-LRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNP 114

Query: 403 L 403
           L
Sbjct: 115 L 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.8 bits (100), Expect = 4e-04
 Identities = 16/98 (16%), Positives = 28/98 (28%), Gaps = 4/98 (4%)

Query: 36  EIPQELGNLAELELVSLTNNFLSGTIPSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRL 94
           +    L     L  + + N      +       L  L   +    + L   +  D     
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN-LTIVKSGLR-FVAPDAFHFT 79

Query: 95  PLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFT 132
           P +  L +S N L   +     Q   L  + L+ N   
Sbjct: 80  PRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.4 bits (99), Expect = 4e-04
 Identities = 20/123 (16%), Positives = 38/123 (30%), Gaps = 24/123 (19%)

Query: 401 NKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIG 460
              +      +    +L  L + + +    +                          D+ 
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLE-----------------------LRDLR 53

Query: 461 NLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSN 520
            L  +  + + ++ L    P A      L  L+L  N L+ S+       +SL+ L LS 
Sbjct: 54  GLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSG 112

Query: 521 NSL 523
           N L
Sbjct: 113 NPL 115

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 62.3 bits (152), Expect = 9e-11
 Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 46/208 (22%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELG---NLAELELVSLTNNFLS 58
           +  + +D+       I  L  ++ L LG NKL      ++     L  L  + LT N L 
Sbjct: 46  IIANNSDIKSVQG--IQYLPNVRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQ 98

Query: 59  GTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQC 118
            ++P+ +F+  +    +    N L  SLPD +  +L  +  L +++N+L           
Sbjct: 99  -SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ---------- 146

Query: 119 KELIVISLAYNQFTERIPRGL-GNLTSLKTLYLGFNNLTGEIPYEMG---NLRNLEILGL 174
                           +P+G+   LT+L  L L +N L   +P   G    L  L+ L L
Sbjct: 147 ---------------SLPKGVFDKLTNLTELDLSYNQLQ-SLP--EGVFDKLTQLKDLRL 188

Query: 175 QLNKLVGFVPTSIF-NLSAMKTLALPSN 201
             N+L   VP  +F  L++++ + L  N
Sbjct: 189 YQNQLKS-VPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 61/236 (25%), Positives = 93/236 (39%), Gaps = 49/236 (20%)

Query: 328 NCSIRG--TIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLE--GPI 383
             S       P +        +  L    +      T  +L ++  +   N+ ++    I
Sbjct: 4   TVSTPIKQIFPDDA--FAETIKANLKKKSV-TDAV-TQNELNSIDQIIANNSDIKSVQGI 59

Query: 384 PNGLCQLARLSVLYMDGNKLSGPIPPCIG---DLTSLRLLSLASNELNSVIPSTFWNLKD 440
                 L  +  L + GNKL       I    +LT+L  L L  N+L S+    F  L +
Sbjct: 60  Q----YLPNVRYLALGGNKLHD-----ISALKELTNLTYLILTGNQLQSLPNGVFDKLTN 110

Query: 441 ILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQ 500
           +  L    N L  SLP+ + +                        L NL  L+L  N LQ
Sbjct: 111 LKELVLVENQLQ-SLPDGVFD-----------------------KLTNLTYLNLAHNQLQ 146

Query: 501 GSIPKSI-GGLVSLESLDLSNNSLSGNIPTSM-EKLLYLKDLNLSFNKLEGEIPRG 554
            S+PK +   L +L  LDLS N L  ++P  + +KL  LKDL L  N+L+  +P G
Sbjct: 147 -SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPDG 199

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 60.4 bits (147), Expect = 4e-10
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 26/223 (11%)

Query: 233 IPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWAN 292
            P   F  +      L + S +  +      L  ++ +  + + + S       +     
Sbjct: 13  FPDDAFAETI--KANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-------VQGIQY 61

Query: 293 CKNLKLLDLSNNPINGVLPSSIG---NLSLSLSRIFISNCSIRGTIPKEIGNLINLRELG 349
             N++ L L  N +       I     L+ +L+ + ++   ++         L NL+EL 
Sbjct: 62  LPNVRYLALGGNKL-----HDISALKELT-NLTYLILTGNQLQSLPNGVFDKLTNLKELV 115

Query: 350 LWGNELIGSIPI-TFGKLQNLQGLDLVNNKLEGPIPNGLC-QLARLSVLYMDGNKLSGPI 407
           L  N+L  S+P   F KL NL  L+L +N+L+  +P G+  +L  L+ L +  N+L   +
Sbjct: 116 LVENQL-QSLPDGVFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQS-L 172

Query: 408 PPCIGD-LTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSN 449
           P  + D LT L+ L L  N+L SV    F  L  +  +    N
Sbjct: 173 PEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 23/211 (10%)

Query: 100 LYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEI 159
             +    +T  +  N  +   +  I    +       +G+  L +++ L LG N L    
Sbjct: 24  ANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLH--- 76

Query: 160 PYEMG---NLRNLEILGLQLNKLVGFVPTSIFN-LSAMKTLALPSNALSGSLPSSIDLVR 215
             ++     L NL  L L  N+L   +P  +F+ L+ +K L L  N L  SLP  +   +
Sbjct: 77  --DISALKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQ-SLPDGV-FDK 131

Query: 216 LPNLEIISLAGNNFSGIIPSFIFNA-SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSY 274
           L NL  ++LA N     +P  +F+  + L+ L+L  N            L +L+ LRL  
Sbjct: 132 LTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQ 190

Query: 275 NFLTSSTSELSFLSSWANCKNLKLLDLSNNP 305
           N L  S  +  F        +L+ + L +NP
Sbjct: 191 NQLK-SVPDGVF----DRLTSLQYIWLHDNP 216

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 55/234 (23%), Positives = 90/234 (38%), Gaps = 46/234 (19%)

Query: 172 LGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSG 231
             L+   +     T    L+++  +   ++ +  S+   I    LPN+  ++L GN    
Sbjct: 24  ANLKKKSVTD-AVTQN-ELNSIDQIIANNSDIK-SVQG-IQ--YLPNVRYLALGGNKLHD 77

Query: 232 IIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSS-- 289
           I  +     + L+ L L  N            L  L+ L L  N L S       L    
Sbjct: 78  I-SAL-KELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS-------LPDGV 128

Query: 290 WANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELG 349
           +    NL  L+L++N +   LP            +F                L NL EL 
Sbjct: 129 FDKLTNLTYLNLAHNQLQ-SLP----------KGVFDK--------------LTNLTELD 163

Query: 350 LWGNELIGSIPI-TFGKLQNLQGLDLVNNKLEGPIPNGLC-QLARLSVLYMDGN 401
           L  N+L  S+P   F KL  L+ L L  N+L+  +P+G+  +L  L  +++  N
Sbjct: 164 LSYNQL-QSLPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 61.9 bits (151), Expect = 3e-10
 Identities = 47/207 (22%), Positives = 89/207 (42%), Gaps = 34/207 (16%)

Query: 641 LPQATRRRFSYKELLQA----TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIK----VF 691
           L    ++ F  +++ +        + +   +G+G +GSV        G +VAIK     F
Sbjct: 2   LSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF 61

Query: 692 HLQLEGALKSFDVECEVLKSVRHRNLVKI----ISSCTNNDFKA--LVLEYMP---NGSL 742
             ++  A +++  E  +LK ++H N++ +      + +  +F    LV+ +M       +
Sbjct: 62  QSEIF-AKRAYR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM 119

Query: 743 EDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSD 802
                     + + Q L         L+Y+H   S  VVH D+KP N+ +++D    + D
Sbjct: 120 GLKFSEEKIQYLVYQMLK-------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILD 169

Query: 803 FGIAKLLSGEESMKQTLTLATIGYMAP 829
           FG+A+    E     T  + T  Y AP
Sbjct: 170 FGLARHADAE----MTGYVVTRWYRAP 192

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 61.5 bits (150), Expect = 4e-10
 Identities = 49/183 (26%), Positives = 80/183 (43%), Gaps = 30/183 (16%)

Query: 667 IGTGGFGSVYKGSFLD---GMEVAIK---VFHLQLEGALKSFDVECEVLKSVRHRNLVK- 719
           +G G +G V   S      G  VAIK    F   L  AL++   E ++LK  +H N++  
Sbjct: 19  LGEGAYGVVC--SATHKPTGEIVAIKKIEPFDKPLF-ALRTLR-EIKILKHFKHENIITI 74

Query: 720 --IISSCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG 775
             I    +  +F    ++ E M    L   + +   S D +Q    I     A++ LH  
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQ--YFIYQTLRAVKVLH-- 129

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL---------ATIGY 826
             + V+H D+KPSN+L++ +    + DFG+A+++    +     T          AT  Y
Sbjct: 130 -GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188

Query: 827 MAP 829
            AP
Sbjct: 189 RAP 191

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 61.7 bits (150), Expect = 4e-10
 Identities = 38/182 (20%), Positives = 74/182 (40%), Gaps = 33/182 (18%)

Query: 667 IGTGGFGSVYKGSFLD---GMEVAIK----VFHLQLEGALKSFDVECEVLKSVRHRNLVK 719
           IG G +G VY     D      VAIK    +F   ++   +    E  +L  ++   +++
Sbjct: 34  IGRGSYGYVY--LAYDKNTEKNVAIKKVNRMFEDLID-CKRILR-EITILNRLKSDYIIR 89

Query: 720 ---IISSCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFDILQRLS------VIIDVALA 768
              +I       F    +VLE   +  L+    +          L+      ++ ++ L 
Sbjct: 90  LYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTP-------IFLTEEHIKTILYNLLLG 141

Query: 769 LEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA 828
             ++H    + ++H D+KP+N LL++D    + DFG+A+ ++ E+       L       
Sbjct: 142 ENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198

Query: 829 PG 830
           P 
Sbjct: 199 PH 200

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 60.4 bits (147), Expect = 9e-10
 Identities = 47/174 (27%), Positives = 82/174 (47%), Gaps = 23/174 (13%)

Query: 667 IGTGGFGSVYKGS-FLDGMEVAIK----VFHLQLEGALKSFDVECEVLKSVRHRNLVKII 721
           +G+G +G+V        G +VAIK     F  +L  A +++  E  +LK +RH N++ ++
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF-AKRAYR-ELRLLKHMRHENVIGLL 90

Query: 722 ----SSCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG 775
                  T +DF    LV+ +M    L   +       D +Q L  +  +   L Y+H  
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFL--VYQMLKGLRYIH-- 145

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            +  ++H D+KP N+ +++D    + DFG+A+    E     T  + T  Y AP
Sbjct: 146 -AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAP 194

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 56.5 bits (137), Expect = 2e-09
 Identities = 38/126 (30%), Positives = 64/126 (50%), Gaps = 8/126 (6%)

Query: 328 NCSIRG--TIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPN 385
            C+ +G  ++P  I    +   L L  N+L       F KL  L  L L  N+++  +P+
Sbjct: 13  RCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPD 69

Query: 386 GLC-QLARLSVLYMDGNKLSGPIPPCIGD-LTSLRLLSLASNELNSVIPSTFWNLKDILS 443
           G+  +L +L++LY+  NKL   +P  + D LT L+ L+L +N+L SV    F  L  +  
Sbjct: 70  GVFDKLTKLTILYLHENKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQK 128

Query: 444 LNFSSN 449
           +   +N
Sbjct: 129 IWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 43.8 bits (104), Expect = 4e-05
 Identities = 34/103 (33%), Positives = 44/103 (42%), Gaps = 4/103 (3%)

Query: 126 LAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPT 185
           L  N+           LT L  L L  N +          L  L IL L  NKL   +P 
Sbjct: 35  LESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQS-LPN 93

Query: 186 SIF-NLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGN 227
            +F  L+ +K LAL +N L  S+P  I   RL +L+ I L  N
Sbjct: 94  GVFDKLTQLKELALDTNQLK-SVPDGI-FDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 43.4 bits (103), Expect = 7e-05
 Identities = 29/88 (32%), Positives = 41/88 (46%), Gaps = 5/88 (5%)

Query: 469 DLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI-GGLVSLESLDLSNNSLSGNI 527
           +L  N L          L  L  LSL  N +Q S+P  +   L  L  L L  N L  ++
Sbjct: 34  ELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SL 91

Query: 528 PTSM-EKLLYLKDLNLSFNKLEGEIPRG 554
           P  + +KL  LK+L L  N+L+  +P G
Sbjct: 92  PNGVFDKLTQLKELALDTNQLKS-VPDG 118

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 42.6 bits (101), Expect = 1e-04
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 4/106 (3%)

Query: 370 QGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGD-LTSLRLLSLASNELN 428
             L+L +NKL+        +L +L+ L +  N++   +P  + D LT L +L L  N+L 
Sbjct: 31  TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHENKLQ 89

Query: 429 SVIPSTFWNLKDILSLNFSSNFLNGSLPEDI-GNLKVVVIIDLSRN 473
           S+    F  L  +  L   +N L  S+P+ I   L  +  I L  N
Sbjct: 90  SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 59.1 bits (142), Expect = 2e-09
 Identities = 36/212 (16%), Positives = 60/212 (28%), Gaps = 55/212 (25%)

Query: 643 QATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHL--------Q 694
           Q     FS+      T +      IG G FG V++    D   VAIK+  +         
Sbjct: 7   QKGPVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGS 62

Query: 695 LEGALKSFDVECEVLKSV---------RHRNLVKIISSC--------------------- 724
            +   +    E  + K +         R    + + S                       
Sbjct: 63  HQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTK 122

Query: 725 ---------TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG 775
                      +D   +VLE+   G   + + +   S       S++  +  +L      
Sbjct: 123 GSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLA--TAKSILHQLTASLAVAEAS 180

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
                 H D+   NVLL K  +  L      K
Sbjct: 181 LR--FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 41/151 (27%), Positives = 67/151 (44%), Gaps = 11/151 (7%)

Query: 328 NCSIRG--TIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPN 385
           +C  +   ++P  I    N + L L  N++    P  F  L NL+ L L +N+L   +P 
Sbjct: 25  DCRSKRHASVPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPV 81

Query: 386 GLC-QLARLSVLYMDGNKLSGPIPPCIGD-LTSLRLLSLASNELNSVIPSTFWNLKDILS 443
           G+   L +L+VL +  N+L+  +P  + D L  L+ L +  N+L   +P     L  +  
Sbjct: 82  GVFDSLTQLTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTH 139

Query: 444 LNFSSNFLNGSLPEDI-GNLKVVVIIDLSRN 473
           L    N L  S+P      L  +    L  N
Sbjct: 140 LALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 55.9 bits (135), Expect = 8e-09
 Identities = 44/167 (26%), Positives = 65/167 (38%), Gaps = 31/167 (18%)

Query: 12  AIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFN-LSS 70
           ++P  I      + L L  N++    P    +L  L+ + L +N L   +P  +F+ L+ 
Sbjct: 33  SVPAGIPTNA--QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQ 89

Query: 71  LSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQ 130
           L+  +D   N LT  LP  +  RL  +K L+M  NKLT                      
Sbjct: 90  LTV-LDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT---------------------- 125

Query: 131 FTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLN 177
               +PRG+  LT L  L L  N L          L +L    L  N
Sbjct: 126 ---ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 38/132 (28%), Positives = 61/132 (46%), Gaps = 11/132 (8%)

Query: 395 VLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGS 454
           +LY+  N+++   P     L +L+ L L SN+L ++    F +L  +  L+  +N L   
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-V 102

Query: 455 LPEDI----GNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI-GG 509
           LP  +     +LK    + +  N L+  +P  I  L +L  L+L  N L+ SIP      
Sbjct: 103 LPSAVFDRLVHLK---ELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK-SIPHGAFDR 157

Query: 510 LVSLESLDLSNN 521
           L SL    L  N
Sbjct: 158 LSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 37/160 (23%)

Query: 245 VLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSS--WANCKNLKLLDLS 302
           +L L +N  +   P    +L  L+ L L  N L +       L    + +   L +LDL 
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-------LPVGVFDSLTQLTVLDLG 96

Query: 303 NNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPIT 362
            N +  VLP          S +F                L++L+EL +  N+L   +P  
Sbjct: 97  TNQLT-VLP----------SAVF--------------DRLVHLKELFMCCNKL-TELPRG 130

Query: 363 FGKLQNLQGLDLVNNKLEGPIPNG-LCQLARLSVLYMDGN 401
             +L +L  L L  N+L+  IP+G   +L+ L+  Y+ GN
Sbjct: 131 IERLTHLTHLALDQNQLKS-IPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 7/150 (4%)

Query: 143 TSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFN-LSAMKTLALPSN 201
           T+ + LYL  N +T   P    +L NL+ L L  N+L   +P  +F+ L+ +  L L +N
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98

Query: 202 ALSGSLPSSI-DLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNT 260
            L+  LPS++ D  RL +L+ + +  N  +  +P  I   + L+ L L +N         
Sbjct: 99  QLT-VLPSAVFD--RLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGA 154

Query: 261 LGNLRKLEWLRLSYNFLTSSTSELSFLSSW 290
              L  L    L  N       ++ +L +W
Sbjct: 155 FDRLSSLTHAYLFGNPWDCECRDIMYLRNW 184

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 39/149 (26%), Positives = 64/149 (42%), Gaps = 30/149 (20%)

Query: 407 IPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVV 466
           +P  I   T+ ++L L  N++  + P  F +L ++  L   SN L  +LP  + +     
Sbjct: 34  VPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDS---- 86

Query: 467 IIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI-GGLVSLESLDLSNNSLSG 525
                              L  L  L L  N L   +P ++   LV L+ L +  N L+ 
Sbjct: 87  -------------------LTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT- 125

Query: 526 NIPTSMEKLLYLKDLNLSFNKLEGEIPRG 554
            +P  +E+L +L  L L  N+L+  IP G
Sbjct: 126 ELPRGIERLTHLTHLALDQNQLKS-IPHG 153

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 58.9 bits (143), Expect = 3e-09
 Identities = 40/162 (24%), Positives = 76/162 (46%), Gaps = 20/162 (12%)

Query: 667 IGTGGFGSVYKGSFLD---GMEVAIK----VFHLQLEGALKSFDVECEVLKSVR-HRNLV 718
           +G G +G V+    +D   G  VA+K     F    + A ++F  E  +L  +  H N+V
Sbjct: 17  LGKGAYGIVW--KSIDRRTGEVVAVKKIFDAFQNSTD-AQRTFR-EIMILTELSGHENIV 72

Query: 719 KIISSCTNNDFKA--LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
            +++    ++ +   LV +YM    L   + +N       Q   V+  +   ++YLH   
Sbjct: 73  NLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQ--YVVYQLIKVIKYLH--- 126

Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT 818
           S  ++H D+KPSN+LL+ +    ++DFG+++       +   
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 56.2 bits (136), Expect = 4e-09
 Identities = 28/131 (21%), Positives = 53/131 (40%), Gaps = 13/131 (9%)

Query: 100 LYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEI 159
           L+     +   +   +   K    ++L+ N   E+I   L  + +L+ L LG N +  +I
Sbjct: 30  LHGMIPPIEK-MDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLIK-KI 85

Query: 160 PYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMK---TLALPSNALSGSLPSSIDLVRL 216
                    LE L +  N++      S+  +  +     L + +N ++ +      L  L
Sbjct: 86  ENLDAVADTLEELWISYNQI-----ASLSGIEKLVNLRVLYMSNNKIT-NWGEIDKLAAL 139

Query: 217 PNLEIISLAGN 227
             LE + LAGN
Sbjct: 140 DKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 39/154 (25%), Positives = 57/154 (37%), Gaps = 36/154 (23%)

Query: 257 IPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGN 316
           +  TL  L+  + L LS N +         +SS +  +NL++L L  N I       I N
Sbjct: 40  MDATLSTLKACKHLALSTNNIEK-------ISSLSGMENLRILSLGRNLI-----KKIEN 87

Query: 317 LSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVN 376
           L                           L EL +  N+ I S+     KL NL+ L + N
Sbjct: 88  LD---------------------AVADTLEELWISYNQ-IASLS-GIEKLVNLRVLYMSN 124

Query: 377 NKLEGPIP-NGLCQLARLSVLYMDGNKLSGPIPP 409
           NK+      + L  L +L  L + GN L      
Sbjct: 125 NKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 44/171 (25%), Positives = 59/171 (34%), Gaps = 44/171 (25%)

Query: 213 LVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRL 272
           L  L   + ++L+ NN   I  S +     L +L LG N     I N       LE L +
Sbjct: 44  LSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWI 100

Query: 273 SYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIR 332
           SYN + S       LS      NL++L +SNN I       I  L+              
Sbjct: 101 SYNQIAS-------LSGIEKLVNLRVLYMSNNKITNW--GEIDKLA-------------- 137

Query: 333 GTIPKEIGNLINLRELGLWGNELIGSIPITFG----------KLQNLQGLD 373
                    L  L +L L GN L                   +L NL+ LD
Sbjct: 138 --------ALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 29/165 (17%), Positives = 60/165 (36%), Gaps = 31/165 (18%)

Query: 396 LYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSL 455
           L+     +   +   +  L + + L+L++N +  +                         
Sbjct: 30  LHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKI------------------------- 63

Query: 456 PEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLES 515
              +  ++ + I+ L RN +   I         L++L +  N +  S+   I  LV+L  
Sbjct: 64  -SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRV 119

Query: 516 LDLSNNSLSG-NIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFAN 559
           L +SNN ++       +  L  L+DL L+ N L  +       + 
Sbjct: 120 LYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 57.7 bits (140), Expect = 5e-09
 Identities = 39/177 (22%), Positives = 79/177 (44%), Gaps = 35/177 (19%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVR-HRNLVKII--- 721
           +G G +  V++   +    +V +K+  L+     K    E ++L+++R   N++ +    
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKI--LKPVKKKKIKR-EIKILENLRGGPNIITLADIV 100

Query: 722 -SSCTNNDFKALVLEYMPN-------GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
               +     ALV E++ N        +L DY     + ++IL+          AL+Y H
Sbjct: 101 KDPVSRTP--ALVFEHVNNTDFKQLYQTLTDYDI-RFYMYEILK----------ALDYCH 147

Query: 774 FGYSNPVVHCDIKPSNVLLD-KDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
              S  ++H D+KP NV++D +     L D+G+A+     +     + +A+  +  P
Sbjct: 148 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGP 199

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 65/332 (19%), Positives = 108/332 (32%), Gaps = 75/332 (22%)

Query: 124 ISLAYNQFTER----IPRGLGNLTSLKTLYLGFNNLT-------GEIPYEMGNLRNLEIL 172
            SL  +  T      +   L    S+K + L  N +         E      +L   E  
Sbjct: 9   KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 68

Query: 173 GLQLNKLVGFVPTSIFNLSAM-------KTLALPSNALS--GSLPSSIDLVRLPNLEIIS 223
            +   ++   +P ++  L           T+ L  NA       P    L +   LE + 
Sbjct: 69  DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 128

Query: 224 LAGNNFS-------------GIIPSFIFNASKLSVLELGENSFSG----FIPNTLGNLRK 266
           L  N                  +     NA  L  +  G N            T  + R 
Sbjct: 129 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 188

Query: 267 LEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFI 326
           L  +++  N +     E   L   A C+ LK+LDL +N       + +G+ +L+      
Sbjct: 189 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF-----THLGSSALA------ 237

Query: 327 SNCSIRGTIPKEIGNLINLRELGLWGNEL--IGSIPI----TFGKLQNLQGLDLVNNKLE 380
                       + +  NLRELGL    L   G+  +    +  +   LQ L L  N++E
Sbjct: 238 ----------IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287

Query: 381 GPIPNGLCQLAR--------LSVLYMDGNKLS 404
               + +  L          L  L ++GN+ S
Sbjct: 288 ---LDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 54.3 bits (131), Expect = 8e-08
 Identities = 61/323 (18%), Positives = 111/323 (34%), Gaps = 55/323 (17%)

Query: 267 LEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPIN--------GVLPSSIGNLS 318
           +E   L  + +T+   + S  +      ++K + LS N I           + S      
Sbjct: 6   IEGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64

Query: 319 LSLSRIFISNCSIRGT-----IPKEIGNLINLRELGLWGNEL--IGSIPIT--FGKLQNL 369
              S IF              + + +     L  + L  N        P+     K   L
Sbjct: 65  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124

Query: 370 QGLDLVNNKLEGPIPNGLCQLAR-LSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELN 428
           + L L NN L    P    ++AR L  L ++    + P          LR +    N L 
Sbjct: 125 EHLYLHNNGLG---PQAGAKIARALQELAVNKKAKNAP---------PLRSIICGRNRLE 172

Query: 429 ----SVIPSTFWNLKDILSLNFSSNFLN-----GSLPEDIGNLKVVVIIDLSRNNLSGD- 478
                    TF + + + ++    N +        L E +   + + ++DL  N  +   
Sbjct: 173 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG 232

Query: 479 ---IPTAIGGLMNLQDLSLRDNGLQG----SIPKSIGGLV--SLESLDLSNNSLSGN--- 526
              +  A+    NL++L L D  L      ++  +   L    L++L L  N +  +   
Sbjct: 233 SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVR 292

Query: 527 -IPTSM-EKLLYLKDLNLSFNKL 547
            + T + EK+  L  L L+ N+ 
Sbjct: 293 TLKTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 48.9 bits (117), Expect = 4e-06
 Identities = 48/333 (14%), Positives = 97/333 (29%), Gaps = 62/333 (18%)

Query: 139 LGNLTSLKTLYLGFNNLTGE----IPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMK 194
           +    S++   L  + +T E    +   +    +++ + L  N +            A +
Sbjct: 1   MARF-SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTI---------GTEAAR 50

Query: 195 TLA--LPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENS 252
            L+  + S      L    +   +    +          ++ + +    KL  + L +N+
Sbjct: 51  WLSENIASKK---DL-EIAEFSDIFTGRVKDEIPEALRLLLQALLKC-PKLHTVRLSDNA 105

Query: 253 FSG----FIPNTLGNLRKLEWLRLSYN--------FLTSSTSELSFLSSWANCKNLKLLD 300
           F       + + L     LE L L  N         +  +  EL+      N   L+ + 
Sbjct: 106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSII 165

Query: 301 LSNNPINGVLPSSIGNL---SLSLSRIFISNCSIR-----GTIPKEIGNLINLRELGLWG 352
              N +                 L  + +    IR       + + +     L+ L L  
Sbjct: 166 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQD 225

Query: 353 NEL--IGSIPI--TFGKLQNLQGLDLVNNKLEGPIPNGLCQLAR---------LSVLYMD 399
           N    +GS  +        NL+ L L +  L      G   +           L  L + 
Sbjct: 226 NTFTHLGSSALAIALKSWPNLRELGLNDCLLS---ARGAAAVVDAFSKLENIGLQTLRLQ 282

Query: 400 GNKLSGPIPPCIGD-----LTSLRLLSLASNEL 427
            N++       +       +  L  L L  N  
Sbjct: 283 YNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 48.2 bits (115), Expect = 7e-06
 Identities = 40/269 (14%), Positives = 86/269 (31%), Gaps = 45/269 (16%)

Query: 313 SIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNEL--IGSIPI--TFGKLQN 368
           SI   SL L  I   +      +   +    +++E+ L GN +    +  +       ++
Sbjct: 5   SIEGKSLKLDAITTEDEKS---VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 61

Query: 369 LQGLDLVNNKL-----EGP-----IPNGLCQLARLSVLYMDGNKLSG----PIPPCIGDL 414
           L+  +  +        E P     +   L +  +L  + +  N        P+   +   
Sbjct: 62  LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 121

Query: 415 TSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNN 474
           T L  L L +N            L        +      ++ +   N   +  I   RN 
Sbjct: 122 TPLEHLYLHNN-----------GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR 170

Query: 475 LSGD----IPTAIGGLMNLQDLSLRDNGL-----QGSIPKSIGGLVSLESLDLSNNSLSG 525
           L                 L  + +  NG+     +  + + +     L+ LDL +N+ + 
Sbjct: 171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH 230

Query: 526 N----IPTSMEKLLYLKDLNLSFNKLEGE 550
                +  +++    L++L L+   L   
Sbjct: 231 LGSSALAIALKSWPNLRELGLNDCLLSAR 259

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 40/157 (25%), Positives = 67/157 (42%), Gaps = 31/157 (19%)

Query: 666 LIGTGGFGSVYKGSFLD---GMEVAIKV------FHLQLEGALKSFDVECEVLKSVRHR- 715
           +IG G FG V K    D      VA+K+      FH Q   A      E  +L+ +R + 
Sbjct: 104 VIGKGSFGQVVKA--YDHKVHQHVALKMVRNEKRFHRQ---AA----EEIRILEHLRKQD 154

Query: 716 -----NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFS-FDILQRLSVIIDVALAL 769
                N++ ++ + T  +   +  E + + +L + +  N F  F +         +   L
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213

Query: 770 EYLHFGYSNPVVHCDIKPSNVLL--DKDMVAHLSDFG 804
           + LH    N ++HCD+KP N+LL         + DFG
Sbjct: 214 DALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG 247

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 26/99 (26%), Positives = 42/99 (42%), Gaps = 9/99 (9%)

Query: 667 IGTGGFGSVYKGSF--LDGMEVAIKVFHLQL-EGA----LKSFDVECEVLKSV-RHRNLV 718
           +G G FG V +     +D       V    L EGA     ++   E ++L  +  H N+V
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 719 KIISSCTNNDFKALV-LEYMPNGSLEDYLYSNNFSFDIL 756
            ++ +CT      +V +E+   G+L  YL S    F   
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 27/131 (20%), Positives = 55/131 (41%), Gaps = 6/131 (4%)

Query: 700 KSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRL 759
           K +     V    R  ++    SS ++   +   L  +      + LY +  + + L  +
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL--I 196

Query: 760 SVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES-MKQT 818
                VA  +E+L    S   +H D+   N+LL +  V  + DFG+A+ +  +   +++ 
Sbjct: 197 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253

Query: 819 LTLATIGYMAP 829
                + +MAP
Sbjct: 254 DARLPLKWMAP 264

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 55.1 bits (133), Expect = 4e-08
 Identities = 42/167 (25%), Positives = 73/167 (43%), Gaps = 29/167 (17%)

Query: 658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKV------FHLQLEGALKSFDVECEVLK 710
            +++   +LIG G FG V K     +   VAIK+      F  Q   A     +E  +L+
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQ---AQ----IEVRLLE 105

Query: 711 SVRHR------NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNF---SFDILQRLSV 761
            +          +V +       +   LV E + + +L D L + NF   S ++ ++ + 
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFA- 163

Query: 762 IIDVALALEYLHFGYSNPVVHCDIKPSNVLL--DKDMVAHLSDFGIA 806
              +  AL +L     + ++HCD+KP N+LL   K     + DFG +
Sbjct: 164 -QQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSS 208

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 44/149 (29%), Positives = 66/149 (44%), Gaps = 6/149 (4%)

Query: 328 NCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGL 387
            C  +G      G       L L  N L       F +L +L  L L  NKL+  +PNG+
Sbjct: 13  ECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGV 71

Query: 388 C-QLARLSVLYMDGNKLSGPIPPCIGD-LTSLRLLSLASNELNSVIPSTFWNLKDILSLN 445
             +L  L+ L +  N+L   +P  + D LT L+ L+L +N+L S+    F  L  +  L 
Sbjct: 72  FNKLTSLTYLNLSTNQLQS-LPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLR 130

Query: 446 FSSNFLNGSLPEDI-GNLKVVVIIDLSRN 473
              N L  S+P+ +   L  +  I L  N
Sbjct: 131 LYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 50.1 bits (120), Expect = 5e-07
 Identities = 45/145 (31%), Positives = 73/145 (50%), Gaps = 12/145 (8%)

Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIW-QCK 119
           +P+ I    + +T +D   NSL  SLP+ +   L  +  LY+  NKL   +PN ++ +  
Sbjct: 22  VPTGI---PAQTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLT 76

Query: 120 ELIVISLAYNQFTERIPRGL-GNLTSLKTLYLGFNNLTGEIPYEM-GNLRNLEILGLQLN 177
            L  ++L+ NQ    +P G+   LT LK L L  N L   +P  +   L  L+ L L  N
Sbjct: 77  SLTYLNLSTNQLQS-LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQN 134

Query: 178 KLVGFVPTSIF-NLSAMKTLALPSN 201
           +L   VP  +F  L++++ + L  N
Sbjct: 135 QLKS-VPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 42/133 (31%), Positives = 60/133 (45%), Gaps = 12/133 (9%)

Query: 395 VLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGS 454
            L ++ N L         +LTSL  L L  N+L S+    F  L  +  LN S+N L  S
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-S 90

Query: 455 LPEDI----GNLKVVVIIDLSRNNLSGDIPT-AIGGLMNLQDLSLRDNGLQGSIPKSI-G 508
           LP  +      LK    + L+ N L   +P      L  L+DL L  N L+ S+P  +  
Sbjct: 91  LPNGVFDKLTQLK---ELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFD 145

Query: 509 GLVSLESLDLSNN 521
            L SL+ + L +N
Sbjct: 146 RLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 43/171 (25%), Positives = 67/171 (39%), Gaps = 36/171 (21%)

Query: 233 IPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWAN 292
           +P+ I   +    L+L  NS           L  L  L L  N L S  + +     +  
Sbjct: 22  VPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGV-----FNK 74

Query: 293 CKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWG 352
             +L  L+LS N +   LP          + +F                L  L+EL L  
Sbjct: 75  LTSLTYLNLSTNQLQ-SLP----------NGVFDK--------------LTQLKELALNT 109

Query: 353 NELIGSIPI-TFGKLQNLQGLDLVNNKLEGPIPNG-LCQLARLSVLYMDGN 401
           N+L  S+P   F KL  L+ L L  N+L+  +P+G   +L  L  +++  N
Sbjct: 110 NQL-QSLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 40/133 (30%), Positives = 57/133 (42%), Gaps = 8/133 (6%)

Query: 98  KGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGN-LTSLKTLYLGFNNLT 156
             L +  N L         +   L  + L  N+    +P G+ N LTSL  L L  N L 
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89

Query: 157 GEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFN-LSAMKTLALPSNALSGSLPSSI-DLV 214
                    L  L+ L L  N+L   +P  +F+ L+ +K L L  N L  S+P  + D  
Sbjct: 90  SLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFD-- 145

Query: 215 RLPNLEIISLAGN 227
           RL +L+ I L  N
Sbjct: 146 RLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 46.6 bits (111), Expect = 9e-06
 Identities = 31/87 (35%), Positives = 42/87 (48%), Gaps = 3/87 (3%)

Query: 469 DLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI-GGLVSLESLDLSNNSLSGNI 527
           DL  N+L          L +L  L L  N LQ S+P  +   L SL  L+LS N L    
Sbjct: 34  DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQSLP 92

Query: 528 PTSMEKLLYLKDLNLSFNKLEGEIPRG 554
               +KL  LK+L L+ N+L+  +P G
Sbjct: 93  NGVFDKLTQLKELALNTNQLQ-SLPDG 118

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 43/150 (28%), Positives = 61/150 (40%), Gaps = 31/150 (20%)

Query: 407 IPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVV 466
           +P  I        L L +N L S+    F  L  +  L    N L  SLP  + N     
Sbjct: 22  VPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFN----- 73

Query: 467 IIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI-GGLVSLESLDLSNNSLSG 525
                              L +L  L+L  N LQ S+P  +   L  L+ L L+ N L  
Sbjct: 74  ------------------KLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ- 113

Query: 526 NIPTSM-EKLLYLKDLNLSFNKLEGEIPRG 554
           ++P  + +KL  LKDL L  N+L+  +P G
Sbjct: 114 SLPDGVFDKLTQLKDLRLYQNQLKS-VPDG 142

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 43.5 bits (103), Expect = 8e-05
 Identities = 40/129 (31%), Positives = 57/129 (44%), Gaps = 8/129 (6%)

Query: 126 LAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPT 185
           L  N            LTSL  LYLG N L          L +L  L L  N+L   +P 
Sbjct: 35  LETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS-LPN 93

Query: 186 SIFN-LSAMKTLALPSNALSGSLPSSI-DLVRLPNLEIISLAGNNFSGIIPSFIF-NASK 242
            +F+ L+ +K LAL +N L  SLP  + D  +L  L+ + L  N     +P  +F   + 
Sbjct: 94  GVFDKLTQLKELALNTNQLQ-SLPDGVFD--KLTQLKDLRLYQNQLKS-VPDGVFDRLTS 149

Query: 243 LSVLELGEN 251
           L  + L +N
Sbjct: 150 LQYIWLHDN 158

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 53.8 bits (129), Expect = 2e-07
 Identities = 63/375 (16%), Positives = 121/375 (32%), Gaps = 49/375 (13%)

Query: 213 LVRLPNLEIISLAGNNFSGIIPSFIF----NASKLSVLELGENSFSGFIPNTL----GNL 264
           +     ++ + +  ++FS     ++     + + L VL      F+   P  L     N 
Sbjct: 160 VTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC 219

Query: 265 RKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRI 324
           R L  +++           + F  + AN +      L+ +        ++      L R+
Sbjct: 220 RSLVSVKVGD---FEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFP-RKLCRL 275

Query: 325 FISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPIT-FGKLQNLQGLDLVNNKLEGPI 383
            +S       +P        +R+L L    L      T   K  NL+ L+  N   +   
Sbjct: 276 GLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGD--- 331

Query: 384 PNGLCQLAR----LSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASN-----ELN------ 428
             GL  LA+    L  L ++       +    G ++   L++LA        +       
Sbjct: 332 -RGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDI 390

Query: 429 -----SVIPSTFWNLKDILSLNFSSNFLNGSLPEDIG------NLKVVVIIDLSRN--NL 475
                  I +   NL D   +          LP D G        K +           L
Sbjct: 391 TNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGL 450

Query: 476 SGDIPTAIG-GLMNLQDLSLRDNGLQ-GSIPKSIGGLVSLESLDLSNNSLSGN-IPTSME 532
           +    + IG    N++ + L   G     + +   G  +L+ L++     S   I  ++ 
Sbjct: 451 TDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVT 510

Query: 533 KLLYLKDLNLSFNKL 547
           KL  L+ L +   + 
Sbjct: 511 KLPSLRYLWVQGYRA 525

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 52/375 (13%), Positives = 113/375 (30%), Gaps = 44/375 (11%)

Query: 210 SIDLVRLPNLEIISLAGNNFSGIIPSFIFNASK----LSVLELGENSFS--GFIPNTLGN 263
           S+ L   P   + +L   N+ G +  ++   S     L  +       S           
Sbjct: 77  SLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKAR 136

Query: 264 LRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSR 323
              LE L+L      ++   LS ++   +C+ +K L +  +  +      +  L+   + 
Sbjct: 137 ADDLETLKLDKCSGFTTDGLLSIVT---HCRKIKTLLMEESSFSEKDGKWLHELAQHNTS 193

Query: 324 IFISNCSIRG-------TIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVN 376
           + + N  +          +     N  +L  + +   E++  +   F    NL+     +
Sbjct: 194 LEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGF-FKAAANLEEFCGGS 252

Query: 377 NKLEGPIPNGLCQLARLSVLYMDGNKLSGP--IPPCIGDLTSLRLLSLASNELNS-VIPS 433
              +  +P     L     L   G    GP  +P        +R L L    L +    +
Sbjct: 253 LNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCT 312

Query: 434 TFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIG-----GLM- 487
                 ++  L   +   +  L       K +  + + R      +    G     GL+ 
Sbjct: 313 LIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIA 372

Query: 488 ------NLQDLSLR-----DNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTS------ 530
                  L+ +++      +  L+ SI   +  L     + L       ++P        
Sbjct: 373 LAQGCQELEYMAVYVSDITNESLE-SIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSL 431

Query: 531 MEKLLYLKDLNLSFN 545
           +     L+       
Sbjct: 432 LIGCKKLRRFAFYLR 446

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 33/170 (19%), Positives = 63/170 (37%), Gaps = 39/170 (22%)

Query: 666 LIGTGGFGSVYKGS-FLDGMEVAIKV------FHLQLEGALKSFDVECEVLKSVRHRNLV 718
            +G G F +V+     ++   VA+K+      +    E        E ++L+ V   +  
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE-------DEIKLLQRVNDADNT 78

Query: 719 KIISSCTNN--------DFKA-------LVLEYMPNGSLEDYLYSNNFS-FDILQRLSVI 762
           K  S   N+        + K        +V E +   +L   +         ++    + 
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQIS 137

Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAH------LSDFGIA 806
             + L L+Y+H      ++H DIKP NVL++            ++D G A
Sbjct: 138 KQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 51.9 bits (125), Expect = 4e-07
 Identities = 37/153 (24%), Positives = 59/153 (38%), Gaps = 34/153 (22%)

Query: 658 TNQFNASNLIGTGGFGSVYKGSFLD---GMEVAIKV------FHLQLEGALKSFDVECEV 708
            N F     +G G FG V              A+KV      +      A     +E ++
Sbjct: 34  NNAFLVIRKMGDGTFGRVLLC--QHIDNKKYYAVKVVRNIKKYTRS---AK----IEADI 84

Query: 709 LKSVRHR-----NLVKIISSCTNNDFKA---LVLEYMPNGSLEDYLYSNNFS-FDILQRL 759
           LK +++      N+VK         +     L+ E +   SL + +  NN++ F I    
Sbjct: 85  LKKIQNDDINNNNIVKYHGKF---MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIK 140

Query: 760 SVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL 792
              I++  AL YL       + H D+KP N+LL
Sbjct: 141 LYCIEILKALNYLR---KMSLTHTDLKPENILL 170

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 49.7 bits (119), Expect = 6e-07
 Identities = 22/89 (24%), Positives = 34/89 (38%), Gaps = 3/89 (3%)

Query: 341 NLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDG 400
           N +  REL L G + I  I      L     +D  +N++   +      L RL  L ++ 
Sbjct: 17  NAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNN 73

Query: 401 NKLSGPIPPCIGDLTSLRLLSLASNELNS 429
           N++          L  L  L L +N L  
Sbjct: 74  NRICRIGEGLDQALPDLTELILTNNSLVE 102

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 46.6 bits (111), Expect = 5e-06
 Identities = 29/159 (18%), Positives = 47/159 (29%), Gaps = 36/159 (22%)

Query: 270 LRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNC 329
           ++L+   +  +           N    + LDL    I       I NL            
Sbjct: 2   VKLTAELIEQAAQYT-------NAVRDRELDLRGYKI-----PVIENLG----------- 38

Query: 330 SIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQ 389
                       L     +    NE I  +   F  L+ L+ L + NN++          
Sbjct: 39  ----------ATLDQFDAIDFSDNE-IRKLD-GFPLLRRLKTLLVNNNRICRIGEGLDQA 86

Query: 390 LARLSVLYMDGNKLSGP-IPPCIGDLTSLRLLSLASNEL 427
           L  L+ L +  N L        +  L SL  L +  N +
Sbjct: 87  LPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 125

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 46.2 bits (110), Expect = 8e-06
 Identities = 22/114 (19%), Positives = 42/114 (36%), Gaps = 6/114 (5%)

Query: 386 GLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLN 445
                 R   L + G K+   I      L     +  + NE+  +    F  L+ + +L 
Sbjct: 14  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLL 70

Query: 446 FSSNFLNGSLPEDIGNLKVVVIIDLSRNNLS--GDIPTAIGGLMNLQDLSLRDN 497
            ++N +          L  +  + L+ N+L   GD+   +  L +L  L +  N
Sbjct: 71  VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.8 bits (109), Expect = 9e-06
 Identities = 24/169 (14%), Positives = 40/169 (23%), Gaps = 57/169 (33%)

Query: 138 GLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLA 197
              N    + L L    +   I      L   + +    N++       +          
Sbjct: 14  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI-----RKLDGFP------ 61

Query: 198 LPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFI 257
                             L  L+ + +  N    I                         
Sbjct: 62  -----------------LLRRLKTLLVNNNRICRIGEGL--------------------- 83

Query: 258 PNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPI 306
                 L  L  L L+ N L     +L  L   A+ K+L  L +  NP+
Sbjct: 84  ---DQALPDLTELILTNNSL-VELGDLDPL---ASLKSLTYLCILRNPV 125

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 25/153 (16%), Positives = 45/153 (29%), Gaps = 31/153 (20%)

Query: 75  MDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTER 134
           +  +   +  +       R    + L +   K+   I N      +   I  + N+   +
Sbjct: 2   VKLTAELIEQAAQYTNAVRD---RELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-K 56

Query: 135 IPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMK 194
           +  G   L  LKTL +  N +          L +L  L L  N         +  L  + 
Sbjct: 57  L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS--------LVELGDLD 107

Query: 195 TLALPSNALSGSLPSSIDLVRLPNLEIISLAGN 227
            LA                  L +L  + +  N
Sbjct: 108 PLA-----------------SLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 21/112 (18%), Positives = 43/112 (38%), Gaps = 8/112 (7%)

Query: 413 DLTSLRLLSLASNELNSV--IPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDL 470
           +    R L L   ++  +  + +T        +++FS N +   L +    L+ +  + +
Sbjct: 17  NAVRDRELDLRGYKIPVIENLGATLDQFD---AIDFSDNEIR-KL-DGFPLLRRLKTLLV 71

Query: 471 SRNNLSGDIPTAIGGLMNLQDLSLRDNGLQG-SIPKSIGGLVSLESLDLSNN 521
           + N +          L +L +L L +N L        +  L SL  L +  N
Sbjct: 72  NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 50.8 bits (122), Expect = 9e-07
 Identities = 31/153 (20%), Positives = 58/153 (37%), Gaps = 32/153 (20%)

Query: 658 TNQFNASNLIGTGGFGSVYKG--SFLDGMEVAIKV------FHLQLEGALKSFDVECEVL 709
             ++     +G G FG V +         +VA+K+      +      A     +E  VL
Sbjct: 18  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA---AR----LEINVL 70

Query: 710 KSVRHR------NLVKIISSCTNNDFKA---LVLEYMPNGSLEDYLYSNNFS-FDILQRL 759
           K ++ +        V +       +F     +  E +   +  ++L  NNF  + +    
Sbjct: 71  KKIKEKDKENKFLCVLMSDWF---NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVR 126

Query: 760 SVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL 792
            +   +  AL +LH    N + H D+KP N+L 
Sbjct: 127 HMAYQLCHALRFLH---ENQLTHTDLKPENILF 156

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 45/329 (13%), Positives = 99/329 (30%), Gaps = 65/329 (19%)

Query: 263 NLRKLEWLRLSYNFLTSSTSEL--SFLSSWANCKNLKLLDLSNNPING----VLPSSIGN 316
               +  L LS N L    S+     L++     N+  L+LS N ++      L  ++  
Sbjct: 49  TPASVTSLNLSGNSLGFKNSDELVQILAA--IPANVTSLNLSGNFLSYKSSDELVKTLAA 106

Query: 317 LSLSLSRIFISNCSIRGTIPKEIGNLI-----NLRELGLWGNEL--IGSIPITFG---KL 366
           +  +++ + +           E          ++  L L GN+L    S  +        
Sbjct: 107 IPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIP 166

Query: 367 QNLQGLDLVNNKLEGPIPNGLCQLAR--------LSVLYMDGNKLSGPIPPCIGDL---- 414
            N+  L+L  N L         +LA+        ++ L +  N L       +  +    
Sbjct: 167 ANVNSLNLRGNNLA---SKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSI 223

Query: 415 -TSLRLLSLASNELNSV----IPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIID 469
              +  L+L  N L+      +     +LK + ++    + +      ++   +   +  
Sbjct: 224 PNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVK-----NMSKEQCKALGA 278

Query: 470 LSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLV-----SLESLDLSNNSL- 523
              N               +  +      +  S    I  L+       +   L N  L 
Sbjct: 279 AFPNI------------QKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLI 326

Query: 524 --SGNIPTSMEKLL--YLKDLNLSFNKLE 548
               +     +  +   L++   +   L 
Sbjct: 327 FAQKHQTNIEDLNIPDELRESIQTCKPLL 355

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 48.9 bits (117), Expect = 4e-06
 Identities = 43/278 (15%), Positives = 96/278 (34%), Gaps = 48/278 (17%)

Query: 121 LIVISLAYNQFTERIPRGLGNL-----TSLKTLYLGFNNLTGEIPYEMGNL-----RNLE 170
           +  ++L+ N  + +    L         ++  L LG+N+ + +   E          ++ 
Sbjct: 82  VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141

Query: 171 ILGLQLNKL-----VGFVPTSIFNLSAMKTLALPSN--------ALSGSLPSSIDLVRLP 217
            L L+ N L        +       + + +L L  N         L+  L S        
Sbjct: 142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLAS-----IPA 196

Query: 218 NLEIISLAGNNF-----SGIIPSFIFNASKLSVLELGENSFSG----FIPNTLGNLRKLE 268
           ++  + L+ N       + +   F    + +  L L  N   G     +     +L+ L+
Sbjct: 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQ 256

Query: 269 WLRLSYNFLTSSTSEL--SFLSSWANCKNLKLLDLSNNPING----VLPSSIGNLSLSLS 322
            + L Y+ + + + E   +  +++ N + + L+D +   I+      + + I  LS    
Sbjct: 257 TVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKAD 316

Query: 323 RIFISNCSI-----RGTIPKEIGNLINLRELGLWGNEL 355
              + N  +       T  +++     LRE       L
Sbjct: 317 VPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 46.2 bits (110), Expect = 3e-05
 Identities = 50/302 (16%), Positives = 101/302 (33%), Gaps = 58/302 (19%)

Query: 139 LGNLTSLKTLYLGFNNLTGEIPYEMG-----NLRNLEILGLQLNKLVGFVPTSIFNLSAM 193
                 + +L L  NNL      E+         ++  L L  N L              
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSL---------GFKNS 68

Query: 194 KTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFS-----GIIPSFIFNASKLSVLEL 248
             L      L+    +         +  ++L+GN  S      ++ +       ++VL+L
Sbjct: 69  DELV---QILAAIPAN---------VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDL 116

Query: 249 GENSFSG----FIPNTLGNL-RKLEWLRLSYNFLT-SSTSELSFLSSWANCKNLKLLDLS 302
           G N FS            NL   +  L L  N L   S+ EL  + +     N+  L+L 
Sbjct: 117 GWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPA-NVNSLNLR 175

Query: 303 NNPIN----GVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIG-----NLINLRELGLWGN 353
            N +       L   + ++  S++ + +S   +      E+         ++  L L  N
Sbjct: 176 GNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLN 235

Query: 354 EL----IGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLAR-------LSVLYMDGNK 402
            L    + ++ +    L++LQ + L  + ++         L         + ++  +G +
Sbjct: 236 CLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKE 295

Query: 403 LS 404
           + 
Sbjct: 296 IH 297

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 43.2 bits (102), Expect = 3e-04
 Identities = 48/285 (16%), Positives = 93/285 (32%), Gaps = 57/285 (20%)

Query: 291 ANCKNLKLLDLSNNPI--NGV--LPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLI--- 343
           +    +  LDLS N +       L  +  N   S++ + +S  S+      E+  ++   
Sbjct: 19  SIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAI 78

Query: 344 --NLRELGLWGNELIGSIPITFGKL-----QNLQGLDLVNNKLEGPIPNGLCQLAR---- 392
             N+  L L GN L         K        +  LDL  N           +  +    
Sbjct: 79  PANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS---SKSSSEFKQAFSN 135

Query: 393 ----LSVLYMDGNKLSGPIPPCIGDL-----TSLRLLSLASNELN--------SVIPSTF 435
               ++ L + GN L       +  +      ++  L+L  N L           + S  
Sbjct: 136 LPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIP 195

Query: 436 WNLKDILSLNFSSNFLNGSLPEDIG-----NLKVVVIIDLSRNNLSGDIPTAIGGLM--- 487
            ++    SL+ S+N L      ++          VV ++L  N L G     +  L    
Sbjct: 196 ASVT---SLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSL 252

Query: 488 -NLQDLSLRDNGLQGSIPKSIGGLVS-------LESLDLSNNSLS 524
            +LQ + L  + ++    +    L +       +  +D +   + 
Sbjct: 253 KHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.4 bits (113), Expect = 2e-06
 Identities = 33/140 (23%), Positives = 56/140 (40%), Gaps = 13/140 (9%)

Query: 239 NASKLSVLELGENSFS-GFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLK 297
             S +  L L  +  + G +        +LE+L      LTS    ++ L        LK
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS----IANLP---KLNKLK 67

Query: 298 LLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRG-TIPKEIGNLINLRELGLWGNELI 356
            L+LS+N ++G L         +L+ + +S   I+  +  + +  L NL+ L L+  E+ 
Sbjct: 68  KLELSDNRVSGGLEVLAEKCP-NLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126

Query: 357 GSI---PITFGKLQNLQGLD 373
                    F  L  L  LD
Sbjct: 127 NLNDYRENVFKLLPQLTYLD 146

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.9 bits (104), Expect = 3e-05
 Identities = 32/137 (23%), Positives = 49/137 (35%), Gaps = 28/137 (20%)

Query: 92  RRLPLIKGLYMSNNKLT-GPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYL 150
           R    +K L + N++   G +     + +EL  +S      T  I   L  L  LK L L
Sbjct: 14  RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLEL 71

Query: 151 GFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSS 210
             N ++G +        NL  L L  NK        I +LS ++ L              
Sbjct: 72  SDNRVSGGLEVLAEKCPNLTHLNLSGNK--------IKDLSTIEPLK------------- 110

Query: 211 IDLVRLPNLEIISLAGN 227
               +L NL+ + L   
Sbjct: 111 ----KLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.5 bits (103), Expect = 5e-05
 Identities = 26/114 (22%), Positives = 43/114 (37%), Gaps = 9/114 (7%)

Query: 292 NCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNL---INLREL 348
              ++K L L N+  N      + +    L  +   N  +       I NL     L++L
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-----TSIANLPKLNKLKKL 69

Query: 349 GLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGP-IPNGLCQLARLSVLYMDGN 401
            L  N + G + +   K  NL  L+L  NK++       L +L  L  L +   
Sbjct: 70  ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.1 bits (102), Expect = 5e-05
 Identities = 24/105 (22%), Positives = 46/105 (43%), Gaps = 5/105 (4%)

Query: 341 NLINLRELGLWGNEL-IGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMD 399
              +++EL L  +    G +     + + L+ L  +N  L       L +L +L  L + 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELS 72

Query: 400 GNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSL 444
            N++SG +        +L  L+L+ N++     ST   LK + +L
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENL 115

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.1 bits (102), Expect = 6e-05
 Identities = 33/167 (19%), Positives = 48/167 (28%), Gaps = 57/167 (34%)

Query: 141 NLTSLKTLYL-GFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALP 199
             + +K L L    +  G++         LE L      L     TSI NL         
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-----TSIANLP-------- 61

Query: 200 SNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPN 259
                          +L  L+ + L+ N  SG +                          
Sbjct: 62  ---------------KLNKLKKLELSDNRVSGGLEVL----------------------- 83

Query: 260 TLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPI 306
                  L  L LS N +     +LS +      +NLK LDL N  +
Sbjct: 84  -AEKCPNLTHLNLSGNKI----KDLSTIEPLKKLENLKSLDLFNCEV 125

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 27/131 (20%), Positives = 50/131 (38%), Gaps = 28/131 (21%)

Query: 393 LSVLYMDGNKLS-GPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFL 451
           +  L +D ++ + G +     +   L  LS  +  L S+                     
Sbjct: 19  VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--------------------- 57

Query: 452 NGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQG-SIPKSIGGL 510
                 ++  L  +  ++LS N +SG +        NL  L+L  N ++  S  + +  L
Sbjct: 58  -----ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKL 112

Query: 511 VSLESLDLSNN 521
            +L+SLDL N 
Sbjct: 113 ENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.8 bits (96), Expect = 3e-04
 Identities = 29/85 (34%), Positives = 42/85 (49%), Gaps = 9/85 (10%)

Query: 467 IIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGL---VSLESLDLSNNSL 523
           ++D SR+N  G +         L+ LS  + GL      SI  L     L+ L+LS+N +
Sbjct: 23  VLDNSRSNE-GKLEGLTDEFEELEFLSTINVGL-----TSIANLPKLNKLKKLELSDNRV 76

Query: 524 SGNIPTSMEKLLYLKDLNLSFNKLE 548
           SG +    EK   L  LNLS NK++
Sbjct: 77  SGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 39.7 bits (93), Expect = 8e-04
 Identities = 30/142 (21%), Positives = 53/142 (37%), Gaps = 9/142 (6%)

Query: 37  IPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLS--TGMDFSNNSLTGSLPDDMCRRL 94
           I  EL N    ++  L  +                     +   N  LT S+ +    +L
Sbjct: 7   IHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN--LPKL 63

Query: 95  PLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTE-RIPRGLGNLTSLKTLYLGFN 153
             +K L +S+N+++G +     +C  L  ++L+ N+  +      L  L +LK+L L   
Sbjct: 64  NKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

Query: 154 NLTGEIPYEM---GNLRNLEIL 172
            +T    Y       L  L  L
Sbjct: 124 EVTNLNDYRENVFKLLPQLTYL 145

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 31/150 (20%), Positives = 61/150 (40%), Gaps = 26/150 (17%)

Query: 658 TNQFNASNLIGTGGFGSVYKG--SFLDGMEVAIKV------FHLQLEGALKSFDVECEVL 709
           + ++   + +G G FG V +       G  VA+K+      +      A      E +VL
Sbjct: 13  SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEA---AR----SEIQVL 65

Query: 710 KSVRHR------NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFS-FDILQRLSVI 762
           + +           V+++    ++    +V E +   S  D++  N F  F +     + 
Sbjct: 66  EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMA 124

Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLL 792
             +  ++ +LH   SN + H D+KP N+L 
Sbjct: 125 YQICKSVNFLH---SNKLTHTDLKPENILF 151

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 44/324 (13%), Positives = 96/324 (29%), Gaps = 57/324 (17%)

Query: 209 SSIDLVRLPNLEIISLAGNNFSGIIPSFIF----NASKLSVLELGENSFSGFIPNTLG-N 263
            S++L   P+    +L  + + G +  +I     + + L  + L     +      +  +
Sbjct: 69  RSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKS 128

Query: 264 LRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSL---S 320
            +  + L LS        S     +  A C+NLK LDL  + ++ V    + +      S
Sbjct: 129 FKNFKVLVLSS---CEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTS 185

Query: 321 LSRIFISNCSIRGT---IPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNN 377
           L  + IS  +   +   + + +    NL+ L L     +  +     +   L+ L     
Sbjct: 186 LVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTG-- 243

Query: 378 KLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWN 437
                                                      +    ++ S +      
Sbjct: 244 ----------------------------------------GYTAEVRPDVYSGLSVALSG 263

Query: 438 LKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGD-IPTAIGGLMNLQDLSLRD 496
            K++  L+   + +   LP        +  ++LS   +    +   +     LQ L + D
Sbjct: 264 CKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLD 323

Query: 497 NGLQGSIPKSIGGLVSLESLDLSN 520
                 +         L  L +  
Sbjct: 324 YIEDAGLEVLASTCKDLRELRVFP 347

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 49.1 bits (117), Expect = 5e-06
 Identities = 41/303 (13%), Positives = 87/303 (28%), Gaps = 45/303 (14%)

Query: 269 WLRLS----YNFLTSSTSELSFLSSWANCKNLKLLDLSNNPI---NGVLPSSIGNLSL-- 319
           W  +           +   +S  +       ++ ++L   P      ++P   G      
Sbjct: 37  WYEIERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPW 96

Query: 320 ---------SLSRIFISNCSIRGTIPKEIG-NLINLRELGLWGNELIGSIPIT--FGKLQ 367
                     L  I +    +     + I  +  N + L L   E   +  +       +
Sbjct: 97  IEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCR 156

Query: 368 NLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNEL 427
           NL+ LDL  + ++    + L                          L SL +  LAS   
Sbjct: 157 NLKELDLRESDVDDVSGHWLSHFPDTY-----------------TSLVSLNISCLASEVS 199

Query: 428 NSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGD------IPT 481
            S +        ++ SL  +       L   +     +  +                +  
Sbjct: 200 FSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSV 259

Query: 482 AIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGN-IPTSMEKLLYLKDL 540
           A+ G   L+ LS   + +   +P        L +L+LS  ++    +   + +   L+ L
Sbjct: 260 ALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRL 319

Query: 541 NLS 543
            + 
Sbjct: 320 WVL 322

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 47.2 bits (112), Expect = 2e-05
 Identities = 78/510 (15%), Positives = 154/510 (30%), Gaps = 66/510 (12%)

Query: 41  LGNLAELELVSLTNNF-------LSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRR 93
           +GN   +   ++   F       L G      FNL     G             + M   
Sbjct: 50  IGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWG------GYVYPWIEAMSSS 103

Query: 94  LPLIKGLYMSNNKLTGPIPNNIWQ-CKELIVISLAY-NQFTER-IPRGLGNLTSLKTLYL 150
              ++ + +    +T      I +  K   V+ L+    F+   +        +LK L L
Sbjct: 104 YTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDL 163

Query: 151 GFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSS 210
             +++          L +       L  L      S  + SA++ L              
Sbjct: 164 RESDVDDV---SGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVT------------ 208

Query: 211 IDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELG---ENSFSGFIPNTLGNLRKL 267
               R PNL+ + L        + + +  A +L  L  G                 L   
Sbjct: 209 ----RCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGC 264

Query: 268 EWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFIS 327
           + LR    F  +  + L  + S   C  L  L+LS   +       +      L R+++ 
Sbjct: 265 KELRCLSGFWDAVPAYLPAVYS--VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVL 322

Query: 328 NCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGK-------LQNLQGLDLVNNKLE 380
           +      +        +LREL ++ +E     P                  L+ V     
Sbjct: 323 DYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCR 382

Query: 381 GPIPNGLCQLAR----LSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFW 436
                 L  +AR    ++   +   +   P    +     +   ++  +           
Sbjct: 383 QMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLE-PLDIGFGAIVEH----------- 430

Query: 437 NLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIG-GLMNLQDLSLR 495
             KD+  L+ S    +          K + ++ ++    S      +  G  +L+ L +R
Sbjct: 431 -CKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIR 489

Query: 496 D-NGLQGSIPKSIGGLVSLESLDLSNNSLS 524
           D      ++  +   L ++ SL +S+ S+S
Sbjct: 490 DCPFGDKALLANASKLETMRSLWMSSCSVS 519

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.4 bits (113), Expect = 2e-06
 Identities = 35/148 (23%), Positives = 55/148 (37%), Gaps = 15/148 (10%)

Query: 239 NASKLSVLEL-GENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLK 297
             + +  L L    S  G I         LE+L L    L S       +S+      LK
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-------VSNLPKLPKLK 74

Query: 298 LLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIR--GTIPKEIGNLINLRELGLWGN-- 353
            L+LS N I G L      L  +L+ + +S   ++   T+ + +  L  L+ L L+    
Sbjct: 75  KLELSENRIFGGLDMLAEKLP-NLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEV 132

Query: 354 -ELIGSIPITFGKLQNLQGLDLVNNKLE 380
             L       F  L  L  LD  + + +
Sbjct: 133 TNLNDYRESVFKLLPQLTYLDGYDREDQ 160

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.6 bits (103), Expect = 5e-05
 Identities = 24/91 (26%), Positives = 41/91 (45%), Gaps = 3/91 (3%)

Query: 341 NLINLRELGLWGNEL-IGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMD 399
               +REL L   +   G I     +  NL+ L L+N  L     + L +L +L  L + 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELS 79

Query: 400 GNKLSGPIPPCIGDLTSLRLLSLASNELNSV 430
            N++ G +      L +L  L+L+ N+L  +
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI 110

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.6 bits (103), Expect = 5e-05
 Identities = 29/137 (21%), Positives = 45/137 (32%), Gaps = 28/137 (20%)

Query: 92  RRLPLIKGLYMSNNKLT-GPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYL 150
           R    ++ L + N K   G I     +   L  +SL        +   L  L  LK L L
Sbjct: 21  RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLEL 78

Query: 151 GFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSS 210
             N + G +      L NL  L L  NK        + ++S ++ L              
Sbjct: 79  SENRIFGGLDMLAEKLPNLTHLNLSGNK--------LKDISTLEPLK------------- 117

Query: 211 IDLVRLPNLEIISLAGN 227
               +L  L+ + L   
Sbjct: 118 ----KLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.2 bits (102), Expect = 7e-05
 Identities = 34/167 (20%), Positives = 49/167 (29%), Gaps = 57/167 (34%)

Query: 141 NLTSLKTLYL-GFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALP 199
              +++ L L    +  G+I        NLE L L    L      S+ NL         
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-----ISVSNLP-------- 68

Query: 200 SNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPN 259
                          +LP L+ + L+ N   G +                          
Sbjct: 69  ---------------KLPKLKKLELSENRIFGGLDML----------------------- 90

Query: 260 TLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPI 306
               L  L  L LS N L     ++S L      + LK LDL N  +
Sbjct: 91  -AEKLPNLTHLNLSGNKL----KDISTLEPLKKLECLKSLDLFNCEV 132

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.2 bits (102), Expect = 8e-05
 Identities = 30/82 (36%), Positives = 45/82 (54%), Gaps = 3/82 (3%)

Query: 467 IIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGN 526
           ++D  ++N  G I       +NL+ LSL + GL  S+  ++  L  L+ L+LS N + G 
Sbjct: 30  VLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGG 86

Query: 527 IPTSMEKLLYLKDLNLSFNKLE 548
           +    EKL  L  LNLS NKL+
Sbjct: 87  LDMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 25/114 (21%), Positives = 43/114 (37%), Gaps = 3/114 (2%)

Query: 289 SWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLREL 348
                  ++ L L N   N      +    ++L  + + N  +       +  L  L++L
Sbjct: 19  RNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKL 76

Query: 349 GLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGP-IPNGLCQLARLSVLYMDGN 401
            L  N + G + +   KL NL  L+L  NKL+       L +L  L  L +   
Sbjct: 77  ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 28/114 (24%), Positives = 51/114 (44%), Gaps = 4/114 (3%)

Query: 413 DLTSLRLLSLASNELN-SVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLS 471
              ++R L L + + N   I        ++  L+  +  L  S+  ++  L  +  ++LS
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79

Query: 472 RNNLSGDIPTAIGGLMNLQDLSLRDNGLQG-SIPKSIGGLVSLESLDLSNNSLS 524
            N + G +      L NL  L+L  N L+  S  + +  L  L+SLDL N  ++
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 49.6 bits (117), Expect = 3e-06
 Identities = 37/164 (22%), Positives = 63/164 (38%), Gaps = 21/164 (12%)

Query: 405 GPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIG---- 460
             + P +  +  L  L +      S+      NLK   SL   S  L  S+ EDI     
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLK---SLEIISGGLPDSVVEDILGSDL 218

Query: 461 -NLKVVVIIDLSRNNLSGDIPTAIGGLM------NLQDLSLRDNGLQGSIPKSIGG---L 510
            NL+ +V+     +            L       NL+ L + D   Q  + +       L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278

Query: 511 VSLESLDLSNNSLSGN----IPTSMEKLLYLKDLNLSFNKLEGE 550
             LE++D+S   L+      +   ++K+ +LK +N+ +N L  E
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 49.2 bits (116), Expect = 3e-06
 Identities = 28/156 (17%), Positives = 52/156 (33%), Gaps = 16/156 (10%)

Query: 163 MGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEII 222
           +  +  L  L ++    +            +K+L + S  L  S+   I    LPNLE +
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGK---KPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKL 224

Query: 223 SLA-------GNNFSGIIPSFIFNAS--KLSVLELGENSFSGFIPNTLGN---LRKLEWL 270
            L         +    +            L  L + +      +         L +LE +
Sbjct: 225 VLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETM 284

Query: 271 RLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPI 306
            +S   LT   + L  L      K+LK +++  N +
Sbjct: 285 DISAGVLTDEGARL-LLDHVDKIKHLKFINMKYNYL 319

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 45.7 bits (107), Expect = 4e-05
 Identities = 24/161 (14%), Positives = 57/161 (35%), Gaps = 13/161 (8%)

Query: 11  GAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVS--LTNNFLSGTIPSTIFNL 68
             +   +  + +L  L +          +   NL  LE++S  L ++ +   + S + NL
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221

Query: 69  SSLSTGMDFSNNSLTGSLPDDM----CRRLPLIKGLYMSNNKLTGPIPNNIWQC---KEL 121
             L   +   +    G +          R P +K L + + +    +     +     +L
Sbjct: 222 EKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQL 281

Query: 122 IVISLAYNQFT----ERIPRGLGNLTSLKTLYLGFNNLTGE 158
             + ++    T      +   +  +  LK + + +N L+ E
Sbjct: 282 ETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 45.3 bits (106), Expect = 5e-05
 Identities = 32/202 (15%), Positives = 61/202 (30%), Gaps = 33/202 (16%)

Query: 214 VRLPNLEIISLAGNNFSGI----IPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEW 269
                   I       S I    +   +     L+ L++   +          NL+ L  
Sbjct: 141 FEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSL-- 198

Query: 270 LRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNC 329
             +    L  S   +  +   ++  NL+ L L     +      +       S+      
Sbjct: 199 -EIISGGLPDSV--VEDILG-SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSK------ 248

Query: 330 SIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGK---LQNLQGLDLVNNKL--EG--P 382
                         NL+ LG+   E    +   F +   L  L+ +D+    L  EG   
Sbjct: 249 ----------DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARL 298

Query: 383 IPNGLCQLARLSVLYMDGNKLS 404
           + + + ++  L  + M  N LS
Sbjct: 299 LLDHVDKIKHLKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 43.0 bits (100), Expect = 3e-04
 Identities = 20/146 (13%), Positives = 51/146 (34%), Gaps = 26/146 (17%)

Query: 142 LTSLKTLYLGFNNLTGEIPYEMG--NLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALP 199
             +LK+L +    L   +  ++   +L NLE L L +          +            
Sbjct: 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRP------- 244

Query: 200 SNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNA---SKLSVLELGENSFSGF 256
               S          R PNL+ + +       ++      +    +L  +++     +  
Sbjct: 245 --LFSKD--------RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE 294

Query: 257 ----IPNTLGNLRKLEWLRLSYNFLT 278
               + + +  ++ L+++ + YN+L+
Sbjct: 295 GARLLLDHVDKIKHLKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 42.6 bits (99), Expect = 4e-04
 Identities = 27/179 (15%), Positives = 53/179 (29%), Gaps = 24/179 (13%)

Query: 366 LQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIG--DLTSLRLLSLA 423
           L  +  L+ +  K    +  G      L  L +    L   +   I   DL +L  L L 
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227

Query: 424 SNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAI 483
               +          + + S            P    NLK    + +        +    
Sbjct: 228 VGVEDYGFDGDMNVFRPLFS--------KDRFP----NLKW---LGIVDAEEQNVVVEMF 272

Query: 484 GG---LMNLQDLSLRDNGLQGS----IPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLL 535
                L  L+ + +    L       +   +  +  L+ +++  N LS  +   ++K L
Sbjct: 273 LESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL 331

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 41/157 (26%), Positives = 67/157 (42%), Gaps = 34/157 (21%)

Query: 658 TNQFNASNLIGTGGFGSVYKGSFLDGME-VAIKVF---HLQLEGALKSFDVECEVLKSVR 713
             +++    +G G F +V+    + G + VA+KV        E AL     E  +LKSVR
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD----EIRLLKSVR 91

Query: 714 -----HRNLVKIISSCTNNDFK---------ALVLEYMPNG-SLEDYLYSNN---FSFDI 755
                  N   ++     +DFK          +V E +  G  L  ++  +N        
Sbjct: 92  NSDPNDPNREMVVQLL--DDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPC 147

Query: 756 LQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL 792
           +++  +I  V   L+YLH      ++H DIKP N+LL
Sbjct: 148 VKK--IIQQVLQGLDYLH--TKCRIIHTDIKPENILL 180

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 32/94 (34%), Positives = 45/94 (47%), Gaps = 6/94 (6%)

Query: 358 SIPITFGKLQNLQGLDLVNNKLEGPIPNGLC-QLARLSVLYMDGNKLSGPIPPCIGD-LT 415
           S+P   G   + Q L L NN++   +  G+   L  L  LY + NKL+  IP  + D LT
Sbjct: 26  SVPA--GIPTDKQRLWLNNNQITK-LEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLT 81

Query: 416 SLRLLSLASNELNSVIPSTFWNLKDILSLNFSSN 449
            L  L L  N L S+    F NLK +  +   +N
Sbjct: 82  QLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNN 115

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 43.8 bits (104), Expect = 4e-05
 Identities = 27/83 (32%), Positives = 43/83 (51%), Gaps = 2/83 (2%)

Query: 368 NLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGD-LTSLRLLSLASNE 426
             Q L L +N++    P    +L +L+ L +D N+L+  +P  + D LT L  LSL  N+
Sbjct: 31  TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTV-LPAGVFDKLTQLTQLSLNDNQ 89

Query: 427 LNSVIPSTFWNLKDILSLNFSSN 449
           L S+    F NLK +  +   +N
Sbjct: 90  LKSIPRGAFDNLKSLTHIWLLNN 112

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Length = 176

 Score = 42.5 bits (100), Expect = 1e-04
 Identities = 17/125 (13%), Positives = 43/125 (34%), Gaps = 15/125 (12%)

Query: 258 PNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNP------INGVLP 311
           P    +  K++ +  + + + S   +          + ++ + L          +  +  
Sbjct: 54  PTGPLDKYKIQAIDATDSCIMSIGFD-----HMEGLQYVEKIRLCKCHYIEDGCLERL-- 106

Query: 312 SSIGNLSLSLSRIFISNCS-IRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQ-NL 369
           S + NL  S+  + I +C  +       + +  NL+ L L     +          + +L
Sbjct: 107 SQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDLPGVKEKEKIVQAFKTSL 166

Query: 370 QGLDL 374
             L+L
Sbjct: 167 PSLEL 171

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 42.0 bits (99), Expect = 6e-04
 Identities = 56/292 (19%), Positives = 97/292 (33%), Gaps = 43/292 (14%)

Query: 264 LRKLEWLRLSYNFLTSS-TSELSF-LSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSL 321
           L  L  L L+   +T    + ++  L S      L  ++L++  ++     ++  + L  
Sbjct: 71  LSSLRQLNLAGVRMTPVKCTVVAAVLGS--GRHALDEVNLASCQLDPAGLRTLLPVFLRA 128

Query: 322 SRIFISNCSIRGTIPKEIG-----NLINLRELGLWGNEL--IGSIPITFGKLQN--LQGL 372
            ++ +   S+     K++      +   +  L L  N L   G   +  G   N  +  L
Sbjct: 129 RKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHL 188

Query: 373 DLVNNKLEGPIPNGLCQLA-------RLSVLYMDGNKLSGPIPPCIGDL-------TSLR 418
            L++  L      GL  LA       +L  L +  N            L        SL 
Sbjct: 189 SLLHTGLG---DEGLELLAAQLDRNRQLQELNVAYNGAG---DTAALALARAAREHPSLE 242

Query: 419 LLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPE--DIGNLKVVVIIDLSRNNLS 476
           LL L  NEL+         L+D+         +  SL E   +     V++ ++ RN  S
Sbjct: 243 LLHLYFNELS---SEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNS 299

Query: 477 GDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLV----SLESLDLSNNSLS 524
            D       L  L    L D+      P     L+     + +L     S  
Sbjct: 300 WDRARVQRHL-ELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	832
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.97
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.96
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.96
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.96
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.96
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.96
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.96
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.96
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.96
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.96
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.96
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.96
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.96
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.96
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.96
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.96
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.96
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.96
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.96
3niz_A	311	Rhodanese family protein; structural genomics, str	99.95
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.95
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.95
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.95
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.95
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.95
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.95
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.95
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.95
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.95
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.95
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.95
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.95
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.95
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.95
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.95
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.95
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.95
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.95
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.95
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.95
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.95
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.95
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.95
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.95
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.95
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.95
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.95
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.95
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.95
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.95
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.95
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.95
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.95
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.95
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.95
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.95
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.95
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.95
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.95
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.95
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.95
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.95
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.95
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.95
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.95
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.95
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.95
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.95
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.94
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.94
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.94
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.94
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.94
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.94
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.94
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.94
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.94
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.94
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.94
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.94
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.94
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.94
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.94
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.94
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.94
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.94
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.94
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.94
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.94
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.94
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.94
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.94
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.94
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.94
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.94
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.94
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.94
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.94
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.94
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.94
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.94
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.94
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.94
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.94
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.94
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.94
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.94
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.94
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.94
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.94
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.94
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.94
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.94
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.94
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.94
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.94
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.94
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.94
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.94
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.94
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.94
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.94
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.94
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.94
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.94
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.94
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.94
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.94
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.94
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.94
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.94
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.94
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.94
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.94
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.94
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.94
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.94
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.94
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.94
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.94
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.94
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.94
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.94
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.94
3bhy_A	283	Death-associated protein kinase 3; death associate	99.94
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.94
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.94
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.94
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.94
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.94
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.94
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.94
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.94
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.94
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.94
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.94
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.94
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.94
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.94
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.94
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.94
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.94
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.94
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.93
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.93
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.93
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.93
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.93
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.93
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.93
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.93
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.93
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.93
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.93
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.93
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.93
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.93
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.93
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.93
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.93
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.93
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.93
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.93
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.93
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.93
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.93
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.93
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.93
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.93
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.93
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.93
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.93
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.93
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.93
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.93
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.93
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.93
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.93
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.93
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.93
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.93
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.93
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.93
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.93
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.93
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.93
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.93
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.93
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.93
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.92
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.92
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.92
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.92
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.92
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.92
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.92
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.92
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.92
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.92
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.92
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.92
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.92
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.92
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.92
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.92
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.92
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.92
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.92
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.91
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.91
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.91
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.91
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.91
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.91
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.9
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.9
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.9
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.89
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.89
3uqc_A	286	Probable conserved transmembrane protein; structur	99.89
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.89
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.89
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.89
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.89
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.88
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.88
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.87
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.87
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.87
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.86
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.85
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.85
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.85
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.84
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.83
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.83
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.82
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.82
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.81
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.81
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.81
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.8
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.8
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.79
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.78
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.78
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.78
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.77
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.77
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.77
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.77
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.77
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.77
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.76
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.76
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.74
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.71
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.68
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.68
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.68
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.68
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.67
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.67
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.66
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.66
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.66
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.66
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.65
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.64
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.59
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.59
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.58
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.57
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.55
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.52
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.5
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.5
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.45
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.43
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.35
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.34
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.34
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.33
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.33
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.19
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.18
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.16
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.02
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.94
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.89
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.67
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.56
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.56
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.46
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.42
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.4
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.4
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.39
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.38
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.32
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.21
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.0
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.95
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.82
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.82
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.67
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.57
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.55
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.47
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.27
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.27
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.24
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.23
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.08
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.08
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.07
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.02
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.83
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.78
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.63
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.51
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.42
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.8
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.42

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.8e-78  Score=726.90  Aligned_cols=572  Identities=33%  Similarity=0.530  Sum_probs=429.3

Q ss_pred             CCCCcceeccCccccCccccCeEeccCCccccCCCc--cccccccCcEEEccCCcCCCCCCCcc-cCccccccccccccc
Q 003301            4 LSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQ--ELGNLAELELVSLTNNFLSGTIPSTI-FNLSSLSTGMDFSNN   80 (832)
Q Consensus         4 l~~n~~~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~--~~~~l~~L~~L~l~~n~l~~~~p~~l-~~l~~l~~~L~ls~n   80 (832)
                      ++.|.+. .+|+.++++++|++|||++|+++|.+|.  .++.+++|++|+|++|.+.+.+|..+ +.+++| ++||+++|
T Consensus        84 ~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L-~~L~Ls~n  161 (768)
T 3rgz_A           84 LSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSL-EVLDLSAN  161 (768)
T ss_dssp             CTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTC-SEEECCSS
T ss_pred             CcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCC-CEEECCCC
Confidence            3334433 2446777777777777777777776776  67777777777777777776666655 666666 77777777


Q ss_pred             ccccCCChhh--hhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccc
Q 003301           81 SLTGSLPDDM--CRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGE  158 (832)
Q Consensus        81 ~l~~~lp~~~--~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~  158 (832)
                      ++++..|..+  +.++++|++|++++|++++..|.  ..+++|++|+|++|++++.+|. ++++++|++|+|++|++++.
T Consensus       162 ~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~  238 (768)
T 3rgz_A          162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGD  238 (768)
T ss_dssp             CCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSC
T ss_pred             ccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCc
Confidence            7775555442  34566666666666666654432  5566666666666666655554 66666666666666666666


Q ss_pred             cCccccCccccceecccccccccccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCccc
Q 003301          159 IPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIF  238 (832)
Q Consensus       159 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~  238 (832)
                      +|..|+++++|++|++++|++.+.+|..  .+++|++|++++|.+++.+|..+ ...+++|++|+|++|++++..|..|.
T Consensus       239 ~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~-~~~~~~L~~L~Ls~n~l~~~~p~~~~  315 (768)
T 3rgz_A          239 FSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFL-SGACDTLTGLDLSGNHFYGAVPPFFG  315 (768)
T ss_dssp             HHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCS-CTTCTTCSEEECCSSEEEECCCGGGG
T ss_pred             ccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHH-HhhcCcCCEEECcCCcCCCccchHHh
Confidence            6666666666666666666666544443  55556666666666555555543 12235555555555555555555555


Q ss_pred             CCCCccEEEcCCCcCcccCCcc-ccCccccceeecccccCCC-CCCcc-------------------cccccccc--CCC
Q 003301          239 NASKLSVLELGENSFSGFIPNT-LGNLRKLEWLRLSYNFLTS-STSEL-------------------SFLSSWAN--CKN  295 (832)
Q Consensus       239 ~l~~L~~L~L~~N~i~~~~~~~-~~~l~~L~~L~L~~N~l~~-~~~~~-------------------~~~~~~~~--l~~  295 (832)
                      .+++|++|++++|.+++.+|.. +..+++|++|++++|.++. ++..+                   .++..+..  +++
T Consensus       316 ~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~  395 (768)
T 3rgz_A          316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT  395 (768)
T ss_dssp             GCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCC
T ss_pred             cCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCC
Confidence            5555555555555555444433 5555555555555555542 12111                   12222333  667


Q ss_pred             CcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEcc
Q 003301          296 LKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLV  375 (832)
Q Consensus       296 L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  375 (832)
                      |++|++++|.+++.+|..+..+. +|++|++++|++++.+|..+..+++|++|++++|++.+.+|..|..+++|++|+|+
T Consensus       396 L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~  474 (768)
T 3rgz_A          396 LQELYLQNNGFTGKIPPTLSNCS-ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD  474 (768)
T ss_dssp             CCEEECCSSEEEEECCGGGGGCT-TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECC
T ss_pred             ccEEECCCCccccccCHHHhcCC-CCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEec
Confidence            88888888888878888888776 88999999999988888889999999999999999988888889999999999999


Q ss_pred             CCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCC
Q 003301          376 NNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSL  455 (832)
Q Consensus       376 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  455 (832)
                      +|++++.+|..+..+++|++|++++|++++.+|.+|+.+++|++|++++|++++.+|..+..+++|+.|++++|+++|.+
T Consensus       475 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~i  554 (768)
T 3rgz_A          475 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI  554 (768)
T ss_dssp             SSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBC
T ss_pred             CCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcC
Confidence            99999889999999999999999999999999999999999999999999999889999999999999999999988777


Q ss_pred             cccc----------------------------------------------------------------------cccccc
Q 003301          456 PEDI----------------------------------------------------------------------GNLKVV  465 (832)
Q Consensus       456 ~~~~----------------------------------------------------------------------~~l~~L  465 (832)
                      |..+                                                                      +.+++|
T Consensus       555 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L  634 (768)
T 3rgz_A          555 PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSM  634 (768)
T ss_dssp             CGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCC
T ss_pred             ChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccc
Confidence            6543                                                                      345778


Q ss_pred             ceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCC
Q 003301          466 VIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFN  545 (832)
Q Consensus       466 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N  545 (832)
                      +.|||++|+++|.+|..|+++++|+.|+|++|+++|.+|..|+.+++|++|||++|+++|.+|..+..+++|++|||++|
T Consensus       635 ~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N  714 (768)
T 3rgz_A          635 MFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN  714 (768)
T ss_dssp             CEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSS
T ss_pred             cEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCcCCCcccCCCCCCCCcccCCCccCCCCC
Q 003301          546 KLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVCKSGNS  587 (832)
Q Consensus       546 ~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~~~~p~c~~~~~  587 (832)
                      +++|.||.++++.++...+|.||+++||.|+.   .|.++..
T Consensus       715 ~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~---~C~~~~~  753 (768)
T 3rgz_A          715 NLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP---RCDPSNA  753 (768)
T ss_dssp             EEEEECCSSSSGGGSCGGGGCSCTEEESTTSC---CCCSCC-
T ss_pred             cccccCCCchhhccCCHHHhcCCchhcCCCCc---CCCCCcc
Confidence            99999999999999999999999999998864   7866443

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=3.9e-72  Score=672.03  Aligned_cols=555  Identities=31%  Similarity=0.456  Sum_probs=480.8

Q ss_pred             CccCCCCcceec---cCccccCccccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCC--cccCcccccccc
Q 003301            1 MLSLSFNDLSGA---IPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPS--TIFNLSSLSTGM   75 (832)
Q Consensus         1 ~ldl~~n~~~~~---~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~--~l~~l~~l~~~L   75 (832)
                      .|||+++.++|.   +|+++++++.|+.++++.+.+. .+|+.|+.+++|++|+|++|.+.|.+|.  .++++++| ++|
T Consensus        54 ~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L-~~L  131 (768)
T 3rgz_A           54 SIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGL-KFL  131 (768)
T ss_dssp             EEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTC-CEE
T ss_pred             EEECCCCCcCCccCccChhHhccCcccccCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCC-CEE
Confidence            379999999998   9999999999999999999987 6788999999999999999999999998  99999999 999


Q ss_pred             cccccccccCCChhhhhcCCCceEEEccCCcccccCCCC---ccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecc
Q 003301           76 DFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNN---IWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGF  152 (832)
Q Consensus        76 ~ls~n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~---l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~  152 (832)
                      |+++|.+.+.+|..++.++++|++|++++|++++..|..   +.++++|++|++++|++++..|  +..+++|++|+|++
T Consensus       132 ~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~  209 (768)
T 3rgz_A          132 NVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSS  209 (768)
T ss_dssp             ECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCB--CTTCTTCCEEECCS
T ss_pred             ECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCC--cccCCcCCEEECcC
Confidence            999999999999887669999999999999999888877   8899999999999999997655  48899999999999


Q ss_pred             cccccccCccccCccccceecccccccccccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccc
Q 003301          153 NNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGI  232 (832)
Q Consensus       153 N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~  232 (832)
                      |++++.+|. ++++++|++|++++|++++.+|.++.++++|++|++++|.+.+.+|..    .+++|++|+|++|++++.
T Consensus       210 n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~----~l~~L~~L~L~~n~l~~~  284 (768)
T 3rgz_A          210 NNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL----PLKSLQYLSLAENKFTGE  284 (768)
T ss_dssp             SCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC----CCTTCCEEECCSSEEEES
T ss_pred             CcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc----ccCCCCEEECcCCccCCc
Confidence            999987777 999999999999999999999999999999999999999999877753    789999999999999988


Q ss_pred             cCCcccCC-CCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccc-cccCCCCcEEeccCCCCCCCC
Q 003301          233 IPSFIFNA-SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSS-WANCKNLKLLDLSNNPINGVL  310 (832)
Q Consensus       233 ~~~~~~~l-~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~-~~~l~~L~~L~L~~N~l~~~~  310 (832)
                      +|..+... ++|++|+|++|.+++..|..|.++++|++|++++|.+++     .++.. +..+++|++|++++|++.+.+
T Consensus       285 ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-----~ip~~~l~~l~~L~~L~Ls~n~l~~~~  359 (768)
T 3rgz_A          285 IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSG-----ELPMDTLLKMRGLKVLDLSFNEFSGEL  359 (768)
T ss_dssp             CCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEE-----ECCHHHHTTCTTCCEEECCSSEEEECC
T ss_pred             cCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccC-----cCCHHHHhcCCCCCEEeCcCCccCccc
Confidence            88888775 999999999999999999999999999999999999973     22322 677788888888888877777


Q ss_pred             CCccccccc--------------------------ccceEEeecCcccccccccccCcCcccEEEeecCccccccccccc
Q 003301          311 PSSIGNLSL--------------------------SLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFG  364 (832)
Q Consensus       311 ~~~~~~~~~--------------------------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  364 (832)
                      |..+..+..                          +|++|++++|++++.+|..+.++++|++|++++|++++..|..|.
T Consensus       360 p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~  439 (768)
T 3rgz_A          360 PESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG  439 (768)
T ss_dssp             CTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGG
T ss_pred             cHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHh
Confidence            766654432                          466666666777777777888888888888888888888888888


Q ss_pred             CCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCccccee
Q 003301          365 KLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSL  444 (832)
Q Consensus       365 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  444 (832)
                      .+++|++|+|++|++++.+|..+..+++|++|++++|++++.+|..+.++++|++|++++|++++.+|.+|..+++|++|
T Consensus       440 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  519 (768)
T 3rgz_A          440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAIL  519 (768)
T ss_dssp             GCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEE
T ss_pred             cCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEE
Confidence            88888888888888888888888888888888888888888888888888888888888888888888888888888888


Q ss_pred             eecCCcccCCCccccccccccceecccCcccCCccCCcc-----------------------------------------
Q 003301          445 NFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAI-----------------------------------------  483 (832)
Q Consensus       445 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-----------------------------------------  483 (832)
                      ++++|++++.+|..++.+++|+.|||++|+++|.+|..+                                         
T Consensus       520 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  599 (768)
T 3rgz_A          520 KLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGI  599 (768)
T ss_dssp             ECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTC
T ss_pred             ECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccc
Confidence            888888888888888888888888888888887666543                                         


Q ss_pred             -----------------------------ccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhh
Q 003301          484 -----------------------------GGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKL  534 (832)
Q Consensus       484 -----------------------------~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  534 (832)
                                                   +++++|+.|+|++|+++|.+|..|+.+++|+.|||++|+++|.+|..++.+
T Consensus       600 ~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L  679 (768)
T 3rgz_A          600 RSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDL  679 (768)
T ss_dssp             CGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGC
T ss_pred             cchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCC
Confidence                                         335678889999999999999999999999999999999999999999999


Q ss_pred             ccCCeeeCCCCcccccCCCC-CCCCCcCCCcccCCC
Q 003301          535 LYLKDLNLSFNKLEGEIPRG-GPFANFSNRSFMGND  569 (832)
Q Consensus       535 ~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~n~  569 (832)
                      ++|++|||++|+++|.+|.. ..+..+......+|.
T Consensus       680 ~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~  715 (768)
T 3rgz_A          680 RGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN  715 (768)
T ss_dssp             TTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSE
T ss_pred             CCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCc
Confidence            99999999999999999873 344444444555554

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.1e-64  Score=602.15  Aligned_cols=568  Identities=23%  Similarity=0.257  Sum_probs=379.7

Q ss_pred             ccCCCCcceeccCccccCccccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCcccccccccccccc
Q 003301            2 LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNS   81 (832)
Q Consensus         2 ldl~~n~~~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~   81 (832)
                      +|.+++.++ .+|..+.  +.+++|+|++|++++..|..|.++++|++|+|++|.+++..|..++.+++| ++|++++|.
T Consensus         9 ~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L-~~L~L~~n~   84 (680)
T 1ziw_A            9 ADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPML-KVLNLQHNE   84 (680)
T ss_dssp             EECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTC-CEEECCSSC
T ss_pred             eECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCc-CEEECCCCc
Confidence            466777777 6676654  677777777777775555567777777777777777776666667777777 777777777


Q ss_pred             cccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCc
Q 003301           82 LTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPY  161 (832)
Q Consensus        82 l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~  161 (832)
                      ++ .+|...+.++++|++|++++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|++++|++++..+.
T Consensus        85 l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  163 (680)
T 1ziw_A           85 LS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE  163 (680)
T ss_dssp             CC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred             cC-ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence            77 66666555777777777777777765566777777777777777777776677777777777777777777755555


Q ss_pred             ccc--CccccceecccccccccccCcccccC---------------------------CcccEEEecCCCCCCCCCcccc
Q 003301          162 EMG--NLRNLEILGLQLNKLVGFVPTSIFNL---------------------------SAMKTLALPSNALSGSLPSSID  212 (832)
Q Consensus       162 ~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l---------------------------~~L~~L~L~~n~l~~~~p~~~~  212 (832)
                      .+.  .+++|++|++++|++++..|..|..+                           ++|++|++++|.+.+..|..+.
T Consensus       164 ~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~  243 (680)
T 1ziw_A          164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL  243 (680)
T ss_dssp             HHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTG
T ss_pred             HhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhh
Confidence            443  44677777777777777666655544                           4566667777777666565542


Q ss_pred             ccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccc----c
Q 003301          213 LVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFL----S  288 (832)
Q Consensus       213 ~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~----~  288 (832)
                      -...++|++|+|++|+++++.+..|..+++|++|++++|.+++..|..|.++++|++|++++|..........++    .
T Consensus       244 ~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~  323 (680)
T 1ziw_A          244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF  323 (680)
T ss_dssp             GGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTT
T ss_pred             ccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChh
Confidence            112234888888888887777777777888888888888887777777777777777777766543210000111    1


Q ss_pred             ccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccc--cccccccCc--CcccEEEeecCccccccccccc
Q 003301          289 SWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRG--TIPKEIGNL--INLRELGLWGNELIGSIPITFG  364 (832)
Q Consensus       289 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~--~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~  364 (832)
                      .|..+++|++|++++|.+.+..+..+..+. +|++|++++|.++.  ..+..|..+  ++|+.|++++|++++..|.+|.
T Consensus       324 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~  402 (680)
T 1ziw_A          324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLI-NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS  402 (680)
T ss_dssp             TTTTCTTCCEEECCSCCBCCCCTTTTTTCT-TCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTT
T ss_pred             hcccCCCCCEEECCCCccCCCChhHhcccc-CCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhh
Confidence            466777778888887777776666666665 77777777766432  222233332  4677777777777766666777


Q ss_pred             CCCCCceEEccCCccCCCCc-hhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCC--CCCCcccccCccc
Q 003301          365 KLQNLQGLDLVNNKLEGPIP-NGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELN--SVIPSTFWNLKDI  441 (832)
Q Consensus       365 ~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L  441 (832)
                      .+++|++|+|++|++++.+| ..+..+++|++|++++|++.+..+..|..+++|+.|++++|.+.  +..|..|.++++|
T Consensus       403 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L  482 (680)
T 1ziw_A          403 WLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL  482 (680)
T ss_dssp             TCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTC
T ss_pred             CCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCC
Confidence            77777777777777765444 56666777777777777776666666777777777777777665  4456667777777


Q ss_pred             ceeeecCCcccCCCccccccccccceecccCcccCCccC--------CccccccccceeecccccccccCCccccCCCCC
Q 003301          442 LSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIP--------TAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSL  513 (832)
Q Consensus       442 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  513 (832)
                      +.|++++|++++..+..|..+++|++|+|++|++++..+        ..|.++++|+.|+|++|+++...+..|+++++|
T Consensus       483 ~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L  562 (680)
T 1ziw_A          483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL  562 (680)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred             CEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCc
Confidence            777777777776666666777777777777777664321        235666777777777777764444456777777


Q ss_pred             CeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCCCC-C-CCCCcCCCcccCCCCCCCCc
Q 003301          514 ESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRG-G-PFANFSNRSFMGNDLLCGLA  575 (832)
Q Consensus       514 ~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~-~~~~~~~~~~~~n~~~c~~~  575 (832)
                      +.|||++|++++..+..|..+++|+.|+|++|++++..|.. . .+.++....+.|||+.|.++
T Consensus       563 ~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~  626 (680)
T 1ziw_A          563 KIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE  626 (680)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred             ceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence            77777777777665556666777777777777776655431 1 23444455566777777654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=4.1e-64  Score=597.37  Aligned_cols=543  Identities=21%  Similarity=0.222  Sum_probs=483.0

Q ss_pred             CccCCCCcceeccCccccCccccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCC-cccCcccccccccccc
Q 003301            1 MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPS-TIFNLSSLSTGMDFSN   79 (832)
Q Consensus         1 ~ldl~~n~~~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~-~l~~l~~l~~~L~ls~   79 (832)
                      .|||++|.+++..+..|+++++|++|+|++|++++..|+.|+++++|++|+|++|.++ .+|+ .++.+++| ++|++++
T Consensus        29 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L-~~L~L~~  106 (680)
T 1ziw_A           29 VLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS-QLSDKTFAFCTNL-TELHLMS  106 (680)
T ss_dssp             EEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCC-CCCTTTTTTCTTC-SEEECCS
T ss_pred             EEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccC-ccChhhhccCCCC-CEEECCC
Confidence            3799999999877778999999999999999999888999999999999999999999 5665 69999999 9999999


Q ss_pred             cccccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCc--CCCcCceEEeccccccc
Q 003301           80 NSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLG--NLTSLKTLYLGFNNLTG  157 (832)
Q Consensus        80 n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~--~l~~L~~L~Ls~N~i~~  157 (832)
                      |+++ .+|...+.++++|++|++++|++++..|..+..+++|++|++++|++++..+..+.  .+++|++|++++|++++
T Consensus       107 n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~  185 (680)
T 1ziw_A          107 NSIQ-KIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE  185 (680)
T ss_dssp             SCCC-CCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCC
T ss_pred             CccC-ccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccc
Confidence            9998 67765556999999999999999988899999999999999999999977666554  56899999999999998


Q ss_pred             ccCccccCc---------------------------cccceecccccccccccCcccccCCc--ccEEEecCCCCCCCCC
Q 003301          158 EIPYEMGNL---------------------------RNLEILGLQLNKLVGFVPTSIFNLSA--MKTLALPSNALSGSLP  208 (832)
Q Consensus       158 ~~p~~~~~l---------------------------~~L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~L~~n~l~~~~p  208 (832)
                      ..|..|..+                           ++|+.|++++|++.+..|.+|.+++.  |++|++++|.+.+..|
T Consensus       186 ~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~  265 (680)
T 1ziw_A          186 FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN  265 (680)
T ss_dssp             BCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECT
T ss_pred             cChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCc
Confidence            888777654                           45778888899999888999998865  9999999999997766


Q ss_pred             ccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcc---------cCCccccCccccceeecccccCCC
Q 003301          209 SSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSG---------FIPNTLGNLRKLEWLRLSYNFLTS  279 (832)
Q Consensus       209 ~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~---------~~~~~~~~l~~L~~L~L~~N~l~~  279 (832)
                      ..+  ..+++|++|++++|++++..|..|.++++|++|++++|...+         +....|..+++|++|++++|.++.
T Consensus       266 ~~~--~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~  343 (680)
T 1ziw_A          266 DSF--AWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG  343 (680)
T ss_dssp             TTT--TTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCC
T ss_pred             ccc--cCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCC
Confidence            654  789999999999999999999999999999999999886543         222378899999999999999998


Q ss_pred             CCCccccccccccCCCCcEEeccCCCCCCC--CCCcccccc-cccceEEeecCcccccccccccCcCcccEEEeecCccc
Q 003301          280 STSELSFLSSWANCKNLKLLDLSNNPINGV--LPSSIGNLS-LSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELI  356 (832)
Q Consensus       280 ~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  356 (832)
                      ++.     ..|..+++|++|++++|.+...  .+..+..+. .+|+.|++++|++++..|..|..+++|++|++++|.+.
T Consensus       344 ~~~-----~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  418 (680)
T 1ziw_A          344 IKS-----NMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIG  418 (680)
T ss_dssp             CCT-----TTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCE
T ss_pred             CCh-----hHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCc
Confidence            544     3588999999999999986432  222333322 37999999999999999999999999999999999998


Q ss_pred             cccc-ccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCC--CCCcccCCCCCCCCeEeCCCCcCCCCCCc
Q 003301          357 GSIP-ITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLS--GPIPPCIGDLTSLRLLSLASNELNSVIPS  433 (832)
Q Consensus       357 ~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~~~  433 (832)
                      +.+| ..|.++++|++|++++|++++..+..|..+++|+.|++++|.+.  +..|..|..+++|+.|++++|+++++.+.
T Consensus       419 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~  498 (680)
T 1ziw_A          419 QELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD  498 (680)
T ss_dssp             EECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred             cccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChh
Confidence            7665 78999999999999999999888999999999999999999997  57899999999999999999999999999


Q ss_pred             ccccCcccceeeecCCcccCCCc--------cccccccccceecccCcccCCccCCccccccccceeecccccccccCCc
Q 003301          434 TFWNLKDILSLNFSSNFLNGSLP--------EDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPK  505 (832)
Q Consensus       434 ~~~~l~~L~~L~Ls~N~l~~~~~--------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  505 (832)
                      .|.++++|++|++++|++++..+        ..|..+++|+.|+|++|+++...+..|.++++|+.|+|++|++++..+.
T Consensus       499 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~  578 (680)
T 1ziw_A          499 MLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS  578 (680)
T ss_dssp             TTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred             hhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHh
Confidence            99999999999999999986422        2478999999999999999966666899999999999999999987778


Q ss_pred             cccCCCCCCeeccCCCcccccCchhhh-hhccCCeeeCCCCcccccCCC
Q 003301          506 SIGGLVSLESLDLSNNSLSGNIPTSME-KLLYLKDLNLSFNKLEGEIPR  553 (832)
Q Consensus       506 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~l~l~~N~l~~~~p~  553 (832)
                      .|..+++|+.|+|++|++++..|..+. .+++|+.+++++|+|.|.|+.
T Consensus       579 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          579 VFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             TTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             HhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            899999999999999999999888888 899999999999999999985

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=7.6e-62  Score=570.06  Aligned_cols=533  Identities=21%  Similarity=0.198  Sum_probs=443.9

Q ss_pred             ccCCCCcceeccCccccCccccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCcccccccccccccc
Q 003301            2 LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNS   81 (832)
Q Consensus         2 ldl~~n~~~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~   81 (832)
                      +|.++..++ .+|..+..  .+++|+|++|++++..|..|.++++|++|+|++|.+.+..|..++.+++| ++|++++|.
T Consensus        17 ~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L-~~L~Ls~n~   92 (606)
T 3t6q_A           17 YNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL-DTLVLTANP   92 (606)
T ss_dssp             EECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTC-CEEECTTCC
T ss_pred             EECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCcccc-CeeeCCCCc
Confidence            456677777 77777754  67888888888887777788888888888888888887777788888888 888888888


Q ss_pred             cccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCc
Q 003301           82 LTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPY  161 (832)
Q Consensus        82 l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~  161 (832)
                      +++..|..+ ..+++|++|++++|++++..|..++.+++|++|++++|++++..+..+..+++|++|++++|++++..|.
T Consensus        93 l~~~~~~~~-~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  171 (606)
T 3t6q_A           93 LIFMAETAL-SGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE  171 (606)
T ss_dssp             CSEECTTTT-SSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHH
T ss_pred             ccccChhhh-cccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChh
Confidence            885445544 4788888888888888866677788888888888888888865444455588888888888888877777


Q ss_pred             cccCccccc--eecccccccccccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCc-----cccccC
Q 003301          162 EMGNLRNLE--ILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNN-----FSGIIP  234 (832)
Q Consensus       162 ~~~~l~~L~--~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~-----i~~~~~  234 (832)
                      .|+.+++|+  .|++++|++.+..|..|. ..+|++|++++|..   ++..+  ..+.++....+..+.     ...+.+
T Consensus       172 ~~~~l~~L~~l~L~l~~n~l~~~~~~~~~-~~~L~~L~l~~~~~---~~~~~--~~l~~~~l~~l~~~~~~~~~~~~i~~  245 (606)
T 3t6q_A          172 DMSSLQQATNLSLNLNGNDIAGIEPGAFD-SAVFQSLNFGGTQN---LLVIF--KGLKNSTIQSLWLGTFEDMDDEDISP  245 (606)
T ss_dssp             HHHTTTTCCSEEEECTTCCCCEECTTTTT-TCEEEEEECTTCSC---HHHHH--HHTTTCEEEEEECCCCTTSCCCCCCG
T ss_pred             hhhhhcccceeEEecCCCccCccChhHhh-hccccccccCCchh---HHHHh--hhccccchhheechhhccccccccCh
Confidence            788888888  788888888876666554 46788888888762   22211  223333322222221     122333


Q ss_pred             CcccCCC--CccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCC
Q 003301          235 SFIFNAS--KLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPS  312 (832)
Q Consensus       235 ~~~~~l~--~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  312 (832)
                      ..|.++.  +|++|++++|.++++.+..|..+++|++|++++|.++.++      ..+..+++|++|++++|++.+..|.
T Consensus       246 ~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp------~~l~~l~~L~~L~l~~n~l~~~~~~  319 (606)
T 3t6q_A          246 AVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELP------SGLVGLSTLKKLVLSANKFENLCQI  319 (606)
T ss_dssp             GGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCC------SSCCSCTTCCEEECTTCCCSBGGGG
T ss_pred             hHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCC------hhhcccccCCEEECccCCcCcCchh
Confidence            4444443  7999999999999998888999999999999999998754      3468899999999999999988888


Q ss_pred             cccccccccceEEeecCcccccccc-cccCcCcccEEEeecCcccccc--cccccCCCCCceEEccCCccCCCCchhhcC
Q 003301          313 SIGNLSLSLSRIFISNCSIRGTIPK-EIGNLINLRELGLWGNELIGSI--PITFGKLQNLQGLDLVNNKLEGPIPNGLCQ  389 (832)
Q Consensus       313 ~~~~~~~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  389 (832)
                      .+..+. +|++|++++|.+.+.+|. .+..+++|++|++++|.+.+..  +..+..+++|++|++++|++++..|..+..
T Consensus       320 ~~~~l~-~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  398 (606)
T 3t6q_A          320 SASNFP-SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKE  398 (606)
T ss_dssp             CGGGCT-TCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTT
T ss_pred             hhhccC-cCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcC
Confidence            888887 999999999999866654 5999999999999999999876  788999999999999999999888999999


Q ss_pred             CCCCcEEEecCCcCCCCCccc-CCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCC---Ccccccccccc
Q 003301          390 LARLSVLYMDGNKLSGPIPPC-IGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGS---LPEDIGNLKVV  465 (832)
Q Consensus       390 l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~~~~l~~L  465 (832)
                      +++|++|++++|++++..|.. |..+++|+.|++++|.+++..|..|..+++|++|++++|++++.   .+..+..+++|
T Consensus       399 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L  478 (606)
T 3t6q_A          399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL  478 (606)
T ss_dssp             CTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTC
T ss_pred             CccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCc
Confidence            999999999999999876654 89999999999999999999999999999999999999999863   33678999999


Q ss_pred             ceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCC
Q 003301          466 VIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFN  545 (832)
Q Consensus       466 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N  545 (832)
                      +.|+|++|++++..|..|.++++|+.|+|++|++++..|..|..+++| .|+|++|++++.+|..+..+++|+.|++++|
T Consensus       479 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  557 (606)
T 3t6q_A          479 EILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQN  557 (606)
T ss_dssp             CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTC
T ss_pred             cEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCC
Confidence            999999999999999999999999999999999999999999999999 9999999999999999999999999999999


Q ss_pred             cccccCCC
Q 003301          546 KLEGEIPR  553 (832)
Q Consensus       546 ~l~~~~p~  553 (832)
                      +++|.|+.
T Consensus       558 ~~~c~c~~  565 (606)
T 3t6q_A          558 PLDCTCSN  565 (606)
T ss_dssp             CEECSGGG
T ss_pred             CccccCCc
Confidence            99998875

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-60  Score=575.00  Aligned_cols=526  Identities=21%  Similarity=0.228  Sum_probs=456.5

Q ss_pred             ccCCCCcceeccCccccCccccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCC-CCcccCccccccccccccc
Q 003301            2 LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI-PSTIFNLSSLSTGMDFSNN   80 (832)
Q Consensus         2 ldl~~n~~~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~-p~~l~~l~~l~~~L~ls~n   80 (832)
                      .|.++++++ .+|.   -.+++++|||++|++++..|..|..+++|++|+|++|...+.+ |..+.++++| ++|+|++|
T Consensus         9 ~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L-~~L~Ls~N   83 (844)
T 3j0a_A            9 AFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNL-RILDLGSS   83 (844)
T ss_dssp             EEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTC-CEEECTTC
T ss_pred             EEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCC-CEEECCCC
Confidence            467889999 7787   5689999999999999888999999999999999999777677 6789999999 99999999


Q ss_pred             ccccCCChhhhhcCCCceEEEccCCcccccCCCC--ccCCCCccEEECcCCcccccCC-CCCcCCCcCceEEeccccccc
Q 003301           81 SLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNN--IWQCKELIVISLAYNQFTERIP-RGLGNLTSLKTLYLGFNNLTG  157 (832)
Q Consensus        81 ~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~--l~~l~~L~~L~Ls~n~i~~~~p-~~~~~l~~L~~L~Ls~N~i~~  157 (832)
                      .+++..|..+. .+++|++|+|++|++++.+|..  +..+++|++|+|++|++++..+ ..|+++++|++|+|++|.+++
T Consensus        84 ~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~  162 (844)
T 3j0a_A           84 KIYFLHPDAFQ-GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL  162 (844)
T ss_dssp             CCCEECTTSSC-SCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCC
T ss_pred             cCcccCHhHcc-CCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCe
Confidence            99955566554 9999999999999999866665  8999999999999999987655 579999999999999999998


Q ss_pred             ccCccccCc--cccceecccccccccccCcccccCCc------ccEEEecCCCCCCCCCcccc-ccCCCCccEEEcc---
Q 003301          158 EIPYEMGNL--RNLEILGLQLNKLVGFVPTSIFNLSA------MKTLALPSNALSGSLPSSID-LVRLPNLEIISLA---  225 (832)
Q Consensus       158 ~~p~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~------L~~L~L~~n~l~~~~p~~~~-~~~l~~L~~L~Ls---  225 (832)
                      ..+..+..+  ++|+.|++++|.+.+..|..+..+++      |++|++++|.+.+..|..+. .....+++.|.++   
T Consensus       163 ~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~  242 (844)
T 3j0a_A          163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI  242 (844)
T ss_dssp             CCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSC
T ss_pred             eCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccc
Confidence            889999888  89999999999999888887777665      99999999999887776652 1234678888877   


Q ss_pred             ------CCccccccCCcccCC--CCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCc
Q 003301          226 ------GNNFSGIIPSFIFNA--SKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLK  297 (832)
Q Consensus       226 ------~n~i~~~~~~~~~~l--~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~  297 (832)
                            .+.+....+..|.++  ++|++|++++|.+.+..+..|..+++|++|+|++|.++.++     +..|..+++|+
T Consensus       243 ~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~-----~~~~~~l~~L~  317 (844)
T 3j0a_A          243 MGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIA-----DEAFYGLDNLQ  317 (844)
T ss_dssp             CBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEEC-----TTTTTTCSSCC
T ss_pred             ccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCC-----hHHhcCCCCCC
Confidence                  344555556666665  78999999999999999999999999999999999998743     34588999999


Q ss_pred             EEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCC
Q 003301          298 LLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNN  377 (832)
Q Consensus       298 ~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  377 (832)
                      +|+|++|++.+..|..+..+. +|++|++++|.+++..+..|..+++|++|+|++|.+++.     ..+++|+.|++++|
T Consensus       318 ~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N  391 (844)
T 3j0a_A          318 VLNLSYNLLGELYSSNFYGLP-KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGN  391 (844)
T ss_dssp             EEEEESCCCSCCCSCSCSSCT-TCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESC
T ss_pred             EEECCCCCCCccCHHHhcCCC-CCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCC
Confidence            999999999988888998887 999999999999988888999999999999999999853     33789999999999


Q ss_pred             ccCCCCchhhcCCCCCcEEEecCCcCCCCC-cccCCCCCCCCeEeCCCCcCCCCCCc-ccccCcccceeeecCCccc---
Q 003301          378 KLEGPIPNGLCQLARLSVLYMDGNKLSGPI-PPCIGDLTSLRLLSLASNELNSVIPS-TFWNLKDILSLNFSSNFLN---  452 (832)
Q Consensus       378 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~---  452 (832)
                      +++ .+|..   ..+++.|++++|++++.. +..+..+++|+.|+|++|++++..+. .+..+++|+.|++++|.++   
T Consensus       392 ~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~  467 (844)
T 3j0a_A          392 KLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAW  467 (844)
T ss_dssp             CCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSC
T ss_pred             Ccc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCcccccc
Confidence            998 45543   467999999999998643 23467899999999999999986554 4677899999999999997   


Q ss_pred             --CCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchh
Q 003301          453 --GSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTS  530 (832)
Q Consensus       453 --~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  530 (832)
                        +..+..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..|..+.  ++|+.|||++|+|++.+|..
T Consensus       468 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~  545 (844)
T 3j0a_A          468 ETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV  545 (844)
T ss_dssp             CSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC
T ss_pred             ccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH
Confidence              44556789999999999999999999999999999999999999999987777776  89999999999999999987


Q ss_pred             hhhhccCCeeeCCCCcccccCCC
Q 003301          531 MEKLLYLKDLNLSFNKLEGEIPR  553 (832)
Q Consensus       531 ~~~l~~L~~l~l~~N~l~~~~p~  553 (832)
                      +.   +|+.+++++|++.|.|+-
T Consensus       546 ~~---~L~~l~l~~Np~~C~c~~  565 (844)
T 3j0a_A          546 FV---SLSVLDITHNKFICECEL  565 (844)
T ss_dssp             CS---SCCEEEEEEECCCCSSSC
T ss_pred             hC---CcCEEEecCCCccccccc
Confidence            64   789999999999999875

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=2.4e-59  Score=548.84  Aligned_cols=528  Identities=20%  Similarity=0.191  Sum_probs=441.8

Q ss_pred             ccCCCCcceeccCccccCccccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCcccccccccccccc
Q 003301            2 LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNS   81 (832)
Q Consensus         2 ldl~~n~~~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~   81 (832)
                      +|.+++.++ .+|..+.  +++++|+|++|++++..|..|.++++|++|+|++|.+++..|..++.+++| ++|++++|.
T Consensus        16 ~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L-~~L~Ls~n~   91 (606)
T 3vq2_A           16 YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHL-SNLILTGNP   91 (606)
T ss_dssp             EECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTC-CEEECTTCC
T ss_pred             eEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhc-CEeECCCCc
Confidence            467788888 7777665  788888888888887777788888888888888888886667778888888 888888888


Q ss_pred             cccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccc-cCCCCCcCCCcCceEEecccccccccC
Q 003301           82 LTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTE-RIPRGLGNLTSLKTLYLGFNNLTGEIP  160 (832)
Q Consensus        82 l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~-~~p~~~~~l~~L~~L~Ls~N~i~~~~p  160 (832)
                      +++..|..+ .++++|++|++++|++++..+..++.+++|++|++++|++++ .+|..|+++++|++|+|++|++++..|
T Consensus        92 l~~~~p~~~-~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~  170 (606)
T 3vq2_A           92 IQSFSPGSF-SGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV  170 (606)
T ss_dssp             CCCCCTTSS-TTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECT
T ss_pred             ccccChhhc-CCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecCh
Confidence            884445544 488888888888888886666778888888888888888875 468888888888888888888887777


Q ss_pred             ccccCccccc----eecccccccccccCcccccCCcccEEEecCCCCCC-CCCccccccCCCCccEEEccCCcccc----
Q 003301          161 YEMGNLRNLE----ILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSG-SLPSSIDLVRLPNLEIISLAGNNFSG----  231 (832)
Q Consensus       161 ~~~~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~~~l~~L~~L~Ls~n~i~~----  231 (832)
                      ..|+.+++|+    +|++++|+++++.+..+... +|++|++++|.+.+ ..|..  +..+++|+.+++..+.+..    
T Consensus       171 ~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~--~~~l~~L~~l~l~~~~~~~~~~l  247 (606)
T 3vq2_A          171 NDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTC--LQNLAGLHVHRLILGEFKDERNL  247 (606)
T ss_dssp             TTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHH--HHTTTTCEEEEEEEECCTTSCCC
T ss_pred             hhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHH--hccccccccccccccccccCCcc
Confidence            7788777765    68888888887666655544 88888888888763 33333  4677888888776554432    


Q ss_pred             --ccCCcccCCC--CccEEEc-CCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCC
Q 003301          232 --IIPSFIFNAS--KLSVLEL-GENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPI  306 (832)
Q Consensus       232 --~~~~~~~~l~--~L~~L~L-~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l  306 (832)
                        ..+..+.++.  .++.+++ ..|.+.+..|. +..+++|+.|++++|.+..++       .+..+++|++|++++|.+
T Consensus       248 ~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~-------~l~~~~~L~~L~l~~n~l  319 (606)
T 3vq2_A          248 EIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYLE-------DVPKHFKWQSLSIIRCQL  319 (606)
T ss_dssp             SCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCCC-------CCCTTCCCSEEEEESCCC
T ss_pred             cccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchhhh-------hccccccCCEEEcccccC
Confidence              2222222222  4667777 78888888887 999999999999999998754       468899999999999999


Q ss_pred             CCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccc--cccccCCCCCceEEccCCccCCCCc
Q 003301          307 NGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSI--PITFGKLQNLQGLDLVNNKLEGPIP  384 (832)
Q Consensus       307 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~  384 (832)
                       +.+|. + .+. +|++|++++|...+..  .+..+++|++|++++|++++..  +..+..+++|++|++++|.+++ +|
T Consensus       320 -~~lp~-~-~l~-~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~  392 (606)
T 3vq2_A          320 -KQFPT-L-DLP-FLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MS  392 (606)
T ss_dssp             -SSCCC-C-CCS-SCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-EC
T ss_pred             -ccccc-C-CCC-ccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-ch
Confidence             57774 4 555 9999999999665443  6789999999999999998763  7889999999999999999984 67


Q ss_pred             hhhcCCCCCcEEEecCCcCCCCCc-ccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccC-CCccccccc
Q 003301          385 NGLCQLARLSVLYMDGNKLSGPIP-PCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNG-SLPEDIGNL  462 (832)
Q Consensus       385 ~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l  462 (832)
                      ..+..+++|++|++++|++.+..| ..|..+++|+.|++++|.+++..|..|.++++|++|++++|++++ .+|..++.+
T Consensus       393 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l  472 (606)
T 3vq2_A          393 ANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANT  472 (606)
T ss_dssp             CCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTC
T ss_pred             hhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccC
Confidence            889999999999999999998877 689999999999999999999999999999999999999999997 478899999


Q ss_pred             cccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhc-cCCeee
Q 003301          463 KVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLL-YLKDLN  541 (832)
Q Consensus       463 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~l~  541 (832)
                      ++|+.|+|++|++++..|..|.++++|+.|+|++|++++.+|..|+.+++|+.|||++|+++ .+|..+..++ +|+.|+
T Consensus       473 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~  551 (606)
T 3vq2_A          473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFN  551 (606)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEE
T ss_pred             CCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEE
Confidence            99999999999999999999999999999999999999989999999999999999999999 5777799887 599999


Q ss_pred             CCCCcccccCCC
Q 003301          542 LSFNKLEGEIPR  553 (832)
Q Consensus       542 l~~N~l~~~~p~  553 (832)
                      +++|++.|.++.
T Consensus       552 l~~N~~~c~c~~  563 (606)
T 3vq2_A          552 LTNNSVACICEH  563 (606)
T ss_dssp             CCSCCCCCSSTT
T ss_pred             ccCCCcccCCcc
Confidence            999999999886

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=3.8e-59  Score=547.18  Aligned_cols=514  Identities=21%  Similarity=0.189  Sum_probs=452.4

Q ss_pred             CccCCCCcceeccCccccCccccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCccccccccccccc
Q 003301            1 MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNN   80 (832)
Q Consensus         1 ~ldl~~n~~~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n   80 (832)
                      +|||++|.|++..|..|+++++|++|+|++|++++..|+.|..+++|++|+|++|.+++..|..++.+++| ++|++++|
T Consensus        37 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L-~~L~L~~n  115 (606)
T 3t6q_A           37 CLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKAL-KHLFFIQT  115 (606)
T ss_dssp             EEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTC-CEEECTTS
T ss_pred             EEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccc-cEeecccc
Confidence            48999999998889999999999999999999998889999999999999999999998889999999999 99999999


Q ss_pred             ccccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCc--eEEecccccccc
Q 003301           81 SLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLK--TLYLGFNNLTGE  158 (832)
Q Consensus        81 ~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~--~L~Ls~N~i~~~  158 (832)
                      .++ .++...+.++++|++|++++|++++..+..+..+++|++|++++|++++..|..|+.+++|+  .|++++|++++.
T Consensus       116 ~i~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~  194 (606)
T 3t6q_A          116 GIS-SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGI  194 (606)
T ss_dssp             CCS-CGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEE
T ss_pred             Ccc-cCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCcc
Confidence            999 55444456999999999999999975545566699999999999999988888899999999  899999999977


Q ss_pred             cCccccCccccceecccccccccccCcccccCCcccEEEecCCCCCCC----CCccccccCCC--CccEEEccCCccccc
Q 003301          159 IPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGS----LPSSIDLVRLP--NLEIISLAGNNFSGI  232 (832)
Q Consensus       159 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~~~l~--~L~~L~Ls~n~i~~~  232 (832)
                      .|..|.. .+|+.|++++|..   .+..+.++.+++...+.-+.+.+.    ++.. .+..+.  +|++|++++|.++++
T Consensus       195 ~~~~~~~-~~L~~L~l~~~~~---~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~-~~~~l~~~~L~~L~l~~n~l~~~  269 (606)
T 3t6q_A          195 EPGAFDS-AVFQSLNFGGTQN---LLVIFKGLKNSTIQSLWLGTFEDMDDEDISPA-VFEGLCEMSVESINLQKHYFFNI  269 (606)
T ss_dssp             CTTTTTT-CEEEEEECTTCSC---HHHHHHHTTTCEEEEEECCCCTTSCCCCCCGG-GGGGGGGSEEEEEECTTCCCSSC
T ss_pred             ChhHhhh-ccccccccCCchh---HHHHhhhccccchhheechhhccccccccChh-HhchhhcCceeEEEeecCccCcc
Confidence            7766654 6899999999972   445566666665555544433211    1111 122222  799999999999999


Q ss_pred             cCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCC
Q 003301          233 IPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPS  312 (832)
Q Consensus       233 ~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  312 (832)
                      .+..|..+++|++|++++|.++ .+|..+..+++|++|++++|.++.++     +..+..+++|++|++++|.+.+.+|.
T Consensus       270 ~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~-----~~~~~~l~~L~~L~l~~n~~~~~~~~  343 (606)
T 3t6q_A          270 SSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLC-----QISASNFPSLTHLSIKGNTKRLELGT  343 (606)
T ss_dssp             CTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGG-----GGCGGGCTTCSEEECCSCSSCCBCCS
T ss_pred             CHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCc-----hhhhhccCcCCEEECCCCCcccccch
Confidence            9999999999999999999999 56778999999999999999998743     34688999999999999999877665


Q ss_pred             c-ccccccccceEEeecCcccccc--cccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCch-hhc
Q 003301          313 S-IGNLSLSLSRIFISNCSIRGTI--PKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPN-GLC  388 (832)
Q Consensus       313 ~-~~~~~~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~  388 (832)
                      . +..+. +|++|++++|.+++..  +..+..+++|++|++++|++.+..|..|..+++|++|++++|++++..|. .+.
T Consensus       344 ~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  422 (606)
T 3t6q_A          344 GCLENLE-NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQ  422 (606)
T ss_dssp             STTTTCT-TCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTT
T ss_pred             hhhhccC-cCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhh
Confidence            4 66665 9999999999999776  78899999999999999999999999999999999999999999977665 489


Q ss_pred             CCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCC---CCcccccCcccceeeecCCcccCCCcccccccccc
Q 003301          389 QLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSV---IPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVV  465 (832)
Q Consensus       389 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  465 (832)
                      .+++|++|++++|.+++..|..|..+++|+.|++++|++++.   .+..|..+++|++|++++|++++..|..|+.+++|
T Consensus       423 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L  502 (606)
T 3t6q_A          423 NLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMM  502 (606)
T ss_dssp             TCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred             CcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCC
Confidence            999999999999999999999999999999999999999873   34679999999999999999999889999999999


Q ss_pred             ceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCch
Q 003301          466 VIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPT  529 (832)
Q Consensus       466 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  529 (832)
                      +.|+|++|++++..|..|.+++.| .|+|++|++++.+|..++.+++|+.|++++|++++..+.
T Consensus       503 ~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  565 (606)
T 3t6q_A          503 NHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN  565 (606)
T ss_dssp             CEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred             CEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence            999999999999999999999999 999999999999999999999999999999999987663

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=3.9e-57  Score=547.64  Aligned_cols=527  Identities=22%  Similarity=0.251  Sum_probs=460.5

Q ss_pred             CeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCcccccccccccccccccCCChhhhhcCCCceEEEcc
Q 003301           24 KKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMS  103 (832)
Q Consensus        24 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~  103 (832)
                      +..|.++++++ .+|.   -.++|++|+|++|.+++..|..+..+++| ++|||++|...+.++...+.++++|++|+|+
T Consensus         7 ~~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L-~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls   81 (844)
T 3j0a_A            7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQL-QLLELGSQYTPLTIDKEAFRNLPNLRILDLG   81 (844)
T ss_dssp             EEEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSC-SEEEECTTCCCCEECTTTTSSCTTCCEEECT
T ss_pred             eEEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccC-eEEeCCCCCCccccCHHHhcCCCCCCEEECC
Confidence            46788999998 7887   55799999999999998888999999999 9999999977778877767799999999999


Q ss_pred             CCcccccCCCCccCCCCccEEECcCCcccccCCCC--CcCCCcCceEEecccccccccC-ccccCccccceecccccccc
Q 003301          104 NNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRG--LGNLTSLKTLYLGFNNLTGEIP-YEMGNLRNLEILGLQLNKLV  180 (832)
Q Consensus       104 ~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~--~~~l~~L~~L~Ls~N~i~~~~p-~~~~~l~~L~~L~L~~N~l~  180 (832)
                      +|++++..|+.|.++++|++|+|++|.+++.+|..  |+++++|++|+|++|.+++..+ ..|+++++|++|+|++|.++
T Consensus        82 ~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~  161 (844)
T 3j0a_A           82 SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF  161 (844)
T ss_dssp             TCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCC
T ss_pred             CCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCC
Confidence            99999888999999999999999999999866665  9999999999999999987655 57999999999999999999


Q ss_pred             cccCcccccC--CcccEEEecCCCCCCCCCccccccCCC------CccEEEccCCccccccCCcccCC---CCccEEEcC
Q 003301          181 GFVPTSIFNL--SAMKTLALPSNALSGSLPSSIDLVRLP------NLEIISLAGNNFSGIIPSFIFNA---SKLSVLELG  249 (832)
Q Consensus       181 ~~~~~~~~~l--~~L~~L~L~~n~l~~~~p~~~~~~~l~------~L~~L~Ls~n~i~~~~~~~~~~l---~~L~~L~L~  249 (832)
                      +..+..+..+  ++|+.|++++|.+.+..|..+  ..++      .|++|++++|.+++..+..+...   ++++.|.++
T Consensus       162 ~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~--~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~  239 (844)
T 3j0a_A          162 LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDW--GKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILA  239 (844)
T ss_dssp             CCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCC--CSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECC
T ss_pred             eeCHHHcccccCCccceEECCCCccccccccch--hhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecc
Confidence            9999999888  899999999999998777654  3444      49999999999998888777643   678889887


Q ss_pred             C---------CcCcccCCccccCc--cccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccc
Q 003301          250 E---------NSFSGFIPNTLGNL--RKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLS  318 (832)
Q Consensus       250 ~---------N~i~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~  318 (832)
                      .         +.+.+..+..|.++  ++|+.|++++|.+..+.     +..|..+++|+.|+|++|++.+..|..+..+.
T Consensus       240 ~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~-----~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~  314 (844)
T 3j0a_A          240 HHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLN-----SRVFETLKDLKVLNLAYNKINKIADEAFYGLD  314 (844)
T ss_dssp             SSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEEC-----SCCSSSCCCCCEEEEESCCCCEECTTTTTTCS
T ss_pred             cccccccccccccCCCChhhhhccccCCccEEECCCCcccccC-----hhhhhcCCCCCEEECCCCcCCCCChHHhcCCC
Confidence            3         44454555666665  78999999999998743     34588999999999999999988888898887


Q ss_pred             cccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEe
Q 003301          319 LSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYM  398 (832)
Q Consensus       319 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  398 (832)
                       +|++|++++|.+++..|..|..+++|+.|++++|++.+..+..|..+++|++|+|++|.+++. +    .+++|+.|++
T Consensus       315 -~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-~----~~~~L~~L~l  388 (844)
T 3j0a_A          315 -NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-H----FIPSIPDIFL  388 (844)
T ss_dssp             -SCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-S----SCCSCSEEEE
T ss_pred             -CCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-c----CCCCcchhcc
Confidence             999999999999999999999999999999999999988888999999999999999999843 3    3789999999


Q ss_pred             cCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCc-ccccCcccceeeecCCcccCCCcc-ccccccccceecccCcccC
Q 003301          399 DGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPS-TFWNLKDILSLNFSSNFLNGSLPE-DIGNLKVVVIIDLSRNNLS  476 (832)
Q Consensus       399 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~  476 (832)
                      ++|+++ .+|..   ..+++.|++++|++++.... .+.++++|++|+|++|++++..+. .+..+++|+.|+|++|.++
T Consensus       389 ~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~  464 (844)
T 3j0a_A          389 SGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQ  464 (844)
T ss_dssp             ESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCS
T ss_pred             CCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccc
Confidence            999998 55544   46799999999999886433 356899999999999999975544 4667899999999999997


Q ss_pred             -----CccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccC
Q 003301          477 -----GDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEI  551 (832)
Q Consensus       477 -----~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~  551 (832)
                           +..+..|.++++|+.|+|++|++++.+|..|..+++|+.|+|++|+|++..|..+.  ++|+.|+|++|++++.+
T Consensus       465 ~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~  542 (844)
T 3j0a_A          465 LAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPN  542 (844)
T ss_dssp             SSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCC
T ss_pred             cccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCC
Confidence                 45567899999999999999999999999999999999999999999988887776  89999999999999998


Q ss_pred             CCCCCCCCcCCCcccCCCCCCCCcc
Q 003301          552 PRGGPFANFSNRSFMGNDLLCGLAQ  576 (832)
Q Consensus       552 p~~~~~~~~~~~~~~~n~~~c~~~~  576 (832)
                      |..  +..+....+.||++.|.++.
T Consensus       543 ~~~--~~~L~~l~l~~Np~~C~c~~  565 (844)
T 3j0a_A          543 PDV--FVSLSVLDITHNKFICECEL  565 (844)
T ss_dssp             SCC--CSSCCEEEEEEECCCCSSSC
T ss_pred             hhH--hCCcCEEEecCCCccccccc
Confidence            863  55666677899999998764

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=9.9e-58  Score=535.13  Aligned_cols=509  Identities=21%  Similarity=0.184  Sum_probs=448.3

Q ss_pred             CccCCCCcceeccCccccCccccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCccccccccccccc
Q 003301            1 MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNN   80 (832)
Q Consensus         1 ~ldl~~n~~~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n   80 (832)
                      .|||++|.+++..+..|+++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..++.+++| ++|++++|
T Consensus        36 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L-~~L~L~~n  114 (606)
T 3vq2_A           36 NIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSL-ENLVAVET  114 (606)
T ss_dssp             EEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTC-CEEECTTS
T ss_pred             EEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccC-CEEEccCC
Confidence            37999999998888899999999999999999998888899999999999999999997779999999999 99999999


Q ss_pred             ccccCCChhhhhcCCCceEEEccCCcccc-cCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCc----eEEeccccc
Q 003301           81 SLTGSLPDDMCRRLPLIKGLYMSNNKLTG-PIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLK----TLYLGFNNL  155 (832)
Q Consensus        81 ~l~~~lp~~~~~~l~~L~~L~l~~N~l~~-~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~----~L~Ls~N~i  155 (832)
                      .++ .+|...+.++++|++|++++|++++ .+|..++++++|++|++++|++++..|..|+.+++|+    +|++++|.+
T Consensus       115 ~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l  193 (606)
T 3vq2_A          115 KLA-SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPI  193 (606)
T ss_dssp             CCC-CSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCC
T ss_pred             ccc-cccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCc
Confidence            999 5664445699999999999999986 5799999999999999999999998899999888776    899999999


Q ss_pred             ccccCccccCccccceecccccccc-cccCcccccCCcccEEEecCCCCCCC-----CCccccccCC--CCccEEEc-cC
Q 003301          156 TGEIPYEMGNLRNLEILGLQLNKLV-GFVPTSIFNLSAMKTLALPSNALSGS-----LPSSIDLVRL--PNLEIISL-AG  226 (832)
Q Consensus       156 ~~~~p~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~-----~p~~~~~~~l--~~L~~L~L-s~  226 (832)
                      ++..+..+... +|+.|++++|.+. +..|..+.++++|+.+++..+.+.+.     ++... +..+  -.++.+++ ..
T Consensus       194 ~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~-~~~l~~l~l~~l~l~~~  271 (606)
T 3vq2_A          194 DFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI-MEGLCDVTIDEFRLTYT  271 (606)
T ss_dssp             CEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGG-GTTGGGSEEEEEEECCC
T ss_pred             ceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHH-hhhhhhccHhheecccc
Confidence            96666556554 8999999999987 46778899999999999876655421     11100 1111  25677777 78


Q ss_pred             CccccccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCC
Q 003301          227 NNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPI  306 (832)
Q Consensus       227 n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l  306 (832)
                      |.+.+..|. +..+++|++|++++|.+... | .+..+++|++|++++|.+..++       .+ .+++|++|++++|+.
T Consensus       272 ~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l-~-~l~~~~~L~~L~l~~n~l~~lp-------~~-~l~~L~~L~l~~n~~  340 (606)
T 3vq2_A          272 NDFSDDIVK-FHCLANVSAMSLAGVSIKYL-E-DVPKHFKWQSLSIIRCQLKQFP-------TL-DLPFLKSLTLTMNKG  340 (606)
T ss_dssp             TTCCGGGGS-CGGGTTCSEEEEESCCCCCC-C-CCCTTCCCSEEEEESCCCSSCC-------CC-CCSSCCEEEEESCSS
T ss_pred             ccccccccc-cccCCCCCEEEecCccchhh-h-hccccccCCEEEcccccCcccc-------cC-CCCccceeeccCCcC
Confidence            888888887 89999999999999999854 4 8899999999999999996543       35 889999999999976


Q ss_pred             CCCCCCcccccccccceEEeecCccccc--ccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCc
Q 003301          307 NGVLPSSIGNLSLSLSRIFISNCSIRGT--IPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIP  384 (832)
Q Consensus       307 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  384 (832)
                      .+..  .+..+. +|++|++++|.+++.  .|..+..+++|++|++++|.+.+ .|..|..+++|++|++++|++++..|
T Consensus       341 ~~~~--~~~~l~-~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~  416 (606)
T 3vq2_A          341 SISF--KKVALP-SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTE  416 (606)
T ss_dssp             CEEC--CCCCCT-TCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTT
T ss_pred             ccch--hhccCC-CCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccC
Confidence            5443  455555 999999999999976  48889999999999999999986 56889999999999999999998877


Q ss_pred             -hhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCC-CCCcccccCcccceeeecCCcccCCCccccccc
Q 003301          385 -NGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNS-VIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNL  462 (832)
Q Consensus       385 -~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  462 (832)
                       ..+..+++|++|++++|++++..|..|.++++|+.|++++|.+++ ..|..|..+++|++|++++|++++..|..|+.+
T Consensus       417 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l  496 (606)
T 3vq2_A          417 FSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTL  496 (606)
T ss_dssp             TTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred             hhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhccc
Confidence             689999999999999999999999999999999999999999998 589999999999999999999999999999999


Q ss_pred             cccceecccCcccCCccCCccccccccceeecccccccccCCccccCCC-CCCeeccCCCcccccCch
Q 003301          463 KVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLV-SLESLDLSNNSLSGNIPT  529 (832)
Q Consensus       463 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~  529 (832)
                      ++|+.|+|++|++++..|..|.++++|+.|+|++|+++ .+|..+..++ +|+.|++++|++.+..+.
T Consensus       497 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~  563 (606)
T 3vq2_A          497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH  563 (606)
T ss_dssp             TTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred             ccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence            99999999999999999999999999999999999999 6777799997 699999999999976654

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.2e-54  Score=500.80  Aligned_cols=508  Identities=21%  Similarity=0.237  Sum_probs=336.1

Q ss_pred             eEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCcccccccccccccccccCCChhhhhcCCCceEEEccC
Q 003301           25 KLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSN  104 (832)
Q Consensus        25 ~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~~  104 (832)
                      ..+.++.+++ .+|..+.  +++++|+|++|.+++..+..+..+++| ++||+++|+++ .++...+.++++|++|++++
T Consensus        11 ~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L-~~L~Ls~n~i~-~i~~~~~~~l~~L~~L~L~~   85 (570)
T 2z63_A           11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPEL-QVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTG   85 (570)
T ss_dssp             EEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSC-CEEECTTCCCC-EECTTTTTTCTTCCEEECTT
T ss_pred             EEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCc-eEEECCCCcCC-ccCcccccCchhCCEEeCcC
Confidence            3444444444 4444332  245555555555543333444445554 55555555554 33333333455555555555


Q ss_pred             CcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEeccccccc-ccCccccCccccceeccccccccccc
Q 003301          105 NKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTG-EIPYEMGNLRNLEILGLQLNKLVGFV  183 (832)
Q Consensus       105 N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~-~~p~~~~~l~~L~~L~L~~N~l~~~~  183 (832)
                      |++++..|..|..+++|++|++++|++++..+..|+++++|++|++++|.+++ .+|..|+++++|++|++++|++++..
T Consensus        86 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~  165 (570)
T 2z63_A           86 NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY  165 (570)
T ss_dssp             CCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEEC
T ss_pred             CcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceec
Confidence            55554444455555555555555555554333345555555555555555543 23555555555555555555555544


Q ss_pred             CcccccCCcc----cEEEecCCCCCCCCCccccccCCCCccEEEccCCccc-cccCCcccCCCCccEEEcCCC------c
Q 003301          184 PTSIFNLSAM----KTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFS-GIIPSFIFNASKLSVLELGEN------S  252 (832)
Q Consensus       184 ~~~~~~l~~L----~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~L~~N------~  252 (832)
                      +..+..+++|    ++|++++|.+.+..|..+  . ..+|++|++++|... ...+..+..+++++.+.+..+      .
T Consensus       166 ~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~--~-~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~  242 (570)
T 2z63_A          166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF--K-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN  242 (570)
T ss_dssp             GGGGHHHHTCTTCCCEEECTTCCCCEECTTTT--T-TCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSS
T ss_pred             HHHccchhccchhhhhcccCCCCceecCHHHh--c-cCcceeEecccccccccchhhhhcCccccceeeeccccccCchh
Confidence            4445555444    455555555554333332  1 124555555554322 122333344444444433321      1


Q ss_pred             CcccCCccccCccc--cceeecccc-cCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecC
Q 003301          253 FSGFIPNTLGNLRK--LEWLRLSYN-FLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNC  329 (832)
Q Consensus       253 i~~~~~~~~~~l~~--L~~L~L~~N-~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n  329 (832)
                      +.......+..+++  ++.+++++| .+..     ..+..+..+++|+.|++++|.+. .+|..+...  +|++|++++|
T Consensus       243 l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~-----~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~--~L~~L~l~~n  314 (570)
T 2z63_A          243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLD-----DIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF--GWQHLELVNC  314 (570)
T ss_dssp             CEECCTTTTGGGGGSEEEEEEEEETTEEES-----CSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC--CCSEEEEESC
T ss_pred             hhhcchhhhccccccchhhhhhhcchhhhh-----hchhhhcCcCcccEEEecCccch-hhhhhhccC--CccEEeeccC
Confidence            22222333333333  455556555 4433     23345677778888888888776 466666555  7888888888


Q ss_pred             cccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCC--chhhcCCCCCcEEEecCCcCCCCC
Q 003301          330 SIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPI--PNGLCQLARLSVLYMDGNKLSGPI  407 (832)
Q Consensus       330 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~  407 (832)
                      .+. .+|.  ..+++|+.|++++|.+.+..+.  ..+++|++|++++|++++..  |..+..+++|++|++++|.+.+..
T Consensus       315 ~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~  389 (570)
T 2z63_A          315 KFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMS  389 (570)
T ss_dssp             BCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEE
T ss_pred             ccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccc
Confidence            877 4444  4678889999999988765554  67888999999999988554  678888999999999999988554


Q ss_pred             cccCCCCCCCCeEeCCCCcCCCCCC-cccccCcccceeeecCCcccCCCccccccccccceecccCcccC-CccCCcccc
Q 003301          408 PPCIGDLTSLRLLSLASNELNSVIP-STFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLS-GDIPTAIGG  485 (832)
Q Consensus       408 p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~  485 (832)
                      + .+..+++|+.|++++|.+.+..+ ..|..+++|++|++++|++.+..|..+..+++|+.|+|++|+++ +.+|..|.+
T Consensus       390 ~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~  468 (570)
T 2z63_A          390 S-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE  468 (570)
T ss_dssp             E-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTT
T ss_pred             c-cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhc
Confidence            4 48899999999999999988766 57889999999999999999888999999999999999999997 578999999


Q ss_pred             ccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCCCC
Q 003301          486 LMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRG  554 (832)
Q Consensus       486 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~  554 (832)
                      +++|++|+|++|++++..|..|+.+++|+.|+|++|++++.+|..+..+++|+.|++++|+++|.||..
T Consensus       469 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  537 (570)
T 2z63_A          469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  537 (570)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred             ccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence            999999999999999988999999999999999999999998888999999999999999999999974

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-53  Score=493.79  Aligned_cols=506  Identities=21%  Similarity=0.199  Sum_probs=434.4

Q ss_pred             cCCCCcceeccCccccCccccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCccccccccccccccc
Q 003301            3 SLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSL   82 (832)
Q Consensus         3 dl~~n~~~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l   82 (832)
                      |-++.+++ .+|..+.  +.+++|+|++|++++..|..|..+++|++|+|++|++++..|..++.+++| ++|++++|.+
T Consensus        13 ~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L-~~L~L~~n~l   88 (570)
T 2z63_A           13 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL-STLILTGNPI   88 (570)
T ss_dssp             ECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTC-CEEECTTCCC
T ss_pred             EeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhC-CEEeCcCCcC
Confidence            55677777 7887664  579999999999997778899999999999999999996667788999999 9999999999


Q ss_pred             ccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccc-cCCCCCcCCCcCceEEecccccccccCc
Q 003301           83 TGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTE-RIPRGLGNLTSLKTLYLGFNNLTGEIPY  161 (832)
Q Consensus        83 ~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~-~~p~~~~~l~~L~~L~Ls~N~i~~~~p~  161 (832)
                      + .+|...+.++++|++|++++|++++..+..++.+++|++|++++|.+++ .+|..|+++++|++|++++|++++..|.
T Consensus        89 ~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~  167 (570)
T 2z63_A           89 Q-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT  167 (570)
T ss_dssp             C-EECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGG
T ss_pred             C-ccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHH
Confidence            9 5666556699999999999999996666679999999999999999987 3699999999999999999999988888


Q ss_pred             cccCcccc----ceecccccccccccCcccccCCcccEEEecCCCCCC-CCCccccccCCCCccEEEccCCcc------c
Q 003301          162 EMGNLRNL----EILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSG-SLPSSIDLVRLPNLEIISLAGNNF------S  230 (832)
Q Consensus       162 ~~~~l~~L----~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~~~l~~L~~L~Ls~n~i------~  230 (832)
                      .++.+++|    +.|++++|.+.+..+..|..+ +|+.|++++|.... .+|.  .+..+++++.+.+....+      .
T Consensus       168 ~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~--~~~~l~~l~~~~l~~~~~~~~~~l~  244 (570)
T 2z63_A          168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKT--CIQGLAGLEVHRLVLGEFRNEGNLE  244 (570)
T ss_dssp             GGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHH--HHHTTTTCEEEEEEEEECCCCSSCE
T ss_pred             HccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhh--hhcCccccceeeeccccccCchhhh
Confidence            89999999    899999999999888888766 89999999986542 1222  235667777666654322      2


Q ss_pred             cccCCcccCCC--CccEEEcCCC-cCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCC
Q 003301          231 GIIPSFIFNAS--KLSVLELGEN-SFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPIN  307 (832)
Q Consensus       231 ~~~~~~~~~l~--~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~  307 (832)
                      .+....+..+.  .++.+++++| .+.+..+..+..+++|++|++++|.++.++.      .+..+ +|++|++++|.+.
T Consensus       245 ~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~------~~~~~-~L~~L~l~~n~~~  317 (570)
T 2z63_A          245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD------FSYNF-GWQHLELVNCKFG  317 (570)
T ss_dssp             ECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEECSCCB------CCSCC-CCSEEEEESCBCS
T ss_pred             hcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccchhhhh------hhccC-CccEEeeccCccc
Confidence            33334444443  3577888888 7888889999999999999999999987443      45677 9999999999998


Q ss_pred             CCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccc--cccccCCCCCceEEccCCccCCCCch
Q 003301          308 GVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSI--PITFGKLQNLQGLDLVNNKLEGPIPN  385 (832)
Q Consensus       308 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~  385 (832)
                       .+|..  .+. +|+.|++++|.+.+..+.  ..+++|++|++++|++++..  +..+..+++|++|++++|++++. +.
T Consensus       318 -~l~~~--~l~-~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~-~~  390 (570)
T 2z63_A          318 -QFPTL--KLK-SLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-SS  390 (570)
T ss_dssp             -SCCBC--BCS-SCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEE-EE
T ss_pred             -ccCcc--ccc-ccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccc-cc
Confidence             55542  333 899999999999876665  78899999999999998764  77899999999999999999965 44


Q ss_pred             hhcCCCCCcEEEecCCcCCCCCc-ccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCccc-CCCcccccccc
Q 003301          386 GLCQLARLSVLYMDGNKLSGPIP-PCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLN-GSLPEDIGNLK  463 (832)
Q Consensus       386 ~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~  463 (832)
                      .+..+++|++|++++|.+.+..| ..|..+++|++|++++|.+.+..|..|.++++|++|++++|+++ +.+|..++.++
T Consensus       391 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~  470 (570)
T 2z63_A          391 NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR  470 (570)
T ss_dssp             EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCT
T ss_pred             cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhccc
Confidence            49999999999999999997766 57899999999999999999999999999999999999999998 57899999999


Q ss_pred             ccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchh
Q 003301          464 VVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTS  530 (832)
Q Consensus       464 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  530 (832)
                      +|+.|+|++|++++..|..|.++++|++|+|++|++++.+|..|+.+++|+.|++++|++++..|..
T Consensus       471 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  537 (570)
T 2z63_A          471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  537 (570)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred             CCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence            9999999999999988999999999999999999999988889999999999999999999988753

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=3.5e-52  Score=482.13  Aligned_cols=490  Identities=21%  Similarity=0.221  Sum_probs=306.0

Q ss_pred             cCCCCcceeccCccccCccccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCccccccccccccccc
Q 003301            3 SLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSL   82 (832)
Q Consensus         3 dl~~n~~~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l   82 (832)
                      |.++|.++ .+|+.+.  +.|++|+|++|++++..|..|..+++|++|++++|++++..|+.++.+++| ++||+++|.+
T Consensus        11 ~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L-~~L~Ls~n~l   86 (549)
T 2z81_A           11 DGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL-EHLDLSDNHL   86 (549)
T ss_dssp             ECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTC-CEEECTTSCC
T ss_pred             ECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccC-CEEECCCCcc
Confidence            66778888 7777665  678888888888887777788888888888888888886666777888887 8888888888


Q ss_pred             ccCCChhhhhcCCCceEEEccCCcccc-cCCCCccCCCCccEEECcCCc-ccccCCCCCcCCCcCceEEecccccccccC
Q 003301           83 TGSLPDDMCRRLPLIKGLYMSNNKLTG-PIPNNIWQCKELIVISLAYNQ-FTERIPRGLGNLTSLKTLYLGFNNLTGEIP  160 (832)
Q Consensus        83 ~~~lp~~~~~~l~~L~~L~l~~N~l~~-~~p~~l~~l~~L~~L~Ls~n~-i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p  160 (832)
                      + .+|...+..+++|++|++++|++++ ..|..++.+++|++|++++|+ +....+..|.++++|++|++++|++++..|
T Consensus        87 ~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  165 (549)
T 2z81_A           87 S-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS  165 (549)
T ss_dssp             C-SCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECT
T ss_pred             C-ccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccCh
Confidence            7 5666555578888888888888875 245677778888888888877 443334577778888888888888877777


Q ss_pred             ccccCccccceecccccccccccCcccccCCcccEEEecCCCCCCCC--CccccccCCCCccEEEccCCccccccCCccc
Q 003301          161 YEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSL--PSSIDLVRLPNLEIISLAGNNFSGIIPSFIF  238 (832)
Q Consensus       161 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~  238 (832)
                      ..++++++|++|+++.|.+....+..+..+++|++|++++|.+.+..  |..+ ...+++|+.|++++|.+++..+..+ 
T Consensus       166 ~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-~~~~~~L~~L~l~~n~l~~~~~~~l-  243 (549)
T 2z81_A          166 QSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPV-DEVSSPMKKLAFRGSVLTDESFNEL-  243 (549)
T ss_dssp             TTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSS-CCCCCCCCEEEEESCEEEHHHHHHH-
T ss_pred             hhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccch-hhhhhcccceeccccccchhHHHHH-
Confidence            77777778888888777776433333345777777777777776431  1111 1234455555555555543322211 


Q ss_pred             CCCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCcc-ccccccccCCCCcEEeccCCCCCCCCC----Cc
Q 003301          239 NASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSEL-SFLSSWANCKNLKLLDLSNNPINGVLP----SS  313 (832)
Q Consensus       239 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~----~~  313 (832)
                                         +..+..+++|+.|++++|.+.++.... .....+..+++|+.|++.++.+.....    ..
T Consensus       244 -------------------~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~  304 (549)
T 2z81_A          244 -------------------LKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLST  304 (549)
T ss_dssp             -------------------HGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCH
T ss_pred             -------------------HHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchh
Confidence                               112233444555555555444322100 001124556677777777776542110    00


Q ss_pred             ccccccccceEEeecCcccccccccc-cCcCcccEEEeecCccccccc---ccccCCCCCceEEccCCccCCCCc--hhh
Q 003301          314 IGNLSLSLSRIFISNCSIRGTIPKEI-GNLINLRELGLWGNELIGSIP---ITFGKLQNLQGLDLVNNKLEGPIP--NGL  387 (832)
Q Consensus       314 ~~~~~~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~~--~~~  387 (832)
                      +.....+|+.|++++|.++ .+|..+ ..+++|++|++++|++.+..|   ..++.+++|++|+|++|++++..+  ..+
T Consensus       305 ~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  383 (549)
T 2z81_A          305 VYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEIL  383 (549)
T ss_dssp             HHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHG
T ss_pred             hhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhh
Confidence            0111124555555555554 333333 345566666666666555432   224555556666666665553221  235


Q ss_pred             cCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccce
Q 003301          388 CQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVI  467 (832)
Q Consensus       388 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  467 (832)
                      ..+++|++|++++|+++ .+|..+..+++|++|++++|++++                         +|..+  .++|++
T Consensus       384 ~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-------------------------l~~~~--~~~L~~  435 (549)
T 2z81_A          384 LTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-------------------------VKTCI--PQTLEV  435 (549)
T ss_dssp             GGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-------------------------CCTTS--CTTCSE
T ss_pred             hcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-------------------------ccchh--cCCceE
Confidence            55555555555555555 344455555555555555555443                         22222  135667


Q ss_pred             ecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcc
Q 003301          468 IDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKL  547 (832)
Q Consensus       468 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l  547 (832)
                      |+|++|++++.+    .++++|++|+|++|+|+ .+|. .+.+++|++|||++|++++.+|..+..+++|+.|++++|++
T Consensus       436 L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~  509 (549)
T 2z81_A          436 LDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW  509 (549)
T ss_dssp             EECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCB
T ss_pred             EECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCc
Confidence            777777776532    46777888888888887 5665 46678888888888888888888888888888888888888


Q ss_pred             cccCCC
Q 003301          548 EGEIPR  553 (832)
Q Consensus       548 ~~~~p~  553 (832)
                      .|.||.
T Consensus       510 ~~~~~~  515 (549)
T 2z81_A          510 DCSCPR  515 (549)
T ss_dssp             CCCHHH
T ss_pred             cCCCcc
Confidence            888874

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1e-52  Score=486.62  Aligned_cols=466  Identities=19%  Similarity=0.221  Sum_probs=281.7

Q ss_pred             CceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceeccc
Q 003301           96 LIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQ  175 (832)
Q Consensus        96 ~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~  175 (832)
                      +|++|++++|++++..|..|..+++|++|+|++|++++..|+.|+++++|++|+|++|++++..|..|+++++|++|+++
T Consensus        27 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls  106 (549)
T 2z81_A           27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLM  106 (549)
T ss_dssp             TCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECT
T ss_pred             CccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECC
Confidence            33444444444443333344444444444444444443333444444444444444444443333334444444444444


Q ss_pred             ccccccc-cCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCc
Q 003301          176 LNKLVGF-VPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFS  254 (832)
Q Consensus       176 ~N~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~  254 (832)
                      +|++++. .|..+.++++|++|++++|.+.+.+|.. .+..+++|++|++++|++++..|..+..+++|++|++++|.+.
T Consensus       107 ~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~  185 (549)
T 2z81_A          107 GNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI-DFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA  185 (549)
T ss_dssp             TCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTT-TTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST
T ss_pred             CCcccccchhhhhhccCCccEEECCCCccccccCHh-hhhcccccCeeeccCCcccccChhhhhccccCceEecccCccc
Confidence            4444331 2233444444444444444422222211 1233444444444444444444444444444444444444443


Q ss_pred             ccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcc----cccccccceEEeecCc
Q 003301          255 GFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSI----GNLSLSLSRIFISNCS  330 (832)
Q Consensus       255 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~----~~~~~~L~~L~l~~n~  330 (832)
                      ...+..+..+++|++|++++|++++.+...  ......+++|+.|++++|.+.+..+..+    ..+. +|+.+++++|.
T Consensus       186 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~--~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~-~L~~l~l~~~~  262 (549)
T 2z81_A          186 FLLEIFADILSSVRYLELRDTNLARFQFSP--LPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL-ELSEVEFDDCT  262 (549)
T ss_dssp             THHHHHHHSTTTBSEEEEESCBCTTCCCCC--CSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCT-TCCEEEEESCE
T ss_pred             ccchhhHhhcccccEEEccCCccccccccc--cchhhhhhcccceeccccccchhHHHHHHHHhhhhc-ccccccccccc
Confidence            222222233444444444444444321100  0011233444444444444433222111    1111 44555555554


Q ss_pred             cccc------ccccccCcCcccEEEeecCcccccc-----cccccCCCCCceEEccCCccCCCCchhh-cCCCCCcEEEe
Q 003301          331 IRGT------IPKEIGNLINLRELGLWGNELIGSI-----PITFGKLQNLQGLDLVNNKLEGPIPNGL-CQLARLSVLYM  398 (832)
Q Consensus       331 l~~~------~~~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L  398 (832)
                      +.+.      ....+..+++|+.|++.++.+....     +..+...++|+.|++++|+++ .+|..+ ..+++|++|++
T Consensus       263 ~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~L  341 (549)
T 2z81_A          263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDL  341 (549)
T ss_dssp             EECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEEC
T ss_pred             ccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEc
Confidence            4432      1234566778888998888765321     222344578999999999998 677666 57999999999


Q ss_pred             cCCcCCCCCc---ccCCCCCCCCeEeCCCCcCCCCCC--cccccCcccceeeecCCcccCCCccccccccccceecccCc
Q 003301          399 DGNKLSGPIP---PCIGDLTSLRLLSLASNELNSVIP--STFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRN  473 (832)
Q Consensus       399 ~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  473 (832)
                      ++|++++.+|   ..++.+++|+.|++++|++++..+  ..+..+++|++|++++|+++ .+|..++.+++|++|++++|
T Consensus       342 s~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N  420 (549)
T 2z81_A          342 SENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSST  420 (549)
T ss_dssp             CSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTS
T ss_pred             cCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCC
Confidence            9999987664   347889999999999999988654  56899999999999999999 57888999999999999999


Q ss_pred             ccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCCC
Q 003301          474 NLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPR  553 (832)
Q Consensus       474 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  553 (832)
                      ++++ +|..+.  ++|+.|+|++|++++.+    ..+++|++|+|++|+|+ .+|. ...+++|++|+|++|++++.+|.
T Consensus       421 ~l~~-l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~  491 (549)
T 2z81_A          421 GIRV-VKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDG  491 (549)
T ss_dssp             CCSC-CCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTT
T ss_pred             Cccc-ccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHH
Confidence            9984 444442  58999999999999743    57899999999999999 5676 46799999999999999998876


Q ss_pred             -CCCCCCcCCCcccCCCCCCCCcc
Q 003301          554 -GGPFANFSNRSFMGNDLLCGLAQ  576 (832)
Q Consensus       554 -~~~~~~~~~~~~~~n~~~c~~~~  576 (832)
                       ...+..+....+.+|++.|.++.
T Consensus       492 ~~~~l~~L~~L~l~~N~~~~~~~~  515 (549)
T 2z81_A          492 IFDRLTSLQKIWLHTNPWDCSCPR  515 (549)
T ss_dssp             GGGGCTTCCEEECCSSCBCCCHHH
T ss_pred             HHhcCcccCEEEecCCCccCCCcc
Confidence             35566777778899999998873

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.2e-52  Score=491.61  Aligned_cols=461  Identities=21%  Similarity=0.259  Sum_probs=253.0

Q ss_pred             cccCeEeccCCccccCCCccccccccCcEEEccCCcC------CC------CCCCcccCcccccccccccccccccCCCh
Q 003301           21 TMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFL------SG------TIPSTIFNLSSLSTGMDFSNNSLTGSLPD   88 (832)
Q Consensus        21 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l------~~------~~p~~l~~l~~l~~~L~ls~n~l~~~lp~   88 (832)
                      .+++.|+|++|.++|.+|++|+.+++|++|+|++|.+      .|      .+|...  +..+ + +++++|.+.+.+|.
T Consensus        81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l-~-l~l~~~~l~~~~~~  156 (636)
T 4eco_A           81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKM-R-MHYQKTFVDYDPRE  156 (636)
T ss_dssp             CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHH-H-THHHHHHTCCCGGG
T ss_pred             CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHH-H-hhHHHhhhccCchh
Confidence            3677888888888888888888888888888888866      22      344333  4444 5 77788877776666


Q ss_pred             hhhhcCCCceEEEccCCcccccCCCCccCCCCccEEEC--cCCcccccCCCCCcCCCcCceEEecccccccc--------
Q 003301           89 DMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISL--AYNQFTERIPRGLGNLTSLKTLYLGFNNLTGE--------  158 (832)
Q Consensus        89 ~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L--s~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~--------  158 (832)
                      .+...+..+..+++....+..      .....++.+.+  .+|++++ +|+.|+++++|++|+|++|++++.        
T Consensus       157 ~~~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~  229 (636)
T 4eco_A          157 DFSDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN  229 (636)
T ss_dssp             GSCHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSC
T ss_pred             hHHHHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccc
Confidence            554333334444444322221      00111222222  2455555 555555555555555555555543        


Q ss_pred             ---------cCcccc--CccccceecccccccccccCcccccCCcccEEEecCCC-CCC-CCCcccc----ccCCCCccE
Q 003301          159 ---------IPYEMG--NLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNA-LSG-SLPSSID----LVRLPNLEI  221 (832)
Q Consensus       159 ---------~p~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~p~~~~----~~~l~~L~~  221 (832)
                               +|..++  ++++|++|+|++|++.+.+|..|.++++|++|++++|+ +++ .+|..+.    +..+++|++
T Consensus       230 ~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~  309 (636)
T 4eco_A          230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI  309 (636)
T ss_dssp             TTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCE
T ss_pred             cccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCE
Confidence                     555555  66666666666666655566666666666666666665 554 4554331    112356666


Q ss_pred             EEccCCccccccCC--cccCCCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCC-CcE
Q 003301          222 ISLAGNNFSGIIPS--FIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKN-LKL  298 (832)
Q Consensus       222 L~Ls~n~i~~~~~~--~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~-L~~  298 (832)
                      |++++|+++ .+|.  .|..+++|++|++++|++++.+| .|..+++|++|++++|.++.+      +..+..+++ |++
T Consensus       310 L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~l------p~~l~~l~~~L~~  381 (636)
T 4eco_A          310 IYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEI------PANFCGFTEQVEN  381 (636)
T ss_dssp             EECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEEEC------CTTSEEECTTCCE
T ss_pred             EECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccccc------cHhhhhhcccCcE
Confidence            666666666 4455  56667777777777777776666 666777777777777776642      334566666 777


Q ss_pred             EeccCCCCCCCCCCcccccc-cccceEEeecCccccccccccc-------CcCcccEEEeecCcccccccccccCCCCCc
Q 003301          299 LDLSNNPINGVLPSSIGNLS-LSLSRIFISNCSIRGTIPKEIG-------NLINLRELGLWGNELIGSIPITFGKLQNLQ  370 (832)
Q Consensus       299 L~L~~N~l~~~~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  370 (832)
                      |++++|+++ .+|..+.... .+|++|++++|.+++..|..+.       .+++|++|+|++|++++..+..+..+++|+
T Consensus       382 L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~  460 (636)
T 4eco_A          382 LSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLS  460 (636)
T ss_dssp             EECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCS
T ss_pred             EEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCC
Confidence            777777766 4454443321 1344444444444444444444       444555555555555533333344455555


Q ss_pred             eEEccCCccCCCCchh-hcCC-------CCCcEEEecCCcCCCCCcccCC--CCCCCCeEeCCCCcCCCCCCcccccCcc
Q 003301          371 GLDLVNNKLEGPIPNG-LCQL-------ARLSVLYMDGNKLSGPIPPCIG--DLTSLRLLSLASNELNSVIPSTFWNLKD  440 (832)
Q Consensus       371 ~L~Ls~N~l~~~~~~~-~~~l-------~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~  440 (832)
                      +|+|++|+++ .+|.. +...       ++|++|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++
T Consensus       461 ~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~  537 (636)
T 4eco_A          461 SINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSST  537 (636)
T ss_dssp             EEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSS
T ss_pred             EEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCC
Confidence            5555555555 33322 2111       14444444444444 3333333  44444444444444444 3444444444


Q ss_pred             cceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCC
Q 003301          441 ILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSN  520 (832)
Q Consensus       441 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  520 (832)
                      |+.|+|++|+                  ++++|++.+.+|..|+++++|+.|+|++|++ +.+|..+.  ++|+.|||++
T Consensus       538 L~~L~Ls~N~------------------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~  596 (636)
T 4eco_A          538 LKGFGIRNQR------------------DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKD  596 (636)
T ss_dssp             CCEEECCSCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCS
T ss_pred             CCEEECCCCc------------------ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcC
Confidence            4444444443                  2355666666666666666666666666666 35555544  5666666666


Q ss_pred             Ccccc
Q 003301          521 NSLSG  525 (832)
Q Consensus       521 N~l~~  525 (832)
                      |++..
T Consensus       597 N~l~~  601 (636)
T 4eco_A          597 NPNIS  601 (636)
T ss_dssp             CTTCE
T ss_pred             CCCcc
Confidence            65543

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.2e-51  Score=483.21  Aligned_cols=440  Identities=18%  Similarity=0.253  Sum_probs=369.6

Q ss_pred             CCceEEEccCCcccccCCCCccCCCCccEEECcCCccc------c------cCCCCCcCCCcCceEEecccccccccCcc
Q 003301           95 PLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFT------E------RIPRGLGNLTSLKTLYLGFNNLTGEIPYE  162 (832)
Q Consensus        95 ~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~------~------~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~  162 (832)
                      .+++.|+|++|.++|.+|..++++++|++|+|++|.+.      +      .+|...  +..|+ +++++|.+.+.+|..
T Consensus        81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~  157 (636)
T 4eco_A           81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED  157 (636)
T ss_dssp             CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred             CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence            35777777777777777777777777777777777652      1      122222  44566 777777777666665


Q ss_pred             ccCc-c------------------ccceeccc--ccccccccCcccccCCcccEEEecCCCCCCC---------------
Q 003301          163 MGNL-R------------------NLEILGLQ--LNKLVGFVPTSIFNLSAMKTLALPSNALSGS---------------  206 (832)
Q Consensus       163 ~~~l-~------------------~L~~L~L~--~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~---------------  206 (832)
                      +..+ .                  .++.+.+.  .|++++ +|.+++++++|++|+|++|.+++.               
T Consensus       158 ~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~  236 (636)
T 4eco_A          158 FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQ  236 (636)
T ss_dssp             SCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHH
T ss_pred             HHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhc
Confidence            5521 1                  23333332  689998 899999999999999999999975               


Q ss_pred             --CCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCc-Ccc-cCCccccCc------cccceeeccccc
Q 003301          207 --LPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENS-FSG-FIPNTLGNL------RKLEWLRLSYNF  276 (832)
Q Consensus       207 --~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~-i~~-~~~~~~~~l------~~L~~L~L~~N~  276 (832)
                        +|..+.+..+++|++|+|++|++.+.+|..|.++++|++|++++|+ +++ .+|..+..+      ++|++|++++|+
T Consensus       237 ~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~  316 (636)
T 4eco_A          237 QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNN  316 (636)
T ss_dssp             HHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSC
T ss_pred             ccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCc
Confidence              8887754589999999999999999999999999999999999998 998 788888877      999999999999


Q ss_pred             CCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCc-ccEEEeecCcc
Q 003301          277 LTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLIN-LRELGLWGNEL  355 (832)
Q Consensus       277 l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~L~~N~l  355 (832)
                      ++.++..    ..+..+++|++|++++|++.|.+| .+..+. +|++|++++|+++ .+|..+..+++ |++|++++|++
T Consensus       317 l~~ip~~----~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~-~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l  389 (636)
T 4eco_A          317 LKTFPVE----TSLQKMKKLGMLECLYNQLEGKLP-AFGSEI-KLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKL  389 (636)
T ss_dssp             CSSCCCH----HHHTTCTTCCEEECCSCCCEEECC-CCEEEE-EESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCC
T ss_pred             CCccCch----hhhccCCCCCEEeCcCCcCccchh-hhCCCC-CCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcC
Confidence            9864430    057899999999999999998888 888777 9999999999999 78888999999 99999999999


Q ss_pred             cccccccccCCC--CCceEEccCCccCCCCchhhc-------CCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCc
Q 003301          356 IGSIPITFGKLQ--NLQGLDLVNNKLEGPIPNGLC-------QLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNE  426 (832)
Q Consensus       356 ~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  426 (832)
                      + .+|..+..++  +|++|++++|++++.+|..+.       .+++|++|++++|++++..+..+..+++|+.|+|++|+
T Consensus       390 ~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~  468 (636)
T 4eco_A          390 K-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNM  468 (636)
T ss_dssp             S-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSC
T ss_pred             c-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCC
Confidence            9 6788887755  899999999999999998888       78899999999999996555557779999999999999


Q ss_pred             CCCCCCcccccCc-------ccceeeecCCcccCCCccccc--cccccceecccCcccCCccCCccccccccceeec---
Q 003301          427 LNSVIPSTFWNLK-------DILSLNFSSNFLNGSLPEDIG--NLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSL---  494 (832)
Q Consensus       427 l~~~~~~~~~~l~-------~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L---  494 (832)
                      ++.+.+..+....       +|++|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+.++++|+.|+|   
T Consensus       469 l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N  546 (636)
T 4eco_A          469 LTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ  546 (636)
T ss_dssp             CSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSC
T ss_pred             CCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCC
Confidence            9966655665443       9999999999999 6788887  99999999999999997 8999999999999999   


Q ss_pred             ---ccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccC
Q 003301          495 ---RDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEI  551 (832)
Q Consensus       495 ---s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~  551 (832)
                         ++|++.+.+|..++.+++|+.|+|++|++ +.+|..+.  ++|+.|+|++|++.+.-
T Consensus       547 ~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~~~  603 (636)
T 4eco_A          547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNISID  603 (636)
T ss_dssp             BCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCEEE
T ss_pred             cccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCcccc
Confidence               56888999999999999999999999999 57888766  79999999999988643

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=4.5e-50  Score=473.30  Aligned_cols=528  Identities=20%  Similarity=0.177  Sum_probs=383.7

Q ss_pred             CCCcceeccCccccCccccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCccccccccccccccccc
Q 003301            5 SFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTG   84 (832)
Q Consensus         5 ~~n~~~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~   84 (832)
                      ++.+++ .+|+.+-  +.+++||||+|+|++..|.+|..+++|++|+|++|++++..|..+..+++| ++|+|++|+|+ 
T Consensus        39 ~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L-~~L~Ls~N~l~-  113 (635)
T 4g8a_A           39 MELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL-STLILTGNPIQ-  113 (635)
T ss_dssp             TTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTC-CEEECTTCCCC-
T ss_pred             CCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCC-CEEEccCCcCC-
Confidence            344555 5666552  466777777777775555677777777777777777774444556777777 77777777777 


Q ss_pred             CCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCccccc-CCCCCcCCCcCceEEecccccccccCccc
Q 003301           85 SLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTER-IPRGLGNLTSLKTLYLGFNNLTGEIPYEM  163 (832)
Q Consensus        85 ~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~-~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~  163 (832)
                      .+|...|.++++|++|+|++|++++..+..|+++++|++|+|++|++++. .|..++.+++|++|+|++|+|++..|..|
T Consensus       114 ~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l  193 (635)
T 4g8a_A          114 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL  193 (635)
T ss_dssp             EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred             CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccc
Confidence            67776666777777777777777765556677777777777777777643 46667777777777777777776666677


Q ss_pred             cCccccc----eecccccccccccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCc------ccccc
Q 003301          164 GNLRNLE----ILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNN------FSGII  233 (832)
Q Consensus       164 ~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~------i~~~~  233 (832)
                      ..+++++    .++++.|.+..+.+..+ ....++.+++.+|.....++.. .+..+..++...+..+.      +....
T Consensus       194 ~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~-~~~~l~~l~~~~l~~~~~~~~~~l~~~~  271 (635)
T 4g8a_A          194 RVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKT-CIQGLAGLEVHRLVLGEFRNEGNLEKFD  271 (635)
T ss_dssp             HHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHH-HHHTTTTCEEEEEEEECCTTSCCCSCCC
T ss_pred             cchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccch-hhcCCccccccccccccccccccccccc
Confidence            6665544    46677777775444433 3445667777777654222221 13455566655554332      22333


Q ss_pred             CCcccCCCCccEEEcCCCcCcc---cCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCC
Q 003301          234 PSFIFNASKLSVLELGENSFSG---FIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVL  310 (832)
Q Consensus       234 ~~~~~~l~~L~~L~L~~N~i~~---~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~  310 (832)
                      ...+.....+...++..+....   ..+..+..+.+++.+++.+|.+..+.       .+....+|+.|++++|.+.+..
T Consensus       272 ~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~-------~~~~~~~L~~L~l~~~~~~~~~  344 (635)
T 4g8a_A          272 KSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK-------DFSYNFGWQHLELVNCKFGQFP  344 (635)
T ss_dssp             TTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG-------GGGSCCCCSEEEEESCEESSCC
T ss_pred             ccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc-------ccccchhhhhhhcccccccCcC
Confidence            4444555556665555443322   23445666778888888888776532       3456678888999988887554


Q ss_pred             CCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccc--cccccccCCCCCceEEccCCccCCCCchhhc
Q 003301          311 PSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIG--SIPITFGKLQNLQGLDLVNNKLEGPIPNGLC  388 (832)
Q Consensus       311 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  388 (832)
                      +..+    ..|+.+++..|.+...  .....+++|+.|++++|.+..  ..+..+..+.+|+.|+++.|.+. ..+..+.
T Consensus       345 ~~~l----~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~  417 (635)
T 4g8a_A          345 TLKL----KSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFL  417 (635)
T ss_dssp             CCBC----TTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCT
T ss_pred             cccc----hhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-ccccccc
Confidence            4322    2688888888887643  334578889999999998753  34556677888999999999887 4566778


Q ss_pred             CCCCCcEEEecCCcCCCCCc-ccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcc-cCCCccccccccccc
Q 003301          389 QLARLSVLYMDGNKLSGPIP-PCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFL-NGSLPEDIGNLKVVV  466 (832)
Q Consensus       389 ~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l-~~~~~~~~~~l~~L~  466 (832)
                      .+++|+.+++++|......+ ..|..+++++.++++.|.+.+..+..+..++.|+.|++++|++ .+..|..|..+++|+
T Consensus       418 ~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~  497 (635)
T 4g8a_A          418 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT  497 (635)
T ss_dssp             TCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCC
T ss_pred             ccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccC
Confidence            88899999998887765544 4678889999999999999988888899999999999999874 445778889999999


Q ss_pred             eecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhh-ccCCeeeCCCC
Q 003301          467 IIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKL-LYLKDLNLSFN  545 (832)
Q Consensus       467 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~l~l~~N  545 (832)
                      +|||++|++++..|.+|.++++|++|+|++|+|++..|..|+.+++|++|||++|+|++..|..+..+ ++|++|+|++|
T Consensus       498 ~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~N  577 (635)
T 4g8a_A          498 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN  577 (635)
T ss_dssp             EEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTC
T ss_pred             EEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCC
Confidence            99999999998888999999999999999999998888889999999999999999999999888887 68999999999


Q ss_pred             cccccCCC
Q 003301          546 KLEGEIPR  553 (832)
Q Consensus       546 ~l~~~~p~  553 (832)
                      +|.|.|.-
T Consensus       578 p~~C~C~~  585 (635)
T 4g8a_A          578 DFACTCEH  585 (635)
T ss_dssp             CBCCSGGG
T ss_pred             CCcccCCc
Confidence            99988763

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.3e-51  Score=471.81  Aligned_cols=456  Identities=21%  Similarity=0.236  Sum_probs=318.1

Q ss_pred             cEEEccCCcCCCCCCCcccCcccccccccccccccccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECc
Q 003301           48 ELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLA  127 (832)
Q Consensus        48 ~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls  127 (832)
                      ++|++++|+++ .+|..+.  +++ ++||+++|.++ .++...+.++++|++|++++|++++..|+.|..+++|++|+|+
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L-~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls   77 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKT-TILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLS   77 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTC-SEEECCSSCCC-CCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECC
T ss_pred             ceEecCCCCcc-ccccccc--ccc-cEEECCCCccc-ccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecC
Confidence            46777777777 5666555  455 66777777776 4554444467777777777777776656666677777777777


Q ss_pred             CCcccccCCCCCcCCCcCceEEeccccccc-ccCccccCccccceecccccccccccCcccccCCcc--cEEEecCCCC-
Q 003301          128 YNQFTERIPRGLGNLTSLKTLYLGFNNLTG-EIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAM--KTLALPSNAL-  203 (832)
Q Consensus       128 ~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~n~l-  203 (832)
                      +|+|++ +|..  .+++|++|+|++|++++ .+|..|+++++|++|++++|++++   ..+..+++|  ++|++++|.+ 
T Consensus        78 ~N~l~~-lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~  151 (520)
T 2z7x_B           78 HNKLVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETY  151 (520)
T ss_dssp             SSCCCE-EECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTT
T ss_pred             CCceee-cCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccc
Confidence            777663 4444  56667777777776664 345666666666666666666654   334555555  6666666665 


Q ss_pred             -CCCCCccccccCCCCccEEEccCCccccccCCcccCCC-CccEEEcCCCcCcccCC-ccccCccccceeeccccc----
Q 003301          204 -SGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNAS-KLSVLELGENSFSGFIP-NTLGNLRKLEWLRLSYNF----  276 (832)
Q Consensus       204 -~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~----  276 (832)
                       .+..|.                          .+..+. +...+++++|.+.+..+ ..+..+++|+.|++++|.    
T Consensus       152 ~~~~~~~--------------------------~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~  205 (520)
T 2z7x_B          152 GEKEDPE--------------------------GLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNK  205 (520)
T ss_dssp             TSSCCTT--------------------------TTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTT
T ss_pred             ccccccc--------------------------cccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccc
Confidence             444443                          333332 23344555555544332 345556666666666664    


Q ss_pred             ---CCCCCCccccccccccCCCCcEEeccCCCCCCCCCCccccc--ccccceEEeecCcccccccccc-----cCcCccc
Q 003301          277 ---LTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNL--SLSLSRIFISNCSIRGTIPKEI-----GNLINLR  346 (832)
Q Consensus       277 ---l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~--~~~L~~L~l~~n~l~~~~~~~~-----~~l~~L~  346 (832)
                         +.+      .++.+..+++|+.|++++|.+.+..+..+...  ..+|++|++++|++++.+|..+     ..+++|+
T Consensus       206 ~~~~~~------~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~  279 (520)
T 2z7x_B          206 CSYFLS------ILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALS  279 (520)
T ss_dssp             THHHHH------HHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEE
T ss_pred             cceeec------chhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeE
Confidence               221      12245666677777776666553322111110  1267778888888877777777     8888899


Q ss_pred             EEEeecCccccccc-ccccCC---CCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeC
Q 003301          347 ELGLWGNELIGSIP-ITFGKL---QNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSL  422 (832)
Q Consensus       347 ~L~L~~N~l~~~~~-~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  422 (832)
                      .+++++|.+  .+| ..+..+   .+|+.|++++|.+....  .+..+++|++|++++|++++.+|..++.+++|+.|++
T Consensus       280 ~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  355 (520)
T 2z7x_B          280 IHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLIL  355 (520)
T ss_dssp             EEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEEC
T ss_pred             eccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEc
Confidence            999999888  334 444444   67899999999887432  1257788999999999999888888999999999999


Q ss_pred             CCCcCCC--CCCcccccCcccceeeecCCcccCCCcc-ccccccccceecccCcccCCccCCccccccccceeecccccc
Q 003301          423 ASNELNS--VIPSTFWNLKDILSLNFSSNFLNGSLPE-DIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGL  499 (832)
Q Consensus       423 ~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  499 (832)
                      ++|++++  ..|..|..+++|++|++++|++++.+|. .+..+++|+.|++++|++++..|..+.  ++|+.|+|++|++
T Consensus       356 ~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l  433 (520)
T 2z7x_B          356 QMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKI  433 (520)
T ss_dssp             CSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCC
T ss_pred             cCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCcc
Confidence            9999987  4557788899999999999999874554 488889999999999999887777665  7899999999999


Q ss_pred             cccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCCC
Q 003301          500 QGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPR  553 (832)
Q Consensus       500 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  553 (832)
                      + .+|..+..+++|+.|+|++|++++..+..+..+++|++|++++|+++|.|+.
T Consensus       434 ~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~  486 (520)
T 2z7x_B          434 K-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  486 (520)
T ss_dssp             C-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             c-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCc
Confidence            8 7888888999999999999999954434488899999999999999998874

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=3.8e-50  Score=477.05  Aligned_cols=472  Identities=21%  Similarity=0.211  Sum_probs=298.4

Q ss_pred             cccCeEeccCCccccCCCccccccccCcEEEc-cCCcCCCCCCCcccCc----ccc-ccc---------ccc-ccccccc
Q 003301           21 TMLKKLGLGYNKLRGEIPQELGNLAELELVSL-TNNFLSGTIPSTIFNL----SSL-STG---------MDF-SNNSLTG   84 (832)
Q Consensus        21 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l-~~n~l~~~~p~~l~~l----~~l-~~~---------L~l-s~n~l~~   84 (832)
                      .++..|+|++|.+.|.+|+.|+.|++|++|+| ++|.+.|..|-.....    +.. +..         ++. ....+.+
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            56888899999998888888999999999999 8888877644321111    000 000         000 0000000


Q ss_pred             CCChhhh----------hcCCCceEEEccC--CcccccCCCCccCCCCccEEECcCCcccc-----------------cC
Q 003301           85 SLPDDMC----------RRLPLIKGLYMSN--NKLTGPIPNNIWQCKELIVISLAYNQFTE-----------------RI  135 (832)
Q Consensus        85 ~lp~~~~----------~~l~~L~~L~l~~--N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~-----------------~~  135 (832)
                      .++..+.          .....++.+.+..  |++++ +|..|+++++|++|+|++|++++                 .+
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i  481 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE  481 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence            0000000          1222334444443  78886 78888888888888888888886                 36


Q ss_pred             CCCCc--CCCcCceEEecccccccccCccccCccccceecccccc-ccc-ccCcccccCC-------cccEEEecCCCCC
Q 003301          136 PRGLG--NLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNK-LVG-FVPTSIFNLS-------AMKTLALPSNALS  204 (832)
Q Consensus       136 p~~~~--~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~~~~~~~l~-------~L~~L~L~~n~l~  204 (832)
                      |+.++  ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..+.+++       +|++|+|++|.+.
T Consensus       482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~  561 (876)
T 4ecn_A          482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE  561 (876)
T ss_dssp             TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred             ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence            77666  77777777777777776777777777777777777776 665 5665555444       5666666666655


Q ss_pred             CCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCccc-cceeecccccCCCCCCc
Q 003301          205 GSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRK-LEWLRLSYNFLTSSTSE  283 (832)
Q Consensus       205 ~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~-L~~L~L~~N~l~~~~~~  283 (832)
                       .+|..-.+..+++|++|+|++|+++ .+| .|..+++|++|+|++|+++ .+|..+..+++ |++|+|++|.++.++. 
T Consensus       562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~lp~-  636 (876)
T 4ecn_A          562 -EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPN-  636 (876)
T ss_dssp             -BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSCCS-
T ss_pred             -ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcCch-
Confidence             4554111245555555555555555 333 4555555555555555555 44444555555 5555555555543322 


Q ss_pred             cccccccccC--CCCcEEeccCCCCCCCCCCcccccccccceEEeecCccccccccccc--CcCcccEEEeecCcccccc
Q 003301          284 LSFLSSWANC--KNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIG--NLINLRELGLWGNELIGSI  359 (832)
Q Consensus       284 ~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~  359 (832)
                           .+..+  ++|+.|++++|++.+.+|...                      ..+.  .+++|+.|+|++|++....
T Consensus       637 -----~~~~~~~~~L~~L~Ls~N~l~g~ip~l~----------------------~~l~~~~~~~L~~L~Ls~N~L~~lp  689 (876)
T 4ecn_A          637 -----IFNAKSVYVMGSVDFSYNKIGSEGRNIS----------------------CSMDDYKGINASTVTLSYNEIQKFP  689 (876)
T ss_dssp             -----CCCTTCSSCEEEEECCSSCTTTTSSSCS----------------------SCTTTCCCCCEEEEECCSSCCCSCC
T ss_pred             -----hhhccccCCCCEEECcCCcCCCccccch----------------------hhhccccCCCcCEEEccCCcCCccC
Confidence                 12222  224555555554443332211                      1111  2346777777777777444


Q ss_pred             cccccCCCCCceEEccCCccCCCCchhhcCC--------CCCcEEEecCCcCCCCCcccCC--CCCCCCeEeCCCCcCCC
Q 003301          360 PITFGKLQNLQGLDLVNNKLEGPIPNGLCQL--------ARLSVLYMDGNKLSGPIPPCIG--DLTSLRLLSLASNELNS  429 (832)
Q Consensus       360 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l--------~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~  429 (832)
                      +..+..+++|+.|+|++|+|+ .+|..+...        ++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++
T Consensus       690 ~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~  767 (876)
T 4ecn_A          690 TELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS  767 (876)
T ss_dssp             HHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS
T ss_pred             HHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc
Confidence            444556777777777777777 455443332        26777777777777 5666665  77777777777777776


Q ss_pred             CCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccC
Q 003301          430 VIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGG  509 (832)
Q Consensus       430 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  509 (832)
                       +|..+..+++|+.|+|++|+                  ++++|++.+.+|..|.++++|+.|+|++|++ +.+|..+. 
T Consensus       768 -lp~~l~~L~~L~~L~Ls~N~------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~-  826 (876)
T 4ecn_A          768 -FPTQPLNSSQLKAFGIRHQR------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT-  826 (876)
T ss_dssp             -CCCGGGGCTTCCEEECCCCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC-
T ss_pred             -cchhhhcCCCCCEEECCCCC------------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc-
Confidence             56666677777777777775                  5677899999999999999999999999999 58888876 


Q ss_pred             CCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccc
Q 003301          510 LVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEG  549 (832)
Q Consensus       510 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~  549 (832)
                       ++|+.|||++|++....+..+.....+..+.|.+|++..
T Consensus       827 -~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~  865 (876)
T 4ecn_A          827 -PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD  865 (876)
T ss_dssp             -SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSE
T ss_pred             -CCCCEEECCCCCCCccChHHccccccchheeecCCCccc
Confidence             699999999999998888888887788888888887764

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.4e-50  Score=459.73  Aligned_cols=457  Identities=22%  Similarity=0.266  Sum_probs=342.2

Q ss_pred             CeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCcccccccccccccccccCCChhhhhcCCCceEEEcc
Q 003301           24 KKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMS  103 (832)
Q Consensus        24 ~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~  103 (832)
                      ++||+++|+++ .+|..+.  ++|++|+|++|.+++..|..+..+++| ++|++++|++++..|..+ .++++|++|+|+
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L-~~L~Ls~n~l~~~~~~~~-~~l~~L~~L~Ls   77 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKL-RILIISHNRIQYLDISVF-KFNQELEYLDLS   77 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTC-CEEECCSSCCCEEEGGGG-TTCTTCCEEECC
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccc-cEEecCCCccCCcChHHh-hcccCCCEEecC
Confidence            58999999999 7888776  899999999999996666789999999 999999999995445554 599999999999


Q ss_pred             CCcccccCCCCccCCCCccEEECcCCcccc-cCCCCCcCCCcCceEEecccccccccCccccCcccc--ceeccccccc-
Q 003301          104 NNKLTGPIPNNIWQCKELIVISLAYNQFTE-RIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNL--EILGLQLNKL-  179 (832)
Q Consensus       104 ~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~-~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L--~~L~L~~N~l-  179 (832)
                      +|+++ .+|..  .+++|++|+|++|++++ .+|..|+++++|++|++++|++++   ..+..+++|  ++|++++|++ 
T Consensus        78 ~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~  151 (520)
T 2z7x_B           78 HNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETY  151 (520)
T ss_dssp             SSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTT
T ss_pred             CCcee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccc
Confidence            99999 56766  89999999999999987 478999999999999999999985   467788888  9999999999 


Q ss_pred             -ccccCcccccCC-cccEEEecCCCCCCCCCccccccCCCCccEEEccCCc-------cccccCCcccCCCCccEEEcCC
Q 003301          180 -VGFVPTSIFNLS-AMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNN-------FSGIIPSFIFNASKLSVLELGE  250 (832)
Q Consensus       180 -~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~-------i~~~~~~~~~~l~~L~~L~L~~  250 (832)
                       .+..|..+..+. +...+++++|.+.+.++... +..+++|+.|++++|.       +.+.++ .+..+++|++|++++
T Consensus       152 ~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~-~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~  229 (520)
T 2z7x_B          152 GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVS-VKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNN  229 (520)
T ss_dssp             TSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCC-CTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEE
T ss_pred             ccccccccccccccceEEEEeccCcchhhhhhhh-hhcccceeeccccccccccccceeecchh-hhccccchhhccccc
Confidence             778888887766 34467788888876665433 4566777777777765       444444 455556666666665


Q ss_pred             CcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcc-----cccccccceEE
Q 003301          251 NSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSI-----GNLSLSLSRIF  325 (832)
Q Consensus       251 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~~~~~L~~L~  325 (832)
                      |.+++..+..+.                         .. ..+++|++|++++|++.+.+|..+     ..+. +|+.++
T Consensus       230 ~~l~~~~~~~~~-------------------------~~-~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~-~L~~l~  282 (520)
T 2z7x_B          230 IETTWNSFIRIL-------------------------QL-VWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLK-ALSIHQ  282 (520)
T ss_dssp             EEEEHHHHHHHH-------------------------HH-HHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCC-EEEEEE
T ss_pred             cccCHHHHHHHH-------------------------HH-hhhCcccEEEeecccccCccccchhhcccccCc-eeEecc
Confidence            555432211111                         00 012344555555555444444444     3333 555555


Q ss_pred             eecCccccccc-ccccCc---CcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCC
Q 003301          326 ISNCSIRGTIP-KEIGNL---INLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGN  401 (832)
Q Consensus       326 l~~n~l~~~~~-~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  401 (832)
                      +++|.+  .+| ..+..+   ++|+.|++++|.+.+..  .+..+++|++|++++|++++..|..+..+++|++|++++|
T Consensus       283 l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N  358 (520)
T 2z7x_B          283 VVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMN  358 (520)
T ss_dssp             EEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSS
T ss_pred             ccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCC
Confidence            555555  233 333333   45777777777765322  1256777888888888887777777777888888888888


Q ss_pred             cCCC--CCcccCCCCCCCCeEeCCCCcCCC-CCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCc
Q 003301          402 KLSG--PIPPCIGDLTSLRLLSLASNELNS-VIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGD  478 (832)
Q Consensus       402 ~l~~--~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  478 (832)
                      ++++  .+|..++.+++|++|++++|.+++ +.+..|..+++|++|++++|++++..|..+.  ++|+.|+|++|+++ .
T Consensus       359 ~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~  435 (520)
T 2z7x_B          359 QLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-S  435 (520)
T ss_dssp             CCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-C
T ss_pred             ccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-c
Confidence            8875  445667888888888888888887 4444577888888888888888877776664  78999999999998 7


Q ss_pred             cCCccccccccceeecccccccccCCcc-ccCCCCCCeeccCCCcccccCc
Q 003301          479 IPTAIGGLMNLQDLSLRDNGLQGSIPKS-IGGLVSLESLDLSNNSLSGNIP  528 (832)
Q Consensus       479 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p  528 (832)
                      +|..+.++++|+.|+|++|++++ +|.. |..+++|+.|+|++|++++..+
T Consensus       436 ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          436 IPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             CCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             cchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCcccCC
Confidence            88888899999999999999995 5554 9999999999999999998665

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1.4e-49  Score=472.26  Aligned_cols=429  Identities=19%  Similarity=0.238  Sum_probs=329.1

Q ss_pred             ccCCCCcceeccCccccCccccCeEec-cCCccccCCCcccc--------------------------------------
Q 003301            2 LSLSFNDLSGAIPKEIGNLTMLKKLGL-GYNKLRGEIPQELG--------------------------------------   42 (832)
Q Consensus         2 ldl~~n~~~~~~~~~~~~l~~L~~L~l-s~n~l~~~~p~~~~--------------------------------------   42 (832)
                      |||++|.++|.+|+++++|++|++|+| ++|.++|..|-...                                      
T Consensus       328 L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~  407 (876)
T 4ecn_A          328 LSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDA  407 (876)
T ss_dssp             EECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHH
T ss_pred             EECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHH
Confidence            799999999999999999999999999 89988776432211                                      


Q ss_pred             -------------ccccCcEEEcc--CCcCCCCCCCcccCccccccccccccccccc-----------------CCChhh
Q 003301           43 -------------NLAELELVSLT--NNFLSGTIPSTIFNLSSLSTGMDFSNNSLTG-----------------SLPDDM   90 (832)
Q Consensus        43 -------------~l~~L~~L~l~--~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~-----------------~lp~~~   90 (832)
                                   ....++.+.+.  +|.+++ +|+.++++++| ++|+|++|.++|                 .+|..+
T Consensus       408 l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L-~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l  485 (876)
T 4ecn_A          408 INRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKL-QIIYFANSPFTYDNIAVDWEDANSDYAKQYENEEL  485 (876)
T ss_dssp             HHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTC-CEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCC
T ss_pred             hhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCC-CEEECcCCcCCCCcccccccccccccccccCChhh
Confidence                         11123333333  378886 89889999998 999999999997                 388876


Q ss_pred             -hhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCc-ccc-cCCCCCcCCC-------cCceEEecccccccccC
Q 003301           91 -CRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQ-FTE-RIPRGLGNLT-------SLKTLYLGFNNLTGEIP  160 (832)
Q Consensus        91 -~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~-i~~-~~p~~~~~l~-------~L~~L~Ls~N~i~~~~p  160 (832)
                       |.++++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..++.++       +|++|+|++|+++ .+|
T Consensus       486 ~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip  564 (876)
T 4ecn_A          486 SWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFP  564 (876)
T ss_dssp             CGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCC
T ss_pred             hhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccC
Confidence             5589999999999999998999999999999999999998 887 6787666555       9999999999999 788


Q ss_pred             c--cccCccccceecccccccccccCcccccCCcccEEEecCCCCCCCCCccccccCCCC-ccEEEccCCccccccCCcc
Q 003301          161 Y--EMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPN-LEIISLAGNNFSGIIPSFI  237 (832)
Q Consensus       161 ~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~-L~~L~Ls~n~i~~~~~~~~  237 (832)
                      .  .|+++++|+.|+|++|+++ .+| .|.++++|++|+|++|.+. .+|..+  ..+++ |++|+|++|+++ .+|..+
T Consensus       565 ~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l--~~l~~~L~~L~Ls~N~L~-~lp~~~  638 (876)
T 4ecn_A          565 ASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDF--CAFTDQVEGLGFSHNKLK-YIPNIF  638 (876)
T ss_dssp             CHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTS--CEECTTCCEEECCSSCCC-SCCSCC
T ss_pred             ChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHH--hhccccCCEEECcCCCCC-cCchhh
Confidence            8  8999999999999999998 567 8999999999999999998 777654  67888 999999999998 567777


Q ss_pred             cCCCC--ccEEEcCCCcCcccCCccc---c--CccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCC
Q 003301          238 FNASK--LSVLELGENSFSGFIPNTL---G--NLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVL  310 (832)
Q Consensus       238 ~~l~~--L~~L~L~~N~i~~~~~~~~---~--~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~  310 (832)
                      ..++.  |+.|+|++|++++.+|...   .  .+++|++|+|++|.++.++..+     +..+++|+.|+|++|++. .+
T Consensus       639 ~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~-----~~~l~~L~~L~Ls~N~L~-~i  712 (876)
T 4ecn_A          639 NAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTEL-----FATGSPISTIILSNNLMT-SI  712 (876)
T ss_dssp             CTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHH-----HHTTCCCSEEECCSCCCS-CC
T ss_pred             hccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHH-----HccCCCCCEEECCCCcCC-cc
Confidence            76654  9999999999988766433   2  3458999999999998755432     457899999999999998 56


Q ss_pred             CCccccccc-------ccceEEeecCccccccccccc--CcCcccEEEeecCcccccccccccCCCCCceEEccCC----
Q 003301          311 PSSIGNLSL-------SLSRIFISNCSIRGTIPKEIG--NLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNN----  377 (832)
Q Consensus       311 ~~~~~~~~~-------~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N----  377 (832)
                      |..+.....       +|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|++|    
T Consensus       713 p~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls  790 (876)
T 4ecn_A          713 PENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAE  790 (876)
T ss_dssp             CTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTT
T ss_pred             ChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcc
Confidence            665544332       7999999999999 6788886  99999999999999997 6888899999999999874    


Q ss_pred             --ccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCc
Q 003301          378 --KLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNF  450 (832)
Q Consensus       378 --~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  450 (832)
                        ++.+.+|..+..+++|+.|+|++|++ +.+|..+.  ++|+.|+|++|++..+.+..|.....+..+.|++|+
T Consensus       791 ~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~  862 (876)
T 4ecn_A          791 GNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDK  862 (876)
T ss_dssp             CCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCT
T ss_pred             cccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCC
Confidence              44445555555555555555555555 34444433  345555555555544444444433333334444443

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=3.1e-48  Score=457.60  Aligned_cols=546  Identities=20%  Similarity=0.215  Sum_probs=426.5

Q ss_pred             ccCccccCccc---cCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCcccccccccccccccccCCCh
Q 003301           12 AIPKEIGNLTM---LKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPD   88 (832)
Q Consensus        12 ~~~~~~~~l~~---L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~   88 (832)
                      .+|++......   -...+-++.+++ .+|+.+.  +++++|||++|+|++..|..+..+++| ++|||++|+|+ .+|+
T Consensus        19 ~~p~~~~~c~~~~~~~~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L-~~L~Ls~N~i~-~i~~   93 (635)
T 4g8a_A           19 SIPESWEPCVEVVPNITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPEL-QVLDLSRCEIQ-TIED   93 (635)
T ss_dssp             ------CCSEEEETTTEEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTC-CEEECTTCCCC-EECT
T ss_pred             CCCCCCCCccccCCCCEEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCC-CEEECCCCcCC-CcCh
Confidence            35555443321   245677777787 7887653  478899999999985445678888888 88999999988 6777


Q ss_pred             hhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEeccccccc-ccCccccCcc
Q 003301           89 DMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTG-EIPYEMGNLR  167 (832)
Q Consensus        89 ~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~-~~p~~~~~l~  167 (832)
                      +.|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|+++++|++|+|++|.+++ ..|..++.++
T Consensus        94 ~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~  173 (635)
T 4g8a_A           94 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT  173 (635)
T ss_dssp             TTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCT
T ss_pred             hHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccch
Confidence            777788999999999999986666778889999999999999987777778889999999999998875 3577788889


Q ss_pred             ccceecccccccccccCcccccCCccc----EEEecCCCCCCCCCccccccCCCCccEEEccCCccc-cccCCcccCCCC
Q 003301          168 NLEILGLQLNKLVGFVPTSIFNLSAMK----TLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFS-GIIPSFIFNASK  242 (832)
Q Consensus       168 ~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~-~~~~~~~~~l~~  242 (832)
                      +|++|++++|++++..+..|..+.+++    .++++.|.+....+..+   ....++.+++++|... ...+..+..+..
T Consensus       174 ~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~---~~~~~~~l~l~~n~~~~~~~~~~~~~l~~  250 (635)
T 4g8a_A          174 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF---KEIRLHKLTLRNNFDSLNVMKTCIQGLAG  250 (635)
T ss_dssp             TCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT---TTCEEEEEEEESCCSSHHHHHHHHHTTTT
T ss_pred             hhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccc---cchhhhhhhhhcccccccccchhhcCCcc
Confidence            999999999998888787777665544    67888888874444332   4456778888888665 234455667777


Q ss_pred             ccEEEcCCC------cCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccc
Q 003301          243 LSVLELGEN------SFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGN  316 (832)
Q Consensus       243 L~~L~L~~N------~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  316 (832)
                      ++...+..+      .+.......+..+..+....+..+.......  .....+..+.+++.+++.+|.+....+  +..
T Consensus       251 l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~--~~~~~~~~~~~l~~l~~~~~~~~~~~~--~~~  326 (635)
T 4g8a_A          251 LEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLD--GIIDLFNCLTNVSSFSLVSVTIERVKD--FSY  326 (635)
T ss_dssp             CEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEE--ECTTTTGGGTTCSEEEEESCEEEECGG--GGS
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhhhhccccc--chhhhhhhhcccccccccccccccccc--ccc
Confidence            776665433      2333445556667777777777665543222  123446778899999999998764432  222


Q ss_pred             cccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCC--CCchhhcCCCCCc
Q 003301          317 LSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEG--PIPNGLCQLARLS  394 (832)
Q Consensus       317 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~  394 (832)
                      .. .++.|++.+|.+.+..+.   .+..|+.+++++|.+...  ..+..+++|+.|++++|.+..  ..+..+..+.+|+
T Consensus       327 ~~-~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~  400 (635)
T 4g8a_A          327 NF-GWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLK  400 (635)
T ss_dssp             CC-CCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCC
T ss_pred             ch-hhhhhhcccccccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhh
Confidence            33 799999999999865543   456789999999987643  345678999999999999853  4567788889999


Q ss_pred             EEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCC-CcccccCcccceeeecCCcccCCCccccccccccceecccCc
Q 003301          395 VLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVI-PSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRN  473 (832)
Q Consensus       395 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  473 (832)
                      +++++.|.+. ..+..+..+++|+.+++++|...... +..|..+.+++.++++.|.+.+..+..+..++.|+.|+|++|
T Consensus       401 ~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N  479 (635)
T 4g8a_A          401 YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN  479 (635)
T ss_dssp             EEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTC
T ss_pred             hhhccccccc-cccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhc
Confidence            9999999987 45667889999999999998876654 456899999999999999999999999999999999999999


Q ss_pred             cc-CCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCC
Q 003301          474 NL-SGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIP  552 (832)
Q Consensus       474 ~l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  552 (832)
                      ++ .+..|..|..+++|++|+|++|+|++.+|..|+++++|++|+|++|+|++..|..|..+++|++|+|++|++++.+|
T Consensus       480 ~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~  559 (635)
T 4g8a_A          480 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK  559 (635)
T ss_dssp             EEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCS
T ss_pred             ccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCH
Confidence            85 44688999999999999999999999999999999999999999999999999999999999999999999999888


Q ss_pred             CC-CCC-CCcCCCcccCCCCCCCCcc
Q 003301          553 RG-GPF-ANFSNRSFMGNDLLCGLAQ  576 (832)
Q Consensus       553 ~~-~~~-~~~~~~~~~~n~~~c~~~~  576 (832)
                      .. ..+ .++......+||+.|.|..
T Consensus       560 ~~l~~l~~~L~~L~L~~Np~~C~C~~  585 (635)
T 4g8a_A          560 QELQHFPSSLAFLNLTQNDFACTCEH  585 (635)
T ss_dssp             SCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred             HHHHhhhCcCCEEEeeCCCCcccCCc
Confidence            74 223 3455567899999998764

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=2.2e-48  Score=450.63  Aligned_cols=460  Identities=21%  Similarity=0.223  Sum_probs=302.2

Q ss_pred             ccccccccccccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecc
Q 003301           73 TGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGF  152 (832)
Q Consensus        73 ~~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~  152 (832)
                      +++|+++|+++ .+|..+.   ++|++|++++|++++..|..|..+++|++|+|++|+|++..|+.|.++++|++|+|++
T Consensus        34 ~~l~ls~~~L~-~ip~~~~---~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  109 (562)
T 3a79_B           34 SMVDYSNRNLT-HVPKDLP---PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH  109 (562)
T ss_dssp             CEEECTTSCCC-SCCTTSC---TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred             cEEEcCCCCCc-cCCCCCC---CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence            34444444444 3444332   4455555555555544444555555555555555555554455555555555555555


Q ss_pred             cccccccCccccCccccceecccccccccc-cCcccccCCcccEEEecCCCCCCCCCccccccCCCCc--cEEEccCCcc
Q 003301          153 NNLTGEIPYEMGNLRNLEILGLQLNKLVGF-VPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNL--EIISLAGNNF  229 (832)
Q Consensus       153 N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L--~~L~Ls~n~i  229 (832)
                      |+|+ .+|..  .+++|++|++++|++++. .|..|.++++|++|++++|.+.+.     ++..+++|  ++|++++|++
T Consensus       110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~-----~~~~l~~L~L~~L~L~~n~l  181 (562)
T 3a79_B          110 NRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL-----DLLPVAHLHLSCILLDLVSY  181 (562)
T ss_dssp             SCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT-----TTGGGTTSCEEEEEEEESSC
T ss_pred             CcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC-----chhhhhhceeeEEEeecccc
Confidence            5555 34433  455555555555555542 234555555555555555555421     12233333  6666666665


Q ss_pred             --ccccCCcccCCC-CccEEEcCCCcCcccCCc-cccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCC
Q 003301          230 --SGIIPSFIFNAS-KLSVLELGENSFSGFIPN-TLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNP  305 (832)
Q Consensus       230 --~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~  305 (832)
                        ++..|..+..+. ....+++++|.+.+..++ .+..+++|+.|++++|..... .-...+..+..+++|+.|+++++.
T Consensus       182 ~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~-~l~~~~~~l~~l~~L~~L~L~~~~  260 (562)
T 3a79_B          182 HIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQ-RLMTFLSELTRGPTLLNVTLQHIE  260 (562)
T ss_dssp             CCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHH-HHHHHHHHHHSCSSCEEEEEEEEE
T ss_pred             cccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccc-hHHHHHHHHhccCcceEEEecCCc
Confidence              555555555443 122456666766654433 355677777777777642100 000123346667777777777776


Q ss_pred             CCCCCCCcccc--cccccceEEeecCcccccccccc-----cCcCcccEEEeecCccccccc-ccccC---CCCCceEEc
Q 003301          306 INGVLPSSIGN--LSLSLSRIFISNCSIRGTIPKEI-----GNLINLRELGLWGNELIGSIP-ITFGK---LQNLQGLDL  374 (832)
Q Consensus       306 l~~~~~~~~~~--~~~~L~~L~l~~n~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~-~~~~~---l~~L~~L~L  374 (832)
                      +.+.....+..  ...+|++|++++|.+++.+|..+     ..++.|+.++++.|.+  .+| ..+..   ..+|++|++
T Consensus       261 l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l  338 (562)
T 3a79_B          261 TTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSI  338 (562)
T ss_dssp             ECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEE
T ss_pred             CcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEc
Confidence            65321111100  01278888888888887788776     7777788888887776  233 23322   257899999


Q ss_pred             cCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCC--CcccccCcccceeeecCCccc
Q 003301          375 VNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVI--PSTFWNLKDILSLNFSSNFLN  452 (832)
Q Consensus       375 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~  452 (832)
                      ++|.+....  ....+++|++|++++|++++.+|..++++++|+.|++++|+++++.  |..|.++++|++|++++|+++
T Consensus       339 ~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~  416 (562)
T 3a79_B          339 SDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLN  416 (562)
T ss_dssp             ESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCB
T ss_pred             cCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCC
Confidence            999886432  1257788999999999999888889999999999999999998754  467889999999999999999


Q ss_pred             CCCc-cccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchh-
Q 003301          453 GSLP-EDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTS-  530 (832)
Q Consensus       453 ~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-  530 (832)
                      +.+| ..+..+++|+.|+|++|++++..|..+.  ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++ +|.. 
T Consensus       417 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~  492 (562)
T 3a79_B          417 SHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGV  492 (562)
T ss_dssp             SCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTS
T ss_pred             CccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHH
Confidence            8444 4588899999999999999887777665  68999999999998 688777799999999999999995 5554 


Q ss_pred             hhhhccCCeeeCCCCcccccCCC
Q 003301          531 MEKLLYLKDLNLSFNKLEGEIPR  553 (832)
Q Consensus       531 ~~~l~~L~~l~l~~N~l~~~~p~  553 (832)
                      +..+++|+.|++++|+|+|.||.
T Consensus       493 ~~~l~~L~~L~l~~N~~~c~c~~  515 (562)
T 3a79_B          493 FDRLTSLQYIWLHDNPWDCTCPG  515 (562)
T ss_dssp             TTTCTTCCCEECCSCCBCCCHHH
T ss_pred             HhcCCCCCEEEecCCCcCCCcch
Confidence            88999999999999999998875

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=7.8e-47  Score=437.65  Aligned_cols=458  Identities=21%  Similarity=0.269  Sum_probs=319.1

Q ss_pred             cEEEccCCcCCCCCCCcccCcccccccccccccccccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECc
Q 003301           48 ELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLA  127 (832)
Q Consensus        48 ~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls  127 (832)
                      +++++++|+++ .+|..+.  +++ ++||+++|.++ .+|...+.++++|++|+|++|++++..|+.|..+++|++|+|+
T Consensus        34 ~~l~ls~~~L~-~ip~~~~--~~L-~~L~Ls~N~i~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  108 (562)
T 3a79_B           34 SMVDYSNRNLT-HVPKDLP--PRT-KALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS  108 (562)
T ss_dssp             CEEECTTSCCC-SCCTTSC--TTC-CEEECCSSCCC-CCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECT
T ss_pred             cEEEcCCCCCc-cCCCCCC--CCc-CEEECCCCCcc-ccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECC
Confidence            56666666666 4665443  444 66666666666 4444444466667777777777666666666666777777777


Q ss_pred             CCcccccCCCCCcCCCcCceEEecccccccc-cCccccCccccceecccccccccccCcccccCCcc--cEEEecCCCC-
Q 003301          128 YNQFTERIPRGLGNLTSLKTLYLGFNNLTGE-IPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAM--KTLALPSNAL-  203 (832)
Q Consensus       128 ~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~n~l-  203 (832)
                      +|+|+ .+|..  .+++|++|+|++|++++. +|..|+++++|++|++++|++++.   .+..+++|  ++|++++|.+ 
T Consensus       109 ~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~  182 (562)
T 3a79_B          109 HNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYH  182 (562)
T ss_dssp             TSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCC
T ss_pred             CCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccc
Confidence            77766 34444  566677777777776642 345666677777777777766542   34444444  7777777766 


Q ss_pred             -CCCCCccccccCCCCccEEEccCCccccccCC-cccCCCCccEEEcCCCc-----CcccCCccccCccccceeeccccc
Q 003301          204 -SGSLPSSIDLVRLPNLEIISLAGNNFSGIIPS-FIFNASKLSVLELGENS-----FSGFIPNTLGNLRKLEWLRLSYNF  276 (832)
Q Consensus       204 -~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~L~~N~-----i~~~~~~~~~~l~~L~~L~L~~N~  276 (832)
                       ++..|..+.-.....+ .+++++|.+.+..+. .+..+++|+.|++++|.     +.+ ....+..+++|+.|+++++.
T Consensus       183 ~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~  260 (562)
T 3a79_B          183 IKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIE  260 (562)
T ss_dssp             CCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEE
T ss_pred             ccccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCc
Confidence             5555554421111122 456666666654333 34556777777777774     221 12345667777777777776


Q ss_pred             CCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcc-----cccccccceEEeecCccccccc-ccccCc---CcccE
Q 003301          277 LTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSI-----GNLSLSLSRIFISNCSIRGTIP-KEIGNL---INLRE  347 (832)
Q Consensus       277 l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~~~~~L~~L~l~~n~l~~~~~-~~~~~l---~~L~~  347 (832)
                      +...... .++. ....++|++|++++|.+.+.+|..+     ..+. .|+.++++.+.+  .+| ..+..+   .+|++
T Consensus       261 l~~~~~~-~~~~-~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~-~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~  335 (562)
T 3a79_B          261 TTWKCSV-KLFQ-FFWPRPVEYLNIYNLTITERIDREEFTYSETALK-SLMIEHVKNQVF--LFSKEALYSVFAEMNIKM  335 (562)
T ss_dssp             ECHHHHH-HHHH-HHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCC-EEEEEEEEECCC--SSCHHHHHHHHHTCCCSE
T ss_pred             CcHHHHH-HHHH-hhhcccccEEEEeccEeeccccchhhhcccccch-heehhhccccee--ecChhhhhhhhccCcceE
Confidence            6541111 0111 1223588888888888887777776     3333 455555566665  233 223222   57999


Q ss_pred             EEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCC--cccCCCCCCCCeEeCCCC
Q 003301          348 LGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPI--PPCIGDLTSLRLLSLASN  425 (832)
Q Consensus       348 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N  425 (832)
                      |++++|.+....  ....+++|++|++++|++++..|..+..+++|++|++++|++++..  |..|..+++|+.|++++|
T Consensus       336 L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N  413 (562)
T 3a79_B          336 LSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLN  413 (562)
T ss_dssp             EEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTS
T ss_pred             EEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCC
Confidence            999999876432  1268899999999999999888999999999999999999999643  567999999999999999


Q ss_pred             cCCC-CCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCC
Q 003301          426 ELNS-VIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIP  504 (832)
Q Consensus       426 ~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  504 (832)
                      ++++ +.+..|..+++|++|++++|++++..|..+.  ++|+.|+|++|+++ .+|..+.++++|+.|+|++|++++ +|
T Consensus       414 ~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~  489 (562)
T 3a79_B          414 SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VP  489 (562)
T ss_dssp             CCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CC
T ss_pred             cCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CC
Confidence            9998 5556689999999999999999887776655  78999999999999 677777799999999999999995 55


Q ss_pred             cc-ccCCCCCCeeccCCCcccccCch
Q 003301          505 KS-IGGLVSLESLDLSNNSLSGNIPT  529 (832)
Q Consensus       505 ~~-~~~l~~L~~L~Ls~N~l~~~~p~  529 (832)
                      .. |+.+++|+.|+|++|++++..|.
T Consensus       490 ~~~~~~l~~L~~L~l~~N~~~c~c~~  515 (562)
T 3a79_B          490 DGVFDRLTSLQYIWLHDNPWDCTCPG  515 (562)
T ss_dssp             TTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred             HHHHhcCCCCCEEEecCCCcCCCcch
Confidence            55 99999999999999999987664

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=2.4e-44  Score=402.66  Aligned_cols=426  Identities=24%  Similarity=0.265  Sum_probs=226.3

Q ss_pred             CccccCccccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCcccccccccccccccccCCChhhhhc
Q 003301           14 PKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRR   93 (832)
Q Consensus        14 ~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~   93 (832)
                      .|.--+.++|++|++++|++ |.+|+.++++++|++|++++|.+.|.+|+.++++.++ +.++++++..           
T Consensus         4 ~p~~~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L-~~l~l~~c~~-----------   70 (454)
T 1jl5_A            4 NPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM-AVSRLRDCLD-----------   70 (454)
T ss_dssp             -------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHH-HHHHHHHHHH-----------
T ss_pred             cccccccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhc-chhhhhhhhc-----------
Confidence            34444568999999999999 6999999999999999999999999999999999888 7777766532           


Q ss_pred             CCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceec
Q 003301           94 LPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILG  173 (832)
Q Consensus        94 l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~  173 (832)
                       .++++|++++|++++ +|..   .++|++|++++|++++ +|..   +++|++|++++|++++ +|...   ++|++|+
T Consensus        71 -~~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~~---~~L~~L~  137 (454)
T 1jl5_A           71 -RQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDLP---PLLEYLG  137 (454)
T ss_dssp             -HTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSCC---TTCCEEE
T ss_pred             -cCCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCCC---CCCCEEE
Confidence             457888888888884 4542   3678888888888886 6653   3778888888888874 33221   6788888


Q ss_pred             ccccccccccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcC
Q 003301          174 LQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSF  253 (832)
Q Consensus       174 L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i  253 (832)
                      +++|++++ +| +|.++++|++|++++|++++ +|...     ++|++|++++|+++++ | .+.++++|++|++++|++
T Consensus       138 L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~-----~~L~~L~L~~n~l~~l-~-~~~~l~~L~~L~l~~N~l  207 (454)
T 1jl5_A          138 VSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP-----PSLEFIAAGNNQLEEL-P-ELQNLPFLTAIYADNNSL  207 (454)
T ss_dssp             CCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC-----TTCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCC
T ss_pred             CcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc-----ccccEEECcCCcCCcC-c-cccCCCCCCEEECCCCcC
Confidence            88888886 55 58888888888888888874 55432     4788888888888764 4 477788888888888887


Q ss_pred             cccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccc
Q 003301          254 SGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRG  333 (832)
Q Consensus       254 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~  333 (832)
                      +++ |...   ++|++|++++|.++.++       .+..+++|++|++++|++++ +|..+    .+|++|++++|++++
T Consensus       208 ~~l-~~~~---~~L~~L~l~~n~l~~lp-------~~~~l~~L~~L~l~~N~l~~-l~~~~----~~L~~L~l~~N~l~~  271 (454)
T 1jl5_A          208 KKL-PDLP---LSLESIVAGNNILEELP-------ELQNLPFLTTIYADNNLLKT-LPDLP----PSLEALNVRDNYLTD  271 (454)
T ss_dssp             SSC-CCCC---TTCCEEECCSSCCSSCC-------CCTTCTTCCEEECCSSCCSS-CCSCC----TTCCEEECCSSCCSC
T ss_pred             CcC-CCCc---CcccEEECcCCcCCccc-------ccCCCCCCCEEECCCCcCCc-ccccc----cccCEEECCCCcccc
Confidence            753 3322   47788888888777533       25677777888887777764 33211    245555555555553


Q ss_pred             cccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCC
Q 003301          334 TIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGD  413 (832)
Q Consensus       334 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  413 (832)
                       +|..   +++|++|++++|++++. |.                     .      .++|++|++++|++++ ++    .
T Consensus       272 -l~~~---~~~L~~L~ls~N~l~~l-~~---------------------~------~~~L~~L~l~~N~l~~-i~----~  314 (454)
T 1jl5_A          272 -LPEL---PQSLTFLDVSENIFSGL-SE---------------------L------PPNLYYLNASSNEIRS-LC----D  314 (454)
T ss_dssp             -CCCC---CTTCCEEECCSSCCSEE-SC---------------------C------CTTCCEEECCSSCCSE-EC----C
T ss_pred             -cCcc---cCcCCEEECcCCccCcc-cC---------------------c------CCcCCEEECcCCcCCc-cc----C
Confidence             2221   23455555555554431 11                     0      1344455555555442 11    1


Q ss_pred             C-CCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCC--ccCCccccccccc
Q 003301          414 L-TSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSG--DIPTAIGGLMNLQ  490 (832)
Q Consensus       414 l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~  490 (832)
                      + ++|+.|++++|++++ +|..   +++|++|++++|++++ +|.   .+++|++|++++|++++  .+|.++..     
T Consensus       315 ~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~-----  381 (454)
T 1jl5_A          315 LPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVED-----  381 (454)
T ss_dssp             CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCE-----
T ss_pred             CcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHh-----
Confidence            1 355555555555554 2222   3556666666666663 444   35667777777777776  55665543     


Q ss_pred             eeecccccccccCCccccCCCCCCeeccCCCcccc--cCchhhhhhccCCeeeCCCCcccccCCC
Q 003301          491 DLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSG--NIPTSMEKLLYLKDLNLSFNKLEGEIPR  553 (832)
Q Consensus       491 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~l~l~~N~l~~~~p~  553 (832)
                         |+.|.+.|.+|..   +++|+.||+++|++++  .+|.+      ++.|.+++|.+.+.+|.
T Consensus       382 ---L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~s------l~~L~~~~~~~~~~~~~  434 (454)
T 1jl5_A          382 ---LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPES------VEDLRMNSERVVDPYEF  434 (454)
T ss_dssp             ---EECCC---------------------------------------------------------
T ss_pred             ---hhhcccccccccc---cCcCCEEECCCCcCCccccchhh------HhheeCcCcccCCcccc
Confidence               2346667777763   4788889999999887  66654      45667888888887765

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=3.3e-44  Score=405.12  Aligned_cols=376  Identities=22%  Similarity=0.241  Sum_probs=212.1

Q ss_pred             CCccEEECcCCcccccCCCCCcCCCcCceEEeccccccccc-CccccCccccceecccccccccccCcccccCCcccEEE
Q 003301          119 KELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEI-PYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLA  197 (832)
Q Consensus       119 ~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  197 (832)
                      ++|++|+|++|++++..|..|+++++|++|+|++|.+.+.+ +..|.++++|++|+|++|++++..|.+|.++++|++|+
T Consensus        30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  109 (455)
T 3v47_A           30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT  109 (455)
T ss_dssp             TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred             CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence            34444444444444444444444444555555544443222 33444455555555555555444444455555555555


Q ss_pred             ecCCCCCCCCCccccccCCCCccEEEccCCccccccCCc-ccCCCCccEEEcCCCcCcccCCccccCc--cccceeeccc
Q 003301          198 LPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSF-IFNASKLSVLELGENSFSGFIPNTLGNL--RKLEWLRLSY  274 (832)
Q Consensus       198 L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~-~~~l~~L~~L~L~~N~i~~~~~~~~~~l--~~L~~L~L~~  274 (832)
                      |++|.+++.+|....+..+++|++|+|++|++++..|.. |.++++|++|++++|.+++..+..+..+  .+|+.|++++
T Consensus       110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~  189 (455)
T 3v47_A          110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS  189 (455)
T ss_dssp             CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred             CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence            555555433332212344455555555555555444443 4556666666666666665555555443  3445555555


Q ss_pred             ccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCc
Q 003301          275 NFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNE  354 (832)
Q Consensus       275 N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~  354 (832)
                      |.+..++..                             .+..                 .....+..+++|++|++++|+
T Consensus       190 n~l~~~~~~-----------------------------~~~~-----------------~~~~~~~~~~~L~~L~Ls~n~  223 (455)
T 3v47_A          190 ITLQDMNEY-----------------------------WLGW-----------------EKCGNPFKNTSITTLDLSGNG  223 (455)
T ss_dssp             CBCTTCSTT-----------------------------CTTH-----------------HHHCCTTTTCEEEEEECTTSC
T ss_pred             Ccccccchh-----------------------------hccc-----------------cccccccccceeeeEecCCCc
Confidence            544442221                             1100                 001112233444444444444


Q ss_pred             ccccccccccCC---CCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCC--CCCCCeEeCCCCcCCC
Q 003301          355 LIGSIPITFGKL---QNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGD--LTSLRLLSLASNELNS  429 (832)
Q Consensus       355 l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~--l~~L~~L~L~~N~l~~  429 (832)
                      +.+..|..+...   ++|+.|++++|.+.+..              +..+.+.+..+..+..  .++|+.|++++|.+++
T Consensus       224 l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~  289 (455)
T 3v47_A          224 FKESMAKRFFDAIAGTKIQSLILSNSYNMGSS--------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFA  289 (455)
T ss_dssp             CCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCE
T ss_pred             ccccchhhhhccccccceeeEeeccccccccc--------------cchhhhccCcccccccccccCceEEEecCccccc
Confidence            444444433322   45555555555443221              1111222222222222  2466667777777666


Q ss_pred             CCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccC
Q 003301          430 VIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGG  509 (832)
Q Consensus       430 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  509 (832)
                      ..|..|..+++|++|++++|++++..|..|+.+++|++|+|++|++++..|..|.++++|+.|+|++|++++..|..|+.
T Consensus       290 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  369 (455)
T 3v47_A          290 LLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLG  369 (455)
T ss_dssp             ECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTT
T ss_pred             cchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccc
Confidence            66666777777777777777777666677777777777777777777777777888888888888888888777888888


Q ss_pred             CCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCCCC
Q 003301          510 LVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRG  554 (832)
Q Consensus       510 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~  554 (832)
                      +++|++|+|++|++++..+..+..+++|+.|++++|+++|.+|..
T Consensus       370 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  414 (455)
T 3v47_A          370 LPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  414 (455)
T ss_dssp             CTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred             cccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcc
Confidence            888888888888888776677788888888888888888888864

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=6e-43  Score=394.77  Aligned_cols=382  Identities=20%  Similarity=0.215  Sum_probs=207.1

Q ss_pred             ccccccccccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccC-CCCCcCCCcCceEEeccc
Q 003301           75 MDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERI-PRGLGNLTSLKTLYLGFN  153 (832)
Q Consensus        75 L~ls~n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~-p~~~~~l~~L~~L~Ls~N  153 (832)
                      ++.++++++ .+|. +   .++|++|+|++|++++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|
T Consensus        15 ~~c~~~~l~-~lp~-l---~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n   89 (455)
T 3v47_A           15 AICINRGLH-QVPE-L---PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN   89 (455)
T ss_dssp             EECCSSCCS-SCCC-C---CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTC
T ss_pred             cCcCCCCcc-cCCC-C---CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCC
Confidence            444444444 4444 1   144555555555555544555555555555555555554222 344555555555555555


Q ss_pred             ccccccCccccCccccceecccccccccccCcc--cccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCcccc
Q 003301          154 NLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTS--IFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSG  231 (832)
Q Consensus       154 ~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~  231 (832)
                      ++++..|..|+++++|++|++++|++++..+..  |.++++|++|+|++|.+.+..|..+ +..+++|++|++++|++++
T Consensus        90 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~~l~~L~~L~L~~n~l~~  168 (455)
T 3v47_A           90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF-FLNMRRFHVLDLTFNKVKS  168 (455)
T ss_dssp             TTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGG-GGGCTTCCEEECTTCCBSC
T ss_pred             ccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccc-cCCCCcccEEeCCCCcccc
Confidence            555555555555555555555555555433322  5555666666666666554444432 3455666666666666665


Q ss_pred             ccCCcccCC--CCccEEEcCCCcCcccCCcccc--------CccccceeecccccCCCCCCcccccccccc---CCCCcE
Q 003301          232 IIPSFIFNA--SKLSVLELGENSFSGFIPNTLG--------NLRKLEWLRLSYNFLTSSTSELSFLSSWAN---CKNLKL  298 (832)
Q Consensus       232 ~~~~~~~~l--~~L~~L~L~~N~i~~~~~~~~~--------~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~---l~~L~~  298 (832)
                      ..+..+..+  .+|+.|++++|.+.+..+..+.        .+++|++|++++|.++.     ..+..+..   .++|+.
T Consensus       169 ~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~-----~~~~~~~~~~~~~~L~~  243 (455)
T 3v47_A          169 ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKE-----SMAKRFFDAIAGTKIQS  243 (455)
T ss_dssp             CCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCH-----HHHHHHHHHTTTCCEEE
T ss_pred             cChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccc-----cchhhhhccccccceee
Confidence            555555544  5666666666666655443322        33455555555555543     12222222   245555


Q ss_pred             EeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCc
Q 003301          299 LDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNK  378 (832)
Q Consensus       299 L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  378 (832)
                      |++++|.+.+...               ..+.+.+..+..+..+                      ..++|++|++++|+
T Consensus       244 L~l~~~~~~~~~~---------------~~~~~~~~~~~~~~~~----------------------~~~~L~~L~l~~n~  286 (455)
T 3v47_A          244 LILSNSYNMGSSF---------------GHTNFKDPDNFTFKGL----------------------EASGVKTCDLSKSK  286 (455)
T ss_dssp             EECTTCTTTSCCT---------------TCCSSCCCCTTTTGGG----------------------TTSCCCEEECCSSC
T ss_pred             Eeecccccccccc---------------chhhhccCcccccccc----------------------cccCceEEEecCcc
Confidence            5555555432110               0011111111111111                      12345555555555


Q ss_pred             cCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccc
Q 003301          379 LEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPED  458 (832)
Q Consensus       379 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  458 (832)
                      +++..|..+..+++|++|++++|++++..|..|.++++|+.|+|++|.+++..|..|.++++|++|+|++|++++..|..
T Consensus       287 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  366 (455)
T 3v47_A          287 IFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQS  366 (455)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTT
T ss_pred             ccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhh
Confidence            55555555555555555555555555555555556666666666666666555666666666666666666666666666


Q ss_pred             cccccccceecccCcccCCccCCccccccccceeecccccccccCC
Q 003301          459 IGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIP  504 (832)
Q Consensus       459 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  504 (832)
                      |..+++|++|+|++|++++..+..|..+++|++|+|++|++++..|
T Consensus       367 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          367 FLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             ccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            6677777777777777776556666777777777777777776555

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=1.5e-42  Score=388.20  Aligned_cols=408  Identities=25%  Similarity=0.306  Sum_probs=250.2

Q ss_pred             CccCCCCcceeccCccccCccccCeEeccCCccccCCCccccccccC-------------cEEEccCCcCCCCCCCcccC
Q 003301            1 MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAEL-------------ELVSLTNNFLSGTIPSTIFN   67 (832)
Q Consensus         1 ~ldl~~n~~~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L-------------~~L~l~~n~l~~~~p~~l~~   67 (832)
                      +|++++|.+ |.+|++++++++|++|++++|+++|.+|+.++.+++|             ++|++++|+++ .+|..   
T Consensus        15 ~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~-~lp~~---   89 (454)
T 1jl5_A           15 EPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPEL---   89 (454)
T ss_dssp             --------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCS-CCCSC---
T ss_pred             hhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccc-cCCCC---
Confidence            478999999 7999999999999999999999999999999999876             88999999988 56652   


Q ss_pred             cccccccccccccccccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCce
Q 003301           68 LSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKT  147 (832)
Q Consensus        68 l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~  147 (832)
                      .+++ ++||+++|.+++ +|..    +++|++|++++|++++ +|..   .++|++|++++|++++ +| .|+++++|++
T Consensus        90 ~~~L-~~L~l~~n~l~~-lp~~----~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~  157 (454)
T 1jl5_A           90 PPHL-ESLVASCNSLTE-LPEL----PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKI  157 (454)
T ss_dssp             CTTC-SEEECCSSCCSS-CCCC----CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCE
T ss_pred             cCCC-CEEEccCCcCCc-cccc----cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCE
Confidence            2455 888999999884 7753    4788899999998884 4432   2688899999998885 66 5888899999


Q ss_pred             EEecccccccccCccccCccccceecccccccccccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCC
Q 003301          148 LYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGN  227 (832)
Q Consensus       148 L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n  227 (832)
                      |++++|++++ +|..+   ++|++|++++|++++ +| .+.++++|++|++++|.+++ +|..     .++|++|++++|
T Consensus       158 L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~-----~~~L~~L~l~~n  225 (454)
T 1jl5_A          158 IDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL-----PLSLESIVAGNN  225 (454)
T ss_dssp             EECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC-----CTTCCEEECCSS
T ss_pred             EECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC-----cCcccEEECcCC
Confidence            9999998884 66544   478888899888887 45 58888888888988888874 5542     258888888888


Q ss_pred             ccccccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCC
Q 003301          228 NFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPIN  307 (832)
Q Consensus       228 ~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~  307 (832)
                      +++. +|. +..+++|++|++++|+++++ |..   +++|++|++++|++++++..         .++|++|++++|+++
T Consensus       226 ~l~~-lp~-~~~l~~L~~L~l~~N~l~~l-~~~---~~~L~~L~l~~N~l~~l~~~---------~~~L~~L~ls~N~l~  290 (454)
T 1jl5_A          226 ILEE-LPE-LQNLPFLTTIYADNNLLKTL-PDL---PPSLEALNVRDNYLTDLPEL---------PQSLTFLDVSENIFS  290 (454)
T ss_dssp             CCSS-CCC-CTTCTTCCEEECCSSCCSSC-CSC---CTTCCEEECCSSCCSCCCCC---------CTTCCEEECCSSCCS
T ss_pred             cCCc-ccc-cCCCCCCCEEECCCCcCCcc-ccc---ccccCEEECCCCcccccCcc---------cCcCCEEECcCCccC
Confidence            8884 443 77888888888888888863 332   37888888888888775432         267888888888887


Q ss_pred             CCCCCcccccccccceEEeecCcccccccccccCc-CcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchh
Q 003301          308 GVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNL-INLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNG  386 (832)
Q Consensus       308 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  386 (832)
                      +. |    ..+.+|++|++++|++++. +    .+ ++|++|++++|++++ +|..   +++|++|++++|+++ .+|. 
T Consensus       291 ~l-~----~~~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~-  354 (454)
T 1jl5_A          291 GL-S----ELPPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE-  354 (454)
T ss_dssp             EE-S----CCCTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC-
T ss_pred             cc-c----CcCCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc-
Confidence            52 1    1123778888888887752 2    22 477888888888775 4433   467788888888877 3555 


Q ss_pred             hcCCCCCcEEEecCCcCCC--CCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccC--CCccccccc
Q 003301          387 LCQLARLSVLYMDGNKLSG--PIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNG--SLPEDIGNL  462 (832)
Q Consensus       387 ~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l  462 (832)
                        .+++|++|++++|++++  .+|.++..        ++.|.+.+.+|..   +++|++|++++|++++  .+|.     
T Consensus       355 --~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~-----  416 (454)
T 1jl5_A          355 --LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPE-----  416 (454)
T ss_dssp             --CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC--------------------------------------
T ss_pred             --hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcCCccccchh-----
Confidence              35778888888888876  55555432        2345555555542   4789999999999987  4554     


Q ss_pred             cccceecccCcccCCccCCcccccc
Q 003301          463 KVVVIIDLSRNNLSGDIPTAIGGLM  487 (832)
Q Consensus       463 ~~L~~L~Ls~N~l~~~~~~~~~~l~  487 (832)
                       .++.|.+++|.+.+..+.+.....
T Consensus       417 -sl~~L~~~~~~~~~~~~~~~~~~~  440 (454)
T 1jl5_A          417 -SVEDLRMNSERVVDPYEFAHETTD  440 (454)
T ss_dssp             -------------------------
T ss_pred             -hHhheeCcCcccCCccccCHHHhh
Confidence             355667889998877766655443

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=3.3e-40  Score=369.54  Aligned_cols=362  Identities=19%  Similarity=0.208  Sum_probs=210.3

Q ss_pred             CCCccccccccCcEEEccCCcCCCCCCCcccCcccccccccccccccccCCChhhhhcCCCceEEEccCCcccccCCCCc
Q 003301           36 EIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNI  115 (832)
Q Consensus        36 ~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l  115 (832)
                      ..+..++.+++|++|++++|.+++ +| .++.+++| ++|++++|+++ .+|   +..+++|++|++++|++++. |  +
T Consensus        33 ~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L-~~L~Ls~n~l~-~~~---~~~l~~L~~L~Ls~N~l~~~-~--~  102 (457)
T 3bz5_A           33 TDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGL-TKLICTSNNIT-TLD---LSQNTNLTYLACDSNKLTNL-D--V  102 (457)
T ss_dssp             TSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTC-SEEECCSSCCS-CCC---CTTCTTCSEEECCSSCCSCC-C--C
T ss_pred             ccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCC-CEEEccCCcCC-eEc---cccCCCCCEEECcCCCCcee-e--c
Confidence            344455555555555555555552 33 35555555 55555555555 233   23556666666666666642 2  5


Q ss_pred             cCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccccccccccCcccccCCcccE
Q 003301          116 WQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKT  195 (832)
Q Consensus       116 ~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  195 (832)
                      +.+++|++|++++|++++ +|  ++.+++|++|++++|++++. +  ++++++|++|++++|+..+.+  .+..+++|++
T Consensus       103 ~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~  174 (457)
T 3bz5_A          103 TPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTT  174 (457)
T ss_dssp             TTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCE
T ss_pred             CCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCE
Confidence            566666666666666654 23  56666666666666666642 2  556666666666666433333  3556666666


Q ss_pred             EEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccc
Q 003301          196 LALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYN  275 (832)
Q Consensus       196 L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N  275 (832)
                      |++++|.+++ +|    +..+++|++|++++|+++++   .+..+++|++|++++|+++++ |  +..+++|++|++++|
T Consensus       175 L~ls~n~l~~-l~----l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i-p--~~~l~~L~~L~l~~N  243 (457)
T 3bz5_A          175 LDCSFNKITE-LD----VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI-D--VTPLTQLTYFDCSVN  243 (457)
T ss_dssp             EECCSSCCCC-CC----CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSS
T ss_pred             EECCCCccce-ec----cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccccc-C--ccccCCCCEEEeeCC
Confidence            6666666653 22    34566666666666666654   255666777777777777653 3  566677777777777


Q ss_pred             cCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcc
Q 003301          276 FLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNEL  355 (832)
Q Consensus       276 ~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l  355 (832)
                      ++++++        +..+++|+.|++++|.               |+.+++++|.+.+.+|  ++.+++|+.|++++|..
T Consensus       244 ~l~~~~--------~~~l~~L~~L~l~~n~---------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~  298 (457)
T 3bz5_A          244 PLTELD--------VSTLSKLTTLHCIQTD---------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQ  298 (457)
T ss_dssp             CCSCCC--------CTTCTTCCEEECTTCC---------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTT
T ss_pred             cCCCcC--------HHHCCCCCEEeccCCC---------------CCEEECCCCccCCccc--ccccccCCEEECCCCcc
Confidence            776532        2445667777766553               3345566666555554  45566677777777766


Q ss_pred             cccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCccc
Q 003301          356 IGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTF  435 (832)
Q Consensus       356 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~  435 (832)
                      .+.+|.   ...+|+.|++++|             ++|++|++++|++++. +  ++++++|+.|++++|++++      
T Consensus       299 l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~------  353 (457)
T 3bz5_A          299 LYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD------  353 (457)
T ss_dssp             CCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB------
T ss_pred             cceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC------
Confidence            555553   3344555555544             4566677777776653 2  6666666666666666654      


Q ss_pred             ccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCcc
Q 003301          436 WNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAI  483 (832)
Q Consensus       436 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  483 (832)
                        ++.|..|++++|++.|.     +.+..|..+++++|+++|.+|..+
T Consensus       354 --l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~  394 (457)
T 3bz5_A          354 --FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDL  394 (457)
T ss_dssp             --CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTC
T ss_pred             --ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhH
Confidence              23455556666666543     234455555666666666555543

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=6.6e-40  Score=367.10  Aligned_cols=359  Identities=19%  Similarity=0.175  Sum_probs=239.2

Q ss_pred             CChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccC
Q 003301           86 LPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGN  165 (832)
Q Consensus        86 lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~  165 (832)
                      .+..+. .+++|++|++++|++++ +| .+..+++|++|+|++|++++. |  ++.+++|++|++++|++++. |  +++
T Consensus        34 ~~~~~~-~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~  104 (457)
T 3bz5_A           34 DTISEE-QLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTP  104 (457)
T ss_dssp             SEEEHH-HHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTT
T ss_pred             cccChh-HcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCC
Confidence            333443 67888888888888885 35 577888888888888888753 3  77788888888888888753 3  777


Q ss_pred             ccccceecccccccccccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccE
Q 003301          166 LRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSV  245 (832)
Q Consensus       166 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~  245 (832)
                      +++|++|++++|+++++ +  +.++++|++|++++|.+++ +    ++..+++|++|++++|+..+..  .+..+++|++
T Consensus       105 l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~-l----~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~  174 (457)
T 3bz5_A          105 LTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTE-I----DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTT  174 (457)
T ss_dssp             CTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSC-C----CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCE
T ss_pred             CCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCccce-e----ccccCCcCCEEECCCCCccccc--ccccCCcCCE
Confidence            78888888888887763 3  6777777777777777764 2    2456677777777777433333  3556666666


Q ss_pred             EEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEE
Q 003301          246 LELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIF  325 (832)
Q Consensus       246 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~  325 (832)
                      |++++|+++++ |  +..+++|++|++++|.++.+        .+..+++|++|++++|++++                 
T Consensus       175 L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~--------~l~~l~~L~~L~Ls~N~l~~-----------------  226 (457)
T 3bz5_A          175 LDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL--------DLNQNIQLTFLDCSSNKLTE-----------------  226 (457)
T ss_dssp             EECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC--------CCTTCTTCSEEECCSSCCSC-----------------
T ss_pred             EECCCCcccee-c--cccCCCCCEEECcCCcCCee--------ccccCCCCCEEECcCCcccc-----------------
Confidence            66666666653 2  55666666666666666552        13455555555555555543                 


Q ss_pred             eecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCC
Q 003301          326 ISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSG  405 (832)
Q Consensus       326 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  405 (832)
                               +|  +..+++|+.|++++|++++..   +..+++|+.|++++|+              |+.|++++|.+.+
T Consensus       227 ---------ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~  278 (457)
T 3bz5_A          227 ---------ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLI  278 (457)
T ss_dssp             ---------CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCC
T ss_pred             ---------cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCC--------------CCEEECCCCccCC
Confidence                     22  445566666666666666543   3345556666665543              3445666666665


Q ss_pred             CCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCcccc
Q 003301          406 PIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGG  485 (832)
Q Consensus       406 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  485 (832)
                      .+|  ++.+++|+.|++++|...+.+|.   ...+|+.|++++|             ++|+.|++++|++++. +  +++
T Consensus       279 ~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~  337 (457)
T 3bz5_A          279 YFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSH  337 (457)
T ss_dssp             EEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTT
T ss_pred             ccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--ccc
Confidence            555  45667777777777776665553   2344555555544             5677888888888863 2  778


Q ss_pred             ccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCCC
Q 003301          486 LMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPR  553 (832)
Q Consensus       486 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  553 (832)
                      +++|+.|++++|+|++        ++.|+.|++++|.++|.     ..+..|+.+++++|+++|.+|.
T Consensus       338 l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~  392 (457)
T 3bz5_A          338 NTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSP  392 (457)
T ss_dssp             CTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCT
T ss_pred             CCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcCh
Confidence            8888888888888875        24677778888888876     3566778888888888888886

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.6e-40  Score=373.29  Aligned_cols=348  Identities=22%  Similarity=0.217  Sum_probs=244.2

Q ss_pred             cEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecc
Q 003301          194 KTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLS  273 (832)
Q Consensus       194 ~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  273 (832)
                      +.++.+++.++ .+|..+    .+++++|+|++|+++++.+..|.++++|++|+|++|.+++..|..|.++++|++|+|+
T Consensus        14 ~~v~c~~~~l~-~ip~~~----~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~   88 (477)
T 2id5_A           14 RAVLCHRKRFV-AVPEGI----PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLR   88 (477)
T ss_dssp             TEEECCSCCCS-SCCSCC----CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CEEEeCCCCcC-cCCCCC----CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECC
Confidence            45666666665 556544    2567778888888877777778888888888888888887777778888888888888


Q ss_pred             cccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecC
Q 003301          274 YNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGN  353 (832)
Q Consensus       274 ~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N  353 (832)
                      +|.++.++..     .|..+++|++|+|++|++.+.                         .|..|..+++|++|++++|
T Consensus        89 ~n~l~~~~~~-----~~~~l~~L~~L~Ls~n~i~~~-------------------------~~~~~~~l~~L~~L~l~~n  138 (477)
T 2id5_A           89 SNRLKLIPLG-----VFTGLSNLTKLDISENKIVIL-------------------------LDYMFQDLYNLKSLEVGDN  138 (477)
T ss_dssp             SSCCCSCCTT-----SSTTCTTCCEEECTTSCCCEE-------------------------CTTTTTTCTTCCEEEECCT
T ss_pred             CCcCCccCcc-----cccCCCCCCEEECCCCccccC-------------------------ChhHccccccCCEEECCCC
Confidence            8877765443     256677777777777766543                         4445556666677777777


Q ss_pred             cccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCc
Q 003301          354 ELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPS  433 (832)
Q Consensus       354 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~  433 (832)
                      .+.+..+..|.++++|++|+|++|++++..+..+..+++|+.|++++|.+.+..+..|..+++|+.|++++|.+.+..|.
T Consensus       139 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~  218 (477)
T 2id5_A          139 DLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTP  218 (477)
T ss_dssp             TCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECT
T ss_pred             ccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCc
Confidence            66666666677777777777777777665555667777777777777777766666677777777777777766665555


Q ss_pred             ccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCC
Q 003301          434 TFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSL  513 (832)
Q Consensus       434 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  513 (832)
                      .+....+|++|++++|++++..+..+..+++|+.|+|++|++++..+..|.++++|+.|+|++|++++..|..|..+++|
T Consensus       219 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  298 (477)
T 2id5_A          219 NCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYL  298 (477)
T ss_dssp             TTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTC
T ss_pred             ccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccC
Confidence            55555577777777777776555667777777777777777777777777777788888888888877777777788888


Q ss_pred             CeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCCCCCCCCCcCCCcccCCCCCCCCcc
Q 003301          514 ESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQ  576 (832)
Q Consensus       514 ~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~  576 (832)
                      +.|+|++|++++..+..|..+++|+.|+|++|+|.|.++....+.......+.++...|..|.
T Consensus       299 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~  361 (477)
T 2id5_A          299 RVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPE  361 (477)
T ss_dssp             CEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESG
T ss_pred             CEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCch
Confidence            888888888877766677777788888888888877765421112222344566666676543

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=3.1e-39  Score=364.78  Aligned_cols=358  Identities=27%  Similarity=0.399  Sum_probs=194.0

Q ss_pred             cccccccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEeccccccc
Q 003301           78 SNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTG  157 (832)
Q Consensus        78 s~n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~  157 (832)
                      ..+.+.+.++..   .+++++.|++++|.++ .+| .+..+++|++|+|++|.+++..|  +.++++|++|++++|++++
T Consensus        32 ~~~~~~~~i~~~---~l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~  104 (466)
T 1o6v_A           32 GKTNVTDTVSQT---DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD  104 (466)
T ss_dssp             TCSSTTSEECHH---HHHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred             cccccccccChh---HhccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCcccc
Confidence            334444444432   3456777788877777 344 36777777777777777775433  7777777777777777774


Q ss_pred             ccCccccCccccceecccccccccccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcc
Q 003301          158 EIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFI  237 (832)
Q Consensus       158 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~  237 (832)
                      ..+  ++++++|++|++++|++++..+  +.++++|++|++++|.+.+ ++   .+..+++|++|+++ |.+.+..+  +
T Consensus       105 ~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~---~~~~l~~L~~L~l~-~~~~~~~~--~  173 (466)
T 1o6v_A          105 ITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS---ALSGLTSLQQLSFG-NQVTDLKP--L  173 (466)
T ss_dssp             CGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG---GGTTCTTCSEEEEE-ESCCCCGG--G
T ss_pred             Chh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch---hhccCCcccEeecC-CcccCchh--h
Confidence            433  7777777777777777765432  6666677777776666653 22   13455555555554 33332222  4


Q ss_pred             cCCCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCccccc
Q 003301          238 FNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNL  317 (832)
Q Consensus       238 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~  317 (832)
                      ..+++|++|++++|.+++.  ..+..+++|++|++++|.++..+.       +..+++|+.|++++|++           
T Consensus       174 ~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-------~~~l~~L~~L~l~~n~l-----------  233 (466)
T 1o6v_A          174 ANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP-------LGILTNLDELSLNGNQL-----------  233 (466)
T ss_dssp             TTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-------GGGCTTCCEEECCSSCC-----------
T ss_pred             ccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc-------ccccCCCCEEECCCCCc-----------
Confidence            4455555555555554432  123444444444444444433111       23334444444444433           


Q ss_pred             ccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEE
Q 003301          318 SLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLY  397 (832)
Q Consensus       318 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  397 (832)
                                    ++.  ..+..+++|++|++++|.+.+..+  +..+++|++|++++|++++..+  +..+++|++|+
T Consensus       234 --------------~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~  293 (466)
T 1o6v_A          234 --------------KDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLE  293 (466)
T ss_dssp             --------------CCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred             --------------ccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEE
Confidence                          321  234455556666666665554433  5555556666666665554322  55555555555


Q ss_pred             ecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCC
Q 003301          398 MDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSG  477 (832)
Q Consensus       398 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  477 (832)
                      +++|++++..+  +..+++|+.|++++|++++..|  +..+++|++|++++|++++.  ..+..+++|+.|++++|++++
T Consensus       294 L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~  367 (466)
T 1o6v_A          294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISD  367 (466)
T ss_dssp             CCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCB
T ss_pred             cCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCc
Confidence            55555554322  4555555555555555555443  44555555555555555542  244555555555555555554


Q ss_pred             ccCCccccccccceeecccccccc
Q 003301          478 DIPTAIGGLMNLQDLSLRDNGLQG  501 (832)
Q Consensus       478 ~~~~~~~~l~~L~~L~Ls~N~l~~  501 (832)
                      ..|  +..+++|+.|++++|++++
T Consensus       368 ~~~--~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          368 LTP--LANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             CGG--GTTCTTCCEEECCCEEEEC
T ss_pred             cch--hhcCCCCCEEeccCCcccC
Confidence            443  4555555555555555553

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=8.6e-39  Score=361.11  Aligned_cols=347  Identities=29%  Similarity=0.420  Sum_probs=190.2

Q ss_pred             cccccCcEEEccCCcCCCCCCCcccCcccccccccccccccccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCc
Q 003301           42 GNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL  121 (832)
Q Consensus        42 ~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L  121 (832)
                      ..+.+++.|++++|.+. .+|. +..+++| ++||+++|.++ .+|.  +..+++|++|++++|++++..+  +..+++|
T Consensus        43 ~~l~~l~~L~l~~~~i~-~l~~-~~~l~~L-~~L~Ls~n~l~-~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L  114 (466)
T 1o6v_A           43 TDLDQVTTLQADRLGIK-SIDG-VEYLNNL-TQINFSNNQLT-DITP--LKNLTKLVDILMNNNQIADITP--LANLTNL  114 (466)
T ss_dssp             HHHHTCCEEECCSSCCC-CCTT-GGGCTTC-CEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTC
T ss_pred             hHhccccEEecCCCCCc-cCcc-hhhhcCC-CEEECCCCccC-Cchh--hhccccCCEEECCCCccccChh--hcCCCCC
Confidence            34566777777777666 4553 5556665 66666666666 3443  3356666666666666663332  5566666


Q ss_pred             cEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccccccccccCcccccCCcccEEEecCC
Q 003301          122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSN  201 (832)
Q Consensus       122 ~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n  201 (832)
                      ++|++++|++++..+  +..+++|++|++++|.+++ ++ .++++++|++|+++ |.+.+..  .+.++++|++|++++|
T Consensus       115 ~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n  187 (466)
T 1o6v_A          115 TGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSN  187 (466)
T ss_dssp             CEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSS
T ss_pred             CEEECCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCC
Confidence            666666666654322  5556666666666666553 22 35555556666554 3333321  2555555555555555


Q ss_pred             CCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCC
Q 003301          202 ALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSST  281 (832)
Q Consensus       202 ~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~  281 (832)
                      .+.                          ++.  .+..+++|++|++++|.+++..|  +..+++|++|++++|.++.+ 
T Consensus       188 ~l~--------------------------~~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-  236 (466)
T 1o6v_A          188 KVS--------------------------DIS--VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI-  236 (466)
T ss_dssp             CCC--------------------------CCG--GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-
T ss_pred             cCC--------------------------CCh--hhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc-
Confidence            554                          321  23444555555555555544333  44455555555555555442 


Q ss_pred             CccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccccc
Q 003301          282 SELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPI  361 (832)
Q Consensus       282 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  361 (832)
                            +.+..+++|+.|++++|.+.+..+  +..+. +|++|++++|.+++..+  +..+++|++|++++|++.+..+ 
T Consensus       237 ------~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~-~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-  304 (466)
T 1o6v_A          237 ------GTLASLTNLTDLDLANNQISNLAP--LSGLT-KLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP-  304 (466)
T ss_dssp             ------GGGGGCTTCSEEECCSSCCCCCGG--GTTCT-TCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG-
T ss_pred             ------hhhhcCCCCCEEECCCCccccchh--hhcCC-CCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh-
Confidence                  124455555555555555543322  22222 44444444444443322  5556666666666666665433 


Q ss_pred             cccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCccc
Q 003301          362 TFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDI  441 (832)
Q Consensus       362 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  441 (832)
                       +..+++|+.|+|++|++++..|  +..+++|++|++++|++++.  ..+..+++|+.|++++|++++..|  +..+++|
T Consensus       305 -~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L  377 (466)
T 1o6v_A          305 -ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRI  377 (466)
T ss_dssp             -GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTC
T ss_pred             -hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCC
Confidence             5566666666666666665443  55566666666666666643  346666666666666666666555  5666666


Q ss_pred             ceeeecCCcccC
Q 003301          442 LSLNFSSNFLNG  453 (832)
Q Consensus       442 ~~L~Ls~N~l~~  453 (832)
                      +.|++++|.+++
T Consensus       378 ~~L~l~~n~~~~  389 (466)
T 1o6v_A          378 TQLGLNDQAWTN  389 (466)
T ss_dssp             CEEECCCEEEEC
T ss_pred             CEEeccCCcccC
Confidence            666666666664

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=353.16  Aligned_cols=320  Identities=22%  Similarity=0.235  Sum_probs=169.8

Q ss_pred             eEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceeccccc
Q 003301           98 KGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLN  177 (832)
Q Consensus        98 ~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N  177 (832)
                      +.++.++++++ .+|..+.  +++++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n   90 (477)
T 2id5_A           14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN   90 (477)
T ss_dssp             TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence            45666666666 4555442  45666666666666555556666666666666666666555555666666666666666


Q ss_pred             ccccccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccC
Q 003301          178 KLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFI  257 (832)
Q Consensus       178 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~  257 (832)
                      +++++.+..|.++++|++|+|++|.+.                          ++.+..|..+++|++|++++|.+++..
T Consensus        91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~--------------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~  144 (477)
T 2id5_A           91 RLKLIPLGVFTGLSNLTKLDISENKIV--------------------------ILLDYMFQDLYNLKSLEVGDNDLVYIS  144 (477)
T ss_dssp             CCCSCCTTSSTTCTTCCEEECTTSCCC--------------------------EECTTTTTTCTTCCEEEECCTTCCEEC
T ss_pred             cCCccCcccccCCCCCCEEECCCCccc--------------------------cCChhHccccccCCEEECCCCccceeC
Confidence            555544444555555555555555544                          444444455555555555555555555


Q ss_pred             CccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccc
Q 003301          258 PNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPK  337 (832)
Q Consensus       258 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~  337 (832)
                      +..|.++++|++|++++|.++.++..     .|..+++|+.|++++|.+.+.                         .+.
T Consensus       145 ~~~~~~l~~L~~L~l~~n~l~~~~~~-----~l~~l~~L~~L~l~~n~i~~~-------------------------~~~  194 (477)
T 2id5_A          145 HRAFSGLNSLEQLTLEKCNLTSIPTE-----ALSHLHGLIVLRLRHLNINAI-------------------------RDY  194 (477)
T ss_dssp             TTSSTTCTTCCEEEEESCCCSSCCHH-----HHTTCTTCCEEEEESCCCCEE-------------------------CTT
T ss_pred             hhhccCCCCCCEEECCCCcCcccChh-----HhcccCCCcEEeCCCCcCcEe-------------------------Chh
Confidence            55555555555555555555443221     244445555555554444322                         222


Q ss_pred             cccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCC
Q 003301          338 EIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSL  417 (832)
Q Consensus       338 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  417 (832)
                      .|..+++|++|++++|...+.++.......+|++|+|++|++++..+..+..+++|++|+|++|++++..+..|..+++|
T Consensus       195 ~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L  274 (477)
T 2id5_A          195 SFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRL  274 (477)
T ss_dssp             CSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTC
T ss_pred             hcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccC
Confidence            33444444444444444444444333333455555555555553333445555555555555555554444555555555


Q ss_pred             CeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccC
Q 003301          418 RLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLS  476 (832)
Q Consensus       418 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  476 (832)
                      +.|+|++|+++++.|..|.++++|++|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus       275 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  333 (477)
T 2id5_A          275 QEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA  333 (477)
T ss_dssp             CEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred             CEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCcc
Confidence            55555555555555555555555555555555555544455555555666666666554

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.4e-38  Score=332.20  Aligned_cols=168  Identities=29%  Similarity=0.374  Sum_probs=152.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      +.|++.++||+|+||+||+|++. +|+.||||++........+.+.+|++++++++|||||+++++|.+++.+|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56999999999999999999986 49999999998766666678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccc
Q 003301          738 PNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ  817 (832)
Q Consensus       738 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~  817 (832)
                      +||+|.+++.+.  .+++..+..++.||+.||+|||   ++|||||||||+|||++.+|.+||+|||+|+.+...... .
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~  227 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-R  227 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-B
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc-c
Confidence            999999999864  5899999999999999999999   999999999999999999999999999999987544332 3


Q ss_pred             ccccccccccCCCCC
Q 003301          818 TLTLATIGYMAPGLF  832 (832)
Q Consensus       818 ~~~~gt~~y~APE~l  832 (832)
                      ...+||+.|||||++
T Consensus       228 ~~~~GTp~YmAPEvl  242 (346)
T 4fih_A          228 KSLVGTPYWMAPELI  242 (346)
T ss_dssp             CCCCSCGGGCCHHHH
T ss_pred             cccccCcCcCCHHHH
Confidence            346899999999974

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=3.9e-37  Score=339.48  Aligned_cols=335  Identities=21%  Similarity=0.237  Sum_probs=221.0

Q ss_pred             CCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCccccce
Q 003301          190 LSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEW  269 (832)
Q Consensus       190 l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  269 (832)
                      +++++.|++++|.+. .+|..+ +..+++|++|+|++|.++++.+..|..+++|++|+|++|.+++..|..|.++++|++
T Consensus        44 l~~l~~l~l~~~~l~-~l~~~~-~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  121 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMR-KLPAAL-LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV  121 (390)
T ss_dssp             GCCCSEEEEESCEES-EECTHH-HHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             cCCceEEEecCCchh-hCChhH-hcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCE
Confidence            455666666666655 334322 345556666666666665555555555666666666666665555555555555555


Q ss_pred             eecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEE
Q 003301          270 LRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELG  349 (832)
Q Consensus       270 L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  349 (832)
                      |++++|.++.++...     |..+++|++|++++|++.                         +..|..|..+++|++|+
T Consensus       122 L~L~~n~l~~l~~~~-----~~~l~~L~~L~L~~n~l~-------------------------~~~~~~~~~l~~L~~L~  171 (390)
T 3o6n_A          122 LVLERNDLSSLPRGI-----FHNTPKLTTLSMSNNNLE-------------------------RIEDDTFQATTSLQNLQ  171 (390)
T ss_dssp             EECCSSCCCCCCTTT-----TTTCTTCCEEECCSSCCC-------------------------BCCTTTTSSCTTCCEEE
T ss_pred             EECCCCccCcCCHHH-----hcCCCCCcEEECCCCccC-------------------------ccChhhccCCCCCCEEE
Confidence            555555555433321     344555555555555554                         44455566666677777


Q ss_pred             eecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCC
Q 003301          350 LWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNS  429 (832)
Q Consensus       350 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  429 (832)
                      +++|++++.   .+..+++|+.|++++|.+++     +...++|++|++++|.+... |..  ..++|+.|++++|.+++
T Consensus       172 l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~  240 (390)
T 3o6n_A          172 LSSNRLTHV---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTD  240 (390)
T ss_dssp             CCSSCCSBC---CGGGCTTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCC
T ss_pred             CCCCcCCcc---ccccccccceeecccccccc-----cCCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCcc
Confidence            777766643   24455667777777776663     23335677777777777643 332  23677788888887776


Q ss_pred             CCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccC
Q 003301          430 VIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGG  509 (832)
Q Consensus       430 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  509 (832)
                      .  ..+..+++|++|++++|.+++..|..|..+++|+.|+|++|++++ +|..+..+++|+.|+|++|+++ .+|..++.
T Consensus       241 ~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~  316 (390)
T 3o6n_A          241 T--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ  316 (390)
T ss_dssp             C--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHH
T ss_pred             c--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccc
Confidence            4  467777888888888888887777788888888888888888874 5666777888888888888888 56777888


Q ss_pred             CCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCCCCCCCCCcCCCcccCCCCCCCCc
Q 003301          510 LVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLA  575 (832)
Q Consensus       510 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~  575 (832)
                      +++|+.|+|++|++++. |  +..+++|+.|++++|+++|.+.. ..+..+....+.+++..|..+
T Consensus       317 l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~  378 (390)
T 3o6n_A          317 FDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID  378 (390)
T ss_dssp             HTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTT
T ss_pred             cCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceeccc
Confidence            88888888888888854 3  56678889999999999886543 233445555677787778754

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.3e-38  Score=327.13  Aligned_cols=170  Identities=31%  Similarity=0.490  Sum_probs=152.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.+.||+|+||+||+|++. +++.||||++....   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999986 48999999997542   344578999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |||+||+|.+++++.+ .+++..+..++.||+.||+|||   ++||+||||||+|||++.++.+||+|||+|+.+.....
T Consensus       112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            9999999999998754 6999999999999999999999   99999999999999999999999999999998754332


Q ss_pred             -cccccccccccccCCCCC
Q 003301          815 -MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 -~~~~~~~gt~~y~APE~l  832 (832)
                       ......+||+.|||||++
T Consensus       188 ~~~~~~~~GTp~YmAPEvl  206 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELL  206 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHH
T ss_pred             cccccCcccCcccCCHHHH
Confidence             233446899999999974

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=8e-37  Score=355.57  Aligned_cols=336  Identities=21%  Similarity=0.229  Sum_probs=226.6

Q ss_pred             CCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCccccce
Q 003301          190 LSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEW  269 (832)
Q Consensus       190 l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  269 (832)
                      +++++.+++++|.+. .+|..+ +..+++|++|+|++|.++++.+..|..+++|++|+|++|.+++..|..|+++++|++
T Consensus        50 l~~l~~l~l~~~~l~-~lp~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  127 (597)
T 3oja_B           50 LNNQKIVTFKNSTMR-KLPAAL-LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV  127 (597)
T ss_dssp             GCCCSEEEESSCEES-EECTHH-HHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             CCCceEEEeeCCCCC-CcCHHH-HccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCE
Confidence            345555555555554 233222 234555555555555555555555555555555555555555555555555555555


Q ss_pred             eecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEE
Q 003301          270 LRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELG  349 (832)
Q Consensus       270 L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  349 (832)
                      |+|++|.++.++...     |..+++                         |++|++++|.+++..|..|..+++|++|+
T Consensus       128 L~L~~n~l~~l~~~~-----~~~l~~-------------------------L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  177 (597)
T 3oja_B          128 LVLERNDLSSLPRGI-----FHNTPK-------------------------LTTLSMSNNNLERIEDDTFQATTSLQNLQ  177 (597)
T ss_dssp             EECCSSCCCCCCTTT-----TTTCTT-------------------------CCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred             EEeeCCCCCCCCHHH-----hccCCC-------------------------CCEEEeeCCcCCCCChhhhhcCCcCcEEE
Confidence            555555554433221     344444                         55555555555555556666677777777


Q ss_pred             eecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCC
Q 003301          350 LWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNS  429 (832)
Q Consensus       350 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  429 (832)
                      +++|.+++..   +..+++|+.|++++|.+++     +....+|+.|++++|.+... +..+  .++|+.|+|++|.+++
T Consensus       178 L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~-~~~~--~~~L~~L~L~~n~l~~  246 (597)
T 3oja_B          178 LSSNRLTHVD---LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTD  246 (597)
T ss_dssp             CTTSCCSBCC---GGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEE-ECSC--CSCCCEEECCSSCCCC
T ss_pred             CcCCCCCCcC---hhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCccccc-cccc--CCCCCEEECCCCCCCC
Confidence            7777776542   4456677777777777763     23445677888888877643 3222  2578888888888876


Q ss_pred             CCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccC
Q 003301          430 VIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGG  509 (832)
Q Consensus       430 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  509 (832)
                        +..+..+++|+.|+|++|.+++..|..|+.+++|+.|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..++.
T Consensus       247 --~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~  322 (597)
T 3oja_B          247 --TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ  322 (597)
T ss_dssp             --CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHH
T ss_pred             --ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCccccc
Confidence              3667888888888888888888888888888889999999998885 5777788899999999999998 67888888


Q ss_pred             CCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCCCCCCCCCcCCCcccCCCCCCCCcc
Q 003301          510 LVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQ  576 (832)
Q Consensus       510 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~  576 (832)
                      +++|+.|+|++|++++..   +..++.|+.|++++|+|+|.++. ..+..+....+.+++..|+.+.
T Consensus       323 l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~~  385 (597)
T 3oja_B          323 FDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKIDY  385 (597)
T ss_dssp             HTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTTC
T ss_pred             CCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcch
Confidence            999999999999998653   56678999999999999987654 3455666667888999998643

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1e-37  Score=330.61  Aligned_cols=171  Identities=27%  Similarity=0.411  Sum_probs=145.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      .++|++.+.||+|+||+||+|++. +|+.||||++....  ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            368999999999999999999986 48999999997553  344578999999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          735 EYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+||+|.+++...+ ..+++..+..|+.||+.||+|||   ++|||||||||+|||++.+|.+||+|||+|+......
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9999999999997543 35799999999999999999999   9999999999999999999999999999998764322


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                      . .....+||+.|||||++
T Consensus       180 ~-~~~~~~GT~~YmAPE~l  197 (350)
T 4b9d_A          180 E-LARACIGTPYYLSPEIC  197 (350)
T ss_dssp             H-HHHHHHSCCTTCCHHHH
T ss_pred             c-cccccCCCccccCHHHH
Confidence            2 22346799999999974

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.8e-37  Score=333.01  Aligned_cols=169  Identities=28%  Similarity=0.371  Sum_probs=152.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .+.|++.++||+|+||+||+|++. +|+.||||++........+.+.+|++++++++|||||+++++|.+++.+|+||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            357999999999999999999986 4899999999876666667889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      |+||+|.++++..  .+++..+..++.||+.||+|||   ++|||||||||+|||++.+|.+||+|||+|+.+...... 
T Consensus       230 ~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~-  303 (423)
T 4fie_A          230 LEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-  303 (423)
T ss_dssp             CTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC-
T ss_pred             CCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc-
Confidence            9999999999765  4899999999999999999999   999999999999999999999999999999987554332 


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      ....+||+.|||||++
T Consensus       304 ~~~~~GTp~YmAPEvl  319 (423)
T 4fie_A          304 RKSLVGTPYWMAPELI  319 (423)
T ss_dssp             BCCCEECTTTCCHHHH
T ss_pred             ccccccCcCcCCHHHH
Confidence            3346899999999974

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=7.9e-36  Score=329.04  Aligned_cols=336  Identities=19%  Similarity=0.190  Sum_probs=260.5

Q ss_pred             CccccceecccccccccccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCcc
Q 003301          165 NLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLS  244 (832)
Q Consensus       165 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~  244 (832)
                      .++++++|++++|.++.+.+..|.++++|++|++++|.+.+..+..  +..+++|++|+|++|+++++.|..|.++++|+
T Consensus        43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  120 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYA--FAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT  120 (390)
T ss_dssp             GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTT--TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhh--ccCCCCcCEEECCCCCCCcCCHHHhcCCCCCC
Confidence            4688999999999999877677899999999999999998655544  47899999999999999999999999999999


Q ss_pred             EEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceE
Q 003301          245 VLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRI  324 (832)
Q Consensus       245 ~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L  324 (832)
                      +|++++|.++.+.+..|..+++|++|++++|.++.++.     ..|..+++|++|++++|++++..              
T Consensus       121 ~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~-----~~~~~l~~L~~L~l~~n~l~~~~--------------  181 (390)
T 3o6n_A          121 VLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED-----DTFQATTSLQNLQLSSNRLTHVD--------------  181 (390)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCT-----TTTSSCTTCCEEECCSSCCSBCC--------------
T ss_pred             EEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccCh-----hhccCCCCCCEEECCCCcCCccc--------------
Confidence            99999999998777778999999999999999987543     34788999999999999987431              


Q ss_pred             EeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCC
Q 003301          325 FISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLS  404 (832)
Q Consensus       325 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  404 (832)
                                    +..+++|+.|++++|.+.+.     ...++|++|++++|+++.. |..  ..++|+.|++++|.++
T Consensus       182 --------------~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~  239 (390)
T 3o6n_A          182 --------------LSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLT  239 (390)
T ss_dssp             --------------GGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCC
T ss_pred             --------------cccccccceeeccccccccc-----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCc
Confidence                          22334555566666655432     2234566777777766632 332  2356777777777776


Q ss_pred             CCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccc
Q 003301          405 GPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIG  484 (832)
Q Consensus       405 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  484 (832)
                      +.  ..+..+++|+.|++++|.+++..|..|..+++|++|++++|++++ +|..+..+++|+.|+|++|+++ .+|..+.
T Consensus       240 ~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~  315 (390)
T 3o6n_A          240 DT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQP  315 (390)
T ss_dssp             CC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHH
T ss_pred             cc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCcccc
Confidence            43  467777888888888888887777888888888888888888875 5666778889999999999998 5677788


Q ss_pred             cccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCC
Q 003301          485 GLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIP  552 (832)
Q Consensus       485 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  552 (832)
                      .+++|+.|+|++|++++. |  +..+++|+.|++++|++++.....  -+..+....+..+...|..|
T Consensus       316 ~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~--~~~~~~~~~~~~~~~~c~~~  378 (390)
T 3o6n_A          316 QFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRA--LFRNVARPAVDDADQHCKID  378 (390)
T ss_dssp             HHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHH--HTTTCCTTTBCCCCSCCCTT
T ss_pred             ccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccchhHHH--HHHHHHhhcccccCceeccc
Confidence            899999999999999854 3  778899999999999998743332  23444444555555555443

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1e-36  Score=324.71  Aligned_cols=256  Identities=34%  Similarity=0.562  Sum_probs=220.3

Q ss_pred             ccceEEeecCcccc--cccccccCcCcccEEEeec-CcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEE
Q 003301          320 SLSRIFISNCSIRG--TIPKEIGNLINLRELGLWG-NELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVL  396 (832)
Q Consensus       320 ~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  396 (832)
                      +++.|++++|.+++  .+|..|.++++|++|++++ |.+.+.+|..|..+++|++|+|++|++++.+|..+..+++|++|
T Consensus        51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L  130 (313)
T 1ogq_A           51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence            57777777777777  7777888888888888884 88888888888888888888888888887888888888888888


Q ss_pred             EecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCc-ccceeeecCCcccCCCccccccccccceecccCccc
Q 003301          397 YMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLK-DILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNL  475 (832)
Q Consensus       397 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  475 (832)
                      ++++|++++.+|..|..+++|++|++++|++++..|..|..++ +|++|++++|++++..|..+..++ |+.|+|++|++
T Consensus       131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l  209 (313)
T 1ogq_A          131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred             eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence            8888888888888888888888888888888878888888887 888888888888888888888887 99999999999


Q ss_pred             CCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCCCCC
Q 003301          476 SGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGG  555 (832)
Q Consensus       476 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~  555 (832)
                      ++..|..|.++++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|++|+|++|+++|.+|...
T Consensus       210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~  288 (313)
T 1ogq_A          210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG  288 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred             cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCc
Confidence            888888899999999999999999876665 8888999999999999999999999999999999999999999999887


Q ss_pred             CCCCcCCCcccCCCCCCCCccc
Q 003301          556 PFANFSNRSFMGNDLLCGLAQV  577 (832)
Q Consensus       556 ~~~~~~~~~~~~n~~~c~~~~~  577 (832)
                      .+..+....+.||+++||.|..
T Consensus       289 ~l~~L~~l~l~~N~~lc~~p~~  310 (313)
T 1ogq_A          289 NLQRFDVSAYANNKCLCGSPLP  310 (313)
T ss_dssp             TGGGSCGGGTCSSSEEESTTSS
T ss_pred             cccccChHHhcCCCCccCCCCC
Confidence            7888888889999999997654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.4e-37  Score=322.39  Aligned_cols=171  Identities=26%  Similarity=0.484  Sum_probs=148.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      ++|.+.+.||+|+||+||+|++.      ++..||||+++.......+.|.+|++++++++|||||+++|+|.+++..|+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            57888999999999999999874      377899999987766667889999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEE
Q 003301          733 VLEYMPNGSLEDYLYSNN------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHL  800 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl  800 (832)
                      |||||++|+|.++++..+            ..+++.++..|+.|++.||+|||   +++||||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence            999999999999997532            35899999999999999999999   999999999999999999999999


Q ss_pred             eccccccccCCCcccc-cccccccccccCCCCC
Q 003301          801 SDFGIAKLLSGEESMK-QTLTLATIGYMAPGLF  832 (832)
Q Consensus       801 ~DFg~a~~~~~~~~~~-~~~~~gt~~y~APE~l  832 (832)
                      +|||+|+......... .....||++|||||++
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~  202 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI  202 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHH
Confidence            9999998765443322 2235699999999963

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=2.5e-35  Score=319.81  Aligned_cols=308  Identities=24%  Similarity=0.370  Sum_probs=213.5

Q ss_pred             ccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCcc
Q 003301          186 SIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLR  265 (832)
Q Consensus       186 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~  265 (832)
                      .+..+++|++|++++|.+. .+|.   +..+++|++|++++|+++++.+  +..+++|++|++++|.+++.  +.+..++
T Consensus        39 ~~~~l~~L~~L~l~~~~i~-~~~~---~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~  110 (347)
T 4fmz_A           39 TQEELESITKLVVAGEKVA-SIQG---IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLT  110 (347)
T ss_dssp             CHHHHTTCSEEECCSSCCC-CCTT---GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCT
T ss_pred             cchhcccccEEEEeCCccc-cchh---hhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCC
Confidence            3557788888888888886 3442   4567788888888888776655  67777888888888877753  3577777


Q ss_pred             ccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcc
Q 003301          266 KLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINL  345 (832)
Q Consensus       266 ~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L  345 (832)
                      +|++|++++|.++.++.       +..+++|+.|++++|......                          ..+..+++|
T Consensus       111 ~L~~L~l~~n~i~~~~~-------~~~l~~L~~L~l~~n~~~~~~--------------------------~~~~~l~~L  157 (347)
T 4fmz_A          111 NLRELYLNEDNISDISP-------LANLTKMYSLNLGANHNLSDL--------------------------SPLSNMTGL  157 (347)
T ss_dssp             TCSEEECTTSCCCCCGG-------GTTCTTCCEEECTTCTTCCCC--------------------------GGGTTCTTC
T ss_pred             cCCEEECcCCcccCchh-------hccCCceeEEECCCCCCcccc--------------------------cchhhCCCC
Confidence            77777777777765321       566777777777777543221                          225566666


Q ss_pred             cEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCC
Q 003301          346 RELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASN  425 (832)
Q Consensus       346 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  425 (832)
                      ++|++++|.+.+..+  +..+++|++|++++|++++. +. +..+++|+.|++++|.+.+..+  +..+++|+.|++++|
T Consensus       158 ~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n  231 (347)
T 4fmz_A          158 NYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI-SP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNN  231 (347)
T ss_dssp             CEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSS
T ss_pred             cEEEecCCCcCCchh--hccCCCCCEEEccCCccccc-cc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCC
Confidence            666666666664433  66666777777777776643 22 6666777777777777764433  666777777777777


Q ss_pred             cCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCc
Q 003301          426 ELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPK  505 (832)
Q Consensus       426 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  505 (832)
                      .+++..+  +..+++|++|++++|.+++.  ..+..+++|+.|++++|++++.  ..+..+++|+.|++++|++++..|.
T Consensus       232 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~  305 (347)
T 4fmz_A          232 KITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDME  305 (347)
T ss_dssp             CCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHH
T ss_pred             ccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChh
Confidence            7766544  66777777777777777653  4567777778888888877754  4577788888888888888877777


Q ss_pred             cccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCccc
Q 003301          506 SIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLE  548 (832)
Q Consensus       506 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~  548 (832)
                      .|+.+++|+.|+|++|++++..|  +..+++|++|++++|+++
T Consensus       306 ~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          306 VIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             HHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             HhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            78888888888888888887655  777888888888888775

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-36  Score=312.73  Aligned_cols=168  Identities=24%  Similarity=0.466  Sum_probs=135.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++....   ....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            478999999999999999999875 58999999997543   23356789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||| +|+|.+++.+.+ .+++..+..++.|++.||+|||   ++||+||||||+|||++.++.+||+|||+|+......
T Consensus        92 mEy~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             EECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             EeCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            9999 789999998765 7999999999999999999999   9999999999999999999999999999998764432


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                        .....+||+.|||||++
T Consensus       167 --~~~~~~GT~~Y~APE~~  183 (275)
T 3hyh_A          167 --FLKTSCGSPNYAAPEVI  183 (275)
T ss_dssp             ----------CTTSCHHHH
T ss_pred             --ccCCeeECcccCChhhh
Confidence              22346799999999974

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-36  Score=317.87  Aligned_cols=170  Identities=27%  Similarity=0.489  Sum_probs=143.2

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ..+++++.++||+|+||+||+|++.  ..||||+++...  ....+.|.+|++++++++|||||+++|++.+ +..|+||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            3467889999999999999999874  369999986433  3445789999999999999999999998865 5689999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |||++|+|.+++...+..+++.++..|+.|||.||+|||   +++||||||||+|||+++++.+||+|||+|+.......
T Consensus       111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            999999999999877668999999999999999999999   99999999999999999999999999999987643322


Q ss_pred             -cccccccccccccCCCCC
Q 003301          815 -MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 -~~~~~~~gt~~y~APE~l  832 (832)
                       ......+||+.|||||++
T Consensus       188 ~~~~~~~~GT~~ymAPE~l  206 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVI  206 (307)
T ss_dssp             ------CCCCTTSCCHHHH
T ss_pred             ceeecccccCCCccCHHHh
Confidence             223446799999999963

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.5e-36  Score=322.14  Aligned_cols=171  Identities=28%  Similarity=0.456  Sum_probs=142.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      ++|.+.++||+|+||+||+|++.      +++.||||+++.......+.|.+|++++++++|||||+++|+|.+++..|+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            56778899999999999999874      378899999987766667889999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcE
Q 003301          733 VLEYMPNGSLEDYLYSNN--------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVA  798 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~  798 (832)
                      |||||++|+|.++++...              ..+++.++..|+.|||.||+|||   +++||||||||+|||+++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence            999999999999997532              34899999999999999999999   9999999999999999999999


Q ss_pred             EEeccccccccCCCccc-ccccccccccccCCCCC
Q 003301          799 HLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       799 kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~l  832 (832)
                      ||+|||+|+........ .....+||+.|||||++
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~  232 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI  232 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhh
Confidence            99999999876443322 23345799999999963

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.4e-36  Score=311.43  Aligned_cols=164  Identities=27%  Similarity=0.424  Sum_probs=142.3

Q ss_pred             CCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEec----CCeeEEEE
Q 003301          662 NASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTN----NDFKALVL  734 (832)
Q Consensus       662 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  734 (832)
                      ++.++||+|+||+||+|.+.. ++.||+|++....  ....+.+.+|++++++++|||||+++++|.+    ++.+|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            667789999999999999864 8899999997543  3345789999999999999999999999865    34689999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeEeC-CCCcEEEeccccccccCC
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP--VVHCDIKPSNVLLD-KDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~-~~~~~kl~DFg~a~~~~~  811 (832)
                      |||+||+|.+++++.+ .+++..+..|+.||+.||+|||   +++  ||||||||+|||++ .++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999998754 6999999999999999999999   888  99999999999997 479999999999986533


Q ss_pred             CcccccccccccccccCCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .   .....+||+.|||||++
T Consensus       185 ~---~~~~~~GTp~YmAPE~~  202 (290)
T 3fpq_A          185 S---FAKAVIGTPEFMAPEMY  202 (290)
T ss_dssp             T---SBEESCSSCCCCCGGGG
T ss_pred             C---ccCCcccCccccCHHHc
Confidence            2   22346799999999974

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=9.9e-35  Score=315.08  Aligned_cols=308  Identities=27%  Similarity=0.394  Sum_probs=233.4

Q ss_pred             cccCccccceecccccccccccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCC
Q 003301          162 EMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNAS  241 (832)
Q Consensus       162 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~  241 (832)
                      .+..+++|++|++++|.+..+ + .+..+++|++|++++|.+++ +|.   +..+++|++|++++|.++.+  ..|..++
T Consensus        39 ~~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~-~~~---~~~l~~L~~L~L~~n~i~~~--~~~~~l~  110 (347)
T 4fmz_A           39 TQEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITD-ISP---LSNLVKLTNLYIGTNKITDI--SALQNLT  110 (347)
T ss_dssp             CHHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CGG---GTTCTTCCEEECCSSCCCCC--GGGTTCT
T ss_pred             cchhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCcccc-chh---hhcCCcCCEEEccCCcccCc--hHHcCCC
Confidence            456789999999999999864 3 48999999999999999984 443   57899999999999999975  3589999


Q ss_pred             CccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCccccccccc
Q 003301          242 KLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSL  321 (832)
Q Consensus       242 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L  321 (832)
                      +|++|++++|.+++..+  +..+++|++|++++|.....      +..+..+++|++|++++|.+.+..+          
T Consensus       111 ~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~------~~~~~~l~~L~~L~l~~~~~~~~~~----------  172 (347)
T 4fmz_A          111 NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSD------LSPLSNMTGLNYLTVTESKVKDVTP----------  172 (347)
T ss_dssp             TCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCC------CGGGTTCTTCCEEECCSSCCCCCGG----------
T ss_pred             cCCEEECcCCcccCchh--hccCCceeEEECCCCCCccc------ccchhhCCCCcEEEecCCCcCCchh----------
Confidence            99999999999997644  88999999999999965542      2337888999999999998764321          


Q ss_pred             ceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCC
Q 003301          322 SRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGN  401 (832)
Q Consensus       322 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  401 (832)
                                       +..+++|++|++++|.+.+..+  +..+++|+.|++++|.+++..+  +..+++|++|++++|
T Consensus       173 -----------------~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n  231 (347)
T 4fmz_A          173 -----------------IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNN  231 (347)
T ss_dssp             -----------------GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSS
T ss_pred             -----------------hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCC
Confidence                             4455566666666666654333  6666667777777776664333  666667777777777


Q ss_pred             cCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCC
Q 003301          402 KLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPT  481 (832)
Q Consensus       402 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  481 (832)
                      ++++..+  +..+++|+.|++++|.+++.  ..+..+++|++|++++|++++.  +.+..+++|+.|++++|++++..|.
T Consensus       232 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~  305 (347)
T 4fmz_A          232 KITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDME  305 (347)
T ss_dssp             CCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHH
T ss_pred             ccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChh
Confidence            7764333  66777777777777777664  3566777777777777777753  3577788888888888888877778


Q ss_pred             ccccccccceeecccccccccCCccccCCCCCCeeccCCCccc
Q 003301          482 AIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLS  524 (832)
Q Consensus       482 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  524 (832)
                      .|+++++|+.|++++|++++..|  ++.+++|+.||+++|+++
T Consensus       306 ~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          306 VIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             HHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             HhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            88888888888888888886655  778888888888888875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.3e-36  Score=320.82  Aligned_cols=166  Identities=24%  Similarity=0.306  Sum_probs=143.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .+.|++.++||+|+||+||+|++. +|+.||||+++.+..     ..+|++++++++|||||++++++.+++..|+||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            456888999999999999999986 489999999975432     24699999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC-cEEEeccccccccCCCccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~DFg~a~~~~~~~~~  815 (832)
                      |+||+|.+++++.+ .+++..+..++.||+.||+|||   +++||||||||+|||++.+| .+||+|||+|+........
T Consensus       132 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            99999999998754 6999999999999999999999   99999999999999999988 6999999999977543321


Q ss_pred             ----ccccccccccccCCCCC
Q 003301          816 ----KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ----~~~~~~gt~~y~APE~l  832 (832)
                          .....+||+.|||||++
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~  228 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVV  228 (336)
T ss_dssp             ------CCCCCCGGGCCHHHH
T ss_pred             cceecCCccccCccccCHHHH
Confidence                12235799999999974

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6e-37  Score=319.41  Aligned_cols=169  Identities=28%  Similarity=0.389  Sum_probs=141.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEec----CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL----DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      ++|++.+.||+|+||+||+|++.    .++.||||+++...  ......+.+|++++++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999874    36789999987543  2233568889999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      |||||+||+|.+++++.+ .+++..+..++.|++.||+|||   ++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            999999999999998754 6999999999999999999999   999999999999999999999999999999875443


Q ss_pred             cccccccccccccccCCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~l  832 (832)
                      .. .....+||+.|||||++
T Consensus       180 ~~-~~~~~~GT~~YmAPE~~  198 (304)
T 3ubd_A          180 EK-KAYSFCGTVEYMAPEVV  198 (304)
T ss_dssp             -C-CCCSCCCCGGGCCHHHH
T ss_pred             Cc-cccccccCcccCCHHHh
Confidence            32 23346799999999974

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.8e-36  Score=312.75  Aligned_cols=172  Identities=26%  Similarity=0.435  Sum_probs=137.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC-------
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNND-------  728 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------  728 (832)
                      .++|++.+.||+|+||+||+|++. +|+.||||+++... +...+.+.+|++++++++|||||+++++|.+.+       
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            356999999999999999999986 58999999997544 334567899999999999999999999987543       


Q ss_pred             -----eeEEEEecCCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEe
Q 003301          729 -----FKALVLEYMPNGSLEDYLYSNNF--SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLS  801 (832)
Q Consensus       729 -----~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~  801 (832)
                           ..|+|||||++|+|.+++.....  ..++..+..++.|++.||+|||   ++||+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEc
Confidence                 37999999999999999986542  2456778899999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCccc-----------ccccccccccccCCCCC
Q 003301          802 DFGIAKLLSGEESM-----------KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       802 DFg~a~~~~~~~~~-----------~~~~~~gt~~y~APE~l  832 (832)
                      |||+|+........           ..+..+||+.|||||++
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~  202 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI  202 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHH
Confidence            99999876543221           12235799999999964

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.4e-36  Score=314.72  Aligned_cols=171  Identities=24%  Similarity=0.407  Sum_probs=146.2

Q ss_pred             cCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  731 (832)
                      .++++.++||+|+||+||+|++.      +++.||||+++... ....+.|.+|+.++++++|||||+++|+|.+++..|
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            45677899999999999999873      36789999987543 234578999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC
Q 003301          732 LVLEYMPNGSLEDYLYSNN---------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM  796 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~  796 (832)
                      +|||||++|+|.+++....               ..+++..+.+|+.|||.||+|||   +++||||||||+|||+++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence            9999999999999996532               34899999999999999999999   99999999999999999999


Q ss_pred             cEEEeccccccccCCCccc-ccccccccccccCCCCC
Q 003301          797 VAHLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       797 ~~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~l  832 (832)
                      .+||+|||+|+........ .....+||++|||||++
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l  219 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAI  219 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHH
Confidence            9999999999876443322 23345799999999963

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.1e-34  Score=337.67  Aligned_cols=310  Identities=22%  Similarity=0.251  Sum_probs=153.9

Q ss_pred             CCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceec
Q 003301           94 LPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILG  173 (832)
Q Consensus        94 l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~  173 (832)
                      +.+++.|++++|.++...+..+..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  129 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  129 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence            44555555555555533333344555555555555555554444555555555555555555544444445555555555


Q ss_pred             ccccccccccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcC
Q 003301          174 LQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSF  253 (832)
Q Consensus       174 L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i  253 (832)
                      |++|.++++.+..|.++++|++|+|++|.+                          +++.|..|..+++|++|+|++|.+
T Consensus       130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l--------------------------~~~~~~~~~~l~~L~~L~L~~N~l  183 (597)
T 3oja_B          130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNL--------------------------ERIEDDTFQATTSLQNLQLSSNRL  183 (597)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCC--------------------------CBCCTTTTTTCTTCCEEECTTSCC
T ss_pred             eeCCCCCCCCHHHhccCCCCCEEEeeCCcC--------------------------CCCChhhhhcCCcCcEEECcCCCC
Confidence            555555443333334444444444444444                          334444444455555555555555


Q ss_pred             cccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccc
Q 003301          254 SGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRG  333 (832)
Q Consensus       254 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~  333 (832)
                      ++..   +..+++|+.|++++|.++.          +...++|+.|++++|.+....+. +                   
T Consensus       184 ~~~~---~~~l~~L~~L~l~~n~l~~----------l~~~~~L~~L~ls~n~l~~~~~~-~-------------------  230 (597)
T 3oja_B          184 THVD---LSLIPSLFHANVSYNLLST----------LAIPIAVEELDASHNSINVVRGP-V-------------------  230 (597)
T ss_dssp             SBCC---GGGCTTCSEEECCSSCCSE----------EECCTTCSEEECCSSCCCEEECS-C-------------------
T ss_pred             CCcC---hhhhhhhhhhhcccCcccc----------ccCCchhheeeccCCcccccccc-c-------------------
Confidence            4432   2334455555555555443          22234455555555555422111 1                   


Q ss_pred             cccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCC
Q 003301          334 TIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGD  413 (832)
Q Consensus       334 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  413 (832)
                              .++|+.|+|++|.+++  +..+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|.+++ +|..+..
T Consensus       231 --------~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~  299 (597)
T 3oja_B          231 --------NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQP  299 (597)
T ss_dssp             --------CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSC
T ss_pred             --------CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCccccc
Confidence                    1234444444444443  2344445555555555555554445555555555555555555553 3444455


Q ss_pred             CCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCC
Q 003301          414 LTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSG  477 (832)
Q Consensus       414 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  477 (832)
                      +++|+.|+|++|.+++ +|..+..+++|++|+|++|.+++. |  +..++.|+.|+|++|.+.+
T Consensus       300 l~~L~~L~Ls~N~l~~-i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~  359 (597)
T 3oja_B          300 IPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC  359 (597)
T ss_dssp             CTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred             CCCCcEEECCCCCCCc-cCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCC
Confidence            5555555555555553 344455555566666666665543 1  4555666666666666654

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=3e-35  Score=313.31  Aligned_cols=252  Identities=32%  Similarity=0.498  Sum_probs=230.1

Q ss_pred             CCCcEEeccCCCCCC--CCCCcccccccccceEEeec-CcccccccccccCcCcccEEEeecCcccccccccccCCCCCc
Q 003301          294 KNLKLLDLSNNPING--VLPSSIGNLSLSLSRIFISN-CSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQ  370 (832)
Q Consensus       294 ~~L~~L~L~~N~l~~--~~~~~~~~~~~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  370 (832)
                      .+++.|+|++|.+.+  .+|..+..+. +|++|++++ |.+.+.+|..|.++++|++|+|++|++++..|..|..+++|+
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~-~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~  128 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV  128 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCT-TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCC-CCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCC
Confidence            467788888888877  7777787776 888888884 888888899999999999999999999988999999999999


Q ss_pred             eEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCC-CCCeEeCCCCcCCCCCCcccccCcccceeeecCC
Q 003301          371 GLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLT-SLRLLSLASNELNSVIPSTFWNLKDILSLNFSSN  449 (832)
Q Consensus       371 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  449 (832)
                      +|+|++|++++.+|..+..+++|++|++++|++++.+|..+..++ +|+.|++++|++++..|..|..+. |++|++++|
T Consensus       129 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N  207 (313)
T 1ogq_A          129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRN  207 (313)
T ss_dssp             EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSS
T ss_pred             EEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCC
Confidence            999999999989999999999999999999999988999999998 999999999999999999999987 999999999


Q ss_pred             cccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCch
Q 003301          450 FLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPT  529 (832)
Q Consensus       450 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  529 (832)
                      ++++..|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..|+.+++|+.|+|++|+++|.+|.
T Consensus       208 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~  286 (313)
T 1ogq_A          208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ  286 (313)
T ss_dssp             EEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred             cccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCC
Confidence            99999999999999999999999999976665 88899999999999999999999999999999999999999999998


Q ss_pred             hhhhhccCCeeeCCCCc-ccc
Q 003301          530 SMEKLLYLKDLNLSFNK-LEG  549 (832)
Q Consensus       530 ~~~~l~~L~~l~l~~N~-l~~  549 (832)
                      . ..+++|+.+++++|+ ++|
T Consensus       287 ~-~~l~~L~~l~l~~N~~lc~  306 (313)
T 1ogq_A          287 G-GNLQRFDVSAYANNKCLCG  306 (313)
T ss_dssp             S-TTGGGSCGGGTCSSSEEES
T ss_pred             C-ccccccChHHhcCCCCccC
Confidence            7 889999999999999 554

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.3e-35  Score=308.18  Aligned_cols=170  Identities=27%  Similarity=0.414  Sum_probs=137.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCC----eeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNND----FKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  734 (832)
                      ++|.+.++||+|+||+||+|++ +|+.||||++...... .....+|+..+.+++|||||++++++.+++    ..|+||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4678889999999999999998 7899999998754322 123344666667889999999999998654    579999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG-----YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      |||++|+|.++++..  .+++..+.+++.|++.||+|+|..     +..+||||||||+|||++.++.+||+|||+|+..
T Consensus        81 Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             cCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            999999999999875  489999999999999999999921     1239999999999999999999999999999876


Q ss_pred             CCCccc---ccccccccccccCCCCC
Q 003301          810 SGEESM---KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       810 ~~~~~~---~~~~~~gt~~y~APE~l  832 (832)
                      ......   .....+||+.|||||++
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l  184 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVL  184 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHH
T ss_pred             cCCCCceeeecccccccccccCHHHh
Confidence            543322   12235799999999963

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2e-33  Score=302.47  Aligned_cols=294  Identities=23%  Similarity=0.266  Sum_probs=164.1

Q ss_pred             cccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCccccceee
Q 003301          192 AMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLR  271 (832)
Q Consensus       192 ~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  271 (832)
                      +++.+++++|.+. .+|..+    .++|++|++++|+++++.+..|.++++|++|++++|.+++..|..|.++++|++|+
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~----~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  108 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEI----SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY  108 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCC----CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred             cCCEEECCCCCcc-ccCCCC----CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence            4666666666665 455433    24566666666666666566666666666666666666655555566666666666


Q ss_pred             cccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEee
Q 003301          272 LSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLW  351 (832)
Q Consensus       272 L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~  351 (832)
                      +++|.++.++...      .  +                         +|++|++++|++++..+..|..+++|++|+++
T Consensus       109 L~~n~l~~l~~~~------~--~-------------------------~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~  155 (332)
T 2ft3_A          109 ISKNHLVEIPPNL------P--S-------------------------SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMG  155 (332)
T ss_dssp             CCSSCCCSCCSSC------C--T-------------------------TCCEEECCSSCCCCCCSGGGSSCSSCCEEECC
T ss_pred             CCCCcCCccCccc------c--c-------------------------cCCEEECCCCccCccCHhHhCCCccCCEEECC
Confidence            6655555433221      0  3                         44444444444444445556777777778887


Q ss_pred             cCccc--ccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCC
Q 003301          352 GNELI--GSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNS  429 (832)
Q Consensus       352 ~N~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  429 (832)
                      +|.++  +..+..|..+ +|++|++++|++++ +|..+.  ++|++|++++|++++..+..|..+++|+.|++++|++++
T Consensus       156 ~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~  231 (332)
T 2ft3_A          156 GNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM  231 (332)
T ss_dssp             SCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCC
T ss_pred             CCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCc
Confidence            77775  3556667666 77777777777774 444333  456666666666665555555555666666665555555


Q ss_pred             CCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccC
Q 003301          430 VIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGG  509 (832)
Q Consensus       430 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  509 (832)
                      ..+..|..+++|++|++++|+++ .+|..+..+++|+.|++++|++++..+..|..+..                  -..
T Consensus       232 ~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~------------------~~~  292 (332)
T 2ft3_A          232 IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGF------------------GVK  292 (332)
T ss_dssp             CCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSC------------------CSS
T ss_pred             CChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcccccc------------------ccc
Confidence            55555555555555555555554 34444444455555555555544443333332200                  000


Q ss_pred             CCCCCeeccCCCccc--ccCchhhhhhccCCeeeCCCCc
Q 003301          510 LVSLESLDLSNNSLS--GNIPTSMEKLLYLKDLNLSFNK  546 (832)
Q Consensus       510 l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~l~l~~N~  546 (832)
                      ..+|+.|++++|++.  +..|..+..++.|+.+++++|+
T Consensus       293 ~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          293 RAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             SCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             cccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence            245566666666665  4555566666666666666653

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=3.7e-33  Score=300.40  Aligned_cols=177  Identities=19%  Similarity=0.253  Sum_probs=125.7

Q ss_pred             CCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCC--CCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCccccee
Q 003301          367 QNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLS--GPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSL  444 (832)
Q Consensus       367 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  444 (832)
                      ++|++|++++|++++..+..|..+++|++|++++|.++  +..|..|..+ +|+.|++++|+++++. ..+.  ++|++|
T Consensus       123 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~-~~~~--~~L~~L  198 (332)
T 2ft3_A          123 SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIP-KDLP--ETLNEL  198 (332)
T ss_dssp             TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCC-SSSC--SSCSCC
T ss_pred             ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCccC-cccc--CCCCEE
Confidence            44555555555555444444555555555555555553  2455556666 6777777777776633 3222  567777


Q ss_pred             eecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCccc
Q 003301          445 NFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLS  524 (832)
Q Consensus       445 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  524 (832)
                      ++++|++++..+..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|+++ .+|..++.+++|+.|++++|+++
T Consensus       199 ~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~  277 (332)
T 2ft3_A          199 HLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT  277 (332)
T ss_dssp             BCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCC
T ss_pred             ECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCC
Confidence            77777777777777888888888888888888777778888888888888888888 67778888888888888888888


Q ss_pred             ccCchhhhh------hccCCeeeCCCCccc
Q 003301          525 GNIPTSMEK------LLYLKDLNLSFNKLE  548 (832)
Q Consensus       525 ~~~p~~~~~------l~~L~~l~l~~N~l~  548 (832)
                      +..+..+..      ...|+.|++++|++.
T Consensus       278 ~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~  307 (332)
T 2ft3_A          278 KVGVNDFCPVGFGVKRAYYNGISLFNNPVP  307 (332)
T ss_dssp             BCCTTSSSCSSCCSSSCCBSEEECCSSSSC
T ss_pred             ccChhHccccccccccccccceEeecCccc
Confidence            777766654      367899999999997

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=6.9e-33  Score=298.14  Aligned_cols=295  Identities=21%  Similarity=0.249  Sum_probs=158.2

Q ss_pred             cccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCccccceee
Q 003301          192 AMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLR  271 (832)
Q Consensus       192 ~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  271 (832)
                      +++.++++++.+. .+|..+    .+++++|+|++|+++++.+..|.++++|++|+|++|.+++..|..|.++++|++|+
T Consensus        32 ~l~~l~~~~~~l~-~lp~~~----~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (330)
T 1xku_A           32 HLRVVQCSDLGLE-KVPKDL----PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY  106 (330)
T ss_dssp             ETTEEECTTSCCC-SCCCSC----CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred             CCeEEEecCCCcc-ccCccC----CCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence            5666666666665 445433    24556666666666655555555555666666666655555555555555555555


Q ss_pred             cccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEee
Q 003301          272 LSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLW  351 (832)
Q Consensus       272 L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~  351 (832)
                      +++|.++.++.                              .+.   .+|++|++++|.+++..+..|.++++|++|+++
T Consensus       107 Ls~n~l~~l~~------------------------------~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  153 (330)
T 1xku_A          107 LSKNQLKELPE------------------------------KMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELG  153 (330)
T ss_dssp             CCSSCCSBCCS------------------------------SCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECC
T ss_pred             CCCCcCCccCh------------------------------hhc---ccccEEECCCCcccccCHhHhcCCccccEEECC
Confidence            55555543322                              211   144444444444444555556666777777777


Q ss_pred             cCcccc--cccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCC
Q 003301          352 GNELIG--SIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNS  429 (832)
Q Consensus       352 ~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  429 (832)
                      +|.+..  ..+..|..+++|++|++++|+++. +|..+.  ++|++|++++|++++..|..|..+++|+.|++++|.+++
T Consensus       154 ~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~  230 (330)
T 1xku_A          154 TNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA  230 (330)
T ss_dssp             SSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCE
T ss_pred             CCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCce
Confidence            776643  455566666666666666666663 443332  456666666666655555555555666666665555555


Q ss_pred             CCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccC
Q 003301          430 VIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGG  509 (832)
Q Consensus       430 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  509 (832)
                      ..+..|..+++|++|++++|+++ .+|..+..+++|++|++++|++++..+..|....                  ....
T Consensus       231 ~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~------------------~~~~  291 (330)
T 1xku_A          231 VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG------------------YNTK  291 (330)
T ss_dssp             ECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSS------------------CCTT
T ss_pred             eChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcc------------------cccc
Confidence            55555555555555555555554 3444444455555555555555444333333210                  0001


Q ss_pred             CCCCCeeccCCCcccc--cCchhhhhhccCCeeeCCCCc
Q 003301          510 LVSLESLDLSNNSLSG--NIPTSMEKLLYLKDLNLSFNK  546 (832)
Q Consensus       510 l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~l~l~~N~  546 (832)
                      ...|+.|++++|++..  ..|..+..+..++.++|++|+
T Consensus       292 ~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          292 KASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             SCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             cccccceEeecCcccccccCccccccccceeEEEecccC
Confidence            2455666666666542  445556666666666666663

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=1.2e-32  Score=296.27  Aligned_cols=289  Identities=24%  Similarity=0.308  Sum_probs=182.3

Q ss_pred             CCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccccccccccCcccccCCcccEEEe
Q 003301          119 KELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLAL  198 (832)
Q Consensus       119 ~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  198 (832)
                      .++++++++++.++ .+|..+.  ++|++|+|++|++++..+..|+++++|++|++++|++++..|.+|.++++|++|++
T Consensus        31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (330)
T 1xku_A           31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL  107 (330)
T ss_dssp             EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence            36888888888887 4666554  57888888888888666667888888888888888888877888888888888888


Q ss_pred             cCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcc--cCCccccCccccceeeccccc
Q 003301          199 PSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSG--FIPNTLGNLRKLEWLRLSYNF  276 (832)
Q Consensus       199 ~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~L~~N~  276 (832)
                      ++|.++ .+|..+    .++|++|++++|+++++.+..|.++++|++|++++|.++.  ..+..|               
T Consensus       108 s~n~l~-~l~~~~----~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~---------------  167 (330)
T 1xku_A          108 SKNQLK-ELPEKM----PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF---------------  167 (330)
T ss_dssp             CSSCCS-BCCSSC----CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGG---------------
T ss_pred             CCCcCC-ccChhh----cccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhc---------------
Confidence            888876 455433    2556666666666665555555555566666666555542  333344               


Q ss_pred             CCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCccc
Q 003301          277 LTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELI  356 (832)
Q Consensus       277 l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  356 (832)
                                    ..+++|++|++++|.++. +|..+.   .+|++|++++|++++..|..|..+++|++|++++|.++
T Consensus       168 --------------~~l~~L~~L~l~~n~l~~-l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~  229 (330)
T 1xku_A          168 --------------QGMKKLSYIRIADTNITT-IPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS  229 (330)
T ss_dssp             --------------GGCTTCCEEECCSSCCCS-CCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCC
T ss_pred             --------------cCCCCcCEEECCCCcccc-CCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCc
Confidence                          445555555555555542 222221   24555555555555555666667777777777777777


Q ss_pred             ccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCC------CCCCeEeCCCCcCCC-
Q 003301          357 GSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDL------TSLRLLSLASNELNS-  429 (832)
Q Consensus       357 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l------~~L~~L~L~~N~l~~-  429 (832)
                      +..+..|..+++|++|+|++|+++ .+|..+..+++|++|++++|++++..+..|...      +.|+.|++++|++.. 
T Consensus       230 ~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~  308 (330)
T 1xku_A          230 AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW  308 (330)
T ss_dssp             EECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred             eeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCccccc
Confidence            666666777777777777777776 566666666677777777777765555555432      445555555555532 


Q ss_pred             -CCCcccccCcccceeeecCC
Q 003301          430 -VIPSTFWNLKDILSLNFSSN  449 (832)
Q Consensus       430 -~~~~~~~~l~~L~~L~Ls~N  449 (832)
                       +.|..|..+.+++.++|++|
T Consensus       309 ~i~~~~f~~~~~l~~l~L~~N  329 (330)
T 1xku_A          309 EIQPSTFRCVYVRAAVQLGNY  329 (330)
T ss_dssp             GSCGGGGTTCCCGGGEEC---
T ss_pred             ccCccccccccceeEEEeccc
Confidence             33344444444444444444

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=1.6e-37  Score=351.05  Aligned_cols=358  Identities=20%  Similarity=0.203  Sum_probs=182.3

Q ss_pred             CccEEECcCCcccccCCCC-CcCCCcCceEEeccccccc----ccCccccCccccceecccccccccccCcccc-cCCcc
Q 003301          120 ELIVISLAYNQFTERIPRG-LGNLTSLKTLYLGFNNLTG----EIPYEMGNLRNLEILGLQLNKLVGFVPTSIF-NLSAM  193 (832)
Q Consensus       120 ~L~~L~Ls~n~i~~~~p~~-~~~l~~L~~L~Ls~N~i~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L  193 (832)
                      +|++|+|++|+++...... +..+++|++|+|++|+++.    .++..+..+++|++|+|++|++....+..+. .++. 
T Consensus         4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~-   82 (461)
T 1z7x_W            4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT-   82 (461)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS-
T ss_pred             cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh-
Confidence            4555555555554322221 4445555555555555542    1233444445555555555554432222221 1220 


Q ss_pred             cEEEecCCCCCCCCCccccccCCCCccEEEccCCcccc----ccCCcccCCCCccEEEcCCCcCcccCCcccc-----Cc
Q 003301          194 KTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSG----IIPSFIFNASKLSVLELGENSFSGFIPNTLG-----NL  264 (832)
Q Consensus       194 ~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~----~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~-----~l  264 (832)
                                           ..++|++|+|++|+++.    ..+..+..+++|++|++++|.+++..+..+.     ..
T Consensus        83 ---------------------~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~  141 (461)
T 1z7x_W           83 ---------------------PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ  141 (461)
T ss_dssp             ---------------------TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTT
T ss_pred             ---------------------CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCC
Confidence                                 00145555555555552    3355556666666666666666543333222     23


Q ss_pred             cccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccc----cccccceEEeecCccccc----cc
Q 003301          265 RKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGN----LSLSLSRIFISNCSIRGT----IP  336 (832)
Q Consensus       265 ~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~----~~~~L~~L~l~~n~l~~~----~~  336 (832)
                      ++|++|++++|.++..... .++..+..+++|++|++++|.+.+..+..+..    ...+|++|++++|.+++.    ++
T Consensus       142 ~~L~~L~L~~n~l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~  220 (461)
T 1z7x_W          142 CRLEKLQLEYCSLSAASCE-PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLC  220 (461)
T ss_dssp             CCCCEEECTTSCCBGGGHH-HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHH
T ss_pred             CcceEEECCCCCCCHHHHH-HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHH
Confidence            4566666666666542221 12344556667777777777665433222222    112566666666665542    35


Q ss_pred             ccccCcCcccEEEeecCcccccc-----cccccCCCCCceEEccCCccCCC----CchhhcCCCCCcEEEecCCcCCCCC
Q 003301          337 KEIGNLINLRELGLWGNELIGSI-----PITFGKLQNLQGLDLVNNKLEGP----IPNGLCQLARLSVLYMDGNKLSGPI  407 (832)
Q Consensus       337 ~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~  407 (832)
                      ..+..+++|++|++++|.+.+..     +..+..+++|++|++++|++++.    ++..+..+++|++|++++|.+++..
T Consensus       221 ~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~  300 (461)
T 1z7x_W          221 GIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG  300 (461)
T ss_dssp             HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHH
T ss_pred             HHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHH
Confidence            55666677777777777665432     22233466677777777766643    4555555666777777776665433


Q ss_pred             cccCC-----CCCCCCeEeCCCCcCCCC----CCcccccCcccceeeecCCcccCCCcccccc-----ccccceecccCc
Q 003301          408 PPCIG-----DLTSLRLLSLASNELNSV----IPSTFWNLKDILSLNFSSNFLNGSLPEDIGN-----LKVVVIIDLSRN  473 (832)
Q Consensus       408 p~~~~-----~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~N  473 (832)
                      +..+.     ..++|+.|++++|.+++.    .+..+..+++|++|++++|++++..+..+..     .+.|+.|+|++|
T Consensus       301 ~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n  380 (461)
T 1z7x_W          301 ARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC  380 (461)
T ss_dssp             HHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred             HHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCC
Confidence            32222     224666666666666543    2333444455555555555555433332221     334555555555


Q ss_pred             ccCC----ccCCccccccccceeeccccccc
Q 003301          474 NLSG----DIPTAIGGLMNLQDLSLRDNGLQ  500 (832)
Q Consensus       474 ~l~~----~~~~~~~~l~~L~~L~Ls~N~l~  500 (832)
                      ++++    .+|..+..+++|++|+|++|+++
T Consensus       381 ~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~  411 (461)
T 1z7x_W          381 DVSDSSCSSLAATLLANHSLRELDLSNNCLG  411 (461)
T ss_dssp             CCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred             CCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence            5543    34444444555555555555544

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.7e-34  Score=308.76  Aligned_cols=181  Identities=22%  Similarity=0.395  Sum_probs=152.8

Q ss_pred             cchHHHHHHhcCCCCCCeeeccCCceEEEEEecC------CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCC-Cceeee
Q 003301          649 FSYKELLQATNQFNASNLIGTGGFGSVYKGSFLD------GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRH-RNLVKI  720 (832)
Q Consensus       649 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~niv~l  720 (832)
                      +..++++...++|++.+.||+|+||+||+|++..      ++.||||++.... ....+.+.+|++++++++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            4555666677899999999999999999998753      3679999987554 3345779999999999965 899999


Q ss_pred             ceEEecC-CeeEEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecC
Q 003301          721 ISSCTNN-DFKALVLEYMPNGSLEDYLYSNN---------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD  784 (832)
Q Consensus       721 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D  784 (832)
                      +|+|.+. +..|+|||||++|+|.++++..+               ..+++..+..++.|||.||+|||   +++|||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCc
Confidence            9998764 57899999999999999997532               24789999999999999999999   99999999


Q ss_pred             CCCCCeEeCCCCcEEEeccccccccCCCcc-cccccccccccccCCCCC
Q 003301          785 IKPSNVLLDKDMVAHLSDFGIAKLLSGEES-MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       785 lkp~NIl~~~~~~~kl~DFg~a~~~~~~~~-~~~~~~~gt~~y~APE~l  832 (832)
                      |||+|||+++++.+||+|||+|+....... ......+||+.|||||++
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l  259 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI  259 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHH
Confidence            999999999999999999999987654433 233446799999999964

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.2e-33  Score=317.69  Aligned_cols=168  Identities=27%  Similarity=0.393  Sum_probs=145.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHH---HHHHHHHhcCCCCceeeeceEEecCCee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSF---DVECEVLKSVRHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~~  730 (832)
                      .++|++.++||+|+||+||+|++.. |+.||||++....   .......   ..++++++.++|||||+++++|.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            4789999999999999999999864 8999999997542   1122233   3346677888999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      |+|||||+||+|.+++.+.+ .+++..+..++.||+.||+|||   ++|||||||||+|||++.+|.+||+|||+|+...
T Consensus       268 ylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999999998754 6999999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCcccccccccccccccCCCCC
Q 003301          811 GEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       811 ~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ...   ....+||+.|||||++
T Consensus       344 ~~~---~~t~~GTp~YmAPEvl  362 (689)
T 3v5w_A          344 KKK---PHASVGTHGYMAPEVL  362 (689)
T ss_dssp             SCC---CCSCCSCGGGCCHHHH
T ss_pred             CCC---CCCccCCcCccCHHHH
Confidence            433   2346899999999974

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-33  Score=306.17  Aligned_cols=169  Identities=27%  Similarity=0.386  Sum_probs=144.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEec------CCe
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTN------NDF  729 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~  729 (832)
                      ++|++.+.||+|+||+||+|.+. +|+.||||+++...  ....+.+.+|++++++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999986 59999999997543  2344678899999999999999999998764      357


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      +|+|||||+ |+|.+++...+ .+++..+..+++||+.||+|||   ++|||||||||+|||++.++.+||+|||+|+.+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            899999995 78999997654 7999999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCc---ccccccccccccccCCCCC
Q 003301          810 SGEE---SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       810 ~~~~---~~~~~~~~gt~~y~APE~l  832 (832)
                      ....   .......+||+.|||||++
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~  234 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELM  234 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHH
T ss_pred             ccCccccccccccceeChHhcCHHHh
Confidence            4322   1223346899999999963

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=5.5e-36  Score=338.46  Aligned_cols=389  Identities=17%  Similarity=0.132  Sum_probs=236.1

Q ss_pred             ccccCeEeccCCccccCCCc-cccccccCcEEEccCCcCCC----CCCCcccCcccccccccccccccccCCChhhhhcC
Q 003301           20 LTMLKKLGLGYNKLRGEIPQ-ELGNLAELELVSLTNNFLSG----TIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRL   94 (832)
Q Consensus        20 l~~L~~L~ls~n~l~~~~p~-~~~~l~~L~~L~l~~n~l~~----~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l   94 (832)
                      .++|++|||++|+++..... .+..+++|++|++++|.++.    .+|..+..++++ ++||+++|.+++..+..++..+
T Consensus         2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L-~~L~Ls~n~l~~~~~~~l~~~l   80 (461)
T 1z7x_W            2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPAL-AELNLRSNELGDVGVHCVLQGL   80 (461)
T ss_dssp             CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTC-CEEECTTCCCHHHHHHHHHHTT
T ss_pred             CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCc-CEEeCCCCcCChHHHHHHHHHH
Confidence            35788899999988733322 37788899999999998874    345556666777 7888888887755555565556


Q ss_pred             C----CceEEEccCCcccc----cCCCCccCCCCccEEECcCCcccccCCCCC-----cCCCcCceEEecccccccc---
Q 003301           95 P----LIKGLYMSNNKLTG----PIPNNIWQCKELIVISLAYNQFTERIPRGL-----GNLTSLKTLYLGFNNLTGE---  158 (832)
Q Consensus        95 ~----~L~~L~l~~N~l~~----~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~-----~~l~~L~~L~Ls~N~i~~~---  158 (832)
                      +    +|++|++++|+++.    .++..+..+++|++|+|++|.+++..+..+     ...++|++|+|++|++++.   
T Consensus        81 ~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~  160 (461)
T 1z7x_W           81 QTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE  160 (461)
T ss_dssp             CSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH
T ss_pred             hhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH
Confidence            5    58888888888773    446677777788888888887765433322     2245677777777777653   


Q ss_pred             -cCccccCccccceecccccccccccCcccc-----cCCcccEEEecCCCCCCC----CCccccccCCCCccEEEccCCc
Q 003301          159 -IPYEMGNLRNLEILGLQLNKLVGFVPTSIF-----NLSAMKTLALPSNALSGS----LPSSIDLVRLPNLEIISLAGNN  228 (832)
Q Consensus       159 -~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~n~l~~~----~p~~~~~~~l~~L~~L~Ls~n~  228 (832)
                       ++..+..+++|++|++++|++....+..+.     ..++|++|++++|.+++.    ++..  +..+++|++|++++|.
T Consensus       161 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~--l~~~~~L~~L~Ls~n~  238 (461)
T 1z7x_W          161 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI--VASKASLRELALGSNK  238 (461)
T ss_dssp             HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHH--HHHCTTCCEEECCSSB
T ss_pred             HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHH--HHhCCCccEEeccCCc
Confidence             244555667777777777776644333332     244666666666665532    1221  1234455555555554


Q ss_pred             cccccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCC
Q 003301          229 FSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPING  308 (832)
Q Consensus       229 i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~  308 (832)
                      ++......+                   .+..+..+++|++|++++|.++..... .++..+..+++|++|++++|.+.+
T Consensus       239 l~~~~~~~l-------------------~~~~~~~~~~L~~L~L~~n~l~~~~~~-~l~~~l~~~~~L~~L~Ls~n~i~~  298 (461)
T 1z7x_W          239 LGDVGMAEL-------------------CPGLLHPSSRLRTLWIWECGITAKGCG-DLCRVLRAKESLKELSLAGNELGD  298 (461)
T ss_dssp             CHHHHHHHH-------------------HHHHTSTTCCCCEEECTTSCCCHHHHH-HHHHHHHHCTTCCEEECTTCCCHH
T ss_pred             CChHHHHHH-------------------HHHHhcCCCCceEEECcCCCCCHHHHH-HHHHHHhhCCCcceEECCCCCCch
Confidence            443211000                   011122344455555555544431110 123334445555555555555543


Q ss_pred             CCCCccccc----ccccceEEeecCccccc----ccccccCcCcccEEEeecCcccccccccccC-----CCCCceEEcc
Q 003301          309 VLPSSIGNL----SLSLSRIFISNCSIRGT----IPKEIGNLINLRELGLWGNELIGSIPITFGK-----LQNLQGLDLV  375 (832)
Q Consensus       309 ~~~~~~~~~----~~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~Ls  375 (832)
                      ..+..+...    ..+|++|++++|.+++.    ++..+..+++|++|++++|++++..+..+..     .++|++|+|+
T Consensus       299 ~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~  378 (461)
T 1z7x_W          299 EGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLA  378 (461)
T ss_dssp             HHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred             HHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECC
Confidence            222222221    12566666666666543    4566677788999999999887665554443     6789999999


Q ss_pred             CCccCC----CCchhhcCCCCCcEEEecCCcCCCCCccc----C-CCCCCCCeEeCCCCcCCCCC
Q 003301          376 NNKLEG----PIPNGLCQLARLSVLYMDGNKLSGPIPPC----I-GDLTSLRLLSLASNELNSVI  431 (832)
Q Consensus       376 ~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~----~-~~l~~L~~L~L~~N~l~~~~  431 (832)
                      +|++++    .+|..+..+++|++|++++|++++.....    + ....+|+.|++.++.+....
T Consensus       379 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~  443 (461)
T 1z7x_W          379 DCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEM  443 (461)
T ss_dssp             TSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHH
T ss_pred             CCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHH
Confidence            999885    67788888899999999999887532111    1 12456888888777765433

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.2e-33  Score=300.25  Aligned_cols=168  Identities=25%  Similarity=0.358  Sum_probs=143.4

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEec----CCcEEEEEEEeccchhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCee
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFL----DGMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  730 (832)
                      +..++|++.++||+|+||+||+|+++    .++.||+|++....  ...++.+|+++++.+ +|||||++++++.+++..
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            34578999999999999999999864    36789999986543  235678999999988 699999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC-CcEEEecccccccc
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD-MVAHLSDFGIAKLL  809 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~kl~DFg~a~~~  809 (832)
                      |+|||||++|+|.++++    .+++.++..++.|++.||+|||   ++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus        96 ~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             EEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            99999999999999984    4899999999999999999999   9999999999999999876 89999999999865


Q ss_pred             CCCcc---------------------------cccccccccccccCCCCC
Q 003301          810 SGEES---------------------------MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       810 ~~~~~---------------------------~~~~~~~gt~~y~APE~l  832 (832)
                      .....                           ......+||+.|||||++
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l  218 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVL  218 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHH
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHH
Confidence            43221                           012235799999999963

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.97  E-value=2.3e-32  Score=312.66  Aligned_cols=170  Identities=23%  Similarity=0.369  Sum_probs=153.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .++|++.+.||+|+||+||+|.++ +|+.||+|++........+.+.+|+++++.++|||||++++++.+++..|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            468999999999999999999886 4899999999877666667889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC--CcEEEeccccccccCCCcc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD--MVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~--~~~kl~DFg~a~~~~~~~~  814 (832)
                      |+||+|.+++......+++..+..+++||+.||+|||   +++|+||||||+|||++.+  +.+||+|||+|+.+.....
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~  312 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  312 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence            9999999999876667999999999999999999999   9999999999999999854  8999999999998755432


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                        ....+||+.|||||++
T Consensus       313 --~~~~~GT~~y~APEv~  328 (573)
T 3uto_A          313 --VKVTTGTAEFAAPEVA  328 (573)
T ss_dssp             --EEEECSSGGGCCHHHH
T ss_pred             --eeeeEECccccCHHHh
Confidence              3346799999999974

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=1.6e-31  Score=290.33  Aligned_cols=258  Identities=20%  Similarity=0.204  Sum_probs=170.8

Q ss_pred             CCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEc
Q 003301          295 NLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDL  374 (832)
Q Consensus       295 ~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  374 (832)
                      +|++|++++|.+++..+..+..+. +|++|++++|++++..|..|.++++|++|++++|++++..+..|..+++|++|+|
T Consensus        53 ~L~~L~l~~n~i~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  131 (353)
T 2z80_A           53 AVKSLDLSNNRITYISNSDLQRCV-NLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL  131 (353)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCT-TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEEC
T ss_pred             cCcEEECCCCcCcccCHHHhccCC-CCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEEC
Confidence            444444444444433333444433 4555555555555555556666677777777777776655555677777777777


Q ss_pred             cCCccCCCCc-hhhcCCCCCcEEEecCC-cCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCccc
Q 003301          375 VNNKLEGPIP-NGLCQLARLSVLYMDGN-KLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLN  452 (832)
Q Consensus       375 s~N~l~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  452 (832)
                      ++|++++..+ ..+..+++|++|++++| .+.+..+..|.++++|+.|++++|.+++..|..|..+++|++|++++|+++
T Consensus       132 ~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~  211 (353)
T 2z80_A          132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI  211 (353)
T ss_dssp             TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST
T ss_pred             CCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc
Confidence            7777764333 35666777777777777 355555666777777777777777777777777777777777777777776


Q ss_pred             CCCccccccccccceecccCcccCCccCCccc---cccccceeecccccccc----cCCccccCCCCCCeeccCCCcccc
Q 003301          453 GSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIG---GLMNLQDLSLRDNGLQG----SIPKSIGGLVSLESLDLSNNSLSG  525 (832)
Q Consensus       453 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~  525 (832)
                      ...+..+..+++|+.|++++|++++..+..+.   ....++.++|++|.+++    .+|..++.+++|+.|||++|+++.
T Consensus       212 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~  291 (353)
T 2z80_A          212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS  291 (353)
T ss_dssp             THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCC
T ss_pred             cchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCc
Confidence            44333445577777777777777765544433   24556667777776665    467788889999999999999985


Q ss_pred             cCchhhhhhccCCeeeCCCCcccccCCC
Q 003301          526 NIPTSMEKLLYLKDLNLSFNKLEGEIPR  553 (832)
Q Consensus       526 ~~p~~~~~l~~L~~l~l~~N~l~~~~p~  553 (832)
                      ..+..+..+++|++|+|++|+++|.+|.
T Consensus       292 i~~~~~~~l~~L~~L~L~~N~~~~~~~~  319 (353)
T 2z80_A          292 VPDGIFDRLTSLQKIWLHTNPWDCSCPR  319 (353)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             cCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence            4333468899999999999999998874

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.97  E-value=7.7e-32  Score=298.45  Aligned_cols=180  Identities=22%  Similarity=0.337  Sum_probs=157.1

Q ss_pred             chHHHHHHhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEe
Q 003301          650 SYKELLQATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCT  725 (832)
Q Consensus       650 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  725 (832)
                      .+.++....++|++.++||+|+||+||+|++.. ++.||+|++....   ....+.+.+|+.+++.++||||+++++++.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            344555567899999999999999999999875 7889999997532   222345888999999999999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccc
Q 003301          726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGI  805 (832)
Q Consensus       726 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~  805 (832)
                      +++..|+|||||++|+|.+++.+....+++..+..++.|++.||+|||   +.||+||||||+|||++.++.+||+|||+
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhh
Confidence            999999999999999999999876567999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCCCCC
Q 003301          806 AKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       806 a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      |+.............+||+.|||||++
T Consensus       222 a~~~~~~~~~~~~~~~GT~~Y~APE~l  248 (437)
T 4aw2_A          222 CLKLMEDGTVQSSVAVGTPDYISPEIL  248 (437)
T ss_dssp             CEECCTTSCEECCSCCSCGGGCCHHHH
T ss_pred             hhhcccCCCcccccccCCcCeeChHHH
Confidence            987765544444456899999999963

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=8.2e-31  Score=278.75  Aligned_cols=230  Identities=22%  Similarity=0.212  Sum_probs=111.8

Q ss_pred             cceEEeecCcccccccccccCcCcccEEEeecCccccc--ccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEe
Q 003301          321 LSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGS--IPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYM  398 (832)
Q Consensus       321 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  398 (832)
                      +++|++++|+++...+..|.++++|++|++++|++...  .+..+..+++|++|+|++|.++ .+|..+..+++|++|++
T Consensus        30 l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l  108 (306)
T 2z66_A           30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF  108 (306)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEEC
T ss_pred             CCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEEC
Confidence            33333333333332223344444444444444444321  1333344444555555555444 23444444445555555


Q ss_pred             cCCcCCCCCc-ccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccC-CCccccccccccceecccCcccC
Q 003301          399 DGNKLSGPIP-PCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNG-SLPEDIGNLKVVVIIDLSRNNLS  476 (832)
Q Consensus       399 ~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~  476 (832)
                      ++|++++..+ ..+..+++|++|++++|.+.+..+..|..+++|++|++++|.+++ ..|..+..+++|++|+|++|+++
T Consensus       109 ~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~  188 (306)
T 2z66_A          109 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE  188 (306)
T ss_dssp             TTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCC
T ss_pred             CCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcC
Confidence            5555443332 344455555555555555554444455555555555555555543 34445555555555555555555


Q ss_pred             CccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhc-cCCeeeCCCCcccccC
Q 003301          477 GDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLL-YLKDLNLSFNKLEGEI  551 (832)
Q Consensus       477 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~l~l~~N~l~~~~  551 (832)
                      +..|..|.++++|+.|+|++|++++..+..+..+++|+.|||++|++++..|..+..++ +|+.|+|++|+++|.+
T Consensus       189 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c  264 (306)
T 2z66_A          189 QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC  264 (306)
T ss_dssp             EECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred             CcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeeccc
Confidence            44455555555555555555555544444455555555555555555555555555542 5555555555555544

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=2.2e-30  Score=275.44  Aligned_cols=278  Identities=21%  Similarity=0.242  Sum_probs=214.9

Q ss_pred             cEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccce
Q 003301          244 SVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSR  323 (832)
Q Consensus       244 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~  323 (832)
                      +.++.+++.++.+ |..+.  ++|++|++++|.++.++..     .|..+++|++|++++|++...              
T Consensus        10 ~~l~c~~~~l~~i-p~~~~--~~l~~L~L~~n~l~~i~~~-----~~~~l~~L~~L~L~~n~l~~~--------------   67 (306)
T 2z66_A           10 TEIRCNSKGLTSV-PTGIP--SSATRLELESNKLQSLPHG-----VFDKLTQLTKLSLSSNGLSFK--------------   67 (306)
T ss_dssp             TEEECCSSCCSSC-CSCCC--TTCCEEECCSSCCCCCCTT-----TTTTCTTCSEEECCSSCCCEE--------------
T ss_pred             CEEEcCCCCcccC-CCCCC--CCCCEEECCCCccCccCHh-----HhhccccCCEEECCCCccCcc--------------
Confidence            3455666665533 22221  4555566666555543332     144555555555555554311              


Q ss_pred             EEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCc-hhhcCCCCCcEEEecCCc
Q 003301          324 IFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIP-NGLCQLARLSVLYMDGNK  402 (832)
Q Consensus       324 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~  402 (832)
                               +..+..+..+++|++|++++|.+.+ +|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.
T Consensus        68 ---------~~~~~~~~~~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~  137 (306)
T 2z66_A           68 ---------GCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH  137 (306)
T ss_dssp             ---------EEEEHHHHSCSCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSC
T ss_pred             ---------cCcccccccccccCEEECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCc
Confidence                     1235566678889999999998884 56668889999999999999986554 578888999999999999


Q ss_pred             CCCCCcccCCCCCCCCeEeCCCCcCCC-CCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCC
Q 003301          403 LSGPIPPCIGDLTSLRLLSLASNELNS-VIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPT  481 (832)
Q Consensus       403 l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  481 (832)
                      +.+..+..|..+++|++|++++|.+++ ..|..|..+++|++|++++|++++..|..+..+++|+.|+|++|++++..+.
T Consensus       138 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  217 (306)
T 2z66_A          138 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF  217 (306)
T ss_dssp             CEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSG
T ss_pred             CCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChh
Confidence            988888889999999999999999987 6788899999999999999999988888999999999999999999988787


Q ss_pred             ccccccccceeecccccccccCCccccCCC-CCCeeccCCCcccccCch--hhhhhccCCeeeCCCCcccccCCC
Q 003301          482 AIGGLMNLQDLSLRDNGLQGSIPKSIGGLV-SLESLDLSNNSLSGNIPT--SMEKLLYLKDLNLSFNKLEGEIPR  553 (832)
Q Consensus       482 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~l~l~~N~l~~~~p~  553 (832)
                      .|.++++|+.|+|++|++++..|..+..++ +|+.|+|++|++++..+.  ....+...+.+.+..+.+.|..|.
T Consensus       218 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~  292 (306)
T 2z66_A          218 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS  292 (306)
T ss_dssp             GGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESG
T ss_pred             hccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCch
Confidence            899999999999999999999999999985 999999999999876432  233455666777788888888776

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.97  E-value=3.2e-30  Score=289.76  Aligned_cols=252  Identities=21%  Similarity=0.237  Sum_probs=208.0

Q ss_pred             CcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEcc
Q 003301          296 LKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLV  375 (832)
Q Consensus       296 L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  375 (832)
                      ...++.+++.++ .+|..+.   .++++|+|++|++++..|..|.++++|++|+|++|++.+..+..|.++++|++|+|+
T Consensus        56 ~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~  131 (452)
T 3zyi_A           56 FSKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF  131 (452)
T ss_dssp             SCEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CcEEEECCCCcC-ccCCCCC---CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence            445666666665 3454433   367777777777777778888888888888888888888888888888888888888


Q ss_pred             CCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCC-CcCCCCCCcccccCcccceeeecCCcccCC
Q 003301          376 NNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLAS-NELNSVIPSTFWNLKDILSLNFSSNFLNGS  454 (832)
Q Consensus       376 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  454 (832)
                      +|++++..+..|..+++|++|+|++|++++..+..|.++++|+.|++++ |.+..+.+..|.++++|++|+|++|++++.
T Consensus       132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~  211 (452)
T 3zyi_A          132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM  211 (452)
T ss_dssp             SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred             CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence            8888876667788888888888888888877777888888999999988 556666666788889999999999988854


Q ss_pred             CccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhh
Q 003301          455 LPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKL  534 (832)
Q Consensus       455 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  534 (832)
                       | .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..+..+
T Consensus       212 -~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  289 (452)
T 3zyi_A          212 -P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL  289 (452)
T ss_dssp             -C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred             -c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence             3 57888899999999999998888899999999999999999998888889999999999999999998888888889


Q ss_pred             ccCCeeeCCCCcccccCCC
Q 003301          535 LYLKDLNLSFNKLEGEIPR  553 (832)
Q Consensus       535 ~~L~~l~l~~N~l~~~~p~  553 (832)
                      ++|+.|+|++|++.|.|.-
T Consensus       290 ~~L~~L~L~~Np~~CdC~~  308 (452)
T 3zyi_A          290 RYLVELHLHHNPWNCDCDI  308 (452)
T ss_dssp             TTCCEEECCSSCEECSTTT
T ss_pred             cCCCEEEccCCCcCCCCCc
Confidence            9999999999999887753

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.97  E-value=4.1e-30  Score=287.85  Aligned_cols=252  Identities=23%  Similarity=0.259  Sum_probs=211.7

Q ss_pred             CcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEcc
Q 003301          296 LKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLV  375 (832)
Q Consensus       296 L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  375 (832)
                      .+.++.+++.++ .+|..+.   .+++.|+|++|++++..+..|.++++|++|+|++|++.+..+..|.++++|++|+|+
T Consensus        45 ~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~  120 (440)
T 3zyj_A           45 FSKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF  120 (440)
T ss_dssp             SCEEECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred             CCEEEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence            445666666665 4454443   267777777777777777888888899999999999888888888899999999999


Q ss_pred             CCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCC-CcCCCCCCcccccCcccceeeecCCcccCC
Q 003301          376 NNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLAS-NELNSVIPSTFWNLKDILSLNFSSNFLNGS  454 (832)
Q Consensus       376 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  454 (832)
                      +|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|++++ |.+..+.+..|.++++|++|++++|+++. 
T Consensus       121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-  199 (440)
T 3zyj_A          121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-  199 (440)
T ss_dssp             SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-
T ss_pred             CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-
Confidence            9999876667788889999999999999877777888999999999998 45666666688899999999999999984 


Q ss_pred             CccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhh
Q 003301          455 LPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKL  534 (832)
Q Consensus       455 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  534 (832)
                      +| .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..|..+++|+.|||++|+|++..+..+..+
T Consensus       200 ~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  278 (440)
T 3zyj_A          200 IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL  278 (440)
T ss_dssp             CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred             cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence            44 48889999999999999998889999999999999999999998888999999999999999999998888888899


Q ss_pred             ccCCeeeCCCCcccccCCC
Q 003301          535 LYLKDLNLSFNKLEGEIPR  553 (832)
Q Consensus       535 ~~L~~l~l~~N~l~~~~p~  553 (832)
                      ++|+.|+|++|+|.|.|.-
T Consensus       279 ~~L~~L~L~~Np~~CdC~l  297 (440)
T 3zyj_A          279 HHLERIHLHHNPWNCNCDI  297 (440)
T ss_dssp             TTCCEEECCSSCEECSSTT
T ss_pred             cCCCEEEcCCCCccCCCCc
Confidence            9999999999999987753

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=1.6e-30  Score=282.46  Aligned_cols=274  Identities=18%  Similarity=0.186  Sum_probs=137.4

Q ss_pred             eEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCcccccccccccccccccCCChhhhhcCCCceEEEccC
Q 003301           25 KLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSN  104 (832)
Q Consensus        25 ~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~~  104 (832)
                      ..++++++++ .+|..+.  ++|++|++++|.+++..+..+..+++| ++|++++|+++ .++...+..+++|++|++++
T Consensus        35 ~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L-~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~  109 (353)
T 2z80_A           35 ICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNL-QALVLTSNGIN-TIEEDSFSSLGSLEHLDLSY  109 (353)
T ss_dssp             EEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTC-CEEECTTSCCC-EECTTTTTTCTTCCEEECCS
T ss_pred             EeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCC-CEEECCCCccC-ccCHhhcCCCCCCCEEECCC
Confidence            3444444444 4444333  244444444444442222244444444 44444444444 22222222444455555555


Q ss_pred             CcccccCCCCccCCCCccEEECcCCcccccCC-CCCcCCCcCceEEeccc-ccccccCccccCccccceecccccccccc
Q 003301          105 NKLTGPIPNNIWQCKELIVISLAYNQFTERIP-RGLGNLTSLKTLYLGFN-NLTGEIPYEMGNLRNLEILGLQLNKLVGF  182 (832)
Q Consensus       105 N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p-~~~~~l~~L~~L~Ls~N-~i~~~~p~~~~~l~~L~~L~L~~N~l~~~  182 (832)
                      |++++..+..+..+++|++|++++|++++..+ ..|..+++|++|++++| .++...+..|+++++|++|++++|++++.
T Consensus       110 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~  189 (353)
T 2z80_A          110 NYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSY  189 (353)
T ss_dssp             SCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEE
T ss_pred             CcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCcc
Confidence            55443222224444455555555555443222 24444555555555554 23433344444555555555555555544


Q ss_pred             cCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCccc---CCCCccEEEcCCCcCcc----
Q 003301          183 VPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIF---NASKLSVLELGENSFSG----  255 (832)
Q Consensus       183 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~---~l~~L~~L~L~~N~i~~----  255 (832)
                      .|..+.++++|++|++++|.+. .+|..+ +..+++|++|++++|++++..+..+.   ..+.++.++++++.+++    
T Consensus       190 ~~~~l~~l~~L~~L~l~~n~l~-~~~~~~-~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~  267 (353)
T 2z80_A          190 EPKSLKSIQNVSHLILHMKQHI-LLLEIF-VDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF  267 (353)
T ss_dssp             CTTTTTTCSEEEEEEEECSCST-THHHHH-HHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHH
T ss_pred             CHHHHhccccCCeecCCCCccc-cchhhh-hhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchh
Confidence            4444555555555555555543 222221 22344555555555555544333222   24556677777776665    


Q ss_pred             cCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCC
Q 003301          256 FIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVL  310 (832)
Q Consensus       256 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~  310 (832)
                      .+|..+..+++|++|++++|+++.++...     |..+++|++|++++|++.+..
T Consensus       268 ~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~-----~~~l~~L~~L~L~~N~~~~~~  317 (353)
T 2z80_A          268 QVMKLLNQISGLLELEFSRNQLKSVPDGI-----FDRLTSLQKIWLHTNPWDCSC  317 (353)
T ss_dssp             HHHHHHHTCTTCCEEECCSSCCCCCCTTT-----TTTCTTCCEEECCSSCBCCCH
T ss_pred             hhHHHHhcccCCCEEECCCCCCCccCHHH-----HhcCCCCCEEEeeCCCccCcC
Confidence            24566777788888888888887655432     567788888888888877543

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=4.2e-30  Score=270.25  Aligned_cols=252  Identities=23%  Similarity=0.257  Sum_probs=175.8

Q ss_pred             cEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccC
Q 003301          297 KLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVN  376 (832)
Q Consensus       297 ~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  376 (832)
                      +.++.+++.++ .+|..+   ..++++|++++|.+++..+..|..+++|++|++++|.+++..+..|..+++|++|++++
T Consensus        14 ~~~~c~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   89 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD   89 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             eEEEcCcCCcc-cCCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence            45666666665 334332   22566666666666666666777777788888888777777777777777788888887


Q ss_pred             Cc-cCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCC
Q 003301          377 NK-LEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSL  455 (832)
Q Consensus       377 N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  455 (832)
                      |+ ++...|..+..+++|++|++++|++++..|..|..+++|++|++++|++++..+..|..+++|++|++++|++++..
T Consensus        90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  169 (285)
T 1ozn_A           90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP  169 (285)
T ss_dssp             CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence            76 66555677777777777777777777766777777777777777777777776667777777777777777777655


Q ss_pred             ccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhc
Q 003301          456 PEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLL  535 (832)
Q Consensus       456 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  535 (832)
                      +..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..+..+..+++|+.|+|++|+++...+.. .-..
T Consensus       170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~  248 (285)
T 1ozn_A          170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWA  248 (285)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHH
T ss_pred             HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHH
Confidence            556777777777777777777666777777777777777777777655566777777777777777776544432 2233


Q ss_pred             cCCeeeCCCCcccccCCC
Q 003301          536 YLKDLNLSFNKLEGEIPR  553 (832)
Q Consensus       536 ~L~~l~l~~N~l~~~~p~  553 (832)
                      .++.+..+.|.+.|..|.
T Consensus       249 ~l~~~~~~~~~~~c~~p~  266 (285)
T 1ozn_A          249 WLQKFRGSSSEVPCSLPQ  266 (285)
T ss_dssp             HHHHCCSEECCCBEEESG
T ss_pred             HHHhcccccCccccCCch
Confidence            455555666777776665

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.97  E-value=6.9e-33  Score=323.47  Aligned_cols=444  Identities=16%  Similarity=0.076  Sum_probs=261.5

Q ss_pred             CCChhhhhcCCCceEEEccCCccc---ccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCc
Q 003301           85 SLPDDMCRRLPLIKGLYMSNNKLT---GPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPY  161 (832)
Q Consensus        85 ~lp~~~~~~l~~L~~L~l~~N~l~---~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~  161 (832)
                      ..|..++.++++|++|+++++...   +.+|..++...            ...++..+..+++|++|+|++|.+++..+.
T Consensus        63 ~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~------------~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~  130 (592)
T 3ogk_B           63 ATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYV------------TPWVTEISNNLRQLKSVHFRRMIVSDLDLD  130 (592)
T ss_dssp             SCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBC------------HHHHHHHHHHCTTCCEEEEESCBCCHHHHH
T ss_pred             cChHHHHHhCCCCeEEEecCCcchhhcccccccccccc------------hHHHHHHHhhCCCCCeEEeeccEecHHHHH
Confidence            455666667777888888775421   23333222100            000000111344555555555555443333


Q ss_pred             cccCc--cccceeccccccc-cc-ccCcccccCCcccEEEecCCCCCCCCCccc--cccCCCCccEEEccCCcccc----
Q 003301          162 EMGNL--RNLEILGLQLNKL-VG-FVPTSIFNLSAMKTLALPSNALSGSLPSSI--DLVRLPNLEIISLAGNNFSG----  231 (832)
Q Consensus       162 ~~~~l--~~L~~L~L~~N~l-~~-~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~--~~~~l~~L~~L~Ls~n~i~~----  231 (832)
                      .+...  .+|++|+|++|.- .. .++....++++|++|+|++|.+.+..+.++  ....+++|++|++++|.+++    
T Consensus       131 ~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~  210 (592)
T 3ogk_B          131 RLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPK  210 (592)
T ss_dssp             HHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHH
T ss_pred             HHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHH
Confidence            44332  2255555555441 10 011112345556666666555543311110  02345666666666666652    


Q ss_pred             ccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCC
Q 003301          232 IIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLP  311 (832)
Q Consensus       232 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  311 (832)
                      ..+..+..+++|++|++++|.+.+ .+..+..+++|++|+++.........  .....+..+++|+.|+++++.. +.+|
T Consensus       211 ~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~--~~~~~l~~~~~L~~L~l~~~~~-~~l~  286 (592)
T 3ogk_B          211 DLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMP--EKYMNLVFPRKLCRLGLSYMGP-NEMP  286 (592)
T ss_dssp             HHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCT--TSSSCCCCCTTCCEEEETTCCT-TTGG
T ss_pred             HHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchH--HHHHHhhccccccccCccccch-hHHH
Confidence            233344556777777777777765 44666777777777776532221101  2233456677777777777533 2455


Q ss_pred             CcccccccccceEEeecCccccccc-ccccCcCcccEEEeecCcccccccccccCCCCCceEEccC-----------Ccc
Q 003301          312 SSIGNLSLSLSRIFISNCSIRGTIP-KEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVN-----------NKL  379 (832)
Q Consensus       312 ~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-----------N~l  379 (832)
                      ..+..+. +|++|++++|.+++... ..+..+++|++|+++++-..+.++..+..+++|++|+|++           |.+
T Consensus       287 ~~~~~~~-~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~  365 (592)
T 3ogk_B          287 ILFPFAA-QIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLV  365 (592)
T ss_dssp             GGGGGGG-GCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCC
T ss_pred             HHHhhcC-CCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCcc
Confidence            5555544 78888888877664433 3467788888888884333333444456678888888883           566


Q ss_pred             CCCCch-hhcCCCCCcEEEecCCcCCCCCcccCCC-CCCCCeEeCC----CCcCCCC-----CCcccccCcccceeeecC
Q 003301          380 EGPIPN-GLCQLARLSVLYMDGNKLSGPIPPCIGD-LTSLRLLSLA----SNELNSV-----IPSTFWNLKDILSLNFSS  448 (832)
Q Consensus       380 ~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~----~N~l~~~-----~~~~~~~l~~L~~L~Ls~  448 (832)
                      ++.... ....+++|++|+++.|.+++..+..+.. +++|+.|+++    .|.+++.     .+..+.++++|++|++++
T Consensus       366 ~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~  445 (592)
T 3ogk_B          366 SQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYL  445 (592)
T ss_dssp             CHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEEC
T ss_pred             CHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEec
Confidence            543222 2345788888888888887666666655 7888888885    6677664     233366788888998875


Q ss_pred             Cc--ccCCCcccccc-ccccceecccCcccCC-ccCCccccccccceeeccccccccc-CCccccCCCCCCeeccCCCcc
Q 003301          449 NF--LNGSLPEDIGN-LKVVVIIDLSRNNLSG-DIPTAIGGLMNLQDLSLRDNGLQGS-IPKSIGGLVSLESLDLSNNSL  523 (832)
Q Consensus       449 N~--l~~~~~~~~~~-l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l  523 (832)
                      |.  +++..+..+.. +++|+.|+|++|++++ .++..+.++++|++|+|++|.+++. ++..+..+++|+.|+|++|++
T Consensus       446 ~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~i  525 (592)
T 3ogk_B          446 RQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRA  525 (592)
T ss_dssp             CGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBC
T ss_pred             CCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcC
Confidence            33  55544444443 7889999999999876 3455567888999999999998754 344456788999999999998


Q ss_pred             cccCchhhh-hhccCCeeeCCCC
Q 003301          524 SGNIPTSME-KLLYLKDLNLSFN  545 (832)
Q Consensus       524 ~~~~p~~~~-~l~~L~~l~l~~N  545 (832)
                      ++.-...+. .++.+....+..+
T Consensus       526 t~~~~~~l~~~~p~l~~~~~~~~  548 (592)
T 3ogk_B          526 SMTGQDLMQMARPYWNIELIPSR  548 (592)
T ss_dssp             CTTCTTGGGGCCTTEEEEEECCC
T ss_pred             CHHHHHHHHHhCCCcEEEEecCc
Confidence            865444333 4566655555544

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=2.4e-30  Score=272.14  Aligned_cols=252  Identities=23%  Similarity=0.205  Sum_probs=223.1

Q ss_pred             cceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecC
Q 003301          321 LSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDG  400 (832)
Q Consensus       321 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  400 (832)
                      -+.++.+++.++. +|..+  .++|++|++++|.+++..+..|..+++|++|+|++|++++..|..|..+++|++|++++
T Consensus        13 ~~~~~c~~~~l~~-ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   89 (285)
T 1ozn_A           13 KVTTSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD   89 (285)
T ss_dssp             SCEEECCSSCCSS-CCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CeEEEcCcCCccc-CCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence            3678899999884 45443  46899999999999988888999999999999999999988899999999999999999


Q ss_pred             Cc-CCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCcc
Q 003301          401 NK-LSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDI  479 (832)
Q Consensus       401 N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  479 (832)
                      |+ +....|..|..+++|++|++++|.+++..|..|.++++|++|++++|++++..+..|+.+++|+.|+|++|++++..
T Consensus        90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  169 (285)
T 1ozn_A           90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP  169 (285)
T ss_dssp             CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence            98 88777899999999999999999999999999999999999999999999887788999999999999999999777


Q ss_pred             CCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCCCCCCCCC
Q 003301          480 PTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFAN  559 (832)
Q Consensus       480 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~  559 (832)
                      +..|.++++|+.|+|++|++++..|..|+.+++|+.|+|++|++++..+..+..+++|+.|++++|++.|.++....+.+
T Consensus       170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~  249 (285)
T 1ozn_A          170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAW  249 (285)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHH
T ss_pred             HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHH
Confidence            77899999999999999999999999999999999999999999998888899999999999999999998876322233


Q ss_pred             cCCCcccCCCCCCCCc
Q 003301          560 FSNRSFMGNDLLCGLA  575 (832)
Q Consensus       560 ~~~~~~~~n~~~c~~~  575 (832)
                      +.......+...|..|
T Consensus       250 l~~~~~~~~~~~c~~p  265 (285)
T 1ozn_A          250 LQKFRGSSSEVPCSLP  265 (285)
T ss_dssp             HHHCCSEECCCBEEES
T ss_pred             HHhcccccCccccCCc
Confidence            3333344455556544

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.96  E-value=1.3e-30  Score=286.56  Aligned_cols=180  Identities=24%  Similarity=0.378  Sum_probs=156.7

Q ss_pred             chHHHHHHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEe
Q 003301          650 SYKELLQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCT  725 (832)
Q Consensus       650 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~  725 (832)
                      ..++.....++|++.+.||+|+||+||+|++. +++.||||++....   ....+.+.+|++++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            34444556789999999999999999999986 58999999997532   223456888999999999999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccc
Q 003301          726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGI  805 (832)
Q Consensus       726 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~  805 (832)
                      +.+..|+||||+++|+|.+++.+.+..+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechh
Confidence            999999999999999999999876557999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCCCCC
Q 003301          806 AKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       806 a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      |+.............+||+.|+|||++
T Consensus       209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l  235 (412)
T 2vd5_A          209 CLKLRADGTVRSLVAVGTPDYLSPEIL  235 (412)
T ss_dssp             CEECCTTSCEECSSCCSCGGGCCHHHH
T ss_pred             heeccCCCccccceeccccCcCCHHHH
Confidence            988765444333446799999999963

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=4.2e-32  Score=316.84  Aligned_cols=408  Identities=14%  Similarity=0.093  Sum_probs=208.6

Q ss_pred             CccccccccCcEEEccCCcC---CCCCCCccc------------CcccccccccccccccccCCChhhhhcCCC-ceEEE
Q 003301           38 PQELGNLAELELVSLTNNFL---SGTIPSTIF------------NLSSLSTGMDFSNNSLTGSLPDDMCRRLPL-IKGLY  101 (832)
Q Consensus        38 p~~~~~l~~L~~L~l~~n~l---~~~~p~~l~------------~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~-L~~L~  101 (832)
                      +..+..+++|++|+++++..   .+.+|...+            .+++| ++|+|++|.+++..+..+...++. |++|+
T Consensus        66 ~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L-~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~  144 (592)
T 3ogk_B           66 DRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQL-KSVHFRRMIVSDLDLDRLAKARADDLETLK  144 (592)
T ss_dssp             HHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC-CEEEEESCBCCHHHHHHHHHHHGGGCCEEE
T ss_pred             HHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCC-CeEEeeccEecHHHHHHHHHhccccCcEEE
Confidence            33455566666666665432   123333333            44555 666666666554444444322333 66666


Q ss_pred             ccCCc-ccc-cCCCCccCCCCccEEECcCCccccc----CCCCCcCCCcCceEEecccccc----cccCccccCccccce
Q 003301          102 MSNNK-LTG-PIPNNIWQCKELIVISLAYNQFTER----IPRGLGNLTSLKTLYLGFNNLT----GEIPYEMGNLRNLEI  171 (832)
Q Consensus       102 l~~N~-l~~-~~p~~l~~l~~L~~L~Ls~n~i~~~----~p~~~~~l~~L~~L~Ls~N~i~----~~~p~~~~~l~~L~~  171 (832)
                      +++|. ++. .++.....+++|++|+|++|.+++.    ++..+..+++|++|++++|.++    +.++..+.++++|++
T Consensus       145 L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~  224 (592)
T 3ogk_B          145 LDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVS  224 (592)
T ss_dssp             EESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCE
T ss_pred             CcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcE
Confidence            66665 221 1112223566677777777766543    2223345566777777777765    233444556677777


Q ss_pred             ecccccccccccCcccccCCcccEEEecCCCCC-CCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCC
Q 003301          172 LGLQLNKLVGFVPTSIFNLSAMKTLALPSNALS-GSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGE  250 (832)
Q Consensus       172 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~  250 (832)
                      |++++|.+.+ ++..+.++++|++|+++..... ...+....+..+++|+.|+++++... ..|..+..+++|++|+|++
T Consensus       225 L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~  302 (592)
T 3ogk_B          225 VKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLY  302 (592)
T ss_dssp             EECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETT
T ss_pred             EeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCC
Confidence            7777777665 4566666777777777643221 00111122345566777776665332 4455556666777777777


Q ss_pred             CcCcccCC-ccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccC-----------CCCCCCCCCcccccc
Q 003301          251 NSFSGFIP-NTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSN-----------NPINGVLPSSIGNLS  318 (832)
Q Consensus       251 N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~-----------N~l~~~~~~~~~~~~  318 (832)
                      |.+++... ..+..+++|++|+++ +.+...    .+...+..+++|++|++++           |.+++.....+....
T Consensus       303 ~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~----~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~  377 (592)
T 3ogk_B          303 ALLETEDHCTLIQKCPNLEVLETR-NVIGDR----GLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGC  377 (592)
T ss_dssp             CCCCHHHHHHHHTTCTTCCEEEEE-GGGHHH----HHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHC
T ss_pred             CcCCHHHHHHHHHhCcCCCEEecc-CccCHH----HHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhC
Confidence            77654332 234566777777776 333220    1222234566777777772           344322111111111


Q ss_pred             cccceEEeecCcccccccccccC-cCcccEEEee----cCccccc-----ccccccCCCCCceEEccCCc--cCCCCchh
Q 003301          319 LSLSRIFISNCSIRGTIPKEIGN-LINLRELGLW----GNELIGS-----IPITFGKLQNLQGLDLVNNK--LEGPIPNG  386 (832)
Q Consensus       319 ~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~--l~~~~~~~  386 (832)
                      ++|++|+++.|.+++..+..+.. +++|++|+++    .|.+++.     ++..+.++++|++|+|++|.  +++..+..
T Consensus       378 ~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~  457 (592)
T 3ogk_B          378 QELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSY  457 (592)
T ss_dssp             TTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHH
T ss_pred             ccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHH
Confidence            25666666555555544444443 5566666664    3444432     22234445566666665322  44333333


Q ss_pred             hcC-CCCCcEEEecCCcCCC-CCcccCCCCCCCCeEeCCCCcCCCCC-CcccccCcccceeeecCCcccC
Q 003301          387 LCQ-LARLSVLYMDGNKLSG-PIPPCIGDLTSLRLLSLASNELNSVI-PSTFWNLKDILSLNFSSNFLNG  453 (832)
Q Consensus       387 ~~~-l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~  453 (832)
                      +.. +++|++|++++|++++ .++..+..+++|+.|++++|.+++.. +..+..+++|++|++++|++++
T Consensus       458 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~  527 (592)
T 3ogk_B          458 IGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASM  527 (592)
T ss_dssp             HHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred             HHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCH
Confidence            322 4556666666665553 22333455555666666666554321 2222345555555555555553

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=2.2e-29  Score=269.64  Aligned_cols=224  Identities=22%  Similarity=0.298  Sum_probs=172.7

Q ss_pred             ccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEec
Q 003301          320 SLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMD  399 (832)
Q Consensus       320 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  399 (832)
                      .++.|++++|.++ .+|..+..+++|++|+|++|.+. .+|..++.+++|++|+|++|+++ .+|..+..+++|++|+++
T Consensus        82 ~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~  158 (328)
T 4fcg_A           82 GRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIR  158 (328)
T ss_dssp             TCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEE
T ss_pred             ceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECC
Confidence            3444444444444 34455555666666666666666 55666666666666666666666 556666666666666666


Q ss_pred             CCcCCCCCcccCC---------CCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecc
Q 003301          400 GNKLSGPIPPCIG---------DLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDL  470 (832)
Q Consensus       400 ~N~l~~~~p~~~~---------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  470 (832)
                      +|++.+.+|..+.         ++++|++|++++|+++ .+|..|..+++|++|++++|++++ +|..++.+++|++|+|
T Consensus       159 ~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~L  236 (328)
T 4fcg_A          159 ACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDL  236 (328)
T ss_dssp             EETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEEC
T ss_pred             CCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEEC
Confidence            6666666666554         4888888888888888 567778888888889999998885 5667888999999999


Q ss_pred             cCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCccc
Q 003301          471 SRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLE  548 (832)
Q Consensus       471 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~  548 (832)
                      ++|++.+.+|..|+++++|+.|+|++|++.+.+|..++.+++|+.|+|++|++.+.+|+.+..+++|+.+++..|.+.
T Consensus       237 s~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             TTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             cCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            999998899999999999999999999999899999999999999999999999999999999999999998877665

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.96  E-value=2.1e-30  Score=284.71  Aligned_cols=176  Identities=24%  Similarity=0.372  Sum_probs=153.6

Q ss_pred             HHHHHHhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecC
Q 003301          652 KELLQATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNN  727 (832)
Q Consensus       652 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  727 (832)
                      .++....++|++.++||+|+||+||+|++.. ++.||+|++....   ....+.+.+|+++++.++||||+++++++.++
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            3444556899999999999999999999864 8899999997532   22234678899999999999999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccc
Q 003301          728 DFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK  807 (832)
Q Consensus       728 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~  807 (832)
                      +..|+||||++||+|.++++..  .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence            9999999999999999999865  4899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCcccccccccccccccCCCCC
Q 003301          808 LLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       808 ~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .............+||+.|+|||++
T Consensus       217 ~~~~~~~~~~~~~~gt~~Y~APE~l  241 (410)
T 3v8s_A          217 KMNKEGMVRCDTAVGTPDYISPEVL  241 (410)
T ss_dssp             ECCTTSEEECCSCCSCGGGCCHHHH
T ss_pred             eeccCCcccccCCcCCccccCHHHh
Confidence            7765544344456899999999963

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.96  E-value=1.2e-29  Score=270.35  Aligned_cols=171  Identities=25%  Similarity=0.419  Sum_probs=151.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .++|++.+.||+|+||+||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+++..|+||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            467899999999999999999986 4899999998766666678899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +++++|.++++.....+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||.|+.........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            9999999999986668999999999999999999999   9999999999999999999999999999998764433211


Q ss_pred             -------------cccccccccccCCCC
Q 003301          817 -------------QTLTLATIGYMAPGL  831 (832)
Q Consensus       817 -------------~~~~~gt~~y~APE~  831 (832)
                                   ....+||+.|+|||+
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~  193 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEM  193 (310)
T ss_dssp             --------------CCCCSCGGGCCHHH
T ss_pred             cccccccccccccccccCCCcceeCHHH
Confidence                         113569999999996

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=6.4e-31  Score=279.98  Aligned_cols=246  Identities=22%  Similarity=0.223  Sum_probs=189.9

Q ss_pred             CCCCcEEeccCCCCCCCCCCcccccccccceEEeecCccc-cccccccc-------CcCcccEEEeecCcccccccccc-
Q 003301          293 CKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIR-GTIPKEIG-------NLINLRELGLWGNELIGSIPITF-  363 (832)
Q Consensus       293 l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~-~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~-  363 (832)
                      .++|+.|++++|.+  .+|..+..   .++.|++++|.++ ..+|..+.       ++++|++|+|++|++++..|..+ 
T Consensus        42 ~~~L~~l~l~~n~l--~~p~~~~~---~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  116 (312)
T 1wwl_A           42 GRSLEYLLKRVDTE--ADLGQFTD---IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL  116 (312)
T ss_dssp             EEECTTHHHHCCTT--CCCHHHHH---HHHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSS
T ss_pred             CCCceeEeeccccc--ccHHHHHH---HHhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHH
Confidence            33444444444444  33333332   2555555555552 33444444       68889999999999988888776 


Q ss_pred             -cCCCCCceEEccCCccCCCCchhhcCC-----CCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCC--CCccc
Q 003301          364 -GKLQNLQGLDLVNNKLEGPIPNGLCQL-----ARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSV--IPSTF  435 (832)
Q Consensus       364 -~~l~~L~~L~Ls~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~~~~~  435 (832)
                       ..+++|++|+|++|++++. |..+..+     ++|++|++++|++++..|..|+.+++|++|++++|++.+.  .+..+
T Consensus       117 ~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  195 (312)
T 1wwl_A          117 EATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL  195 (312)
T ss_dssp             SCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHS
T ss_pred             HhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHH
Confidence             8889999999999999876 7777776     8899999999999988888899999999999999998764  23333


Q ss_pred             --ccCcccceeeecCCcccCC---CccccccccccceecccCcccCCccC-CccccccccceeecccccccccCCccccC
Q 003301          436 --WNLKDILSLNFSSNFLNGS---LPEDIGNLKVVVIIDLSRNNLSGDIP-TAIGGLMNLQDLSLRDNGLQGSIPKSIGG  509 (832)
Q Consensus       436 --~~l~~L~~L~Ls~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  509 (832)
                        ..+++|++|++++|++++.   ....+..+++|++|+|++|++++..| ..+..+++|++|+|++|+|+ .+|..+. 
T Consensus       196 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~-  273 (312)
T 1wwl_A          196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP-  273 (312)
T ss_dssp             CTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC-
T ss_pred             HhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc-
Confidence              7889999999999998832   22344677899999999999998775 56777899999999999998 7887776 


Q ss_pred             CCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccc
Q 003301          510 LVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEG  549 (832)
Q Consensus       510 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~  549 (832)
                       ++|+.|||++|+|++. |. +..+++|++|+|++|++++
T Consensus       274 -~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          274 -AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             -SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             -CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence             8999999999999976 66 8899999999999999986

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.96  E-value=1.7e-29  Score=267.11  Aligned_cols=168  Identities=33%  Similarity=0.455  Sum_probs=151.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .++|++.+.||+|+||+||+|.+. +++.||||++........+.+.+|+.++++++||||+++++++..++..|+||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            478999999999999999999874 5899999999876666667889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +++|+|.+++...  .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+|......... 
T Consensus        99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  172 (297)
T 3fxz_A           99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-  172 (297)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred             CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-
Confidence            9999999999875  4899999999999999999999   999999999999999999999999999999876544332 


Q ss_pred             cccccccccccCCCC
Q 003301          817 QTLTLATIGYMAPGL  831 (832)
Q Consensus       817 ~~~~~gt~~y~APE~  831 (832)
                      ....+||+.|+|||+
T Consensus       173 ~~~~~gt~~y~aPE~  187 (297)
T 3fxz_A          173 RSTMVGTPYWMAPEV  187 (297)
T ss_dssp             BCCCCSCGGGCCHHH
T ss_pred             cCCccCCcCccChhh
Confidence            334579999999996

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.96  E-value=1e-29  Score=272.07  Aligned_cols=169  Identities=28%  Similarity=0.452  Sum_probs=150.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++....  ....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            578999999999999999999984 69999999997653  334567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||+++|+|.+++...+ .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+|+...... 
T Consensus        94 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  168 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-  168 (328)
T ss_dssp             CCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred             ECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence            9999999999997654 6899999999999999999999   9999999999999999999999999999998765433 


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                       .....+||+.|+|||++
T Consensus       169 -~~~~~~gt~~y~aPE~~  185 (328)
T 3fe3_A          169 -KLDAFCGAPPYAAPELF  185 (328)
T ss_dssp             -GGGTTSSSGGGCCHHHH
T ss_pred             -ccccccCCcceeCcccc
Confidence             23346799999999963

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.96  E-value=1.4e-29  Score=271.68  Aligned_cols=170  Identities=29%  Similarity=0.373  Sum_probs=149.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.+.||+|+||+||+|++. +++.||+|+++...   ....+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            468999999999999999999886 48999999997642   33456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+++|+|.+++.+.+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+......
T Consensus        84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            99999999999997654 6899999999999999999999   9999999999999999999999999999998643332


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                      . .....+||+.|+|||++
T Consensus       160 ~-~~~~~~gt~~y~aPE~~  177 (337)
T 1o6l_A          160 A-TMKTFCGTPEYLAPEVL  177 (337)
T ss_dssp             C-CBCCCEECGGGCCGGGG
T ss_pred             C-cccccccChhhCChhhh
Confidence            2 22345799999999974

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.96  E-value=1.3e-29  Score=273.90  Aligned_cols=171  Identities=24%  Similarity=0.360  Sum_probs=145.1

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  731 (832)
                      ..++|++.+.||+|+||+||+|++.. ++.||||+++...   ....+.+.+|.++++.+ +||||+++++++.+.+..|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            35789999999999999999998864 8999999997542   33456788899999988 7999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +||||+++|+|.+++.+.+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+....
T Consensus       101 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            9999999999999997654 6999999999999999999999   99999999999999999999999999999986433


Q ss_pred             CcccccccccccccccCCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ... .....+||+.|+|||++
T Consensus       177 ~~~-~~~~~~gt~~y~aPE~~  196 (353)
T 3txo_A          177 NGV-TTATFCGTPDYIAPEIL  196 (353)
T ss_dssp             ----------CCGGGCCHHHH
T ss_pred             CCc-cccccCCCcCeEChhhc
Confidence            322 23345799999999963

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=8.2e-29  Score=265.16  Aligned_cols=225  Identities=20%  Similarity=0.271  Sum_probs=149.9

Q ss_pred             CCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEE
Q 003301          294 KNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLD  373 (832)
Q Consensus       294 ~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  373 (832)
                      ++++.|+|++|.+. .+|..+..+. +|++|++++|.++ .+|..+..+++|++|+|++|++. .+|..|..+++|++|+
T Consensus        81 ~~l~~L~L~~n~l~-~lp~~l~~l~-~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~  156 (328)
T 4fcg_A           81 PGRVALELRSVPLP-QFPDQAFRLS-HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS  156 (328)
T ss_dssp             TTCCEEEEESSCCS-SCCSCGGGGT-TCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred             cceeEEEccCCCch-hcChhhhhCC-CCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence            34444444444444 3344444433 4555555555544 44555555555555555555555 4455555555555555


Q ss_pred             ccCCccCCCCchhhc---------CCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCccccee
Q 003301          374 LVNNKLEGPIPNGLC---------QLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSL  444 (832)
Q Consensus       374 Ls~N~l~~~~~~~~~---------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  444 (832)
                      |++|++.+.+|..+.         .+++|++|++++|+++ .+|..++.+++|++|++++|++++ +|..|..+++|++|
T Consensus       157 L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L  234 (328)
T 4fcg_A          157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEEL  234 (328)
T ss_dssp             EEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEE
T ss_pred             CCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEE
Confidence            555555555555443         3677777777777777 666677777777777777777775 34457777777777


Q ss_pred             eecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCccc
Q 003301          445 NFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLS  524 (832)
Q Consensus       445 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  524 (832)
                      ++++|++.+.+|..++.+++|+.|+|++|++.+.+|..+.++++|+.|+|++|++.+.+|..++.+++|+.+++..|.+.
T Consensus       235 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             ECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             ECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            77777777777777888888888888888887788888888888888888888888888888888888888888777655

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.96  E-value=1.5e-29  Score=271.76  Aligned_cols=183  Identities=36%  Similarity=0.611  Sum_probs=160.6

Q ss_pred             ccccchHHHHHHhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccch-hhHHHHHHHHHHHhcCCCCceeeeceEE
Q 003301          646 RRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVKIISSC  724 (832)
Q Consensus       646 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~  724 (832)
                      ...+++.++....++|++.+.||+|+||.||+|++.+++.||||++..... .....+.+|+++++.++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            456889999999999999999999999999999987899999999875432 2234788999999999999999999999


Q ss_pred             ecCCeeEEEEecCCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCC---CeEecCCCCCCeEeCCCCcE
Q 003301          725 TNNDFKALVLEYMPNGSLEDYLYSNN---FSFDILQRLSVIIDVALALEYLHFGYSN---PVVHCDIKPSNVLLDKDMVA  798 (832)
Q Consensus       725 ~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~---~ivH~Dlkp~NIl~~~~~~~  798 (832)
                      .+.+..++||||+++|+|.+++....   ..+++..+..++.|++.||+|||   +.   ||+||||||+||+++.++.+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~~~~~~  173 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKAANILLDEEFEA  173 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEEECTTCCE
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEEECCCCCE
Confidence            99999999999999999999998643   24899999999999999999999   77   99999999999999999999


Q ss_pred             EEeccccccccCCCcccccccccccccccCCCC
Q 003301          799 HLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       799 kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      ||+|||+|+..............||+.|+|||+
T Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~  206 (326)
T 3uim_A          174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEY  206 (326)
T ss_dssp             EECCCSSCEECCSSSSCEECCCCSCGGGCCHHH
T ss_pred             EeccCccccccCcccccccccccCCcCccCHHH
Confidence            999999998876554444445569999999996

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.96  E-value=3.2e-29  Score=272.89  Aligned_cols=169  Identities=29%  Similarity=0.436  Sum_probs=150.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.+.||+|+||.||+|.+.. ++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            4679999999999999999998864 8899999997543   23456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|+......
T Consensus        94 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence            99999999999998654 6999999999999999999999   9999999999999999999999999999998765432


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                        .....+||+.|+|||++
T Consensus       170 --~~~~~~gt~~Y~aPE~~  186 (384)
T 4fr4_A          170 --QITTMAGTKPYMAPEMF  186 (384)
T ss_dssp             --CBCCCCSCGGGCCGGGT
T ss_pred             --ceeccCCCccccCCeee
Confidence              23346799999999975

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=1.5e-28  Score=276.06  Aligned_cols=251  Identities=22%  Similarity=0.209  Sum_probs=202.7

Q ss_pred             cceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCccc
Q 003301          267 LEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLR  346 (832)
Q Consensus       267 L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~  346 (832)
                      ...++.+++.++.+|..+        .++++.|+|++|.+++..+..|..+. +|++|+|++|++++..+..|.++++|+
T Consensus        56 ~~~v~c~~~~l~~iP~~~--------~~~l~~L~L~~n~i~~~~~~~~~~l~-~L~~L~Ls~n~i~~~~~~~~~~l~~L~  126 (452)
T 3zyi_A           56 FSKVVCTRRGLSEVPQGI--------PSNTRYLNLMENNIQMIQADTFRHLH-HLEVLQLGRNSIRQIEVGAFNGLASLN  126 (452)
T ss_dssp             SCEEECCSSCCSSCCSCC--------CTTCSEEECCSSCCCEECTTTTTTCT-TCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred             CcEEEECCCCcCccCCCC--------CCCccEEECcCCcCceECHHHcCCCC-CCCEEECCCCccCCcChhhccCcccCC
Confidence            345555666666554432        14667777777777666666666665 777777777777777777888888888


Q ss_pred             EEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecC-CcCCCCCcccCCCCCCCCeEeCCCC
Q 003301          347 ELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDG-NKLSGPIPPCIGDLTSLRLLSLASN  425 (832)
Q Consensus       347 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N  425 (832)
                      +|+|++|++++..+..|..+++|++|+|++|+++...+..|..+++|++|++++ |.+....+..|.++++|+.|+|++|
T Consensus       127 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n  206 (452)
T 3zyi_A          127 TLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMC  206 (452)
T ss_dssp             EEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTS
T ss_pred             EEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCC
Confidence            888888888877777888888888888888888876667888888888888888 4555444557888999999999999


Q ss_pred             cCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCc
Q 003301          426 ELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPK  505 (832)
Q Consensus       426 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  505 (832)
                      ++++. | .+..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+.
T Consensus       207 ~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  284 (452)
T 3zyi_A          207 NIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHD  284 (452)
T ss_dssp             CCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred             ccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChH
Confidence            99875 3 478889999999999999988899999999999999999999988899999999999999999999988888


Q ss_pred             cccCCCCCCeeccCCCcccccCc
Q 003301          506 SIGGLVSLESLDLSNNSLSGNIP  528 (832)
Q Consensus       506 ~~~~l~~L~~L~Ls~N~l~~~~p  528 (832)
                      .|..+++|+.|+|++|++.....
T Consensus       285 ~~~~l~~L~~L~L~~Np~~CdC~  307 (452)
T 3zyi_A          285 LFTPLRYLVELHLHHNPWNCDCD  307 (452)
T ss_dssp             SSTTCTTCCEEECCSSCEECSTT
T ss_pred             HhccccCCCEEEccCCCcCCCCC
Confidence            89999999999999999876443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.96  E-value=9.4e-30  Score=272.57  Aligned_cols=182  Identities=37%  Similarity=0.617  Sum_probs=157.1

Q ss_pred             cccchHHHHHHhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEec
Q 003301          647 RRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN  726 (832)
Q Consensus       647 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  726 (832)
                      .++.+.++....++|++.+.||+|+||.||+|++.+++.||||++........+.+.+|+++++.++||||+++++++.+
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            34555566667899999999999999999999988899999999877666666889999999999999999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecc
Q 003301          727 NDFKALVLEYMPNGSLEDYLYSNN---FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDF  803 (832)
Q Consensus       727 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DF  803 (832)
                      .+..|+||||+++|+|.+++....   ..+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeec
Confidence            999999999999999999997543   24899999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCcc-cccccccccccccCCCC
Q 003301          804 GIAKLLSGEES-MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       804 g~a~~~~~~~~-~~~~~~~gt~~y~APE~  831 (832)
                      |+++....... .......||+.|+|||+
T Consensus       184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~  212 (321)
T 2qkw_B          184 GISKKGTELDQTHLSTVVKGTLGYIDPEY  212 (321)
T ss_dssp             TTCEECSSSSCCCCBCCCEEETTTCCHHH
T ss_pred             ccccccccccccccccccCCCccccCHHH
Confidence            99987543222 12233469999999996

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=2.2e-28  Score=273.81  Aligned_cols=250  Identities=24%  Similarity=0.235  Sum_probs=205.1

Q ss_pred             cceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCccc
Q 003301          267 LEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLR  346 (832)
Q Consensus       267 L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~  346 (832)
                      ...++.+++.++.+|..+        .++++.|+|++|++.+..+..|..+. +|++|+|++|.+++..+..|.++++|+
T Consensus        45 ~~~v~c~~~~l~~iP~~~--------~~~l~~L~L~~n~i~~~~~~~~~~l~-~L~~L~Ls~n~i~~i~~~~~~~l~~L~  115 (440)
T 3zyj_A           45 FSKVICVRKNLREVPDGI--------STNTRLLNLHENQIQIIKVNSFKHLR-HLEILQLSRNHIRTIEIGAFNGLANLN  115 (440)
T ss_dssp             SCEEECCSCCCSSCCSCC--------CTTCSEEECCSCCCCEECTTTTSSCS-SCCEEECCSSCCCEECGGGGTTCSSCC
T ss_pred             CCEEEeCCCCcCcCCCCC--------CCCCcEEEccCCcCCeeCHHHhhCCC-CCCEEECCCCcCCccChhhccCCccCC
Confidence            445666666666655432        15667777777777766666666665 777777777777777778888888999


Q ss_pred             EEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCC-cCCCCCcccCCCCCCCCeEeCCCC
Q 003301          347 ELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGN-KLSGPIPPCIGDLTSLRLLSLASN  425 (832)
Q Consensus       347 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N  425 (832)
                      +|+|++|++++..+..|..+++|++|+|++|+++...+..|..+++|++|++++| .+....+..|.++++|+.|++++|
T Consensus       116 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n  195 (440)
T 3zyj_A          116 TLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMC  195 (440)
T ss_dssp             EEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTS
T ss_pred             EEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCC
Confidence            9999999888777778888999999999999988777778888899999999884 455444557888999999999999


Q ss_pred             cCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCc
Q 003301          426 ELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPK  505 (832)
Q Consensus       426 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  505 (832)
                      .++.+ | .+..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+..|.++++|+.|+|++|+|++..+.
T Consensus       196 ~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  273 (440)
T 3zyj_A          196 NLREI-P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHD  273 (440)
T ss_dssp             CCSSC-C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTT
T ss_pred             cCccc-c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChh
Confidence            99865 3 478889999999999999988889999999999999999999988899999999999999999999988888


Q ss_pred             cccCCCCCCeeccCCCcccccC
Q 003301          506 SIGGLVSLESLDLSNNSLSGNI  527 (832)
Q Consensus       506 ~~~~l~~L~~L~Ls~N~l~~~~  527 (832)
                      .|..+++|+.|+|++|++....
T Consensus       274 ~~~~l~~L~~L~L~~Np~~CdC  295 (440)
T 3zyj_A          274 LFTPLHHLERIHLHHNPWNCNC  295 (440)
T ss_dssp             TTSSCTTCCEEECCSSCEECSS
T ss_pred             HhccccCCCEEEcCCCCccCCC
Confidence            8999999999999999987543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.96  E-value=2.5e-29  Score=265.42  Aligned_cols=170  Identities=28%  Similarity=0.479  Sum_probs=144.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            468999999999999999999875 58999999986432   33456889999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+++++|.+++...+ .+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+|+......
T Consensus        90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            99999999999998654 6899999999999999999999   9999999999999999999999999999998765444


Q ss_pred             ccccccccccccccCCCC
Q 003301          814 SMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~  831 (832)
                      ........||+.|+|||+
T Consensus       166 ~~~~~~~~gt~~y~aPE~  183 (294)
T 4eqm_A          166 LTQTNHVLGTVQYFSPEQ  183 (294)
T ss_dssp             ---------CCSSCCHHH
T ss_pred             ccccCccccCccccCHhH
Confidence            333444579999999996

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.96  E-value=6e-29  Score=265.91  Aligned_cols=179  Identities=26%  Similarity=0.339  Sum_probs=156.1

Q ss_pred             cccchHHHHHHhcC----------CCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCC
Q 003301          647 RRFSYKELLQATNQ----------FNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHR  715 (832)
Q Consensus       647 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~  715 (832)
                      ..++++++..+.+.          |+..+.||+|+||.||+|++. +|+.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45677777666653          677789999999999999986 5999999999876666667889999999999999


Q ss_pred             ceeeeceEEecCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC
Q 003301          716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD  795 (832)
Q Consensus       716 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~  795 (832)
                      ||+++++++...+..|+||||+++++|.+++...  .+++..+..++.|++.|++|||   +.||+||||||+||+++.+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCC
Confidence            9999999999999999999999999999998754  5899999999999999999999   9999999999999999999


Q ss_pred             CcEEEeccccccccCCCcccccccccccccccCCCC
Q 003301          796 MVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       796 ~~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      +.+||+|||+++........ .....||+.|+|||+
T Consensus       178 ~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~  212 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEV  212 (321)
T ss_dssp             CCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHH
T ss_pred             CcEEEeeeeeeeecccCccc-cccccCCccccCHhh
Confidence            99999999999876543322 234579999999996

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=2.3e-30  Score=275.76  Aligned_cols=252  Identities=19%  Similarity=0.221  Sum_probs=198.2

Q ss_pred             cccccccCcEEEccCCcCCCCCCCcccCcccccccccccccccc-cCCChhhh------hcCCCceEEEccCCcccccCC
Q 003301           40 ELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLT-GSLPDDMC------RRLPLIKGLYMSNNKLTGPIP  112 (832)
Q Consensus        40 ~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~-~~lp~~~~------~~l~~L~~L~l~~N~l~~~~p  112 (832)
                      .++..++|++|++++|.+  .+|..+...  + +.|++++|.++ +.+|....      .++++|++|++++|++++.+|
T Consensus        38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L-~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  112 (312)
T 1wwl_A           38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI--I-KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAP  112 (312)
T ss_dssp             EEEEEEECTTHHHHCCTT--CCCHHHHHH--H-HHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCC
T ss_pred             EEccCCCceeEeeccccc--ccHHHHHHH--H-hhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhH
Confidence            456677888888888888  677766554  4 88888888884 45666553      157889999999999988888


Q ss_pred             CCc--cCCCCccEEECcCCcccccCCCCCcCC-----CcCceEEecccccccccCccccCccccceecccccccccc--c
Q 003301          113 NNI--WQCKELIVISLAYNQFTERIPRGLGNL-----TSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGF--V  183 (832)
Q Consensus       113 ~~l--~~l~~L~~L~Ls~n~i~~~~p~~~~~l-----~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~--~  183 (832)
                      ..+  ..+++|++|+|++|++++. |..++.+     ++|++|+|++|++++..|..|+++++|++|++++|++.+.  .
T Consensus       113 ~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  191 (312)
T 1wwl_A          113 PPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL  191 (312)
T ss_dssp             CCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHH
T ss_pred             HHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHH
Confidence            876  8888999999999999876 7777777     8899999999999877778888999999999999987654  2


Q ss_pred             Cccc--ccCCcccEEEecCCCCCC--CCCccccccCCCCccEEEccCCccccccC-CcccCCCCccEEEcCCCcCcccCC
Q 003301          184 PTSI--FNLSAMKTLALPSNALSG--SLPSSIDLVRLPNLEIISLAGNNFSGIIP-SFIFNASKLSVLELGENSFSGFIP  258 (832)
Q Consensus       184 ~~~~--~~l~~L~~L~L~~n~l~~--~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~  258 (832)
                      +..+  .++++|++|+|++|.+++  .++..+ +..+++|++|+|++|++++..| ..+..+++|++|+|++|+|+ .+|
T Consensus       192 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip  269 (312)
T 1wwl_A          192 ISALCPLKFPTLQVLALRNAGMETPSGVCSAL-AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVP  269 (312)
T ss_dssp             HHHSCTTSCTTCCEEECTTSCCCCHHHHHHHH-HHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCC
T ss_pred             HHHHHhccCCCCCEEECCCCcCcchHHHHHHH-HhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhh
Confidence            3334  788999999999998873  122222 3467899999999999988775 45667889999999999998 456


Q ss_pred             ccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCC
Q 003301          259 NTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPING  308 (832)
Q Consensus       259 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~  308 (832)
                      ..+.  ++|++|++++|+|++++      . +..+++|++|++++|++++
T Consensus       270 ~~~~--~~L~~L~Ls~N~l~~~p------~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          270 KGLP--AKLSVLDLSYNRLDRNP------S-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             SSCC--SEEEEEECCSSCCCSCC------C-TTTSCEEEEEECTTCTTTC
T ss_pred             hhcc--CCceEEECCCCCCCCCh------h-HhhCCCCCEEeccCCCCCC
Confidence            6555  88999999999998742      2 6788999999999999875

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.96  E-value=2.2e-29  Score=275.06  Aligned_cols=170  Identities=24%  Similarity=0.333  Sum_probs=147.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  732 (832)
                      .++|++.++||+|+||+||+|++.. ++.||+|+++...   ....+.+.+|..++.++ +||||+++++++.+++..|+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            4689999999999999999999864 7889999998653   22335678899999877 89999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||||+++|+|.+++.+.+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.....
T Consensus       131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            999999999999998654 6999999999999999999999   999999999999999999999999999999864332


Q ss_pred             cccccccccccccccCCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~l  832 (832)
                      .. .....+||+.|+|||++
T Consensus       207 ~~-~~~~~~gt~~Y~aPE~l  225 (396)
T 4dc2_A          207 GD-TTSTFCGTPNYIAPEIL  225 (396)
T ss_dssp             TC-CBCCCCBCGGGCCHHHH
T ss_pred             CC-ccccccCCcccCCchhh
Confidence            22 23346799999999963

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.96  E-value=5.4e-29  Score=265.14  Aligned_cols=167  Identities=28%  Similarity=0.411  Sum_probs=148.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.+.||+|+||+||+|+.. +|+.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            467999999999999999999886 58999999997543   23456788899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+..... 
T Consensus        85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            99999999999998754 6899999999999999999999   999999999999999999999999999999876432 


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                         ....+||+.|+|||++
T Consensus       160 ---~~~~~gt~~y~aPE~~  175 (318)
T 1fot_A          160 ---TYTLCGTPDYIAPEVV  175 (318)
T ss_dssp             ---BCCCCSCTTTCCHHHH
T ss_pred             ---cccccCCccccCHhHh
Confidence               2235799999999963

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.96  E-value=3.4e-29  Score=269.44  Aligned_cols=172  Identities=27%  Similarity=0.423  Sum_probs=148.9

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCee
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  730 (832)
                      ...++|++.+.||+|+||.||+|++. +++.||||+++...   ....+.+..|.++++.+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            35689999999999999999999986 48999999997643   23456778899999876 899999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      |+||||+++|+|.+++...+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+...
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            99999999999999998654 6899999999999999999999   9999999999999999999999999999998653


Q ss_pred             CCcccccccccccccccCCCCC
Q 003301          811 GEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       811 ~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .... .....+||+.|+|||++
T Consensus       170 ~~~~-~~~~~~gt~~y~aPE~~  190 (345)
T 1xjd_A          170 LGDA-KTNTFCGTPDYIAPEIL  190 (345)
T ss_dssp             CTTC-CBCCCCSCGGGCCHHHH
T ss_pred             cCCC-cccCCCCCcccCChhhh
Confidence            3222 23346799999999963

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=2.7e-29  Score=261.80  Aligned_cols=170  Identities=28%  Similarity=0.456  Sum_probs=151.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      .++|++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+++..|+||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            467999999999999999999998899999999975543 3367899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccc
Q 003301          738 PNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ  817 (832)
Q Consensus       738 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~  817 (832)
                      ++++|.+++......+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||.|+..........
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  164 (269)
T 4hcu_A           88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  164 (269)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence            999999999877667999999999999999999999   99999999999999999999999999999987655443333


Q ss_pred             ccccccccccCCCC
Q 003301          818 TLTLATIGYMAPGL  831 (832)
Q Consensus       818 ~~~~gt~~y~APE~  831 (832)
                      ....+|+.|+|||+
T Consensus       165 ~~~~~~~~y~aPE~  178 (269)
T 4hcu_A          165 TGTKFPVKWASPEV  178 (269)
T ss_dssp             TSTTCCGGGCCHHH
T ss_pred             cCcccccccCCHHH
Confidence            44567889999996

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.96  E-value=3.1e-30  Score=275.40  Aligned_cols=268  Identities=22%  Similarity=0.231  Sum_probs=203.0

Q ss_pred             CccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCccccccccc
Q 003301          242 KLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSL  321 (832)
Q Consensus       242 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L  321 (832)
                      +++.++++.+.+.......+..+++|++|+|++|.++.++     +..|..+++|++|+|++|+++              
T Consensus        11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~-----~~~~~~l~~L~~L~Ls~n~l~--------------   71 (317)
T 3o53_A           11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQIS-----AADLAPFTKLELLNLSSNVLY--------------   71 (317)
T ss_dssp             EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCC-----HHHHTTCTTCCEEECTTSCCE--------------
T ss_pred             ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCC-----HHHhhCCCcCCEEECCCCcCC--------------
Confidence            3455666677666555555556666777777777766532     224566666666666666654              


Q ss_pred             ceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCC
Q 003301          322 SRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGN  401 (832)
Q Consensus       322 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  401 (832)
                                 +..+  +..+++|++|++++|++++..+     .++|++|++++|++++..+..   +++|++|++++|
T Consensus        72 -----------~~~~--~~~l~~L~~L~Ls~n~l~~l~~-----~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N  130 (317)
T 3o53_A           72 -----------ETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAANNNISRVSCSR---GQGKKNIYLANN  130 (317)
T ss_dssp             -----------EEEE--ETTCTTCCEEECCSSEEEEEEE-----CTTCCEEECCSSCCSEEEECC---CSSCEEEECCSS
T ss_pred             -----------cchh--hhhcCCCCEEECcCCccccccC-----CCCcCEEECCCCccCCcCccc---cCCCCEEECCCC
Confidence                       2222  6677788888888888775432     378888888888887654433   567888888888


Q ss_pred             cCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccc-cCcccceeeecCCcccCCCccccccccccceecccCcccCCccC
Q 003301          402 KLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFW-NLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIP  480 (832)
Q Consensus       402 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  480 (832)
                      ++++..+..|..+++|++|++++|.+++..+..+. .+++|++|++++|++++. + ....+++|++|+|++|++++ +|
T Consensus       131 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~-l~  207 (317)
T 3o53_A          131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAF-MG  207 (317)
T ss_dssp             CCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCE-EC
T ss_pred             CCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCc-ch
Confidence            88877777888888888888888888887777764 688899999999988864 3 23458899999999999985 55


Q ss_pred             CccccccccceeecccccccccCCccccCCCCCCeeccCCCccc-ccCchhhhhhccCCeeeCC-CCcccccCCC
Q 003301          481 TAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLS-GNIPTSMEKLLYLKDLNLS-FNKLEGEIPR  553 (832)
Q Consensus       481 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~l~l~-~N~l~~~~p~  553 (832)
                      ..|..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ +.+|..+..++.|+.++++ .+.++|..|.
T Consensus       208 ~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~  281 (317)
T 3o53_A          208 PEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE  281 (317)
T ss_dssp             GGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred             hhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence            56999999999999999999 57888999999999999999999 7888999999999999998 4567776654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.96  E-value=5.7e-29  Score=268.22  Aligned_cols=170  Identities=24%  Similarity=0.334  Sum_probs=148.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  732 (832)
                      .++|++.+.||+|+||.||+|++.. ++.||+|++....   ....+.+.+|+.+++++ +||||+++++++.+.+..|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            3679999999999999999999864 8899999998653   23446788899999987 89999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||||+++|+|.+++...+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.....
T Consensus        88 v~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            999999999999997654 6899999999999999999999   999999999999999999999999999999864332


Q ss_pred             cccccccccccccccCCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~l  832 (832)
                      .. .....+||+.|+|||++
T Consensus       164 ~~-~~~~~~gt~~y~aPE~~  182 (345)
T 3a8x_A          164 GD-TTSTFCGTPNYIAPEIL  182 (345)
T ss_dssp             TC-CBCCCCSCGGGCCHHHH
T ss_pred             CC-cccccCCCccccCcccc
Confidence            22 23345799999999963

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.96  E-value=8.8e-29  Score=267.94  Aligned_cols=169  Identities=25%  Similarity=0.398  Sum_probs=149.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchh------hHHHHHHHHHHHhcCCCCceeeeceEEecCCee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEG------ALKSFDVECEVLKSVRHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  730 (832)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++......      ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            478999999999999999999986 4899999999765321      346789999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC----cEEEeccccc
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM----VAHLSDFGIA  806 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~----~~kl~DFg~a  806 (832)
                      |+||||+++|+|.+++.... .+++..+..++.|++.|++|||   +.||+||||||+||+++.++    .+||+|||+|
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            99999999999999997654 6999999999999999999999   99999999999999998777    7999999999


Q ss_pred             cccCCCcccccccccccccccCCCCC
Q 003301          807 KLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       807 ~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +.......  ....+||+.|+|||++
T Consensus       167 ~~~~~~~~--~~~~~gt~~y~aPE~~  190 (361)
T 2yab_A          167 HEIEDGVE--FKNIFGTPEFVAPEIV  190 (361)
T ss_dssp             EECCTTCC--CCCCCSCGGGCCHHHH
T ss_pred             eEcCCCCc--cccCCCCccEECchHH
Confidence            87654332  2335799999999963

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=7.7e-29  Score=264.81  Aligned_cols=168  Identities=21%  Similarity=0.353  Sum_probs=149.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .++|++.+.||+|+||.||+|.+.. ++.||+|++.... .....+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            4789999999999999999998864 8899999987543 3346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC--CCcEEEeccccccccCCCcc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK--DMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~--~~~~kl~DFg~a~~~~~~~~  814 (832)
                      +++++|.+++......+++..+..++.|++.|++|||   +.||+||||||+||+++.  ++.+||+|||+|+.......
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            9999999999876667999999999999999999999   999999999999999987  78999999999988754432


Q ss_pred             cccccccccccccCCCC
Q 003301          815 MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~  831 (832)
                        .....||+.|+|||+
T Consensus       160 --~~~~~gt~~y~aPE~  174 (321)
T 1tki_A          160 --FRLLFTAPEYYAPEV  174 (321)
T ss_dssp             --EEEEESCGGGSCHHH
T ss_pred             --cccccCChhhcCcHH
Confidence              234579999999996

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.96  E-value=5.9e-29  Score=268.42  Aligned_cols=171  Identities=23%  Similarity=0.314  Sum_probs=149.1

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  731 (832)
                      ..++|++.+.||+|+||.||+|++.. ++.||+|++....   ....+.+.+|..+++.+ +||+|+++++++.+.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            45789999999999999999999875 7899999997643   23456788899999988 7999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +||||++||+|.+++...+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+....
T Consensus        98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            9999999999999998654 6999999999999999999999   99999999999999999999999999999986433


Q ss_pred             CcccccccccccccccCCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ... .....+||+.|+|||++
T Consensus       174 ~~~-~~~~~~gt~~y~aPE~~  193 (353)
T 2i0e_A          174 DGV-TTKTFCGTPDYIAPEII  193 (353)
T ss_dssp             TTC-CBCCCCSCGGGCCHHHH
T ss_pred             CCc-ccccccCCccccChhhh
Confidence            222 23345799999999963

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.96  E-value=6e-29  Score=258.99  Aligned_cols=170  Identities=26%  Similarity=0.441  Sum_probs=151.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      .++|++.+.||+|+||.||+|++.++..||+|++..... ..+.+.+|++++++++||||+++++++.+++..|+||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            468999999999999999999998888999999975543 3467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccc
Q 003301          738 PNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ  817 (832)
Q Consensus       738 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~  817 (832)
                      ++++|.+++......+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||.|...........
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  162 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS  162 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence            999999999876656999999999999999999999   99999999999999999999999999999987755544333


Q ss_pred             ccccccccccCCCC
Q 003301          818 TLTLATIGYMAPGL  831 (832)
Q Consensus       818 ~~~~gt~~y~APE~  831 (832)
                      ....+|+.|+|||+
T Consensus       163 ~~~~~~~~y~aPE~  176 (268)
T 3sxs_A          163 VGTKFPVKWSAPEV  176 (268)
T ss_dssp             CSCCCCGGGCCHHH
T ss_pred             cCCCcCcccCCHHH
Confidence            44557788999996

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.96  E-value=7.5e-30  Score=272.39  Aligned_cols=266  Identities=23%  Similarity=0.225  Sum_probs=137.7

Q ss_pred             cEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEE
Q 003301          220 EIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLL  299 (832)
Q Consensus       220 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L  299 (832)
                      +..+++.+.+.......+..+++|++|+|++|.+++..|..|..+++|++|+|++|.++..+       .+..+++|++|
T Consensus        13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-------~~~~l~~L~~L   85 (317)
T 3o53_A           13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL-------DLESLSTLRTL   85 (317)
T ss_dssp             EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEE-------EETTCTTCCEE
T ss_pred             eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcch-------hhhhcCCCCEE
Confidence            33444445444444444444555666666666666555555666666666666666654311       14555666666


Q ss_pred             eccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCcc
Q 003301          300 DLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKL  379 (832)
Q Consensus       300 ~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  379 (832)
                      ++++|++++..+     . .+|++|++++|++++..+..   +++|++|++++|++++..+..|..+++|++|+|++|++
T Consensus        86 ~Ls~n~l~~l~~-----~-~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  156 (317)
T 3o53_A           86 DLNNNYVQELLV-----G-PSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI  156 (317)
T ss_dssp             ECCSSEEEEEEE-----C-TTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCC
T ss_pred             ECcCCccccccC-----C-CCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCC
Confidence            666665542211     1 14444444444444333322   34566666666666655555666666666666666666


Q ss_pred             CCCCchhhc-CCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccc
Q 003301          380 EGPIPNGLC-QLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPED  458 (832)
Q Consensus       380 ~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  458 (832)
                      ++..+..+. .+++|++|++++|++++. +. ...+++|+.|+|++|+++++                         |..
T Consensus       157 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l-------------------------~~~  209 (317)
T 3o53_A          157 DTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFM-------------------------GPE  209 (317)
T ss_dssp             CEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEE-------------------------CGG
T ss_pred             CcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcc-------------------------hhh
Confidence            654444442 455555555555555533 21 22245555555555555432                         223


Q ss_pred             cccccccceecccCcccCCccCCccccccccceeeccccccc-ccCCccccCCCCCCeeccC-CCcccccCch
Q 003301          459 IGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQ-GSIPKSIGGLVSLESLDLS-NNSLSGNIPT  529 (832)
Q Consensus       459 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls-~N~l~~~~p~  529 (832)
                      +..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ +.+|..++.+++|+.|+++ .+.++|..|.
T Consensus       210 ~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~  281 (317)
T 3o53_A          210 FQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE  281 (317)
T ss_dssp             GGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred             hcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence            444555555555555554 34445555555555555555555 4455555555555555555 3344444443

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.95  E-value=7.7e-29  Score=263.85  Aligned_cols=169  Identities=27%  Similarity=0.410  Sum_probs=147.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .++|++.+.||+|+||+||+|++.+++.||+|++....  ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            47899999999999999999999889999999987543  2234678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      |++ +++.+++......+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|+....... 
T Consensus       100 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-  174 (311)
T 3niz_A          100 FME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-  174 (311)
T ss_dssp             CCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred             CCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence            996 5899988877767999999999999999999999   99999999999999999999999999999987643322 


Q ss_pred             ccccccccccccCCCC
Q 003301          816 KQTLTLATIGYMAPGL  831 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~  831 (832)
                      ......||+.|+|||+
T Consensus       175 ~~~~~~~t~~y~aPE~  190 (311)
T 3niz_A          175 SYTHEVVTLWYRAPDV  190 (311)
T ss_dssp             ---CCCCCCTTCCHHH
T ss_pred             cccCCcccCCcCCHHH
Confidence            2233568999999996

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.95  E-value=8.9e-29  Score=267.07  Aligned_cols=167  Identities=28%  Similarity=0.383  Sum_probs=149.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.+.||+|+||.||+|++. +|+.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            468999999999999999999986 58999999997543   23456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+++|+|.+++.+.+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+......
T Consensus       120 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~  195 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT  195 (350)
T ss_dssp             EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCCc
Confidence            99999999999998654 6899999999999999999999   9999999999999999999999999999998764332


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                          ...+||+.|+|||++
T Consensus       196 ----~~~~gt~~y~aPE~~  210 (350)
T 1rdq_E          196 ----WTLCGTPEALAPEII  210 (350)
T ss_dssp             ----CCCEECGGGCCHHHH
T ss_pred             ----ccccCCccccCHHHh
Confidence                235799999999963

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.95  E-value=1.3e-28  Score=263.87  Aligned_cols=168  Identities=26%  Similarity=0.451  Sum_probs=148.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            478999999999999999999985 58999999997543   22345788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+ +|+|.+++...+ .+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||+|.......
T Consensus        88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            9999 789999887654 6999999999999999999999   9999999999999999999999999999998765443


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                      .  ....+||+.|+|||++
T Consensus       163 ~--~~~~~gt~~y~aPE~~  179 (336)
T 3h4j_B          163 F--LKTSCGSPNYAAPEVI  179 (336)
T ss_dssp             T--TCCCTTSTTTSCGGGS
T ss_pred             c--cccccCCcCcCCHHHH
Confidence            2  2335799999999975

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.95  E-value=1.2e-28  Score=264.10  Aligned_cols=172  Identities=28%  Similarity=0.493  Sum_probs=146.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec----CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL----DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      .++|++.+.||+|+||.||+|.+.    .+..||||++.... ....+.+.+|++++++++||||+++++++.+.+..|+
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            467889999999999999999885    34569999997653 3445788999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||||+++++|.++++.....+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|+.....
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            99999999999999877667999999999999999999999   999999999999999999999999999999876543


Q ss_pred             ccc--ccccccccccccCCCCC
Q 003301          813 ESM--KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~--~~~~~~gt~~y~APE~l  832 (832)
                      ...  ......+|+.|+|||++
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~  226 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAI  226 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHH
T ss_pred             ccceeeccCCCCcccccCHhHh
Confidence            322  12223467889999963

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.95  E-value=1.8e-28  Score=267.96  Aligned_cols=170  Identities=21%  Similarity=0.381  Sum_probs=151.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++..........+.+|++++++++||||+++++++.+.+..|+||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            468999999999999999999886 4889999999876555567889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC--CCcEEEeccccccccCCCcc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK--DMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~--~~~~kl~DFg~a~~~~~~~~  814 (832)
                      +++|+|.+++......+++..+..++.|++.||+|||   +.||+||||||+||+++.  ++.+||+|||+|+.......
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            9999999999876667999999999999999999999   999999999999999974  47899999999988754432


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                        .....||+.|+|||++
T Consensus       207 --~~~~~gt~~y~aPE~~  222 (387)
T 1kob_A          207 --VKVTTATAEFAAPEIV  222 (387)
T ss_dssp             --EEEECSSGGGCCHHHH
T ss_pred             --eeeeccCCCccCchhc
Confidence              2235699999999963

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=3.2e-27  Score=271.82  Aligned_cols=270  Identities=24%  Similarity=0.267  Sum_probs=183.2

Q ss_pred             CcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCcccccee
Q 003301          191 SAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWL  270 (832)
Q Consensus       191 ~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  270 (832)
                      .+++.|++++|.++ .+|..+    .++|++|+|++|+++.+.+    .+++|++|+|++|+|+.+ |.   .+++|++|
T Consensus        40 ~~l~~L~ls~n~L~-~lp~~l----~~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~l-p~---~l~~L~~L  106 (622)
T 3g06_A           40 NGNAVLNVGESGLT-TLPDCL----PAHITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLTSL-PV---LPPGLLEL  106 (622)
T ss_dssp             HCCCEEECCSSCCS-CCCSCC----CTTCSEEEECSCCCSCCCC----CCTTCCEEEECSCCCSCC-CC---CCTTCCEE
T ss_pred             CCCcEEEecCCCcC-ccChhh----CCCCcEEEecCCCCCCCCC----cCCCCCEEEcCCCcCCcC-CC---CCCCCCEE
Confidence            35788888888887 667654    1677777887777775433    356777777777777743 32   55677777


Q ss_pred             ecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEe
Q 003301          271 RLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGL  350 (832)
Q Consensus       271 ~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  350 (832)
                      ++++|.++.++.         .+++|+.|++++|++++ +|.                         .   +++|++|++
T Consensus       107 ~Ls~N~l~~l~~---------~l~~L~~L~L~~N~l~~-lp~-------------------------~---l~~L~~L~L  148 (622)
T 3g06_A          107 SIFSNPLTHLPA---------LPSGLCKLWIFGNQLTS-LPV-------------------------L---PPGLQELSV  148 (622)
T ss_dssp             EECSCCCCCCCC---------CCTTCCEEECCSSCCSC-CCC-------------------------C---CTTCCEEEC
T ss_pred             ECcCCcCCCCCC---------CCCCcCEEECCCCCCCc-CCC-------------------------C---CCCCCEEEC
Confidence            777777665432         23556666666666552 222                         1   245666666


Q ss_pred             ecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCC
Q 003301          351 WGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSV  430 (832)
Q Consensus       351 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  430 (832)
                      ++|++++. |.   .+++|+.|++++|++++ +|   ..+++|+.|++++|++++ +|..   +++|+.|++++|.++.+
T Consensus       149 s~N~l~~l-~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~l  216 (622)
T 3g06_A          149 SDNQLASL-PA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSL  216 (622)
T ss_dssp             CSSCCSCC-CC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSSC
T ss_pred             cCCcCCCc-CC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccccc
Confidence            66666542 22   23456667777777663 44   345667777777777764 3332   35677777777777653


Q ss_pred             CCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCC
Q 003301          431 IPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGL  510 (832)
Q Consensus       431 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  510 (832)
                      . .   .+++|+.|++++|+|++ +|   ..+++|+.|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .+|..|+.+
T Consensus       217 ~-~---~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l  283 (622)
T 3g06_A          217 P-A---LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHL  283 (622)
T ss_dssp             C-C---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGS
T ss_pred             C-C---CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhc
Confidence            3 2   23677788888888775 44   45577888888888888 4555   5678899999999998 678889999


Q ss_pred             CCCCeeccCCCcccccCchhhhhhcc
Q 003301          511 VSLESLDLSNNSLSGNIPTSMEKLLY  536 (832)
Q Consensus       511 ~~L~~L~Ls~N~l~~~~p~~~~~l~~  536 (832)
                      ++|+.|+|++|++++.+|..+..++.
T Consensus       284 ~~L~~L~L~~N~l~~~~~~~l~~L~~  309 (622)
T 3g06_A          284 SSETTVNLEGNPLSERTLQALREITS  309 (622)
T ss_dssp             CTTCEEECCSCCCCHHHHHHHHHHHH
T ss_pred             cccCEEEecCCCCCCcCHHHHHhccc
Confidence            99999999999999988888887763

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=9.7e-28  Score=276.10  Aligned_cols=269  Identities=25%  Similarity=0.269  Sum_probs=217.8

Q ss_pred             cccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCcccccccccccccccccCCChhhhhcCCCceEE
Q 003301           21 TMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGL  100 (832)
Q Consensus        21 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L  100 (832)
                      ..+++|++++|+++ .+|..+.  ++|++|+|++|.++ .+|.   .+++| ++|||++|+++ .+|.    .+++|++|
T Consensus        40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L-~~L~Ls~N~l~-~lp~----~l~~L~~L  106 (622)
T 3g06_A           40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPEL-RTLEVSGNQLT-SLPV----LPPGLLEL  106 (622)
T ss_dssp             HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTC-CEEEECSCCCS-CCCC----CCTTCCEE
T ss_pred             CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCC-CEEEcCCCcCC-cCCC----CCCCCCEE
Confidence            35889999999998 8888776  78999999999998 7777   45677 88999999998 7887    57889999


Q ss_pred             EccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccccccc
Q 003301          101 YMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLV  180 (832)
Q Consensus       101 ~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~  180 (832)
                      ++++|++++ +|.   .+++|+.|++++|++++ +|..   +++|++|+|++|++++ +|.   .+++|+.|++++|+++
T Consensus       107 ~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~  174 (622)
T 3g06_A          107 SIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLT  174 (622)
T ss_dssp             EECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS
T ss_pred             ECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCC
Confidence            999999984 555   56889999999999985 5653   4889999999999984 554   3467888999999998


Q ss_pred             cccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCcc
Q 003301          181 GFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNT  260 (832)
Q Consensus       181 ~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~  260 (832)
                      + +|   ..+++|+.|++++|.+++ +|..     +++|+.|++++|.++.+..    .+++|++|+|++|.|+++ |  
T Consensus       175 ~-l~---~~~~~L~~L~Ls~N~l~~-l~~~-----~~~L~~L~L~~N~l~~l~~----~~~~L~~L~Ls~N~L~~l-p--  237 (622)
T 3g06_A          175 S-LP---MLPSGLQELSVSDNQLAS-LPTL-----PSELYKLWAYNNRLTSLPA----LPSGLKELIVSGNRLTSL-P--  237 (622)
T ss_dssp             C-CC---CCCTTCCEEECCSSCCSC-CCCC-----CTTCCEEECCSSCCSSCCC----CCTTCCEEECCSSCCSCC-C--
T ss_pred             C-Cc---ccCCCCcEEECCCCCCCC-CCCc-----cchhhEEECcCCcccccCC----CCCCCCEEEccCCccCcC-C--
Confidence            6 44   456889999999999984 5542     4789999999999986543    257899999999999864 4  


Q ss_pred             ccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCccccccccccc
Q 003301          261 LGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIG  340 (832)
Q Consensus       261 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~  340 (832)
                       ..+++|++|++++|.|+.++.         .+++|+.|+|++|+++ .+|..+..+. +|+.|++++|.+++..|..+.
T Consensus       238 -~~l~~L~~L~Ls~N~L~~lp~---------~~~~L~~L~Ls~N~L~-~lp~~l~~l~-~L~~L~L~~N~l~~~~~~~l~  305 (622)
T 3g06_A          238 -VLPSELKELMVSGNRLTSLPM---------LPSGLLSLSVYRNQLT-RLPESLIHLS-SETTVNLEGNPLSERTLQALR  305 (622)
T ss_dssp             -CCCTTCCEEECCSSCCSCCCC---------CCTTCCEEECCSSCCC-SCCGGGGGSC-TTCEEECCSCCCCHHHHHHHH
T ss_pred             -CCCCcCcEEECCCCCCCcCCc---------ccccCcEEeCCCCCCC-cCCHHHhhcc-ccCEEEecCCCCCCcCHHHHH
Confidence             456889999999999987553         4578999999999998 6788888877 899999999999988888777


Q ss_pred             CcC
Q 003301          341 NLI  343 (832)
Q Consensus       341 ~l~  343 (832)
                      .++
T Consensus       306 ~L~  308 (622)
T 3g06_A          306 EIT  308 (622)
T ss_dssp             HHH
T ss_pred             hcc
Confidence            665

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.95  E-value=2e-28  Score=258.52  Aligned_cols=168  Identities=27%  Similarity=0.403  Sum_probs=146.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      ++|++.+.||+|+||+||+|.+. +++.||+|++....  ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999986 48999999997543  2334678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      |++ +++.+++......+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||.|+....... 
T Consensus        82 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  156 (292)
T 3o0g_A           82 FCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred             cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence            996 5777777766667999999999999999999999   99999999999999999999999999999987643332 


Q ss_pred             ccccccccccccCCCC
Q 003301          816 KQTLTLATIGYMAPGL  831 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~  831 (832)
                      ......||+.|+|||+
T Consensus       157 ~~~~~~~t~~y~aPE~  172 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDV  172 (292)
T ss_dssp             CCCSCCSCGGGCCHHH
T ss_pred             cccCCccccCCcChHH
Confidence            2233568999999996

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.95  E-value=1.8e-28  Score=264.02  Aligned_cols=172  Identities=26%  Similarity=0.416  Sum_probs=143.8

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC------
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNND------  728 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  728 (832)
                      ..++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            3568999999999999999999986 68999999997543 334578899999999999999999999986543      


Q ss_pred             ---------------------------------------------------eeEEEEecCCCCCHHHHHhhCCC--CCCH
Q 003301          729 ---------------------------------------------------FKALVLEYMPNGSLEDYLYSNNF--SFDI  755 (832)
Q Consensus       729 ---------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~--~~~~  755 (832)
                                                                         ..|+||||+++++|.+++.....  ..++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               37999999999999999986542  2566


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc-----------cccccccccc
Q 003301          756 LQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES-----------MKQTLTLATI  824 (832)
Q Consensus       756 ~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~-----------~~~~~~~gt~  824 (832)
                      ..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.......           ......+||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            778999999999999999   99999999999999999999999999999987754421           1123356999


Q ss_pred             cccCCCC
Q 003301          825 GYMAPGL  831 (832)
Q Consensus       825 ~y~APE~  831 (832)
                      .|+|||+
T Consensus       241 ~y~aPE~  247 (332)
T 3qd2_B          241 LYMSPEQ  247 (332)
T ss_dssp             GGSCHHH
T ss_pred             CccChHH
Confidence            9999996

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.95  E-value=1.3e-28  Score=268.57  Aligned_cols=171  Identities=26%  Similarity=0.489  Sum_probs=147.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec--------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEecC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL--------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTNN  727 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  727 (832)
                      .++|++.+.||+|+||.||+|++.        ++..||||+++... ....+.+.+|+++++++ +||||+++++++.++
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            478999999999999999999863        34579999987553 33456889999999999 899999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe
Q 003301          728 DFKALVLEYMPNGSLEDYLYSNN---------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL  792 (832)
Q Consensus       728 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~  792 (832)
                      +..|+||||+++|+|.++++..+               ..+++..+..++.|++.||+|||   ++||+||||||+||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            99999999999999999998653               24789999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeccccccccCCCccc-ccccccccccccCCCC
Q 003301          793 DKDMVAHLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGL  831 (832)
Q Consensus       793 ~~~~~~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~  831 (832)
                      +.++.+||+|||+|+........ ......+|+.|+|||+
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~  276 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEA  276 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhH
Confidence            99999999999999876543322 2233457889999996

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.95  E-value=8.1e-29  Score=260.24  Aligned_cols=171  Identities=28%  Similarity=0.448  Sum_probs=148.6

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ..++|++.+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            3578999999999999999999998888999999975533 336788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +++++|.+++......+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||.++.........
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  177 (283)
T 3gen_A          101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  177 (283)
T ss_dssp             CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence            9999999999875557999999999999999999999   9999999999999999999999999999998765543333


Q ss_pred             cccccccccccCCCC
Q 003301          817 QTLTLATIGYMAPGL  831 (832)
Q Consensus       817 ~~~~~gt~~y~APE~  831 (832)
                      .....+|+.|+|||+
T Consensus       178 ~~~~~~~~~y~aPE~  192 (283)
T 3gen_A          178 SVGSKFPVRWSPPEV  192 (283)
T ss_dssp             TTSTTSCGGGCCHHH
T ss_pred             ccCCccCcccCCHHH
Confidence            333457889999996

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.95  E-value=2.1e-28  Score=271.98  Aligned_cols=171  Identities=23%  Similarity=0.377  Sum_probs=148.0

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++....  ....+.+.+|+++++.++||||+++++++.+++..|+|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            4578999999999999999999875 58999999987554  23456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeC---CCCcEEEeccccccccC
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~---~~~~~kl~DFg~a~~~~  810 (832)
                      |||+++|+|.+++.... .+++..+..++.|++.|++|||   ++||+||||||+||+++   .++.+||+|||+|+...
T Consensus        89 ~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            99999999999998764 6999999999999999999999   99999999999999998   56889999999998765


Q ss_pred             CCcccccccccccccccCCCCC
Q 003301          811 GEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       811 ~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ..... ....+||+.|+|||++
T Consensus       165 ~~~~~-~~~~~gt~~Y~APE~l  185 (444)
T 3soa_A          165 GEQQA-WFGFAGTPGYLSPEVL  185 (444)
T ss_dssp             TTCCB-CCCSCSCGGGCCHHHH
T ss_pred             CCCce-eecccCCcccCCHHHh
Confidence            44322 2335799999999963

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.95  E-value=9.2e-29  Score=264.55  Aligned_cols=171  Identities=25%  Similarity=0.379  Sum_probs=146.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch-hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE-GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .++|++.+.||+|+||+||+|.+. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            478999999999999999999886 589999999875432 234668899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc-c
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE-S  814 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~-~  814 (832)
                      |+++++|.+++.... .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|+...... .
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            999999999997654 6999999999999999999999   9999999999999999999999999999998653222 1


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                      ......+||+.|+|||++
T Consensus       162 ~~~~~~~gt~~y~aPE~~  179 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELL  179 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHH
T ss_pred             cccCCCccCcCccCcHHh
Confidence            122345799999999963

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.95  E-value=6.3e-29  Score=264.06  Aligned_cols=174  Identities=30%  Similarity=0.487  Sum_probs=141.1

Q ss_pred             HHHHHhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCee
Q 003301          653 ELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       653 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  730 (832)
                      ++....++|++.+.||+|+||+||+|++ +++.||||++....  ....+.+.+|++++++++||||+++++++.+.+..
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL  109 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence            3334467899999999999999999987 78899999987553  33446788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeEeCCCCcEEEeccccc
Q 003301          731 ALVLEYMPNGSLEDYLYSNNF--SFDILQRLSVIIDVALALEYLHFGYSNP--VVHCDIKPSNVLLDKDMVAHLSDFGIA  806 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~~~~~~kl~DFg~a  806 (832)
                      |+||||+++|+|.+++.....  .+++..+..++.|++.||+|||   +.|  |+||||||+||+++.++.+||+|||+|
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  186 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS  186 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence            999999999999999986542  2899999999999999999999   899  999999999999999999999999999


Q ss_pred             cccCCCcccccccccccccccCCCC
Q 003301          807 KLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       807 ~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      +....... ......||+.|+|||+
T Consensus       187 ~~~~~~~~-~~~~~~gt~~y~aPE~  210 (309)
T 3p86_A          187 RLKASTFL-SSKSAAGTPEWMAPEV  210 (309)
T ss_dssp             ----------------CCTTSCHHH
T ss_pred             cccccccc-ccccCCCCccccChhh
Confidence            86543322 2233569999999996

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.95  E-value=1.1e-28  Score=264.66  Aligned_cols=169  Identities=26%  Similarity=0.411  Sum_probs=138.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec----CCcEEEEEEEeccc----hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL----DGMEVAIKVFHLQL----EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDF  729 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  729 (832)
                      .++|++.+.||+|+||.||+|+..    +++.||+|+++...    ......+.+|++++++++||||+++++++..++.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            468999999999999999999873    68999999987542    2234567889999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      .|+||||+++++|.+++...+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            999999999999999997654 6899999999999999999999   999999999999999999999999999999864


Q ss_pred             CCCcccccccccccccccCCCC
Q 003301          810 SGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       810 ~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      ..... .....+||+.|+|||+
T Consensus       172 ~~~~~-~~~~~~gt~~y~aPE~  192 (327)
T 3a62_A          172 IHDGT-VTHTFCGTIEYMAPEI  192 (327)
T ss_dssp             --------CTTSSCCTTSCHHH
T ss_pred             ccCCc-cccccCCCcCccCHhh
Confidence            33322 2233579999999996

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.95  E-value=1.1e-28  Score=259.71  Aligned_cols=168  Identities=27%  Similarity=0.429  Sum_probs=144.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccch--hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ++|++.+.||+|+||.||+|++.+++.||+|++.....  ...+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57999999999999999999997799999999875432  2346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      ++ ++|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||.|+....... .
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  156 (288)
T 1ob3_A           82 LD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K  156 (288)
T ss_dssp             CS-EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-c
Confidence            96 5999999876667999999999999999999999   99999999999999999999999999999987643322 2


Q ss_pred             cccccccccccCCCC
Q 003301          817 QTLTLATIGYMAPGL  831 (832)
Q Consensus       817 ~~~~~gt~~y~APE~  831 (832)
                      .....||+.|+|||+
T Consensus       157 ~~~~~~t~~y~aPE~  171 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDV  171 (288)
T ss_dssp             -----CCCTTCCHHH
T ss_pred             cccccccccccCchh
Confidence            233568999999996

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.95  E-value=2.4e-28  Score=258.70  Aligned_cols=169  Identities=28%  Similarity=0.429  Sum_probs=142.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch--------------------------hhHHHHHHHHHHHh
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE--------------------------GALKSFDVECEVLK  710 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~  710 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            478999999999999999999875 488999999865421                          12356889999999


Q ss_pred             cCCCCceeeeceEEec--CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCC
Q 003301          711 SVRHRNLVKIISSCTN--NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPS  788 (832)
Q Consensus       711 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~  788 (832)
                      +++||||+++++++.+  .+..|+||||+++++|.++...  ..+++..+..++.|++.||+|||   +.||+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence            9999999999999986  5689999999999999887643  35899999999999999999999   999999999999


Q ss_pred             CeEeCCCCcEEEeccccccccCCCcccccccccccccccCCCCC
Q 003301          789 NVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       789 NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ||+++.++.+||+|||+|+........ .....||+.|+|||++
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~  209 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESL  209 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGC
T ss_pred             HEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhh
Confidence            999999999999999999876544322 2335799999999974

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.95  E-value=1.2e-28  Score=268.03  Aligned_cols=170  Identities=31%  Similarity=0.382  Sum_probs=139.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHH-HhcCCCCceeeeceEEecCCeeEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEV-LKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      .++|++.+.||+|+||+||+|++.. ++.||+|++....   ......+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            4679999999999999999999864 8889999997653   2233456667776 577899999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||||++||+|.+++.+.+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.+|.+||+|||+|+.....
T Consensus       117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999999998654 6899999999999999999999   999999999999999999999999999999864332


Q ss_pred             cccccccccccccccCCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~l  832 (832)
                      .. .....+||+.|+|||++
T Consensus       193 ~~-~~~~~~gt~~y~aPE~~  211 (373)
T 2r5t_A          193 NS-TTSTFCGTPEYLAPEVL  211 (373)
T ss_dssp             CC-CCCSBSCCCCCCCHHHH
T ss_pred             CC-ccccccCCccccCHHHh
Confidence            22 23346799999999963

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.95  E-value=2.7e-28  Score=264.95  Aligned_cols=170  Identities=24%  Similarity=0.454  Sum_probs=148.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++....  ....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3578999999999999999999886 48999999997543  33456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC---CcEEEeccccccccC
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD---MVAHLSDFGIAKLLS  810 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~---~~~kl~DFg~a~~~~  810 (832)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++.+   +.+||+|||+|+...
T Consensus       107 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          107 FDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             ECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            99999999999997654 6899999999999999999999   9999999999999999865   459999999998765


Q ss_pred             CCcccccccccccccccCCCCC
Q 003301          811 GEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       811 ~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ....  ....+||+.|+|||++
T Consensus       183 ~~~~--~~~~~gt~~y~aPE~~  202 (362)
T 2bdw_A          183 DSEA--WHGFAGTPGYLSPEVL  202 (362)
T ss_dssp             TCCS--CCCSCSCTTTCCHHHH
T ss_pred             CCcc--cccCCCCccccCHHHH
Confidence            4332  2335799999999963

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.95  E-value=1.7e-28  Score=267.67  Aligned_cols=170  Identities=19%  Similarity=0.252  Sum_probs=143.5

Q ss_pred             HhcCCCCCCeeeccCCceEEEEE------ecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCC---CCceeeeceEEecC
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGS------FLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVR---HRNLVKIISSCTNN  727 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~  727 (832)
                      ..++|.+.+.||+|+||+||+|.      ..+++.||||++....   ...+.+|+++++.++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            35789999999999999999994      3358899999987543   346677777777776   99999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC---------
Q 003301          728 DFKALVLEYMPNGSLEDYLYS----NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK---------  794 (832)
Q Consensus       728 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---------  794 (832)
                      +..|+||||+++|+|.+++..    ....+++..+..++.|++.||+|||   ++||+||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccc
Confidence            999999999999999999974    3446999999999999999999999   999999999999999998         


Q ss_pred             --CCcEEEeccccccccCC-CcccccccccccccccCCCCC
Q 003301          795 --DMVAHLSDFGIAKLLSG-EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       795 --~~~~kl~DFg~a~~~~~-~~~~~~~~~~gt~~y~APE~l  832 (832)
                        ++.+||+|||+|+.+.. .........+||+.|||||++
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~  257 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML  257 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHH
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHh
Confidence              89999999999976432 122233446799999999963

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.95  E-value=1.9e-28  Score=262.26  Aligned_cols=167  Identities=28%  Similarity=0.413  Sum_probs=144.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCC----eeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNND----FKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv  733 (832)
                      .++|++.+.||+|+||+||+|++ .++.||||++..... ......+|+.++++++||||+++++++....    ..|+|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            47899999999999999999988 489999999975533 2345566899999999999999999998744    46999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------CeEecCCCCCCeEeCCCCcEEEecc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN----------PVVHCDIKPSNVLLDKDMVAHLSDF  803 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~----------~ivH~Dlkp~NIl~~~~~~~kl~DF  803 (832)
                      |||+++|+|.++++..  .+++..+..++.|++.|++|||   +.          ||+||||||+||+++.++.+||+||
T Consensus       101 ~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          101 TAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            9999999999999875  4899999999999999999999   88          9999999999999999999999999


Q ss_pred             ccccccCCCccc-ccccccccccccCCCC
Q 003301          804 GIAKLLSGEESM-KQTLTLATIGYMAPGL  831 (832)
Q Consensus       804 g~a~~~~~~~~~-~~~~~~gt~~y~APE~  831 (832)
                      |+|+........ ......||+.|+|||+
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~  204 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEV  204 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHH
T ss_pred             CcccccccccCccccccCccCccccCHhh
Confidence            999876543322 2233579999999996

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.95  E-value=3.4e-28  Score=260.60  Aligned_cols=168  Identities=23%  Similarity=0.382  Sum_probs=148.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchh------hHHHHHHHHHHHhcCCCCceeeeceEEecCCee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEG------ALKSFDVECEVLKSVRHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  730 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++......      ..+.+.+|++++++++||||+++++++.+.+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            357999999999999999999986 4899999998754321      356789999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC----cEEEeccccc
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM----VAHLSDFGIA  806 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~----~~kl~DFg~a  806 (832)
                      |+||||+++++|.+++.... .+++..+..++.|++.||+|||   +.||+||||||+||+++.++    .+||+|||+|
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            99999999999999997654 6999999999999999999999   99999999999999998887    8999999999


Q ss_pred             cccCCCcccccccccccccccCCCC
Q 003301          807 KLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       807 ~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      +.......  ....+||+.|+|||+
T Consensus       166 ~~~~~~~~--~~~~~gt~~y~aPE~  188 (326)
T 2y0a_A          166 HKIDFGNE--FKNIFGTPEFVAPEI  188 (326)
T ss_dssp             EECCTTSC--CCCCCSCTTTCCHHH
T ss_pred             eECCCCCc--cccccCCcCcCCcee
Confidence            87754332  233569999999996

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.95  E-value=1.6e-28  Score=265.88  Aligned_cols=171  Identities=22%  Similarity=0.358  Sum_probs=146.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch-----hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE-----GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  731 (832)
                      .++|++.+.||+|+||+||+|.+. +++.||||++.....     ...+.+.+|+++++.++||||+++++++.+++..|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            467999999999999999999886 589999999875321     13577899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCc---EEEecccc
Q 003301          732 LVLEYMPNGSLEDYLYSN---NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMV---AHLSDFGI  805 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~---~kl~DFg~  805 (832)
                      +||||+++++|.+++...   ...+++..+..++.|++.||+|||   ++||+||||||+||+++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999998887542   335899999999999999999999   999999999999999986654   99999999


Q ss_pred             ccccCCCcccccccccccccccCCCCC
Q 003301          806 AKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       806 a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      |+....... .....+||+.|+|||++
T Consensus       180 a~~~~~~~~-~~~~~~gt~~y~aPE~~  205 (351)
T 3c0i_A          180 AIQLGESGL-VAGGRVGTPHFMAPEVV  205 (351)
T ss_dssp             CEECCTTSC-BCCCCCSCGGGCCHHHH
T ss_pred             eeEecCCCe-eecCCcCCcCccCHHHH
Confidence            987754332 22335799999999963

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.95  E-value=1.8e-28  Score=267.48  Aligned_cols=171  Identities=25%  Similarity=0.495  Sum_probs=138.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec----CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL----DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      .++|++.+.||+|+||.||+|++.    ++..||||+++... ....+.+.+|++++++++||||+++++++.+.+..|+
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            368999999999999999999875    46789999987543 3445689999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||||+++|+|.++++.....+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.....
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            99999999999999887667999999999999999999999   999999999999999999999999999999876543


Q ss_pred             cccc--cccccccccccCCCC
Q 003301          813 ESMK--QTLTLATIGYMAPGL  831 (832)
Q Consensus       813 ~~~~--~~~~~gt~~y~APE~  831 (832)
                      ....  .....+|+.|+|||+
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~  221 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEA  221 (373)
T ss_dssp             -------------CTTSCHHH
T ss_pred             CccceeccCCCcCCCccChhh
Confidence            3211  112245788999996

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.95  E-value=3.8e-28  Score=271.60  Aligned_cols=169  Identities=29%  Similarity=0.489  Sum_probs=150.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|.+.+.||+|+||.||+|++. +|+.||||++....   ....+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            468999999999999999999986 59999999997543   22346788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+++|+|.+++.+.+ .+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||+|+......
T Consensus        95 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            99999999999997654 6999999999999999999999   9999999999999999999999999999998765433


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                      .  ....+||+.|+|||++
T Consensus       171 ~--~~~~~gt~~y~aPE~~  187 (476)
T 2y94_A          171 F--LRTSCGSPNYAAPEVI  187 (476)
T ss_dssp             C--BCCCCSCSTTCCHHHH
T ss_pred             c--ccccCCCcCeEChhhc
Confidence            2  2335799999999963

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.95  E-value=3.3e-28  Score=275.56  Aligned_cols=170  Identities=28%  Similarity=0.391  Sum_probs=149.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.+.||+|+||.||+|++. +|+.||+|++....   ......+.+|+++++.++||||+++++++.+.+..|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999986 58999999997542   23346788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          734 LEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      |||++||+|.+++...+ ..+++..+..++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+|+.....
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999997654 34899999999999999999999   999999999999999999999999999999876543


Q ss_pred             cccccccccccccccCCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~l  832 (832)
                      ..  ....+||+.|+|||++
T Consensus       340 ~~--~~~~~GT~~Y~APEvl  357 (576)
T 2acx_A          340 QT--IKGRVGTVGYMAPEVV  357 (576)
T ss_dssp             CC--EECCCSCGGGCCHHHH
T ss_pred             cc--ccccCCCccccCHHHH
Confidence            32  2335799999999963

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.95  E-value=1.2e-28  Score=260.74  Aligned_cols=171  Identities=29%  Similarity=0.504  Sum_probs=144.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-----cCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEec--CCee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSF-----LDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN--NDFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  730 (832)
                      .++|++.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46899999999999999999984     2588999999987766667889999999999999999999999865  3568


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      |+||||+++++|.+++...+..+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||+|+...
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            9999999999999999887666999999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCccc--ccccccccccccCCCC
Q 003301          811 GEESM--KQTLTLATIGYMAPGL  831 (832)
Q Consensus       811 ~~~~~--~~~~~~gt~~y~APE~  831 (832)
                      .....  ......+|+.|+|||+
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~  188 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPES  188 (295)
T ss_dssp             ----------CTTCGGGGCCHHH
T ss_pred             CCcceeeeccCCCCccceeCcHH
Confidence            43221  1223457888999996

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.95  E-value=1.6e-28  Score=261.60  Aligned_cols=169  Identities=26%  Similarity=0.299  Sum_probs=141.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch--hhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE--GALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.++||+|+||+||+|.+. +++.||||++.....  ........|+..+.++ +||||+++++++.+++..|+|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            367999999999999999999987 589999999865432  2233445566555554 899999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+ +++|.+++...+..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+......
T Consensus       136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence            9999 77999998876667999999999999999999999   9999999999999999999999999999998764433


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                      .  .....||+.|+|||++
T Consensus       212 ~--~~~~~gt~~y~aPE~~  228 (311)
T 3p1a_A          212 A--GEVQEGDPRYMAPELL  228 (311)
T ss_dssp             -----CCCCCGGGCCGGGG
T ss_pred             C--CcccCCCccccCHhHh
Confidence            2  2335699999999974

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.95  E-value=1.8e-27  Score=248.78  Aligned_cols=210  Identities=25%  Similarity=0.269  Sum_probs=143.9

Q ss_pred             cccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCC
Q 003301          344 NLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLA  423 (832)
Q Consensus       344 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  423 (832)
                      +|++|++++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|++++|++++..+..|.++++|++|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            45556666666555555555566666666666666655444555666666666666666665555566666666666666


Q ss_pred             CCcCCCCCCcccccCcccceeeecCCcccCC-CccccccccccceecccCcccCCccCCccccccccc----eeeccccc
Q 003301          424 SNELNSVIPSTFWNLKDILSLNFSSNFLNGS-LPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQ----DLSLRDNG  498 (832)
Q Consensus       424 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~----~L~Ls~N~  498 (832)
                      +|.+++..+..|..+++|++|++++|++++. +|..++.+++|+.|+|++|++++..+..|..+.+|+    .|++++|+
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~  188 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP  188 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred             CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence            6666666555666666666666666666653 466677777777777777777766666777666666    78888888


Q ss_pred             ccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCCCC
Q 003301          499 LQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRG  554 (832)
Q Consensus       499 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~  554 (832)
                      +++..+..+.. .+|+.|+|++|++++..+..+..+++|+.|+|++|+++|.+|..
T Consensus       189 l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l  243 (276)
T 2z62_A          189 MNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  243 (276)
T ss_dssp             CCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred             ccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence            88655555544 47889999999988777777788899999999999999888764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.95  E-value=4.4e-28  Score=258.85  Aligned_cols=170  Identities=27%  Similarity=0.454  Sum_probs=132.7

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            3578999999999999999999876 48999999997553 233467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          735 EYMPNGSLEDYLYSNN-----FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      ||++ ++|.+++....     ..+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||.|+..
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9997 69999886532     35899999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCcccccccccccccccCCCC
Q 003301          810 SGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       810 ~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      ..... ......||+.|+|||+
T Consensus       159 ~~~~~-~~~~~~~t~~y~aPE~  179 (317)
T 2pmi_A          159 GIPVN-TFSSEVVTLWYRAPDV  179 (317)
T ss_dssp             TSCCC-CCCCCCSCCTTCCHHH
T ss_pred             CCCcc-cCCCCcccccccCchH
Confidence            43322 2233569999999996

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.95  E-value=5.7e-28  Score=273.15  Aligned_cols=171  Identities=27%  Similarity=0.390  Sum_probs=149.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.+.||+|+||.||+|++. +|+.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            368999999999999999999986 48999999997543   23346788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          734 LEYMPNGSLEDYLYSNN---FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      |||++||+|.+++....   ..+++..+..++.||+.||+|||   ++||+||||||+||+++.+|.+||+|||+|+...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999987542   35899999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCcccccccccccccccCCCCC
Q 003301          811 GEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       811 ~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ..... ....+||+.|+|||++
T Consensus       341 ~~~~~-~~~~~GT~~Y~APE~l  361 (543)
T 3c4z_A          341 AGQTK-TKGYAGTPGFMAPELL  361 (543)
T ss_dssp             TTCCC-BCCCCSCTTTSCHHHH
T ss_pred             CCCcc-cccccCCccccChhhh
Confidence            44322 2335799999999963

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.95  E-value=4.3e-28  Score=264.33  Aligned_cols=164  Identities=23%  Similarity=0.427  Sum_probs=141.0

Q ss_pred             CCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCCCC
Q 003301          663 ASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGS  741 (832)
Q Consensus       663 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  741 (832)
                      ..+.||+|+||.||+|.+. +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..|+||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            3678999999999999875 589999999987665566789999999999999999999999999999999999999999


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe--CCCCcEEEeccccccccCCCccccccc
Q 003301          742 LEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL--DKDMVAHLSDFGIAKLLSGEESMKQTL  819 (832)
Q Consensus       742 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~--~~~~~~kl~DFg~a~~~~~~~~~~~~~  819 (832)
                      |.+++......+++..+..++.|++.||+|||   +.||+||||||+||++  +.++.+||+|||+|+.......  ...
T Consensus       173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~  247 (373)
T 2x4f_A          173 LFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKV  247 (373)
T ss_dssp             EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCC
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--ccc
Confidence            99999876667999999999999999999999   9999999999999999  6678999999999987754432  223


Q ss_pred             ccccccccCCCC
Q 003301          820 TLATIGYMAPGL  831 (832)
Q Consensus       820 ~~gt~~y~APE~  831 (832)
                      .+||+.|+|||+
T Consensus       248 ~~gt~~y~aPE~  259 (373)
T 2x4f_A          248 NFGTPEFLAPEV  259 (373)
T ss_dssp             CCSSCTTCCHHH
T ss_pred             ccCCCcEeChhh
Confidence            569999999996

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.95  E-value=1.5e-28  Score=268.86  Aligned_cols=172  Identities=26%  Similarity=0.430  Sum_probs=148.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ..++|++.+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|++++++++||||+++++++..++..|+||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            3568899999999999999999986 58999999987543 233457889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||+++|+|.++++..+..+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||+|+.......
T Consensus       192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            999999999999876656899999999999999999999   99999999999999999999999999999987543322


Q ss_pred             ccc-ccccccccccCCCC
Q 003301          815 MKQ-TLTLATIGYMAPGL  831 (832)
Q Consensus       815 ~~~-~~~~gt~~y~APE~  831 (832)
                      ... ....+++.|+|||+
T Consensus       269 ~~~~~~~~~~~~y~aPE~  286 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEA  286 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHH
T ss_pred             eecCCCCCCCcCcCCHhH
Confidence            111 12336788999996

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.95  E-value=3.8e-28  Score=263.86  Aligned_cols=168  Identities=23%  Similarity=0.313  Sum_probs=139.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .++|++.+.||+|+||+||+|++. +++.||||++..... ..+.+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            578999999999999999999986 589999999975432 236788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCc--EEEeccccccccCCCcc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMV--AHLSDFGIAKLLSGEES  814 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~--~kl~DFg~a~~~~~~~~  814 (832)
                      +++|+|.+++...+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.  +||+|||+|+...... 
T Consensus        98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-  172 (361)
T 3uc3_A           98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  172 (361)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence            99999999997654 6999999999999999999999   999999999999999987765  9999999998543222 


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                       .....+||+.|+|||++
T Consensus       173 -~~~~~~gt~~y~aPE~~  189 (361)
T 3uc3_A          173 -QPKSTVGTPAYIAPEVL  189 (361)
T ss_dssp             ---------CTTSCHHHH
T ss_pred             -CCCCCcCCCCcCChhhh
Confidence             22335699999999963

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.95  E-value=3.3e-28  Score=273.78  Aligned_cols=169  Identities=25%  Similarity=0.382  Sum_probs=133.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEec-----CCe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTN-----NDF  729 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~  729 (832)
                      .++|++.+.||+|+||+||+|.+. +++.||||++....  ....+++.+|++++++++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            478999999999999999999876 58999999986543  3345778899999999999999999999844     357


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      .|+||||+ +++|.++++... .+++..+..++.||+.||+|||   +.||+||||||+|||++.++.+||+|||+|+..
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            89999998 679999997654 6999999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCcc--------------------------cccccccccccccCCCC
Q 003301          810 SGEES--------------------------MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       810 ~~~~~--------------------------~~~~~~~gt~~y~APE~  831 (832)
                      .....                          ...+..+||+.|+|||+
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~  254 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPEL  254 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHH
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHH
Confidence            43221                          12234578999999995

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.95  E-value=1.3e-28  Score=278.13  Aligned_cols=234  Identities=22%  Similarity=0.252  Sum_probs=145.6

Q ss_pred             CCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEc
Q 003301          295 NLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDL  374 (832)
Q Consensus       295 ~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  374 (832)
                      +|++|+|++|.+++..|..+..+. +|++|+|++|.+++..|  +..+++|++|+|++|.+++..+.     ++|++|++
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~-----~~L~~L~L  106 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFT-KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG-----PSIETLHA  106 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCT-TCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC-----TTCCEEEC
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCC-CCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC-----CCcCEEEC
Confidence            455555555555544444444443 45555555555544433  66666777777777766644322     56777777


Q ss_pred             cCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccc-cCcccceeeecCCcccC
Q 003301          375 VNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFW-NLKDILSLNFSSNFLNG  453 (832)
Q Consensus       375 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~  453 (832)
                      ++|.+++..+.   .+++|+.|+|++|.+++..|..|+.+++|+.|+|++|.+++..|..|. .+++|+.|+|++|.+++
T Consensus       107 ~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~  183 (487)
T 3oja_A          107 ANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD  183 (487)
T ss_dssp             CSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred             cCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence            77777654433   245667777777777766666666677777777777777666666664 56677777777777665


Q ss_pred             CCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCccc-ccCchhhh
Q 003301          454 SLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLS-GNIPTSME  532 (832)
Q Consensus       454 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~  532 (832)
                      . | ....+++|+.|+|++|++++ +|..|..+++|+.|+|++|.|++ +|..++.+++|+.|++++|+++ +.+|..+.
T Consensus       184 ~-~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~  259 (487)
T 3oja_A          184 V-K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS  259 (487)
T ss_dssp             E-E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHT
T ss_pred             c-c-ccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHH
Confidence            4 2 23346677777777777764 33446677777777777777764 5666667777777777777776 55666666


Q ss_pred             hhccCCeeeCC
Q 003301          533 KLLYLKDLNLS  543 (832)
Q Consensus       533 ~l~~L~~l~l~  543 (832)
                      .++.|+.++++
T Consensus       260 ~l~~L~~l~~~  270 (487)
T 3oja_A          260 KNQRVQTVAKQ  270 (487)
T ss_dssp             TCHHHHHHHHH
T ss_pred             hCCCCcEEecc
Confidence            66666666654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.95  E-value=1.3e-27  Score=254.13  Aligned_cols=182  Identities=36%  Similarity=0.546  Sum_probs=158.1

Q ss_pred             ccccchHHHHHHhcCCCCC------CeeeccCCceEEEEEecCCcEEEEEEEeccc----hhhHHHHHHHHHHHhcCCCC
Q 003301          646 RRRFSYKELLQATNQFNAS------NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL----EGALKSFDVECEVLKSVRHR  715 (832)
Q Consensus       646 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~  715 (832)
                      ...|++.++...+++|...      +.||+|+||.||+|.+ +++.||||++....    ....+.+.+|++++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            3568899999999988877      9999999999999987 78899999986532    33457889999999999999


Q ss_pred             ceeeeceEEecCCeeEEEEecCCCCCHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeC
Q 003301          716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSN--NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD  793 (832)
Q Consensus       716 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~  793 (832)
                      ||+++++++.+.+..|+||||+++++|.+++...  ...+++..+..++.|++.||+|||   +.||+||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence            9999999999999999999999999999998743  235899999999999999999999   99999999999999999


Q ss_pred             CCCcEEEeccccccccCCCccc-ccccccccccccCCCC
Q 003301          794 KDMVAHLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGL  831 (832)
Q Consensus       794 ~~~~~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~  831 (832)
                      .++.+||+|||.++........ ......||+.|+|||+
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~  206 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA  206 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHH
Confidence            9999999999999876543222 2233569999999996

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.95  E-value=3.3e-28  Score=253.17  Aligned_cols=170  Identities=28%  Similarity=0.450  Sum_probs=151.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      .++|++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+++..|+||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            467899999999999999999998889999999976543 3367899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccc
Q 003301          738 PNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ  817 (832)
Q Consensus       738 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~  817 (832)
                      ++++|.+++......+++..+..++.|++.|++|||   ++|++||||||+||+++.++.+||+|||.++..........
T Consensus        86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  162 (267)
T 3t9t_A           86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  162 (267)
T ss_dssp             TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence            999999999887667999999999999999999999   99999999999999999999999999999987654333233


Q ss_pred             ccccccccccCCCC
Q 003301          818 TLTLATIGYMAPGL  831 (832)
Q Consensus       818 ~~~~gt~~y~APE~  831 (832)
                      ....+|+.|+|||+
T Consensus       163 ~~~~~~~~y~aPE~  176 (267)
T 3t9t_A          163 TGTKFPVKWASPEV  176 (267)
T ss_dssp             TSTTCCGGGCCHHH
T ss_pred             ccccccccccChhh
Confidence            33557889999996

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.95  E-value=8.6e-28  Score=251.56  Aligned_cols=168  Identities=26%  Similarity=0.375  Sum_probs=150.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .++|++.+.||+|+||.||+|.+.. +..||+|++........+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            4679999999999999999998865 778999999876666678899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe---CCCCcEEEeccccccccCCCc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~---~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      +++++|.+++...+ .+++..+..++.|++.|++|||   ++||+||||||+||++   +.++.+||+|||.|.......
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           88 CTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            99999999987654 5899999999999999999999   9999999999999999   788999999999998765443


Q ss_pred             ccccccccccccccCCCC
Q 003301          814 SMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~  831 (832)
                      .  .....||+.|+|||+
T Consensus       164 ~--~~~~~~t~~y~aPE~  179 (277)
T 3f3z_A          164 M--MRTKVGTPYYVSPQV  179 (277)
T ss_dssp             C--BCCCCSCTTTCCHHH
T ss_pred             c--hhccCCCCCccChHH
Confidence            2  233569999999996

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.95  E-value=2.2e-28  Score=273.98  Aligned_cols=170  Identities=29%  Similarity=0.359  Sum_probs=139.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||||++....   ......+.+|+++++.++||||+++++++.+.+..|+|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999876 48999999997542   23345677899999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      |||+++|+|.+++...+ .+++..+..++.|++.||+|||   + +||+||||||+||+++.++.+||+|||+|+.....
T Consensus       227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999997654 6899999999999999999999   8 89999999999999999999999999999864333


Q ss_pred             cccccccccccccccCCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~l  832 (832)
                      .. .....+||+.|+|||++
T Consensus       303 ~~-~~~~~~gt~~y~aPE~~  321 (446)
T 4ejn_A          303 GA-TMKTFCGTPEYLAPEVL  321 (446)
T ss_dssp             -----CCSSSCGGGCCHHHH
T ss_pred             Cc-ccccccCCccccCHhhc
Confidence            22 23346799999999963

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.95  E-value=5.6e-29  Score=268.27  Aligned_cols=164  Identities=21%  Similarity=0.260  Sum_probs=135.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccc--------hhhHHHHHHHHHHHhcCC---------CCce---
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--------EGALKSFDVECEVLKSVR---------HRNL---  717 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~ni---  717 (832)
                      .++|++.+.||+|+||+||+|++ +|+.||||++....        ....+.+.+|+++++.++         ||||   
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46799999999999999999998 78999999997653        223467889999988886         5554   


Q ss_pred             --------------eeeceEEec-------------CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHH
Q 003301          718 --------------VKIISSCTN-------------NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALE  770 (832)
Q Consensus       718 --------------v~l~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~  770 (832)
                                    +++++++.+             .+..|+||||+++|++.+.+.+  ..+++..+..++.|++.||+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence                          444544443             6789999999999977666644  35899999999999999999


Q ss_pred             HHhcCCCCCeEecCCCCCCeEeCCCC--------------------cEEEeccccccccCCCcccccccccccccccCCC
Q 003301          771 YLHFGYSNPVVHCDIKPSNVLLDKDM--------------------VAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPG  830 (832)
Q Consensus       771 ~LH~~~~~~ivH~Dlkp~NIl~~~~~--------------------~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE  830 (832)
                      |||.  ++||+||||||+|||++.++                    .+||+|||+|+.....      ..+||+.|||||
T Consensus       176 ~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE  247 (336)
T 2vuw_A          176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDED  247 (336)
T ss_dssp             HHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSG
T ss_pred             HHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChh
Confidence            9992  37899999999999999887                    9999999999876432      247999999999


Q ss_pred             CC
Q 003301          831 LF  832 (832)
Q Consensus       831 ~l  832 (832)
                      ++
T Consensus       248 ~~  249 (336)
T 2vuw_A          248 LF  249 (336)
T ss_dssp             GG
T ss_pred             hh
Confidence            75

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.95  E-value=1.5e-27  Score=249.91  Aligned_cols=171  Identities=26%  Similarity=0.488  Sum_probs=137.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            467999999999999999999875 58999999997543   22346788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+++++|.+++......+++..+..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||.+.......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            9999999999999877667999999999999999999999   9999999999999999999999999999998765333


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                      .. .....||+.|+|||++
T Consensus       167 ~~-~~~~~~~~~y~aPE~~  184 (278)
T 3cok_A          167 EK-HYTLCGTPNYISPEIA  184 (278)
T ss_dssp             -------------------
T ss_pred             Cc-ceeccCCCCcCCcchh
Confidence            22 2235699999999974

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.95  E-value=7.2e-28  Score=257.64  Aligned_cols=169  Identities=31%  Similarity=0.444  Sum_probs=146.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC--eeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNND--FKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv  733 (832)
                      .++|++.+.||+|+||+||+|.+.. ++.||||++.... ....+.+.+|++++++++||||+++++++...+  ..|+|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            3679999999999999999999865 8999999997543 334567889999999999999999999987655  78999


Q ss_pred             EecCCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe----CCCCcEEEecccccc
Q 003301          734 LEYMPNGSLEDYLYSNNF--SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL----DKDMVAHLSDFGIAK  807 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~----~~~~~~kl~DFg~a~  807 (832)
                      |||+++++|.++++....  .+++..+..++.|++.||+|||   +.||+||||||+||++    +.++.+||+|||+|+
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976432  3899999999999999999999   9999999999999999    788899999999998


Q ss_pred             ccCCCcccccccccccccccCCCC
Q 003301          808 LLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       808 ~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      .......  .....||+.|+|||+
T Consensus       165 ~~~~~~~--~~~~~gt~~y~aPE~  186 (319)
T 4euu_A          165 ELEDDEQ--FVSLYGTEEYLHPDM  186 (319)
T ss_dssp             ECCTTCC--BCCCCSCGGGCCHHH
T ss_pred             ecCCCCc--eeecccCCCccCHHH
Confidence            7754432  223569999999996

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.95  E-value=5.2e-28  Score=259.99  Aligned_cols=168  Identities=26%  Similarity=0.378  Sum_probs=146.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEEEe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||||++.....  .+.+.+|+++++++ +||||+++++++..++..|+|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            367999999999999999999974 589999999875532  24688899999999 99999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCc-----EEEeccccccccC
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMV-----AHLSDFGIAKLLS  810 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~-----~kl~DFg~a~~~~  810 (832)
                      |+ +++|.+++......+++..+..++.|++.||+|||   +.||+||||||+||+++.++.     +||+|||+|+...
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99 99999999876667999999999999999999999   999999999999999998887     9999999998764


Q ss_pred             CCccc------ccccccccccccCCCC
Q 003301          811 GEESM------KQTLTLATIGYMAPGL  831 (832)
Q Consensus       811 ~~~~~------~~~~~~gt~~y~APE~  831 (832)
                      .....      .....+||+.|+|||+
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~  188 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINT  188 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred             cCCCCccccccccCCcCCCccccChHH
Confidence            43321      1234579999999996

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.95  E-value=3.8e-28  Score=254.78  Aligned_cols=170  Identities=26%  Similarity=0.441  Sum_probs=135.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC----CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD----GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      .++|++.+.||+|+||.||+|.+..    +..||+|++.... ....+.+.+|+.++++++||||+++++++. ++..|+
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4689999999999999999998753    4569999876543 334567889999999999999999999985 457899


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||||+++++|.+++......+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||+|+.....
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  169 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence            99999999999999877667999999999999999999999   999999999999999999999999999999877554


Q ss_pred             cccccccccccccccCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~  831 (832)
                      .........+|+.|+|||+
T Consensus       170 ~~~~~~~~~~~~~y~aPE~  188 (281)
T 1mp8_A          170 TYYKASKGKLPIKWMAPES  188 (281)
T ss_dssp             ---------CCGGGCCHHH
T ss_pred             cccccccCCCcccccChhh
Confidence            4333334457889999996

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.95  E-value=1.5e-27  Score=255.32  Aligned_cols=161  Identities=24%  Similarity=0.356  Sum_probs=126.5

Q ss_pred             CCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCC-CCceeeeceEEecCCeeEEEEecCCCCC
Q 003301          664 SNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVR-HRNLVKIISSCTNNDFKALVLEYMPNGS  741 (832)
Q Consensus       664 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  741 (832)
                      .+.||+|+||.||+|.+. +++.||||++...   ....+.+|+++++.+. ||||+++++++.+++..|+||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999986 4899999998754   2356778999999997 9999999999999999999999999999


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC---cEEEeccccccccCCCcccccc
Q 003301          742 LEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM---VAHLSDFGIAKLLSGEESMKQT  818 (832)
Q Consensus       742 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~---~~kl~DFg~a~~~~~~~~~~~~  818 (832)
                      |.+++...+ .+++..+..++.|++.|++|||   ++||+||||||+||+++.++   .+||+|||+|+....... ...
T Consensus        93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~  167 (325)
T 3kn6_A           93 LFERIKKKK-HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLK  167 (325)
T ss_dssp             HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-ccc
Confidence            999998764 6999999999999999999999   99999999999999997765   899999999987644332 223


Q ss_pred             cccccccccCCCCC
Q 003301          819 LTLATIGYMAPGLF  832 (832)
Q Consensus       819 ~~~gt~~y~APE~l  832 (832)
                      ..+||+.|+|||++
T Consensus       168 ~~~~t~~y~aPE~~  181 (325)
T 3kn6_A          168 TPCFTLHYAAPELL  181 (325)
T ss_dssp             --------------
T ss_pred             ccCCCcCccCHHHh
Confidence            35689999999974

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.95  E-value=6.6e-28  Score=268.67  Aligned_cols=169  Identities=24%  Similarity=0.377  Sum_probs=143.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecC-----Ce
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNN-----DF  729 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  729 (832)
                      .++|++.+.||+|+||.||+|.+.. ++.||||++....  ....+++.+|++++++++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            4789999999999999999998864 8899999997543  33456888999999999999999999999766     57


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      .|+||||++ ++|.++++... .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|+..
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            899999995 69999997653 6999999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCccc---------------------ccccccccccccCCCC
Q 003301          810 SGEESM---------------------KQTLTLATIGYMAPGL  831 (832)
Q Consensus       810 ~~~~~~---------------------~~~~~~gt~~y~APE~  831 (832)
                      ......                     ..+..+||+.|+|||+
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  222 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPEL  222 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHH
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHH
Confidence            443211                     1244679999999996

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=2.5e-28  Score=264.82  Aligned_cols=170  Identities=28%  Similarity=0.394  Sum_probs=148.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec----CCcEEEEEEEeccc----hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL----DGMEVAIKVFHLQL----EGALKSFDVECEVLKSV-RHRNLVKIISSCTNND  728 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  728 (832)
                      .++|++.+.||+|+||.||+|++.    +++.||||+++...    ....+.+.+|+++++++ +||||+++++++..++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            468999999999999999999883    68999999986432    23345677899999999 6999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          729 FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      ..|+||||+++++|.+++.... .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|+.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            9999999999999999998654 6899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCcccccccccccccccCCCC
Q 003301          809 LSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       809 ~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      ............+||+.|+|||+
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~  231 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDI  231 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHH
T ss_pred             cccCCCCcccCcccCcCccChhh
Confidence            65444434444679999999996

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.95  E-value=2.1e-28  Score=260.69  Aligned_cols=170  Identities=24%  Similarity=0.446  Sum_probs=138.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCe----
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDF----  729 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  729 (832)
                      .++|++.+.||+|+||.||+|++. +++.||||++....   ......+.+|++++++++||||+++++++...+.    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            478999999999999999999974 58999999997653   2334678899999999999999999999876543    


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      .|+||||+++++|.+++...+ .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+..
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            499999999999999997654 6899999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCccc--ccccccccccccCCCC
Q 003301          810 SGEESM--KQTLTLATIGYMAPGL  831 (832)
Q Consensus       810 ~~~~~~--~~~~~~gt~~y~APE~  831 (832)
                      ......  .....+||+.|+|||+
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~  190 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQ  190 (311)
T ss_dssp             ---------------CCTTCCHHH
T ss_pred             cccccccccccccCcCcccCCHHH
Confidence            443221  2223569999999996

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.95  E-value=3.9e-28  Score=255.85  Aligned_cols=166  Identities=27%  Similarity=0.428  Sum_probs=147.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-C-------cEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-G-------MEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDF  729 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  729 (832)
                      .++|++.+.||+|+||.||+|.+.. +       ..||+|++........+.+.+|++++++++||||+++++++.+++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            4679999999999999999998754 3       4799999987666667889999999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCc--------EEEe
Q 003301          730 KALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMV--------AHLS  801 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~--------~kl~  801 (832)
                      .|+||||+++++|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            99999999999999999887656999999999999999999999   999999999999999998887        9999


Q ss_pred             ccccccccCCCcccccccccccccccCCCC
Q 003301          802 DFGIAKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       802 DFg~a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      |||.+......     ....||+.|+|||+
T Consensus       164 Dfg~~~~~~~~-----~~~~~~~~y~aPE~  188 (289)
T 4fvq_A          164 DPGISITVLPK-----DILQERIPWVPPEC  188 (289)
T ss_dssp             CCCSCTTTSCH-----HHHHHTTTTSCHHH
T ss_pred             cCcccccccCc-----cccCCcCcccCHHH
Confidence            99999765332     22458999999996

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.95  E-value=3e-28  Score=265.39  Aligned_cols=182  Identities=21%  Similarity=0.391  Sum_probs=152.0

Q ss_pred             cccchHHHHHHhcCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCcee
Q 003301          647 RRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLV  718 (832)
Q Consensus       647 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv  718 (832)
                      ..+...++....++|++.+.||+|+||.||+|++.      +++.||||++.... ....+.+.+|+++++++ +||||+
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence            34556666667899999999999999999999742      36789999997643 33456789999999999 799999


Q ss_pred             eeceEEecCC-eeEEEEecCCCCCHHHHHhhCCC----------------------------------------------
Q 003301          719 KIISSCTNND-FKALVLEYMPNGSLEDYLYSNNF----------------------------------------------  751 (832)
Q Consensus       719 ~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------  751 (832)
                      ++++++.+.+ ..++||||+++|+|.+++.....                                              
T Consensus        90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            9999988755 48999999999999999976532                                              


Q ss_pred             -------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          752 -------------------SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       752 -------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                                         .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                               1889999999999999999999   999999999999999999999999999999876433


Q ss_pred             cc-cccccccccccccCCCC
Q 003301          813 ES-MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       813 ~~-~~~~~~~gt~~y~APE~  831 (832)
                      .. .......||+.|+|||+
T Consensus       247 ~~~~~~~~~~~t~~y~aPE~  266 (359)
T 3vhe_A          247 PDYVRKGDARLPLKWMAPET  266 (359)
T ss_dssp             TTCEEC--CEECGGGCCHHH
T ss_pred             ccchhccccCCCceeEChhh
Confidence            22 22334568999999996

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.95  E-value=2.1e-28  Score=274.46  Aligned_cols=174  Identities=22%  Similarity=0.428  Sum_probs=149.5

Q ss_pred             HHHHhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          654 LLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       654 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      +....++|++.+.||+|+||.||+|.+.++..||||+++... ...+.+.+|++++++++||||+++++++. .+..|+|
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence            344567899999999999999999999888999999997543 34578999999999999999999999986 5678999


Q ss_pred             EecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          734 LEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      |||+++|+|.++++... ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus       261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            99999999999997532 25789999999999999999999   999999999999999999999999999999876543


Q ss_pred             cccccccccccccccCCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~l  832 (832)
                      .........+|+.|+|||++
T Consensus       338 ~~~~~~~~~~~~~y~aPE~~  357 (454)
T 1qcf_A          338 EYTAREGAKFPIKWTAPEAI  357 (454)
T ss_dssp             HHHTTCSSSSCGGGSCHHHH
T ss_pred             ceeccCCCcccccccCHHHh
Confidence            32223334578899999963

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.94  E-value=1.1e-27  Score=262.74  Aligned_cols=171  Identities=27%  Similarity=0.472  Sum_probs=147.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec--------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEecC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL--------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTNN  727 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  727 (832)
                      .++|++.+.||+|+||.||+|++.        .+..||||++.... ....+.+.+|+++++++ +||||+++++++..+
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            468999999999999999999863        23579999997653 33457788999999999 999999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe
Q 003301          728 DFKALVLEYMPNGSLEDYLYSNN---------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL  792 (832)
Q Consensus       728 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~  792 (832)
                      +..|+||||+++|+|.+++....               ..+++..+..++.|++.||+|||   +.||+||||||+||++
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence            99999999999999999998654               34899999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeccccccccCCCcc-cccccccccccccCCCC
Q 003301          793 DKDMVAHLSDFGIAKLLSGEES-MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       793 ~~~~~~kl~DFg~a~~~~~~~~-~~~~~~~gt~~y~APE~  831 (832)
                      +.++.+||+|||+|+....... .......||+.|+|||+
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~  264 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEA  264 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHH
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHH
Confidence            9999999999999987654332 12233457899999996

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.94  E-value=6.5e-28  Score=259.28  Aligned_cols=169  Identities=25%  Similarity=0.398  Sum_probs=147.7

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch--------hhHHHHHHHHHHHhcCCCCceeeeceEEecC
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE--------GALKSFDVECEVLKSVRHRNLVKIISSCTNN  727 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  727 (832)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++.....        ...+.+.+|++++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            4578999999999999999999875 588999999975431        1234677899999999999999999999999


Q ss_pred             CeeEEEEecCCCC-CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccc
Q 003301          728 DFKALVLEYMPNG-SLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA  806 (832)
Q Consensus       728 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a  806 (832)
                      +..++||||+.+| +|.+++.... .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            9999999999776 9999998654 6999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCcccccccccccccccCCCC
Q 003301          807 KLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       807 ~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      +.......  ....+||+.|+|||+
T Consensus       178 ~~~~~~~~--~~~~~gt~~y~aPE~  200 (335)
T 3dls_A          178 AYLERGKL--FYTFCGTIEYCAPEV  200 (335)
T ss_dssp             EECCTTCC--BCEECSCGGGCCHHH
T ss_pred             eECCCCCc--eeccCCCccccChhh
Confidence            87654432  233569999999996

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.94  E-value=2.1e-27  Score=261.45  Aligned_cols=172  Identities=19%  Similarity=0.274  Sum_probs=148.8

Q ss_pred             hcCCCCCCeeecc--CCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          658 TNQFNASNLIGTG--GFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      .++|++.+.||+|  +||.||+|++. +++.||||++....  ....+.+.+|+++++.++||||+++++++.+++..|+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4789999999999  99999999987 58999999997654  3345678889999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          733 VLEYMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      ||||+++|+|.+++... ...+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||.+.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            99999999999999765 235899999999999999999999   99999999999999999999999999999865422


Q ss_pred             Ccc------cccccccccccccCCCCC
Q 003301          812 EES------MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~------~~~~~~~gt~~y~APE~l  832 (832)
                      ...      ......+||+.|+|||++
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~  207 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVL  207 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHH
T ss_pred             ccccccccccccccccccccccCHHHH
Confidence            211      111224699999999963

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.94  E-value=4.3e-30  Score=299.99  Aligned_cols=435  Identities=17%  Similarity=0.185  Sum_probs=236.4

Q ss_pred             CCChhhhhcCCCceEEEccCCcccc---cCCCC------------ccCCCCccEEECcCCcccccCCCCCc-CCCcCceE
Q 003301           85 SLPDDMCRRLPLIKGLYMSNNKLTG---PIPNN------------IWQCKELIVISLAYNQFTERIPRGLG-NLTSLKTL  148 (832)
Q Consensus        85 ~lp~~~~~~l~~L~~L~l~~N~l~~---~~p~~------------l~~l~~L~~L~Ls~n~i~~~~p~~~~-~l~~L~~L  148 (832)
                      ..|..++.++++|++|++++|....   ..|..            ...+++|++|+|++|.+++..+..+. .+++|++|
T Consensus        56 ~~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L  135 (594)
T 2p1m_B           56 VSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVL  135 (594)
T ss_dssp             SCHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEE
T ss_pred             cCHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEE
Confidence            4566777788889999988875321   22221            12455666666666666554444443 45666666


Q ss_pred             Eeccc-ccccc-cCccccCccccceecccccccccccCcccc----cCCcccEEEecCCCCCCCCCc-ccc--ccCCCCc
Q 003301          149 YLGFN-NLTGE-IPYEMGNLRNLEILGLQLNKLVGFVPTSIF----NLSAMKTLALPSNALSGSLPS-SID--LVRLPNL  219 (832)
Q Consensus       149 ~Ls~N-~i~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~----~l~~L~~L~L~~n~l~~~~p~-~~~--~~~l~~L  219 (832)
                      +|++| .++.. ++..+.++++|++|++++|.+++..+.++.    .+++|++|++++|. . .+.. .+.  ...+++|
T Consensus       136 ~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~-~~~~~~l~~l~~~~~~L  213 (594)
T 2p1m_B          136 VLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-S-EVSFSALERLVTRCPNL  213 (594)
T ss_dssp             EEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-S-CCCHHHHHHHHHHCTTC
T ss_pred             eCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-C-cCCHHHHHHHHHhCCCC
Confidence            66666 34321 333334566666666666665543333332    34455555555554 1 1110 000  1123445


Q ss_pred             cEEEccCC-ccccccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcE
Q 003301          220 EIISLAGN-NFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKL  298 (832)
Q Consensus       220 ~~L~Ls~n-~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~  298 (832)
                      ++|++++| .+.+ .+..+..+++|++|+++.+...                 ++.|.+..      ++..+.++++|+.
T Consensus       214 ~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~-----------------~~~~~~~~------l~~~l~~~~~L~~  269 (594)
T 2p1m_B          214 KSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAE-----------------VRPDVYSG------LSVALSGCKELRC  269 (594)
T ss_dssp             CEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCC-----------------CCHHHHHH------HHHHHHTCTTCCE
T ss_pred             cEEecCCCCcHHH-HHHHHhcCCcceEcccccccCc-----------------cchhhHHH------HHHHHhcCCCccc
Confidence            55555544 2222 3333444444444443322110                 11111211      1223455555555


Q ss_pred             E-eccCCCCCCCCCCcccccccccceEEeecCcccccc-cccccCcCcccEEEeecCccccc-ccccccCCCCCceEEcc
Q 003301          299 L-DLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTI-PKEIGNLINLRELGLWGNELIGS-IPITFGKLQNLQGLDLV  375 (832)
Q Consensus       299 L-~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls  375 (832)
                      | .+.+... +.++..+..+. +|++|++++|.+++.. +..+..+++|++|++++| +... .+.....+++|++|+++
T Consensus       270 Ls~~~~~~~-~~l~~~~~~~~-~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~  346 (594)
T 2p1m_B          270 LSGFWDAVP-AYLPAVYSVCS-RLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVF  346 (594)
T ss_dssp             EECCBTCCG-GGGGGGHHHHT-TCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEE
T ss_pred             ccCCcccch-hhHHHHHHhhC-CCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEe
Confidence            5 2322211 12222222222 5566666555554322 223456677777777777 3322 22223346777777773


Q ss_pred             ---------CCccCCCCchhhc-CCCCCcEEEecCCcCCCCCcccCC-CCCCCCeEeCC--C----CcCCCCCC-----c
Q 003301          376 ---------NNKLEGPIPNGLC-QLARLSVLYMDGNKLSGPIPPCIG-DLTSLRLLSLA--S----NELNSVIP-----S  433 (832)
Q Consensus       376 ---------~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~--~----N~l~~~~~-----~  433 (832)
                               .+.+++.....+. .+++|++|.++.|.+++..+..+. .+++|+.|+++  +    |.+++...     .
T Consensus       347 ~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~  426 (594)
T 2p1m_B          347 PSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGA  426 (594)
T ss_dssp             CSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHH
T ss_pred             cCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHH
Confidence                     3444433333333 367788887777777655444443 46778888887  3    45543221     1


Q ss_pred             ccccCcccceeeecCCcccCCCcccccc-ccccceecccCcccCCccCCcc-ccccccceeecccccccccCCc-cccCC
Q 003301          434 TFWNLKDILSLNFSSNFLNGSLPEDIGN-LKVVVIIDLSRNNLSGDIPTAI-GGLMNLQDLSLRDNGLQGSIPK-SIGGL  510 (832)
Q Consensus       434 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l  510 (832)
                      .+..+++|++|++++ .+++..+..+.. +++|+.|+|++|.+++..+..+ .++++|+.|+|++|.+++..+. .+..+
T Consensus       427 l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l  505 (594)
T 2p1m_B          427 IVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKL  505 (594)
T ss_dssp             HHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGG
T ss_pred             HHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhC
Confidence            255677888888876 566554555554 7888888888888876555555 6688899999999988654443 34558


Q ss_pred             CCCCeeccCCCcccccCchhh-hhhccCCeeeCCCCcccc
Q 003301          511 VSLESLDLSNNSLSGNIPTSM-EKLLYLKDLNLSFNKLEG  549 (832)
Q Consensus       511 ~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~l~l~~N~l~~  549 (832)
                      ++|+.|++++|+++......+ ..++.|+...+..+.-..
T Consensus       506 ~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~~~  545 (594)
T 2p1m_B          506 ETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAPD  545 (594)
T ss_dssp             GGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSCGG
T ss_pred             CCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCccc
Confidence            889999999998865444444 456677666666554443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.94  E-value=1.2e-27  Score=253.77  Aligned_cols=171  Identities=26%  Similarity=0.470  Sum_probs=145.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-----cCCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecC--Ce
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSF-----LDGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNN--DF  729 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~  729 (832)
                      .++|++.+.||+|+||.||+|++     .+++.||+|++.... ....+.+.+|++++++++||||+++++++...  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            35689999999999999999984     358899999987543 33457889999999999999999999999876  66


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      .|+||||+++++|.+++......+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||.|+..
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence            89999999999999999766667999999999999999999999   999999999999999999999999999999877


Q ss_pred             CCCcc--cccccccccccccCCCC
Q 003301          810 SGEES--MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       810 ~~~~~--~~~~~~~gt~~y~APE~  831 (832)
                      .....  .......||+.|+|||+
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~  200 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPEC  200 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHH
T ss_pred             cCCCcceeccCCCCCCccccCCee
Confidence            54432  12233568889999996

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.94  E-value=9e-28  Score=259.71  Aligned_cols=166  Identities=27%  Similarity=0.407  Sum_probs=131.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .++|++.+.||+|+||.||+|++.. ++.||||++....  ..+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  129 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL  129 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence            4689999999999999999999874 7899999987553  236788899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC---CCcEEEeccccccccCCCc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK---DMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~DFg~a~~~~~~~  813 (832)
                      +++++|.+++...+ .+++..+..++.|++.||+|||   +.||+||||||+||+++.   ++.+||+|||+++......
T Consensus       130 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  205 (349)
T 2w4o_A          130 VTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV  205 (349)
T ss_dssp             CCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence            99999999997654 6899999999999999999999   999999999999999975   8899999999998764332


Q ss_pred             ccccccccccccccCCCC
Q 003301          814 SMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~  831 (832)
                      .  ....+||+.|+|||+
T Consensus       206 ~--~~~~~gt~~y~aPE~  221 (349)
T 2w4o_A          206 L--MKTVCGTPGYCAPEI  221 (349)
T ss_dssp             ---------CGGGSCHHH
T ss_pred             c--cccccCCCCccCHHH
Confidence            2  233569999999996

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.94  E-value=7.7e-28  Score=260.36  Aligned_cols=172  Identities=24%  Similarity=0.431  Sum_probs=147.8

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC------CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCe
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD------GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDF  729 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  729 (832)
                      ..++|++.+.||+|+||.||+|++.+      ++.||||+++... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            45789999999999999999998853      4789999987553 3345788999999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 003301          730 KALVLEYMPNGSLEDYLYSNN-----------------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIK  786 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk  786 (832)
                      .|+||||+++|+|.+++....                       ..+++..+..++.|++.||+|||   ++||+|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence            999999999999999998642                       46899999999999999999999   9999999999


Q ss_pred             CCCeEeCCCCcEEEeccccccccCCCcc-cccccccccccccCCCC
Q 003301          787 PSNVLLDKDMVAHLSDFGIAKLLSGEES-MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       787 p~NIl~~~~~~~kl~DFg~a~~~~~~~~-~~~~~~~gt~~y~APE~  831 (832)
                      |+||+++.++.+||+|||+++....... .......||+.|+|||+
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~  247 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES  247 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHH
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhh
Confidence            9999999999999999999987643322 12233468999999996

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.94  E-value=7.6e-28  Score=272.56  Aligned_cols=171  Identities=25%  Similarity=0.491  Sum_probs=149.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .++|++.+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|++++++++||||+++++++...+..|+||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            4678899999999999999999875 8899999987543 3357899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          737 MPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       737 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      +++|+|.++++... ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+........
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  374 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT  374 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence            99999999998643 45899999999999999999999   999999999999999999999999999999877544333


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                      ......+|+.|+|||++
T Consensus       375 ~~~~~~~~~~y~aPE~~  391 (495)
T 1opk_A          375 AHAGAKFPIKWTAPESL  391 (495)
T ss_dssp             CCTTCCCCGGGCCHHHH
T ss_pred             ecCCCcCCcceeCHhHH
Confidence            33334577899999963

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.94  E-value=1.1e-27  Score=258.58  Aligned_cols=164  Identities=28%  Similarity=0.396  Sum_probs=144.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      +.|++.+.||+|+||.||+|++. +++.||||++....   ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45888999999999999999874 58999999997543   233467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||++ |++.+++......+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|+.....  
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence            9996 6888888765567999999999999999999999   999999999999999999999999999999876432  


Q ss_pred             cccccccccccccCCCC
Q 003301          815 MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~  831 (832)
                         ....||+.|+|||+
T Consensus       208 ---~~~~gt~~y~aPE~  221 (348)
T 1u5q_A          208 ---NSFVGTPYWMAPEV  221 (348)
T ss_dssp             ---CCCCSCGGGCCHHH
T ss_pred             ---CcccCCcceeCHhh
Confidence               23569999999996

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.94  E-value=1.8e-27  Score=278.36  Aligned_cols=171  Identities=23%  Similarity=0.314  Sum_probs=149.3

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  731 (832)
                      ..++|++.+.||+|+||+||+|++.. ++.||||+++...   ....+.+..|.+++..+ +||+|+++++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            45789999999999999999999864 7889999997542   33456788899999988 7999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +||||+++|+|.+++...+ .+++..+..++.||+.||+|||   ++||+||||||+|||++.++.+||+|||+|+....
T Consensus       419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            9999999999999998754 6999999999999999999999   99999999999999999999999999999986433


Q ss_pred             CcccccccccccccccCCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ... .....+||+.|||||++
T Consensus       495 ~~~-~~~~~~GT~~Y~APE~l  514 (674)
T 3pfq_A          495 DGV-TTKTFCGTPDYIAPEII  514 (674)
T ss_dssp             TTC-CBCCCCSCSSSCCHHHH
T ss_pred             CCc-ccccccCCCcccCHhhh
Confidence            332 23346799999999963

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.94  E-value=2.6e-27  Score=262.54  Aligned_cols=170  Identities=27%  Similarity=0.404  Sum_probs=137.9

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc--------hhhHHHHHHHHHHHhcCCCCceeeeceEEec
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL--------EGALKSFDVECEVLKSVRHRNLVKIISSCTN  726 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  726 (832)
                      ...++|++.+.||+|+||.||+|.+.. ++.||||++....        ......+.+|++++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            346889999999999999999998764 8999999987543        1122357899999999999999999999854


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC---CcEEEecc
Q 003301          727 NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD---MVAHLSDF  803 (832)
Q Consensus       727 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~---~~~kl~DF  803 (832)
                       +..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++.+   +.+||+||
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             -CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeec
Confidence             55799999999999999987654 6999999999999999999999   9999999999999999754   45999999


Q ss_pred             ccccccCCCcccccccccccccccCCCCC
Q 003301          804 GIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       804 g~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      |+|+......  .....+||+.|+|||++
T Consensus       287 G~a~~~~~~~--~~~~~~gt~~y~aPE~~  313 (419)
T 3i6u_A          287 GHSKILGETS--LMRTLCGTPTYLAPEVL  313 (419)
T ss_dssp             STTTSCC-------------CTTCCTTTT
T ss_pred             ccceecCCCc--cccccCCCCCccCceee
Confidence            9998765432  22345799999999974

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.94  E-value=2.4e-27  Score=252.21  Aligned_cols=172  Identities=24%  Similarity=0.328  Sum_probs=141.9

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++....   ....+.+.+|+.++++++||||+++++++..++..|+
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3578999999999999999999986 58899999987543   2234678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||||+++++|.+++.... .+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||.+......
T Consensus       112 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            999999999999998654 6899999999999999999999   999999999999999999999999999999876544


Q ss_pred             cccccccccccccccCCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~l  832 (832)
                      .........||+.|+|||++
T Consensus       188 ~~~~~~~~~~~~~y~aPE~~  207 (309)
T 2h34_A          188 KLTQLGNTVGTLYYMAPERF  207 (309)
T ss_dssp             ---------CCGGGCCGGGT
T ss_pred             ccccccccCCCcCccCHHHH
Confidence            33333345799999999974

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.94  E-value=4.4e-28  Score=255.36  Aligned_cols=172  Identities=26%  Similarity=0.487  Sum_probs=151.9

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ...++|++.+.||+|+||.||+|.+.. +..||+|++.... ...+.+.+|++++++++||||+++++++.+++..|+||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            346789999999999999999999875 8899999987543 34578899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          735 EYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      ||+++++|.+++.... ..+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||.|.......
T Consensus        89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            9999999999998643 35899999999999999999999   9999999999999999999999999999998876554


Q ss_pred             ccccccccccccccCCCC
Q 003301          814 SMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~  831 (832)
                      ........+|+.|+|||+
T Consensus       166 ~~~~~~~~~~~~y~aPE~  183 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPES  183 (288)
T ss_dssp             SEEETTEEECGGGCCHHH
T ss_pred             cccccCCccccCcCChhh
Confidence            444444568889999996

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.94  E-value=6.1e-28  Score=252.96  Aligned_cols=170  Identities=24%  Similarity=0.464  Sum_probs=147.3

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ..++|++.+.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|++++++++||||+++++++.. +..|+||||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            457899999999999999999998888899999987543 234788999999999999999999999864 568999999


Q ss_pred             CCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          737 MPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       737 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      +++++|.+++.... ..+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||.++........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence            99999999997532 25899999999999999999999   999999999999999999999999999999887554433


Q ss_pred             ccccccccccccCCCC
Q 003301          816 KQTLTLATIGYMAPGL  831 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~  831 (832)
                      ......+++.|+|||+
T Consensus       166 ~~~~~~~~~~y~aPE~  181 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEA  181 (279)
T ss_dssp             CCTTCCCCTTTSCHHH
T ss_pred             cccCCCCccCccChhh
Confidence            3334457889999996

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=1.9e-27  Score=261.52  Aligned_cols=170  Identities=25%  Similarity=0.401  Sum_probs=135.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCC-CCceeeeceEEecCC--ee
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVR-HRNLVKIISSCTNND--FK  730 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~  730 (832)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++....  ....+.+.+|+.+++++. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            4678999999999999999999875 58999999986432  344567889999999997 999999999997544  68


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      |+|||||+ ++|.++++..  .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|+...
T Consensus        87 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             EEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            99999996 6999999874  5899999999999999999999   9999999999999999999999999999998653


Q ss_pred             CCc--------------------ccccccccccccccCCCCC
Q 003301          811 GEE--------------------SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       811 ~~~--------------------~~~~~~~~gt~~y~APE~l  832 (832)
                      ...                    ....+..+||+.|+|||++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  202 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEIL  202 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHh
Confidence            211                    1122335799999999963

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.94  E-value=2.2e-27  Score=251.77  Aligned_cols=168  Identities=29%  Similarity=0.481  Sum_probs=139.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhc--CCCCceeeeceEEec----CCeeE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKS--VRHRNLVKIISSCTN----NDFKA  731 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~----~~~~~  731 (832)
                      .++|++.+.||+|+||+||+|++ +++.||||++....   .+.+.+|.+++..  ++||||+++++++..    ....|
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46899999999999999999998 79999999987543   2455667776665  799999999998654    34689


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCCeEeCCCCcEEEeccccc
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG-----YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA  806 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a  806 (832)
                      +||||+++|+|.++++..  .+++..+..++.|++.|++|||..     ++++|+||||||+||+++.++.+||+|||+|
T Consensus        83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            999999999999999654  589999999999999999999932     2679999999999999999999999999999


Q ss_pred             cccCCCcccc---cccccccccccCCCC
Q 003301          807 KLLSGEESMK---QTLTLATIGYMAPGL  831 (832)
Q Consensus       807 ~~~~~~~~~~---~~~~~gt~~y~APE~  831 (832)
                      +.........   .....||+.|+|||+
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~  188 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEV  188 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHH
T ss_pred             eecccccccccccccccccccceeChhh
Confidence            8654433221   223479999999996

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.94  E-value=2.2e-27  Score=253.02  Aligned_cols=169  Identities=30%  Similarity=0.401  Sum_probs=141.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccch--hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      .++|++.+.||+|+||.||+|.+.. ++.||+|++.....  ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            3689999999999999999999864 89999999865432  33467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||++++++.+++...+ .+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||.|+.......
T Consensus        82 e~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           82 EYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             ECCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EeCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence            9999999998876543 6899999999999999999999   99999999999999999999999999999987654332


Q ss_pred             cccccccccccccCCCC
Q 003301          815 MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~  831 (832)
                      . .....||+.|+|||+
T Consensus       158 ~-~~~~~~~~~y~aPE~  173 (311)
T 4agu_A          158 Y-YDDEVATRWYRSPEL  173 (311)
T ss_dssp             ---------GGGCCHHH
T ss_pred             c-cCCCcCCccccChHH
Confidence            2 233569999999996

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.94  E-value=1.6e-27  Score=255.84  Aligned_cols=171  Identities=27%  Similarity=0.418  Sum_probs=149.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-----cCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEe--cCCee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSF-----LDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT--NNDFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~  730 (832)
                      .++|++.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++.  .....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            36899999999999999999984     358899999998776666678999999999999999999999886  45678


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      |+||||+++++|.+++......+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||.++...
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            9999999999999999875556999999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCccc--ccccccccccccCCCC
Q 003301          811 GEESM--KQTLTLATIGYMAPGL  831 (832)
Q Consensus       811 ~~~~~--~~~~~~gt~~y~APE~  831 (832)
                      .....  ......||+.|+|||+
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~  201 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPES  201 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHH
T ss_pred             cCCccceeeccCCccccccCHHH
Confidence            43322  2233468889999996

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.94  E-value=1.7e-26  Score=241.49  Aligned_cols=225  Identities=23%  Similarity=0.241  Sum_probs=190.7

Q ss_pred             EeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCc
Q 003301          299 LDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNK  378 (832)
Q Consensus       299 L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  378 (832)
                      .+.++..+. .+|..+.   .++++|++++|++++..+..|.++++|++|++++|++.+..+..|..+++|++|+|++|+
T Consensus        12 ~~c~~~~l~-~ip~~l~---~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~   87 (276)
T 2z62_A           12 YQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP   87 (276)
T ss_dssp             EECTTSCCS-SCCSSSC---TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             EEecCCCcc-ccCCCCC---CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence            444444444 3444432   267788888888877777788889999999999999998888889999999999999999


Q ss_pred             cCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCC-CCcccccCcccceeeecCCcccCCCcc
Q 003301          379 LEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSV-IPSTFWNLKDILSLNFSSNFLNGSLPE  457 (832)
Q Consensus       379 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~  457 (832)
                      +++..+..|..+++|++|++++|.+++..+..++.+++|++|++++|.+++. .|..|..+++|++|++++|++++..+.
T Consensus        88 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~  167 (276)
T 2z62_A           88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT  167 (276)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred             cCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHH
Confidence            9987778899999999999999999987777899999999999999999885 488999999999999999999988788


Q ss_pred             ccccccccc----eecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCc
Q 003301          458 DIGNLKVVV----IIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIP  528 (832)
Q Consensus       458 ~~~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  528 (832)
                      .+..+..|+    .|++++|++++..+..+.. .+|+.|+|++|++++..+..|+.+++|+.|+|++|++++..|
T Consensus       168 ~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  241 (276)
T 2z62_A          168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  241 (276)
T ss_dssp             GGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred             HhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence            888888887    8999999999766665554 489999999999998777788999999999999999998765

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.94  E-value=2.6e-27  Score=253.46  Aligned_cols=168  Identities=25%  Similarity=0.402  Sum_probs=148.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchh------hHHHHHHHHHHHhcCCCCceeeeceEEecCCee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEG------ALKSFDVECEVLKSVRHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  730 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++......      ..+.+.+|++++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            467999999999999999999986 4899999998754321      356789999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC----cEEEeccccc
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM----VAHLSDFGIA  806 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~----~~kl~DFg~a  806 (832)
                      |+||||+++++|.+++.... .+++..+..++.|++.||+|||   +.||+||||||+||+++.++    .+||+|||.+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            99999999999999997654 6899999999999999999999   99999999999999999888    7999999999


Q ss_pred             cccCCCcccccccccccccccCCCC
Q 003301          807 KLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       807 ~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      +.......  .....||+.|+|||+
T Consensus       167 ~~~~~~~~--~~~~~gt~~y~aPE~  189 (321)
T 2a2a_A          167 HEIEDGVE--FKNIFGTPEFVAPEI  189 (321)
T ss_dssp             EECCTTCC--CCCCCSCGGGCCHHH
T ss_pred             eecCcccc--ccccCCCCCccCccc
Confidence            87654332  233569999999996

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.94  E-value=2.6e-27  Score=253.08  Aligned_cols=170  Identities=26%  Similarity=0.373  Sum_probs=142.4

Q ss_pred             hcCCCCC-CeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEEE
Q 003301          658 TNQFNAS-NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       658 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      .+.|++. +.||+|+||.||+|.+. +++.||||++........+.+.+|++++.++ +||||+++++++.+++..|+||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4678884 78999999999999875 5899999999876555567889999999885 7999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCc---EEEeccccccccCC
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMV---AHLSDFGIAKLLSG  811 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~---~kl~DFg~a~~~~~  811 (832)
                      ||+++++|.+++.... .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.   +||+|||+++....
T Consensus        91 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            9999999999997654 6899999999999999999999   999999999999999988775   99999999976532


Q ss_pred             Ccc------cccccccccccccCCCC
Q 003301          812 EES------MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       812 ~~~------~~~~~~~gt~~y~APE~  831 (832)
                      ...      ......+||+.|+|||+
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~  192 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEV  192 (316)
T ss_dssp             ---------------CCSGGGCCHHH
T ss_pred             CCccccccccccccccCCcCccChHH
Confidence            211      11123469999999996

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.94  E-value=2.2e-27  Score=255.40  Aligned_cols=167  Identities=26%  Similarity=0.431  Sum_probs=142.8

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++.....    ...+|++++.++ +||||+++++++.+++..|+||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4578999999999999999999886 488999999976543    234688888887 7999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC----CcEEEeccccccccC
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD----MVAHLSDFGIAKLLS  810 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~----~~~kl~DFg~a~~~~  810 (832)
                      ||+++|+|.+++...+ .+++..+..++.|++.|++|||   ++||+||||||+||++..+    +.+||+|||+|+...
T Consensus        96 E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            9999999999997654 6999999999999999999999   9999999999999998433    359999999998764


Q ss_pred             CCcccccccccccccccCCCCC
Q 003301          811 GEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       811 ~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ..... ....+||+.|+|||++
T Consensus       172 ~~~~~-~~~~~gt~~y~aPE~~  192 (342)
T 2qr7_A          172 AENGL-LMTPCYTANFVAPEVL  192 (342)
T ss_dssp             CTTCC-BCCSSCCSSCCCHHHH
T ss_pred             CCCCc-eeccCCCccccCHHHh
Confidence            43322 2335799999999963

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.94  E-value=2.3e-27  Score=248.61  Aligned_cols=167  Identities=29%  Similarity=0.451  Sum_probs=144.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.+.||+|+||.||+|.+.. ++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            4789999999999999999998864 7789999986543   22346788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+++++|.+++.... .+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||++.......
T Consensus        88 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~  163 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  163 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence            99999999999997654 6899999999999999999999   9999999999999999999999999999986543322


Q ss_pred             ccccccccccccccCCCC
Q 003301          814 SMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~  831 (832)
                         .....||+.|+|||+
T Consensus       164 ---~~~~~~~~~y~aPE~  178 (279)
T 3fdn_A          164 ---RTDLCGTLDYLPPEM  178 (279)
T ss_dssp             -------CCCCTTCCHHH
T ss_pred             ---ccccCCCCCccCHhH
Confidence               233569999999996

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.94  E-value=6.7e-28  Score=262.64  Aligned_cols=171  Identities=27%  Similarity=0.426  Sum_probs=144.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  730 (832)
                      .++|++.+.||+|+||+||+|++.      +++.||||+++... ......+.+|+.++++++||||+++++++.+.+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467899999999999999999853      36789999986442 33446788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC---cEEEe
Q 003301          731 ALVLEYMPNGSLEDYLYSNN------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM---VAHLS  801 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~---~~kl~  801 (832)
                      |+||||+++|+|.++++..+      ..+++..+..++.|++.||+|||   ++||+||||||+||+++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999997643      34899999999999999999999   99999999999999999555   59999


Q ss_pred             ccccccccCCCcc-cccccccccccccCCCC
Q 003301          802 DFGIAKLLSGEES-MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       802 DFg~a~~~~~~~~-~~~~~~~gt~~y~APE~  831 (832)
                      |||+|+....... .......||+.|+|||+
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~  257 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEA  257 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHH
T ss_pred             CCccccccccccccccCCCcCCcccEECHHH
Confidence            9999975422211 12223468999999996

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.94  E-value=3.8e-27  Score=256.44  Aligned_cols=173  Identities=29%  Similarity=0.477  Sum_probs=150.9

Q ss_pred             HHHHHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--------hhhHHHHHHHHHHHhcC-CCCceeeece
Q 003301          653 ELLQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--------EGALKSFDVECEVLKSV-RHRNLVKIIS  722 (832)
Q Consensus       653 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~l~~  722 (832)
                      ......++|++.+.||+|+||.||+|.+. +|+.||||++....        ....+.+.+|+++++++ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            33455678999999999999999999986 59999999987543        12245678899999999 7999999999


Q ss_pred             EEecCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEec
Q 003301          723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSD  802 (832)
Q Consensus       723 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D  802 (832)
                      ++...+..|+||||+++++|.+++.... .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|
T Consensus       168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~D  243 (365)
T 2y7j_A          168 SYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSD  243 (365)
T ss_dssp             EEEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEe
Confidence            9999999999999999999999997643 6899999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCcccccccccccccccCCCC
Q 003301          803 FGIAKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       803 Fg~a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      ||++........  ....+||+.|+|||+
T Consensus       244 fG~~~~~~~~~~--~~~~~gt~~y~aPE~  270 (365)
T 2y7j_A          244 FGFSCHLEPGEK--LRELCGTPGYLAPEI  270 (365)
T ss_dssp             CTTCEECCTTCC--BCCCCSCGGGCCHHH
T ss_pred             cCcccccCCCcc--cccCCCCCCccChhh
Confidence            999987754332  233579999999996

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.94  E-value=4.4e-27  Score=248.42  Aligned_cols=169  Identities=24%  Similarity=0.397  Sum_probs=148.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.+.||+|+||.||+|.+.+ ++.||+|++....   ....+.+.+|+++++.++||||+++++++.+++..|+|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            4689999999999999999999864 7889999987553   33456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+++++|.+++.... .+++..+..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||.++......
T Consensus        94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            99999999999987654 6899999999999999999999   9999999999999999999999999999998764332


Q ss_pred             ccccccccccccccCCCC
Q 003301          814 SMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~  831 (832)
                      . ......||+.|+|||+
T Consensus       170 ~-~~~~~~~~~~y~aPE~  186 (294)
T 2rku_A          170 E-RKKVLCGTPNYIAPEV  186 (294)
T ss_dssp             C-CBCCCCSCCSSCCHHH
T ss_pred             c-ccccccCCCCcCCcch
Confidence            2 2233569999999996

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.94  E-value=2.2e-27  Score=249.42  Aligned_cols=169  Identities=30%  Similarity=0.427  Sum_probs=143.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .++|.+.+.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            367999999999999999999885 48899999987654 3345788999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe---CCCCcEEEecccccccc
Q 003301          736 YMPNGSLEDYLYSN---NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       736 ~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~---~~~~~~kl~DFg~a~~~  809 (832)
                      |+++++|.+++...   ...+++..+..++.|++.||+|||   +.||+||||||+||++   +.++.+||+|||.|+..
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999988542   346999999999999999999999   9999999999999999   45688999999999876


Q ss_pred             CCCcccccccccccccccCCCC
Q 003301          810 SGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       810 ~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      .....  .....||+.|+|||+
T Consensus       178 ~~~~~--~~~~~~t~~y~aPE~  197 (285)
T 3is5_A          178 KSDEH--STNAAGTALYMAPEV  197 (285)
T ss_dssp             -----------CTTGGGCCHHH
T ss_pred             CCccc--CcCcccccCcCChHH
Confidence            44322  233569999999996

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=8e-28  Score=271.58  Aligned_cols=235  Identities=18%  Similarity=0.210  Sum_probs=130.9

Q ss_pred             cCcEEEccCCcCCCCCCCcccCcccccccccccccccccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEE
Q 003301           46 ELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVIS  125 (832)
Q Consensus        46 ~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~  125 (832)
                      +|++|+|++|.+++..|..++.+++| ++|+|++|.+++..|   +..+++|++|+|++|.|++..     ..++|++|+
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~---l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~  105 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFTKL-ELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQELL-----VGPSIETLH  105 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCTTC-CEEECTTSCCEEEEE---CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEE
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCCCC-CEEEeeCCCCCCCcc---cccCCCCCEEEecCCcCCCCC-----CCCCcCEEE
Confidence            44444444444443333344444444 444444444443222   224555555555555555322     125566666


Q ss_pred             CcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccccccccccCcccc-cCCcccEEEecCCCCC
Q 003301          126 LAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIF-NLSAMKTLALPSNALS  204 (832)
Q Consensus       126 Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~n~l~  204 (832)
                      +++|.+++..+.   .+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..+. .+++|++|+|++|.++
T Consensus       106 L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~  182 (487)
T 3oja_A          106 AANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY  182 (487)
T ss_dssp             CCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred             CcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccc
Confidence            666666544433   234566666666666655555666666666666666666665555554 5666666666666665


Q ss_pred             CCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCcc
Q 003301          205 GSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSEL  284 (832)
Q Consensus       205 ~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  284 (832)
                      +. |.   ...+++|++|+|++|++++++|. |..+++|+.|+|++|.+++ +|..+..+++|+.|++++|.+...    
T Consensus       183 ~~-~~---~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~----  252 (487)
T 3oja_A          183 DV-KG---QVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG----  252 (487)
T ss_dssp             EE-EC---CCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHH----
T ss_pred             cc-cc---cccCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCc----
Confidence            33 22   12466666666766666655444 5666777777777777774 455566677777777777776520    


Q ss_pred             ccccccccCCCCcEEecc
Q 003301          285 SFLSSWANCKNLKLLDLS  302 (832)
Q Consensus       285 ~~~~~~~~l~~L~~L~L~  302 (832)
                      ..+..+..++.|+.++++
T Consensus       253 ~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          253 TLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             HHHHHHTTCHHHHHHHHH
T ss_pred             chHHHHHhCCCCcEEecc
Confidence            233445566666666665

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.94  E-value=4.1e-27  Score=253.46  Aligned_cols=169  Identities=24%  Similarity=0.397  Sum_probs=148.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.+.||+|+||.||+|.+.+ ++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            4689999999999999999999865 7889999987543   33456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+++++|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||.++......
T Consensus       120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            99999999999987653 6899999999999999999999   9999999999999999999999999999998765333


Q ss_pred             ccccccccccccccCCCC
Q 003301          814 SMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~  831 (832)
                      . ......||+.|+|||+
T Consensus       196 ~-~~~~~~gt~~y~aPE~  212 (335)
T 2owb_A          196 E-RKKVLCGTPNYIAPEV  212 (335)
T ss_dssp             C-CBCCCCSCCSSCCHHH
T ss_pred             c-cccccCCCccccCHHH
Confidence            2 2233569999999996

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.94  E-value=8.6e-28  Score=257.44  Aligned_cols=168  Identities=26%  Similarity=0.396  Sum_probs=139.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchh-hHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEG-ALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++...... ....+.+|++++++++||||+++++++.+++..|+||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999986 5899999998754322 122455799999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      ++ |+|.+++...+..+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||.|+....... .
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~  156 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T  156 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-c
Confidence            96 6999999887767999999999999999999999   99999999999999999999999999999986543322 2


Q ss_pred             cccccccccccCCCC
Q 003301          817 QTLTLATIGYMAPGL  831 (832)
Q Consensus       817 ~~~~~gt~~y~APE~  831 (832)
                      .....||+.|+|||+
T Consensus       157 ~~~~~~t~~y~aPE~  171 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDI  171 (324)
T ss_dssp             ------CGGGCCHHH
T ss_pred             cccccCcccccChhh
Confidence            233568999999996

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.94  E-value=5.1e-27  Score=246.64  Aligned_cols=168  Identities=24%  Similarity=0.456  Sum_probs=147.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      .++|++.+.||+|+||.||+|.+.. ++.||+|++....  ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            5789999999999999999998864 8999999997553  334567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCc---EEEeccccccccCC
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMV---AHLSDFGIAKLLSG  811 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~---~kl~DFg~a~~~~~  811 (832)
                      ||+++++|.+++.... .+++..+..++.|++.|++|||   +.||+||||||+||+++.++.   +||+|||.+.....
T Consensus        85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            9999999999887654 6899999999999999999999   999999999999999986655   99999999987654


Q ss_pred             CcccccccccccccccCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~  831 (832)
                      ...  .....||+.|+|||+
T Consensus       161 ~~~--~~~~~~~~~y~aPE~  178 (284)
T 3kk8_A          161 SEA--WHGFAGTPGYLSPEV  178 (284)
T ss_dssp             SCB--CCCSCSCGGGCCHHH
T ss_pred             Ccc--ccCCCCCcCCcCchh
Confidence            332  233569999999996

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=1.1e-27  Score=259.34  Aligned_cols=176  Identities=24%  Similarity=0.366  Sum_probs=145.2

Q ss_pred             HHHHHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-----hhhHHHHHHHHHHHhcCCCCceeeeceEEec
Q 003301          653 ELLQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-----EGALKSFDVECEVLKSVRHRNLVKIISSCTN  726 (832)
Q Consensus       653 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  726 (832)
                      ++....++|++.+.||+|+||.||+|.+. +++.||+|++....     ....+.+.+|++++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            45567789999999999999999999885 48899999987542     3445788999999999999999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhC---------------------------------------CCCCCHHHHHHHHHHHHH
Q 003301          727 NDFKALVLEYMPNGSLEDYLYSN---------------------------------------NFSFDILQRLSVIIDVAL  767 (832)
Q Consensus       727 ~~~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~  767 (832)
                      .+..|+||||+++|+|.+++...                                       ...+++..+..++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            99999999999999999998521                                       111356778899999999


Q ss_pred             HHHHHhcCCCCCeEecCCCCCCeEeCCCC--cEEEeccccccccCCCc---ccccccccccccccCCCC
Q 003301          768 ALEYLHFGYSNPVVHCDIKPSNVLLDKDM--VAHLSDFGIAKLLSGEE---SMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       768 ~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~--~~kl~DFg~a~~~~~~~---~~~~~~~~gt~~y~APE~  831 (832)
                      |++|||   +.||+||||||+||+++.++  .+||+|||.|+......   ........||+.|+|||+
T Consensus       180 ~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~  245 (345)
T 3hko_A          180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV  245 (345)
T ss_dssp             HHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHH
T ss_pred             HHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchh
Confidence            999999   99999999999999998776  89999999998653321   112334579999999996

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.94  E-value=4e-26  Score=237.58  Aligned_cols=207  Identities=25%  Similarity=0.309  Sum_probs=148.3

Q ss_pred             cccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCC
Q 003301          344 NLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLA  423 (832)
Q Consensus       344 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  423 (832)
                      +.+.+++++++++. +|..+.  ++|++|+|++|++++..+..|..+++|++|++++|++++..+..|.++++|++|+++
T Consensus        17 ~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~   93 (270)
T 2o6q_A           17 NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT   93 (270)
T ss_dssp             TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred             CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence            34566666666653 333332  456666666666665555566666777777777777765555556677777777777


Q ss_pred             CCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccC
Q 003301          424 SNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSI  503 (832)
Q Consensus       424 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  503 (832)
                      +|+++++.+..|..+++|++|++++|++++..+..|+.+++|++|+|++|++++..+..|.++++|+.|+|++|++++..
T Consensus        94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  173 (270)
T 2o6q_A           94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP  173 (270)
T ss_dssp             SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence            77777766666777777777777777777766667777777777888888777666666778888888888888888766


Q ss_pred             CccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCCC
Q 003301          504 PKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPR  553 (832)
Q Consensus       504 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  553 (832)
                      +..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++.|.++.
T Consensus       174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  223 (270)
T 2o6q_A          174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNG  223 (270)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSS
T ss_pred             hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCcc
Confidence            66788888888888888888876666777888888888888888877753

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.94  E-value=2.7e-27  Score=252.69  Aligned_cols=171  Identities=25%  Similarity=0.423  Sum_probs=147.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  730 (832)
                      .++|++.+.||+|+||.||+|.+.      +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            578999999999999999999863      35789999987543 34457788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCC-----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNF-----------------------SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKP  787 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~-----------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp  787 (832)
                      |+||||+++++|.+++.....                       .+++..+..++.|++.||+|||   ++||+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence            999999999999999986432                       3789999999999999999999   99999999999


Q ss_pred             CCeEeCCCCcEEEeccccccccCCCccc-ccccccccccccCCCC
Q 003301          788 SNVLLDKDMVAHLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGL  831 (832)
Q Consensus       788 ~NIl~~~~~~~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~  831 (832)
                      +||+++.++.+||+|||+|+........ ......+|+.|+|||+
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  223 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIES  223 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHH
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhh
Confidence            9999999999999999999876543322 2233457889999995

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.94  E-value=4.1e-30  Score=300.19  Aligned_cols=441  Identities=14%  Similarity=0.140  Sum_probs=270.8

Q ss_pred             CcEEEccCCcCCCCCCCcccCcccccccccccccccccCC---C-----------hhhhhcCCCceEEEccCCcccccCC
Q 003301           47 LELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSL---P-----------DDMCRRLPLIKGLYMSNNKLTGPIP  112 (832)
Q Consensus        47 L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~l---p-----------~~~~~~l~~L~~L~l~~N~l~~~~p  112 (832)
                      -+.++++++... ..+..+..++++ +.|+++++.....+   |           ..+...+++|++|+|++|.+++..+
T Consensus        45 ~~~l~~~~~~~~-~~~~~~~~~~~L-~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~  122 (594)
T 2p1m_B           45 RRKVFIGNCYAV-SPATVIRRFPKV-RSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCL  122 (594)
T ss_dssp             CCEEEESSTTSS-CHHHHHHHCTTC-CEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHH
T ss_pred             ceEEeecccccc-CHHHHHhhCCCc-eEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHH
Confidence            346777665433 222334566777 99999987532122   2           2334578999999999999987766


Q ss_pred             CCcc-CCCCccEEECcCC-ccccc-CCCCCcCCCcCceEEecccccccccCcccc----Cccccceecccccc--ccc-c
Q 003301          113 NNIW-QCKELIVISLAYN-QFTER-IPRGLGNLTSLKTLYLGFNNLTGEIPYEMG----NLRNLEILGLQLNK--LVG-F  182 (832)
Q Consensus       113 ~~l~-~l~~L~~L~Ls~n-~i~~~-~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~----~l~~L~~L~L~~N~--l~~-~  182 (832)
                      ..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+.    .+++|++|++++|.  +.. .
T Consensus       123 ~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~  202 (594)
T 2p1m_B          123 ELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSA  202 (594)
T ss_dssp             HHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHH
T ss_pred             HHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHH
Confidence            6665 6899999999999 56532 344455789999999999998865544443    67799999999997  221 1


Q ss_pred             cCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCc-------cccccCCcccCCCCccEE-EcCCCcCc
Q 003301          183 VPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNN-------FSGIIPSFIFNASKLSVL-ELGENSFS  254 (832)
Q Consensus       183 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~-------i~~~~~~~~~~l~~L~~L-~L~~N~i~  254 (832)
                      ++..+.++++|++|++++|...+.+|..  +..+++|++|+++.+.       +.+.. ..+.++++|+.| .+.+....
T Consensus       203 l~~l~~~~~~L~~L~L~~~~~~~~l~~~--~~~~~~L~~L~l~~~~~~~~~~~~~~l~-~~l~~~~~L~~Ls~~~~~~~~  279 (594)
T 2p1m_B          203 LERLVTRCPNLKSLKLNRAVPLEKLATL--LQRAPQLEELGTGGYTAEVRPDVYSGLS-VALSGCKELRCLSGFWDAVPA  279 (594)
T ss_dssp             HHHHHHHCTTCCEEECCTTSCHHHHHHH--HHHCTTCSEEECSBCCCCCCHHHHHHHH-HHHHTCTTCCEEECCBTCCGG
T ss_pred             HHHHHHhCCCCcEEecCCCCcHHHHHHH--HhcCCcceEcccccccCccchhhHHHHH-HHHhcCCCcccccCCcccchh
Confidence            1122345799999999999433234443  3578999999966543       33332 245666777776 33332221


Q ss_pred             ccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCccccc
Q 003301          255 GFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGT  334 (832)
Q Consensus       255 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~  334 (832)
                       ..+..+..+++|++|++++|.++..    .+...+..+++|++|++++| +.+                        ..
T Consensus       280 -~l~~~~~~~~~L~~L~L~~~~l~~~----~l~~~~~~~~~L~~L~l~~~-~~~------------------------~~  329 (594)
T 2p1m_B          280 -YLPAVYSVCSRLTTLNLSYATVQSY----DLVKLLCQCPKLQRLWVLDY-IED------------------------AG  329 (594)
T ss_dssp             -GGGGGHHHHTTCCEEECTTCCCCHH----HHHHHHTTCTTCCEEEEEGG-GHH------------------------HH
T ss_pred             -hHHHHHHhhCCCCEEEccCCCCCHH----HHHHHHhcCCCcCEEeCcCc-cCH------------------------HH
Confidence             2333334556666666666654320    11112344555555555554 221                        11


Q ss_pred             ccccccCcCcccEEEeec---------Cccccccccccc-CCCCCceEEccCCccCCCCchhhc-CCCCCcEEEec--C-
Q 003301          335 IPKEIGNLINLRELGLWG---------NELIGSIPITFG-KLQNLQGLDLVNNKLEGPIPNGLC-QLARLSVLYMD--G-  400 (832)
Q Consensus       335 ~~~~~~~l~~L~~L~L~~---------N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~--~-  400 (832)
                      ++.....+++|++|++++         +.+++.....+. .+++|+.|+++.|++++..+..+. .+++|+.|+++  + 
T Consensus       330 l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~  409 (594)
T 2p1m_B          330 LEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEP  409 (594)
T ss_dssp             HHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESST
T ss_pred             HHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccC
Confidence            112222355566666622         344432222222 366777777777776655444444 36677777777  3 


Q ss_pred             ---CcCCCCC-----cccCCCCCCCCeEeCCCCcCCCCCCccccc-CcccceeeecCCcccCCCcccc-ccccccceecc
Q 003301          401 ---NKLSGPI-----PPCIGDLTSLRLLSLASNELNSVIPSTFWN-LKDILSLNFSSNFLNGSLPEDI-GNLKVVVIIDL  470 (832)
Q Consensus       401 ---N~l~~~~-----p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L  470 (832)
                         |.+++..     +..+..+++|+.|++++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|
T Consensus       410 ~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L  488 (594)
T 2p1m_B          410 KAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEI  488 (594)
T ss_dssp             TCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEE
T ss_pred             CCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEEC
Confidence               4454221     11245667788888866 555544444444 6778888888888765544444 56788888888


Q ss_pred             cCcccCCccCC-ccccccccceeecccccccccCCccc-cCCCCCCeeccCCCcc
Q 003301          471 SRNNLSGDIPT-AIGGLMNLQDLSLRDNGLQGSIPKSI-GGLVSLESLDLSNNSL  523 (832)
Q Consensus       471 s~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l  523 (832)
                      ++|.+++.... ....+++|+.|++++|+++......+ ..++.|+...+..+.-
T Consensus       489 ~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~  543 (594)
T 2p1m_B          489 RDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGA  543 (594)
T ss_dssp             ESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSC
T ss_pred             cCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCc
Confidence            88888654443 34558889999999998864444444 4567777767666543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.94  E-value=6.9e-27  Score=246.05  Aligned_cols=166  Identities=29%  Similarity=0.502  Sum_probs=143.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchh-------hHHHHHHHHHHHhcCCCCceeeeceEEecCCe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEG-------ALKSFDVECEVLKSVRHRNLVKIISSCTNNDF  729 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  729 (832)
                      .++|++.+.||+|+||.||+|++. +++.||+|++......       ..+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            478999999999999999999885 5899999998644321       1267889999999999999999999987665 


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeEeCCCCc-----EEEec
Q 003301          730 KALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP--VVHCDIKPSNVLLDKDMV-----AHLSD  802 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~~~~~-----~kl~D  802 (832)
                       ++||||+++++|.+++......+++..+..++.|++.|++|||   +.|  |+||||||+||+++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             7999999999999999877667999999999999999999999   899  999999999999988776     99999


Q ss_pred             cccccccCCCcccccccccccccccCCCCC
Q 003301          803 FGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       803 Fg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ||+|+.....    .....||+.|+|||++
T Consensus       173 fg~~~~~~~~----~~~~~g~~~y~aPE~~  198 (287)
T 4f0f_A          173 FGLSQQSVHS----VSGLLGNFQWMAPETI  198 (287)
T ss_dssp             CTTCBCCSSC----EECCCCCCTTSCGGGS
T ss_pred             CCcccccccc----ccccCCCccccCchhh
Confidence            9999854332    2335699999999974

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.94  E-value=2.1e-27  Score=261.65  Aligned_cols=169  Identities=31%  Similarity=0.460  Sum_probs=146.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC--eeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNND--FKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv  733 (832)
                      .++|++.++||+|+||.||+|++.. ++.||||++.... ....+.+.+|++++++++||||+++++++...+  ..|+|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            4679999999999999999999865 8999999997543 334567889999999999999999999988655  78999


Q ss_pred             EecCCCCCHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe----CCCCcEEEecccccc
Q 003301          734 LEYMPNGSLEDYLYSNN--FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL----DKDMVAHLSDFGIAK  807 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~----~~~~~~kl~DFg~a~  807 (832)
                      |||+++|+|.++++...  ..+++..+..++.|++.||+|||   +.||+||||||+||++    +.++.+||+|||.|+
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999997643  23899999999999999999999   9999999999999999    778889999999998


Q ss_pred             ccCCCcccccccccccccccCCCC
Q 003301          808 LLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       808 ~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      .......  ....+||+.|+|||+
T Consensus       165 ~~~~~~~--~~~~~gt~~y~aPE~  186 (396)
T 4eut_A          165 ELEDDEQ--FVSLYGTEEYLHPDM  186 (396)
T ss_dssp             ECCCGGG--SSCSSSCCTTCCHHH
T ss_pred             EccCCCc--cccccCCccccCHHH
Confidence            7654432  233569999999996

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=1.3e-27  Score=258.46  Aligned_cols=171  Identities=28%  Similarity=0.446  Sum_probs=141.9

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch-----hhHHHHHHHHHHHhcCCCCceeeeceEEecCCe
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE-----GALKSFDVECEVLKSVRHRNLVKIISSCTNNDF  729 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  729 (832)
                      ...++|++.+.||+|+||.||+|.+. +|+.||||++.....     ...+.+.+|++++++++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            44678999999999999999999986 489999999864321     123467899999999999999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      .|+||||+++ +|.+++......+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|+..
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            9999999965 999999877667899999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCcccccccccccccccCCCC
Q 003301          810 SGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       810 ~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      ..... .....+||+.|+|||+
T Consensus       163 ~~~~~-~~~~~~~t~~y~aPE~  183 (346)
T 1ua2_A          163 GSPNR-AYTHQVVTRWYRAPEL  183 (346)
T ss_dssp             TSCCC-CCCCSCCCCTTCCHHH
T ss_pred             cCCcc-cCCcccccccccCchH
Confidence            44332 2233579999999996

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.94  E-value=2.2e-27  Score=266.14  Aligned_cols=166  Identities=25%  Similarity=0.325  Sum_probs=137.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecC------C
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNN------D  728 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  728 (832)
                      .++|++.+.||+|+||+||+|.+. +++.||||++....  ....+++.+|+++++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            578999999999999999999876 48999999997542  34457788999999999999999999999654      3


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          729 FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      ..|+||||+++ ++.+.+..   .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            57999999964 67777753   4899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCcccccccccccccccCCCCC
Q 003301          809 LSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       809 ~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .....  .....+||+.|+|||++
T Consensus       214 ~~~~~--~~~~~~gt~~y~aPE~~  235 (464)
T 3ttj_A          214 AGTSF--MMTPYVVTRYYRAPEVI  235 (464)
T ss_dssp             ---CC--CC----CCCTTCCHHHH
T ss_pred             cCCCc--ccCCCcccccccCHHHH
Confidence            64432  23346799999999963

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.94  E-value=3.8e-27  Score=267.05  Aligned_cols=170  Identities=26%  Similarity=0.414  Sum_probs=147.3

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      ..++|++.+.||+|+||+||+|.+. +++.||||++....  ......+.+|++++++++||||+++++++.+.+..|+|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3467999999999999999999986 58999999987543  23457789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeC---CCCcEEEeccccccccC
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~---~~~~~kl~DFg~a~~~~  810 (832)
                      |||+++|+|.+++...+ .+++..+..++.|++.||+|||   ++||+||||||+||+++   .++.+||+|||+|+...
T Consensus       100 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            99999999999887654 6899999999999999999999   99999999999999995   45689999999998765


Q ss_pred             CCcccccccccccccccCCCCC
Q 003301          811 GEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       811 ~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ....  ....+||+.|+|||++
T Consensus       176 ~~~~--~~~~~gt~~y~aPE~~  195 (486)
T 3mwu_A          176 QNTK--MKDRIGTAYYIAPEVL  195 (486)
T ss_dssp             CC------CCTTGGGGCCGGGG
T ss_pred             CCCc--cCCCcCCCCCCCHHHh
Confidence            4332  2335799999999974

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.94  E-value=2.5e-27  Score=258.10  Aligned_cols=178  Identities=29%  Similarity=0.398  Sum_probs=151.7

Q ss_pred             ccccchHHHHHHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCC-----CCceee
Q 003301          646 RRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVR-----HRNLVK  719 (832)
Q Consensus       646 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~  719 (832)
                      ...+++.+.....++|++.++||+|+||+||+|++. +++.||||++... ....+.+..|+++++.++     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            344555555566789999999999999999999985 5889999998743 233466778999999886     999999


Q ss_pred             eceEEecCCeeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC----
Q 003301          720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK----  794 (832)
Q Consensus       720 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~----  794 (832)
                      +++++...+..|+||||+ +++|.+++.... ..+++..+..++.|++.||+|||   ++||+||||||+||+++.    
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccc
Confidence            999999999999999999 999999998654 35899999999999999999999   999999999999999975    


Q ss_pred             ---------------------CCcEEEeccccccccCCCcccccccccccccccCCCCC
Q 003301          795 ---------------------DMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       795 ---------------------~~~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                                           ++.+||+|||+|+......    ....||+.|+|||++
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~  231 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVI  231 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHH
Confidence                                 7899999999998654322    235699999999963

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.94  E-value=2.1e-27  Score=256.65  Aligned_cols=169  Identities=25%  Similarity=0.391  Sum_probs=142.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCC--CceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRH--RNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.+.||+|+||.||+|.+.+++.||||++....  ....+.+.+|++++++++|  |||+++++++.+++..|+|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            45799999999999999999999889999999987543  3345678899999999976  9999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      ||+ .+++|.+++...+ .+++..+..++.|++.||+|||   +.||+||||||+||+++ ++.+||+|||+|+......
T Consensus        88 ~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             ECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            995 4889999998754 6899999999999999999999   99999999999999997 6789999999998765433


Q ss_pred             cc-ccccccccccccCCCCC
Q 003301          814 SM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~-~~~~~~gt~~y~APE~l  832 (832)
                      .. .....+||+.|+|||++
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~  181 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAI  181 (343)
T ss_dssp             --------CCCCSSCCHHHH
T ss_pred             ccccCCCCcCCcCcCCHHHH
Confidence            22 22345799999999963

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.94  E-value=5.9e-27  Score=248.03  Aligned_cols=168  Identities=21%  Similarity=0.302  Sum_probs=146.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEEEe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||||++....  ..+.+.+|+++++.+ +|++++++++++......|+|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            467999999999999999999974 58999999986543  235678899999999 79999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCc-----EEEeccccccccC
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMV-----AHLSDFGIAKLLS  810 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~-----~kl~DFg~a~~~~  810 (832)
                      |+ +++|.+++...+..+++..+..++.|++.|++|||   ++||+||||||+||+++.++.     +||+|||+|+...
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99 99999999877667999999999999999999999   999999999999999987776     9999999998765


Q ss_pred             CCccc------ccccccccccccCCCC
Q 003301          811 GEESM------KQTLTLATIGYMAPGL  831 (832)
Q Consensus       811 ~~~~~------~~~~~~gt~~y~APE~  831 (832)
                      .....      ......||+.|+|||+
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~  189 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINT  189 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred             cccccccccccCccCCCCCcccCCchh
Confidence            43321      1234569999999996

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=5.5e-27  Score=252.96  Aligned_cols=168  Identities=30%  Similarity=0.485  Sum_probs=140.1

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcC--CCCceeeeceEEecC----Ce
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV--RHRNLVKIISSCTNN----DF  729 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~----~~  729 (832)
                      ...++|++.+.||+|+||.||+|++ .++.||||++.....   ....+|.+++...  +||||+++++++...    ..
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  109 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ  109 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred             ccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence            3457899999999999999999998 589999999864432   3455566666554  899999999999877    78


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--------CeEecCCCCCCeEeCCCCcEEEe
Q 003301          730 KALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN--------PVVHCDIKPSNVLLDKDMVAHLS  801 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~--------~ivH~Dlkp~NIl~~~~~~~kl~  801 (832)
                      .|+||||+++|+|.++++..  .+++..+..++.|++.|++|||   +.        ||+||||||+||+++.++.+||+
T Consensus       110 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             eEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence            99999999999999999765  4899999999999999999999   77        99999999999999999999999


Q ss_pred             ccccccccCCCcccc---cccccccccccCCCCC
Q 003301          802 DFGIAKLLSGEESMK---QTLTLATIGYMAPGLF  832 (832)
Q Consensus       802 DFg~a~~~~~~~~~~---~~~~~gt~~y~APE~l  832 (832)
                      |||+|+.........   .....||+.|+|||++
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  218 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL  218 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHH
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhc
Confidence            999998764433221   1235799999999963

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.94  E-value=5.7e-27  Score=245.13  Aligned_cols=172  Identities=24%  Similarity=0.368  Sum_probs=149.7

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            4578999999999999999999886 58999999997543 334578889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||+++++|.+++.... .+++..+..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||.+........
T Consensus        85 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           85 EYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             ECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            9999999999987643 6899999999999999999999   99999999999999999999999999999986533221


Q ss_pred             -cccccccccccccCCCCC
Q 003301          815 -MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 -~~~~~~~gt~~y~APE~l  832 (832)
                       .......||+.|+|||++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~  179 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELL  179 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGG
T ss_pred             hhcccCCccccCccChHHH
Confidence             122335699999999974

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=2.7e-27  Score=256.19  Aligned_cols=172  Identities=24%  Similarity=0.426  Sum_probs=145.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCC
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTNND  728 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  728 (832)
                      ..++|++.+.||+|+||.||+|.+.      ++..||+|++.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            4578999999999999999999862      35689999997543 33457889999999999 8999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCC----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 003301          729 FKALVLEYMPNGSLEDYLYSNNF----------------------SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIK  786 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk  786 (832)
                      ..|+||||+++|+|.+++.....                      .+++..+..++.|++.||+|||   ++||+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence            99999999999999999986542                      2789999999999999999999   9999999999


Q ss_pred             CCCeEeCCCCcEEEeccccccccCCCccc-ccccccccccccCCCC
Q 003301          787 PSNVLLDKDMVAHLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGL  831 (832)
Q Consensus       787 p~NIl~~~~~~~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~  831 (832)
                      |+||+++.++.+||+|||+|......... ......||+.|+|||+
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~  245 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES  245 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHH
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHH
Confidence            99999999999999999999866433221 2233457889999996

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.94  E-value=5.4e-27  Score=250.66  Aligned_cols=172  Identities=23%  Similarity=0.312  Sum_probs=145.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEe----cCCeeEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT----NNDFKAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~l  732 (832)
                      .++|++.+.||+|+||.||+|... +++.||||++........+.+.+|+++++.++||||+++++++.    .....|+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            478999999999999999999984 58999999987766666788999999999999999999999986    3347899


Q ss_pred             EEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          733 VLEYMPNGSLEDYLYS---NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      ||||+++|+|.+++..   ....+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||.+...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            9999999999999875   3456999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCccc--------ccccccccccccCCCCC
Q 003301          810 SGEESM--------KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       810 ~~~~~~--------~~~~~~gt~~y~APE~l  832 (832)
                      ......        ......||+.|+|||++
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  215 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELF  215 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGS
T ss_pred             ccccccccccccccccccccCCcccCCHhHh
Confidence            322111        11224579999999974

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.94  E-value=5e-27  Score=247.24  Aligned_cols=167  Identities=28%  Similarity=0.401  Sum_probs=144.7

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  732 (832)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++....  ......+.+|+..+..+ +||||+++++++.+++..|+
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3578999999999999999999986 58999999987543  23456788899999999 99999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC--------------
Q 003301          733 VLEYMPNGSLEDYLYSNN---FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD--------------  795 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~--------------  795 (832)
                      ||||+++++|.+++....   ..+++..+..++.|++.||+|||   ++||+||||||+||+++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999997531   35899999999999999999999   9999999999999999844              


Q ss_pred             -----CcEEEeccccccccCCCcccccccccccccccCCCC
Q 003301          796 -----MVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       796 -----~~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                           ..+||+|||.+.......     ...||+.|+|||+
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~  201 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEV  201 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHH
T ss_pred             ccCCceEEEEcccccccccCCcc-----ccCCCccccChhH
Confidence                 479999999998765432     2359999999996

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.94  E-value=6.4e-27  Score=248.97  Aligned_cols=170  Identities=29%  Similarity=0.453  Sum_probs=141.0

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch-----hhHHHHHHHHHHHhcCC---CCceeeeceEEecC
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE-----GALKSFDVECEVLKSVR---HRNLVKIISSCTNN  727 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~  727 (832)
                      ..++|++.+.||+|+||+||+|++. +++.||||++.....     .....+.+|+++++.++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            3579999999999999999999975 589999999874431     12346677888777664   99999999999875


Q ss_pred             C-----eeEEEEecCCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEe
Q 003301          728 D-----FKALVLEYMPNGSLEDYLYSNNF-SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLS  801 (832)
Q Consensus       728 ~-----~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~  801 (832)
                      .     ..++||||++ ++|.+++..... .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence            5     5799999995 699999987543 3899999999999999999999   9999999999999999999999999


Q ss_pred             ccccccccCCCcccccccccccccccCCCCC
Q 003301          802 DFGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       802 DFg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      |||.|+.......  .....||+.|+|||++
T Consensus       163 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~  191 (308)
T 3g33_A          163 DFGLARIYSYQMA--LTPVVVTLWYRAPEVL  191 (308)
T ss_dssp             SCSCTTTSTTCCC--SGGGGCCCSSCCHHHH
T ss_pred             eCccccccCCCcc--cCCccccccccCchHH
Confidence            9999987644332  2345799999999963

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.94  E-value=4.4e-27  Score=253.21  Aligned_cols=171  Identities=26%  Similarity=0.494  Sum_probs=146.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec--------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEecC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL--------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTNN  727 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  727 (832)
                      .++|++.+.||+|+||.||+|++.        ++..||||++.... ....+.+.+|+++++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            478999999999999999999873        46789999987543 33456788999999999 899999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCCC---------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe
Q 003301          728 DFKALVLEYMPNGSLEDYLYSNNF---------------SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL  792 (832)
Q Consensus       728 ~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~  792 (832)
                      +..|+||||+++|+|.+++.....               .+++..+..++.|++.||+|||   +.||+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence            999999999999999999986532               3889999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeccccccccCCCccc-ccccccccccccCCCC
Q 003301          793 DKDMVAHLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGL  831 (832)
Q Consensus       793 ~~~~~~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~  831 (832)
                      +.++.+||+|||+|+........ ......+|+.|+|||+
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  230 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEA  230 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHH
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHH
Confidence            99999999999999876543322 2223457889999996

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.94  E-value=1.3e-27  Score=267.72  Aligned_cols=170  Identities=26%  Similarity=0.458  Sum_probs=141.1

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ..++|++.+.||+|+||.||+|.+.++..||||+++... ...+.+.+|++++++++||||+++++++.+ +..|+||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            356788999999999999999999888889999987543 234688999999999999999999999876 678999999


Q ss_pred             CCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          737 MPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       737 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      +++|+|.++++.. ...+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+........
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  336 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  336 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence            9999999999753 235899999999999999999999   999999999999999999999999999999876543333


Q ss_pred             ccccccccccccCCCC
Q 003301          816 KQTLTLATIGYMAPGL  831 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~  831 (832)
                      ......+|+.|+|||+
T Consensus       337 ~~~~~~~~~~y~aPE~  352 (452)
T 1fmk_A          337 ARQGAKFPIKWTAPEA  352 (452)
T ss_dssp             ------CCGGGSCHHH
T ss_pred             cccCCcccccccCHhH
Confidence            3333457889999996

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.94  E-value=3.7e-27  Score=258.74  Aligned_cols=168  Identities=24%  Similarity=0.389  Sum_probs=142.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCC--CCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVR--HRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.+.||+|+||.||+|.+.+++.||||++....  ....+.+.+|++++++++  ||||+++++++..++..|+||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4699999999999999999998889999999997543  334578899999999996  599999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |+ .+++|.+++.... .+++..+..++.||+.||+|||   +.||+||||||+||+++ ++.+||+|||+|+.......
T Consensus       136 E~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          136 EC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             EC-CSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             ec-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            95 5889999998765 7899999999999999999999   99999999999999995 58999999999987654332


Q ss_pred             c-ccccccccccccCCCCC
Q 003301          815 M-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~-~~~~~~gt~~y~APE~l  832 (832)
                      . .....+||+.|+|||++
T Consensus       210 ~~~~~~~~gt~~y~aPE~~  228 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAI  228 (390)
T ss_dssp             ----CCSCCCGGGCCHHHH
T ss_pred             cccCCCCCcCCCccChHHh
Confidence            1 22345799999999963

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.94  E-value=5.7e-27  Score=258.02  Aligned_cols=165  Identities=24%  Similarity=0.353  Sum_probs=133.5

Q ss_pred             hcCCCCC-CeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHh-cCCCCceeeeceEEec----CCee
Q 003301          658 TNQFNAS-NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLK-SVRHRNLVKIISSCTN----NDFK  730 (832)
Q Consensus       658 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~----~~~~  730 (832)
                      .++|.+. +.||+|+||+||+|.+. +++.||||++...     ..+.+|++++. ..+||||+++++++..    .+..
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            4567776 78999999999999886 4889999998643     45667888874 4589999999998865    5678


Q ss_pred             EEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC---CCcEEEeccccc
Q 003301          731 ALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK---DMVAHLSDFGIA  806 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~DFg~a  806 (832)
                      |+||||+++|+|.+++.... ..+++..+..++.|++.||+|||   +.||+||||||+||+++.   ++.+||+|||+|
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            99999999999999998653 35899999999999999999999   999999999999999987   789999999999


Q ss_pred             cccCCCcccccccccccccccCCCCC
Q 003301          807 KLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       807 ~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +.......  ....+||+.|+|||++
T Consensus       212 ~~~~~~~~--~~~~~gt~~y~aPE~~  235 (400)
T 1nxk_A          212 KETTSHNS--LTTPCYTPYYVAPEVL  235 (400)
T ss_dssp             EECC-------------CTTCCGGGS
T ss_pred             cccCCCCc--cccCCCCCCccCHhhc
Confidence            87643322  2345799999999975

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.94  E-value=4.1e-27  Score=267.15  Aligned_cols=169  Identities=26%  Similarity=0.427  Sum_probs=143.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      .++|++.+.||+|+||+||+|++. ++..||+|++....  ......+.+|+++++.++||||+++++++.+.+..|+||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457999999999999999999986 58899999987543  233567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC---CCcEEEeccccccccCC
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK---DMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~DFg~a~~~~~  811 (832)
                      |||++|+|.+++.... .+++..+..++.|++.||+|||   +.||+||||||+||+++.   ++.+||+|||+|+....
T Consensus       116 e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            9999999999887654 6899999999999999999999   999999999999999976   45699999999987654


Q ss_pred             CcccccccccccccccCCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ...  ....+||+.|+|||++
T Consensus       192 ~~~--~~~~~gt~~y~aPE~l  210 (494)
T 3lij_A          192 QKK--MKERLGTAYYIAPEVL  210 (494)
T ss_dssp             TBC--BCCCCSCTTTCCHHHH
T ss_pred             Ccc--ccccCCCcCeeCHHHH
Confidence            332  2335799999999963

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.94  E-value=4.4e-27  Score=263.33  Aligned_cols=165  Identities=33%  Similarity=0.492  Sum_probs=142.7

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCC-eeEEEEe
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNND-FKALVLE  735 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  735 (832)
                      ..++|++.+.||+|+||.||+|.+ .++.||||+++...  ..+.+.+|++++++++||||+++++++...+ ..|+|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            357889999999999999999998 58899999997553  4478999999999999999999999987655 7899999


Q ss_pred             cCCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          736 YMPNGSLEDYLYSNNF-SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |+++|+|.++++..+. .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+...... 
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  343 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  343 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence            9999999999986543 3799999999999999999999   9999999999999999999999999999998643221 


Q ss_pred             cccccccccccccCCCC
Q 003301          815 MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~  831 (832)
                         ....+|+.|+|||+
T Consensus       344 ---~~~~~~~~y~aPE~  357 (450)
T 1k9a_A          344 ---DTGKLPVKWTAPEA  357 (450)
T ss_dssp             ------CCCTTTSCHHH
T ss_pred             ---cCCCCCcceeCHHH
Confidence               12357889999996

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.94  E-value=7.1e-27  Score=244.41  Aligned_cols=169  Identities=28%  Similarity=0.490  Sum_probs=141.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||||++....   ....+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            468999999999999999999986 58999999987543   23356788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+++++|.+++.... .+++..+..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||.+.......
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            99999999999997654 6899999999999999999999   9999999999999999999999999999998765433


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                      .  .....||+.|+|||++
T Consensus       166 ~--~~~~~~~~~y~aPE~~  182 (276)
T 2h6d_A          166 F--LRTSCGSPNYAAPEVI  182 (276)
T ss_dssp             -------------CCTGGG
T ss_pred             c--eecccCCccccCHHHH
Confidence            2  2234699999999974

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.94  E-value=3.9e-27  Score=256.83  Aligned_cols=177  Identities=24%  Similarity=0.307  Sum_probs=144.3

Q ss_pred             cchHHHHHHhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccch-----------hhHHHHHHHHHHHhcCCCCce
Q 003301          649 FSYKELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLE-----------GALKSFDVECEVLKSVRHRNL  717 (832)
Q Consensus       649 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~ni  717 (832)
                      ...+++....++|++.+.||+|+||.||+|.+.+++.||||++.....           ...+.+.+|++++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            345677778899999999999999999999988899999999864321           123678999999999999999


Q ss_pred             eeeceEEec-----CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe
Q 003301          718 VKIISSCTN-----NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL  792 (832)
Q Consensus       718 v~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~  792 (832)
                      +++++++..     ....|+||||++ |++.+++......+++..+..++.|++.||+|||   +.||+||||||+||++
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILL  167 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEE
Confidence            999999843     346899999996 6999998877667999999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeccccccccCCCcccccccccccccccCCCC
Q 003301          793 DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       793 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      +.++.+||+|||.|+......  ......||+.|+|||+
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~  204 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPEL  204 (362)
T ss_dssp             CTTCCEEECCTTC-----------------CGGGCCHHH
T ss_pred             cCCCCEEEEecCccccccccc--ccceecccceecCcHH
Confidence            999999999999998653332  2233569999999995

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.94  E-value=6.9e-27  Score=248.21  Aligned_cols=168  Identities=27%  Similarity=0.421  Sum_probs=145.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .++|++.+.||+|+||.||+|++. +|+.||+|++........+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            467999999999999999999986 5899999999866544456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe---CCCCcEEEeccccccccCCCc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~---~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      +++++|.+++...+ .+++..+..++.|++.|++|||   +.||+||||||+||++   +.++.+||+|||.++..... 
T Consensus        88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-  162 (304)
T 2jam_A           88 VSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-  162 (304)
T ss_dssp             CCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred             CCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence            99999999987654 6899999999999999999999   9999999999999999   78899999999999765332 


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                        ......||+.|+|||++
T Consensus       163 --~~~~~~~~~~y~aPE~~  179 (304)
T 2jam_A          163 --IMSTACGTPGYVAPEVL  179 (304)
T ss_dssp             --TTHHHHSCCCBCCTTTB
T ss_pred             --ccccccCCCCccChHHh
Confidence              12234699999999974

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.94  E-value=7.1e-27  Score=265.90  Aligned_cols=170  Identities=26%  Similarity=0.415  Sum_probs=145.8

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccch-------------hhHHHHHHHHHHHhcCCCCceeeece
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLE-------------GALKSFDVECEVLKSVRHRNLVKIIS  722 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~~  722 (832)
                      ..++|++.+.||+|+||+||+|.+.. ++.||+|++.....             ...+.+.+|++++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            35789999999999999999999864 78999999875421             23467889999999999999999999


Q ss_pred             EEecCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC---cEE
Q 003301          723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM---VAH  799 (832)
Q Consensus       723 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~---~~k  799 (832)
                      ++.+.+..|+|||||++|+|.+++.... .+++..+..++.|++.||+|||   +.||+||||||+||+++.++   .+|
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEE
Confidence            9999999999999999999999987654 6999999999999999999999   99999999999999998776   699


Q ss_pred             EeccccccccCCCcccccccccccccccCCCCC
Q 003301          800 LSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       800 l~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      |+|||+|+.......  ....+||+.|+|||++
T Consensus       190 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~  220 (504)
T 3q5i_A          190 IVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVL  220 (504)
T ss_dssp             ECCCTTCEECCTTSC--BCCCCSCTTTCCHHHH
T ss_pred             EEECCCCEEcCCCCc--cccccCCcCCCCHHHh
Confidence            999999987754332  2335799999999963

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.94  E-value=4.1e-27  Score=249.80  Aligned_cols=171  Identities=27%  Similarity=0.408  Sum_probs=142.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEec---------
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN---------  726 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------  726 (832)
                      ..++|++.+.||+|+||.||+|++. +++.||||++... ....+.+.+|++++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            3568999999999999999999975 5899999998654 3445788899999999999999999998865         


Q ss_pred             ----CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEec
Q 003301          727 ----NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSD  802 (832)
Q Consensus       727 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D  802 (832)
                          .+..|+||||+++++|.+++......+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEee
Confidence                35689999999999999999876667889999999999999999999   99999999999999999999999999


Q ss_pred             cccccccCCCc-------------ccccccccccccccCCCC
Q 003301          803 FGIAKLLSGEE-------------SMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       803 Fg~a~~~~~~~-------------~~~~~~~~gt~~y~APE~  831 (832)
                      ||.++......             ........||+.|+|||+
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  201 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEV  201 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCccc
Confidence            99998764321             112233569999999996

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.94  E-value=2.9e-27  Score=248.01  Aligned_cols=170  Identities=27%  Similarity=0.474  Sum_probs=142.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC----CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD----GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      .++|++.+.||+|+||.||+|.+..    +..||+|++.... ....+.+.+|++++++++||||+++++++.+ +..|+
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4789999999999999999998653    3459999987553 3445788999999999999999999999875 45689


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||||+++++|.+++...+..+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||.+......
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            99999999999999876667999999999999999999999   999999999999999999999999999999876554


Q ss_pred             cccccccccccccccCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~  831 (832)
                      .........+|+.|+|||+
T Consensus       167 ~~~~~~~~~~~~~y~aPE~  185 (281)
T 3cc6_A          167 DYYKASVTRLPIKWMSPES  185 (281)
T ss_dssp             ------CCCCCGGGCCHHH
T ss_pred             cccccccCCCCcceeCchh
Confidence            4333344567889999996

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.94  E-value=5.4e-27  Score=251.63  Aligned_cols=171  Identities=29%  Similarity=0.500  Sum_probs=148.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe-----cCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCC--ee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSF-----LDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNND--FK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~  730 (832)
                      .++|++.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            46789999999999999999984     358899999998766666678999999999999999999999987644  78


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      ++||||+++++|.+++......+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||.|+...
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            9999999999999999887667999999999999999999999   9999999999999999999999999999998775


Q ss_pred             CCccc--ccccccccccccCCCC
Q 003301          811 GEESM--KQTLTLATIGYMAPGL  831 (832)
Q Consensus       811 ~~~~~--~~~~~~gt~~y~APE~  831 (832)
                      .....  ......++..|+|||+
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~  219 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPES  219 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHH
T ss_pred             ccccccccccCCCCceeEECchh
Confidence            44321  1223457888999996

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.94  E-value=4.6e-27  Score=255.00  Aligned_cols=170  Identities=29%  Similarity=0.455  Sum_probs=144.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEec--------
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTN--------  726 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  726 (832)
                      .++|++.+.||+|+||.||+|++. +++.||||++....  ......+.+|+++++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            468999999999999999999985 58999999986543  2234577899999999999999999999876        


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccc
Q 003301          727 NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA  806 (832)
Q Consensus       727 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a  806 (832)
                      .+..|+||||++ +++.+.+......+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|
T Consensus        96 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            446899999996 5888888776667999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCcc---cccccccccccccCCCC
Q 003301          807 KLLSGEES---MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       807 ~~~~~~~~---~~~~~~~gt~~y~APE~  831 (832)
                      +.......   .......||+.|+|||+
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~  199 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPEL  199 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHH
T ss_pred             ccccccccccccccCCcccccCccCchh
Confidence            87643221   12234568999999995

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.94  E-value=2.9e-27  Score=253.44  Aligned_cols=172  Identities=23%  Similarity=0.479  Sum_probs=130.8

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecCC----cEEEEEEEecc--chhhHHHHHHHHHHHhcCCCCceeeeceEEecCCee
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQ--LEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  730 (832)
                      ..++|++.+.||+|+||.||+|++...    ..||||++...  .....+.+.+|++++++++||||+++++++...+..
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            357899999999999999999987643    27999998754  234457889999999999999999999999877655


Q ss_pred             ------EEEEecCCCCCHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEE
Q 003301          731 ------ALVLEYMPNGSLEDYLYSNN-----FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAH  799 (832)
Q Consensus       731 ------~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k  799 (832)
                            |+||||+++|+|.+++....     ..+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence                  99999999999999986432     25899999999999999999999   99999999999999999999999


Q ss_pred             EeccccccccCCCccc-ccccccccccccCCCC
Q 003301          800 LSDFGIAKLLSGEESM-KQTLTLATIGYMAPGL  831 (832)
Q Consensus       800 l~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~  831 (832)
                      |+|||.|+........ ......+|+.|+|||+
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~  210 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALES  210 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHH
T ss_pred             EeeccccccccccccccccccccCcccccCchh
Confidence            9999999876443322 2223457889999996

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.94  E-value=3.7e-27  Score=251.50  Aligned_cols=171  Identities=25%  Similarity=0.425  Sum_probs=147.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEe------cCCcEEEEEEEeccch-hhHHHHHHHHHHHhcC-CCCceeeeceEEecCCe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSF------LDGMEVAIKVFHLQLE-GALKSFDVECEVLKSV-RHRNLVKIISSCTNNDF  729 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  729 (832)
                      .++|++.+.||+|+||.||+|++      .+++.||+|++..... ...+.+.+|+++++++ +||||+++++++..++.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            46899999999999999999985      2467899999975542 3457889999999999 99999999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCCC-----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe
Q 003301          730 KALVLEYMPNGSLEDYLYSNNF-----------------SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL  792 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~  792 (832)
                      .|+||||+++|+|.+++.....                 .+++..+..++.|++.|++|||   ++||+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence            9999999999999999986542                 3899999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeccccccccCCCccc-ccccccccccccCCCC
Q 003301          793 DKDMVAHLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGL  831 (832)
Q Consensus       793 ~~~~~~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~  831 (832)
                      +.++.+||+|||.++........ ......||+.|+|||+
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  218 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPES  218 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHH
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHH
Confidence            99999999999999876544322 1223457889999995

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.94  E-value=4e-27  Score=266.99  Aligned_cols=169  Identities=28%  Similarity=0.463  Sum_probs=149.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467999999999999999999986 58999999986543   33457889999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe---CCCCcEEEeccccccccC
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~---~~~~~~kl~DFg~a~~~~  810 (832)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||++   +.++.+||+|||+|+...
T Consensus       105 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            99999999999987654 6999999999999999999999   9999999999999999   567899999999998775


Q ss_pred             CCcccccccccccccccCCCCC
Q 003301          811 GEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       811 ~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ....  ....+||+.|+|||++
T Consensus       181 ~~~~--~~~~~gt~~y~aPE~~  200 (484)
T 3nyv_A          181 ASKK--MKDKIGTAYYIAPEVL  200 (484)
T ss_dssp             CCCS--HHHHTTGGGTCCHHHH
T ss_pred             cccc--cccCCCCccccCceee
Confidence            4432  2335799999999963

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.94  E-value=1.7e-27  Score=252.77  Aligned_cols=171  Identities=26%  Similarity=0.409  Sum_probs=144.7

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      ..++|++.+.||+|+||.||+|.+.. ++.||+|++........+.+.+|+++++.++||||+++++++..++..|+|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            35789999999999999999999864 88999999877666666889999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      |+++++|.+++......+++..+..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||++........ 
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  172 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ-  172 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH-
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc-
Confidence            99999999998875557999999999999999999999   99999999999999999999999999999764321111 


Q ss_pred             ccccccccccccCCCC
Q 003301          816 KQTLTLATIGYMAPGL  831 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~  831 (832)
                      ......||+.|+|||+
T Consensus       173 ~~~~~~~~~~y~aPE~  188 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEV  188 (302)
T ss_dssp             C-----CCGGGCCHHH
T ss_pred             ccccccCChhhcCCee
Confidence            1223469999999996

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.94  E-value=8e-27  Score=245.11  Aligned_cols=167  Identities=27%  Similarity=0.453  Sum_probs=147.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.+.||+|+||.||+|.+.. ++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            3679999999999999999998864 7889999987543   22346788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+++++|.+++...+ .+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||.+.......
T Consensus        93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR  168 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred             EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence            99999999999998654 6899999999999999999999   9999999999999999999999999999997654322


Q ss_pred             ccccccccccccccCCCC
Q 003301          814 SMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~  831 (832)
                         .....||+.|+|||+
T Consensus       169 ---~~~~~~~~~y~aPE~  183 (284)
T 2vgo_A          169 ---RRTMCGTLDYLPPEM  183 (284)
T ss_dssp             ---BCCCCSCGGGCCHHH
T ss_pred             ---cccccCCCCcCCHHH
Confidence               223569999999996

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.94  E-value=2.5e-27  Score=254.47  Aligned_cols=170  Identities=27%  Similarity=0.439  Sum_probs=137.6

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch--hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      ...++|++.+.||+|+||+||+|.+. +++.||||++.....  ...+.+.+|++++++++||||+++++++.+++..|+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            34678999999999999999999875 589999999865432  234567789999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe-----CCCCcEEEecccccc
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL-----DKDMVAHLSDFGIAK  807 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~-----~~~~~~kl~DFg~a~  807 (832)
                      ||||++ |+|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||++     +.++.+||+|||.|+
T Consensus       111 v~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          111 IFEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EEECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EEecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            999996 59999998765 6899999999999999999999   9999999999999999     455569999999998


Q ss_pred             ccCCCcccccccccccccccCCCC
Q 003301          808 LLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       808 ~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      ....... .....+||+.|+|||+
T Consensus       186 ~~~~~~~-~~~~~~~t~~y~aPE~  208 (329)
T 3gbz_A          186 AFGIPIR-QFTHEIITLWYRPPEI  208 (329)
T ss_dssp             HHC------------CCTTCCHHH
T ss_pred             ccCCccc-ccCCCcCCccccCHHH
Confidence            7653322 2233568999999996

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.94  E-value=7.1e-27  Score=243.65  Aligned_cols=165  Identities=22%  Similarity=0.416  Sum_probs=145.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecC--CeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNN--DFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  733 (832)
                      .++|++.+.||+|+||.||+|++ +++.||||++....  ....+.+.+|++++++++||||+++++++.+.  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            46799999999999999999998 58999999997653  33456789999999999999999999999877  788999


Q ss_pred             EecCCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          734 LEYMPNGSLEDYLYSNNF-SFDILQRLSVIIDVALALEYLHFGYSNP--VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      |||+++|+|.+++..... .+++..+..++.|++.|++|||   +.+  ++||||||+||+++.++.++++|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999987543 4899999999999999999999   889  9999999999999999999999999876532


Q ss_pred             CCcccccccccccccccCCCCC
Q 003301          811 GEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       811 ~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ..      ...||+.|+|||++
T Consensus       165 ~~------~~~~t~~y~aPE~~  180 (271)
T 3kmu_A          165 SP------GRMYAPAWVAPEAL  180 (271)
T ss_dssp             CT------TCBSCGGGSCHHHH
T ss_pred             cc------CccCCccccChhhh
Confidence            22      24689999999963

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.94  E-value=1.5e-27  Score=255.55  Aligned_cols=178  Identities=24%  Similarity=0.378  Sum_probs=149.8

Q ss_pred             hHHHHHHhcCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceE
Q 003301          651 YKELLQATNQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISS  723 (832)
Q Consensus       651 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~  723 (832)
                      .+++....++|++.+.||+|+||.||+|.+.      .++.||+|++.... ......+.+|++++++++||||++++++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            3444455688999999999999999999765      36789999987543 2344578899999999999999999999


Q ss_pred             EecCCeeEEEEecCCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC
Q 003301          724 CTNNDFKALVLEYMPNGSLEDYLYSNN---------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK  794 (832)
Q Consensus       724 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~  794 (832)
                      +.+.+..|+||||+++|+|.+++...+         ..+++..+..++.|++.||+|||   ++||+||||||+||+++.
T Consensus        97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~  173 (322)
T 1p4o_A           97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAE  173 (322)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECT
T ss_pred             EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcC
Confidence            999999999999999999999987522         34689999999999999999999   999999999999999999


Q ss_pred             CCcEEEeccccccccCCCccc-ccccccccccccCCCC
Q 003301          795 DMVAHLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGL  831 (832)
Q Consensus       795 ~~~~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~  831 (832)
                      ++.+||+|||+++........ ......||+.|+|||+
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  211 (322)
T 1p4o_A          174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES  211 (322)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHH
T ss_pred             CCeEEECcCccccccccccccccccCCCCCCCccChhh
Confidence            999999999999865433221 2223457899999996

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=5.1e-27  Score=255.57  Aligned_cols=164  Identities=25%  Similarity=0.373  Sum_probs=137.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC------
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNND------  728 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  728 (832)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++....  ....+++.+|+++++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            478999999999999999999885 58999999986432  334567889999999999999999999997653      


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          729 FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      ..|+||||+ +++|.++++..  .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|+.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            469999999 88999999874  5899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCcccccccccccccccCCCC
Q 003301          809 LSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       809 ~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      ....    ....+||+.|+|||+
T Consensus       178 ~~~~----~~~~~~t~~y~aPE~  196 (367)
T 1cm8_A          178 ADSE----MTGYVVTRWYRAPEV  196 (367)
T ss_dssp             CCSS----CCSSCSCGGGCCTHH
T ss_pred             cccc----cCcCcCCCCcCCHHH
Confidence            6432    233579999999996

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.94  E-value=3e-27  Score=257.59  Aligned_cols=171  Identities=20%  Similarity=0.269  Sum_probs=140.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC------CcEEEEEEEeccchhh-----------HHHHHHHHHHHhcCCCCceeee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD------GMEVAIKVFHLQLEGA-----------LKSFDVECEVLKSVRHRNLVKI  720 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~l  720 (832)
                      .++|++.+.||+|+||.||+|.+..      ++.||||++.......           ......|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4689999999999999999998864      4789999987553211           1233456667788899999999


Q ss_pred             ceEEecC----CeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeC--C
Q 003301          721 ISSCTNN----DFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD--K  794 (832)
Q Consensus       721 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~--~  794 (832)
                      ++++...    ...|+||||+ +++|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++  .
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCC
Confidence            9998764    4589999999 99999999887667999999999999999999999   99999999999999998  8


Q ss_pred             CCcEEEeccccccccCCCccc------ccccccccccccCCCCC
Q 003301          795 DMVAHLSDFGIAKLLSGEESM------KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       795 ~~~~kl~DFg~a~~~~~~~~~------~~~~~~gt~~y~APE~l  832 (832)
                      ++.+||+|||+|+.+......      .....+||+.|||||++
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  233 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAH  233 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHh
Confidence            899999999999876433211      11234599999999963

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.94  E-value=6.2e-27  Score=253.79  Aligned_cols=168  Identities=26%  Similarity=0.396  Sum_probs=148.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhh-----------------HHHHHHHHHHHhcCCCCceeee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGA-----------------LKSFDVECEVLKSVRHRNLVKI  720 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~l  720 (832)
                      .++|++.+.||+|+||.||+|.+ +++.||||++.......                 .+.+.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            47899999999999999999999 99999999987543211                 1788999999999999999999


Q ss_pred             ceEEecCCeeEEEEecCCCCCHHHH------HhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeEe
Q 003301          721 ISSCTNNDFKALVLEYMPNGSLEDY------LYSN-NFSFDILQRLSVIIDVALALEYLHFGYS-NPVVHCDIKPSNVLL  792 (832)
Q Consensus       721 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~  792 (832)
                      ++++.+.+..|+||||+++++|.++      +... ...+++..+..++.|++.|++|||   + .||+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence            9999999999999999999999998      6542 346999999999999999999999   8 999999999999999


Q ss_pred             CCCCcEEEeccccccccCCCcccccccccccccccCCCCC
Q 003301          793 DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       793 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +.++.+||+|||.+......   ......||+.|+|||++
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~  222 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFF  222 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGG
T ss_pred             cCCCcEEEeccccccccccc---cccCCCCCcCccCchhh
Confidence            99999999999999876433   22335699999999974

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.94  E-value=6e-27  Score=247.96  Aligned_cols=171  Identities=26%  Similarity=0.470  Sum_probs=143.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC----CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEe-cCCeeE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD----GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCT-NNDFKA  731 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~  731 (832)
                      ..+|++.+.||+|+||.||+|.+.+    ...||+|.+.... ....+.+.+|++++++++||||+++++++. .++..|
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            4578899999999999999998653    2358999887543 344577899999999999999999999864 566889


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +||||+++|+|.++++.....+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||.|+....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            999999999999999876667899999999999999999999   99999999999999999999999999999987654


Q ss_pred             Cccc---ccccccccccccCCCC
Q 003301          812 EESM---KQTLTLATIGYMAPGL  831 (832)
Q Consensus       812 ~~~~---~~~~~~gt~~y~APE~  831 (832)
                      ....   ......||+.|+|||+
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~  203 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALES  203 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHH
T ss_pred             cchhccccccCCCCCccccChHH
Confidence            3321   2233457889999996

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.94  E-value=3e-27  Score=253.58  Aligned_cols=170  Identities=29%  Similarity=0.468  Sum_probs=139.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcE----EEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GME----VAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  731 (832)
                      .++|++.+.||+|+||+||+|++.. ++.    ||+|.+.... ....+.+.+|++++++++||||+++++++.+.. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            3679999999999999999998753 443    5777765332 334578899999999999999999999998765 78


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +|+||+++|+|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+....
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            999999999999999887778999999999999999999999   99999999999999999999999999999987654


Q ss_pred             Cccc-ccccccccccccCCCC
Q 003301          812 EESM-KQTLTLATIGYMAPGL  831 (832)
Q Consensus       812 ~~~~-~~~~~~gt~~y~APE~  831 (832)
                      .... ......||+.|+|||+
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~  190 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALES  190 (327)
T ss_dssp             TCC-------CCCGGGSCHHH
T ss_pred             CcccccccCCCccccccChHH
Confidence            3322 2223457889999996

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=7.3e-27  Score=245.82  Aligned_cols=170  Identities=25%  Similarity=0.455  Sum_probs=145.0

Q ss_pred             hcCCCCCC-eeeccCCceEEEEEec---CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          658 TNQFNASN-LIGTGGFGSVYKGSFL---DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       658 ~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      .++|.+.+ .||+|+||.||+|.+.   ++..||||+++... ....+.+.+|++++++++||||+++++++ ..+..|+
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            35566666 9999999999999864   47889999997643 34457889999999999999999999999 4556899


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||||+++++|.+++......+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||.++.....
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            99999999999999876667999999999999999999999   999999999999999999999999999999877543


Q ss_pred             cccc--cccccccccccCCCC
Q 003301          813 ESMK--QTLTLATIGYMAPGL  831 (832)
Q Consensus       813 ~~~~--~~~~~gt~~y~APE~  831 (832)
                      ....  .....||+.|+|||+
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~  184 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPEC  184 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHH
T ss_pred             cceeeccccccccccccCHHH
Confidence            3221  222357899999996

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.94  E-value=8.8e-27  Score=244.68  Aligned_cols=168  Identities=25%  Similarity=0.403  Sum_probs=144.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch------hhHHHHHHHHHHHhcCCCCceeeeceEEecCCee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE------GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  730 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.....      ...+.+.+|++++++++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            357999999999999999999986 589999999875431      1357889999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC----cEEEeccccc
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM----VAHLSDFGIA  806 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~----~~kl~DFg~a  806 (832)
                      |+||||+++++|.+++.... .+++..+..++.|++.|++|||   +.|++||||||+||+++.++    .+||+|||.+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            99999999999999997643 6899999999999999999999   99999999999999998877    8999999999


Q ss_pred             cccCCCcccccccccccccccCCCC
Q 003301          807 KLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       807 ~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      ........  .....||+.|+|||+
T Consensus       160 ~~~~~~~~--~~~~~~~~~y~aPE~  182 (283)
T 3bhy_A          160 HKIEAGNE--FKNIFGTPEFVAPEI  182 (283)
T ss_dssp             EECC----------CCCGGGCCHHH
T ss_pred             eeccCCCc--ccccCCCcCccCcce
Confidence            87644332  233569999999996

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.94  E-value=3.8e-27  Score=248.20  Aligned_cols=168  Identities=28%  Similarity=0.484  Sum_probs=134.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .++|++.+.||+|+||.||+|++.  ..||+|+++...  ....+.+.+|++++++++||||+++++++ ..+..++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            578999999999999999999863  369999987543  33457789999999999999999999965 4556899999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc-c
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE-S  814 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~-~  814 (832)
                      |+++++|.+++......+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|+...... .
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  176 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS  176 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence            99999999999877667999999999999999999999   9999999999999999999999999999998654322 1


Q ss_pred             cccccccccccccCCCC
Q 003301          815 MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~  831 (832)
                      .......||+.|+|||+
T Consensus       177 ~~~~~~~gt~~y~aPE~  193 (289)
T 3og7_A          177 HQFEQLSGSILWMAPEV  193 (289)
T ss_dssp             -------CCCTTCCHHH
T ss_pred             ccccccCCCccccCchh
Confidence            22233569999999996

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.94  E-value=2.9e-27  Score=252.64  Aligned_cols=181  Identities=22%  Similarity=0.403  Sum_probs=151.3

Q ss_pred             ccchHHHHHHhcCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceee
Q 003301          648 RFSYKELLQATNQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVK  719 (832)
Q Consensus       648 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~  719 (832)
                      .+...++....++|++.+.||+|+||.||+|.+.      +++.||||++.... ....+.+.+|+++++++ +||||++
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            3455555556789999999999999999999752      46889999997653 23446788999999999 7999999


Q ss_pred             eceEEecCC-eeEEEEecCCCCCHHHHHhhCCCC---------------CCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 003301          720 IISSCTNND-FKALVLEYMPNGSLEDYLYSNNFS---------------FDILQRLSVIIDVALALEYLHFGYSNPVVHC  783 (832)
Q Consensus       720 l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~  783 (832)
                      +++++...+ ..|+||||+++++|.+++......               +++..+..++.|++.|++|||   +.||+||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence            999987654 589999999999999999875432               789999999999999999999   9999999


Q ss_pred             CCCCCCeEeCCCCcEEEeccccccccCCCcc-cccccccccccccCCCC
Q 003301          784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEES-MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       784 Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~-~~~~~~~gt~~y~APE~  831 (832)
                      ||||+||+++.++.+||+|||.|+....... .......||+.|+|||+
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~  221 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET  221 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHH
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchh
Confidence            9999999999999999999999987644332 22233568899999996

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.94  E-value=6.5e-27  Score=252.25  Aligned_cols=166  Identities=34%  Similarity=0.547  Sum_probs=136.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHH--HhcCCCCceeeeceEEec-----CCee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEV--LKSVRHRNLVKIISSCTN-----NDFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~-----~~~~  730 (832)
                      .++|++.+.||+|+||.||+|++ +++.||||++.....   ..+..|.++  +..++||||+++++++..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            57899999999999999999987 789999999875432   334444444  455899999999985532     3367


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------CeEecCCCCCCeEeCCCCcEEEe
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN---------PVVHCDIKPSNVLLDKDMVAHLS  801 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~---------~ivH~Dlkp~NIl~~~~~~~kl~  801 (832)
                      |+||||+++|+|.++++...  .++..+..++.|++.||+|||   +.         ||+||||||+||+++.++.+||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            89999999999999998764  588999999999999999999   88         99999999999999999999999


Q ss_pred             ccccccccCCCcc-------cccccccccccccCCCCC
Q 003301          802 DFGIAKLLSGEES-------MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       802 DFg~a~~~~~~~~-------~~~~~~~gt~~y~APE~l  832 (832)
                      |||+|+.......       ......+||+.|+|||++
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  200 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVL  200 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHH
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhh
Confidence            9999987643221       112234699999999963

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.94  E-value=1.6e-26  Score=247.02  Aligned_cols=166  Identities=27%  Similarity=0.458  Sum_probs=142.9

Q ss_pred             CCCCCeeeccCCceEEEEEec-----CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEec--CCeeEE
Q 003301          661 FNASNLIGTGGFGSVYKGSFL-----DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTN--NDFKAL  732 (832)
Q Consensus       661 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l  732 (832)
                      |++.+.||+|+||.||+|.+.     +++.||||++.... ....+.+.+|++++++++||||+++++++.+  ....|+
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            489999999999999988653     57889999997654 3445778999999999999999999999987  467899


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||||+++++|.+++....  +++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||.|+.....
T Consensus       113 v~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            999999999999998754  899999999999999999999   999999999999999999999999999999887544


Q ss_pred             ccc--ccccccccccccCCCC
Q 003301          813 ESM--KQTLTLATIGYMAPGL  831 (832)
Q Consensus       813 ~~~--~~~~~~gt~~y~APE~  831 (832)
                      ...  ......||+.|+|||+
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~  208 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPEC  208 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHH
T ss_pred             ccccccccCCCCCceeeChHH
Confidence            321  1233458889999996

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.94  E-value=1.5e-26  Score=245.54  Aligned_cols=168  Identities=31%  Similarity=0.448  Sum_probs=148.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .+.|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            467999999999999999999875 58999999997554 3445788999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      |+++++|.+++...  .+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||.+........ 
T Consensus       101 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  174 (303)
T 3a7i_A          101 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  174 (303)
T ss_dssp             CCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred             eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence            99999999999753  5899999999999999999999   99999999999999999999999999999987654332 


Q ss_pred             ccccccccccccCCCC
Q 003301          816 KQTLTLATIGYMAPGL  831 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~  831 (832)
                      ......||+.|+|||+
T Consensus       175 ~~~~~~~~~~y~aPE~  190 (303)
T 3a7i_A          175 KRNTFVGTPFWMAPEV  190 (303)
T ss_dssp             CBCCCCSCGGGCCHHH
T ss_pred             ccCccCCCcCccCHHH
Confidence            2233569999999996

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=7.5e-27  Score=251.06  Aligned_cols=171  Identities=26%  Similarity=0.485  Sum_probs=140.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-----CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-----GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  731 (832)
                      .++|++.+.||+|+||.||+|.+..     +..||||+++... ......+.+|++++++++||||+++++++...+..|
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            3577888999999999999998753     2459999987543 334567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +||||+++++|.+++......+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||.++....
T Consensus       123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            999999999999999887667999999999999999999999   99999999999999999999999999999987654


Q ss_pred             Cccc--ccccccccccccCCCC
Q 003301          812 EESM--KQTLTLATIGYMAPGL  831 (832)
Q Consensus       812 ~~~~--~~~~~~gt~~y~APE~  831 (832)
                      ....  ......+|+.|+|||+
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~  221 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEA  221 (333)
T ss_dssp             -----------CCCGGGSCHHH
T ss_pred             ccccccccCCCCccccccCchh
Confidence            3221  1122346889999996

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.94  E-value=6.2e-27  Score=251.72  Aligned_cols=169  Identities=31%  Similarity=0.442  Sum_probs=141.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccch--hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      .++|++.+.||+|+||.||+|.+.. ++.||||++.....  ...+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            4789999999999999999999865 89999999865432  33456789999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||++++++.++..... .+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||.++.......
T Consensus       104 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  179 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  179 (331)
T ss_dssp             ECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             ecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence            9999988888765443 6999999999999999999999   99999999999999999999999999999987644332


Q ss_pred             cccccccccccccCCCC
Q 003301          815 MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~  831 (832)
                       ......||+.|+|||+
T Consensus       180 -~~~~~~~t~~y~aPE~  195 (331)
T 4aaa_A          180 -VYDDEVATRWYRAPEL  195 (331)
T ss_dssp             -----CCCCCTTCCHHH
T ss_pred             -ccCCCcCCccccCccc
Confidence             2233569999999996

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.94  E-value=2.3e-26  Score=242.34  Aligned_cols=167  Identities=27%  Similarity=0.409  Sum_probs=143.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEec----CCeeE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTN----NDFKA  731 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~  731 (832)
                      ..|++.+.||+|+||.||+|.+. ++..||+|++....  ....+.+.+|++++++++||||+++++++..    ....|
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            45788899999999999999886 47889999987543  3445778899999999999999999998865    45689


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeEeC-CCCcEEEeccccccc
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP--VVHCDIKPSNVLLD-KDMVAHLSDFGIAKL  808 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~-~~~~~kl~DFg~a~~  808 (832)
                      +||||+++++|.+++.... .+++..+..++.|++.|++|||   +.+  |+||||||+||+++ .++.+||+|||+|..
T Consensus       106 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            9999999999999998653 6899999999999999999999   888  99999999999997 789999999999976


Q ss_pred             cCCCcccccccccccccccCCCCC
Q 003301          809 LSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       809 ~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .....   .....||+.|+|||++
T Consensus       182 ~~~~~---~~~~~~t~~y~aPE~~  202 (290)
T 1t4h_A          182 KRASF---AKAVIGTPEFMAPEMY  202 (290)
T ss_dssp             CCTTS---BEESCSSCCCCCGGGG
T ss_pred             ccccc---cccccCCcCcCCHHHH
Confidence            54332   2235699999999974

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.94  E-value=1.3e-26  Score=245.27  Aligned_cols=169  Identities=26%  Similarity=0.396  Sum_probs=148.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---------hhhHHHHHHHHHHHhcCC-CCceeeeceEEe
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---------EGALKSFDVECEVLKSVR-HRNLVKIISSCT  725 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~  725 (832)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++....         ....+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4578999999999999999999986 48999999997542         123467789999999995 999999999999


Q ss_pred             cCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccc
Q 003301          726 NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGI  805 (832)
Q Consensus       726 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~  805 (832)
                      .++..|+||||+++++|.+++.... .+++..+..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||.
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            9999999999999999999998653 6899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCCCC
Q 003301          806 AKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       806 a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      +........  .....||+.|+|||+
T Consensus       171 ~~~~~~~~~--~~~~~~~~~y~aPE~  194 (298)
T 1phk_A          171 SCQLDPGEK--LREVCGTPSYLAPEI  194 (298)
T ss_dssp             CEECCTTCC--BCCCCSCGGGCCHHH
T ss_pred             hhhcCCCcc--cccccCCccccCHHH
Confidence            987654332  233569999999996

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.94  E-value=2e-26  Score=243.48  Aligned_cols=169  Identities=30%  Similarity=0.439  Sum_probs=143.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      ++|.....||+|+||.||+|.+. +++.||||++........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            34556679999999999999975 48899999998766556678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC-CCcEEEeccccccccCCCcc
Q 003301          738 PNGSLEDYLYSNNF--SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK-DMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       738 ~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ++++|.+++.....  .+++..+..++.|++.|++|||   +.|++||||||+||+++. ++.+||+|||.++.......
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            99999999986532  4678899999999999999999   999999999999999987 89999999999987654322


Q ss_pred             cccccccccccccCCCC
Q 003301          815 MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~  831 (832)
                      . .....||+.|+|||+
T Consensus       179 ~-~~~~~~~~~y~aPE~  194 (295)
T 2clq_A          179 C-TETFTGTLQYMAPEI  194 (295)
T ss_dssp             ---CCCCCCGGGCCHHH
T ss_pred             c-ccccCCCccccChhh
Confidence            1 223569999999996

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.94  E-value=4.9e-27  Score=255.75  Aligned_cols=167  Identities=26%  Similarity=0.375  Sum_probs=146.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            467999999999999999999986 58999999987653 3445788999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN-PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |+++++|.+++...+ .+++..+..++.|++.|++|||   +. ||+||||||+||+++.++.+||+|||+|+.....  
T Consensus       112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            999999999998754 6899999999999999999999   75 9999999999999999999999999999765222  


Q ss_pred             cccccccccccccCCCC
Q 003301          815 MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~  831 (832)
                       ......||+.|+|||+
T Consensus       186 -~~~~~~gt~~y~aPE~  201 (360)
T 3eqc_A          186 -MANSFVGTRSYMSPER  201 (360)
T ss_dssp             -C----CCCCTTCCHHH
T ss_pred             -cccCCCCCCCeECHHH
Confidence             1223569999999996

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.94  E-value=5.8e-27  Score=244.40  Aligned_cols=165  Identities=24%  Similarity=0.474  Sum_probs=133.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccc----hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL----EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.+.||+|+||.||+|.+ .++.||||++....    ....+.+.+|+++++.++||||+++++++.+++..|+|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            46899999999999999999998 58999999986543    22346788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---eEecCCCCCCeEeCC--------CCcEEEec
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP---VVHCDIKPSNVLLDK--------DMVAHLSD  802 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~---ivH~Dlkp~NIl~~~--------~~~~kl~D  802 (832)
                      |||+++++|.+++...  .+++..+..++.|++.|++|||   ++|   |+||||||+||+++.        ++.+||+|
T Consensus        85 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            9999999999999643  5899999999999999999999   888   999999999999986        77899999


Q ss_pred             cccccccCCCcccccccccccccccCCCC
Q 003301          803 FGIAKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       803 Fg~a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      ||.++.......   ....||+.|+|||+
T Consensus       160 fg~~~~~~~~~~---~~~~~~~~y~aPE~  185 (271)
T 3dtc_A          160 FGLAREWHRTTK---MSAAGAYAWMAPEV  185 (271)
T ss_dssp             CCC----------------CCGGGSCHHH
T ss_pred             CCcccccccccc---cCCCCccceeCHHH
Confidence            999987644322   23469999999996

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.94  E-value=1.2e-26  Score=247.71  Aligned_cols=169  Identities=30%  Similarity=0.422  Sum_probs=143.9

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      ..++|++.+.||+|+||.||+|.+.. |+.||+|++....  ..+.+.+|++++++++||||+++++++...+..|+|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            45789999999999999999998864 8999999987543  34678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      |+++++|.+++......+++..+..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||.+........ 
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-  180 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-  180 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence            99999999999755557999999999999999999999   99999999999999999999999999999987644322 


Q ss_pred             ccccccccccccCCCC
Q 003301          816 KQTLTLATIGYMAPGL  831 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~  831 (832)
                      ......||+.|+|||+
T Consensus       181 ~~~~~~~~~~y~aPE~  196 (314)
T 3com_A          181 KRNTVIGTPFWMAPEV  196 (314)
T ss_dssp             CBCCCCSCGGGCCHHH
T ss_pred             ccCccCCCCCccChhh
Confidence            2233569999999996

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.94  E-value=2.6e-27  Score=255.03  Aligned_cols=174  Identities=24%  Similarity=0.411  Sum_probs=147.2

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEecC------CcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEec
Q 003301          655 LQATNQFNASNLIGTGGFGSVYKGSFLD------GMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTN  726 (832)
Q Consensus       655 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  726 (832)
                      ....++|++.+.||+|+||.||+|.+..      ...||+|++.... ....+.+.+|+++++++ +||||+++++++..
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            3446789999999999999999998753      2479999987553 33456788999999999 89999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeC
Q 003301          727 NDFKALVLEYMPNGSLEDYLYSN-------------NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD  793 (832)
Q Consensus       727 ~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~  793 (832)
                      .+..|+||||+++|+|.+++...             ...+++..+..++.|++.||+|||   +.||+||||||+||+++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEEC
Confidence            99999999999999999998753             235789999999999999999999   99999999999999999


Q ss_pred             CCCcEEEeccccccccCCCccc-ccccccccccccCCCC
Q 003301          794 KDMVAHLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGL  831 (832)
Q Consensus       794 ~~~~~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~  831 (832)
                      .++.+||+|||+|+........ ......||+.|+|||+
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  237 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPES  237 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHH
Confidence            9999999999999865433221 2223457889999995

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.94  E-value=3e-27  Score=270.18  Aligned_cols=171  Identities=26%  Similarity=0.454  Sum_probs=147.3

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      ...++|++.+.||+|+||.||+|.+.++..||||+++.... ..+.+.+|++++++++||||+++++++.+ +..|+|||
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            34577899999999999999999998888899999976542 34688999999999999999999999876 67899999


Q ss_pred             cCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          736 YMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       736 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |+++|+|.++++.. ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.......
T Consensus       342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred             hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence            99999999999753 235899999999999999999999   99999999999999999999999999999987654332


Q ss_pred             cccccccccccccCCCC
Q 003301          815 MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~  831 (832)
                      .......++..|+|||+
T Consensus       419 ~~~~~~~~~~~y~aPE~  435 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEA  435 (535)
T ss_dssp             HTTCSTTSCGGGSCHHH
T ss_pred             ecccCCcCcccccCHHH
Confidence            22233457889999996

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.94  E-value=1e-26  Score=247.57  Aligned_cols=171  Identities=28%  Similarity=0.419  Sum_probs=137.0

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEecc---chhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQ---LEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++...   .....+.+.+|++++++++||||+++++++..++..|+
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            3568999999999999999999875 5899999999753   23445678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          733 VLEYMPNGSLEDYLYS---NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      ||||+++++|.+++..   ....+++..+..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||+++..
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999999864   3446899999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCcccccccccccccccCCCC
Q 003301          810 SGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       810 ~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      ..... ......||+.|+|||+
T Consensus       187 ~~~~~-~~~~~~~~~~y~aPE~  207 (310)
T 2wqm_A          187 SSKTT-AAHSLVGTPYYMSPER  207 (310)
T ss_dssp             -------------CCSSCCHHH
T ss_pred             cCCCc-cccccCCCeeEeChHH
Confidence            44332 2223469999999995

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=4.7e-27  Score=255.91  Aligned_cols=170  Identities=25%  Similarity=0.456  Sum_probs=134.2

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC----CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEec-CCeeEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD----GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTN-NDFKAL  732 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~l  732 (832)
                      ..|++.+.||+|+||.||+|++.+    +..||+|.+.... ....+.+.+|+.++++++||||+++++++.. ++..|+
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            356778999999999999998743    2458999886433 3455788999999999999999999998754 567899


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||||+++|+|.++++.....+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.....
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            99999999999999877667899999999999999999999   999999999999999999999999999999876433


Q ss_pred             ccc---ccccccccccccCCCC
Q 003301          813 ESM---KQTLTLATIGYMAPGL  831 (832)
Q Consensus       813 ~~~---~~~~~~gt~~y~APE~  831 (832)
                      ...   ......+|+.|+|||+
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~  267 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALES  267 (373)
T ss_dssp             ------------CCGGGSCHHH
T ss_pred             ccccccccCCCCCcccccChHH
Confidence            211   1223457889999996

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.93  E-value=3.9e-27  Score=252.53  Aligned_cols=170  Identities=25%  Similarity=0.413  Sum_probs=140.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcE----EEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GME----VAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  731 (832)
                      .++|++.+.||+|+||+||+|.+.. ++.    ||+|.+.... ....+.+.+|+.++++++||||+++++++.. +..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccE
Confidence            3679999999999999999998754 444    7777765432 2233567789999999999999999999864 5689


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +||||+++|+|.+++...+..+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|+....
T Consensus        91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            999999999999999876557899999999999999999999   99999999999999999999999999999988754


Q ss_pred             Cccc-ccccccccccccCCCC
Q 003301          812 EESM-KQTLTLATIGYMAPGL  831 (832)
Q Consensus       812 ~~~~-~~~~~~gt~~y~APE~  831 (832)
                      .... ......||+.|+|||+
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~  188 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALES  188 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHH
T ss_pred             ccccccccCCCCcccccChHH
Confidence            4322 2233568889999996

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.93  E-value=1.1e-26  Score=243.92  Aligned_cols=166  Identities=26%  Similarity=0.473  Sum_probs=144.0

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEec---------
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN---------  726 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------  726 (832)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++....    +.+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3567999999999999999999986 68999999987553    356789999999999999999998854         


Q ss_pred             -------CCeeEEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcE
Q 003301          727 -------NDFKALVLEYMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVA  798 (832)
Q Consensus       727 -------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~  798 (832)
                             ....|+||||+++++|.+++... ...+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCE
Confidence                   34579999999999999999754 246899999999999999999999   9999999999999999999999


Q ss_pred             EEeccccccccCCCcccccccccccccccCCCC
Q 003301          799 HLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       799 kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      ||+|||.+........  .....||+.|+|||+
T Consensus       162 kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~  192 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQ  192 (284)
T ss_dssp             EECCCTTCEESSCCSC--CCCCCSCCTTSCHHH
T ss_pred             EECcchhheecccccc--ccccCCcccccChhh
Confidence            9999999987654332  223469999999996

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.93  E-value=1.9e-26  Score=252.99  Aligned_cols=166  Identities=28%  Similarity=0.430  Sum_probs=137.7

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEec--------
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN--------  726 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  726 (832)
                      ...++|++.+.||+|+||+||+|.+. +|+.||||++.....    ...+|+++++.++||||+++++++..        
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            45678999999999999999999875 589999999875432    23469999999999999999999844        


Q ss_pred             ------------------------------CCeeEEEEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHh
Q 003301          727 ------------------------------NDFKALVLEYMPNGSLEDYLYS---NNFSFDILQRLSVIIDVALALEYLH  773 (832)
Q Consensus       727 ------------------------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH  773 (832)
                                                    ....++||||++ ++|.+.+..   ....+++..+..++.|++.||+|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                          334889999996 588777653   3446999999999999999999999


Q ss_pred             cCCCCCeEecCCCCCCeEeC-CCCcEEEeccccccccCCCcccccccccccccccCCCC
Q 003301          774 FGYSNPVVHCDIKPSNVLLD-KDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       774 ~~~~~~ivH~Dlkp~NIl~~-~~~~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                         +.||+||||||+||+++ .++.+||+|||.|+.......  .....||+.|+|||+
T Consensus       159 ---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~  212 (383)
T 3eb0_A          159 ---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPEL  212 (383)
T ss_dssp             ---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHH
T ss_pred             ---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHH
Confidence               99999999999999997 689999999999987644432  233568999999995

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=1.6e-26  Score=244.74  Aligned_cols=170  Identities=24%  Similarity=0.396  Sum_probs=143.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC----CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCee-EE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD----GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFK-AL  732 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~l  732 (832)
                      -.|+..+.||+|+||.||+|.+.+    +..||+|++.... ....+.+.+|++++++++||||+++++++.+.+.. ++
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            356677999999999999998653    2369999987543 33457888999999999999999999999876654 99


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||||+.+++|.+++......+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||.|+.....
T Consensus       101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            99999999999999886667999999999999999999999   999999999999999999999999999999866443


Q ss_pred             cc---cccccccccccccCCCC
Q 003301          813 ES---MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       813 ~~---~~~~~~~gt~~y~APE~  831 (832)
                      ..   .......+|+.|+|||+
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~  199 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALES  199 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHH
T ss_pred             cccccccCcCCCCCccccChhh
Confidence            21   12223468899999995

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.93  E-value=3.1e-27  Score=258.72  Aligned_cols=166  Identities=16%  Similarity=0.214  Sum_probs=135.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEecc---chhhHHHHHHHHH---HHhcCCCCceeeec-------eE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQ---LEGALKSFDVECE---VLKSVRHRNLVKII-------SS  723 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~---~l~~l~h~niv~l~-------~~  723 (832)
                      .++|++.+.||+|+||+||+|++. +|+.||||++...   .....+.+.+|++   .+++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            467999999999999999999974 5899999999743   2345578889994   55566899999998       66


Q ss_pred             EecCC-----------------eeEEEEecCCCCCHHHHHhhCCC------CCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 003301          724 CTNND-----------------FKALVLEYMPNGSLEDYLYSNNF------SFDILQRLSVIIDVALALEYLHFGYSNPV  780 (832)
Q Consensus       724 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  780 (832)
                      +.+.+                 ..|+||||+ +|+|.+++...+.      .+++..+..++.|++.||+|||   ++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            65543                 278999999 6899999975421      1235788889999999999999   9999


Q ss_pred             EecCCCCCCeEeCCCCcEEEeccccccccCCCcccccccccccccccCCCCC
Q 003301          781 VHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       781 vH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +||||||+||+++.++.+||+|||+|+....    .....+| +.|+|||++
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~  274 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELE  274 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhh
Confidence            9999999999999999999999999986432    2233567 999999963

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.93  E-value=5.6e-27  Score=251.64  Aligned_cols=177  Identities=28%  Similarity=0.428  Sum_probs=144.9

Q ss_pred             chHHHHHHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcC-CCCceeeeceEEec-
Q 003301          650 SYKELLQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLVKIISSCTN-  726 (832)
Q Consensus       650 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-  726 (832)
                      +..++....++|++.+.||+|+||.||+|++. +++.||||++..... ..+.+.+|+++++++ +||||+++++++.. 
T Consensus        15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            33344456789999999999999999999985 589999999875533 346788999999998 79999999999976 


Q ss_pred             -----CCeeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEE
Q 003301          727 -----NDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHL  800 (832)
Q Consensus       727 -----~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl  800 (832)
                           .+..|+||||+++++|.+++.... ..+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl  170 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKL  170 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEE
Confidence                 468899999999999999998643 35899999999999999999999   999999999999999999999999


Q ss_pred             eccccccccCCCcccccccccccccccCCCC
Q 003301          801 SDFGIAKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       801 ~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      +|||++........ ......||+.|+|||+
T Consensus       171 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~  200 (326)
T 2x7f_A          171 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEV  200 (326)
T ss_dssp             CCCTTTC--------------CCGGGCCHHH
T ss_pred             eeCcCceecCcCcc-ccccccCCccccChhh
Confidence            99999987643322 2233569999999996

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.93  E-value=1.2e-26  Score=248.58  Aligned_cols=167  Identities=29%  Similarity=0.416  Sum_probs=140.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc--------hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL--------EGALKSFDVECEVLKSVRHRNLVKIISSCTNND  728 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  728 (832)
                      .++|++.+.||+|+||.||+|.+.. ++.||||++....        ......+.+|++++++++||||+++++++..++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            4689999999999999999998864 8899999986432        122345788999999999999999999987665


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCc---EEEecccc
Q 003301          729 FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMV---AHLSDFGI  805 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~---~kl~DFg~  805 (832)
                       .|+||||+++++|.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.   +||+|||.
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             -eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence             799999999999999987654 6899999999999999999999   999999999999999987654   99999999


Q ss_pred             ccccCCCcccccccccccccccCCCC
Q 003301          806 AKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       806 a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      ++......  ......||+.|+|||+
T Consensus       164 ~~~~~~~~--~~~~~~gt~~y~aPE~  187 (322)
T 2ycf_A          164 SKILGETS--LMRTLCGTPTYLAPEV  187 (322)
T ss_dssp             CEECCCCH--HHHHHHSCCTTCCHHH
T ss_pred             ceeccccc--ccccccCCcCccCchh
Confidence            98764432  2233569999999996

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.93  E-value=1.3e-26  Score=248.31  Aligned_cols=170  Identities=29%  Similarity=0.468  Sum_probs=137.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcE----EEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GME----VAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  731 (832)
                      .++|++.+.||+|+||.||+|.+.. ++.    ||+|.+.... ....+.+.+|++++++++||||+++++++..+. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            4689999999999999999998753 444    5667665332 344578899999999999999999999998765 78


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +|+||+++|+|.+++......+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            999999999999999887777999999999999999999999   99999999999999999999999999999987644


Q ss_pred             Cccc-ccccccccccccCCCC
Q 003301          812 EESM-KQTLTLATIGYMAPGL  831 (832)
Q Consensus       812 ~~~~-~~~~~~gt~~y~APE~  831 (832)
                      .... ......||+.|+|||+
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~  190 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALES  190 (327)
T ss_dssp             ----------CCCGGGSCHHH
T ss_pred             ccccccccCCCccccccCHHH
Confidence            3221 2223457889999996

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.93  E-value=2.8e-26  Score=247.40  Aligned_cols=171  Identities=23%  Similarity=0.329  Sum_probs=133.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCC-CCceeeeceEEe--------cC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVR-HRNLVKIISSCT--------NN  727 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~--------~~  727 (832)
                      ..+|++.+.||+|+||.||+|++. +++.||||++........+.+.+|+.+++++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            458999999999999999999976 58999999987666666678899999999996 999999999984        34


Q ss_pred             CeeEEEEecCCCCCHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeEeCCCCcEEEecc
Q 003301          728 DFKALVLEYMPNGSLEDYLYS--NNFSFDILQRLSVIIDVALALEYLHFGYSNP--VVHCDIKPSNVLLDKDMVAHLSDF  803 (832)
Q Consensus       728 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~~~~~~kl~DF  803 (832)
                      ...++||||++ |+|.+++..  ....+++..+..++.|++.||+|||   +.|  |+||||||+||+++.++.+||+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecC
Confidence            45899999995 799998865  3446999999999999999999999   888  999999999999999999999999


Q ss_pred             ccccccCCCccc-----------ccccccccccccCCCCC
Q 003301          804 GIAKLLSGEESM-----------KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       804 g~a~~~~~~~~~-----------~~~~~~gt~~y~APE~l  832 (832)
                      |+++........           ......||+.|+|||++
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~  222 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII  222 (337)
T ss_dssp             TTCBCCSSCC------------------------------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhh
Confidence            999876543221           11134599999999974

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.93  E-value=1.2e-26  Score=246.41  Aligned_cols=165  Identities=30%  Similarity=0.461  Sum_probs=134.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      .++|++.+.||+|+||.||+|++ .++.||||++...  ...+.+.+|++++++++||||+++++++.+  ..|+||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence            36789999999999999999998 5789999998643  345788999999999999999999998874  479999999


Q ss_pred             CCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCc-EEEeccccccccCCCcc
Q 003301          738 PNGSLEDYLYSNNF--SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMV-AHLSDFGIAKLLSGEES  814 (832)
Q Consensus       738 ~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~-~kl~DFg~a~~~~~~~~  814 (832)
                      ++++|.+++.....  .+++..+..++.|++.|++|||..+.+||+||||||+||+++.++. +||+|||.|....... 
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-  160 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-  160 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-
Confidence            99999999986542  3788999999999999999999222289999999999999998886 7999999998654321 


Q ss_pred             cccccccccccccCCCC
Q 003301          815 MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~  831 (832)
                         ....||+.|+|||+
T Consensus       161 ---~~~~gt~~y~aPE~  174 (307)
T 2eva_A          161 ---TNNKGSAAWMAPEV  174 (307)
T ss_dssp             -------CCTTSSCHHH
T ss_pred             ---ccCCCCCceEChhh
Confidence               23469999999996

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.93  E-value=2.4e-26  Score=250.48  Aligned_cols=168  Identities=25%  Similarity=0.321  Sum_probs=144.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecC-----Cee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNN-----DFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  730 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999876 58889999987433 33447788999999999999999999998654     368


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      |+||||++ ++|.++++..  .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||.|+...
T Consensus       106 ~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            99999995 6999999765  4899999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCcccc--cccccccccccCCCC
Q 003301          811 GEESMK--QTLTLATIGYMAPGL  831 (832)
Q Consensus       811 ~~~~~~--~~~~~gt~~y~APE~  831 (832)
                      ......  ....+||+.|+|||+
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~  202 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEI  202 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHH
T ss_pred             CCCCccccccccccccCCCCCHH
Confidence            432211  233579999999995

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.93  E-value=1.9e-26  Score=247.44  Aligned_cols=169  Identities=28%  Similarity=0.498  Sum_probs=141.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcE--EEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GME--VAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~--vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  732 (832)
                      .++|++.+.||+|+||.||+|++.. +..  ||+|.+.... ....+.+.+|+++++++ +||||+++++++.+.+..|+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            3689999999999999999998754 554  4999887532 33456788999999999 89999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCc
Q 003301          733 VLEYMPNGSLEDYLYSNN---------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMV  797 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~  797 (832)
                      ||||+++++|.+++...+               ..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCe
Confidence            999999999999997653               35899999999999999999999   999999999999999999999


Q ss_pred             EEEeccccccccCCCcccccccccccccccCCCC
Q 003301          798 AHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       798 ~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      +||+|||+++......  ......+++.|+|||+
T Consensus       181 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~  212 (327)
T 1fvr_A          181 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIES  212 (327)
T ss_dssp             EEECCTTCEESSCEEC--CC----CCTTTCCHHH
T ss_pred             EEEcccCcCccccccc--cccCCCCCccccChhh
Confidence            9999999997543221  2223457889999996

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.93  E-value=5.7e-27  Score=248.73  Aligned_cols=172  Identities=25%  Similarity=0.390  Sum_probs=130.1

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..|+||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            4578999999999999999999875 58899999886443 234567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhh-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccc
Q 003301          735 EYMPNGSLEDYLYS-------NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK  807 (832)
Q Consensus       735 e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~  807 (832)
                      ||+++++|.+++..       ....+++..+..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||.+.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            99999999999874       2345899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCccc----ccccccccccccCCCC
Q 003301          808 LLSGEESM----KQTLTLATIGYMAPGL  831 (832)
Q Consensus       808 ~~~~~~~~----~~~~~~gt~~y~APE~  831 (832)
                      ........    ......||+.|+|||+
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~  197 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEV  197 (303)
T ss_dssp             HCC---------------CCCTTCCHHH
T ss_pred             eeccCCCccchhhhcccCCCccccCHHH
Confidence            76433211    1223469999999996

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.93  E-value=7.3e-27  Score=267.22  Aligned_cols=159  Identities=20%  Similarity=0.188  Sum_probs=125.3

Q ss_pred             eeeccCCceEEEEEec-CCcEEEEEEEeccc----------hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEE
Q 003301          666 LIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL----------EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       666 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  733 (832)
                      ..+.|+.|.+..++.. .|+.||+|++....          +...+++.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            3556666666655432 48899999997542          23346799999999999 799999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||++|++|.+++++.+ .+++.   +|+.||+.||+|+|   ++|||||||||+|||++.+|.+||+|||+|+......
T Consensus       321 MEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             EecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            99999999999998764 56654   58899999999999   9999999999999999999999999999998775543


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                      .. ....+||+.|||||++
T Consensus       394 ~~-~~t~vGTp~YmAPE~l  411 (569)
T 4azs_A          394 SW-PTNLVQSFFVFVNELF  411 (569)
T ss_dssp             CC-SHHHHHHHHHHHHHHC
T ss_pred             cc-ccCceechhhccHHHh
Confidence            32 3346799999999974

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.93  E-value=1.6e-26  Score=267.97  Aligned_cols=170  Identities=24%  Similarity=0.451  Sum_probs=139.5

Q ss_pred             cCCCCCC-eeeccCCceEEEEEec---CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          659 NQFNASN-LIGTGGFGSVYKGSFL---DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       659 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      +++.+.+ .||+|+||.||+|.+.   ++..||||+++... ....+.+.+|++++++++||||+++++++.. +..|+|
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  413 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV  413 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence            3444444 7999999999999875   35679999987643 3356789999999999999999999999976 568999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+......
T Consensus       414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred             EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence            9999999999999877667999999999999999999999   9999999999999999999999999999998764433


Q ss_pred             ccc--cccccccccccCCCCC
Q 003301          814 SMK--QTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~--~~~~~gt~~y~APE~l  832 (832)
                      ...  .....+|+.|+|||++
T Consensus       491 ~~~~~~~~~~~~~~y~APE~~  511 (613)
T 2ozo_A          491 SYYTARSAGKWPLKWYAPECI  511 (613)
T ss_dssp             -----------CCTTSCHHHH
T ss_pred             ceeeeccCCCCccceeCHhhh
Confidence            221  1223467899999963

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.93  E-value=1.7e-25  Score=234.84  Aligned_cols=206  Identities=25%  Similarity=0.206  Sum_probs=137.8

Q ss_pred             ccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCC
Q 003301          339 IGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLR  418 (832)
Q Consensus       339 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  418 (832)
                      +.++++++++++++|.++. +|..+.  ++++.|+|++|++++..+..|..+++|++|+|++|.+++. +. .+.+++|+
T Consensus         6 ~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~   80 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QV-DGTLPVLG   80 (290)
T ss_dssp             EECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-EC-CSCCTTCC
T ss_pred             ccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cC-CCCCCcCC
Confidence            4455566666666666653 333332  4566666666666655556666666666666666666643 22 25666677


Q ss_pred             eEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeeccccc
Q 003301          419 LLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNG  498 (832)
Q Consensus       419 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  498 (832)
                      .|++++|+++. +|..+..+++|++|++++|++++..|..|..+++|++|+|++|++++..+..|..+++|+.|+|++|+
T Consensus        81 ~L~Ls~N~l~~-l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  159 (290)
T 1p9a_G           81 TLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (290)
T ss_dssp             EEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             EEECCCCcCCc-CchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence            77777776663 45566666777777777777776666667777777777777777776666667777777777777777


Q ss_pred             ccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccC
Q 003301          499 LQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEI  551 (832)
Q Consensus       499 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~  551 (832)
                      |++..+..|..+++|+.|+|++|+|+ .+|..+..+..|+.++|++|+|.|.+
T Consensus       160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c  211 (290)
T 1p9a_G          160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC  211 (290)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence            77655566677777777777777777 56666666777788888888877665

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.93  E-value=1.8e-26  Score=243.27  Aligned_cols=168  Identities=23%  Similarity=0.298  Sum_probs=131.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch--hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++.....  ...+.+.++...++.++||||+++++++.+++..|+||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            478999999999999999999985 589999999875432  22334445555688889999999999999999999999


Q ss_pred             ecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          735 EYMPNGSLEDYLYS---NNFSFDILQRLSVIIDVALALEYLHFGYSN-PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       735 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      ||++ |+|.+++..   ....+++..+..++.|++.|++|||   ++ ||+||||||+||+++.++.+||+|||.|+...
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9996 588887754   4457999999999999999999999   87 99999999999999999999999999998764


Q ss_pred             CCcccccccccccccccCCCC
Q 003301          811 GEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       811 ~~~~~~~~~~~gt~~y~APE~  831 (832)
                      ....  .....||+.|+|||+
T Consensus       162 ~~~~--~~~~~~t~~y~aPE~  180 (290)
T 3fme_A          162 DDVA--KDIDAGCKPYMAPER  180 (290)
T ss_dssp             ----------CCCCCCSCHHH
T ss_pred             cccc--ccccCCCccccChhh
Confidence            4332  223469999999996

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.93  E-value=6.1e-26  Score=236.39  Aligned_cols=180  Identities=28%  Similarity=0.314  Sum_probs=92.5

Q ss_pred             CCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCccccee
Q 003301          365 KLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSL  444 (832)
Q Consensus       365 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  444 (832)
                      .+++|++|++++|++++.  ..+..+++|++|++++|.+++..+..|..+++|++|++++|++++..+..|..+++|++|
T Consensus        61 ~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  138 (272)
T 3rfs_A           61 YLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYL  138 (272)
T ss_dssp             GCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred             cCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEE
Confidence            333444444444444321  133444444444444444444444444444444444444444444444444444555555


Q ss_pred             eecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCccc
Q 003301          445 NFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLS  524 (832)
Q Consensus       445 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  524 (832)
                      ++++|++++..+..++.+++|+.|++++|++++..+..|+++++|+.|+|++|++++..|..|+.+++|+.|+|++|+++
T Consensus       139 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  218 (272)
T 3rfs_A          139 NLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD  218 (272)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             ECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcc
Confidence            55555555444444455555555555555555555555555666666666666666555555566666666666666665


Q ss_pred             ccCchhhhhhccCCeeeCCCCcccccCCC
Q 003301          525 GNIPTSMEKLLYLKDLNLSFNKLEGEIPR  553 (832)
Q Consensus       525 ~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  553 (832)
                      +..|       .|+.++++.|.++|.+|.
T Consensus       219 ~~~~-------~l~~l~~~~n~~~g~ip~  240 (272)
T 3rfs_A          219 CTCP-------GIRYLSEWINKHSGVVRN  240 (272)
T ss_dssp             CCTT-------TTHHHHHHHHHTGGGBBC
T ss_pred             ccCc-------HHHHHHHHHHhCCCcccC
Confidence            4433       355566666666666665

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.93  E-value=4.6e-25  Score=229.55  Aligned_cols=185  Identities=25%  Similarity=0.272  Sum_probs=130.3

Q ss_pred             cccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCC
Q 003301          344 NLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLA  423 (832)
Q Consensus       344 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  423 (832)
                      ++++|++++|++.+..+..|..+++|++|+|++|+++...+..|..+++|++|++++|++++..+..|..+++|++|+++
T Consensus        38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  117 (270)
T 2o6q_A           38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD  117 (270)
T ss_dssp             TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred             CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence            45566666666655555556666666666666666664444445666666666666666665555566666777777777


Q ss_pred             CCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccC
Q 003301          424 SNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSI  503 (832)
Q Consensus       424 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  503 (832)
                      +|.++++.+..|..+++|++|++++|++++..+..|..+++|+.|+|++|++++..+..|.++++|+.|+|++|++++..
T Consensus       118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  197 (270)
T 2o6q_A          118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVP  197 (270)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCC
Confidence            77777666666777777777777777777665666777778888888888887766677888888888888888888766


Q ss_pred             CccccCCCCCCeeccCCCcccccCc
Q 003301          504 PKSIGGLVSLESLDLSNNSLSGNIP  528 (832)
Q Consensus       504 p~~~~~l~~L~~L~Ls~N~l~~~~p  528 (832)
                      +..|..+++|+.|+|++|++....+
T Consensus       198 ~~~~~~l~~L~~L~l~~N~~~c~c~  222 (270)
T 2o6q_A          198 EGAFDSLEKLKMLQLQENPWDCTCN  222 (270)
T ss_dssp             TTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred             HHHhccccCCCEEEecCCCeeCCCc
Confidence            6778888888888888888876544

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.93  E-value=2.4e-26  Score=243.46  Aligned_cols=169  Identities=28%  Similarity=0.451  Sum_probs=144.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      .++|++.+.||+|+||.||+|++. +++.||||++....  ....+.+.+|++++++++||||+++++++..++..|+||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (299)
T 2r3i_A            2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   81 (299)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEE
Confidence            368999999999999999999986 58999999986543  223467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          735 EYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      ||++ ++|.+++.... ..+++..+..++.|++.|++|||   +.|++||||||+||+++.++.+||+|||.+.......
T Consensus        82 e~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  157 (299)
T 2r3i_A           82 EFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  157 (299)
T ss_dssp             ECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             Eccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHeEEcCCCCEEECcchhhhhccCCc
Confidence            9996 69999997653 35899999999999999999999   9999999999999999999999999999998764432


Q ss_pred             ccccccccccccccCCCC
Q 003301          814 SMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~  831 (832)
                      . ......||+.|+|||+
T Consensus       158 ~-~~~~~~~~~~y~aPE~  174 (299)
T 2r3i_A          158 R-TYTHEVVTLWYRAPEI  174 (299)
T ss_dssp             B-CTTSCBCCCTTCCHHH
T ss_pred             c-ccCcccccccccCcHH
Confidence            2 2233468999999996

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.93  E-value=6e-26  Score=245.34  Aligned_cols=171  Identities=27%  Similarity=0.452  Sum_probs=145.5

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhc--CCCCceeeeceEEecCC----
Q 003301          655 LQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKS--VRHRNLVKIISSCTNND----  728 (832)
Q Consensus       655 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----  728 (832)
                      ....++|++.+.||+|+||.||+|++ +++.||||++....   .+.+.+|++++..  ++||||+++++++...+    
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            34567899999999999999999998 69999999986442   3567788888877  78999999999998776    


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCCeEeCCCCcEEEecc
Q 003301          729 FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG-----YSNPVVHCDIKPSNVLLDKDMVAHLSDF  803 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~NIl~~~~~~~kl~DF  803 (832)
                      ..|+||||+++|+|.+++.+.  .+++..+..++.|++.|++|||..     ++.+|+||||||+||+++.++.+||+||
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  191 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  191 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred             eeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence            789999999999999999865  489999999999999999999932     1479999999999999999999999999


Q ss_pred             ccccccCCCccc---ccccccccccccCCCC
Q 003301          804 GIAKLLSGEESM---KQTLTLATIGYMAPGL  831 (832)
Q Consensus       804 g~a~~~~~~~~~---~~~~~~gt~~y~APE~  831 (832)
                      |+|+........   ......||+.|+|||+
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  222 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEV  222 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHH
T ss_pred             CCceeccccccccccccccCCcCcccCCHhh
Confidence            999876443321   1233569999999996

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.93  E-value=1.5e-26  Score=243.99  Aligned_cols=170  Identities=26%  Similarity=0.433  Sum_probs=142.1

Q ss_pred             HhcCCCCCC-eeeccCCceEEEEEec---CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCee
Q 003301          657 ATNQFNASN-LIGTGGFGSVYKGSFL---DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       657 ~~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  730 (832)
                      ..++|++.+ .||+|+||.||+|.+.   .++.||||++....  ....+.+.+|+++++.++||||+++++++ ..+..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            346788888 9999999999999653   36889999987543  23357889999999999999999999999 55678


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      |+||||+++++|.+++...+ .+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||+++...
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            99999999999999998754 6899999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCcccc--cccccccccccCCCC
Q 003301          811 GEESMK--QTLTLATIGYMAPGL  831 (832)
Q Consensus       811 ~~~~~~--~~~~~gt~~y~APE~  831 (832)
                      ......  .....+|+.|+|||+
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~  191 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPEC  191 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHH
T ss_pred             cCCCcccccccCCCCceeeChHH
Confidence            443321  222346789999996

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.93  E-value=2.9e-26  Score=250.33  Aligned_cols=165  Identities=24%  Similarity=0.319  Sum_probs=133.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC------
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNND------  728 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  728 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||||++....  ....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999876 48899999997542  334567889999999999999999999997654      


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          729 FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      ..|+||||++ ++|.+++..   .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+.
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCC-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            7899999996 588888863   4899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCcccccccccccccccCCCC
Q 003301          809 LSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       809 ~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      .....  .....+||+.|+|||+
T Consensus       177 ~~~~~--~~~~~~gt~~y~aPE~  197 (371)
T 2xrw_A          177 AGTSF--MMTPYVVTRYYRAPEV  197 (371)
T ss_dssp             ---------------CTTCCHHH
T ss_pred             ccccc--ccCCceecCCccCHHH
Confidence            64332  2233579999999996

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.93  E-value=2.5e-26  Score=246.42  Aligned_cols=174  Identities=22%  Similarity=0.302  Sum_probs=145.3

Q ss_pred             HHHHHhcCCCCC-CeeeccCCceEEEEEec-CCcEEEEEEEeccch--hhHHHHHHHHHHHhcCC-CCceeeeceEEecC
Q 003301          653 ELLQATNQFNAS-NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE--GALKSFDVECEVLKSVR-HRNLVKIISSCTNN  727 (832)
Q Consensus       653 ~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~  727 (832)
                      ......++|.+. +.||+|+||.||+|.+. +++.||+|++.....  .....+.+|+.+++.+. ||||+++++++.+.
T Consensus        22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~  101 (327)
T 3lm5_A           22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT  101 (327)
T ss_dssp             CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence            334556778877 89999999999999886 489999999875432  33568889999999994 69999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC---CCcEEEecc
Q 003301          728 DFKALVLEYMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK---DMVAHLSDF  803 (832)
Q Consensus       728 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~DF  803 (832)
                      +..|+||||+++|+|.+++... ...+++..+..++.|++.||+|||   ++||+||||||+||+++.   ++.+||+||
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Df  178 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDF  178 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred             CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence            9999999999999999998653 346899999999999999999999   999999999999999987   789999999


Q ss_pred             ccccccCCCcccccccccccccccCCCC
Q 003301          804 GIAKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       804 g~a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      |+|+.......  .....||+.|+|||+
T Consensus       179 g~a~~~~~~~~--~~~~~gt~~y~aPE~  204 (327)
T 3lm5_A          179 GMSRKIGHACE--LREIMGTPEYLAPEI  204 (327)
T ss_dssp             GGCEEC-----------CCCGGGCCHHH
T ss_pred             ccccccCCccc--cccccCCcCccCCee
Confidence            99987644322  233569999999996

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.93  E-value=1e-26  Score=243.57  Aligned_cols=170  Identities=28%  Similarity=0.422  Sum_probs=144.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEe--cCCeeEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCT--NNDFKAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~l  732 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++....  ....+.+.+|++++++++||||+++++++.  ..+..|+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999886 58999999997543  344567899999999999999999999874  4678999


Q ss_pred             EEecCCCCCHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEecCCCCCCeEeCCCCcEEEeccc
Q 003301          733 VLEYMPNGSLEDYLYSN---NFSFDILQRLSVIIDVALALEYLHFGYSNP-----VVHCDIKPSNVLLDKDMVAHLSDFG  804 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~Dlkp~NIl~~~~~~~kl~DFg  804 (832)
                      ||||+++++|.+++...   ...+++..+..++.|++.|++|||   +.+     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999998753   234899999999999999999999   888     9999999999999999999999999


Q ss_pred             cccccCCCcccccccccccccccCCCC
Q 003301          805 IAKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       805 ~a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      .++........ .....||+.|+|||+
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~y~aPE~  187 (279)
T 2w5a_A          162 LARILNHDTSF-AKTFVGTPYYMSPEQ  187 (279)
T ss_dssp             HHHHC---CHH-HHHHHSCCTTCCHHH
T ss_pred             hheeecccccc-ccccCCCccccChHH
Confidence            99876543321 223469999999996

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.93  E-value=1e-26  Score=251.46  Aligned_cols=169  Identities=24%  Similarity=0.258  Sum_probs=137.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec----CCcEEEEEEEeccchh-----------hHHHHHHHHHHHhcCCCCceeeece
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL----DGMEVAIKVFHLQLEG-----------ALKSFDVECEVLKSVRHRNLVKIIS  722 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~  722 (832)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|++......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            367999999999999999999986    4688999998754321           1234667888999999999999999


Q ss_pred             EEec----CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC--
Q 003301          723 SCTN----NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM--  796 (832)
Q Consensus       723 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~--  796 (832)
                      ++..    ....|+||||+ +++|.+++...+ .+++..+..++.|++.||+|||   +.||+||||||+||+++.++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTT
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCC
Confidence            9987    67899999999 999999998765 7999999999999999999999   99999999999999998887  


Q ss_pred             cEEEeccccccccCCCccc------ccccccccccccCCCC
Q 003301          797 VAHLSDFGIAKLLSGEESM------KQTLTLATIGYMAPGL  831 (832)
Q Consensus       797 ~~kl~DFg~a~~~~~~~~~------~~~~~~gt~~y~APE~  831 (832)
                      .+||+|||+|+.+......      ......||+.|+|||+
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  231 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDA  231 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHH
Confidence            9999999999876432211      1133579999999996

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.93  E-value=4.8e-26  Score=244.77  Aligned_cols=162  Identities=21%  Similarity=0.397  Sum_probs=142.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCC-CCceeeeceEEec--CCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVR-HRNLVKIISSCTN--NDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv  733 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||||++....   .+.+.+|++++++++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            378999999999999999999875 58999999987433   367889999999997 9999999999987  6678999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC-cEEEeccccccccCCC
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAKLLSGE  812 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~DFg~a~~~~~~  812 (832)
                      |||+++++|.++++.    +++..+..++.|++.|++|||   ++||+||||||+||+++.++ .+||+|||+|+.....
T Consensus       112 ~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            999999999999853    789999999999999999999   99999999999999999776 8999999999876543


Q ss_pred             cccccccccccccccCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~  831 (832)
                      ..  .....||+.|+|||+
T Consensus       185 ~~--~~~~~~~~~y~aPE~  201 (330)
T 3nsz_A          185 QE--YNVRVASRYFKGPEL  201 (330)
T ss_dssp             CC--CCSCCSCGGGCCHHH
T ss_pred             Cc--cccccccccccChhh
Confidence            32  233569999999996

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.93  E-value=1.2e-26  Score=252.45  Aligned_cols=164  Identities=26%  Similarity=0.386  Sum_probs=125.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecC------C
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNN------D  728 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  728 (832)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++....  ....+.+.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            478999999999999999999875 58999999986532  33456788999999999999999999998654      5


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          729 FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      ..|+||||+ +++|.++++..  .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||+|+.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            679999999 78999998763  5899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCcccccccccccccccCCCC
Q 003301          809 LSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       809 ~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      ....    ....+||+.|+|||+
T Consensus       182 ~~~~----~~~~~~t~~y~aPE~  200 (367)
T 2fst_X          182 TADE----MTGYVATRWYRAPEI  200 (367)
T ss_dssp             -------------CCCTTCCHHH
T ss_pred             cccc----CCCcCcCcCccChHH
Confidence            5432    233579999999996

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.93  E-value=3.6e-26  Score=243.77  Aligned_cols=174  Identities=24%  Similarity=0.485  Sum_probs=135.3

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEecC----CcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC
Q 003301          655 LQATNQFNASNLIGTGGFGSVYKGSFLD----GMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNND  728 (832)
Q Consensus       655 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  728 (832)
                      ....++|++.+.||+|+||.||+|.+..    ++.||+|++....  ....+.+.+|++++++++||||+++++++.+.+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            3345789999999999999999997653    4579999987543  334567889999999999999999999998755


Q ss_pred             -----eeEEEEecCCCCCHHHHHhh-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcE
Q 003301          729 -----FKALVLEYMPNGSLEDYLYS-----NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVA  798 (832)
Q Consensus       729 -----~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~  798 (832)
                           ..|+||||+++++|.+++..     ....+++..++.++.|++.||+|||   ++||+||||||+||+++.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcE
Confidence                 35999999999999999853     2345899999999999999999999   9999999999999999999999


Q ss_pred             EEeccccccccCCCccc-ccccccccccccCCCC
Q 003301          799 HLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGL  831 (832)
Q Consensus       799 kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~  831 (832)
                      ||+|||+++........ ......+++.|+|||+
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  220 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES  220 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHH
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchh
Confidence            99999999876443321 2233457889999996

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.93  E-value=6.6e-26  Score=240.81  Aligned_cols=171  Identities=23%  Similarity=0.369  Sum_probs=142.0

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc----hhhHHHHHHHHHHHhcCCCCceeeeceEEe--cCCe
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL----EGALKSFDVECEVLKSVRHRNLVKIISSCT--NNDF  729 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~  729 (832)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++....    ....+.+.+|++++++++||||+++++++.  +.+.
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            3578999999999999999999985 48899999997543    234578899999999999999999999984  4557


Q ss_pred             eEEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          730 KALVLEYMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      .|+||||++++ +.+++... ...+++..+..++.|++.|++|||   ++||+||||||+||+++.++.+||+|||.+..
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            89999999765 77777653 346899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCc-ccccccccccccccCCCC
Q 003301          809 LSGEE-SMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       809 ~~~~~-~~~~~~~~gt~~y~APE~  831 (832)
                      ..... ........||+.|+|||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~  182 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEI  182 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHH
T ss_pred             cCccccccccccCCCCCCCcChhh
Confidence            64322 112233569999999996

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.93  E-value=2.5e-26  Score=267.89  Aligned_cols=171  Identities=27%  Similarity=0.444  Sum_probs=143.3

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC----CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD----GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  731 (832)
                      ..++|++.+.||+|+||.||+|.+..    +..||+|++.... ....+.+.+|+.++++++||||+++++++. ++..|
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            34779999999999999999998753    4579999876543 334578899999999999999999999985 45689


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +||||+++|+|.++++..+..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||+|+....
T Consensus       467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            999999999999999877667999999999999999999999   99999999999999999999999999999987755


Q ss_pred             CcccccccccccccccCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~  831 (832)
                      ..........+|+.|||||+
T Consensus       544 ~~~~~~~~~~~t~~y~aPE~  563 (656)
T 2j0j_A          544 STYYKASKGKLPIKWMAPES  563 (656)
T ss_dssp             ----------CCGGGCCHHH
T ss_pred             CcceeccCCCCCcceeCHHH
Confidence            44333334567889999996

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.93  E-value=4.5e-26  Score=240.95  Aligned_cols=169  Identities=27%  Similarity=0.452  Sum_probs=139.4

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEE-ecCCeeEEEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC-TNNDFKALVL  734 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~  734 (832)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++......  +.+.+|+++++.++|++++..++++ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            4578999999999999999999974 5899999987654322  4678899999999988776666655 6677889999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe---CCCCcEEEeccccccccCC
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~---~~~~~~kl~DFg~a~~~~~  811 (832)
                      ||+ +++|.+++......+++..+..++.|++.|++|||   ++||+||||||+||++   +.++.+||+|||.|+....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999 99999999876667999999999999999999999   9999999999999999   7889999999999987654


Q ss_pred             Cccc------ccccccccccccCCCC
Q 003301          812 EESM------KQTLTLATIGYMAPGL  831 (832)
Q Consensus       812 ~~~~------~~~~~~gt~~y~APE~  831 (832)
                      ....      ......||+.|+|||+
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~  186 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINT  186 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHH
T ss_pred             cccCccCCCCcccccCCCccccchHH
Confidence            3321      1223579999999996

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.93  E-value=2.2e-26  Score=254.62  Aligned_cols=168  Identities=23%  Similarity=0.328  Sum_probs=127.1

Q ss_pred             cCCCC-CCeeeccCCceEEEEEec---CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEe--cCCeeEE
Q 003301          659 NQFNA-SNLIGTGGFGSVYKGSFL---DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT--NNDFKAL  732 (832)
Q Consensus       659 ~~~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~l  732 (832)
                      +.|++ +++||+|+||+||+|++.   +++.||||++.....  ...+.+|++++++++||||+++++++.  .+...|+
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            45665 568999999999999975   478899999865432  356789999999999999999999995  4678999


Q ss_pred             EEecCCCCCHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe----CCCCcEEE
Q 003301          733 VLEYMPNGSLEDYLYSN--------NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL----DKDMVAHL  800 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~----~~~~~~kl  800 (832)
                      ||||++ ++|.+++...        ...+++..+..++.|++.||+|||   +.||+||||||+||++    +.++.+||
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            999995 6888887531        124899999999999999999999   9999999999999999    67789999


Q ss_pred             eccccccccCCCcc--cccccccccccccCCCCC
Q 003301          801 SDFGIAKLLSGEES--MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       801 ~DFg~a~~~~~~~~--~~~~~~~gt~~y~APE~l  832 (832)
                      +|||+|+.......  ......+||+.|+|||++
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~  207 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL  207 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhh
Confidence            99999987643321  122345799999999963

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.93  E-value=1.9e-25  Score=232.67  Aligned_cols=227  Identities=25%  Similarity=0.265  Sum_probs=183.5

Q ss_pred             CCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEc
Q 003301          295 NLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDL  374 (832)
Q Consensus       295 ~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  374 (832)
                      ++..+++..+.+.+..  ....+. +|+.|++++|.++..  ..+..+++|++|++++|.+.+.  ..+..+++|++|+|
T Consensus        20 ~l~~l~l~~~~~~~~~--~~~~l~-~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L   92 (272)
T 3rfs_A           20 ETIKANLKKKSVTDAV--TQNELN-SIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLIL   92 (272)
T ss_dssp             HHHHHHHTCSCTTSEE--CHHHHT-TCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEEC
T ss_pred             HHHHHHhcCccccccc--cccccc-ceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEEC
Confidence            3444555555554332  233444 788999999888743  3578888999999999988863  37888889999999


Q ss_pred             cCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCC
Q 003301          375 VNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGS  454 (832)
Q Consensus       375 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  454 (832)
                      ++|++++..+..+..+++|++|++++|++++..+..|..+++|++|++++|.+++..+..|..+++|++|++++|++++.
T Consensus        93 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  172 (272)
T 3rfs_A           93 TGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSL  172 (272)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred             CCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCcc
Confidence            99999877777788889999999999999887777788899999999999999888888888889999999999999887


Q ss_pred             CccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhh
Q 003301          455 LPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKL  534 (832)
Q Consensus       455 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  534 (832)
                      .+..++.+++|+.|++++|++++..|..|..+++|+.|+|++|.+.+.       +++|+.|+++.|.++|.+|.+++.+
T Consensus       173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~  245 (272)
T 3rfs_A          173 PEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSV  245 (272)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred             CHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCccccc
Confidence            777788889999999999999888888888899999999999988754       4578888999999999998887765


Q ss_pred             c
Q 003301          535 L  535 (832)
Q Consensus       535 ~  535 (832)
                      .
T Consensus       246 ~  246 (272)
T 3rfs_A          246 A  246 (272)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.93  E-value=5.4e-26  Score=243.25  Aligned_cols=168  Identities=27%  Similarity=0.398  Sum_probs=137.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEe-----------
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCT-----------  725 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-----------  725 (832)
                      .++|++.+.||+|+||.||+|.+.. ++.||+|++........+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            4689999999999999999999875 8999999998776666788999999999999999999999874           


Q ss_pred             ---cCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeC-CCCcEEEe
Q 003301          726 ---NNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD-KDMVAHLS  801 (832)
Q Consensus       726 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-~~~~~kl~  801 (832)
                         +.+..|+||||++ |+|.++++..  .+++..+..++.|++.|++|||   ++||+||||||+||+++ .++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence               3467899999996 6999999753  5899999999999999999999   99999999999999997 56799999


Q ss_pred             ccccccccCCCccc--ccccccccccccCCCC
Q 003301          802 DFGIAKLLSGEESM--KQTLTLATIGYMAPGL  831 (832)
Q Consensus       802 DFg~a~~~~~~~~~--~~~~~~gt~~y~APE~  831 (832)
                      |||.++........  ......+|+.|+|||+
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  195 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRL  195 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHH
T ss_pred             cCccccccCCCcccccccccccccccccCcHH
Confidence            99999876432211  1223457999999995

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.93  E-value=3e-26  Score=245.98  Aligned_cols=171  Identities=27%  Similarity=0.430  Sum_probs=141.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  730 (832)
                      .++|++.+.||+|+||.||+|++.      +++.||||++.... ......+.+|+.++++++||||+++++++...+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            478999999999999999999842      47789999986442 34456788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC---CCcEEEe
Q 003301          731 ALVLEYMPNGSLEDYLYSNN------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK---DMVAHLS  801 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~  801 (832)
                      |+||||+++++|.+++....      ..+++..+..++.|++.|++|||   +.||+||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999998654      34889999999999999999999   999999999999999984   4469999


Q ss_pred             ccccccccCCCcc-cccccccccccccCCCC
Q 003301          802 DFGIAKLLSGEES-MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       802 DFg~a~~~~~~~~-~~~~~~~gt~~y~APE~  831 (832)
                      |||.++....... .......||+.|+|||+
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  216 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEA  216 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhH
Confidence            9999976533221 12223468999999996

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.93  E-value=1.6e-26  Score=241.90  Aligned_cols=164  Identities=34%  Similarity=0.495  Sum_probs=135.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecC-CeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNN-DFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  736 (832)
                      .++|++.+.||+|+||.||+|++ +++.||||++....  ..+.+.+|++++++++||||+++++++.+. +..|+||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            47899999999999999999988 58899999987543  447789999999999999999999987554 478999999


Q ss_pred             CCCCCHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          737 MPNGSLEDYLYSNNF-SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      +++++|.+++..... .+++..+..++.|++.|++|||   ++|++||||||+||+++.++.+||+|||.+.......  
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  171 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  171 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence            999999999976432 2789999999999999999999   9999999999999999999999999999998654322  


Q ss_pred             ccccccccccccCCCC
Q 003301          816 KQTLTLATIGYMAPGL  831 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~  831 (832)
                        ....+++.|+|||+
T Consensus       172 --~~~~~~~~y~aPE~  185 (278)
T 1byg_A          172 --DTGKLPVKWTAPEA  185 (278)
T ss_dssp             ------CCTTTSCHHH
T ss_pred             --cCCCccccccCHHH
Confidence              22357889999996

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.93  E-value=7.6e-26  Score=251.45  Aligned_cols=166  Identities=22%  Similarity=0.349  Sum_probs=142.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcC------CCCceeeeceEEecCCee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSV------RHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~  730 (832)
                      ..+|++.+.||+|+||.||+|.+.. ++.||||++.... ...+.+.+|+++++.+      .|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            4679999999999999999998764 8999999997543 3345677788887776      577999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCc--EEEecccccc
Q 003301          731 ALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMV--AHLSDFGIAK  807 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~--~kl~DFg~a~  807 (832)
                      |+||||++ ++|.+++.... ..+++..+..++.|++.||+|||   +.||+||||||+||+++.++.  +||+|||+|+
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999995 69999988754 34899999999999999999999   999999999999999999987  9999999997


Q ss_pred             ccCCCcccccccccccccccCCCCC
Q 003301          808 LLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       808 ~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .....    ....+||+.|+|||++
T Consensus       251 ~~~~~----~~~~~gt~~y~aPE~~  271 (429)
T 3kvw_A          251 YEHQR----VYTYIQSRFYRAPEVI  271 (429)
T ss_dssp             ETTCC----CCSSCSCGGGCCHHHH
T ss_pred             ecCCc----ccccCCCCCccChHHH
Confidence            65332    2235799999999963

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.93  E-value=2.6e-26  Score=242.10  Aligned_cols=170  Identities=26%  Similarity=0.410  Sum_probs=136.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC--Cc--EEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD--GM--EVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~--~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  730 (832)
                      .++|++.+.||+|+||.||+|++..  ++  .||||+++...   ....+.+.+|++++++++||||+++++++..+. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            4679999999999999999998642  33  68999887542   344578899999999999999999999998765 8


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      ++||||+++++|.+++......+++..+..++.|++.|++|||   ++|++||||||+||+++.++.+||+|||.++...
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            9999999999999999876556899999999999999999999   9999999999999999999999999999998775


Q ss_pred             CCccc--ccccccccccccCCCC
Q 003301          811 GEESM--KQTLTLATIGYMAPGL  831 (832)
Q Consensus       811 ~~~~~--~~~~~~gt~~y~APE~  831 (832)
                      .....  ......+|+.|+|||+
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~  195 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPES  195 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHH
T ss_pred             ccccchhhhccCCCCceeeCchh
Confidence            43322  1223457889999996

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.93  E-value=3.8e-26  Score=251.21  Aligned_cols=164  Identities=31%  Similarity=0.460  Sum_probs=135.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCC------eeE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNND------FKA  731 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~  731 (832)
                      ..+|++.+.||+|+||+||+|++..+..||+|++.....    ...+|+++++.++||||+++++++...+      ..|
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            357999999999999999999998877899998865432    2236999999999999999999985433      378


Q ss_pred             EEEecCCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeC-CCCcEEEecccccc
Q 003301          732 LVLEYMPNGSLEDYLY---SNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD-KDMVAHLSDFGIAK  807 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-~~~~~kl~DFg~a~  807 (832)
                      +||||+++ ++.+.+.   .....+++..+..++.|++.||+|||   ++||+||||||+||+++ .++.+||+|||+|+
T Consensus       115 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          115 LVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            99999976 4444332   23446999999999999999999999   99999999999999998 79999999999998


Q ss_pred             ccCCCcccccccccccccccCCCC
Q 003301          808 LLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       808 ~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      .......  ....+||+.|+|||+
T Consensus       191 ~~~~~~~--~~~~~~t~~y~aPE~  212 (394)
T 4e7w_A          191 ILIAGEP--NVSYICSRYYRAPEL  212 (394)
T ss_dssp             ECCTTCC--CCSSCSCGGGCCHHH
T ss_pred             cccCCCC--CcccccCcCccCHHH
Confidence            7644332  223568999999996

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.93  E-value=7.9e-26  Score=239.06  Aligned_cols=168  Identities=27%  Similarity=0.454  Sum_probs=142.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEE-ecCCeeEEEEe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC-TNNDFKALVLE  735 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e  735 (832)
                      .++|++.+.||+|+||.||+|++. +++.||||++.....  .+.+.+|+++++.++|++++..+.++ ...+..|+|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            478999999999999999999974 689999999875533  25688999999999988766665554 66778899999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe---CCCCcEEEeccccccccCCC
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~---~~~~~~kl~DFg~a~~~~~~  812 (832)
                      |+ +++|.+++......+++..+..++.|++.|++|||   ++||+||||||+||++   +.++.+||+|||.|+.....
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 99999999866667999999999999999999999   9999999999999999   48899999999999876543


Q ss_pred             ccc------ccccccccccccCCCC
Q 003301          813 ESM------KQTLTLATIGYMAPGL  831 (832)
Q Consensus       813 ~~~------~~~~~~gt~~y~APE~  831 (832)
                      ...      ......||+.|+|||+
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~  186 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINT  186 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHH
T ss_pred             ccccccccccccccccccccCChhh
Confidence            321      1234579999999996

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.93  E-value=1.6e-26  Score=250.82  Aligned_cols=165  Identities=17%  Similarity=0.231  Sum_probs=140.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC---------CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceee---------
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD---------GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVK---------  719 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~---------  719 (832)
                      .++|++.+.||+|+||.||+|.+..         ++.||+|++...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999998864         789999998754     46778999999999999988         


Q ss_pred             ------eceEEec-CCeeEEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 003301          720 ------IISSCTN-NDFKALVLEYMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVL  791 (832)
Q Consensus       720 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl  791 (832)
                            +++++.. ++..|+||||+ +++|.+++... ...+++..+..++.|++.||+|||   ++||+||||||+||+
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEE
Confidence                  5677765 67899999999 99999999875 246999999999999999999999   999999999999999


Q ss_pred             eCCCC--cEEEeccccccccCCCccc------ccccccccccccCCCC
Q 003301          792 LDKDM--VAHLSDFGIAKLLSGEESM------KQTLTLATIGYMAPGL  831 (832)
Q Consensus       792 ~~~~~--~~kl~DFg~a~~~~~~~~~------~~~~~~gt~~y~APE~  831 (832)
                      ++.++  .+||+|||+|+........      ......||+.|+|||+
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  239 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDL  239 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHH
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHH
Confidence            99998  9999999999876433211      1123479999999996

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.93  E-value=7.3e-26  Score=245.83  Aligned_cols=168  Identities=24%  Similarity=0.336  Sum_probs=142.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecC-----Cee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNN-----DFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  730 (832)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++.... ......+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            478999999999999999999986 48999999986433 33456788999999999999999999988654     678


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      |+||||++ ++|.+++...  .+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+|||.|+...
T Consensus        90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999996 6999999874  5899999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCccc---------ccccccccccccCCCC
Q 003301          811 GEESM---------KQTLTLATIGYMAPGL  831 (832)
Q Consensus       811 ~~~~~---------~~~~~~gt~~y~APE~  831 (832)
                      .....         .....+||+.|+|||+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  193 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEV  193 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHH
T ss_pred             cccccccCccccccchhhccccccccCCee
Confidence            32211         1122468999999995

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.93  E-value=2.5e-26  Score=251.03  Aligned_cols=167  Identities=13%  Similarity=0.125  Sum_probs=124.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch---hhHHHHHHHHHHHhcC--CCCceeeec-------eEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE---GALKSFDVECEVLKSV--RHRNLVKII-------SSC  724 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~  724 (832)
                      ..+|++.+.||+|+||.||+|.+. +++.||||++.....   ...+.+.+|+++++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            356899999999999999999976 589999999986542   3345677785444433  799988755       444


Q ss_pred             ecC-----------------CeeEEEEecCCCCCHHHHHhhCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCeE
Q 003301          725 TNN-----------------DFKALVLEYMPNGSLEDYLYSNNFSFDILQR------LSVIIDVALALEYLHFGYSNPVV  781 (832)
Q Consensus       725 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~------~~i~~~i~~~l~~LH~~~~~~iv  781 (832)
                      ...                 ...|+||||++ |+|.+++...+..+++..+      ..++.|++.||+|||   ++||+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence            433                 33799999997 8999999864334455555      677899999999999   99999


Q ss_pred             ecCCCCCCeEeCCCCcEEEeccccccccCCCcccccccccccccccCCCCC
Q 003301          782 HCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       782 H~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ||||||+||+++.++.+||+|||+|+......    ....+|+.|+|||++
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~  263 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFL  263 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHH
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhc
Confidence            99999999999999999999999998764322    134577999999963

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.93  E-value=6.8e-26  Score=251.27  Aligned_cols=163  Identities=29%  Similarity=0.452  Sum_probs=134.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecC------CeeE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNN------DFKA  731 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~  731 (832)
                      .+|++.+.||+|+||.||+|++. +++.||||++.....    ...+|+++++.++||||+++++++...      ...+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46889999999999999999986 489999999865432    234699999999999999999988532      2467


Q ss_pred             EEEecCCCCCHHHHHh---hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC-CcEEEecccccc
Q 003301          732 LVLEYMPNGSLEDYLY---SNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD-MVAHLSDFGIAK  807 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~kl~DFg~a~  807 (832)
                      +||||+++ ++.+++.   .....+++..+..++.|++.||+|||   ++||+||||||+|||++.+ +.+||+|||+|+
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999964 6766654   23456999999999999999999999   9999999999999999965 678999999998


Q ss_pred             ccCCCcccccccccccccccCCCC
Q 003301          808 LLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       808 ~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      .......  ....+||+.|+|||+
T Consensus       206 ~~~~~~~--~~~~~~t~~y~aPE~  227 (420)
T 1j1b_A          206 QLVRGEP--NVSYICSRYYRAPEL  227 (420)
T ss_dssp             ECCTTCC--CCSCCSCTTSCCHHH
T ss_pred             hcccCCC--ceeeeeCCCcCCHHH
Confidence            7644332  233579999999996

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.93  E-value=8.5e-26  Score=237.65  Aligned_cols=169  Identities=25%  Similarity=0.398  Sum_probs=147.0

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            4578999999999999999999986 58999999987543  23457888999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC---CcEEEeccccccccC
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD---MVAHLSDFGIAKLLS  810 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~---~~~kl~DFg~a~~~~  810 (832)
                      |||+++++|.+++.... .+++..+..++.|++.|++|||   +.|++||||||+||+++.+   +.+||+|||.+....
T Consensus       100 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A          100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            99999999999887654 6899999999999999999999   9999999999999999754   479999999998764


Q ss_pred             CCcccccccccccccccCCCC
Q 003301          811 GEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       811 ~~~~~~~~~~~gt~~y~APE~  831 (832)
                      ....  .....||+.|+|||+
T Consensus       176 ~~~~--~~~~~~~~~y~aPE~  194 (287)
T 2wei_A          176 QNTK--MKDRIGTAYYIAPEV  194 (287)
T ss_dssp             CCSS--CSCHHHHHTTCCHHH
T ss_pred             CCCc--cccccCcccccChHH
Confidence            4332  223458999999996

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.92  E-value=5.5e-26  Score=264.01  Aligned_cols=163  Identities=28%  Similarity=0.455  Sum_probs=135.3

Q ss_pred             CeeeccCCceEEEEEec---CCcEEEEEEEeccch--hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCC
Q 003301          665 NLIGTGGFGSVYKGSFL---DGMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      +.||+|+||.||+|.+.   .++.||||+++....  ...+.+.+|++++++++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999664   367899999976432  345789999999999999999999999965 457899999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc--cc
Q 003301          740 GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM--KQ  817 (832)
Q Consensus       740 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~--~~  817 (832)
                      |+|.+++...+ .+++..+..++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+|+........  ..
T Consensus       454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            99999998654 6899999999999999999999   999999999999999999999999999999876543321  22


Q ss_pred             ccccccccccCCCCC
Q 003301          818 TLTLATIGYMAPGLF  832 (832)
Q Consensus       818 ~~~~gt~~y~APE~l  832 (832)
                      ....||+.|+|||++
T Consensus       530 ~~~~~t~~y~APE~~  544 (635)
T 4fl3_A          530 THGKWPVKWYAPECI  544 (635)
T ss_dssp             -----CGGGSCHHHH
T ss_pred             cCCCCceeeeChhhh
Confidence            234578899999963

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.92  E-value=1.4e-25  Score=251.21  Aligned_cols=168  Identities=24%  Similarity=0.385  Sum_probs=143.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCC-CceeeeceEEecCCeeEEEEe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRH-RNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .++|++.++||+|+||.||+|.+. +++.||||++......  +.+.+|+++++.++| ++++.+..++...+..|+|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            468999999999999999999975 5899999988755432  457889999999987 566666677778889999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe---CCCCcEEEeccccccccCCC
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL---DKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~---~~~~~~kl~DFg~a~~~~~~  812 (832)
                      |+ +++|.+++......+++..++.++.||+.||+|||   ++||+||||||+|||+   +.++.+||+|||+|+.+...
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 99999999876667999999999999999999999   9999999999999999   68899999999999876543


Q ss_pred             ccc------ccccccccccccCCCC
Q 003301          813 ESM------KQTLTLATIGYMAPGL  831 (832)
Q Consensus       813 ~~~------~~~~~~gt~~y~APE~  831 (832)
                      ...      ......||+.|+|||+
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~  184 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNT  184 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred             ccccccccccccccCCCccccCHHH
Confidence            321      1124579999999996

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.92  E-value=6.3e-26  Score=267.39  Aligned_cols=163  Identities=25%  Similarity=0.373  Sum_probs=139.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec--CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCe-----
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL--DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDF-----  729 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  729 (832)
                      .++|++.+.||+|+||.||+|.+.  +++.||||++.... ....+.+.+|++++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            378999999999999999999986  58999999886443 3445678899999999999999999999987655     


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      .|+||||+++++|.+++..   .+++..+..++.|++.||+|||   ++||+||||||+||+++.+ .+||+|||+++..
T Consensus       159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            6999999999999988754   5899999999999999999999   9999999999999999885 9999999999876


Q ss_pred             CCCcccccccccccccccCCCCC
Q 003301          810 SGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       810 ~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ...     ...+||+.|+|||++
T Consensus       232 ~~~-----~~~~gt~~y~aPE~~  249 (681)
T 2pzi_A          232 NSF-----GYLYGTPGFQAPEIV  249 (681)
T ss_dssp             TCC-----SCCCCCTTTSCTTHH
T ss_pred             ccC-----CccCCCccccCHHHH
Confidence            443     235699999999963

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.92  E-value=1e-25  Score=246.03  Aligned_cols=163  Identities=28%  Similarity=0.389  Sum_probs=138.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCee----
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFK----  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~----  730 (832)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++....  ....+.+.+|+++++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999999876 48999999997543  33457788999999999999999999999877654    


Q ss_pred             --EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          731 --ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       731 --~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                        |+||||++ ++|.+++..   .+++..+..++.|++.|++|||   +.||+||||||+||+++.++.+||+|||.|+.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              99999996 688888743   4899999999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCcccccccccccccccCCCC
Q 003301          809 LSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       809 ~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      ....    ....+||+.|+|||+
T Consensus       194 ~~~~----~~~~~~t~~y~aPE~  212 (371)
T 4exu_A          194 ADAE----MTGYVVTRWYRAPEV  212 (371)
T ss_dssp             ----------CTTCCCTTSCHHH
T ss_pred             cccC----cCCcccCccccCHHH
Confidence            5432    233568999999996

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.92  E-value=5.9e-26  Score=252.03  Aligned_cols=168  Identities=24%  Similarity=0.446  Sum_probs=136.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ..+|++.+.||+|+||+||.....+++.||||++.....   ..+.+|+++++++ +||||+++++++.+.+..|+||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            356888999999999997665556899999999865432   2356799999999 799999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC-----CCcEEEeccccccccCC
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK-----DMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-----~~~~kl~DFg~a~~~~~  811 (832)
                      |+ |+|.+++........+..+..++.|++.||+|||   +.||+||||||+||+++.     ...+||+|||+|+....
T Consensus       100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            95 6999999877656666677899999999999999   999999999999999953     23688999999987654


Q ss_pred             Ccc--cccccccccccccCCCCC
Q 003301          812 EES--MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~--~~~~~~~gt~~y~APE~l  832 (832)
                      ...  ......+||+.|+|||++
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l  198 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEML  198 (432)
T ss_dssp             ----------CCSCTTSCCGGGT
T ss_pred             CCcceeeccccCCCcCccChhhh
Confidence            321  122345799999999975

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.92  E-value=2.6e-26  Score=244.75  Aligned_cols=172  Identities=30%  Similarity=0.400  Sum_probs=137.1

Q ss_pred             HHHHHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch------hhHHHHHHHHHHHhcC----CCCceeeec
Q 003301          653 ELLQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE------GALKSFDVECEVLKSV----RHRNLVKII  721 (832)
Q Consensus       653 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~niv~l~  721 (832)
                      +.....++|++.+.||+|+||.||+|.+. +++.||||++.....      .....+.+|+++++++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            34455789999999999999999999875 588999999865432      1223455788888888    899999999


Q ss_pred             eEEecCCeeEEEEec-CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeC-CCCcEE
Q 003301          722 SSCTNNDFKALVLEY-MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD-KDMVAH  799 (832)
Q Consensus       722 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-~~~~~k  799 (832)
                      +++...+..++|||| +++++|.+++.... .+++..+..++.|++.||+|||   +.||+||||||+||+++ .++.+|
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEE
Confidence            999999999999999 78999999998754 6899999999999999999999   99999999999999999 889999


Q ss_pred             EeccccccccCCCcccccccccccccccCCCC
Q 003301          800 LSDFGIAKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       800 l~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      |+|||.++......   .....||+.|+|||+
T Consensus       181 l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~  209 (312)
T 2iwi_A          181 LIDFGSGALLHDEP---YTDFDGTRVYSPPEW  209 (312)
T ss_dssp             ECCCSSCEECCSSC---BCCCCSCTTTSCHHH
T ss_pred             EEEcchhhhcccCc---ccccCCcccccCcee
Confidence            99999998765432   233569999999996

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.92  E-value=9.9e-26  Score=249.07  Aligned_cols=166  Identities=24%  Similarity=0.348  Sum_probs=140.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCC--------CCceeeeceEEe---
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVR--------HRNLVKIISSCT---  725 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~---  725 (832)
                      .++|++.+.||+|+||+||+|++. +++.||||++... ....+.+.+|+++++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            478999999999999999999875 4889999998754 334567889999999885        788999999987   


Q ss_pred             -cCCeeEEEEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCeEeCCCC------
Q 003301          726 -NNDFKALVLEYMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSN-PVVHCDIKPSNVLLDKDM------  796 (832)
Q Consensus       726 -~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIl~~~~~------  796 (832)
                       .....|+||||+ ++++.+++... ...+++..+..++.|++.||+|||   ++ ||+||||||+||+++.++      
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhh
Confidence             556889999999 66776666544 346999999999999999999999   88 999999999999998775      


Q ss_pred             -------------------------------------------cEEEeccccccccCCCcccccccccccccccCCCCC
Q 003301          797 -------------------------------------------VAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       797 -------------------------------------------~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                                                                 .+||+|||.|+.....    ....+||+.|+|||++
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence                                                       7999999999876432    2235699999999963

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.92  E-value=3.3e-25  Score=237.91  Aligned_cols=169  Identities=25%  Similarity=0.323  Sum_probs=127.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHH-HHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECE-VLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||||++.... ......+..|+. +++.++||||+++++++..++..|+||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            478999999999999999999985 58999999997653 233345556665 677889999999999999999999999


Q ss_pred             ecCCCCCHHHHHhh----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          735 EYMPNGSLEDYLYS----NNFSFDILQRLSVIIDVALALEYLHFGYSN-PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       735 e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      ||++ ++|.+++..    ....+++..+..++.|++.|++|||   +. ||+||||||+||+++.++.+||+|||+++..
T Consensus       101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            9996 588887763    2346899999999999999999999   88 9999999999999999999999999999876


Q ss_pred             CCCcccccccccccccccCCCCC
Q 003301          810 SGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       810 ~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .....  .....||+.|+|||++
T Consensus       177 ~~~~~--~~~~~gt~~y~aPE~~  197 (327)
T 3aln_A          177 VDSIA--KTRDAGCRPYMAPERI  197 (327)
T ss_dssp             -----------------------
T ss_pred             ccccc--cccCCCCccccCceee
Confidence            44322  2234699999999974

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.92  E-value=1.3e-25  Score=241.07  Aligned_cols=169  Identities=31%  Similarity=0.456  Sum_probs=141.6

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec--CCcEEEEEEEeccch--hhHHHHHHHHHHHhcC---CCCceeeeceEEe----
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL--DGMEVAIKVFHLQLE--GALKSFDVECEVLKSV---RHRNLVKIISSCT----  725 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~----  725 (832)
                      ..++|++.+.||+|+||.||+|.+.  +++.||+|++.....  .....+.+|+++++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999984  588999999875432  2224566777777666   8999999999987    


Q ss_pred             -cCCeeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecc
Q 003301          726 -NNDFKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDF  803 (832)
Q Consensus       726 -~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DF  803 (832)
                       .....++||||++ |+|.+++.... ..+++..+..++.|++.||+|||   +.||+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence             4567899999996 69999998654 34899999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCcccccccccccccccCCCC
Q 003301          804 GIAKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       804 g~a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      |.++......  ......||+.|+|||+
T Consensus       165 g~~~~~~~~~--~~~~~~~~~~y~aPE~  190 (326)
T 1blx_A          165 GLARIYSFQM--ALTSVVVTLWYRAPEV  190 (326)
T ss_dssp             CSCCCCCGGG--GGCCCCCCCTTCCHHH
T ss_pred             cccccccCCC--CccccccccceeCHHH
Confidence            9998764322  2234569999999996

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.92  E-value=2.3e-24  Score=226.18  Aligned_cols=205  Identities=22%  Similarity=0.208  Sum_probs=125.9

Q ss_pred             cccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCC
Q 003301          290 WANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNL  369 (832)
Q Consensus       290 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  369 (832)
                      +.++++++++++++|.++ .+|..+.   ..++.|++++|.+++..+..|..+++|++|+|++|.+++..+.        
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--------   73 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--------   73 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--------
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--------
Confidence            456677777777777776 3333322   1444444444444444444444455555555555544432221        


Q ss_pred             ceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCC
Q 003301          370 QGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSN  449 (832)
Q Consensus       370 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  449 (832)
                                        ..+++|++|++++|+++ .+|..+..+++|++|++++|+++++.+..|.++++|++|+|++|
T Consensus        74 ------------------~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N  134 (290)
T 1p9a_G           74 ------------------GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN  134 (290)
T ss_dssp             ------------------SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTS
T ss_pred             ------------------CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCC
Confidence                              34455555555555555 44555556666666666666666655666666666666666666


Q ss_pred             cccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCccccc
Q 003301          450 FLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGN  526 (832)
Q Consensus       450 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  526 (832)
                      ++++..+..|..+++|+.|+|++|++++..+..|.++++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|++...
T Consensus       135 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~  210 (290)
T 1p9a_G          135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN  210 (290)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             CCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence            666655556666777777777777777655566677777888888888887 5777777777888888888887643

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.92  E-value=1.5e-26  Score=247.41  Aligned_cols=173  Identities=25%  Similarity=0.438  Sum_probs=142.3

Q ss_pred             HHHHHhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCee
Q 003301          653 ELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       653 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  730 (832)
                      ++....++|++.+.||+|+||.||+|.+.+  .||+|++....  ....+.+.+|++++++++||||+++++++.+.+..
T Consensus        27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (319)
T 2y4i_B           27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL  104 (319)
T ss_dssp             GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred             cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence            333446889999999999999999998743  59999986543  22335677899999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      ++||||+++++|.+++...+..+++..+..++.|++.|++|||   +.|++||||||+||+++ ++.+||+|||+|+...
T Consensus       105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            9999999999999999877667999999999999999999999   99999999999999998 6799999999987653


Q ss_pred             CCc----ccccccccccccccCCCC
Q 003301          811 GEE----SMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       811 ~~~----~~~~~~~~gt~~y~APE~  831 (832)
                      ...    ........||+.|+|||+
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~  205 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEI  205 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHH
T ss_pred             cccccccccccccCCCcccccChHH
Confidence            211    112223459999999996

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.92  E-value=2.9e-25  Score=241.84  Aligned_cols=175  Identities=28%  Similarity=0.348  Sum_probs=132.7

Q ss_pred             HHHHHHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCC--
Q 003301          652 KELLQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNND--  728 (832)
Q Consensus       652 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--  728 (832)
                      .+.....++|++.+.||+|+||.||+|++. +++.||||++.... .......+|++.++.++||||+++++++...+  
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            455667899999999999999999999985 48999999986543 22356677888888899999999999986533  


Q ss_pred             -----eeEEEEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC-CCcEE
Q 003301          729 -----FKALVLEYMPNGSLEDYLYS---NNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK-DMVAH  799 (832)
Q Consensus       729 -----~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-~~~~k  799 (832)
                           ..++||||+++ ++.+.+..   ....+++..+..++.|++.|++|+| .++.||+||||||+||+++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT-STTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh-CCCCCeecCcCCHHHEEEeCCCCcEE
Confidence                 27899999965 65554432   3446899999999999999999999 33689999999999999996 89999


Q ss_pred             EeccccccccCCCcccccccccccccccCCCC
Q 003301          800 LSDFGIAKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       800 l~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      |+|||+|+.......  .....||+.|+|||+
T Consensus       173 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~  202 (360)
T 3e3p_A          173 LCDFGSAKKLSPSEP--NVAYICSRYYRAPEL  202 (360)
T ss_dssp             ECCCTTCBCCCTTSC--CCSTTSCGGGCCHHH
T ss_pred             EeeCCCceecCCCCC--cccccCCcceeCHHH
Confidence            999999987654432  223568999999996

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.92  E-value=2.7e-25  Score=239.90  Aligned_cols=165  Identities=22%  Similarity=0.384  Sum_probs=142.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec--CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCc------eeeeceEEecCCe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL--DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRN------LVKIISSCTNNDF  729 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~  729 (832)
                      .++|++.+.||+|+||.||+|.+.  +++.||||++... ....+.+.+|+++++.++|++      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            468999999999999999999873  5889999998754 334567888999998887654      9999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC--------------
Q 003301          730 KALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK--------------  794 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~--------------  794 (832)
                      .|+||||+ +++|.+++.... ..+++..+..++.|++.||+|||   ++||+||||||+||+++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 899999998654 35889999999999999999999   999999999999999987              


Q ss_pred             -----CCcEEEeccccccccCCCcccccccccccccccCCCC
Q 003301          795 -----DMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       795 -----~~~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                           ++.+||+|||.|+......    ....||+.|+|||+
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~  205 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEV  205 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHH
T ss_pred             cccccCCCceEeeCcccccCcccc----ccccCCccccChHH
Confidence                 6689999999998754322    23569999999996

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.92  E-value=1.7e-25  Score=238.46  Aligned_cols=169  Identities=24%  Similarity=0.377  Sum_probs=140.9

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCC--CCceeeeceEEecCCeeEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVR--HRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~l  732 (832)
                      ..++|++.+.||+|+||.||+|.+.+++.||||++....  ....+.+.+|++++++++  ||||+++++++..++..|+
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            457899999999999999999999889999999997543  334578899999999997  5999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      |||+ .+++|.+++.... .+++..+..++.|++.||+|||   +.||+||||||+||++++ +.+||+|||.++.....
T Consensus       106 v~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          106 VMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             EECC-CSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred             EEec-CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence            9995 5889999998764 6899999999999999999999   999999999999999964 89999999999876443


Q ss_pred             ccc-ccccccccccccCCCC
Q 003301          813 ESM-KQTLTLATIGYMAPGL  831 (832)
Q Consensus       813 ~~~-~~~~~~gt~~y~APE~  831 (832)
                      ... ......||+.|+|||+
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~  199 (313)
T 3cek_A          180 TTSVVKDSQVGTVNYMPPEA  199 (313)
T ss_dssp             ----------CCGGGCCHHH
T ss_pred             cccccccCCCCCCCcCCHHH
Confidence            321 1223569999999996

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.92  E-value=1.8e-25  Score=242.58  Aligned_cols=163  Identities=28%  Similarity=0.385  Sum_probs=138.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCe-----
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDF-----  729 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  729 (832)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++....  ....+.+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            468999999999999999999886 48999999987543  2335678899999999999999999999987654     


Q ss_pred             -eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          730 -KALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       730 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                       .|+||||++ ++|.+++..   .+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||.++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             499999996 688887753   4899999999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCcccccccccccccccCCCC
Q 003301          809 LSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       809 ~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      ....    .....||+.|+|||+
T Consensus       176 ~~~~----~~~~~~t~~y~aPE~  194 (353)
T 3coi_A          176 ADAE----MTGYVVTRWYRAPEV  194 (353)
T ss_dssp             ------------CCSBCCSCHHH
T ss_pred             CCCC----ccccccCcCcCCHHH
Confidence            5332    223568999999995

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.92  E-value=3.9e-25  Score=235.08  Aligned_cols=203  Identities=21%  Similarity=0.175  Sum_probs=169.5

Q ss_pred             CcCcccEEEeecCcccccccccc--cCCCCCceEEccCCccCCCCc----hhhcCCCCCcEEEecCCcCCCCCcccCCCC
Q 003301          341 NLINLRELGLWGNELIGSIPITF--GKLQNLQGLDLVNNKLEGPIP----NGLCQLARLSVLYMDGNKLSGPIPPCIGDL  414 (832)
Q Consensus       341 ~l~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  414 (832)
                      .+++|++|++++|.+.+..|..+  ..+++|++|+|++|++++..+    ..+..+++|++|+|++|++++..|..|+.+
T Consensus        89 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l  168 (310)
T 4glp_A           89 AYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAF  168 (310)
T ss_dssp             HHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCC
T ss_pred             ccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccC
Confidence            34668999999999988888887  888999999999999987655    345678899999999999998888899999


Q ss_pred             CCCCeEeCCCCcCCCC---C-CcccccCcccceeeecCCcccCCCcc----ccccccccceecccCcccCCccCCccccc
Q 003301          415 TSLRLLSLASNELNSV---I-PSTFWNLKDILSLNFSSNFLNGSLPE----DIGNLKVVVIIDLSRNNLSGDIPTAIGGL  486 (832)
Q Consensus       415 ~~L~~L~L~~N~l~~~---~-~~~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  486 (832)
                      ++|++|+|++|++.+.   . +..+..+++|++|+|++|+++. ++.    .++.+++|++|||++|++++..|..+..+
T Consensus       169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~  247 (310)
T 4glp_A          169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC  247 (310)
T ss_dssp             TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred             CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence            9999999999998652   2 2334788999999999999973 333    35778999999999999998888888777


Q ss_pred             ---cccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccc
Q 003301          487 ---MNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEG  549 (832)
Q Consensus       487 ---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~  549 (832)
                         ++|++|+|++|+|+ .+|..+.  ++|+.|||++|+|++. |. +..+++|+.|+|++|+++.
T Consensus       248 ~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          248 MWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             CCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred             cCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence               69999999999999 6787775  7999999999999974 43 6778999999999999874

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.92  E-value=5.2e-25  Score=236.92  Aligned_cols=165  Identities=24%  Similarity=0.362  Sum_probs=121.3

Q ss_pred             hcCCCCC-CeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEec----CCeeE
Q 003301          658 TNQFNAS-NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN----NDFKA  731 (832)
Q Consensus       658 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~  731 (832)
                      .++|++. +.||+|+||.||+|.+. +++.||||++.....    ........++.++||||+++++++..    +...|
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            5788885 46999999999999987 589999999875421    11222334566799999999999876    44589


Q ss_pred             EEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC---CCcEEEecccccc
Q 003301          732 LVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK---DMVAHLSDFGIAK  807 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~DFg~a~  807 (832)
                      +||||+++|+|.+++.... ..+++..+..++.|++.||+|||   ++||+||||||+||+++.   ++.+||+|||+|+
T Consensus       103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            9999999999999998654 35999999999999999999999   999999999999999976   4569999999998


Q ss_pred             ccCCCcccccccccccccccCCCCC
Q 003301          808 LLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       808 ~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ......   .....||+.|+|||++
T Consensus       180 ~~~~~~---~~~~~~t~~y~aPE~~  201 (336)
T 3fhr_A          180 ETTQNA---LQTPCYTPYYVAPEVL  201 (336)
T ss_dssp             EC-----------------------
T ss_pred             eccccc---cccCCCCcCccChhhh
Confidence            764332   2235689999999974

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.92  E-value=1.1e-25  Score=240.72  Aligned_cols=169  Identities=28%  Similarity=0.350  Sum_probs=145.3

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchh------hHHHHHHHHHHHhcCC--CCceeeeceEEec
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEG------ALKSFDVECEVLKSVR--HRNLVKIISSCTN  726 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~~~~  726 (832)
                      ...++|++.+.||+|+||.||+|.+. +++.||||++......      ..+.+.+|++++++++  ||||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            34578999999999999999999875 5899999999755321      2245677999999996  5999999999999


Q ss_pred             CCeeEEEEecCCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeC-CCCcEEEeccc
Q 003301          727 NDFKALVLEYMPN-GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD-KDMVAHLSDFG  804 (832)
Q Consensus       727 ~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~-~~~~~kl~DFg  804 (832)
                      .+..++||||+.+ ++|.+++.... .+++..+..++.|++.||+|||   +.||+||||||+||+++ .++.+||+|||
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            9999999999976 89999998654 6899999999999999999999   99999999999999999 78999999999


Q ss_pred             cccccCCCcccccccccccccccCCCC
Q 003301          805 IAKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       805 ~a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      +++......   .....||+.|+|||+
T Consensus       196 ~~~~~~~~~---~~~~~gt~~y~aPE~  219 (320)
T 3a99_A          196 SGALLKDTV---YTDFDGTRVYSPPEW  219 (320)
T ss_dssp             TCEECCSSC---BCCCCSCGGGSCHHH
T ss_pred             ccccccccc---ccCCCCCccCCChHH
Confidence            998765432   223569999999996

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.92  E-value=2.6e-25  Score=247.76  Aligned_cols=166  Identities=28%  Similarity=0.399  Sum_probs=129.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEEEecC
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      +.|.+.+.||+|+||+||.+...+|+.||||++....   .+.+.+|+++++++ +||||+++++++.+++..|+|||||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            3455678899999999987766689999999987543   35678899999876 8999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCC------CCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC-------------CcE
Q 003301          738 PNGSLEDYLYSNNFS------FDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD-------------MVA  798 (832)
Q Consensus       738 ~~g~L~~~l~~~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-------------~~~  798 (832)
                      + |+|.+++......      .++..+..++.|++.||+|||   +.||+||||||+||+++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            5 6999999865421      123345779999999999999   9999999999999999754             489


Q ss_pred             EEeccccccccCCCccc---ccccccccccccCCCC
Q 003301          799 HLSDFGIAKLLSGEESM---KQTLTLATIGYMAPGL  831 (832)
Q Consensus       799 kl~DFg~a~~~~~~~~~---~~~~~~gt~~y~APE~  831 (832)
                      ||+|||+|+........   .....+||+.|+|||+
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~  203 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPEL  203 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHH
Confidence            99999999887544322   1223579999999996

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.91  E-value=2e-25  Score=255.00  Aligned_cols=170  Identities=31%  Similarity=0.472  Sum_probs=143.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEec------CCe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTN------NDF  729 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~  729 (832)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|++++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            478999999999999999999875 48999999987542 3445778999999999999999999998765      667


Q ss_pred             eEEEEecCCCCCHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCc---EEEeccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNNF--SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMV---AHLSDFG  804 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~---~kl~DFg  804 (832)
                      .|+||||+++|+|.+++.....  .+++..+..++.|++.|++|||   +.||+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999986432  5888999999999999999999   999999999999999987664   9999999


Q ss_pred             cccccCCCcccccccccccccccCCCCC
Q 003301          805 IAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       805 ~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .|+.......  .....||+.|+|||++
T Consensus       170 ~a~~~~~~~~--~~~~~gt~~Y~APE~l  195 (676)
T 3qa8_A          170 YAKELDQGEL--CTEFVGTLQYLAPELL  195 (676)
T ss_dssp             CCCBTTSCCC--CCCCCSCCTTCSSCSS
T ss_pred             cccccccccc--cccccCCcccCChHHh
Confidence            9987654432  2335799999999975

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.91  E-value=4.8e-25  Score=235.64  Aligned_cols=168  Identities=26%  Similarity=0.305  Sum_probs=127.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch--hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE--GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      .++|++.+.||+|+||.||+|.+. +++.||||++.....  ...+.+..+..+++.++||||+++++++.+++..|+||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467999999999999999999986 589999999975532  22234445556788889999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN-PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      ||+ ++.+..+.......+++..+..++.|++.|++|||   ++ |++||||||+||+++.++.+||+|||.+.......
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 66777666654557999999999999999999999   85 99999999999999999999999999997764432


Q ss_pred             ccccccccccccccCCCC
Q 003301          814 SMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~  831 (832)
                      .  .....||+.|+|||+
T Consensus       180 ~--~~~~~~~~~y~aPE~  195 (318)
T 2dyl_A          180 A--KDRSAGCAAYMAPER  195 (318)
T ss_dssp             ---------CCTTCCHHH
T ss_pred             c--ccccCCCccccChhh
Confidence            2  223469999999996

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=5.9e-24  Score=218.54  Aligned_cols=180  Identities=26%  Similarity=0.303  Sum_probs=92.4

Q ss_pred             cccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCC
Q 003301          344 NLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLA  423 (832)
Q Consensus       344 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  423 (832)
                      ..++++++++.++. +|..+.  ++++.|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|+
T Consensus        15 ~~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~   91 (251)
T 3m19_A           15 GKKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA   91 (251)
T ss_dssp             GGTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             CCeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence            34555555555552 333222  345555555555554444445555555555555555554444445555555555555


Q ss_pred             CCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccC
Q 003301          424 SNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSI  503 (832)
Q Consensus       424 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  503 (832)
                      +|++++..+..|                        ..+++|++|+|++|++++..+..|.++++|+.|+|++|+|++..
T Consensus        92 ~n~l~~~~~~~~------------------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  147 (251)
T 3m19_A           92 NNQLASLPLGVF------------------------DHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIP  147 (251)
T ss_dssp             TSCCCCCCTTTT------------------------TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             CCcccccChhHh------------------------cccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccC
Confidence            555554444444                        44455555555555555444444455555555555555555444


Q ss_pred             CccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCccccc
Q 003301          504 PKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGE  550 (832)
Q Consensus       504 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~  550 (832)
                      +..|+.+++|+.|+|++|++++..|..+..+++|+.|+|++|+++|.
T Consensus       148 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          148 AGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             HHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            44555555555555555555555444555555555555555555554

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.91  E-value=1.4e-24  Score=238.02  Aligned_cols=169  Identities=25%  Similarity=0.349  Sum_probs=141.3

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCC-CC-----ceeeeceEEecCCe
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVR-HR-----NLVKIISSCTNNDF  729 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~~  729 (832)
                      ..++|++.+.||+|+||+||+|.+. +++.||||+++... ...+.+.+|+++++.++ |+     +|+++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            3578999999999999999999876 48899999997543 33466778888888774 44     59999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeC--CCCcEEEeccccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD--KDMVAHLSDFGIA  806 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~--~~~~~kl~DFg~a  806 (832)
                      .|+||||++ ++|.+++.... ..+++..+..++.|++.|++|||. +..||+||||||+||+++  .++.+||+|||+|
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            999999995 69999998754 358999999999999999999992 246899999999999994  5788999999999


Q ss_pred             cccCCCcccccccccccccccCCCCC
Q 003301          807 KLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       807 ~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +.....    ....+||+.|+|||++
T Consensus       209 ~~~~~~----~~~~~~t~~y~aPE~~  230 (382)
T 2vx3_A          209 CQLGQR----IYQYIQSRFYRSPEVL  230 (382)
T ss_dssp             EETTCC----CCSSCSCGGGCCHHHH
T ss_pred             eecccc----cccccCCccccChHHH
Confidence            876432    2235799999999963

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.91  E-value=5.3e-26  Score=247.34  Aligned_cols=228  Identities=18%  Similarity=0.165  Sum_probs=95.8

Q ss_pred             EccCCccccccCCcccCCCCccEEEcCCCcCcccCC----ccccCcc-ccceeecccccCCCCCCccccccccccC-CCC
Q 003301          223 SLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIP----NTLGNLR-KLEWLRLSYNFLTSSTSELSFLSSWANC-KNL  296 (832)
Q Consensus       223 ~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~~~~~l-~~L  296 (832)
                      ++++|.+++.+|..+...++|++|+|++|.+++..+    ..|..++ +|++|+|++|.++...... +...+... ++|
T Consensus         4 ~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~-l~~~l~~~~~~L   82 (362)
T 3goz_A            4 KLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDE-LVQILAAIPANV   82 (362)
T ss_dssp             ECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHH-HHHHHHTSCTTC
T ss_pred             ccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHH-HHHHHhccCCCc
Confidence            344444444444443334444444444444444333    3344444 4444444444444321110 01111111 444


Q ss_pred             cEEeccCCCCCCCCCCccccc----ccccceEEeecCcccccccccc----cC-cCcccEEEeecCcccccc----cccc
Q 003301          297 KLLDLSNNPINGVLPSSIGNL----SLSLSRIFISNCSIRGTIPKEI----GN-LINLRELGLWGNELIGSI----PITF  363 (832)
Q Consensus       297 ~~L~L~~N~l~~~~~~~~~~~----~~~L~~L~l~~n~l~~~~~~~~----~~-l~~L~~L~L~~N~l~~~~----~~~~  363 (832)
                      ++|+|++|++++..+..+...    ..+|++|++++|++++..+..+    .. .++|++|+|++|++++..    +..+
T Consensus        83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l  162 (362)
T 3goz_A           83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL  162 (362)
T ss_dssp             CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred             cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence            555555554443333322221    0134444444444433333222    22 135555555555555322    2223


Q ss_pred             cCCC-CCceEEccCCccCCCCchhhc----CC-CCCcEEEecCCcCCCC----CcccCCC-CCCCCeEeCCCCcCCCCCC
Q 003301          364 GKLQ-NLQGLDLVNNKLEGPIPNGLC----QL-ARLSVLYMDGNKLSGP----IPPCIGD-LTSLRLLSLASNELNSVIP  432 (832)
Q Consensus       364 ~~l~-~L~~L~Ls~N~l~~~~~~~~~----~l-~~L~~L~L~~N~l~~~----~p~~~~~-l~~L~~L~L~~N~l~~~~~  432 (832)
                      ..++ +|++|+|++|++++..+..++    .. ++|++|+|++|.+++.    ++..+.. .++|+.|+|++|.+++..+
T Consensus       163 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~  242 (362)
T 3goz_A          163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSL  242 (362)
T ss_dssp             HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCH
T ss_pred             hcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHH
Confidence            3333 555556665555544443332    22 3555555555555532    2223333 2355555555555554433


Q ss_pred             ----cccccCcccceeeecCCcc
Q 003301          433 ----STFWNLKDILSLNFSSNFL  451 (832)
Q Consensus       433 ----~~~~~l~~L~~L~Ls~N~l  451 (832)
                          ..+..+++|++|+|++|.+
T Consensus       243 ~~l~~~~~~l~~L~~L~L~~n~l  265 (362)
T 3goz_A          243 ENLKLLKDSLKHLQTVYLDYDIV  265 (362)
T ss_dssp             HHHHHTTTTTTTCSEEEEEHHHH
T ss_pred             HHHHHHHhcCCCccEEEeccCCc
Confidence                2223344455555555543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.91  E-value=1.1e-24  Score=236.85  Aligned_cols=166  Identities=23%  Similarity=0.379  Sum_probs=140.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC-C-cEEEEEEEeccchhhHHHHHHHHHHHhcCCCCc------eeeeceEEecCCe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD-G-MEVAIKVFHLQLEGALKSFDVECEVLKSVRHRN------LVKIISSCTNNDF  729 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~  729 (832)
                      .++|++.+.||+|+||+||+|.+.. + +.||+|+++.. ....+.+.+|++++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            4789999999999999999998753 4 68999998754 234467888999999987665      8999999999999


Q ss_pred             eEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe----------------
Q 003301          730 KALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL----------------  792 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~----------------  792 (832)
                      .|+||||+ ++++.+++.... ..+++..+..++.|++.||+|||   ++||+||||||+||++                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 677777776543 46899999999999999999999   9999999999999999                


Q ss_pred             ---CCCCcEEEeccccccccCCCcccccccccccccccCCCCC
Q 003301          793 ---DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       793 ---~~~~~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                         +.++.+||+|||.|+......    ....||+.|+|||++
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~  211 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVI  211 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHH
T ss_pred             ccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeee
Confidence               567899999999998653322    235699999999963

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.91  E-value=3e-24  Score=219.15  Aligned_cols=196  Identities=18%  Similarity=0.223  Sum_probs=103.4

Q ss_pred             cccEEEeecCcccccccccccCCCCCceEEccCCc-cCCCCchhhcCCCCCcEEEecC-CcCCCCCcccCCCCCCCCeEe
Q 003301          344 NLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNK-LEGPIPNGLCQLARLSVLYMDG-NKLSGPIPPCIGDLTSLRLLS  421 (832)
Q Consensus       344 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~  421 (832)
                      +|++|++++|++++..+..|.++++|++|++++|+ +++..+..|..+++|++|++++ |++++..+..|.++++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            44444444444444444444444445555555443 4433333444444555555554 444444444445555555555


Q ss_pred             CCCCcCCCCCCcccccCcccc---eeeecCC-cccCCCccccccccccc-eecccCcccCCccCCccccccccceeeccc
Q 003301          422 LASNELNSVIPSTFWNLKDIL---SLNFSSN-FLNGSLPEDIGNLKVVV-IIDLSRNNLSGDIPTAIGGLMNLQDLSLRD  496 (832)
Q Consensus       422 L~~N~l~~~~~~~~~~l~~L~---~L~Ls~N-~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  496 (832)
                      +++|++++ +|. |..+++|+   +|++++| ++++..+..|..+++|+ .|++++|+++...+..|.. ++|+.|+|++
T Consensus       112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~  188 (239)
T 2xwt_C          112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK  188 (239)
T ss_dssp             EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred             CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence            55555544 222 44444444   5555555 55554445556666666 6666666665333333333 5666666666


Q ss_pred             cc-ccccCCccccCC-CCCCeeccCCCcccccCchhhhhhccCCeeeCCCC
Q 003301          497 NG-LQGSIPKSIGGL-VSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFN  545 (832)
Q Consensus       497 N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N  545 (832)
                      |+ +++..+..|..+ ++|+.|||++|++++..+.   .+++|+.|+++++
T Consensus       189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             CTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred             CCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence            63 665555666666 6667777777666643333   4556666666654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=3.5e-25  Score=251.92  Aligned_cols=156  Identities=21%  Similarity=0.251  Sum_probs=123.2

Q ss_pred             CCCCeeeccCCceEEEEEecCCcEEEEEEEeccc--------hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          662 NASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--------EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       662 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      ...+.||+|+||+||+|+. .++.+|+|+.....        ....+++.+|++++++++||||+++..++...+..|+|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4567999999999999955 67889999865432        11235688999999999999999777777677788999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      |||+++++|.++++.         +..++.|++.|++|||   ++||+||||||+||+++.  .+||+|||+|+......
T Consensus       418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            999999999999875         4589999999999999   999999999999999998  99999999999875543


Q ss_pred             ccc------cccccccccccCCCCC
Q 003301          814 SMK------QTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~------~~~~~gt~~y~APE~l  832 (832)
                      ...      ....+||+.|||||++
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~  508 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIW  508 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHH
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHH
Confidence            221      1245799999999974

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.91  E-value=5.5e-26  Score=247.26  Aligned_cols=258  Identities=19%  Similarity=0.176  Sum_probs=149.0

Q ss_pred             eeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCC----CcccccccccceEEeecCcccccccccccCc--
Q 003301          269 WLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLP----SSIGNLSLSLSRIFISNCSIRGTIPKEIGNL--  342 (832)
Q Consensus       269 ~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l--  342 (832)
                      ++.+++|.+++     .++..+...++|++|+|++|.+++..+    ..+..++.+|++|++++|.+++..+..+..+  
T Consensus         2 ~~~ls~n~~~~-----~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~   76 (362)
T 3goz_A            2 NYKLTLHPGSN-----PVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILA   76 (362)
T ss_dssp             EEECCCCTTCC-----HHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHH
T ss_pred             ccccccccchH-----HHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHh
Confidence            35677777776     233334445558888888888776554    3444443357777777777776666655554  


Q ss_pred             ---CcccEEEeecCccccccccccc----CC-CCCceEEccCCccCCCCchhhcC-----CCCCcEEEecCCcCCCCCcc
Q 003301          343 ---INLRELGLWGNELIGSIPITFG----KL-QNLQGLDLVNNKLEGPIPNGLCQ-----LARLSVLYMDGNKLSGPIPP  409 (832)
Q Consensus       343 ---~~L~~L~L~~N~l~~~~~~~~~----~l-~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~~~p~  409 (832)
                         ++|++|+|++|++++..+..+.    .+ ++|++|+|++|++++..+..++.     .++|++|+|++|++++..+.
T Consensus        77 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~  156 (362)
T 3goz_A           77 AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSD  156 (362)
T ss_dssp             TSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHH
T ss_pred             ccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHH
Confidence               6677777777776655554333    33 66777777777776555544332     24677777777776643332


Q ss_pred             ----cCCCCC-CCCeEeCCCCcCCCCCCccccc----C-cccceeeecCCcccCC----Ccccccc-ccccceecccCcc
Q 003301          410 ----CIGDLT-SLRLLSLASNELNSVIPSTFWN----L-KDILSLNFSSNFLNGS----LPEDIGN-LKVVVIIDLSRNN  474 (832)
Q Consensus       410 ----~~~~l~-~L~~L~L~~N~l~~~~~~~~~~----l-~~L~~L~Ls~N~l~~~----~~~~~~~-l~~L~~L~Ls~N~  474 (832)
                          .+..++ +|++|+|++|++++..+..+..    . ++|++|+|++|.+++.    ++..+.. .++|+.|||++|+
T Consensus       157 ~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~  236 (362)
T 3goz_A          157 ELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNC  236 (362)
T ss_dssp             HHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSC
T ss_pred             HHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCC
Confidence                233443 6777777777766655544332    2 4666666666666642    2333333 2366666666666


Q ss_pred             cCCccC----Cccccccccceeeccccccccc-------CCccccCCCCCCeeccCCCcccccCchhh
Q 003301          475 LSGDIP----TAIGGLMNLQDLSLRDNGLQGS-------IPKSIGGLVSLESLDLSNNSLSGNIPTSM  531 (832)
Q Consensus       475 l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~-------~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  531 (832)
                      +++..+    ..+..+++|+.|+|++|.+.+.       ++..+..+++|+.||+++|++.+..+..+
T Consensus       237 l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~~  304 (362)
T 3goz_A          237 LHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPI  304 (362)
T ss_dssp             CCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCHHH
T ss_pred             CCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchHHH
Confidence            665433    2334556666666666664322       22345556666666666666665544443

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=1.4e-23  Score=215.80  Aligned_cols=180  Identities=26%  Similarity=0.277  Sum_probs=140.5

Q ss_pred             ccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEec
Q 003301          320 SLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMD  399 (832)
Q Consensus       320 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  399 (832)
                      ..++++++++.++ .+|..+.  ++++.|+|++|++.+..+..|.++++|++|+|++|++++..+..|..+++|++|+|+
T Consensus        15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~   91 (251)
T 3m19_A           15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA   91 (251)
T ss_dssp             GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence            6789999999998 4565554  689999999999999999999999999999999999998888889999999999999


Q ss_pred             CCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCcc
Q 003301          400 GNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDI  479 (832)
Q Consensus       400 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  479 (832)
                      +|++++..+..|..+++|++|+|++|+++++.+..|..+++|++|+|++|++++..+.                      
T Consensus        92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~----------------------  149 (251)
T 3m19_A           92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAG----------------------  149 (251)
T ss_dssp             TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT----------------------
T ss_pred             CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHH----------------------
Confidence            9999988888999999999999999999887666666666666666666666544443                      


Q ss_pred             CCccccccccceeecccccccccCCccccCCCCCCeeccCCCccccc
Q 003301          480 PTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGN  526 (832)
Q Consensus       480 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  526 (832)
                        .|+++++|+.|+|++|++++..+..|..+++|+.|+|++|++++.
T Consensus       150 --~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          150 --AFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             --TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             --HcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence              444455555555555555544445555566666666666666554

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.91  E-value=8.8e-25  Score=239.25  Aligned_cols=166  Identities=20%  Similarity=0.354  Sum_probs=140.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCC-----------CCceeeeceEEe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVR-----------HRNLVKIISSCT  725 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~  725 (832)
                      .++|++.+.||+|+||+||+|++. +++.||||++.... ...+.+.+|++++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            468999999999999999999875 58999999987543 33467788999988876           899999999987


Q ss_pred             cCC----eeEEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCeEeC------
Q 003301          726 NND----FKALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSN-PVVHCDIKPSNVLLD------  793 (832)
Q Consensus       726 ~~~----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIl~~------  793 (832)
                      ..+    ..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||   ++ ||+||||||+||+++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence            654    789999999 899999998643 35899999999999999999999   87 999999999999994      


Q ss_pred             CCCcEEEeccccccccCCCcccccccccccccccCCCCC
Q 003301          794 KDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       794 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ..+.+||+|||+|+.....    .....||+.|+|||++
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~  207 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVL  207 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHH
T ss_pred             CcceEEEcccccccccCCC----CCCCCCCccccCcHHH
Confidence            4458999999999876432    2234699999999963

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.90  E-value=6.9e-24  Score=216.39  Aligned_cols=197  Identities=19%  Similarity=0.213  Sum_probs=164.6

Q ss_pred             ccceEEeecCcccccccccccCcCcccEEEeecCc-ccccccccccCCCCCceEEccC-CccCCCCchhhcCCCCCcEEE
Q 003301          320 SLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNE-LIGSIPITFGKLQNLQGLDLVN-NKLEGPIPNGLCQLARLSVLY  397 (832)
Q Consensus       320 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~  397 (832)
                      ++++|++++|++++..+..|.++++|++|++++|+ +++..+..|.++++|++|++++ |++++..+..|..+++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            67777888888877777788888999999999997 8877777888999999999998 888876677888899999999


Q ss_pred             ecCCcCCCCCcccCCCCCCCC---eEeCCCC-cCCCCCCcccccCcccc-eeeecCCcccCCCccccccccccceecccC
Q 003301          398 MDGNKLSGPIPPCIGDLTSLR---LLSLASN-ELNSVIPSTFWNLKDIL-SLNFSSNFLNGSLPEDIGNLKVVVIIDLSR  472 (832)
Q Consensus       398 L~~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  472 (832)
                      +++|++++ +|. |..+++|+   .|++++| .++++.+..|.++++|+ +|++++|+++...+..+.. ++|+.|+|++
T Consensus       112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~  188 (239)
T 2xwt_C          112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK  188 (239)
T ss_dssp             EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred             CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence            99999986 565 88888888   9999999 89888888899999999 9999999998544444555 8999999999


Q ss_pred             cc-cCCccCCccccc-cccceeecccccccccCCccccCCCCCCeeccCCCc
Q 003301          473 NN-LSGDIPTAIGGL-MNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNS  522 (832)
Q Consensus       473 N~-l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  522 (832)
                      |+ +++..+..|.++ ++|+.|++++|++++ +|..  .+++|+.|+++++.
T Consensus       189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~~  237 (239)
T 2xwt_C          189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNTW  237 (239)
T ss_dssp             CTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC-
T ss_pred             CCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCcc
Confidence            95 987778889999 999999999999985 4544  67789999998763

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.90  E-value=3.7e-24  Score=227.56  Aligned_cols=201  Identities=18%  Similarity=0.204  Sum_probs=148.3

Q ss_pred             ccceEEeecCcccccccccc--cCcCcccEEEeecCccccccc----ccccCCCCCceEEccCCccCCCCchhhcCCCCC
Q 003301          320 SLSRIFISNCSIRGTIPKEI--GNLINLRELGLWGNELIGSIP----ITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARL  393 (832)
Q Consensus       320 ~L~~L~l~~n~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  393 (832)
                      +|++|++++|.+++..|..+  ..+++|++|+|++|.+.+..+    ..+..+++|++|+|++|++++..+..+..+++|
T Consensus        92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L  171 (310)
T 4glp_A           92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL  171 (310)
T ss_dssp             CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred             ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence            45666666666666666665  667777777777777765433    334567778888888888877777777778888


Q ss_pred             cEEEecCCcCCCC--C--cccCCCCCCCCeEeCCCCcCCCCCCc---ccccCcccceeeecCCcccCCCccccccc---c
Q 003301          394 SVLYMDGNKLSGP--I--PPCIGDLTSLRLLSLASNELNSVIPS---TFWNLKDILSLNFSSNFLNGSLPEDIGNL---K  463 (832)
Q Consensus       394 ~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l---~  463 (832)
                      ++|+|++|++.+.  +  +..+..+++|++|+|++|+++...+.   .+..+++|++|+|++|++++..|..+..+   +
T Consensus       172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~  251 (310)
T 4glp_A          172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSS  251 (310)
T ss_dssp             CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCT
T ss_pred             CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcC
Confidence            8888888876542  1  23346788888888888888643222   35677888888888888888777777776   6


Q ss_pred             ccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccc
Q 003301          464 VVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSG  525 (832)
Q Consensus       464 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  525 (832)
                      +|++|+|++|+++ .+|..+.  ++|+.|+|++|+|++. |. +..+++|+.|+|++|+++.
T Consensus       252 ~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          252 ALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             TCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred             cCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence            8999999999998 6677664  7899999999999864 43 6788999999999999874

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.90  E-value=2.9e-26  Score=252.04  Aligned_cols=250  Identities=18%  Similarity=0.184  Sum_probs=113.5

Q ss_pred             CccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCC---CCCCCcccccccccceEEeecCccccc
Q 003301          258 PNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPIN---GVLPSSIGNLSLSLSRIFISNCSIRGT  334 (832)
Q Consensus       258 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~---~~~~~~~~~~~~~L~~L~l~~n~l~~~  334 (832)
                      +..+..+++|++|+|++|.++..... .+...+..+++|++|+|++|.+.   +.+|..+..                  
T Consensus        25 ~~~l~~~~~L~~L~L~~n~i~~~~~~-~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~------------------   85 (386)
T 2ca6_A           25 FAVLLEDDSVKEIVLSGNTIGTEAAR-WLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRL------------------   85 (386)
T ss_dssp             SHHHHHCSCCCEEECTTSEECHHHHH-HHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHH------------------
T ss_pred             HHHHhcCCCccEEECCCCCCCHHHHH-HHHHHHHhCCCccEEeCcccccCccccchhHHHHH------------------
Confidence            34445555566666666655542111 12223445555555555554332   111211110                  


Q ss_pred             ccccccCcCcccEEEeecCcccc----cccccccCCCCCceEEccCCccCCCCchhhcC----C---------CCCcEEE
Q 003301          335 IPKEIGNLINLRELGLWGNELIG----SIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQ----L---------ARLSVLY  397 (832)
Q Consensus       335 ~~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~----l---------~~L~~L~  397 (832)
                      +...+..+++|++|+|++|.+.+    .++..+..+++|++|+|++|.+++..+..++.    +         ++|++|+
T Consensus        86 l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~  165 (386)
T 2ca6_A           86 LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSII  165 (386)
T ss_dssp             HHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEE
T ss_pred             HHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEE
Confidence            11223555666666666666654    34555556666666666666665333322222    2         5555555


Q ss_pred             ecCCcCC-CCCc---ccCCCCCCCCeEeCCCCcCCC-----CCCcccccCcccceeeecCCccc----CCCccccccccc
Q 003301          398 MDGNKLS-GPIP---PCIGDLTSLRLLSLASNELNS-----VIPSTFWNLKDILSLNFSSNFLN----GSLPEDIGNLKV  464 (832)
Q Consensus       398 L~~N~l~-~~~p---~~~~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~Ls~N~l~----~~~~~~~~~l~~  464 (832)
                      +++|+++ +.++   ..+..+++|+.|++++|+++.     ..+..+..+++|++|+|++|.++    +.+|..+..+++
T Consensus       166 L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~  245 (386)
T 2ca6_A          166 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN  245 (386)
T ss_dssp             CCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTT
T ss_pred             CCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCC
Confidence            5555554 2222   234445555555555555541     22224444444445555544443    233444444444


Q ss_pred             cceecccCcccCCc----cCCcc--ccccccceeecccccccc----cCCccc-cCCCCCCeeccCCCccccc
Q 003301          465 VVIIDLSRNNLSGD----IPTAI--GGLMNLQDLSLRDNGLQG----SIPKSI-GGLVSLESLDLSNNSLSGN  526 (832)
Q Consensus       465 L~~L~Ls~N~l~~~----~~~~~--~~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~Ls~N~l~~~  526 (832)
                      |+.|+|++|++++.    +|..+  +.+++|+.|+|++|.+++    .+|..+ ..+++|++|+|++|++++.
T Consensus       246 L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~  318 (386)
T 2ca6_A          246 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE  318 (386)
T ss_dssp             CCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred             cCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcc
Confidence            44444444444432    22333  124444444444444443    233333 3344444444444444433

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.90  E-value=6.6e-26  Score=249.21  Aligned_cols=246  Identities=22%  Similarity=0.261  Sum_probs=194.4

Q ss_pred             cccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecC---ccccccccc
Q 003301          286 FLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGN---ELIGSIPIT  362 (832)
Q Consensus       286 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N---~l~~~~~~~  362 (832)
                      ++..+..+++|++|+|++|.+.+..+.                     .++..+..+++|++|+|++|   ++.+.+|..
T Consensus        24 l~~~l~~~~~L~~L~L~~n~i~~~~~~---------------------~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~   82 (386)
T 2ca6_A           24 VFAVLLEDDSVKEIVLSGNTIGTEAAR---------------------WLSENIASKKDLEIAEFSDIFTGRVKDEIPEA   82 (386)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHH---------------------HHHHTTTTCTTCCEEECCSCCTTSCGGGSHHH
T ss_pred             HHHHHhcCCCccEEECCCCCCCHHHHH---------------------HHHHHHHhCCCccEEeCcccccCccccchhHH
Confidence            334456667777777777766532111                     13344667888888888885   344444544


Q ss_pred             c-------cCCCCCceEEccCCccCC----CCchhhcCCCCCcEEEecCCcCCCCCcccCC----CC---------CCCC
Q 003301          363 F-------GKLQNLQGLDLVNNKLEG----PIPNGLCQLARLSVLYMDGNKLSGPIPPCIG----DL---------TSLR  418 (832)
Q Consensus       363 ~-------~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~l---------~~L~  418 (832)
                      +       ..+++|++|+|++|++++    .+|..+..+++|++|+|++|.+++..+..+.    .+         ++|+
T Consensus        83 ~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~  162 (386)
T 2ca6_A           83 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLR  162 (386)
T ss_dssp             HHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred             HHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCc
Confidence            4       789999999999999997    4777889999999999999999754444333    33         8999


Q ss_pred             eEeCCCCcCC-CCCC---cccccCcccceeeecCCcccC-----CCccccccccccceecccCcccC----CccCCcccc
Q 003301          419 LLSLASNELN-SVIP---STFWNLKDILSLNFSSNFLNG-----SLPEDIGNLKVVVIIDLSRNNLS----GDIPTAIGG  485 (832)
Q Consensus       419 ~L~L~~N~l~-~~~~---~~~~~l~~L~~L~Ls~N~l~~-----~~~~~~~~l~~L~~L~Ls~N~l~----~~~~~~~~~  485 (832)
                      +|++++|+++ ...+   ..|..+++|++|++++|+++.     ..|..+..+++|+.|+|++|.++    +.+|..+..
T Consensus       163 ~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~  242 (386)
T 2ca6_A          163 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS  242 (386)
T ss_dssp             EEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGG
T ss_pred             EEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHcc
Confidence            9999999997 3344   467788999999999999983     34558889999999999999996    578889999


Q ss_pred             ccccceeeccccccccc----CCccc--cCCCCCCeeccCCCcccc----cCchhh-hhhccCCeeeCCCCcccccCC
Q 003301          486 LMNLQDLSLRDNGLQGS----IPKSI--GGLVSLESLDLSNNSLSG----NIPTSM-EKLLYLKDLNLSFNKLEGEIP  552 (832)
Q Consensus       486 l~~L~~L~Ls~N~l~~~----~p~~~--~~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~l~l~~N~l~~~~p  552 (832)
                      +++|+.|+|++|++++.    +|..+  +.+++|+.|+|++|.+++    .+|..+ .++++|++|++++|++++..|
T Consensus       243 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             CTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             CCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence            99999999999999876    56666  449999999999999998    588887 668999999999999986554

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.89  E-value=2.3e-23  Score=220.86  Aligned_cols=193  Identities=25%  Similarity=0.401  Sum_probs=104.4

Q ss_pred             CcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeE
Q 003301          341 NLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLL  420 (832)
Q Consensus       341 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  420 (832)
                      .+++|++|++++|.+.. ++ .+..+++|++|+|++|++++..+  +..+++|++|++++|++++. + .+..+++|+.|
T Consensus        39 ~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L  112 (308)
T 1h6u_A           39 DLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIKTL  112 (308)
T ss_dssp             HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEE
T ss_pred             HcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEE
Confidence            34445555555555443 22 34455555555555555553222  55555555555555555532 2 35555555555


Q ss_pred             eCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeeccccccc
Q 003301          421 SLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQ  500 (832)
Q Consensus       421 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  500 (832)
                      ++++|++++..+  +..+++|++|++++|++++..+  ++.+++|+.|+|++|++++..+  +.++++|+.|+|++|+++
T Consensus       113 ~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~  186 (308)
T 1h6u_A          113 DLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS  186 (308)
T ss_dssp             ECTTSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             ECCCCCCCCchh--hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccC
Confidence            555555554322  5555555555555555554322  5555666666666666654322  556666666666666665


Q ss_pred             ccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccc
Q 003301          501 GSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEG  549 (832)
Q Consensus       501 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~  549 (832)
                      +..+  +..+++|+.|+|++|++++..|  +..+++|+.|++++|++++
T Consensus       187 ~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          187 DISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             CCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred             cChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence            4332  5566666666666666664432  5566666666666666654

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.89  E-value=9.7e-25  Score=235.21  Aligned_cols=250  Identities=20%  Similarity=0.219  Sum_probs=182.6

Q ss_pred             CcEEeccCCCCCCCCCCccccc-ccccceEEeecCcccccccccccCcCcccEEEeecCccccc-ccccccCCCCCceEE
Q 003301          296 LKLLDLSNNPINGVLPSSIGNL-SLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGS-IPITFGKLQNLQGLD  373 (832)
Q Consensus       296 L~~L~L~~N~l~~~~~~~~~~~-~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~  373 (832)
                      ++.+++++|.+.   +..+..+ ...++.+++++|.+.+..+. +..+++|++|++++|.+.+. ++..+..+++|++|+
T Consensus        49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~  124 (336)
T 2ast_B           49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS  124 (336)
T ss_dssp             SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred             heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence            555666665554   2223332 12566666666666655444 44577788888888877655 666777788888888


Q ss_pred             ccCCccCCCCchhhcCCCCCcEEEecCC-cCCCC-CcccCCCCCCCCeEeCCCC-cCCCC-CCcccccCc-ccceeeecC
Q 003301          374 LVNNKLEGPIPNGLCQLARLSVLYMDGN-KLSGP-IPPCIGDLTSLRLLSLASN-ELNSV-IPSTFWNLK-DILSLNFSS  448 (832)
Q Consensus       374 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L~~L~Ls~  448 (832)
                      |++|++++..+..+..+++|++|++++| .+++. ++..+..+++|++|++++| .+++. .+..+..++ +|++|++++
T Consensus       125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~  204 (336)
T 2ast_B          125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG  204 (336)
T ss_dssp             CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred             CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence            8888877777777778888888888888 56642 5556777888888888888 77654 466677788 888888888


Q ss_pred             C--ccc-CCCccccccccccceecccCcc-cCCccCCccccccccceeeccccc-ccccCCccccCCCCCCeeccCCCcc
Q 003301          449 N--FLN-GSLPEDIGNLKVVVIIDLSRNN-LSGDIPTAIGGLMNLQDLSLRDNG-LQGSIPKSIGGLVSLESLDLSNNSL  523 (832)
Q Consensus       449 N--~l~-~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l  523 (832)
                      |  .++ +.+|..+..+++|+.|++++|. +++..+..+.++++|+.|++++|. +.......++.+++|+.|++++| +
T Consensus       205 ~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i  283 (336)
T 2ast_B          205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-V  283 (336)
T ss_dssp             CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-S
T ss_pred             CcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-c
Confidence            8  444 3466777889999999999999 777788889999999999999995 33222236888999999999999 3


Q ss_pred             cccCchhhhhhc-cCCeeeCCCCcccccCCC
Q 003301          524 SGNIPTSMEKLL-YLKDLNLSFNKLEGEIPR  553 (832)
Q Consensus       524 ~~~~p~~~~~l~-~L~~l~l~~N~l~~~~p~  553 (832)
                      +   ...+..+. .++.|++++|++++..|.
T Consensus       284 ~---~~~~~~l~~~l~~L~l~~n~l~~~~~~  311 (336)
T 2ast_B          284 P---DGTLQLLKEALPHLQINCSHFTTIARP  311 (336)
T ss_dssp             C---TTCHHHHHHHSTTSEESCCCSCCTTCS
T ss_pred             C---HHHHHHHHhhCcceEEecccCccccCC
Confidence            3   33455553 488889999999998886

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.89  E-value=2.4e-23  Score=218.18  Aligned_cols=144  Identities=14%  Similarity=0.077  Sum_probs=129.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.+.||+|+||.||+|.+.. ++.||||++....   ....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            679999999999999999999865 8999999987553   233477889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      ||++|++|.++++..   ....++.+++.|++.||+|||   ++||+||||||+||+++.++.+||+++|....
T Consensus       111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~~~~~  178 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPATMPD  178 (286)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCCCCTT
T ss_pred             EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEeccccCC
Confidence            999999999999643   356678899999999999999   99999999999999999999999998877543

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.89  E-value=6e-23  Score=217.58  Aligned_cols=213  Identities=19%  Similarity=0.329  Sum_probs=124.0

Q ss_pred             cccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCc
Q 003301          265 RKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLIN  344 (832)
Q Consensus       265 ~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~  344 (832)
                      .++..+.+..+.++..       ..+..+++|++|++++|.+.. ++                          .+..+++
T Consensus        19 ~~~~~~~l~~~~~~~~-------~~~~~l~~L~~L~l~~~~i~~-l~--------------------------~~~~l~~   64 (308)
T 1h6u_A           19 ANAIKIAAGKSNVTDT-------VTQADLDGITTLSAFGTGVTT-IE--------------------------GVQYLNN   64 (308)
T ss_dssp             HHHHHHHTTCSSTTSE-------ECHHHHHTCCEEECTTSCCCC-CT--------------------------TGGGCTT
T ss_pred             HHHHHHHhCCCCcCce-------ecHHHcCCcCEEEeeCCCccC-ch--------------------------hhhccCC
Confidence            3444455555555441       123556777777777777653 22                          2344555


Q ss_pred             ccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCC
Q 003301          345 LRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLAS  424 (832)
Q Consensus       345 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  424 (832)
                      |++|++++|++.+..+  +..+++|++|+|++|++++ ++ .+..+++|++|++++|++++. +. +..+++|+.|++++
T Consensus        65 L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~  138 (308)
T 1h6u_A           65 LIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDV-TP-LAGLSNLQVLYLDL  138 (308)
T ss_dssp             CCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCC-GG-GTTCTTCCEEECCS
T ss_pred             CCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCCc-hh-hcCCCCCCEEECCC
Confidence            5555555555554333  5555566666666666553 22 455556666666666666542 22 56666666666666


Q ss_pred             CcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCC
Q 003301          425 NELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIP  504 (832)
Q Consensus       425 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  504 (832)
                      |.+++..+  +..+++|++|++++|++++..+  +..+++|+.|++++|++++..+  +..+++|+.|+|++|++++.. 
T Consensus       139 n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~-  211 (308)
T 1h6u_A          139 NQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS-  211 (308)
T ss_dssp             SCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG-
T ss_pred             CccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc-
Confidence            66655433  5566666666666666664322  6666666666666666664333  666667777777777776443 


Q ss_pred             ccccCCCCCCeeccCCCcccc
Q 003301          505 KSIGGLVSLESLDLSNNSLSG  525 (832)
Q Consensus       505 ~~~~~l~~L~~L~Ls~N~l~~  525 (832)
                       .+..+++|+.|+|++|++++
T Consensus       212 -~l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          212 -PLANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             -GGTTCTTCCEEEEEEEEEEC
T ss_pred             -cccCCCCCCEEEccCCeeec
Confidence             26666777777777777764

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.89  E-value=5.1e-23  Score=222.56  Aligned_cols=202  Identities=16%  Similarity=0.121  Sum_probs=85.6

Q ss_pred             EEEccCCcCCCCCCCcccCcccccccccccccccccCCChhhhhcCCCceEEEccCCcccccCC-CCccCCCCccE-EEC
Q 003301           49 LVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIP-NNIWQCKELIV-ISL  126 (832)
Q Consensus        49 ~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~-L~L  126 (832)
                      +++.++++++ .+|..+.  +++ ++|+|++|+|+ .+|.+.|.++++|++|+|++|++.+.+| ..|.+++++++ +.+
T Consensus        13 ~v~C~~~~Lt-~iP~~l~--~~l-~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~   87 (350)
T 4ay9_X           13 VFLCQESKVT-EIPSDLP--RNA-IELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   87 (350)
T ss_dssp             EEEEESTTCC-SCCTTCC--TTC-SEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred             EEEecCCCCC-ccCcCcC--CCC-CEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence            3444444444 4444331  222 44444444444 3444433344444444444444433222 23344444332 333


Q ss_pred             cCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccc-cccccccCcccccCCcccEEEecCCCCCC
Q 003301          127 AYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQL-NKLVGFVPTSIFNLSAMKTLALPSNALSG  205 (832)
Q Consensus       127 s~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~n~l~~  205 (832)
                      ++|+++...|+.|..+++|++|++++|+++...+..+....++..|++.+ +++..+.+.+|..+.              
T Consensus        88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~--------------  153 (350)
T 4ay9_X           88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS--------------  153 (350)
T ss_dssp             EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSB--------------
T ss_pred             cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcc--------------
Confidence            34444444444444444444444444444433333333333444444432 333333333333332              


Q ss_pred             CCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcC-CCcCcccCCccccCccccceeecccccCCCCC
Q 003301          206 SLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELG-ENSFSGFIPNTLGNLRKLEWLRLSYNFLTSST  281 (832)
Q Consensus       206 ~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~-~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~  281 (832)
                                 ..++.|+|++|+|+.+.+..| ...+|++|+++ +|.++.+.+++|.++++|++|+|++|+|+.++
T Consensus       154 -----------~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp  218 (350)
T 4ay9_X          154 -----------FESVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP  218 (350)
T ss_dssp             -----------SSCEEEECCSSCCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCC
T ss_pred             -----------hhhhhhccccccccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccC
Confidence                       234444555555544333333 23345555554 24444444444555555555555555555443

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.89  E-value=1.1e-22  Score=219.95  Aligned_cols=243  Identities=16%  Similarity=0.165  Sum_probs=167.8

Q ss_pred             cEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccc-cccccCCCCCce-EEc
Q 003301          297 KLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSI-PITFGKLQNLQG-LDL  374 (832)
Q Consensus       297 ~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~-L~L  374 (832)
                      ++++.++++++ .+|..+.   .++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+ +.+|.+++++++ +++
T Consensus        12 ~~v~C~~~~Lt-~iP~~l~---~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~   87 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   87 (350)
T ss_dssp             TEEEEESTTCC-SCCTTCC---TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred             CEEEecCCCCC-ccCcCcC---CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence            45566666665 4454442   26777777777777655667888888888888888876544 456777777664 566


Q ss_pred             cCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCC-CcCCCCCCcccccCc-ccceeeecCCccc
Q 003301          375 VNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLAS-NELNSVIPSTFWNLK-DILSLNFSSNFLN  452 (832)
Q Consensus       375 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~  452 (832)
                      +.|+++...|..|..+++|++|++++|++++..+..+....++..|++.+ |.+..+.+..|..+. .++.|+|++|+|+
T Consensus        88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~  167 (350)
T 4ay9_X           88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ  167 (350)
T ss_dssp             EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred             cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence            67788876677788888888888888888866666676777777787754 567777777777765 5777888888888


Q ss_pred             CCCccccccccccceecccC-cccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhh
Q 003301          453 GSLPEDIGNLKVVVIIDLSR-NNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSM  531 (832)
Q Consensus       453 ~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  531 (832)
                      . +|.......+|+.|++++ |.++...+.+|.++++|+.|+|++|+|+...+..|.++++|+.+++.  .+. .+| .+
T Consensus       168 ~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~~--~l~-~lP-~l  242 (350)
T 4ay9_X          168 E-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY--NLK-KLP-TL  242 (350)
T ss_dssp             E-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTCT--TCC-CCC-CT
T ss_pred             C-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccCC--CcC-cCC-Cc
Confidence            5 444444556788888874 66665555678888888888888888885555556665555555442  343 455 36


Q ss_pred             hhhccCCeeeCCCCccc
Q 003301          532 EKLLYLKDLNLSFNKLE  548 (832)
Q Consensus       532 ~~l~~L~~l~l~~N~l~  548 (832)
                      ..+++|+.++++++.-+
T Consensus       243 ~~l~~L~~l~l~~~~~c  259 (350)
T 4ay9_X          243 EKLVALMEASLTYPSHC  259 (350)
T ss_dssp             TTCCSCCEEECSCHHHH
T ss_pred             hhCcChhhCcCCCCccc
Confidence            77888888888765433

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.89  E-value=1e-22  Score=215.43  Aligned_cols=148  Identities=24%  Similarity=0.392  Sum_probs=129.2

Q ss_pred             hcCCCCC-CeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHH-hcCCCCceeeeceEEec----CCee
Q 003301          658 TNQFNAS-NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVL-KSVRHRNLVKIISSCTN----NDFK  730 (832)
Q Consensus       658 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~  730 (832)
                      .++|.+. +.||+|+||.||+|.+. +++.||+|++...     ..+.+|++++ +..+||||+++++++..    +...
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            4667776 78999999999999885 5899999998643     4567788887 56699999999999876    6678


Q ss_pred             EEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC---CCcEEEeccccc
Q 003301          731 ALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK---DMVAHLSDFGIA  806 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~DFg~a  806 (832)
                      |+||||+++|+|.+++.... ..+++..+..++.|++.||+|||   +.||+||||||+||+++.   ++.+||+|||+|
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999998754 35899999999999999999999   999999999999999998   789999999999


Q ss_pred             cccCCCc
Q 003301          807 KLLSGEE  813 (832)
Q Consensus       807 ~~~~~~~  813 (832)
                      .......
T Consensus       168 ~~~~~~~  174 (299)
T 3m2w_A          168 KETTGEK  174 (299)
T ss_dssp             EECTTCG
T ss_pred             ccccccc
Confidence            8765443

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.88  E-value=6.2e-24  Score=228.88  Aligned_cols=252  Identities=17%  Similarity=0.210  Sum_probs=164.1

Q ss_pred             ccccccccccccCCChhhhhcC--CCceEEEccCCcccccCCCCccCCCCccEEECcCCccccc-CCCCCcCCCcCceEE
Q 003301           73 TGMDFSNNSLTGSLPDDMCRRL--PLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTER-IPRGLGNLTSLKTLY  149 (832)
Q Consensus        73 ~~L~ls~n~l~~~lp~~~~~~l--~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~-~p~~~~~l~~L~~L~  149 (832)
                      +.+|+++|.+.    +..+..+  +.++.|++++|.+++..+. +..+++|++|++++|.+++. +|..+..+++|++|+
T Consensus        50 ~~l~l~~~~~~----~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~  124 (336)
T 2ast_B           50 QTLDLTGKNLH----PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS  124 (336)
T ss_dssp             SEEECTTCBCC----HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred             eeeccccccCC----HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence            66677776554    2223345  6777788888877755444 55677788888888777654 666677777888888


Q ss_pred             ecccccccccCccccCccccceeccccc-ccccc-cCcccccCCcccEEEecCC-CCCCC-CCccccccCCC-CccEEEc
Q 003301          150 LGFNNLTGEIPYEMGNLRNLEILGLQLN-KLVGF-VPTSIFNLSAMKTLALPSN-ALSGS-LPSSIDLVRLP-NLEIISL  224 (832)
Q Consensus       150 Ls~N~i~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~L~~n-~l~~~-~p~~~~~~~l~-~L~~L~L  224 (832)
                      |++|.+++..+..++.+++|++|++++| .+++. ++..+.++++|++|++++| .+++. ++..  +..++ +|++|++
T Consensus       125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~--~~~l~~~L~~L~l  202 (336)
T 2ast_B          125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA--VAHVSETITQLNL  202 (336)
T ss_dssp             CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHH--HHHSCTTCCEEEC
T ss_pred             CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHH--HHhcccCCCEEEe
Confidence            8888777667777777788888888877 56542 4555677778888888887 76632 2322  34567 7788888


Q ss_pred             cCC--ccc-cccCCcccCCCCccEEEcCCCc-CcccCCccccCccccceeeccccc-CCCCCCccccccccccCCCCcEE
Q 003301          225 AGN--NFS-GIIPSFIFNASKLSVLELGENS-FSGFIPNTLGNLRKLEWLRLSYNF-LTSSTSELSFLSSWANCKNLKLL  299 (832)
Q Consensus       225 s~n--~i~-~~~~~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~~~~~l~~L~~L  299 (832)
                      ++|  .++ ...+..+..+++|++|++++|. +++..+..+..+++|++|++++|. +..     .....+..+++|+.|
T Consensus       203 ~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~-----~~~~~l~~~~~L~~L  277 (336)
T 2ast_B          203 SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP-----ETLLELGEIPTLKTL  277 (336)
T ss_dssp             CSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCG-----GGGGGGGGCTTCCEE
T ss_pred             CCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCH-----HHHHHHhcCCCCCEE
Confidence            877  344 3445566677888888888887 666666677777888888888875 221     112346677888888


Q ss_pred             eccCCCCCCCCCCcccccccccceEEeecCccccccccccc
Q 003301          300 DLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIG  340 (832)
Q Consensus       300 ~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~  340 (832)
                      ++++| ++   ...+..+...++.|++++|++++..|..++
T Consensus       278 ~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~  314 (336)
T 2ast_B          278 QVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIG  314 (336)
T ss_dssp             ECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred             eccCc-cC---HHHHHHHHhhCcceEEecccCccccCCccc
Confidence            88877 32   223333322355555555555555554443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.88  E-value=1.5e-23  Score=231.88  Aligned_cols=166  Identities=17%  Similarity=0.202  Sum_probs=126.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch---hhHHHHHHHHHHHhcCCC-Cceee-------------
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE---GALKSFDVECEVLKSVRH-RNLVK-------------  719 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~niv~-------------  719 (832)
                      ...|...+.||+|+||+||+|.+. +|+.||||++.....   ...+.+.+|+.+++.++| ++...             
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            345778899999999999999975 589999999874332   235778999999999976 22111             


Q ss_pred             --------eceEEec-----CCeeEEEEecCCCCCHHHHHh------hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 003301          720 --------IISSCTN-----NDFKALVLEYMPNGSLEDYLY------SNNFSFDILQRLSVIIDVALALEYLHFGYSNPV  780 (832)
Q Consensus       720 --------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  780 (832)
                              +..++..     ....+++|+++ +++|.++++      .....+++..+..++.|++.||+|||   ++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence                    1111111     12457788877 789999984      22334778889999999999999999   9999


Q ss_pred             EecCCCCCCeEeCCCCcEEEeccccccccCCCcccccccccccccccCCCCC
Q 003301          781 VHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       781 vH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +||||||+|||++.++.+||+|||+|+.....    ....+| +.|||||++
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~  279 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETT  279 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhh
Confidence            99999999999999999999999999875332    233567 999999963

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.87  E-value=8.5e-23  Score=212.73  Aligned_cols=141  Identities=16%  Similarity=0.155  Sum_probs=115.4

Q ss_pred             HHHHHhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccch------------------hhHHHHHHHHHHHhcCCC
Q 003301          653 ELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLE------------------GALKSFDVECEVLKSVRH  714 (832)
Q Consensus       653 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h  714 (832)
                      .+......|.+.+.||+|+||.||+|.+.+|+.||+|+++....                  .....+.+|++++++++ 
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-  162 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-  162 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence            34455567778899999999999999996799999999864321                  13456889999999998 


Q ss_pred             CceeeeceEEecCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC
Q 003301          715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK  794 (832)
Q Consensus       715 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~  794 (832)
                       | +++.+++.. +..|+||||++|++|.+ +..       .....++.|++.|++|||   +.||+||||||+||+++ 
T Consensus       163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-  227 (282)
T 1zar_A          163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-  227 (282)
T ss_dssp             -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-
T ss_pred             -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-
Confidence             4 666665544 55699999999999988 422       124469999999999999   99999999999999999 


Q ss_pred             CCcEEEecccccccc
Q 003301          795 DMVAHLSDFGIAKLL  809 (832)
Q Consensus       795 ~~~~kl~DFg~a~~~  809 (832)
                      ++.+||+|||+|+..
T Consensus       228 ~~~vkl~DFG~a~~~  242 (282)
T 1zar_A          228 EEGIWIIDFPQSVEV  242 (282)
T ss_dssp             TTEEEECCCTTCEET
T ss_pred             CCcEEEEECCCCeEC
Confidence            999999999999854

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.87  E-value=1.3e-21  Score=194.75  Aligned_cols=132  Identities=26%  Similarity=0.231  Sum_probs=58.4

Q ss_pred             cccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCC
Q 003301          344 NLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLA  423 (832)
Q Consensus       344 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  423 (832)
                      +|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+++
T Consensus        29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  108 (208)
T 2o6s_A           29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN  108 (208)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence            34444444444444444444444444444444444443333334444444444444444443333334444444444444


Q ss_pred             CCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCccc
Q 003301          424 SNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNL  475 (832)
Q Consensus       424 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  475 (832)
                      +|++++..+..|..+++|++|++++|++++..+..+..+++|+.|++++|.+
T Consensus       109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~  160 (208)
T 2o6s_A          109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPW  160 (208)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCB
T ss_pred             CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCe
Confidence            4444444444444444444444444444433333334444444444444433

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.87  E-value=7.8e-22  Score=196.47  Aligned_cols=178  Identities=24%  Similarity=0.243  Sum_probs=96.5

Q ss_pred             cEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCC
Q 003301          346 RELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASN  425 (832)
Q Consensus       346 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  425 (832)
                      +.++.+++.++.. |..+  .++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++|
T Consensus        10 ~~v~c~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n   86 (208)
T 2o6s_A           10 TTVECYSQGRTSV-PTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN   86 (208)
T ss_dssp             TEEECCSSCCSSC-CSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCccCC-CCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence            3455555555532 2222  235666666666666544445556666666666666666554455566666666666666


Q ss_pred             cCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCc
Q 003301          426 ELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPK  505 (832)
Q Consensus       426 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  505 (832)
                      +++++.+..|..+++|++|++++|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+.+    
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~----  162 (208)
T 2o6s_A           87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC----  162 (208)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC----
T ss_pred             cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec----
Confidence            6665555555555555555555555555444445555555555555555554444445555555555555554442    


Q ss_pred             cccCCCCCCeeccCCCcccccCchhhhh
Q 003301          506 SIGGLVSLESLDLSNNSLSGNIPTSMEK  533 (832)
Q Consensus       506 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  533 (832)
                         .+++|+.|+++.|+++|.+|+.++.
T Consensus       163 ---~~~~l~~L~~~~n~~~g~ip~~~~~  187 (208)
T 2o6s_A          163 ---TCPGIRYLSEWINKHSGVVRNSAGS  187 (208)
T ss_dssp             ---CTTTTHHHHHHHHHCTTTBBCTTSS
T ss_pred             ---CCCCHHHHHHHHHhCCceeeccCcc
Confidence               2234555555555555555554443

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.86  E-value=1.5e-21  Score=221.80  Aligned_cols=189  Identities=24%  Similarity=0.343  Sum_probs=112.3

Q ss_pred             CCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEc
Q 003301          295 NLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDL  374 (832)
Q Consensus       295 ~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  374 (832)
                      +|+.|+|++|.+++ +|..+.   .+|++|++++|+|+ .+|   ..+                        ++|++|+|
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~---~~L~~L~Ls~N~l~-~ip---~~l------------------------~~L~~L~L  107 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP---PQITVLEITQNALI-SLP---ELP------------------------ASLEYLDA  107 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC---TTCSEEECCSSCCS-CCC---CCC------------------------TTCCEEEC
T ss_pred             CccEEEeCCCCCCc-cCHhHc---CCCCEEECcCCCCc-ccc---ccc------------------------CCCCEEEc
Confidence            78888888887775 444332   24555555555555 233   223                        44455555


Q ss_pred             cCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCC
Q 003301          375 VNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGS  454 (832)
Q Consensus       375 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  454 (832)
                      ++|+|++ +|. +..  +|++|+|++|+|++ +|.   .+++|+.|+|++|.|+++ |.   .+++|++|+|++|+|++ 
T Consensus       108 s~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~l-p~---~l~~L~~L~Ls~N~L~~-  174 (571)
T 3cvr_A          108 CDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTML-PE---LPTSLEVLSVRNNQLTF-  174 (571)
T ss_dssp             CSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSC-
T ss_pred             cCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCcC-CC---cCCCcCEEECCCCCCCC-
Confidence            5555543 333 332  45555555555553 333   345555555555555542 22   34555556666666554 


Q ss_pred             CccccccccccceecccCcccCCccCCcccccccc-------ceeecccccccccCCccccCCCCCCeeccCCCcccccC
Q 003301          455 LPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNL-------QDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNI  527 (832)
Q Consensus       455 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  527 (832)
                      +|. |.  ++|+.|+|++|+|+ .+|. |..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+
T Consensus       175 lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~  246 (571)
T 3cvr_A          175 LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRI  246 (571)
T ss_dssp             CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHH
T ss_pred             cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcC
Confidence            344 44  56666666666666 4444 443  55       88888888888 57877777888999999999998888


Q ss_pred             chhhhhhcc
Q 003301          528 PTSMEKLLY  536 (832)
Q Consensus       528 p~~~~~l~~  536 (832)
                      |..+..+..
T Consensus       247 p~~l~~l~~  255 (571)
T 3cvr_A          247 RESLSQQTA  255 (571)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHhhc
Confidence            888887754

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.85  E-value=2.6e-21  Score=219.72  Aligned_cols=182  Identities=25%  Similarity=0.305  Sum_probs=157.4

Q ss_pred             cccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCC
Q 003301          344 NLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLA  423 (832)
Q Consensus       344 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  423 (832)
                      +|+.|+|++|++++ +|..+.  ++|++|+|++|+|+ .+|   ..+++|++|++++|+|++ +|. |.+  +|+.|+|+
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls  128 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD  128 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence            89999999999987 555443  78999999999999 677   457899999999999997 666 665  99999999


Q ss_pred             CCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccC
Q 003301          424 SNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSI  503 (832)
Q Consensus       424 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  503 (832)
                      +|.|+++ |.   .+++|+.|++++|+|++ +|.   .+++|+.|+|++|+|++ +|. |.  ++|+.|+|++|+|+ .+
T Consensus       129 ~N~l~~l-p~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l  195 (571)
T 3cvr_A          129 NNQLTML-PE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL  195 (571)
T ss_dssp             SSCCSCC-CC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred             CCcCCCC-CC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence            9999994 44   68999999999999997 555   67899999999999996 666 76  89999999999999 67


Q ss_pred             CccccCCCCC-------CeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCCC
Q 003301          504 PKSIGGLVSL-------ESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPR  553 (832)
Q Consensus       504 p~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  553 (832)
                      |. |..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|.
T Consensus       196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~  248 (571)
T 3cvr_A          196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE  248 (571)
T ss_dssp             CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred             hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence            77 665  77       99999999999 5888888899999999999999998875

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.85  E-value=1.4e-21  Score=212.05  Aligned_cols=180  Identities=27%  Similarity=0.243  Sum_probs=120.1

Q ss_pred             ceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCC-CCCCCCeEeCCCCcCCCCCCcccccCcccceeeecC
Q 003301          370 QGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIG-DLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSS  448 (832)
Q Consensus       370 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  448 (832)
                      +.+++++|+++ .+|..+.  ..++.|+|++|+|++..+..|. .+++|+.|+|++|+|+++.+..|.++++|++|+|++
T Consensus        21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            35555555555 3444333  3456666666666655555555 666666666666666666666666666677777777


Q ss_pred             CcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccc---cCCCCCCeeccCCCcccc
Q 003301          449 NFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI---GGLVSLESLDLSNNSLSG  525 (832)
Q Consensus       449 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~  525 (832)
                      |+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|   ..+++|+.|||++|+|++
T Consensus        98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~  177 (361)
T 2xot_A           98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK  177 (361)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred             CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence            77666556667777777777777777776667777777777777777777775444444   567788888888888887


Q ss_pred             cCchhhhhhcc--CCeeeCCCCcccccCC
Q 003301          526 NIPTSMEKLLY--LKDLNLSFNKLEGEIP  552 (832)
Q Consensus       526 ~~p~~~~~l~~--L~~l~l~~N~l~~~~p  552 (832)
                      ..+..+..++.  ++.|+|++|+|.|.+.
T Consensus       178 l~~~~~~~l~~~~l~~l~l~~N~~~C~C~  206 (361)
T 2xot_A          178 LPLTDLQKLPAWVKNGLYLHNNPLECDCK  206 (361)
T ss_dssp             CCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred             cCHHHhhhccHhhcceEEecCCCccCCcC
Confidence            66667777766  4778888888887654

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.85  E-value=7.7e-22  Score=197.94  Aligned_cols=136  Identities=26%  Similarity=0.272  Sum_probs=81.0

Q ss_pred             CCeEeCCCCcCCCCCC-cccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecc
Q 003301          417 LRLLSLASNELNSVIP-STFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLR  495 (832)
Q Consensus       417 L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  495 (832)
                      ++.|+|++|.|++..+ ..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..|.++++|++|+|+
T Consensus        34 ~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  113 (220)
T 2v70_A           34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLR  113 (220)
T ss_dssp             CSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECT
T ss_pred             CCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECC
Confidence            3455555555544432 334555555555555555555444455555566666666666655555556666666666666


Q ss_pred             cccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCC
Q 003301          496 DNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIP  552 (832)
Q Consensus       496 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  552 (832)
                      +|+|++..|..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|+|+|.++
T Consensus       114 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A          114 SNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             TSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             CCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            666666556666666666666666666666666666666666666666666666655

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.84  E-value=6.9e-21  Score=191.01  Aligned_cols=137  Identities=20%  Similarity=0.267  Sum_probs=72.3

Q ss_pred             CCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecc
Q 003301          416 SLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLR  495 (832)
Q Consensus       416 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  495 (832)
                      +|+.|++++|.|+++.+..|..+++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..|.++++|+.|+|+
T Consensus        33 ~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~  112 (220)
T 2v9t_B           33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN  112 (220)
T ss_dssp             TCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECC
Confidence            34444444444444444444444444444444444444444445555555555555555554444445555555555555


Q ss_pred             cccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCC
Q 003301          496 DNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIP  552 (832)
Q Consensus       496 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  552 (832)
                      +|+|++..|..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+|.|.+.
T Consensus       113 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  169 (220)
T 2v9t_B          113 ANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH  169 (220)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             CCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence            555555555555555556666666666555555555555666666666666655443

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.83  E-value=1.9e-20  Score=187.76  Aligned_cols=156  Identities=22%  Similarity=0.263  Sum_probs=124.0

Q ss_pred             ceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCc-ccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecC
Q 003301          370 QGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIP-PCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSS  448 (832)
Q Consensus       370 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  448 (832)
                      +++++++|.++ .+|..+.  ..+++|+|++|++++..| ..|..+++|+.|+|++|+|+++.+..|.++++|++|+|++
T Consensus        14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            36666666666 3554443  345677777777775543 4467778888888888888877777888888888888888


Q ss_pred             CcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCc
Q 003301          449 NFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIP  528 (832)
Q Consensus       449 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  528 (832)
                      |++++..+..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..+
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            88887777778888888889999999988888889999999999999999998888999999999999999999987665

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.83  E-value=3.5e-20  Score=187.19  Aligned_cols=156  Identities=24%  Similarity=0.328  Sum_probs=83.3

Q ss_pred             CceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecC
Q 003301          369 LQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSS  448 (832)
Q Consensus       369 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  448 (832)
                      -+.++.++++++ .+|..+.  ++|++|+|++|++++..|..|..+++|+.|+|++|+|+.+.+..|..+++|++|+|++
T Consensus        21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~   97 (229)
T 3e6j_A           21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT   97 (229)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence            345666666655 3444333  4555555555555555555555555555555555555554444445555555555555


Q ss_pred             CcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCc
Q 003301          449 NFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIP  528 (832)
Q Consensus       449 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  528 (832)
                      |+|                        ++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+
T Consensus        98 N~l------------------------~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~  152 (229)
T 3e6j_A           98 NQL------------------------TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPH  152 (229)
T ss_dssp             SCC------------------------CCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCT
T ss_pred             CcC------------------------CccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCH
Confidence            544                        4444444455555555555555555 445555555555555555555554444


Q ss_pred             hhhhhhccCCeeeCCCCcccccCC
Q 003301          529 TSMEKLLYLKDLNLSFNKLEGEIP  552 (832)
Q Consensus       529 ~~~~~l~~L~~l~l~~N~l~~~~p  552 (832)
                      ..+..+++|+.|+|++|+++|.++
T Consensus       153 ~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A          153 GAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             TTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             HHHhCCCCCCEEEeeCCCccCCcc
Confidence            455555555555555555555554

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.82  E-value=2e-20  Score=196.32  Aligned_cols=171  Identities=26%  Similarity=0.397  Sum_probs=94.4

Q ss_pred             CcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeE
Q 003301          341 NLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLL  420 (832)
Q Consensus       341 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  420 (832)
                      .+++|+.|++++|.+... + .+..+++|++|+|++|++++..+  +..+++|++|++++|++++ +| .+..+++|++|
T Consensus        44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L  117 (291)
T 1h6t_A           44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL  117 (291)
T ss_dssp             HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred             hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEE
Confidence            445556666666655533 2 25555666666666666654322  5556666666666666653 22 35566666666


Q ss_pred             eCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeeccccccc
Q 003301          421 SLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQ  500 (832)
Q Consensus       421 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  500 (832)
                      ++++|++++.  ..+..+++|+.|++++|++++.  ..++.+++|+.|++++|++++..|  +..+++|+.|+|++|+++
T Consensus       118 ~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~  191 (291)
T 1h6t_A          118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS  191 (291)
T ss_dssp             ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             ECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence            6666666553  3455555555555655555543  345555555556666665554333  555555666666666555


Q ss_pred             ccCCccccCCCCCCeeccCCCcccc
Q 003301          501 GSIPKSIGGLVSLESLDLSNNSLSG  525 (832)
Q Consensus       501 ~~~p~~~~~l~~L~~L~Ls~N~l~~  525 (832)
                      + +| .+..+++|+.|++++|+++.
T Consensus       192 ~-l~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          192 D-LR-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             B-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred             C-Ch-hhccCCCCCEEECcCCcccC
Confidence            3 22 25555555666666555553

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.82  E-value=3.7e-20  Score=185.62  Aligned_cols=154  Identities=22%  Similarity=0.283  Sum_probs=118.8

Q ss_pred             ceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCC
Q 003301          370 QGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSN  449 (832)
Q Consensus       370 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  449 (832)
                      +.+++++|.++ .+|..+.  ++++.|++++|+|++..+..|..+++|+.|+|++|+++++.|..|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            45666666666 4454443  56777777777777666667777777777777777777777777777778888888888


Q ss_pred             cccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCccccc
Q 003301          450 FLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGN  526 (832)
Q Consensus       450 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  526 (832)
                      +|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++...
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  167 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD  167 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence            88766666677888888888888888887788888888888888888888877777888888999999999988754

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.81  E-value=1.9e-19  Score=181.78  Aligned_cols=157  Identities=25%  Similarity=0.272  Sum_probs=118.7

Q ss_pred             cccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCC
Q 003301          344 NLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLA  423 (832)
Q Consensus       344 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  423 (832)
                      ..+.++.+++.+.. +|..+.  ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus        20 s~~~v~c~~~~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls   96 (229)
T 3e6j_A           20 SGTTVDCRSKRHAS-VPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG   96 (229)
T ss_dssp             ETTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             eCCEeEccCCCcCc-cCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence            35789999999884 554443  789999999999999889999999999999999999997777889999999999999


Q ss_pred             CCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccC
Q 003301          424 SNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSI  503 (832)
Q Consensus       424 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  503 (832)
                      +|+|+++.+..|..+++|++|+|++|+|+ .+|..+..+++                        |+.|+|++|+|++..
T Consensus        97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~------------------------L~~L~L~~N~l~~~~  151 (229)
T 3e6j_A           97 TNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTH------------------------LTHLALDQNQLKSIP  151 (229)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTT------------------------CSEEECCSSCCCCCC
T ss_pred             CCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCC------------------------CCEEECCCCcCCccC
Confidence            99999988877877777777777777766 34554444444                        455555555555444


Q ss_pred             CccccCCCCCCeeccCCCcccccCc
Q 003301          504 PKSIGGLVSLESLDLSNNSLSGNIP  528 (832)
Q Consensus       504 p~~~~~l~~L~~L~Ls~N~l~~~~p  528 (832)
                      +..|..+++|+.|+|++|++++..+
T Consensus       152 ~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A          152 HGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             TTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             HHHHhCCCCCCEEEeeCCCccCCcc
Confidence            4455555666666666666655443

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.81  E-value=7.8e-20  Score=191.81  Aligned_cols=151  Identities=28%  Similarity=0.370  Sum_probs=88.5

Q ss_pred             ccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCC
Q 003301          339 IGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLR  418 (832)
Q Consensus       339 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  418 (832)
                      +..+++|++|++++|++++..+  +..+++|++|+|++|++++ +| .+..+++|++|++++|++++.  ..+..+++|+
T Consensus        64 ~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~  137 (291)
T 1h6t_A           64 IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLE  137 (291)
T ss_dssp             GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCC
T ss_pred             HhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCC
Confidence            3344455555555555544333  5555555555555555553 22 255555555556665555532  3455566666


Q ss_pred             eEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeeccccc
Q 003301          419 LLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNG  498 (832)
Q Consensus       419 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  498 (832)
                      .|++++|++++.  ..+..+++|+.|++++|++++..|  +..+++|+.|+|++|++++. | .+..+++|+.|++++|+
T Consensus       138 ~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~  211 (291)
T 1h6t_A          138 SLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQE  211 (291)
T ss_dssp             EEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEE
T ss_pred             EEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCc
Confidence            666666666554  455666666666666666665433  66677777777777777643 3 36777777777777777


Q ss_pred             ccc
Q 003301          499 LQG  501 (832)
Q Consensus       499 l~~  501 (832)
                      ++.
T Consensus       212 i~~  214 (291)
T 1h6t_A          212 CLN  214 (291)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            775

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.81  E-value=9.6e-20  Score=209.41  Aligned_cols=175  Identities=25%  Similarity=0.377  Sum_probs=102.9

Q ss_pred             cCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCe
Q 003301          340 GNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRL  419 (832)
Q Consensus       340 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  419 (832)
                      ..+++|+.|++++|.+... + .+..+++|+.|+|++|++++..|  +..+++|+.|+|++|++++ +| .+..+++|+.
T Consensus        40 ~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~  113 (605)
T 1m9s_A           40 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKS  113 (605)
T ss_dssp             HHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCE
T ss_pred             hcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCE
Confidence            3455556666666655532 2 35556666666666666654333  5556666666666666653 22 4566666666


Q ss_pred             EeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccc
Q 003301          420 LSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGL  499 (832)
Q Consensus       420 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  499 (832)
                      |+|++|+++++  ..+..+++|+.|+|++|++++.  ..+..+++|+.|+|++|++++..|  +..+++|+.|+|++|+|
T Consensus       114 L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i  187 (605)
T 1m9s_A          114 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI  187 (605)
T ss_dssp             EECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             EEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCC
Confidence            66666666553  3355666666666666666643  456666666666666666665444  66666666666666666


Q ss_pred             cccCCccccCCCCCCeeccCCCcccccCc
Q 003301          500 QGSIPKSIGGLVSLESLDLSNNSLSGNIP  528 (832)
Q Consensus       500 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  528 (832)
                      ++.  ..+..+++|+.|+|++|++++...
T Consensus       188 ~~l--~~l~~l~~L~~L~L~~N~l~~~p~  214 (605)
T 1m9s_A          188 SDL--RALAGLKNLDVLELFSQECLNKPI  214 (605)
T ss_dssp             CBC--GGGTTCTTCSEEECCSEEEECCCC
T ss_pred             CCC--hHHccCCCCCEEEccCCcCcCCcc
Confidence            642  246666666666666666665433

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.80  E-value=1.1e-19  Score=197.20  Aligned_cols=156  Identities=26%  Similarity=0.223  Sum_probs=76.6

Q ss_pred             ccEEEeecCccccccccccc-CCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCC
Q 003301          345 LRELGLWGNELIGSIPITFG-KLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLA  423 (832)
Q Consensus       345 L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  423 (832)
                      ++.|+|++|+|++..+..|. .+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|+.|+|+
T Consensus        41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  120 (361)
T 2xot_A           41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY  120 (361)
T ss_dssp             CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECC
Confidence            34444444444443333443 44444444444444443333444444444444444444444434444445555555555


Q ss_pred             CCcCCCCCCcccccCcccceeeecCCcccCCCcccc---ccccccceecccCcccCCccCCccccccc--cceeeccccc
Q 003301          424 SNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDI---GNLKVVVIIDLSRNNLSGDIPTAIGGLMN--LQDLSLRDNG  498 (832)
Q Consensus       424 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~---~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~--L~~L~Ls~N~  498 (832)
                      +|+|+++.|..|.++++|+.|+|++|+|++..+..|   ..+++|+.|||++|+|++..+..|..++.  ++.|+|++|.
T Consensus       121 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~  200 (361)
T 2xot_A          121 NNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNP  200 (361)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSC
T ss_pred             CCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCC
Confidence            555554444555555555555555555554333333   34556666666666666544455555555  3667777776


Q ss_pred             cc
Q 003301          499 LQ  500 (832)
Q Consensus       499 l~  500 (832)
                      +.
T Consensus       201 ~~  202 (361)
T 2xot_A          201 LE  202 (361)
T ss_dssp             EE
T ss_pred             cc
Confidence            65

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.80  E-value=2.2e-19  Score=206.35  Aligned_cols=171  Identities=24%  Similarity=0.334  Sum_probs=80.4

Q ss_pred             CccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCc
Q 003301          263 NLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNL  342 (832)
Q Consensus       263 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l  342 (832)
                      .+++|+.|++++|.+..++       .+..+++|+.|+|++|++.+..+  +..+. +|+.|+|++|.+++.  ..+..+
T Consensus        41 ~L~~L~~L~l~~n~i~~l~-------~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~-~L~~L~Ls~N~l~~l--~~l~~l  108 (605)
T 1m9s_A           41 ELNSIDQIIANNSDIKSVQ-------GIQYLPNVTKLFLNGNKLTDIKP--LTNLK-NLGWLFLDENKIKDL--SSLKDL  108 (605)
T ss_dssp             HHTTCCCCBCTTCCCCCCT-------TGGGCTTCCEEECTTSCCCCCGG--GGGCT-TCCEEECCSSCCCCC--TTSTTC
T ss_pred             cCCCCCEEECcCCCCCCCh-------HHccCCCCCEEEeeCCCCCCChh--hccCC-CCCEEECcCCCCCCC--hhhccC
Confidence            4444444444444444321       13444444444444444443222  22222 333344444433321  134455


Q ss_pred             CcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeC
Q 003301          343 INLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSL  422 (832)
Q Consensus       343 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  422 (832)
                      ++|+.|+|++|++.+.  ..+..+++|+.|+|++|++++.  ..+..+++|+.|+|++|++++..|  +..+++|+.|+|
T Consensus       109 ~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L  182 (605)
T 1m9s_A          109 KKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL  182 (605)
T ss_dssp             TTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             CCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEEC
Confidence            5555555555555432  2345555555555555555532  345555555555555555554333  555555555555


Q ss_pred             CCCcCCCCCCcccccCcccceeeecCCcccC
Q 003301          423 ASNELNSVIPSTFWNLKDILSLNFSSNFLNG  453 (832)
Q Consensus       423 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  453 (832)
                      ++|+|+++  ..+..+++|+.|+|++|.+.+
T Consensus       183 s~N~i~~l--~~l~~l~~L~~L~L~~N~l~~  211 (605)
T 1m9s_A          183 SKNHISDL--RALAGLKNLDVLELFSQECLN  211 (605)
T ss_dssp             CSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred             cCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence            55555543  234555555555555555544

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.79  E-value=4.6e-20  Score=190.41  Aligned_cols=171  Identities=22%  Similarity=0.288  Sum_probs=104.9

Q ss_pred             CcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeE
Q 003301          341 NLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLL  420 (832)
Q Consensus       341 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  420 (832)
                      ++.+++.+++++|.+++..  .+..+++|++|++++|+++. ++ .+..+++|++|++++|++++..+  +..+++|+.|
T Consensus        17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            3455666666666666433  45666677777777777663 34 56666777777777777764433  6667777777


Q ss_pred             eCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeeccccccc
Q 003301          421 SLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQ  500 (832)
Q Consensus       421 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  500 (832)
                      ++++|++++..+...   ++|+.|++++|++++.  +.+..+++|+.|+|++|++++. + .++.+++|+.|+|++|+++
T Consensus        91 ~L~~N~l~~l~~~~~---~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~  163 (263)
T 1xeu_A           91 SVNRNRLKNLNGIPS---ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEIT  163 (263)
T ss_dssp             ECCSSCCSCCTTCCC---SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCC
T ss_pred             ECCCCccCCcCcccc---CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCc
Confidence            777777766433221   6666666666666642  2466666666666666666643 2 4566666666666666666


Q ss_pred             ccCCccccCCCCCCeeccCCCccccc
Q 003301          501 GSIPKSIGGLVSLESLDLSNNSLSGN  526 (832)
Q Consensus       501 ~~~p~~~~~l~~L~~L~Ls~N~l~~~  526 (832)
                      +.  ..+..+++|+.|++++|++++.
T Consensus       164 ~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          164 NT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             BC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             ch--HHhccCCCCCEEeCCCCcccCC
Confidence            44  4556666666666666666544

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.78  E-value=3.9e-21  Score=219.74  Aligned_cols=204  Identities=23%  Similarity=0.246  Sum_probs=125.5

Q ss_pred             cCccccCeEeccCCccccCCCccccccccCcEEEccCCc-------------CCCCCCCcccCccccccccc-ccccccc
Q 003301           18 GNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNF-------------LSGTIPSTIFNLSSLSTGMD-FSNNSLT   83 (832)
Q Consensus        18 ~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~-------------l~~~~p~~l~~l~~l~~~L~-ls~n~l~   83 (832)
                      ...+.|+.|+|++|+++ .+|+.++.+++|+.|++++|.             ..+.+|+.++.+++| +.|| ++.|.+.
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L-~~L~~l~~n~~~  423 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTL-KAVDPMRAAYLD  423 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHH-HHHCGGGHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhc-ccCcchhhcccc
Confidence            66888999999999998 889999999999999998775             556677777888887 7787 6666544


Q ss_pred             cCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccc
Q 003301           84 GSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEM  163 (832)
Q Consensus        84 ~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~  163 (832)
                       .           |+.+++++|.++...+      ..|++|+|++|+|++ +|. |+.+++|++|+|++|+|+ .+|..|
T Consensus       424 -~-----------L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~  482 (567)
T 1dce_A          424 -D-----------LRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPAL  482 (567)
T ss_dssp             -H-----------HHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGG
T ss_pred             -h-----------hhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhh
Confidence             2           2233344444442111      135555666665553 343 555556666666666655 455555


Q ss_pred             cCccccceecccccccccccCcccccCCcccEEEecCCCCCCCC-CccccccCCCCccEEEccCCccccccCCc---ccC
Q 003301          164 GNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSL-PSSIDLVRLPNLEIISLAGNNFSGIIPSF---IFN  239 (832)
Q Consensus       164 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~---~~~  239 (832)
                      +++++|+.|+|++|++++ +| .+.++++|++|+|++|.+++.. |..+  ..+++|+.|+|++|.+++.+|..   +..
T Consensus       483 ~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l--~~l~~L~~L~L~~N~l~~~~~~~~~l~~~  558 (567)
T 1dce_A          483 AALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPL--VSCPRLVLLNLQGNSLCQEEGIQERLAEM  558 (567)
T ss_dssp             GGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGG--GGCTTCCEEECTTSGGGGSSSCTTHHHHH
T ss_pred             hcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHH--hcCCCCCEEEecCCcCCCCccHHHHHHHH
Confidence            556666666666666554 33 5555666666666666655443 4433  45566666666666665544422   223


Q ss_pred             CCCccEEEc
Q 003301          240 ASKLSVLEL  248 (832)
Q Consensus       240 l~~L~~L~L  248 (832)
                      +++|+.|++
T Consensus       559 lp~L~~L~l  567 (567)
T 1dce_A          559 LPSVSSILT  567 (567)
T ss_dssp             CTTCSEEEC
T ss_pred             CcccCccCC
Confidence            566666653

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.78  E-value=8.1e-22  Score=225.35  Aligned_cols=200  Identities=23%  Similarity=0.233  Sum_probs=123.2

Q ss_pred             ccceEEeecCcccccccccccCcCcccEEEeecCc-------------ccccccccccCCCCCceEE-ccCCccCCCCch
Q 003301          320 SLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNE-------------LIGSIPITFGKLQNLQGLD-LVNNKLEGPIPN  385 (832)
Q Consensus       320 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~-------------l~~~~~~~~~~l~~L~~L~-Ls~N~l~~~~~~  385 (832)
                      +|+.|+|++|+++ .+|..++++++|++|++++|.             +.+..|..++.+++|+.|+ ++.|.+.     
T Consensus       350 ~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-----  423 (567)
T 1dce_A          350 QLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-----  423 (567)
T ss_dssp             TSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-----
T ss_pred             cceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-----
Confidence            3444444444443 345555555555555554443             3344455555555555555 4444332     


Q ss_pred             hhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCcccccccccc
Q 003301          386 GLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVV  465 (832)
Q Consensus       386 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  465 (832)
                            .|..+.+++|.+++..+      ..|+.|+|++|.|+++ |. |..+++|+.|+|++|+|+ .+|..|+.+++|
T Consensus       424 ------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~l-p~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L  488 (567)
T 1dce_A          424 ------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTVL-CH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCL  488 (567)
T ss_dssp             ------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSSC-CC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTC
T ss_pred             ------hhhhhhhhcccccccCc------cCceEEEecCCCCCCC-cC-ccccccCcEeecCccccc-ccchhhhcCCCC
Confidence                  23333444555542211      1367777777777663 44 777777777777777777 567777777777


Q ss_pred             ceecccCcccCCccCCccccccccceeecccccccccC-CccccCCCCCCeeccCCCcccccCchh---hhhhccCCeee
Q 003301          466 VIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSI-PKSIGGLVSLESLDLSNNSLSGNIPTS---MEKLLYLKDLN  541 (832)
Q Consensus       466 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~---~~~l~~L~~l~  541 (832)
                      +.|+|++|+|++ +| .|+++++|+.|+|++|+|++.+ |..|+.+++|+.|+|++|++++.+|..   +..+++|+.||
T Consensus       489 ~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~  566 (567)
T 1dce_A          489 EVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL  566 (567)
T ss_dssp             CEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred             CEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence            777777777775 45 6777777788888888777665 777777888888888888877665532   33467777776


Q ss_pred             C
Q 003301          542 L  542 (832)
Q Consensus       542 l  542 (832)
                      +
T Consensus       567 l  567 (567)
T 1dce_A          567 T  567 (567)
T ss_dssp             C
T ss_pred             C
Confidence            4

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.78  E-value=1.3e-18  Score=170.39  Aligned_cols=156  Identities=25%  Similarity=0.295  Sum_probs=98.7

Q ss_pred             cEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCc-ccccCcccceeeecCCcccCCCccccccccccceecccC
Q 003301          394 SVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPS-TFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSR  472 (832)
Q Consensus       394 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  472 (832)
                      +.+++++|.++ .+|..+..  +|+.|++++|.++++.+. .|..+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            45555555554 34443322  566666666666665553 366666666666666666666666677777777777777


Q ss_pred             cccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCC
Q 003301          473 NNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIP  552 (832)
Q Consensus       473 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  552 (832)
                      |+|++..+..|.++++|++|+|++|+|++.+|..|+.+++|++|+|++|++++..+-... ...++...+..+...|.-|
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~-~~~l~~~~~~~~~~~C~~P  166 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWF-AEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHH-HHHHHHHCCSGGGCBBCSS
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHH-HHHHHHcCCCCCCCCCCCC
Confidence            777766666777777777777777777777777777777777777777777766553211 1123333445555555555


Q ss_pred             C
Q 003301          553 R  553 (832)
Q Consensus       553 ~  553 (832)
                      .
T Consensus       167 ~  167 (192)
T 1w8a_A          167 S  167 (192)
T ss_dssp             T
T ss_pred             h
Confidence            4

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.77  E-value=2.7e-19  Score=184.65  Aligned_cols=169  Identities=20%  Similarity=0.264  Sum_probs=125.3

Q ss_pred             ccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEec
Q 003301          320 SLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMD  399 (832)
Q Consensus       320 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  399 (832)
                      .+..+++++|.+++..  .+..+++|++|++++|+++. ++ .+..+++|++|+|++|++++..+  +..+++|++|+++
T Consensus        20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~   93 (263)
T 1xeu_A           20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVN   93 (263)
T ss_dssp             HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECC
T ss_pred             HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECC
Confidence            3444455555555332  46667778888888887774 33 57777888888888888875433  7778888888888


Q ss_pred             CCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCcc
Q 003301          400 GNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDI  479 (832)
Q Consensus       400 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  479 (832)
                      +|++++. |. +.. ++|+.|++++|++++.  ..+..+++|+.|++++|++++. + .++.+++|+.|+|++|++++. 
T Consensus        94 ~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~-  165 (263)
T 1xeu_A           94 RNRLKNL-NG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT-  165 (263)
T ss_dssp             SSCCSCC-TT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC-
T ss_pred             CCccCCc-Cc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch-
Confidence            8888753 33 223 7888888888888774  3578888888888888888864 3 688888899999999998865 


Q ss_pred             CCccccccccceeecccccccccC
Q 003301          480 PTAIGGLMNLQDLSLRDNGLQGSI  503 (832)
Q Consensus       480 ~~~~~~l~~L~~L~Ls~N~l~~~~  503 (832)
                       ..+..+++|+.|++++|++++..
T Consensus       166 -~~l~~l~~L~~L~l~~N~~~~~~  188 (263)
T 1xeu_A          166 -GGLTRLKKVNWIDLTGQKCVNEP  188 (263)
T ss_dssp             -TTSTTCCCCCEEEEEEEEEECCC
T ss_pred             -HHhccCCCCCEEeCCCCcccCCc
Confidence             67888999999999999998653

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.77  E-value=1.5e-19  Score=213.33  Aligned_cols=228  Identities=22%  Similarity=0.248  Sum_probs=113.6

Q ss_pred             CCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEE
Q 003301          294 KNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLD  373 (832)
Q Consensus       294 ~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  373 (832)
                      +.++.|+|.+|.+... +..      .++.++|+.|.|.              .++++.|.+. ..+..|..++.|+.|+
T Consensus       173 ~~~~~l~L~~n~~~~~-~~~------~l~~l~Ls~~~i~--------------~~~~~~n~~~-~~~~~~~~l~~L~~L~  230 (727)
T 4b8c_D          173 PLTPKIELFANGKDEA-NQA------LLQHKKLSQYSID--------------EDDDIENRMV-MPKDSKYDDQLWHALD  230 (727)
T ss_dssp             -----------------------------------------------------------------------CCCCCCEEE
T ss_pred             CccceEEeeCCCCCcc-hhh------HhhcCccCccccc--------------Ccccccccee-cChhhhccCCCCcEEE
Confidence            4566777777766532 211      3344445444433              3344555555 5677788888888888


Q ss_pred             ccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccC
Q 003301          374 LVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNG  453 (832)
Q Consensus       374 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  453 (832)
                      |++|++. .+|..+..+++|++|+|++|.|+ .+|..|+.+++|++|+|++|.|+ .+|..|.++++|++|+|++|.|+ 
T Consensus       231 Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-  306 (727)
T 4b8c_D          231 LSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-  306 (727)
T ss_dssp             CTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-
T ss_pred             CCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-
Confidence            8888887 56666677888888888888888 67777888888888888888888 45777888888888888888887 


Q ss_pred             CCccccccccccceecccCcccCCccCCccccccc-cceeecccccccccCCccccCCCCCCeeccCCC--------ccc
Q 003301          454 SLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMN-LQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNN--------SLS  524 (832)
Q Consensus       454 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N--------~l~  524 (832)
                      .+|..|+.+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|..      |+.|++++|        .|.
T Consensus       307 ~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~  380 (727)
T 4b8c_D          307 TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQ  380 (727)
T ss_dssp             CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC--------------------------
T ss_pred             ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecccccccccCCcc
Confidence            56777888888888888888888888877766533 234788888888877764      455666666        455


Q ss_pred             ccCchhhhhhccCCeeeCCCCcccccCCC
Q 003301          525 GNIPTSMEKLLYLKDLNLSFNKLEGEIPR  553 (832)
Q Consensus       525 ~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  553 (832)
                      +..+..+..+..+....+++|-+.+....
T Consensus       381 ~~~~~~~~~l~~~~~~~ls~Nil~~~~~~  409 (727)
T 4b8c_D          381 QSTEHLATDLAKRTFTVLSYNTLCQHYAT  409 (727)
T ss_dssp             ---------------------CCCGGGCC
T ss_pred             ccccchhhcccccceeeeeccccccccCc
Confidence            55555566666777778888887654443

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.77  E-value=3.3e-19  Score=190.92  Aligned_cols=222  Identities=13%  Similarity=0.087  Sum_probs=108.6

Q ss_pred             CCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccccC----CCCCCccccccccc
Q 003301          216 LPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFL----TSSTSELSFLSSWA  291 (832)
Q Consensus       216 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l----~~~~~~~~~~~~~~  291 (832)
                      +++|+.|+|.+ .++.+.+.+|.++++|++|++++|.+..+.+.+|.++.++..+.+..+..    ..+..     .+|.
T Consensus       100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~-----~~f~  173 (329)
T 3sb4_A          100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEH-----FAFI  173 (329)
T ss_dssp             CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTT-----SCEE
T ss_pred             cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccc-----cccc
Confidence            56666666666 66666666777777777777777777767777777766666666554221    11111     2355


Q ss_pred             cCCCCc-EEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCc
Q 003301          292 NCKNLK-LLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQ  370 (832)
Q Consensus       292 ~l~~L~-~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  370 (832)
                      .+..|+ .+.+....   .++..+...                     -....+++.+.+.++-...........+++|+
T Consensus       174 ~~~~L~~~i~~~~~~---~l~~~~~~~---------------------~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~  229 (329)
T 3sb4_A          174 EGEPLETTIQVGAMG---KLEDEIMKA---------------------GLQPRDINFLTIEGKLDNADFKLIRDYMPNLV  229 (329)
T ss_dssp             ESCCCEEEEEECTTC---CHHHHHHHT---------------------TCCGGGCSEEEEEECCCHHHHHHHHHHCTTCC
T ss_pred             cccccceeEEecCCC---cHHHHHhhc---------------------ccCccccceEEEeeeecHHHHHHHHHhcCCCe
Confidence            666666 44443321   111111100                     01122333333333311111110111234455


Q ss_pred             eEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCC-eEeCCCCcCCCCCCcccccCcccceeeecCC
Q 003301          371 GLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLR-LLSLASNELNSVIPSTFWNLKDILSLNFSSN  449 (832)
Q Consensus       371 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  449 (832)
                      .|+|++|+++...+.+|.++.+|+.+++.+| ++...+.+|.++++|+ .+++.+ .++.+.+.+|.++++|+.+++++|
T Consensus       230 ~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n  307 (329)
T 3sb4_A          230 SLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGD  307 (329)
T ss_dssp             EEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSS
T ss_pred             EEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCC
Confidence            5555554444333344555555555555544 4434444555555555 555555 455555555555555555555555


Q ss_pred             cccCCCccccccccccceec
Q 003301          450 FLNGSLPEDIGNLKVVVIID  469 (832)
Q Consensus       450 ~l~~~~~~~~~~l~~L~~L~  469 (832)
                      +++...+..|.++++|+.++
T Consensus       308 ~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          308 KITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             CCCEECTTTTCTTCCCCEEE
T ss_pred             ccCccchhhhcCCcchhhhc
Confidence            55554455555555555543

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.77  E-value=2.5e-19  Score=175.55  Aligned_cols=155  Identities=26%  Similarity=0.340  Sum_probs=131.1

Q ss_pred             CeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCcc-ccccccccceecccCcccCCccCCccccccccceeeccc
Q 003301          418 RLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPE-DIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRD  496 (832)
Q Consensus       418 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  496 (832)
                      +.+++++|.++.+ |..+..  ++++|++++|++++..+. .|+.+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus        11 ~~l~~s~~~l~~i-p~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLKEI-PRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCSSC-CSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcCcC-ccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            7899999999764 444433  899999999999987664 489999999999999999999999999999999999999


Q ss_pred             ccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCCCCCCCCCcCCCcccCCCCCCCCc
Q 003301          497 NGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLA  575 (832)
Q Consensus       497 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~  575 (832)
                      |+|++..|..|+.+++|++|+|++|++++.+|..+..+++|++|+|++|+|+|.++-......+....+.++...|+.|
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P  166 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence            9999999999999999999999999999999999999999999999999999998752111112223445555566654

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.77  E-value=6.8e-19  Score=173.37  Aligned_cols=151  Identities=21%  Similarity=0.277  Sum_probs=69.5

Q ss_pred             CCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceee
Q 003301          366 LQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLN  445 (832)
Q Consensus       366 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  445 (832)
                      +++|++|++++|.++ .+| .+..+++|++|++++|.++.  +..+..+++|++|++++|.+++..+..|..+++|++|+
T Consensus        43 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~  118 (197)
T 4ezg_A           43 MNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD  118 (197)
T ss_dssp             HHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred             cCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence            344444444444444 223 34444444444444444331  12344444555555555544444444444444444444


Q ss_pred             ecCCcccCCCccccccccccceecccCcc-cCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCccc
Q 003301          446 FSSNFLNGSLPEDIGNLKVVVIIDLSRNN-LSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLS  524 (832)
Q Consensus       446 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  524 (832)
                      +++|++++..|..++.+++|++|++++|+ ++ .+| .+.++++|+.|++++|++++ ++ .+..+++|+.|++++|++.
T Consensus       119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~  194 (197)
T 4ezg_A          119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIG  194 (197)
T ss_dssp             CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred             ecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccC
Confidence            44444444444445555555555555554 33 222 34555555555555555553 22 4445555555555555543

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.77  E-value=5.2e-19  Score=181.94  Aligned_cols=141  Identities=18%  Similarity=0.230  Sum_probs=109.3

Q ss_pred             CCCCCCeeeccCCceEEEEEe-cCCcE--EEEEEEeccchh------------------------hHHHHHHHHHHHhcC
Q 003301          660 QFNASNLIGTGGFGSVYKGSF-LDGME--VAIKVFHLQLEG------------------------ALKSFDVECEVLKSV  712 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l  712 (832)
                      -|++.+.||+|+||.||+|.+ .+|+.  ||||+++.....                        ....+.+|+++++++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            467889999999999999988 67888  999987543111                        113678899999999


Q ss_pred             CCCce--eeeceEEecCCeeEEEEecCCC-C----CHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 003301          713 RHRNL--VKIISSCTNNDFKALVLEYMPN-G----SLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI  785 (832)
Q Consensus       713 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl  785 (832)
                      .|+++  +..+++    +..++||||+.+ |    +|.++...    .++..+..++.|++.|++|||.  +.||+||||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl  197 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADL  197 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence            88764  334432    356899999942 3    77776543    2344677899999999999994  579999999


Q ss_pred             CCCCeEeCCCCcEEEeccccccccCCC
Q 003301          786 KPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       786 kp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||+|||++.  .++|+|||+|.....+
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~~~~  222 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTLRHP  222 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEETTST
T ss_pred             CHHHEEEcC--cEEEEECcccccCCCc
Confidence            999999988  9999999999876443

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.76  E-value=7.6e-19  Score=173.03  Aligned_cols=155  Identities=16%  Similarity=0.253  Sum_probs=137.0

Q ss_pred             hcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccc
Q 003301          387 LCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVV  466 (832)
Q Consensus       387 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  466 (832)
                      ...+++|++|++++|.++ .+| .+..+++|++|++++|.++..  ..+..+++|++|++++|++++..|..++.+++|+
T Consensus        40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~  115 (197)
T 4ezg_A           40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT  115 (197)
T ss_dssp             HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSCC--GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred             hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCcc--hhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence            356788999999999999 556 689999999999999977653  4789999999999999999988899999999999


Q ss_pred             eecccCcccCCccCCccccccccceeeccccc-ccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCC
Q 003301          467 IIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNG-LQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFN  545 (832)
Q Consensus       467 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N  545 (832)
                      +|+|++|++++..|..++++++|+.|+|++|+ ++ .+| .++.+++|+.|++++|++++ ++ .+..+++|++|++++|
T Consensus       116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N  191 (197)
T 4ezg_A          116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQ  191 (197)
T ss_dssp             EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC
T ss_pred             EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCc
Confidence            99999999998889999999999999999998 65 566 79999999999999999996 44 7889999999999999


Q ss_pred             cccc
Q 003301          546 KLEG  549 (832)
Q Consensus       546 ~l~~  549 (832)
                      ++.+
T Consensus       192 ~i~~  195 (197)
T 4ezg_A          192 TIGG  195 (197)
T ss_dssp             ----
T ss_pred             ccCC
Confidence            9864

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.76  E-value=2.6e-19  Score=211.17  Aligned_cols=190  Identities=21%  Similarity=0.200  Sum_probs=113.0

Q ss_pred             EeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCC
Q 003301          325 FISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLS  404 (832)
Q Consensus       325 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  404 (832)
                      ++..|.+. ..+..|..++.|+.|+|++|.+. .+|..+..+++|++|+|++|+|+ .+|..|..+++|++|+|++|+|+
T Consensus       207 ~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~  283 (727)
T 4b8c_D          207 DDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT  283 (727)
T ss_dssp             ----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS
T ss_pred             ccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC
Confidence            33444444 55677788888888888888887 45555668888888888888888 77888888888888888888888


Q ss_pred             CCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccc-cceecccCcccCCccCCcc
Q 003301          405 GPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKV-VVIIDLSRNNLSGDIPTAI  483 (832)
Q Consensus       405 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~~~~~  483 (832)
                       .+|..|+.+++|++|+|++|.|+. +|..|..+++|+.|+|++|.|++.+|..+..+.. +..++|++|.+++.+|..+
T Consensus       284 -~lp~~~~~l~~L~~L~L~~N~l~~-lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l  361 (727)
T 4b8c_D          284 -SLPAELGSCFQLKYFYFFDNMVTT-LPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHER  361 (727)
T ss_dssp             -SCCSSGGGGTTCSEEECCSSCCCC-CCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-
T ss_pred             -ccChhhcCCCCCCEEECCCCCCCc-cChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcccc
Confidence             678888888888888888888874 5666888888888888888888888877766533 2347888888888877654


Q ss_pred             ccccccceeecccc--------cccccCCccccCCCCCCeeccCCCcccc
Q 003301          484 GGLMNLQDLSLRDN--------GLQGSIPKSIGGLVSLESLDLSNNSLSG  525 (832)
Q Consensus       484 ~~l~~L~~L~Ls~N--------~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  525 (832)
                            +.|++++|        .+.+..+..+..+..++...++.|-+.+
T Consensus       362 ------~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~  405 (727)
T 4b8c_D          362 ------RFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQ  405 (727)
T ss_dssp             ----------------------------------------------CCCG
T ss_pred             ------ceeEeecccccccccCCccccccchhhcccccceeeeecccccc
Confidence                  45566666        4555555566677777888888888753

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.74  E-value=3.1e-19  Score=191.17  Aligned_cols=102  Identities=16%  Similarity=0.126  Sum_probs=55.3

Q ss_pred             CCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccc-eecccCcccCCccCCcccccccccee
Q 003301          414 LTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVV-IIDLSRNNLSGDIPTAIGGLMNLQDL  492 (832)
Q Consensus       414 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L  492 (832)
                      +++|+.++|++|.++.+.+.+|.++++|+.++|++| ++...+.+|.++.+|+ .+++.+ +++.+.+.+|.++++|+.|
T Consensus       225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l  302 (329)
T 3sb4_A          225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV  302 (329)
T ss_dssp             CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred             cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence            455555555555555555555555555555555555 4444444555555555 555554 4444445555555555555


Q ss_pred             ecccccccccCCccccCCCCCCeec
Q 003301          493 SLRDNGLQGSIPKSIGGLVSLESLD  517 (832)
Q Consensus       493 ~Ls~N~l~~~~p~~~~~l~~L~~L~  517 (832)
                      ++++|+++...+.+|.++++|+.++
T Consensus       303 ~l~~n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          303 LATGDKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             EECSSCCCEECTTTTCTTCCCCEEE
T ss_pred             EeCCCccCccchhhhcCCcchhhhc
Confidence            5555555544445555555555543

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.71  E-value=1.1e-17  Score=163.76  Aligned_cols=112  Identities=28%  Similarity=0.360  Sum_probs=76.0

Q ss_pred             ccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccC
Q 003301          440 DILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLS  519 (832)
Q Consensus       440 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  519 (832)
                      +|++|++++|+|+ .+|..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|+
T Consensus        32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~  110 (193)
T 2wfh_A           32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH  110 (193)
T ss_dssp             TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence            4555555555555 345566666666666666666666666667777777777777777776666667777777777777


Q ss_pred             CCcccccCchhhhhhccCCeeeCCCCcccccCC
Q 003301          520 NNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIP  552 (832)
Q Consensus       520 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  552 (832)
                      +|+|++..+..|..+++|+.|+|++|+|.|.+.
T Consensus       111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~  143 (193)
T 2wfh_A          111 GNDISVVPEGAFNDLSALSHLAIGANPLYCDCN  143 (193)
T ss_dssp             SSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             CCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence            777776655567777777777777777776654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.68  E-value=1.2e-17  Score=177.46  Aligned_cols=143  Identities=13%  Similarity=0.127  Sum_probs=102.6

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccch--------------hhHHH--------HHHHHHHHhcCCC
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLE--------------GALKS--------FDVECEVLKSVRH  714 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~e~~~l~~l~h  714 (832)
                      ...-|.+...||+|++|.||+|...+|+.||||+++....              .....        ..+|...+.++.+
T Consensus        93 rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~  172 (397)
T 4gyi_A           93 RKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE  172 (397)
T ss_dssp             TTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence            3345899999999999999999998899999998753210              00111        2345555655544


Q ss_pred             CceeeeceEEecCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC
Q 003301          715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK  794 (832)
Q Consensus       715 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~  794 (832)
                      .++....-+...  ..++||||++|+++.++...       ..+..++.|++.++.|+|   +.|||||||||.|||+++
T Consensus       173 ~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          173 EGFPVPEPIAQS--RHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIRE  240 (397)
T ss_dssp             TTCSCCCEEEEE--TTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEE
T ss_pred             cCCCCCeeeecc--CceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeC
Confidence            433222112111  23799999999888665321       134568899999999999   999999999999999987


Q ss_pred             CC----------cEEEeccccccccCC
Q 003301          795 DM----------VAHLSDFGIAKLLSG  811 (832)
Q Consensus       795 ~~----------~~kl~DFg~a~~~~~  811 (832)
                      ++          .+.|+||+-|.....
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~~~h  267 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVSMDH  267 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred             CCCcccccccccceEEEEeCCcccCCC
Confidence            76          389999998876543

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.68  E-value=3.6e-17  Score=156.54  Aligned_cols=42  Identities=19%  Similarity=0.071  Sum_probs=16.6

Q ss_pred             ccccccccceeecccccccccCC---ccccCCCCCCeeccCCCcc
Q 003301          482 AIGGLMNLQDLSLRDNGLQGSIP---KSIGGLVSLESLDLSNNSL  523 (832)
Q Consensus       482 ~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l  523 (832)
                      .+..+++|+.|++++|++++..+   ..+..+++|+.|++++|.+
T Consensus       115 ~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~  159 (168)
T 2ell_A          115 PLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRED  159 (168)
T ss_dssp             GGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred             HHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCCh
Confidence            33344444444444444442222   2334444444444444443

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.68  E-value=6.2e-16  Score=168.88  Aligned_cols=258  Identities=12%  Similarity=0.136  Sum_probs=134.2

Q ss_pred             ccccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCC
Q 003301          230 SGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGV  309 (832)
Q Consensus       230 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~  309 (832)
                      +.+...+|.++ +|+.+.+.+| ++.+...+|.+ .+|+.+.+.. .++.++..     +|.+|++|+.+++++|.++..
T Consensus       125 ~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~-----aF~~c~~L~~l~l~~n~l~~I  195 (401)
T 4fdw_A          125 KSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKED-----IFYYCYNLKKADLSKTKITKL  195 (401)
T ss_dssp             CEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSS-----TTTTCTTCCEEECTTSCCSEE
T ss_pred             CEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHH-----HhhCcccCCeeecCCCcceEe
Confidence            33444555543 4666665554 55455555555 3466666653 44443322     356666666666666665533


Q ss_pred             CCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcC
Q 003301          310 LPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQ  389 (832)
Q Consensus       310 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  389 (832)
                      ....|. . .+|+.+.+.++ ++.+...+|.++++|+.+++..| +..+...+|.+ .+|+.+++. +.++...+.+|.+
T Consensus       196 ~~~aF~-~-~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~  269 (401)
T 4fdw_A          196 PASTFV-Y-AGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIASRAFYY  269 (401)
T ss_dssp             CTTTTT-T-CCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTT
T ss_pred             chhhEe-e-cccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEEChhHhhC
Confidence            333333 1 24555555422 44444556666666666666653 44445555555 556666663 3344344455555


Q ss_pred             CCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceec
Q 003301          390 LARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIID  469 (832)
Q Consensus       390 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  469 (832)
                      +++|+.+++.+|.+..                   +.+..+.+.+|.++++|+.+++. +.++......|.++.+|+.++
T Consensus       270 c~~L~~l~l~~~~~~~-------------------~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~  329 (401)
T 4fdw_A          270 CPELAEVTTYGSTFND-------------------DPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLT  329 (401)
T ss_dssp             CTTCCEEEEESSCCCC-------------------CTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEE
T ss_pred             CCCCCEEEeCCccccC-------------------CcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEE
Confidence            5555555555554430                   00012334445555555555554 224444444555555555555


Q ss_pred             ccCcccCCccCCccccccccceeecccccccccCCccccCCC-CCCeeccCCCccc
Q 003301          470 LSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLV-SLESLDLSNNSLS  524 (832)
Q Consensus       470 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~  524 (832)
                      |..| ++.+.+.+|.++ +|+.+++++|.+....+..|.+++ +++.|.+..|.+.
T Consensus       330 lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          330 IPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             ECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             ECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            5333 444555666666 666666666666655556666663 5666666665543

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.68  E-value=8.1e-17  Score=154.06  Aligned_cols=133  Identities=25%  Similarity=0.231  Sum_probs=68.1

Q ss_pred             CcccEEEeecCccc-ccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEe
Q 003301          343 INLRELGLWGNELI-GSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLS  421 (832)
Q Consensus       343 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  421 (832)
                      ++|++|++++|++. +.+|..+..+++|++|+|++|.+++.  ..+..+++|++|++++|++++.+|..+..+++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            44555555555554 34444455555555555555555533  4444455555555555555444444444444444444


Q ss_pred             CCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccC---Cccccccccceeeccccc
Q 003301          422 LASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIP---TAIGGLMNLQDLSLRDNG  498 (832)
Q Consensus       422 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~Ls~N~  498 (832)
                      +++|.++++.+                       +..+..+++|+.|++++|.+++..+   ..|..+++|++|++++|.
T Consensus       102 Ls~N~l~~~~~-----------------------~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~  158 (168)
T 2ell_A          102 LSGNKLKDIST-----------------------LEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRE  158 (168)
T ss_dssp             CBSSSCCSSGG-----------------------GGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETT
T ss_pred             ccCCccCcchh-----------------------HHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCC
Confidence            44444444211                       1445555555555555555554333   355566666666666666


Q ss_pred             cc
Q 003301          499 LQ  500 (832)
Q Consensus       499 l~  500 (832)
                      +.
T Consensus       159 ~~  160 (168)
T 2ell_A          159 DQ  160 (168)
T ss_dssp             SC
T ss_pred             hh
Confidence            55

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.67  E-value=1.3e-16  Score=153.98  Aligned_cols=131  Identities=24%  Similarity=0.267  Sum_probs=67.1

Q ss_pred             CcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccC
Q 003301          393 LSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSR  472 (832)
Q Consensus       393 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  472 (832)
                      .+.+++++|+++. +|..+  .++|+.|++++|+++++.+..|..+++|++|++++|++++..+..|..+++|+.|+|++
T Consensus         9 ~~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   85 (177)
T 2o6r_A            9 GTEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE   85 (177)
T ss_dssp             TTEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence            3556666666663 33322  24566666666666655555555555555555555555544444445555555555555


Q ss_pred             cccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCccccc
Q 003301          473 NNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGN  526 (832)
Q Consensus       473 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  526 (832)
                      |++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|++++.
T Consensus        86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  139 (177)
T 2o6r_A           86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  139 (177)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence            555544444444445555555555555433333344444444444444444443

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.67  E-value=1.6e-15  Score=165.61  Aligned_cols=263  Identities=10%  Similarity=0.152  Sum_probs=149.1

Q ss_pred             cccceecccccccccccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEE
Q 003301          167 RNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVL  246 (832)
Q Consensus       167 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L  246 (832)
                      ..++.+.+.+ .++.+...+|.+. +|+.+.+..+ +.......  |.+ .+|+.+.+.. .++.+.+.+|.++++|+.+
T Consensus       113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~a--F~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l  185 (401)
T 4fdw_A          113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMA--FFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKA  185 (401)
T ss_dssp             SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTT--TTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEE
T ss_pred             CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHh--cCC-CCceEEEeCC-CccEehHHHhhCcccCCee
Confidence            4555555543 3444555566664 5777776655 43222222  233 3577777764 5666677777777777777


Q ss_pred             EcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEe
Q 003301          247 ELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFI  326 (832)
Q Consensus       247 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l  326 (832)
                      ++++|.++.+...+|. ..+|+.+.+..+ ++.++..     +|.+|++|+.+++..| ++.....+|..  .+|+.+.+
T Consensus       186 ~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~-----aF~~~~~L~~l~l~~~-l~~I~~~aF~~--~~L~~i~l  255 (401)
T 4fdw_A          186 DLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQ-----AFLKTSQLKTIEIPEN-VSTIGQEAFRE--SGITTVKL  255 (401)
T ss_dssp             ECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTT-----TTTTCTTCCCEECCTT-CCEECTTTTTT--CCCSEEEE
T ss_pred             ecCCCcceEechhhEe-ecccCEEEeCCc-hheehhh-----HhhCCCCCCEEecCCC-ccCcccccccc--CCccEEEe
Confidence            7777777766666666 467777777643 5554443     4777777777777764 33333344443  25666666


Q ss_pred             ecCcccccccccccCcCcccEEEeecCccc-----ccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCC
Q 003301          327 SNCSIRGTIPKEIGNLINLRELGLWGNELI-----GSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGN  401 (832)
Q Consensus       327 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  401 (832)
                       .+.++.+...+|.++++|+.+++.+|.+.     .+.+.+|.++++|+.++|. +.++.....+|.++.+|+.+.+..|
T Consensus       256 -p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~  333 (401)
T 4fdw_A          256 -PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN  333 (401)
T ss_dssp             -ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT
T ss_pred             -CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc
Confidence             34455455566666666666666665543     3445556666666666665 3344444455555555555555433


Q ss_pred             cCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCc-ccceeeecCCc
Q 003301          402 KLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLK-DILSLNFSSNF  450 (832)
Q Consensus       402 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~  450 (832)
                       ++...+.+|.++ +|+.+++++|.+..+.+..|.+++ +++.|++..+.
T Consensus       334 -l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~  381 (401)
T 4fdw_A          334 -VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAES  381 (401)
T ss_dssp             -CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGG
T ss_pred             -ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHH
Confidence             443444455555 555555555555555555555442 34444444443

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.66  E-value=4.5e-15  Score=162.89  Aligned_cols=334  Identities=13%  Similarity=0.068  Sum_probs=154.2

Q ss_pred             ccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccccccccccCcc
Q 003301          107 LTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTS  186 (832)
Q Consensus       107 l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~  186 (832)
                      ++.+-..+|.+|++|+.+.+..+ ++.+...+|.++++|+.+++.++ ++.+....|.++++|+.+.+..+ +..+...+
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~a  135 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEA  135 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTT
T ss_pred             EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeeccee
Confidence            34333445666666666666532 54444556666666666666543 44344455666666665555433 33333444


Q ss_pred             cccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCccc
Q 003301          187 IFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRK  266 (832)
Q Consensus       187 ~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~  266 (832)
                      |.++..++......                            +..+...+|.++++|+.+.+.++. ..+...+|.++.+
T Consensus       136 F~~~~~~~~~~~~~----------------------------~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~  186 (394)
T 4fs7_A          136 FKGCDFKEITIPEG----------------------------VTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGK  186 (394)
T ss_dssp             TTTCCCSEEECCTT----------------------------CCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTT
T ss_pred             eecccccccccCcc----------------------------ccccchhhhcccCCCcEEecCCcc-ceeccccccCCCC
Confidence            44443222211111                            111223345555555555554432 2244455555555


Q ss_pred             cceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCccc
Q 003301          267 LEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLR  346 (832)
Q Consensus       267 L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~  346 (832)
                      |+.+.+..| ++.+..     .+|.++..|+.+.+..+...  +.+...... .|+.+.+... ++.+....|.++..|+
T Consensus       187 L~~i~l~~~-~~~I~~-----~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~-~l~~i~ip~~-~~~i~~~~f~~~~~l~  256 (394)
T 4fs7_A          187 LKSIKLPRN-LKIIRD-----YCFAECILLENMEFPNSLYY--LGDFALSKT-GVKNIIIPDS-FTELGKSVFYGCTDLE  256 (394)
T ss_dssp             CCBCCCCTT-CCEECT-----TTTTTCTTCCBCCCCTTCCE--ECTTTTTTC-CCCEEEECTT-CCEECSSTTTTCSSCC
T ss_pred             ceEEEcCCC-ceEeCc-----hhhccccccceeecCCCceE--eehhhcccC-CCceEEECCC-ceecccccccccccce
Confidence            555555544 332222     13555555655555444321  111111111 3444443321 2223334455556666


Q ss_pred             EEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCc
Q 003301          347 ELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNE  426 (832)
Q Consensus       347 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  426 (832)
                      .+.+..+... +....|..+..++.+....+.+.   ...|..+.+|+.+.+..+ ++.....+|.++++|+.+++.++ 
T Consensus       257 ~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-  330 (394)
T 4fs7_A          257 SISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-  330 (394)
T ss_dssp             EEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-
T ss_pred             eEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-
Confidence            6666555332 44455555555555555544322   123444455555555433 33233344555555555554322 


Q ss_pred             CCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCcc
Q 003301          427 LNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKS  506 (832)
Q Consensus       427 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  506 (832)
                      ++.+...                        +|.++.+|+.+++..| ++.+...+|.++.+|+.+++..+ ++ .+..+
T Consensus       331 v~~I~~~------------------------aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~  383 (394)
T 4fs7_A          331 VEEIGKR------------------------SFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYD  383 (394)
T ss_dssp             CCEECTT------------------------TTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGG
T ss_pred             ccEEhHH------------------------hccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-Ehhhe
Confidence            3333344                        4444455555555443 44344455555555665555443 22 23345


Q ss_pred             ccCCCCCCe
Q 003301          507 IGGLVSLES  515 (832)
Q Consensus       507 ~~~l~~L~~  515 (832)
                      |.++++|+.
T Consensus       384 F~~c~~L~~  392 (394)
T 4fs7_A          384 FEDTTKFKW  392 (394)
T ss_dssp             BCTTCEEEE
T ss_pred             ecCCCCCcE
Confidence            555555554

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.66  E-value=7.4e-17  Score=150.94  Aligned_cols=108  Identities=20%  Similarity=0.277  Sum_probs=48.9

Q ss_pred             CCCcEEEecCCcCC-CCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceec
Q 003301          391 ARLSVLYMDGNKLS-GPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIID  469 (832)
Q Consensus       391 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  469 (832)
                      ++|+.|++++|.++ +.+|..+..+++|+.|++++|.+++.  ..|..+++|++|++++|++++.+|..++.+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            34555555555554 34444455555555555555555443  3344444444444444444433344444444444444


Q ss_pred             ccCcccCCc-cCCccccccccceeeccccccc
Q 003301          470 LSRNNLSGD-IPTAIGGLMNLQDLSLRDNGLQ  500 (832)
Q Consensus       470 Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~  500 (832)
                      +++|++++. .+..++++++|++|++++|+++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~  126 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT  126 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGG
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCccc
Confidence            444444431 1233444444444444444444

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.66  E-value=8.6e-17  Score=150.49  Aligned_cols=129  Identities=20%  Similarity=0.182  Sum_probs=117.7

Q ss_pred             CCCCCeEeCCCCcCC-CCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCcccccccccee
Q 003301          414 LTSLRLLSLASNELN-SVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDL  492 (832)
Q Consensus       414 l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  492 (832)
                      .++|+.|++++|.++ +.+|..+..+++|++|++++|++++.  ..++.+++|++|+|++|++++.+|..+.++++|+.|
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            478999999999998 67888999999999999999999976  789999999999999999998788888899999999


Q ss_pred             eccccccccc-CCccccCCCCCCeeccCCCcccccCc---hhhhhhccCCeeeCCC
Q 003301          493 SLRDNGLQGS-IPKSIGGLVSLESLDLSNNSLSGNIP---TSMEKLLYLKDLNLSF  544 (832)
Q Consensus       493 ~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~l~l~~  544 (832)
                      ++++|++++. .|..++.+++|+.|++++|++++..+   ..+..+++|+.|++++
T Consensus        94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            9999999974 35889999999999999999998776   6899999999999874

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.66  E-value=4.9e-16  Score=149.98  Aligned_cols=134  Identities=23%  Similarity=0.208  Sum_probs=100.5

Q ss_pred             CCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeeccc
Q 003301          417 LRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRD  496 (832)
Q Consensus       417 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  496 (832)
                      .+.+++++|.++.+....   .++|++|++++|++++..+..|+.+++|++|++++|++++..+..|.++++|+.|+|++
T Consensus         9 ~~~l~~~~~~l~~~p~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   85 (177)
T 2o6r_A            9 GTEIRCNSKGLTSVPTGI---PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE   85 (177)
T ss_dssp             TTEEECCSSCCSSCCTTC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCccCCCCC---CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence            467777888777644322   25777888888888776666677788888888888888766666777888888888888


Q ss_pred             ccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCCC
Q 003301          497 NGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPR  553 (832)
Q Consensus       497 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~  553 (832)
                      |++++..+..|+.+++|++|+|++|++++..+..+..+++|++|++++|+++|.+|.
T Consensus        86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  142 (177)
T 2o6r_A           86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  142 (177)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence            888876666777788888888888888766666667778888888888888877763

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.65  E-value=4.8e-16  Score=152.01  Aligned_cols=110  Identities=24%  Similarity=0.318  Sum_probs=71.7

Q ss_pred             CCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecc
Q 003301          416 SLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLR  495 (832)
Q Consensus       416 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  495 (832)
                      +|+.|++++|.|+. +|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus        32 ~l~~L~L~~n~i~~-ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~  110 (193)
T 2wfh_A           32 DVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH  110 (193)
T ss_dssp             TCCEEECCSSCCCS-CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCch-hHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence            45555555555543 33455555555555555555555555556666666666666666666666677777777777777


Q ss_pred             cccccccCCccccCCCCCCeeccCCCccccc
Q 003301          496 DNGLQGSIPKSIGGLVSLESLDLSNNSLSGN  526 (832)
Q Consensus       496 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  526 (832)
                      +|+|++..+..|..+++|+.|+|++|++...
T Consensus       111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~  141 (193)
T 2wfh_A          111 GNDISVVPEGAFNDLSALSHLAIGANPLYCD  141 (193)
T ss_dssp             SSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             CCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence            7777765556677788888888888887753

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.64  E-value=9e-15  Score=160.52  Aligned_cols=336  Identities=12%  Similarity=0.100  Sum_probs=218.9

Q ss_pred             cccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccccccccccCcccccCCcccEEEecCCCCCCCCCc
Q 003301          130 QFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPS  209 (832)
Q Consensus       130 ~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~  209 (832)
                      .++.+...+|.++++|+.+.+..+ ++.+-..+|.++++|+.+++..+ ++.+...+|.++.+|+.+.+..+        
T Consensus        58 ~VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~--------  127 (394)
T 4fs7_A           58 DVVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM--------  127 (394)
T ss_dssp             EEEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT--------
T ss_pred             eEeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc--------
Confidence            355555667888888888888643 66455667777777777777654 55455566767766666554432        


Q ss_pred             cccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccc
Q 003301          210 SIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSS  289 (832)
Q Consensus       210 ~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~  289 (832)
                                         +..+...+|.++..+......  .+..+...+|.++++|+.+.+..+. ..++.     .+
T Consensus       128 -------------------l~~i~~~aF~~~~~~~~~~~~--~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~-----~~  180 (394)
T 4fs7_A          128 -------------------LKSIGVEAFKGCDFKEITIPE--GVTVIGDEAFATCESLEYVSLPDSM-ETLHN-----GL  180 (394)
T ss_dssp             -------------------CCEECTTTTTTCCCSEEECCT--TCCEECTTTTTTCTTCCEEECCTTC-CEECT-----TT
T ss_pred             -------------------eeeecceeeecccccccccCc--cccccchhhhcccCCCcEEecCCcc-ceecc-----cc
Confidence                               222344455555444433322  2333566789999999999997653 33333     35


Q ss_pred             cccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCC
Q 003301          290 WANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNL  369 (832)
Q Consensus       290 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  369 (832)
                      |.++++|+.+++..| +...                         ...+|.++..|+.+.+..+...  +.+.+....+|
T Consensus       181 F~~c~~L~~i~l~~~-~~~I-------------------------~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l  232 (394)
T 4fs7_A          181 FSGCGKLKSIKLPRN-LKII-------------------------RDYCFAECILLENMEFPNSLYY--LGDFALSKTGV  232 (394)
T ss_dssp             TTTCTTCCBCCCCTT-CCEE-------------------------CTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCC
T ss_pred             ccCCCCceEEEcCCC-ceEe-------------------------CchhhccccccceeecCCCceE--eehhhcccCCC
Confidence            889999999888765 3212                         2233445555555555444322  12223334566


Q ss_pred             ceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCC
Q 003301          370 QGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSN  449 (832)
Q Consensus       370 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  449 (832)
                      +.+.+..+. +......+.....|+.+.+..+... .....|..+..++.+....+.+   ....|..+.+|+.+.+..+
T Consensus       233 ~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~  307 (394)
T 4fs7_A          233 KNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS  307 (394)
T ss_dssp             CEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT
T ss_pred             ceEEECCCc-eecccccccccccceeEEcCCCcce-eeccccccccccceeccCceee---ccccccccccccccccccc
Confidence            666665432 2233445666667777777666443 4556677777777777666543   3456777788888887655


Q ss_pred             cccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCch
Q 003301          450 FLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPT  529 (832)
Q Consensus       450 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  529 (832)
                       ++.....+|.++.+|+.++|..+ ++.+...+|.++.+|+.+++..| ++.....+|.++.+|+.+++..+ ++ .+..
T Consensus       308 -i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~  382 (394)
T 4fs7_A          308 -VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRY  382 (394)
T ss_dssp             -CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGG
T ss_pred             -cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-Ehhh
Confidence             55556677888888998888754 77677889999999999999887 77677889999999999999866 33 3456


Q ss_pred             hhhhhccCCee
Q 003301          530 SMEKLLYLKDL  540 (832)
Q Consensus       530 ~~~~l~~L~~l  540 (832)
                      .|.+.++|+.+
T Consensus       383 ~F~~c~~L~~I  393 (394)
T 4fs7_A          383 DFEDTTKFKWI  393 (394)
T ss_dssp             GBCTTCEEEEE
T ss_pred             eecCCCCCcEE
Confidence            77777777654

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.59  E-value=6.2e-16  Score=149.05  Aligned_cols=123  Identities=20%  Similarity=0.276  Sum_probs=70.1

Q ss_pred             CccCCCCcceeccCccccCccccCeEeccCCccccCCCccccccc-cCcEEEccCCcCCCCCCCcccCcccccccccccc
Q 003301            1 MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLA-ELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSN   79 (832)
Q Consensus         1 ~ldl~~n~~~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~-~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~   79 (832)
                      |+.++.+.+.  -.+.+.+.+.|++|++++|+++ .+|. +..+. +|++|++++|.+++ + +.++.+++| ++|++++
T Consensus         1 m~~lt~~~i~--~~~~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~-~-~~l~~l~~L-~~L~Ls~   73 (176)
T 1a9n_A            1 MVKLTAELIE--QAAQYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRK-L-DGFPLLRRL-KTLLVNN   73 (176)
T ss_dssp             -CCCCHHHHH--TSCEEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCE-E-CCCCCCSSC-CEEECCS
T ss_pred             CccccHHHHH--HHHhcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCc-c-cccccCCCC-CEEECCC
Confidence            4455555454  2455677778888888888887 5554 44444 78888888887773 3 445555555 5566666


Q ss_pred             cccccCCChhhhhcCCCceEEEccCCcccccCCC--CccCCCCccEEECcCCccc
Q 003301           80 NSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPN--NIWQCKELIVISLAYNQFT  132 (832)
Q Consensus        80 n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~--~l~~l~~L~~L~Ls~n~i~  132 (832)
                      |.++ .+|..++..+++|++|++++|+|+ .+|.  .+..+++|++|++++|.++
T Consensus        74 N~l~-~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~  126 (176)
T 1a9n_A           74 NRIC-RIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT  126 (176)
T ss_dssp             SCCC-EECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             Cccc-ccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC
Confidence            6655 445444445555555555555554 3333  3444444444444444443

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.59  E-value=1.2e-15  Score=146.95  Aligned_cols=105  Identities=19%  Similarity=0.213  Sum_probs=61.0

Q ss_pred             ccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCc--cccCCCCCCeec
Q 003301          440 DILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPK--SIGGLVSLESLD  517 (832)
Q Consensus       440 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~  517 (832)
                      +|++|++++|++++.  ..++.+++|++|+|++|++++..+..|.++++|++|+|++|+|+ .+|.  .++.+++|+.|+
T Consensus        43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~  119 (176)
T 1a9n_A           43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC  119 (176)
T ss_dssp             CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred             CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence            444444455544432  34555555666666666665443344466666666666666664 3444  566666667777


Q ss_pred             cCCCcccccCch----hhhhhccCCeeeCCCCccc
Q 003301          518 LSNNSLSGNIPT----SMEKLLYLKDLNLSFNKLE  548 (832)
Q Consensus       518 Ls~N~l~~~~p~----~~~~l~~L~~l~l~~N~l~  548 (832)
                      +++|+++. +|.    .+..+++|+.||+++|...
T Consensus       120 l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A          120 ILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             CCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             ecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence            77776663 344    3666677777777776655

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.58  E-value=1.6e-17  Score=163.71  Aligned_cols=161  Identities=19%  Similarity=0.312  Sum_probs=103.7

Q ss_pred             ccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccc
Q 003301          363 FGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDIL  442 (832)
Q Consensus       363 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  442 (832)
                      +.....++.++++.|.+++..|.                 ++ .+|..|..+++|++|++++|.+++ +| .+..+++|+
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~-----------------l~-~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~   73 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPP-----------------IE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLR   73 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTT-----------------CC-CCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCC
T ss_pred             HHhcccccCcchheeEeccccCc-----------------Hh-hhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCC
Confidence            44455666666666666655443                 11 122355555666666666666655 33 556666666


Q ss_pred             eeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCC-ccccCCCCCCeeccCCC
Q 003301          443 SLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIP-KSIGGLVSLESLDLSNN  521 (832)
Q Consensus       443 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N  521 (832)
                      +|++++|+++ .+|..+..+++|+.|+|++|++++ +| .+.++++|+.|+|++|++++..+ ..+..+++|+.|++++|
T Consensus        74 ~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N  150 (198)
T 1ds9_A           74 ILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN  150 (198)
T ss_dssp             EEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSC
T ss_pred             EEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCC
Confidence            6666666666 355666666777777777777775 34 57777778888888888774332 46777888888888888


Q ss_pred             cccccCchh----------hhhhccCCeeeCCCCccc
Q 003301          522 SLSGNIPTS----------MEKLLYLKDLNLSFNKLE  548 (832)
Q Consensus       522 ~l~~~~p~~----------~~~l~~L~~l~l~~N~l~  548 (832)
                      ++++.+|..          +..+++|+.||  +|+++
T Consensus       151 ~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          151 PLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred             ccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence            887766653          67788888776  56554

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.57  E-value=2.2e-17  Score=162.63  Aligned_cols=162  Identities=23%  Similarity=0.252  Sum_probs=102.3

Q ss_pred             ccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCC
Q 003301          339 IGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLR  418 (832)
Q Consensus       339 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  418 (832)
                      +.....++.++++.+.+.+..|.                 ++ .+|..+..+++|++|++++|++++ +| .+..+++|+
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~-----------------l~-~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~   73 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPP-----------------IE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLR   73 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTT-----------------CC-CCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCC
T ss_pred             HHhcccccCcchheeEeccccCc-----------------Hh-hhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCC
Confidence            45556777777888777765554                 22 233344444444444554444443 33 444555555


Q ss_pred             eEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccC-Cccccccccceeecccc
Q 003301          419 LLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIP-TAIGGLMNLQDLSLRDN  497 (832)
Q Consensus       419 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N  497 (832)
                      .|++++|.++. +|..+..+++|++|++++|++++ +| .+..+++|+.|++++|++++..+ ..+..+++|++|++++|
T Consensus        74 ~L~l~~n~l~~-l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N  150 (198)
T 1ds9_A           74 ILSLGRNLIKK-IENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN  150 (198)
T ss_dssp             EEEEEEEEECS-CSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSC
T ss_pred             EEECCCCCccc-ccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCC
Confidence            55555555553 34455555666666777777665 34 56777778888888888775332 46778888888888888


Q ss_pred             cccccCCcc----------ccCCCCCCeeccCCCcccc
Q 003301          498 GLQGSIPKS----------IGGLVSLESLDLSNNSLSG  525 (832)
Q Consensus       498 ~l~~~~p~~----------~~~l~~L~~L~Ls~N~l~~  525 (832)
                      ++++.+|..          +..+++|+.||  +|.++.
T Consensus       151 ~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~  186 (198)
T 1ds9_A          151 PLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV  186 (198)
T ss_dssp             HHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred             ccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence            887766553          77888899887  777764

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.55  E-value=7.4e-15  Score=140.36  Aligned_cols=108  Identities=21%  Similarity=0.244  Sum_probs=64.9

Q ss_pred             ceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCC
Q 003301          442 LSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNN  521 (832)
Q Consensus       442 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  521 (832)
                      +.+++++|+++. +|..+.  +.|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus        12 ~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A           12 TTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            344555555543 333332  45566666666666555666666666666666666666555555666666666666666


Q ss_pred             cccccCchhhhhhccCCeeeCCCCcccccCC
Q 003301          522 SLSGNIPTSMEKLLYLKDLNLSFNKLEGEIP  552 (832)
Q Consensus       522 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  552 (832)
                      +|++..+..|..+++|+.|+|++|+|+|.++
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            6665555556666666666666666666655

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.52  E-value=2.2e-14  Score=137.53  Aligned_cols=107  Identities=25%  Similarity=0.253  Sum_probs=58.6

Q ss_pred             eeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCc
Q 003301          443 SLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNS  522 (832)
Q Consensus       443 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  522 (832)
                      .+++++|+++ .+|..+.  +.|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|+.+++|++|+|++|+
T Consensus        16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~   92 (174)
T 2r9u_A           16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH   92 (174)
T ss_dssp             EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence            3444444443 2333332  455555555555555555555555566666666666655444445556666666666666


Q ss_pred             ccccCchhhhhhccCCeeeCCCCcccccCC
Q 003301          523 LSGNIPTSMEKLLYLKDLNLSFNKLEGEIP  552 (832)
Q Consensus       523 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  552 (832)
                      |++..+..+..+++|+.|+|++|+|.+.++
T Consensus        93 l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~  122 (174)
T 2r9u_A           93 LKSIPRGAFDNLKSLTHIYLYNNPWDCECR  122 (174)
T ss_dssp             CCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred             cceeCHHHhccccCCCEEEeCCCCcccccc
Confidence            665444445556666666666666665544

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.50  E-value=1.5e-12  Score=142.75  Aligned_cols=88  Identities=15%  Similarity=0.096  Sum_probs=52.1

Q ss_pred             CCCccCCC-CccEEECcCCcccccCCCCCcCCCcCceEEecccc---cccccCccccCccccceecccccccccccCccc
Q 003301          112 PNNIWQCK-ELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNN---LTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSI  187 (832)
Q Consensus       112 p~~l~~l~-~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~---i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~  187 (832)
                      ..+|.++. .|+.+.+..+ ++.+...+|.++++|+.+.++.|.   ++.+-..+|.++.+|+.+.+..+ ++.+...+|
T Consensus        56 ~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF  133 (394)
T 4gt6_A           56 DRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAF  133 (394)
T ss_dssp             TTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTT
T ss_pred             HhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhh
Confidence            34555553 4666666543 555556667777777777776653   44344456666677776666543 444445566


Q ss_pred             ccCCcccEEEecCC
Q 003301          188 FNLSAMKTLALPSN  201 (832)
Q Consensus       188 ~~l~~L~~L~L~~n  201 (832)
                      .++.+|+.+.+..+
T Consensus       134 ~~c~~L~~i~lp~~  147 (394)
T 4gt6_A          134 HHCEELDTVTIPEG  147 (394)
T ss_dssp             TTCTTCCEEECCTT
T ss_pred             hhhcccccccccce
Confidence            66666666666543

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.50  E-value=1.1e-13  Score=132.10  Aligned_cols=108  Identities=24%  Similarity=0.239  Sum_probs=74.4

Q ss_pred             CeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccc
Q 003301          418 RLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDN  497 (832)
Q Consensus       418 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  497 (832)
                      +.+++++|.++.+ |..+  .++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus        12 ~~l~~s~n~l~~i-p~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A           12 TTVDCSGKSLASV-PTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             TEEECTTSCCSSC-CSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcCcc-CccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            4555555555542 2222  145566666666666666666777777777777777777666667777888888888888


Q ss_pred             cccccCCccccCCCCCCeeccCCCcccccCc
Q 003301          498 GLQGSIPKSIGGLVSLESLDLSNNSLSGNIP  528 (832)
Q Consensus       498 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  528 (832)
                      +|++..+..|..+++|+.|+|++|+++...+
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            8887666678888888888888888876544

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.45  E-value=2.2e-13  Score=130.49  Aligned_cols=41  Identities=24%  Similarity=0.295  Sum_probs=16.8

Q ss_pred             ccccccceecccCcccCCccCCccccccccceeeccccccc
Q 003301          460 GNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQ  500 (832)
Q Consensus       460 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  500 (832)
                      ..+++|++|+|++|+|++..+..|.++++|+.|+|++|++.
T Consensus        78 ~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           78 DKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             TTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             CCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcc
Confidence            33334444444444444333333444444444444444444

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.43  E-value=9.5e-12  Score=136.33  Aligned_cols=114  Identities=11%  Similarity=0.148  Sum_probs=88.5

Q ss_pred             CCChhhhhcCC-CceEEEccCCcccccCCCCccCCCCccEEECcCCc---ccccCCCCCcCCCcCceEEecccccccccC
Q 003301           85 SLPDDMCRRLP-LIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQ---FTERIPRGLGNLTSLKTLYLGFNNLTGEIP  160 (832)
Q Consensus        85 ~lp~~~~~~l~-~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~---i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p  160 (832)
                      .|.+..|.+.. .|+.+.+..+ ++.+-..+|.+|++|+.+.++.|.   ++.+...+|.++.+|+.+.+..+ ++....
T Consensus        53 ~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~  130 (394)
T 4gt6_A           53 KIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDS  130 (394)
T ss_dssp             EECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECT
T ss_pred             EcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehh
Confidence            56777776664 5888888765 665667789999999999998774   66666778999999999888765 554666


Q ss_pred             ccccCccccceecccccccccccCcccccCCcccEEEecCC
Q 003301          161 YEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSN  201 (832)
Q Consensus       161 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n  201 (832)
                      ..|.++.+|+.+.+..+ +..+...+|.++.+|+.+.+..+
T Consensus       131 ~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~  170 (394)
T 4gt6_A          131 EAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS  170 (394)
T ss_dssp             TTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT
T ss_pred             hhhhhhcccccccccce-eeeecccceecccccccccccce
Confidence            78899999999999754 44466677888888888888655

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.35  E-value=6.1e-15  Score=159.46  Aligned_cols=73  Identities=22%  Similarity=0.257  Sum_probs=35.4

Q ss_pred             ccccccceecccCcccCCc----cCCccccccccceeeccccccccc----CCccccCCCCCCeeccCCCcccccCchhh
Q 003301          460 GNLKVVVIIDLSRNNLSGD----IPTAIGGLMNLQDLSLRDNGLQGS----IPKSIGGLVSLESLDLSNNSLSGNIPTSM  531 (832)
Q Consensus       460 ~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  531 (832)
                      ...+.|++|||++|.|++.    ++..+...++|+.|+|++|.|++.    ++..+...++|++|||++|.|+..-...+
T Consensus       180 ~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L  259 (372)
T 3un9_A          180 AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL  259 (372)
T ss_dssp             HTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred             hcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence            3344455555555555431    133344445555555555555532    22233344556666666666654443333


Q ss_pred             h
Q 003301          532 E  532 (832)
Q Consensus       532 ~  532 (832)
                      .
T Consensus       260 ~  260 (372)
T 3un9_A          260 R  260 (372)
T ss_dssp             H
T ss_pred             H
Confidence            3

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.34  E-value=2.6e-12  Score=132.50  Aligned_cols=147  Identities=12%  Similarity=0.092  Sum_probs=116.0

Q ss_pred             HHHhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCC-CCceeeeceEEecCCeeEEE
Q 003301          655 LQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVR-HRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       655 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  733 (832)
                      ....+.|++....+.|+.+.||++.. .++.+++|+...........+.+|+++++.+. +..++++++++...+..|+|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            34557898888999999999999986 47899999987543233356888999998884 67788999999988899999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG--------------------------------------  775 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------------------------------------  775 (832)
                      |||++|.++.+.+..      ......++.+++.+++.||.-                                      
T Consensus        89 ~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           89 MSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            999999999876321      122346788999999999940                                      


Q ss_pred             ------------------CCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          776 ------------------YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       776 ------------------~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                                        ....++|+|++|.||+++.+..+.|+||+.|..
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                              015689999999999998766678999998864

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.34  E-value=5.4e-13  Score=143.75  Aligned_cols=132  Identities=20%  Similarity=0.140  Sum_probs=90.7

Q ss_pred             eEeCCCC-cCCCCCCcccccCcccceeeecC-CcccCCCccccccccccceecccCcccCCccCCccccccccceeeccc
Q 003301          419 LLSLASN-ELNSVIPSTFWNLKDILSLNFSS-NFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRD  496 (832)
Q Consensus       419 ~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  496 (832)
                      .++++++ .+++ +|. +..+++|++|+|++ |+|++..+..|+.+++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus        12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            4677777 7776 455 77777888888875 888777667788888888888888888877777778888888888888


Q ss_pred             ccccccCCccccCCCCCCeeccCCCcccccCc-hhhhhhccCCeeeCCCCcccccCCC
Q 003301          497 NGLQGSIPKSIGGLVSLESLDLSNNSLSGNIP-TSMEKLLYLKDLNLSFNKLEGEIPR  553 (832)
Q Consensus       497 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~~p~  553 (832)
                      |+|++..+..|..++ |+.|+|++|++..... .++..........+..++++|.-|.
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~  146 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence            888765556666555 7788888887775433 2333333333444455566665554

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.33  E-value=2e-12  Score=139.30  Aligned_cols=107  Identities=22%  Similarity=0.243  Sum_probs=64.3

Q ss_pred             eeeecCC-cccCCCccccccccccceecccC-cccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCC
Q 003301          443 SLNFSSN-FLNGSLPEDIGNLKVVVIIDLSR-NNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSN  520 (832)
Q Consensus       443 ~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  520 (832)
                      .++++++ +|++ +|. +..+++|+.|+|++ |+|++..+..|.++++|+.|+|++|+|++..|..|+.+++|+.|||++
T Consensus        12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            3455555 5653 454 66666666666664 666655555666666666666666666666666666666666666666


Q ss_pred             CcccccCchhhhhhccCCeeeCCCCcccccCC
Q 003301          521 NSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIP  552 (832)
Q Consensus       521 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  552 (832)
                      |+|++..+..+..+. |+.|+|++|+|.|.+.
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~  120 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLHCSCA  120 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCCCCGG
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCccCCCc
Confidence            666655544444444 6666666666665543

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.33  E-value=1.6e-14  Score=156.22  Aligned_cols=112  Identities=17%  Similarity=0.139  Sum_probs=49.2

Q ss_pred             CcCceEEeccccccc----ccCccccCccccceecccccccccc----cCcccccCCcccEEEecCCCCCCCCCccc--c
Q 003301          143 TSLKTLYLGFNNLTG----EIPYEMGNLRNLEILGLQLNKLVGF----VPTSIFNLSAMKTLALPSNALSGSLPSSI--D  212 (832)
Q Consensus       143 ~~L~~L~Ls~N~i~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~p~~~--~  212 (832)
                      ++|++|+|++|.|+.    .++..+..+++|++|+|++|+++..    ++.++...++|++|+|++|.++......+  .
T Consensus       155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~  234 (372)
T 3un9_A          155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA  234 (372)
T ss_dssp             CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred             CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence            445555555555432    1222334444555555555554421    13334445556666666665542211111  0


Q ss_pred             ccCCCCccEEEccCCccccccCCcccCC---C--CccEEE--cCCCcCc
Q 003301          213 LVRLPNLEIISLAGNNFSGIIPSFIFNA---S--KLSVLE--LGENSFS  254 (832)
Q Consensus       213 ~~~l~~L~~L~Ls~n~i~~~~~~~~~~l---~--~L~~L~--L~~N~i~  254 (832)
                      +...++|++|+|++|.|+......+..+   .  .|+.+.  +..|.++
T Consensus       235 L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~  283 (372)
T 3un9_A          235 AREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS  283 (372)
T ss_dssp             HHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred             HHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence            1234566666666666654433333322   1  166666  6666554

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.19  E-value=1.2e-09  Score=119.07  Aligned_cols=59  Identities=3%  Similarity=-0.016  Sum_probs=30.7

Q ss_pred             CCcCCCcCceEEecccccccccCccccCccccceecccccccccccCcccccCCcccEEEec
Q 003301          138 GLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALP  199 (832)
Q Consensus       138 ~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  199 (832)
                      ++....+|+.+.+.. .++.+-..+|.++++|+.+.+..+ ++.+...+|.++ +|+.+.+.
T Consensus        41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~   99 (379)
T 4h09_A           41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGM   99 (379)
T ss_dssp             TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEEC
T ss_pred             ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECC
Confidence            444455666666643 344344455666666666666433 444444555554 45555443

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.18  E-value=2.5e-11  Score=124.98  Aligned_cols=139  Identities=16%  Similarity=0.078  Sum_probs=102.2

Q ss_pred             cCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCc--eeeeceEEecCCeeEEEEec
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRN--LVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~  736 (832)
                      ..+.+....+.|..+.||++...+|+.|++|+....   ....+.+|+++++.+.+.+  +++++++...++..|+||||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            345544333466679999998767888999987643   2245778999998885444  56788888887888999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY----------------------------------------  776 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------  776 (832)
                      ++|.++.  ..    ..+   ...++.+++..+..+|...                                        
T Consensus        97 i~G~~l~--~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (264)
T 1nd4_A           97 VPGQDLL--SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP  167 (264)
T ss_dssp             CSSEETT--TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred             cCCcccC--cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence            9998884  21    112   2356778888888888311                                        


Q ss_pred             ---------------CCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          777 ---------------SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       777 ---------------~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                                     ..+++|+|++|.||+++.++.++|+|||.|...
T Consensus       168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                           123999999999999987767789999998753

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.16  E-value=3.8e-09  Score=114.97  Aligned_cols=123  Identities=13%  Similarity=0.114  Sum_probs=55.8

Q ss_pred             cccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCc
Q 003301          360 PITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLK  439 (832)
Q Consensus       360 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  439 (832)
                      ..+|.++..|+.+.+..+ ++.....+|.++.+|+.+.+..+ +......+|.++++|+.+.+.++.++.+...+|.++.
T Consensus       233 ~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~  310 (379)
T 4h09_A          233 DGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCV  310 (379)
T ss_dssp             TTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCT
T ss_pred             cccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCC
Confidence            334444444444444433 22223334444444444444322 2223333445555555555555545444445555555


Q ss_pred             ccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccc
Q 003301          440 DILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGL  486 (832)
Q Consensus       440 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  486 (832)
                      +|+.++|..+ ++.....+|.++.+|+.+.+..+ ++.+...+|.+.
T Consensus       311 ~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c  355 (379)
T 4h09_A          311 KLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS  355 (379)
T ss_dssp             TCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred             CCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence            5555555432 33333445555555555555433 443444555554

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.02  E-value=5.8e-10  Score=120.43  Aligned_cols=142  Identities=13%  Similarity=0.176  Sum_probs=106.1

Q ss_pred             CCCeeeccCCceEEEEEecCCcEEEEEEEe--ccc-hhhHHHHHHHHHHHhcCC--CCceeeeceEEecC---CeeEEEE
Q 003301          663 ASNLIGTGGFGSVYKGSFLDGMEVAIKVFH--LQL-EGALKSFDVECEVLKSVR--HRNLVKIISSCTNN---DFKALVL  734 (832)
Q Consensus       663 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~  734 (832)
                      ..+.++.|.++.||+++.. +..+++|+..  ... ......+.+|.++++.+.  +..+++++.++.+.   +..|+||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3567899999999999874 5688888765  322 122356788999999886  45588889888766   4589999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG---------------------------------------  775 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~---------------------------------------  775 (832)
                      ||++|..+.+..   ...++...+..++.+++.+|+.||..                                       
T Consensus       121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            999987774421   12367888889999999999999941                                       


Q ss_pred             ----------------CCCCeEecCCCCCCeEeCCCCc--EEEeccccccc
Q 003301          776 ----------------YSNPVVHCDIKPSNVLLDKDMV--AHLSDFGIAKL  808 (832)
Q Consensus       776 ----------------~~~~ivH~Dlkp~NIl~~~~~~--~kl~DFg~a~~  808 (832)
                                      ...+++|||++|.||+++.++.  +.|+||+.|..
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                            0257999999999999987753  69999999875

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.94  E-value=2.7e-10  Score=121.84  Aligned_cols=158  Identities=13%  Similarity=0.135  Sum_probs=81.4

Q ss_pred             hhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccc--cCcccceeeecC--CcccCC-----C
Q 003301          385 NGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFW--NLKDILSLNFSS--NFLNGS-----L  455 (832)
Q Consensus       385 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~--N~l~~~-----~  455 (832)
                      ..+..+++|+.|+|++|.-. .++. +. +++|+.|++..|.+.......+.  .+++|++|+|+.  |...+.     +
T Consensus       166 ~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l  242 (362)
T 2ra8_A          166 PVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF  242 (362)
T ss_dssp             HHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGT
T ss_pred             HHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHH
Confidence            34455556666666555211 1222 22 55666666666555432222222  455666666542  111110     0


Q ss_pred             cccc--ccccccceecccCcccCCccCCccc---cccccceeeccccccccc----CCccccCCCCCCeeccCCCccccc
Q 003301          456 PEDI--GNLKVVVIIDLSRNNLSGDIPTAIG---GLMNLQDLSLRDNGLQGS----IPKSIGGLVSLESLDLSNNSLSGN  526 (832)
Q Consensus       456 ~~~~--~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~  526 (832)
                      ...+  ..+++|+.|+|++|.+.+..+..+.   .+++|+.|+|+.|.+.+.    ++..+..+++|+.|+|++|.++..
T Consensus       243 ~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~  322 (362)
T 2ra8_A          243 RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE  322 (362)
T ss_dssp             GGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred             HHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHH
Confidence            0111  2356777777777776543333332   367777777777777653    233344567788888888777644


Q ss_pred             CchhhhhhccCCeeeCCCCc
Q 003301          527 IPTSMEKLLYLKDLNLSFNK  546 (832)
Q Consensus       527 ~p~~~~~l~~L~~l~l~~N~  546 (832)
                      .-..+...- ...+++++|+
T Consensus       323 ~~~~l~~al-g~~~~~~~~~  341 (362)
T 2ra8_A          323 MKKELQKSL-PMKIDVSDSQ  341 (362)
T ss_dssp             HHHHHHHHC-CSEEECCSBC
T ss_pred             HHHHHHHHc-CCEEEecCCc
Confidence            333333311 2456777665

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.89  E-value=6.4e-10  Score=118.94  Aligned_cols=140  Identities=24%  Similarity=0.237  Sum_probs=100.5

Q ss_pred             CcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccc--cccccceecccC--cccCCc----
Q 003301          407 IPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIG--NLKVVVIIDLSR--NNLSGD----  478 (832)
Q Consensus       407 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~Ls~--N~l~~~----  478 (832)
                      +...+..+++|+.|+|++|.-.. .+. +. +++|+.|+|..+.+.......+.  .+++|+.|+|+.  |...+.    
T Consensus       164 L~~ll~~~P~L~~L~L~g~~~l~-l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~  240 (362)
T 2ra8_A          164 LSPVLDAMPLLNNLKIKGTNNLS-IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMN  240 (362)
T ss_dssp             CHHHHHTCTTCCEEEEECCBTCB-CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGG
T ss_pred             HHHHHhcCCCCcEEEEeCCCCce-ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHH
Confidence            44556778999999999884222 222 33 78999999999988654334443  689999999864  332211    


Q ss_pred             -cCCcc--ccccccceeecccccccccCCcccc---CCCCCCeeccCCCccccc----CchhhhhhccCCeeeCCCCccc
Q 003301          479 -IPTAI--GGLMNLQDLSLRDNGLQGSIPKSIG---GLVSLESLDLSNNSLSGN----IPTSMEKLLYLKDLNLSFNKLE  548 (832)
Q Consensus       479 -~~~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~  548 (832)
                       +...+  ..+++|+.|+|++|.+.+..+..+.   .+++|++|||+.|.+++.    ++..+..+++|+.|+|++|.++
T Consensus       241 ~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~  320 (362)
T 2ra8_A          241 VFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS  320 (362)
T ss_dssp             GTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred             HHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence             11223  2478999999999999864443332   578999999999999874    4445567899999999999887


Q ss_pred             c
Q 003301          549 G  549 (832)
Q Consensus       549 ~  549 (832)
                      .
T Consensus       321 d  321 (362)
T 2ra8_A          321 D  321 (362)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.56  E-value=1.1e-08  Score=103.59  Aligned_cols=105  Identities=24%  Similarity=0.292  Sum_probs=64.9

Q ss_pred             cccCcccce--eeecCCccc---CCCccccccccccceecccCcccCC--ccCCccccccccceeecccccccccCCccc
Q 003301          435 FWNLKDILS--LNFSSNFLN---GSLPEDIGNLKVVVIIDLSRNNLSG--DIPTAIGGLMNLQDLSLRDNGLQGSIPKSI  507 (832)
Q Consensus       435 ~~~l~~L~~--L~Ls~N~l~---~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~  507 (832)
                      |...+.|..  ++++.|+..   +.++-...+++.|+.|+||+|+|++  .+|..+..+++|+.|+|++|+|++.  ..+
T Consensus       137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l  214 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL  214 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred             cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence            333444444  556666433   1111122456777777777777776  3456667777888888888888754  233


Q ss_pred             cCCC--CCCeeccCCCcccccCch-------hhhhhccCCeee
Q 003301          508 GGLV--SLESLDLSNNSLSGNIPT-------SMEKLLYLKDLN  541 (832)
Q Consensus       508 ~~l~--~L~~L~Ls~N~l~~~~p~-------~~~~l~~L~~l~  541 (832)
                      ..+.  +|+.|+|++|++++.+|.       .+..+++|+.||
T Consensus       215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence            3333  788888888888776652       356677777764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.56  E-value=1.1e-07  Score=99.80  Aligned_cols=137  Identities=17%  Similarity=0.214  Sum_probs=100.2

Q ss_pred             CCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCC-CCc--eeeeceEEecCC---eeEEEEecC
Q 003301          664 SNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVR-HRN--LVKIISSCTNND---FKALVLEYM  737 (832)
Q Consensus       664 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~  737 (832)
                      .+.++.|....||++.    ..+++|+....  .....+.+|.++++.+. +..  +++.+......+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4668999999999863    57899986533  33467889999998873 332  455555544333   358999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 003301          738 PNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG------------------------------------------  775 (832)
Q Consensus       738 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------------------------------------------  775 (832)
                      +|.++.+....   .++..++..++.+++..++.||..                                          
T Consensus        99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            99888654332   367777788888888888888830                                          


Q ss_pred             -------------CCCCeEecCCCCCCeEeCC--CCcEEEecccccccc
Q 003301          776 -------------YSNPVVHCDIKPSNVLLDK--DMVAHLSDFGIAKLL  809 (832)
Q Consensus       776 -------------~~~~ivH~Dlkp~NIl~~~--~~~~kl~DFg~a~~~  809 (832)
                                   ....++|+|++|.||++++  ...+.++||+.+...
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                         1145899999999999988  556899999998754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.46  E-value=7.8e-07  Score=93.25  Aligned_cols=137  Identities=12%  Similarity=0.099  Sum_probs=96.2

Q ss_pred             CCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCC---ceeeeceEEe-cCCeeEEEEecCCC
Q 003301          664 SNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHR---NLVKIISSCT-NNDFKALVLEYMPN  739 (832)
Q Consensus       664 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~  739 (832)
                      .+.++.|....||+.    +..+++|+...  ......+.+|.++++.+.+.   .+++.+.++. ..+..|+||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456888998999987    67789998532  23346788999999998642   3667777764 45667899999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 003301          740 GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG--------------------------------------------  775 (832)
Q Consensus       740 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------------------------------------------  775 (832)
                      .++.+....   .++..+...++.+++..++.||..                                            
T Consensus        98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            888763221   234444555555555555555521                                            


Q ss_pred             -------------CCCCeEecCCCCCCeEeCC---CCc-EEEecccccccc
Q 003301          776 -------------YSNPVVHCDIKPSNVLLDK---DMV-AHLSDFGIAKLL  809 (832)
Q Consensus       776 -------------~~~~ivH~Dlkp~NIl~~~---~~~-~kl~DFg~a~~~  809 (832)
                                   ....++|+|++|.||+++.   ++. +.|+||+.+..-
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                         2346799999999999987   455 589999988754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.42  E-value=1.9e-06  Score=88.70  Aligned_cols=137  Identities=18%  Similarity=0.086  Sum_probs=98.7

Q ss_pred             CeeeccCCc-eEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCC-CCceeeeceEEecCCeeEEEEecCCCCC
Q 003301          665 NLIGTGGFG-SVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVR-HRNLVKIISSCTNNDFKALVLEYMPNGS  741 (832)
Q Consensus       665 ~~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  741 (832)
                      +.+..|..| .||+.... ++..+++|+-...   ....+.+|.+.++.+. +--+.++++++.+.+..|+|||+++|.+
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            345566665 68988765 4678999986543   3356788999888774 3347888999998899999999999988


Q ss_pred             HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 003301          742 LEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG----------------------------------------------  775 (832)
Q Consensus       742 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~----------------------------------------------  775 (832)
                      +.+.....     ......++.+++..+..||..                                              
T Consensus       107 ~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          107 AFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             ccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            87765432     122334566666667777621                                              


Q ss_pred             ---------CCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          776 ---------YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       776 ---------~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                               ....++|+|+.+.||+++.++.+-|+||+.|...
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                     0113799999999999998877789999988753

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.40  E-value=1e-07  Score=96.36  Aligned_cols=104  Identities=17%  Similarity=0.244  Sum_probs=59.3

Q ss_pred             ccCccccCe--EeccCCccccCCCcc----ccccccCcEEEccCCcCCC--CCCCcccCcccccccccccccccccCCCh
Q 003301           17 IGNLTMLKK--LGLGYNKLRGEIPQE----LGNLAELELVSLTNNFLSG--TIPSTIFNLSSLSTGMDFSNNSLTGSLPD   88 (832)
Q Consensus        17 ~~~l~~L~~--L~ls~n~l~~~~p~~----~~~l~~L~~L~l~~n~l~~--~~p~~l~~l~~l~~~L~ls~n~l~~~lp~   88 (832)
                      |...+.|+.  ++++.|+.. .++..    ...+++|++|+|++|.+++  .+|..+..+++| +.|+|++|+|++ + .
T Consensus       137 l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L-~~L~Ls~N~i~~-~-~  212 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNL-KILNLSGNELKS-E-R  212 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTC-CEEECTTSCCCS-G-G
T ss_pred             cCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCC-CEEECCCCccCC-c-h
Confidence            444555554  556666443 23322    2345666666666666664  344555566666 666666666663 2 1


Q ss_pred             hhhhcCC--CceEEEccCCcccccCCC-------CccCCCCccEEE
Q 003301           89 DMCRRLP--LIKGLYMSNNKLTGPIPN-------NIWQCKELIVIS  125 (832)
Q Consensus        89 ~~~~~l~--~L~~L~l~~N~l~~~~p~-------~l~~l~~L~~L~  125 (832)
                      ++ ..+.  +|++|+|++|.+.+.+|+       .+..+++|+.||
T Consensus       213 ~l-~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          213 EL-DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             GG-GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             hh-hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence            11 1233  677777777777765552       256677777775

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.39  E-value=3e-08  Score=95.55  Aligned_cols=120  Identities=14%  Similarity=0.162  Sum_probs=59.1

Q ss_pred             ccCCCCCCCCeEeCCCC-cCCCCC----CcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCcc
Q 003301          409 PCIGDLTSLRLLSLASN-ELNSVI----PSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAI  483 (832)
Q Consensus       409 ~~~~~l~~L~~L~L~~N-~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  483 (832)
                      ..+...++|+.|+|++| .+....    ...+...++|++|+|++|+|.......                    +...+
T Consensus        30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~--------------------l~~~L   89 (185)
T 1io0_A           30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFA--------------------LAEML   89 (185)
T ss_dssp             HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHH--------------------HHHHH
T ss_pred             HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHH--------------------HHHHH
Confidence            34556677777777777 665421    222333445555555555554211111                    12222


Q ss_pred             ccccccceeeccccccccc----CCccccCCCCCCeecc--CCCcccccC----chhhhhhccCCeeeCCCCccc
Q 003301          484 GGLMNLQDLSLRDNGLQGS----IPKSIGGLVSLESLDL--SNNSLSGNI----PTSMEKLLYLKDLNLSFNKLE  548 (832)
Q Consensus       484 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~~~~----p~~~~~l~~L~~l~l~~N~l~  548 (832)
                      ...+.|++|+|++|.|.+.    +...+...++|++|+|  ++|.++..-    ...+...+.|++|+|++|.+.
T Consensus        90 ~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A           90 KVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            2334455555555555432    2334445555666666  556665432    223333456666666666654

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.38  E-value=3e-08  Score=95.51  Aligned_cols=94  Identities=19%  Similarity=0.201  Sum_probs=55.5

Q ss_pred             cccccCcCcccEEEeecC-ccccc----ccccccCCCCCceEEccCCccCCCC----chhhcCCCCCcEEEecCCcCCCC
Q 003301          336 PKEIGNLINLRELGLWGN-ELIGS----IPITFGKLQNLQGLDLVNNKLEGPI----PNGLCQLARLSVLYMDGNKLSGP  406 (832)
Q Consensus       336 ~~~~~~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~  406 (832)
                      ...+...+.|++|+|++| .+...    +...+...++|++|+|++|+|....    ...+...++|++|+|++|.|...
T Consensus        29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~  108 (185)
T 1io0_A           29 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS  108 (185)
T ss_dssp             HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred             HHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHH
Confidence            344556677777777777 66532    3344555667777777777775422    23344445677777777766532


Q ss_pred             ----CcccCCCCCCCCeEeC--CCCcCCC
Q 003301          407 ----IPPCIGDLTSLRLLSL--ASNELNS  429 (832)
Q Consensus       407 ----~p~~~~~l~~L~~L~L--~~N~l~~  429 (832)
                          +...+...++|++|+|  ++|.|+.
T Consensus       109 g~~~l~~~L~~n~~L~~L~L~~~~N~i~~  137 (185)
T 1io0_A          109 GILALVEALQSNTSLIELRIDNQSQPLGN  137 (185)
T ss_dssp             HHHHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred             HHHHHHHHHHhCCCceEEEecCCCCCCCH
Confidence                2344555566666666  5566654

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.21  E-value=1.2e-06  Score=94.12  Aligned_cols=80  Identities=11%  Similarity=-0.011  Sum_probs=55.9

Q ss_pred             CCee-eccCCceEEEEEec-------CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCC-C--CceeeeceEEecC--
Q 003301          664 SNLI-GTGGFGSVYKGSFL-------DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVR-H--RNLVKIISSCTNN--  727 (832)
Q Consensus       664 ~~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~--  727 (832)
                      .+.| +.|....+|+....       +++.+++|+.....   ......+.+|+++++.+. +  -.+++++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88889999998764       26788999765432   101245778888888874 2  3577788877654  


Q ss_pred             -CeeEEEEecCCCCCHH
Q 003301          728 -DFKALVLEYMPNGSLE  743 (832)
Q Consensus       728 -~~~~lv~e~~~~g~L~  743 (832)
                       +..|+||||++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3568999999886654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.00  E-value=1.8e-05  Score=86.27  Aligned_cols=75  Identities=15%  Similarity=0.131  Sum_probs=49.9

Q ss_pred             CCeeeccCCceEEEEEec-CCcEEEEEEEeccch-------hhHHHHHHHHHHHhcCCC--C-ceeeeceEEecCCeeEE
Q 003301          664 SNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE-------GALKSFDVECEVLKSVRH--R-NLVKIISSCTNNDFKAL  732 (832)
Q Consensus       664 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-niv~l~~~~~~~~~~~l  732 (832)
                      .+.+|.|..+.||+++.. +++.|+||.......       ...+++..|.++++.+..  | .+++++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467999999999999754 468899998653211       123466789988887632  3 45566654  3345689


Q ss_pred             EEecCCCC
Q 003301          733 VLEYMPNG  740 (832)
Q Consensus       733 v~e~~~~g  740 (832)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.95  E-value=3.2e-05  Score=82.42  Aligned_cols=139  Identities=16%  Similarity=0.112  Sum_probs=79.0

Q ss_pred             CeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCC--Cceeeece------EEecCCeeEEEEec
Q 003301          665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRH--RNLVKIIS------SCTNNDFKALVLEY  736 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~  736 (832)
                      +.++.|..+.||++...+ ..+++|+.....    ..+..|.++++.+..  -.+++++.      +....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~-~~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDS-GAVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETT-EEEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCC-CCEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            446667789999998744 459999887532    233445555554421  12334433      12346678999999


Q ss_pred             CCCCCHH-----------HH---Hhh--CCC--C---------CCHHHH-------------------------------
Q 003301          737 MPNGSLE-----------DY---LYS--NNF--S---------FDILQR-------------------------------  758 (832)
Q Consensus       737 ~~~g~L~-----------~~---l~~--~~~--~---------~~~~~~-------------------------------  758 (832)
                      ++|..+.           +.   ++.  ...  .         ..|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9886432           01   111  100  0         112110                               


Q ss_pred             HHHHHHHHHHHHHHhc----------CCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          759 LSVIIDVALALEYLHF----------GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       759 ~~i~~~i~~~l~~LH~----------~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      ..+..++..++++++.          ....+++|+|+++.||+++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            0111123345556541          0257899999999999998888999999998864

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.82  E-value=5.9e-06  Score=77.27  Aligned_cols=83  Identities=12%  Similarity=0.087  Sum_probs=40.8

Q ss_pred             cccEEEeecCcccccccccccCCCCCceEEccCCc-cCCCCchhhcCC----CCCcEEEecCCc-CCCCCcccCCCCCCC
Q 003301          344 NLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNK-LEGPIPNGLCQL----ARLSVLYMDGNK-LSGPIPPCIGDLTSL  417 (832)
Q Consensus       344 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~L  417 (832)
                      .|++||++++.++...-..+.++++|++|+|++|. |++..-..++.+    ++|++|+|++|. ++...-..+..+++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            45555555555544444445555555555555553 443333334433    245555555553 443323334455555


Q ss_pred             CeEeCCCCc
Q 003301          418 RLLSLASNE  426 (832)
Q Consensus       418 ~~L~L~~N~  426 (832)
                      +.|+++++.
T Consensus       142 ~~L~L~~c~  150 (176)
T 3e4g_A          142 KYLFLSDLP  150 (176)
T ss_dssp             CEEEEESCT
T ss_pred             CEEECCCCC
Confidence            555555553

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.82  E-value=6.4e-06  Score=77.04  Aligned_cols=84  Identities=8%  Similarity=0.019  Sum_probs=44.4

Q ss_pred             CCccEEECcCCcccccCCCCCcCCCcCceEEecccc-cccccCccccCc----cccceecccccc-cccccCcccccCCc
Q 003301          119 KELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNN-LTGEIPYEMGNL----RNLEILGLQLNK-LVGFVPTSIFNLSA  192 (832)
Q Consensus       119 ~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~-i~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~~~~~~~l~~  192 (832)
                      .+|++||++++.|+..--..+.++++|++|+|++|. |+..--..++.+    ++|++|+|++|. ++..--..+.++++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            355666666665554444445566666666666664 443222223332    356666666653 54322233555666


Q ss_pred             ccEEEecCCC
Q 003301          193 MKTLALPSNA  202 (832)
Q Consensus       193 L~~L~L~~n~  202 (832)
                      |++|++++|.
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            6666666654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.67  E-value=0.00029  Score=73.29  Aligned_cols=136  Identities=11%  Similarity=0.063  Sum_probs=92.0

Q ss_pred             CCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCC---CCceeeeceEEecCCeeEEEEecCCCC
Q 003301          664 SNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVR---HRNLVKIISSCTNNDFKALVLEYMPNG  740 (832)
Q Consensus       664 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g  740 (832)
                      .+.|+.|....+|+... +++.+++|+....   ....+.+|.+.++.+.   ...++++++++...+..|+||||++|.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            46789999999999986 5778999987643   2467888999888873   356888999888888899999999987


Q ss_pred             CHH--------H---HHhhCCC--C-------------------CCHHHHH---HHH----------------HHHHHH-
Q 003301          741 SLE--------D---YLYSNNF--S-------------------FDILQRL---SVI----------------IDVALA-  768 (832)
Q Consensus       741 ~L~--------~---~l~~~~~--~-------------------~~~~~~~---~i~----------------~~i~~~-  768 (832)
                      .+.        +   .++....  .                   -+|....   ++.                .+++.. 
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            542        1   1222111  0                   1233211   111                111111 


Q ss_pred             HHHHh-cCCCCCeEecCCCCCCeEeCCCCcEEEeccc
Q 003301          769 LEYLH-FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFG  804 (832)
Q Consensus       769 l~~LH-~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg  804 (832)
                      ...+. ......++|+|+.+.|++++.++ +.|+||+
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            12332 12357899999999999999887 8999984

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.57  E-value=0.00021  Score=78.25  Aligned_cols=73  Identities=12%  Similarity=0.146  Sum_probs=45.3

Q ss_pred             CCeeeccCCceEEEEEecCCcEEEEEEEeccc----hh-----hHHHHHHHHHHHh-cCCCCceeeeceEEecCCeeEEE
Q 003301          664 SNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL----EG-----ALKSFDVECEVLK-SVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       664 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~-----~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .+.+|.|..+.||++.. +++.++||......    ..     ....+..|+..+. ......+++++.+.  .+..++|
T Consensus        39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv  115 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG  115 (420)
T ss_dssp             EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred             EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence            46789999999999965 57789999432111    00     1223333333222 12234577777765  4567899


Q ss_pred             EecC-CC
Q 003301          734 LEYM-PN  739 (832)
Q Consensus       734 ~e~~-~~  739 (832)
                      |||+ ++
T Consensus       116 ~e~l~~g  122 (420)
T 2pyw_A          116 MRYLEPP  122 (420)
T ss_dssp             ECCCCTT
T ss_pred             EeecCCc
Confidence            9999 76

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.55  E-value=0.00039  Score=71.80  Aligned_cols=78  Identities=14%  Similarity=0.123  Sum_probs=56.9

Q ss_pred             CCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCC---CceeeeceEEecCCeeEEEEec
Q 003301          660 QFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRH---RNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ...-.+.+|.|..+.||+.+..+|+.|++|+...........+.+|.+.++.+..   --+++++++.    ..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            3444678999999999999998999999998665443334567889999887742   2345555542    23799999


Q ss_pred             CCCCC
Q 003301          737 MPNGS  741 (832)
Q Consensus       737 ~~~g~  741 (832)
                      ++++.
T Consensus        92 l~~~~   96 (288)
T 3f7w_A           92 VDERP   96 (288)
T ss_dssp             CCCCC
T ss_pred             ecccC
Confidence            97764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.47  E-value=0.00021  Score=75.22  Aligned_cols=157  Identities=13%  Similarity=0.142  Sum_probs=87.1

Q ss_pred             cchHHHHHHhcCCCCC-----CeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCc--eeeec
Q 003301          649 FSYKELLQATNQFNAS-----NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRN--LVKII  721 (832)
Q Consensus       649 ~~~~~~~~~~~~~~~~-----~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~  721 (832)
                      .+.+++......|.+.     +.|+.|....+|+....+| .+++|+.....  ..+.+..|.++++.+....  +++++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            4455555555666653     3466788889999987545 78899887531  1234556777776663212  33443


Q ss_pred             eE------EecCCeeEEEEecCCCCCHHH----H----------Hhh--CC--CC----CC---HHHHHH----------
Q 003301          722 SS------CTNNDFKALVLEYMPNGSLED----Y----------LYS--NN--FS----FD---ILQRLS----------  760 (832)
Q Consensus       722 ~~------~~~~~~~~lv~e~~~~g~L~~----~----------l~~--~~--~~----~~---~~~~~~----------  760 (832)
                      ..      ....+..+++|+|++|..+..    .          ++.  ..  ..    ..   |.....          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            21      123456789999998864311    0          111  00  00    01   111000          


Q ss_pred             --HHHHHHHHHHHHhc----CCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          761 --VIIDVALALEYLHF----GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       761 --i~~~i~~~l~~LH~----~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                        +...+...+++++.    ....+++|+|+.+.||+++.++.+.++||+.+..
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence              00113334444441    1246899999999999998876668999998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.27  E-value=0.0013  Score=69.49  Aligned_cols=140  Identities=12%  Similarity=0.062  Sum_probs=74.5

Q ss_pred             CeeeccCCce-EEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCC--CceeeeceEEecCCeeEEEEecCCCCC
Q 003301          665 NLIGTGGFGS-VYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRH--RNLVKIISSCTNNDFKALVLEYMPNGS  741 (832)
Q Consensus       665 ~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~  741 (832)
                      +.++.|+... +|+....+++.+++|.......   ..+..|+++++.+..  -.+++++.+....+  +++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            4565565544 6677654477788875443211   234456666666532  23566666644443  78999997766


Q ss_pred             HHHHHhhCC-------------------------CCCCHHHHH-------HHH-------------HHHHHHHHHHh---
Q 003301          742 LEDYLYSNN-------------------------FSFDILQRL-------SVI-------------IDVALALEYLH---  773 (832)
Q Consensus       742 L~~~l~~~~-------------------------~~~~~~~~~-------~i~-------------~~i~~~l~~LH---  773 (832)
                      +.+++....                         ..++.....       .+.             ..+...++.+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            654432110                         012221110       000             01111222221   


Q ss_pred             cCCCCCeEecCCCCCCeEeCCC----CcEEEecccccccc
Q 003301          774 FGYSNPVVHCDIKPSNVLLDKD----MVAHLSDFGIAKLL  809 (832)
Q Consensus       774 ~~~~~~ivH~Dlkp~NIl~~~~----~~~kl~DFg~a~~~  809 (832)
                      ......++|||+.+.||+++.+    +.+.++||+.|..-
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            1125689999999999999875    68999999988754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.27  E-value=0.00067  Score=70.55  Aligned_cols=138  Identities=12%  Similarity=0.090  Sum_probs=76.4

Q ss_pred             CCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCce-eeeceEEecCCeeEEEEecC-CCC
Q 003301          663 ASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNL-VKIISSCTNNDFKALVLEYM-PNG  740 (832)
Q Consensus       663 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g  740 (832)
                      -.+.|+.|....+|++     +.+++|+........ ....+|.++++.+....+ ++++++.  .+.-++++||+ +|.
T Consensus        22 ~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           22 GPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             SCEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred             ceeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence            3678999999999998     578999876432211 123457777766642222 4565543  33347899999 664


Q ss_pred             CHHHH------------------HhhCCCC----CCH-HHHHHHHHH--------------HHHHH----HHHh-cCCCC
Q 003301          741 SLEDY------------------LYSNNFS----FDI-LQRLSVIID--------------VALAL----EYLH-FGYSN  778 (832)
Q Consensus       741 ~L~~~------------------l~~~~~~----~~~-~~~~~i~~~--------------i~~~l----~~LH-~~~~~  778 (832)
                      ++...                  ++.....    .+. .....+...              +...+    +.+. .....
T Consensus        94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~  173 (301)
T 3dxq_A           94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL  173 (301)
T ss_dssp             ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred             cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence            44210                  0111110    111 111111000              11111    1111 12245


Q ss_pred             CeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       779 ~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      .++|+|+.+.||+ ..++.+.++||+.|..-
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            6899999999999 56678899999988753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.24  E-value=0.0014  Score=68.97  Aligned_cols=140  Identities=12%  Similarity=0.080  Sum_probs=81.2

Q ss_pred             CeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCC--ceeeeceE-----EecCCeeEEEEecC
Q 003301          665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHR--NLVKIISS-----CTNNDFKALVLEYM  737 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~  737 (832)
                      +.++ |....||++...+|+.+++|...... .....+..|.++++.+...  .+++++..     ....+..+++|||+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            3566 88889999877667789999986431 1234566788877766321  24444442     12345678999999


Q ss_pred             CCCCHH-----HH---------Hhh----CC----CCCCHHHH----------------------HHHHHHHHHHHHHHh
Q 003301          738 PNGSLE-----DY---------LYS----NN----FSFDILQR----------------------LSVIIDVALALEYLH  773 (832)
Q Consensus       738 ~~g~L~-----~~---------l~~----~~----~~~~~~~~----------------------~~i~~~i~~~l~~LH  773 (832)
                      +|..+.     .+         ++.    ..    ..++....                      ...+.+++..++-.-
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            874431     11         110    00    11222111                      011111222222211


Q ss_pred             c-CCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          774 F-GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       774 ~-~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      . .....++|+|+++.||+++ + .+.++||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            0 1256789999999999998 4 899999988764

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.23  E-value=0.00034  Score=62.27  Aligned_cols=60  Identities=23%  Similarity=0.303  Sum_probs=40.5

Q ss_pred             eeeccccccc-ccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCC
Q 003301          491 DLSLRDNGLQ-GSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIP  552 (832)
Q Consensus       491 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p  552 (832)
                      .++.+++.++ ..+|..+.  ++|+.|||++|+|+...+..|..+++|+.|+|++|+|.+.+-
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~   72 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCR   72 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGG
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCc
Confidence            5666666665 23454322  357777888888877666677777788888888888876553

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.08  E-value=0.00078  Score=73.73  Aligned_cols=72  Identities=14%  Similarity=0.179  Sum_probs=48.9

Q ss_pred             CCeeeccCCceEEEEEecC--------CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCc-eeeeceEEecCCeeEEEE
Q 003301          664 SNLIGTGGFGSVYKGSFLD--------GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRN-LVKIISSCTNNDFKALVL  734 (832)
Q Consensus       664 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  734 (832)
                      .+.|+.|....||++...+        ++.|++|+.....  ..+.+.+|..+++.+...+ .+++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3568888899999998753        5789999884321  1134557888888774333 4667766542    3899


Q ss_pred             ecCCCCC
Q 003301          735 EYMPNGS  741 (832)
Q Consensus       735 e~~~~g~  741 (832)
                      ||++|.+
T Consensus       152 e~l~G~~  158 (429)
T 1nw1_A          152 EYIPSRP  158 (429)
T ss_dssp             CCCCEEE
T ss_pred             EEeCCcc
Confidence            9998643

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.08  E-value=0.0013  Score=70.22  Aligned_cols=139  Identities=14%  Similarity=0.139  Sum_probs=83.4

Q ss_pred             CeeeccCCceEEEEEec--------CCcEEEEEEEeccchhhHHHHHHHHHHHhcCC-CCceeeeceEEecCCeeEEEEe
Q 003301          665 NLIGTGGFGSVYKGSFL--------DGMEVAIKVFHLQLEGALKSFDVECEVLKSVR-HRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      +.+..|-...+|++...        +++.|++|+.... ........+|.++++.+. +.-.+++++++..    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            56778888999999864        2478999986332 223355668999888774 3334667766543    39999


Q ss_pred             cCCCCCHHH-----------H------HhhCC----CCCC--HHHHHHHHHHHHH-------------------HHHHHh
Q 003301          736 YMPNGSLED-----------Y------LYSNN----FSFD--ILQRLSVIIDVAL-------------------ALEYLH  773 (832)
Q Consensus       736 ~~~~g~L~~-----------~------l~~~~----~~~~--~~~~~~i~~~i~~-------------------~l~~LH  773 (832)
                      |++|.++..           +      ++...    ....  +.++.++..++..                   .++++.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            998755421           1      11111    1122  3455555544322                   223322


Q ss_pred             -----cCCCCCeEecCCCCCCeEeCCC----CcEEEeccccccc
Q 003301          774 -----FGYSNPVVHCDIKPSNVLLDKD----MVAHLSDFGIAKL  808 (832)
Q Consensus       774 -----~~~~~~ivH~Dlkp~NIl~~~~----~~~kl~DFg~a~~  808 (832)
                           ......++|+|+.+.||+++.+    +.+.++||..|..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                 1224578999999999999876    7899999998874

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.07  E-value=7.2e-05  Score=71.31  Aligned_cols=17  Identities=12%  Similarity=0.177  Sum_probs=9.0

Q ss_pred             cCCCCccEEEcCCC-cCc
Q 003301          238 FNASKLSVLELGEN-SFS  254 (832)
Q Consensus       238 ~~l~~L~~L~L~~N-~i~  254 (832)
                      .+-+.|++|+|++| .|.
T Consensus        38 ~~n~~L~~L~L~~nn~ig   55 (197)
T 1pgv_A           38 EDDTDLKEVNINNMKRVS   55 (197)
T ss_dssp             TTCSSCCEEECTTCCSSC
T ss_pred             hcCCCccEEECCCCCCCC
Confidence            34455666666653 554

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.02  E-value=0.00015  Score=69.12  Aligned_cols=87  Identities=13%  Similarity=0.082  Sum_probs=49.2

Q ss_pred             ccCcCcccEEEeecC-cccc----cccccccCCCCCceEEccCCccCCCC----chhhcCCCCCcEEEecCCcCCCC---
Q 003301          339 IGNLINLRELGLWGN-ELIG----SIPITFGKLQNLQGLDLVNNKLEGPI----PNGLCQLARLSVLYMDGNKLSGP---  406 (832)
Q Consensus       339 ~~~l~~L~~L~L~~N-~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~---  406 (832)
                      +.+-+.|++|+|++| +|..    .+.+++..-+.|+.|+|++|+|....    ...+..-+.|++|+|++|.|...   
T Consensus        37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~  116 (197)
T 1pgv_A           37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA  116 (197)
T ss_dssp             HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred             HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence            344456777777764 5542    23344555667777777777775332    23333445677777777776532   


Q ss_pred             -CcccCCCCCCCCeEeCCCC
Q 003301          407 -IPPCIGDLTSLRLLSLASN  425 (832)
Q Consensus       407 -~p~~~~~l~~L~~L~L~~N  425 (832)
                       +...+..-+.|+.|+|++|
T Consensus       117 ala~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A          117 RLLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HHHHHTTTTCCCSEEECCCC
T ss_pred             HHHHHHhhCCceeEEECCCC
Confidence             2233445556677776654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.83  E-value=0.0027  Score=69.73  Aligned_cols=74  Identities=16%  Similarity=0.134  Sum_probs=47.8

Q ss_pred             CCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCc-eeeeceEEecCCeeEEEEecCCCCC
Q 003301          664 SNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRN-LVKIISSCTNNDFKALVLEYMPNGS  741 (832)
Q Consensus       664 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g~  741 (832)
                      .+.|+.|-...+|++...+ +..|++|+........ -.-.+|..+++.+...+ .+++++++.  +  ..||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            3578889899999998754 4789999875432211 11257888888875433 366777663  2  35999998744


Q ss_pred             H
Q 003301          742 L  742 (832)
Q Consensus       742 L  742 (832)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.78  E-value=0.0016  Score=69.94  Aligned_cols=72  Identities=14%  Similarity=0.231  Sum_probs=43.5

Q ss_pred             CeeeccCCceEEEEEecC---------CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCc-eeeeceEEecCCeeEEEE
Q 003301          665 NLIGTGGFGSVYKGSFLD---------GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRN-LVKIISSCTNNDFKALVL  734 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  734 (832)
                      +.++.|....+|++...+         ++.|++|+....... ......|.++++.+...+ ++++++..  .  -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            467788889999998643         268888886543221 112356888877774323 45666554  2  26899


Q ss_pred             ecCCCCC
Q 003301          735 EYMPNGS  741 (832)
Q Consensus       735 e~~~~g~  741 (832)
                      ||++|.+
T Consensus       114 e~i~G~~  120 (369)
T 3c5i_A          114 EWLYGDP  120 (369)
T ss_dssp             ECCCSEE
T ss_pred             EEecCCc
Confidence            9998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.63  E-value=0.013  Score=61.90  Aligned_cols=33  Identities=24%  Similarity=0.343  Sum_probs=28.9

Q ss_pred             CCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       777 ~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      ...++|+|+.+.||+++.++.+.++||+.+...
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            457999999999999998889999999887653

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.51  E-value=0.0042  Score=55.13  Aligned_cols=37  Identities=24%  Similarity=0.235  Sum_probs=17.9

Q ss_pred             CccEEEcCCCcCcccCCccccCccccceeecccccCC
Q 003301          242 KLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLT  278 (832)
Q Consensus       242 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  278 (832)
                      +|++|+|++|+|+.+.++.|..+++|++|+|++|.+.
T Consensus        32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            3444444444444444444444555555555555443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.80  E-value=0.011  Score=63.90  Aligned_cols=138  Identities=13%  Similarity=0.172  Sum_probs=82.7

Q ss_pred             CeeeccCCceEEEEEecC--------CcEEEEEEEeccchhhHHHHHHHHHHHhcCC-CCceeeeceEEecCCeeEEEEe
Q 003301          665 NLIGTGGFGSVYKGSFLD--------GMEVAIKVFHLQLEGALKSFDVECEVLKSVR-HRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      +.+..|-...+|++...+        ++.|++|+.....+. .-...+|.++++.+. +.-.+++++.+.    -+.|||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            567778889999998753        578999986543221 122356888877774 333456665432    278999


Q ss_pred             cCCCCCHHH-----------H---Hh------h-----C---CCC-CCHHHHHHHHHHH-------------------HH
Q 003301          736 YMPNGSLED-----------Y---LY------S-----N---NFS-FDILQRLSVIIDV-------------------AL  767 (832)
Q Consensus       736 ~~~~g~L~~-----------~---l~------~-----~---~~~-~~~~~~~~i~~~i-------------------~~  767 (832)
                      |++|.++..           +   +.      .     .   ... .-+.++.++..++                   ..
T Consensus       151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  230 (424)
T 3mes_A          151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE  230 (424)
T ss_dssp             CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred             EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence            998865311           0   00      0     0   101 1133333333222                   12


Q ss_pred             HHHHHh---------------------cCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          768 ALEYLH---------------------FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       768 ~l~~LH---------------------~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      .+++|.                     ......++|+|+.+.||+ +.++.+.++||..|..
T Consensus       231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            233332                     111356899999999999 7888999999998874

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.42  E-value=0.16  Score=54.73  Aligned_cols=30  Identities=27%  Similarity=0.368  Sum_probs=25.7

Q ss_pred             CeEecCCCCCCeEe------CCCCcEEEeccccccc
Q 003301          779 PVVHCDIKPSNVLL------DKDMVAHLSDFGIAKL  808 (832)
Q Consensus       779 ~ivH~Dlkp~NIl~------~~~~~~kl~DFg~a~~  808 (832)
                      .++|+|+.+.||++      +++..++++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46799999999999      4567899999998874

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	832
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-45
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-44
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-44
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-43
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-42
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-42
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-42
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-41
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-41
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-40
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-40
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-39
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-39
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-38
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-38
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-38
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-38
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-38
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-37
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-37
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-37
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-37
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-37
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-37
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-36
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-36
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-36
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-35
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-35
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-35
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-34
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-33
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-33
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-33
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-32
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-32
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-31
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-31
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-31
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-31
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-31
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-31
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-30
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-29
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-29
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-28
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-28
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-28
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-28
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-28
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-27
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-27
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-27
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-27
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-27
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-26
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-25
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-25
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-24
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-20
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-20
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-16
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-09
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-07
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-24
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-23
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-20
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-06
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-22
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-22
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-21
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-20
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	9e-16
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	7e-14
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-19
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-16
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-15
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-15
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-13
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-11
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	5e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	9e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	7e-09
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	8e-09
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	8e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.004
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.004
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	9e-08
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	7e-07
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	9e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-07
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	4e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	8e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	7e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.004
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	4e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	5e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	1e-05
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	1e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	5e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.002
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.004
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	7e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	8e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.001
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.002
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	1e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.002
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	4e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	5e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	5e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	6e-04

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 3e-45
 Identities = 49/174 (28%), Positives = 89/174 (51%), Gaps = 9/174 (5%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRN 716
            Q      IG+G FG+VYKG +    +VA+K+ ++       L++F  E  VL+  RH N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
           ++  +   T     A+V ++    SL  +L+     F++++ + +    A  ++YLH   
Sbjct: 66  ILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-- 122

Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
              ++H D+K +N+ L +D+   + DFG+A + S      Q   L+ +I +MAP
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  159 bits (404), Expect = 3e-44
 Identities = 48/199 (24%), Positives = 90/199 (45%), Gaps = 21/199 (10%)

Query: 649 FSYKELLQATNQFNAS---------NLIGTGGFGSVYKGSFL----DGMEVAIKVFHLQL 695
           F++++  +A  +F             +IG G FG V  G         + VAIK      
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 696 -EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFD 754
            E   + F  E  ++    H N++ +    T +    ++ E+M NGSL+ +L  N+  F 
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 755 ILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
           ++Q + ++  +A  ++YL        VH D+   N+L++ ++V  +SDFG+++ L  + S
Sbjct: 127 VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 815 MKQTLT----LATIGYMAP 829
                +       I + AP
Sbjct: 184 DPTYTSALGGKIPIRWTAP 202

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 3e-44
 Identities = 44/188 (23%), Positives = 82/188 (43%), Gaps = 11/188 (5%)

Query: 652 KELLQATNQFNASNL-IGTGGFGSVYKGSFL---DGMEVAIKVFHLQL-EGALKSFDVEC 706
           K+L    +    +++ +G G FGSV +G +      ++VAIKV      +   +    E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 707 EVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVA 766
           +++  + +  +V++I  C       LV+E    G L  +L        +     ++  V+
Sbjct: 61  QIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119

Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA--TI 824
           + ++YL        VH D+   NVLL     A +SDFG++K L  ++S     +     +
Sbjct: 120 MGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176

Query: 825 GYMAPGLF 832
            + AP   
Sbjct: 177 KWYAPECI 184

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 6e-43
 Identities = 41/172 (23%), Positives = 80/172 (46%), Gaps = 6/172 (3%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLV 718
                   +G G FG V+ G +    +VA+K        +  +F  E  ++K ++H+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYS 777
           ++ +  T      ++ EYM NGSL D+L +       I + L +   +A  + ++     
Sbjct: 72  RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127

Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
              +H D++ +N+L+   +   ++DFG+A+L+   E   +      I + AP
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 3e-42
 Identities = 44/175 (25%), Positives = 74/175 (42%), Gaps = 8/175 (4%)

Query: 657 ATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRH 714
             + F   + +G G  G V+K S    G+ +A K+ HL++          E +VL     
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             +V    +  ++   ++ +E+M  GSL+  L              V I V   L YL  
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE 122

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
              + ++H D+KPSN+L++      L DFG++  L    +        T  YM+P
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSP 172

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 6e-42
 Identities = 47/171 (27%), Positives = 75/171 (43%), Gaps = 4/171 (2%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLV 718
                   +GTG FG V  G +    +VAIK+           F  E +V+ ++ H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLV 62

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
           ++   CT      ++ EYM NG L +YL      F   Q L +  DV  A+EYL      
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---K 119

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             +H D+   N L++   V  +SDFG+++ +  +E      +   + +  P
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 9e-42
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 4/171 (2%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLV 718
           ++      IG+G FG V+ G +L+  +VAIK          + F  E EV+  + H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 63

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
           ++   C       LV E+M +G L DYL +    F     L + +DV   + YL      
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EA 120

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            V+H D+   N L+ ++ V  +SDFG+ + +  ++    T T   + + +P
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 1e-41
 Identities = 44/166 (26%), Positives = 76/166 (45%), Gaps = 5/166 (3%)

Query: 665 NLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISS 723
             +G G FG VYK    +  +  A KV   + E  L+ + VE ++L S  H N+VK++ +
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
               +   +++E+   G+++  +          Q   V      AL YLH    N ++H 
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134

Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           D+K  N+L   D    L+DFG++   +     + +    T  +MAP
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAP 179

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 3e-41
 Identities = 46/172 (26%), Positives = 82/172 (47%), Gaps = 6/172 (3%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLV 718
                   +G G FG V+ G++     VAIK          ++F  E +V+K +RH  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 75

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDIL-QRLSVIIDVALALEYLHFGYS 777
           ++ +  +      +V EYM  GSL D+L      +  L Q + +   +A  + Y+     
Sbjct: 76  QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131

Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
              VH D++ +N+L+ +++V  ++DFG+A+L+   E   +      I + AP
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  149 bits (376), Expect = 1e-40
 Identities = 45/185 (24%), Positives = 86/185 (46%), Gaps = 6/185 (3%)

Query: 647 RRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVE 705
              +Y +           + +G G +G VY+G +    + VA+K         ++ F  E
Sbjct: 5   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKE 63

Query: 706 CEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLY-SNNFSFDILQRLSVIID 764
             V+K ++H NLV+++  CT      ++ E+M  G+L DYL   N      +  L +   
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123

Query: 765 VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATI 824
           ++ A+EYL        +H D+   N L+ ++ +  ++DFG+++L++G+           I
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180

Query: 825 GYMAP 829
            + AP
Sbjct: 181 KWTAP 185

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (373), Expect = 5e-40
 Identities = 44/176 (25%), Positives = 70/176 (39%), Gaps = 13/176 (7%)

Query: 658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHL---QLEGALKSFDVECEVLKSVR 713
              F+    IG G FG+VY    + +   VAIK       Q     +    E   L+ +R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
           H N ++            LV+EY    + +            ++  +V       L YLH
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH 132

Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
              S+ ++H D+K  N+LL +  +  L DFG A +++   S   T       +MAP
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTP-----YWMAP 180

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 2e-39
 Identities = 48/178 (26%), Positives = 74/178 (41%), Gaps = 11/178 (6%)

Query: 665 NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKII 721
             IGTG +G   K     DG  +  K        E   +    E  +L+ ++H N+V+  
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 722 SSCT--NNDFKALVLEYMPNGSLEDYLYSN---NFSFDILQRLSVIIDVALALEYLH--F 774
                  N    +V+EY   G L   +          D    L V+  + LAL+  H   
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
              + V+H D+KP+NV LD      L DFG+A++L+ + S  +     T  YM+P   
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMSPEQM 186

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 3e-39
 Identities = 56/176 (31%), Positives = 81/176 (46%), Gaps = 12/176 (6%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLV 718
            +      IG G FG V  G    G +VA+K   ++ +   ++F  E  V+  +RH NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLV 63

Query: 719 KIISSCTNNDFK-ALVLEYMPNGSLEDYLYSNNFS-FDILQRLSVIIDVALALEYLHFGY 776
           +++           +V EYM  GSL DYL S   S       L   +DV  A+EYL    
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120

Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
            N  VH D+   NVL+ +D VA +SDFG+ K  S  +   +      + + AP   
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL----PVKWTAPEAL 172

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 2e-38
 Identities = 44/172 (25%), Positives = 77/172 (44%), Gaps = 12/172 (6%)

Query: 665 NLIGTGGFGSVYKGSFLD---GMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVK 719
             +G+G FG+V KG +        VA+K+   +            E  V++ + +  +V+
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
           +I  C    +  LV+E    G L  YL  N         + ++  V++ ++YL     + 
Sbjct: 73  MIGICEAESW-MLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEE---SN 127

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA--TIGYMAP 829
            VH D+   NVLL     A +SDFG++K L  +E+  +  T     + + AP
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 2e-38
 Identities = 41/168 (24%), Positives = 68/168 (40%), Gaps = 7/168 (4%)

Query: 665 NLIGTGGFGSVYKGSFL-DGMEVAIKVFHL-QLEGALKSFDVECEVLKSVRHRNLVKIIS 722
             +G G +G V           VA+K+  + +     ++   E  + K + H N+VK   
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70

Query: 723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVH 782
                + + L LEY   G L D +  +               +   + YLH      + H
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITH 126

Query: 783 CDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
            DIKP N+LLD+     +SDFG+A +       +    +  T+ Y+AP
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  143 bits (362), Expect = 4e-38
 Identities = 40/174 (22%), Positives = 77/174 (44%), Gaps = 8/174 (4%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNL 717
           + ++    +GTG FG V++ +    G   A K      E   ++   E + +  +RH  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           V +  +  +++   ++ E+M  G L + +   +      + +  +  V   L ++H    
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 142

Query: 778 NPVVHCDIKPSNVLL--DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           N  VH D+KP N++    +     L DFG+   L  ++S+K   T  T  + AP
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--TTGTAEFAAP 194

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (355), Expect = 4e-38
 Identities = 47/169 (27%), Positives = 74/169 (43%), Gaps = 11/169 (6%)

Query: 665 NLIGTGGFGSVYKGSFL-DGMEVAIKVFH---LQLEGALKSFDVECEVLKSVRHRNLVKI 720
             +G G FG+VY          +A+KV     L+  G       E E+   +RH N++++
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPV 780
                +     L+LEY P G++   L   +  FD  +  + I ++A AL Y H   S  V
Sbjct: 72  YGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRV 127

Query: 781 VHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +H DIKP N+LL       ++DFG +                T+ Y+ P
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC---GTLDYLPP 173

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (355), Expect = 8e-38
 Identities = 52/173 (30%), Positives = 82/173 (47%), Gaps = 9/173 (5%)

Query: 665 NLIGTGGFGSVYKGSFL-DGMEVAIKVF---HLQLEGALKSFDVECEVLKSVRHRNLVKI 720
            ++G G F +V     L    E AIK+    H+  E  +     E +V+  + H   VK+
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73

Query: 721 ISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPV 780
             +  +++     L Y  NG L  Y+     SFD         ++  ALEYLH      +
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGI 129

Query: 781 VHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAPGLF 832
           +H D+KP N+LL++DM   ++DFG AK+LS E    +  +   T  Y++P L 
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (355), Expect = 1e-37
 Identities = 55/166 (33%), Positives = 83/166 (50%), Gaps = 7/166 (4%)

Query: 665 NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISS 723
             IG G  G+VY    +  G EVAI+  +LQ +   +    E  V++  ++ N+V  + S
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 724 CTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHC 783
               D   +V+EY+  GSL D +          Q  +V  +   ALE+LH   SN V+H 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEG--QIAAVCRECLQALEFLH---SNQVIHR 140

Query: 784 DIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           DIK  N+LL  D    L+DFG    ++ E+S + T  + T  +MAP
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAP 185

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  142 bits (358), Expect = 1e-37
 Identities = 37/167 (22%), Positives = 75/167 (44%), Gaps = 8/167 (4%)

Query: 666 LIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
            +G+G FG V++      G     K  +        +   E  ++  + H  L+ +  + 
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
            +     L+LE++  G L D + + ++     + ++ +      L+++H    + +VH D
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152

Query: 785 IKPSNVLLD--KDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           IKP N++ +  K     + DFG+A  L+ +E +K T    T  + AP
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA--TAEFAAP 197

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 1e-37
 Identities = 44/237 (18%), Positives = 87/237 (36%), Gaps = 43/237 (18%)

Query: 633 QSNIESNMLPQATRRRFSYKELLQAT---------NQFNASNLIGTGGFGSVYKGSFLD- 682
           +S ++   +  ++   + Y +  +                  ++G+G FG V   +    
Sbjct: 2   ESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGI 61

Query: 683 -----GMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALVLE 735
                 ++VA+K+   +      ++   E +++  +  H N+V ++ +CT +    L+ E
Sbjct: 62  SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 121

Query: 736 YMPNGSLEDYLYSNNFSF----------------------DILQRLSVIIDVALALEYLH 773
           Y   G L +YL S    F                           L     VA  +E+L 
Sbjct: 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 181

Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
                  VH D+   NVL+    V  + DFG+A+ +  + +          + +MAP
Sbjct: 182 ---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 235

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-37
 Identities = 47/178 (26%), Positives = 80/178 (44%), Gaps = 16/178 (8%)

Query: 667 IGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN 726
           IG G FG V++G    G EVA+K+F  + E +    + E      +RH N++  I++   
Sbjct: 11  IGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68

Query: 727 NDFKA----LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH-----FGYS 777
           ++       LV +Y  +GSL DYL  N ++  +   + + +  A  L +LH         
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126

Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT---LATIGYMAPGLF 832
             + H D+K  N+L+ K+    ++D G+A                 + T  YMAP + 
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 3e-37
 Identities = 46/179 (25%), Positives = 84/179 (46%), Gaps = 11/179 (6%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDG-----MEVAIKVFHLQL-EGALKSFDVECEVLKSV 712
           +      +IG G FG VYKG          + VAIK       E     F  E  ++   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 713 RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYL 772
            H N++++    +      ++ EYM NG+L+ +L   +  F +LQ + ++  +A  ++YL
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 773 HFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA--TIGYMAP 829
               +   VH D+   N+L++ ++V  +SDFG++++L  +     T +     I + AP
Sbjct: 127 A---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 4e-37
 Identities = 45/175 (25%), Positives = 75/175 (42%), Gaps = 9/175 (5%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLD----GMEVAIKVFHLQL-EGALKSFDVECEVLKSVR 713
            +      IG G FG V++G ++      + VAIK       +   + F  E   ++   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
           H ++VK+I   T N    +++E    G L  +L    +S D+   +     ++ AL YL 
Sbjct: 67  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA 828
              S   VH DI   NVL+  +    L DFG+++ +      K +     I +MA
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 2e-36
 Identities = 46/174 (26%), Positives = 76/174 (43%), Gaps = 13/174 (7%)

Query: 667 IGTGGFGSVYKGSFLD-GMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISS 723
           IG G F +VYKG   +  +EVA      +   +   + F  E E+LK ++H N+V+   S
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 724 C----TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
                       LV E M +G+L+ YL        I    S    +   L++LH   + P
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT-RTPP 134

Query: 780 VVHCDIKPSNVLL-DKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
           ++H D+K  N+ +        + D G+A L     +      + T  +MAP ++
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMY 185

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 5e-36
 Identities = 43/175 (24%), Positives = 69/175 (39%), Gaps = 13/175 (7%)

Query: 667 IGTGGFGSVYKGSFL----DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVK 719
           +G G FG V +G +       + VA+K     +     A+  F  E   + S+ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 720 IISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP 779
           +         K +V E  P GSL D L  +   F +       + VA  + YL    S  
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131

Query: 780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA--TIGYMAPGLF 832
            +H D+   N+LL    +  + DFG+ + L   +              + AP   
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  135 bits (340), Expect = 8e-36
 Identities = 44/202 (21%), Positives = 76/202 (37%), Gaps = 34/202 (16%)

Query: 659 NQFNASNLIGTGGFGSVYKG------SFLDGMEVAIKVFHLQL-EGALKSFDVECEVLKS 711
           N       IG G FG V++        +     VA+K+   +        F  E  ++  
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFS------------------- 752
             + N+VK++  C       L+ EYM  G L ++L S +                     
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 753 ----FDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL 808
                   ++L +   VA  + YL        VH D+   N L+ ++MV  ++DFG+++ 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 809 LSGEESMKQTLTLA-TIGYMAP 829
           +   +  K     A  I +M P
Sbjct: 190 IYSADYYKADGNDAIPIRWMPP 211

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 2e-35
 Identities = 42/197 (21%), Positives = 80/197 (40%), Gaps = 29/197 (14%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHL-QLEGALKSFDVECEVLKS 711
           N+ +    +G G FG V + +          M VA+K+          ++   E +VL  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 712 V-RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLY-----------------SNNFSF 753
           +  H N+V ++ +CT      ++ EY   G L ++L                   +  + 
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 754 DILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
           D+   LS    VA  + +L    S   +H D+   N+LL    +  + DFG+A+ +  + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 814 S-MKQTLTLATIGYMAP 829
           + + +      + +MAP
Sbjct: 200 NYVVKGNARLPVKWMAP 216

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 5e-35
 Identities = 49/191 (25%), Positives = 86/191 (45%), Gaps = 25/191 (13%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDG---MEVAIKVFHLQL-EGALKSFDVECEVLKSV-R 713
           N     ++IG G FG V K         M+ AIK       +   + F  E EVL  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNF---------------SFDILQR 758
           H N++ ++ +C +  +  L +EY P+G+L D+L  +                 +    Q 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 759 LSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT 818
           L    DVA  ++YL        +H D+   N+L+ ++ VA ++DFG+++    E  +K+T
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 184

Query: 819 LTLATIGYMAP 829
           +    + +MA 
Sbjct: 185 MGRLPVRWMAI 195

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 6e-35
 Identities = 44/205 (21%), Positives = 90/205 (43%), Gaps = 17/205 (8%)

Query: 634 SNIESNMLPQATRRRFSYKELLQATNQFNASNLIGTGGFGSVYKGSFLD----GMEVAIK 689
           S +   ++            L+      + + +IG G FG VY G+ LD     +  A+K
Sbjct: 7   SALNPELVQAVQHVVIGPSSLI-----VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 61

Query: 690 VFH-LQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKA-LVLEYMPNGSLEDYLY 747
             + +   G +  F  E  ++K   H N++ ++  C  ++    +VL YM +G L +++ 
Sbjct: 62  SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 121

Query: 748 SNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAK 807
           +   +  +   +   + VA  +++L        VH D+   N +LD+     ++DFG+A+
Sbjct: 122 NETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

Query: 808 LLSGEESMK---QTLTLATIGYMAP 829
            +  +E      +T     + +MA 
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMAL 203

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 2e-34
 Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 11/177 (6%)

Query: 660 QFNASNLIGTGGFGSVYKGSFLD-----GMEVAIKVFHLQL-EGALKSFDVECEVLKSVR 713
           +F    ++G+G FG+VYKG ++       + VAIK         A K    E  V+ SV 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
           + ++ +++  C  +  + L+ + MP G L DY+  +  +      L+  + +A  + YL 
Sbjct: 70  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128

Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLA-TIGYMAP 829
                 +VH D+   NVL+       ++DFG+AKLL  EE           I +MA 
Sbjct: 129 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (324), Expect = 2e-33
 Identities = 44/184 (23%), Positives = 76/184 (41%), Gaps = 5/184 (2%)

Query: 651 YKELLQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQ-LEGALKSFDVECEV 708
           +K+     + ++  +++GTG F  V           VAIK    + LEG   S + E  V
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 709 LKSVRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALA 768
           L  ++H N+V +     +     L+++ +  G L D +    F +       +I  V  A
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDA 119

Query: 769 LEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA 828
           ++YLH                  LD+D    +SDFG++K+      +       T GY+A
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST--ACGTPGYVA 177

Query: 829 PGLF 832
           P + 
Sbjct: 178 PEVL 181

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  129 bits (325), Expect = 4e-33
 Identities = 42/170 (24%), Positives = 73/170 (42%), Gaps = 11/170 (6%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHL------QLEGALKSFDVECEVLKS 711
           N F+   +IG GGFG VY     D G   A+K          Q E    +  +   ++ +
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEY 771
                +V +  +    D  + +L+ M  G L  +L  +    +         ++ L LE+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-ADMRFYAAEIILGLEH 122

Query: 772 LHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTL 821
           +H   +  VV+ D+KP+N+LLD+     +SD G+A   S ++      T 
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 169

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  127 bits (319), Expect = 4e-33
 Identities = 44/181 (24%), Positives = 80/181 (44%), Gaps = 17/181 (9%)

Query: 660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHL---------QLEGALKSFDVECEVL 709
            +    ++G G    V +        E A+K+  +         +++   ++   E ++L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 710 KSVR-HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALA 768
           + V  H N++++  +   N F  LV + M  G L DYL     +    +   ++  +   
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEV 122

Query: 769 LEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA 828
           +  LH      +VH D+KP N+LLD DM   L+DFG +  L   E +++     T  Y+A
Sbjct: 123 ICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCG--TPSYLA 177

Query: 829 P 829
           P
Sbjct: 178 P 178

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  123 bits (310), Expect = 6e-32
 Identities = 39/182 (21%), Positives = 79/182 (43%), Gaps = 14/182 (7%)

Query: 658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVR 713
           ++++    ++G GG   V+    L    +VA+KV    L         F  E +   ++ 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 714 HRNLVKIISSCTNNDFKA----LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL 769
           H  +V +  +            +V+EY+   +L D +++        + + VI D   AL
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQAL 124

Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATIGYM 827
            + H    N ++H D+KP+N+++       + DFGIA+ ++   +        + T  Y+
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 828 AP 829
           +P
Sbjct: 182 SP 183

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 7e-32
 Identities = 35/167 (20%), Positives = 73/167 (43%), Gaps = 9/167 (5%)

Query: 666 LIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
            +G G FG V++            K   ++          E  +L   RHRN++ +  S 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESF 70

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
            + +   ++ E++    + + + ++ F  +  + +S +  V  AL++LH   S+ + H D
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127

Query: 785 IKPSNVLLDKDMVAH--LSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           I+P N++      +   + +FG A+ L   ++ +   T     Y AP
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT--APEYYAP 172

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 2e-31
 Identities = 43/185 (23%), Positives = 80/185 (43%), Gaps = 13/185 (7%)

Query: 653 ELLQATNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFH-LQLEGALKSFDVECEVLK 710
           ++     ++   + IG G +G V       + + VAIK     + +   +    E ++L 
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 711 SVRHRNLVKIISSCTNNDFKAL----VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVA 766
             RH N++ I         + +    ++ ++    L   L + + S D       +  + 
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSND--HICYFLYQIL 119

Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT--LATI 824
             L+Y+H   S  V+H D+KPSN+LL+      + DFG+A++   +      LT  +AT 
Sbjct: 120 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176

Query: 825 GYMAP 829
            Y AP
Sbjct: 177 WYRAP 181

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 2e-31
 Identities = 39/188 (20%), Positives = 78/188 (41%), Gaps = 20/188 (10%)

Query: 659 NQFNASNLIGTGGFGSVYKG------SFLDGMEVAIKVFHL-QLEGALKSFDVECEVLKS 711
            +   S  +G G FG VY+G             VAIK  +          F  E  V+K 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 712 VRHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFS---------FDILQRLSVI 762
               ++V+++   +      +++E M  G L+ YL S   +           + + + + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 763 IDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLT-L 821
            ++A  + YL+   +N  VH D+   N ++ +D    + DFG+ + +   +  ++    L
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 822 ATIGYMAP 829
             + +M+P
Sbjct: 197 LPVRWMSP 204

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  123 bits (309), Expect = 2e-31
 Identities = 47/178 (26%), Positives = 82/178 (46%), Gaps = 12/178 (6%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRH 714
             F     +GTG FG V+      +G   A+KV   ++      ++  + E  +L  V H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             ++++  +  +     ++++Y+  G L       +  F          +V LALEYLH 
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSL-LRKSQRFPNPVAKFYAAEVCLALEYLH- 121

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
             S  +++ D+KP N+LLDK+    ++DFG AK +     +  TL   T  Y+AP + 
Sbjct: 122 --SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYTLC-GTPDYIAPEVV 173

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 6e-31
 Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 10/176 (5%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFH---LQLEGALKSFDVECEVL-KSVR 713
             F    ++G G FG V+   F       AIK      + ++  ++   VE  VL  +  
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 714 HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLH 773
           H  L  +  +    +    V+EY+  G L  ++ S +  FD+ +      ++ L L++LH
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH 120

Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
              S  +V+ D+K  N+LLDKD    ++DFG+ K     ++   T    T  Y+AP
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAP 172

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 6e-31
 Identities = 46/171 (26%), Positives = 82/171 (47%), Gaps = 11/171 (6%)

Query: 665 NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-----EGALKSFDVECEVLKSVRHRNLV 718
           + +G G F +VYK         VAIK   L       +G  ++   E ++L+ + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
            ++ +  +    +LV ++M        +  N+         + ++     LEYLH    +
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 779 PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
            ++H D+KP+N+LLD++ V  L+DFG+AK   G  +   T  + T  Y AP
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVVTRWYRAP 169

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  120 bits (302), Expect = 8e-31
 Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 7/176 (3%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRN 716
            +++    IG G +G VYK     G   A+K   L+   EG   +   E  +LK ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 717 LVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY 776
           +VK+           LV E++ +  L+  L       + +   S ++ +   + Y H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117

Query: 777 SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
              V+H D+KP N+L++++    ++DFG+A+   G    K T  + T+ Y AP + 
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIVTLWYRAPDVL 172

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 2e-30
 Identities = 46/197 (23%), Positives = 85/197 (43%), Gaps = 29/197 (14%)

Query: 659 NQFNASNLIGTGGFGSVYKG--------SFLDGMEVAIKVFHLQL-EGALKSFDVECEVL 709
           ++      +G G FG V                 +VA+K+      E  L     E E++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 710 KSV-RHRNLVKIISSCTNNDFKALVLEYMPNGSLEDYL---------------YSNNFSF 753
           K + +H+N++ ++ +CT +    +++EY   G+L +YL               ++     
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 754 DILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE 813
                +S    VA  +EYL    S   +H D+   NVL+ +D V  ++DFG+A+ +   +
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 814 SMKQTLTLA-TIGYMAP 829
             K+T      + +MAP
Sbjct: 190 YYKKTTNGRLPVKWMAP 206

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 3e-29
 Identities = 45/172 (26%), Positives = 72/172 (41%), Gaps = 7/172 (4%)

Query: 661 FNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNL 717
           F     IG G +G VYK      G  VA+K   L    EG   +   E  +LK + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           VK++      +   LV E++     +    S      +    S +  +   L + H   S
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---S 120

Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           + V+H D+KP N+L++ +    L+DFG+A+             +    Y AP
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL-WYRAP 171

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 4e-29
 Identities = 37/196 (18%), Positives = 71/196 (36%), Gaps = 28/196 (14%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHL-QLEGALKSFDVECEVLKS 711
           ++      +G G FG V +              VA+K+          ++   E ++L  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 712 VRHRNLVKII--SSCTNNDFKALVLEYMPNGSLEDYLYSNNFSF---------------D 754
           + H   V  +  +         +++E+   G+L  YL S    F                
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 755 ILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
           +   +     VA  +E+L    S   +H D+   N+LL +  V  + DFG+A+ +  +  
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 815 MKQTLTLA-TIGYMAP 829
             +       + +MAP
Sbjct: 190 YVRKGDARLPLKWMAP 205

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 1e-28
 Identities = 37/177 (20%), Positives = 73/177 (41%), Gaps = 20/177 (11%)

Query: 666 LIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVL-KSVRHRNLVKIISS 723
           ++G G  G V +        + A+K+              E E+  ++ +  ++V+I+  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73

Query: 724 C----TNNDFKALVLEYMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSN 778
                       +V+E +  G L   +    + +F   +   ++  +  A++YLH   S 
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130

Query: 779 PVVHCDIKPSNVLLDK---DMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
            + H D+KP N+L      + +  L+DFG AK  +   S+       T  Y+AP + 
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 2e-28
 Identities = 49/182 (26%), Positives = 79/182 (43%), Gaps = 19/182 (10%)

Query: 661 FNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVK 719
           +  + +IG G FG VY+    D G  VAIK          +  + E ++++ + H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVR 77

Query: 720 IISSCT------NNDFKALVLEYMPNGSLEDYLY--SNNFSFDILQRLSVIIDVALALEY 771
           +           +  +  LVL+Y+P        +      +  ++     +  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 772 LHFGYSNPVVHCDIKPSNVLLDKD-MVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPG 830
           +H   S  + H DIKP N+LLD D  V  L DFG AK L   E     +   +  Y AP 
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRAPE 192

Query: 831 LF 832
           L 
Sbjct: 193 LI 194

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (282), Expect = 2e-28
 Identities = 46/181 (25%), Positives = 69/181 (38%), Gaps = 16/181 (8%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL------EGALKSFDVECEVLKS 711
           +Q+    L+G+GGFGSVY G  + D + VAIK                    +E  +LK 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 712 VR--HRNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL 769
           V      +++++      D   L+LE            +   +       S    V  A+
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKD-MVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA 828
            + H   +  V+H DIK  N+L+D +     L DFG   LL        T    T  Y  
Sbjct: 124 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 177

Query: 829 P 829
           P
Sbjct: 178 P 178

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  113 bits (282), Expect = 4e-28
 Identities = 42/181 (23%), Positives = 77/181 (42%), Gaps = 15/181 (8%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNL 717
           N++     IG+G FG +Y G+ +  G EVAIK+  ++ +       +E ++ K ++    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVG 64

Query: 718 VKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
           +  I  C       +++  +   SLED     +  F +   L +   +   +EY+H   S
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---S 121

Query: 778 NPVVHCDIKPSNVL---LDKDMVAHLSDFGIAKLLSGEES------MKQTLTLATIGYMA 828
              +H D+KP N L     K  + ++ DFG+AK      +       +      T  Y +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181

Query: 829 P 829
            
Sbjct: 182 I 182

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 8e-28
 Identities = 52/178 (29%), Positives = 81/178 (45%), Gaps = 9/178 (5%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRH 714
           N F+   L+G G FG V        G   A+K+   ++   +  +     E  VL++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
             L  +  +   +D    V+EY   G L  +L S    F   +      ++  ALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH- 122

Query: 775 GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
             S  VV+ DIK  N++LDKD    ++DFG+ K    + +  +T    T  Y+AP + 
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVL 177

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 2e-27
 Identities = 41/178 (23%), Positives = 72/178 (40%), Gaps = 17/178 (9%)

Query: 666 LIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL------EGALKSFDVECEVLKSVRHRNLV 718
            +G+G F  V K      G++ A K    +         + +  + E  +LK ++H N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 719 KIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN 778
            +     N     L+LE +  G L D+L     S    +    +  +   + YLH   S 
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SL 132

Query: 779 PVVHCDIKPSNVLLDKDMVA----HLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
            + H D+KP N++L    V      + DFG+A  +      K      T  ++AP + 
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIV 188

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  112 bits (280), Expect = 2e-27
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 15/209 (7%)

Query: 628 EKNAKQSNIESNMLPQATRRRFSYKELLQAT---NQFNASNLIGTGGFGSVYKGSFL-DG 683
           +K ++Q +++  +          ++   Q T   +QF+    +GTG FG V        G
Sbjct: 7   KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66

Query: 684 MEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPNG 740
              A+K+   Q       ++    E  +L++V    LVK+  S  +N    +V+EY+  G
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126

Query: 741 SLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHL 800
            +  +L      F           + L  EYLH   S  +++ D+KP N+L+D+     +
Sbjct: 127 EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQV 182

Query: 801 SDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           +DFG AK        +      T   +AP
Sbjct: 183 TDFGFAK----RVKGRTWTLCGTPEALAP 207

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 3e-27
 Identities = 46/189 (24%), Positives = 88/189 (46%), Gaps = 20/189 (10%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHR 715
           +++     IG G FG V+K      G +VA+K   ++   EG   +   E ++L+ ++H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 716 NLVKIISSCTNNDFKA--------LVLEYMPNGSLEDYLYSN-NFSFDILQRLSVIIDVA 766
           N+V +I  C               LV ++  +            F+   ++R+  ++   
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126

Query: 767 LALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES---MKQTLTLAT 823
             L  L++ + N ++H D+K +NVL+ +D V  L+DFG+A+  S  ++    + T  + T
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184

Query: 824 IGYMAPGLF 832
           + Y  P L 
Sbjct: 185 LWYRPPELL 193

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 3e-27
 Identities = 52/188 (27%), Positives = 81/188 (43%), Gaps = 17/188 (9%)

Query: 657 ATNQFNASNLIGTGGFGSVYKGSFL--DGMEVAIKVFHLQL--EGALKSFDVECEVLK-- 710
           A  Q+     IG G +G V+K   L   G  VA+K   +Q   EG   S   E  VL+  
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 711 -SVRHRNLVKIISSCTNNDFKA-----LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIID 764
            +  H N+V++   CT +         LV E++                       ++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 765 VALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATI 824
           +   L++LH   S+ VVH D+KP N+L+       L+DFG+A++ S    M  T  + T+
Sbjct: 125 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTL 179

Query: 825 GYMAPGLF 832
            Y AP + 
Sbjct: 180 WYRAPEVL 187

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (274), Expect = 3e-27
 Identities = 40/174 (22%), Positives = 75/174 (43%), Gaps = 8/174 (4%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHR 715
            ++     IG G +G+V+K         VA+K   L    EG   S   E  +LK ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG 775
           N+V++     ++    LV E+      + +   N          S +  +   L + H  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE-IVKSFLFQLLKGLGFCHS- 119

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
               V+H D+KP N+L++++    L++FG+A+          +  + T+ Y  P
Sbjct: 120 --RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTLWYRPP 170

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  106 bits (265), Expect = 7e-26
 Identities = 34/176 (19%), Positives = 65/176 (36%), Gaps = 17/176 (9%)

Query: 666 LIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
            IG G FG +++G+ L +  +VAIK    + +        E    K +     +  +   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 725 TNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCD 784
                  +++  +   SLED L      F +         +   ++ +H      +V+ D
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 126

Query: 785 IKPSNVLLDKDMVAH-----LSDFGIAKLLSGEES------MKQTLTLATIGYMAP 829
           IKP N L+ +    +     + DFG+ K      +       ++     T  YM+ 
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 2e-25
 Identities = 45/197 (22%), Positives = 85/197 (43%), Gaps = 23/197 (11%)

Query: 646 RRRFSYKELLQATNQFNAS----NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGA 698
           R  F  +E+ +   +  A       +G+G +G+V        G +VAIK  +     E  
Sbjct: 1   RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60

Query: 699 LKSFDVECEVLKSVRHRNLVKIISSCTNNDFKA------LVLEYMPNGSLEDYLYSNNFS 752
            K    E  +LK +RH N++ ++   T ++         LV+ +M  G+    L  +   
Sbjct: 61  AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE-K 117

Query: 753 FDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE 812
               +   ++  +   L Y+H   +  ++H D+KP N+ +++D    + DFG+A+     
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS- 173

Query: 813 ESMKQTLTLATIGYMAP 829
              + T  + T  Y AP
Sbjct: 174 ---EMTGYVVTRWYRAP 187

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 5e-25
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 13/173 (7%)

Query: 665 NLIGTGGFGSVYKG----SFLDGMEVAIKVFH----LQLEGALKSFDVECEVLKSVRHR- 715
            ++GTG +G V+          G   A+KV      +Q     +    E +VL+ +R   
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 716 NLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG 775
            LV +  +        L+L+Y+  G L  +L      F   +    + ++ LALE+LH  
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLS-QRERFTEHEVQIYVGEIVLALEHLH-- 146

Query: 776 YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMA 828
               +++ DIK  N+LLD +    L+DFG++K    +E+ +      TI YMA
Sbjct: 147 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  104 bits (259), Expect = 2e-24
 Identities = 82/389 (21%), Positives = 140/389 (35%), Gaps = 33/389 (8%)

Query: 165 NLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSID-LVRLPNLEIIS 223
            L       L    +   V  +  +L  + TL      +      SID +  L NL  I+
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-----SIDGVEYLNNLTQIN 72

Query: 224 LAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSE 283
            + N  + I P  + N +KL  + +  N  +   P           L  +          
Sbjct: 73  FSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 130

Query: 284 LSFLSSWANCKNL-------KLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIP 336
           L+ L+      N          L        G   + +  L+   +   +   S + +  
Sbjct: 131 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI 190

Query: 337 KEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVL 396
             +  L NL  L    N++    P+      NL  L L  N+L+      L  L  L+ L
Sbjct: 191 SVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKDI--GTLASLTNLTDL 246

Query: 397 YMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLP 456
            +  N++S   P  +  LT L  L L +N+++++ P     L  + +L  + N L     
Sbjct: 247 DLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--I 300

Query: 457 EDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESL 516
             I NLK +  + L  NN+S   P  +  L  LQ L   +N +      S+  L ++  L
Sbjct: 301 SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWL 356

Query: 517 DLSNNSLSGNIPTSMEKLLYLKDLNLSFN 545
              +N +S   P  +  L  +  L L+  
Sbjct: 357 SAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 93.1 bits (230), Expect = 8e-21
 Identities = 67/354 (18%), Positives = 133/354 (37%), Gaps = 25/354 (7%)

Query: 206 SLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLR 265
           ++  ++    L  +  +         I    +   + L+ +    N  +   P  L NL 
Sbjct: 33  NVTDTVSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLT 88

Query: 266 KLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIF 325
           KL  + ++ N +   T   +  +          +   +   N    + +   S ++S I 
Sbjct: 89  KLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDIS 148

Query: 326 ISNCSIRGTIPKEIGNLINLRELGL-------WGNELIGSIPITFGKLQNLQGLDLVNNK 378
             +             + +L+ L           +    S      KL NL+ L   NN+
Sbjct: 149 ALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQ 208

Query: 379 LEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNL 438
           +    P G+     L  L ++GN+L       +  LT+L  L LA+N+++++ P     L
Sbjct: 209 ISDITPLGILT--NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGL 262

Query: 439 KDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNG 498
             +  L   +N ++   P  +  L  +  ++L+ N    +  + I  L NL  L+L  N 
Sbjct: 263 TKLTELKLGANQISNISP--LAGLTALTNLELNENQ--LEDISPISNLKNLTYLTLYFNN 318

Query: 499 LQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIP 552
           +    P  +  L  L+ L  +NN +S    +S+  L  +  L+   N++    P
Sbjct: 319 ISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 92.0 bits (227), Expect = 2e-20
 Identities = 76/398 (19%), Positives = 143/398 (35%), Gaps = 41/398 (10%)

Query: 100 LYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEI 159
             +    +T  +        ++  +             G+  L +L  +    N LT   
Sbjct: 27  TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDIT 82

Query: 160 PYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNL 219
           P  + NL  L  +             +   ++ +  LA  +N    +L ++      P  
Sbjct: 83  P--LKNLTKLVDI-----------LMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 129

Query: 220 EIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTS 279
            + +L     S    S I   S L+ L+             L NL  LE L +S N ++ 
Sbjct: 130 NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS- 188

Query: 280 STSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEI 339
                  +S  A   NL+ L  +NN I+ + P  I     +L  + ++   ++      +
Sbjct: 189 ------DISVLAKLTNLESLIATNNQISDITPLGILT---NLDELSLNGNQLKD--IGTL 237

Query: 340 GNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMD 399
            +L NL +L L  N++    P     L  L  L L  N++    P         ++  ++
Sbjct: 238 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLT----ALTNLE 291

Query: 400 GNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDI 459
            N+        I +L +L  L+L  N ++ + P    +L  +  L F++N ++      +
Sbjct: 292 LNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSL 347

Query: 460 GNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDN 497
            NL  +  +    N +S   P  +  L  +  L L D 
Sbjct: 348 ANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 90.8 bits (224), Expect = 5e-20
 Identities = 76/385 (19%), Positives = 140/385 (36%), Gaps = 47/385 (12%)

Query: 19  NLTMLKKLGLGYNKLRGEIPQ-ELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDF 77
            L    K  LG   +   + Q +L  +  L+   L    + G     +  L++L+  ++F
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQ-INF 73

Query: 78  SNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPN------NIWQCKELIVISLAYNQF 131
           SNN LT   P     +L  I         +T            ++  +   +  L     
Sbjct: 74  SNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 132 TERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQL----NKLVGFVPTSI 187
             R+      ++ +  L    +        ++ +L+ L  L        +       + +
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193

Query: 188 FNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLE 247
             L+ +++L   +N +S   P  I      NL+ +SL GN    I    + + + L+ L+
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL----TNLDELSLNGNQLKDI--GTLASLTNLTDLD 247

Query: 248 LGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSS---------------WAN 292
           L  N  S   P  L  L KL  L+L  N +++ +      +                 +N
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305

Query: 293 CKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWG 352
            KNL  L L  N I+ + P  + +L+  L R+F +N  +       + NL N+  L    
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLT-KLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360

Query: 353 NELIGSIPITFGKLQNLQGLDLVNN 377
           N++    P     L  +  L L + 
Sbjct: 361 NQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 78.1 bits (191), Expect = 8e-16
 Identities = 42/177 (23%), Positives = 70/177 (39%), Gaps = 16/177 (9%)

Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
            LSL+ N L       + +LT L  L L  N++    P  L  L +L  + L  N +S  
Sbjct: 223 ELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI 278

Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
            P  +  L++L+      N              L  +  L +  N ++   P  +    +
Sbjct: 279 SP--LAGLTALTNLELNENQLE----DISPISNLKNLTYLTLYFNNISDISP--VSSLTK 330

Query: 121 LIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLN 177
           L  +  A N+ ++     L NLT++  L  G N ++   P  + NL  +  LGL   
Sbjct: 331 LQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 56.9 bits (136), Expect = 4e-09
 Identities = 61/323 (18%), Positives = 105/323 (32%), Gaps = 51/323 (15%)

Query: 263 NLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLS 322
            L +     L    +T + S+        +   +  L      I  +    +  L+ +L+
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQ-------TDLDQVTTLQADRLGIKSI--DGVEYLN-NLT 69

Query: 323 RIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGP 382
           +I  SN  +    P  + NL  L ++ +  N++    P+          L         P
Sbjct: 70  QINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 127

Query: 383 IP------------NGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSV 430
           +             N +  ++ LS L        G     +  L +L  L       N V
Sbjct: 128 LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKV 187

Query: 431 IPSTFW-NLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNL 489
              +    L ++ SL  ++N ++   P  I     +  + L+ N L       +  L NL
Sbjct: 188 SDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNL 243

Query: 490 QDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIP--------------------T 529
            DL L +N +    P  + GL  L  L L  N +S   P                    +
Sbjct: 244 TDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDIS 301

Query: 530 SMEKLLYLKDLNLSFNKLEGEIP 552
            +  L  L  L L FN +    P
Sbjct: 302 PISNLKNLTYLTLYFNNISDISP 324

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.4 bits (119), Expect = 5e-07
 Identities = 55/287 (19%), Positives = 98/287 (34%), Gaps = 52/287 (18%)

Query: 303 NNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPIT 362
           + PIN +   +   L+  + +  +   ++  T+ +   +L  +  L       I SI   
Sbjct: 9   DTPINQIFTDT--ALAEKM-KTVLGKTNVTDTVSQT--DLDQVTTLQADRLG-IKSID-G 61

Query: 363 FGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSL 422
              L NL  ++  NN+L    P  L  L +L  + M+ N+++   P       +   L  
Sbjct: 62  VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 119

Query: 423 ASNELNSVIPSTFWNLKDILSLN------------------------------------- 445
                   + +     +  LS N                                     
Sbjct: 120 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179

Query: 446 FSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPK 505
              +    S    +  L  +  +  + N +S   P  I    NL +LSL  N L+     
Sbjct: 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IG 235

Query: 506 SIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIP 552
           ++  L +L  LDL+NN +S   P  +  L  L +L L  N++    P
Sbjct: 236 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 280

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  102 bits (254), Expect = 3e-24
 Identities = 32/176 (18%), Positives = 75/176 (42%), Gaps = 17/176 (9%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVR-HRN 716
           + +     +G G +  V++   + +  +V +K+     +   K    E ++L+++R   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91

Query: 717 LVKIISSCTNNDFK--ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHF 774
           ++ +     +   +  ALV E++ N   +    +             + ++  AL+Y H 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH- 146

Query: 775 GYSNPVVHCDIKPSNVLLD-KDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
             S  ++H D+KP NV++D +     L D+G+A+     +     +   +  +  P
Sbjct: 147 --SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA--SRYFKGP 198

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 98.6 bits (244), Expect = 4e-23
 Identities = 55/261 (21%), Positives = 100/261 (38%), Gaps = 12/261 (4%)

Query: 294 KNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGN 353
            +  LLDL NN I  +      NL  +L  + + N  I    P     L+ L  L L  N
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLK-NLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89

Query: 354 ELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGD 413
           +L          LQ L+  +    K+   + NGL Q+  +  L  +  K SG        
Sbjct: 90  QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQG 148

Query: 414 LTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRN 473
           +  L  + +A   + ++      +L     L+   N +       +  L  +  + LS N
Sbjct: 149 MKKLSYIRIADTNITTIPQGLPPSLT---ELHLDGNKITKVDAASLKGLNNLAKLGLSFN 205

Query: 474 NLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSG------NI 527
           ++S     ++    +L++L L +N L   +P  +     ++ + L NN++S         
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264

Query: 528 PTSMEKLLYLKDLNLSFNKLE 548
           P    K      ++L  N ++
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 90.9 bits (224), Expect = 1e-20
 Identities = 59/298 (19%), Positives = 97/298 (32%), Gaps = 25/298 (8%)

Query: 206 SLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLR 265
            +P  +     P+  ++ L  N  + I      N   L  L L  N  S   P     L 
Sbjct: 24  KVPKDLP----PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLV 79

Query: 266 KLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSL-SLSRI 324
           KLE L LS N L     ++         K L+ L +  N I  V  S    L+   +  +
Sbjct: 80  KLERLYLSKNQLKELPEKM--------PKTLQELRVHENEITKVRKSVFNGLNQMIVVEL 131

Query: 325 FISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIP 384
             +     G        +  L  + +    +     I  G   +L  L L  NK+     
Sbjct: 132 GTNPLKSSGIENGAFQGMKKLSYIRIADTNI---TTIPQGLPPSLTELHLDGNKITKVDA 188

Query: 385 NGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSL 444
             L  L  L+ L +  N +S      + +   LR L L +N+L   +P    + K I  +
Sbjct: 189 ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVV 247

Query: 445 NFSSNFLNG------SLPEDIGNLKVVVIIDLSRNNLSGD--IPTAIGGLMNLQDLSL 494
              +N ++         P           + L  N +      P+    +     + L
Sbjct: 248 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 87.8 bits (216), Expect = 2e-19
 Identities = 61/306 (19%), Positives = 104/306 (33%), Gaps = 15/306 (4%)

Query: 72  STGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQF 131
              +  S+  L   +P D+    P    L + NNK+T     +    K L  + L  N+ 
Sbjct: 12  LRVVQCSDLGLE-KVPKDL---PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67

Query: 132 TERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLS 191
           ++  P     L  L+ LYL  N L          L+ L +     N++     +    L+
Sbjct: 68  SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHE---NEITKVRKSVFNGLN 124

Query: 192 AMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGEN 251
            M  + L +N L  S   +     +  L  I +A  N + I          L+ L L  N
Sbjct: 125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP---PSLTELHLDGN 181

Query: 252 SFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLP 311
             +     +L  L  L  L LS+N +++  +     +      +L    L   P      
Sbjct: 182 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADH 241

Query: 312 SSIGNLSLSLSRI-FISNCSIRGTIPKEIGNLINLRELGLWGNEL--IGSIPITFGKLQN 368
             I  + L  + I  I +       P       +   + L+ N +      P TF  +  
Sbjct: 242 KYIQVVYLHNNNISAIGSNDFCP--PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 299

Query: 369 LQGLDL 374
              + L
Sbjct: 300 RAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 86.2 bits (212), Expect = 6e-19
 Identities = 63/280 (22%), Positives = 106/280 (37%), Gaps = 17/280 (6%)

Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
           +L L  N ++     +  NL  L  L L  NK+    P     L +LE + L+ N L   
Sbjct: 35  LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-E 93

Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKE 120
           +P  +          +     +  S+ + + + + +   L  +  K +G         K+
Sbjct: 94  LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE--LGTNPLKSSGIENGAFQGMKK 151

Query: 121 LIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLV 180
           L  I +A    T  IP+GL    SL  L+L  N +T      +  L NL  LGL  N + 
Sbjct: 152 LSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208

Query: 181 GFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGI------IP 234
                S+ N   ++ L L +N L        D      ++++ L  NN S I       P
Sbjct: 209 AVDNGSLANTPHLRELHLNNNKLVKVPGGLAD---HKYIQVVYLHNNNISAIGSNDFCPP 265

Query: 235 SFIFNASKLSVLELGEN--SFSGFIPNTLGNLRKLEWLRL 272
            +    +  S + L  N   +    P+T   +     ++L
Sbjct: 266 GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 79.7 bits (195), Expect = 1e-16
 Identities = 61/247 (24%), Positives = 103/247 (41%), Gaps = 12/247 (4%)

Query: 328 NCSIRG--TIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPN 385
            CS  G   +PK++    +   L L  N++       F  L+NL  L L+NNK+    P 
Sbjct: 16  QCSDLGLEKVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG 73

Query: 386 GLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKD--ILS 443
               L +L  LY+  N+L   +P  +      + L +  NE+  V  S F  L    ++ 
Sbjct: 74  AFAPLVKLERLYLSKNQLKE-LPEKMPKTL--QELRVHENEITKVRKSVFNGLNQMIVVE 130

Query: 444 LNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSI 503
           L  +    +G        +K +  I ++  N++  IP  +    +L +L L  N +    
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVD 187

Query: 504 PKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNR 563
             S+ GL +L  L LS NS+S     S+    +L++L+L+ NKL                
Sbjct: 188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVV 247

Query: 564 SFMGNDL 570
               N++
Sbjct: 248 YLHNNNI 254

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 79.3 bits (194), Expect = 1e-16
 Identities = 48/217 (22%), Positives = 78/217 (35%), Gaps = 10/217 (4%)

Query: 358 SIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSL 417
            +P       +   LDL NNK+          L  L  L +  NK+S   P     L  L
Sbjct: 24  KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 418 RLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDL--SRNNL 475
             L L+ N+L  +       L+    L    N +          L  +++++L  +    
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQ---ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS 138

Query: 476 SGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLL 535
           SG    A  G+  L  + + D  +  +IP+ +    SL  L L  N ++     S++ L 
Sbjct: 139 SGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLN 195

Query: 536 YLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLC 572
            L  L LSFN +                  + N+ L 
Sbjct: 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 232

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 77.4 bits (189), Expect = 5e-16
 Identities = 56/297 (18%), Positives = 104/297 (35%), Gaps = 36/297 (12%)

Query: 12  AIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSL 71
            +PK++        L L  NK+      +  NL  L  + L NN +S   P     L  L
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 72  STGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQF 131
              +  S N L   LP+ M + L  ++       K+   + N + Q   + + +    + 
Sbjct: 82  ER-LYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT-NPLKS 138

Query: 132 TERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLS 191
           +         +  L  + +   N+T  IP   G   +L  L L  NK+      S+    
Sbjct: 139 SGIENGAFQGMKKLSYIRIADTNIT-TIP--QGLPPSLTELHLDGNKITKVDAASLKG-- 193

Query: 192 AMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGEN 251
                                   L NL  + L+ N+ S +    + N   L  L L  N
Sbjct: 194 ------------------------LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 229

Query: 252 SFSGFIPNTLGNLRKLEWLRLSYNFLTS-STSELSFLSSWANCKNLKLLDLSNNPIN 307
                +P  L + + ++ + L  N +++  +++           +   + L +NP+ 
Sbjct: 230 KLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 46.6 bits (109), Expect = 7e-06
 Identities = 26/155 (16%), Positives = 51/155 (32%), Gaps = 3/155 (1%)

Query: 416 SLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNL 475
            LR++  +   L  V      +      L+  +N +      D  NLK +  + L  N +
Sbjct: 11  HLRVVQCSDLGLEKVPKDLPPDTA---LLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67

Query: 476 SGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLL 535
           S   P A   L+ L+ L L  N L+    K    L  L   +     +  ++   + +++
Sbjct: 68  SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127

Query: 536 YLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDL 570
            ++           E          S       ++
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 162

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.9 bits (240), Expect = 3e-22
 Identities = 40/180 (22%), Positives = 73/180 (40%), Gaps = 18/180 (10%)

Query: 659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHR 715
            ++     IG+G  G V           VAIK        +   K    E  ++K V H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 716 NLVKIISSCTNNDFK------ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL 769
           N++ +++  T            LV+E M     +      +      +   ++  +   +
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE----RMSYLLYQMLCGI 132

Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAP 829
           ++LH   S  ++H D+KPSN+++  D    + DFG+A+  +   S   T  + T  Y AP
Sbjct: 133 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 187

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 91.8 bits (227), Expect = 8e-22
 Identities = 23/161 (14%), Positives = 49/161 (30%), Gaps = 20/161 (12%)

Query: 665 NLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL----------EGALKSFDVECEVLKSVRH 714
            L+G G   +V+        E  +K   +            +     F V          
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 715 RNLVKIISSCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDIL-QRLSVIIDVALALEYLH 773
           R L K+        +      +  N  L + + +       +     V+  +   +   +
Sbjct: 66  RALQKLQGLAVPKVY-----AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 774 FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES 814
                 +VH D+   NVL+ ++ +  + DF  +  +  E  
Sbjct: 121 ---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGW 157

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.3 bits (236), Expect = 1e-21
 Identities = 41/175 (23%), Positives = 75/175 (42%), Gaps = 15/175 (8%)

Query: 665 NLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKII 721
           + +G+G +GSV        G+ VA+K            K    E  +LK ++H N++ ++
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 722 SSCTNN----DFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYS 777
              T      +F  + L     G+  + +              +I  +   L+Y+H   S
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIH---S 139

Query: 778 NPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF 832
             ++H D+KPSN+ +++D    + DFG    L+     + T  +AT  Y AP + 
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFG----LARHTDDEMTGYVATRWYRAPEIM 190

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.1 bits (219), Expect = 5e-20
 Identities = 62/259 (23%), Positives = 104/259 (40%), Gaps = 9/259 (3%)

Query: 267 LEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFI 326
            + + L  N ++   +      S+  C+NL +L L +N +  +  ++   L+L       
Sbjct: 34  SQRIFLHGNRISHVPAA-----SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88

Query: 327 SNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNG 386
            N  +R   P     L  L  L L    L    P  F  L  LQ L L +N L+    + 
Sbjct: 89  DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148

Query: 387 LCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNF 446
              L  L+ L++ GN++S         L SL  L L  N +  V P  F +L  +++L  
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208

Query: 447 SSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKS 506
            +N L+    E +  L+ +  + L+ N    D   A      LQ      + +  S+P+ 
Sbjct: 209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQR 267

Query: 507 IGGLVSLESLDLSNNSLSG 525
           + G    +   L+ N L G
Sbjct: 268 LAG---RDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.8 bits (200), Expect = 1e-17
 Identities = 57/256 (22%), Positives = 95/256 (37%), Gaps = 5/256 (1%)

Query: 316 NLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLV 375
            +  +  RIF+    I            NL  L L  N L       F  L  L+ LDL 
Sbjct: 29  GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88

Query: 376 NNKLEGPI-PNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPST 434
           +N     + P     L RL  L++D   L    P     L +L+ L L  N L ++   T
Sbjct: 89  DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148

Query: 435 FWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSL 494
           F +L ++  L    N ++         L  +  + L +N ++   P A   L  L  L L
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208

Query: 495 RDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIP-- 552
             N L     +++  L +L+ L L++N    +   +     +L+    S +++   +P  
Sbjct: 209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQR 267

Query: 553 -RGGPFANFSNRSFMG 567
             G      +     G
Sbjct: 268 LAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.0 bits (198), Expect = 3e-17
 Identities = 54/281 (19%), Positives = 87/281 (30%), Gaps = 13/281 (4%)

Query: 50  VSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTG 109
            S     L   +P     + + S  +    N ++            L      SN     
Sbjct: 16  TSCPQQGLQ-AVPV---GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71

Query: 110 PIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNL 169
                        +      Q     P     L  L TL+L    L    P     L  L
Sbjct: 72  DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131

Query: 170 EILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNF 229
           + L LQ N L      +  +L  +  L L  N +S     +     L +L+ + L  N  
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFR--GLHSLDRLLLHQNRV 189

Query: 230 SGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSS 289
           + + P    +  +L  L L  N+ S      L  LR L++LRL+ N            + 
Sbjct: 190 AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWA- 248

Query: 290 WANCKNLKLLDLSNNPINGVLPSSIGNLSL-SLSRIFISNC 329
                 L+    S++ +   LP  +    L  L+   +  C
Sbjct: 249 -----WLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQGC 284

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.4 bits (186), Expect = 9e-16
 Identities = 52/277 (18%), Positives = 94/277 (33%), Gaps = 10/277 (3%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
            S     L  A+P  I   +  +++ L  N++             L ++ L +N L+   
Sbjct: 16  TSCPQQGLQ-AVPVGIPAAS--QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
            +    L+ L       N  L  S+       L  +  L++    L    P        L
Sbjct: 73  AAAFTGLALLEQLDLSDNAQL-RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131

Query: 122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVG 181
             + L  N           +L +L  L+L  N ++         L +L+ L L  N++  
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191

Query: 182 FVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNAS 241
             P +  +L  + TL L +N LS     ++    L  L+ + L  N +     +     +
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALA--PLRALQYLRLNDNPWVCDCRARPL-WA 248

Query: 242 KLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLT 278
            L       +     +P     L   +  RL+ N L 
Sbjct: 249 WLQKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQ 282

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.6 bits (171), Expect = 7e-14
 Identities = 57/248 (22%), Positives = 89/248 (35%), Gaps = 5/248 (2%)

Query: 328 NCSIRG--TIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPN 385
           +C  +G   +P  I      + + L GN +      +F   +NL  L L +N L      
Sbjct: 17  SCPQQGLQAVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA 74

Query: 386 GLCQLARLSVLYMDGNKLSGPIPP-CIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSL 444
               LA L  L +  N     + P     L  L  L L    L  + P  F  L  +  L
Sbjct: 75  AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134

Query: 445 NFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIP 504
               N L     +   +L  +  + L  N +S     A  GL +L  L L  N +    P
Sbjct: 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194

Query: 505 KSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRS 564
            +   L  L +L L  N+LS     ++  L  L+ L L+ N    +      +A      
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFR 254

Query: 565 FMGNDLLC 572
              +++ C
Sbjct: 255 GSSSEVPC 262

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 89.3 bits (220), Expect = 1e-19
 Identities = 36/182 (19%), Positives = 69/182 (37%), Gaps = 21/182 (11%)

Query: 666 LIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSC 724
            +G G F +V+    + +   VA+K+     +   ++ + E ++L+ V   +  K  S  
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 725 TNNDFK---------------ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALAL 769
            N+  K                +V E +    L       +    ++    +   + L L
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 770 EYLHFGYSNPVVHCDIKPSNVLLDK-DMVAHLSDFGIAKLLSGEESMKQTLTLATI-GYM 827
           +Y+H      ++H DIKP NVL++  D   +L    IA L +     +          Y 
Sbjct: 139 DYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 828 AP 829
           +P
Sbjct: 197 SP 198

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 82.9 bits (203), Expect = 1e-17
 Identities = 72/287 (25%), Positives = 112/287 (39%), Gaps = 32/287 (11%)

Query: 299 LDLSNNPINGV--LPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELI 356
           LDLS   +     +PSS+ NL            ++ G IP  I  L  L  L +    + 
Sbjct: 55  LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS 114

Query: 357 GSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTS 416
           G+IP    +++ L  LD   N L G +P  +  L  L  +  DGN++SG IP   G  + 
Sbjct: 115 GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174

Query: 417 LRL-LSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNL 475
           L   ++++ N L   IP TF NL         +     +      +     I     +  
Sbjct: 175 LFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234

Query: 476 SGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLL 535
                  +   +N  DL   +N + G++P+ +  L  L SL++S N+L            
Sbjct: 235 FDLGKVGLSKNLNGLDLR--NNRIYGTLPQGLTQLKFLHSLNVSFNNLC----------- 281

Query: 536 YLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVC 582
                        GEIP+GG    F   ++  N  LCG     +P C
Sbjct: 282 -------------GEIPQGGNLQRFDVSAYANNKCLCGS---PLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 79.4 bits (194), Expect = 1e-16
 Identities = 55/258 (21%), Positives = 100/258 (38%), Gaps = 14/258 (5%)

Query: 51  SLTNNFLSG--TIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLT 108
            L+   L     IPS++ NL  L+       N+L G +P  + +   L    Y+++  ++
Sbjct: 56  DLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL-YITHTNVS 114

Query: 109 GPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRN 168
           G IP+ + Q K L+ +  +YN  +  +P  + +L +L  +    N ++G IP   G+   
Sbjct: 115 GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174

Query: 169 LEILGLQL-NKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGN 227
           L        N+L G +P +  NL+        +         +  L              
Sbjct: 175 LFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM----LEGDASVLFGSDKNTQKIHLAK 230

Query: 228 NFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFL 287
           N        +  +  L+ L+L  N   G +P  L  L+ L  L +S+N L         +
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE------I 284

Query: 288 SSWANCKNLKLLDLSNNP 305
               N +   +   +NN 
Sbjct: 285 PQGGNLQRFDVSAYANNK 302

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 75.6 bits (184), Expect = 3e-15
 Identities = 67/298 (22%), Positives = 102/298 (34%), Gaps = 14/298 (4%)

Query: 67  NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTG--PIPNNIWQCKELIVI 124
            LSS     D  N +  G L D   +   +   L +S   L    PIP+++     L  +
Sbjct: 23  TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVN-NLDLSGLNLPKPYPIPSSLANLPYLNFL 81

Query: 125 SLAYN-QFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFV 183
            +         IP  +  LT L  LY+   N++G IP  +  ++ L  L    N L G +
Sbjct: 82  YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTL 141

Query: 184 PTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKL 243
           P SI +L  +  +    N +SG++P S        L        N               
Sbjct: 142 PPSISSLPNLVGITFDGNRISGAIPDSYG--SFSKLFTSMTISRN------RLTGKIPPT 193

Query: 244 SVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSN 303
                                      + +     +  S    L      KNL  LDL N
Sbjct: 194 FANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRN 253

Query: 304 NPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPI 361
           N I G LP  +  L   L  + +S  ++ G IP + GNL          N+ +   P+
Sbjct: 254 NRIYGTLPQGLTQLK-FLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPL 309

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 75.6 bits (184), Expect = 3e-15
 Identities = 57/282 (20%), Positives = 107/282 (37%), Gaps = 11/282 (3%)

Query: 226 GNNFSGIIPSFIFNASKLSVLELGENSFSGF--IPNTLGNLRKLEWLRLSYNFLTSSTSE 283
              + G++        +++ L+L   +      IP++L NL  L +L +           
Sbjct: 35  NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP-- 92

Query: 284 LSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLI 343
                + A    L  L +++  ++G       +   +L  +  S  ++ GT+P  I +L 
Sbjct: 93  --IPPAIAKLTQLHYLYITHTNVSGA-IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLP 149

Query: 344 NLRELGLWGNELIGSIPITFGKLQNLQG-LDLVNNKLEGPIPNGLCQLARLSVLYMDGNK 402
           NL  +   GN + G+IP ++G    L   + +  N+L G IP     L    V       
Sbjct: 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNML 209

Query: 403 LSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNL 462
                     D          +    +         K++  L+  +N + G+LP+ +  L
Sbjct: 210 EGDASVLFGSDKN--TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQL 267

Query: 463 KVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIP 504
           K +  +++S NNL G+IP   G L      +  +N      P
Sbjct: 268 KFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 69.8 bits (169), Expect = 2e-13
 Identities = 53/200 (26%), Positives = 79/200 (39%), Gaps = 22/200 (11%)

Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
            L ++  ++SGAIP  +  +  L  L   YN L G +P  + +L  L  ++   N +SG 
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164

Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIK---------------------G 99
           IP +  + S L T M  S N LTG +P                                 
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQ 224

Query: 100 LYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEI 159
                          +   K L  + L  N+    +P+GL  L  L +L + FNNL GEI
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284

Query: 160 PYEMGNLRNLEILGLQLNKL 179
           P + GNL+  ++     NK 
Sbjct: 285 P-QGGNLQRFDVSAYANNKC 303

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 63.2 bits (152), Expect = 3e-11
 Identities = 58/256 (22%), Positives = 97/256 (37%), Gaps = 11/256 (4%)

Query: 2   LSLSFNDLSGA--IPKEIGNLTMLKKLGL-GYNKLRGEIPQELGNLAELELVSLTNNFLS 58
           L LS  +L     IP  + NL  L  L + G N L G IP  +  L +L  + +T+  +S
Sbjct: 55  LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS 114

Query: 59  GTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQC 118
           G IP  +  + +L T     N              LP + G+    N+++G IP++    
Sbjct: 115 GAIPDFLSQIKTLVTLDFSYNALSGT--LPPSISSLPNLVGITFDGNRISGAIPDSYGSF 172

Query: 119 KELIV-ISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLN 177
            +L   ++++ N+ T +IP    NL                      +            
Sbjct: 173 SKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT--QKIHLAK 230

Query: 178 KLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFI 237
             + F    +     +  L L +N + G+LP    L +L  L  ++++ NN  G IP   
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQG--LTQLKFLHSLNVSFNNLCGEIPQG- 287

Query: 238 FNASKLSVLELGENSF 253
            N  +  V     N  
Sbjct: 288 GNLQRFDVSAYANNKC 303

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 57.8 bits (138), Expect = 1e-09
 Identities = 19/59 (32%), Positives = 29/59 (49%), Gaps = 1/59 (1%)

Query: 4   LSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIP 62
           L  N + G +P+ +  L  L  L + +N L GEIP + GNL   ++ +  NN      P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.7 bits (143), Expect = 3e-10
 Identities = 49/210 (23%), Positives = 74/210 (35%), Gaps = 7/210 (3%)

Query: 338 EIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLY 397
           E+  + +  E+      L  ++P    K  +   L L  N L       L    RL+ L 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 398 MDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPE 457
           +D  +         G L  L  L L+ N+L S+           +  + S N L      
Sbjct: 62  LDRAE--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLG 118

Query: 458 DIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLD 517
            +  L  +  + L  N L    P  +     L+ LSL +N L       + GL +L++L 
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178

Query: 518 LSNNSLSGNIPTSMEKLLYLKDLNLSFNKL 547
           L  NSL   IP        L    L  N  
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.3 bits (134), Expect = 4e-09
 Identities = 41/209 (19%), Positives = 72/209 (34%), Gaps = 8/209 (3%)

Query: 292 NCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLW 351
              +   ++     +   LP  +       + + +S   +       +     L +L L 
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDLPK---DTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 352 GNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCI 411
             EL        G L  L  LDL +N+L+     G    A   +  +  N+L+      +
Sbjct: 64  RAELT--KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLGAL 120

Query: 412 GDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLS 471
             L  L+ L L  NEL ++ P        +  L+ ++N L       +  L+ +  + L 
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180

Query: 472 RNNLSGDIPTAIGGLMNLQDLSLRDNGLQ 500
            N+L   IP    G   L    L  N   
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.5 bits (132), Expect = 7e-09
 Identities = 36/210 (17%), Positives = 54/210 (25%), Gaps = 28/210 (13%)

Query: 117 QCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGL-- 174
           +    + ++      T  +P  L        L+L  N L       +     L  L L  
Sbjct: 8   KVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 175 ----------QLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLP-------SSIDLVRLP 217
                      L  L     +     S               +            L  L 
Sbjct: 65  AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124

Query: 218 NLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFL 277
            L+ + L GN    + P  +    KL  L L  N+ +      L  L  L+ L L  N L
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184

Query: 278 TSSTSELSFLSSWANCKNLKLLDLSNNPIN 307
                  +    +     L    L  NP  
Sbjct: 185 Y------TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.7 bits (130), Expect = 1e-08
 Identities = 44/214 (20%), Positives = 67/214 (31%), Gaps = 13/214 (6%)

Query: 215 RLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSY 274
           ++ +   ++    N + + P  +      ++L L EN    F   TL    +L  L L  
Sbjct: 8   KVASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 275 NFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGT 334
                            +     L  L  +         +G    +L+ + +S   +   
Sbjct: 65  A---------ELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSL 115

Query: 335 IPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLS 394
               +  L  L+EL L GNEL    P        L+ L L NN L       L  L  L 
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175

Query: 395 VLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELN 428
            L +  N L   IP        L    L  N   
Sbjct: 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.0 bits (128), Expect = 2e-08
 Identities = 41/178 (23%), Positives = 63/178 (35%), Gaps = 6/178 (3%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L LS N L       +   T L +L L   +L             L ++   +   +   
Sbjct: 36  LHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG-----TLPVLGTLDLSHNQLQ 90

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
              +   +  +  +   + +   SLP    R L  ++ LY+  N+L    P  +    +L
Sbjct: 91  SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKL 150

Query: 122 IVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKL 179
             +SLA N  TE     L  L +L TL L  N+L   IP        L    L  N  
Sbjct: 151 EKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.8 bits (125), Expect = 5e-08
 Identities = 42/207 (20%), Positives = 76/207 (36%), Gaps = 13/207 (6%)

Query: 272 LSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSI 331
                LT+   +L         K+  +L LS N +     +++   +  L+++ +    +
Sbjct: 17  CDKRNLTALPPDLP--------KDTTILHLSENLLYTFSLATLMPYT-RLTQLNLDRAEL 67

Query: 332 RGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLA 391
                +  G L  L  L L  N+L     +           D+  N+L       L  L 
Sbjct: 68  T--KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLGALRGLG 124

Query: 392 RLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFL 451
            L  LY+ GN+L    P  +     L  LSLA+N L  +       L+++ +L    N L
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184

Query: 452 NGSLPEDIGNLKVVVIIDLSRNNLSGD 478
             ++P+      ++    L  N    +
Sbjct: 185 Y-TIPKGFFGSHLLPFAFLHGNPWLCN 210

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 56.8 bits (135), Expect = 5e-09
 Identities = 54/328 (16%), Positives = 94/328 (28%), Gaps = 27/328 (8%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           L L+   LS ++P+   +L     L    N L  E+P+   +L  L + +     LS   
Sbjct: 43  LELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLP 97

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNK----LTGPIPNNIWQ 117
           P   +   S +          +  L         L K   +  +             + +
Sbjct: 98  PLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPE 157

Query: 118 CKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLN 177
            + L  ++  Y             L+    +              +  L  +      L 
Sbjct: 158 LQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK 217

Query: 178 KLVGFVPTSIFN---LSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIP 234
            L    P+        + +  L     +L+    S      L  L       N  S  I 
Sbjct: 218 TLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIR 277

Query: 235 SFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCK 294
           S       L  L +  N     +P     L +L     S+N L                 
Sbjct: 278 SLCDLPPSLEELNVSNNKLIE-LPALPPRLERL---IASFNHLAEVPELPQ--------- 324

Query: 295 NLKLLDLSNNPINGV--LPSSIGNLSLS 320
           NLK L +  NP+     +P S+ +L ++
Sbjct: 325 NLKQLHVEYNPLREFPDIPESVEDLRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.4 bits (121), Expect = 2e-07
 Identities = 23/94 (24%), Positives = 37/94 (39%), Gaps = 9/94 (9%)

Query: 397 YMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLP 456
               N  S  I        SL  L++++N+L   +P+    L+    L  S N L   +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHLA-EVP 320

Query: 457 EDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQ 490
           E   NLK    + +  N L    P     + +L+
Sbjct: 321 ELPQNLKQ---LHVEYNPLRE-FPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.4 bits (116), Expect = 9e-07
 Identities = 21/103 (20%), Positives = 40/103 (38%), Gaps = 10/103 (9%)

Query: 434 TFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLS 493
            F  L ++    +  N  +  +         +  +++S N L  ++P        L+ L 
Sbjct: 255 IFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLI 310

Query: 494 LRDNGLQGSIPKSIGGLVSLESLDLSNNSLSG--NIPTSMEKL 534
              N L   +P+      +L+ L +  N L    +IP S+E L
Sbjct: 311 ASFNHLA-EVPELPQ---NLKQLHVEYNPLREFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 48.7 bits (114), Expect = 2e-06
 Identities = 22/83 (26%), Positives = 37/83 (44%), Gaps = 9/83 (10%)

Query: 470 LSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPT 529
              N  S +I +      +L++L++ +N L   +P        LE L  S N L+  +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPE 321

Query: 530 SMEKLLYLKDLNLSFNKLEGEIP 552
             + L   K L++ +N L  E P
Sbjct: 322 LPQNL---KQLHVEYNPLR-EFP 340

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.5 bits (111), Expect = 4e-06
 Identities = 22/102 (21%), Positives = 40/102 (39%), Gaps = 10/102 (9%)

Query: 269 WLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISN 328
              L  N    + S     S      +L+ L++SNN +   LP+        L R+  S 
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR----LERLIASF 313

Query: 329 CSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQ 370
             +   +P+      NL++L +  N L    P     +++L+
Sbjct: 314 NHL-AEVPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.4 bits (108), Expect = 8e-06
 Identities = 23/96 (23%), Positives = 38/96 (39%), Gaps = 10/96 (10%)

Query: 350 LWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPP 409
            + N     I        +L+ L++ NNKL   +P       RL  L    N L+  +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERLIASFNHLAE-VPE 321

Query: 410 CIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLN 445
                 +L+ L +  N L    P    +++D L +N
Sbjct: 322 LPQ---NLKQLHVEYNPLRE-FPDIPESVED-LRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 44.0 bits (102), Expect = 5e-05
 Identities = 54/333 (16%), Positives = 96/333 (28%), Gaps = 30/333 (9%)

Query: 196 LALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSG 255
           L L +  LS SLP        P+LE +  + N+ +  +P    +   L V      + S 
Sbjct: 43  LELNNLGLS-SLPELP-----PHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSD 95

Query: 256 FIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIG 315
             P           L        SS  ++  + + +  K   L         G       
Sbjct: 96  LPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEEL 155

Query: 316 NLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQN------- 368
               +L  +                 L     +                 L         
Sbjct: 156 PELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNL 215

Query: 369 -LQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNEL 427
                DL  +     + +            +    +S  I   + +L        AS+  
Sbjct: 216 LKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNE 275

Query: 428 NSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLM 487
              +     +L+    LN S+N L   LP     L+    +  S N+L+ ++P       
Sbjct: 276 IRSLCDLPPSLE---ELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVPELPQ--- 324

Query: 488 NLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSN 520
           NL+ L +  N L+   P       S+E L +++
Sbjct: 325 NLKQLHVEYNPLR-EFPDIPE---SVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 43.3 bits (100), Expect = 8e-05
 Identities = 25/108 (23%), Positives = 38/108 (35%), Gaps = 10/108 (9%)

Query: 113 NNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEIL 172
           N      EL       N  +  I        SL+ L +  N L  E+P     L  L   
Sbjct: 254 NIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLIAS 312

Query: 173 GLQLNKLVGFVPTSIFNLSAMKTLALPSNALSG--SLPSSIDLVRLPN 218
              L ++    P    NL   K L +  N L     +P S++ +R+ +
Sbjct: 313 FNHLAEV----PELPQNL---KQLHVEYNPLREFPDIPESVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.0 bits (89), Expect = 0.002
 Identities = 20/62 (32%), Positives = 29/62 (46%), Gaps = 8/62 (12%)

Query: 488 NLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKL 547
              +L L + GL  S+P+       LESL  S NSL+  +P   +    LK L +  N L
Sbjct: 39  QAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQS---LKSLLVDNNNL 90

Query: 548 EG 549
           + 
Sbjct: 91  KA 92

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.5 bits (132), Expect = 7e-09
 Identities = 41/289 (14%), Positives = 92/289 (31%), Gaps = 32/289 (11%)

Query: 246 LELGENSFSGFIPNTLGNL--RKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSN 303
           L+L   +     P+  G L  + +   R   +F+         L+   +   ++ +DLSN
Sbjct: 5   LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQP------LAEHFSPFRVQHMDLSN 55

Query: 304 NPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITF 363
           + I       I +    L  + +    +   I   +    NL  L L G           
Sbjct: 56  SVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC---------- 105

Query: 364 GKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLA 423
                  G      +      + L +L            +   +      +T L L    
Sbjct: 106 ------SGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR 159

Query: 424 SNELNSVIPSTFWNLKDILSLNFSSNFL-NGSLPEDIGNLKVVVIIDLSR-NNLSGDIPT 481
            N   S + +      +++ L+ S + +      ++   L  +  + LSR  ++  +   
Sbjct: 160 KNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLL 219

Query: 482 AIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTS 530
            +G +  L+ L +      G++        +L  L ++ +  +     +
Sbjct: 220 ELGEIPTLKTLQVFGIVPDGTLQLLKE---ALPHLQINCSHFTTIARPT 265

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.5 bits (132), Expect = 8e-09
 Identities = 37/291 (12%), Positives = 76/291 (26%), Gaps = 22/291 (7%)

Query: 71  LSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQ 130
           L   +D +  +L   +   +  +  +        + +  P+  +      +  + L+ + 
Sbjct: 1   LWQTLDLTGKNLHPDVTGRLLSQGVIA--FRCPRSFMDQPLAEHF-SPFRVQHMDLSNSV 57

Query: 131 FT-ERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSI-- 187
                +   L   + L+ L L    L+  I   +    NL  L L               
Sbjct: 58  IEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL 117

Query: 188 ---FNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNN--FSGIIPSFIFNASK 242
                L  +               +   +        +S    N   S +        + 
Sbjct: 118 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 177

Query: 243 LSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLS 302
           + +                  L  L+ L LS  +     +    L        LK L + 
Sbjct: 178 VHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPET----LLELGEIPTLKTLQVF 233

Query: 303 NNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGN 353
                 V   ++  L  +L  + I+           IG   N +   +WG 
Sbjct: 234 GI----VPDGTLQLLKEALPHLQINCSHFTTIARPTIG---NKKNQEIWGI 277

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.4 bits (124), Expect = 8e-08
 Identities = 44/265 (16%), Positives = 83/265 (31%), Gaps = 17/265 (6%)

Query: 299 LDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNEL-IG 357
           LDL+   +    P   G L       F    S       E  +   ++ + L  + + + 
Sbjct: 5   LDLTGKNL---HPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61

Query: 358 SIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDG--NKLSGPIPPCIGDLT 415
           ++     +   LQ L L   +L  PI N L + + L  L + G        +   +   +
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121

Query: 416 SLRLLSLASNELNS-------VIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVII 468
            L  L+L+     +       V   +    +  LS    +   +           +V + 
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181

Query: 469 DLSRNNLSGDIPTAIGGLMNLQDLSLRD-NGLQGSIPKSIGGLVSLESLDLSNNSLSGNI 527
                 L  D       L  LQ LSL     +       +G + +L++L +      G +
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241

Query: 528 PTSMEKLLYLKDLNLSFNKLEGEIP 552
               E    L  L ++ +       
Sbjct: 242 QLLKEA---LPHLQINCSHFTTIAR 263

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.2 bits (113), Expect = 2e-06
 Identities = 36/298 (12%), Positives = 84/298 (28%), Gaps = 29/298 (9%)

Query: 24  KKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLT 83
           + L L    L  ++   L +   +       +F+   +    F+   +   MD SN+ + 
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQGVIAF-RCPRSFMDQPLAEH-FSPFRVQH-MDLSNSVIE 59

Query: 84  GSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLT 143
            S    +  +   ++ L +   +L+ PI N + +   L+ ++L+               +
Sbjct: 60  VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119

Query: 144 SLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNAL 203
             +   L  +         +          +    L G+      +              
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKS-------------- 165

Query: 204 SGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLEL-GENSFSGFIPNTLG 262
                S++       + +                F  + L  L L             LG
Sbjct: 166 ---DLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELG 222

Query: 263 NLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLS 320
            +  L+ L++       +   L         + L  L ++ +    +   +IGN    
Sbjct: 223 EIPTLKTLQVFGIVPDGTLQLLK--------EALPHLQINCSHFTTIARPTIGNKKNQ 272

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.0 bits (123), Expect = 5e-08
 Identities = 41/232 (17%), Positives = 79/232 (34%), Gaps = 25/232 (10%)

Query: 303 NNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPIT 362
              IN + P     L+ +  +I     ++  T+ +   +L  +  L  +G   + +I   
Sbjct: 6   PTAINVIFPDP--ALA-NAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTG-VTTIE-G 58

Query: 363 FGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSL 422
              L NL GL+L +N++    P           L  +  K    I       T     + 
Sbjct: 59  VQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQ 118

Query: 423 ASNELNSVIPSTFWNLKDILSLNFSSNFL--------------NGSLPEDIGNLKVVVII 468
            ++       S    L   L+   + + L                S    + NL  +  +
Sbjct: 119 ITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTL 178

Query: 469 DLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSN 520
               N +S   P  +  L NL ++ L++N +    P  +    +L  + L+N
Sbjct: 179 KADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.2 bits (108), Expect = 5e-06
 Identities = 30/222 (13%), Positives = 68/222 (30%), Gaps = 26/222 (11%)

Query: 239 NASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKL 298
             +    +  G+++ +  +  T  +L  +  L      +T+       +       NL  
Sbjct: 17  ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-------IEGVQYLNNLIG 67

Query: 299 LDLSNNPINGVLPSS-------------IGNLSLSLSRIFISNCSIRGTIPKEIGNLINL 345
           L+L +N I  + P                     +++ +         +        +  
Sbjct: 68  LELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127

Query: 346 RELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSG 405
                     +  I              L     +      L  L++L+ L  D NK+S 
Sbjct: 128 LSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187

Query: 406 PIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFS 447
             P  +  L +L  + L +N+++ V P    N  ++  +  +
Sbjct: 188 ISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.0 bits (105), Expect = 1e-05
 Identities = 31/218 (14%), Positives = 70/218 (32%), Gaps = 18/218 (8%)

Query: 189 NLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLEL 248
            L+    +A   + ++ ++  +     L  +  +S  G   + I    +   + L  LEL
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA----DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLEL 70

Query: 249 GENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPING 308
            +N  +   P           L  +     S+ + L  + +                ++ 
Sbjct: 71  KDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130

Query: 309 VLPSSIGNLSLSLSRIFI--------SNCSIRGTIPKEIGNLINLRELGLWGNELIGSIP 360
           +    +    ++              S  + + +    + NL  L  L    N++    P
Sbjct: 131 LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP 190

Query: 361 ITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYM 398
                L NL  + L NN++    P  L   + L ++ +
Sbjct: 191 --LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.9 bits (102), Expect = 3e-05
 Identities = 31/219 (14%), Positives = 65/219 (29%), Gaps = 17/219 (7%)

Query: 216 LPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYN 275
           L N   I+   +N +  +     +   ++ L       +      +  L  L  L L  N
Sbjct: 18  LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73

Query: 276 FLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGT- 334
            +T      +         +   L   +         ++   S  ++ +           
Sbjct: 74  QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133

Query: 335 -------IPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGL 387
                  I              L       S       L  L  L   +NK+    P  L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191

Query: 388 CQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNE 426
             L  L  +++  N++S   P  + + ++L +++L +N+
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL-TNQ 227

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.9 bits (102), Expect = 3e-05
 Identities = 42/222 (18%), Positives = 75/222 (33%), Gaps = 26/222 (11%)

Query: 119 KELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNK 178
              I I+   +  T+ +     +L  + TL      +T  I   +  L NL  L L+ N+
Sbjct: 19  ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQ 74

Query: 179 LVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGI------ 232
           +    P           L+        ++     +  L             +G+      
Sbjct: 75  ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134

Query: 233 ------IPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSF 286
                 I +    A   ++  L   +        L NL KL  L+   N ++        
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD------- 187

Query: 287 LSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISN 328
           +S  A+  NL  + L NN I+ V P  + N S +L  + ++N
Sbjct: 188 ISPLASLPNLIEVHLKNNQISDVSP--LANTS-NLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.3 bits (98), Expect = 1e-04
 Identities = 16/74 (21%), Positives = 31/74 (41%), Gaps = 4/74 (5%)

Query: 101 YMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIP 160
           Y+S           +    +L  +    N+ ++  P  L +L +L  ++L  N ++   P
Sbjct: 155 YLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212

Query: 161 YEMGNLRNLEILGL 174
             + N  NL I+ L
Sbjct: 213 --LANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 37/222 (16%), Positives = 73/222 (32%), Gaps = 20/222 (9%)

Query: 341 NLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDG 400
            L N  ++    + +     +T   L  +  L      +      G+  L  L  L +  
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 401 NKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIG 460
           N+++   P       +   LS    +  S I          L+    ++    +   ++ 
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 461 NLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSN 520
            L + +    + + L+G        + N Q           S    +  L  L +L   +
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQV----------SDLTPLANLSKLTTLKADD 182

Query: 521 NSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSN 562
           N +S   P  +  L  L +++L  N++        P AN SN
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVS----PLANTSN 218

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.3 bits (85), Expect = 0.004
 Identities = 31/209 (14%), Positives = 67/209 (32%), Gaps = 20/209 (9%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
           ++   ++++  + +   +L  +  L      +     + +  L  L  + L +N ++   
Sbjct: 24  IAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLA 79

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGP----------- 110
           P       +          +++        + L L          L G            
Sbjct: 80  PLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLN 139

Query: 111 -IPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNL 169
            I N         +  L+           L NL+ L TL    N ++   P  + +L NL
Sbjct: 140 QITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNL 197

Query: 170 EILGLQLNKLVGFVPTSIFNLSAMKTLAL 198
             + L+ N++    P  + N S +  + L
Sbjct: 198 IEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.3 bits (85), Expect = 0.004
 Identities = 43/230 (18%), Positives = 80/230 (34%), Gaps = 22/230 (9%)

Query: 19  NLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFS 78
            L    K+  G + +   + Q   +L  +  +S     ++      +  L++L  G++  
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNL-IGLELK 71

Query: 79  NNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRG 138
           +N +T   P     ++  ++        ++        +  +                  
Sbjct: 72  DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLD-------LTSTQITDVTP 124

Query: 139 LGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLAL 198
           L  L++L+ LYL  N +T   P               +        T + NLS + TL  
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQYL----SIGNAQVSDLTPLANLSKLTTLKA 180

Query: 199 PSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLEL 248
             N +S   P    L  LPNL  + L  N  S + P  + N S L ++ L
Sbjct: 181 DDNKISDISP----LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 51.0 bits (120), Expect = 9e-08
 Identities = 43/180 (23%), Positives = 71/180 (39%), Gaps = 10/180 (5%)

Query: 50  VSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTG 109
           V  T   L   IP    ++   +T +  ++N L     D +  RLP +  L +  N+LTG
Sbjct: 13  VDCTGRGLK-EIPR---DIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG 68

Query: 110 PIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNL 169
             PN       +  + L  N+  E   +    L  LKTL L  N ++  +P    +L +L
Sbjct: 69  IEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSL 128

Query: 170 EILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNF 229
             L L  N        + F    ++  +L   A     PS      + +++I  L  + F
Sbjct: 129 TSLNLASNPFNCNCHLAWF-AEWLRKKSLNGGAARCGAPSK-----VRDVQIKDLPHSEF 182

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 48.3 bits (113), Expect = 7e-07
 Identities = 30/166 (18%), Positives = 59/166 (35%), Gaps = 4/166 (2%)

Query: 295 NLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNE 354
           +   L L++N +  +    +      L ++ +    + G  P       +++EL L  N+
Sbjct: 30  HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89

Query: 355 LIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDL 414
           +       F  L  L+ L+L +N++   +P     L  L+ L +  N  +          
Sbjct: 90  IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWF-A 148

Query: 415 TSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIG 460
             LR  SL         PS    ++D+   +   +    S     G
Sbjct: 149 EWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEFKCSSENSEG 191

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 39.0 bits (89), Expect = 9e-04
 Identities = 38/189 (20%), Positives = 68/189 (35%), Gaps = 16/189 (8%)

Query: 117 QCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEM-GNLRNLEILGLQ 175
            C+   V         E IPR +        L L  N L       + G L +L  L L+
Sbjct: 7   HCEGTTV-DCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELK 62

Query: 176 LNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPS 235
            N+L G  P +    S ++ L L  N +            L  L+ ++L  N  S ++P 
Sbjct: 63  RNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFL--GLHQLKTLNLYDNQISCVMPG 120

Query: 236 FIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKN 295
              + + L+ L L  N F+            L W        + +        + +  ++
Sbjct: 121 SFEHLNSLTSLNLASNPFNCNCH--------LAWFAEWLRKKSLNGGAAR-CGAPSKVRD 171

Query: 296 LKLLDLSNN 304
           +++ DL ++
Sbjct: 172 VQIKDLPHS 180

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 52.2 bits (123), Expect = 1e-07
 Identities = 39/324 (12%), Positives = 88/324 (27%), Gaps = 18/324 (5%)

Query: 236 FIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKN 295
           F      L +  +        +   L     ++ + LS N + +  +      + A+ K+
Sbjct: 3   FSIEGKSLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAAR-WLSENIASKKD 60

Query: 296 LKLLDLSNNPINGVLPSSIGNLSLSLSRIFISN---CSIRGTIPKEIGNLINLRELGLWG 352
           L++ + S+      +   I      L +  +      ++R +               L  
Sbjct: 61  LEIAEFSDIFTG-RVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 119

Query: 353 NELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIG 412
           +  +  + +    L    G  +     E  +         L  +    N+L         
Sbjct: 120 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 179

Query: 413 DLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSR 472
                     +   L++V         + +              + +           S 
Sbjct: 180 KTFQ------SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS 233

Query: 473 NNLSGDIPTAIGGLMNLQDLSLRDNGLQGSI-PKSIGGLVSLESLDLSNNSLSGNIPTSM 531
                         + L D  L   G    +   S    + L++L L  N +  +   ++
Sbjct: 234 ALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTL 293

Query: 532 -----EKLLYLKDLNLSFNKLEGE 550
                EK+  L  L L+ N+   E
Sbjct: 294 KTVIDEKMPDLLFLELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 47.6 bits (111), Expect = 4e-06
 Identities = 37/333 (11%), Positives = 85/333 (25%), Gaps = 21/333 (6%)

Query: 2   LSLSFNDLSG----AIPKEIGNLTMLKKLGLGYNKLRGE----IPQELGNLAELELVSLT 53
            SL  + ++     ++   +     +K++ L  N +  E    + + + +  +LE+   +
Sbjct: 8   KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67

Query: 54  NNF---LSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGP 110
           + F   +   IP  +  L      +            +            ++S +     
Sbjct: 68  DIFTGRVKDEIPEALRLLLQAL--LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEH 125

Query: 111 IPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLE 170
           +  +           +A       + +   N   L+++  G N L      E        
Sbjct: 126 LYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSH 185

Query: 171 ILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFS 230
            L   +  +   +         ++ LA         L               S       
Sbjct: 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQE-----LKVLDLQDNTFTHLGSSALAIALK 240

Query: 231 GIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSW 290
                     +   +   G  +              L+ LRL YN +             
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSK--LENIGLQTLRLQYNEIELDAVRTLKTVID 298

Query: 291 ANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSR 323
               +L  L+L+ N         +  +    S 
Sbjct: 299 EKMPDLLFLELNGNRF-SEEDDVVDEIREVFST 330

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.1 bits (89), Expect = 0.002
 Identities = 46/333 (13%), Positives = 100/333 (30%), Gaps = 32/333 (9%)

Query: 117 QCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMG-------NLRNL 169
           + K L + ++        +   L    S+K + L  N +  E    +        +L   
Sbjct: 6   EGKSLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64

Query: 170 EILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNF 229
           E   +   ++   +P ++  L          + +  S  +     + P ++ +S      
Sbjct: 65  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124

Query: 230 SGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSS 289
              + +        + +          +     N   L  +    N L + + +     +
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQEL--AVNKKAKNAPPLRSIICGRNRLENGSMKEWA-KT 181

Query: 290 WANCKNLKLLDLSNNPINGVLPS--------SIGNLSLSLSRIFISNCSIRGTIPKEIGN 341
           + + + L  + +  N I                  L +   +           +   + +
Sbjct: 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241

Query: 342 LINLRELGLWGNELIGSIP------ITFGKLQNLQGLDLVNNKLEGPIPNGLCQ-----L 390
             NLRELGL    L            +  +   LQ L L  N++E      L       +
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301

Query: 391 ARLSVLYMDGNKLS--GPIPPCIGDLTSLRLLS 421
             L  L ++GN+ S    +   I ++ S R   
Sbjct: 302 PDLLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.9 bits (122), Expect = 2e-07
 Identities = 18/86 (20%), Positives = 32/86 (37%), Gaps = 10/86 (11%)

Query: 468 IDLSRNNLS-GDIPTAIGGLMNLQDLSLRDNGLQG----SIPKSIGGLVSLESLDLSNNS 522
           +D+    LS       +  L   Q + L D GL       I  ++    +L  L+L +N 
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 523 LSGNIPTSMEKLL-----YLKDLNLS 543
           L       + + L      ++ L+L 
Sbjct: 67  LGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.6 bits (116), Expect = 1e-06
 Identities = 19/97 (19%), Positives = 29/97 (29%), Gaps = 4/97 (4%)

Query: 234 PSFIFNASKLSVLELGENSFSG----FIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSS 289
                  S L VL L +   S      +  TL     L  L LS N L  +       S 
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 290 WANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFI 326
                 L+ L L +   +  +   +  L      + +
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRV 458

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (111), Expect = 5e-06
 Identities = 18/94 (19%), Positives = 36/94 (38%), Gaps = 9/94 (9%)

Query: 263 NLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPING----VLPSSIGNLS 318
               L  L L+   ++ S+   S  ++     +L+ LDLSNN +       L  S+    
Sbjct: 367 PGSVLRVLWLADCDVSDSSCS-SLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425

Query: 319 LSLSRIFISNCSIRGTIPKEIGNLI----NLREL 348
             L ++ + +      +   +  L     +LR +
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.3 bits (110), Expect = 6e-06
 Identities = 16/100 (16%), Positives = 32/100 (32%), Gaps = 5/100 (5%)

Query: 343 INLRELGLWGNELIGS-IPITFGKLQNLQGLDLVNNKLEG----PIPNGLCQLARLSVLY 397
           ++++ L +   EL  +        LQ  Q + L +  L       I + L     L+ L 
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 398 MDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWN 437
           +  N+L      C+          +    L +   +    
Sbjct: 62  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 101

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 1e-05
 Identities = 15/81 (18%), Positives = 32/81 (39%), Gaps = 9/81 (11%)

Query: 467 IIDLSRNNLSGD----IPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLV-----SLESLD 517
           ++ L+  ++S      +   +    +L++L L +N L  +    +   V      LE L 
Sbjct: 373 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 432

Query: 518 LSNNSLSGNIPTSMEKLLYLK 538
           L +   S  +   ++ L   K
Sbjct: 433 LYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 1e-05
 Identities = 21/97 (21%), Positives = 36/97 (37%), Gaps = 5/97 (5%)

Query: 440 DILSLNFSSNFLNGS-LPEDIGNLKVVVIIDLSRNNLSGD----IPTAIGGLMNLQDLSL 494
           DI SL+     L+ +   E +  L+   ++ L    L+      I +A+     L +L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 495 RDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSM 531
           R N L       +   +   S  +   SL     T  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 99

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 1e-05
 Identities = 13/72 (18%), Positives = 31/72 (43%), Gaps = 5/72 (6%)

Query: 487 MNLQDLSLRDNGLQGS-IPKSIGGLVSLESLDLSNNSLSG----NIPTSMEKLLYLKDLN 541
           +++Q L ++   L  +   + +  L   + + L +  L+     +I +++     L +LN
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 542 LSFNKLEGEIPR 553
           L  N+L      
Sbjct: 62  LRSNELGDVGVH 73

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 3e-05
 Identities = 16/118 (13%), Positives = 35/118 (29%), Gaps = 5/118 (4%)

Query: 218 NLEIISLAGNNFSGI-IPSFIFNASKLSVLELGENSFSG----FIPNTLGNLRKLEWLRL 272
           +++ + +     S       +    +  V+ L +   +      I + L     L  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 273 SYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCS 330
             N L                  ++ L L N  + G     + +   +L  +   + S
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 120

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 3e-05
 Identities = 18/76 (23%), Positives = 28/76 (36%), Gaps = 9/76 (11%)

Query: 487 MNLQDLSLRDNGLQG----SIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLL-----YL 537
             L+ L L D  +      S+  ++    SL  LDLSNN L       + + +      L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 538 KDLNLSFNKLEGEIPR 553
           + L L       E+  
Sbjct: 429 EQLVLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 5e-05
 Identities = 17/89 (19%), Positives = 30/89 (33%), Gaps = 10/89 (11%)

Query: 97  IKGLYMSNNKLTGPIPNNIW-QCKELIVISLAYNQFTER----IPRGLGNLTSLKTLYLG 151
           I+ L +   +L+      +    ++  V+ L     TE     I   L    +L  L L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 152 FNNLTGEIPYEMG-----NLRNLEILGLQ 175
            N L     + +          ++ L LQ
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 5e-05
 Identities = 17/92 (18%), Positives = 34/92 (36%), Gaps = 9/92 (9%)

Query: 295 NLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLI----NLRELGL 350
           +++ LD+    ++    + +  L      + + +C +     K+I + +     L EL L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 351 WGNELIGSIPITFGKL-----QNLQGLDLVNN 377
             NEL         +        +Q L L N 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (101), Expect = 7e-05
 Identities = 13/97 (13%), Positives = 32/97 (32%), Gaps = 13/97 (13%)

Query: 67  NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTG----PIPNNIWQCKELI 122
           ++ SL    D     L+ +   ++   L   + + + +  LT      I + +     L 
Sbjct: 3   DIQSL----DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA 58

Query: 123 VISLAYNQFTERIPRGLG-----NLTSLKTLYLGFNN 154
            ++L  N+  +     +          ++ L L    
Sbjct: 59  ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 1e-04
 Identities = 23/94 (24%), Positives = 34/94 (36%), Gaps = 13/94 (13%)

Query: 341 NLINLRELGLWGNEL----IGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLAR---- 392
               LR L L   ++      S+  T     +L+ LDL NN L       L +  R    
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 393 -LSVLYMDGNKLSGPIPPCIGDL----TSLRLLS 421
            L  L +     S  +   +  L     SLR++S
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 18/118 (15%), Positives = 32/118 (27%), Gaps = 25/118 (21%)

Query: 112 PNNIWQCKELIVISLAYNQFT----ERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLR 167
                    L V+ LA    +      +   L    SL+ L L  N L      ++    
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE-- 419

Query: 168 NLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSID--LVRLPNLEIIS 223
                 ++                 ++ L L     S  +   +       P+L +IS
Sbjct: 420 -----SVRQPG------------CLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (97), Expect = 2e-04
 Identities = 16/106 (15%), Positives = 31/106 (29%), Gaps = 15/106 (14%)

Query: 428 NSVIPSTFWNLKDILSLNFSSNFLNG----SLPEDIGNLKVVVIIDLSRNNLSGDIPTAI 483
             +          +  L  +   ++     SL   +     +  +DLS N L       +
Sbjct: 358 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL 417

Query: 484 GGLM-----NLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLS 524
              +      L+ L L D      +         L++L+    SL 
Sbjct: 418 VESVRQPGCLLEQLVLYDIYWSEEMED------RLQALEKDKPSLR 457

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 3e-04
 Identities = 19/85 (22%), Positives = 33/85 (38%), Gaps = 7/85 (8%)

Query: 189 NLSAMKTLALPSNALSGSLPSSI--DLVRLPNLEIISLAGNNFSG-----IIPSFIFNAS 241
             S ++ L L    +S S  SS+   L+   +L  + L+ N         ++ S      
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 242 KLSVLELGENSFSGFIPNTLGNLRK 266
            L  L L +  +S  + + L  L K
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEK 451

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 0.001
 Identities = 13/91 (14%), Positives = 28/91 (30%), Gaps = 5/91 (5%)

Query: 120 ELIVISLAYNQFT-ERIPRGLGNLTSLKTLYLGFNNLTGE----IPYEMGNLRNLEILGL 174
           ++  + +   + +  R    L  L   + + L    LT      I   +     L  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 175 QLNKLVGFVPTSIFNLSAMKTLALPSNALSG 205
           + N+L       +       +  +   +L  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.2 bits (110), Expect = 3e-06
 Identities = 38/243 (15%), Positives = 65/243 (26%), Gaps = 14/243 (5%)

Query: 72  STGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQF 131
           +       + +T  +P D+ R       L     KL            +L  I ++ N  
Sbjct: 10  NRVFLCQESKVT-EIPSDLPRNA---IELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65

Query: 132 TERIPRGLGNLTSLKTLYLGF--NNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFN 189
            E I   + +             NNL    P    NL NL+ L +    +         +
Sbjct: 66  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125

Query: 190 LSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELG 249
                 L +  N    ++  +  +       I+ L  N    I            +    
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185

Query: 250 ENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGV 309
            N+      +          L +S   + S  S         N K L+     N      
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSY-----GLENLKKLRARSTYN---LKK 237

Query: 310 LPS 312
           LP+
Sbjct: 238 LPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.5 bits (103), Expect = 2e-05
 Identities = 32/224 (14%), Positives = 58/224 (25%), Gaps = 7/224 (3%)

Query: 233 IPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWAN 292
           IPS +        L                    LE + +S N +        F +    
Sbjct: 23  IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80

Query: 293 CKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWG 352
            +     + +NN +     +     +L    I  +       + K       L ++    
Sbjct: 81  HEIRI--EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI 138

Query: 353 NELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIG 412
           N          G       L L  N ++              +   D N L         
Sbjct: 139 NIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFH 198

Query: 413 DLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLP 456
             +   +L ++   ++S+      NLK    L   S +    LP
Sbjct: 199 GASGPVILDISRTRIHSLPSYGLENLK---KLRARSTYNLKKLP 239

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 8e-05
 Identities = 35/236 (14%), Positives = 68/236 (28%), Gaps = 9/236 (3%)

Query: 144 SLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNAL 203
           S +      + +T EIP ++   RN   L   L KL      +      ++ + +  N +
Sbjct: 9   SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65

Query: 204 SGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGN 263
              + + +        EI     NN   I P    N   L  L +              +
Sbjct: 66  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125

Query: 264 LRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSR 323
             +   L +  N    +    SF+        L L       I+    +           
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLD-----E 180

Query: 324 IFISNCSIRGTIPKEI-GNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNK 378
           + +S+ +    +P ++         L +    +          L+ L+     N K
Sbjct: 181 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.4 bits (95), Expect = 2e-04
 Identities = 33/225 (14%), Positives = 62/225 (27%), Gaps = 8/225 (3%)

Query: 328 NCSIRG--TIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPN 385
            C       IP ++    N  EL     +L       F    +L+ +++  N +   I  
Sbjct: 14  LCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 71

Query: 386 GLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELN----SVIPSTFWNLKDI 441
            +                +              L  L  +         +       K +
Sbjct: 72  DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL 131

Query: 442 LSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQG 501
           L +  + N         +G     VI+ L++N +      A  G    +     +N L+ 
Sbjct: 132 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEE 191

Query: 502 SIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNK 546
                  G      LD+S   +       +E L  L+  +    K
Sbjct: 192 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.9 bits (91), Expect = 7e-04
 Identities = 34/246 (13%), Positives = 74/246 (30%), Gaps = 13/246 (5%)

Query: 87  PDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLK 146
              +C      +      +K+T  IP+++   +  I +     +              L+
Sbjct: 2   HHRICHCSN--RVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLE 56

Query: 147 TLYLGFNNLTGEIPYEMGNLRNLEILGLQL--NKLVGFVPTSIFNLSAMKTLALPSNALS 204
            + +  N++   I  ++ +             N L+   P +  NL  ++ L + +  + 
Sbjct: 57  KIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK 116

Query: 205 GSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNL 264
                         L  I    N  +    SF+  + +  +L L +N             
Sbjct: 117 HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGT 176

Query: 265 RKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRI 324
           +  E      N L    ++      +       +LD+S   I+ +    + NL   L   
Sbjct: 177 QLDELNLSDNNNLEELPND-----VFHGASGPVILDISRTRIHSLPSYGLENLK-KLRAR 230

Query: 325 FISNCS 330
              N  
Sbjct: 231 STYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.1 bits (89), Expect = 0.001
 Identities = 31/221 (14%), Positives = 59/221 (26%), Gaps = 6/221 (2%)

Query: 206 SLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLR 265
            +PS +      N   +         I          L  +E+ +N     I        
Sbjct: 22  EIPSDL----PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD--VFS 75

Query: 266 KLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIF 325
            L  L        ++   ++  +         LL  +    +      I +L   L  I 
Sbjct: 76  NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQ 135

Query: 326 ISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPN 385
            +           +G       L L  N +       F   Q  +     NN LE    +
Sbjct: 136 DNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPND 195

Query: 386 GLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNE 426
                +   +L +   ++       + +L  LR  S  + +
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (88), Expect = 0.002
 Identities = 33/227 (14%), Positives = 68/227 (29%), Gaps = 9/227 (3%)

Query: 50  VSLTNNFLSGTIPSTIF-NLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLT 108
                + ++  IPS +  N   L     F    L   +          ++ + +S N + 
Sbjct: 13  FLCQESKVT-EIPSDLPRNAIEL----RFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVL 66

Query: 109 GPIPNNIWQCKELIVISLAY--NQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNL 166
             I  +++     +        N      P    NL +L+ L +    +         + 
Sbjct: 67  EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS 126

Query: 167 RNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAG 226
               +L +Q N  +  +  + F   + +++ L  N        +         E+     
Sbjct: 127 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDN 186

Query: 227 NNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLS 273
           NN   +       AS   +L++            L NL+KL      
Sbjct: 187 NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (88), Expect = 0.002
 Identities = 31/245 (12%), Positives = 69/245 (28%), Gaps = 41/245 (16%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
                + ++  IP ++       +L     KLR           +LE + ++ N +   I
Sbjct: 13  FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
            + +F+       +     +    +  +  + LP ++ L +SN  +      +     + 
Sbjct: 70  EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129

Query: 122 IV--------------------------ISLAYNQFTERIPRGLGNLTSLKTLYLGFNNL 155
           ++                          + L  N   E            +      NNL
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189

Query: 156 TGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVR 215
                          IL +   ++       + NL  ++  +  +            L +
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN------------LKK 237

Query: 216 LPNLE 220
           LP LE
Sbjct: 238 LPTLE 242

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (85), Expect = 0.004
 Identities = 26/205 (12%), Positives = 55/205 (26%), Gaps = 3/205 (1%)

Query: 294 KNLKLLDLSNNPINGVLPSSIGNLS--LSLSRIFISNCSIRGTIPKEIGNLINLRELGLW 351
           +N   L      +  +   +         +         +           ++   +   
Sbjct: 29  RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88

Query: 352 GNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCI 411
            N L  +             L         P  + +  L ++ +   D   +        
Sbjct: 89  NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 148

Query: 412 GDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDI-GNLKVVVIIDL 470
             L+   ++   +      I +  +N   +  LN S N     LP D+       VI+D+
Sbjct: 149 VGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 208

Query: 471 SRNNLSGDIPTAIGGLMNLQDLSLR 495
           SR  +       +  L  L+  S  
Sbjct: 209 SRTRIHSLPSYGLENLKKLRARSTY 233

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.5 bits (109), Expect = 3e-06
 Identities = 39/219 (17%), Positives = 65/219 (29%), Gaps = 27/219 (12%)

Query: 101 YMSNNKLTGPIPNNIW----QCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLT 156
            + +  +T P P           E I  +L     T+ +      L S+  +    +++ 
Sbjct: 2   PLGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 59

Query: 157 GEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRL 216
                 +  L N+  L L  NKL    P +         L         SL     L  L
Sbjct: 60  SVQG--IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSL 117

Query: 217 PNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNT------------LGNL 264
                     N    +            + ++   S    +               L  L
Sbjct: 118 SLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGL 177

Query: 265 RKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSN 303
            KL+ L LS N ++        L + A  KNL +L+L +
Sbjct: 178 TKLQNLYLSKNHISD-------LRALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.2 bits (103), Expect = 2e-05
 Identities = 35/216 (16%), Positives = 70/216 (32%), Gaps = 19/216 (8%)

Query: 305 PINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFG 364
           PI  +        +    +  +   S+   + +    L ++ ++    +++     I + 
Sbjct: 13  PIKQIFSDD--AFA-ETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQY- 66

Query: 365 KLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLAS 424
            L N+  L L  NKL    P    +      L  +  K    +       +         
Sbjct: 67  -LPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKS--------- 116

Query: 425 NELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIG 484
             L     S    L  +  L       N      + +    +      +N   DI   + 
Sbjct: 117 LSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLA 175

Query: 485 GLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSN 520
           GL  LQ+L L  N +     +++ GL +L+ L+L +
Sbjct: 176 GLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 4e-05
 Identities = 42/216 (19%), Positives = 78/216 (36%), Gaps = 22/216 (10%)

Query: 334 TIPKEIG------NLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGL 387
           T+P  I             +  L    +  ++     +L ++  +   N+ ++     G+
Sbjct: 9   TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSV--QGI 64

Query: 388 CQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFS 447
             L  ++ L+++GNKL+   P        L  L                +    L    S
Sbjct: 65  QYLPNVTKLFLNGNKLTDIKP--------LANLKNLGWLFLDENKVKDLSSLKDLKKLKS 116

Query: 448 SNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI 507
            +  +  + +  G + +  +  L   N      T +  L  L  LSL DN +   +P  +
Sbjct: 117 LSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--L 174

Query: 508 GGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLS 543
            GL  L++L LS N +S     ++  L  L  L L 
Sbjct: 175 AGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.1 bits (100), Expect = 5e-05
 Identities = 31/210 (14%), Positives = 70/210 (33%), Gaps = 22/210 (10%)

Query: 239 NASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKL 298
             ++     L + S +  +  T   L  ++ +  + + + S       +       N+  
Sbjct: 22  AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-------VQGIQYLPNVTK 72

Query: 299 LDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGS 358
           L L+ N +  + P +      +L  +                  +   +     +  I  
Sbjct: 73  LFLNGNKLTDIKPLA------NLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISD 126

Query: 359 IPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLR 418
           I       Q        N   +  + + L +   L  L ++ N++S  +P  +  LT L+
Sbjct: 127 INGLVHLPQLESLYLGNNKITDITVLSRLTK---LDTLSLEDNQISDIVP--LAGLTKLQ 181

Query: 419 LLSLASNELNSVIPSTFWNLKDILSLNFSS 448
            L L+ N ++ +       LK++  L   S
Sbjct: 182 NLYLSKNHISDL--RALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.5 bits (96), Expect = 2e-04
 Identities = 26/185 (14%), Positives = 58/185 (31%), Gaps = 18/185 (9%)

Query: 2   LSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTI 61
            +L    ++ A+ +    L  + ++    + ++      +  L  +  + L  N L+   
Sbjct: 29  DNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIK 84

Query: 62  PSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKEL 121
           P             +     L+        + L L        N L              
Sbjct: 85  PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNN 144

Query: 122 IVISLAYNQFTERIPR------------GLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNL 169
            +  +       ++               L  LT L+ LYL  N+++ ++   +  L+NL
Sbjct: 145 KITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNL 202

Query: 170 EILGL 174
           ++L L
Sbjct: 203 DVLEL 207

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.6 bits (101), Expect = 1e-05
 Identities = 25/106 (23%), Positives = 39/106 (36%), Gaps = 2/106 (1%)

Query: 468 IDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSI-GGLVSLESLDLSNNSLSGN 526
           +  +R+    D    + G  NL +L + +      +      GL  L +L +  + L   
Sbjct: 13  LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71

Query: 527 IPTSMEKLLYLKDLNLSFNKLEGEIPRGGPFANFSNRSFMGNDLLC 572
            P +      L  LNLSFN LE    +     +       GN L C
Sbjct: 72  APDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.9 bits (94), Expect = 1e-04
 Identities = 26/146 (17%), Positives = 45/146 (30%), Gaps = 4/146 (2%)

Query: 367 QNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPP-CIGDLTSLRLLSLASN 425
               GL    +       + L     L+ LY++  +    +    +  L  LR L++  +
Sbjct: 8   HGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 426 ELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDI-PTAIG 484
            L  V P  F     +  LN S N    SL         +  + LS N L        + 
Sbjct: 67  GLRFVAPDAFHFTPRLSRLNLSFNA-LESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQ 125

Query: 485 GLMNLQDLSLRDNGLQGSIPKSIGGL 510
                    + +  LQ      +  +
Sbjct: 126 RWEEEGLGGVPEQKLQCHGQGPLAHM 151

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (90), Expect = 5e-04
 Identities = 17/144 (11%), Positives = 42/144 (29%), Gaps = 2/144 (1%)

Query: 47  LELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNK 106
              +  T +         +    +  T +   N      L     R L  ++ L +  + 
Sbjct: 10  SSGLRCTRDGAL-DSLHHLPGAEN-LTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67

Query: 107 LTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNL 166
           L    P+       L  ++L++N       + +  L+  + +  G           +   
Sbjct: 68  LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRW 127

Query: 167 RNLEILGLQLNKLVGFVPTSIFNL 190
               + G+   KL       + ++
Sbjct: 128 EEEGLGGVPEQKLQCHGQGPLAHM 151

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (85), Expect = 0.002
 Identities = 23/128 (17%), Positives = 38/128 (29%), Gaps = 7/128 (5%)

Query: 293 CKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWG 352
                 L  + +         +            +   ++    +++  L  LR L +  
Sbjct: 7   PHGSSGLRCTRDGALDS-LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65

Query: 353 NELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIG 412
           + L    P  F     L  L+L  N LE  +     Q   L  L + GN L      C  
Sbjct: 66  SGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH-----CSC 119

Query: 413 DLTSLRLL 420
            L  L+  
Sbjct: 120 ALRWLQRW 127

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.8 bits (100), Expect = 2e-05
 Identities = 24/117 (20%), Positives = 40/117 (34%), Gaps = 10/117 (8%)

Query: 334 TIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARL 393
           T+   +  L+ +  L L  N L    P     L+ L+ L   +N LE           + 
Sbjct: 11  TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVANLPRLQ- 68

Query: 394 SVLYMDGNKL-SGPIPPCIGDLTSLRLLSLASNELNSV------IPSTFWNLKDILS 443
             L +  N+L        +     L LL+L  N L         +     ++  IL+
Sbjct: 69  -ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 124

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.0 bits (98), Expect = 4e-05
 Identities = 25/109 (22%), Positives = 41/109 (37%), Gaps = 6/109 (5%)

Query: 1   MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGT 60
           +L L+  DL+  +   +  L ++  L L +N+LR   P  L  L  LE++  ++N L   
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58

Query: 61  IPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTG 109
                         +   NN L  S         P +  L +  N L  
Sbjct: 59  DGVANLPRLQE---LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 39.7 bits (92), Expect = 2e-04
 Identities = 30/108 (27%), Positives = 42/108 (38%), Gaps = 6/108 (5%)

Query: 444 LNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSI 503
           L+ +   L  ++   +  L +V  +DLS N L    P A+  L  L+ L   DN      
Sbjct: 3   LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--ALEN 57

Query: 504 PKSIGGLVSLESLDLSNNSL-SGNIPTSMEKLLYLKDLNLSFNKLEGE 550
              +  L  L+ L L NN L        +     L  LNL  N L  E
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 39.3 bits (91), Expect = 2e-04
 Identities = 30/121 (24%), Positives = 50/121 (41%), Gaps = 8/121 (6%)

Query: 418 RLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSG 477
           R+L LA  +L          L  +  L+ S N L    P  +  L+ + ++  S N    
Sbjct: 1   RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNA--L 55

Query: 478 DIPTAIGGLMNLQDLSLRDNGLQG-SIPKSIGGLVSLESLDLSNNSLSG--NIPTSMEKL 534
           +    +  L  LQ+L L +N LQ  +  + +     L  L+L  NSL     I   + ++
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

Query: 535 L 535
           L
Sbjct: 116 L 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 39.3 bits (91), Expect = 2e-04
 Identities = 20/113 (17%), Positives = 38/113 (33%), Gaps = 8/113 (7%)

Query: 51  SLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGP 110
            L +  L  T+   +  L  ++  +D S+N L    P        L     +  +     
Sbjct: 4   HLAHKDL--TVLCHLEQLLLVTH-LDLSHNRLRALPPALAA----LRCLEVLQASDNALE 56

Query: 111 IPNNIWQCKELIVISLAYNQFTE-RIPRGLGNLTSLKTLYLGFNNLTGEIPYE 162
             + +     L  + L  N+  +    + L +   L  L L  N+L  E   +
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 109

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 38.9 bits (90), Expect = 3e-04
 Identities = 29/134 (21%), Positives = 51/134 (38%), Gaps = 13/134 (9%)

Query: 194 KTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSF 253
           + L L    L+  L     L +L  +  + L+ N    + P+       L VL+  +N+ 
Sbjct: 1   RVLHLAHKDLT-VLCH---LEQLLLVTHLDLSHNRLRALPPAL-AALRCLEVLQASDNAL 55

Query: 254 SGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGV--LP 311
                    NL +L+ L L  N L       + +    +C  L LL+L  N +     + 
Sbjct: 56  ENVDGVA--NLPRLQELLLCNNRLQQ----SAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 109

Query: 312 SSIGNLSLSLSRIF 325
             +  +  S+S I 
Sbjct: 110 ERLAEMLPSVSSIL 123

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 35.8 bits (82), Expect = 0.004
 Identities = 22/124 (17%), Positives = 39/124 (31%), Gaps = 23/124 (18%)

Query: 245 VLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELS----------------FLS 288
           VL L     +  +   L  L  +  L LS+N L +    L+                 + 
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59

Query: 289 SWANCKNLKLLDLSNNPINGV-LPSSIGNLSLSLSRIFISN---CSIRGTIPKEIGNLIN 344
             AN   L+ L L NN +        + +    L  + +     C   G   +    L +
Sbjct: 60  GVANLPRLQELLLCNNRLQQSAAIQPLVSCP-RLVLLNLQGNSLCQEEGIQERLAEMLPS 118

Query: 345 LREL 348
           +  +
Sbjct: 119 VSSI 122

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.8 bits (97), Expect = 7e-05
 Identities = 26/144 (18%), Positives = 47/144 (32%), Gaps = 12/144 (8%)

Query: 233 IPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWAN 292
              +  NA +   L+L        I N    L + + +  S N       E+  L  +  
Sbjct: 11  AAQYT-NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN-------EIRKLDGFPL 61

Query: 293 CKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWG 352
            + LK L ++NN I  +       L      I  +N  +       + +L +L  L +  
Sbjct: 62  LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILR 121

Query: 353 ---NELIGSIPITFGKLQNLQGLD 373
                          K+  ++ LD
Sbjct: 122 NPVTNKKHYRLYVIYKVPQVRVLD 145

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (96), Expect = 8e-05
 Identities = 23/96 (23%), Positives = 36/96 (37%), Gaps = 3/96 (3%)

Query: 341 NLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDG 400
           N +  REL L G + I  I      L     +D  +N++     +G   L RL  L ++ 
Sbjct: 16  NAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNN 72

Query: 401 NKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFW 436
           N++          L  L  L L +N L  +      
Sbjct: 73  NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPL 108

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (88), Expect = 0.001
 Identities = 16/97 (16%), Positives = 32/97 (32%), Gaps = 3/97 (3%)

Query: 486 LMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFN 545
            +  ++L LR   +   I      L   +++D S+N +          L  LK L ++ N
Sbjct: 17  AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNN 73

Query: 546 KLEGEIPRGGPFANFSNRSFMGNDLLCGLAQVQVPVC 582
           ++                  + N+ L  L  +     
Sbjct: 74  RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLAS 110

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (86), Expect = 0.002
 Identities = 25/143 (17%), Positives = 49/143 (34%), Gaps = 8/143 (5%)

Query: 354 ELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGD 413
           ELI      +      + LDL   K+   I N    L +   +    N++          
Sbjct: 6   ELIEQAA-QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI--RKLDGFPL 61

Query: 414 LTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNG-SLPEDIGNLKVVVIIDLS- 471
           L  L+ L + +N +  +       L D+  L  ++N L      + + +LK +  + +  
Sbjct: 62  LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILR 121

Query: 472 --RNNLSGDIPTAIGGLMNLQDL 492
               N        I  +  ++ L
Sbjct: 122 NPVTNKKHYRLYVIYKVPQVRVL 144

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.0 bits (97), Expect = 1e-04
 Identities = 34/206 (16%), Positives = 69/206 (33%), Gaps = 22/206 (10%)

Query: 239 NASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKL 298
             ++     LG+ + +  +  +  +L ++  L+     + S       +       NL  
Sbjct: 16  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS-------IDGVEYLNNLTQ 66

Query: 299 LDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGS 358
           ++ SNN +            L      +        I             GL       +
Sbjct: 67  INFSNNQLTD-------ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT 119

Query: 359 IPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLR 418
                  L NL  L+L +N +             L  L    N+++   P  + +LT+L 
Sbjct: 120 DIDPLKNLTNLNRLELSSNTISDISALSGLT--SLQQLNFSSNQVTDLKP--LANLTTLE 175

Query: 419 LLSLASNELNSVIPSTFWNLKDILSL 444
            L ++SN+++ +  S    L ++ SL
Sbjct: 176 RLDISSNKVSDI--SVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 38/206 (18%), Positives = 65/206 (31%), Gaps = 27/206 (13%)

Query: 303 NNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPIT 362
           + PIN +   +   L+    +  +   ++  T+ +   +L  +  L       I SI   
Sbjct: 5   DTPINQIFTDT--ALA-EKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLG-IKSID-G 57

Query: 363 FGKLQNLQGLDLVNNKLEGPI----------------PNGLCQLARLSVLYMDGNKLSGP 406
              L NL  ++  NN+L                                        +  
Sbjct: 58  VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ 117

Query: 407 IPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVV 466
           I           L  L  +       S    L  +  LNFSSN +    P  + NL  + 
Sbjct: 118 ITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLE 175

Query: 467 IIDLSRNNLSGDIPTAIGGLMNLQDL 492
            +D+S N +S    + +  L NL+ L
Sbjct: 176 RLDISSNKVSD--ISVLAKLTNLESL 199

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (92), Expect = 4e-04
 Identities = 29/146 (19%), Positives = 53/146 (36%), Gaps = 5/146 (3%)

Query: 407 IPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVV 466
           +   +         +L    L S            + LN  S+    +L     N+  ++
Sbjct: 12  LKLIMSKRYDGSQQALDLKGLRS--DPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELL 68

Query: 467 IIDLSRNNLSG--DIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLS 524
            ++LS N L    D+ + +    NL+ L+L  N L+          + LE L L  NSLS
Sbjct: 69  SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128

Query: 525 GNIPTSMEKLLYLKDLNLSFNKLEGE 550
                    +  +++      +L+G 
Sbjct: 129 DTFRDQSTYISAIRERFPKLLRLDGH 154

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (91), Expect = 5e-04
 Identities = 27/133 (20%), Positives = 48/133 (36%), Gaps = 9/133 (6%)

Query: 282 SELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGT--IPKEI 339
             L             +L+  ++     L     N+   L  + +SN  +     +   +
Sbjct: 30  KGLRSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIP-ELLSLNLSNNRLYRLDDMSSIV 87

Query: 340 GNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARL-----S 394
               NL+ L L GNEL     +   K   L+ L L  N L     +    ++ +      
Sbjct: 88  QKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPK 147

Query: 395 VLYMDGNKLSGPI 407
           +L +DG++L  PI
Sbjct: 148 LLRLDGHELPPPI 160

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (91), Expect = 5e-04
 Identities = 23/140 (16%), Positives = 44/140 (31%), Gaps = 12/140 (8%)

Query: 316 NLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLV 375
             +L L  +             ++        L    + +  ++ I    +  L  L+L 
Sbjct: 24  QQALDLKGL---------RSDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPELLSLNLS 73

Query: 376 NNKLEG--PIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPS 433
           NN+L     + + + +   L +L + GN+L             L  L L  N L+     
Sbjct: 74  NNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRD 133

Query: 434 TFWNLKDILSLNFSSNFLNG 453
               +  I         L+G
Sbjct: 134 QSTYISAIRERFPKLLRLDG 153

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (90), Expect = 6e-04
 Identities = 26/115 (22%), Positives = 45/115 (39%), Gaps = 8/115 (6%)

Query: 296 LKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNEL 355
            + LDL     +  L +   ++ L+      +      T+     N+  L  L L  N L
Sbjct: 24  QQALDLKGLRSDPDLVAQNIDVVLNRRSSMAA------TLRIIEENIPELLSLNLSNNRL 77

Query: 356 --IGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIP 408
             +  +     K  NL+ L+L  N+L+        +  +L  L++DGN LS    
Sbjct: 78  YRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	832
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.98
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.98
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.98
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.98
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.98
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.98
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.97
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.97
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.97
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.97
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.97
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.97
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.97
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.97
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.97
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.97
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.97
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.97
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.97
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.97
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.96
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.96
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.96
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.96
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.96
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.96
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.96
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.96
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.96
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.96
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.96
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.96
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.96
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.95
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.95
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.95
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.94
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.94
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.92
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.91
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.88
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.87
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.86
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.85
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.82
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.8
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.8
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.8
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.79
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.79
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.79
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.79
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.75
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.75
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.74
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.73
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.61
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.57
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.55
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.55
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.54
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.54
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.53
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.53
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.41
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.37
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.36
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.32
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.6
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.58
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.51
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.99
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.71
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.59
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.51
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.89
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.85
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.82
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.8
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.7

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-36  Score=311.54  Aligned_cols=171  Identities=25%  Similarity=0.375  Sum_probs=148.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            467999999999999999999986 58999999997553 2334678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc-
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES-  814 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~-  814 (832)
                      ||++|+|.++++... .+++..+..++.|++.||+|||   ++||+||||||+|||+++++.+||+|||+|+....... 
T Consensus        84 y~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          84 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            999999999997654 7999999999999999999999   99999999999999999999999999999987643322 


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                      ......+||+.|||||++
T Consensus       160 ~~~~~~~GT~~Y~APE~~  177 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELL  177 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHH
T ss_pred             ccccceeeCcCccCHhHh
Confidence            223446799999999964

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-36  Score=310.04  Aligned_cols=168  Identities=33%  Similarity=0.464  Sum_probs=151.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            57999999999999999999875 59999999998766556678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccc
Q 003301          738 PNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ  817 (832)
Q Consensus       738 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~  817 (832)
                      +||+|.+++.+.  .+++..+..++.|++.||+|||   ++||+||||||+|||++.++.+||+|||+|+....... ..
T Consensus       100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~  173 (293)
T d1yhwa1         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR  173 (293)
T ss_dssp             TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred             CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-cc
Confidence            999999988764  5899999999999999999999   99999999999999999999999999999998754433 23


Q ss_pred             ccccccccccCCCCC
Q 003301          818 TLTLATIGYMAPGLF  832 (832)
Q Consensus       818 ~~~~gt~~y~APE~l  832 (832)
                      ...+||+.|||||++
T Consensus       174 ~~~~gt~~Y~aPE~~  188 (293)
T d1yhwa1         174 STMVGTPYWMAPEVV  188 (293)
T ss_dssp             CCCCSCGGGCCHHHH
T ss_pred             cccccCCCccChhhh
Confidence            345799999999963

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-36  Score=311.39  Aligned_cols=170  Identities=26%  Similarity=0.399  Sum_probs=151.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      +.|++.+.||+|+||+||+|++. +++.||||++........+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            57899999999999999999986 48899999998776666788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccc
Q 003301          738 PNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ  817 (832)
Q Consensus       738 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~  817 (832)
                      ++|+|.+++.+....+++..+..++.|++.||+|||   ++||+||||||+|||++.++.+||+|||+|+....... ..
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~~  167 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR  167 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-HH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCcc-cc
Confidence            999999998766557999999999999999999999   99999999999999999999999999999976532221 22


Q ss_pred             ccccccccccCCCCC
Q 003301          818 TLTLATIGYMAPGLF  832 (832)
Q Consensus       818 ~~~~gt~~y~APE~l  832 (832)
                      ...+||+.|||||++
T Consensus       168 ~~~~Gt~~y~APE~l  182 (288)
T d2jfla1         168 DSFIGTPYWMAPEVV  182 (288)
T ss_dssp             TCCCSCCTTCCHHHH
T ss_pred             cccccccccCCHHHH
Confidence            346799999999963

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-35  Score=302.79  Aligned_cols=167  Identities=29%  Similarity=0.460  Sum_probs=149.2

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.+.||+|+||+||+|++. +++.||+|++....   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999986 48899999987542   334567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |||++|+|.+++.+.+ .+++..+..++.||+.||+|||   ++||+||||||+|||++.++.+||+|||+|+...... 
T Consensus        86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-  160 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-  160 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred             eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence            9999999999998654 6999999999999999999999   9999999999999999999999999999998764432 


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                        ....+||+.|||||++
T Consensus       161 --~~~~~Gt~~Y~APE~~  176 (263)
T d2j4za1         161 --RTTLCGTLDYLPPEMI  176 (263)
T ss_dssp             --CEETTEEGGGCCHHHH
T ss_pred             --ccccCCCCcccCHHHH
Confidence              2345799999999974

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-36  Score=305.46  Aligned_cols=170  Identities=29%  Similarity=0.467  Sum_probs=141.9

Q ss_pred             cCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCC
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMP  738 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  738 (832)
                      ++|++.+.||+|+||+||+|.+.+++.||||+++... ...+++.+|++++++++|||||+++|++.+++..|+|||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            5789999999999999999999888999999987543 334789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccccc
Q 003301          739 NGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQT  818 (832)
Q Consensus       739 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~~  818 (832)
                      +|+|.+++......+++..+..++.|+|.||+|+|   +++|+||||||+||++++++.+||+|||+|+...........
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~  160 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  160 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence            99999999877767999999999999999999999   999999999999999999999999999999877555444444


Q ss_pred             cccccccccCCCCC
Q 003301          819 LTLATIGYMAPGLF  832 (832)
Q Consensus       819 ~~~gt~~y~APE~l  832 (832)
                      ...||+.|||||++
T Consensus       161 ~~~gt~~y~aPE~l  174 (263)
T d1sm2a_         161 GTKFPVKWASPEVF  174 (263)
T ss_dssp             ----CTTSCCHHHH
T ss_pred             ceecCcccCChHHh
Confidence            46799999999963

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.7e-36  Score=310.53  Aligned_cols=175  Identities=25%  Similarity=0.469  Sum_probs=153.8

Q ss_pred             HHHHhcCCCCCCeeeccCCceEEEEEecC-CcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          654 LLQATNQFNASNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       654 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      ++...++|++.+.||+|+||+||+|.+.. ++.||||+++... ...+++.+|++++++++|||||++++++.+++..|+
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            33445789999999999999999999864 8899999987543 345789999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          733 VLEYMPNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      |||||++|+|.+++... ...+++..+..++.|++.||+|||   ++||+||||||+|||+++++.+||+|||+|+....
T Consensus        91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred             EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence            99999999999998754 346899999999999999999999   99999999999999999999999999999998765


Q ss_pred             CcccccccccccccccCCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ..........||+.|||||++
T Consensus       168 ~~~~~~~~~~g~~~y~aPE~~  188 (287)
T d1opja_         168 DTYTAHAGAKFPIKWTAPESL  188 (287)
T ss_dssp             SSSEEETTEEECGGGCCHHHH
T ss_pred             CCceeeccccccccccChHHH
Confidence            554444445689999999963

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-35  Score=304.57  Aligned_cols=170  Identities=31%  Similarity=0.490  Sum_probs=147.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.+.||+|+||+||+|++. +++.||||++....   ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999985 58999999997542   334577899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |||++|+|.+++...+ .+++..+..++.|++.||+|+|   ++||+||||||+||++++++.+||+|||+|+.......
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            9999999999988654 6999999999999999999999   99999999999999999999999999999987754332


Q ss_pred             -cccccccccccccCCCCC
Q 003301          815 -MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 -~~~~~~~gt~~y~APE~l  832 (832)
                       ......+||+.|||||++
T Consensus       164 ~~~~~~~~GT~~Y~APE~~  182 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELL  182 (288)
T ss_dssp             ------CCCCGGGCCHHHH
T ss_pred             ccccccccCCccccCceee
Confidence             223345799999999974

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-35  Score=305.67  Aligned_cols=170  Identities=28%  Similarity=0.498  Sum_probs=143.2

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ..++|++.+.||+|+||+||+|++.  ..||||+++...  ....+.+.+|++++++++|||||++++++.+ +..|+||
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            3578999999999999999999863  369999986442  4456789999999999999999999998754 5689999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |||++|+|.+++...+..+++..+..++.|++.||+|||   +++||||||||+|||++.++.+||+|||+|+.......
T Consensus        83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            999999999999877667999999999999999999999   99999999999999999999999999999987654322


Q ss_pred             -cccccccccccccCCCCC
Q 003301          815 -MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 -~~~~~~~gt~~y~APE~l  832 (832)
                       .......||+.|||||++
T Consensus       160 ~~~~~~~~gt~~y~APE~l  178 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVI  178 (276)
T ss_dssp             ------CCCCGGGCCHHHH
T ss_pred             cccccccccCcccCCHHHH
Confidence             223345799999999963

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-35  Score=311.59  Aligned_cols=168  Identities=26%  Similarity=0.376  Sum_probs=148.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .++|++.+.||+|+||+||+|++. +|+.||+|+++... ....+.+.+|+.++++++|||||+++++|.+++..|+|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            578999999999999999999986 58999999997653 3345678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSN-PVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||++|+|.+++.+.+ .+++..+..++.|++.||+|||   ++ ||+||||||+|||++.++.+||+|||+|+.....  
T Consensus        85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  158 (322)
T ss_dssp             CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence            999999999998654 6999999999999999999999   74 8999999999999999999999999999875322  


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                       .....+||+.|||||++
T Consensus       159 -~~~~~~GT~~Y~APEvl  175 (322)
T d1s9ja_         159 -MANSFVGTRSYMSPERL  175 (322)
T ss_dssp             -TC---CCSSCCCCHHHH
T ss_pred             -ccccccCCccccCchHH
Confidence             22345799999999974

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.1e-34  Score=308.50  Aligned_cols=170  Identities=23%  Similarity=0.374  Sum_probs=152.6

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .++|++.+.||+|+||+||+|++. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            468999999999999999999985 5899999999876666667899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeC--CCCcEEEeccccccccCCCcc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD--KDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~--~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |+||+|.+++......+++..+..++.||+.||+|||   ++|||||||||+|||++  .++.+||+|||+|+.......
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  181 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  181 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence            9999999999766667999999999999999999999   99999999999999995  457899999999998754432


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                        ....+||+.|||||++
T Consensus       182 --~~~~~gT~~Y~aPEv~  197 (350)
T d1koaa2         182 --VKVTTGTAEFAAPEVA  197 (350)
T ss_dssp             --EEEECSCTTTCCHHHH
T ss_pred             --cceecCcccccCHHHH
Confidence              2345799999999974

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-35  Score=303.08  Aligned_cols=171  Identities=24%  Similarity=0.463  Sum_probs=149.2

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ..++|++.+.||+|+||+||+|.+.+++.||||+++... ...+.+.+|++++++++|||||+++|++.+ +..|+||||
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            356889999999999999999999888999999997543 334789999999999999999999998765 567999999


Q ss_pred             CCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          737 MPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       737 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      +++|+|.+++.... ..+++..+..++.||+.||+|||   +++|+||||||+||++++++.+||+|||+|+........
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence            99999999875432 24899999999999999999999   999999999999999999999999999999987655544


Q ss_pred             ccccccccccccCCCCC
Q 003301          816 KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~l  832 (832)
                      ......||+.|||||++
T Consensus       166 ~~~~~~gt~~y~APE~~  182 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAI  182 (272)
T ss_dssp             CCTTCCCCTTTSCHHHH
T ss_pred             cccccCCcccccChHHH
Confidence            44456799999999963

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-34  Score=294.78  Aligned_cols=171  Identities=28%  Similarity=0.452  Sum_probs=154.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      .++|++.++||+|+||+||+|++++++.||||+++.... ..+.+.+|++++++++||||++++|++.+++..|+||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            368999999999999999999998888999999986543 3478999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccccc
Q 003301          738 PNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMKQ  817 (832)
Q Consensus       738 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~~  817 (832)
                      ++|++.+++......+++..+.+++.|+++||+|||   ++||+||||||+||+++.++.+||+|||+|+..........
T Consensus        82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  158 (258)
T d1k2pa_          82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS  158 (258)
T ss_dssp             TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred             CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence            999999998776667999999999999999999999   99999999999999999999999999999987765554444


Q ss_pred             ccccccccccCCCCC
Q 003301          818 TLTLATIGYMAPGLF  832 (832)
Q Consensus       818 ~~~~gt~~y~APE~l  832 (832)
                      ....||+.|||||++
T Consensus       159 ~~~~~t~~y~aPE~~  173 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVL  173 (258)
T ss_dssp             CCSCCCGGGCCHHHH
T ss_pred             cccCCCCCcCCcHHh
Confidence            456799999999963

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-34  Score=304.57  Aligned_cols=170  Identities=29%  Similarity=0.373  Sum_probs=151.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      .++|++.+.||+|+||+||+|++. +|+.||||++....   ....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            467999999999999999999985 59999999997542   33457788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      ||||+||+|.+++.+.+ .+++..++.++.|++.||+|||   ++||+||||||+|||++++|.+||+|||+|+......
T Consensus        84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            99999999999998755 6899999999999999999999   9999999999999999999999999999998764433


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                      . .....+||+.|||||++
T Consensus       160 ~-~~~~~~GT~~Y~aPE~~  177 (337)
T d1o6la_         160 A-TMKTFCGTPEYLAPEVL  177 (337)
T ss_dssp             C-CBCCCEECGGGCCGGGG
T ss_pred             c-ccccceeCHHHhhhhhc
Confidence            2 23346799999999974

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-35  Score=299.69  Aligned_cols=171  Identities=28%  Similarity=0.428  Sum_probs=136.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEec--CCeeEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTN--NDFKAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l  732 (832)
                      .++|++.+.||+|+||+||+|++. +|+.||||++....  +...+.+.+|++++++++|||||++++++.+  ++..|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            367999999999999999999886 58999999987543  3345678899999999999999999999865  456899


Q ss_pred             EEecCCCCCHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEecCCCCCCeEeCCCCcEEEeccc
Q 003301          733 VLEYMPNGSLEDYLYS---NNFSFDILQRLSVIIDVALALEYLHFGYSNP-----VVHCDIKPSNVLLDKDMVAHLSDFG  804 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~Dlkp~NIl~~~~~~~kl~DFg  804 (832)
                      |||||++|+|.+++.+   .+..+++..++.++.|++.||+|||   +++     |+||||||+|||++.++.+||+|||
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG  159 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  159 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HhcCCCCCEEeCcCchhhcCcCCCCcEEEeecc
Confidence            9999999999999864   2346999999999999999999999   654     9999999999999999999999999


Q ss_pred             cccccCCCcccccccccccccccCCCCC
Q 003301          805 IAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       805 ~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +|+........ ....+||+.|||||++
T Consensus       160 ~a~~~~~~~~~-~~~~~gt~~Y~APE~l  186 (269)
T d2java1         160 LARILNHDTSF-AKAFVGTPYYMSPEQM  186 (269)
T ss_dssp             HHHHC------------CCCSCCCHHHH
T ss_pred             ceeecccCCCc-cccCCCCcccCCHHHH
Confidence            99987543332 2346799999999964

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-34  Score=303.05  Aligned_cols=165  Identities=25%  Similarity=0.365  Sum_probs=145.7

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      +.|+..+.||+|+||+||+|++. +++.||||++....   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            45899999999999999999875 58899999987543   234467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |||++|++..++...+ .+++..+..++.||+.||+|||   ++||+||||||+|||++.++.+||+|||+|+.....  
T Consensus        95 E~~~~g~l~~~~~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (309)
T ss_dssp             ECCSEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             EecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence            9999999887766543 6999999999999999999999   999999999999999999999999999999875432  


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                         ...+||+.|||||++
T Consensus       169 ---~~~~GT~~Y~APE~~  183 (309)
T d1u5ra_         169 ---NSFVGTPYWMAPEVI  183 (309)
T ss_dssp             ---CCCCSCGGGCCHHHH
T ss_pred             ---CccccCccccCHHHH
Confidence               235799999999963

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.7e-34  Score=305.84  Aligned_cols=170  Identities=22%  Similarity=0.387  Sum_probs=152.7

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            367999999999999999999985 5999999999876655567888999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeC--CCCcEEEeccccccccCCCcc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD--KDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~--~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |+||+|.+++......+++..+..++.||+.||+|||   ++||+||||||+|||++  .++.+||+|||+|+.......
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence            9999999988777667999999999999999999999   99999999999999997  678999999999998755432


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                        .....||+.|||||++
T Consensus       185 --~~~~~gt~~y~aPE~~  200 (352)
T d1koba_         185 --VKVTTATAEFAAPEIV  200 (352)
T ss_dssp             --EEEECSSGGGCCHHHH
T ss_pred             --eeeccCcccccCHHHH
Confidence              3345799999999963

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-34  Score=291.90  Aligned_cols=164  Identities=27%  Similarity=0.417  Sum_probs=141.7

Q ss_pred             CCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEec----CCeeEEEE
Q 003301          662 NASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTN----NDFKALVL  734 (832)
Q Consensus       662 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  734 (832)
                      ++.++||+|+||+||+|.+. +++.||+|++....  ....+.+.+|++++++++|||||++++++.+    +..+|+||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            56778999999999999986 48899999987553  3345678999999999999999999999865    34689999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecCCCCCCeEeC-CCCcEEEeccccccccCC
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNP--VVHCDIKPSNVLLD-KDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~NIl~~-~~~~~kl~DFg~a~~~~~  811 (832)
                      |||++|+|.+++.+.. .+++..+..++.||+.||+|||   +++  |+||||||+|||++ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999998654 6899999999999999999999   888  99999999999996 578999999999986543


Q ss_pred             CcccccccccccccccCCCCC
Q 003301          812 EESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ..   ....+||+.|||||++
T Consensus       168 ~~---~~~~~GT~~Y~aPE~~  185 (270)
T d1t4ha_         168 SF---AKAVIGTPEFMAPEMY  185 (270)
T ss_dssp             TS---BEESCSSCCCCCGGGG
T ss_pred             Cc---cCCcccCccccCHHHh
Confidence            32   2345799999999974

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5e-34  Score=299.58  Aligned_cols=166  Identities=28%  Similarity=0.416  Sum_probs=149.0

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++...   ....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            67999999999999999999985 58999999997543   334578899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |||+||++.+++.... .+++..+..++.|++.|++|||   ++||+||||||+|||++.+|.+||+|||+|+...... 
T Consensus        84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-  158 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-  158 (316)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred             eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence            9999999999988765 6889999999999999999999   9999999999999999999999999999998764432 


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                         ...+||+.|||||++
T Consensus       159 ---~~~~Gt~~Y~APE~l  173 (316)
T d1fota_         159 ---YTLCGTPDYIAPEVV  173 (316)
T ss_dssp             ---CCCCSCTTTCCHHHH
T ss_pred             ---ccccCcccccCHHHH
Confidence               235799999999974

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-34  Score=301.46  Aligned_cols=170  Identities=27%  Similarity=0.473  Sum_probs=136.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-C---cEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-G---MEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      ++|++.+.||+|+||+||+|++.. +   ..||||++.... ....+.+.+|++++++++|||||+++|++.+++..|+|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            567788999999999999998753 3   358888876543 34557899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      ||||++|+|.+++......+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+......
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            9999999999999887767999999999999999999999   9999999999999999999999999999998765433


Q ss_pred             ccc----cccccccccccCCCC
Q 003301          814 SMK----QTLTLATIGYMAPGL  831 (832)
Q Consensus       814 ~~~----~~~~~gt~~y~APE~  831 (832)
                      ...    .....||+.|||||+
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~  204 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEA  204 (299)
T ss_dssp             -------------CGGGSCHHH
T ss_pred             CcceeeecccccCCccccCHHH
Confidence            221    122458999999996

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-34  Score=301.37  Aligned_cols=169  Identities=27%  Similarity=0.416  Sum_probs=132.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      .+.|++.+.||+|+||+||+|++. +++.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            467999999999999999999986 48999999987553 2334567899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeC---CCCcEEEeccccccccCCC
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLD---KDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~---~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||+||+|.+++...+ .+++..+..++.|++.||+|||   ++||+||||||+||++.   +++.+||+|||+|+.....
T Consensus        88 ~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          88 LVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             ccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            999999999997654 7999999999999999999999   99999999999999994   5789999999999876443


Q ss_pred             cccccccccccccccCCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~l  832 (832)
                      ..  ....+||+.|||||++
T Consensus       164 ~~--~~~~~GT~~y~APE~~  181 (307)
T d1a06a_         164 SV--LSTACGTPGYVAPEVL  181 (307)
T ss_dssp             -----------CTTSCHHHH
T ss_pred             Ce--eeeeeeCccccCcHHH
Confidence            32  2335799999999974

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.5e-33  Score=298.29  Aligned_cols=258  Identities=34%  Similarity=0.589  Sum_probs=227.4

Q ss_pred             ccceEEeecCcccc--cccccccCcCcccEEEeec-CcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEE
Q 003301          320 SLSRIFISNCSIRG--TIPKEIGNLINLRELGLWG-NELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVL  396 (832)
Q Consensus       320 ~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  396 (832)
                      .++.|+|++|.+++  .+|..++++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            46677777777765  4678888899999999986 78888888889999999999999999988888888888899999


Q ss_pred             EecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCccc-ceeeecCCcccCCCccccccccccceecccCccc
Q 003301          397 YMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDI-LSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNL  475 (832)
Q Consensus       397 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  475 (832)
                      ++++|.+.+.+|..+.+++.|+.+++++|.+.+.+|..+..+..+ +.+++++|++++..|..+..+..+ .+++++|.+
T Consensus       131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~  209 (313)
T d1ogqa_         131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred             ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence            999999888888899999999999999999988888888888776 789999999998888888887655 699999999


Q ss_pred             CCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccCCCCC
Q 003301          476 SGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEIPRGG  555 (832)
Q Consensus       476 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~  555 (832)
                      .+.+|..+..+++|+.+++++|.+++.+| .++.+++|+.|||++|+++|.+|+.+.++++|++|+|++|+++|.+|..+
T Consensus       210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~  288 (313)
T d1ogqa_         210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG  288 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred             ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence            99999999999999999999999997655 68889999999999999999999999999999999999999999999988


Q ss_pred             CCCCcCCCcccCCCCCCCCcccCCCcc
Q 003301          556 PFANFSNRSFMGNDLLCGLAQVQVPVC  582 (832)
Q Consensus       556 ~~~~~~~~~~~~n~~~c~~~~~~~p~c  582 (832)
                      .+.++....+.||+.+||.|+   |+|
T Consensus       289 ~L~~L~~l~l~~N~~l~g~pl---p~c  312 (313)
T d1ogqa_         289 NLQRFDVSAYANNKCLCGSPL---PAC  312 (313)
T ss_dssp             TGGGSCGGGTCSSSEEESTTS---SCC
T ss_pred             cCCCCCHHHhCCCccccCCCC---CCC
Confidence            888888889999999999875   466

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-33  Score=292.35  Aligned_cols=170  Identities=25%  Similarity=0.470  Sum_probs=145.7

Q ss_pred             cCCCCCCe-eeccCCceEEEEEec---CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEE
Q 003301          659 NQFNASNL-IGTGGFGSVYKGSFL---DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       659 ~~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      ++|.+.+. ||+|+||+||+|.+.   ++..||||+++... ....+++.+|++++++++|||||+++|++.+ +..|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            56677774 999999999999874   35579999997543 3445789999999999999999999999875 457999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      ||||++|+|.+++...+..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+......
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            9999999999998877667999999999999999999999   9999999999999999999999999999999875443


Q ss_pred             cc--ccccccccccccCCCCC
Q 003301          814 SM--KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~--~~~~~~gt~~y~APE~l  832 (832)
                      ..  ......||+.|||||++
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~  184 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECI  184 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHH
T ss_pred             cccccccccccCccccChHHH
Confidence            22  22234689999999963

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-33  Score=292.30  Aligned_cols=169  Identities=23%  Similarity=0.374  Sum_probs=149.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc------hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL------EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  730 (832)
                      .++|++.+.||+|+||+||+|++. +|+.||||++....      ....+.+.+|++++++++|||||++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            468999999999999999999985 58999999987542      12357889999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC----cEEEeccccc
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM----VAHLSDFGIA  806 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~----~~kl~DFg~a  806 (832)
                      |+|||||++|+|.+++...+ .+++..+..++.|++.||+|||   +++|+||||||+||+++.++    .+|++|||+|
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence            99999999999999998754 6999999999999999999999   99999999999999998776    5999999999


Q ss_pred             cccCCCcccccccccccccccCCCCC
Q 003301          807 KLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       807 ~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +.......  .....||+.|||||++
T Consensus       165 ~~~~~~~~--~~~~~~t~~y~APE~~  188 (293)
T d1jksa_         165 HKIDFGNE--FKNIFGTPEFVAPEIV  188 (293)
T ss_dssp             EECTTSCB--CSCCCCCGGGCCHHHH
T ss_pred             hhcCCCcc--ccccCCCCcccCHHHH
Confidence            88754432  2335799999999963

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-33  Score=291.23  Aligned_cols=171  Identities=26%  Similarity=0.489  Sum_probs=141.4

Q ss_pred             cCCCCCCeeeccCCceEEEEEecCC-----cEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLDG-----MEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      +.|+..++||+|+||+||+|.+...     ..||||++.... ......+.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            5688899999999999999987642     469999987543 3345678999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      |||||.++++.+++......+++..+..++.|++.|++|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            99999999999998887778999999999999999999999   999999999999999999999999999999876443


Q ss_pred             ccc--ccccccccccccCCCCC
Q 003301          813 ESM--KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~--~~~~~~gt~~y~APE~l  832 (832)
                      ...  ......||+.|||||++
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l  185 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAI  185 (283)
T ss_dssp             ----------CCCGGGSCHHHH
T ss_pred             CccceEeccCCCCccccCHHHH
Confidence            221  22334689999999963

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.98  E-value=3.2e-33  Score=297.55  Aligned_cols=166  Identities=28%  Similarity=0.388  Sum_probs=149.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  734 (832)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++....   ....+.+.+|+++++.++|||||++++++.+.+..|+||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            68999999999999999999985 59999999987543   234567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      ||+.+|++.+++.+.+ .+++..+..++.||+.||+|||   ++|||||||||+|||++.+|.+||+|||+|+...... 
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-  195 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-  195 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-
Confidence            9999999999997654 6999999999999999999999   9999999999999999999999999999999875432 


Q ss_pred             cccccccccccccCCCCC
Q 003301          815 MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~l  832 (832)
                         ...+||+.|||||++
T Consensus       196 ---~~~~Gt~~Y~APE~~  210 (350)
T d1rdqe_         196 ---WTLCGTPEALAPEII  210 (350)
T ss_dssp             ---CCCEECGGGCCHHHH
T ss_pred             ---ccccCccccCCHHHH
Confidence               235799999999974

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.98  E-value=4.1e-33  Score=286.75  Aligned_cols=168  Identities=26%  Similarity=0.403  Sum_probs=149.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---------hhhHHHHHHHHHHHhcCC-CCceeeeceEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---------EGALKSFDVECEVLKSVR-HRNLVKIISSCTN  726 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  726 (832)
                      .++|++.+.||+|+||+||+|++. +++.||||++....         +...+.+.+|++++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            368999999999999999999985 58999999987543         122356889999999997 9999999999999


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccc
Q 003301          727 NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA  806 (832)
Q Consensus       727 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a  806 (832)
                      ++..|+|||||++|+|.++++..+ .+++..+..++.||+.||+|||   ++||+||||||+||+++.++.+||+|||+|
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhe
Confidence            999999999999999999998754 7999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCcccccccccccccccCCCC
Q 003301          807 KLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       807 ~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      +.......  ....+||+.|+|||+
T Consensus       158 ~~~~~~~~--~~~~~gt~~y~~PE~  180 (277)
T d1phka_         158 CQLDPGEK--LREVCGTPSYLAPEI  180 (277)
T ss_dssp             EECCTTCC--BCCCCSCGGGCCHHH
T ss_pred             eEccCCCc--eeeeeccCCCCCHHH
Confidence            98754332  234679999999996

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=3.8e-33  Score=287.56  Aligned_cols=163  Identities=28%  Similarity=0.444  Sum_probs=137.3

Q ss_pred             CeeeccCCceEEEEEecC---CcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecCCC
Q 003301          665 NLIGTGGFGSVYKGSFLD---GMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYMPN  739 (832)
Q Consensus       665 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  739 (832)
                      ++||+|+||+||+|.+.+   ++.||||+++...  ....+.+.+|++++++++|||||++++++.++ ..|+|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            479999999999998753   4689999986543  33457899999999999999999999998654 57899999999


Q ss_pred             CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc--c
Q 003301          740 GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK--Q  817 (832)
Q Consensus       740 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~--~  817 (832)
                      |+|.+++++.. .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+|+.........  .
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            99999998765 6999999999999999999999   9999999999999999999999999999998765443222  2


Q ss_pred             ccccccccccCCCCC
Q 003301          818 TLTLATIGYMAPGLF  832 (832)
Q Consensus       818 ~~~~gt~~y~APE~l  832 (832)
                      ....||+.|||||++
T Consensus       168 ~~~~gt~~y~APE~l  182 (277)
T d1xbba_         168 THGKWPVKWYAPECI  182 (277)
T ss_dssp             ---CCCGGGCCHHHH
T ss_pred             cccCCCceecCchhh
Confidence            235699999999963

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.3e-33  Score=291.46  Aligned_cols=170  Identities=26%  Similarity=0.453  Sum_probs=141.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEecC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEYM  737 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  737 (832)
                      .++|++.+.||+|+||+||+|++.+++.||||+++... ...+.+.+|+.++++++|||||++++++.+ +..|+||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            46899999999999999999999888899999987543 334789999999999999999999999865 5679999999


Q ss_pred             CCCCHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          738 PNGSLEDYLYSN-NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       738 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      ++|++.+++... ...+++.++..++.||+.|++|||   +.||+||||||+|||++.++.+||+|||+|+.........
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~  170 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  170 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence            999999988653 235899999999999999999999   9999999999999999999999999999998775544444


Q ss_pred             cccccccccccCCCCC
Q 003301          817 QTLTLATIGYMAPGLF  832 (832)
Q Consensus       817 ~~~~~gt~~y~APE~l  832 (832)
                      .....||+.|+|||++
T Consensus       171 ~~~~~gt~~y~aPE~~  186 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAA  186 (285)
T ss_dssp             -----CCGGGSCHHHH
T ss_pred             eccccccccccChHHH
Confidence            4456799999999963

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.98  E-value=5.2e-33  Score=297.61  Aligned_cols=168  Identities=27%  Similarity=0.384  Sum_probs=144.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHH---HHHHHHHhcCCCCceeeeceEEecCCee
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSF---DVECEVLKSVRHRNLVKIISSCTNNDFK  730 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~~  730 (832)
                      .++|++.+.||+|+||.||+|++. +|+.||||++....   ......+   ..|+++++.++|||||++++++.+++..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            468999999999999999999986 48999999987432   1122233   3457778888999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccC
Q 003301          731 ALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLS  810 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~  810 (832)
                      |+|||||+||+|.+++.+.. .+++..+..++.||+.||+|||   ++|||||||||+|||++.+|.+||+|||+|+...
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            99999999999999997654 6899999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCcccccccccccccccCCCCC
Q 003301          811 GEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       811 ~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ...   ....+||+.|||||++
T Consensus       159 ~~~---~~~~~GT~~y~APE~~  177 (364)
T d1omwa3         159 KKK---PHASVGTHGYMAPEVL  177 (364)
T ss_dssp             SSC---CCSCCSCGGGCCHHHH
T ss_pred             CCc---ccccccccccchhHHh
Confidence            432   2335799999999963

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=3.5e-33  Score=295.34  Aligned_cols=173  Identities=24%  Similarity=0.434  Sum_probs=144.9

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEecC-C-----cEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCC
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFLD-G-----MEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTNND  728 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  728 (832)
                      ..++|++.++||+|+||+||+|++.. +     ..||+|++.... ......+.+|+.++.++ +|||||++++++.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            34689999999999999999998753 2     368999886543 33456788999999998 8999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCC----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCC
Q 003301          729 FKALVLEYMPNGSLEDYLYSNNF----------------------SFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIK  786 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk  786 (832)
                      ..|+|||||++|+|.++++..+.                      .+++..+..++.|++.||+|||   +++|||||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCc
Confidence            99999999999999999976432                      3788999999999999999999   9999999999


Q ss_pred             CCCeEeCCCCcEEEeccccccccCCCccc-ccccccccccccCCCCC
Q 003301          787 PSNVLLDKDMVAHLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       787 p~NIl~~~~~~~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~l  832 (832)
                      |+||+++.++.+||+|||+|+........ ......||+.|||||++
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l  238 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL  238 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHH
Confidence            99999999999999999999876443322 22345689999999963

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.1e-32  Score=288.11  Aligned_cols=168  Identities=21%  Similarity=0.353  Sum_probs=148.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      .++|++.+.||+|+||+||+|.+. +++.||||+++.... ....+.+|++++++++|||||++++++.+++..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            478999999999999999999986 588999999976543 335688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC--CcEEEeccccccccCCCcc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD--MVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~--~~~kl~DFg~a~~~~~~~~  814 (832)
                      |+||+|.+++...+..+++.++..++.||+.|++|||   ++||+||||||+||+++.+  +.+||+|||+|+.......
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~  159 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence            9999999999877667999999999999999999999   9999999999999999854  5899999999987654332


Q ss_pred             cccccccccccccCCCC
Q 003301          815 MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~  831 (832)
                        ....+||+.|+|||+
T Consensus       160 --~~~~~~t~~y~ape~  174 (321)
T d1tkia_         160 --FRLLFTAPEYYAPEV  174 (321)
T ss_dssp             --EEEEESCGGGSCHHH
T ss_pred             --ccccccccccccchh
Confidence              233579999999995

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.3e-32  Score=289.19  Aligned_cols=169  Identities=28%  Similarity=0.437  Sum_probs=147.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHh-cCCCCceeeeceEEecCCeeEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLK-SVRHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv  733 (832)
                      ++|++.+.||+|+||+||+|++. +++.||||+++...   ....+.+.+|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            68999999999999999999986 48999999997542   334456677777765 68999999999999999999999


Q ss_pred             EecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCc
Q 003301          734 LEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~  813 (832)
                      ||||++|+|.++++... .+++..+..++.||+.||+|||   +++|+||||||+|||+++++.+||+|||.|+......
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            99999999999998654 6899999999999999999999   9999999999999999999999999999998765433


Q ss_pred             ccccccccccccccCCCCC
Q 003301          814 SMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~l  832 (832)
                      . .....+||+.|||||++
T Consensus       158 ~-~~~~~~gt~~y~aPE~~  175 (320)
T d1xjda_         158 A-KTNTFCGTPDYIAPEIL  175 (320)
T ss_dssp             C-CBCCCCSCGGGCCHHHH
T ss_pred             c-cccccCCCCCcCCHHHH
Confidence            3 23345799999999964

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.6e-33  Score=284.86  Aligned_cols=171  Identities=26%  Similarity=0.440  Sum_probs=136.1

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC----CcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD----GMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      .++|++.+.||+|+||+||+|.+..    +..||||+++... ....+.+.+|++++++++|||||++++++. ++..|+
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4689999999999999999998753    3568888876443 344577999999999999999999999986 467899


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      ||||+++|++.+++......+++..+..++.|++.||+|+|   +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            99999999999998877778999999999999999999999   999999999999999999999999999999877654


Q ss_pred             cccccccccccccccCCCCC
Q 003301          813 ESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~~~~~~~gt~~y~APE~l  832 (832)
                      .........||+.|||||++
T Consensus       162 ~~~~~~~~~gt~~y~apE~l  181 (273)
T d1mp8a_         162 TYYKASKGKLPIKWMAPESI  181 (273)
T ss_dssp             ---------CCGGGCCHHHH
T ss_pred             cceeccceecCcccchhhHh
Confidence            44444456789999999963

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=5e-32  Score=286.49  Aligned_cols=252  Identities=33%  Similarity=0.493  Sum_probs=221.3

Q ss_pred             CCcEEeccCCCCCC--CCCCcccccccccceEEeec-CcccccccccccCcCcccEEEeecCcccccccccccCCCCCce
Q 003301          295 NLKLLDLSNNPING--VLPSSIGNLSLSLSRIFISN-CSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQG  371 (832)
Q Consensus       295 ~L~~L~L~~N~l~~--~~~~~~~~~~~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  371 (832)
                      .++.|+|++|.+.+  .+|..++.+. +|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~-~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~  129 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCT-TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCc-cccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence            46667777776665  3567777776 778888875 6788888888999999999999999999888888999999999


Q ss_pred             EEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCC-CeEeCCCCcCCCCCCcccccCcccceeeecCCc
Q 003301          372 LDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSL-RLLSLASNELNSVIPSTFWNLKDILSLNFSSNF  450 (832)
Q Consensus       372 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  450 (832)
                      +++++|++.+.+|..+..+++++.+++++|.+.+.+|..+..+..+ +.+++++|++++..|..+..+..+ .+++++|.
T Consensus       130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~  208 (313)
T d1ogqa_         130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNM  208 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSE
T ss_pred             cccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence            9999999998999999999999999999999998899988888776 889999999999889888887655 69999999


Q ss_pred             ccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchh
Q 003301          451 LNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTS  530 (832)
Q Consensus       451 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  530 (832)
                      ..+.+|..++.++.++.+++++|.+.+.+| .+..+++|+.|+|++|+++|.+|..|+.+++|++|||++|+|+|.+|+ 
T Consensus       209 ~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-  286 (313)
T d1ogqa_         209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-  286 (313)
T ss_dssp             EEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-
T ss_pred             cccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-
Confidence            999999999999999999999999987654 688899999999999999999999999999999999999999999985 


Q ss_pred             hhhhccCCeeeCCCCc-cccc
Q 003301          531 MEKLLYLKDLNLSFNK-LEGE  550 (832)
Q Consensus       531 ~~~l~~L~~l~l~~N~-l~~~  550 (832)
                      +.++++|+.+++++|+ ++|.
T Consensus       287 ~~~L~~L~~l~l~~N~~l~g~  307 (313)
T d1ogqa_         287 GGNLQRFDVSAYANNKCLCGS  307 (313)
T ss_dssp             STTGGGSCGGGTCSSSEEEST
T ss_pred             cccCCCCCHHHhCCCccccCC
Confidence            5789999999999998 5654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.9e-32  Score=286.15  Aligned_cols=165  Identities=24%  Similarity=0.351  Sum_probs=140.9

Q ss_pred             hcCCCCCC-eeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhc-CCCCceeeeceEEec----CCee
Q 003301          658 TNQFNASN-LIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKS-VRHRNLVKIISSCTN----NDFK  730 (832)
Q Consensus       658 ~~~~~~~~-~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~  730 (832)
                      .++|++.+ +||+|+||+||+|++. +++.||||+++..     +.+.+|++++.+ .+|||||+++++|.+    +...
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46888764 6999999999999885 5899999998643     456789998765 489999999999865    4578


Q ss_pred             EEEEecCCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC---CCcEEEeccccc
Q 003301          731 ALVLEYMPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK---DMVAHLSDFGIA  806 (832)
Q Consensus       731 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~DFg~a  806 (832)
                      |+|||||+||+|.+++.+.+ ..+++.++..++.|++.||+|||   ++||+||||||+||+++.   ++.+||+|||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence            99999999999999998653 46999999999999999999999   999999999999999975   567999999999


Q ss_pred             cccCCCcccccccccccccccCCCCC
Q 003301          807 KLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       807 ~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +.......  ....+||+.|||||++
T Consensus       162 ~~~~~~~~--~~~~~gt~~y~aPE~~  185 (335)
T d2ozaa1         162 KETTSHNS--LTTPCYTPYYVAPEVL  185 (335)
T ss_dssp             EECCCCCC--CCCCSCCCSSCCCCCC
T ss_pred             eeccCCCc--cccccCCcccCCcHHH
Confidence            87755433  2345799999999985

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.5e-32  Score=285.54  Aligned_cols=168  Identities=29%  Similarity=0.454  Sum_probs=143.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      ++|++.+.||+|+||+||+|++. +|+.||||+++...  +...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            68999999999999999999985 58999999996543  2235688899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHH-hhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcc
Q 003301          736 YMPNGSLEDYL-YSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEES  814 (832)
Q Consensus       736 ~~~~g~L~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~  814 (832)
                      |+.+ ++.+++ ......+++..+..++.|++.||+|||   ++|||||||||+||+++.++.+||+|||.|+.......
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            9965 554444 444556999999999999999999999   99999999999999999999999999999987754433


Q ss_pred             cccccccccccccCCCC
Q 003301          815 MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       815 ~~~~~~~gt~~y~APE~  831 (832)
                       ......||+.|+|||+
T Consensus       158 -~~~~~~gt~~y~apE~  173 (298)
T d1gz8a_         158 -TYTHEVVTLWYRAPEI  173 (298)
T ss_dssp             -CTTCCBCCCTTCCHHH
T ss_pred             -cceeecccceeeehhh
Confidence             2333579999999995

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.97  E-value=3.5e-32  Score=281.46  Aligned_cols=171  Identities=23%  Similarity=0.435  Sum_probs=140.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC----e
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNND----F  729 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~  729 (832)
                      .++|++.+.||+|+||+||+|.+. +|+.||||+++...   ....+.+.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            467999999999999999999975 59999999997543   334567899999999999999999999987644    4


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      .|+||||++|++|.+++...+ .+++.++..++.|++.|++|||   ++||+||||||+||+++.++.++++|||.+...
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence            799999999999999987654 6999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCcc--cccccccccccccCCCCC
Q 003301          810 SGEES--MKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       810 ~~~~~--~~~~~~~gt~~y~APE~l  832 (832)
                      .....  ......+||+.|||||++
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~  186 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQA  186 (277)
T ss_dssp             C----------------TTCCHHHH
T ss_pred             ccccccccccccccCcccccCHHHH
Confidence            43322  223345799999999963

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.8e-32  Score=285.69  Aligned_cols=164  Identities=28%  Similarity=0.403  Sum_probs=137.6

Q ss_pred             CCCeeeccCCceEEEEEec-CCcEEEEEEEeccch-----hhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          663 ASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE-----GALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       663 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ..++||+|+||+||+|++. +|+.||||+++....     ...+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4578999999999999986 489999999864432     1235688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      ++++++..+.. ....+++..+..++.||+.||+|||   ++||+||||||+||+++.++.+||+|||.|+........ 
T Consensus        82 ~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-  156 (299)
T d1ua2a_          82 METDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-  156 (299)
T ss_dssp             CSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-
T ss_pred             hcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCccc-
Confidence            98776665544 4447899999999999999999999   999999999999999999999999999999876544332 


Q ss_pred             cccccccccccCCCC
Q 003301          817 QTLTLATIGYMAPGL  831 (832)
Q Consensus       817 ~~~~~gt~~y~APE~  831 (832)
                      ....+||+.|||||+
T Consensus       157 ~~~~~gt~~y~aPE~  171 (299)
T d1ua2a_         157 YTHQVVTRWYRAPEL  171 (299)
T ss_dssp             CCCSCCCCTTCCHHH
T ss_pred             ccceecChhhccHHH
Confidence            233579999999996

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.3e-32  Score=281.14  Aligned_cols=170  Identities=27%  Similarity=0.414  Sum_probs=137.8

Q ss_pred             cCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecCC----eeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNND----FKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  734 (832)
                      ++|.+.+.||+|+||.||+|++ +|+.||||++...... ......|+..+.+++||||+++++++.+++    ..|+||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4678889999999999999997 7899999998754321 122334555556789999999999997654    679999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFG-----YSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      |||++|+|.+++++.  .+++..+.+++.|+|.|++|+|..     +++||+||||||+|||++.++.+||+|||+|+..
T Consensus        81 Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            999999999999875  489999999999999999999931     1369999999999999999999999999999876


Q ss_pred             CCCccc---ccccccccccccCCCCC
Q 003301          810 SGEESM---KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       810 ~~~~~~---~~~~~~gt~~y~APE~l  832 (832)
                      ......   .....+||++|||||++
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~  184 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVL  184 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHH
T ss_pred             cCCCcceeccccceecccCcCChhhc
Confidence            443321   22346799999999963

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=5.5e-30  Score=279.21  Aligned_cols=357  Identities=24%  Similarity=0.316  Sum_probs=195.4

Q ss_pred             EEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceeccccccc
Q 003301          100 LYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKL  179 (832)
Q Consensus       100 L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l  179 (832)
                      ..++.+.+++.++  ...+.+|++|++++|.|+..  +.+..+++|++|+|++|+|++ +| .++++++|++|++++|++
T Consensus        27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i  100 (384)
T d2omza2          27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQI  100 (384)
T ss_dssp             HHTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCC
T ss_pred             HHhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCC-Cc-cccCCccccccccccccc
Confidence            3566666665443  34566788888888888742  457777888888888888874 33 277777777777777777


Q ss_pred             ccccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCc
Q 003301          180 VGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPN  259 (832)
Q Consensus       180 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~  259 (832)
                      .++.  .+.++++|+.|++++|.+++..+.    .....+..+....|.+....+..................+      
T Consensus       101 ~~i~--~l~~l~~L~~L~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~------  168 (384)
T d2omza2         101 ADIT--PLANLTNLTGLTLFNNQITDIDPL----KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL------  168 (384)
T ss_dssp             CCCG--GGTTCTTCCEEECCSSCCCCCGGG----TTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCC------
T ss_pred             cccc--cccccccccccccccccccccccc----cccccccccccccccccccccccccccccccccccccchh------
Confidence            6543  266677777777776666532211    1233444444444444332222211111111111111100      


Q ss_pred             cccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccc
Q 003301          260 TLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEI  339 (832)
Q Consensus       260 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~  339 (832)
                                                  ..+...+.........|...                           ....+
T Consensus       169 ----------------------------~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~  193 (384)
T d2omza2         169 ----------------------------KPLANLTTLERLDISSNKVS---------------------------DISVL  193 (384)
T ss_dssp             ----------------------------GGGTTCTTCCEEECCSSCCC---------------------------CCGGG
T ss_pred             ----------------------------hhhccccccccccccccccc---------------------------ccccc
Confidence                                        01122222222222222221                           12233


Q ss_pred             cCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCe
Q 003301          340 GNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRL  419 (832)
Q Consensus       340 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  419 (832)
                      ..+++++.+++++|.+++..|  +...++|++|++++|+++. + ..+..+++|+.|++++|++++..  .+..+++|+.
T Consensus       194 ~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~  267 (384)
T d2omza2         194 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTE  267 (384)
T ss_dssp             GGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSE
T ss_pred             ccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--cccccccCCE
Confidence            444455555555555554332  2334455555555555552 2 23455555666666666655432  2555566666


Q ss_pred             EeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccc
Q 003301          420 LSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGL  499 (832)
Q Consensus       420 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  499 (832)
                      |++++|++++..  .+..+..++.+++++|++++  ...+..++.++.|++++|++++..  .+..+++|++|++++|+|
T Consensus       268 L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l  341 (384)
T d2omza2         268 LKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKV  341 (384)
T ss_dssp             EECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCC
T ss_pred             eeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCC
Confidence            666666665433  24555666666666666654  233566666667777777776543  266677777777777777


Q ss_pred             cccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCC
Q 003301          500 QGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFN  545 (832)
Q Consensus       500 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N  545 (832)
                      ++ ++ .|+++++|++|+|++|++++.+|  +.++++|+.|+|++|
T Consensus       342 ~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         342 SD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            63 33 46677777777777777776544  666777777777766

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=1.1e-29  Score=276.81  Aligned_cols=358  Identities=24%  Similarity=0.309  Sum_probs=211.2

Q ss_pred             cccccccccccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEeccc
Q 003301           74 GMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFN  153 (832)
Q Consensus        74 ~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N  153 (832)
                      ..+++.+.+++.++.+   .+.+|++|++++|.|+. + +.+..+++|++|+|++|+|++..  .|+++++|++|++++|
T Consensus        26 ~~~l~~~~~~~~~~~~---~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n   98 (384)
T d2omza2          26 KTVLGKTNVTDTVSQT---DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNN   98 (384)
T ss_dssp             HHHTTCSSTTSEECHH---HHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSS
T ss_pred             HHHhCCCCCCCccCHH---HhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCc--cccCCccccccccccc
Confidence            3467788888766654   56789999999999994 4 46899999999999999999653  3999999999999999


Q ss_pred             ccccccCccccCccccceecccccccccccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCcccccc
Q 003301          154 NLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGII  233 (832)
Q Consensus       154 ~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~  233 (832)
                      ++++. + .++++++|+.|++++|.+++..+  ......+..+....|.+....+...  ...............+    
T Consensus        99 ~i~~i-~-~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~----  168 (384)
T d2omza2          99 QIADI-T-PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSG--LTSLQQLSFGNQVTDL----  168 (384)
T ss_dssp             CCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTT--CTTCSEEEEEESCCCC----
T ss_pred             ccccc-c-ccccccccccccccccccccccc--ccccccccccccccccccccccccc--cccccccccccccchh----
Confidence            99854 3 38899999999999999986533  4556778888888887763322211  1222222222222222    


Q ss_pred             CCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCc
Q 003301          234 PSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSS  313 (832)
Q Consensus       234 ~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  313 (832)
                       ..+...+.........|...  ....+..+++++.+++++|.++.+..       +..+++|++|++++|++++     
T Consensus       169 -~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~-------~~~~~~L~~L~l~~n~l~~-----  233 (384)
T d2omza2         169 -KPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP-------LGILTNLDELSLNGNQLKD-----  233 (384)
T ss_dssp             -GGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG-------GGGCTTCCEEECCSSCCCC-----
T ss_pred             -hhhccccccccccccccccc--cccccccccccceeeccCCccCCCCc-------ccccCCCCEEECCCCCCCC-----
Confidence             22344455555555555544  23444555666666666666554221       2334455555555554431     


Q ss_pred             ccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCC
Q 003301          314 IGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARL  393 (832)
Q Consensus       314 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  393 (832)
                                            ++.+..+++|+.|++++|.+++..+  +..+++|++|++++|++++..  .+..++.+
T Consensus       234 ----------------------~~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l  287 (384)
T d2omza2         234 ----------------------IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTAL  287 (384)
T ss_dssp             ----------------------CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTC
T ss_pred             ----------------------cchhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccc
Confidence                                  1234455566666666666554332  555556666666666655322  24445555


Q ss_pred             cEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCc
Q 003301          394 SVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRN  473 (832)
Q Consensus       394 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  473 (832)
                      +.++++.|.+++.  ..+..+++++.|++++|+++++.+                          +..+++|+.|++++|
T Consensus       288 ~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~--------------------------l~~l~~L~~L~L~~n  339 (384)
T d2omza2         288 TNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDISP--------------------------VSSLTKLQRLFFANN  339 (384)
T ss_dssp             SEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGG--------------------------GGGCTTCCEEECCSS
T ss_pred             ccccccccccccc--cccchhcccCeEECCCCCCCCCcc--------------------------cccCCCCCEEECCCC
Confidence            5555555555431  234445555555555555544321                          344444444444444


Q ss_pred             ccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCC
Q 003301          474 NLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNN  521 (832)
Q Consensus       474 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  521 (832)
                      +|++ ++ .|+++++|++|++++|+|++..|  ++++++|+.|+|++|
T Consensus       340 ~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         340 KVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            4442 22 34455555555555555554332  455555555555554

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.4e-32  Score=283.80  Aligned_cols=170  Identities=29%  Similarity=0.463  Sum_probs=141.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-Cc----EEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GM----EVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  732 (832)
                      ++|++.++||+|+||+||+|.+.. |+    +||+|+++... ....+.+.+|++++++++|||||+++|++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            469999999999999999998753 43    58888876433 34567899999999999999999999999875 4678


Q ss_pred             EEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCC
Q 003301          733 VLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGE  812 (832)
Q Consensus       733 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~  812 (832)
                      +|||+.+|+|.+++......+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            88999999999999887778999999999999999999999   999999999999999999999999999999987544


Q ss_pred             ccc-ccccccccccccCCCCC
Q 003301          813 ESM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       813 ~~~-~~~~~~gt~~y~APE~l  832 (832)
                      ... ......||+.|||||++
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l  185 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESI  185 (317)
T ss_dssp             CC--------CCTTTSCHHHH
T ss_pred             cccccccccccCccccChHHH
Confidence            332 22334689999999963

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=4.7e-32  Score=283.77  Aligned_cols=173  Identities=24%  Similarity=0.426  Sum_probs=147.8

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNND  728 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  728 (832)
                      -..++|++.+.||+|+||+||+|++.      +++.||||++.... ....+++.+|++++++++||||+++++++.+.+
T Consensus        10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~   89 (301)
T d1lufa_          10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK   89 (301)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence            34678999999999999999999874      25789999987544 334568999999999999999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCC
Q 003301          729 FKALVLEYMPNGSLEDYLYSNN-----------------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDI  785 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl  785 (832)
                      ..++||||+++|+|.+++....                       ..+++..+..++.|++.|++|+|   +++||||||
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDl  166 (301)
T d1lufa_          90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL  166 (301)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEE
Confidence            9999999999999999996532                       23788999999999999999999   999999999


Q ss_pred             CCCCeEeCCCCcEEEeccccccccCCCccc-ccccccccccccCCCC
Q 003301          786 KPSNVLLDKDMVAHLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGL  831 (832)
Q Consensus       786 kp~NIl~~~~~~~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~  831 (832)
                      ||+|||++.++.+||+|||+|+........ ..+...||+.|||||+
T Consensus       167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~  213 (301)
T d1lufa_         167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES  213 (301)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHH
T ss_pred             cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHH
Confidence            999999999999999999999876443322 2234568999999996

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.7e-32  Score=282.79  Aligned_cols=178  Identities=22%  Similarity=0.395  Sum_probs=138.6

Q ss_pred             HHHHHHhcCCCCCCeeeccCCceEEEEEecC------CcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceE
Q 003301          652 KELLQATNQFNASNLIGTGGFGSVYKGSFLD------GMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISS  723 (832)
Q Consensus       652 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~  723 (832)
                      ++++...++|++.+.||+|+||+||+|.+..      ++.||||+++... ....+.+.+|.+++.++ +|+||+.++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            3443445789999999999999999998642      4689999986543 33456777888888776 68999999998


Q ss_pred             EecC-CeeEEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCC
Q 003301          724 CTNN-DFKALVLEYMPNGSLEDYLYSNN---------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKP  787 (832)
Q Consensus       724 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp  787 (832)
                      +..+ +..++|||||++|+|.++++..+               ..+++..+..++.|++.||+|||   +++||||||||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp  162 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAA  162 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCG
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCc
Confidence            7654 46899999999999999997542               24789999999999999999999   99999999999


Q ss_pred             CCeEeCCCCcEEEeccccccccCCCccc-ccccccccccccCCCCC
Q 003301          788 SNVLLDKDMVAHLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       788 ~NIl~~~~~~~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~l  832 (832)
                      +|||++.++.+||+|||+|+........ ......||+.|||||++
T Consensus       163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l  208 (299)
T d1ywna1         163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI  208 (299)
T ss_dssp             GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHH
T ss_pred             cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHh
Confidence            9999999999999999999876443322 23345799999999963

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.2e-32  Score=277.45  Aligned_cols=168  Identities=29%  Similarity=0.352  Sum_probs=143.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccch------hhHHHHHHHHHHHhcCC--CCceeeeceEEecCC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLE------GALKSFDVECEVLKSVR--HRNLVKIISSCTNND  728 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~  728 (832)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.....      ....++.+|++++++++  |||||++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            368999999999999999999986 589999999875421      11234668999999986  899999999999999


Q ss_pred             eeEEEEecCCC-CCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCC-CcEEEeccccc
Q 003301          729 FKALVLEYMPN-GSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKD-MVAHLSDFGIA  806 (832)
Q Consensus       729 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~-~~~kl~DFg~a  806 (832)
                      ..|+||||+.+ +++.+++.... .+++..+..++.|++.||+|||   ++||+||||||+||+++.+ +.+||+|||+|
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccc
Confidence            99999999976 57888887654 6999999999999999999999   9999999999999999854 79999999999


Q ss_pred             cccCCCcccccccccccccccCCCCC
Q 003301          807 KLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       807 ~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      +......   .+..+||+.|||||++
T Consensus       159 ~~~~~~~---~~~~~GT~~y~aPE~~  181 (273)
T d1xwsa_         159 ALLKDTV---YTDFDGTRVYSPPEWI  181 (273)
T ss_dssp             EECCSSC---BCCCCSCGGGSCHHHH
T ss_pred             eeccccc---ccccccCCCcCCHHHH
Confidence            8754332   2345799999999963

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.97  E-value=1.9e-31  Score=277.48  Aligned_cols=168  Identities=26%  Similarity=0.396  Sum_probs=143.2

Q ss_pred             cCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEec
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ++|++.++||+|+||+||+|++.+|+.||||++....  +...+.+.+|+.++++++|||||++++++.+++..|++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            6899999999999999999999889999999997543  23357899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCcccc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESMK  816 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~~  816 (832)
                      +.++.+..+.. ....+++..+..++.||+.||+|||   +.+||||||||+||+++.++.+|++|||.|........ .
T Consensus        82 ~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~  156 (286)
T d1ob3a_          82 LDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K  156 (286)
T ss_dssp             CSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-c
Confidence            97655555544 4457999999999999999999999   99999999999999999999999999999987654433 2


Q ss_pred             cccccccccccCCCC
Q 003301          817 QTLTLATIGYMAPGL  831 (832)
Q Consensus       817 ~~~~~gt~~y~APE~  831 (832)
                      .....|++.|+|||+
T Consensus       157 ~~~~~~~~~y~~pE~  171 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDV  171 (286)
T ss_dssp             -----CCCTTCCHHH
T ss_pred             cceecccchhhhHHH
Confidence            233569999999996

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.3e-31  Score=275.40  Aligned_cols=170  Identities=25%  Similarity=0.400  Sum_probs=136.2

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC----CcEEEEEEEeccc---hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD----GMEVAIKVFHLQL---EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  731 (832)
                      ++|++.+.||+|+||+||+|++..    ...||||++....   ....+++.+|++++++++||||++++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            579999999999999999998643    2468999886542   3445789999999999999999999999975 4678


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      +||||+++|++.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            999999999999988776667999999999999999999999   99999999999999999999999999999998754


Q ss_pred             Cccc--ccccccccccccCCCCC
Q 003301          812 EESM--KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~--~~~~~~gt~~y~APE~l  832 (832)
                      ....  ......||+.|+|||++
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~  186 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESL  186 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHH
T ss_pred             CCCcceecCccccCcccCCHHHH
Confidence            4322  22334688899999963

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1e-31  Score=273.91  Aligned_cols=164  Identities=34%  Similarity=0.499  Sum_probs=135.5

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEec-CCeeEEEEec
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTN-NDFKALVLEY  736 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~  736 (832)
                      .++|++.+.||+|+||.||+|++ .|++||||+++..  ...+.+.+|++++++++||||++++|++.+ .+..|+||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            45788999999999999999998 6889999998654  334789999999999999999999999865 4568999999


Q ss_pred             CCCCCHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          737 MPNGSLEDYLYSNN-FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       737 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      +++|+|.+++.... ..+++..+.+++.||+.|++|||   +.+|+||||||+||+++.++.+|++|||+++......  
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--  157 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  157 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCCC--
Confidence            99999999997543 24899999999999999999999   9999999999999999999999999999998754322  


Q ss_pred             ccccccccccccCCCC
Q 003301          816 KQTLTLATIGYMAPGL  831 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~  831 (832)
                        ....+|+.|+|||+
T Consensus       158 --~~~~~~~~y~aPE~  171 (262)
T d1byga_         158 --DTGKLPVKWTAPEA  171 (262)
T ss_dssp             ------CCTTTSCHHH
T ss_pred             --ccccccccCCChHH
Confidence              22458999999996

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.7e-31  Score=276.96  Aligned_cols=169  Identities=28%  Similarity=0.506  Sum_probs=141.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEecC-Cc--EEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCCeeEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFLD-GM--EVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTNNDFKALV  733 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  733 (832)
                      ++|++.++||+|+||+||+|++.+ +.  .||||++.... ....+.+.+|+++++++ +|||||++++++.+++..|+|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            689999999999999999998864 43  47788875432 33456899999999998 799999999999999999999


Q ss_pred             EecCCCCCHHHHHhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcE
Q 003301          734 LEYMPNGSLEDYLYSN---------------NFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVA  798 (832)
Q Consensus       734 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~  798 (832)
                      |||+++|+|.++++..               ...+++..+.+++.||+.|+.|+|   +++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            9999999999999754               246899999999999999999999   9999999999999999999999


Q ss_pred             EEeccccccccCCCcccccccccccccccCCCCC
Q 003301          799 HLSDFGIAKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       799 kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ||+|||+|+.......  .....||+.|+|||++
T Consensus       167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l  198 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESL  198 (309)
T ss_dssp             EECCTTCEESSCEECC--C----CCTTTCCHHHH
T ss_pred             EEcccccccccccccc--ccceecCCcccchHHh
Confidence            9999999986543222  2234699999999963

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.2e-30  Score=273.19  Aligned_cols=165  Identities=26%  Similarity=0.479  Sum_probs=141.9

Q ss_pred             CCeeeccCCceEEEEEecCC----cEEEEEEEecc-chhhHHHHHHHHHHHhcCCCCceeeeceEEec-CCeeEEEEecC
Q 003301          664 SNLIGTGGFGSVYKGSFLDG----MEVAIKVFHLQ-LEGALKSFDVECEVLKSVRHRNLVKIISSCTN-NDFKALVLEYM  737 (832)
Q Consensus       664 ~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  737 (832)
                      .++||+|+||+||+|++.++    ..||||+++.. .....+++.+|++++++++||||++++|++.+ ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            57899999999999987542    35899998643 34456789999999999999999999999865 56899999999


Q ss_pred             CCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc--
Q 003301          738 PNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM--  815 (832)
Q Consensus       738 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~--  815 (832)
                      ++|+|.+++.......++..+.+++.|++.|+.|+|   +++|+||||||+|||+++++.+||+|||+|+........  
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999999887777889999999999999999999   999999999999999999999999999999876543322  


Q ss_pred             -ccccccccccccCCCC
Q 003301          816 -KQTLTLATIGYMAPGL  831 (832)
Q Consensus       816 -~~~~~~gt~~y~APE~  831 (832)
                       ......||+.|+|||+
T Consensus       189 ~~~~~~~gt~~y~aPE~  205 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALES  205 (311)
T ss_dssp             TCTTCSSCCGGGSCHHH
T ss_pred             eecccccccccccChHH
Confidence             2223568999999996

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=7e-31  Score=275.94  Aligned_cols=172  Identities=24%  Similarity=0.441  Sum_probs=148.9

Q ss_pred             HhcCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcC-CCCceeeeceEEecCC
Q 003301          657 ATNQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSV-RHRNLVKIISSCTNND  728 (832)
Q Consensus       657 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  728 (832)
                      ..++|++.++||+|+||.||+|++.      +++.||||+++... ......+.+|+.+++++ +|||||++++++.+.+
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            3478999999999999999999863      35789999997543 34456788999999999 6999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhhCC-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeE
Q 003301          729 FKALVLEYMPNGSLEDYLYSNN-----------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVL  791 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl  791 (832)
                      ..|+|||||++|+|.++++...                 ..+++..+..++.||+.|++|||   ++++|||||||+||+
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl  177 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL  177 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccc
Confidence            9999999999999999997643                 24889999999999999999999   999999999999999


Q ss_pred             eCCCCcEEEeccccccccCCCcc-cccccccccccccCCCC
Q 003301          792 LDKDMVAHLSDFGIAKLLSGEES-MKQTLTLATIGYMAPGL  831 (832)
Q Consensus       792 ~~~~~~~kl~DFg~a~~~~~~~~-~~~~~~~gt~~y~APE~  831 (832)
                      ++.++.+|++|||.|+....... ......+||+.|+|||+
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~  218 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPES  218 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHH
T ss_pred             ccccCcccccccchheeccCCCcceEeeecccChHHcCHHH
Confidence            99999999999999987654332 23344679999999996

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.7e-31  Score=278.50  Aligned_cols=173  Identities=24%  Similarity=0.394  Sum_probs=147.7

Q ss_pred             HHhcCCCCCCeeeccCCceEEEEEec------CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC
Q 003301          656 QATNQFNASNLIGTGGFGSVYKGSFL------DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNND  728 (832)
Q Consensus       656 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  728 (832)
                      ...++|++.+.||+|+||.||+|.+.      +++.||||+++... ......+.+|++++++++||||+++++++..++
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence            34578999999999999999999874      25789999987543 334467899999999999999999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEE
Q 003301          729 FKALVLEYMPNGSLEDYLYSNN---------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAH  799 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~k  799 (832)
                      ..++||||+++|+|.+++...+         ..+++..+.+++.|++.||+|||   +++|+||||||+|||++.++.+|
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~K  173 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK  173 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEE
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEE
Confidence            9999999999999999986421         24688999999999999999999   99999999999999999999999


Q ss_pred             EeccccccccCCCccc-ccccccccccccCCCC
Q 003301          800 LSDFGIAKLLSGEESM-KQTLTLATIGYMAPGL  831 (832)
Q Consensus       800 l~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~  831 (832)
                      |+|||+|+........ ......||+.|+|||.
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~  206 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES  206 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHH
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHH
Confidence            9999999876443322 2333468999999995

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.5e-30  Score=271.79  Aligned_cols=172  Identities=26%  Similarity=0.469  Sum_probs=142.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEecC--------CcEEEEEEEeccch-hhHHHHHHHHHHHhcC-CCCceeeeceEEecC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFLD--------GMEVAIKVFHLQLE-GALKSFDVECEVLKSV-RHRNLVKIISSCTNN  727 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  727 (832)
                      .++|++++.||+|+||.||+|+...        +..||||+++.... .....+.+|...+.++ +|||||++++++.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            4789999999999999999998643        24799999876543 3456788899888888 899999999999999


Q ss_pred             CeeEEEEecCCCCCHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEe
Q 003301          728 DFKALVLEYMPNGSLEDYLYSNN---------------FSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLL  792 (832)
Q Consensus       728 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~  792 (832)
                      +..|+|||||++|+|.+++....               ..+++..+..++.|++.||+|||   +++||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence            99999999999999999997543               34899999999999999999999   9999999999999999


Q ss_pred             CCCCcEEEeccccccccCCCccc-ccccccccccccCCCCC
Q 003301          793 DKDMVAHLSDFGIAKLLSGEESM-KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       793 ~~~~~~kl~DFg~a~~~~~~~~~-~~~~~~gt~~y~APE~l  832 (832)
                      +.++.+||+|||.++........ ......||+.|+|||++
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l  209 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL  209 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHH
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHh
Confidence            99999999999999876443322 23345699999999963

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.96  E-value=5.5e-30  Score=266.62  Aligned_cols=168  Identities=21%  Similarity=0.317  Sum_probs=144.3

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCC-CceeeeceEEecCCeeEEEEec
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRH-RNLVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~  736 (832)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.....  .+.+.+|+++++.++| +|++.+++++.++...|+||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            57999999999999999999986 589999998865432  2457789999999965 8999999999999999999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC-----CCcEEEeccccccccCC
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK-----DMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~-----~~~~kl~DFg~a~~~~~  811 (832)
                      + +++|.+++......+++..+..++.|++.|++|||   ++||+||||||+||+++.     ++.+||+|||+|+....
T Consensus        83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9 78999999887777999999999999999999999   999999999999999964     57899999999987643


Q ss_pred             Cccc------ccccccccccccCCCCC
Q 003301          812 EESM------KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~------~~~~~~gt~~y~APE~l  832 (832)
                      ....      .....+||+.|||||++
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~  185 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTH  185 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred             CccccceeecccCceEEchhhcCHHHh
Confidence            3211      12235799999999963

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.9e-30  Score=273.78  Aligned_cols=170  Identities=24%  Similarity=0.309  Sum_probs=140.0

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc-hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC----eeE
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL-EGALKSFDVECEVLKSVRHRNLVKIISSCTNND----FKA  731 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~  731 (832)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++.... ....+.+.+|++++++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            357999999999999999999875 69999999997543 344568889999999999999999999987543    234


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCC
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSG  811 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~  811 (832)
                      ++++|+.+|+|.+++...  .+++..++.++.|++.||+|||   ++|||||||||+|||++.++.+||+|||+|+....
T Consensus        87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            445556699999999765  5899999999999999999999   99999999999999999999999999999987644


Q ss_pred             Cccc--ccccccccccccCCCCC
Q 003301          812 EESM--KQTLTLATIGYMAPGLF  832 (832)
Q Consensus       812 ~~~~--~~~~~~gt~~y~APE~l  832 (832)
                      ....  .....+||+.|+|||++
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l  184 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIM  184 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGT
T ss_pred             CCccceeeccccccceechHHHh
Confidence            3221  23345799999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2e-30  Score=272.60  Aligned_cols=170  Identities=29%  Similarity=0.409  Sum_probs=140.4

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-C-CcEEEEEEEeccch--hhHHHHHHHHHHHhcC---CCCceeeeceEEec----
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-D-GMEVAIKVFHLQLE--GALKSFDVECEVLKSV---RHRNLVKIISSCTN----  726 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----  726 (832)
                      .++|++.+.||+|+||+||+|++. + ++.||||+++....  .....+.+|+++++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            478999999999999999999984 3 56799999875432  2234566788777665   79999999999853    


Q ss_pred             -CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccc
Q 003301          727 -NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGI  805 (832)
Q Consensus       727 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~  805 (832)
                       ....|++|||++++.+..........+++..++.++.|++.||+|||   +++||||||||+|||++.++.+||+|||.
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhh
Confidence             34689999999887776666555567999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCcccccccccccccccCCCCC
Q 003301          806 AKLLSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       806 a~~~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ++......  .....+||+.|||||++
T Consensus       163 ~~~~~~~~--~~~~~~gT~~Y~APE~~  187 (305)
T d1blxa_         163 ARIYSFQM--ALTSVVVTLWYRAPEVL  187 (305)
T ss_dssp             CCCCCGGG--GGCCCCCCCTTCCHHHH
T ss_pred             hhhhcccc--cCCCcccChhhcCcchh
Confidence            98654332  33446799999999963

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=6.1e-30  Score=273.70  Aligned_cols=165  Identities=25%  Similarity=0.370  Sum_probs=138.3

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCC------
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNND------  728 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  728 (832)
                      .++|++.+.||+|+||+||+|.+. +|+.||||+++...  ....+.+.+|++++++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999986 49999999987543  334567889999999999999999999997654      


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          729 FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      ..|+||||+ +.++..+.+..  .+++..++.++.|++.||+|||   ++||+||||||+|||++.++.+|++|||.|+.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence            579999999 77888887664  5999999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCcccccccccccccccCCCCC
Q 003301          809 LSGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       809 ~~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      .....    +..+||+.|+|||++
T Consensus       171 ~~~~~----~~~~~t~~y~aPE~~  190 (346)
T d1cm8a_         171 ADSEM----TGYVVTRWYRAPEVI  190 (346)
T ss_dssp             CCSSC----CSSCSCGGGCCTHHH
T ss_pred             cCCcc----ccccccccccCHHHH
Confidence            64432    335799999999963

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.96  E-value=9.1e-30  Score=270.33  Aligned_cols=161  Identities=21%  Similarity=0.400  Sum_probs=139.5

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCC-CCceeeeceEEec--CCeeEEEE
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVR-HRNLVKIISSCTN--NDFKALVL  734 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  734 (832)
                      ++|++.++||+|+||+||+|++. +++.||||+++...   .+++.+|++++++++ ||||+++++++..  ....|+||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            68999999999999999999985 58999999987543   367889999999995 9999999999874  45689999


Q ss_pred             ecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC-cEEEeccccccccCCCc
Q 003301          735 EYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       735 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~DFg~a~~~~~~~  813 (832)
                      |||++++|.++.+    .+++..+..++.||+.||+|||   ++||+||||||+|||++.++ .+||+|||+|+......
T Consensus       112 e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            9999999977642    5899999999999999999999   99999999999999998655 69999999998765443


Q ss_pred             ccccccccccccccCCCC
Q 003301          814 SMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       814 ~~~~~~~~gt~~y~APE~  831 (832)
                      .  ....+||+.|+|||+
T Consensus       185 ~--~~~~~~t~~y~aPE~  200 (328)
T d3bqca1         185 E--YNVRVASRYFKGPEL  200 (328)
T ss_dssp             C--CCSCCSCGGGCCHHH
T ss_pred             c--ccccccCccccCccc
Confidence            2  234579999999996

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.6e-30  Score=271.02  Aligned_cols=170  Identities=28%  Similarity=0.403  Sum_probs=149.2

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec----CCcEEEEEEEeccc----hhhHHHHHHHHHHHhcCCC-CceeeeceEEecCC
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL----DGMEVAIKVFHLQL----EGALKSFDVECEVLKSVRH-RNLVKIISSCTNND  728 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~  728 (832)
                      .++|++.+.||+|+||+||+|...    +|+.||||+++...    ....+.+.+|++++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            367999999999999999999863    37899999986432    2334678889999999976 89999999999999


Q ss_pred             eeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          729 FKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       729 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      ..|+||||+.+|+|.+++...+ .+++..+..++.|++.|++|+|   +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             ceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            9999999999999999998765 5788999999999999999999   99999999999999999999999999999988


Q ss_pred             cCCCcccccccccccccccCCCC
Q 003301          809 LSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       809 ~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      +............|++.|+|||+
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~  201 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDI  201 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHH
T ss_pred             hcccccccccccccccccchhHH
Confidence            76555544555679999999995

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.7e-29  Score=262.45  Aligned_cols=168  Identities=25%  Similarity=0.370  Sum_probs=147.2

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecCCeeEEEEe
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNNDFKALVLE  735 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  735 (832)
                      ++|++.++||+|+||+||+|++. +++.||||+++...  ....+++.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999986 58899999997543  3345788999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccccccCCCccc
Q 003301          736 YMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLLSGEESM  815 (832)
Q Consensus       736 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~~~~~~~  815 (832)
                      ++.++++..++... ..+++..+..++.|++.||+|||   ++||+||||||+||+++.++.+||+|||.|+........
T Consensus        82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred             eccccccccccccc-cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence            99888888777654 47899999999999999999999   999999999999999999999999999999887544332


Q ss_pred             ccccccccccccCCCC
Q 003301          816 KQTLTLATIGYMAPGL  831 (832)
Q Consensus       816 ~~~~~~gt~~y~APE~  831 (832)
                       .....+++.|+|||+
T Consensus       158 -~~~~~~~~~~~~pe~  172 (292)
T d1unla_         158 -YSAEVVTLWYRPPDV  172 (292)
T ss_dssp             -CCSCCSCGGGCCHHH
T ss_pred             -ceeeccccchhhhhH
Confidence             223457888999985

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.6e-29  Score=270.39  Aligned_cols=163  Identities=29%  Similarity=0.442  Sum_probs=134.4

Q ss_pred             CCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCceeeeceEEecC------CeeEE
Q 003301          660 QFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNLVKIISSCTNN------DFKAL  732 (832)
Q Consensus       660 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l  732 (832)
                      +|+..++||+|+||+||+|++. +|+.||||++.....    ...+|++++++++||||+++++++...      .+.|+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            6888899999999999999986 489999999975532    234699999999999999999998542      35789


Q ss_pred             EEecCCCCCHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCC-cEEEecccccccc
Q 003301          733 VLEYMPNGSLEDYLY--SNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDM-VAHLSDFGIAKLL  809 (832)
Q Consensus       733 v~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~-~~kl~DFg~a~~~  809 (832)
                      |||||+++....+..  .....+++..++.++.|++.||+|||   ++||+||||||+|||++.++ .+||+|||+|+..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999997653333322  34446999999999999999999999   99999999999999999775 8999999999876


Q ss_pred             CCCcccccccccccccccCCCC
Q 003301          810 SGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       810 ~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      .....  ....+||+.|+|||+
T Consensus       174 ~~~~~--~~~~~gt~~y~aPE~  193 (350)
T d1q5ka_         174 VRGEP--NVSYICSRYYRAPEL  193 (350)
T ss_dssp             CTTSC--CCSCCSCTTSCCHHH
T ss_pred             cCCcc--cccccccccccChHH
Confidence            54332  233579999999995

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.8e-29  Score=266.97  Aligned_cols=170  Identities=28%  Similarity=0.445  Sum_probs=138.9

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEec--------
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTN--------  726 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  726 (832)
                      .++|++.+.||+|+||+||+|++. +|+.||||++....  +...+++.+|++++++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            478999999999999999999985 59999999976442  3345678899999999999999999998855        


Q ss_pred             CCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEeccccc
Q 003301          727 NDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIA  806 (832)
Q Consensus       727 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a  806 (832)
                      ++..|+||||++++.+. ........+++..++.++.|++.||+|||   +.||+||||||+||+++.++.+|++|||+|
T Consensus        89 ~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence            34689999999766555 44444557999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCccc---ccccccccccccCCCC
Q 003301          807 KLLSGEESM---KQTLTLATIGYMAPGL  831 (832)
Q Consensus       807 ~~~~~~~~~---~~~~~~gt~~y~APE~  831 (832)
                      +........   .....+||+.|+|||+
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~  192 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPEL  192 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHH
T ss_pred             eecccccccccccccceecCHHHhhHHH
Confidence            876543221   2223579999999996

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.95  E-value=4.6e-29  Score=261.15  Aligned_cols=167  Identities=26%  Similarity=0.423  Sum_probs=139.1

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCc-eeeeceEEecCCeeEEEEec
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRN-LVKIISSCTNNDFKALVLEY  736 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~  736 (832)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.....  .+.+.+|+++++.++|++ |+.+.+++.+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            57999999999999999999885 489999999875533  246788999999998766 45555666788899999999


Q ss_pred             CCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCC---CCcEEEeccccccccCCCc
Q 003301          737 MPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDK---DMVAHLSDFGIAKLLSGEE  813 (832)
Q Consensus       737 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~---~~~~kl~DFg~a~~~~~~~  813 (832)
                      + ++++.+.+......+++..+..++.|++.||+|||   ++||+||||||+||+++.   +..+|++|||+|+.+....
T Consensus        85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            9 67888887776668999999999999999999999   999999999999999864   4579999999999875433


Q ss_pred             cc------ccccccccccccCCCC
Q 003301          814 SM------KQTLTLATIGYMAPGL  831 (832)
Q Consensus       814 ~~------~~~~~~gt~~y~APE~  831 (832)
                      ..      .....+||+.|||||+
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~  184 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINT  184 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHH
T ss_pred             cccceeccccCCcCCCccccCHHH
Confidence            21      2233579999999996

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=6.2e-27  Score=246.08  Aligned_cols=289  Identities=21%  Similarity=0.278  Sum_probs=204.1

Q ss_pred             cCcEEEccCCcCCCCCCCcccCcccccccccccccccccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEE
Q 003301           46 ELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVIS  125 (832)
Q Consensus        46 ~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~  125 (832)
                      .+++++.++++++ ++|..+.  +++ ++|||++|+|+ ++|+..+.++++|++|++++|+++...|..|.++++|++|+
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~--~~l-~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~   85 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP--PDT-ALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY   85 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTC-CEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred             cCCEEEecCCCCC-ccCCCCC--CCC-CEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEec
Confidence            4677888888887 7777654  345 77888888887 77776666888888888888888876677788888888888


Q ss_pred             CcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccccccc--cccCcccccCCcccEEEecCCCC
Q 003301          126 LAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLV--GFVPTSIFNLSAMKTLALPSNAL  203 (832)
Q Consensus       126 Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~n~l  203 (832)
                      +++|+++. +|..+.  ..++.|++++|.+.+..+..+.....++.++...|...  ...+..+..+++|+.+++++|.+
T Consensus        86 l~~n~l~~-l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l  162 (305)
T d1xkua_          86 LSKNQLKE-LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI  162 (305)
T ss_dssp             CCSSCCSB-CCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred             ccCCccCc-Cccchh--hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCc
Confidence            88888874 554433  56788888888888665556667777777777776543  33455677788888888888887


Q ss_pred             CCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCc
Q 003301          204 SGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSE  283 (832)
Q Consensus       204 ~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  283 (832)
                      . .+|..    .+++|++|++++|.++...+..|.+++.+++|++++|.+++..+..|.++++|++|+|++|+|+.++  
T Consensus       163 ~-~l~~~----~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp--  235 (305)
T d1xkua_         163 T-TIPQG----LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP--  235 (305)
T ss_dssp             C-SCCSS----CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCC--
T ss_pred             c-ccCcc----cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccccc--
Confidence            6 44443    2577888888888888787788888888888888888888777777888888888888888887643  


Q ss_pred             cccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCccc--ccccc
Q 003301          284 LSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELI--GSIPI  361 (832)
Q Consensus       284 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~  361 (832)
                          .+|..+++|++|+|++|+|+......|..                   +..+..+.+|+.|+|++|.+.  ...|.
T Consensus       236 ----~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~-------------------~~~~~~~~~L~~L~L~~N~~~~~~~~~~  292 (305)
T d1xkua_         236 ----GGLADHKYIQVVYLHNNNISAIGSNDFCP-------------------PGYNTKKASYSGVSLFSNPVQYWEIQPS  292 (305)
T ss_dssp             ----TTTTTCSSCCEEECCSSCCCCCCTTSSSC-------------------SSCCTTSCCCSEEECCSSSSCGGGSCGG
T ss_pred             ----cccccccCCCEEECCCCccCccChhhccC-------------------cchhcccCCCCEEECCCCcCccCcCCHh
Confidence                34677778888888888776433222221                   223344556666666666653  34455


Q ss_pred             cccCCCCCceE
Q 003301          362 TFGKLQNLQGL  372 (832)
Q Consensus       362 ~~~~l~~L~~L  372 (832)
                      +|..+.....+
T Consensus       293 ~f~~~~~~~~~  303 (305)
T d1xkua_         293 TFRCVYVRAAV  303 (305)
T ss_dssp             GGTTCCCGGGE
T ss_pred             HhcccccCccc
Confidence            55554444433

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=8.7e-27  Score=244.94  Aligned_cols=266  Identities=24%  Similarity=0.327  Sum_probs=155.3

Q ss_pred             CccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccccccccccCcccccCCcccEEEec
Q 003301          120 ELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALP  199 (832)
Q Consensus       120 ~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  199 (832)
                      ..+.+|.+++.++ .+|..+.  +++++|+|++|+|+...+.+|.++++|++|++++|++..+.|.+|.++++|++|+++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~   87 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS   87 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence            4555666666665 4455553  466677777777764444466667777777777777766666666677777777777


Q ss_pred             CCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcc--cCCccccCccccceeecccccC
Q 003301          200 SNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSG--FIPNTLGNLRKLEWLRLSYNFL  277 (832)
Q Consensus       200 ~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~L~~N~l  277 (832)
                      +|+++ .+|...    .+.+..|++++|.+..+.+..+.....+..++...|....  ..+.                  
T Consensus        88 ~n~l~-~l~~~~----~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~------------------  144 (305)
T d1xkua_          88 KNQLK-ELPEKM----PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG------------------  144 (305)
T ss_dssp             SSCCS-BCCSSC----CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTT------------------
T ss_pred             CCccC-cCccch----hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCcc------------------
Confidence            77665 344322    2455556666665555555445555555555555554321  1222                  


Q ss_pred             CCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccc
Q 003301          278 TSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIG  357 (832)
Q Consensus       278 ~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  357 (832)
                                 .|..+++|+.+++++|.+.. +|..+   ..+|+.|++++|.+++..+..|.+++.++.|++++|.+.+
T Consensus       145 -----------~~~~l~~L~~l~l~~n~l~~-l~~~~---~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~  209 (305)
T d1xkua_         145 -----------AFQGMKKLSYIRIADTNITT-IPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA  209 (305)
T ss_dssp             -----------GGGGCTTCCEEECCSSCCCS-CCSSC---CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCE
T ss_pred             -----------ccccccccCccccccCCccc-cCccc---CCccCEEECCCCcCCCCChhHhhccccccccccccccccc
Confidence                       34445555555555555542 22222   1245555555555555556666666777777777777776


Q ss_pred             cccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccC------CCCCCCCeEeCCCCcC
Q 003301          358 SIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCI------GDLTSLRLLSLASNEL  427 (832)
Q Consensus       358 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~------~~l~~L~~L~L~~N~l  427 (832)
                      ..+..|.++++|++|+|++|+|+ .+|.+|..+++|++|+|++|+|+......|      ..+.+|+.|+|++|++
T Consensus       210 ~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~  284 (305)
T d1xkua_         210 VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV  284 (305)
T ss_dssp             ECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSS
T ss_pred             cccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcC
Confidence            66667777777777777777776 456666666777777777777664433333      2344455555555554

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.3e-28  Score=261.86  Aligned_cols=165  Identities=25%  Similarity=0.328  Sum_probs=130.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEec------CCe
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTN------NDF  729 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~  729 (832)
                      ++|++.++||+|+||+||+|.+. +|+.||||++....  ....+++.+|+.++++++|||||++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999999986 59999999997543  3344678899999999999999999999964      367


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      .|+|||||.+ ++.+.+.   ..+++..++.++.|++.|++|||   +.||+||||||+||+++.++.+|++|||.++..
T Consensus        97 ~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccch-HHHHhhh---cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence            8999999965 5555553   25899999999999999999999   999999999999999999999999999998865


Q ss_pred             CCCcccccccccccccccCCCCC
Q 003301          810 SGEESMKQTLTLATIGYMAPGLF  832 (832)
Q Consensus       810 ~~~~~~~~~~~~gt~~y~APE~l  832 (832)
                      ....  .....+||+.|+|||++
T Consensus       170 ~~~~--~~~~~~~t~~y~aPE~l  190 (355)
T d2b1pa1         170 GTSF--MMTPYVVTRYYRAPEVI  190 (355)
T ss_dssp             -------------CCTTCCHHHH
T ss_pred             cccc--ccccccccccccChhhh
Confidence            4432  23345799999999963

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.9e-28  Score=262.66  Aligned_cols=165  Identities=24%  Similarity=0.363  Sum_probs=137.8

Q ss_pred             hcCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccc--hhhHHHHHHHHHHHhcCCCCceeeeceEEecC-----Ce
Q 003301          658 TNQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQL--EGALKSFDVECEVLKSVRHRNLVKIISSCTNN-----DF  729 (832)
Q Consensus       658 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  729 (832)
                      .++|++.+.||+|+||+||+|++. +|+.||||++....  ....+++.+|++++++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            468999999999999999999875 59999999987543  23446788999999999999999999998643     33


Q ss_pred             eEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEecccccccc
Q 003301          730 KALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKLL  809 (832)
Q Consensus       730 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~~  809 (832)
                      .+++|+|+.+|+|.+++...  .+++..+..++.||+.||+|||   ++||+||||||+||+++.++.+|++|||.|...
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence            46667777899999999654  5999999999999999999999   999999999999999999999999999999765


Q ss_pred             CCCcccccccccccccccCCCC
Q 003301          810 SGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       810 ~~~~~~~~~~~~gt~~y~APE~  831 (832)
                      ...    .....||+.|+|||+
T Consensus       172 ~~~----~~~~~g~~~y~apE~  189 (348)
T d2gfsa1         172 DDE----MTGYVATRWYRAPEI  189 (348)
T ss_dssp             TGG----GSSSCHHHHTSCHHH
T ss_pred             Ccc----cccccccccccCchh
Confidence            322    233569999999995

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.3e-27  Score=246.39  Aligned_cols=227  Identities=26%  Similarity=0.262  Sum_probs=114.6

Q ss_pred             EEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEcc-C
Q 003301          298 LLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLV-N  376 (832)
Q Consensus       298 ~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls-~  376 (832)
                      .++.+++.++ .+|..+.   .++++|+|++|+|++..+..|.++++|++|++++|++....+..+..+..++.++.+ .
T Consensus        15 ~v~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~   90 (284)
T d1ozna_          15 TTSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (284)
T ss_dssp             EEECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             EEEcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence            3455665555 3444332   245555555555554444455555555555555555555555555555555554433 3


Q ss_pred             CccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCc
Q 003301          377 NKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLP  456 (832)
Q Consensus       377 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  456 (832)
                      |.++...+..|.++++|++|++++|.+....+..+...++|+.+++++|.++++.+..|                     
T Consensus        91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f---------------------  149 (284)
T d1ozna_          91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF---------------------  149 (284)
T ss_dssp             TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT---------------------
T ss_pred             cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHh---------------------
Confidence            34443334445555555555555555544444444444455555555555544444444                     


Q ss_pred             cccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhcc
Q 003301          457 EDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLY  536 (832)
Q Consensus       457 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  536 (832)
                         ..+++|+.|++++|++++..+.+|.++++|+.+++++|++++..|..|..+++|++||+++|++++..|..+..+++
T Consensus       150 ---~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~  226 (284)
T d1ozna_         150 ---RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA  226 (284)
T ss_dssp             ---TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred             ---ccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccc
Confidence               44444555555555554444445555555555555555555444555555555555555555555554455555555


Q ss_pred             CCeeeCCCCcccccCC
Q 003301          537 LKDLNLSFNKLEGEIP  552 (832)
Q Consensus       537 L~~l~l~~N~l~~~~p  552 (832)
                      |++|++++|+|.|.++
T Consensus       227 L~~L~l~~N~l~C~C~  242 (284)
T d1ozna_         227 LQYLRLNDNPWVCDCR  242 (284)
T ss_dssp             CCEEECCSSCEECSGG
T ss_pred             cCEEEecCCCCCCCcc
Confidence            5555555555555443

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=7.4e-27  Score=242.57  Aligned_cols=268  Identities=23%  Similarity=0.198  Sum_probs=209.6

Q ss_pred             ceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccE
Q 003301          268 EWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRE  347 (832)
Q Consensus       268 ~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  347 (832)
                      ..++.++++++++|..+  |      +++++|+|++|+|+...+.+|..+. .|++|++++|++....+..+..++.++.
T Consensus        14 ~~v~c~~~~L~~iP~~i--p------~~~~~L~Ls~N~i~~i~~~~f~~l~-~L~~L~ls~n~l~~i~~~~~~~~~~~~~   84 (284)
T d1ozna_          14 VTTSCPQQGLQAVPVGI--P------AASQRIFLHGNRISHVPAASFRACR-NLTILWLHSNVLARIDAAAFTGLALLEQ   84 (284)
T ss_dssp             CEEECCSSCCSSCCTTC--C------TTCSEEECTTSCCCEECTTTTTTCT-TCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred             eEEEcCCCCCCccCCCC--C------CCCCEEECcCCcCCCCCHHHhhccc-cccccccccccccccccccccccccccc
Confidence            45677888888877643  1      5789999999999977777888887 8999999999999999999999999999


Q ss_pred             EEee-cCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCc
Q 003301          348 LGLW-GNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNE  426 (832)
Q Consensus       348 L~L~-~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  426 (832)
                      ++.. .|.+....+..|+++++|++|++++|.+....+..+....+|+.+++++|++++..+..|..+++|+.|++++|+
T Consensus        85 l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~  164 (284)
T d1ozna_          85 LDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR  164 (284)
T ss_dssp             EECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             cccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCc
Confidence            9875 567777778899999999999999999987778888889999999999999998888899999999999999999


Q ss_pred             CCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCcc
Q 003301          427 LNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKS  506 (832)
Q Consensus       427 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  506 (832)
                      ++++.+.+|.++++|+++++++|++++..|..|..+++|++||+++|++.+..+..|+++++|++|+|++|++...-+ .
T Consensus       165 l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~  243 (284)
T d1ozna_         165 ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-A  243 (284)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-G
T ss_pred             ccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-c
Confidence            998888888888888888888888887777777777777777777777777666677777777777777777764322 1


Q ss_pred             ccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCccc
Q 003301          507 IGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLE  548 (832)
Q Consensus       507 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~  548 (832)
                      -.-...++.+....+++....|..+.+   ....+++.+.|+
T Consensus       244 ~~l~~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~  282 (284)
T d1ozna_         244 RPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQ  282 (284)
T ss_dssp             HHHHHHHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSC
T ss_pred             hHHHHHHHhCcCCCCceEeCCchHHcC---CccccCCHHHCC
Confidence            111123455555556666555555442   233334444444

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=6.7e-25  Score=225.00  Aligned_cols=180  Identities=27%  Similarity=0.220  Sum_probs=103.6

Q ss_pred             CCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeec
Q 003301          368 NLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFS  447 (832)
Q Consensus       368 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  447 (832)
                      ++++|+|++|+|++..+..|.++++|++|+|++|+|+. +| .++.+++|++|+|++|+++. .+..+.++++|+.|+++
T Consensus        32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~  108 (266)
T d1p9ag_          32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVS  108 (266)
T ss_dssp             TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECC
T ss_pred             CCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccccccccccccc-ccccccccccccccccc
Confidence            34455555555543333444445555555555555442 22 23445555555555555543 23345555555555555


Q ss_pred             CCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccC
Q 003301          448 SNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNI  527 (832)
Q Consensus       448 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  527 (832)
                      +|.+.+..+..+..+.+++.|++++|.++...+..+..+++|+.|++++|+|++..+..|+.+++|++|||++|+|+ .+
T Consensus       109 ~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~l  187 (266)
T d1p9ag_         109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TI  187 (266)
T ss_dssp             SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CC
T ss_pred             ccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-cc
Confidence            55555555555555666666666666666555556666666666666666666666666666667777777777766 56


Q ss_pred             chhhhhhccCCeeeCCCCcccccC
Q 003301          528 PTSMEKLLYLKDLNLSFNKLEGEI  551 (832)
Q Consensus       528 p~~~~~l~~L~~l~l~~N~l~~~~  551 (832)
                      |+.+..+++|+.|+|++|+|.|.|
T Consensus       188 p~~~~~~~~L~~L~L~~Np~~CdC  211 (266)
T d1p9ag_         188 PKGFFGSHLLPFAFLHGNPWLCNC  211 (266)
T ss_dssp             CTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             ChhHCCCCCCCEEEecCCCCCCCc
Confidence            666666667777777777776654

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=6.4e-24  Score=217.63  Aligned_cols=178  Identities=25%  Similarity=0.227  Sum_probs=132.7

Q ss_pred             cccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCC
Q 003301          344 NLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLA  423 (832)
Q Consensus       344 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  423 (832)
                      ++++|+|++|+|++..+.+|.++++|++|+|++|+|+. +| .++.+++|++|+|++|+++ ..+..+..+++|+.|+++
T Consensus        32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~  108 (266)
T d1p9ag_          32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS  108 (266)
T ss_dssp             TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred             CCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccccccccccc-cccccccccccccccccc
Confidence            45666666666665555566666666666666666652 33 2455666777777777776 345567777777777777


Q ss_pred             CCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccC
Q 003301          424 SNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSI  503 (832)
Q Consensus       424 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  503 (832)
                      +|.+.+..+..+..+.++++|++++|.++...+..+..++.|+.+++++|++++..+..|..+++|++|+|++|+|+ .+
T Consensus       109 ~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~l  187 (266)
T d1p9ag_         109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TI  187 (266)
T ss_dssp             SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CC
T ss_pred             ccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-cc
Confidence            77777777777777777888888888887777777777888888888888888777788888888889999999888 78


Q ss_pred             CccccCCCCCCeeccCCCcccc
Q 003301          504 PKSIGGLVSLESLDLSNNSLSG  525 (832)
Q Consensus       504 p~~~~~l~~L~~L~Ls~N~l~~  525 (832)
                      |..+..+++|+.|+|++|++..
T Consensus       188 p~~~~~~~~L~~L~L~~Np~~C  209 (266)
T d1p9ag_         188 PKGFFGSHLLPFAFLHGNPWLC  209 (266)
T ss_dssp             CTTTTTTCCCSEEECCSCCBCC
T ss_pred             ChhHCCCCCCCEEEecCCCCCC
Confidence            8888888899999999998864

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.88  E-value=6.9e-24  Score=228.29  Aligned_cols=165  Identities=20%  Similarity=0.306  Sum_probs=129.6

Q ss_pred             cCCCCCCeeeccCCceEEEEEec-CCcEEEEEEEeccchhhHHHHHHHHHHHhcCC-----------CCceeeeceEEec
Q 003301          659 NQFNASNLIGTGGFGSVYKGSFL-DGMEVAIKVFHLQLEGALKSFDVECEVLKSVR-----------HRNLVKIISSCTN  726 (832)
Q Consensus       659 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~  726 (832)
                      ++|++.++||+|+||+||+|++. +|+.||||+++... ...+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            45999999999999999999985 59999999997553 23467788998887764           5789999998864


Q ss_pred             --CCeeEEEEecCCCCC-HHHH-HhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEecCCCCCCeEeCCCC-----
Q 003301          727 --NDFKALVLEYMPNGS-LEDY-LYSNNFSFDILQRLSVIIDVALALEYLHFGYS-NPVVHCDIKPSNVLLDKDM-----  796 (832)
Q Consensus       727 --~~~~~lv~e~~~~g~-L~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dlkp~NIl~~~~~-----  796 (832)
                        ....+++|+++..+. .... .......+++..+..++.|++.|++|||   + .||+||||||+|||++.++     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh---~~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHh---hhcCcccccCChhHeeeeccCccccc
Confidence              345666666654443 2222 2333446899999999999999999999   6 8999999999999998665     


Q ss_pred             -cEEEeccccccccCCCcccccccccccccccCCCC
Q 003301          797 -VAHLSDFGIAKLLSGEESMKQTLTLATIGYMAPGL  831 (832)
Q Consensus       797 -~~kl~DFg~a~~~~~~~~~~~~~~~gt~~y~APE~  831 (832)
                       .+|++|||.|.......    ...+||+.|+|||+
T Consensus       169 ~~~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~  200 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEHY----TNSIQTREYRSPEV  200 (362)
T ss_dssp             EEEEECCCTTCEETTBCC----CSCCSCGGGCCHHH
T ss_pred             ceeeEeeccccccccccc----ccccccccccChhh
Confidence             49999999998653322    33579999999996

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.87  E-value=1.7e-20  Score=200.64  Aligned_cols=300  Identities=28%  Similarity=0.325  Sum_probs=136.8

Q ss_pred             cCcEEEccCCcCCCCCCCcccCcccccccccccccccccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEE
Q 003301           46 ELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVIS  125 (832)
Q Consensus        46 ~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~  125 (832)
                      +++.|||++|.++ .+|+.+   +++ ++|++++|+|+ ++|..    +.+|+.|++++|+++ .+++-   .+.|++|+
T Consensus        39 ~l~~LdLs~~~L~-~lp~~~---~~L-~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~  104 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPELP---PHL-ESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLK-ALSDL---PPLLEYLG  104 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSCC---TTC-SEEECCSSCCS-SCCCC----CTTCCEEECCSSCCS-CCCSC---CTTCCEEE
T ss_pred             CCCEEEeCCCCCC-CCCCCC---CCC-CEEECCCCCCc-ccccc----hhhhhhhhhhhcccc-hhhhh---cccccccc
Confidence            3455555555554 444422   233 44555555555 45432    234555555555555 23221   12466666


Q ss_pred             CcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccccccccccCcccccCCcccEEEecCCCCCC
Q 003301          126 LAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMKTLALPSNALSG  205 (832)
Q Consensus       126 Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~  205 (832)
                      +++|++. .+|. ++.+++|++|++++|.+. ..+..+   ..+..+.+..+...  ....+..++.++.+++++|....
T Consensus       105 L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~-~~~~~~---~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~  176 (353)
T d1jl5a_         105 VSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLP---PSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKK  176 (353)
T ss_dssp             CCSSCCS-SCCC-CTTCTTCCEEECCSSCCS-CCCCCC---TTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSS
T ss_pred             ccccccc-cccc-hhhhccceeecccccccc-cccccc---ccccchhhcccccc--ccccccccccceecccccccccc
Confidence            6666665 2342 455666666666666665 222222   33444444444332  22334555566666666665542


Q ss_pred             CCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccccCCCCCCccc
Q 003301          206 SLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYNFLTSSTSELS  285 (832)
Q Consensus       206 ~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  285 (832)
                       ++..     ....+.+..+++.+... + .+..++.|+.+++++|..... +.   ...++..+.+.+|.+...+.   
T Consensus       177 -~~~~-----~~~~~~l~~~~~~~~~~-~-~~~~l~~L~~l~l~~n~~~~~-~~---~~~~l~~~~~~~~~~~~~~~---  241 (353)
T d1jl5a_         177 -LPDL-----PLSLESIVAGNNILEEL-P-ELQNLPFLTTIYADNNLLKTL-PD---LPPSLEALNVRDNYLTDLPE---  241 (353)
T ss_dssp             -CCCC-----CTTCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSSC-CS---CCTTCCEEECCSSCCSCCCC---
T ss_pred             -cccc-----ccccccccccccccccc-c-ccccccccccccccccccccc-cc---cccccccccccccccccccc---
Confidence             2211     12233444444443321 1 123455555555555554421 21   22344455555554443211   


Q ss_pred             cccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccC
Q 003301          286 FLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGK  365 (832)
Q Consensus       286 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  365 (832)
                            ....+...++..+.+.+.     ..+.                        ......++..+.+.+.    ...
T Consensus       242 ------~~~~l~~~~~~~~~~~~l-----~~l~------------------------~~~~~~~~~~~~~~~~----~~~  282 (353)
T d1jl5a_         242 ------LPQSLTFLDVSENIFSGL-----SELP------------------------PNLYYLNASSNEIRSL----CDL  282 (353)
T ss_dssp             ------CCTTCCEEECCSSCCSEE-----SCCC------------------------TTCCEEECCSSCCSEE----CCC
T ss_pred             ------cccccccccccccccccc-----cccc------------------------chhcccccccCccccc----ccc
Confidence                  123344444444333211     1111                        1233344444444321    122


Q ss_pred             CCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCC
Q 003301          366 LQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNS  429 (832)
Q Consensus       366 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  429 (832)
                      +++|++|+|++|+|+ .+|..   +++|+.|+|++|+|+ .+|..   +++|+.|++++|+++.
T Consensus       283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~  338 (353)
T d1jl5a_         283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLRE  338 (353)
T ss_dssp             CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSS
T ss_pred             CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCCC
Confidence            345666666666665 34432   345666666666665 34432   3456666666666654

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.86  E-value=5.3e-20  Score=196.73  Aligned_cols=314  Identities=26%  Similarity=0.309  Sum_probs=207.9

Q ss_pred             cccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCcccccccccccccccccCCChhhhhcCCCceEE
Q 003301           21 TMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGL  100 (832)
Q Consensus        21 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L  100 (832)
                      +++++|||++++++ .+|+.   +++|++|+|++|+|+ .+|+.++   +| ++|++++|+++ .++.    -.+.|++|
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~~---~L-~~L~l~~n~l~-~l~~----lp~~L~~L  103 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQ---SL-KSLLVDNNNLK-ALSD----LPPLLEYL  103 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCCT---TC-CEEECCSSCCS-CCCS----CCTTCCEE
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccchh---hh-hhhhhhhcccc-hhhh----hccccccc
Confidence            46889999999998 78864   468999999999999 8887655   45 77899999988 6664    12469999


Q ss_pred             EccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccccccc
Q 003301          101 YMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLV  180 (832)
Q Consensus       101 ~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~  180 (832)
                      ++++|.++ .+|. ++.+++|++|++++|.+.. .+..   ...+..+.+.++...  ....+..++.++.|++++|...
T Consensus       104 ~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~  175 (353)
T d1jl5a_         104 GVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK  175 (353)
T ss_dssp             ECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS
T ss_pred             cccccccc-cccc-hhhhccceeeccccccccc-cccc---cccccchhhcccccc--ccccccccccceeccccccccc
Confidence            99999998 5664 6789999999999999874 3333   456777888777765  3456778899999999999887


Q ss_pred             cccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccCCccccccCCcccCCCCccEEEcCCCcCcccCCcc
Q 003301          181 GFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGIIPSFIFNASKLSVLELGENSFSGFIPNT  260 (832)
Q Consensus       181 ~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~  260 (832)
                      ... .   .....+.+...++.+. .+|.   +..++.|+.+++++|..... +   ....++..+.+.+|.+... +. 
T Consensus       176 ~~~-~---~~~~~~~l~~~~~~~~-~~~~---~~~l~~L~~l~l~~n~~~~~-~---~~~~~l~~~~~~~~~~~~~-~~-  241 (353)
T d1jl5a_         176 KLP-D---LPLSLESIVAGNNILE-ELPE---LQNLPFLTTIYADNNLLKTL-P---DLPPSLEALNVRDNYLTDL-PE-  241 (353)
T ss_dssp             SCC-C---CCTTCCEEECCSSCCS-SCCC---CTTCTTCCEEECCSSCCSSC-C---SCCTTCCEEECCSSCCSCC-CC-
T ss_pred             ccc-c---cccccccccccccccc-cccc---cccccccccccccccccccc-c---ccccccccccccccccccc-cc-
Confidence            532 2   2234566677666665 4443   35788999999999987743 2   2356788899999988743 22 


Q ss_pred             ccCccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCccccccccccc
Q 003301          261 LGNLRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIG  340 (832)
Q Consensus       261 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~  340 (832)
                        ....+...++..+.+..+..-         .......++..+.+.+.                             ..
T Consensus       242 --~~~~l~~~~~~~~~~~~l~~l---------~~~~~~~~~~~~~~~~~-----------------------------~~  281 (353)
T d1jl5a_         242 --LPQSLTFLDVSENIFSGLSEL---------PPNLYYLNASSNEIRSL-----------------------------CD  281 (353)
T ss_dssp             --CCTTCCEEECCSSCCSEESCC---------CTTCCEEECCSSCCSEE-----------------------------CC
T ss_pred             --ccccccccccccccccccccc---------cchhcccccccCccccc-----------------------------cc
Confidence              234566677766665542211         13445566666665421                             11


Q ss_pred             CcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeE
Q 003301          341 NLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLL  420 (832)
Q Consensus       341 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  420 (832)
                      .+++|++|+|++|+++. +|.   .+++|+.|+|++|+|+ .+|..   +++|++|++++|+|+ .+|...   .+|+.|
T Consensus       282 ~~~~L~~L~Ls~N~l~~-lp~---~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~---~~L~~L  349 (353)
T d1jl5a_         282 LPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIP---ESVEDL  349 (353)
T ss_dssp             CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCC---TTCCEE
T ss_pred             cCCCCCEEECCCCccCc-ccc---ccCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCccc---cccCee
Confidence            13455556666665552 332   2345666666666666 34432   345666677777666 444422   234554


Q ss_pred             eC
Q 003301          421 SL  422 (832)
Q Consensus       421 ~L  422 (832)
                      .+
T Consensus       350 ~~  351 (353)
T d1jl5a_         350 RM  351 (353)
T ss_dssp             EC
T ss_pred             EC
Confidence            43

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.85  E-value=7.3e-22  Score=191.02  Aligned_cols=136  Identities=18%  Similarity=0.164  Sum_probs=107.7

Q ss_pred             CCCCCeeeccCCceEEEEEecCCcEEEEEEEeccc------------------hhhHHHHHHHHHHHhcCCCCceeeece
Q 003301          661 FNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQL------------------EGALKSFDVECEVLKSVRHRNLVKIIS  722 (832)
Q Consensus       661 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~e~~~l~~l~h~niv~l~~  722 (832)
                      +.++++||+|+||+||+|.+.+|+.||||+++...                  ........+|...+.++.|++++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            34678999999999999998889999999875321                  011234456888999999999998876


Q ss_pred             EEecCCeeEEEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecCCCCCCeEeCCCCcEEEec
Q 003301          723 SCTNNDFKALVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGYSNPVVHCDIKPSNVLLDKDMVAHLSD  802 (832)
Q Consensus       723 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl~~~~~~~kl~D  802 (832)
                      +..    .+++|||+++....+        ++...+..++.|++.|++|||   ++||+||||||+|||++++ .++++|
T Consensus        82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECC
T ss_pred             ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEE
Confidence            632    379999998765432        334456679999999999999   9999999999999999865 589999


Q ss_pred             cccccccCCC
Q 003301          803 FGIAKLLSGE  812 (832)
Q Consensus       803 Fg~a~~~~~~  812 (832)
                      ||.|+....+
T Consensus       146 FG~a~~~~~~  155 (191)
T d1zara2         146 FPQSVEVGEE  155 (191)
T ss_dssp             CTTCEETTST
T ss_pred             CCCcccCCCC
Confidence            9999876533

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=3.4e-23  Score=230.45  Aligned_cols=389  Identities=20%  Similarity=0.191  Sum_probs=187.7

Q ss_pred             CccEEECcCCcccccC-CCCCcCCCcCceEEeccccccc----ccCccccCccccceecccccccccccCcccccCCccc
Q 003301          120 ELIVISLAYNQFTERI-PRGLGNLTSLKTLYLGFNNLTG----EIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAMK  194 (832)
Q Consensus       120 ~L~~L~Ls~n~i~~~~-p~~~~~l~~L~~L~Ls~N~i~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  194 (832)
                      +|++||+++|++++.. .+.+..+++++.|+|++|.|+.    .++..+..+++|++|+|++|+|+......+..     
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~-----   77 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQ-----   77 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHH-----
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHH-----
Confidence            4667777777775421 2234456666677777776652    22334455566666666666554211111110     


Q ss_pred             EEEecCCCCCCCCCccccccCCCCccEEEccCCccccc----cCCcccCCCCccEEEcCCCcCcccCCcccc-----Ccc
Q 003301          195 TLALPSNALSGSLPSSIDLVRLPNLEIISLAGNNFSGI----IPSFIFNASKLSVLELGENSFSGFIPNTLG-----NLR  265 (832)
Q Consensus       195 ~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~n~i~~~----~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~-----~l~  265 (832)
                                     .+ .....+|++|+|++|+++..    .+..+..+++|++|++++|.|+......+.     ...
T Consensus        78 ---------------~l-~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~  141 (460)
T d1z7xw1          78 ---------------GL-QTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQC  141 (460)
T ss_dssp             ---------------TT-CSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred             ---------------HH-hcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhccccccc
Confidence                           00 00112344444444444422    233445556666666666665532222111     111


Q ss_pred             ccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCC----CCcccccccccceEEeecCccccc----ccc
Q 003301          266 KLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVL----PSSIGNLSLSLSRIFISNCSIRGT----IPK  337 (832)
Q Consensus       266 ~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~~~~~L~~L~l~~n~l~~~----~~~  337 (832)
                      ...........+...... .....+.....++.++++++.+....    ...+.........+.+..+.+...    ...
T Consensus       142 ~~~~~~~~~~~~~~~~~~-~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~  220 (460)
T d1z7xw1         142 RLEKLQLEYCSLSAASCE-PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG  220 (460)
T ss_dssp             CCCEEECTTSCCBGGGHH-HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHH
T ss_pred             ccccccccccccchhhhc-ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccc
Confidence            122222222222211100 11122344566777777766653210    011111122445566666655421    112


Q ss_pred             cccCcCcccEEEeecCcccc-----cccccccCCCCCceEEccCCccCCCC----chhhcCCCCCcEEEecCCcCCCCCc
Q 003301          338 EIGNLINLRELGLWGNELIG-----SIPITFGKLQNLQGLDLVNNKLEGPI----PNGLCQLARLSVLYMDGNKLSGPIP  408 (832)
Q Consensus       338 ~~~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~p  408 (832)
                      .+...+.++.+++++|.+..     ..+..+.....++.+++++|.+....    ...+...+.++.+++++|.++....
T Consensus       221 ~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~  300 (460)
T d1z7xw1         221 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA  300 (460)
T ss_dssp             HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHH
T ss_pred             cccccccccccchhhccccccccchhhccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            34455677888888877542     22334455667888888888775322    2234556777888888887753211


Q ss_pred             cc-----CCCCCCCCeEeCCCCcCCCCCCccc----ccCcccceeeecCCcccCC----Cccccc-cccccceecccCcc
Q 003301          409 PC-----IGDLTSLRLLSLASNELNSVIPSTF----WNLKDILSLNFSSNFLNGS----LPEDIG-NLKVVVIIDLSRNN  474 (832)
Q Consensus       409 ~~-----~~~l~~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L~Ls~N~l~~~----~~~~~~-~l~~L~~L~Ls~N~  474 (832)
                      ..     ....+.|+.+++++|.++......+    ....+|++|+|++|++++.    ++..+. ..+.|++|+|++|+
T Consensus       301 ~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~  380 (460)
T d1z7xw1         301 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD  380 (460)
T ss_dssp             HHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred             chhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCC
Confidence            11     1234567777777777665432222    3334566666666666532    122222 23456666666666


Q ss_pred             cCCc----cCCccccccccceeecccccccccCCccc----c-CCCCCCeeccCCCcccccCchh
Q 003301          475 LSGD----IPTAIGGLMNLQDLSLRDNGLQGSIPKSI----G-GLVSLESLDLSNNSLSGNIPTS  530 (832)
Q Consensus       475 l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~-~l~~L~~L~Ls~N~l~~~~p~~  530 (832)
                      |++.    ++..+..+++|++|+|++|+|+......|    . ....|+.|++++|.+....+..
T Consensus       381 i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~  445 (460)
T d1z7xw1         381 VSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR  445 (460)
T ss_dssp             CCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHH
T ss_pred             CChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHHH
Confidence            6532    23334445566666666666553222222    1 2234566666666555443333

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=1.8e-19  Score=181.54  Aligned_cols=219  Identities=13%  Similarity=0.125  Sum_probs=123.9

Q ss_pred             cEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCcccccc-cccccCCCCCceEEcc
Q 003301          297 KLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSI-PITFGKLQNLQGLDLV  375 (832)
Q Consensus       297 ~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls  375 (832)
                      +.++.++..++ .+|..+.   .++++|++++|+|+...+..|.++++|++|++++|.+...+ +.+|..+++++++++.
T Consensus        11 ~~i~c~~~~l~-~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~   86 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   86 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred             CEEEEeCCCCC-CcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence            45566665555 4444332   25666666666666555556777777777777777665433 4456677777777665


Q ss_pred             C-CccCCCCchhhcCCCCCcEEEecCCcCCCCCcc-cCCCCCCCCeEeCCCCcCCCCCCcccccCc-ccceeeecCCccc
Q 003301          376 N-NKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPP-CIGDLTSLRLLSLASNELNSVIPSTFWNLK-DILSLNFSSNFLN  452 (832)
Q Consensus       376 ~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~  452 (832)
                      . |++....+..|.++++|+++++++|.+....+. .+..++.+..+..+++.+..+.+..|.+++ .++.|++++|+++
T Consensus        87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~  166 (242)
T d1xwdc1          87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ  166 (242)
T ss_dssp             CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred             ccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence            3 556655566667777777777777776533221 233344555555566666665555555543 5556666666666


Q ss_pred             CCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccC
Q 003301          453 GSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLS  519 (832)
Q Consensus       453 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  519 (832)
                      ...+..+.....++.+++++|+++...+..|.++++|++|+|++|+|+...+..|.++++|+.|++.
T Consensus       167 ~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~  233 (242)
T d1xwdc1         167 EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY  233 (242)
T ss_dssp             EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred             ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence            4333333333223334455555654444455666666666666666654444445555555555543

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.80  E-value=3.8e-20  Score=178.94  Aligned_cols=174  Identities=19%  Similarity=0.220  Sum_probs=82.7

Q ss_pred             eEEccCCccCCCCchhhcCCCCCcEEEecCCcCCC-CCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCC
Q 003301          371 GLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSG-PIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSN  449 (832)
Q Consensus       371 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  449 (832)
                      +++.++|+++ .+|..+.  +++++|+|++|+|++ ..+..|.++++|+.|+|++|.+..+.+..|..+++|++|+|++|
T Consensus        12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N   88 (192)
T d1w8aa_          12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence            4455555554 3443332  345555555555543 22334455555555555555555555555555555555555555


Q ss_pred             cccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCch
Q 003301          450 FLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPT  529 (832)
Q Consensus       450 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  529 (832)
                      +|++..|..|.++++|++|+|++|+|++..|.+|.++++|++|+|++|.+....+ ...-...++.+.++.|.++...|.
T Consensus        89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~p~  167 (192)
T d1w8aa_          89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPS  167 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCSST
T ss_pred             cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCCCh
Confidence            5554444445555555555555555554444455555555555555555542211 111112244444555555544444


Q ss_pred             hhhhhccCCeeeCCCCcccccC
Q 003301          530 SMEKLLYLKDLNLSFNKLEGEI  551 (832)
Q Consensus       530 ~~~~l~~L~~l~l~~N~l~~~~  551 (832)
                      .+   ..++.++|+.|.|.|..
T Consensus       168 ~l---~~~~l~~L~~n~l~C~~  186 (192)
T d1w8aa_         168 KV---RDVQIKDLPHSEFKCSS  186 (192)
T ss_dssp             TT---TTSBGGGSCTTTCCCCC
T ss_pred             hh---cCCEeeecCHhhCcCCC
Confidence            32   23344555555555443

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=2e-19  Score=181.30  Aligned_cols=222  Identities=17%  Similarity=0.147  Sum_probs=178.4

Q ss_pred             ccceEEeecCcccccccccccCcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCC-chhhcCCCCCcEEEe
Q 003301          320 SLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPI-PNGLCQLARLSVLYM  398 (832)
Q Consensus       320 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L  398 (832)
                      ..+.++.+++.++ .+|+.+.  +++++|++++|+|+...+.+|.++++|++|++++|.+...+ +.+|..+++++++.+
T Consensus         9 ~~~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~   85 (242)
T d1xwdc1           9 SNRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI   85 (242)
T ss_dssp             CSSEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEE
T ss_pred             cCCEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccc
Confidence            4567888888888 5665543  57999999999999877788999999999999999987644 457889999999997


Q ss_pred             cC-CcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcc-cccCcccceeeecCCcccCCCcccccccc-ccceecccCccc
Q 003301          399 DG-NKLSGPIPPCIGDLTSLRLLSLASNELNSVIPST-FWNLKDILSLNFSSNFLNGSLPEDIGNLK-VVVIIDLSRNNL  475 (832)
Q Consensus       399 ~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l  475 (832)
                      .. |.+....+..|.++++|+.+++++|.+....+.. +..+..+..+..+++++....+..|..+. .++.|++++|++
T Consensus        86 ~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l  165 (242)
T d1xwdc1          86 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI  165 (242)
T ss_dssp             ECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCC
T ss_pred             cccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccc
Confidence            64 7888788888999999999999999998654433 45567777778888888877677777765 788999999999


Q ss_pred             CCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCC
Q 003301          476 SGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSF  544 (832)
Q Consensus       476 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~  544 (832)
                      +...+..|.....++.+++++|+++...+..|.++++|+.|||++|+|+...+..|.+++.|+.+++.+
T Consensus       166 ~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         166 QEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN  234 (242)
T ss_dssp             CEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred             cccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence            965555555444445557888999865566799999999999999999977677788888888877654

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=6e-23  Score=228.41  Aligned_cols=109  Identities=20%  Similarity=0.219  Sum_probs=62.5

Q ss_pred             ccccccccccccCCChhhhhcCCCceEEEccCCcccc----cCCCCccCCCCccEEECcCCccccc----CCCCCc-CCC
Q 003301           73 TGMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTG----PIPNNIWQCKELIVISLAYNQFTER----IPRGLG-NLT  143 (832)
Q Consensus        73 ~~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~----~~p~~l~~l~~L~~L~Ls~n~i~~~----~p~~~~-~l~  143 (832)
                      ++||+++|++++..-..++..++++++|+|++|.++.    .++..+..+++|++|||++|+|+..    +.+.+. ..+
T Consensus         5 ~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~   84 (460)
T d1z7xw1           5 QSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSC   84 (460)
T ss_dssp             EEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTC
T ss_pred             CEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCC
Confidence            5556666666532223334456667777777776662    2334456667777777777776521    122222 224


Q ss_pred             cCceEEecccccccc----cCccccCccccceeccccccccc
Q 003301          144 SLKTLYLGFNNLTGE----IPYEMGNLRNLEILGLQLNKLVG  181 (832)
Q Consensus       144 ~L~~L~Ls~N~i~~~----~p~~~~~l~~L~~L~L~~N~l~~  181 (832)
                      +|++|+|++|+++..    ++..+..+++|++|++++|++..
T Consensus        85 ~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          85 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             CCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence            677777777777532    33455666677777777776653

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.79  E-value=2.7e-19  Score=178.18  Aligned_cols=187  Identities=24%  Similarity=0.380  Sum_probs=96.6

Q ss_pred             CcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeE
Q 003301          341 NLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLL  420 (832)
Q Consensus       341 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  420 (832)
                      .+.+|+.|++++|+|+..  ..+..+++|++|++++|++++..|  +..+++++++++++|.++. ++ .+.++++|+.+
T Consensus        39 ~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l  112 (227)
T d1h6ua2          39 DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTL  112 (227)
T ss_dssp             HHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEE
T ss_pred             HcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-cc-ccccccccccc
Confidence            344455555555554432  124445555555555555543222  4445555555555555542 22 34455555555


Q ss_pred             eCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeeccccccc
Q 003301          421 SLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQ  500 (832)
Q Consensus       421 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  500 (832)
                      +++++...+.  ..+...+.+..+.++++.+...  ..+...++|+.|++++|.+++.  ..++++++|+.|+|++|+++
T Consensus       113 ~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~  186 (227)
T d1h6ua2         113 DLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKIS  186 (227)
T ss_dssp             ECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCC
T ss_pred             cccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--hhhcccccceecccCCCccC
Confidence            5555554432  2234444555555555555432  2244555566666666665532  22556666666666666665


Q ss_pred             ccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCC
Q 003301          501 GSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLS  543 (832)
Q Consensus       501 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~  543 (832)
                      + ++ .++.+++|+.|+|++|++++..|  +..+++|+.|+++
T Consensus       187 ~-l~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls  225 (227)
T d1h6ua2         187 D-IS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT  225 (227)
T ss_dssp             C-CG-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred             C-Ch-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence            3 22 25666666666666666664322  5566666666665

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.79  E-value=3.6e-19  Score=171.96  Aligned_cols=177  Identities=23%  Similarity=0.272  Sum_probs=147.6

Q ss_pred             CcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCcCCC-CCCcccccCcccceeeecCCcccCCCccccccccccceeccc
Q 003301          393 LSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNELNS-VIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLS  471 (832)
Q Consensus       393 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  471 (832)
                      .+.++.++|+++ .+|..+.  +++++|+|++|+|++ ..+..|.++++|+.|+|++|++.+..+..|..+++|++|+|+
T Consensus        10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls   86 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence            457999999999 6676653  689999999999986 557788999999999999999999999999999999999999


Q ss_pred             CcccCCccCCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchhhhhhccCCeeeCCCCcccccC
Q 003301          472 RNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDLNLSFNKLEGEI  551 (832)
Q Consensus       472 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~  551 (832)
                      +|+|++..|.+|.++++|++|+|++|+|++..|.+|..+++|++|+|++|++....+..+ -...++.+.+..|.++|..
T Consensus        87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~~  165 (192)
T d1w8aa_          87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGA  165 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCS
T ss_pred             cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHH-HhhhhhhhcccCCCeEeCC
Confidence            999998889999999999999999999999889999999999999999999986544332 2345677888999999888


Q ss_pred             CCCCCCCCcCCCcccCCCCCCCCc
Q 003301          552 PRGGPFANFSNRSFMGNDLLCGLA  575 (832)
Q Consensus       552 p~~~~~~~~~~~~~~~n~~~c~~~  575 (832)
                      |..  +....-.....|...|..+
T Consensus       166 p~~--l~~~~l~~L~~n~l~C~~~  187 (192)
T d1w8aa_         166 PSK--VRDVQIKDLPHSEFKCSSE  187 (192)
T ss_dssp             STT--TTTSBGGGSCTTTCCCCCC
T ss_pred             Chh--hcCCEeeecCHhhCcCCCC
Confidence            763  2333333455666666543

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.79  E-value=7e-19  Score=175.13  Aligned_cols=209  Identities=18%  Similarity=0.293  Sum_probs=135.6

Q ss_pred             ccccceeecccccCCCCCCccccccccccCCCCcEEeccCCCCCCCCCCcccccccccceEEeecCcccccccccccCcC
Q 003301          264 LRKLEWLRLSYNFLTSSTSELSFLSSWANCKNLKLLDLSNNPINGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLI  343 (832)
Q Consensus       264 l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~  343 (832)
                      +.++..++++.+++++..       .++.+.+|+.|++++|.|+.                          + +.+..++
T Consensus        18 l~~~~~~~l~~~~~~d~~-------~~~~l~~L~~L~l~~~~i~~--------------------------l-~~l~~l~   63 (227)
T d1h6ua2          18 LANAIKIAAGKSNVTDTV-------TQADLDGITTLSAFGTGVTT--------------------------I-EGVQYLN   63 (227)
T ss_dssp             HHHHHHHHTTCSSTTSEE-------CHHHHHTCCEEECTTSCCCC--------------------------C-TTGGGCT
T ss_pred             HHHHHHHHhCCCCcCCcC-------CHHHcCCcCEEECCCCCCCc--------------------------c-hhHhcCC
Confidence            344445566666555421       23455666666666666542                          1 2355566


Q ss_pred             cccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCC
Q 003301          344 NLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLA  423 (832)
Q Consensus       344 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  423 (832)
                      +|++|++++|++++..|  +..+++|+.+++++|.++. + ..+..+++|+.+++++|...+.  ..+...+.++.+.++
T Consensus        64 ~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~  137 (227)
T d1h6ua2          64 NLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLD  137 (227)
T ss_dssp             TCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECC
T ss_pred             CCcEeecCCceeecccc--ccccccccccccccccccc-c-cccccccccccccccccccccc--chhccccchhhhhch
Confidence            67777777776665433  6666777777777776663 2 2466677777777777766543  235566777777777


Q ss_pred             CCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccC
Q 003301          424 SNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSI  503 (832)
Q Consensus       424 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  503 (832)
                      ++.+....  .+...++|+.|++++|.+.+.  ..++++++|+.|+|++|++++. + .++++++|++|+|++|++++. 
T Consensus       138 ~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i-  210 (227)
T d1h6ua2         138 LNQITNIS--PLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDV-  210 (227)
T ss_dssp             SSCCCCCG--GGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBC-
T ss_pred             hhhhchhh--hhccccccccccccccccccc--hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCC-
Confidence            77765432  356667777777777777643  2377788888888888888753 2 377888888888888888853 


Q ss_pred             CccccCCCCCCeeccCC
Q 003301          504 PKSIGGLVSLESLDLSN  520 (832)
Q Consensus       504 p~~~~~l~~L~~L~Ls~  520 (832)
                      + .++++++|+.|++++
T Consensus       211 ~-~l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         211 S-PLANTSNLFIVTLTN  226 (227)
T ss_dssp             G-GGTTCTTCCEEEEEE
T ss_pred             c-ccccCCCCCEEEeeC
Confidence            3 377888888888863

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=6.1e-19  Score=171.39  Aligned_cols=178  Identities=25%  Similarity=0.399  Sum_probs=108.7

Q ss_pred             EEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeCCCCc
Q 003301          347 ELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSLASNE  426 (832)
Q Consensus       347 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  426 (832)
                      .+.++.+.+++.++  ...+.++++|++++|.++. + +.+..+++|++|++++|++++..|  ++++++|+.|++++|.
T Consensus        22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~   95 (199)
T d2omxa2          22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ   95 (199)
T ss_dssp             HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccccccccc
Confidence            33444555443322  2345566666666666653 2 235556666666666666664322  6666666666666666


Q ss_pred             CCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccccccccCCcc
Q 003301          427 LNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGSIPKS  506 (832)
Q Consensus       427 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  506 (832)
                      +..+.  .+.+++.|+.|++++|.+...  ..+..+++|+.|++++|++.. + ..+..+++|+.|++++|++++. + .
T Consensus        96 ~~~~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l-~-~  167 (199)
T d2omxa2          96 IADIT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDL-K-P  167 (199)
T ss_dssp             CCCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCC-G-G
T ss_pred             ccccc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCC-c-c
Confidence            65533  356666666666666666532  336667777777777777753 2 3466777777777777777743 2 3


Q ss_pred             ccCCCCCCeeccCCCcccccCchhhhhhccCCee
Q 003301          507 IGGLVSLESLDLSNNSLSGNIPTSMEKLLYLKDL  540 (832)
Q Consensus       507 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l  540 (832)
                      ++++++|++|++++|++++ +| .+..+++|++|
T Consensus       168 l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         168 LANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             GTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             ccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence            6777777777887777774 33 46667777654

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=2.1e-18  Score=168.97  Aligned_cols=162  Identities=25%  Similarity=0.381  Sum_probs=66.3

Q ss_pred             CcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeEeC
Q 003301          343 INLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLLSL  422 (832)
Q Consensus       343 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  422 (832)
                      .+|++|++++|.+....  .+..+++|++|+|++|+|++. + .++.+++|++|++++|++++ +| .+..+++|+.|++
T Consensus        46 ~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l  119 (210)
T d1h6ta2          46 NSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL  119 (210)
T ss_dssp             HTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred             cCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-ccccccccccccc
Confidence            34444444444444221  134444445555555544432 1 23444444444444444442 22 2444444444444


Q ss_pred             CCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeeccccccccc
Q 003301          423 ASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQGS  502 (832)
Q Consensus       423 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  502 (832)
                      ++|.+...  ..+..++.++.+++++|.+++  +..+..+++|+.+++++|++++..  .++++++|+.|+|++|+|++ 
T Consensus       120 ~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~-  192 (210)
T d1h6ta2         120 EHNGISDI--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD-  192 (210)
T ss_dssp             TTSCCCCC--GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB-
T ss_pred             cccccccc--ccccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCC-
Confidence            44444321  123334444444444444432  122333444444444444443211  13344444444444444432 


Q ss_pred             CCccccCCCCCCeecc
Q 003301          503 IPKSIGGLVSLESLDL  518 (832)
Q Consensus       503 ~p~~~~~l~~L~~L~L  518 (832)
                      +| .|.++++|++|+|
T Consensus       193 l~-~l~~l~~L~~L~L  207 (210)
T d1h6ta2         193 LR-ALAGLKNLDVLEL  207 (210)
T ss_dssp             CG-GGTTCTTCSEEEE
T ss_pred             Ch-hhcCCCCCCEEEc
Confidence            22 2344444444444

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.74  E-value=2.7e-18  Score=168.27  Aligned_cols=186  Identities=25%  Similarity=0.386  Sum_probs=131.8

Q ss_pred             cccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCcccccccccccccccccCCChhhhhcCCCceEE
Q 003301           21 TMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRRLPLIKGL  100 (832)
Q Consensus        21 ~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~l~~L~~L  100 (832)
                      ......+++.+++++.++.  ..+.+|++|++++|.++ .++ ++..+++| ++|++++|.++ .++. + ..+++|++|
T Consensus        24 ~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~-~l~-~l~~l~~L-~~L~L~~n~i~-~l~~-~-~~l~~L~~L   95 (210)
T d1h6ta2          24 AETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-SVQ-GIQYLPNV-TKLFLNGNKLT-DIKP-L-ANLKNLGWL   95 (210)
T ss_dssp             HHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCC-CCT-TGGGCTTC-CEEECCSSCCC-CCGG-G-TTCTTCCEE
T ss_pred             HHHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCC-Cch-hHhhCCCC-CEEeCCCcccc-Cccc-c-ccCcccccc
Confidence            3444556666666644443  45667788888888777 444 36777777 77888888877 4553 2 367888888


Q ss_pred             EccCCcccccCCCCccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccccccc
Q 003301          101 YMSNNKLTGPIPNNIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLV  180 (832)
Q Consensus       101 ~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~  180 (832)
                      ++++|++++ +| .+..+++|+.|++++|.+..  ...+..+++++.+++++|.++.  +..+..+++|+++++++|+++
T Consensus        96 ~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~  169 (210)
T d1h6ta2          96 FLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS  169 (210)
T ss_dssp             ECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCC
T ss_pred             ccccccccc-cc-cccccccccccccccccccc--cccccccccccccccccccccc--ccccccccccccccccccccc
Confidence            888888873 44 47778888888888888763  2457777888888888888873  235677788888888888887


Q ss_pred             cccCcccccCCcccEEEecCCCCCCCCCccccccCCCCccEEEccC
Q 003301          181 GFVPTSIFNLSAMKTLALPSNALSGSLPSSIDLVRLPNLEIISLAG  226 (832)
Q Consensus       181 ~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~~~l~~L~~L~Ls~  226 (832)
                      ++.  .+.++++|++|+|++|.++ .+|   .+..+++|++|+|++
T Consensus       170 ~i~--~l~~l~~L~~L~Ls~N~i~-~l~---~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         170 DIV--PLAGLTKLQNLYLSKNHIS-DLR---ALAGLKNLDVLELFS  209 (210)
T ss_dssp             CCG--GGTTCTTCCEEECCSSCCC-BCG---GGTTCTTCSEEEEEE
T ss_pred             ccc--cccCCCCCCEEECCCCCCC-CCh---hhcCCCCCCEEEccC
Confidence            643  3778888888888888886 444   246788888888764

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=9.2e-18  Score=162.91  Aligned_cols=162  Identities=25%  Similarity=0.370  Sum_probs=109.9

Q ss_pred             CcCcccEEEeecCcccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecCCcCCCCCcccCCCCCCCCeE
Q 003301          341 NLINLRELGLWGNELIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDGNKLSGPIPPCIGDLTSLRLL  420 (832)
Q Consensus       341 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  420 (832)
                      .+.++++|++++|.+...  +.+..+++|++|++++|++++..|  ++++++|++|++++|.+.. ++ .+.++++|+.|
T Consensus        38 ~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L  111 (199)
T d2omxa2          38 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGL  111 (199)
T ss_dssp             HHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEE
T ss_pred             HhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccc
Confidence            455666777777766632  235666777777777777764322  6677777777777777663 33 36677777777


Q ss_pred             eCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeeccccccc
Q 003301          421 SLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDNGLQ  500 (832)
Q Consensus       421 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  500 (832)
                      ++++|.+...  ..+..+++|+.|++++|++.. + +.+..+++|+.|++++|++++..  .++++++|++|++++|+++
T Consensus       112 ~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~  185 (199)
T d2omxa2         112 TLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVS  185 (199)
T ss_dssp             ECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred             cccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCCc--cccCCCCCCEEECCCCCCC
Confidence            7777777653  236667777777777777763 2 34777778888888888877532  3778888888888888887


Q ss_pred             ccCCccccCCCCCCee
Q 003301          501 GSIPKSIGGLVSLESL  516 (832)
Q Consensus       501 ~~~p~~~~~l~~L~~L  516 (832)
                      + ++ .++.+++|+.|
T Consensus       186 ~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         186 D-IS-VLAKLTNLESL  199 (199)
T ss_dssp             C-CG-GGGGCTTCSEE
T ss_pred             C-Cc-cccCCCCCCcC
Confidence            4 43 46777777765

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.61  E-value=9e-17  Score=165.14  Aligned_cols=222  Identities=15%  Similarity=0.151  Sum_probs=119.9

Q ss_pred             cccccccccccCCChhhhhcCCCceEEEccCCcccccCCCCccCCCCccEEECcCCccccc-CCCCCcCCCcCceEEecc
Q 003301           74 GMDFSNNSLTGSLPDDMCRRLPLIKGLYMSNNKLTGPIPNNIWQCKELIVISLAYNQFTER-IPRGLGNLTSLKTLYLGF  152 (832)
Q Consensus        74 ~L~ls~n~l~~~lp~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~-~p~~~~~l~~L~~L~Ls~  152 (832)
                      .+|++++.+.+.....+..  ..+..+.++...+... ........+|++||++++.++.. ++..+.++++|++|+|++
T Consensus         4 ~lDLs~~~l~~~~l~~l~~--~~~~~lrl~~~~~~~~-~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~   80 (284)
T d2astb2           4 TLDLTGKNLHPDVTGRLLS--QGVIAFRCPRSFMDQP-LAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG   80 (284)
T ss_dssp             EEECTTCBCCHHHHHHHHH--TTCSEEECTTCEECSC-CCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred             EEECCCCCCCchHHHHHHh--ccceEeeccccccccc-hhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence            4566655544322233321  1234555555554422 22233445677777777666532 233455667777777777


Q ss_pred             cccccccCccccCccccceeccccc-ccccc-cCcccccCCcccEEEecCCC-CCCC-CCccccccCCCCccEEEccCC-
Q 003301          153 NNLTGEIPYEMGNLRNLEILGLQLN-KLVGF-VPTSIFNLSAMKTLALPSNA-LSGS-LPSSIDLVRLPNLEIISLAGN-  227 (832)
Q Consensus       153 N~i~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~L~~n~-l~~~-~p~~~~~~~l~~L~~L~Ls~n-  227 (832)
                      |.++...+..++.+++|++|+++++ .++.. +..-+.++++|++|++++|. ++.. +...+ ....++|+.|+++++ 
T Consensus        81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~-~~~~~~L~~L~l~~~~  159 (284)
T d2astb2          81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV-AHVSETITQLNLSGYR  159 (284)
T ss_dssp             CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHH-HHSCTTCCEEECCSCG
T ss_pred             cCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhh-cccccccchhhhcccc
Confidence            7766555566666777777777764 34321 11123456777777777653 3211 11111 122356777777654 


Q ss_pred             -ccccc-cCCcccCCCCccEEEcCCC-cCcccCCccccCccccceeecccc-cCCCCCCccccccccccCCCCcEEeccC
Q 003301          228 -NFSGI-IPSFIFNASKLSVLELGEN-SFSGFIPNTLGNLRKLEWLRLSYN-FLTSSTSELSFLSSWANCKNLKLLDLSN  303 (832)
Q Consensus       228 -~i~~~-~~~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~~~l~~L~~L~L~~  303 (832)
                       .++.. ....+.++++|++|++++| .+++.....+..+++|++|++++| .+++     ..+..+..+++|+.|++++
T Consensus       160 ~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~-----~~l~~L~~~~~L~~L~l~~  234 (284)
T d2astb2         160 KNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP-----ETLLELGEIPTLKTLQVFG  234 (284)
T ss_dssp             GGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCG-----GGGGGGGGCTTCCEEECTT
T ss_pred             cccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCCh-----HHHHHHhcCCCCCEEeeeC
Confidence             23321 2222345677777777765 466556666677777777777774 4443     2233456677777777776


Q ss_pred             C
Q 003301          304 N  304 (832)
Q Consensus       304 N  304 (832)
                      +
T Consensus       235 ~  235 (284)
T d2astb2         235 I  235 (284)
T ss_dssp             S
T ss_pred             C
Confidence            5

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.57  E-value=7.6e-16  Score=143.02  Aligned_cols=113  Identities=19%  Similarity=0.247  Sum_probs=71.9

Q ss_pred             CccccCccccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCcccccccccccccccccCCChhhhhc
Q 003301           14 PKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNNSLTGSLPDDMCRR   93 (832)
Q Consensus        14 ~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n~l~~~lp~~~~~~   93 (832)
                      .+.+.+...+++|||++|+|+ .+|..+..+++|++|+|++|.++ .++ .+..+++| ++|++++|+++ .+|..++..
T Consensus        11 ~~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L-~~L~ls~N~i~-~l~~~~~~~   85 (162)
T d1a9na_          11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRL-KTLLVNNNRIC-RIGEGLDQA   85 (162)
T ss_dssp             SCEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSC-CEEECCSSCCC-EECSCHHHH
T ss_pred             hHhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcch-hhhhccccccc-CCCcccccc
Confidence            345667778888888888887 66766677888888888888887 553 35666666 66666666666 555555555


Q ss_pred             CCCceEEEccCCcccccCC--CCccCCCCccEEECcCCccc
Q 003301           94 LPLIKGLYMSNNKLTGPIP--NNIWQCKELIVISLAYNQFT  132 (832)
Q Consensus        94 l~~L~~L~l~~N~l~~~~p--~~l~~l~~L~~L~Ls~n~i~  132 (832)
                      +++|++|++++|+|+. ++  ..+..+++|++|++++|.++
T Consensus        86 l~~L~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          86 LPDLTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             CTTCCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             ccccccceeccccccc-cccccccccccccchhhcCCCccc
Confidence            6666666666666652 22  23344444444444444443

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=1.9e-15  Score=140.26  Aligned_cols=124  Identities=19%  Similarity=0.165  Sum_probs=58.8

Q ss_pred             CCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeec
Q 003301          415 TSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSL  494 (832)
Q Consensus       415 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  494 (832)
                      ..+++|+|++|+|+.+ +..+..+++|+.|+|++|+|+. + +.|..+++|++|++++|+++...+..+..+++|+.|++
T Consensus        18 ~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L   94 (162)
T d1a9na_          18 VRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL   94 (162)
T ss_dssp             TSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred             CcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCcccccccccccccee
Confidence            3344444444444332 2333334444444444444442 1 22444555555555555555433333445555555555


Q ss_pred             ccccccccCC-ccccCCCCCCeeccCCCcccccC---chhhhhhccCCeee
Q 003301          495 RDNGLQGSIP-KSIGGLVSLESLDLSNNSLSGNI---PTSMEKLLYLKDLN  541 (832)
Q Consensus       495 s~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~l~  541 (832)
                      ++|+|+.... ..+..+++|+.|++++|+++...   +..+..+++|++||
T Consensus        95 ~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          95 TNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             ccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            5555553211 34555566666666666665322   12355566666654

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.55  E-value=8.5e-15  Score=129.03  Aligned_cols=118  Identities=28%  Similarity=0.356  Sum_probs=62.5

Q ss_pred             CeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccccceeecccc
Q 003301          418 RLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMNLQDLSLRDN  497 (832)
Q Consensus       418 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  497 (832)
                      |+|+|++|+++...  .+..+++|++|++++|+|+. +|..++.+++|+.|++++|+|++ +| .++++++|+.|++++|
T Consensus         1 R~L~Ls~n~l~~l~--~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLTVLC--HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCSSCC--CGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCCCCc--ccccCCCCCEEECCCCccCc-chhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            34555555554331  24555555555555555552 44455555666666666666653 22 3556666666666666


Q ss_pred             cccccC-CccccCCCCCCeeccCCCccccc---CchhhhhhccCCee
Q 003301          498 GLQGSI-PKSIGGLVSLESLDLSNNSLSGN---IPTSMEKLLYLKDL  540 (832)
Q Consensus       498 ~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~l  540 (832)
                      +|++.. ...++.+++|+.|++++|++++.   .......+++|+.+
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence            665332 13456666666666666666532   12233335555543

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.54  E-value=4.5e-15  Score=130.85  Aligned_cols=77  Identities=30%  Similarity=0.496  Sum_probs=42.3

Q ss_pred             CccCCCCcceeccCccccCccccCeEeccCCccccCCCccccccccCcEEEccCCcCCCCCCCcccCccccccccccccc
Q 003301            1 MLSLSFNDLSGAIPKEIGNLTMLKKLGLGYNKLRGEIPQELGNLAELELVSLTNNFLSGTIPSTIFNLSSLSTGMDFSNN   80 (832)
Q Consensus         1 ~ldl~~n~~~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~l~~~L~ls~n   80 (832)
                      +|||++|+|+ .++ .+++++.|++|++++|+|+ .+|+.|+.+++|++|++++|.++ .+| +++.++++ ++|++++|
T Consensus         2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L-~~L~l~~N   75 (124)
T d1dcea3           2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRL-QELLLCNN   75 (124)
T ss_dssp             EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSC-CEEECCSS
T ss_pred             EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-cccccccc-CeEECCCC
Confidence            3566666666 333 3566666666666666665 55555666666666666666665 333 24444444 44444444


Q ss_pred             ccc
Q 003301           81 SLT   83 (832)
Q Consensus        81 ~l~   83 (832)
                      +++
T Consensus        76 ~i~   78 (124)
T d1dcea3          76 RLQ   78 (124)
T ss_dssp             CCC
T ss_pred             ccC
Confidence            444

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=1e-15  Score=157.06  Aligned_cols=181  Identities=21%  Similarity=0.212  Sum_probs=85.8

Q ss_pred             CCccEEEccCCccccc-cCCcccCCCCccEEEcCCCcCcccCCccccCccccceeecccc-cCCCCCCccccccccccCC
Q 003301          217 PNLEIISLAGNNFSGI-IPSFIFNASKLSVLELGENSFSGFIPNTLGNLRKLEWLRLSYN-FLTSSTSELSFLSSWANCK  294 (832)
Q Consensus       217 ~~L~~L~Ls~n~i~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~~~l~  294 (832)
                      .+|++|+++++.++.. .+..+..+++|++|+|++|.+++..+..+..+++|++|+++++ .++..    .+..-+..++
T Consensus        46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~----~l~~l~~~~~  121 (284)
T d2astb2          46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF----ALQTLLSSCS  121 (284)
T ss_dssp             BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHH----HHHHHHHHCT
T ss_pred             CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccccccccc----ccchhhHHHH
Confidence            3555555555555422 2333455666666666666666555556666666677766663 34321    1111234567


Q ss_pred             CCcEEeccCCC-CCCC-CCCcccccccccceEEeecCcccccccccccCcCcccEEEeecC--ccccc-ccccccCCCCC
Q 003301          295 NLKLLDLSNNP-INGV-LPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGN--ELIGS-IPITFGKLQNL  369 (832)
Q Consensus       295 ~L~~L~L~~N~-l~~~-~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N--~l~~~-~~~~~~~l~~L  369 (832)
                      +|++|+++++. +++. +...+...                        .++|+.|+++++  .++.. +...+..+++|
T Consensus       122 ~L~~L~ls~c~~~~~~~~~~~~~~~------------------------~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L  177 (284)
T d2astb2         122 RLDELNLSWCFDFTEKHVQVAVAHV------------------------SETITQLNLSGYRKNLQKSDLSTLVRRCPNL  177 (284)
T ss_dssp             TCCEEECCCCTTCCHHHHHHHHHHS------------------------CTTCCEEECCSCGGGSCHHHHHHHHHHCTTC
T ss_pred             hccccccccccccccccchhhhccc------------------------ccccchhhhcccccccccccccccccccccc
Confidence            77777777653 2211 00111111                        123444444432  12111 11122334455


Q ss_pred             ceEEccCC-ccCCCCchhhcCCCCCcEEEecCC-cCCCCCcccCCCCCCCCeEeCCCC
Q 003301          370 QGLDLVNN-KLEGPIPNGLCQLARLSVLYMDGN-KLSGPIPPCIGDLTSLRLLSLASN  425 (832)
Q Consensus       370 ~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N  425 (832)
                      ++|++++| .+++.....+.++++|++|++++| .+++.....++++++|+.|+++++
T Consensus       178 ~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         178 VHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             SEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             cccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            55555543 244444444555555555555553 344333344555556666666554

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.53  E-value=1.1e-16  Score=169.98  Aligned_cols=192  Identities=20%  Similarity=0.187  Sum_probs=95.5

Q ss_pred             cccCcCcccEEEeecCccccc----ccccccCCCCCceEEccCCccCCCCchhh-------------cCCCCCcEEEecC
Q 003301          338 EIGNLINLRELGLWGNELIGS----IPITFGKLQNLQGLDLVNNKLEGPIPNGL-------------CQLARLSVLYMDG  400 (832)
Q Consensus       338 ~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-------------~~l~~L~~L~L~~  400 (832)
                      .+...++|++|+|++|.+...    +...+...++|++|++++|.+.......+             ...+.|+.+.+++
T Consensus        88 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~  167 (344)
T d2ca6a1          88 ALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR  167 (344)
T ss_dssp             HHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCS
T ss_pred             HHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccc
Confidence            344556677777777766542    22233455666667776666542111111             1233455555555


Q ss_pred             CcCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCC-----CccccccccccceecccCccc
Q 003301          401 NKLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGS-----LPEDIGNLKVVVIIDLSRNNL  475 (832)
Q Consensus       401 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l  475 (832)
                      |++.......                    +...+...+.|+.|+|++|++...     +...+...+.|+.|+|++|.+
T Consensus       168 n~i~~~~~~~--------------------l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i  227 (344)
T d2ca6a1         168 NRLENGSMKE--------------------WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF  227 (344)
T ss_dssp             SCCTGGGHHH--------------------HHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCC
T ss_pred             cccccccccc--------------------ccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccc
Confidence            5443211110                    111122334444455555444321     223344555566666666665


Q ss_pred             CCc----cCCccccccccceeecccccccccCCcc----cc--CCCCCCeeccCCCcccccC----chhhh-hhccCCee
Q 003301          476 SGD----IPTAIGGLMNLQDLSLRDNGLQGSIPKS----IG--GLVSLESLDLSNNSLSGNI----PTSME-KLLYLKDL  540 (832)
Q Consensus       476 ~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~----~~--~l~~L~~L~Ls~N~l~~~~----p~~~~-~l~~L~~l  540 (832)
                      +..    +...+...++|++|+|++|.|++.....    +.  ..+.|++||+++|+|+..-    ...+. +.+.|+.|
T Consensus       228 ~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L  307 (344)
T d2ca6a1         228 THLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL  307 (344)
T ss_dssp             HHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEE
T ss_pred             cccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEE
Confidence            422    2344555666667777777665432222    22  2346777777777776432    22232 45667777


Q ss_pred             eCCCCcccc
Q 003301          541 NLSFNKLEG  549 (832)
Q Consensus       541 ~l~~N~l~~  549 (832)
                      +|++|++..
T Consensus       308 ~l~~N~~~~  316 (344)
T d2ca6a1         308 ELNGNRFSE  316 (344)
T ss_dssp             ECTTSBSCT
T ss_pred             ECCCCcCCC
Confidence            777777753

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.53  E-value=7.4e-17  Score=171.29  Aligned_cols=250  Identities=17%  Similarity=0.210  Sum_probs=149.6

Q ss_pred             CcccCCCCccEEEcCCCcCcccC----CccccCccccceeecccccCCCCCCcc-----ccccccccCCCCcEEeccCCC
Q 003301          235 SFIFNASKLSVLELGENSFSGFI----PNTLGNLRKLEWLRLSYNFLTSSTSEL-----SFLSSWANCKNLKLLDLSNNP  305 (832)
Q Consensus       235 ~~~~~l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~-----~~~~~~~~l~~L~~L~L~~N~  305 (832)
                      ..+...++|++|+|++|.|....    ...+...++|+.|+++++.........     .+...+..+++|++|+|++|.
T Consensus        25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~  104 (344)
T d2ca6a1          25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA  104 (344)
T ss_dssp             HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred             HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccc
Confidence            34566788889999988886432    234556778888888877665433211     123345566777777777777


Q ss_pred             CCCCCCCcccccccccceEEeecCcccccccccccCcCcccEEEeecCccccccccc-------------ccCCCCCceE
Q 003301          306 INGVLPSSIGNLSLSLSRIFISNCSIRGTIPKEIGNLINLRELGLWGNELIGSIPIT-------------FGKLQNLQGL  372 (832)
Q Consensus       306 l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-------------~~~l~~L~~L  372 (832)
                      +......                     .+...+...++|++|++++|.+.......             ....+.|+.+
T Consensus       105 i~~~~~~---------------------~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l  163 (344)
T d2ca6a1         105 FGPTAQE---------------------PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSI  163 (344)
T ss_dssp             CCTTTHH---------------------HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEE
T ss_pred             ccccccc---------------------chhhhhcccccchheecccccccccccccccccccccccccccccCccccee
Confidence            6532111                     12344556789999999999875321111             1356789999


Q ss_pred             EccCCccCCCC----chhhcCCCCCcEEEecCCcCCCC-----CcccCCCCCCCCeEeCCCCcCCCC----CCcccccCc
Q 003301          373 DLVNNKLEGPI----PNGLCQLARLSVLYMDGNKLSGP-----IPPCIGDLTSLRLLSLASNELNSV----IPSTFWNLK  439 (832)
Q Consensus       373 ~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~  439 (832)
                      ++++|+++...    ...+...+.|+.|+|++|++...     +...+..+++|+.|+|++|.++..    +...+...+
T Consensus       164 ~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~  243 (344)
T d2ca6a1         164 ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP  243 (344)
T ss_dssp             ECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCT
T ss_pred             ecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccc
Confidence            99999987433    23345667888899988887632     233456667777777777776432    122334444


Q ss_pred             ccceeeecCCcccCCCccccccccccceecccCcccCCccCCccc--cccccceeeccccccccc----CCcccc-CCCC
Q 003301          440 DILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIG--GLMNLQDLSLRDNGLQGS----IPKSIG-GLVS  512 (832)
Q Consensus       440 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~  512 (832)
                      +|++|+|++|.|++.....+                    ...+.  ....|+.|++++|+|+..    +...+. ++++
T Consensus       244 ~L~~L~Ls~n~i~~~g~~~l--------------------~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~  303 (344)
T d2ca6a1         244 NLRELGLNDCLLSARGAAAV--------------------VDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD  303 (344)
T ss_dssp             TCCEEECTTCCCCHHHHHHH--------------------HHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTT
T ss_pred             cchhhhhhcCccCchhhHHH--------------------HHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCC
Confidence            55555555555442211111                    11111  124567777777776532    222332 4567


Q ss_pred             CCeeccCCCcccc
Q 003301          513 LESLDLSNNSLSG  525 (832)
Q Consensus       513 L~~L~Ls~N~l~~  525 (832)
                      |+.|+|++|++..
T Consensus       304 L~~L~l~~N~~~~  316 (344)
T d2ca6a1         304 LLFLELNGNRFSE  316 (344)
T ss_dssp             CCEEECTTSBSCT
T ss_pred             CCEEECCCCcCCC
Confidence            8888888888863

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.41  E-value=3.8e-15  Score=143.35  Aligned_cols=128  Identities=20%  Similarity=0.303  Sum_probs=69.5

Q ss_pred             ccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCCcccCCCccccccccccceecccCcccCCccCCccccccc
Q 003301          409 PCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSNFLNGSLPEDIGNLKVVVIIDLSRNNLSGDIPTAIGGLMN  488 (832)
Q Consensus       409 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  488 (832)
                      ..+..+++|++|+|++|+|+.+ + .|.++++|++|+|++|+|+. +|..+..++.|+.|++++|+++..  ..+.++++
T Consensus        42 ~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~  116 (198)
T d1m9la_          42 ATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASL--SGIEKLVN  116 (198)
T ss_dssp             HHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCCH--HHHHHHHH
T ss_pred             hHHhcccccceeECcccCCCCc-c-cccCCccccChhhccccccc-cccccccccccccccccccccccc--cccccccc
Confidence            3344444455555555544433 1 24445555555555555542 333344445566666666666532  23556666


Q ss_pred             cceeecccccccccCC-ccccCCCCCCeeccCCCcccccCchh----------hhhhccCCeee
Q 003301          489 LQDLSLRDNGLQGSIP-KSIGGLVSLESLDLSNNSLSGNIPTS----------MEKLLYLKDLN  541 (832)
Q Consensus       489 L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------~~~l~~L~~l~  541 (832)
                      |+.|++++|+|+.... ..++.+++|+.|+|++|+++...+..          +..+++|+.||
T Consensus       117 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD  180 (198)
T d1m9la_         117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD  180 (198)
T ss_dssp             SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred             ccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence            6666666666663221 34666677777777777766544332          45667777765

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.37  E-value=7.2e-15  Score=141.38  Aligned_cols=86  Identities=22%  Similarity=0.312  Sum_probs=38.9

Q ss_pred             CccCCCCccEEECcCCcccccCCCCCcCCCcCceEEecccccccccCccccCccccceecccccccccccCcccccCCcc
Q 003301          114 NIWQCKELIVISLAYNQFTERIPRGLGNLTSLKTLYLGFNNLTGEIPYEMGNLRNLEILGLQLNKLVGFVPTSIFNLSAM  193 (832)
Q Consensus       114 ~l~~l~~L~~L~Ls~n~i~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  193 (832)
                      .+..+++|++|+|++|+|+. ++ .|..+++|++|+|++|+|+ .+|..+..+++|++|++++|+++.+  +.+.++++|
T Consensus        43 sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L  117 (198)
T d1m9la_          43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNL  117 (198)
T ss_dssp             HHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHS
T ss_pred             HHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccccccc
Confidence            34444444444444444442 22 2444445555555555544 3333333344455555555554432  124444445


Q ss_pred             cEEEecCCCCC
Q 003301          194 KTLALPSNALS  204 (832)
Q Consensus       194 ~~L~L~~n~l~  204 (832)
                      ++|++++|+++
T Consensus       118 ~~L~L~~N~i~  128 (198)
T d1m9la_         118 RVLYMSNNKIT  128 (198)
T ss_dssp             SEEEESEEECC
T ss_pred             cccccccchhc
Confidence            55555544443

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.36  E-value=1.1e-12  Score=120.43  Aligned_cols=103  Identities=24%  Similarity=0.230  Sum_probs=45.0

Q ss_pred             eEEccCCccCCCCchhhcCCCCCcEEEecCC-cCCCCCcccCCCCCCCCeEeCCCCcCCCCCCcccccCcccceeeecCC
Q 003301          371 GLDLVNNKLEGPIPNGLCQLARLSVLYMDGN-KLSGPIPPCIGDLTSLRLLSLASNELNSVIPSTFWNLKDILSLNFSSN  449 (832)
Q Consensus       371 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  449 (832)
                      .++.+++.+. ..|..+..+++|++|++++| .|+...+..|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|++|
T Consensus        12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N   90 (156)
T d2ifga3          12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (156)
T ss_dssp             CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence            3444444443 23344444444444444433 244333344444444444444444444444444444444444444444


Q ss_pred             cccCCCccccccccccceecccCccc
Q 003301          450 FLNGSLPEDIGNLKVVVIIDLSRNNL  475 (832)
Q Consensus       450 ~l~~~~~~~~~~l~~L~~L~Ls~N~l  475 (832)
                      +|+...+..|..+ .|+.|+|++|.+
T Consensus        91 ~l~~l~~~~~~~~-~l~~L~L~~Np~  115 (156)
T d2ifga3          91 ALESLSWKTVQGL-SLQELVLSGNPL  115 (156)
T ss_dssp             CCSCCCSTTTCSC-CCCEEECCSSCC
T ss_pred             CCcccChhhhccc-cccccccCCCcc
Confidence            4443222223222 344444444444

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.32  E-value=2.7e-12  Score=117.74  Aligned_cols=104  Identities=23%  Similarity=0.154  Sum_probs=48.1

Q ss_pred             ceEEeecCcccccccccccCcCcccEEEeecCc-ccccccccccCCCCCceEEccCCccCCCCchhhcCCCCCcEEEecC
Q 003301          322 SRIFISNCSIRGTIPKEIGNLINLRELGLWGNE-LIGSIPITFGKLQNLQGLDLVNNKLEGPIPNGLCQLARLSVLYMDG  400 (832)
Q Consensus       322 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  400 (832)
                      +.++.+++.+. ..|..+..+++|++|++++|+ ++.+.+.+|.++++|+.|+|++|+|+...+.+|..+++|++|+|++
T Consensus        11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~   89 (156)
T d2ifga3          11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (156)
T ss_dssp             SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence            34444554444 234444455555555554332 4444444455555555555555555544444455555555555555


Q ss_pred             CcCCCCCcccCCCCCCCCeEeCCCCcC
Q 003301          401 NKLSGPIPPCIGDLTSLRLLSLASNEL  427 (832)
Q Consensus       401 N~l~~~~p~~~~~l~~L~~L~L~~N~l  427 (832)
                      |+|+...+..|.. .+|+.|+|++|.+
T Consensus        90 N~l~~l~~~~~~~-~~l~~L~L~~Np~  115 (156)
T d2ifga3          90 NALESLSWKTVQG-LSLQELVLSGNPL  115 (156)
T ss_dssp             SCCSCCCSTTTCS-CCCCEEECCSSCC
T ss_pred             CCCcccChhhhcc-ccccccccCCCcc
Confidence            5554322223322 2344444444444

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.60  E-value=2.6e-09  Score=98.15  Aligned_cols=86  Identities=26%  Similarity=0.179  Sum_probs=49.8

Q ss_pred             ccccccccccceecccCcccCCcc--CCccccccccceeecccccccccCCccccCCCCCCeeccCCCcccccCchh---
Q 003301          456 PEDIGNLKVVVIIDLSRNNLSGDI--PTAIGGLMNLQDLSLRDNGLQGSIPKSIGGLVSLESLDLSNNSLSGNIPTS---  530 (832)
Q Consensus       456 ~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~---  530 (832)
                      +..+..++.|++|+||+|+|+...  +..+..+++|+.|+|++|+|+...+-.+.....|+.|++++|++++.....   
T Consensus        58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y  137 (162)
T d1koha1          58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY  137 (162)
T ss_dssp             HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHH
T ss_pred             HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhH
Confidence            333445666666677777666432  344556667777777777776433323333445777777777776544422   


Q ss_pred             ----hhhhccCCeee
Q 003301          531 ----MEKLLYLKDLN  541 (832)
Q Consensus       531 ----~~~l~~L~~l~  541 (832)
                          +..+++|+.||
T Consensus       138 ~~~i~~~~P~L~~LD  152 (162)
T d1koha1         138 ISAIRERFPKLLRLD  152 (162)
T ss_dssp             HHHHHTTSTTCCEET
T ss_pred             HHHHHHHCCCCCEEC
Confidence                44566676654

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.58  E-value=1.3e-07  Score=94.36  Aligned_cols=149  Identities=13%  Similarity=0.114  Sum_probs=104.9

Q ss_pred             HHHHHhcCCCCCCeeeccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCC-CCceeeeceEEecCCeeE
Q 003301          653 ELLQATNQFNASNLIGTGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVR-HRNLVKIISSCTNNDFKA  731 (832)
Q Consensus       653 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~  731 (832)
                      ++......|+..+..+.++.+.||+... +++.+++|+...........+.+|...+..+. +--+++++.+...++..|
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            4555566777666655555678999864 67778899887665444456778888877663 434678888888888999


Q ss_pred             EEEecCCCCCHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 003301          732 LVLEYMPNGSLEDYLYSNNFSFDILQRLSVIIDVALALEYLHFGY-----------------------------------  776 (832)
Q Consensus       732 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------  776 (832)
                      +||++++|.++.+.....   .   ....++.+++..++.||...                                   
T Consensus        87 lv~~~l~G~~~~~~~~~~---~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE---Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC---S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             EEEEeccccccccccccc---c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            999999998886654321   1   12234555666666666210                                   


Q ss_pred             ---------------------CCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          777 ---------------------SNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       777 ---------------------~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                                           ...++|+|+.|.||++++++.+-|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                 12379999999999999877778999998875

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.51  E-value=6e-09  Score=95.67  Aligned_cols=17  Identities=35%  Similarity=0.397  Sum_probs=7.6

Q ss_pred             cCccccceecccccccc
Q 003301          164 GNLRNLEILGLQLNKLV  180 (832)
Q Consensus       164 ~~l~~L~~L~L~~N~l~  180 (832)
                      .++++|++|+|++|+|+
T Consensus        62 ~~~~~L~~L~Ls~N~i~   78 (162)
T d1koha1          62 ENIPELLSLNLSNNRLY   78 (162)
T ss_dssp             HHCTTCCCCCCCSSCCC
T ss_pred             HhCCCCCEeeCCCcccc
Confidence            33444444444444444

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.99  E-value=5e-06  Score=82.07  Aligned_cols=131  Identities=17%  Similarity=0.102  Sum_probs=86.6

Q ss_pred             eeeccCC-ceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCC--CCceeeeceEEecCCeeEEEEecCCCCCH
Q 003301          666 LIGTGGF-GSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVR--HRNLVKIISSCTNNDFKALVLEYMPNGSL  742 (832)
Q Consensus       666 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L  742 (832)
                      .+..|.. +.||+....++..+++|.......   ..+..|.+.++.+.  .-.+++++.+..+.+..++||+|++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4455553 679999887788889997654432   34667777777663  23367788888888889999999988655


Q ss_pred             HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHhc------------------------------------------------
Q 003301          743 EDYLYSNNFSFDILQRLSVIIDVALALEYLHF------------------------------------------------  774 (832)
Q Consensus       743 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~------------------------------------------------  774 (832)
                      .+.      ..+..   ..+.+++..++-||.                                                
T Consensus        94 ~~~------~~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          94 LSS------HLAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTS------CCCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             ccc------cccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            321      01111   112233333333331                                                


Q ss_pred             -------CCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          775 -------GYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       775 -------~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                             .....++|+|+.|.||+++.+..+-|+||+.+..
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                   0122479999999999999877788999998865

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.71  E-value=5.1e-05  Score=79.62  Aligned_cols=76  Identities=16%  Similarity=0.163  Sum_probs=49.7

Q ss_pred             CCeeeccCCceEEEEEecC-CcEEEEEEEeccc-------hhhHHHHHHHHHHHhcCC-C--CceeeeceEEecCCeeEE
Q 003301          664 SNLIGTGGFGSVYKGSFLD-GMEVAIKVFHLQL-------EGALKSFDVECEVLKSVR-H--RNLVKIISSCTNNDFKAL  732 (832)
Q Consensus       664 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~l  732 (832)
                      .+.||.|....||+++..+ ++.|+||.-....       ....++...|.++++.+. +  ..+++++.+  +++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3568999999999998754 6789999754321       112345667888887662 2  346666655  3445679


Q ss_pred             EEecCCCCC
Q 003301          733 VLEYMPNGS  741 (832)
Q Consensus       733 v~e~~~~g~  741 (832)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.59  E-value=1.2e-05  Score=73.48  Aligned_cols=89  Identities=11%  Similarity=0.101  Sum_probs=49.0

Q ss_pred             CcCcccEEEeecC-ccccc----ccccccCCCCCceEEccCCccCCC----CchhhcCCCCCcEEEecCCcCCCC----C
Q 003301          341 NLINLRELGLWGN-ELIGS----IPITFGKLQNLQGLDLVNNKLEGP----IPNGLCQLARLSVLYMDGNKLSGP----I  407 (832)
Q Consensus       341 ~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~  407 (832)
                      +.+.|++|+|+++ .+...    +...+...+.|++|+|++|.++..    +...+...+.|++|+|++|.++..    +
T Consensus        13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l   92 (167)
T d1pgva_          13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL   92 (167)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred             CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence            3456666666653 34321    223455556677777777766532    223334456677777777766532    1


Q ss_pred             cccCCCCCCCCeEeCCCCcCCC
Q 003301          408 PPCIGDLTSLRLLSLASNELNS  429 (832)
Q Consensus       408 p~~~~~l~~L~~L~L~~N~l~~  429 (832)
                      ...+...++|++|++++|.+..
T Consensus        93 ~~aL~~n~sL~~L~l~~n~~~~  114 (167)
T d1pgva_          93 LRSTLVTQSIVEFKADNQRQSV  114 (167)
T ss_dssp             HHHTTTTCCCSEEECCCCSSCC
T ss_pred             HHHHHhCCcCCEEECCCCcCCC
Confidence            2245556667777777666543

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.51  E-value=9.9e-06  Score=73.93  Aligned_cols=18  Identities=28%  Similarity=0.449  Sum_probs=8.4

Q ss_pred             cccCCCCcEEeccCCCCC
Q 003301          290 WANCKNLKLLDLSNNPIN  307 (832)
Q Consensus       290 ~~~l~~L~~L~L~~N~l~  307 (832)
                      +...++|++|+|++|.+.
T Consensus        40 L~~n~~L~~L~Ls~n~l~   57 (167)
T d1pgva_          40 ACNSKHIEKFSLANTAIS   57 (167)
T ss_dssp             HTTCSCCCEEECTTSCCB
T ss_pred             HhhCCccceeeccccccc
Confidence            334444555555554443

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.89  E-value=0.0012  Score=66.89  Aligned_cols=134  Identities=12%  Similarity=0.096  Sum_probs=77.4

Q ss_pred             CceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCce--eeec-----eEEecCCeeEEEEecCCCCCH--
Q 003301          672 FGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRNL--VKII-----SSCTNNDFKALVLEYMPNGSL--  742 (832)
Q Consensus       672 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~e~~~~g~L--  742 (832)
                      --.||+++..+|+.|++|+.+... ...+.+..|.+.+..+....+  +..+     ..+...+..+.++++++|..+  
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            358999998889999999987542 234667788888877642221  1111     122346678899999976322  


Q ss_pred             ---HHH------H---h----hC----CCCCCHH----------------------HHHHHHHHHHHHHHHH-hcCCCCC
Q 003301          743 ---EDY------L---Y----SN----NFSFDIL----------------------QRLSVIIDVALALEYL-HFGYSNP  779 (832)
Q Consensus       743 ---~~~------l---~----~~----~~~~~~~----------------------~~~~i~~~i~~~l~~L-H~~~~~~  779 (832)
                         ..+      +   +    ..    +...+..                      .....+.++...+.-. ......+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence               111      0   0    00    0111111                      1112222222222221 1223568


Q ss_pred             eEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          780 VVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       780 ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      +||+|+.+.||+++.+  ..++||+-|..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhccc
Confidence            9999999999999743  45899998874

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.85  E-value=8.1e-05  Score=67.59  Aligned_cols=63  Identities=22%  Similarity=0.284  Sum_probs=33.7

Q ss_pred             cccccceeeccccccccc----CCccccCCCCCCe--eccCCCcccc----cCchhhhhhccCCeeeCCCCcc
Q 003301          485 GLMNLQDLSLRDNGLQGS----IPKSIGGLVSLES--LDLSNNSLSG----NIPTSMEKLLYLKDLNLSFNKL  547 (832)
Q Consensus       485 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~--L~Ls~N~l~~----~~p~~~~~l~~L~~l~l~~N~l  547 (832)
                      ..+.++.+++++|.+...    +-..+...++|+.  |++++|.+..    .+...+...+.|+.|+++.+..
T Consensus        72 ~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          72 VNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             hcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence            344556666666655422    2234455566665  3445566643    2334455566777777766544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.82  E-value=0.0018  Score=65.23  Aligned_cols=157  Identities=13%  Similarity=0.087  Sum_probs=85.3

Q ss_pred             cchHHHHHHhcCCCCCCeee-----ccCCceEEEEEecCCcEEEEEEEeccchhhHHHHHHHHHHHhcCCCCc-----ee
Q 003301          649 FSYKELLQATNQFNASNLIG-----TGGFGSVYKGSFLDGMEVAIKVFHLQLEGALKSFDVECEVLKSVRHRN-----LV  718 (832)
Q Consensus       649 ~~~~~~~~~~~~~~~~~~lg-----~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-----iv  718 (832)
                      .+.+++.....+|.+++...     .|---+.|+.+..+| .+++|++.....  .+.+..|++++..+...+     .+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence            45677777888898866554     455577899887544 599999864321  244555676666653222     22


Q ss_pred             eec-e--EEecCCeeEEEEecCCCCCHHH-----------H---Hhh----CC----CCCCH------------------
Q 003301          719 KII-S--SCTNNDFKALVLEYMPNGSLED-----------Y---LYS----NN----FSFDI------------------  755 (832)
Q Consensus       719 ~l~-~--~~~~~~~~~lv~e~~~~g~L~~-----------~---l~~----~~----~~~~~------------------  755 (832)
                      ... |  +....+..+.++.+..+.....           .   ++.    ..    .....                  
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            111 1  1222445567777766532211           0   000    00    00000                  


Q ss_pred             HHHHHHHHHHHHHHHHHh-cCCCCCeEecCCCCCCeEeCCCCcEEEeccccccc
Q 003301          756 LQRLSVIIDVALALEYLH-FGYSNPVVHCDIKPSNVLLDKDMVAHLSDFGIAKL  808 (832)
Q Consensus       756 ~~~~~i~~~i~~~l~~LH-~~~~~~ivH~Dlkp~NIl~~~~~~~kl~DFg~a~~  808 (832)
                      ......+......+.-.+ .....|+||+|+.+.||+++.+...-|+||+.|..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            001112222222233322 22367899999999999999888788999998863

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.80  E-value=8.7e-05  Score=67.38  Aligned_cols=109  Identities=12%  Similarity=0.092  Sum_probs=53.5

Q ss_pred             cCCCceEEEccC-Ccccc----cCCCCccCCCCccEEECcCCcccccC----CCCCcCCCcCceEEecccccccc----c
Q 003301           93 RLPLIKGLYMSN-NKLTG----PIPNNIWQCKELIVISLAYNQFTERI----PRGLGNLTSLKTLYLGFNNLTGE----I  159 (832)
Q Consensus        93 ~l~~L~~L~l~~-N~l~~----~~p~~l~~l~~L~~L~Ls~n~i~~~~----p~~~~~l~~L~~L~Ls~N~i~~~----~  159 (832)
                      +.+.|++|+|++ +.++.    .+-..+...++|++|+|++|.++...    -+.+...+.++.+++++|.+...    +
T Consensus        15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l   94 (166)
T d1io0a_          15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL   94 (166)
T ss_dssp             TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred             cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHH
Confidence            456666777765 34542    12223445566677777776665321    12234456666677766666422    1


Q ss_pred             CccccCccccceecc--ccccccc----ccCcccccCCcccEEEecCC
Q 003301          160 PYEMGNLRNLEILGL--QLNKLVG----FVPTSIFNLSAMKTLALPSN  201 (832)
Q Consensus       160 p~~~~~l~~L~~L~L--~~N~l~~----~~~~~~~~l~~L~~L~L~~n  201 (832)
                      ...+...++|+.++|  ++|.+..    .+...+...++|++|+++.+
T Consensus        95 ~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~  142 (166)
T d1io0a_          95 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT  142 (166)
T ss_dssp             HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred             HHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCC
Confidence            233444455554333  3444432    12223334455555555443

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.70  E-value=0.0015  Score=68.23  Aligned_cols=73  Identities=15%  Similarity=0.187  Sum_probs=49.7

Q ss_pred             CCeeeccCCceEEEEEecC--------CcEEEEEEEeccchhhHHHHHHHHHHHhcCC-CCceeeeceEEecCCeeEEEE
Q 003301          664 SNLIGTGGFGSVYKGSFLD--------GMEVAIKVFHLQLEGALKSFDVECEVLKSVR-HRNLVKIISSCTNNDFKALVL  734 (832)
Q Consensus       664 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  734 (832)
                      .+.|+.|-.-.+|+++..+        .+.|++++.. .... .....+|.++++.+. +.-.+++++++..    ++||
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            3578889999999998643        3557777765 2222 234567888888774 4445677777643    6899


Q ss_pred             ecCCCCCH
Q 003301          735 EYMPNGSL  742 (832)
Q Consensus       735 e~~~~g~L  742 (832)
                      ||++|.++
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987543